PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bakrac, B; Kladnik, A; Macek, P; McHaffie, G; Werner, A; Lakey, JH; Anderluh, G				Bakrac, Biserka; Kladnik, Ales; Macek, Peter; McHaffie, Gavin; Werner, Andreas; Lakey, Jeremy H.; Anderluh, Gregor			A Toxin-based Probe Reveals Cytoplasmic Exposure of Golgi Sphingomyelin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING TOXIN; SEA-ANEMONE; NEUTRAL SPHINGOMYELINASE; STICHOLYSIN-II; MEMBRANE-BINDING; LIPID-MEMBRANES; EQUINATOXIN-II; DISTINCT POOL; BREFELDIN-A; CIS-GOLGI	Although sphingomyelin is an important cellular lipid, its subcellular distribution is not precisely known. Here we use a sea anemone cytolysin, equinatoxin II (EqtII), which specifically binds sphingomyelin, as a new marker to detect cellular sphingomyelin. A purified fusion protein composed of EqtII and green fluorescent protein (EqtII-GFP) binds to the SM rich apical membrane of Madin-Darby canine kidney (MDCK) II cells when added exogenously, but not to the SM-free basolateral membrane. When expressed intracellularly within MDCK II cells, EqtII-GFP colocalizes with markers for Golgi apparatus and not with those for nucleus, mitochondria, endoplasmic reticulum or plasma membrane. Colocalization with the Golgi apparatus was confirmed by also using NIH 3T3 fibroblasts. Moreover, EqtII-GFP was enriched in cis-Golgi compartments isolated by gradient ultracentrifugation. The data reveal that EqtII-GFP is a sensitive probe for membrane sphingomyelin, which provides new information on cytosolic exposure, essential to understand its diverse physiological roles.	[Bakrac, Biserka; Kladnik, Ales; Macek, Peter; Anderluh, Gregor] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana 1000, Slovenia; [McHaffie, Gavin; Werner, Andreas; Lakey, Jeremy H.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [McHaffie, Gavin] Nottingham Univ Hosp NHS Trust, Nottingham Renal Unit, Nottingham NG5 1PB, England	University of Ljubljana; Newcastle University - UK; Nottingham University Hospital NHS Trust	Anderluh, G (corresponding author), Univ Ljubljana, Dept Biol, Biotech Fac, Vecna Pot 111, Ljubljana 1000, Slovenia.	gregor.anderluh@bf.uni-lj.si	Maček, Peter/Y-9877-2019; Maček, Peter/U-4662-2017; Kladnik, Aleš/B-6045-2008; Anderluh, Gregor/C-6905-2014	Maček, Peter/0000-0001-6470-7759; Maček, Peter/0000-0001-6470-7759; Kladnik, Aleš/0000-0002-3466-0088; Anderluh, Gregor/0000-0002-9916-8465	Slovenian Research Agency [P1-0207]; Slovene Human Resources Development and Scholarship Fund	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Slovene Human Resources Development and Scholarship Fund	This work was supported in part by the Slovenian Research Agency (P1-0207) and a fellowship from the Slovene Human Resources Development and Scholarship Fund (to B. B.).	Alegre-Cebollada J, 2004, FEBS LETT, V575, P14, DOI 10.1016/j.febslet.2004.08.031; Anderluh G, 2005, ANAL BIOCHEM, V344, P43, DOI 10.1016/j.ab.2005.06.013; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 1999, EUR J BIOCHEM, V263, P128, DOI 10.1046/j.1432-1327.1999.00477.x; Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Andrieu N, 1996, EUR J BIOCHEM, V236, P738, DOI 10.1111/j.1432-1033.1996.00738.x; Aye ILMH, 2009, CHEM-BIOL INTERACT, V180, P327, DOI 10.1016/j.cbi.2009.04.012; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Collins MD, 2008, P NATL ACAD SCI USA, V105, P124, DOI 10.1073/pnas.0702970105; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Gutierrez-Aguirre I, 2006, BIOCHEM J, V398, P381, DOI 10.1042/BJ20060206; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; JECKEL D, 1990, FEBS LETT, V261, P155, DOI 10.1016/0014-5793(90)80659-7; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kiessling V, 2009, BBA-BIOMEMBRANES, V1788, P64, DOI 10.1016/j.bbamem.2008.09.003; KOVAL M, 1991, BIOCHIM BIOPHYS ACTA, V1082, P113, DOI 10.1016/0005-2760(91)90184-J; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; Kristan K, 2007, FEBS J, V274, P539, DOI 10.1111/j.1742-4658.2006.05608.x; Li ZQ, 2007, BBA-MOL CELL BIOL L, V1771, P1186, DOI 10.1016/j.bbalip.2007.05.007; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; MARCHESELLI VL, 1990, J BIOL CHEM, V265, P9140; Marchetti B, 2002, ONCOGENE, V21, P7808, DOI 10.1038/sj.onc.1205885; MEINARDI E, 1995, BIOCHEM BIOPH RES CO, V216, P348, DOI 10.1006/bbrc.1995.2630; Meng AM, 2004, EXP CELL RES, V292, P385, DOI 10.1016/j.yexcr.2003.10.001; Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200; Nagata Y, 2006, J CELL BIOL, V174, P245, DOI 10.1083/jcb.200605028; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Openshaw AEA, 2005, J BIOL CHEM, V280, P35011, DOI 10.1074/jbc.M506800200; Shogomori H, 2008, BBA-GEN SUBJECTS, V1780, P612, DOI 10.1016/j.bbagen.2007.09.001; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Tani M, 2007, FEBS LETT, V581, P1323, DOI 10.1016/j.febslet.2007.02.046; ULLMAN MD, 1974, J BIOL CHEM, V249, P1506; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; VAN MEER G, 1988, J CELL BIOCHEM, V36, P51, DOI 10.1002/jcb.240360106; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Zhang P, 1997, J BIOL CHEM, V272, P9609	62	52	52	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22186	22195		10.1074/jbc.M110.105122	http://dx.doi.org/10.1074/jbc.M110.105122			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463009	hybrid, Green Published			2022-12-25	WOS:000279702200031
J	Grishin, AA; Wang, CIA; Muttenthaler, M; Alewood, PF; Lewis, RJ; Adams, DJ				Grishin, Anton A.; Wang, Ching-I A.; Muttenthaler, Markus; Alewood, Paul F.; Lewis, Richard J.; Adams, David J.			alpha-Conotoxin AuIB Isomers Exhibit Distinct Inhibitory Mechanisms and Differential Sensitivity to Stoichiometry of alpha 3 beta 4 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACH-BINDING PROTEIN; SUBUNIT INTERFACES; CRYSTAL-STRUCTURE; ALTERNATE STOICHIOMETRIES; ANTAGONISTS; IMII; (ALPHA-4)(2)(BETA-2)(3); PHARMACOLOGY; EXPRESSION; DIVERSITY	Non-native disulfide isomers of alpha-conotoxins are generally inactive although some unexpectedly demonstrate comparable or enhanced bioactivity. The actions of "globular" and "ribbon" isomers of alpha-conotoxin AuIB have been characterized on alpha 3 beta 4 nicotinic acetylcholine receptors (nAChRs) heterologously expressed in Xenopus oocytes. Using two-electrode voltage clamp recording, we showed that the inhibitory efficacy of the ribbon isomer of AuIB is limited to similar to 50%. The maximal inhibition was stoichiometry-dependent because altering alpha 3:beta 4 RNA injection ratios either increased AuIB(ribbon) efficacy (10 alpha:1 beta) or completely abolished blockade (1 alpha:10 beta). In contrast, inhibition by AuIB(globular) was independent of injection ratios. ACh-evoked current amplitude was largest for 1:10 injected oocytes and smallest for the 10:1 ratio. ACh concentration-response curves revealed high (HS, 1:10) and low (LS, 10:1) sensitivity alpha 3 beta 4 nAChRs with corresponding EC50 values of 22.6 and 176.9 mu M, respectively. Increasing the agonist concentration antagonized the inhibition of LS alpha 3 beta 4 nAChRs by AuIB(ribbon), whereas inhibition of HS and LS alpha 3 beta 4 nAChRs by AuIB-(globular) was unaffected. Inhibition of LS and HS alpha 3 beta 4 nAChRs by AuIB(globular) was insurmountable and independent of membrane potential. Molecular docking simulation suggested that AuIB(globular) is likely to bind to both alpha 3 beta 4 nAChR stoichiometries outside of the ACh-binding pocket, whereas AuIB(ribbon) binds to the classical agonist-binding site of the LS alpha 3 beta 4 nAChR only. In conclusion, the two isomers of AuIB differ in their inhibitory mechanisms such that AuIB(ribbon) inhibits only LS alpha 3 beta 4 nAChRs competitively, whereas AuIB( globular) inhibits alpha 3 beta 4 nAChRs irrespective of receptor stoichiometry, primarily by a non-competitive mechanism.	[Grishin, Anton A.; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia; [Grishin, Anton A.; Adams, David J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia; [Wang, Ching-I A.; Muttenthaler, Markus; Alewood, Paul F.; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	Royal Melbourne Institute of Technology (RMIT); University of Queensland; University of Queensland	Adams, DJ (corresponding author), RMIT Univ, Hlth Innovat Res Inst, POB 71, Bundoora, Vic 3083, Australia.	david.adams@rmit.edu.au	Muttenthaler, Markus/B-4944-2017; Lewis, Richard/T-8763-2019; Alewood, Paul F/J-2412-2014; Adams, David/J-9125-2014; Muttenthaler, Markus/AAF-5944-2021; Lewis, Richard J/E-8674-2013; Adams, David John/K-3578-2019	Muttenthaler, Markus/0000-0003-1996-4646; Lewis, Richard/0000-0003-3470-923X; Adams, David/0000-0002-7030-2288; Muttenthaler, Markus/0000-0003-1996-4646; Lewis, Richard J/0000-0003-3470-923X; Adams, David John/0000-0002-7030-2288; Alewood, Paul/0000-0001-7454-6522	National Health & Medical Research Council	National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health & Medical Research Council Program Grant ( to R.J.L., P.F.A., and D.J.A.).	Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Boorman JPB, 2000, J PHYSIOL-LONDON, V529, P565, DOI 10.1111/j.1469-7793.2000.00565.x; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Ellison M, 2004, BIOCHEMISTRY-US, V43, P16019, DOI 10.1021/bi048918g; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gotti C, 2008, MOL PHARMACOL, V73, P1796, DOI 10.1124/mol.108.045203; Groot-Kormelink PJ, 2006, MOL PHARMACOL, V69, P558, DOI 10.1124/mol.105.019356; Groot-Kormelink PJ, 2004, J GEN PHYSIOL, V123, P697, DOI 10.1085/jgp.200409042; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Jacobsen R, 1997, J BIOL CHEM, V272, P22531, DOI 10.1074/jbc.272.36.22531; Kasheverov IE, 2009, J NEUROCHEM, V111, P934, DOI 10.1111/j.1471-4159.2009.06359.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Loughnan M, 2006, J BIOL CHEM, V281, P24745, DOI 10.1074/jbc.M603703200; Luo SQ, 1998, J NEUROSCI, V18, P8571; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, J MOL NEUROSCI, V30, P95, DOI 10.1385/JMN:30:1:95; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nicke A, 2003, FEBS LETT, V554, P219, DOI 10.1016/S0014-5793(03)01161-X; PAPKE RL, 1991, J PHYSIOL-LONDON, V440, P95, DOI 10.1113/jphysiol.1991.sp018698; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Shon KJ, 1997, BIOCHEMISTRY-US, V36, P9581, DOI 10.1021/bi970235w; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	43	59	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22254	22263		10.1074/jbc.M110.111880	http://dx.doi.org/10.1074/jbc.M110.111880			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20466726	Green Published, hybrid			2022-12-25	WOS:000279702200038
J	Martin, F; Baskaran, P; Ma, XL; Dunten, PW; Schaefer, M; Stasch, JP; Beuve, A; van den Akker, F				Martin, Faye; Baskaran, Padmamalini; Ma, Xiaolei; Dunten, Pete W.; Schaefer, Martina; Stasch, Johannes-Peter; Beuve, Annie; van den Akker, Focco			Structure of Cinaciguat (BAY 58-2667) Bound to Nostoc H-NOX Domain Reveals Insights into Heme-mimetic Activation of the Soluble Guanylyl Cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; DRUG DEVELOPMENT; BINDING; IDENTIFICATION; DISCOVERY; MOIETY; SENSOR	Heme is a vital molecule for all life forms with heme being capable of assisting in catalysis, binding ligands, and undergoing redox changes. Heme-related dysfunction can lead to cardiovascular diseases with the oxidation of the heme of soluble guanylyl cyclase (sGC) critically implicated in some of these cardiovascular diseases. sGC, the main nitric oxide (NO) receptor, stimulates second messenger cGMP production, whereas reactive oxygen species are known to scavenge NO and oxidize/inactivate the heme leading to sGC degradation. This vulnerability of NO-heme signaling to oxidative stress led to the discovery of an NO-independent activator of sGC, cinaciguat (BAY 58-2667), which is a candidate drug in clinical trials to treat acute decompensated heart failure. Here, we present crystallographic and mutagenesis data that reveal the mode of action of BAY 58-2667. The 2.3-angstrom resolution structure of BAY 58-2667 bound to a heme NO and oxygen binding domain (H-NOX) from Nostoc homologous to that of sGC reveals that the trifurcated BAY 58-2667 molecule has displaced the heme and acts as a heme mimetic. Carboxylate groups of BAY 58-2667 make interactions similar to the heme-propionate groups, whereas its hydrophobic phenyl ring linker folds up within the heme cavity in a planar-like fashion. BAY 58-2667 binding causes a rotation of the alpha F helix away from the heme pocket, as this helix is normally held in place via the inhibitory His(105)-heme covalent bond. The structure provides insights into how BAY 58-2667 binds and activates sGC to rescue heme-NO dysfunction in cardiovascular diseases.	[Martin, Faye; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem RT500, Cleveland, OH 44120 USA; [Baskaran, Padmamalini; Beuve, Annie] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Ma, Xiaolei] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Dunten, Pete W.] Stanford Univ, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA; [Stasch, Johannes-Peter] Bayer Schering Pharma AG, Cardiovasc Res, D-42096 Wuppertal, Germany	Case Western Reserve University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Roche Holding; Genentech; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Bayer AG; Bayer Healthcare Pharmaceuticals	van den Akker, F (corresponding author), Case Western Reserve Univ, Dept Biochem RT500, 10900 Euclid Ave, Cleveland, OH 44106 USA.	focco.vandenakker@case.edu	Martin, Faye/I-1759-2012; Ma, Xiaolei/G-2058-2010	Ma, Xiaolei/0000-0002-5307-827X	National Institutes of Health [R01 HL075329, R01 GM067640]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology; NIGMS, National Institutes of Health; National Center for Research Resources (NCRR), National Institutes of Health [5 P41 RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources (NCRR), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported, in whole or in part, by National Institutes of Health Grants R01 HL075329 (to F. v. d. A.) and R01 GM067640 (to A. B.). The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program and the NIGMS, National Institutes of Health. The projects described were partially supported by Grant 5 P41 RR001209 from the National Center for Research Resources (NCRR), National Institutes of Health.	Behrends S, 2003, CURR MED CHEM, V10, P291, DOI 10.2174/0929867033368286; BITTNER AR, 2009, Patent No. 20090209556; Boerrigter Guido, 2009, V191, P485, DOI 10.1007/978-3-540-68964-5_21; Bryan NS, 2009, FRONT BIOSCI-LANDMRK, V14, P1, DOI 10.2741/3228; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erbil WK, 2009, P NATL ACAD SCI USA, V106, P19753, DOI 10.1073/pnas.0911645106; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Rothkegel C, 2006, FEBS LETT, V580, P4205, DOI 10.1016/j.febslet.2006.06.079; Schmidt Harald H. H. W., 2009, V191, P309, DOI 10.1007/978-3-540-68964-5_14; Schmidt PM, 2005, EUR J PHARMACOL, V513, P67, DOI 10.1016/j.ejphar.2005.02.046; Schmidt PM, 2004, J BIOL CHEM, V279, P3025, DOI 10.1074/jbc.M310141200; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3	29	87	91	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22651	22657		10.1074/jbc.M110.111559	http://dx.doi.org/10.1074/jbc.M110.111559			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463019	Green Published, hybrid			2022-12-25	WOS:000279702200075
J	Lee, DE; Lee, KW; Song, NR; Seo, SK; Heo, YS; Kang, NJ; Bode, AM; Lee, HJ; Dong, ZG				Lee, Dong Eun; Lee, Ki Won; Song, Nu Ry; Seo, Sang Kwon; Heo, Yong-Seok; Kang, Nam Joo; Bode, Ann M.; Lee, Hyong Joo; Dong, Zigang			7,3 ',4 '-Trihydroxyisoflavone Inhibits Epidermal Growth Factor-induced Proliferation and Transformation of JB6 P+ Mouse Epidermal Cells by Suppressing Cyclin-dependent Kinases and Phosphatidylinositol 3-Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; IN-VITRO; OXIDATIVE-METABOLISM; THERAPEUTIC TARGETS; PROSTATE-CANCER; SOY ISOFLAVONES; D1 EXPRESSION; CL41 CELLS; GENISTEIN; PATHWAY	Numerous in vitro and in vivo studies have shown that isoflavones exhibit anti-proliferative activity against epidermal growth factor (EGF) receptor-positive malignancies of the breast, colon, skin, and prostate. 7,3',4'-Trihydroxyisoflavone (7,3',4'-THIF) is one of the metabolites of daidzein, a well known soy isoflavone, but its chemopreventive activity and the underlying molecular mechanisms are poorly understood. In this study, 7,3',4'-THIF prevented EGF-induced neoplastic transformation and proliferation of JB6 P+ mouse epidermal cells. It significantly blocked cell cycle progression of EGF-stimulated cells at the G(1) phase. As shown by Western blot, 7,3',4'-THIF suppressed the phosphorylation of retinoblastoma protein at Ser-795 and Ser-807/Ser-811, which are the specific sites of phosphorylation by cyclin-dependent kinase (CDK) 4. It also inhibited the expression of G(1) phase-regulatory proteins, including cyclin D1, CDK4, cyclin E, and CDK2. In addition to regulating the expression of cell cycle-regulatory proteins, 7,3',4'-THIF bound to CDK4 and CDK2 and strongly inhibited their kinase activities. It also bound to phosphatidylinositol 3-kinase (PI3K), strongly inhibiting its kinase activity and thereby suppressing the Akt/GSK-3 beta/AP-1 pathway and subsequently attenuating the expression of cyclin D1. Collectively, these results suggest that CDKs and PI3K are the primary molecular targets of 7,3',4'-THIF in the suppression of EGF-induced cell proliferation. These insights into the biological actions of 7,3',4'-THIF provide a molecular basis for the possible development of new chemoprotective agents.	[Lee, Dong Eun; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Lee, Dong Eun; Song, Nu Ry; Seo, Sang Kwon; Lee, Hyong Joo] Seoul Natl Univ, Dept Agr Biotechnol, WCU, Seoul 151921, South Korea; [Lee, Dong Eun; Lee, Ki Won] Konkuk Univ, Dept Biosci & Biotechnol, Bio Mol Informat Ctr, Seoul 143701, South Korea; [Heo, Yong-Seok] Konkuk Univ, Dept Chem, Seoul 143701, South Korea; [Kang, Nam Joo] Kyungpook Natl Univ, Sch Appl Biosci, Taegu 702701, South Korea	University of Minnesota System; Seoul National University (SNU); Konkuk University; Konkuk University; Kyungpook National University	Lee, HJ (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea.	leehyjo@snu.ac.kr; zgdong@hi.umn.edu	Heo, Yong-Seok/D-8244-2011; Lee, Ki Won/M-4114-2018		National Institutes of Health [CA027502, CA120388, CA111536, CA077646, CA081064]; Hormel Foundation; World Class University [R31-2008-00-10056-0]; Priority Research Centers Program [2009-0093824]; Ministry of Education, Science and Technology, Republic of Korea [314-2007-1-F00054, 2009-0090797]; NATIONAL CANCER INSTITUTE [R01CA081064, R37CA081064, R01CA111536, R01CA120388, R01CA077646, P01CA027502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; World Class University; Priority Research Centers Program; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA027502, CA120388, CA111536, CA077646, and CA081064. This work was also supported by The Hormel Foundation, by grants from the World Class University Program (R31-2008-00-10056-0), Priority Research Centers Program (2009-0093824), and Basic Science Research Program (314-2007-1-F00054, and 2009-0090797) through the National Research Foundation (NRF) of Korea, Funded by the Ministry of Education, Science and Technology, Republic of Korea.	Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Bennink MR, 2001, ADV EXP MED BIOL, V492, P11; Bode AM, 2006, MOL CARCINOGEN, V45, P422, DOI 10.1002/mc.20222; BROWN PH, 1993, ONCOGENE, V8, P877; COLBURN NH, 1979, NATURE, V281, P589, DOI 10.1038/281589a0; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Elangovan S, 2008, ANTICANCER RES, V28, P2641; Farina HG, 2006, ONCOL REP, V16, P885; Furuse J, 2008, CRIT REV ONCOL HEMAT, V67, P8, DOI 10.1016/j.critrevonc.2008.02.009; Hewitt AL, 2003, CANCER LETT, V192, P133, DOI 10.1016/S0304-3835(02)00712-7; Jian L, 2009, MOL NUTR FOOD RES, V53, P217, DOI 10.1002/mnfr.200800167; Kang NJ, 2007, J BIOL CHEM, V282, P32856, DOI 10.1074/jbc.M701459200; Khalil Mazen Y, 2003, Expert Rev Anticancer Ther, V3, P367, DOI 10.1586/14737140.3.3.367; Kulling SE, 2000, J AGR FOOD CHEM, V48, P4963, DOI 10.1021/jf000524i; Kulling SE, 2002, J CHROMATOGR B, V777, P211, DOI 10.1016/S1570-0232(02)00215-5; Kulling SE, 2001, J AGR FOOD CHEM, V49, P3024, DOI 10.1021/jf0012695; Lee MH, 2003, CANCER METAST REV, V22, P435, DOI 10.1023/A:1023785332315; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Mimeault M, 2003, GROWTH FACTORS, V21, P1, DOI 10.1080/0897719031000094921; Ouyang W, 2006, CARCINOGENESIS, V27, P864, DOI 10.1093/carcin/bgi321; Petty WJ, 2003, LUNG CANCER, V41, pS155, DOI 10.1016/S0169-5002(03)00159-4; Rogozin EA, 2008, CARCINOGENESIS, V29, P1228, DOI 10.1093/carcin/bgn016; Rufer CE, 2006, DRUG METAB DISPOS, V34, P51, DOI 10.1124/dmd.105.004929; Sarkar FH, 2006, MINI-REV MED CHEM, V6, P401, DOI 10.2174/138955706776361439; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shukla S, 2007, CELL CYCLE, V6, P1102, DOI 10.4161/cc.6.9.4146; Song WO, 2007, J MED FOOD, V10, P571, DOI 10.1089/jmf.2006.0620; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wang J, 2004, MOL CELL ENDOCRINOL, V219, P171, DOI 10.1016/j.mce.2003.12.018; Wu AH, 1998, AM J CLIN NUTR, V68, p1437S, DOI 10.1093/ajcn/68.6.1437S; Yokota T, 2007, CANCER SCI, V98, P1447, DOI 10.1111/j.1349-7006.2007.00560.x; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang DY, 2009, TOXICOL APPL PHARM, V235, P18, DOI 10.1016/j.taap.2008.11.002	45	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21458	21466		10.1074/jbc.M109.094797	http://dx.doi.org/10.1074/jbc.M109.094797			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444693	hybrid, Green Published			2022-12-25	WOS:000279516100032
J	Lee, TY; Lai, TY; Lin, SC; Wu, CW; Ni, IF; Yang, YS; Hung, LY; Law, BK; Chiang, CW				Lee, Ting-Yuan; Lai, Tai-Yu; Lin, Shin-Chih; Wu, Cheng-Wei; Ni, In-Fan; Yang, Yu-San; Hung, Liang-Yi; Law, Brian K.; Chiang, Chi-Wu			The B56 gamma 3 Regulatory Subunit of Protein Phosphatase 2A (PP2A) Regulates S Phase-specific Nuclear Accumulation of PP2A and the G(1) to S Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; CDK INHIBITOR; B-SUBUNIT; PHOSPHORYLATION; P27(KIP1); IDENTIFICATION; FAMILY; LOCALIZATION; CLONING; BETA	Protein phosphatase 2A (PP2A) is a heterotrimeric enzyme consisting of a scaffold subunit (A), a catalytic subunit (C), and a variable regulatory subunit (B). The regulatory B subunits determine the substrate specificity and subcellular localization of the PP2A holoenzyme. Here, we demonstrate that the subcellular localization of the B56 gamma 3 regulatory subunit is regulated in a cell cycle-specific manner. Notably, B56 gamma 3 becomes enriched in the nucleus at the G(1)/S border and in S phase. The S phase-specific nuclear enrichment of B56 gamma 3 is accompanied by increases of nuclear A and C subunits and nuclear PP2A activity. Overexpression of B56 gamma 3 promotes nuclear localization of the A and C subunits, whereas silencing both B56 gamma 2 and B56 gamma 3 blocks the S phase-specific increase in the nuclear localization and activity of PP2A. In NIH3T3 cells, B56 gamma 3 overexpression reduces p27 phosphorylation at Thr-187, concomitantly elevates p27 protein levels, delays the G(1) to S transition, and retards cell proliferation. Consistently, knockdown of endogenous B56 gamma 3 expression reduces p27 protein levels and increases cell proliferation in HeLa cells. These findings demonstrate that the dynamic nuclear distribution of the B56 gamma 3 regulatory subunit controls nuclear PP2A activity, which regulates cell cycle controllers, such as p27, to restrain cell cycle progression, and may be responsible for the tumor suppressor function of PP2A.	[Lin, Shin-Chih; Wu, Cheng-Wei; Ni, In-Fan; Yang, Yu-San; Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 701, Taiwan; [Lee, Ting-Yuan; Lai, Tai-Yu; Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan; [Hung, Liang-Yi] Natl Cheng Kung Univ, Coll Med, Inst Biosignal Transduct, Tainan 701, Taiwan; [Hung, Liang-Yi; Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Ctr Gene Regulat & Signal Transduct Res, Tainan 701, Taiwan; [Law, Brian K.] Univ Florida, Dept Pharmacol & Therapeut, Shands Canc Ctr, Gainesville, FL 32610 USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; State University System of Florida; University of Florida	Chiang, CW (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Mol Med, 1 Univ Rd, Tainan 701, Taiwan.	chiangcw@mail.ncku.edu.tw	Law, Brian/L-6043-2019; Hung, Liang-Yi/AAG-4174-2019	, Liang-Yi/0000-0002-7284-2608	National Science Council [96-2320-B006-045-MY3, DOH99-TD-C-111-003]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council Grants 96-2320-B006-045-MY3 and DOH99-TD-C-111-003 (to the Comprehensive Cancer Center in southern Taiwan).	Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Gigena MS, 2005, AM J PHYSIOL-HEART C, V289, pH285, DOI 10.1152/ajpheart.01291.2004; Harper Jane V., 2004, V296, P157; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jiang W, 2000, GENETICS, V154, P1025; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Lubert EJ, 2003, BIOCHEM BIOPH RES CO, V303, P908, DOI 10.1016/S0006-291X(03)00434-0; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Morisaki H, 1997, BIOCHEM BIOPH RES CO, V240, P386, DOI 10.1006/bbrc.1997.7590; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Strack S, 1999, FEBS LETT, V460, P462, DOI 10.1016/S0014-5793(99)01377-0; Strack S, 1998, J COMP NEUROL, V392, P515; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tanabe O, 1996, FEBS LETT, V379, P107, DOI 10.1016/0014-5793(95)01500-0; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tehrani MA, 1996, J BIOL CHEM, V271, P5164; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033	40	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21567	21580		10.1074/jbc.M109.094953	http://dx.doi.org/10.1074/jbc.M109.094953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448040	Green Published, hybrid			2022-12-25	WOS:000279516100043
J	Claessen, JHL; Mueller, B; Spooner, E; Pivorunas, VL; Ploegh, HL				Claessen, Jasper H. L.; Mueller, Britta; Spooner, Eric; Pivorunas, Valerie L.; Ploegh, Hidde L.			The Transmembrane Segment of a Tail-anchored Protein Determines Its Degradative Fate through Dislocation from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; MEMBRANE-PROTEIN; QUALITY-CONTROL; MISFOLDED PROTEINS; UBIQUITIN-LIGASE; COMPLEX; CYTOSOL; RECOGNITION; INSERTION; ENZYME	Terminally misfolded proteins that accumulate in the endoplasmic reticulum (ER) are dislocated and targeted for ubiquitin-dependent destruction by the proteasome. UBC6e is a tail-anchored E2 ubiquitin-conjugating enzyme that is part of a dislocation complex nucleated by the ER-resident protein SEL1L. Little is known about the turnover of tail-anchored ER proteins. We constructed a set of UBC6e transmembrane domain replacement mutants and found that the tail anchor of UBC6e is vital for its function, its stability, and its mode of membrane integration, the last step dependent on the ASNA1/TRC40 chaperone. We constructed a tail-anchored UBC6e variant that requires for its removal from the ER membrane not only YOD1 and p97, two cytosolic proteins involved in the extraction of ER transmembrane or luminal proteins, but also UBXD8, AUP1 and members of the Derlin family. Degradation of tail-anchored proteins thus relies on components that are also used in other aspects of protein quality control in the ER.	[Ploegh, Hidde L.] MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, HL (corresponding author), MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge Ctr 9, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu			National Institutes of Health; Boehringer Ingelheim Fonds	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was supported, in whole or in part, by grants from the National Institutes of Health (to H. L. P.). This work was also supported by a fellowship from the Boehringer Ingelheim Fonds (to J. H. L. C.).	Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; HEBERT DN, 2010, SEMIN CELL IN PRESS; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Oh RS, 2006, J BIOL CHEM, V281, P21480, DOI 10.1074/jbc.M601843200; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Ronchi P, 2008, J CELL BIOL, V181, P105, DOI 10.1083/jcb.200710093; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	26	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20732	20739		10.1074/jbc.M110.120766	http://dx.doi.org/10.1074/jbc.M110.120766			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435896	Green Published, hybrid			2022-12-25	WOS:000279228600037
J	Wada, M; Higo, N; Moizumi, S; Kitazawa, S				Wada, Makoto; Higo, Noriyuki; Moizumi, Shunjiro; Kitazawa, Shigeru			c-Fos Expression during Temporal Order Judgment in Mice	PLOS ONE			English	Article							IMMEDIATE-EARLY GENES; MEDIAL PREFRONTAL CORTEX; IN-SITU HYBRIDIZATION; RAT BARREL CORTEX; SOMATOSENSORY CORTEX; MESSENGER-RNAS; TRANSCRIPTION FACTORS; SELF-STIMULATION; TIME PERCEPTION; MACAQUE MONKEY	The neuronal mechanisms for ordering sensory signals in time still need to be clarified despite a long history of research. To address this issue, we recently developed a behavioral task of temporal order judgment in mice. In the present study, we examined the expression of c-Fos, a marker of neural activation, in mice just after they carried out the temporal order judgment task. The expression of c-Fos was examined in C57BL/6N mice (male, n = 5) that were trained to judge the order of two air-puff stimuli delivered bilaterally to the right and left whiskers with stimulation intervals of 50-750 ms. The mice were rewarded with a food pellet when they responded by orienting their head toward the first stimulus (n = 2) or toward the second stimulus (n = 3) after a visual "go'' signal. c-Fos-stained cell densities of these mice (test group) were compared with those of two control groups in coronal brain sections prepared at bregma -2, -1, 0, +1, and +2 mm by applying statistical parametric mapping to the c-Fos immuno-stained sections. The expression of c-Fos was significantly higher in the test group than in the other groups in the bilateral barrel fields of the primary somatosensory cortex, the left secondary somatosensory cortex, the dorsal part of the right secondary auditory cortex. Laminar analyses in the primary somatosensory cortex revealed that c-Fos expression in the test group was most evident in layers II and III, where callosal fibers project. The results suggest that temporal order judgment involves processing bilateral somatosensory signals through the supragranular layers of the primary sensory cortex and in the multimodal sensory areas, including marginal zone between the primary somatosensory cortex and the secondary sensory cortex.	[Wada, Makoto; Moizumi, Shunjiro; Kitazawa, Shigeru] Juntendo Univ, Sch Med, Dept Physiol, Tokyo 113, Japan; [Wada, Makoto; Kitazawa, Shigeru] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Wada, Makoto; Higo, Noriyuki; Kitazawa, Shigeru] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki, Japan; [Wada, Makoto] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Sensory Funct, Cognit Funct Sect, Tokorozawa, Saitama, Japan	Juntendo University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST)	Wada, M (corresponding author), Juntendo Univ, Sch Med, Dept Physiol, Tokyo 113, Japan.	m-wada@juntendo.ac.jp		Lauwereyns, Jan/0000-0003-0551-2550	Japan Society for the Promotion of Science [18200024, 21240029]; Industry-University Joint Research from Agency of Japan Science and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Industry-University Joint Research from Agency of Japan Science and Technology	This study was supported in part by Grants-in-Aid for Scientific Research (A) (#18200024; #21240029) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) to S. K. and Industry-University Joint Research from Agency of Japan Science and Technology (http://www.jst.go.jp/EN/index.html) to M. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitogiannis A, 2000, BEHAV BRAIN RES, V107, P123, DOI 10.1016/S0166-4328(99)00120-5; Boguszewski P, 2005, ACTA NEUROBIOL EXP, V65, P191; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Brown CE, 2005, J COMP NEUROL, V486, P48, DOI 10.1002/cne.20522; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Chaudhuri A, 1997, NEUROREPORT, V8, pR3, DOI 10.1097/00001756-199709080-00002; DENNET DC, 1992, BEHAV BRAIN SCI, P183; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Eagleman DM, 2005, NAT NEUROSCI, V8, P850, DOI 10.1038/nn0705-850; Eagleman DM, 2002, TRENDS COGN SCI, V6, P323, DOI 10.1016/S1364-6613(02)01945-9; EFRON R, 1963, BRAIN, V86, P261, DOI 10.1093/brain/86.2.261; Filipkowski RK, 2000, LEARN MEMORY, V7, P116, DOI 10.1101/lm.7.2.116; HAMLIN AJ, 1994, AM J PSYCHOL, P564; Higo N, 2003, J COMP NEUROL, V467, P135, DOI 10.1002/cne.10850; Higo N, 1998, HIPPOCAMPUS, V8, P533, DOI 10.1002/(SICI)1098-1063(1998)8:5<533::AID-HIPO11>3.0.CO;2-#; Higo N, 2000, J NEUROSCI, V20, P6030, DOI 10.1523/JNEUROSCI.20-16-06030.2000; Hirokawa J, 2008, NEUROSCIENCE, V153, P1402, DOI 10.1016/j.neuroscience.2008.01.011; Hirokawa J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003266; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; Hoffer ZS, 2003, J COMP NEUROL, V466, P525, DOI 10.1002/cne.10895; Hu ZL, 2003, J NEUROSCI, V23, P10963; Hunt GE, 1998, NEUROSCIENCE, V83, P501, DOI 10.1016/S0306-4522(97)00409-0; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; INNOCENTI GM, 1984, CEREB CORTEX, P291; JONES EG, 1994, J NEUROSCI, V14, P611; Lee YI, 1998, NEUROREPORT, V9, P2733, DOI 10.1097/00001756-199808240-00009; MACK KJ, 1992, MOL BRAIN RES, V12, P141, DOI 10.1016/0169-328X(92)90077-O; Mead AN, 1999, EUR J NEUROSCI, V11, P4089, DOI 10.1046/j.1460-9568.1999.00828.x; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Melzer P, 1997, J COMP NEUROL, V380, P145, DOI 10.1002/(SICI)1096-9861(19970331)380:1<145::AID-CNE11>3.0.CO;2-Z; MENZEL RR, 2005, CEREB CORTEX; MEUNIER M, 1991, BEHAV BRAIN RES, V44, P133, DOI 10.1016/S0166-4328(05)80018-X; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Nagahara AH, 1997, NEUROBIOL AGING, V18, P45, DOI 10.1016/S0197-4580(96)00166-2; Nicholls M E, 1996, Laterality, V1, P97; Nishida S, 2002, CURR BIOL, V12, P359, DOI 10.1016/S0960-9822(02)00698-X; Nordquist RE, 2003, BEHAV BRAIN RES, V146, P65, DOI 10.1016/j.bbr.2003.09.014; Panagis G, 1997, NEUROSCIENCE, V77, P175, DOI 10.1016/S0306-4522(96)00471-X; Paxinos G., 2001, MOUSE BRAIN STEREOTA; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Sakata S, 2002, EUR J NEUROSCI, V15, P735, DOI 10.1046/j.1460-9568.2002.01905.x; Schochet TL, 2005, NEUROSCIENCE, V135, P285, DOI 10.1016/j.neuroscience.2005.05.057; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shibuya S, 2007, EXP BRAIN RES, V179, P709, DOI 10.1007/s00221-006-0829-4; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; Sternberg S., 1973, ATTENTION PERFORM, VIV, P629; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Wada M, 2005, BEHAV BRAIN RES, V157, P167, DOI 10.1016/j.bbr.2004.06.026; Wada M, 2004, NEUROPSYCHOLOGIA, V42, P1887, DOI 10.1016/j.neuropsychologia.2004.05.009; WADA M, 2004, SOC NEUR ABST; WADA M, 2009, BEHAV BRAIN RES; Wada M, 2006, NEUROSCI RES, V56, P96, DOI 10.1016/j.neures.2006.05.013; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wedzony K, 2003, N-S ARCH PHARMACOL, V368, P331, DOI 10.1007/s00210-003-0811-7; Yamamoto S, 2005, J NEUROPHYSIOL, V93, P2856, DOI 10.1152/jn.01015.2004; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559; Yamamoto S, 2001, NAT NEUROSCI, V4, P979, DOI 10.1038/nn721	59	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10483	10.1371/journal.pone.0010483	http://dx.doi.org/10.1371/journal.pone.0010483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463958	gold, Green Submitted, Green Published			2022-12-25	WOS:000277379400019
J	Bergstad, OA; Gjelsvik, G; Schander, C; Hoines, AS				Bergstad, Odd Aksel; Gjelsvik, Guro; Schander, Christoffer; Hoines, Age S.			Feeding Ecology of Coryphaenoides rupestris from the Mid-Atlantic Ridge	PLOS ONE			English	Article							MIDOCEAN RIDGE; FISHES; DEEP; PREY; STRATEGIES; PATTERNS	The Macrourid fish roundnose grenadier, Coryphaenoides rupestris, is one of the most common benthopelagic fishes on the northern mid-Atlantic Ridge. The ecology of the species is comparatively well studied in continental slope waters of the North Atlantic, but not on the mid-Atlantic Ridge, which is a central mid-ocean area of its distribution. In total, 166 specimens from the RV G.O. Sars cruise in July 2004 were examined. The diet mainly comprised cephalopods, pelagic shrimps and fish. Pelagic and benthopelagic copepods were the most numerous prey, but did not contribute much on a weight basis. Cephalopods were by far the most important prey of the small grenadiers, while shrimps and fish became increasingly significant with increasing size. Previous studies from other areas have also found pelagic prey to be important, but in contrast to this study, cephalopods were generally of less importance. The study was an element of more wide-ranging food-web studies of the mid-Atlantic Ridge macro-and megafauna communities within the international MAR-ECO project.	[Bergstad, Odd Aksel] Inst Marine Res, Arendal, Norway; [Gjelsvik, Guro] Norwegian Directorate Fisheries, Bergen, Norway; [Schander, Christoffer] Univ Bergen, Dept Biol, Bergen, Norway; [Schander, Christoffer] Univ Bergen, Ctr Geobiol, Bergen, Norway; [Hoines, Age S.] Inst Marine Res, N-5024 Bergen, Norway	Institute of Marine Research - Norway; University of Bergen; University of Bergen; Institute of Marine Research - Norway	Bergstad, OA (corresponding author), Inst Marine Res, Arendal, Norway.	oddaksel@imr.no		Bergstad, Odd Aksel/0000-0002-4096-0896	Institute of Marine Research, University of Bergen	Institute of Marine Research, University of Bergen	The study was funded by the institutions with which the senior authors are affiliated (Institute of Marine Research, University of Bergen). The institutions provided facilities and salaries, but were otherwise not involved in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, HDB IDENTIFICATION C; Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P185, DOI 10.1016/j.dsr2.2007.09.005; Bergstad O. A., 2003, Journal of Northwest Atlantic Fishery Science, V31, P165; BERGSTAD OA, 1990, NETH J SEA RES, V25, P237, DOI 10.1016/0077-7579(90)90025-C; Bergstad OA, 2002, OCEANOL ACTA, V25, P219, DOI 10.1016/S0399-1784(02)01203-3; Bergstad OA, 2008, AM FISH S S, V63, P65; GARRISON T, 2002, OCEANOGRAPHY INVITAT; GEISTDOERFER P, 1986, FISHES N E ATLANTIC, V1, P644; HAEDRICH RL, 1988, J NAT HIST, V22, P1325, DOI 10.1080/00222938800770811; HAEDRICH RL, 1974, DEEP-SEA RES, V21, P977, DOI 10.1016/0011-7471(74)90030-8; JORGENSEN O, 1991, 50 NW ATL FISH ORG; Jorgensen Ole A., 1996, Journal of Northwest Atlantic Fishery Science, V18, P7; MAUCHLINE J, 1991, MAR ECOL PROG SER, V74, P109, DOI 10.3354/meps074109; MAUCHLINE J, 1984, MAR BIOL, V81, P107, DOI 10.1007/BF00393109; MCLELLAN T, 1977, DEEP-SEA RES, V24, P1019, DOI 10.1016/0146-6291(77)90572-0; PECHENICK LN, 1977, 5977 ISR PROGR SCI T; PODRAZHANSKAYA SG, 1971, 7189 INT COMM NW ATL; Schander C, 2005, MAR BIOL RES, V1, P79, DOI 10.1080/17451000510018962; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Sutton TT, 2008, DEEP-SEA RES PT II, V55, P161, DOI 10.1016/j.dsr2.2007.09.013; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; TROYANOVSKY FM, 1995, NATO ASI SERIES E, V296, P357; Vecchione M, 2010, MAR BIOL RES, V6, P25, DOI 10.1080/17451000902810751; Wenneek TL, 2008, DEEP-SEA RES PT II, V55, P6, DOI 10.1016/j.dsr2.2007.09.017	24	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10453	10.1371/journal.pone.0010453	http://dx.doi.org/10.1371/journal.pone.0010453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454674	Green Published, Green Accepted, gold			2022-12-25	WOS:000277240300024
J	Bradshaw, CJA; Giam, X; Sodhi, NS				Bradshaw, Corey J. A.; Giam, Xingli; Sodhi, Navjot S.			Evaluating the Relative Environmental Impact of Countries	PLOS ONE			English	Article							BIODIVERSITY; MARINE; CARBON; SUSTAINABILITY; DEFORESTATION; DEMOCRACY; FORESTS; CRISIS; FORCES; EXTENT	Environmental protection is critical to maintain ecosystem services essential for human well-being. It is important to be able to rank countries by their environmental impact so that poor performers as well as policy 'models' can be identified. We provide novel metrics of country-specific environmental impact ranks - one proportional to total resource availability per country and an absolute (total) measure of impact - that explicitly avoid incorporating confounding human health or economic indicators. Our rankings are based on natural forest loss, habitat conversion, marine captures, fertilizer use, water pollution, carbon emissions and species threat, although many other variables were excluded due to a lack of country-specific data. Of 228 countries considered, 179 (proportional) and 171 (absolute) had sufficient data for correlations. The proportional index ranked Singapore, Korea, Qatar, Kuwait, Japan, Thailand, Bahrain, Malaysia, Philippines and Netherlands as having the highest proportional environmental impact, whereas Brazil, USA, China, Indonesia, Japan, Mexico, India, Russia, Australia and Peru had the highest absolute impact (i.e., total resource use, emissions and species threatened). Proportional and absolute environmental impact ranks were correlated, with mainly Asian countries having both high proportional and absolute impact. Despite weak concordance among the drivers of environmental impact, countries often perform poorly for different reasons. We found no evidence to support the environmental Kuznets curve hypothesis of a non-linear relationship between impact and per capita wealth, although there was a weak reduction in environmental impact as per capita wealth increases. Using structural equation models to account for cross-correlation, we found that increasing wealth was the most important driver of environmental impact. Our results show that the global community not only has to encourage better environmental performance in less-developed countries, especially those in Asia, there is also a requirement to focus on the development of environmentally friendly practices in wealthier countries.	[Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Bradshaw, Corey J. A.] S Australian Res & Dev Inst, Henley Beach, SA, Australia; [Giam, Xingli; Sodhi, Navjot S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Giam, Xingli] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Sodhi, Navjot S.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Adelaide; University of Adelaide; National University of Singapore; Princeton University; Harvard University	Bradshaw, CJA (corresponding author), Univ Adelaide, Inst Environm, Adelaide, SA, Australia.	corey.bradshaw@adelaide.edu.au	Bradshaw, Corey J.A./A-1311-2008	Bradshaw, Corey J.A./0000-0002-5328-7741; Giam, Xingli/0000-0002-5239-9477	Sarah and Daniel Hrdy Fellowship; National University of Singapore	Sarah and Daniel Hrdy Fellowship; National University of Singapore(National University of Singapore)	N.S.S. thanks the Sarah and Daniel Hrdy Fellowship for support while the manuscript was being prepared. The National University of Singapore provided additional financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABED, 2002, GOVERNANCE CORRUPTIO; Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2008, WORLD DEV IND 2008; [Anonymous], 1997, NATURES SERVICES; Barbier EB, 2001, J ECON SURV, V15, P413, DOI 10.1111/1467-6419.00144; Bawa KS, 1997, NATURE, V386, P562, DOI 10.1038/386562a0; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bohringer C, 2007, ECOL ECON, V63, P1, DOI 10.1016/j.ecolecon.2007.03.008; Bradshaw CJA, 2009, FRONT ECOL ENVIRON, V7, P79, DOI 10.1890/070193; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butchart SHM, 2005, PHILOS T R SOC B, V360, P255, DOI 10.1098/rstb.2004.1583; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Clausen R, 2008, SOC SCI RES, V37, P1310, DOI 10.1016/j.ssresearch.2007.10.002; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; Didia DO, 1997, GLOBAL ENVIRON CHANG, V7, P63, DOI 10.1016/S0959-3780(96)00024-6; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Ehrlich PR, 2008, P NATL ACAD SCI USA, V105, P11579, DOI 10.1073/pnas.0801911105; *EUR COMM JOINT RE, 2002, GLC 2000 GLOB LAND C; Ewers RM, 2006, GLOBAL ENVIRON CHANG, V16, P161, DOI 10.1016/j.gloenvcha.2005.12.001; *FAO, 2007, FISHSTAT PLUS UN SOF; *FAO, 2009, AQUASTAT GLOB INF SY; FOSTER JR, 1992, LITHIUM, V3, P77; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Ghertner DA, 2007, ECOL ECON, V63, P563, DOI 10.1016/j.ecolecon.2006.12.010; GIAM X, 2010, BIOL CONSER IN PRESS; Guan D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036540; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HIJMANS R, 2008, GLOBAL ADM AREAS VER; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hoffmann JP, 2004, SOCIOL PERSPECT, V47, P79, DOI 10.1525/sop.2004.47.1.79; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; Jepson P, 2001, SCIENCE, V292, P859, DOI 10.1126/science.1061727; Kaufmann D., 2007, GOVERNANCE MATTERS 6; Kauppi PE, 2006, P NATL ACAD SCI USA, V103, P17574, DOI 10.1073/pnas.0608343103; Laurance WF, 2007, CURR SCI INDIA, V93, P1544; Li Q, 2006, INT STUD QUART, V50, P935, DOI 10.1111/j.1468-2478.2006.00432.x; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; MITCHELL RJ, 1992, FUNCT ECOL, V6, P123, DOI 10.2307/2389745; Morse S, 2006, ECOL SOC, V11; Naidoo R, 2001, CONSERV BIOL, V15, P1021, DOI 10.1046/j.1523-1739.2001.0150041021.x; Olsthoorn X, 2001, J AIR TRANSP MANAG, V7, P87, DOI 10.1016/S0969-6997(00)00031-4; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Scrieciu SS, 2007, ECOL ECON, V62, P603, DOI 10.1016/j.ecolecon.2006.07.028; Shi AQ, 2003, ECOL ECON, V44, P29, DOI 10.1016/S0921-8009(02)00223-9; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Stern DI, 1996, WORLD DEV, V24, P1151, DOI 10.1016/0305-750X(96)00032-0; STRASSBURG BBN, 2010, CONSERVATION LETT, V3, DOI DOI 10.1111/J.1755-1263X.2009.00092.X; Transparency International, 2002, CORR PERC IND 2002; *UN, 2004, SESS NAT RES GOV CON; *US BUR CENS, 2008, INT DAT BAS IDB; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vohringer F., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P217, DOI 10.1023/B:MITI.0000029918.24860.3e; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; York R, 2003, AM SOCIOL REV, V68, P279, DOI 10.2307/1519769; [No title captured]	63	112	114	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10440	10.1371/journal.pone.0010440	http://dx.doi.org/10.1371/journal.pone.0010440			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	590PW	20454670	gold, Green Published			2022-12-25	WOS:000277240300016
J	Fan, HC; Quake, SR				Fan, H. Christina; Quake, Stephen R.			Sensitivity of Noninvasive Prenatal Detection of Fetal Aneuploidy from Maternal Plasma Using Shotgun Sequencing Is Limited Only by Counting Statistics	PLOS ONE			English	Article							DIAGNOSIS; DNA; GENOME; SERUM	We recently demonstrated noninvasive detection of fetal aneuploidy by shotgun sequencing cell-free DNA in maternal plasma using next-generation high throughput sequencer. However, GC bias introduced by the sequencer placed a practical limit on the sensitivity of aneuploidy detection. In this study, we describe a method to computationally remove GC bias in short read sequencing data by applying weight to each sequenced read based on local genomic GC content. We show that sensitivity is limited only by counting statistics and that sensitivity can be increased to arbitrary precision in sample containing arbitrarily small fraction of fetal DNA simply by sequencing more DNA molecules. High throughput shotgun sequencing of maternal plasma DNA should therefore enable noninvasive diagnosis of any type of fetal aneuploidy.	[Fan, H. Christina] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Howard Hughes Med Inst, Stanford, CA USA	Stanford University; Howard Hughes Medical Institute	Fan, HC (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	quake@stanford.edu			Wallace H. Coulter Foundation; National Institutes of Health	Wallace H. Coulter Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the Wallace H. Coulter Foundation (http://www.whcf.org/) and the National Institutes of Health Director's Pioneer Award (http://nihroadmap.nih.gov/pioneer/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1459; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; CHIU RW, 2009, CLIN CHEM; Chu TJ, 2009, BIOINFORMATICS, V25, P1244, DOI 10.1093/bioinformatics/btp156; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Guibert J, 2003, HUM REPROD, V18, P1733, DOI 10.1093/humrep/deg320; Lo YMD, 2007, NAT REV GENET, V8, P71, DOI 10.1038/nrg1982; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Oliver JL, 2002, GENE, V300, P117, DOI 10.1016/S0378-1119(02)01034-X	11	104	189	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10439	10.1371/journal.pone.0010439	http://dx.doi.org/10.1371/journal.pone.0010439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454671	Green Published, Green Submitted, gold			2022-12-25	WOS:000277240300015
J	Labalette, C; Nouet, Y; Levillayer, F; Colnot, S; Chen, J; Claude, V; Huerre, M; Perret, C; Buendia, MA; Wei, Y				Labalette, Charlotte; Nouet, Yann; Levillayer, Florence; Colnot, Sabine; Chen, Ju; Claude, Valere; Huerre, Michel; Perret, Christine; Buendia, Marie-Annick; Wei, Yu			Deficiency of the LIM-Only Protein FHL2 Reduces Intestinal Tumorigenesis in Apc Mutant Mice	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR FHL2; FAMILIAL ADENOMATOUS POLYPOSIS; BETA-CATENIN; CYCLIN D1; ANDROGEN RECEPTOR; CELL-DIFFERENTIATION; PROSTATE-CANCER; BREAST-CANCER; EXPRESSION; INTERACTS	Background: The four and a half LIM-only protein 2 (FHL2) is capable of shuttling between focal adhesion and nucleus where it signals through direct interaction with a number of proteins including beta-catenin. Although FHL2 activation has been found in various human cancers, evidence of its functional contribution to carcinogenesis has been lacking. Methodology/Principal Findings: Here we have investigated the role of FHL2 in intestinal tumorigenesis in which activation of the Wnt pathway by mutations in the adenomatous polyposis coli gene (Apc) or in beta-catenin constitutes the primary transforming event. In this murine model, introduction of a biallelic deletion of FHL2 into mutant Apc(Delta 14/+) mice substantially reduces the number of intestinal adenomas but not tumor growth, suggesting a role of FHL2 in the initial steps of tumorigenesis. In the lesions, Wnt signalling is not affected by FHL2 deficiency, remaining constitutively active. Nevertheless, loss of FHL2 activity is associated with increased epithelial cell migration in intestinal epithelium, which might allow to eliminate more efficiently deleterious cells and reduce the risk of tumorigenesis. This finding may provide a mechanistic basis for tumor suppression by FHL2 deficiency. In human colorectal carcinoma but not in low-grade dysplasia, we detected up-regulation and enhanced nuclear localization of FHL2, indicating the activation of FHL2 during the development of malignancy. Conclusions/Significance: Our data demonstrate that FHL2 represents a critical factor in intestinal tumorigenesis.	[Labalette, Charlotte; Nouet, Yann; Levillayer, Florence; Buendia, Marie-Annick; Wei, Yu] Inst Pasteur, Dept Virol, Paris, France; [Labalette, Charlotte; Nouet, Yann; Levillayer, Florence; Buendia, Marie-Annick; Wei, Yu] INSERM, U579, Paris, France; [Colnot, Sabine; Perret, Christine] Inst Cochin, Dept Endocrinol Metab & Canc, Paris, France; [Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Colnot, Sabine; Perret, Christine] INSERM, U567, Paris, France; [Claude, Valere] Hop Begin, Dept Anapathol, St Mande, France; [Huerre, Michel] Inst Pasteur, Dept Infect & Epidemiol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Labalette, C (corresponding author), Inst Pasteur, Dept Virol, Paris, France.	yu.wei@pasteur.fr	Chen, Ju/E-5579-2011; Perret-Mayeux, Christine/L-3297-2017; Colnot, Sabine/A-9169-2008; Wei, Yu/A-7289-2016	Colnot, Sabine/0000-0002-3949-9107; perret, christine/0000-0003-4710-7051	Association pour la Recherche sur le Cancer; Ligue contre le Cancer (Comite de Paris); French Institut National du Cancer; Ecole Normale Superieure de Lyon; Canceropele Ile-de-France	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue contre le Cancer (Comite de Paris)(Ligue nationale contre le cancer); French Institut National du Cancer(Institut National du Cancer (INCA) France); Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); Canceropele Ile-de-France	This work was supported in part by grants from the Association pour la Recherche sur le Cancer, the Ligue contre le Cancer (Comite de Paris) and the French Institut National du Cancer. C. L. was supported by the Ecole Normale Superieure de Lyon and Y.N. by the Canceropele Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ST, 2005, J CLIN INVEST, V115, P2742, DOI 10.1172/JCI24921; Campo-Fernandez B, 2007, J VIROL, V81, P1027, DOI 10.1128/JVI.01699-06; Chen DH, 2003, CANCER RES, V63, P6626; Chu PH, 2008, INVEST OPHTH VIS SCI, V49, P5314, DOI 10.1167/iovs.08-2209; Chu PH, 2000, MOL CELL BIOL, V20, P7460, DOI 10.1128/MCB.20.20.7460-7462.2000; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Du XJ, 2002, BBA-GENE STRUCT EXPR, V1577, P93, DOI 10.1016/S0167-4781(02)00414-1; Fenton JI, 2002, CARCINOGENESIS, V23, P1065, DOI 10.1093/carcin/23.6.1065; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Gabriel B, 2006, J SOC GYNECOL INVEST, V13, P69, DOI 10.1016/j.jsgi.2005.10.001; Gabriel B, 2004, ANTICANCER RES, V24, P921; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Heemers HV, 2007, CANCER RES, V67, P10592, DOI 10.1158/0008-5472.CAN-07-1917; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kirfel J, 2008, EXP CELL RES, V314, P3684, DOI 10.1016/j.yexcr.2008.09.023; Kong YF, 2001, CIRCULATION, V103, P2731; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Labalette C, 2008, J BIOL CHEM, V283, P15201, DOI 10.1074/jbc.M800708200; Labalette C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003761; Li M, 2008, GLIA, V56, P1328, DOI 10.1002/glia.20701; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Mahmoud NN, 1999, CANCER RES, V59, P353; Mahmoud NN, 1997, CANCER RES, V57, P5045; Mahmoud NN, 1998, SURGERY, V124, P225, DOI 10.1016/S0039-6060(98)70124-2; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Martin BT, 2007, CELL CYCLE, V6, P1779, DOI 10.4161/cc.6.14.4448; McLoughlin P, 2002, J BIOL CHEM, V277, P37045, DOI 10.1074/jbc.M203336200; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Park J, 2008, FASEB J, V22, P2508, DOI 10.1096/fj.07-095521; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Samson T, 2004, J BIOL CHEM, V279, P28641, DOI 10.1074/jbc.M312894200; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sansom OJ, 2007, GUT, V56, P1410, DOI 10.1136/gut.2006.116921; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Wang JD, 2007, GASTROENTEROLOGY, V132, P1066, DOI 10.1053/j.gastro.2006.12.004; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Wilding J, 2002, CANCER RES, V62, P4562; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Yan JH, 2003, FEBS LETT, V553, P183, DOI 10.1016/S0014-5793(03)00978-5; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570	49	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10371	10.1371/journal.pone.0010371	http://dx.doi.org/10.1371/journal.pone.0010371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442768	gold, Green Submitted, Green Published			2022-12-25	WOS:000277154200013
J	Gopal, S; Berg, D; Hagen, N; Schriefer, EM; Stoll, R; Goebel, W; Kreft, J				Gopal, Shubha; Berg, Daniela; Hagen, Nicole; Schriefer, Eva-Maria; Stoll, Regina; Goebel, Werner; Kreft, Juergen			Maltose and Maltodextrin Utilization by Listeria monocytogenes Depend on an Inducible ABC Transporter which Is Repressed by Glucose	PLOS ONE			English	Article							BACILLUS-SUBTILIS; PHOSPHOTRANSFERASE SYSTEM; LACTOBACILLUS-PLANTARUM; GASTROINTESTINAL-TRACT; CATABOLITE REPRESSION; COMPARATIVE GENOMICS; LACTOCOCCUS-LACTIS; VIRULENCE GENES; MINIMAL MEDIUM; FOOD SAFETY	Background: In the environment as well as in the vertebrate intestine, Listeriae have access to complex carbohydrates like maltodextrins. Bacterial exploitation of such compounds requires specific uptake and utilization systems. Methodology/Principal Findings: We could show that Listeria monocytogenes and other Listeria species contain genes/gene products with high homology to the maltodextrin ABC transporter and utilization system of B. subtilis. Mutant construction and growth tests revealed that the L. monocytogenes gene cluster was required for the efficient utilization of maltodextrins as well as maltose. The gene for the ATP binding protein of the transporter was located distant from the cluster. Transcription analyses demonstrated that the system was induced by maltose/maltodextrins and repressed by glucose. Its induction was dependent on a LacI type transcriptional regulator. Repression by glucose was independent of the catabolite control protein CcpA, but was relieved in a mutant defective for Hpr kinase/phosphorylase. Conclusions/Significance: The data obtained show that in L. monocytogenes the uptake of maltodextrin and, in contrast to B. subtilis, also maltose is exclusively mediated by an ABC transporter. Furthermore, the results suggest that glucose repression of the uptake system possibly is by inducer exclusion, a mechanism not described so far in this organism.	[Gopal, Shubha] Univ Mysore, Dept Studies Microbiol, Mysore, Karnataka, India; [Berg, Daniela; Hagen, Nicole; Schriefer, Eva-Maria; Stoll, Regina; Goebel, Werner; Kreft, Juergen] Univ Wurzburg, Lehrstuhl Mikrobiol, Biozentrum, Wurzburg, Germany; [Berg, Daniela] Tech Univ Munich, Inst Pathol, Munich, Germany; [Schriefer, Eva-Maria; Goebel, Werner] Univ Munich, Max Von Pettenkofer Inst, Lehrstuhl Bakteriol, Munich, Germany	University of Mysore; University of Wurzburg; Technical University of Munich; University of Munich	Gopal, S (corresponding author), Univ Mysore, Dept Studies Microbiol, Mysore, Karnataka, India.	sguom@yahoo.com			Deutsche Forschungsgemeinschaft DFG [SFB479/B1]; Deutscher Akademischer Austauschdienst DAAD	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (www.dfg.de) (SFB479/B1) and a research fellowship (to SG) from the Deutscher Akademischer Austauschdienst DAAD (www.daad.de). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson U, 2005, SYST APPL MICROBIOL, V28, P187, DOI 10.1016/j.syapm.2004.11.004; Andersson U, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-28; Behari J, 1998, J BACTERIOL, V180, P6316; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Creti R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-60; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; EGETER O, 1995, J BACTERIOL, V177, P2408, DOI 10.1128/jb.177.9.2408-2415.1995; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Fichant G, 2006, FEMS MICROBIOL LETT, V256, P333, DOI 10.1111/j.1574-6968.2006.00139.x; Francke C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-145; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Gahan CGM, 2005, J APPL MICROBIOL, V98, P1345, DOI 10.1111/j.1365-2672.2005.02559.x; Gandhi M, 2007, INT J FOOD MICROBIOL, V113, P1, DOI 10.1016/j.ijfoodmicro.2006.07.008; Glaser P, 2001, SCIENCE, V294, P849; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Ivanek R, 2006, FOODBORNE PATHOG DIS, V3, P319, DOI 10.1089/fpd.2006.3.319; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Joseph B, 2007, MICROBES INFECT, V9, P1188, DOI 10.1016/j.micinf.2007.05.006; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Kuenne CT, 2007, BIOINFORMATICS, V23, P125, DOI 10.1093/bioinformatics/btl556; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Le Breton Y, 2005, J APPL MICROBIOL, V98, P806, DOI 10.1111/j.1365-2672.2004.02468.x; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mertins S, 2007, J BACTERIOL, V189, P473, DOI 10.1128/JB.00972-06; Milillo SR, 2008, FOOD MICROBIOL, V25, P698, DOI 10.1016/j.fm.2008.03.003; Monedero V, 2001, J BACTERIOL, V183, P3391, DOI 10.1128/JB.183.11.3391-3398.2001; Monedero V, 2008, RES MICROBIOL, V159, P94, DOI 10.1016/j.resmic.2007.10.002; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; Nieto C, 1997, J BIOL CHEM, V272, P30860, DOI 10.1074/jbc.272.49.30860; Ooi ST, 2005, CLIN INFECT DIS, V40, P1327, DOI 10.1086/429324; Palumbo JD, 2005, APPL ENVIRON MICROB, V71, P5236, DOI 10.1128/AEM.71.9.5236-5243.2005; Pei JM, 2001, TRENDS BIOCHEM SCI, V26, P275, DOI 10.1016/S0968-0004(01)01813-8; PINE L, 1989, CAN J MICROBIOL, V35, P245, DOI 10.1139/m89-037; PREMARATNE RJ, 1991, APPL ENVIRON MICROB, V57, P3046, DOI 10.1128/AEM.57.10.3046-3048.1991; Sambrook J, 2001, MOL CLONING LAB MANU; SAUNDERS B, 2007, LISTERIA LISTERIOSIS, P21; Schlosser A, 2001, FEMS MICROBIOL LETT, V196, P77, DOI 10.1016/S0378-1097(00)00566-8; Schmid MW, 2005, SYST APPL MICROBIOL, V28, P1, DOI 10.1016/j.syapm.2004.09.005; Schonert S, 2006, J BACTERIOL, V188, P3911, DOI 10.1128/JB.00213-06; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shim JH, 2009, J BACTERIOL, V191, P4835, DOI 10.1128/JB.00176-09; Sleator RD, 2009, MICROBIOL-SGM, V155, P2463, DOI 10.1099/mic.0.030205-0; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Sue D, 2004, MICROBIOL-SGM, V150, P3843, DOI 10.1099/mic.0.27257-0; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Titgemeyer F, 2002, ANTON LEEUW INT J G, V82, P59, DOI 10.1023/A:1020628909429; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Trost M, 2005, PROTEOMICS, V5, P1544, DOI 10.1002/pmic.200401024; Tsai HN, 2003, APPL ENVIRON MICROB, V69, P6943, DOI 10.1128/AEM.69.11.6943-6945.2003; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; WEIS J, 1975, APPL MICROBIOL, V30, P29, DOI 10.1128/AEM.30.1.29-32.1975; WELSHIMER HJ, 1960, J BACTERIOL, V80, P316, DOI 10.1128/JB.80.3.316-320.1960; WELSHIMER HJ, 1971, APPL MICROBIOL, V21, P516, DOI 10.1128/AEM.21.3.516-519.1971; Wing EJ, 2002, J INFECT DIS, V185, pS18, DOI 10.1086/338465; Yip VLY, 2007, BIOCHEMISTRY-US, V46, P9840, DOI 10.1021/bi700536p	63	42	45	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10349	10.1371/journal.pone.0010349	http://dx.doi.org/10.1371/journal.pone.0010349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436965	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000277079700008
J	Reigadas, S; Anies, G; Masquelier, B; Calmels, C; Stuyver, LJ; Parissi, V; Fleury, H; Andreola, ML				Reigadas, Sandrine; Anies, Guerric; Masquelier, Bernard; Calmels, Christina; Stuyver, Lieven J.; Parissi, Vincent; Fleury, Herve; Andreola, Marie-Line			The HIV-1 Integrase Mutations Y143C/R Are an Alternative Pathway for Resistance to Raltegravir and Impact the Enzyme Functions	PLOS ONE			English	Article							OPTIMIZED BACKGROUND THERAPY; INHIBITORS; REPLICATION; VIRUS; ELVITEGRAVIR; PATTERNS; MK-0518; GENE	Resistance to HIV-1 integrase (IN) inhibitor raltegravir (RAL), is encoded by mutations in the IN region of the pol gene. The emergence of the N155H mutation was replaced by a pattern including the Y143R/C/H mutations in three patients with anti-HIV treatment failure. Cloning analysis of the IN gene showed an independent selection of the mutations at loci 155 and 143. Characterization of the phenotypic evolution showed that the switch from N155H to Y143C/R was linked to an increase in resistance to RAL. Wild-type (WT) IN and IN with mutations Y143C or Y143R were assayed in vitro in 3' end-processing, strand transfer and concerted integration assays. Activities of mutants were moderately impaired for 3' end-processing and severely affected for strand transfer. Concerted integration assay demonstrated a decrease in mutant activities using an uncleaved substrate. With 3' end-processing assay, IC50 were 0.4 mu M, 0.9 mu M (FC = 2.25) and 1.2 mu M (FC = 3) for WT, IN Y143C and IN Y143R, respectively. An FC of 2 was observed only for IN Y143R in the strand transfer assay. In concerted integration, integrases were less sensitive to RAL than in ST or 3'P but mutants were more resistant to RAL than WT.	[Reigadas, Sandrine; Anies, Guerric; Masquelier, Bernard; Fleury, Herve] Univ Victor Segalen, EA 2968, CHU Bordeaux, Virol Lab, Bordeaux, France; [Stuyver, Lieven J.] Virco BVBA, Mechelen, Belgium; [Calmels, Christina; Parissi, Vincent; Andreola, Marie-Line] Univ Victor Segalen, UMR 5234, CNRS, Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Reigadas, S (corresponding author), Univ Victor Segalen, EA 2968, CHU Bordeaux, Virol Lab, Bordeaux, France.	marie-line.andreola@reger.u-bordeaux2.fr		Andreola, Marie-Line/0000-0001-9808-7391	French Ministry of Education and Research [EA2968, AI18-3-01354]; European Community's [FP7/2007-2013, 223131]; Agence Nationale de Recherche sur le SIDA et les Hepatites virales (ANRS, France); Centre National de la Recherche Scientifique (CNRS, France)	French Ministry of Education and Research; European Community's(European Commission); Agence Nationale de Recherche sur le SIDA et les Hepatites virales (ANRS, France)(ANRS); Centre National de la Recherche Scientifique (CNRS, France)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the French Ministry of Education and Research through the quadrennial contract of the EA2968 and by grant number AI18-3-01354 from Sidaction. The research leading to these results received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" - grant agreement no 223131. The authors also thank the Agence Nationale de Recherche sur le SIDA et les Hepatites virales (ANRS, France) and the Centre National de la Recherche Scientifique (CNRS, France) for support and funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alian A, 2009, P NATL ACAD SCI USA, V106, P8192, DOI 10.1073/pnas.0811919106; Asante-Appiah E, 1997, ANTIVIR RES, V36, P139, DOI 10.1016/S0166-3542(97)00046-6; Bonnenfant S, 2004, J VIROL, V78, P5728, DOI 10.1128/JVI.78.11.5728-5736.2004; Canducci F, 2010, J ANTIMICROB CHEMOTH, V65, P425, DOI 10.1093/jac/dkp477; Canducci F, 2009, AIDS, V23, P455, DOI 10.1097/QAD.0b013e328323da60; Caumont AB, 1996, CURR GENET, V29, P503; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; De Luca L, 2005, BIOCHEM BIOPH RES CO, V336, P1010, DOI 10.1016/j.bbrc.2005.08.211; de Soultrait VR, 2002, J MOL BIOL, V324, P195, DOI 10.1016/S0022-2836(02)01064-1; Delelis O, 2010, ANTIMICROB AGENTS CH, V54, P491, DOI 10.1128/AAC.01075-09; Delelis O, 2009, NUCLEIC ACIDS RES, V37, P1193, DOI 10.1093/nar/gkn1050; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Fransen S, 2009, ANTIVIR THER, V14, pA109; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Buzon MJ, 2010, AIDS, V24, P17, DOI 10.1097/QAD.0b013e328331c81e; Lataillade M, 2007, ANTIVIR THER, V12, P563; Lesbats P, 2008, NUCLEIC ACIDS RES, V36, P7043, DOI 10.1093/nar/gkn796; Marinello J, 2008, BIOCHEMISTRY-US, V47, P9345, DOI 10.1021/bi800791q; Markowitz M, 2006, JAIDS-J ACQ IMM DEF, V43, P509, DOI 10.1097/QAI.0b013e31802b4956; Moreau K, 2003, EUR J BIOCHEM, V270, P4426, DOI 10.1046/j.1432-1033.2003.03833.x; Mouscadet JF, 2009, J MOL RECOGNIT, V22, P480, DOI 10.1002/jmr.970; Pannecouque C, 2002, CURR BIOL, V12, P1169, DOI 10.1016/S0960-9822(02)00952-1; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Van Baelen K, 2008, AIDS, V22, P1877, DOI 10.1097/QAD.0b013e32830f9703; Van Baelen K, 2009, J VIROL METHODS, V161, P231, DOI 10.1016/j.jviromet.2009.06.015; Wittkop L, 2009, J ANTIMICROB CHEMOTH, V63, P1251, DOI 10.1093/jac/dkp114; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3	31	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10311	10.1371/journal.pone.0010311	http://dx.doi.org/10.1371/journal.pone.0010311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436677	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079500005
J	Cussiol, JRR; Alegria, TGP; Szweda, LI; Netto, LES				Cussiol, Jose R. R.; Alegria, Thiago G. P.; Szweda, Luke I.; Netto, Luis E. S.			Ohr (Organic Hydroperoxide Resistance Protein) Possesses a Previously Undescribed Activity, Lipoyl-dependent Peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID DEHYDROGENASE COMPLEXES; ESCHERICHIA-COLI; DIHYDROLIPOAMIDE DEHYDROGENASE; FUNCTIONAL-CHARACTERIZATION; STREPTOCOCCUS-PNEUMONIAE; HYPERSENSITIVE REACTION; XYLELLA-FASTIDIOSA; LIPID-PEROXIDATION; PEROXIREDOXINS; THIOREDOXIN	The Ohr (organic hydroperoxide resistance) family of 15-kDa Cys-based, thiol-dependent peroxidases is central to the bacterial response to stress induced by organic hydroperoxides but not by hydrogen peroxide. Ohr has a unique three-dimensional structure and requires dithiols, but not monothiols, to support its activity. However, the physiological reducing system of Ohr has not yet been identified. Here we show that lipoylated enzymes present in the bacterial extracts of Xylella fastidiosa interacted physically and functionally with this Cys-based peroxidase, whereas thioredoxin and glutathione systems failed to support Ohr peroxidase activity. Furthermore, we could reconstitute in vitro three lipoyl-dependent systems as the Ohr physiological reducing systems. We also showed that OsmC from Escherichia coli, an orthologue of Ohr from Xylella fastidiosa, is specifically reduced by lipoyl-dependent systems. These results represent the first description of a Cys-based peroxidase that is directly reduced by lipoylated enzymes.	[Cussiol, Jose R. R.; Alegria, Thiago G. P.; Netto, Luis E. S.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, BR-05508900 Sao Paulo, Brazil; [Szweda, Luke I.] Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, Oklahoma City, OK 73104 USA	Universidade de Sao Paulo; Oklahoma Medical Research Foundation	Netto, LES (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Rua Matao 277, BR-05508900 Sao Paulo, Brazil.	nettoles@ib.usp.br	Cussiol, José Renato/E-5142-2015; Netto, Luis/A-3783-2008	Cussiol, José Renato/0000-0001-5909-8215; Netto, Luis/0000-0002-4250-9177; Alegria, Thiago Geronimo Pires/0000-0002-3086-4059	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [07/58147-6]; National Institute of Science and Technology	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute of Science and Technology	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 07/58147-6 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico under the National Institute of Science and Technology for Redox Processes in Biomedicine (Redoxome).	Allary M, 2007, MOL MICROBIOL, V63, P1331, DOI 10.1111/j.1365-2958.2007.05592.x; Atichartpongkul S, 2001, MICROBIOL-SGM, V147, P1775, DOI 10.1099/00221287-147-7-1775; Beckwith J, 2009, J BIOL CHEM, V284, P12585, DOI 10.1074/jbc.X800017200; Brehelin C, 2003, PLANT PHYSIOL, V132, P2045, DOI 10.1104/pp.103.022533; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Bunik VI, 2003, EUR J BIOCHEM, V270, P1036, DOI 10.1046/j.1432-1033.2003.03470.x; ELLMAN G, 1979, ANAL BIOCHEM, V93, P98, DOI 10.1016/S0003-2697(79)80122-0; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; Gobel C, 2003, J BIOL CHEM, V278, P52834, DOI 10.1074/jbc.M310833200; GUTIERREZ C, 1991, J MOL BIOL, V220, P959, DOI 10.1016/0022-2836(91)90366-E; Hakansson AP, 2007, J BIOL CHEM, V282, P29521, DOI 10.1074/jbc.M703144200; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Jalloul A, 2002, PLANT J, V32, P1, DOI 10.1046/j.1365-313X.2002.01393.x; Janssen R, 2003, MICROBES INFECT, V5, P527, DOI 10.1016/S1286-4579(03)00069-8; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lesniak J, 2002, EMBO J, V21, P6649, DOI 10.1093/emboj/cdf670; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Ma QJ, 2006, P NATL ACAD SCI USA, V103, P8662, DOI 10.1073/pnas.0510436103; Maeng JH, 1996, J BACTERIOL, V178, P3695, DOI 10.1128/jb.178.13.3695-3700.1996; Meunier-Jamin C, 2004, J BIOL CHEM, V279, P25830, DOI 10.1074/jbc.M312983200; Moini H, 2002, TOXICOL APPL PHARM, V182, P84, DOI 10.1006/taap.2002.9437; Montillet JL, 2002, PLANT PHYSIOL BIOCH, V40, P633, DOI 10.1016/S0981-9428(02)01402-X; MORRIS TW, 1995, J BACTERIOL, V177, P1; Munhoz DC, 2004, J BIOL CHEM, V279, P35219, DOI 10.1074/jbc.M313773200; NOLL KM, 1988, J BACTERIOL, V170, P4315, DOI 10.1128/jb.170.9.4315-4321.1988; O'Riordan M, 2003, SCIENCE, V302, P462, DOI 10.1126/science.1088170; Oliveira MA, 2006, J MOL BIOL, V359, P433, DOI 10.1016/j.jmb.2006.03.054; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; REED LJ, 1958, J BIOL CHEM, V232, P143; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Renato J, 2003, J BIOL CHEM, V278, P11570, DOI 10.1074/jbc.M300252200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Schupke H, 2001, DRUG METAB DISPOS, V29, P855; SEGEL H, 1993, ENZYME KINETICS BEHA, P606; Shin DH, 2004, ACTA CRYSTALLOGR D, V60, P903, DOI 10.1107/S0907444904005013; Smith AW, 2002, MOL MICROBIOL, V44, P431, DOI 10.1046/j.1365-2958.2002.02883.x; SMITH MW, 1983, J BACTERIOL, V154, P344, DOI 10.1128/JB.154.1.344-350.1983; Smolka MB, 2003, PROTEOMICS, V3, P224, DOI 10.1002/pmic.200390031; SUZUKI YJ, 1994, METHODS ENZYMOL, V234, P454; TENHAKEN R, 1995, P NATL ACAD SCI USA, V92, P4158, DOI 10.1073/pnas.92.10.4158; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; Trujillo Madia, 2007, V44, P83; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004	51	46	47	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21943	21950		10.1074/jbc.M110.117283	http://dx.doi.org/10.1074/jbc.M110.117283			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463026	Green Published, hybrid			2022-12-25	WOS:000279702200006
J	Hall, J; Song, YJ; Karplus, PA; Barbar, E				Hall, Justin; Song, Yujuan; Karplus, P. Andrew; Barbar, Elisar			The Crystal Structure of Dynein Intermediate Chain-Light Chain Roadblock Complex Gives New Insights into Dynein Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INTERACTING PROTEIN; CYTOPLASMIC DYNEIN; AXONAL-TRANSPORT; DIFFRACTION DATA; GENETIC-ANALYSIS; DATA QUALITY; MOTOR; LC8; IDENTIFICATION; DYNACTIN	The roadblock/LC7 dynein light chain is a ubiquitous component of all dyneins and is essential for many diverse processes including proper axonal transport and dendrite growth. In addition, LC7 functions in non-dynein transcriptional activation of the transforming growth factor-beta complex. Crystal structures of Drosophila melanogaster LC7 in the apo form and in complex with a segment of the disordered N-terminal domain of dynein intermediate chain (IC) provide the first definitive identification of the IC sequence recognized by LC7. The site, confirmed by isothermal titration calorimetry studies, overlaps the IC sequence considered in the literature to be an IC self-association domain. The IC peptide binds as two amphipathic helices that lie along an extensive hydrophobic cleft on LC7 and ends with a polar side-chain interaction network that includes conserved residues from both proteins. The LC7 recognition sequence on IC and its interface with LC7 are well conserved and are, thus, likely representative of all IC.LC7 structures. Interestingly, the position of bound IC in the IC.LC7 complex mimics a helix that is integrated into the primary structure in distantly related LC7 homologs. The IC.LC7 structure further shows that the naturally occurring robl(Z) deletion mutation contains the majority of the IC binding site and suggests that promotion of IC binding by phosphorylation of LC7 is an indirect effect.	[Hall, Justin; Song, Yujuan; Karplus, P. Andrew; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu		Karplus, Paul/0000-0001-8725-6292; Barbar, Elisar/0000-0003-4892-5259	National Science Foundation [0818896]; American Heart Association [09PRE2250819]	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association)	This work was supported by National Science Foundation Grant MCB 0818896 (to E. B.) and American Heart Association Predoctoral Fellowship 09PRE2250819 (to J. H.).	Ashokkumar B, 2009, AM J PHYSIOL-GASTR L, V297, pG480, DOI 10.1152/ajpgi.00154.2009; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bowman AB, 1999, J CELL BIOL, V146, P165; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Ding W, 2005, CANCER RES, V65, P6526, DOI 10.1158/0008-5472.CAN-04-4385; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; El-Kadi AM, 2007, J NEUROSCI RES, V85, P2557, DOI 10.1002/jnr.21188; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Hollingsworth SA, 2009, PROTEIN SCI, V18, P1321, DOI 10.1002/pro.133; Ilangovan U, 2005, J MOL BIOL, V352, P338, DOI 10.1016/j.jmb.2005.07.002; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jiang JM, 2001, GENE, V281, P103, DOI 10.1016/S0378-1119(01)00787-9; Jin QY, 2009, J CELL PHYSIOL, V221, P707, DOI 10.1002/jcp.21910; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Koonin EV, 2000, CURR BIOL, V10, pR774, DOI 10.1016/S0960-9822(00)00774-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Liu JF, 2006, BIOCHEM BIOPH RES CO, V349, P1125, DOI 10.1016/j.bbrc.2006.08.161; Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikulina K, 2004, CELL MOTIL CYTOSKEL, V57, P233, DOI 10.1002/cm.10172; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Pazour GJ, 2000, METHODS, V22, P285, DOI 10.1006/meth.2000.1081; Persson BD, 2009, J VIROL, V83, P673, DOI 10.1128/JVI.01967-08; Reuter JE, 2003, DEVELOPMENT, V130, P1203, DOI 10.1242/dev.00319; Sarma GN, 2003, J MOL BIOL, V328, P893, DOI 10.1016/S0022-2836(03)00347-4; Soetens JC, 1997, J PHYS CHEM B, V101, P10910, DOI 10.1021/jp972113j; Song J, 2005, J MOL BIOL, V354, P1043, DOI 10.1016/j.jmb.2005.10.017; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Susalka SJ, 2000, J NEUROCYTOL, V29, P819, DOI 10.1023/A:1010995408343; Tang Q, 2002, MOL BIOL CELL, V13, P4484, DOI 10.1091/mbc.e02-05-0245; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Wanschers B, 2008, CELL MOTIL CYTOSKEL, V65, P183, DOI 10.1002/cm.20254; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; Wilkins MR, 1999, METH MOL B, V112, P531; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Ye GJ, 2000, J VIROL, V74, P1355, DOI 10.1128/JVI.74.3.1355-1363.2000; Zhang J, 2009, J BIOL CHEM, V284, P34760, DOI 10.1074/jbc.M109.026872; Zuccarello D, 2008, HUM REPROD, V23, P1957, DOI 10.1093/humrep/den193	59	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22566	22575		10.1074/jbc.M110.103861	http://dx.doi.org/10.1074/jbc.M110.103861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472935	Green Published, hybrid			2022-12-25	WOS:000279702200068
J	Kokhan, O; Shinkarev, VP; Wraight, CA				Kokhan, Oleksandr; Shinkarev, Vladimir P.; Wraight, Colin A.			Binding of Imidazole to the Heme of Cytochrome c(1) and Inhibition of the bc(1) Complex from Rhodobacter sphaeroides I. EQUILIBRIUM AND MODELING STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; C-TYPE CYTOCHROMES; LIGAND-BINDING; ELECTRON-TRANSFER; Q-CYCLE; PHYSICOCHEMICAL PROPERTIES; MOLECULAR-DYNAMICS; CYANIDE INHIBITION; AXIAL LIGAND; BC COMPLEXES	We have used imidazole (Im) and N-methylimidazole (MeIm) as probes of the heme-binding cavity of membrane-bound cytochrome (cyt) c(1) in detergent-solubilized bc(1) complex from Rhodobacter sphaeroides. Imidazole binding to cyt c1 substantially lowers the midpoint potential of the heme and fully inhibits bc1 complex activity. Temperature dependences showed that binding of Im (K-d approximate to 330 mu M, 25 degrees C, pH 8) is enthalpically driven (Delta H-0 = -56 kJ/mol, Delta S-0 = -121 J/mol/K), whereas binding of MeIm is 30 times weaker (K-d approximate to 9.3 mM) and is entropically driven (Delta H-0 = 47 kJ/mol, Delta S-0 degrees = 197 J/mol/K). The large enthalpic and entropic contributions suggest significant structural and solvation changes in cyt c1 triggered by ligand binding. Comparison of these results with those obtained previously for soluble cyts c and c(2) suggested that Im binding to cyt c(1) is assisted by formation of hydrogen bonds within the heme cleft. This was strongly supported by molecular dynamics simulations of Im adducts of cyts c, c2, and c1, which showed hydrogen bonds formed between the N delta H of Im and the cyt c(1) protein, or with a water molecule sequestered with the ligand in the heme cleft.	[Kokhan, Oleksandr; Wraight, Colin A.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Shinkarev, Vladimir P.; Wraight, Colin A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Wraight, CA (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, 156 Davenport Hall,607 S Mathews Ave, Urbana, IL 61801 USA.	cwraight@illinois.edu		Kokhan, Oleksandr/0000-0001-9867-8044	National Institutes of Health [R01GM053508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM053508.	Autenrieth F, 2004, J COMPUT CHEM, V25, P1613, DOI 10.1002/jcc.20079; AXELROD HL, 1994, ACTA CRYSTALLOGR D, V50, P596, DOI 10.1107/S0907444994001319; Banci L, 2001, J BIOL INORG CHEM, V6, P628, DOI 10.1007/s007750100240; Battistuzzi G, 2001, ANTIOXID REDOX SIGN, V3, P279, DOI 10.1089/152308601300185232; Battistuzzi G, 2002, J AM CHEM SOC, V124, P5315, DOI 10.1021/ja017479v; Baymann F, 2004, P NATL ACAD SCI USA, V101, P17737, DOI 10.1073/pnas.0407442101; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cape JL, 2006, TRENDS PLANT SCI, V11, P46, DOI 10.1016/j.tplants.2005.11.007; Caroppi P, 2009, CURR MED CHEM, V16, P4058, DOI 10.2174/092986709789378206; CLARK WM, 1972, OXIDATION REDUCTION, P469; Cooper A, 2005, BIOPHYS CHEM, V115, P89, DOI 10.1016/j.bpc.2004.12.011; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1079, DOI 10.1016/j.bbabio.2008.04.022; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Darrouzet E, 1999, BIOCHEMISTRY-US, V38, P7908, DOI 10.1021/bi990211k; Driscoll WJ, 2007, J BIOL CHEM, V282, P22353, DOI 10.1074/jbc.M610070200; Dumortier C, 1998, J BIOL CHEM, V273, P25647, DOI 10.1074/jbc.273.40.25647; Dumortier C, 2004, BIOCHEMISTRY-US, V43, P7717, DOI 10.1021/bi0362370; Dumortier C, 1999, ARCH BIOCHEM BIOPHYS, V371, P142, DOI 10.1006/abbi.1999.1440; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Elberry M, 2006, BIOCHEMISTRY-US, V45, P4991, DOI 10.1021/bi0522246; Elberry M, 2006, BBA-BIOENERGETICS, V1757, P835, DOI 10.1016/j.bbabio.2006.05.031; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Engstrom G, 2003, BIOCHEMISTRY-US, V42, P2816, DOI 10.1021/bi027213g; Engstrom G, 2002, J BIOL CHEM, V277, P31072, DOI 10.1074/jbc.M202594200; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P723, DOI 10.1021/bi00169a014; GRAY KA, 1992, BIOCHEMISTRY-US, V31, P11864, DOI 10.1021/bi00162a027; GREENWOOD C, 1965, J BIOL CHEM, V240, P3660; Guergova-Kuras M, 1999, PROTEIN EXPRES PURIF, V15, P370, DOI 10.1006/prep.1998.1018; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IKEDASAITO M, 1975, BIOCHIM BIOPHYS ACTA, V393, P335, DOI 10.1016/0005-2795(75)90059-8; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kalanxhi E, 2007, BIOCHEM J, V407, P179, DOI 10.1042/BJ20070459; Kokhan O, 2010, J BIOL CHEM, V285, P22522, DOI 10.1074/jbc.M110.128082; Li J, 2002, BBA-BIOENERGETICS, V1556, P175, DOI 10.1016/S0005-2728(02)00360-2; LIU GH, 1995, J INORG BIOCHEM, V60, P123, DOI 10.1016/0162-0134(95)00007-B; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maity H, 2004, J MOL BIOL, V343, P223, DOI 10.1016/j.jmb.2004.08.005; MARGALIT R, 1973, EUR J BIOCHEM, V32, P492, DOI 10.1111/j.1432-1033.1973.tb02633.x; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; Millett F, 2004, PHOTOSYNTH RES, V82, P1, DOI 10.1023/B:PRES.0000040434.77061.ca; MOORE GR, 1990, CYTOCHROMES EVOLUTIO; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Osyczka A, 2004, BBA-BIOENERGETICS, V1655, P71, DOI 10.1016/j.bbabio.2003.07.005; PERRIN DD, 1965, DISSOCIATION CONSTAN, P190; PETTIGREW GW, 1975, BIOCHEM J, V149, P155, DOI 10.1042/bj1490155; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Potter VR, 1941, J BIOL CHEM, V137, P13; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P112, DOI 10.1016/0003-9861(91)90171-E; SALEEM MMM, 1988, INORG CHIM A-BIOINOR, V153, P93, DOI 10.1016/S0020-1693(00)83865-7; SCHEJTER A, 1964, BIOCHEMISTRY-US, V3, P1045, DOI 10.1021/bi00896a006; SCHEJTER A, 1969, BIOCHEMISTRY-US, V8, P149, DOI 10.1021/bi00829a021; SCHEJTER A, 1968, BIOCHIM BIOPHYS ACTA, V162, P459, DOI 10.1016/0005-2728(68)90133-3; SCOTT RA, 1996, CYTOCHROME MULTIDISC; SHAO WP, 1992, ACTA CHIM SINICA, V50, P1129; SHAO WP, 1995, J INORG BIOCHEM, V57, P103; Stephanos JJ, 1996, BBA-PROTEIN STRUCT M, V1295, P209, DOI 10.1016/0167-4838(96)00041-6; Stewart JM, 2000, BIOCHEM CELL BIOL, V78, P675, DOI 10.1139/bcb-78-6-675; SUTIN N, 1972, J BIOL CHEM, V247, P6932; TALER G, 1995, BIOCHEMISTRY-US, V34, P14209, DOI 10.1021/bi00043a027; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Viola F, 1996, J INORG BIOCHEM, V62, P213, DOI 10.1016/0162-0134(95)00155-7; WOOD PM, 1980, BIOCHEM J, V192, P761, DOI 10.1042/bj1920761; Yao Y, 2002, J BIOL INORG CHEM, V7, P539, DOI 10.1007/s00775-001-0334-y; Zakariassen H, 2007, THERMOCHIM ACTA, V464, P24, DOI 10.1016/j.tca.2007.07.021; Zhang HB, 2006, BIOCHEMISTRY-US, V45, P14247, DOI 10.1021/bi061345i	70	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22513	22521		10.1074/jbc.M110.128058	http://dx.doi.org/10.1074/jbc.M110.128058			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20448035	Green Published, hybrid			2022-12-25	WOS:000279702200063
J	Manna, SK; Bose, JS; Gangan, V; Raviprakash, N; Navaneetha, T; Raghavendra, PB; Babajan, B; Kumar, CS; Jain, SK				Manna, Sunil K.; Bose, Julie S.; Gangan, Vijay; Raviprakash, Nune; Navaneetha, Thota; Raghavendra, Pongali B.; Babajan, Banaganapalli; Kumar, Chitta S.; Jain, Swatantra K.			Novel Derivative of Benzofuran Induces Cell Death Mostly by G2/M Cell Cycle Arrest through p53-dependent Pathway but Partially by Inhibition of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR KAPPAB; RELA PHOSPHORYLATION; APOPTOSIS; P53; ACTIVATION; MDM2; DOXORUBICIN; INDUCTION; KINASE; REQUIREMENT	The Dracaena resin is widely used in traditional medicine as an anticancer agent, and benzofuran lignan is the active component. In this report, we provide evidence that the synthetic derivative of benzofuran lignan (Benfur) showed antitumor activities. It induced apoptosis in p53-positive cells. Though it inhibited endotoxin-induced nuclear factor kappa B (NF-kappa B) activation in both p53-positive and -negative cells, the activation of caspase 3 was observed in p53-positive cells. It showed partial cell death effect in both p53-positive and -negative cells through inhibition of NF-kappa B. Cell cycle analysis using flow cytometry showed that treatment with this novel benozofuran lignan derivative to Jurkat T-cells, but not U-937 cells, resulted in a G2/M arrest in a dose- and time-dependent manner. It increased amounts of p21, p27, and cyclin B, but not phospho-Rb through p53 nuclear translocation in Jurkat T-cells, but not in U-937 cells. It inhibited amounts of MDM2(murine double minute 2) by repressing the transcription factor Sp1, which was also proved in silico. It induced cell death in tumor cells, but not in primary T-cells. Overall, our data suggest that Benfur-mediated cell death is partially dependent upon NF-kappa B, but predominantly dependent on p53. Thus, this novel benzofuran lignan derivative can be effective chemopreventive or chemo-therapeutic agent against malignant T-cells.	[Manna, Sunil K.; Raviprakash, Nune; Navaneetha, Thota] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India; [Bose, Julie S.; Gangan, Vijay] Reliance Life Sci Pvt Ltd, Bombay 400701, Maharashtra, India; [Raghavendra, Pongali B.; Babajan, Banaganapalli; Kumar, Chitta S.] Sri Krishnadevaraya Univ, Dept Biochem, Anantapur 515003, Andhra Pradesh, India; [Jain, Swatantra K.] Jamia Hamdard, Dept Biotechnol, New Delhi 110062, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Reliance Life Sciences Private Limited; Sri Krishnadevaraya University; Jamia Hamdard University	Manna, SK (corresponding author), Ctr DNA Fingerprinting & Diagnost, Hyderabad 500076, Andhra Pradesh, India.	manna@cdfd.org.in	Kumar, Dr Suresh/HHZ-2615-2022; KUMAR, P. SURESH/AAT-8951-2020; chitta, suresh kumar/N-1569-2016; Banaganapalli, Babajan/A-6282-2013	Kumar, Dr Suresh/0000-0002-2539-6553; KUMAR, P. SURESH/0000-0003-3222-2604; Banaganapalli, Babajan/0000-0001-8089-2210; Navaneetha, Thota/0000-0002-0669-7107	Department of Biotechnology (DBT), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology (DBT), Government of India.	Aggarwal BB, 2004, EXPERT OPIN INV DRUG, V13, P1327, DOI 10.1517/13543784.13.10.1327; Apers S, 2002, J NAT PROD, V65, P718, DOI 10.1021/np0103968; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen HW, 1998, BRIT J PHARMACOL, V124, P1029, DOI 10.1038/sj.bjp.0701914; Chene P, 2004, MOL CANCER RES, V2, P20; Concin N, 2003, INT J ONCOL, V22, P51; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Dash BC, 2005, MOL CELL BIOL, V25, P3364, DOI 10.1128/MCB.25.8.3364-3387.2005; Gangadharan C, 2010, BREAST CANCER RES TR, V120, P671, DOI 10.1007/s10549-009-0493-z; Gangadharan C, 2009, J CELL BIOCHEM, V107, P203, DOI 10.1002/jcb.22115; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; Hausott B, 2003, J CANCER RES CLIN, V129, P569, DOI 10.1007/s00432-003-0461-7; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Kaku S, 2001, NUCLEIC ACIDS RES, V29, P1989, DOI 10.1093/nar/29.9.1989; Levi MS, 2001, CURR MED CHEM, V8, P1349, DOI 10.2174/0929867013372229; Li Q, 1999, ANNU REP MED CHEM, V34, P139; Manna SK, 2007, CELL DEATH DIFFER, V14, P158, DOI 10.1038/sj.cdd.4401929; Manna SK, 2010, J BIOL CHEM, V285, P11617, DOI 10.1074/jbc.M109.094961; Manna SK, 2009, MOL IMMUNOL, V46, P1340, DOI 10.1016/j.molimm.2008.11.014; Mansilla S, 2003, BIOCHEM J, V372, P703, DOI 10.1042/BJ20021950; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Narayan VA, 1997, J BIOL CHEM, V272, P7801, DOI 10.1074/jbc.272.12.7801; Perez-Stable C, 2006, CANCER LETT, V231, P49, DOI 10.1016/j.canlet.2005.01.018; PIETERS L, 1993, J NAT PROD, V56, P899, DOI 10.1021/np50096a013; Pieters L, 1999, J MED CHEM, V42, P5475, DOI 10.1021/jm990251m; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Poppelmann B, 2005, J BIOL CHEM, V280, P15635, DOI 10.1074/jbc.M413006200; Potter AJ, 2002, CARCINOGENESIS, V23, P389, DOI 10.1093/carcin/23.3.389; Raghavendra PB, 2007, APOPTOSIS, V12, P307, DOI 10.1007/s10495-006-0626-3; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sreenivasan Y, 2003, ONCOGENE, V22, P4356, DOI 10.1038/sj.onc.1206486; STEWART N, 1995, ONCOGENE, V10, P109; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; TRIZIO D, 1974, J IMMUNOL, V113, P1093	39	38	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22318	22327		10.1074/jbc.M110.131797	http://dx.doi.org/10.1074/jbc.M110.131797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472557	Green Published, hybrid			2022-12-25	WOS:000279702200045
J	Low, KL; Shui, GH; Natter, K; Yeo, WK; Kohlwein, SD; Dick, T; Rao, SPS; Wenk, MR				Low, Kai Leng; Shui, Guanghou; Natter, Klaus; Yeo, Wee Kiang; Kohlwein, Sepp D.; Dick, Thomas; Rao, Srinivasa P. S.; Wenk, Markus R.			Lipid Droplet-associated Proteins Are Involved in the Biosynthesis and Hydrolysis of Triacylglycerol in Mycobacterium bovis Bacillus Calmette-Guerin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; DIACYLGLYCEROL ACYLTRANSFERASE; PHOSPHATIDATE PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; TUBERCULOSIS; IDENTIFICATION; FAMILY; LOCALIZATION; ACCUMULATION; METABOLISM	Mycobacteria store triacylglycerols (TGs) in the form of intracellular lipid droplets (LDs) during hypoxia-induced nonreplicating persistence. These bacteria are phenotypically drug-resistant and therefore are believed to be the cause for prolonged tuberculosis treatment. LDs are also associated with bacilli in tuberculosis patient sputum and hypervirulent strains. Although proteins bound to LDs are well characterized in eukaryotes, the identities and functions of such proteins have not been described in mycobacteria. Here, we have identified five proteins: Tgs1 (BCG3153c), Tgs2 (BCG3794c), BCG1169c, BCG1489c, and BCG1721, which are exclusively associated with LDs purified from hypoxic nonreplicating Mycobacterium bovis bacillus Calmette-Guerin (BCG). Disruption of genes tgs1, tgs2, BCG1169c, and BCG1489c in M. bovis BCG revealed that they are indeed involved in TG metabolism. We also characterized BCG1721, an essential bi-functional enzyme capable of promoting buildup and hydrolysis of TGs, depending on the metabolic state. Nonreplicating mycobacteria overexpressing a BCG1721 construct with an inactive lipase domain displayed a phenotype of attenuated TG breakdown and regrowth upon resuscitation. In addition, by heterologous expression in baker's yeast, these mycobacterial proteins also co-localized with LDs and complemented a lipase-deficient yeast strain, indicating that neutral lipid deposition and homeostasis in eukaryotic and prokaryotic microorganisms are functionally related. The demonstrated functional role of BCG1721 to support growth upon resuscitation makes this novel LD-associated factor a potential new target for therapeutic intervention.	[Low, Kai Leng; Wenk, Markus R.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117456, Singapore; [Wenk, Markus R.] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117456, Singapore; [Yeo, Wee Kiang; Dick, Thomas; Rao, Srinivasa P. S.] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Natter, Klaus; Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	National University of Singapore; National University of Singapore; National University of Singapore; Novartis; University of Graz	Rao, SPS (corresponding author), 10 Biopolis Rd,Chromos Bldg,Level 05-01, Singapore 138670, Singapore.	srinivasa.rao@novartis.com; bchmrw@nus.edu.sg	Wenk, Markus Rene/D-1441-2014; Dick, Thomas/AAB-4109-2019; Yeo, Wee Kiang/A-4566-2009; Dick, Thomas/AAC-4824-2019	Dick, Thomas/0000-0002-9604-9452; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Yeo, Wee Kiang/0000-0002-5329-1062; Shui, Guanghou/0000-0002-1621-9643	Singapore National Research Foundation [2007-04]; Academic Research Fund [R-183-000-160-112]; Novartis Institute for Tropical Diseases [R-183-000-166-592]; FWF; NUS Graduate School for Integrative Sciences and Engineering; Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish	Singapore National Research Foundation(National Research Foundation, Singapore); Academic Research Fund(Ministry of Education, Singapore); Novartis Institute for Tropical Diseases; FWF(Austrian Science Fund (FWF)); NUS Graduate School for Integrative Sciences and Engineering(National University of Singapore); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Singapore National Research Foundation Competitive Research Programme Award 2007-04, Academic Research Fund Grant R-183-000-160-112, Novartis Institute for Tropical Diseases Grant R-183-000-166-592, and Austrian Science Fund FWF Project SFB LIPOTOX (to K.N. and S.D.K.).; Recipient of a scholarship from the NUS Graduate School for Integrative Sciences and Engineering.	Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Hanisch J, 2006, APPL ENVIRON MICROB, V72, P6743, DOI 10.1128/AEM.00584-06; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Kalscheuer R, 2004, APPL ENVIRON MICROB, V70, P7119, DOI 10.1128/AEM.70.12.7119-7125.2004; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; KLEIN HP, 1953, J BIOL CHEM, V203, P95; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIN YP, 1989, J BIOL CHEM, V264, P8641; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; MAHLER HR, 1953, J BIOL CHEM, V204, P453; Marmiesse M, 2004, MICROBIOL-SGM, V150, P483, DOI 10.1099/mic.0.26662-0; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Secundo F, 2006, J MOL CATAL B-ENZYM, V39, P166, DOI 10.1016/j.molcatb.2006.01.018; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Waltermann M, 2005, MOL MICROBIOL, V55, P750, DOI 10.1111/j.1365-2958.2004.04441.x; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	51	55	57	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21662	21670		10.1074/jbc.M110.135731	http://dx.doi.org/10.1074/jbc.M110.135731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452973	Green Published, hybrid			2022-12-25	WOS:000279516100053
J	Blais, JD; Chin, KT; Zito, E; Zhang, YH; Heldman, N; Harding, HP; Fass, D; Thorpe, C; Ron, D				Blais, Jaime D.; Chin, King-Tung; Zito, Ester; Zhang, Yuhong; Heldman, Nimrod; Harding, Heather P.; Fass, Deborah; Thorpe, Colin; Ron, David			A Small Molecule Inhibitor of Endoplasmic Reticulum Oxidation 1 (ERO1) with Selectively Reversible Thiol Reactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; DISULFIDE-BOND FORMATION; CELL-SURVIVAL; REVEAL; DEGRADATION; HOMEOSTASIS; EXPRESSION; ERO1-BETA; OXIDASE; STRESS	Endoplasmic reticulum oxidation 1 (ERO1) is a conserved eukaryotic flavin adenine nucleotide-containing enzyme that promotes disulfide bond formation by accepting electrons from reduced protein disulfide isomerase (PDI) and passing them on to molecular oxygen. Although disulfide bond formation is an essential process, recent experiments suggest a surprisingly broad tolerance to genetic manipulations that attenuate the rate of disulfide bond formation and that a hyperoxidizing ER may place stressed cells at a disadvantage. In this study, we report on the development of a high throughput in vitro assay for mammalian ERO1 alpha activity and its application to identify small molecule inhibitors. The inhibitor EN460 (IC50, 1.9 mu M) interacts selectively with the reduced, active form of ERO1 alpha and prevents its reoxidation. Despite rapid and promiscuous reactivity with thiolates, EN460 exhibits selectivity for ERO1. This selectivity is explained by the rapid reversibility of the reaction of EN460 with unstructured thiols, in contrast to the formation of a stable bond with ERO1 alpha followed by displacement of bound flavin adenine dinucleotide from the active site of the enzyme. Modest concentrations of EN460 and a functionally related inhibitor, QM295, promote signaling in the unfolded protein response and precondition cells against severe ER stress. Together, these observations point to the feasibility of targeting the enzymatic activity of ERO1 alpha with small molecule inhibitors.	[Blais, Jaime D.; Chin, King-Tung; Zito, Ester; Zhang, Yuhong; Harding, Heather P.; Ron, David] NYU, Sch Med, Kimmel Ctr Biol, New York, NY 10016 USA; [Blais, Jaime D.; Chin, King-Tung; Zito, Ester; Zhang, Yuhong; Harding, Heather P.; Ron, David] NYU, Sch Med, Med Skirball Inst, New York, NY 10016 USA; [Blais, Jaime D.; Chin, King-Tung; Zito, Ester; Zhang, Yuhong; Harding, Heather P.; Ron, David] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Blais, Jaime D.; Chin, King-Tung; Zito, Ester; Zhang, Yuhong; Harding, Heather P.; Ron, David] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Harding, Heather P.; Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England; [Heldman, Nimrod; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Thorpe, Colin] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA	New York University; New York University; New York University; New York University; University of Cambridge; Weizmann Institute of Science; University of Delaware	Blais, JD (corresponding author), NYU, Sch Med, Kimmel Ctr Biol, Sl 3-10,540 1st Ave, New York, NY 10016 USA.	jaime.blais@med.nyu.edu; david.ron@med.nyu.edu	Zito, Ester/ABB-9687-2020; Zito, Ester/AAA-7246-2020	Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636	National Institutes of Health [DK075311, DK47119, ES08681, GM26643]; National Cancer Institute of Canada; Canadian Institute of Health Research; Medical Research Council [G0600717B] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047119, R37DK047119, R01DK075311, R29DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK075311, DK47119, and ES08681(to D. R.) and GM26643(to C. T.). This work was also supported by fellowships from the National Cancer Institute of Canada and the Canadian Institute of Health Research (to J.D.B.).	ANFINSEN CB, 1956, ADV PROTEIN CHEM, V11, P1, DOI 10.1016/S0065-3233(08)60420-9; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dias-Gunasekara S, 2005, J BIOL CHEM, V280, P33066, DOI 10.1074/jbc.M505023200; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V70, P82; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2005, CELL METAB, V2, P361, DOI 10.1016/j.cmet.2005.11.005; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Rokita S. E., 2009, QUINONE METHIDES REA, V1, P297; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	25	73	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20993	21003		10.1074/jbc.M110.126599	http://dx.doi.org/10.1074/jbc.M110.126599			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20442408	hybrid, Green Published			2022-12-25	WOS:000279228600063
J	Bruzzone, S; Basile, G; Chothi, MP; Nobbio, L; Usai, C; Jacchetti, E; Schenone, A; Guse, AH; Di Virgilio, F; De Flora, A; Zocchi, E				Bruzzone, Santina; Basile, Giovanna; Chothi, Madhu Parakkottil; Nobbio, Lucilla; Usai, Cesare; Jacchetti, Emanuela; Schenone, Angelo; Guse, Andreas H.; Di Virgilio, Francesco; De Flora, Antonio; Zocchi, Elena			Diadenosine Homodinucleotide Products of ADP-ribosyl Cyclases Behave as Modulators of the Purinergic Receptor P2X7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(7) RECEPTOR; ADENINE-DINUCLEOTIDE; NEUROPATHIC PAIN; CALCIUM; CELLS; ACTIVATION; ATP; ANTAGONISTS; CHANNEL; NAADP	ADP-ribosyl cyclases from both vertebrates and invertebrates were previously shown to produce two isomers of P1,P2 diadenosine 5',5'''-P1, P2-diphosphate, P18 and P24, from cyclic ADP-ribose (cADPR) and adenine. P18 and P24 are characterized by an unusual N-glycosidic linkage in one of the adenylic mononucleotides (Basile, G., Taglialatela-Scafati, O., Damonte, G., Armirotti, A., Bruzzone, S., Guida, L., Franco, L., Usai, C., Fattorusso, E., De Flora, A., and Zocchi, E. (2005) Proc. Natl. Acad. Sci. U.S.A. 102, 14509-14514). P24, but not P18, proved to increase the intracellular Ca2+ concentration ([Ca2+](i)) in HeLa cells and to negatively affect mitochondrial function. Here we show that micromolar P24, but not P18, triggers a slow and sustained influx of extracellular Ca2+ through the opening of the purinergic receptor/channel P2X7. On the other hand, P18 inhibits the Ca2+ influx induced by 0.6 mM ATP in HEK293 cells stably transfected with P2X7, with an IC50 of similar to 1 mu M. Thus, P18 is devoid of intrinsic P2X7 stimulatory activity and behaves as an ATP antagonist. A P2X7-mediated increase of the basal [Ca2+](i) has been demonstrated to negatively affect Schwann cell (SC) function in rats with the inherited, peripheral neuropathy Charcot-Marie-Tooth 1A (CMT1A) (Nobbio, L., Sturla, L., Fiorese, F., Usai, C., Basile, G., Moreschi, I., Benvenuto, F., Zocchi, E., De Flora, A., Schenone, A., and Bruzzone S. (2009) J. Biol. Chem. 284, 23146-23158). Preincubation of CMT1A SC with 200 nM P18 restored the basal [Ca2+](i) to values similar to those recorded in wild-type SC. These results identify P18 as a new P2X7 antagonist, potentially useful in the treatment of CMT1A.	[Bruzzone, Santina] Univ Genoa, Dept Expt Med, Biochem Sect, DIMES Sect Biochem, I-16132 Genoa, Italy; [Bruzzone, Santina; Basile, Giovanna; Chothi, Madhu Parakkottil; Nobbio, Lucilla; Schenone, Angelo; De Flora, Antonio; Zocchi, Elena] Univ Genoa, CEBR, I-16132 Genoa, Italy; [Chothi, Madhu Parakkottil; Nobbio, Lucilla; Schenone, Angelo] Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy; [Usai, Cesare; Jacchetti, Emanuela] CNR, Inst Biophys, I-16149 Genoa, Italy; [Nobbio, Lucilla; Schenone, Angelo] CNR, Inst Physiol & Bioimages, I-16149 Genoa, Italy; [Guse, Andreas H.] Univ Med Ctr Hamburg Eppendorf, Inst Biochem & Mol Biol 1, Ctr Med Expt, D-20246 Hamburg, Germany; [Di Virgilio, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; [Di Virgilio, Francesco] Univ Ferrara, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy	University of Genoa; University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Consiglio Nazionale delle Ricerche (CNR); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Ferrara; University of Ferrara	Bruzzone, S (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, DIMES Sect Biochem, Viale Benedetto XV-1, I-16132 Genoa, Italy.	santina.bruzzone@unige.it	JACCHETTI, Emanuela/AAP-2453-2021; schenone, angelo/I-3194-2012; Madhu, Parakkottil Chothi/AAF-8251-2021; Nobbio, Lucilla/J-1213-2018; Bruzzone, Santina/A-4264-2015; Di Virgilio, Francesco/J-3754-2018; DI VIRGILIO, Francesco/O-4634-2019	JACCHETTI, Emanuela/0000-0001-5990-001X; schenone, angelo/0000-0002-2604-7830; Madhu, Parakkottil Chothi/0000-0002-3138-1075; Nobbio, Lucilla/0000-0003-2150-3953; Bruzzone, Santina/0000-0003-2034-3716; Di Virgilio, Francesco/0000-0003-3566-1362; DI VIRGILIO, Francesco/0000-0003-3566-1362; Usai, Cesare/0000-0001-8863-7759	Telethon [GGP06178, GUP05007]; Regione Liguria; Italian Ministry of Education, University and Scientific Research [MIUR-PRIN 2005, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF, MIUR FIRB RBIP06LSS2]; University of Genova; Fondazione Cassa di Risparmio di Genova e Imperia; Fondazione Compagnia di S. Paolo; Associazione Italiana per la Ricerca sul Cancro (AIRC)	Telethon(Fondazione Telethon); Regione Liguria(Regione Liguria); Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Genova; Fondazione Cassa di Risparmio di Genova e Imperia; Fondazione Compagnia di S. Paolo(Compagnia di San Paolo); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by grants from Telethon (GGP06178 and GUP05007), from Regione Liguria, from the Italian Ministry of Education, University and Scientific Research (MIUR-PRIN 2005, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF, MIUR FIRB RBIP06LSS2) from the University of Genova, from Fondazione Cassa di Risparmio di Genova e Imperia, from Fondazione Compagnia di S. Paolo, and from Associazione Italiana per la Ricerca sul Cancro (AIRC).	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adriouch S, 2008, FASEB J, V22, P861, DOI 10.1096/fj.07-9294com; Baraldi PG, 2004, CURR TOP MED CHEM, V4, P1707, DOI 10.2174/1568026043387223; Basile G, 2005, P NATL ACAD SCI USA, V102, P14509, DOI 10.1073/pnas.0503691102; Bruzzone S, 2007, J BIOL CHEM, V282, P5045, DOI 10.1074/jbc.M609802200; Chen LF, 2006, J IMMUNOL, V176, P3115, DOI 10.4049/jimmunol.176.5.3115; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; DeFlora A, 1997, J BIOL CHEM, V272, P12945, DOI 10.1074/jbc.272.20.12945; Dell'Antonio G, 2002, ARTHRITIS RHEUM-US, V46, P3378, DOI 10.1002/art.10678; Dell'Antonio G, 2002, NEUROSCI LETT, V327, P87, DOI 10.1016/S0304-3940(02)00385-3; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Ferrari D, 2007, BRIT J PHARMACOL, V150, P445, DOI 10.1038/sj.bjp.0706994; Gargett CE, 1997, BRIT J PHARMACOL, V120, P1483, DOI 10.1038/sj.bjp.0701081; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Hong SY, 2009, J IMMUNOL, V183, P578, DOI 10.4049/jimmunol.0900120; Honore P, 2006, BEHAV BRAIN RES, V167, P355, DOI 10.1016/j.bbr.2005.09.024; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Jankowski J, 2001, J BIOL CHEM, V276, P8904, DOI 10.1074/jbc.M009527200; Kawamura H, 2006, J IMMUNOL, V176, P2152, DOI 10.4049/jimmunol.176.4.2152; Klapperstuck M, 2001, J PHYSIOL-LONDON, V534, P25, DOI 10.1111/j.1469-7793.2001.00025.x; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Magnone M, 2008, J BIOL CHEM, V283, P24460, DOI 10.1074/jbc.M710568200; Michel AD, 2007, BRIT J PHARMACOL, V152, P523, DOI 10.1038/sj.bjp.0707417; Michel AD, 1999, N-S ARCH PHARMACOL, V359, P102, DOI 10.1007/PL00005328; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Nelson DW, 2006, J MED CHEM, V49, P3659, DOI 10.1021/jm051202e; Nobbio L, 2009, J BIOL CHEM, V284, P23146, DOI 10.1074/jbc.M109.027128; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schluter H, 1996, J AUTON PHARMACOL, V16, P357, DOI 10.1111/j.1474-8673.1996.tb00053.x; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Verhoef PA, 2005, J IMMUNOL, V175, P7623, DOI 10.4049/jimmunol.175.11.7623; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Walseth TF, 2005, P NATL ACAD SCI USA, V102, P14941, DOI 10.1073/pnas.0507258102; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017	49	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21165	21174		10.1074/jbc.M109.097964	http://dx.doi.org/10.1074/jbc.M109.097964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439466	Green Published, hybrid			2022-12-25	WOS:000279228600079
J	Dubielecka, PM; Cui, P; Xiong, XL; Hossain, S; Heck, S; Angelov, L; Kotula, L				Dubielecka, Patrycja M.; Cui, Ping; Xiong, Xiaoling; Hossain, Sajjad; Heck, Susanne; Angelov, Lyudmil; Kotula, Leszek			Differential Regulation of Macropinocytosis by Abi1/Hssh3bp1 Isoforms	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; BINDING PROTEIN RAC; GROWTH-FACTOR; DENDRITIC CELLS; 3T3 CELLS; ACTIVATION; DISTINCT; EPS8; GTP; PINOCYTOSIS	Background: Macropinocytosis, which is a constitutive cellular process of fluid and macromolecule uptake, is regulated by actin cytoskeleton rearrangements near the plasma membrane. Activation of Rac1, which is proposed to act upstream of the actin polymerization regulatory Wave 2 complex, has been found to correlate with enhanced macropinocytosis. One of the components of the Wave 2 complex is Abi1. Multiple, alternatively spliced isoforms of Abi1 are expressed in mammalian cells, but the functional significance of the various isoforms is unknown. Principal Findings: Here, using flow cytometric assay analysis for Alexa Fluor 647, we demonstrate that Abi1 isoforms 2 and 3 differentially regulate macropinocytosis. LNCaP cells expressing isoform 3 had increased macropinocytic uptake that correlated with enhanced cell spreading and higher Rac1 activation in comparison to cells expressing isoform 2. Isoform 2 expressing cells had decreased macropinocytic uptake, but demonstrated greater sensitivity to Rac1 activation. Moreover, more isoform 2 was localized within the cytoplasm in comparison to isoform 3, which was more associated with the plasma membrane. Activated Rac1 was found to specifically bind to a site in exon 10 of isoform 2 in vitro. Because of alternative mRNA splicing, exon 10 is absent from isoform 3, precluding similar binding of activated Rac1. Both isoforms, however, bound to inactive Rac1 through the same non-exon 10 site. Thus, Abi1 isoform 3-containing Wave 2 complex exhibited a differential binding to activated vs. inactive Rac1, whereas isoform 2-containing Wave 2 complex bound activated or inactive Rac1 comparably. Conclusion: Based on these observations, we postulate that Abi1 isoforms differentially regulate macropinocytosis as a consequence of their different relative affinities for activated Rac1 in Wave 2 complex. These findings also raise the possibility that isoform-specific roles occur in other Abi1 functions.	[Dubielecka, Patrycja M.; Cui, Ping; Xiong, Xiaoling; Hossain, Sajjad; Kotula, Leszek] New York Blood Ctr, Lab Cell Signaling, New York, NY 10021 USA; [Angelov, Lyudmil] New York Blood Ctr, Confocal Microscopy Lab, New York, NY 10021 USA	New York Blood Center; New York Blood Center	Dubielecka, PM (corresponding author), New York Blood Ctr, Lab Cell Signaling, New York, NY 10021 USA.	lkotula@nybloodcenter.org	Dubielecka, Patrycja/AAF-8128-2019	Kotula, Leszek/0000-0002-7977-7124	National Institutes of Health [R01 NS044968]; Department of Defense [W81XWH-08-1-0320]; F. M. Kirby Foundation, Inc., Morristown, New Jersey; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); F. M. Kirby Foundation, Inc., Morristown, New Jersey; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants R01 NS044968 (National Institutes of Health) and W81XWH-08-1-0320 (Department of Defense) (L. K.). Xiaoling Xiong and Sajjad Hossain were supported in part by a grant (L. K.) from the F. M. Kirby Foundation, Inc., Morristown, New Jersey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amyere M, 2002, INT J MED MICROBIOL, V291, P487; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Cardelli J, 2001, TRAFFIC, V2, P311, DOI 10.1034/j.1600-0854.2001.002005311.x; DAVIES PF, 1978, J CELL BIOL, V79, P663, DOI 10.1083/jcb.79.3.663; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Fiorentini C, 2003, CELL DEATH DIFFER, V10, P147, DOI 10.1038/sj.cdd.4401151; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Goi T, 1999, MOL CELL BIOL, V19, P1731; Hackstein H, 2002, BLOOD, V100, P1084, DOI 10.1182/blood.V100.3.1084; HAIGLER HT, 1979, J CELL BIOL, V83, P82, DOI 10.1083/jcb.83.1.82; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Ibarra N, 2005, BIOCHEM SOC T, V33, P1243, DOI 10.1042/BST0331243; Ikeguchi A, 2001, ONCOGENE, V20, P4926, DOI 10.1038/sj.onc.1204502; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kitamura Y, 1997, BIOCHEM J, V322, P873, DOI 10.1042/bj3220873; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Macoska JA, 2001, NEOPLASIA, V3, P99, DOI 10.1038/sj.neo.7900145; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Oda A, 2005, BLOOD, V105, P3141, DOI 10.1182/blood-2003-04-1319; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Ohmori T, 2001, BIOCHEMISTRY-US, V40, P12992, DOI 10.1021/bi0109459; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; RACOOSIN EL, 1992, J CELL SCI, V102, P867; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Shi J, 2005, J BIOL CHEM, V280, P29849, DOI 10.1074/jbc.M500617200; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Watts C., 1989, COLD SPRING HARB SYM, V1, P345; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Xiong XL, 2008, BBA-MOL CELL RES, V1783, P737, DOI 10.1016/j.bbamcr.2008.01.028; Xu JL, 2000, J CELL SCI, V113, P3805; Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207; Ziemnicka-Kotula D, 1998, J BIOL CHEM, V273, P13681, DOI 10.1074/jbc.273.22.13681	54	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10430	10.1371/journal.pone.0010430	http://dx.doi.org/10.1371/journal.pone.0010430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479892	Green Published, Green Submitted, gold			2022-12-25	WOS:000277467900001
J	Busch, MSA; Sedano, A; Simonson, T				Busch, Marcel Schmidt Am; Sedano, Audrey; Simonson, Thomas			Computational Protein Design: Validation and Possible Relevance as a Tool for Homology Searching and Fold Recognition	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; STRUCTURAL GENOMICS; ENERGY FUNCTIONS; SCOP DATABASE; PSI-BLAST; SEQUENCE; STABILITY; PFAM; ALIGNMENTS; PREDICTION	Background: Protein fold recognition usually relies on a statistical model of each fold; each model is constructed from an ensemble of natural sequences belonging to that fold. A complementary strategy may be to employ sequence ensembles produced by computational protein design. Designed sequences can be more diverse than natural sequences, possibly avoiding some limitations of experimental databases. Methodology/Principal Findings: We explore this strategy for four SCOP families: Small Kunitz-type inhibitors (SKIs), Interleukin-8 chemokines, PDZ domains, and large Caspase catalytic subunits, represented by 43 structures. An automated procedure is used to redesign the 43 proteins. We use the experimental backbones as fixed templates in the folded state and a molecular mechanics model to compute the interaction energies between sidechain and backbone groups. Calculations are done with the Proteins@Home volunteer computing platform. A heuristic algorithm is used to scan the sequence and conformational space, yielding 200,000-300,000 sequences per backbone template. The results confirm and generalize our earlier study of SH2 and SH3 domains. The designed sequences ressemble moderately-distant, natural homologues of the initial templates; e. g., the SUPERFAMILY, profile Hidden-Markov Model library recognizes 85% of the low-energy sequences as native-like. Conversely, Position Specific Scoring Matrices derived from the sequences can be used to detect natural homologues within the SwissProt database: 60% of known PDZ domains are detected and around 90% of known SKIs and chemokines. Energy components and inter-residue correlations are analyzed and ways to improve the method are discussed. Conclusions/Significance: For some families, designed sequences can be a useful complement to experimental ones for homologue searching. However, improved tools are needed to extract more information from the designed profiles before the method can be of general use.	[Busch, Marcel Schmidt Am; Sedano, Audrey; Simonson, Thomas] Ecole Polytech, Biochim Lab, CNRS, Dept Biol,UMR7654, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris	Busch, MSA (corresponding author), Ecole Polytech, Biochim Lab, CNRS, Dept Biol,UMR7654, F-91128 Palaiseau, France.	thomas.simonson@polytechnique.fr		Simonson, Thomas/0000-0002-5117-7338	ANR (Agence Nationale de la Recherche)	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR))	The project was supported by the ANR (Agence Nationale de la Recherche) High Performance Computing program (PROTEUS project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson David P., 2004, 5 IEEE ACM INT WORKS; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Busch MSA, 2008, J COMPUT CHEM, V29, P1092, DOI 10.1002/jcc.20870; Busch MSA, 2009, PROTEINS, V77, P139, DOI 10.1002/prot.22426; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chowdry AB, 2007, J COMPUT CHEM, V28, P2378, DOI 10.1002/jcc.20727; Dahiyat BI, 1996, PROTEIN SCI, V5, P895, DOI 10.1002/pro.5560050511; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Desjarlais JR, 1999, J MOL BIOL, V290, P305, DOI 10.1006/jmbi.1999.2866; Dessailly BH, 2009, STRUCTURE, V17, P869, DOI 10.1016/j.str.2009.03.015; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dokholyan NV, 2001, J MOL BIOL, V312, P289, DOI 10.1006/jmbi.2001.4949; Durbin R., 2002, BIOL SEQUENCE ANAL; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; George RA, 2005, P NATL ACAD SCI USA, V102, P12299, DOI 10.1073/pnas.0504833102; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guerler A, 2008, PROTEIN SCI, V17, P1374, DOI 10.1110/ps.035469.108; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; HELLINGA HW, 1994, P NATL ACAD SCI USA, V91, P5803, DOI 10.1073/pnas.91.13.5803; Hubner IA, 2006, P NATL ACAD SCI USA, V103, P17747, DOI 10.1073/pnas.0605580103; Jaramillo A, 2002, P NATL ACAD SCI USA, V99, P13554, DOI 10.1073/pnas.212068599; Kang SG, 2007, CURR OPIN CHEM BIOL, V11, P329, DOI 10.1016/j.cbpa.2007.05.006; Karplus K, 1999, PROTEINS, P121; Koehl P, 1999, P NATL ACAD SCI USA, V96, P12524, DOI 10.1073/pnas.96.22.12524; Koehl P, 1999, J MOL BIOL, V293, P1183, DOI 10.1006/jmbi.1999.3212; Koehl P, 1999, J MOL BIOL, V293, P1161, DOI 10.1006/jmbi.1999.3211; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Larson SM, 2003, J MOL BIOL, V332, P275, DOI 10.1016/S0022-2836(03)00832-5; Larson SM, 2003, PROTEINS, V51, P390, DOI 10.1002/prot.10346; Larson SM, 2002, PROTEIN SCI, V11, P2804, DOI 10.1110/ps.0203902; Launay G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-270; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145; Liu XS, 2004, PROTEINS, V54, P491, DOI 10.1002/prot.10514; Lopes A, 2007, PROTEINS, V67, P853, DOI 10.1002/prot.21379; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Madera M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/nar/gkf544; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marin A, 2002, PROTEINS, V49, P493, DOI 10.1002/prot.10231; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Murphy LR, 2000, PROTEIN ENG, V13, P149, DOI 10.1093/protein/13.3.149; Panchenko AR, 2002, PROTEIN SCI, V11, P361, DOI 10.1110/ps.19902; Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Pokala N, 2004, PROTEIN SCI, V13, P925, DOI 10.1110/ps.03486104; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Raha K, 2000, PROTEIN SCI, V9, P1106, DOI 10.1110/ps.9.6.1106; Saunders CT, 2005, J MOL BIOL, V346, P631, DOI 10.1016/j.jmb.2004.11.062; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schmidt am Busch M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-148; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sillitoe I, 2005, PROTEIN SCI, V14, P1800, DOI 10.1110/ps.041056105; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Street AG, 1998, FOLD DES, V3, P253, DOI 10.1016/S1359-0278(98)00036-4; Swift J, 2006, J AM CHEM SOC, V128, P6611, DOI 10.1021/ja057069x; Todd AE, 2005, J MOL BIOL, V348, P1235, DOI 10.1016/j.jmb.2005.03.037; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; TUFFERY P, 1991, J BIOMOL STRUCT DYN, V8, P1267, DOI 10.1080/07391102.1991.10507882; Venclovas C, 2001, PROTEINS, P47; Ventura S, 2004, PROTEINS, V56, P1, DOI 10.1002/prot.20142; Wang Y, 2009, NUCLEIC ACIDS RES, V37, P3522, DOI 10.1093/nar/gkp212; Wernisch L, 2000, J MOL BIOL, V301, P713, DOI 10.1006/jmbi.2000.3984; WLODAWER A, 1987, J MOL BIOL, V193, P145, DOI 10.1016/0022-2836(87)90633-4; Wollacott AM, 2007, PROTEIN SCI, V16, P165, DOI 10.1110/ps.062270707; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308	86	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10410	10.1371/journal.pone.0010410	http://dx.doi.org/10.1371/journal.pone.0010410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463972	Green Published, gold			2022-12-25	WOS:000277379400004
J	Janssen, PJ; Van Houdt, R; Moors, H; Monsieurs, P; Morin, N; Michaux, A; Benotmane, MA; Leys, N; Vallaeys, T; Lapidus, A; Monchy, B; Medigue, C; Taghavi, S; McCorkle, S; Dunn, J; van der Lelie, D; Mergeay, M				Janssen, Paul J.; Van Houdt, Rob; Moors, Hugo; Monsieurs, Pieter; Morin, Nicolas; Michaux, Arlette; Benotmane, Mohammed A.; Leys, Natalie; Vallaeys, Tatiana; Lapidus, Alla; Monchy, Bastien; Medigue, Claudine; Taghavi, Safiyh; McCorkle, Sean; Dunn, John; van der Lelie, Daniel; Mergeay, Max			The Complete Genome Sequence of Cupriavidus metallidurans Strain CH34, a Master Survivalist in Harsh and Anthropogenic Environments	PLOS ONE			English	Article							ALCALIGENES-EUTROPHUS CH34; HEAVY-METAL RESISTANCE; INTRACELLULAR 3-HYDROXYBUTYRATE-OLIGOMER HYDROLASE; TRANSPORTER CLASSIFICATION DATABASE; MICROBIAL SIGNAL-TRANSDUCTION; COMPLETE NUCLEOTIDE-SEQUENCE; 2 CAPSULAR POLYSACCHARIDES; COPPER-BINDING PROTEIN; COENZYME-A REDUCTASE; RALSTONIA-EUTROPHA	Many bacteria in the environment have adapted to the presence of toxic heavy metals. Over the last 30 years, this heavy metal tolerance was the subject of extensive research. The bacterium Cupriavidus metallidurans strain CH34, originally isolated by us in 1976 from a metal processing factory, is considered a major model organism in this field because it withstands milli-molar range concentrations of over 20 different heavy metal ions. This tolerance is mostly achieved by rapid ion efflux but also by metal-complexation and -reduction. We present here the full genome sequence of strain CH34 and the manual annotation of all its genes. The genome of C. metallidurans CH34 is composed of two large circular chromosomes CHR1 and CHR2 of, respectively, 3,928,089 bp and 2,580,084 bp, and two megaplasmids pMOL28 and pMOL30 of, respectively, 171,459 bp and 233,720 bp in size. At least 25 loci for heavy-metal resistance (HMR) are distributed over the four replicons. Approximately 67% of the 6,717 coding sequences (CDSs) present in the CH34 genome could be assigned a putative function, and 9.1% (611 genes) appear to be unique to this strain. One out of five proteins is associated with either transport or transcription while the relay of environmental stimuli is governed by more than 600 signal transduction systems. The CH34 genome is most similar to the genomes of other Cupriavidus strains by correspondence between the respective CHR1 replicons but also displays similarity to the genomes of more distantly related species as a result of gene transfer and through the presence of large genomic islands. The presence of at least 57 IS elements and 19 transposons and the ability to take in and express foreign genes indicates a very dynamic and complex genome shaped by evolutionary forces. The genome data show that C. metallidurans CH34 is particularly well equipped to live in extreme conditions and anthropogenic environments that are rich in metals.	[Janssen, Paul J.; Van Houdt, Rob; Moors, Hugo; Monsieurs, Pieter; Morin, Nicolas; Michaux, Arlette; Benotmane, Mohammed A.; Leys, Natalie; Mergeay, Max] Belgian Nucl Res Ctr SCK CEN, Mol, Belgium; [Vallaeys, Tatiana] Univ Montpellier 2, Lab Ecosyst Lagunaires ECOLAG, CNRS, UMR 5119, Montpellier, France; [Lapidus, Alla] Lawrence Berkeley Natl Lab, Joint Genome Inst, Walnut Creek, CA USA; [Monchy, Bastien] Univ Blaise Pascal, LMGE, CNRS, UMR 6023, Aubiere, France; [Medigue, Claudine] CNRS, UMR8030, Lab Anal Bioinformat Genom & Metab LABGeM, Evry, France; [Medigue, Claudine] CEA DSV IG Genoscope, Evry, France; [Taghavi, Safiyh; McCorkle, Sean; Dunn, John; van der Lelie, Daniel] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Belgian Nuclear Research Centre (SCK-CEN); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; CEA; UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Brookhaven National Laboratory	Janssen, PJ (corresponding author), Belgian Nucl Res Ctr SCK CEN, Mol, Belgium.	pjanssen@sckcen.be	Mergeay, Max/H-2003-2011; Monsieurs, Pieter/A-2917-2009; Vallaeys, Tatiana/AAE-5508-2019; Van Houdt, Rob/B-8599-2011; Janssen, Paul/V-8575-2019; Leys, Natalie M.E.J./P-2761-2017; Lapidus, Alla L/I-4348-2013; Monsieurs, Pieter/W-3916-2019	Van Houdt, Rob/0000-0002-7459-496X; Janssen, Paul/0000-0002-7877-0270; Lapidus, Alla L/0000-0003-0427-8731; Monsieurs, Pieter/0000-0003-2214-6652; MONCHY, Sebastien/0000-0001-5808-4700; McCorkle, Sean/0000-0003-1126-4071; Benotmane, Rafi/0000-0002-8985-1578	SCK/CEN; European Space Agency [90037, 90094]; Brookhaven and Lawrence Berkeley National Laboratories [LDRD09-005]; United States Department of Energy, Office of Science, Biological and Environmental Research (BER) [KP1102010, DE-AC02-98CH10886]; U.S. Department of Energy	SCK/CEN; European Space Agency(European Space AgencyEuropean Commission); Brookhaven and Lawrence Berkeley National Laboratories; United States Department of Energy, Office of Science, Biological and Environmental Research (BER)(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	The work was partially supported by internal funds of SCK/CEN, by the European Space Agency through the MESSAGE contracts (PRODEX agreements No. 90037 and 90094), and by Laboratory Directed Research and Development funds at the Brookhaven and Lawrence Berkeley National Laboratories. JD, SMcC, ST and DvdL acknowledge support by the United States Department of Energy, Office of Science, Biological and Environmental Research (BER), project number KP1102010 under contract DE-AC02-98CH10886, and by Laboratory Directed Research and Development funds (LDRD09-005) at the Brookhaven National Laboratory under contract with the U.S. Department of Energy. SM and NM acknowledge the support via a SCK/CEN PhD grant (AWM-programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano D.C., 2001, TRACE ELEMENTS TERRE, DOI 10.1007/978-0-387-21510-5; Alber B, 2006, J BACTERIOL, V188, P8551, DOI 10.1128/JB.00987-06; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amadou C, 2008, GENOME RES, V18, P1472, DOI 10.1101/gr.076448.108; Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; Antoine R, 2005, J MOL BIOL, V351, P799, DOI 10.1016/j.jmb.2005.05.071; Antoine R, 2003, J BACTERIOL, V185, P1470, DOI 10.1128/JB.185.4.1470-1474.2003; Antoine R, 2000, INT J MED MICROBIOL, V290, P301; Arrecubieta C, 2001, J BIOL CHEM, V276, P4245, DOI 10.1074/jbc.M008183200; Atomi H, 2002, J BIOSCI BIOENG, V94, P497, DOI 10.1016/S1389-1723(02)80186-4; Audic S, 2007, PLOS GENET, V3, P1454, DOI 10.1371/journal.pgen.0030138; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bersch B, 2008, J MOL BIOL, V380, P386, DOI 10.1016/j.jmb.2008.05.017; Bhatt G, 2004, J BACTERIOL, V186, P7896, DOI 10.1128/JB.186.23.7896-7904.2004; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Borremans B, 2001, J BACTERIOL, V183, P5651, DOI 10.1128/JB.183.19.5651-5658.2001; Boyd JM, 2004, J BIOL CHEM, V279, P46644, DOI 10.1074/jbc.M407177200; Braud A, 2009, CHEMOSPHERE, V74, P280, DOI 10.1016/j.chemosphere.2008.09.013; Brickman TJ, 1996, J BACTERIOL, V178, P54, DOI 10.1128/jb.178.1.54-60.1996; BROWN NL, 1995, MOL MICROBIOL, V17, P1153, DOI 10.1111/j.1365-2958.1995.mmi_17061153.x; Cafaro V, 2004, APPL ENVIRON MICROB, V70, P2211, DOI 10.1128/AEM.70.4.2211-2219.2004; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Clarke BR, 1999, J BACTERIOL, V181, P2279, DOI 10.1128/JB.181.7.2279-2285.1999; Clough SJ, 1997, APPL ENVIRON MICROB, V63, P844, DOI 10.1128/AEM.63.3.844-850.1997; Coenye T, 2005, J CLIN MICROBIOL, V43, P3463, DOI 10.1128/JCM.43.7.3463-3466.2005; COLLARD JM, 1994, FEMS MICROBIOL REV, V14, P405, DOI 10.1016/0168-6445(94)90059-0; Cramm R, 2009, J MOL MICROB BIOTECH, V16, P38, DOI 10.1159/000142893; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; De Gelder J, 2009, MICROGRAVITY SCI TEC, V21, P217, DOI 10.1007/s12217-008-9037-0; Defrance M, 2008, NAT PROTOC, V3, P1589, DOI 10.1038/nprot.2008.98; Denger K, 1997, ARCH MICROBIOL, V168, P297, DOI 10.1007/s002030050502; Denger K, 2008, MICROBIOL-SGM, V154, P256, DOI 10.1099/mic.0.2007/011650-0; DERORE H, 1994, FEMS MICROBIOL ECOL, V14, P263, DOI 10.1111/j.1574-6941.1994.tb00112.x; DIELS L, 1995, J IND MICROBIOL, V14, P142, DOI 10.1007/BF01569896; DIELS L, 1985, ARCH INT PHYSIOL BIO, V93, pB27; DIELS L, 1993, SCI TOTAL ENVIRON, V140, P471, DOI 10.1016/0048-9697(93)90044-7; Diels L, 2009, ANTON LEEUW INT J G, V96, P247, DOI 10.1007/s10482-009-9361-4; DONG Q, 1992, J BACTERIOL, V174, P8133, DOI 10.1128/JB.174.24.8133-8138.1992; DONG QH, 1994, MOL MICROBIOL, V14, P185, DOI 10.1111/j.1365-2958.1994.tb01278.x; Egan ES, 2005, MOL MICROBIOL, V56, P1129, DOI 10.1111/j.1365-2958.2005.04622.x; Elsen S, 2004, MICROBIOL MOL BIOL R, V68, P263, DOI 10.1128/MMBR.68.2.263-279.2004; Enright AJ, 2000, BIOINFORMATICS, V16, P451, DOI 10.1093/bioinformatics/16.5.451; Fergusson JE, 1990, HEAVY ELEMENTS CHEM; FEULNER G, 1990, J BACTERIOL, V172, P446, DOI 10.1128/JB.172.1.446-456.1990; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Fricke WF, 2009, J MOL MICROB BIOTECH, V16, P124, DOI 10.1159/000142899; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Fry NK, 2005, EMERG INFECT DIS, V11, P1131, DOI 10.3201/eid1107.050046; Galperin MY, 2005, ASM NEWS, V71, P326; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Garg RP, 2000, MOL MICROBIOL, V38, P359, DOI 10.1046/j.1365-2958.2000.02131.x; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Gibson JL, 1997, J BACTERIOL, V179, P663, DOI 10.1128/jb.179.3.663-669.1997; Gilis A, 1998, J IND MICROBIOL BIOT, V20, P61, DOI 10.1038/sj.jim.2900478; Gilis A, 1996, J BACTERIOL, V178, P5499, DOI 10.1128/jb.178.18.5499-5507.1996; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goris J, 2001, INT J SYST EVOL MICR, V51, P1773, DOI 10.1099/00207713-51-5-1773; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Gross R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-449; Grosse C, 1999, J BACTERIOL, V181, P2385; Grosse C, 2007, J MOL MICROB BIOTECH, V12, P227, DOI 10.1159/000099644; Guine V, 2006, ENVIRON SCI TECHNOL, V40, P1806, DOI 10.1021/es050981l; Haines AS, 2007, PLASMID, V58, P76, DOI 10.1016/j.plasmid.2007.01.001; Harrison FH, 2005, MICROBIOL-SGM, V151, P727, DOI 10.1099/mic.0.27731-0; Harwood CS, 1998, FEMS MICROBIOL REV, V22, P439, DOI 10.1016/S0168-6445(98)00026-6; Hassan MET, 1999, GENE, V238, P417, DOI 10.1016/S0378-1119(99)00349-2; Herrou J, 2007, J MOL BIOL, V373, P954, DOI 10.1016/j.jmb.2007.08.006; HILL CW, 1994, MOL MICROBIOL, V12, P865, DOI 10.1111/j.1365-2958.1994.tb01074.x; Hugler M, 2002, J BACTERIOL, V184, P2404, DOI 10.1128/JB.184.9.2404-2410.2002; Huvent I, 2006, J MOL BIOL, V356, P1014, DOI 10.1016/j.jmb.2005.11.096; Hynninen A, 2009, MOL MICROBIOL, V74, P384, DOI 10.1111/j.1365-2958.2009.06868.x; JENDROSSEK D, 1990, J BACTERIOL, V172, P4844, DOI 10.1128/jb.172.9.4844-4851.1990; Jian X, 2009, J AM CHEM SOC, V131, P10869, DOI 10.1021/ja904279n; Juhnke S, 2002, ARCH MICROBIOL, V179, P15, DOI 10.1007/s00203-002-0492-5; Kageyama C, 2005, ARCH MICROBIOL, V183, P56, DOI 10.1007/s00203-004-0746-5; Khanna S, 2005, PROCESS BIOCHEM, V40, P607, DOI 10.1016/j.procbio.2004.01.053; King GM, 2007, NAT REV MICROBIOL, V5, P107, DOI 10.1038/nrmicro1595; Kiss E, 2001, MOL PLANT MICROBE IN, V14, P1395, DOI 10.1094/MPMI.2001.14.12.1395; Kitada M, 2000, EXTREMOPHILES, V4, P253, DOI 10.1007/s007920070010; Klockgether J, 2007, J BACTERIOL, V189, P2443, DOI 10.1128/JB.01688-06; Kobayashi T, 2005, J BACTERIOL, V187, P5129, DOI 10.1128/JB.187.15.5129-5135.2005; Kobayashi T, 2003, J BACTERIOL, V185, P3485, DOI 10.1128/JB.185.12.3485-3490.2003; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larbig KD, 2002, J BACTERIOL, V184, P6665, DOI 10.1128/JB.184.23.6665-6680.2002; Leedjarv A, 2008, J BACTERIOL, V190, P2680, DOI 10.1128/JB.01494-07; Legatzki A, 2003, J BACTERIOL, V185, P4354, DOI 10.1128/JB.185.15.4354-4361.2003; LEJEUNE P, 1983, J BACTERIOL, V155, P1015, DOI 10.1128/JB.155.3.1015-1026.1983; Lenz RW, 2005, BIOMACROMOLECULES, V6, P1, DOI 10.1021/bm049700c; Leys N, 2009, ANTON LEEUW INT J G, V96, P227, DOI 10.1007/s10482-009-9360-5; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; LIESEGANG H, 1993, J BACTERIOL, V175, P767, DOI 10.1128/JB.175.3.767-778.1993; Lorite MJ, 2000, APPL ENVIRON MICROB, V66, P1871, DOI 10.1128/AEM.66.5.1871-1876.2000; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Lutke-Eversloh T, 1999, FEMS MICROBIOL LETT, V181, P63; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mergeay M, 2003, FEMS MICROBIOL REV, V27, P385, DOI 10.1016/S0168-6445(03)00045-7; MERGEAY M, 1978, ARCH INT PHYSIOL BIO, V86, P440; Mergeay M, 2000, BACTERIAL STRESS RESPONSES, P403; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; MERGEAY M, 1987, MOL GEN GENET, V209, P61, DOI 10.1007/BF00329837; MERGEAY M, 1987, ARCH INT PHYSIOL BIO, V95, pB36; Mergeay Max, 2009, V11, P209, DOI 10.1007/7171_2008_19; Merlin C, 1999, PLASMID, V41, P40, DOI 10.1006/plas.1998.1375; Merlin C, 1997, MOL GEN GENET, V253, P499; Mikolay A, 2009, ANTON LEEUW INT J G, V96, P183, DOI 10.1007/s10482-008-9303-6; Moissl C, 2007, FEMS MICROBIOL ECOL, V61, P509, DOI 10.1111/j.1574-6941.2007.00360.x; Monchy S, 2006, INT J ENVIRON AN CH, V86, P677, DOI 10.1080/03067310600583824; Monchy S, 2007, J BACTERIOL, V189, P7417, DOI 10.1128/JB.00375-07; Monchy S, 2006, MICROBIOL-SGM, V152, P1765, DOI 10.1099/mic.0.28593-0; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Muller D, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030053; Munkelt D, 2004, J BACTERIOL, V186, P8036, DOI 10.1128/JB.186.23.8036-8043.2004; Munzinger M, 1999, Z NATURFORSCH C, V54, P867; Nicholson TL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-220; NIES A, 1989, J BACTERIOL, V171, P5065, DOI 10.1128/jb.171.9.5065-5070.1989; NIES A, 1990, J BIOL CHEM, V265, P5648; NIES D, 1987, J BACTERIOL, V169, P4865, DOI 10.1128/jb.169.10.4865-4868.1987; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Nies DH, 2004, ARCH MICROBIOL, V181, P255, DOI 10.1007/s00203-004-0658-4; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; NIES DH, 1989, J BACTERIOL, V171, P896, DOI 10.1128/jb.171.2.896-900.1989; Nies DH, 2006, J MOL MICROB BIOTECH, V11, P82, DOI 10.1159/000092820; Noel-Georis I, 2004, PROTEOMICS, V4, P151, DOI 10.1002/pmic.200300551; Notomista E, 2003, J MOL EVOL, V56, P435, DOI 10.1007/s00239-002-2414-1; NOVICK RP, 1968, J BACTERIOL, V95, P1335, DOI 10.1128/JB.95.4.1335-1342.1968; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Pompidor G, 2009, ANTON LEEUW INT J G, V96, P141, DOI 10.1007/s10482-008-9283-6; Promponas VJ, 2000, BIOINFORMATICS, V16, P915, DOI 10.1093/bioinformatics/16.10.915; Reith F, 2006, SCIENCE, V313, P233, DOI 10.1126/science.1125878; Ren QH, 2005, PLOS COMPUT BIOL, V1, P190, DOI 10.1371/journal.pcbi.0010027; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Rosch V, 2008, ARCH MICROBIOL, V190, P11, DOI 10.1007/s00203-008-0357-7; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Roux M, 2001, APPL ENVIRON MICROB, V67, P769, DOI 10.1128/AEM.67.2.769-773.2001; Russo TA, 1998, J BACTERIOL, V180, P338, DOI 10.1128/JB.180.2.338-349.1998; Ryan MP, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-242; SADOUK A, 1993, MOL GEN GENET, V240, P181, DOI 10.1007/BF00277055; Saegusa H, 2002, J BIOSCI BIOENG, V94, P106, DOI 10.1263/jbb.94.106; SAIER MH, 1994, MOL MICROBIOL, V11, P841, DOI 10.1111/j.1365-2958.1994.tb00362.x; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sakakibara Yasubumi, 2007, Nihon Hansenbyo Gakkai Zasshi, V76, P251; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Sarro MI, 2005, INT MICROBIOL, V8, P223; Sato Y, 2006, INT J SYST EVOL MICR, V56, P973, DOI 10.1099/ijs.0.63922-0; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Schleheck D, 2004, APPL ENVIRON MICROB, V70, P4053, DOI 10.1128/AEM.70.7.4053-4063.2004; Schmalenberger A, 2007, ENVIRON MICROBIOL, V9, P535, DOI 10.1111/j.1462-2920.2006.01172.x; SCHMIDT T, 1994, J BACTERIOL, V176, P7045, DOI 10.1128/JB.176.22.7045-7054.1994; Schwartz E, 2003, J MOL BIOL, V332, P369, DOI 10.1016/S0022-2836(03)00894-5; Sendra V, 2006, BIOCHEMISTRY-US, V45, P5557, DOI 10.1021/bi060328q; Siedow A, 1999, J BACTERIOL, V181, P4919, DOI 10.1128/JB.181.16.4919-4928.1999; Siegele DA, 2005, J BACTERIOL, V187, P6253, DOI 10.1128/JB.187.18.6253-6254.2005; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; SILVER S, 1988, ANNU REV MICROBIOL, V42, P717, DOI 10.1146/annurev.mi.42.100188.003441; Sluis MK, 2002, J BACTERIOL, V184, P2969, DOI 10.1128/JB.184.11.2969-2977.2002; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Sousa MC, 2001, STRUCTURE, V9, P1135, DOI 10.1016/S0969-2126(01)00680-3; Springer N, 1996, FEMS MICROBIOL LETT, V135, P333; Stark D, 2007, J MED MICROBIOL, V56, P435, DOI 10.1099/jmm.0.46976-0; Stokes HW, 2007, ANTIMICROB AGENTS CH, V51, P1827, DOI 10.1128/AAC.01279-06; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Sugiyama A, 2004, CURR MICROBIOL, V48, P424, DOI 10.1007/s00284-003-4227-x; SUMMERS AO, 1972, J BACTERIOL, V112, P1228, DOI 10.1128/JB.112.3.1228-1236.1972; TABITA FR, 1992, FEMS MICROBIOL LETT, V99, P107; Taghavi S, 1997, PLASMID, V37, P22, DOI 10.1006/plas.1996.1274; TAGHAVI S, 1994, APPL ENVIRON MICROB, V60, P3585, DOI 10.1128/AEM.60.10.3585-3591.1994; Taghavi S, 1996, MOL GEN GENET, V250, P169, DOI 10.1007/BF02174176; Taghavi S, 2009, ANTON LEEUW INT J G, V96, P171, DOI 10.1007/s10482-008-9289-0; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tauch A, 2002, MICROBIOL-SGM, V148, P1637, DOI 10.1099/00221287-148-6-1637; Tibazarwa C, 2000, J BACTERIOL, V182, P1399, DOI 10.1128/JB.182.5.1399-1409.2000; TOP E, 1994, APPL ENVIRON MICROB, V60, P831, DOI 10.1128/AEM.60.3.831-839.1994; TOP E, 1990, APPL ENVIRON MICROB, V56, P2471, DOI 10.1128/AEM.56.8.2471-2479.1990; TOP EM, 1995, FEMS MICROBIOL ECOL, V18, P191, DOI 10.1016/0168-6496(95)00054-7; Toussaint A, 2003, APPL ENVIRON MICROB, V69, P4837, DOI 10.1128/AEM.69.8.4837-4845.2003; Tseng SP, 2007, ANTIMICROB AGENTS CH, V51, P4187, DOI 10.1128/AAC.00542-07; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Ulrich LE, 2007, NUCLEIC ACIDS RES, V35, pD386, DOI 10.1093/nar/gkl932; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Van der Auwera GA, 2009, ANTON LEEUW INT J G, V96, P193, DOI 10.1007/s10482-009-9316-9; van Elsas JD, 1998, APPL ENVIRON MICROB, V64, P880; Van Houdt R, 2009, ANTON LEEUW INT J G, V96, P205, DOI 10.1007/s10482-009-9345-4; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; Vandamme P, 2004, INT J SYST EVOL MICR, V54, P2285, DOI 10.1099/ijs.0.63247-0; Vaneechoutte M, 2004, INT J SYST EVOL MICR, V54, P317, DOI 10.1099/ijs.0.02754-0; VANGIJSEGEM F, 1982, PLASMID, V7, P30, DOI 10.1016/0147-619X(82)90024-5; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Vimr ER, 2009, MICROBIOL-SGM, V155, P9, DOI 10.1099/mic.0.023564-0; Vincent KA, 2006, CHEM COMMUN, P5033, DOI 10.1039/b614272a; von Rozycki T, 2005, COMP FUNCT GENOM, V6, P17, DOI 10.1002/cfg.454; von Rozycki T, 2009, ANTON LEEUW INT J G, V96, P115, DOI 10.1007/s10482-008-9284-5; von Wintzingerode F, 2001, INT J SYST EVOL MICR, V51, P1257, DOI 10.1099/00207713-51-4-1257; Wang F, 2007, CHEMOSPHERE, V67, P896, DOI 10.1016/j.chemosphere.2006.11.019; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wrighton KC, 2009, MICROBE, V4, P281; York GM, 2003, J BACTERIOL, V185, P3788, DOI 10.1128/JB.185.13.3788-3794.2003; Zhang YB, 2009, ANTON LEEUW INT J G, V96, P161, DOI 10.1007/s10482-009-9313-z; Zoropogui A, 2008, BIOCHEM BIOPH RES CO, V365, P735, DOI 10.1016/j.bbrc.2007.11.030	226	202	454	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10433	10.1371/journal.pone.0010433	http://dx.doi.org/10.1371/journal.pone.0010433			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463976	Green Submitted, Green Published, gold			2022-12-25	WOS:000277379400008
J	Knapp, S				Knapp, Sandra			Four New Vining Species of Solanum (Dulcamaroid Clade) from Montane Habitats in Tropical America	PLOS ONE			English	Article								Background: Solanum (Solanaceae), with approximately 1500 species, is one of the largest genera of flowering plants, and has a centre of diversity in the New World tropics. The genus is divided into 13 major clades, of which two, the Dulcamaroid clade and the "African Non-Spiny'' clade, exhibit vine morphology with twining petioles. I am currently preparing a worldwide monograph of these two groups, comprising some 70 species. Methods: I formally describe here four new species of Solanum from montane Mexico and South America all belonging to the Dulcamaroid clade (including the traditionally recognised section Jasminosolanum Bitter). Descriptions, discussions of closely related species and preliminary conservation assessments are provided for all species; all species are illustrated. This paper is also a test case for the electronic publication of new names in flowering plants. Conclusions: These new species are all relatively rare, but not currently of conservation concern. Solanum aspersum sp. nov. is distributed in Colombia and Ecuador, S. luculentum sp. nov. in Colombia and Venezuela, S. sanchez-vegae sp. nov. is endemic to northern Peru and S. sousae sp. nov. to southern Mexico. Solanum luculentum has the morphology of a dioecious species; this is the first report of this breeding system in the Dulcamaroid clade.	Nat Hist Museum, Dept Bot, London SW7 5BD, England	Natural History Museum London	Knapp, S (corresponding author), Nat Hist Museum, Dept Bot, Cromwell Rd, London SW7 5BD, England.	s.knapp@nhm.ac.uk	Knapp, Sandra/A-4856-2011	Knapp, Sandra/0000-0001-7698-3945	National Science Foundation [DEB-0316614]	National Science Foundation(National Science Foundation (NSF))	Financial support for this work came from the National Science Foundation Planetary Biodiversity Inventory (award DEB-0316614, "PBI Solanum-A Worldwide Treatment'') (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohs L., 2005, MONOGRAPHS SYSTEMATI, P27, DOI DOI 10.1111/J.1365-2699.2007.01870.X; Candolle, 1852, PRODROMUS SYSTEMATIS, V13, P1, DOI [10.5962/bhl.title.286, DOI 10.5962/BHL.TITLE.286]; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Knapp S, 2006, TAXON, V55, P2, DOI 10.2307/25065662; Knapp S, 1998, PLANT SYST EVOL, V210, P113, DOI 10.1007/BF00984731; Knapp S., 1989, B BRIT MUS NAT HIST, V19, p63 ; KNAPP S, 2010, SYSTEMA NATURAE, V250, P83, DOI DOI 10.1201/EBK1420095012-C8; Knapp S, 2002, FLORA NEOTROPICA, V84, P1; Knapp S, 2008, ANN MO BOT GARD, V95, P405, DOI 10.3417/2006159; Knapp S, 2007, NATURE, V446, P261, DOI 10.1038/446261a; McNeill J., 2006, V146, P1; Mentz Lilian Auler, 2004, Pesquisas Botanica, V54, P1; Nee M., 1999, SOLANACEAE, VIV, P285; Weese TL, 2007, SYST BOT, V32, P445, DOI 10.1600/036364407781179671	14	18	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10502	10.1371/journal.pone.0010502	http://dx.doi.org/10.1371/journal.pone.0010502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463921	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379400035
J	Parsons, MH; Blumstein, DT				Parsons, Michael H.; Blumstein, Daniel T.			Familiarity Breeds Contempt: Kangaroos Persistently Avoid Areas with Experimentally Deployed Dingo Scents	PLOS ONE			English	Article							PREDATOR RECOGNITION; BEHAVIOR; CUES; HABITUATION; ODOR; RESPONSES; MARKING; FEAR; REPELLENTS; WALLABIES	Background: Whether or not animals habituate to repeated exposure to predator scents may depend upon whether there are predators associated with the cues. Understanding the contexts of habituation is theoretically important and has profound implication for the application of predator-based herbivore deterrents. We repeatedly exposed a mixed mob of macropod marsupials to olfactory scents (urine, feces) from a sympatric predator (Canis lupus dingo), along with a control (water). If these predator cues were alarming, we expected that over time, some red kangaroos (Macropus rufous), western grey kangaroos (Macropus fuliginosus) and agile wallabies (Macropus agilis) would elect to not participate in cafeteria trials because the scents provided information about the riskiness of the area. Methodology/Principal Findings: We evaluated the effects of urine and feces independently and expected that urine would elicit a stronger reaction because it contains a broader class of infochemicals (pheromones, kairomones). Finally, we scored non-invasive indicators (flight and alarm stomps) to determine whether fear or altered palatability was responsible for the response. Repeated exposure reduced macropodid foraging on food associated with 40 ml of dingo urine, X = 986.75+/-3.97 g food remained as compared to the tap water control, X = 209.0+/-107.0 g (P<0.001). Macropodids fled more when encountering a urine treatment, X = 4.50+/-2.08 flights, as compared to the control, X = 0 flights (P< 0.001). There was no difference in effect between urine or feces treatments (P>0.5). Macropodids did not habituate to repeated exposure to predator scents, rather they avoided the entire experimental area after 10 days of trials (R-2 = 83.8; P<0.001). Conclusions/Significance: Responses to urine and feces were indistinguishable; both elicited fear-based responses and deterred foraging. Despite repeated exposure to predator-related cues in the absence of a predator, macropodids persistently avoided an area of highly palatable food. Area avoidance is consistent with that observed from other species following repeated anti-predator conditioning, However, this is the first time this response has been experimentally observed among medium or large vertebrates 2 where a local response is observed spatially and an area effect is revealed over time.	[Parsons, Michael H.] Curtin Univ Technol, Dept Environm Biol, CEDD, Perth, WA, Australia; [Parsons, Michael H.] Murdoch Univ, Sch Vet Biol & Biomed Sci, Murdoch, WA 6150, Australia; [Blumstein, Daniel T.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Curtin University; Murdoch University; University of California System; University of California Los Angeles	Parsons, MH (corresponding author), Curtin Univ Technol, Dept Environm Biol, CEDD, Perth, WA, Australia.	M.Parsons@Murdoch.edu.au	Blumstein, Daniel T./B-6199-2012	Blumstein, Daniel T./0000-0001-5793-9244	Australian Research Council [LPO776652]; Rural Industries Research and Development Corporation (RIRDC) [PRJ000676]; Minerals and Energy Resources Institute of Western Australia (MERIWA) [M394]; Barrick Gold, Iluka Resources; WA Chemistry Centre	Australian Research Council(Australian Research Council); Rural Industries Research and Development Corporation (RIRDC)(Rural Industries R&D Corp); Minerals and Energy Resources Institute of Western Australia (MERIWA); Barrick Gold, Iluka Resources; WA Chemistry Centre	This research was part-supported by the Australian Research Council (LPO776652; http://www.arc.gov.au), the Rural Industries Research and Development Corporation (RIRDC PRJ000676; http://www.rirdc.gov.au), and the Minerals and Energy Resources Institute of Western Australia (MERIWA M394; http://www.doir.wa.gov.au/meriwa) sponsored by Barrick Gold, Iluka Resources and the WA Chemistry Centre. Except as described, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN G, 1989, ANIM BEHAV, V37, P11, DOI 10.1016/0003-3472(89)90002-X; [Anonymous], 2014, PHEROMONES ANIMAL BE; Arnould C, 1998, J CHEM ECOL, V24, P559, DOI 10.1023/A:1022321104758; ARNOULD C, 1993, J CHEM ECOL, V19, P225, DOI 10.1007/BF00993691; Bednekoff PA, 1997, AM NAT, V150, P373, DOI 10.1086/286070; Belton LE, 2007, AFR ZOOL, V42, P135, DOI 10.3377/1562-7020(2007)42[135:DCGSXI]2.0.CO;2; BENDER H, 2005, THESIS U MELBOURNE M; Blumstein DT, 2000, BEHAV ECOL, V11, P528, DOI 10.1093/beheco/11.5.528; Blumstein DT, 2002, ANIM CONSERV, V5, P87, DOI 10.1017/S1367943002002123; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Burger BV, 2005, TOP CURR CHEM, V240, P231, DOI 10.1007/b98318; Cohen J., 1998, STAT POWER ANAL BEHA; Deecke VB, 2002, NATURE, V420, P171, DOI 10.1038/nature01030; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; EPPLE G, 1995, ECOL APPL, V5, P1163, DOI 10.2307/2269363; Erhard HW, 2006, APPL ANIM BEHAV SCI, V99, P132, DOI 10.1016/j.applanim.2005.10.008; ERLINGE S, 1982, ANIM BEHAV, V30, P811, DOI 10.1016/S0003-3472(82)80154-1; EVANS JP, 2007, BEHAV ECO SOCIOBIOL, V61, P340; Gelperin A, 2008, J CHEM ECOL, V34, P928, DOI 10.1007/s10886-008-9483-6; Godard RD, 2007, J AVIAN BIOL, V38, P128, DOI 10.1111/j.2007.0908-8857.03788.x; Gonzalo A, 2007, ANIM BEHAV, V74, P447, DOI 10.1016/j.anbehav.2006.11.032; Gorman M.L., 1989, P57; Hazlett BA, 1999, BEHAVIOUR, V136, P161, DOI 10.1163/156853999501261; HOLLEN LL, 2007, ETHOL, V113; HOLOMUZKI JR, 1994, FRESHWATER BIOL, V32, P585, DOI 10.1111/j.1365-2427.1994.tb01149.x; Hunt M, 1999, PHYSIOL BEHAV, V67, P365, DOI 10.1016/S0031-9384(99)00084-0; JEDRZEJEWSKI W, 1990, CAN J ZOOL, V68, P660, DOI 10.1139/z90-096; Jones M, 2000, J CHEM ECOL, V26, P455, DOI 10.1023/A:1005417707588; Kesavaraju B, 2007, ETHOLOGY, V113, P199, DOI 10.1111/j.1439-0310.2006.01317.x; KIMBALL BA, 2006, ADV VERTEBR PEST MAN, V4, P59; Masini CV, 2005, BEHAV NEUROSCI, V119, P280, DOI 10.1037/0735-7044.119.1.280; MILLS MGL, 1980, S AFR J ZOOL, V15, P240; Monclus R, 2006, CHEMOECOLOGY, V16, P25, DOI 10.1007/s00049-005-0324-6; Muller-Schwarze D, 2006, CHEM ECOLOGY VERTEBR; MURRAY PJ, 2006, AGRIC, V47, P851; NOLTE DL, 1994, J CHEM ECOL, V20, P1505, DOI 10.1007/BF02059876; Parsons MH, 2007, J WILDLIFE MANAGE, V71, P1225, DOI 10.2193/2006-096; Pyare S, 2003, BIOL CONSERV, V113, P63, DOI 10.1016/S0006-3207(02)00350-6; Rameshkumar K, 2008, ZOOL SCI, V25, P349, DOI 10.2108/zsj.25.349; Rosell F, 1998, J CHEM ECOL, V24, P207, DOI 10.1023/A:1022524223435; Rosell F, 2000, WILDLIFE BIOL, V6, P13, DOI 10.2981/wlb.2000.033; SANKAR R, 2008, ANIM SCI, V103; Schultz CJ, 2000, DIABETIC MED, V17, P7, DOI 10.1046/j.1464-5491.2000.00200.x; Seamans TW, 2002, INT J PEST MANAGE, V48, P301, DOI 10.1080/09670870210149853; Shrader AM, 2008, J ARID ENVIRON, V72, P1811, DOI 10.1016/j.jaridenv.2008.05.004; Sprague AJ, 2008, AVIAN CONSERV ECOL, V3; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; SULLIVAN TP, 1986, J CHEM ECOL, V12, P729, DOI 10.1007/BF01012105; Vilhunen S, 2006, J FISH BIOL, V68, P25, DOI 10.1111/j.0022-1112.2006.00873.x; Wilton AN, 1999, J HERED, V90, P108, DOI 10.1093/jhered/90.1.108; Ylonen H, 2006, BEHAV ECOL SOCIOBIOL, V60, P350, DOI 10.1007/s00265-006-0171-7	51	56	59	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10403	10.1371/journal.pone.0010403	http://dx.doi.org/10.1371/journal.pone.0010403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463952	gold, Green Published			2022-12-25	WOS:000277379400003
J	Boni, MF; de Jong, MD; van Doorn, HR; Holmes, EC				Boni, Maciej F.; de Jong, Menno D.; van Doorn, H. Rogier; Holmes, Edward C.			Guidelines for Identifying Homologous Recombination Events in Influenza A Virus	PLOS ONE			English	Article							HEMAGGLUTININ GENE; ANTIGENIC DRIFT; GENOME ANALYSIS; EVOLUTION; RESISTANCE; SEQUENCE; SURVEILLANCE; REASSORTMENT; SELECTION; ALIGNMENT	The rapid evolution of influenza viruses occurs both clonally and non-clonally through a variety of genetic mechanisms and selection pressures. The non-clonal evolution of influenza viruses comprises relatively frequent reassortment among gene segments and a more rarely reported process of non-homologous RNA recombination. Homologous RNA recombination within segments has been proposed as a third such mechanism, but to date the evidence for the existence of this process among influenza viruses has been both weak and controversial. As homologous recombination has not yet been demonstrated in the laboratory, supporting evidence, if it exists, may come primarily from patterns of phylogenetic incongruence observed in gene sequence data. Here, we review the necessary criteria related to laboratory procedures and sample handling, bioinformatic analysis, and the known ecology and evolution of influenza viruses that need to be met in order to confirm that a homologous recombination event occurred in the history of a set of sequences. To determine if these criteria have an effect on recombination analysis, we gathered 8307 publicly available full-length sequences of influenza A segments and divided them into those that were sequenced via the National Institutes of Health Influenza Genome Sequencing Project (IGSP) and those that were not. As sample handling and sequencing are executed to a very high standard in the IGSP, these sequences should be less likely to be exposed to contamination by other samples or by laboratory strains, and thus should not exhibit laboratory-generated signals of homologous recombination. Our analysis shows that the IGSP data set contains only two phylogenetically-supported single recombinant sequences and no recombinant clades. In marked contrast, the non-IGSP data show a very large amount of potential recombination. We conclude that the presence of false positive signals in the non-IGSP data is more likely than false negatives in the IGSP data, and that given the evidence to date, homologous recombination seems to play little or no role in the evolution of influenza A viruses.	[Boni, Maciej F.; de Jong, Menno D.; van Doorn, H. Rogier] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Boni, Maciej F.] Univ Oxford, Ctr Genom & Global Hlth, MRC, Oxford, England; [Boni, Maciej F.; van Doorn, H. Rogier] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Holmes, Edward C.] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, State Coll, University Pk, PA 16802 USA; [Holmes, Edward C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Oxford; University of Oxford; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Boni, MF (corresponding author), Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam.	mboni@oucru.org	Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019; van Doorn, H. Rogier/H-3080-2019	Holmes, Edward/0000-0001-9596-3552; van Doorn, H. Rogier/0000-0002-9807-1821	United Kingdom Medical Research Council [G0600718]; University of Amsterdam; Wellcome Trust [081613/Z/06/Z, 077078/Z/05/Z]; National Institutes of Health [GM080533]; MRC [G0600718] Funding Source: UKRI; Medical Research Council [G0600718] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080533] Funding Source: NIH RePORTER	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Amsterdam; Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MFB is supported by United Kingdom Medical Research Council grant G0600718. MDdJ is supported by the University of Amsterdam. HRvD is supported by Wellcome Trust grants 081613/Z/06/Z and 077078/Z/05/Z. ECH is supported by National Institutes of Health grant GM080533. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki FY, 2007, ANTIVIR THER, V12, P603; Boni MF, 2008, J VIROL, V82, P4807, DOI 10.1128/JVI.02683-07; Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; BOTH GW, 1983, J VIROL, V48, P52, DOI 10.1128/JVI.48.1.52-60.1983; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Chen R, 2009, VIROLOGY, V383, P156, DOI 10.1016/j.virol.2008.10.015; Conzelmann KK, 1998, ANNU REV GENET, V32, P123, DOI 10.1146/annurev.genet.32.1.123; Daly JM, 1996, J GEN VIROL, V77, P661, DOI 10.1099/0022-1317-77-4-661; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Dunham EJ, 2009, J VIROL, V83, P5485, DOI 10.1128/JVI.02565-08; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Ghedin E, 2009, J VIROL, V83, P8832, DOI 10.1128/JVI.00773-09; Gibbs MJ, 2001, SCIENCE, V293, P1842, DOI 10.1126/science.1061662; Gollin D, 2009, LIVEST SCI, V120, P248, DOI 10.1016/j.livsci.2008.07.017; Grassly NC, 1997, MOL BIOL EVOL, V14, P239, DOI 10.1093/oxfordjournals.molbev.a025760; Han GZ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-65; He CQ, 2008, VIROLOGY, V380, P12, DOI 10.1016/j.virol.2008.07.014; He CQ, 2009, MOL BIOL EVOL, V26, P177, DOI 10.1093/molbev/msn238; HOGAN ML, 1986, ADV APPL MATH, V7, P2, DOI 10.1016/0196-8858(86)90003-5; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Krasnitz M, 2008, J VIROL, V82, P8947, DOI 10.1128/JVI.00101-08; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; NELSON M, 2008, PLOS PATHOG, V4; ORLICH M, 1994, VIROLOGY, V204, P462, DOI 10.1006/viro.1994.1555; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r33; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Unitied Nations, 2010, UN COMM TRAD STAT DA; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Worobey M, 2002, SCIENCE, V296; Worobey M, 2008, J VIROL, V82, P3769, DOI 10.1128/JVI.02207-07	49	60	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10434	10.1371/journal.pone.0010434	http://dx.doi.org/10.1371/journal.pone.0010434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454662	Green Published, Green Submitted, gold			2022-12-25	WOS:000277240300010
J	Isingrini, E; Camus, V; Le Guisquet, AM; Pingaud, M; Devers, S; Belzung, C				Isingrini, Elsa; Camus, Vincent; Le Guisquet, Anne-Marie; Pingaud, Maryse; Devers, Severine; Belzung, Catherine			Association between Repeated Unpredictable Chronic Mild Stress (UCMS) Procedures with a High Fat Diet: A Model of Fluoxetine Resistance in Mice	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; DEFINED VASCULAR DEPRESSION; STAR-ASTERISK-D; HIPPOCAMPAL NEUROGENESIS; RISK-FACTORS; SUBCORTICAL HYPERINTENSITIES; ANTIDEPRESSANT REVERSAL; GERIATRIC DEPRESSION; SUCROSE PREFERENCE; STRAIN DIFFERENCES	Major depressive disorder is a debilitating disease. Unfortunately, treatment with antidepressants (ADs) has limited therapeutic efficacy since resistance to AD is common. Research in this field is hampered by the lack of a reliable natural animal model of AD resistance. Depression resistance is related to various factors, including the attendance of cardiovascular risk factors and past depressive episodes. We aimed to design a rodent model of depression resistance to ADs, associating cardiovascular risk factors with repeated unpredicted chronic mild stress (UCMS). Male BALB/c mice were given either a regular (4% fat) or a high fat diet (45% fat) and subjected to two 7-week periods of UCMS separated by 6 weeks. From the second week of each UCMS procedure, vehicle or fluoxetine (10 mg/kg, i.p.) was administrated daily. The effects of the UCMS and fluoxetine in both diet conditions were assessed using physical (coat state and body weight) and behavioural tests (the reward maze test and the splash test). The results demonstrate that during the second procedure, UCMS induced behavioural changes, including coat state degradation, disturbances in self-care behaviour (splash test) and anhedonia (reward maze test) and these were reversed by fluoxetine in the regular diet condition. In contrast, the high-fat diet regimen prevented the AD fluoxetine from abolishing the UCMS-induced changes. In conclusion, by associating UCMS-an already validated animal model of depression-with high-fat diet regimen, we designed a naturalistic animal model of AD resistance related to a sub-nosographic clinical entity of depression.	[Isingrini, Elsa; Camus, Vincent; Le Guisquet, Anne-Marie; Pingaud, Maryse; Devers, Severine; Belzung, Catherine] Univ Tours, ERL 3106, CNRS, INSERM,U930,UMRS UMR, Tours, France; [Camus, Vincent] CHRU Tours, Clin Psychiat Univ, Tours, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Isingrini, E (corresponding author), Univ Tours, ERL 3106, CNRS, INSERM,U930,UMRS UMR, Tours, France.	Isingrini.elsa@voila.fr	Camus, Vincent/ABC-4021-2020; Belzung, Catherine/P-6512-2016; Elsa, Isingrini/T-2406-2018	Belzung, Catherine/0000-0001-6095-5974; Elsa, Isingrini/0000-0002-0698-4237; Camus, Vincent/0000-0002-6845-221X				Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Alexopoulos GS, 2004, NEUROPSYCHOPHARMACOL, V29, P2278, DOI 10.1038/sj.npp.1300557; Alexopoulos GS, 1997, AM J PSYCHIAT, V154, P562; Camus V, 2004, J AFFECT DISORDERS, V81, P1, DOI 10.1016/j.jad.2003.08.003; Carney RM, 2009, AM J PSYCHIAT, V166, P410, DOI 10.1176/appi.ajp.2008.08081239; Cryan JF, 2001, J PHARMACOL EXP THER, V298, P651; Ducottet C, 2004, BEHAV BRAIN RES, V155, P291, DOI 10.1016/j.bbr.2004.04.020; Ducottet C, 2003, PROG NEURO-PSYCHOPH, V27, P625, DOI 10.1016/S0278-5846(03)00051-4; Griebel G, 2005, BIOL PSYCHIAT, V57, P261, DOI 10.1016/j.biopsych.2004.10.032; Hickie I, 1997, BIOL PSYCHIAT, V42, P367, DOI 10.1016/S0006-3223(96)00363-0; HICKIE I, 1995, BIOL PSYCHIAT, V37, P151, DOI 10.1016/0006-3223(94)00174-2; Ibarguen-Vargas Y, 2009, BEHAV BRAIN RES, V202, P245, DOI 10.1016/j.bbr.2009.03.040; Ibarguen-Vargas Y, 2008, PSYCHONEUROENDOCRINO, V33, P1357, DOI 10.1016/j.psyneuen.2008.07.010; Iosifescu DV, 2005, PSYCHOSOM MED, V67, P703, DOI 10.1097/01.psy.0000170338.75346.d0; Jama A, 2008, PSYCHOPHARMACOLOGY, V198, P333, DOI 10.1007/s00213-008-1126-7; Jans V, 2006, Tijdschr Psychiatr, V48, P223; Kaymaz N, 2008, J CLIN PSYCHIAT, V69, P1423, DOI 10.4088/JCP.v69n0910; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kong H, 2009, NEUROPSYCHOPHARMACOL, V34, P1263, DOI 10.1038/npp.2008.185; Krishnan KRR, 1997, AM J PSYCHIAT, V154, P497; Liu GX, 2007, NEUROPSYCHOPHARMACOL, V32, P1531, DOI 10.1038/sj.npp.1301281; Lyness JM, 2000, AM J PSYCHIAT, V157, P1499, DOI 10.1176/appi.ajp.157.9.1499; Mast BT, 2004, AM J GERIAT PSYCHIAT, V12, P93, DOI 10.1176/appi.ajgp.12.1.93; Mineur YS, 2006, BEHAV BRAIN RES, V175, P43, DOI 10.1016/j.bbr.2006.07.029; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; Papakostas GI, 2003, NEUROPSYCHOBIOLOGY, V47, P146, DOI 10.1159/000070584; Partonen T, 1999, BRIT J PSYCHIAT, V175, P259, DOI 10.1192/bjp.175.3.259; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sonawalla SB, 2002, PSYCHOSOMATICS, V43, P310, DOI 10.1176/appi.psy.43.4.310; Souery D, 2007, J CLIN PSYCHIAT, V68, P1062, DOI 10.4088/JCP.v68n0713; Steegmans PHA, 2000, PSYCHOSOM MED, V62, P205, DOI 10.1097/00006842-200003000-00009; Steiner MA, 2008, PHARMACOGENOMICS J, V8, P196, DOI 10.1038/sj.tpj.6500466; Stewart LQ, 2008, PSYCHONEUROENDOCRINO, V33, P405, DOI 10.1016/j.psyneuen.2007.12.009; Surget A, 2008, EXPT MODELS NEUROBEH, P79; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Yalcin I, 2005, EUR J PHARMACOL, V514, P165, DOI 10.1016/j.ejphar.2005.03.029; Yalcin I, 2008, BEHAV BRAIN RES, V193, P140, DOI 10.1016/j.bbr.2008.04.021; Yalcin I, 2007, BEHAV PHARMACOL, V18, P623, DOI 10.1097/FBP.0b013e3282eff109	45	149	151	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10404	10.1371/journal.pone.0010404	http://dx.doi.org/10.1371/journal.pone.0010404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20436931	Green Published, Green Submitted, gold			2022-12-25	WOS:000277154200030
J	King, LE; Soltis, J; Douglas-Hamilton, I; Savage, A; Vollrath, F				King, Lucy E.; Soltis, Joseph; Douglas-Hamilton, Iain; Savage, Anne; Vollrath, Fritz			Bee Threat Elicits Alarm Call in African Elephants	PLOS ONE			English	Article							ACOUSTIC STRUCTURE; VOCALIZATIONS; DISTANCE; COMMUNICATION; EXPRESSION; RESPONSES; CONFLICT; IDENTITY; MONKEYS	Unlike the smaller and more vulnerable mammals, African elephants have relatively few predators that threaten their survival. The sound of disturbed African honeybees Apis meliffera scutellata causes African elephants Loxodonta africana to retreat and produce warning vocalizations that lead other elephants to join the flight. In our first experiment, audio playbacks of bee sounds induced elephants to retreat and elicited more head-shaking and dusting, reactive behaviors that may prevent bee stings, compared to white noise control playbacks. Most importantly, elephants produced distinctive "rumble" vocalizations in response to bee sounds. These rumbles exhibited an upward shift in the second formant location, which implies active vocal tract modulation, compared to rumbles made in response to white noise playbacks. In a second experiment, audio playbacks of these rumbles produced in response to bees elicited increased headshaking, and further and faster retreat behavior in other elephants, compared to control rumble playbacks with lower second formant frequencies. These responses to the bee rumble stimuli occurred in the absence of any bees or bee sounds. This suggests that these elephant rumbles may function as referential signals, in which a formant frequency shift alerts nearby elephants about an external threat, in this case, the threat of bees.	[King, Lucy E.; Douglas-Hamilton, Iain; Vollrath, Fritz] Univ Oxford, Dept Zool, Anim Behav Res Grp, Oxford OX1 3PS, England; [Soltis, Joseph; Savage, Anne] Disneys Anim Kingdom, Educ & Sci, Bay Lake, FL USA; [King, Lucy E.; Douglas-Hamilton, Iain; Vollrath, Fritz] Save Elephants, Nairobi, Kenya	University of Oxford; Walt Disney Company	King, LE (corresponding author), Univ Oxford, Dept Zool, Anim Behav Res Grp, S Parks Rd, Oxford OX1 3PS, England.	lucy.king@zoo.ox.ac.uk		Vollrath, Fritz/0000-0003-3484-9005; King, Dr Lucy/0000-0002-2877-5225	ESRC/NERC; Disney Worldwide Conservation; Save the Elephants	ESRC/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Economic & Social Research Council (ESRC)); Disney Worldwide Conservation; Save the Elephants	ESRC/NERC Joint Studentship Grant; Disney Worldwide Conservation Fund; Save the Elephants. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bates LA, 2007, CURR BIOL, V17, P1938, DOI 10.1016/j.cub.2007.09.060; BAYART F, 1990, BEHAV NEUROSCI, V104, P98, DOI 10.1037/0735-7044.104.1.98; Blumstein DT, 1997, ANIM BEHAV, V53, P143, DOI 10.1006/anbe.1996.0285; Boersma P., 2010, PRAAT DOING PHONETIC, DOI DOI 10.1007/s10072-018-3598-5; Fichtel C, 2002, ETHOLOGY, V108, P763, DOI 10.1046/j.1439-0310.2002.00816.x; Hoare R, 2000, ORYX, V34, P34, DOI 10.1017/S0030605300030878; King LE, 2007, CURR BIOL, V17, pR832, DOI 10.1016/j.cub.2007.07.038; King LE, 2009, AFR J ECOL, V47, P131, DOI 10.1111/j.1365-2028.2009.01114.x; Langbauer WR, 2000, ZOO BIOL, V19, P425, DOI 10.1002/1098-2361(2000)19:5&lt;425::AID-ZOO11&gt;3.0.CO;2-A; Leighty KA, 2008, ANIM BEHAV, V76, P1601, DOI 10.1016/j.anbehav.2008.06.022; Leong K. M., 2003, Bioacoustics, V13, P213; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; MCCOMB K, AMBOSELI EL IN PRESS; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P1; Monticelli PE, 2004, AN ACAD BRAS CIENC, V76, P368, DOI 10.1590/S0001-37652004000200027; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Riede T, 2003, J ACOUST SOC AM, V114, P1132, DOI 10.1121/1.1580812; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; SHAW RG, 1993, ECOLOGY, V74, P1638, DOI 10.2307/1939922; SOLTIS J, ZOO BIOL IN PRESS; Soltis J, 2009, J COMP PSYCHOL, V123, P222, DOI 10.1037/a0015223; Titze IR, 1994, PRINCIPLES VOICE PRO; Vollrath F, 2002, NATURWISSENSCHAFTEN, V89, P508, DOI 10.1007/s00114-002-0375-2; Wesolek CM, 2009, BIOACOUSTICS, V18, P227, DOI 10.1080/09524622.2009.9753603; Wittemyer G, 2007, ANIM BEHAV, V73, P671, DOI 10.1016/j.anbehav.2006.10.008; Wittemyer G, 2001, AFR J ECOL, V39, P357, DOI 10.1046/j.1365-2028.2001.00324.x; Wood JD, 2005, BIOACOUSTICS, V15, P143, DOI 10.1080/09524622.2005.9753544; Zuberbuhler K, 2001, BEHAV ECOL SOCIOBIOL, V50, P414, DOI 10.1007/s002650100383; Zuberbuhler K, 1997, ANIM BEHAV, V53, P589, DOI 10.1006/anbe.1996.0334; Zuberbuhler K, 2000, ANIM BEHAV, V59, P917, DOI 10.1006/anbe.1999.1317	35	36	36	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10346	10.1371/journal.pone.0010346	http://dx.doi.org/10.1371/journal.pone.0010346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436682	Green Published, gold			2022-12-25	WOS:000277079500016
J	Manes, S; Fuentes, G; Peregil, RM; Rojas, AM; Lacalle, RA				Manes, Santos; Fuentes, Gloria; Peregil, Rosa M.; Rojas, Ana M.; Ana Lacalle, Rosa			An isoform-specific PDZ-binding motif targets type I PIP5 kinase beta to the uropod and controls polarization of neutrophil-like HL60 cells	FASEB JOURNAL			English	Article						cell migration; NHERF-1; PIPK; polarization	SCAFFOLDING PROTEIN NHERF1; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; EUKARYOTIC CHEMOTAXIS; PLASMA-MEMBRANE; FOCAL ADHESIONS; FERM DOMAIN; EZRIN; TALIN; PHOSPHORYLATION; PHAGOCYTOSIS	Type I phosphatidylinositol 4-phosphate 5-kinase (PIP5KI)-beta participates in establishing polarity during leukocyte chemotaxis. Its final 83 amino acids localize PIP5KI beta to the uropod of chemotaxing neutrophils and T cells, and interact with ezrin-radixin-moesin (ERM) proteins and EBP50 (4.1-ERM-binding phosphoprotein 50), a scaffold protein with 2 PDZ (PSD-95, disc large, ZO-1) domains. The structural motifs at the PIP5KI beta C terminus that confer signaling specificity are, nonetheless, unknown. We show that the last 4 residues of PIP5KI beta constitute an atypical PDZ-binding motif, which steers PIP5KI beta to the uropod by binding to both EBP50 PDZ domains. Molecular modeling and mutagenesis indicated that PDZ-binding motif is necessary for PIP5KI beta localization and for chemoattractant-induced neutrophil polarization. Polarity in cells that express PIP5KI beta mutants lacking the PDZ-binding motif was restored by overexpression of PIP5KI beta, but not of PIP5KI gamma_i2, another isoform that localizes to the neutrophil uropod. Our results identify an isoform-specific PDZ-binding motif in PIP5KI beta, which confers specificity for PIP5KI beta signaling at the uropod during leukocyte chemotaxis.-Manes, S., Fuentes, G., Peregil, R. M., Rojas, A. M., Lacalle, R. A. An isoform-specific PDZ-binding motif targets type I PIP5 kinase beta to the uropod and controls polarization of neutrophil-like HL60 cells. FASEB J. 24, 3381-3392 (2010). www.fasebj.org	[Manes, Santos; Peregil, Rosa M.; Ana Lacalle, Rosa] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain; [Fuentes, Gloria] ASTAR, Bioinformat Inst, Biomol Modelling & Design Div, Singapore, Singapore; [Rojas, Ana M.] Inst Predict & Personalized Med Canc, Computat Cell Biol Grp, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Manes, S (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Darwin 3,Campus Cantoblanco, E-28049 Madrid, Spain.	smanes@cnb.csic.es; rlacalle@cnb.csic.es	IBIS, BIOINFORMATICA/O-1882-2015; Rojas, Ana M./I-2882-2019; fuentes, gloria/A-5018-2010; Manes, Santos/E-4725-2011; Rojas, Ana M/D-5777-2011	Rojas, Ana M./0000-0003-0750-9099; fuentes, gloria/0000-0003-3676-9666; Rojas, Ana M/0000-0003-0750-9099; Lacalle, Rosa Ana/0000-0003-0082-167X; Manes, Santos/0000-0001-8023-957X	Spanish Ministry of Science and Innovation [SAF2008-00649]; Carlos III Health Institute RIER network [RD08/0075/0007]; European Union [LSHB-CT-2005-518167]; ERAnet program (e-rare) [PI07/1314]; Comunidad de Madrid (DIFHEMAT) [S-SAL-0304-2006]; Genoma Espana Foundation (MEICA)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Health Institute RIER network; European Union(European Commission); ERAnet program (e-rare); Comunidad de Madrid (DIFHEMAT)(Comunidad de Madrid); Genoma Espana Foundation (MEICA)	We thank A. Huttenlocher (University of Wisconsin-Madison, Madison, WI, USA), E. J. Weinman and D. A. Steplock (University of Maryland, School of Medicine, Baltimore, MD, USA), M. M. Georgescu (University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA), and T. Fischer (Centro Nacional de Biotecnologia/CSIC, Madrid, Spain) for generous gifts of plasmids and advice, I. Merida for critical reading of the manuscript, and C. Mark for editorial assistance. This work was supported, in part, by the Spanish Ministry of Science and Innovation (SAF2008-00649), the Carlos III Health Institute RIER network (RD08/0075/0007), the European Union FP6 (INNOCHEM, LSHB-CT-2005-518167), the ERAnet program (e-rare, PI07/1314), the Comunidad de Madrid (DIFHEMAT, S-SAL-0304-2006), and the Genoma Espana Foundation (MEICA).	Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; Bagorda A, 2008, J CELL SCI, V121, P2621, DOI 10.1242/jcs.018077; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Carro A, 2006, NUCLEIC ACIDS RES, V34, pW110, DOI 10.1093/nar/gkl203; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen MZ, 2009, J BIOL CHEM, V284, P23743, DOI 10.1074/jbc.M109.036509; Cheng H, 2009, STRUCTURE, V17, P660, DOI 10.1016/j.str.2009.03.009; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Divecha N, 2000, EMBO J, V19, P5440, DOI 10.1093/emboj/19.20.5440; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Elkins JM, 2010, PROTEIN SCI, V19, P731, DOI 10.1002/pro.349; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Grembecka J, 2006, BIOCHEMISTRY-US, V45, P3674, DOI 10.1021/bi052225y; Hubbard SJ, 1993, NACCESS COMPUTER PRO; ISHII K, 1998, ENG DESIGN AUTOMATIO, V4, P5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanaho Y, 2007, BIOL PHARM BULL, V30, P1605, DOI 10.1248/bpb.30.1605; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saxena A, 2009, METHOD ENZYMOL, V467, P307, DOI 10.1016/S0076-6879(09)67012-9; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vasudevan L, 2009, J CELL SCI, V122, P2567, DOI 10.1242/jcs.048124; Wang YF, 2008, P NATL ACAD SCI USA, V105, P14064, DOI 10.1073/pnas.0804139105; Wang YF, 2008, J CLIN INVEST, V118, P812, DOI 10.1172/JCI34239; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2003, BIOCHEMISTRY-US, V42, P12662, DOI 10.1021/bi035244l	49	11	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2010	24	9					3381	3392		10.1096/fj.09-153106	http://dx.doi.org/10.1096/fj.09-153106			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20442317				2022-12-25	WOS:000281446400026
J	Matilainen, JM; Malinen, M; Turunen, MM; Carlberg, C; Vaisanen, S				Matilainen, Juha M.; Malinen, Marjo; Turunen, Mikko M.; Carlberg, Carsten; Vaisanen, Sami			The Number of Vitamin D Receptor Binding Sites Defines the Different Vitamin D Responsiveness of the CYP24 Gene in Malignant and Normal Mammary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; DEVELOPMENTAL REGULATORS; RESPONSE ELEMENTS; CO-REPRESSOR; HUMAN GENOME; TRANSCRIPTION; CHROMATIN; ACTIVATION; ENHANCERS	Primary 1 alpha,25-dihydroxyvitamin D-3 (1 alpha,25(OH)(2)D-3)-responding genes are controlled by the vitamin D receptor (VDR) binding to specific sites (VDREs) that are located within the regulatory regions of these genes. According to previous studies, the gene encoding 25-dihydroxyvitamin D-3 24-hydroxylase, CYP24, which is the strongest known 1 alpha,25(OH)(2)D-3-responsive gene, has multiple VDREs that locate within the proximal and the distal promoter. However, it has remained unclear, what is the biological role of these regions and how they participate in the regulation of transcription. In this study, we found a different CYP24 expression profile in normal (MCF-10A) and malignant (MCF-7) human mammary cells. Moreover, CYP24 mRNA showed to be three times more stable in MCF-7 cells than in MCF-10A cells. We studied the mechanism of this difference using expression profiling, quantitative chromatin immunoprecipitation and chromosome conformation capture assays. Interestingly, the number of functional VDREs was higher in MCF-7 cells than in MCF-10A cells. Three functional VDREs in MCF-7 cells are connected to linear mRNA accumulation, whereas only one VDRE seems to lead to stepwise CYP24 mRNA accumulation in MCF-10A cells. The distal VDREs were involved in transcriptional regulation via ligand-dependent, dynamic chromatin looping, which brings cyclically the distal elements together either individually or simultaneously next to the transcription start site. In conclusion, our data suggest that in comparison to normal cells, clearing of 1 alpha,25(OH)(2)D-3 is enhanced in malignant cells due to differences in transcriptional regulation of CYP24 and metabolism of CYP24 mRNA.	[Matilainen, Juha M.; Malinen, Marjo; Turunen, Mikko M.; Carlberg, Carsten; Vaisanen, Sami] Univ Eastern Finland, Dept Biosci, FIN-70211 Kuopio, Finland; [Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, L-1511 Luxembourg, Luxembourg	University of Eastern Finland; University of Luxembourg	Vaisanen, S (corresponding author), Univ Eastern Finland, Dept Biosci, POB 1627, FIN-70211 Kuopio, Finland.	Sami.Vaisanen@uef.fi	Carlberg, Carsten/C-9075-2011	Carlberg, Carsten/0000-0003-2633-0684; Turunen, Mikko/0000-0001-5134-1559	Academy of Finland [129139]	Academy of Finland(Academy of Finland)	This work was supported by The Academy of Finland Grant Number 129139.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Carlberg C, 1998, CRIT REV EUKAR GENE, V8, P19, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.20; Chan HM, 2001, J CELL SCI, V114, P2363; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; de Lyra EC, 2006, J STEROID BIOCHEM, V100, P184, DOI 10.1016/j.jsbmb.2006.04.009; Degenhardt T, 2009, CELL, V138, P489, DOI 10.1016/j.cell.2009.05.029; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Makkonen H, 2009, NUCLEIC ACIDS RES, V37, P4135, DOI 10.1093/nar/gkp352; Matilainen M, 2005, NUCLEIC ACIDS RES, V33, P5521, DOI 10.1093/nar/gki872; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miele A, 2006, CURR PROTOC MOL BIOL; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; Saramaki A, 2009, J BIOL CHEM, V284, P8073, DOI 10.1074/jbc.M808090200; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363; Turunen MM, 2007, NUCLEIC ACIDS RES, V35, P2734, DOI 10.1093/nar/gkm179; Vaisanen S, 1997, EUR J BIOCHEM, V248, P156, DOI 10.1111/j.1432-1033.1997.t01-1-00156.x; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xu W, 2005, BIOCHEM CELL BIOL, V83, P418, DOI 10.1139/O05-057; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zhang B, 2007, ONCOGENE, V26, P7153, DOI 10.1038/sj.onc.1210509	32	28	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24174	24183		10.1074/jbc.M110.124073	http://dx.doi.org/10.1074/jbc.M110.124073			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20460683	hybrid, Green Published			2022-12-25	WOS:000280291400067
J	Chen, L; Jeffries, O; Rowe, ICM; Liang, Z; Knaus, HG; Ruth, P; Shipston, MJ				Chen, Lie; Jeffries, Owen; Rowe, Iain C. M.; Liang, Zhi; Knaus, Hans-Guenther; Ruth, Peter; Shipston, Michael J.			Membrane Trafficking of Large Conductance Calcium-activated Potassium Channels Is Regulated by Alternative Splicing of a Transplantable, Acidic Trafficking Motif in the RCK1-RCK2 Linker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; SURFACE EXPRESSION; BK CHANNEL; G-PROTEIN; PHOSPHORYLATION; DYSFUNCTION; MOVEMENT; SIGNALS; VARIANT; SUBUNIT	Trafficking of the pore-forming alpha-subunits of large conductance calcium-and voltage-activated potassium (BK) channels to the cell surface represents an important regulatory step in controlling BK channel function. Here, we identify multiple trafficking signals within the intracellular RCK1-RCK2 linker of the cytosolic C terminus of the channel that are required for efficient cell surface expression of the channel. In particular, an acidic cluster-like motif was essential for channel exit from the endoplasmic reticulum and subsequent cell surface expression. This motif could be transplanted onto a heterologous nonchannel protein to enhance cell surface expression by accelerating endoplasmic reticulum export. Importantly, we identified a human alternatively spliced BK channel variant, hSlo Delta(579-664), in which these trafficking signals are excluded because of in-frame exon skipping. The hSlo Delta(579-664) variant is expressed in multiple human tissues and cannot form functional channels at the cell surface even though it retains the putative RCK domains and down stream trafficking signals. Functionally, the hSlo Delta(579-664) variant acts as a dominant negative subunit to suppress cell surface expression of BK channels. Thus alternative splicing of the intracellular RCK1-RCK2 linker plays a critical role in determining cell surface expression of BK channels by controlling the inclusion/exclusion of multiple trafficking motifs.	[Chen, Lie; Jeffries, Owen; Rowe, Iain C. M.; Liang, Zhi; Shipston, Michael J.] Univ Edinburgh, Ctr Integrat Physiol, Coll Med & Vet Med, Edinburgh EH8 9XD, Midlothian, Scotland; [Knaus, Hans-Guenther] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Mol & Cellular Pharmacol, A-6020 Innsbruck, Austria; [Ruth, Peter] Univ Tubingen, Inst Pharm, D-72076 Tubingen, Germany	University of Edinburgh; Medical University of Innsbruck; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Shipston, MJ (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Coll Med & Vet Med, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; jeffries, owen/0000-0002-8169-1100; Chen, Lie/0000-0001-9764-4299; Rowe, Iain C M/0000-0002-0148-5332	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chen L, 2005, J BIOL CHEM, V280, P33599, DOI 10.1074/jbc.M505383200; Davies KP, 2007, EUR UROL, V52, P1229, DOI 10.1016/j.eururo.2006.11.028; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Korovkina VP, 2006, J PHYSIOL-LONDON, V573, P329, DOI 10.1113/jphysiol.2006.106922; Kwon SH, 2004, P NATL ACAD SCI USA, V101, P15237, DOI 10.1073/pnas.0404877101; Lee JH, 2009, BIOPHYS J, V97, P730, DOI 10.1016/j.bpj.2009.04.058; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma DH, 2007, FEBS LETT, V581, P1000, DOI 10.1016/j.febslet.2007.01.077; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Marijic J, 2001, CIRC RES, V88, P210; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Mikosch M, 2009, TRAFFIC, V10, P1481, DOI 10.1111/j.1600-0854.2009.00962.x; Raffaelli G, 2004, J PHYSIOL-LONDON, V557, P147, DOI 10.1113/jphysiol.2004.062661; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Saleem F, 2009, BRIT J PHARMACOL, V156, P143, DOI 10.1111/j.1476-5381.2008.00011.x; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Song M, 1999, FEBS LETT, V460, P427, DOI 10.1016/S0014-5793(99)01394-0; Sorensen MV, 2008, J PHYSIOL-LONDON, V586, P4251, DOI 10.1113/jphysiol.2008.156968; Taneja TK, 2009, HUM MOL GENET, V18, P2400, DOI 10.1093/hmg/ddp179; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Werner ME, 2005, J PHYSIOL-LONDON, V567, P545, DOI 10.1113/jphysiol.2005.093823; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zarei MM, 2001, J BIOL CHEM, V276, P16232, DOI 10.1074/jbc.M008852200; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	35	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23263	23273		10.1074/jbc.M110.139758	http://dx.doi.org/10.1074/jbc.M110.139758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20479001	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000279999900060
J	Garg, P; Verma, R; Cook, L; Soofi, A; Venkatareddy, M; George, B; Mizuno, K; Gurniak, C; Witke, W; Holzman, LB				Garg, Puneet; Verma, Rakesh; Cook, Leslie; Soofi, Abdul; Venkatareddy, Madhusudan; George, Britta; Mizuno, Kensaku; Gurniak, Christine; Witke, Walter; Holzman, Lawrence B.			Actin-depolymerizing Factor Cofilin-1 Is Necessary in Maintaining Mature Podocyte Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; SLIT DIAPHRAGM; PROTEIN-KINASE; CELL MOTILITY; PHOSPHATASE SLINGSHOT; LAMELLIPOD EXTENSION; NEPHROTIC-SYNDROME; REGULATES COFILIN; TRANSGENIC MICE; ARP2/3 COMPLEX	Actin dynamics determines podocyte morphology during development and in response to podocyte injury and might be necessary for maintaining normal podocyte morphology. Because podocyte intercellular junction receptor Nephrin plays a role in regulating actin dynamics, and given the described role of cofilin in actin filament polymerization and severing, we hypothesized that cofilin-1 activity is regulated by Nephrin and is necessary in normal podocyte actin dynamics. Nephrin activation induced cofilin dephosphorylation via intermediaries that include phosphatidylinositol 3-kinase, SSH1, 14-3-3, and LIMK in a cell culture model. This Nephrin-induced cofilin activation required a direct interaction between Nephrin and the p85 subunit of phosphatidylinositol 3-kinase. In a similar fashion, cofilin-1 dephosphorylation was observed in a rat model of podocyte injury at a time when foot process spreading is initially observed. To investigate the necessity of cofilin-1 in the glomerulus, podocyte-specific Cfl1 null mice were generated. Cfl1 null podocytes developed normally. However, these mice developed persistent proteinuria by 3 months of age, although they did not exhibit foot process spreading until 8 months, when the rate of urinary protein excretion became more exaggerated. In a mouse model of podocyte injury, protamine sulfate perfusion of the Cfl1 mutant mouse induced a broadened and flattened foot process morphology that was distinct from that observed following perfusion of control kidneys, and mutant podocytes did not recover normal structure following additional perfusion with heparin sulfate. We conclude that cofilin-1 is necessary for maintenance of normal podocyte architecture and for actin structural changes that occur during induction and recovery from podocyte injury.	[Garg, Puneet; Verma, Rakesh; Cook, Leslie; Soofi, Abdul; Venkatareddy, Madhusudan] Univ Michigan, Sch Med, Div Nephrol, Ann Arbor, MI 48109 USA; [George, Britta; Holzman, Lawrence B.] Dept Vet Affairs, Philadelphia, PA 19104 USA; [Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Gurniak, Christine; Witke, Walter] Univ Bonn, Inst Genet, D-53117 Bonn, Germany; [Holzman, Lawrence B.] Univ Penn, Sch Med, Div Nephrol, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; Tohoku University; University of Bonn; University of Pennsylvania	Holzman, LB (corresponding author), 410E Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	lholzman@upenn.edu	George, Britta/AAL-2031-2021; Mizuno, Kensaku/G-8631-2015	Holzman, Lawrence/0000-0002-8961-234X; George, Britta/0000-0001-5430-5086; Garg, Puneet/0000-0001-7439-459X	National Institutes of Health [DK081403]; American Recovery and Reinvestment Act [DK081403-02W1]; Veterans Affairs Merit Review; National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; Veterans Affairs Merit Review(US Department of Veterans Affairs); National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK081403 (to P.G.). This work was also supported by American Recovery and Reinvestment Act supplement DK081403-02W1 (to L.B.H.), a Veterans Affairs Merit Review (to L.B.H.), and a National Kidney Foundation Young Investigator Award (to P.G.).	Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; BOLENDER RP, 1979, ANAT REC, V195, P257, DOI 10.1002/ar.1091950202; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Garg P, 2007, NEPHRON EXP NEPHROL, V106, pE67, DOI 10.1159/000101795; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Hatanaka H, 1996, CELL, V85, P1047, DOI 10.1016/S0092-8674(00)81305-7; Holzman LB, 1999, KIDNEY INT, V56, P1481, DOI 10.1046/j.1523-1755.1999.00719.x; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Lehtonen S, 2008, KIDNEY INT, V73, P903, DOI 10.1038/ki.2008.69; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; MIZUNO K, 1994, ONCOGENE, V9, P1605; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Moeller MJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015614.68893.0B; Moriyama K, 1999, EMBO J, V18, P6752, DOI 10.1093/emboj/18.23.6752; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Pollak MR, 2003, SEMIN NEPHROL, V23, P141, DOI 10.1053/snep.2003.50014; Reiser J, 2004, J AM SOC NEPHROL, V15, P2246, DOI 10.1097/01.ASN.0000136312.46464.33; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schiwek D, 2004, KIDNEY INT, V66, P91, DOI 10.1111/j.1523-1755.2004.00711.x; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; WEIBEL ER, 1962, J APPL PHYSIOL, V17, P343, DOI 10.1152/jappl.1962.17.2.343; Wharram BL, 2000, J CLIN INVEST, V106, P1281, DOI 10.1172/JCI7236; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	53	84	91	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22676	22688		10.1074/jbc.M110.122929	http://dx.doi.org/10.1074/jbc.M110.122929			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472933	Green Published, hybrid			2022-12-25	WOS:000279702200078
J	Jain, A; Lamark, T; Sjottem, E; Larsen, KB; Awuh, JA; Overvatn, A; McMahon, M; Hayes, JD; Johansen, T				Jain, Ashish; Lamark, Trond; Sjottem, Eva; Larsen, Kenneth Bowitz; Awuh, Jane Atesoh; Overvatn, Aud; McMahon, Michael; Hayes, John D.; Johansen, Terje			p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PHOSPHOTYROSINE-INDEPENDENT LIGAND; CUL3-BASED E3 LIGASE; KAPPA-B ACTIVATION; OXIDATIVE STRESS; SELECTIVE AUTOPHAGY; PROTEASOMAL DEGRADATION; NEURITE OUTGROWTH; SIGNALING PATHWAY; BINDING PROTEIN	The p62/SQSTM1 (sequestosome 1) protein, which acts as a cargo receptor for autophagic degradation of ubiquitinated targets, is up-regulated by various stressors. Induction of the p62 gene by oxidative stress is mediated by NF-E2-related factor 2 (NRF2) and, at the same time, p62 protein contributes to the activation of NRF2, but hitherto the mechanisms involved were not known. Herein, we have mapped an antioxidant response element (ARE) in the p62 promoter that is responsible for its induction by oxidative stress via NRF2. Chromatin immunoprecipitation and gel mobility-shift assays verified that NRF2 binds to this cis-element in vivo and in vitro. Also, p62 docks directly onto the Kelch-repeat domain of Kelch-like ECH-associated protein 1 (KEAP1), via a motif designated the KEAP1 interacting region (KIR), thereby blocking binding between KEAP1 and NRF2 that leads to ubiquitylation and degradation of the transcription factor. The KIR motif in p62 is located immediately C-terminal to the LC3-interacting region (LIR) and resembles the ETGE motif utilized by NRF2 for its interaction with KEAP1. KIR is required for p62 to stabilize NRF2, and inhibition of KEAP1 by p62 occurs from a cytoplasmic location within the cell. The LIR and KIR motifs cannot be engaged simultaneously by LC3 and KEAP1, but because p62 is polymeric the interaction between KEAP1 and p62 leads to accumulation of KEAP1 in p62 bodies, which is followed by autophagic degradation of KEAP1. Our data explain how p62 contributes to activation of NRF2 target genes in response to oxidative stress through creating a positive feedback loop.	[Jain, Ashish; Lamark, Trond; Sjottem, Eva; Larsen, Kenneth Bowitz; Awuh, Jane Atesoh; Overvatn, Aud; Johansen, Terje] Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway; [McMahon, Michael; Hayes, John D.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland	UiT The Arctic University of Tromso; University of Dundee	Johansen, T (corresponding author), Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway.	terje.johansen@uit.no	Johansen, Terje/N-2971-2015; Jain, Ashish/H-7356-2017; Johansen, Terje/AAY-1753-2021; McMahon, Michael J/A-1702-2008; McMahon, Michael J/F-7070-2010; Larsen, Kenneth/HDO-5510-2022	Johansen, Terje/0000-0003-1451-9578; Jain, Ashish/0000-0001-6549-2788; Johansen, Terje/0000-0003-1451-9578; McMahon, Michael J/0000-0001-8615-9351; Lamark, Trond/0000-0001-6338-3342; Hayes, John/0000-0002-2927-5548; Sjottem, Eva/0000-0003-2668-1708; Awuh, Jane Atesoh/0000-0001-9737-927X	Norwegian Research Council; Norwegian Cancer Society; Blix Foundation; Cancer Research-UK [C4909/A9990]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Blix Foundation; Cancer Research-UK(Cancer Research UK)	This work was supported by grants from the FUGE programme of the Norwegian Research Council, the Norwegian Cancer Society, and the Blix Foundation (to T. J.) and by Cancer Research-UK (project grant C4909/A9990 to J. D. H.).	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Du YF, 2009, NEUROBIOL DIS, V35, P302, DOI 10.1016/j.nbd.2009.05.015; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Gal J, 2009, J NEUROCHEM, V111, P1062, DOI 10.1111/j.1471-4159.2009.06388.x; Halliwell B., 2007, FREE RADICALS BIOL M, V4, P187, DOI DOI 10.1093/ACPROF:OSO/9780198717478.001.0001; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishii T, 1997, BIOCHEM BIOPH RES CO, V232, P33, DOI 10.1006/bbrc.1997.6221; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kimura M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706863200; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kosaka K, 2010, J BIOCHEM, V147, P73, DOI 10.1093/jb/mvp149; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nakaso K, 2006, BIOCHEM BIOPH RES CO, V339, P915, DOI 10.1016/j.bbrc.2005.11.095; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; PRESTERA T, 1993, P NATL ACAD SCI USA, V90, P2965, DOI 10.1073/pnas.90.7.2965; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Rekdal C, 2000, J BIOL CHEM, V275, P40288, DOI 10.1074/jbc.M006978200; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Sjottem E, 2007, NUCLEIC ACIDS RES, V35, P6648, DOI 10.1093/nar/gkm739; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Torocsik B, 2002, J NEUROSCI, V22, P8971; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Velichkova M, 2005, MOL CELL BIOL, V25, P4501, DOI 10.1128/MCB.25.11.4501-4513.2005; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Wooten MW, 2000, MOL CELL BIOL, V20, P4494, DOI 10.1128/MCB.20.13.4494-4504.2000; Yamamoto T, 2006, GENES CELLS, V11, P575, DOI 10.1111/j.1365-2443.2006.00965.x; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	64	948	973	4	78	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22576	22591		10.1074/jbc.M110.118976	http://dx.doi.org/10.1074/jbc.M110.118976			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20452972	hybrid, Green Published			2022-12-25	WOS:000279702200069
J	Chang, L; Thompson, AD; Ung, P; Carlson, HA; Gestwicki, JE				Chang, Lyra; Thompson, Andrea D.; Ung, Peter; Carlson, Heather A.; Gestwicki, Jason E.			Mutagenesis Reveals the Complex Relationships between ATPase Rate and the Chaperone Activities of Escherichia coli Heat Shock Protein 70 (Hsp70/DnaK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; SUBSTRATE-BINDING DOMAIN; EXCHANGE FACTOR GRPE; MOLECULAR CHAPERONE; DNAK CHAPERONE; NUCLEOTIDE EXCHANGE; PEPTIDE-BINDING; INTERDOMAIN COMMUNICATION; CONFORMATIONAL-CHANGES; HIGH-THROUGHPUT	The Escherichia coli 70-kDa heat shock protein, DnaK, is a molecular chaperone that engages in a variety of cellular activities, including the folding of proteins. During this process, DnaK binds its substrates in coordination with a catalytic ATPase cycle. Both the ATPase and protein folding activities of DnaK are stimulated by its co-chaperones, DnaJ and GrpE. However, it is not yet clear how changes in the stimulated ATPase rate of DnaK impact the folding process. In this study, we performed mutagenesis throughout the nucleotide-binding domain of DnaK to generate a collection of mutants in which the stimulated ATPase rates varied from 0.7 to 13.6 pmol/mu g/min(-1). We found that this range was largely established by differences in the ability of the mutants to be stimulated by one or both of the co-chaperones. Next, we explored how changes in ATPase rate might impact refolding of denatured luciferase in vitro and found that the two activities were poorly correlated. Unexpectedly, we found several mutants that refold luciferase normally in the absence of significant ATP turnover, presumably by increasing the flexibility of DnaK. Finally, we tested whether DnaK mutants could complement growth of Delta dnaK E. coli cells under heat shock and found that the ability to refold luciferase was more predictive of in vivo activity than ATPase rate. This study provides insights into how flexibility and co-chaperone interactions affect DnaK-mediated ATP turnover and protein folding.	[Gestwicki, Jason E.] Univ Michigan, Inst Life Sci, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Ung, Peter; Carlson, Heather A.; Gestwicki, Jason E.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gestwicki, JE (corresponding author), Univ Michigan, Inst Life Sci, Chem Biol Grad Program, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	gestwick@umich.edu	Thompson, Andrea/AAQ-5735-2020; Ung, Peter Man-Un/J-1654-2019; Chang, Lyra/A-9516-2012	Ung, Peter Man-Un/0000-0002-6849-5252; Thompson, Andrea/0000-0001-8798-2024; Carlson, Heather/0000-0002-7495-1699; Chang, Chia Yin/0000-0002-9608-4952	National Institutes of Health [NS059690, MCB-0844512, F30AG035464]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG035464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS059690 and MCB-0844512 (to J.E.G.).; Supported by National Institutes of Health Predoctoral Fellowship F30AG035464.	ANG D, 1989, J BACTERIOL, V171, P2748, DOI 10.1128/jb.171.5.2748-2755.1989; BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Barthel TK, 2001, J BACTERIOL, V183, P5482, DOI 10.1128/JB.183.19.5482-5490.2001; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bhattacharya A, 2009, J MOL BIOL, V388, P475, DOI 10.1016/j.jmb.2009.01.062; Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Buchberger A, 1999, J BIOL CHEM, V274, P38017, DOI 10.1074/jbc.274.53.38017; BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang TC, 2001, ARCH BIOCHEM BIOPHYS, V386, P30, DOI 10.1006/abbi.2000.2176; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Goffin L, 1998, MOL MICROBIOL, V30, P329, DOI 10.1046/j.1365-2958.1998.01067.x; GRAGEROV A, 1992, P NATL ACAD SCI USA, V89, P10341, DOI 10.1073/pnas.89.21.10341; Grimshaw JPA, 2005, J MOL BIOL, V353, P888, DOI 10.1016/j.jmb.2005.08.069; Grimshaw JPA, 2003, J BIOL CHEM, V278, P19048, DOI 10.1074/jbc.M300924200; Groemping Y, 2001, J MOL BIOL, V314, P167, DOI 10.1006/jmbi.2001.5116; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hesterkamp T, 1998, EMBO J, V17, P4818, DOI 10.1093/emboj/17.16.4818; Hu SM, 2002, ARCH BIOCHEM BIOPHYS, V407, P135, DOI 10.1016/S0003-9861(02)00515-5; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; KAMATHLOEB AS, 1995, J BIOL CHEM, V270, P30051; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Klucken J, 2004, BIOCHEM BIOPH RES CO, V325, P367, DOI 10.1016/j.bbrc.2004.10.037; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1995, P NATL ACAD SCI USA, V92, P6224, DOI 10.1073/pnas.92.14.6224; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Linke K, 2003, J BIOL CHEM, V278, P44457, DOI 10.1074/jbc.M307491200; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; McClellan AJ, 2000, GENETICS, V156, P501; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; PAEK KH, 1987, J BACTERIOL, V169, P283, DOI 10.1128/jb.169.1.283-290.1987; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Patury S, 2009, CURR TOP MED CHEM, V9, P1337, DOI 10.2174/156802609789895674; Pierpaoli EV, 1997, J MOL BIOL, V269, P757, DOI 10.1006/jmbi.1997.1072; RENSING SA, 1994, J MOL EVOL, V39, P80, DOI 10.1007/BF00178252; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; SELL SM, 1990, J BACTERIOL, V172, P4827, DOI 10.1128/jb.172.9.4827-4835.1990; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Slepenkov SV, 2003, FEBS LETT, V539, P100, DOI 10.1016/S0014-5793(03)00207-2; Stevens SY, 2003, PROTEIN SCI, V12, P2588, DOI 10.1110/ps.03269103; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Sugimoto S, 2008, BIOSCI BIOTECH BIOCH, V72, P811, DOI 10.1271/bbb.70691; Sugimoto S, 2008, PROTEIN EXPRES PURIF, V60, P31, DOI 10.1016/j.pep.2008.03.007; Sugimoto S, 2007, FEBS LETT, V581, P2993, DOI 10.1016/j.febslet.2007.05.055; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Tanaka N, 2002, P NATL ACAD SCI USA, V99, P15398, DOI 10.1073/pnas.242317099; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; WALL D, 1995, J BIOL CHEM, V270, P2139, DOI 10.1074/jbc.270.5.2139; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Woo HJ, 2009, BIOCHEMISTRY-US, V48, P11470, DOI 10.1021/bi901256y; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	65	53	55	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21282	21291		10.1074/jbc.M110.124149	http://dx.doi.org/10.1074/jbc.M110.124149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20439464	Green Published, hybrid			2022-12-25	WOS:000279516100013
J	Munter, LM; Botev, A; Richter, L; Hildebrand, PW; Althoff, V; Weise, C; Kaden, D; Multhaup, G				Munter, Lisa-Marie; Botev, Anne; Richter, Luise; Hildebrand, Peter W.; Althoff, Veit; Weise, Christoph; Kaden, Daniela; Multhaup, Gerd			Aberrant Amyloid Precursor Protein (APP) Processing in Hereditary Forms of Alzheimer Disease Caused by APP Familial Alzheimer Disease Mutations Can Be Rescued by Mutations in the APP GxxxG Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE; BETA-PROTEIN; TRANSMEMBRANE DOMAIN; PRESENILIN MUTATIONS; TERMINAL FRAGMENT; A-BETA-42; CLEAVAGE; DIMERIZATION; DEPOSITION; INCREASES	The identification of hereditary familial Alzheimer disease (FAD) mutations in the amyloid precursor protein (APP) and presenilin-1 (PS1) corroborated the causative role of amyloid-beta peptides with 42 amino acid residues (A beta 42) in the pathogenesis of AD. Although most FAD mutations are known to increase A beta 42 levels, mutations within the APP GxxxG motif are known to lower A beta 42 levels by attenuating transmembrane sequence dimerization. Here, we show that aberrant A beta 42 levels of FAD mutations can be rescued by GxxxG mutations. The combination of the APP-GxxxG mutation G33A with APP-FAD mutations yielded a constant 60% decrease of A beta 42 levels and a concomitant 3-fold increase of A beta 38 levels compared with the Gly(33) wild-type as determined by ELISA. In the presence of PS1-FAD mutations, the effects of G33A were attenuated, apparently attributable to a different mechanism of PS1-FAD mutants compared with APP-FAD mutants. Our results contribute to a general understanding of the mechanism how APP is processed by the gamma-secretase module and strongly emphasize the potential of the GxxxG motif in the prevention of sporadic AD as well as FAD.	[Munter, Lisa-Marie; Botev, Anne; Richter, Luise; Althoff, Veit; Weise, Christoph; Kaden, Daniela; Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Hildebrand, Peter W.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Multhaup, G (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Thielallee 63, D-14195 Berlin, Germany.	multhaup@biochemie.fu-berlin.de		Munter, Lisa/0000-0001-5736-1462	Alzheimer Forschung Initiative e.V.; Deutsche Forschungsgemeinschaft [MU901, HI 1502/1-1]; Kompetenznetz Degenerative Demenzen [Forderkennzeichen 01 GI 0723]; Hans und Ilse Breuer Stiftung;  [SFB740]	Alzheimer Forschung Initiative e.V.; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kompetenznetz Degenerative Demenzen; Hans und Ilse Breuer Stiftung; 	This work was supported by the Alzheimer Forschung Initiative e.V. (to L.-M. M.), the Deutsche Forschungsgemeinschaft (MU901 (to G. M.), HI 1502/1-1 (to P. W. H.)), the SFB740, Kompetenznetz Degenerative Demenzen (Forderkennzeichen 01 GI 0723), and the Hans und Ilse Breuer Stiftung.	Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; DYRKS T, 1992, FEBS LETT, V309, P20, DOI 10.1016/0014-5793(92)80730-5; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Ikeuchi T, 2008, DEMENT GERIATR COGN, V26, P43, DOI 10.1159/000141483; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; KAMINO K, 1992, AM J HUM GENET, V51, P998; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kumar-Singh S, 2000, HUM MOL GENET, V9, P2589, DOI 10.1093/hmg/9.18.2589; Kwok JBJ, 2000, ANN NEUROL, V47, P249, DOI 10.1002/1531-8249(200002)47:2<249::AID-ANA18>3.3.CO;2-#; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Soba P, 2006, EMBO J, V25, P653, DOI 10.1038/sj.emboj.7600956; St George-Hyslop PH, 2000, BIOL PSYCHIAT, V47, P183, DOI 10.1016/S0006-3223(99)00301-7; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2007, J NEUROCHEM, V100, P1234, DOI 10.1111/j.1471-4159.2006.04302.x	44	51	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21636	21643		10.1074/jbc.M109.088005	http://dx.doi.org/10.1074/jbc.M109.088005			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452985	Green Published, hybrid			2022-12-25	WOS:000279516100050
J	Bobrovnikova-Marjon, E; Grigoriadou, C; Pytel, D; Zhang, F; Ye, J; Koumenis, C; Cavener, D; Diehl, JA				Bobrovnikova-Marjon, E.; Grigoriadou, C.; Pytel, D.; Zhang, F.; Ye, J.; Koumenis, C.; Cavener, D.; Diehl, J. A.			PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage	ONCOGENE			English	Article						PERK; Nrf2; ROS; DNA damage; cell cycle checkpoints	INTEGRATED STRESS-RESPONSE; SUBUNIT GENE-EXPRESSION; CUL3-BASED E3 LIGASE; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; LUNG-CANCER; TRANSLATIONAL REGULATION; MESSENGER-RNA; COMPLEX-III; PROTEIN	To proliferate and expand in an environment with limited nutrients, cancer cells co-opt cellular regulatory pathways that facilitate adaptation and thereby maintain tumor growth and survival potential. The endoplasmic reticulum (ER) is uniquely positioned to sense nutrient deprivation stress and subsequently engage signaling pathways that promote adaptive strategies. As such, components of the ER stress-signaling pathway represent potential antineoplastic targets. However, recent investigations into the role of the ER resident protein kinase, RNA-dependent protein kinase (PKR)-like ER kinase (PERK) have paradoxically suggested both pro- and anti-tumorigenic properties. We have used animal models of mammary carcinoma to interrogate the contribution of PERK in the neoplastic process. The ablation of PERK in tumor cells resulted in impaired regeneration of intracellular antioxidants and accumulation of reactive oxygen species triggering oxidative DNA damage. Ultimately, PERK deficiency impeded progression through the cell cycle because of the activation of the DNA damage checkpoint. Our data reveal that PERK-dependent signaling is used during both tumor initiation and expansion to maintain redox homeostasis, thereby facilitating tumor growth. Oncogene (2010) 29, 3881-3895; doi:10.1038/onc.2010.153; published online 10 May 2010	[Diehl, J. A.] Univ Penn, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Bobrovnikova-Marjon, E.; Grigoriadou, C.; Pytel, D.; Zhang, F.; Diehl, J. A.] Univ Penn, Leonard & Madlyn Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Bobrovnikova-Marjon, E.; Grigoriadou, C.; Pytel, D.; Zhang, F.; Diehl, J. A.] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; [Ye, J.; Koumenis, C.] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Cavener, D.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Diehl, JA (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Dept Canc Biol, 454 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	adiehl@mail.med.upenn.edu	Ye, Jiangbin/A-1094-2007; Cavener, Douglas R/E-3524-2010; Koumenis, Constantinos/B-2002-2008	Koumenis, Costas/0000-0001-5945-4726; Ye, Jiangbin/0000-0003-1117-4869	National Institutes of Health [F32CA1238252, P01 CA104838]; Leukemia & Lymphoma Scholar award; NATIONAL CANCER INSTITUTE [P01CA104838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Scholar award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Serge Fuchs for critical reading of the paper, Margarita Romero for outstanding technical assistance and the AFCRI histology core. This work was supported by the National Institutes of Health Grants F32CA1238252 (to EBM), P01 CA104838 and a Leukemia & Lymphoma Scholar award (to JAD).	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassing CH, 2004, CELL CYCLE, V3, P149; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Bobrovnikova-Marjon E, 2008, P NATL ACAD SCI USA, V105, P16314, DOI 10.1073/pnas.0808517105; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Bruns CJ, 2004, CLIN CANCER RES, V10, P2109, DOI 10.1158/1078-0432.CCR-03-0502; BUETLER TM, 1995, TOXICOL APPL PHARM, V135, P45, DOI 10.1006/taap.1995.1207; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Evans, 2000, Mol Med Today, V6, P459, DOI 10.1016/S1357-4310(00)01824-4; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; FOLKMAN J, 1966, ANN SURG, V164, P491, DOI 10.1097/00000658-196609000-00012; Frohlich DA, 2008, ONCOGENE, V27, P4353, DOI 10.1038/onc.2008.79; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hayes JD, 2000, BIOCHEM SOC T, V28, P33, DOI 10.1042/bst0280033; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kim WJ, 2002, ONCOGENE, V21, P3864, DOI 10.1038/sj.onc.1205485; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Lee HK, 2008, NEURO-ONCOLOGY, V10, P236, DOI 10.1215/15228517-2008-006; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lin DI, 2008, ONCOGENE, V27, P1231, DOI 10.1038/sj.onc.1210738; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Nicco C, 2005, BIOMED PHARMACOTHER, V59, P169, DOI 10.1016/j.biopha.2005.03.009; Nioi P, 2007, BIOCHEM BIOPH RES CO, V362, P816, DOI 10.1016/j.bbrc.2007.08.051; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Ranganathan AC, 2008, CANCER RES, V68, P3260, DOI 10.1158/0008-5472.CAN-07-6215; Reddy NM, 2008, ONCOGENE, V27, P5821, DOI 10.1038/onc.2008.188; Sequeira SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000615; Shenvi SV, 2009, PHARMACOL RES, V60, P229, DOI 10.1016/j.phrs.2009.06.003; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Shimizu Y, 2009, ANTIOXID REDOX SIGN, V11, P2317, DOI [10.1089/ars.2009.2501, 10.1089/ARS.2009.2501]; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Stracker TH, 2008, MOL CELL, V31, P21, DOI 10.1016/j.molcel.2008.04.028; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Tommiska J, 2008, ONCOGENE, V27, P2501, DOI 10.1038/sj.onc.1210885; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Wild AC, 2000, FREE RADICAL RES, V32, P281, DOI 10.1080/10715760000300291; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Wu WG, 1998, CANCER RES, V58, P4082; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	74	195	209	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2010	29	27					3881	3895		10.1038/onc.2010.153	http://dx.doi.org/10.1038/onc.2010.153			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	621SL	20453876	Green Accepted			2022-12-25	WOS:000279603200002
J	Peng, L; Liang, DY; Tong, WY; Li, JH; Yuan, ZH				Peng, Lu; Liang, Dongyu; Tong, Wenyan; Li, Jianhua; Yuan, Zhenghong			Hepatitis C Virus NS5A Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Contributing to Cell Survival by Disrupting the Interaction between FK506-binding Protein 38 (FKBP38) and mTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA REPLICATION; CORE PROTEIN; DOMAIN-III; APOPTOSIS; INTERFERON; INHIBITOR; MUTATIONS; KINASE; P53; 5A	Hepatitis C virus (HCV) often establishes a persistent infection that most likely involves a complex host-virus interplay. We previously reported that the HCV nonstructural protein 5A (NS5A) bound to cellular protein FKBP38 and resulted in apoptosis suppression in human hepatoma cell line Huh7. In the present research we further found that NS5A increased phosphorylation levels of two mTOR-targeted substrates, S6K1 and 4EBP1, in Huh7 in the absence of serum. mTOR inhibitor rapamycin or NS5A knockdown blocked S6K1 and 4EBP1 phosphorylation increase in NS5A-Huh7 and HCV replicon cells, suggesting that NS5A specifically regulated mTOR activation. Overexpression of NS5A and FKBP38 mutants or FKBP38 knockdown revealed this mTOR activation was dependent on NS5A-FKBP38 interaction. Phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 treatment in NS5A-Huh7 showed that the mTOR activation was independent of PI3K. Moreover, NS5A suppressed caspase 3 and poly(ADP-ribose) polymerase activation, which was abolished by NS5A knockdown or rapamycin, indicating NS5A inhibited apoptosis specifically through the mTOR pathway. Further analyses suggested that apoptotic inhibition exerted by NS5A via mTOR also required NS5A-FKBP38 interaction. Glutathione S-transferase pulldown and co-immunoprecipitation showed that NS5A disrupted the mTOR-FKBP38 association. Additionally, NS5A or FKBP38 mutants recovered the mTOR-FKBP38 interaction; this indicated that the impairment of mTOR-FKBP38 association was dependent on NS5A-FKBP38 binding. Collectively, our data demonstrate that HCV NS5A activates the mTOR pathway to inhibit apoptosis through impairing the interaction between mTOR and FKBP38, which may represent a pivotal mechanism for HCV persistence and pathogenesis.	[Peng, Lu; Liang, Dongyu; Tong, Wenyan; Li, Jianhua; Yuan, Zhenghong] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200032, Peoples R China; [Yuan, Zhenghong] Fudan Univ, Inst Med Microbiol & Biomed Sci, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Yuan, ZH (corresponding author), POB 228,138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	zhyuan@shmu.edu.cn	liang, dy/GZA-4770-2022		Chinese State Basic Research Foundation [2005CB522902]; National Natural Science Fund for Distinguished Scholars of China [30425041]; Chinese National Mega Projects for Infectious Diseases [2008ZX10203]; National Natural Science Fund of China [30970158]; Program for Outstanding Medical Academic Leader of Shanghai	Chinese State Basic Research Foundation; National Natural Science Fund for Distinguished Scholars of China; Chinese National Mega Projects for Infectious Diseases; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Program for Outstanding Medical Academic Leader of Shanghai	This work was supported by Chinese State Basic Research Foundation Grant 2005CB522902, National Natural Science Fund for Distinguished Scholars of China Grant 30425041, Chinese National Mega Projects for Infectious Diseases Grant 2008ZX10203, National Natural Science Fund of China Grant 30970158, and the Program for Outstanding Medical Academic Leader of Shanghai.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Arima N, 2001, J BIOL CHEM, V276, P12675, DOI 10.1074/jbc.M008329200; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Castedo M, 2002, EMBO J, V21, P4070, DOI 10.1093/emboj/cdf391; Chiou HL, 2006, BIOCHEM BIOPH RES CO, V345, P453, DOI 10.1016/j.bbrc.2006.04.118; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Ciccaglione AR, 2004, VIRUS RES, V104, P1, DOI 10.1016/j.virusres.2004.02.002; Clarke P, 2009, NAT REV MICROBIOL, V7, P144, DOI 10.1038/nrmicro2071; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Pastor MD, 2009, J BIOL CHEM, V284, P22067, DOI 10.1074/jbc.M109.033100; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Erdtmann L, 2003, J BIOL CHEM, V278, P18256, DOI 10.1074/jbc.M209732200; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hughes M, 2009, J VIROL, V83, P10788, DOI 10.1128/JVI.02406-08; Hughes M, 2009, J GEN VIROL, V90, P1329, DOI 10.1099/vir.0.009332-0; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; KNIPE D, 2007, FIELDS VIROLOGY, P1253; Kriegs M, 2009, J BIOL CHEM, V284, P28343, DOI 10.1074/jbc.M109.038877; Kudchodkar SB, 2007, J VIROL, V81, P3649, DOI 10.1128/JVI.02079-06; Lan KH, 2002, ONCOGENE, V21, P4801, DOI 10.1038/sj.onc.1205589; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; Mannova P, 2005, J VIROL, V79, P8742, DOI 10.1128/JVI.79.14.8742-8749.2005; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Nanda SK, 2006, GASTROENTEROLOGY, V130, P794, DOI 10.1053/j.gastro.2005.12.030; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; O'Shea C, 2005, EMBO J, V24, P1211, DOI 10.1038/sj.emboj.7600597; Oh KJ, 2006, J VIROL, V80, P7079, DOI 10.1128/JVI.02380-05; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Tanaka M, 2006, BIOCHEM BIOPH RES CO, V340, P792, DOI 10.1016/j.bbrc.2005.12.076; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Tran G, 2008, BIOSCIENCE HORIZONS, V1, P167, DOI DOI 10.1093/BIOHORIZONS/HZN020; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang JD, 2006, FEBS LETT, V580, P4392, DOI 10.1016/j.febslet.2006.07.002; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004	60	50	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20870	20881		10.1074/jbc.M110.112045	http://dx.doi.org/10.1074/jbc.M110.112045			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439463	hybrid, Green Published			2022-12-25	WOS:000279228600051
J	Sousa-Neves, R; Rosas, A				Sousa-Neves, Rui; Rosas, Alexandre			An Analysis of Genetic Changes during the Divergence of Drosophila Species	PLOS ONE			English	Article							HYBRID LETHAL SYSTEMS; MELANOGASTER; SIMULANS; INVIABILITY; COMPLEX; CHROMOSOMES; MAURITIANA; EVOLUTION; STERILITY; SECHELLIA	Background: It has been long appreciated that speciation involves changes in body plans and establishes genetic, reproductive, developmental and behavioral incompatibilities between populations. However, little is still known about the genetic components involved in these changes or the sequence and scale of events that lead to the differentiation of species. Principal Findings: In this paper, we investigated the genetic changes in three closely related species of Drosophila by making pair-wise comparisons of their genomes. We focused our analysis on the modern relatives of the alleles likely to be segregating in pre-historic populations at the time or after the ancestor of D. simulans became separated from the ancestor of D. melanogaster. Some of these genes were previously implicated in the genetics of reproduction and behavior while the biological functions of others are not yet clear. Conclusions: Together these results identify different classes of genes that might have participated in the beginning of segregation of these species millions of years ago in Africa.	[Sousa-Neves, Rui] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Rosas, Alexandre] Univ Fed Paraiba, CCEN, Dept Fis, BR-58059900 Joao Pessoa, Paraiba, Brazil	Case Western Reserve University; Universidade Federal da Paraiba	Sousa-Neves, R (corresponding author), Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.	rui.sousaneves@case.edu	Rosas, Alexandre/F-7412-2010	Rosas, Alexandre/0000-0001-7983-358X				Acebes A, 2003, J EXP BIOL, V206, P3095, DOI 10.1242/jeb.00522; BAKER BS, 1972, GENETICS, V71, P255; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Galindo K, 2001, GENETICS, V159, P1059; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Hadorn E., 1961, Revue Suisse de Zoologie, V68, P197; Horton IH, 1939, GENETICS, V24, P234; HUTTER P, 1990, GENETICS, V124, P909; LACHAISE D, 1986, EVOLUTION, V40, P262, DOI 10.1111/j.1558-5646.1986.tb00468.x; LEMEUNIER F, 1976, PROC R SOC SER B-BIO, V193, P275, DOI 10.1098/rspb.1976.0046; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Orr HA, 1997, GENETICS, V145, P1031; Podemski L, 2001, CHROMOSOMA, V110, P305, DOI 10.1007/s004120100151; SANCHEZ L, 1983, ROUX ARCH DEV BIOL, V192, P48, DOI 10.1007/BF00848770; SAWAMURA K, 1993, GENETICS, V133, P307; Sawamura K, 2004, GENETICA, V120, P253, DOI 10.1023/B:GENE.0000017646.11191.b0; SAWAMURA K, 1993, GENETICS, V133, P299; SEILER T, 1974, EXPERIENTIA, V30, P709; STURTEVANT AH, 1929, PUBL CARNEG I WASH, V399, P1; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tomaru M, 2000, EVOLUTION, V54, P1286, DOI 10.1111/j.0014-3820.2000.tb00561.x; WATANABE TK, 1979, SCIENCE, V205, P906, DOI 10.1126/science.205.4409.906; WATANABE TK, 1979, JAPANESE J GENETICS, P325; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P825, DOI 10.1016/S0965-1748(97)00056-8; Wu CJ, 2008, GENETICS, V180, P61, DOI 10.1534/genetics.108.091140	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10485	10.1371/journal.pone.0010485	http://dx.doi.org/10.1371/journal.pone.0010485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463966	Green Published, Green Submitted, gold			2022-12-25	WOS:000277379400021
J	Chuankhayan, P; Hsieh, CY; Huang, YC; Hsieh, YY; Guan, HH; Hsieh, YC; Tien, YC; Chen, CD; Chiang, CM; Chen, CJ				Chuankhayan, Phimonphan; Hsieh, Chih-Yu; Huang, Yen-Chieh; Hsieh, Yi-You; Guan, Hong-Hsiang; Hsieh, Yin-Cheng; Tien, Yueh-Chu; Chen, Chung-De; Chiang, Chien-Min; Chen, Chun-Jung			Crystal Structures of Aspergillus japonicus Fructosyltransferase Complex with Donor/Acceptor Substrates Reveal Complete Subsites in the Active Site for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICORY FRUCTAN 1-EXOHYDROLASE; BACILLUS-SUBTILIS LEVANSUCRASE; RAY-DIFFRACTION STRUCTURE; CELL-WALL INVERTASE; HYDROLASE FAMILY 32; MICROBIAL-PRODUCTION; PROTEIN; SUCROSE; INSIGHTS; 6G-FRUCTOSYLTRANSFERASE	Fructosyltransferases catalyze the transfer of a fructose unit from one sucrose/fructan to another and are engaged in the production of fructooligosaccharide/fructan. The enzymes belong to the glycoside hydrolase family 32 (GH32) with a retaining catalytic mechanism. Here we describe the crystal structures of recombinant fructosyltransferase (AjFT) from Aspergillus japonicus CB05 and its mutant D191A complexes with various donor/acceptor substrates, including sucrose, 1-kestose, nystose, and raffinose. This is the first structure of fructosyltransferase of the GH32 with a high transfructosylation activity. The structure of AjFT comprises two domains with an N-terminal catalytic domain containing a five-blade beta-propeller fold linked to a C-terminal beta-sandwich domain. Structures of various mutant AjFT-substrate complexes reveal complete four substrate-binding subsites (-1 to +3) in the catalytic pocket with shapes and characters distinct from those of clan GH-J enzymes. Residues Asp-60, Asp-191, and Glu-292 that are proposed for nucleophile, transition-state stabilizer, and general acid/base catalyst, respectively, govern the binding of the terminal fructose at the -1 subsite and the catalytic reaction. Mutants D60A, D191A, and E292A completely lost their activities. Residues Ile-143, Arg-190, Glu-292, Glu-318, and His-332 combine the hydrophobic Phe-118 and Tyr-369 to define the -1 subsite for its preference of fructosyl and glucosyl moieties. Ile-143 and Gln-327 define the +2 subsite for raffinose, whereas Tyr-404 and Glu-405 define the +2 and +3 subsites for inulin-type substrates with higher structural flexibilities. Structural geometries of 1-kestose, nystose and raffinose are different from previous data. All results shed light on the catalytic mechanism and substrate recognition of AjFT and other clan GH-J fructosyltransferases.	[Hsieh, Chih-Yu; Hsieh, Yi-You; Chiang, Chien-Min] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan 71710, Taiwan; [Chuankhayan, Phimonphan; Huang, Yen-Chieh; Guan, Hong-Hsiang; Hsieh, Yin-Cheng; Tien, Yueh-Chu; Chen, Chung-De; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu 30076, Taiwan; [Chen, Chung-De; Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30043, Taiwan; [Guan, Hong-Hsiang; Hsieh, Yin-Cheng; Tien, Yueh-Chu] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30043, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan	Chia Nan University of Pharmacy & Science; National Synchrotron Radiation Research Center; National Tsing Hua University; National Tsing Hua University; National Cheng Kung University	Chiang, CM (corresponding author), Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan 71710, Taiwan.	cmchiang@mail.chna.edu.tw; cjchen@nsrrc.org.tw	Chen, Chun-Jung/A-6880-2011	Chen, Chun-Jung/0000-0002-5157-4288	National Science Council [94-2313-B-213-001, 95-2313-B-009-001-MY3]; NSRRC [963RSB02, 973RSB02, 983RSB02]; Chia Nan University [CNBT-9502, CNBT-9723]	National Science Council(Ministry of Science and Technology, Taiwan); NSRRC; Chia Nan University	This work was supported by National Science Council Grants 94-2313-B-213-001 and 95-2313-B-009-001-MY3 and NSRRC Grants 963RSB02, 973RSB02, and 983RSB02 (to C.-J.C.) and by Chia Nan University Grants CNBT-9502 and CNBT-9723 (to C.-M.C.).	Alberto F, 2006, BIOCHEM J, V395, P457, DOI [10.1042/BJ20051936, 10.1042/Bj20051936]; Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Altenbach D, 2009, PLANT MOL BIOL, V69, P47, DOI 10.1007/s11103-008-9404-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cairns AJ, 2003, J EXP BOT, V54, P549, DOI 10.1093/jxb/erg056; CHAMBERT R, 1991, BIOCHEM J, V279, P35, DOI 10.1042/bj2790035; COTE GL, 2003, SCI TECHNOLOGY FRUCT, P141; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Heyer AG, 2001, APPL ENVIRON MICROB, V67, P363, DOI 10.1128/AEM.67.1.363-370.2001; HIRAYAMA M, 1989, AGR BIOL CHEM TOKYO, V53, P667, DOI 10.1080/00021369.1989.10869350; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Homann A, 2007, BIOCHEM J, V407, P189, DOI 10.1042/BJ20070600; JEFFREY GA, 1972, ACTA CRYSTALL B-STRU, VB 28, P257, DOI 10.1107/S056774087200216X; Lammens W, 2008, J MOL BIOL, V377, P378, DOI 10.1016/j.jmb.2007.12.074; Lammens W, 2009, J EXP BOT, V60, P727, DOI 10.1093/jxb/ern333; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lasseur B, 2009, PLANT PHYSIOL, V149, P327, DOI 10.1104/pp.108.125559; Le Roy K, 2008, NEW PHYTOL, V178, P572, DOI 10.1111/j.1469-8137.2008.02386.x; Le Roy K, 2007, PLANT PHYSIOL, V145, P616, DOI 10.1104/pp.107.105049; Le Roy K, 2007, NEW PHYTOL, V176, P317, DOI 10.1111/j.1469-8137.2007.02174.x; Lindblom-Ylanne S, 2000, EUR J PSYCHOL EDUC, V15, P19, DOI 10.1007/BF03173164; Maiorano AE, 2008, BIOTECHNOL LETT, V30, P1867, DOI 10.1007/s10529-008-9793-3; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Meng G, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-16; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Nishizawa K., 2001, Food Science and Technology Research, V7, P39, DOI 10.3136/fstr.7.39; OKUYAMA K, 1993, B CHEM SOC JPN, V66, P374, DOI 10.1246/bcsj.66.374; Ortiz-Soto ME, 2008, PROTEIN ENG DES SEL, V21, P589, DOI 10.1093/protein/gzn036; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; Pool-Zobel BL, 2005, BRIT J NUTR, V93, pS73, DOI 10.1079/BJN20041349; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; Ritsema T, 2005, PLANT MOL BIOL, V58, P597, DOI 10.1007/s11103-005-6504-5; Ritsema T, 2003, J PLANT PHYSIOL, V160, P811, DOI 10.1078/0176-1617-01029; Ritsema T, 2003, CURR OPIN PLANT BIOL, V6, P223, DOI 10.1016/S1369-5266(03)00034-7; Ritsema T, 2006, PLANT J, V48, P228, DOI 10.1111/j.1365-313X.2006.02862.x; Sangeetha PT, 2005, TRENDS FOOD SCI TECH, V16, P442, DOI 10.1016/j.tifs.2005.05.003; Schroeven L, 2008, NEW PHYTOL, V180, P822, DOI 10.1111/j.1469-8137.2008.02603.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Valluru R, 2008, J EXP BOT, V59, P2905, DOI 10.1093/jxb/ern164; Van den Ende W, 2009, FEBS J, V276, P5788, DOI 10.1111/j.1742-4658.2009.07316.x; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Vereyken IJ, 2003, BIOPHYS J, V84, P3147, DOI 10.1016/S0006-3495(03)70039-3; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x; Verhaest M, 2007, NEW PHYTOL, V174, P90, DOI 10.1111/j.1469-8137.2007.01988.x; Verhaest M, 2006, ACTA CRYSTALLOGR D, V62, P1555, DOI 10.1107/S0907444906044489; Vijn I, 1999, PLANT PHYSIOL, V120, P351, DOI 10.1104/pp.120.2.351; Yun JW, 1996, ENZYME MICROB TECH, V19, P107, DOI 10.1016/0141-0229(95)00188-3; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101	57	62	69	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23249	23262		10.1074/jbc.M110.113027	http://dx.doi.org/10.1074/jbc.M110.113027			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20466731	hybrid, Green Published			2022-12-25	WOS:000279999900059
J	Meng, H; Zhang, XJ; Lee, SJ; Strickland, DK; Lawrence, DA; Wang, MM				Meng, He; Zhang, Xiaojie; Lee, Soo Jung; Strickland, Dudley K.; Lawrence, Daniel A.; Wang, Michael M.			Low Density Lipoprotein Receptor-related Protein-1 (LRP1) Regulates Thrombospondin-2 (TSP2) Enhancement of Notch3 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND ENDOCYTOSIS; PLASMINOGEN-ACTIVATOR; DELTA-ENDOCYTOSIS; CELL-MIGRATION; DISULFIDE BOND; DROSOPHILA; CLEAVAGE; PATHWAY; BINDING; DISSOCIATION	Intracellular trafficking of Notch and Notch ligands modulates signaling, suggesting that choreography of ligand and receptor translocation is essential for optimal Notch activity. Indeed, a major model for Notch signaling posits that Notch trans-endocytosis into the ligand-expressing (signal sending) cell is a key driving force for Notch signal transduction. The extracellular protein thrombospondin-2 (TSP2) enhances Notch signaling and binds to both Jagged1 and Notch3 ectodomains, potentially bridging two essential extracellular components of Notch signaling. We investigated the role of low density lipoprotein receptor-related protein-1 (LRP1), a TSP2 receptor, in the regulation of Notch3 signaling. TSP2 potentiation of Notch is blocked by the receptor-associated protein (an inhibitor of low density lipoprotein receptor-related protein function) and requires LRP1 expression in the signal-sending cell. TSP2 stimulates Notch3 endocytosis into wild type fibroblasts but not LRP1-deficient fibroblasts. Finally, recombinant Notch3 and Jagged1 interact with the LRP1 85-kDa B-chain, a subunit that lacks known ligand binding function. Our data suggest that LRP1 and TSP2 stimulate Notch activity by driving trans-endocytosis of the Notch ectodomain into the signal-sending cell and demonstrate a novel, non-cell autonomous function of LRP1 in cell-cell signaling.	[Meng, He; Zhang, Xiaojie; Lee, Soo Jung; Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Lawrence, Daniel A.] Univ Michigan, Dept Cardiol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore	Wang, MM (corresponding author), 7629 Med Sci Bldg 2,Box 5622,1137 Catherine St, Ann Arbor, MI 48109 USA.	micwang@umich.edu		Lawrence, Daniel/0000-0003-3126-1935	National Institutes of Health [NS054724, NS052681, PO1 HL54710, HL50784, HL55374, HL089407]; American Heart Association [0726004Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089407, R01HL050784, P01HL054710, R01HL055374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052681, K02NS054724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS054724 (to M. M. W.), NS052681 (to M. M. W.), PO1 HL54710 (to D. K. S. and D. A. L.), HL50784 (to D. K. S.), HL55374 (to D. A. L.), and HL089407 (to D. A. L.). This work was also supported by American Heart Association Fellowship 0726004Z (to H.M.).	Baron M, 2002, MOL MEMBR BIOL, V19, P27, DOI 10.1080/09687680110112929; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; Christensen L, 1996, INT J CANCER, V66, P441; Gaultier A, 2008, J CLIN INVEST, V118, P161, DOI 10.1172/JCI32371; Hagedorn EJ, 2006, J CELL BIOL, V173, P443, DOI 10.1083/jcb.200602054; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HOGG PJ, 1993, J BIOL CHEM, V268, P7139; Klueg KM, 1999, J CELL SCI, V112, P3289; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Lutz C, 2002, J BIOL CHEM, V277, P43143, DOI 10.1074/jbc.M204426200; Meng H, 2009, J BIOL CHEM, V284, P7866, DOI 10.1074/jbc.M803650200; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Morel V, 2003, DEV GENES EVOL, V213, P65, DOI 10.1007/s00427-003-0296-x; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pimanda JE, 2004, J BIOL CHEM, V279, P21439, DOI 10.1074/jbc.M313560200; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ranganathan S, 2004, J BIOL CHEM, V279, P40536, DOI 10.1074/jbc.M407592200; Rodrigues RG, 2001, J BIOL CHEM, V276, P27913, DOI 10.1074/jbc.M009518200; Schouwey K, 2007, DEV DYNAM, V236, P282, DOI 10.1002/dvdy.21000; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; SPEZIALE MV, 1991, ARCH BIOCHEM BIOPHYS, V286, P546, DOI 10.1016/0003-9861(91)90077-V; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; SUN X, 1992, J CELL BIOL, V118, P693, DOI 10.1083/jcb.118.3.693; Takayama Y, 2003, J BIOL CHEM, V278, P22112, DOI 10.1074/jbc.M300894200; TURK JL, 1986, ARCH BIOCHEM BIOPHYS, V245, P446, DOI 10.1016/0003-9861(86)90236-5; Wilkin MB, 2005, MOL MEMBR BIOL, V22, P279, DOI 10.1080/09687860500129778; WILLNOW TE, 1994, J CELL SCI, V107, P719; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Zhang YM, 2007, BIOCHEM BIOPH RES CO, V355, P245, DOI 10.1016/j.bbrc.2007.01.151	40	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23045	23053		10.1074/jbc.M110.144634	http://dx.doi.org/10.1074/jbc.M110.144634			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20472562	Green Published, hybrid			2022-12-25	WOS:000279999900039
J	Jacobs, RL; Zhao, Y; Koonen, DPY; Sletten, T; Su, B; Lingrell, S; Cao, GQ; Peake, DA; Kuo, MS; Proctor, SD; Kennedy, BP; Dyck, JRB; Vance, DE				Jacobs, Rene L.; Zhao, Yang; Koonen, Debby P. Y.; Sletten, Torunn; Su, Brian; Lingrell, Susanne; Cao, Guoqing; Peake, David A.; Kuo, Ming-Shang; Proctor, Spencer D.; Kennedy, Brian P.; Dyck, Jason R. B.; Vance, Dennis E.			Impaired de Novo Choline Synthesis Explains Why Phosphatidylethanolamine N-Methyltransferase-deficient Mice Are Protected from Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; PLASMA HIGH-DENSITY; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE-ALPHA; INDUCED INSULIN-RESISTANCE; STEAROYL-COA DESATURASE-1; HEPATIC STEATOSIS; PHOSPHATIDYLCHOLINE SYNTHESIS; TARGETED DELETION; RAT HEPATOCYTES; FATTY LIVER	Phosphatidylcholine (PC) is synthesized from choline via the CDP-choline pathway. Liver cells can also synthesize PC via the sequential methylation of phosphatidylethanolamine, catalyzed by phosphatidylethanolamine N-methyltransferase (PEMT). The current study investigates whether or not hepatic PC biosynthesis is linked to diet-induced obesity. Pemt(+/+) mice fed a high fat diet for 10 weeks increased in body mass by 60% and displayed insulin resistance, whereas Pemt(-/-) mice did not. Compared with Pemt(+/+) mice, Pemt(-/-) mice had increased energy expenditure and maintained normal peripheral insulin sensitivity; however, they developed hepatomegaly and steatosis. In contrast, mice with impaired biosynthesis of PC via the CDP-choline pathway in liver became obese when fed a high fat diet. We, therefore, hypothesized that insufficient choline, rather than decreased hepatic phosphatidylcholine, was responsible for the lack of weight gain in Pemt(-/-) mice despite the presence of 1.3 g of choline/kg high fat diet. Supplementation with an additional 2.7 g of choline (but not betaine)/kg of diet normalized energy metabolism, weight gain, and insulin resistance in high fat diet-fed Pemt(-/-) mice. Furthermore, Pemt(+/+) mice that were fed a choline-deficient diet had increased oxygen consumption, had improved glucose tolerance, and gained less weight. Thus, de novo synthesis of choline via PEMT has a previously unappreciated role in regulating whole body energy metabolism.	[Jacobs, Rene L.; Zhao, Yang; Sletten, Torunn; Su, Brian; Lingrell, Susanne; Proctor, Spencer D.; Vance, Dennis E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Jacobs, Rene L.; Zhao, Yang; Sletten, Torunn; Su, Brian; Lingrell, Susanne; Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Koonen, Debby P. Y.; Dyck, Jason R. B.] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB T6G 2S2, Canada; [Koonen, Debby P. Y.; Dyck, Jason R. B.] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2S2, Canada; [Cao, Guoqing; Peake, David A.; Kuo, Ming-Shang] Eli Lilly & Co, Lilly Res Labs, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Jacobs, Rene L.; Proctor, Spencer D.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2S2, Canada; [Kennedy, Brian P.] Merck Frosst Ctr Therapeut Res, Dept Biochem Mol Biol, Montreal, PQ H9H 3L1, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Eli Lilly; University of Alberta; Merck & Company	Vance, DE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca	Proctor, Spencer/F-2774-2012	Dyck, Jason/0000-0002-7045-2884; Proctor, Spencer/0000-0002-7597-5262; Jacobs, Rene/0000-0002-5525-1355	Canadian Institutes for Health Research [MOP 89793, MOP 67053]; Merck Frosst	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Merck Frosst	This work was supported in part by the Canadian Institutes for Health Research (Grants MOP 89793 and MOP 67053) and Merck Frosst.	Abdelmalek MF, 2001, AM J GASTROENTEROL, V96, P2711; Agellon LB, 1999, HEPATOLOGY, V30, P725, DOI 10.1002/hep.510300305; Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Bernal-Mizrachi C, 2007, CELL METAB, V5, P91, DOI 10.1016/j.cmet.2006.12.010; BUCHMAN AL, 1995, HEPATOLOGY, V22, P1399, DOI 10.1002/hep.1840220510; Cansev M, 2008, EUR J PHARMACOL, V589, P315, DOI 10.1016/j.ejphar.2008.05.017; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; COHEN EL, 1976, SCIENCE, V191, P561, DOI 10.1126/science.1251187; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; Delgado-Reyes CV, 2005, AM J PHYSIOL-REG I, V288, pR182, DOI 10.1152/ajpregu.00406.2004; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dobrzyn A, 2005, J BIOL CHEM, V280, P23356, DOI 10.1074/jbc.M502436200; Dyck JRB, 2004, CIRC RES, V94, pE78, DOI 10.1161/01.RES.0000129255.19569.8f; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Hartmann J, 2008, NEUROCHEM INT, V52, P972, DOI 10.1016/j.neuint.2007.10.008; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Ilcol YO, 2003, EUR J BIOCHEM, V270, P991, DOI 10.1046/j.1432-1033.2003.03472.x; Jacobs RL, 2008, J BIOL CHEM, V283, P2147, DOI 10.1074/jbc.M706628200; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jacobs RL, 2005, J BIOL CHEM, V280, P28299, DOI 10.1074/jbc.M501971200; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Kim SJ, 2008, BIOCHEM BIOPH RES CO, V368, P893, DOI 10.1016/j.bbrc.2008.02.003; Klein J, 1998, NEUROCHEM INT, V32, P479, DOI 10.1016/S0197-0186(97)00127-7; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Koppen A, 1997, J PHARMACOL EXP THER, V282, P1139; KUKSIS A, 1989, ADV CHROMATOGR, V28, P267; Leclercq IA, 2007, LAB INVEST, V87, P56, DOI 10.1038/labinvest.3700489; Li ZQ, 2007, BBA-MOL CELL BIOL L, V1771, P1186, DOI 10.1016/j.bbalip.2007.05.007; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; PRITCHARD PH, 1981, BIOCHEM J, V196, P261, DOI 10.1042/bj1960261; Raubenheimer PJ, 2006, DIABETES, V55, P2015, DOI 10.2337/db06-0097; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Robichaud JC, 2008, J BIOL CHEM, V283, P35496, DOI 10.1074/jbc.M807433200; Schattenberg JRM, 2005, J BIOL CHEM, V280, P9887, DOI 10.1074/jbc.M410310200; Schwahn BC, 2007, ATHEROSCLEROSIS, V195, pE100, DOI 10.1016/j.atherosclerosis.2007.06.030; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Song Z, 2007, AM J PHYSIOL-GASTR L, V293, pG894, DOI 10.1152/ajpgi.00133.2007; Tang W, 1997, J BIOL CHEM, V272, P13146, DOI 10.1074/jbc.272.20.13146; Ueland PM, 2005, CLIN CHEM LAB MED, V43, P1069, DOI 10.1515/CCLM.2005.187; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Vance DE, 2007, J BIOL CHEM, V282, P33237, DOI 10.1074/jbc.R700028200; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; Verkade HJ, 2007, J LIPID RES, V48, P2058, DOI 10.1194/jlr.M700278-JLR200; Vetelainen R, 2007, J GASTROEN HEPATOL, V22, P1526, DOI 10.1111/j.1440-1746.2006.04701.x; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; YAO ZM, 1988, J BIOL CHEM, V263, P2998; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; Zhao Y, 2009, ARTERIOSCL THROM VAS, V29, P1349, DOI 10.1161/ATVBAHA.109.188672	60	137	138	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22403	22413		10.1074/jbc.M110.108514	http://dx.doi.org/10.1074/jbc.M110.108514			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20452975	hybrid, Green Published			2022-12-25	WOS:000279702200053
J	Tando, T; Ishizaka, A; Watanabe, H; Ito, T; Iida, S; Haraguchi, T; Mizutani, T; Izumi, T; Isobe, T; Akiyama, T; Inoue, J; Iba, H				Tando, Toshio; Ishizaka, Aya; Watanabe, Hirotaka; Ito, Taiji; Iida, Shun; Haraguchi, Takeshi; Mizutani, Taketoshi; Izumi, Tomonori; Isobe, Toshiaki; Akiyama, Taishin; Inoue, Jun-ichiro; Iba, Hideo			Requiem Protein Links RelB/p52 and the Brm-type SWI/SNF Complex in a Noncanonical NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; PANCREATIC-CANCER CELLS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; PROSTATE-CANCER; SNF COMPLEX; ACTIVATION; SUBUNIT; SYSTEM; GROWTH	The SWI/SNF chromatin remodeling complex plays pivotal roles in mammalian transcriptional regulation. In this study, we identify the human requiem protein (REQ/DPF2) as an adaptor molecule that links the NF-kappa B and SWI/SNF chromatin remodeling factor. Through in vitro binding experiments, REQ was found to bind to several SWI/SNF complex subunits and also to the p52 NF-kappa B subunit through its nuclear localization signal containing the N-terminal region. REQ, together with Brm, a catalytic subunit of the SWI/SNF complex, enhances the NF-kappa B dependent transcriptional activation that principally involves the RelB/p52 dimer. Both REQ and Brm were further found to be required for the induction of the endogenous BLC (CXCL13) gene in response to lymphotoxin stimulation, an inducer of the noncanonical NF-kappa B pathway. Upon lymphotoxin treatment, REQ and Brm form a larger complex with RelB/p52 and are recruited to the BLC promoter in a ligand-dependent manner. Moreover, a REQ knockdown efficiently suppresses anchorage-independent growth in several cell lines in which the noncanonical NF-kappa B pathway was constitutively activated. From these results, we conclude that REQ functions as an efficient adaptor protein between the SWI/SNF complex and RelB/p52 and plays important roles in noncanonical NF-kappa B transcriptional activation and its associated oncogenic activity.	[Tando, Toshio; Ishizaka, Aya; Watanabe, Hirotaka; Ito, Taiji; Iida, Shun; Haraguchi, Takeshi; Mizutani, Taketoshi; Iba, Hideo] Univ Tokyo, Dept Microbiol & Immunol, Div Host Parasite Interact, Minato Ku, Tokyo 1088639, Japan; [Akiyama, Taishin; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Minato Ku, Tokyo 1088639, Japan; [Izumi, Tomonori; Isobe, Toshiaki] Univ Tokyo, Div Prote Res, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Iba, H (corresponding author), Univ Tokyo, Dept Microbiol & Immunol, Div Host Parasite Interact, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	iba@ims.u-tokyo.ac.jp	Watanabe, Hirotaka/GZA-8002-2022	Ishizaka, Aya/0000-0003-2800-2430	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17016015]; Grants-in-Aid for Scientific Research [21590507, 21390148, 22659094] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research on Priority Areas 17016015 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and in part by the strategic cooperation to control emerging and reemerging infections funded by the Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Cultures, Sports, Science, and Technology of Japan.	Arai T, 1998, J VIROL, V72, P1115, DOI 10.1128/JVI.72.2.1115-1121.1998; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chestkov AV, 1996, GENOMICS, V36, P174, DOI 10.1006/geno.1996.0440; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; GABIG TG, 1994, J BIOL CHEM, V269, P29515; Iba H, 2003, REV MED VIROL, V13, P99, DOI 10.1002/rmv.378; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Ito T, 2008, BIOCHEM J, V411, P201, DOI 10.1042/BJ20071075; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; MacKay C, 2009, BIOCHEM BIOPH RES CO, V390, P187, DOI 10.1016/j.bbrc.2009.08.151; Mackay F, 1996, J BIOL CHEM, V271, P24934, DOI 10.1074/jbc.271.40.24934; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Mizutani T, 2002, J BIOL CHEM, V277, P15859, DOI 10.1074/jbc.M112421200; Mizutani T, 2009, J VIROL, V83, P11569, DOI 10.1128/JVI.00742-09; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nishina T, 2009, BIOCHEM BIOPH RES CO, V388, P96, DOI 10.1016/j.bbrc.2009.07.125; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Ui M, 2000, BIOCHEM BIOPH RES CO, V278, P97, DOI 10.1006/bbrc.2000.3777; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; Wharry CE, 2009, CANCER BIOL THER, V8, P1567, DOI 10.4161/cbt.8.16.8961; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Yamamichi N, 2009, EXP CELL RES, V315, P1779, DOI 10.1016/j.yexcr.2009.01.006; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601	40	37	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21951	21960		10.1074/jbc.M109.087783	http://dx.doi.org/10.1074/jbc.M109.087783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460684	hybrid, Green Published			2022-12-25	WOS:000279702200007
J	Herrera, M; Silva, GB; Garvin, JL				Herrera, Marcela; Silva, Guillermo B.; Garvin, Jeffrey L.			Angiotensin II Stimulates Thick Ascending Limb Superoxide Production via Protein Kinase C alpha-dependent NADPH Oxidase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY OXIDATIVE STRESS; NAD(P)H OXIDASE; NITRIC-OXIDE; ANTIOXIDANT TREATMENT; NACL ABSORPTION; RENAL MEDULLA; HYPERTENSION; PKC; PRESSURE; KIDNEY	Angiotensin II (Ang II) stimulates thick ascending limb (TAL) O(2)radical anion. production, but the receptor(s) and signaling mechanism(s) involved are unknown. The effect of Ang II on O(2)radical anion is generally attributed to the AT(1) receptor. In some cells, Ang II stimulates protein kinase C (PKC), whose alpha isoform (PKC alpha) can activate NADPH oxidase. We hypothesized that in TALs, Ang II stimulates O(2)radical anion via AT(1) and PKC alpha-dependent NADPH oxidase activation. In rat TALs, 1 nM Ang II stimulated O(2)radical anion from 0.76 +/- 0.17 to 1.97 +/- 0.21 nmol/min/mg (p < 0.001). An AT(1) antagonist blocked the stimulatory effect of Ang II on O(2)radical anion (0.87 +/- 0.25 nmol/min/mg; p < 0.006), whereas an AT(2) antagonist had no effect (2.16 +/- 0.133 nmol/min/mg; p < 0.05 versus vehicle). Apocynin, an NADPH oxidase inhibitor, blocked Ang II-stimulated O(2)radical anion by 90% (p < 0.01). Ang II failed to stimulate O(2)radical anion in TALs from p47(phox-/-) mice (p < 0.02). Monitored by fluorescence resonance energy transfer, Ang II increased PKC activity from 0.02 +/- 0.03 to 0.13 +/- 0.02 arbitrary units (p < 0.03). A general PKC inhibitor, GF109203X, blocked the effect of Ang II on O(2)radical anion (1.47 +/- 0.21 versus 2.72 +/- 0.47 nmol/min/mg with Ang II alone; p < 0.03). A PKC alpha- and beta-selective inhibitor, Go6976, also blocked the stimulatory effect of Ang II on O(2)radical anion (0.59 +/- 0.15 versus 2.05 +/- 0.28 nmol/min/mg with Ang II alone; p < 0.001). To distinguish between PKC alpha and PKC beta, we used tubules expressing dominant-negative PKC alpha or -beta. In control TALs, Ang II stimulated O(2)radical anion by 2.17 +/- 0.44 nmol/min/mg (p < 0.011). In tubules expressing dominant-negative PKC alpha, Ang II failed to stimulate O(2)radical anion (change: -0.30 +/- 0.27 nmol/min/mg). In tubules expressing dominant-negative PKC beta 1, Ang II stimulated O(2)radical anion by 2.08 +/- 0.69 nmol/min/mg (p< 0.002). We conclude that Ang II stimulates TAL O(2)radical anion production via activation of AT1 receptors and PKC alpha-dependent NADPH oxidase.	[Herrera, Marcela; Silva, Guillermo B.; Garvin, Jeffrey L.] Henry Ford Hosp, Hypertens & Vasc Res Div, Dept Internal Med, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Herrera, M (corresponding author), Henry Ford Hosp, Hypertens & Vasc Res Div, Dept Internal Med, E&R 7018,2799 W Grand Blvd, Detroit, MI 48202 USA.	mherrer1@hfhs.org			National Institutes of Health [HL-70985, HL-028982]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070985, P01HL028982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-70985 and HL-028982 (to J.L.G.).	Amlal H, 1998, AM J PHYSIOL-CELL PH, V274, pC1047, DOI 10.1152/ajpcell.1998.274.4.C1047; Aristimuno PC, 1997, AM J PHYSIOL-RENAL, V272, pF624, DOI 10.1152/ajprenal.1997.272.5.F624; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Balla T, 1998, ENDOCR RES, V24, P335, DOI 10.3109/07435809809032613; Costa CA, 2009, AM J HYPERTENS, V22, P1242, DOI 10.1038/ajh.2009.186; Cowley AW, 2008, HYPERTENSION, V52, P777, DOI 10.1161/HYPERTENSIONAHA.107.092858; Evans RG, 2005, CURR OPIN NEPHROL HY, V14, P9, DOI 10.1097/00041552-200501000-00003; Fu YL, 2010, AM J PHYSIOL-REG I, V298, pR707, DOI 10.1152/ajpregu.00762.2009; Herrera M, 2005, AM J PHYSIOL-RENAL, V288, pF58, DOI 10.1152/ajprenal.00209.2004; Herrera M, 2004, AM J PHYSIOL-RENAL, V287, pF231, DOI 10.1152/ajprenal.00413.2003; Herrera M, 2010, J BIOL CHEM, V285, P14932, DOI 10.1074/jbc.M110.109041; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hong NJ, 2007, AM J PHYSIOL-RENAL, V292, pF993, DOI 10.1152/ajprenal.00383.2006; Hong NJ, 2010, AM J PHYSIOL-RENAL, V298, pF885, DOI 10.1152/ajprenal.00543.2009; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Inoguchi T, 2003, J AM SOC NEPHROL, V14, pS227, DOI 10.1097/01.ASN.0000077407.90309.65; Jaimes EA, 1998, KIDNEY INT, V54, P775, DOI 10.1046/j.1523-1755.1998.00068.x; Juncos R, 2006, AM J PHYSIOL-REG I, V290, pR79, DOI 10.1152/ajpregu.00447.2005; Juncos R, 2005, AM J PHYSIOL-RENAL, V288, pF982, DOI 10.1152/ajprenal.00348.2004; Kopkan L, 2006, HYPERTENSION, V47, P568, DOI 10.1161/01.HYP.0000200027.34925.93; Li N, 2002, AM J PHYSIOL-RENAL, V282, pF1111, DOI 10.1152/ajprenal.00218.2001; Li NJ, 2005, AM J PHYSIOL-RENAL, V289, pF1048, DOI 10.1152/ajprenal.00416.2004; Liu RS, 2004, KIDNEY INT, V66, P268, DOI 10.1111/j.1523-1755.2004.00727.x; Makino A, 2002, HYPERTENSION, V39, P667, DOI 10.1161/hy0202.103469; Manning RD, 2005, AM J NEPHROL, V25, P311, DOI 10.1159/000086411; Manning RD, 2003, ACTA PHYSIOL SCAND, V179, P243, DOI 10.1046/j.0001-6772.2003.01204.x; Mizuno N, 2009, NEUROSIGNALS, V17, P42, DOI 10.1159/000186689; Mori T, 2003, HYPERTENSION, V42, P588, DOI 10.1161/01.HYP.0000091821.39824.09; Navar LG, 2000, AM J HYPERTENS, V13, p45S, DOI 10.1016/S0895-7061(99)00248-4; Ortiz PA, 2003, HYPERTENSION, V42, P674, DOI 10.1161/01.HYP.0000085561.00001.81; Ortiz PA, 2003, KIDNEY INT, V63, P1141, DOI 10.1046/j.1523-1755.2003.00827.x; Peixoto EBMI, 2009, AM J NEPHROL, V29, P309, DOI 10.1159/000163767; PENG Y, 1995, AM J PHYSIOL-RENAL, V269, pF40, DOI 10.1152/ajprenal.1995.269.1.F40; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Silva GB, 2008, HYPERTENSION, V52, P1091, DOI 10.1161/HYPERTENSIONAHA.108.120212; Silva GB, 2006, HYPERTENSION, V48, P467, DOI 10.1161/01.HYP.0000236646.83354.51; Silva GB, 2010, AM J PHYSIOL-RENAL, V298, pF421, DOI 10.1152/ajprenal.00472.2009; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Taylor NE, 2006, HYPERTENSION, V47, P692, DOI 10.1161/01.HYP.0000203161.02046.8d; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wilcox CS, 2002, CURR HYPERTENS REP, V4, P160, DOI 10.1007/s11906-002-0041-2; Yang J, 2009, AM J PHYSIOL-RENAL, V297, pF1220, DOI 10.1152/ajprenal.00314.2009; Zhang Z, 2004, AM J PHYSIOL-HEART C, V287, pH773, DOI 10.1152/ajpheart.01135.2003; Zou AP, 2001, HYPERTENSION, V37, P547, DOI 10.1161/01.HYP.37.2.547	45	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21323	21328		10.1074/jbc.M110.109157	http://dx.doi.org/10.1074/jbc.M110.109157			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448043	hybrid, Green Published			2022-12-25	WOS:000279516100017
J	Aust, S; Brusselbach, F; Putz, S; Hovemann, BT				Aust, Silvia; Bruesselbach, Florian; Puetz, Stefanie; Hovemann, Bernhard T.			Alternative Tasks of Drosophila Tan in Neurotransmitter Recycling Versus Cuticle Sclerotization Disclosed by Kinetic Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENICILLIN-N-ACYLTRANSFERASE; ACYL-COENZYME-A; AMINO-ACID SUBSTITUTIONS; PENICILLIUM-CHRYSOGENUM; HISTAMINERGIC PHOTORECEPTOR; MOLECULAR CHARACTERIZATION; PROENZYME CLEAVAGE; ESCHERICHIA-COLI; NERVOUS-SYSTEM; GENE PENDE	Upon a stimulus of light, histamine is released from Drosophila photoreceptor axonal endings. It is taken up into glia where Ebony converts it into beta-alanyl-histamine (carcinine). Carcinine moves into photoreceptor cells and is there cleaved into beta-alanine and histamine by Tan activity. Tan thus provides a key function in the recycling pathway of the neurotransmitter histamine. It is also involved in the process of cuticle formation. There, it cleaves beta-alanyl-dopamine, a major component in cuticle sclerotization. Active Tan enzyme is generated by a self-processing proteolytic cleavage from a pre-protein at a conserved Gly-Cys sequence motif. We confirmed the dependence on the Gly-Cys motif by in vitro mutagenesis. Processing time delays the rise to full Tan activity up to 3 h behind its putative circadian RNA expression in head. To investigate its pleiotropic functions, we have expressed Tan as a His(6) fusion protein in Escherichia coli and have purified it to homogeneity. We found wild type and mutant His(6)-Tan protein co-migrating in size exclusion chromatography with a molecular weight compatible with homodimer formation. We conclude that dimer formation is preceding pre-protein processing. Drosophila tan(1) null mutant analysis revealed that amino acid Arg(217) is absolutely required for processing. Substitution of Met(256) in tan(5), on the contrary, does not affect processing extensively but renders it prone to degradation. This also leads to a strong tan phenotype although His(6)-Tan(5) retains activity. Kinetic parameters of Tan reveal characteristic differences in K-m and k(cat) values of carcinine and beta-alanyl-dopamine cleavage, which conclusively illustrate the divergent tasks met by Tan.	[Aust, Silvia; Bruesselbach, Florian; Puetz, Stefanie; Hovemann, Bernhard T.] Ruhr Univ Bochum, AG Mol Zellbiochem, Fac Chem & Biochem, D-44780 Bochum, Germany	Ruhr University Bochum	Hovemann, BT (corresponding author), NC5-170,Univ Str 150, D-44780 Bochum, Germany.	bernhard.hovemann@rub.de			Deutsche Forschungsgemeinschaft [HO 714/13-2]; International Graduate School of Neuroscience	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School of Neuroscience	This work was supported by Deutsche Forschungsgemeinschaft Grant HO 714/13-2 (to B. T. H.) and a scholarship of the International Graduate School of Neuroscience (to S. A.).	ALVAREZ E, 1993, EUR J BIOCHEM, V215, P323, DOI 10.1111/j.1432-1033.1993.tb18038.x; ALVAREZ E, 1987, ANTIMICROB AGENTS CH, V31, P1675, DOI 10.1128/AAC.31.11.1675; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bokhove M, 2010, STRUCTURE, V18, P301, DOI 10.1016/j.str.2010.01.005; Borycz J, 2002, J NEUROSCI, V22, P10549; Borycz JA, 2005, J NEUROPHYSIOL, V93, P1611, DOI 10.1152/jn.00894.2004; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; FERNANDEZ FJ, 1994, J BACTERIOL, V176, P4941, DOI 10.1128/jb.176.16.4941-4948.1994; Garcia-Estrada C, 2008, FUNGAL GENET BIOL, V45, P1043, DOI 10.1016/j.fgb.2008.03.005; Gavin BA, 2007, PLOS GENET, V3, P2358, DOI 10.1371/journal.pgen.0030206; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Hovemann BT, 1998, GENE, V221, P1, DOI 10.1016/S0378-1119(98)00440-5; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McEwen RS, 1918, J EXP ZOOL, V25, P49, DOI 10.1002/jez.1400250103; Michaelis L, 1913, BIOCHEM Z, V49, P333; MORGAN CB, 1925, BIBLIOG GENET, V2, P237; Morgan JR, 1999, J NEUROSCI, V19, P1217; MULLER WH, 1992, BIOCHIM BIOPHYS ACTA, V1116, P210, DOI 10.1016/0304-4165(92)90118-E; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Richardt A, 2003, J BIOL CHEM, V278, P41160, DOI 10.1074/jbc.M304303200; Richardt A, 2002, J COMP NEUROL, V452, P93, DOI 10.1002/cne.10360; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Stuart AE, 2007, PROG NEUROBIOL, V82, P202, DOI 10.1016/j.pneurobio.2007.03.006; SUGUMARAN M, 1992, ARCH INSECT BIOCHEM, V19, P271, DOI 10.1002/arch.940190406; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; TOBIN MB, 1990, J BACTERIOL, V172, P5908, DOI 10.1128/jb.172.10.5908-5914.1990; TOBIN MB, 1995, GENE, V162, P29, DOI 10.1016/0378-1119(95)00369-H; TOBIN MB, 1994, FEMS MICROBIOL LETT, V121, P39, DOI 10.1016/0378-1097(94)90143-0; TOBIN MB, 1993, GENE, V132, P199, DOI 10.1016/0378-1119(93)90196-A; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Wagner S, 2007, J COMP NEUROL, V500, P601, DOI 10.1002/cne.21138; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5	37	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20740	20747		10.1074/jbc.M110.120170	http://dx.doi.org/10.1074/jbc.M110.120170			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439462	Green Published, hybrid			2022-12-25	WOS:000279228600038
J	Tuite, AR; Fisman, DN; Kwong, JC; Greer, AL				Tuite, Ashleigh R.; Fisman, David N.; Kwong, Jeffrey C.; Greer, Amy L.			Optimal Pandemic Influenza Vaccine Allocation Strategies for the Canadian Population	PLOS ONE			English	Article							HEALTHY-CHILDREN; H1N1 VIRUS; MORTALITY; SPREAD; PRIORITIZATION; INFECTION; IMPACT; RATES; AGE	Background: The world is currently confronting the first influenza pandemic of the 21(st) century. Influenza vaccination is an effective preventive measure, but the unique epidemiological features of swine-origin influenza A (H1N1) (pH1N1) introduce uncertainty as to the best strategy for prioritization of vaccine allocation. We sought to determine optimal prioritization of vaccine distribution among different age and risk groups within the Canadian population, to minimize influenza-attributable morbidity and mortality. Methodology/Principal Findings: We developed a deterministic, age-structured compartmental model of influenza transmission, with key parameter values estimated from data collected during the initial phase of the epidemic in Ontario, Canada. We examined the effect of different vaccination strategies on attack rates, hospitalizations, intensive care unit admissions, and mortality. In all scenarios, prioritization of high-risk individuals (those with underlying chronic conditions and pregnant women), regardless of age, markedly decreased the frequency of severe outcomes. When individuals with underlying medical conditions were not prioritized and an age group-based approach was used, preferential vaccination of age groups at increased risk of severe outcomes following infection generally resulted in decreased mortality compared to targeting vaccine to age groups with higher transmission, at a cost of higher population-level attack rates. All simulations were sensitive to the timing of the epidemic peak in relation to vaccine availability, with vaccination having the greatest impact when it was implemented well in advance of the epidemic peak. Conclusions/Significance: Our model simulations suggest that vaccine should be allocated to high-risk groups, regardless of age, followed by age groups at increased risk of severe outcomes. Vaccination may significantly reduce influenza-attributable morbidity and mortality, but the benefits are dependent on epidemic dynamics, time for program roll-out, and vaccine uptake.	[Tuite, Ashleigh R.; Fisman, David N.; Kwong, Jeffrey C.] Univ Toronto, Dept Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Fisman, David N.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Greer, Amy L.] Publ Hlth Agcy Canada, Modelling & Project Sect, Surveillance & Risk Assessment Div, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Public Health Agency of Canada	Tuite, AR (corresponding author), Univ Toronto, Dept Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	david.fisman@utoronto.ca			Mathematics of Information Technology and Complex Systems (MITACS); Ontario Agency for Health Protection and Promotion; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research	Mathematics of Information Technology and Complex Systems (MITACS); Ontario Agency for Health Protection and Promotion; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Ms. Tuite receives support from the Mathematics of Information Technology and Complex Systems (MITACS) Accelerate program as a result of both MITACS funding and a matching contribution from the Ontario Agency for Health Protection and Promotion. Dr. Fisman is supported by an Early Researcher Award from the Ontario Ministry of Research and Innovation, the Canadian Institutes of Health Research-supported PanCanadian Pandemic Influenza Modeling Network, and MITACS. Dr. Greer was supported by a Post-doctoral Fellowship Award from the School of Graduate Studies at the University of Toronto during the initial phases of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Beland Yves, 2002, Health Rep, V13, P9; Bingle CL, 2005, CAN J PUBLIC HEALTH, V96, P145, DOI 10.1007/BF03403679; Centers for Disease Control and Prevention, 2008, PREV CONTR INFL REC; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chan M., 2009, WORLD NOW START 2009; Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Fisman DN, 2009, NEW ENGL J MED, V361, P2000, DOI 10.1056/NEJMc0907256; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Henderson DA, 2009, BIOSECUR BIOTERROR, V7, P265, DOI 10.1089/bsp.2009.0729; Kelly H, 2009, EUROSURVEILLANCE, V14, P6; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Manzoli L, 2007, PEDIATR INFECT DIS J, V26, P97, DOI 10.1097/01.inf.0000253053.01151.bd; MEDLOCK J, 2009, PLOS CURR INFLUENZA; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Miller MA, 2008, J INFECT DIS, V198, P305, DOI 10.1086/589716; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Moran K, 2009, VACCINE, V27, P2350, DOI 10.1016/j.vaccine.2009.02.017; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; National Advisory Committee on Immunization (NACI), 2008, Can Commun Dis Rep, V34, P1; Negri E, 2005, VACCINE, V23, P2851, DOI 10.1016/j.vaccine.2004.11.053; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; *PUBL HLTH AG CAN, 2009, GUID H1N1 FLU VACC S; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Smith S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub2; *STAT CAN, 2005, PREGN OUTC AG GROUP; Statistics Canada, 2007, AG SEX HIGHL TABL 20; Statistics Canada, 2007, CAN COMM HLTH SURV C; Sypsa V, 2009, EUROSURVEILLANCE, V14, P2; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Uphoff H, 2009, EUROSURVEILLANCE, V14, P11; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wilson N, 2009, EUROSURVEILLANCE, V14	49	61	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10520	10.1371/journal.pone.0010520	http://dx.doi.org/10.1371/journal.pone.0010520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463898	Green Published, Green Submitted, gold			2022-12-25	WOS:000277379800014
J	Hasegawa, S; Kohro, Y; Shiratori, M; Ishii, S; Shimizu, T; Tsuda, M; Inoue, K				Hasegawa, Shigeo; Kohro, Yuta; Shiratori, Miho; Ishii, Satoshi; Shimizu, Takao; Tsuda, Makoto; Inoue, Kazuhide			Role of PAF Receptor in Proinflammatory Cytokine Expression in the Dorsal Root Ganglion and Tactile Allodynia in a Rodent Model of Neuropathic Pain	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; NECROSIS-FACTOR-ALPHA; SPINAL NERVE LIGATION; CYTOSOLIC PHOSPHOLIPASE A(2); PRIMARY SENSORY NEURONS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; PROTEIN-KINASE ACTIVATION; RAT SCIATIC-NERVE; PRIMARY AFFERENT; PERIPHERAL NEUROPATHY	Background: Neuropathic pain is a highly debilitating chronic pain following damage to peripheral sensory neurons and is often resistant to all treatments currently available, including opioids. We have previously shown that peripheral nerve injury induces activation of cytosolic phospholipase A(2) (cPLA(2)) in injured dorsal root ganglion (DRG) neurons that contribute to tactile allodynia, a hallmark of neuropathic pain. However, lipid mediators downstream of cPLA2 activation to produce tactile allodynia remain to be determined. Principal Findings: Here we provide evidence that platelet-activating factor (PAF) is a potential candidate. Pharmacological blockade of PAF receptors (PAFRs) reduced the development and expression of tactile allodynia following nerve injury. The expression of PAFR mRNA was increased in the DRG ipsilateral to nerve injury, which was seen mainly in macrophages. Furthermore, mice lacking PAFRs showed a reduction of nerve injury-induced tactile allodynia and, interestingly, a marked suppression of upregulation of tumor necrosis factor alpha (TNF alpha) and interleukin-1 beta (IL-1 beta) expression in the injured DRG, crucial proinflammatory cytokines involved in pain hypersensitivity. Conversely, a single injection of PAF near the DRG of naive rats caused a decrease in the paw withdrawal threshold to mechanical stimulation in a dose-dependent manner and an increase in the expression of mRNAs for TNF-alpha and IL-1 beta, both of which were inhibited by pretreatment with a PAFR antagonist. Conclusions: Our results indicate that the PAF/PAFR system has an important role in production of TNF alpha and IL-1 beta in the DRG and tactile allodynia following peripheral nerve injury and suggest that blocking PAFRs may be a viable therapeutic strategy for treating neuropathic pain.	[Hasegawa, Shigeo; Kohro, Yuta; Shiratori, Miho; Tsuda, Makoto; Inoue, Kazuhide] Kyushu Univ, Dept Mol & Syst Pharmacol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Ishii, Satoshi; Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 113, Japan	Kyushu University; University of Tokyo	Hasegawa, S (corresponding author), Kyushu Univ, Dept Mol & Syst Pharmacol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan.	inoue@phar.kyushu-u.ac.jp	Tsuda, Makoto/AAE-7256-2020; Shimizu, Takao/AAV-7052-2021	Kohro, Yuta/0000-0002-3128-7388	Ministry of Education, Culture, Sports, Science and Technology of Japan [20689030, 18GS0319]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#20689030 to MT, #18GS0319 to KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHO H, 1991, J MED CHEM, V34, P1503, DOI 10.1021/jm00108a039; Chopra B, 2000, EUR J NEUROSCI, V12, P911, DOI 10.1046/j.1460-9568.2000.00979.x; Doi K, 2006, AM J PATHOL, V168, P1413, DOI 10.2353/ajpath.2006.050634; Dou WK, 2004, PROSTAG OTH LIPID M, V74, P29, DOI 10.1016/j.prostaglandins.2004.06.001; Elmes SJR, 2004, BRAIN RES, V1022, P205, DOI 10.1016/j.brainres.2004.07.005; Fernandes ES, 2005, BRIT J PHARMACOL, V146, P209, DOI 10.1038/sj.bjp.0706327; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Hasegawa S, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-22; Hefferan MP, 2003, ANESTHESIOLOGY, V99, P1180, DOI 10.1097/00000542-200311000-00027; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kihara Y, 2005, J EXP MED, V202, P853, DOI 10.1084/jem.20050660; Kihara Y, 2008, J IMMUNOL, V181, P5008, DOI 10.4049/jimmunol.181.7.5008; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; LEVINE JD, 1986, P NATL ACAD SCI USA, V83, P5331, DOI 10.1073/pnas.83.14.5331; LEVINE JD, 1984, SCIENCE, V225, P743, DOI 10.1126/science.6087456; Li HQ, 2007, ANESTHESIOLOGY, V107, P469, DOI 10.1097/01.anes.0000278907.37774.8d; LINDSBERG PJ, 1991, ANN NEUROL, V30, P117, DOI 10.1002/ana.410300202; Liu LJ, 2006, J NEUROPHYSIOL, V95, P1478, DOI 10.1152/jn.00509.2005; Ma L, 2009, J NEUROCHEM, V109, P603, DOI 10.1111/j.1471-4159.2009.05987.x; Mantyh PW, 2006, NAT REV NEUROSCI, V7, P797, DOI 10.1038/nrn1914; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Marotta DM, 2009, BIOCHEM PHARMACOL, V77, P1223, DOI 10.1016/j.bcp.2008.12.025; Mika J, 2008, PAIN, V138, P587, DOI 10.1016/j.pain.2008.02.015; MINAMI T, 1992, PAIN, V50, P223, DOI 10.1016/0304-3959(92)90166-9; MINAMI T, 1994, PAIN, V57, P217, DOI 10.1016/0304-3959(94)90226-7; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Morita K, 2004, PAIN, V111, P351, DOI 10.1016/j.pain.2004.07.016; Morita K, 2008, PAIN, V138, P525, DOI 10.1016/j.pain.2008.01.030; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Park KA, 2005, TRENDS PHARMACOL SCI, V26, P571, DOI 10.1016/j.tips.2005.09.010; Renback K, 1999, NEUROSCI LETT, V270, P59, DOI 10.1016/S0304-3940(99)00464-4; Ririe DG, 2006, ANESTHESIOLOGY, V104, P426, DOI 10.1097/00000542-200603000-00008; Sacerdote P, 2008, NEUROSCI LETT, V436, P210, DOI 10.1016/j.neulet.2008.03.023; Sadik CD, 2003, BIOCHEM PHARMACOL, V65, P773, DOI 10.1016/S0006-2952(02)01621-0; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Schafers M, 2002, J NEUROSCI, V22, P536, DOI 10.1523/JNEUROSCI.22-02-00536.2002; Schafers M, 2003, J NEUROSCI, V23, P2517; Schafers M, 2003, J NEUROSCI, V23, P3028; Schafers M, 2003, EUR J NEUROSCI, V17, P791, DOI 10.1046/j.1460-9568.2003.02504.x; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shimizu T, 2006, IUBMB LIFE, V58, P328, DOI 10.1080/15216540600702289; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; TERASHITA Z, 1983, LIFE SCI, V32, P1975, DOI 10.1016/0024-3205(83)90049-8; Trang T, 2004, EUR J PHARMACOL, V491, P21, DOI 10.1016/j.ejphar.2004.03.022; Trang T, 2003, BRIT J PHARMACOL, V140, P295, DOI 10.1038/sj.bjp.0705440; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2007, J NEUROCHEM, V103, P1408, DOI 10.1111/j.1471-4159.2007.04861.x; Tsuda M, 2007, J NEUROCHEM, V102, P1658, DOI 10.1111/j.1471-4159.2007.04796.x; Tsuda M, 2009, P NATL ACAD SCI USA, V106, P8032, DOI 10.1073/pnas.0810420106; Uceyler N, 2007, BRAIN BEHAV IMMUN, V21, P553, DOI 10.1016/j.bbi.2006.10.003; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470; Zhao Z, 2000, NEUROSCIENCE, V97, P743, DOI 10.1016/S0306-4522(00)00052-X; Zhu XY, 2003, ANESTHESIOLOGY, V99, P1175, DOI 10.1097/00000542-200311000-00026; Zhu XY, 2003, PAIN, V104, P15, DOI 10.1016/S0304-3959(02)00465-7	66	38	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10467	10.1371/journal.pone.0010467	http://dx.doi.org/10.1371/journal.pone.0010467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454616	Green Submitted, Green Published, gold			2022-12-25	WOS:000277240300028
J	Kauh, J; Fan, SQ; Xia, MJ; Yue, P; Yang, L; Khuri, FR; Sun, SY				Kauh, John; Fan, Songqing; Xia, Mingjing; Yue, Ping; Yang, Lily; Khuri, Fadlo R.; Sun, Shi-Yong			c-FLIP Degradation Mediates Sensitization of Pancreatic Cancer Cells to TRAIL-Induced Apoptosis by the Histone Deacetylase Inhibitor LBH589	PLOS ONE			English	Article							CELECOXIB-INDUCED APOPTOSIS; DOWN-REGULATION; HDAC INHIBITORS; LIGAND TRAIL; HEPATOMA-CELLS; DEATH; XIAP; ACTIVATION; RESISTANCE; SURVIVIN	Great efforts have been made to develop novel and efficacious therapeutics against pancreatic cancer to improve the treatment outcomes. Tumor-necrosis factor-related apoptosis-inducing ligand ( TRAIL) is such a therapeutic cytokine with selective killing effect toward malignant cells. However, some human pancreatic cancers are intrinsically resistant to TRAIL-mediated apoptosis or therapy. In this study, we have shown that the histone deacetylase inhibitor LBH589 can synergize with TRAIL to augment apoptosis even in TRAIL-resistant cells. LBH589 decreased c-FLIP levels in every tested cell line and survivin levels in some of the tested cell lines. Enforced expression of ectopic c-FLIP, but not survivin, abolished the cooperative induction of apoptosis by the combination of LBH589 and TRAIL, indicating that c-FLIP downregulation plays a critical role in LBH589 sensitization of pancreatic cancer cells to TRAIL. Moreover, LBH589 decreased c-FLIP stability and the presence of the proteasome inhibitor MG132 prevented c-FLIP from reduction by LBH589. Correspondingly, we detected increased levels of ubiqutinated c-FLIP in LBH589-treated cells. These data thus indicate that LBH589 promotes ubiqutin/proteasome-mediated degradation of c-FLIP, leading to downregulation of c-FLIP. Collectively, LBH589 induces c-FLIP degradation and accordingly sensitizes pancreatic cancer cells to TRAIL-induced apoptosis, highlighting a novel therapeutic regimen against pancreatic cancer.	[Kauh, John; Fan, Songqing; Xia, Mingjing; Yue, Ping; Khuri, Fadlo R.; Sun, Shi-Yong] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Kauh, John; Fan, Songqing; Xia, Mingjing; Yue, Ping; Yang, Lily; Khuri, Fadlo R.; Sun, Shi-Yong] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA; [Yang, Lily] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Kauh, J (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	ssun@emory.edu	Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618	Georgia Cancer Coalition Distinguished Cancer Scholar	Georgia Cancer Coalition Distinguished Cancer Scholar	This work was supported by the Georgia Cancer Coalition Distinguished Cancer Scholar award (to S-Y.S.) and departmental research fund (to J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chen SZ, 2007, MOL PHARMACOL, V72, P1269, DOI 10.1124/mol.107.037465; DARVAS K, 2010, INT J CANC; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Fulda S, 2009, J CELL MOL MED, V13, P1221, DOI 10.1111/j.1582-4934.2009.00748.x; Giles F, 2006, CLIN CANCER RES, V12, P4628, DOI 10.1158/1078-0432.CCR-06-0511; Guo F, 2004, CANCER RES, V64, P2580, DOI 10.1158/0008-5472.CAN-03-2629; Haefner M, 2008, WORLD J GASTROENTERO, V14, P3681, DOI 10.3748/wjg.14.3681; Hamacher R, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-64; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; Hylander BL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-22; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kim EH, 2005, ONCOGENE, V24, P6877, DOI 10.1038/sj.onc.1208851; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Liu X, 2006, CANCER RES, V66, P11115, DOI 10.1158/0008-5472.CAN-06-2471; Lucas DM, 2004, LEUKEMIA, V18, P1207, DOI 10.1038/sj.leu.2403388; Matsuzaki H, 2001, CLIN CANCER RES, V7, P407; Murtaza I, 2009, CANCER RES, V69, P1156, DOI 10.1158/0008-5472.CAN-08-2917; Neuzil H, 2004, BIOCHEM BIOPH RES CO, V314, P186, DOI 10.1016/j.bbrc.2003.12.074; Pathil A, 2006, HEPATOLOGY, V43, P425, DOI 10.1002/hep.21054; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Rosato RR, 2003, MOL CANCER THER, V2, P1273; Rowinsky EK, 2005, J CLIN ONCOL, V23, P9394, DOI 10.1200/JCO.2005.02.2889; Sanda T, 2007, LEUKEMIA, V21, P2344, DOI 10.1038/sj.leu.2404902; Schneider G, 2005, GASTROENTEROLOGY, V128, P1606, DOI 10.1053/j.gastro.2005.04.001; Schuchmann M, 2006, ONCOL REP, V15, P227; Singh TR, 2005, ONCOGENE, V24, P4609, DOI 10.1038/sj.onc.1208585; Sun SY, 1999, ONCOGENE, V18, P2357, DOI 10.1038/sj.onc.1202543; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Sun SY, 1997, CANCER RES, V57, P4931; Symanowski J, 2009, J THORAC ONCOL, V4, P149, DOI 10.1097/JTO.0b013e318194f991; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Vogler M, 2007, ONCOGENE, V26, P248, DOI 10.1038/sj.onc.1209776; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Wajant Harald, 2003, Mol Interv, V3, P124, DOI 10.1124/mi.3.3.124; Wang P, 2007, CELL SIGNAL, V19, P2237, DOI 10.1016/j.cellsig.2007.06.001; Watanabe K, 2005, CELL DEATH DIFFER, V12, P10, DOI 10.1038/sj.cdd.4401507; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Wood TE, 2010, MOL CANCER THER, V9, P246, DOI 10.1158/1535-7163.MCT-09-0495; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Xu ZW, 2003, ANTICANCER RES, V23, P251; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang XD, 2003, BIOCHEM PHARMACOL, V66, P1537, DOI 10.1016/S0006-2952(03)00509-4; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	53	45	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10376	10.1371/journal.pone.0010376	http://dx.doi.org/10.1371/journal.pone.0010376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442774	Green Published, gold, Green Submitted			2022-12-25	WOS:000277154200016
J	Goetzl, EJ; Huang, MC; Kon, J; Patel, K; Schwartz, JB; Fast, K; Ferrucci, L; Madara, K; Taub, DD; Longo, DL				Goetzl, Edward J.; Huang, Mei-Chuan; Kon, Junko; Patel, Kalpesh; Schwartz, Janice B.; Fast, Katharine; Ferrucci, Luigi; Madara, Karen; Taub, Dennis D.; Longo, Dan L.			Gender specificity of altered human immune cytokine profiles in aging	FASEB JOURNAL			English	Article						T cells; monocytes; immunodeficiency; autoimmunity	REGULATORY T-CELLS; INTERFERON-GAMMA-PRODUCTION; IFN-GAMMA; CLONAL EXPANSIONS; ELDERLY-PEOPLE; OLD SUBJECTS; IN-VITRO; AGE; LYMPHOCYTES; ACTIVATION	Cytokine generation by T cells and monocytes was determined for 50 subjects aged 65 yr or older and concurrently studied young subjects individually matched to each old subject for sex, race, and national origin. Highly significant differences between cytokine levels of old and young subjects all were gender specific. For T cells stimulated with anti-CD3 plus anti-CD28 antibodies, mean ratios of IFN-gamma generation for healthy old to young subjects were 0.22 for men (P<0.001; n=15) and 3.35 for women (P<0.001; n=13), and those of IL-17 were 0.30 for men (P<0.001) and no difference for women. CD8 T cells were the source of high IFN-gamma in healthy old women. For old men with an inflammatory or immune disease (n=10), mean old to young ratios of T-cell-generated IFN-gamma and IL-17 increased with disease severity up to 5.78 and 2.97 (both P<0.01), respectively, without changes for old women with similar diseases (n=12). For differentiated LPS-stimulated monocytes, old to young ratios of TNF-alpha and IL-6 generation were high only in women with immune or inflammatory disease (2.38, P<0.05 and 1.62, P<0.01, respectively), whereas ratios of IFN-gamma-evoked IP-10 chemokine were low in all groups. Alterations in immune cytokine profiles with aging show significant gender specificity.-Goetzl, E. J., Huang, M.-C., Kon, J., Patel, K., Schwartz, J. B., Fast, K., Ferrucci, L., Madara, K., Taub, D. D., Longo, D. L. Gender specificity of altered human immune cytokine profiles in aging. FASEB J. 24, 3580-3589 (2010). www.fasebj.org	[Goetzl, Edward J.; Huang, Mei-Chuan; Kon, Junko; Schwartz, Janice B.; Fast, Katharine] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Goetzl, Edward J.; Huang, Mei-Chuan; Kon, Junko; Schwartz, Janice B.; Fast, Katharine] Univ Calif San Francisco, Dept Microbiol Immunol, San Francisco, CA 94143 USA; [Goetzl, Edward J.; Patel, Kalpesh; Ferrucci, Luigi; Madara, Karen; Taub, Dennis D.; Longo, Dan L.] NIA, NIH, Baltimore, MD 21224 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Dept Med, Rm UB8B,UC Box 0711,533 Parnassus & 4th Ave, San Francisco, CA 94143 USA.	edward.goetzl@ucsf.edu	Patel, Kalpesh/G-6685-2012; Longo, Dan L./F-6022-2011; Schwartz, Janice/K-6354-2019	Patel, Kalpesh/0000-0002-2952-6773; 	National Institute on Aging; Kenneth Rainin Foundation; National Institutes of Health [HL31809]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000015, ZIAAG000104] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Kenneth Rainin Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute on Aging, a grant from the Kenneth Rainin Foundation, and National Institutes of Health RO-1 grant HL31809. E.J.G., M. C. H., J.B.S., D. D. T., and D. L. L. designed research; E.J.G., J.B.S., K. F., L. F., and K. M. evaluated and selected subjects; E.J.G., M. C. H., J.K., and K. P. performed laboratory research; E.J.G., M. C. H., J.B.S., and D. L. L. analyzed data and wrote the paper. The authors are grateful to Judith H. Goetzl for preparation of the figures and tables.	ABB J, 1984, BLUT, V48, P285; ALRAYES H, 1992, J ALLERGY CLIN IMMUN, V90, P630, DOI 10.1016/0091-6749(92)90136-P; Bryl E, 2004, EXP GERONTOL, V39, P587, DOI 10.1016/j.exger.2003.10.029; Bujak M, 2009, CIRC RES, V105, P973, DOI 10.1161/CIRCRESAHA.109.199471; CANDORE G, 1993, AUTOIMMUNITY, V16, P275, DOI 10.3109/08916939309014646; Caruso C, 1996, IMMUNOL RES, V15, P84, DOI 10.1007/BF02918286; Cone RE, 2007, IMMUNOLOGY, V120, P112, DOI 10.1111/j.1365-2567.2006.02486.x; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; COSSARIZZA A, 1989, FEBS LETT, V248, P141, DOI 10.1016/0014-5793(89)80449-1; Dixit VD, 2007, J CLIN INVEST, V117, P2778, DOI 10.1172/JCI30248; FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950; FOX HS, 1991, J IMMUNOL, V146, P4362; Gerlini G, 2008, J IMMUNOL, V181, P2999, DOI 10.4049/jimmunol.181.5.2999; GILLIS S, 1981, J CLIN INVEST, V67, P937, DOI 10.1172/JCI110143; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; Gupta Sudhir, 2006, Immun Ageing, V3, P5, DOI 10.1186/1742-4933-3-5; Huang MC, 2010, FASEB J, V24, P2558, DOI 10.1096/fj.09-153148; Karpuzoglu-Sahin E, 2001, CYTOKINE, V14, P208, DOI 10.1006/cyto.2001.0876; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Lu BF, 1998, P NATL ACAD SCI USA, V95, P8233, DOI 10.1073/pnas.95.14.8233; Matalka KZ, 2003, NEUROENDOCRINOL LETT, V24, P185; McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655; Micallef MJ, 1996, EUR J IMMUNOL, V26, P1647, DOI 10.1002/eji.1830260736; Nakaya M, 2006, BIOSCI BIOTECH BIOCH, V70, P47, DOI 10.1271/bbb.70.47; Nishikawa H, 2005, J IMMUNOL, V175, P4433, DOI 10.4049/jimmunol.175.7.4433; OGarra A, 1996, CHEM IMMUNOL, V63, P1; Pawelec G, 2007, EMBO REP, V8, P220, DOI 10.1038/sj.embor.7400922; POSNETT DN, 1994, J EXP MED, V179, P609, DOI 10.1084/jem.179.2.609; Rea IM, 1996, GERONTOLOGY, V42, P69, DOI 10.1159/000213775; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Taub DD, 1996, J IMMUNOL, V156, P2095; Tsaknaridis L, 2003, J NEUROSCI RES, V74, P296, DOI 10.1002/jnr.10766; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wack A, 1998, INT IMMUNOL, V10, P1281, DOI 10.1093/intimm/10.9.1281; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Yen CJ, 2000, J BIOMED SCI, V7, P317; Zheng YH, 2000, FASEB J, V14, P2387	37	71	71	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2010	24	9					3580	3589		10.1096/fj.10-160911	http://dx.doi.org/10.1096/fj.10-160911			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20453111	Green Published			2022-12-25	WOS:000281446400045
J	Deacon, K; Knox, AJ				Deacon, Karl; Knox, Alan J.			Endothelin-1 (ET-1) Increases the Expression of Remodeling Genes in Vascular Smooth Muscle through Linked Calcium and cAMP Pathways ROLE OF A PHOSPHOLIPASE A(2)(cPLA(2))/CYCLOOXYGENASE-2 (COX-2)/PROSTACYCLIN RECEPTOR-DEPENDENT AUTOCRINE LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; CANCER CELLS; CYCLIC-AMP; IN-VITRO; AMPHIREGULIN EXPRESSION; SIGNAL-TRANSDUCTION; PROSTAGLANDIN E-2; MESSENGER-RNA; UP-REGULATION; NITRIC-OXIDE	Several important genes that are involved in inflammation and tissue remodeling are switched on by virtue of CRE response elements in their promoters. The upstream signaling mechanisms that inflammatory mediators use to activate cAMP response elements (CREs) are poorly understood. Endothelin (ET) is an important vasoactive mediator that plays roles in inflammation, vascular remodeling, angiogenesis, and carcinogenesis by activating 7 transmembrane G protein-coupled receptors (GPCR). Here we characterized the mechanisms ET-1 uses to regulate CRE-dependent remodeling genes in pulmonary vascular smooth muscle cells. These studies revealed activation pathways involving a cyclooxygenase-2 (COX-2)/prostacyclin receptor (IP receptor) autocrine loop and an interlinked calcium-dependent pathway. We found that ET-1 activated several CRE response genes in vascular smooth muscle cells, particularly COX-2, amphiregulin, follistatin, inhibin-beta-A, and CYR61. ET-1 also activated two other genes epiregulin and HB-EGF. Amphiregulin, follistatin, and inhibin-beta-A and epiregulin were activated by an autocrine loop involving cPLA2, arachidonic acid release, COX-2-dependent PGI(2) synthesis, and IP receptor-linked elevation of cAMP leading to CRE transcription activation. In contrast COX-2, CYR61, and HB-EGF transcription were regulated in a calcium-dependent, COX-2 independent, manner. Observations with IP receptor antagonists and COX-2 inhibitors were confirmed with IP receptor or COX-2-specific small interfering RNAs. ET-1 increases in intracellular calcium and gene transcription were dependent upon ETa activation and calcium influx through T type voltage-dependent calcium channels. These studies give important insights into the upstream signaling mechanisms used by G protein-coupled receptor-linked mediators such as ET-1, to activate CRE response genes involved in angiogenesis, vascular remodeling, inflammation, and carcinogenesis.	[Deacon, Karl; Knox, Alan J.] Univ Nottingham, Div Resp Med, Ctr Resp Res, Nottingham NG5 1PB, England	University of Nottingham	Deacon, K (corresponding author), Univ Nottingham, Div Resp Med, Ctr Resp Res, City Hosp Site,Hucknall Rd, Nottingham NG5 1PB, England.	karl.deacon@nottingham.ac.uk		Knox, Alan/0000-0002-5906-4143	British Heart Foundation; Wellcome Trust	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the British Heart Foundation and the Wellcome Trust.	Baba I, 2000, CANCER RES, V60, P6886; Ben-Ami I, 2006, MOL HUM REPROD, V12, P593, DOI 10.1093/molehr/gal068; Bley KR, 2006, BRIT J PHARMACOL, V147, P335, DOI 10.1038/sj.bjp.0706554; BRUNNER F, 1995, AGENT ACTION SUPPL, V45, P269; Castanares C, 2007, J CELL SCI, V120, P1256, DOI 10.1242/jcs.03419; Chansel D, 2006, FASEB J, V20, P1936, DOI 10.1096/fj.05-5328fje; Coleman R A, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17A, P467; Davis A, 2003, CELL SIGNAL, V15, P597, DOI 10.1016/S0898-6568(02)00148-1; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; DellaFazia MA, 1997, FEBS LETT, V410, P22, DOI 10.1016/S0014-5793(97)00445-6; DORLEANSJUSTE P, 1993, J CARDIOVASC PHARM, V22, pS235, DOI 10.1097/00005344-199322008-00063; Egan CG, 2004, CELL SIGNAL, V16, P1387, DOI 10.1016/j.cellsig.2004.04.008; EGUCHI S, 1993, ENDOCRINOLOGY, V132, P524, DOI 10.1210/en.132.2.524; EHRENREICH H, 1990, J EXP MED, V172, P1741, DOI 10.1084/jem.172.6.1741; Endoh M, 1998, LIFE SCI, V62, P1485, DOI 10.1016/S0024-3205(98)00094-0; Feger GI, 1997, RES EXP MED, V196, P327, DOI 10.1007/s004330050042; Freimann S, 2004, BIOCHEM BIOPH RES CO, V324, P829, DOI 10.1016/j.bbrc.2004.09.129; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; GREENWALD JE, 1989, J CLIN INVEST, V83, P1061, DOI 10.1172/JCI113948; HAMROUN D, 1995, J CARDIOVASC PHARM, V26, pS156; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; HISLOP AA, 1995, AM J RESP CELL MOL, V12, P557, DOI 10.1165/ajrcmb.12.5.7742018; Kato M, 2003, BIOCHEM BIOPH RES CO, V301, P1109, DOI 10.1016/S0006-291X(03)00093-7; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Kumari R, 2006, INT J CANCER, V119, P49, DOI 10.1002/ijc.21802; LUSCHER TF, 1992, J HUM HYPERTENS, V6, pS3; Ma WY, 2005, J NEUROCHEM, V93, P664, DOI 10.1111/j.1471-4159.2005.03050.x; MARKEWITZ BA, 1995, AM J PHYSIOL-LUNG C, V268, pL192, DOI 10.1152/ajplung.1995.268.2.L192; MATSUDA H, 1993, HEART VESSELS, V8, P121, DOI 10.1007/BF01744796; Matsumae H, 2008, ARTERIOSCL THROM VAS, V28, P1077, DOI 10.1161/ATVBAHA.108.162362; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MEHRKE G, 1994, J PHARMACOL EXP THER, V271, P1483; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; NISHIMURA J, 1992, BIOCHEM BIOPH RES CO, V188, P719, DOI 10.1016/0006-291X(92)91115-7; OHLSTEIN EH, 1992, EUR J PHARM-MOLEC PH, V225, P347, DOI 10.1016/0922-4106(92)90109-9; Ornskov D, 2007, BIOCHEM BIOPH RES CO, V354, P885, DOI 10.1016/j.bbrc.2007.01.047; Ornskov D, 2006, FEBS J, V273, P5479, DOI 10.1111/j.1742-4658.2006.05539.x; Pang LH, 1998, AM J PHYSIOL-LUNG C, V275, pL322, DOI 10.1152/ajplung.1998.275.2.L322; Pang LH, 1997, AM J PHYSIOL-LUNG C, V273, pL1132, DOI 10.1152/ajplung.1997.273.6.L1132; Rodman DM, 2005, CIRC RES, V96, P864, DOI 10.1161/01.RES.0000163066.07472.ff; Rosethorne EM, 2008, BIOCHEM PHARMACOL, V75, P942, DOI 10.1016/j.bcp.2007.10.015; RUSSELL FD, 1995, J CARDIOVASC PHARM, V26, pS346; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Scott MGH, 1999, BRIT J PHARMACOL, V128, P721, DOI 10.1038/sj.bjp.0702829; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; SHAREFKIN JB, 1991, J VASC SURG, V14, P1; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; SUGIURA M, 1989, BIOCHEM BIOPH RES CO, V161, P1220, DOI 10.1016/0006-291X(89)91372-7; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V191, P823, DOI 10.1006/bbrc.1993.1291; TELEMAQUE S, 1993, EUR J PHARMACOL, V237, P275, DOI 10.1016/0014-2999(93)90279-Q; Tirapelli CR, 2005, BRIT J PHARMACOL, V146, P903, DOI 10.1038/sj.bjp.0706388; Trevisi L, 2002, BIOCHEM PHARMACOL, V64, P425, DOI 10.1016/S0006-2952(02)01066-3; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Weinreb M, 2006, PROSTAG LEUKOTR ESS, V75, P81, DOI 10.1016/j.plefa.2006.06.004; Woods M, 1999, MOL PHARMACOL, V55, P902; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YU JCM, 1995, J CARDIOVASC PHARM, V26, pS348; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003	62	36	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25913	25927		10.1074/jbc.M110.139485	http://dx.doi.org/10.1074/jbc.M110.139485			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20452970	Green Published, hybrid			2022-12-25	WOS:000280921000006
J	Kim, JY; Henrichs, S; Bailly, A; Vincenzetti, V; Sovero, V; Mancuso, S; Pollmann, S; Kim, D; Geisler, M; Nam, HG				Kim, Jun-Young; Henrichs, Sina; Bailly, Aurelien; Vincenzetti, Vincent; Sovero, Valpuri; Mancuso, Stefano; Pollmann, Stephan; Kim, Daehwang; Geisler, Markus; Nam, Hong-Gil			Identification of an ABCB/P-glycoprotein-specific Inhibitor of Auxin Transport by Chemical Genomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATERAL ROOT CAP; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; P-GLYCOPROTEINS; PIN PROTEINS; EFFLUX; GRAVITROPISM; GROWTH; ACID; IMMUNOPHILIN	Plant development and physiology are widely determined by the polar transport of the signaling molecule auxin. This process is controlled on the cellular efflux level catalyzed by members of the PIN (pin-formed) and ABCB (ATP-binding cassette protein subfamily B)/P-glycoprotein family that can function independently and coordinately. In this study, we have identified by means of chemical genomics a novel auxin transport inhibitor (ATI), BUM (2-[4-(diethylamino)-2-hydroxybenzoyl] benzoic acid), that efficiently blocks auxin-regulated plant physiology and development. In many respects, BUM resembles the functionality of the diagnostic ATI, 1-N-naphtylphtalamic acid (NPA), but it has an IC50 value that is roughly a factor 30 lower. Physiological analysis and binding assays identified ABCBs, primarily ABCB1, as key targets of BUM and NPA, whereas PIN proteins are apparently not directly affected. BUM is complementary to NPA by having distinct ABCB target spectra and impacts on basipetal polar auxin transport in the shoot and root. In comparison with the recently identified ATI, gravacin, it lacks interference with ABCB membrane trafficking. Individual modes or targets of action compared with NPA are reflected by apically shifted root influx maxima that might be the result of altered BUM binding preferences or affinities to the ABCB nucleotide binding folds. This qualifies BUM as a valuable tool for auxin research, allowing differentiation between ABCB- and PIN-mediated efflux systems. Besides its obvious application as a powerful weed herbicide, BUM is a bona fide human ABCB inhibitor with the potential to restrict multidrug resistance during chemotherapy.	[Henrichs, Sina; Bailly, Aurelien; Vincenzetti, Vincent; Sovero, Valpuri; Geisler, Markus] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Henrichs, Sina; Bailly, Aurelien; Vincenzetti, Vincent; Sovero, Valpuri; Geisler, Markus] Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Nam, Hong-Gil] Pohang Univ Sci & Technol, Lab Plant Syst Biodynam, Pohang 790784, South Korea; [Mancuso, Stefano] Univ Florence, Dept Hort, I-50019 Sesto Fiorentino, Italy; [Pollmann, Stephan] Ruhr Univ Bochum, Lehrstuhl Pflanzenphysiol, D-44801 Bochum, Germany; [Kim, Daehwang] Korea Res Inst Chem Technol, Biomat Res Ctr, Taejon 305600, South Korea	University of Zurich; Pohang University of Science & Technology (POSTECH); University of Florence; Ruhr University Bochum; Korea Research Institute of Chemical Technology (KRICT)	Geisler, M (corresponding author), Univ Zurich, Inst Plant Biol, Zolliker Str 107, CH-8008 Zurich, Switzerland.	markus.geisler@botinst.uzh.ch; nam@postech.ac.kr	Pollmann, Stephan/ABC-8203-2020; Mancuso, Stefano/G-6515-2012; Geisler, Markus M/B-3921-2012; Pollmann, Stephan/C-2776-2009	Pollmann, Stephan/0000-0002-5111-4425; Mancuso, Stefano/0000-0003-1752-3986; Geisler, Markus M/0000-0002-6641-5810; Pollmann, Stephan/0000-0002-5111-4425	Forschungskredit of the University of Zurich [KN57150702]; Novartis Foundation; Swiss National Funds [NF31-125001]; Korea government (MEST) [2009-0091504]; Crop Functional Genomics Frontier Research Program [CG3132]	Forschungskredit of the University of Zurich; Novartis Foundation(Novartis); Swiss National Funds(Swiss National Science Foundation (SNSF)); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Crop Functional Genomics Frontier Research Program	This work was supported by grants from the Forschungskredit of the University of Zurich (KN57150702, to A. B.), from the Novartis Foundation (to M. G.), from the Swiss National Funds (NF31-125001, to M. G.), from the National Research Foundation of Korea (NRF) funded by the Korea government (MEST) (no. 2009-0091504), and from the Crop Functional Genomics Frontier Research Program (CG3132) (to H.-G.N.).; We thank A. Murphy for gravacin, S. pombe strains, and expression plasmids, E. Martinoia for discussion and support, and the Korean Chemical Bank for the chemical library donation.	Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; Armstrong JI, 2004, P NATL ACAD SCI USA, V101, P14978, DOI 10.1073/pnas.0404312101; Bailly A, 2008, J BIOL CHEM, V283, P21817, DOI 10.1074/jbc.M709655200; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bernasconi P, 1996, PLANT PHYSIOL, V111, P427, DOI 10.1104/pp.111.2.427; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; COX DN, 1994, PLANT CELL, V6, P1941, DOI 10.1105/tpc.6.12.1941; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Granzin J, 2006, J MOL BIOL, V364, P799, DOI 10.1016/j.jmb.2006.09.052; Jensen PJ, 1998, PLANT PHYSIOL, V116, P455, DOI 10.1104/pp.116.2.455; KATEKAR GF, 1980, PLANT PHYSIOL, V66, P1190, DOI 10.1104/pp.66.6.1190; Kepinski S, 2005, CURR BIOL, V15, pR208, DOI 10.1016/j.cub.2005.03.012; Lewis DR, 2009, NAT PROTOC, V4, P437, DOI 10.1038/nprot.2009.1; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Lomax Terri L., 1995, P509; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Luschnig C, 2001, CURR BIOL, V11, pR831, DOI 10.1016/S0960-9822(01)00497-3; Mancuso S, 2005, ANAL BIOCHEM, V341, P344, DOI 10.1016/j.ab.2005.03.054; MICHALKE W, 1992, PLANTA, V187, P254, DOI 10.1007/BF00201948; Morris DA, 2000, PLANT GROWTH REGUL, V32, P161, DOI 10.1023/A:1010701527848; Mravec J, 2008, DEVELOPMENT, V135, P3345, DOI 10.1242/dev.021071; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Nagashima A, 2008, PLANT CELL PHYSIOL, V49, P1250, DOI 10.1093/pcp/pcn092; Nagashima A, 2008, PLANT J, V53, P516, DOI 10.1111/j.1365-313X.2007.03358.x; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Norambuena Lorena, 2009, V495, P133, DOI 10.1007/978-1-59745-477-3_12; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Petrasek J, 2003, PLANT PHYSIOL, V131, P254, DOI 10.1104/pp.012740; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; Robert S, 2008, P NATL ACAD SCI USA, V105, P8464, DOI 10.1073/pnas.0711650105; Rojas-Pierce M, 2007, CHEM BIOL, V14, P1366, DOI 10.1016/j.chembiol.2007.10.014; Santelia D, 2005, FEBS LETT, V579, P5399, DOI 10.1016/j.febslet.2005.08.061; Santelia D, 2008, J BIOL CHEM, V283, P31218, DOI 10.1074/jbc.M710122200; Savaldi-Goldstein S, 2008, P NATL ACAD SCI USA, V105, P15190, DOI 10.1073/pnas.0806324105; Surpin M, 2005, P NATL ACAD SCI USA, V102, P4902, DOI 10.1073/pnas.0500222102; SUSSMAN MR, 1980, PLANT PHYSIOL, V66, P1074, DOI 10.1104/pp.66.6.1074; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Yang HB, 2009, PLANT J, V59, P179, DOI 10.1111/j.1365-313X.2009.03856.x; Zhao YD, 2003, SCIENCE, V301, P1107, DOI 10.1126/science.1084161	57	89	90	3	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23307	23315		10.1074/jbc.M110.105981	http://dx.doi.org/10.1074/jbc.M110.105981			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20472555	hybrid, Green Published			2022-12-25	WOS:000279999900064
J	Darbellay, B; Arnaudeau, S; Ceroni, D; Bader, CR; Konig, S; Bernheim, L				Darbellay, Basile; Arnaudeau, Serge; Ceroni, Dimitri; Bader, Charles R.; Konig, Stephane; Bernheim, Laurent			Human Muscle Economy Myoblast Differentiation and Excitation-Contraction Coupling Use the Same Molecular Partners, STIM1 and STIM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; T-CELL-ACTIVATION; CRAC CHANNEL ACTIVATION; PLASMA-MEMBRANE; SKELETAL-MUSCLE; ENDOPLASMIC-RETICULUM; CALCIUM-CHANNEL; ORAI1 CHANNELS; PORE SUBUNIT; MICE LACKING	Our recent work identified store-operated Ca2+ entry (SOCE) as the critical Ca2+ source required for the induction of human myoblast differentiation (Darbellay, B., Arnaudeau, S., Konig, S., Jousset, H., Bader, C., Demaurex, N., and Bernheim, L. (2009) J. Biol. Chem. 284, 5370-5380). The present work indicates that STIM2 silencing, similar to STIM1 silencing, reduces myoblast SOCE amplitude and differentiation. Because myoblasts in culture can be induced to differentiate into myotubes, which spontaneously contract in culture, we used the same molecular tools to explore whether the Ca2+ mechanism of excitation-contraction coupling also relies on STIM1 and STIM2. Live cell imaging of early differentiating myoblasts revealed a characteristic clustering of activated STIM1 and STIM2 during the first few hours of differentiation. Thapsigargin-induced depletion of endoplasmic reticulum Ca2+ content caused STIM1 and STIM2 redistribution into clusters, and co-localization of both STIM proteins. Interaction of STIM1 and STIM2 was revealed by a rapid increase in fluorescence resonance energy transfer between CFP-STIM1 and YFP-STIM2 after SOCE activation and confirmed by co-immunoprecipitation of endogenous STIM1 and STIM2. Although both STIM proteins clearly contribute to SOCE and are required during the differentiation process, STIM1 and STIM2 are functionally largely redundant as overexpression of either STIM1 or STIM2 corrected most of the impact of STIM2 or STIM1 silencing on SOCE and differentiation. With respect to excitation-contraction, we observed that human myotubes rely also on STIM1 and STIM2 to refill their endoplasmic reticulum Ca2+-content during repeated KCl-induced Ca2+ releases. This indicates that STIM2 is a necessary partner of STIM1 for excitation-contraction coupling. Thus, both STIM proteins are required and interact to control SOCE during human myoblast differentiation and human myotube excitation-contraction coupling.	[Darbellay, Basile; Bader, Charles R.] Univ Hosp Geneva, Dept Clin Neurosci, CH-1211 Geneva 4, Switzerland; [Ceroni, Dimitri] Univ Hosp Geneva, Dept Pediat, CH-1211 Geneva 4, Switzerland; [Arnaudeau, Serge; Konig, Stephane; Bernheim, Laurent] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva	Bernheim, L (corresponding author), 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	laurent.bernheim@unige.ch	Darbellay, Basile/B-1708-2018	Koenig, Stephane/0000-0002-0801-279X	Fonds National Suisse pour la Recherche Scientifique [310030-124910]; Fondation Suisse pour la Recherche sur les Maladies Musculaires; Fondation Hans Wilsdorf; Fondation Marcel Levaillant	Fonds National Suisse pour la Recherche Scientifique; Fondation Suisse pour la Recherche sur les Maladies Musculaires; Fondation Hans Wilsdorf; Fondation Marcel Levaillant	This work was supported by the Fonds National Suisse pour la Recherche Scientifique (Grant 310030-124910 to L. B.), the Fondation Suisse pour la Recherche sur les Maladies Musculaires, the Fondation Hans Wilsdorf, and the Fondation Marcel Levaillant.	Arnaudeau S, 2006, J CELL PHYSIOL, V208, P435, DOI 10.1002/jcp.20679; BAROFFIO A, 1993, MUSCLE NERVE, V16, P498, DOI 10.1002/mus.880160511; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2010, CLIN IMMUNOL, V135, P169, DOI 10.1016/j.clim.2010.01.011; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hinard V, 2008, DEVELOPMENT, V135, P859, DOI 10.1242/dev.011387; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Lorenzon P, 1997, EUR J NEUROSCI, V9, P800, DOI 10.1111/j.1460-9568.1997.tb01429.x; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosenberg P, 2004, P NATL ACAD SCI USA, V101, P9387, DOI 10.1073/pnas.0308179101; Schuhmann MK, 2010, J IMMUNOL, V184, P1536, DOI 10.4049/jimmunol.0902161; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; Stiber JA, 2005, DEV BIOL, V287, P213, DOI 10.1016/j.ydbio.2005.06.030; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	54	60	64	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22437	22447		10.1074/jbc.M110.118984	http://dx.doi.org/10.1074/jbc.M110.118984			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20436167	hybrid, Green Published			2022-12-25	WOS:000279702200056
J	Shiraya, K; Hirata, T; Hatano, R; Nagamori, S; Wiriyasermkul, P; Jutabha, P; Matsubara, M; Muto, S; Tanaka, H; Asano, S; Anzai, N; Endou, H; Yamada, A; Sakurai, H; Kanai, Y				Shiraya, Katsuko; Hirata, Taku; Hatano, Ryo; Nagamori, Shushi; Wiriyasermkul, Pattama; Jutabha, Promsuk; Matsubara, Mitsunobu; Muto, Shigeaki; Tanaka, Hidekazu; Asano, Shinji; Anzai, Naohiko; Endou, Hitoshi; Yamada, Akira; Sakurai, Hiroyuki; Kanai, Yoshikatsu			A Novel Transporter of SLC22 Family Specifically Transports Prostaglandins and Co-localizes with 15-Hydroxyprostaglandin Dehydrogenase in Renal Proximal Tubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTER; AMINO-ACID TRANSPORTER; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; INTRACELLULAR VOLUME; CATION TRANSPORTERS; EXPRESSION CLONING; CELL LINES; IDENTIFICATION	We identified a novel prostaglandin (PG)-specific organic anion transporter (OAT) in the OAT group of the SLC22 family. The transporter designated OAT-PG from mouse kidney exhibited Na+-independent and saturable transport of PGE(2) when expressed in a proximal tubule cell line (S-2). Unusual for OAT members, OAT-PG showed narrow substrate selectivity and high affinity for a specific subset of PGs, including PGE(2), PGF(2 alpha), and PGD(2). Similar to PGE(2) receptor and PGT, a structurally distinct PG transporter, OAT-PG requires for its substrates an alpha-carboxyl group, with a double bond between C13 and C14 as well as a (S)-hydroxyl group at C15. Unlike the PGE(2) receptor, however, the hydroxyl group at C11 in a cyclopentane ring is not essential for OAT-PG substrates. Addition of a hydroxyl group at C19 or C20 impairs the interaction with OAT-PG, whereas an ethyl group at C20 enhances the interaction, suggesting the importance of hydrophobicity around the omega-tail tip forming a "hydrophobic core" accompanied by a negative charge, which is essential for substrates of OAT members. OAT-PG-mediated transport is concentrative in nature, although OAT-PG mediates both facilitative and exchange transport. OAT-PG is kidney-specific and localized on the basolateral membrane of proximal tubules where a PG-inactivating enzyme, 15-hydroxyprostaglandin dehydrogenase, is expressed. Because of the fact that 15-keto-PGE(2), the metabolite of PGE(2) produced by 15-hydroxyprostaglandin dehydrogenase, is not a substrate of OAT-PG, the transport-metabolism coupling would make unidirectional PGE(2) transport more efficient. By removing extracellular PGE(2), OAT-PG is proposed to be involved in the local PGE(2) clearance and metabolism for the inactivation of PG signals in the kidney cortex.	[Hatano, Ryo; Nagamori, Shushi; Wiriyasermkul, Pattama; Tanaka, Hidekazu; Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Dept Pharmacol, Div Biosyst Pharmacol, Suita, Osaka 5650871, Japan; [Shiraya, Katsuko; Hirata, Taku; Wiriyasermkul, Pattama; Jutabha, Promsuk; Anzai, Naohiko; Endou, Hitoshi; Sakurai, Hiroyuki] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan; [Shiraya, Katsuko; Yamada, Akira] Kyorin Univ, Sch Med, Dept Internal Med, Tokyo 1818611, Japan; [Matsubara, Mitsunobu] Tohoku Univ, Sch Med, Ctr Translat & Adv Anim Res, Div Mol Med, Sendai, Miyagi 9800871, Japan; [Muto, Shigeaki] Jichi Med Univ, Dept Nephrol, Jichi, Tochigi 3290498, Japan; [Asano, Shinji] Ritsumeikan Univ, Coll Pharmaceut Sci, Dept Mol Physiol, Shiga 5258577, Japan	Osaka University; Kyorin University; Kyorin University; Tohoku University; Jichi Medical University; Ritsumeikan University	Kanai, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Pharmacol, Div Biosyst Pharmacol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ykanai@pharma1.med.osaka-u.ac.jp	ANZAI, NAOHIKO/K-9492-2017; Nagamori, Shushi/P-4530-2018; Jutabha, Promsuk/AAE-9872-2022; Jutabha, Promsuk/AFF-4363-2022	ANZAI, NAOHIKO/0000-0003-0605-0458; Nagamori, Shushi/0000-0003-0203-2754; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid for scientific research on priority areas of "transportsomes" from the Ministry of Education, Culture, Sports, Science and Technology of Japan and grants-in-aid for scientific research from the Japan Society for the Promotion of Science.	ADAM SA, 1991, METHOD CELL BIOL, V35, P469; ADEBODUN F, 1993, J CELL PHYSIOL, V154, P199, DOI 10.1002/jcp.1041540123; Anzai N, 2005, J PHARMACOL EXP THER, V315, P534, DOI 10.1124/jpet.105.088583; Apiwattanakul N, 1999, MOL PHARMACOL, V55, P847; Burckhardt G, 2000, AM J PHYSIOL-RENAL, V278, pF853, DOI 10.1152/ajprenal.2000.278.6.F853; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Chairoungdua A, 1999, J BIOL CHEM, V274, P28845, DOI 10.1074/jbc.274.41.28845; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Hosoyamada M, 1996, ARCH TOXICOL, V70, P284, DOI 10.1007/s002040050275; Hosoyamada M, 2004, J AM SOC NEPHROL, V15, P261, DOI 10.1097/01.ASN.0000107560.80107.19; ITOH S, 1996, MOL PHARMACOL, V50, P738; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; Kanai Y, 2004, PFLUG ARCH EUR J PHY, V447, P469, DOI 10.1007/s00424-003-1146-4; KANAI Y, 1992, AM J PHYSIOL, V263, pF1087, DOI 10.1152/ajprenal.1992.263.6.F1087; Kimura H, 2002, J PHARMACOL EXP THER, V301, P293, DOI 10.1124/jpet.301.1.293; Koepsell H, 2004, PFLUG ARCH EUR J PHY, V447, P666, DOI 10.1007/s00424-003-1089-9; Kusuhara H, 1999, J BIOL CHEM, V274, P13675, DOI 10.1074/jbc.274.19.13675; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Morita N, 2005, DRUG METAB DISPOS, V33, P1151, DOI 10.1124/dmd.104.001552; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nomura T, 2004, MOL PHARMACOL, V65, P973, DOI 10.1124/mol.65.4.973; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; PIPER PJ, 1970, NATURE, V225, P600, DOI 10.1038/225600a0; Pucci ML, 2006, AM J PHYSIOL-RENAL, V290, pF641, DOI 10.1152/ajprenal.00426.2004; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Rottenberg H, 1979, Methods Enzymol, V55, P547; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Sekine T, 1998, FEBS LETT, V429, P179, DOI 10.1016/S0014-5793(98)00585-7; Sekine T, 2000, PFLUG ARCH EUR J PHY, V440, P337, DOI 10.1007/s004240000297; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Shin HJ, 2007, HEPATOLOGY, V45, P1046, DOI 10.1002/hep.21596; Takeda M, 1999, KIDNEY INT, V56, P2128, DOI 10.1046/j.1523-1755.1999.00789.x; Takeda M, 2002, J PHARMACOL EXP THER, V302, P666, DOI 10.1124/jpet.102.034330; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; UCHIDA S, 1985, PFLUG ARCH EUR J PHY, V404, P278, DOI 10.1007/BF00581251; Uchino H, 2002, MOL PHARMACOL, V61, P729, DOI 10.1124/mol.61.4.729; Ungrin MD, 2001, MOL PHARMACOL, V59, P1446, DOI 10.1124/mol.59.6.1446; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; VASQUEZ B, 1982, IN VITRO CELL DEV B, V18, P643; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wolff NA, 1997, FEBS LETT, V417, P287, DOI 10.1016/S0014-5793(97)01304-5; Yao B, 2008, AM J PHYSIOL-RENAL, V294, pF433, DOI 10.1152/ajprenal.00436.2007; Yokoyama H, 2008, CELL PHYSIOL BIOCHEM, V21, P269, DOI 10.1159/000129385	48	30	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22141	22151		10.1074/jbc.M109.084426	http://dx.doi.org/10.1074/jbc.M109.084426			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20448048	hybrid, Green Published			2022-12-25	WOS:000279702200027
J	Grzmil, M; Rzymski, T; Milani, M; Harris, AL; Capper, RG; Saunders, NJ; Salhan, A; Ragoussis, J; Norbury, CJ				Grzmil, M.; Rzymski, T.; Milani, M.; Harris, A. L.; Capper, R. G.; Saunders, N. J.; Salhan, A.; Ragoussis, J.; Norbury, C. J.			An oncogenic role of eIF3e/INT6 in human breast cancer	ONCOGENE			English	Article						MAD2L1; BCL-XL; PLAU; urokinase-type plasminogen activator; breast cancer	INITIATION-FACTOR EIF3; MAMMARY-TUMOR VIRUS; TRANSLATION INITIATION; MESSENGER-RNA; FISSION YEAST; SUBCELLULAR-LOCALIZATION; MALIGNANT-TRANSFORMATION; PROTEIN-SYNTHESIS; CELL-GROWTH; INT6	Altered expression of the eukaryotic translation initiation factor 3 (eIF3) subunit eIF3e/INT6 has been described in various types of human cancer, but the nature of its involvement in tumorigenesis is not yet clear. Using immunohistochemical analysis of 81 primary breast cancers, we found that high tumor grade correlated significantly with elevated cytoplasmic eIF3e level in epithelial tumor cells. Analysis of protein synthesis after siRNA-mediated knockdown in breast cancer cell lines indicated that eIF3e is not required for bulk translation. Microarray analysis of total and polysomal RNAs nonetheless identified distinct sets of mRNAs regulated either positively or negatively by eIF3e; functional classification of these revealed a marked enrichment of genes involved in cell proliferation, invasion and apoptosis. Validated mRNA targets regulated positively at the translational level by eIF3e included urokinase-type plasminogen activator and apoptotic regulator BCL-XL, whereas synthesis of proteins including the mitotic checkpoint component MAD2L1 was negatively regulated. Finally, eIF3e-depleted breast carcinoma cells showed reduced in vitro invasion and proliferation. Taken together, our study data suggest that eIF3e has a positive role in breast cancer progression. It regulates the translation, and in some cases abundance, of mRNAs involved in key aspects of cancer cell biology. Oncogene (2010) 29, 4080-4089; doi:10.1038/onc.2010.152; published online 10 May 2010	[Grzmil, M.; Capper, R. G.; Saunders, N. J.; Norbury, C. J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Rzymski, T.; Milani, M.; Harris, A. L.] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX1 3RE, England; [Salhan, A.; Ragoussis, J.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 3RE, England	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Norbury, CJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	chris.norbury@path.ox.ac.uk	Ragoussis, Ioannis/AAD-9790-2022; Harris, Adrian L/ABA-3343-2020; Saunders, Nigel J/W-6745-2019	Harris, Adrian L/0000-0003-1376-8409; Grzmil, Michal/0000-0002-7866-8145; Ragoussis, Ioannis/0000-0002-8515-0934; Saunders, Nigel/0000-0002-0160-4573	Cancer Research UK; Association for International Cancer Research; Wellcome Trust [075491/Z/04]	Cancer Research UK(Cancer Research UK); Association for International Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Ben Thomas and Sasha Akoulitchev for help and advice with 2D liquid chromatography, Cheng Han for help with the statistical analysis, Dan Scott and other members of the laboratory for their comments on the article. This work was supported by Cancer Research UK, the Association for International Cancer Research and the Wellcome Trust (through grant 075491/Z/04 to JR).	Ahlemann M, 2006, MOL CARCINOGEN, V45, P957, DOI 10.1002/mc.20269; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; BENNE R, 1978, J BIOL CHEM, V253, P3078; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Bubendorf L, 2001, J PATHOL, V195, P72, DOI 10.1002/path.893; Buchsbaum S, 2007, ONCOGENE, V26, P5132, DOI 10.1038/sj.onc.1210314; Buratti E, 1998, NUCLEIC ACIDS RES, V26, P3179, DOI 10.1093/nar/26.13.3179; Buttitta F, 2005, CLIN CANCER RES, V11, P3198, DOI 10.1158/1078-0432.CCR-04-2308; Chen L, 2007, J BIOL CHEM, V282, P12707, DOI 10.1074/jbc.M700423200; Crane R, 2000, MOL BIOL CELL, V11, P3993, DOI 10.1091/mbc.11.11.3993; De Quinto SL, 2001, RNA, V7, P1213, DOI 10.1017/S1355838201010433; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Grzmil M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000959; Han B, 2005, ONCOL REP, V14, P105; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jivotovskaya AV, 2006, MOL CELL BIOL, V26, P1355, DOI 10.1128/MCB.26.4.1355-1372.2006; Mack DL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1742; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Marchetti A, 2001, INT J ONCOL, V18, P175; Mavrakis KJ, 2008, CELL CYCLE, V7, P2791, DOI 10.4161/cc.7.18.6683; Mayeur GL, 2002, FEBS LETT, V514, P49, DOI 10.1016/S0014-5793(02)02307-4; MERRICK WC, 1979, J BIOL CHEM, V254, P3708; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; Miyazaki S, 1997, GENOMICS, V46, P155, DOI 10.1006/geno.1997.4996; Morris C, 2005, ONCOGENE, V24, P1203, DOI 10.1038/sj.onc.1208268; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; Rencus-Lazar S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002239; Saal LH, 2002, GENOME BIOL, V3; Savinainen KJ, 2006, PROSTATE, V66, P1144, DOI 10.1002/pros.20452; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Thumma SC, 2007, CANCER LETT, V258, P1, DOI 10.1016/j.canlet.2007.08.022; Traicoff JL, 2007, J BIOMED SCI, V14, P395, DOI 10.1007/s11373-007-9149-3; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; von Arnim AG, 2003, CURR BIOL, V13, pR323, DOI 10.1016/S0960-9822(03)00238-0; Watkins SJ, 2004, CELL PROLIFERAT, V37, P149, DOI 10.1111/j.1365-2184.2004.00305.x; Watkins SJ, 2002, BRIT J CANCER, V86, P1023, DOI 10.1038/sj/bjc/6600222; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Winters ZE, 2001, EUR J CANCER, V37, P2405, DOI 10.1016/S0959-8049(01)00327-6; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	47	42	46	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 15	2010	29	28					4080	4089		10.1038/onc.2010.152	http://dx.doi.org/10.1038/onc.2010.152			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	625JW	20453879				2022-12-25	WOS:000279892400008
J	Takizawa, M; Kim, JS; Tessarollo, L; McNeil, N; Waldschmidt, TJ; Casellas, R; Ried, T; Janz, S				Takizawa, M.; Kim, J. S.; Tessarollo, L.; McNeil, N.; Waldschmidt, T. J.; Casellas, R.; Ried, T.; Janz, S.			Genetic reporter system for oncogenic Igh-Myc translocations in mice	ONCOGENE			English	Article						mouse plasmacytoma T(12;15) translocation; human Burkitt lymphoma t(8;14)(q24;q32) translocation; green fluorescence protein	CLASS SWITCH RECOMBINATION; C-MYC; CHROMOSOMAL TRANSLOCATIONS; B-CELL; BALB/C PLASMACYTOMAS; DNA-REPAIR; IN-VIVO; T(12/15); AID; HYPERMUTATION	The Myc-deregulating chromosomal T(12; 15)(Igh-Myc) translocation, the hallmark mutation of inflammation-and interleukin 6-dependent mouse plasmacytoma (PCT), is the premier model of cancer-associated chromosomal translocations because it is the only translocation in mice that occurs spontaneously (B lymphocyte lineage) and with predictably high incidence (similar to 85% of PCT), and has a direct counterpart in humans: Burkitt lymphoma t(8;14)(q24;q32) translocation. Here, we report on the development of a genetic system for the detection of T(12;15)(Igh-Myc) translocations in plasma cells of a mouse strain in which an enhanced green fluorescent protein (GFP)-encoding reporter gene has been targeted to Myc. Four of the PCTs that developed in the newly generated translocation reporter mice, designated iGFP(5/Myc), expressed GFP consequent to naturally occurring T(12;15) translocation. GFP expression did not interfere with tumor development or the deregulation of Myc on derivative 12 of translocation, der (12), because the reporter gene was allocated to the reciprocal product of translocation, der (15). Although the described reporter gene approach requires refinement before T(12;15) translocations can be quantitatively detected in vivo, including in B lymphocyte lineage cells that have not yet completed malignant transformation, our findings provide proof of principle that reporter gene tagging of oncogenes in gene-targeted mice can be used to elucidate unresolved questions on the occurrence, distribution and trafficking of cells that have acquired cancer-causing chromosomal translocations of great relevance for humans. Oncogene (2010) 29, 4113-4120; doi:10.1038/onc.2010.150; published online 10 May 2010	[Waldschmidt, T. J.; Janz, S.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52246 USA; [Takizawa, M.; Kim, J. S.] NCI, Genet Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Takizawa, M.; Casellas, R.] Natl Inst Arthrit & Musculoskeletal Dis, Bethesda, MD USA; [Tessarollo, L.] NCI, Mouse Canc Genet Program, CCR, Bethesda, MD 20892 USA; [McNeil, N.; Ried, T.] NCI, Genet Branch, CCR, NIH, Bethesda, MD 20892 USA	University of Iowa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Janz, S (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, 500 Newton Rd,1046C ML, Iowa City, IA 52246 USA.	siegfried-janz@uiowa.edu		Waldschmidt, Thomas/0000-0001-6147-6991; McNeil, Nicole/0000-0003-1440-6880	NIH; National Cancer Institute [P50CA097274]; NATIONAL CANCER INSTITUTE [ZICBC011265, ZIABC010836, R01CA151354, P50CA097274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041149, ZIAAR041148, Z01AR041149] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank our colleagues from NCI and NIAID, NIH for their contributions to this project: Tina Willington, Vaishali Jarral and Wendy DuBois for genotyping and assistance with the mouse experiments; Eileen Southon for gene targeting; Dr Alexander L Kovalchuk for advice on PCR analysis and providing primers; Drs Sung Sup Park and Santiago Silva for contributions to early stages of this project; and Drs Michael Potter and Beverly Mock for stimulating discussion and laboratory support. For assistance with transfer, cryopreservation, maintenance and rederivation of mice under SPF conditions, we thank: Ling Hu, CCOM, Iowa City, Iowa; the staff of the Jackson Laboratory, Bar Harbor, Maine; and the Office of Animal Resources, CCOM, particularly Dr Kem Singletary and James Hynes. We also thank Lorraine Tygrett, CCOM for assistance with flow cytometry. This work was supported, in part, by the Intramural Research Program of the NIH (LT, RC, TR) and Award Number P50CA097274 from the National Cancer Institute (SJ).	ANDERSON PN, 1969, NATURE, V222, P994, DOI 10.1038/222994a0; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Germain RN, 2005, SEMIN IMMUNOL, V17, P431, DOI 10.1016/j.smim.2005.09.003; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Gostissa M, 2009, P NATL ACAD SCI USA, V106, P2265, DOI 10.1073/pnas.0812763106; JANZ S, 1993, P NATL ACAD SCI USA, V90, P7361, DOI 10.1073/pnas.90.15.7361; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Kovalchuk AL, 2000, LEUKEMIA, V14, P1127, DOI 10.1038/sj.leu.2401767; Kovalchuk AL, 1997, ONCOGENE, V15, P2369, DOI 10.1038/sj.onc.1201409; Kovalchuk AL, 2000, LEUKEMIA, V14, P909, DOI 10.1038/sj.leu.2401676; Kovalchuk AL, 2003, ONCOGENE, V22, P2842, DOI 10.1038/sj.onc.1206345; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Levens DL, 2003, GENE DEV, V17, P1071, DOI 10.1101/gad.1095203; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Muller JR, 1996, CANCER RES, V56, P419; Muller JR, 1997, BLOOD, V89, P291, DOI 10.1182/blood.V89.1.291.291_291_296; Muller JR, 1997, CURR TOP MICROBIOL, V224, P251; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Silva S, 2003, CANCER RES, V63, P8656; SUEMATSU S, 1992, P NATL ACAD SCI USA, V89, P232, DOI 10.1073/pnas.89.1.232; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wessels JT, 2007, CYTOM PART A, V71A, P542, DOI 10.1002/cyto.a.20419; Willis TG, 2000, BLOOD, V96, P808, DOI 10.1182/blood.V96.3.808.015k30_808_822	31	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 15	2010	29	28					4113	4120		10.1038/onc.2010.150	http://dx.doi.org/10.1038/onc.2010.150			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	625JW	20453890	Green Accepted			2022-12-25	WOS:000279892400011
J	Castelle, C; Ilbert, M; Infossi, P; Leroy, G; Giudici-Orticoni, MT				Castelle, Cindy; Ilbert, Marianne; Infossi, Pascale; Leroy, Gisele; Giudici-Orticoni, Marie-Therese			An Unconventional Copper Protein Required for Cytochrome c Oxidase Respiratory Function under Extreme Acidic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER; COMPLEX-I; RUSTICYANIN; IDENTIFICATION; STABILITY; SEQUENCE; BINDING; SEARCH; MODEL; CHAIN	Very little is known about the processes used by acidophile organisms to preserve stability and function of respiratory pathways. Here, we reveal a potential strategy of these organisms for protecting and keeping functional key enzymes under extreme conditions. Using Acidithiobacillus ferrooxidans, we have identified a protein belonging to a new cupredoxin subfamily, AcoP, for "acidophile CcO partner," which is required for the cytochrome c oxidase (CcO) function. We show that it is a multifunctional copper protein with at least two roles as follows: (i) as a chaperone-like protein involved in the protection of the Cu-A center of the CcO complex and (ii) as a linker between the periplasmic cytochrome c and the inner membrane cytochrome c oxidase. It could represent an interesting model for investigating the multifunctionality of proteins known to be crucial in pathways of energy metabolism.	[Castelle, Cindy; Ilbert, Marianne; Infossi, Pascale; Leroy, Gisele; Giudici-Orticoni, Marie-Therese] IMM CNRS, Lab Bioenerget & Ingn Prot, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Giudici-Orticoni, MT (corresponding author), IMM CNRS, Lab Bioenerget & Ingn Prot, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	giudici@ifr88.cnrs-mrs.fr	Ilbert, marianne/ABG-5015-2021	Castelle, Cindy/0000-0002-0751-9804; ilbert, marianne/0000-0002-9070-2334				Appia-Ayme C, 1999, APPL ENVIRON MICROB, V65, P4781; Arnesano F, 2005, J PROTEOME RES, V4, P63, DOI 10.1021/pr049862f; Balatri E, 2003, STRUCTURE, V11, P1431, DOI 10.1016/j.str.2003.10.004; Bertini I, 2005, J BIOL INORG CHEM, V10, P613, DOI 10.1007/s00775-005-0011-7; Botuyan MV, 1996, J MOL BIOL, V263, P752, DOI 10.1006/jmbi.1996.0613; Castelle C, 2008, J BIOL CHEM, V283, P25803, DOI 10.1074/jbc.M802496200; Cavazza C, 1996, EUR J BIOCHEM, V242, P308, DOI 10.1111/j.1432-1033.1996.0308r.x; Dennison C, 2005, COORDIN CHEM REV, V249, P3025, DOI 10.1016/j.ccr.2005.04.021; Drosou V, 2002, EUR J BIOCHEM, V269, P2980, DOI 10.1046/j.1432-1033.2002.02979.x; Elbehti A, 1996, FEMS MICROBIOL LETT, V136, P51; Elbehti A, 1999, J BIOL CHEM, V274, P16760, DOI 10.1074/jbc.274.24.16760; Erales J, 2009, J BIOL CHEM, V284, P12735, DOI 10.1074/jbc.M808254200; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Giudici-Orticoni MT, 1999, J BIOL CHEM, V274, P30365, DOI 10.1074/jbc.274.43.30365; Giudici-Orticoni MT, 2000, BIOCHEMISTRY-US, V39, P7205, DOI 10.1021/bi992846p; GIUDICIORTICONI MT, 2001, FUNDAMENTALS TECHNOL, P291; GIUDICIORTICONI MT, 1997, BIOHYDROMETALLURGY F, P1; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Hinchliffe P, 2006, BIOCHEMISTRY-US, V45, P4413, DOI 10.1021/bi0600998; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Lane Darius J R, 2010, Biochem J, V426, pe1, DOI 10.1042/BJ20091959; Lemos SS, 2000, BIOPHYS J, V79, P1085, DOI 10.1016/S0006-3495(00)76362-4; Ma BY, 2000, PROTEIN ENG, V13, P617, DOI 10.1093/protein/13.9.617; Malarte G, 2005, BIOCHEMISTRY-US, V44, P6471, DOI 10.1021/bi048425b; Maneg O, 2004, BBA-BIOENERGETICS, V1655, P274, DOI 10.1016/j.bbabio.2003.10.010; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Richter OMH, 2009, BBA-BIOENERGETICS, V1787, P626, DOI 10.1016/j.bbabio.2009.02.020; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; Siluvai GS, 2009, BIOCHEMISTRY-US, V48, P12133, DOI 10.1021/bi901480g; Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; Walter RL, 1996, J MOL BIOL, V263, P730, DOI 10.1006/jmbi.1996.0612; Witt H, 1998, EUR J BIOCHEM, V251, P367, DOI 10.1046/j.1432-1327.1998.2510367.x	39	17	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21519	21525		10.1074/jbc.M110.131359	http://dx.doi.org/10.1074/jbc.M110.131359			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442397	Green Published, hybrid			2022-12-25	WOS:000279516100038
J	Horne, BE; Li, TF; Genevaux, P; Georgopoulos, C; Landry, SJ				Horne, B. Erin; Li, Tingfeng; Genevaux, Pierre; Georgopoulos, Costa; Landry, Samuel J.			The Hsp40 J-domain Stimulates Hsp70 When Tethered by the Client to the ATPase Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE DNAK; ESCHERICHIA-COLI DNAJ; IN-VIVO; SUBSTRATE-BINDING; MECHANISM; PROTEINS; SPECTROSCOPY; MUTANTS; TEMPERATURES; COCHAPERONE	The Escherichia coli Hsp40 DnaJ uses its J-domain (Jd) to couple ATP hydrolysis and client protein capture in Hsp70 DnaK. Fusion of the Jd to peptide p5 (as in Jdp5) dramatically increases the apparent affinity of the p5 moiety for DnaK in the presence of ATP, and Jdp5 stimulates ATP hydrolysis in DnaK by several orders of magnitude. NMR experiments with [N-15]Jdp5 demonstrated that the peptide tethers the Jd to the ATPase domain. Thus, ATP hydrolysis and client protein binding in DnaK are coupled principally through the association of the client with DnaJ. Overexpression of a recombinant Jd was specifically toxic to cells that simultaneously expressed DnaK. No toxicity was observed when overexpressing Jdp5 or mutant Jd or when co-overexpressing the Jd and the nucleotide exchange factor GrpE. The results suggest that the Jd shifts DnaK to a client-bound form by stimulating the DnaK ATPase but only when the Jd is brought to DnaK by a client-Hsp40 complex.	[Landry, Samuel J.] Tulane Univ, Hlth Sci Ctr, Dept Biochem, New Orleans, LA 70112 USA; [Genevaux, Pierre] Univ Toulouse 3, CNRS, IBCG, Dept Microbiol & Mol Genet, F-31062 Toulouse, France; [Georgopoulos, Costa] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Tulane University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Utah System of Higher Education; University of Utah	Landry, SJ (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Biochem, SL43,1430 Tulane Ave, New Orleans, LA 70112 USA.	landry@tulane.edu	Li, Tingfeng/B-7890-2010; Genevaux, Pierre/A-4851-2015; Landry, Samuel/AAK-5778-2020	Landry, Samuel/0000-0002-4082-0543; GENEVAUX, Pierre/0000-0001-7539-3126	National Science Foundation; Swiss National Science Foundation; Canton of Geneva; CNRS	National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Geneva; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the National Science Foundation (to S.J.L.), the Swiss National Science Foundation (to C.G.), the Canton of Geneva (to C.G.), and the CNRS-Action Thematique et Incitative sur Programme (to P.G.).	ANG D, 1989, J BACTERIOL, V171, P2748, DOI 10.1128/jb.171.5.2748-2755.1989; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; Barthel TK, 2001, J BACTERIOL, V183, P5482, DOI 10.1128/JB.183.19.5482-5490.2001; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; BUKAU B, 1989, J BACTERIOL, V171, P6030, DOI 10.1128/jb.171.11.6030-6038.1989; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Chai YH, 1999, J NEUROSCI, V19, P10338; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; COLIGAN JE, 1998, CURRENT PROTOCOLS PR, V2; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Genevaux P, 2002, GENETICS, V162, P1045; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Gisler SM, 1998, J MOL BIOL, V279, P833, DOI 10.1006/jmbi.1998.1815; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Greener T, 2001, NAT CELL BIOL, V3, P215, DOI 10.1038/35055137; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Russell R, 1999, BIOCHEMISTRY-US, V38, P4165, DOI 10.1021/bi9824036; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; Slepenkov SV, 2002, BIOCHEMISTRY-US, V41, P12224, DOI 10.1021/bi0263208; Slepenkov SV, 1998, BIOCHEMISTRY-US, V37, P16749, DOI 10.1021/bi981738k; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	42	15	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21679	21688		10.1074/jbc.M110.113118	http://dx.doi.org/10.1074/jbc.M110.113118			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448033	hybrid, Green Published			2022-12-25	WOS:000279516100055
J	Kondo, MY; Okamoto, DN; Santos, JAN; Juliano, MA; Oda, K; Pillai, B; James, MNG; Juliano, L; Gouvea, IE				Kondo, Marcia Y.; Okamoto, Debora N.; Santos, Jorge A. N.; Juliano, Maria A.; Oda, Kohei; Pillai, Bindu; James, Michael N. G.; Juliano, Luiz; Gouvea, Iuri E.			Studies on the Catalytic Mechanism of a Glutamic Peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; PROTON INVENTORY; ASPERGILLOGLUTAMIC PEPTIDASE; SCYTALIDOGLUTAMIC PEPTIDASE; SCYTALIDIUM-LIGNICOLUM; ASPARTIC PROTEASES; PAPAIN; THERMOLYSIN; INHIBITION; HYDROLYSES	Scytalidoglutamic peptidase (SGP) is the prototype of fungal glutamic peptidases that are characteristically pepstatin insensitive. These enzymes have a unique catalytic dyad comprised of Gln(53) and Glu(136) that activate a bound water molecule for nucleophilic attack on the carbonyl carbon atom of the scissile peptide bond. The hydrolysis by SGP at peptide bonds with proline in the P-1' position is a rare event among peptidases that we investigated using the series of fluorescence resonance energy transfer peptides, Abz-KLXPSKQ-EDDnp, compared with the series Abz-KLXSSKQ-EDDnp. The preference observed in these two series for Phe and His over Leu, Ile, Val, Arg, and Lys, seems to be related to the structure of the S-1 subsite of SGP. These results and the pH profiles of SGP activity showed that its S-1 subsite can accommodate the benzyl group of Phe at pH 4 as well as the positively charged imidazolium group of His. In the pH range 2 to 7, SGP maintains its structure and activity, but at pH 8 or higher it is irreversibly denatured. The intrinsic fluorescence of the Trp residues of SGP were sensitive to the titration of carboxyl groups having low pK values; this can be attributed to the buried Asp(57) and/or Asp(43) as described in SGP three-dimensional structure. The solvent kinetic isotope effects and the proton inventory experiments support a mechanism for the glutamic peptidase SGP that involves the nucleophilic attack of the general base (Glu(136)) activated water, and establish a fundamental role of the S-1 subsite interactions in promoting catalysis.	[Kondo, Marcia Y.; Okamoto, Debora N.; Santos, Jorge A. N.; Juliano, Maria A.; Juliano, Luiz; Gouvea, Iuri E.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, BR-0404420 Sao Paulo, Brazil; [Oda, Kohei] Kyoto Inst Technol, Dept Appl Biol, Kyoto 6068585, Japan; [Pillai, Bindu; James, Michael N. G.] Univ Alberta, Fac Med & Dent, Sch Mol & Syst Med, Dept Biochem, Edmonton, AB T6G 2H7, Canada	Universidade Federal de Sao Paulo (UNIFESP); Kyoto Institute of Technology; University of Alberta	Gouvea, IE (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, Rua Tres de Maio 100, BR-0404420 Sao Paulo, Brazil.	iuri.gouvea@unifesp.br	PILLAI, BINDU Raman/ABD-7571-2020; Juliano, Luiz/D-7204-2012; Complexos, INCT Fluidos/H-9172-2013	PILLAI, BINDU Raman/0000-0001-7193-9507; Juliano, Luiz/0000-0002-5589-2822; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	BENDER ML, 1962, J AM CHEM SOC, V84, P2582, DOI 10.1021/ja00872a024; COHN EJ, 1943, PROTEINS AMINO ACIDS, P444; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Enyedy EJ, 2004, J AM CHEM SOC, V126, P6017, DOI 10.1021/ja0320166; Ferscht A., 1999, STRUCTURE MECH PROTE, P54; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Hershcovitz YF, 2007, FEBS J, V274, P3864, DOI 10.1111/j.1742-4658.2007.05912.x; Hirata IY, 1995, LETT PEPT SCI, V1, P299, DOI DOI 10.1007/BF00119771; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8454, DOI 10.1021/bi00098a024; IZQUIERDO MC, 1990, J AM CHEM SOC, V112, P6054, DOI 10.1021/ja00172a023; IZQUIERDOMARTIN M, 1992, J AM CHEM SOC, V114, P325, DOI 10.1021/ja00027a042; James MNG, 2006, BIOL CHEM, V387, P1023, DOI 10.1515/BC.2006.126; KARSTEN WE, 1995, J AM CHEM SOC, V117, P5914, DOI 10.1021/ja00127a002; Kataoka Y, 2005, FEBS LETT, V579, P2991, DOI 10.1016/j.febslet.2005.04.050; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; Leskovac V., 2003, COMPREHENSIVE ENZYME, P317; MAITA T, 1984, J BIOCHEM-TOKYO, V95, P465, DOI 10.1093/oxfordjournals.jbchem.a134628; MAJIMA E, 1988, AGR BIOL CHEM TOKYO, V52, P787; Murao S., 1985, ASPARTIC PROTEINASES, P379; Northrop DB, 2001, ACCOUNTS CHEM RES, V34, P790, DOI 10.1021/ar000184m; O'Donoghue AJ, 2008, J BIOL CHEM, V283, P29186, DOI 10.1074/jbc.M802366200; ODA K, 2004, HDB PROTEOLYTIC ENZY, P219; Okamoto DN, 2009, BBA-PROTEINS PROTEOM, V1794, P367, DOI 10.1016/j.bbapap.2008.10.017; Pillai B, 2007, J MOL BIOL, V365, P343, DOI 10.1016/j.jmb.2006.09.058; POLGAR L, 1979, EUR J BIOCHEM, V98, P369, DOI 10.1111/j.1432-1033.1979.tb13196.x; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; POLGAR L, 1987, FEBS LETT, V219, P1, DOI 10.1016/0014-5793(87)81179-1; POLGAR L, 1989, MECH PROTEASE ACTION, P16; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Reshetnyak YK, 2001, BIOPHYS J, V81, P1710, DOI 10.1016/S0006-3495(01)75824-9; Santos JAN, 2009, BIOCHEMISTRY-US, V48, P7948, DOI 10.1021/bi9004446; Sasaki H, 2005, P JPN ACAD B-PHYS, V81, P441, DOI 10.2183/pjab.81.441; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Schowen KB, 2000, BBA-BIOENERGETICS, V1458, P43, DOI 10.1016/S0005-2728(00)00059-1; Sims AH, 2004, FEMS MICROBIOL LETT, V239, P95, DOI 10.1016/j.femsle.2004.08.023; SZAWELSKI RJ, 1981, BIOCHEM J, V199, P681, DOI 10.1042/bj1990681; Theodorou LG, 2001, BIOCHEMISTRY-US, V40, P3996, DOI 10.1021/bi001615b; Yabuki Y, 2004, FEBS LETT, V569, P161, DOI 10.1016/j.febslet.2004.05.041	40	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21437	21445		10.1074/jbc.M110.122432	http://dx.doi.org/10.1074/jbc.M110.122432			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442413	Green Published, hybrid			2022-12-25	WOS:000279516100030
J	Lee, S; Miller, M; Shuman, JD; Johnson, PF				Lee, Sook; Miller, Maria; Shuman, Jon D.; Johnson, Peter F.			CCAAT/Enhancer-binding Protein beta DNA Binding Is Auto-inhibited by Multiple Elements That Also Mediate Association with p300/CREB-binding Protein (CBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPHOBIC CLUSTER-ANALYSIS; C/EBP-BETA; TRANSCRIPTION FACTOR; STRUCTURAL BASIS; LEUCINE-ZIPPER; NF-M; MYELOMONOCYTIC CELLS; CELLULAR SENESCENCE; V-MYB; PHOSPHORYLATION	Signaling through Ras GTPases controls the activity of many transcription factors including CCAAT/enhancer-binding protein (C/EBP beta), which regulates oncogenic H-Ras(V12)-induced senescence and growth arrest. Here we report that C/EBP beta (LAP) DNA binding is inhibited by N-terminal sequences and derepressed by oncogenic Ras signaling. Sequence and mutational analyses showed that auto-repression involves two LXXLF (phi XX phi phi)-like motifs (LX1 and LX2) and a third element, auto-inhibitory domain (AID), located within conserved region CR5. LX1 is a critical component of the transactivation domain and has been shown to mediate C/EBP beta binding to the TAZ2 region of p300/CREB-binding protein coactivators. C/EBP beta auto-repression also involves a C-terminal regulatory domain (CRD) adjacent to the leucine zipper. CRD contains a third phi XX phi phi motif (LX3) and a short sequence, KQL, which has similarity to a region in the protein-binding site of TAZ2. The C/EBP beta N- and C-terminal domains physically associate in a manner that requires the basic region and CRD. We propose a model in which the regulatory sequences form a hydrophobic core that reciprocally inhibits DNA binding and transactivation. We also suggest a mechanism for C/EBP beta derepression involving several recently identified modifications within AID and CRD. Finally, we show that association of activatedC/EBP beta with p300/CREB-binding protein requires the LX2 and AID auto-inhibitory elements. Thus, the N-terminal regulatory elements have dual roles in auto-inhibition and coactivator binding.	[Lee, Sook; Shuman, Jon D.; Johnson, Peter F.] NCI Frederick, Lab Canc Prevent, NIH, Frederick, MD 21702 USA; [Miller, Maria] NCI Frederick, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Johnson, PF (corresponding author), NCI Frederick, Lab Canc Prevent, NIH, Bldg 539,Rm 122, Frederick, MD 21702 USA.	johnsope@mail.nih.gov	Miller, Maria/I-1636-2013; Johnson, Peter/A-1940-2012	Miller, Maria/0000-0003-0252-5348; Johnson, Peter/0000-0002-4145-4725; Shuman, Jon/0000-0001-8412-9087	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010328, ZIABC010348] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research.	BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; Burk O, 1997, EMBO J, V16, P1371, DOI 10.1093/emboj/16.6.1371; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Choi Y, 2000, J BIOL CHEM, V275, P15912, DOI 10.1074/jbc.275.21.15912; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Coeytaux K, 2005, BIOINFORMATICS, V21, P1891, DOI 10.1093/bioinformatics/bti266; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Feng HQ, 2009, STRUCTURE, V17, P202, DOI 10.1016/j.str.2008.12.009; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Gao HW, 2002, J BIOL CHEM, V277, P38827, DOI 10.1074/jbc.M206224200; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Graves BJ, 1998, COLD SPRING HARB SYM, V63, P621, DOI 10.1101/sqb.1998.63.621; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; Hu HM, 2000, J BIOL CHEM, V275, P16373, DOI 10.1074/jbc.M910269199; Jenkins LMM, 2009, BIOCHEMISTRY-US, V48, P1244, DOI 10.1021/bi801716h; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KATZ S, 1993, EMBO J, V12, P1321, DOI 10.1002/j.1460-2075.1993.tb05777.x; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lee S, 2010, MOL CELL BIOL, V30, P2621, DOI 10.1128/MCB.00782-09; Lee YH, 1997, MOL CELL BIOL, V17, P2038, DOI 10.1128/MCB.17.4.2038; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rost B, 1996, METHOD ENZYMOL, V266, P525; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; SHUMAN JD, 1990, SCIENCE, V249, P771, DOI 10.1126/science.2202050; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; Spooner CJ, 2007, MOL IMMUNOL, V44, P1384, DOI 10.1016/j.molimm.2006.05.004; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; TRAUTWEIN C, 1995, J BIOL CHEM, V270, P15130, DOI 10.1074/jbc.270.25.15130; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Wessells J, 2004, MOL CELL BIOL, V24, P3238, DOI 10.1128/MCB.24.8.3238-3250.2004; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Yamamoto KR, 1998, COLD SPRING HARB SYM, V63, P587, DOI 10.1101/sqb.1998.63.587; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	55	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21399	21410		10.1074/jbc.M110.128413	http://dx.doi.org/10.1074/jbc.M110.128413			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452968	Green Published, hybrid			2022-12-25	WOS:000279516100026
J	Lim, ST; Chen, XL; Tomar, A; Miller, NLG; Yoo, J; Schlaepfer, DD				Lim, Ssang-Taek; Chen, Xiao Lei; Tomar, Alok; Miller, Nichol L. G.; Yoo, Jiyeon; Schlaepfer, David D.			Knock-in Mutation Reveals an Essential Role for Focal Adhesion Kinase Activity in Blood Vessel Morphogenesis and Cell Motility-Polarity but Not Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHOA ACTIVITY; FAK; SRC; ANGIOGENESIS; PAXILLIN; SURVIVAL; PYK2; PHOSPHORYLATION; MIGRATION; GAP	Focal adhesion kinase (FAK) associates with both integrins and growth factor receptors in the control of cell motility and survival. Loss of FAK during mouse development results in lethality at embryonic day 8.5 (E8.5) and a block in cell proliferation. Because FAK serves as both a scaffold and signaling protein, gene knock-outs do not provide mechanistic insights in distinguishing between these modes of FAK function. To determine the role of FAK activity during development, a knock-in point mutation (lysine 454 to arginine (R454)) within the catalytic domain was introduced by homologous recombination. Homozygous FAK(R454/R454) mutation was lethal at E9.5 with defects in blood vessel formation as determined by lack of yolk sac primary capillary plexus formation and disorganized endothelial cell patterning in FAK(R454/R454) embryos. In contrast to the inability of embryonic FAK(-/-) cells to proliferate ex vivo, primary FAK(R454/R454) mouse embryo fibroblasts (MEFs) were established from E8.5 embryos. R454 MEFs exhibited no difference in cell growth compared with normal MEFs, and R454 FAK localized to focal adhesions but was not phosphorylated at Tyr-397. In E8.5 embryos and primary MEFs, FAK R454 mutation resulted in decreased c-Src Tyr-416 phosphorylation. R454 MEFs exhibited enhanced focal adhesion formation, decreased migration, and defects in cell polarity. Within immortalized MEFs, FAK activity was required for fibronectin-stimulated FAK-p190RhoGAP association and p190RhoGAP tyrosine phosphorylation linked to decreased RhoA GTPase activity, focal adhesion turnover, and directional motility. Our results establish that intrinsic FAK activity is essential for developmental processes controlling blood vessel formation and cell motility-polarity but not cell proliferation. This work supports the use of FAK inhibitors to disrupt neovascularization.	[Lim, Ssang-Taek; Chen, Xiao Lei; Tomar, Alok; Miller, Nichol L. G.; Yoo, Jiyeon; Schlaepfer, David D.] Univ Calif San Diego, Moores Canc Ctr, Dept Reprod Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Schlaepfer, DD (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Dept Reprod Med, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	dschlaepfer@ucsd.edu		Lim, Steve/0000-0003-0323-8607	National Institutes of Health [HL093156, GM087400]; American Heart Association [0540115N, 0725169Y, 0825166F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093156 and GM087400. This work was also supported by American Heart Association Established Investigator Award 0540115N (to D. D. S.).; Supported in part by American Heart Association postdoctoral fellowship 0725169Y.; Supported in part by American Heart Association postdoctoral fellowship 0825166F.	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bonnette PC, 2010, J PROTEOMICS, V73, P1306, DOI 10.1016/j.jprot.2010.01.011; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen BH, 2002, J BIOL CHEM, V277, P33857, DOI 10.1074/jbc.M204429200; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Corsi JM, 2009, J BIOL CHEM, V284, P34769, DOI 10.1074/jbc.M109.067280; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; FURUTA Y, 1995, ONCOGENE, V11, P1989; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Han DC, 2000, J BIOL CHEM, V275, P28911, DOI 10.1074/jbc.M001997200; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Ilic D, 2003, CIRC RES, V92, P300, DOI 10.1161/01.RES.0000055016.36679.23; ILIC D, 1995, BIOCHEM BIOPH RES CO, V209, P300, DOI 10.1006/bbrc.1995.1503; ILLC D, 1995, NATURE, V377, P539; Izaguirre G, 2001, J BIOL CHEM, V276, P28676, DOI 10.1074/jbc.M101678200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P1743, DOI 10.1074/jbc.M109.064212; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Liu E, 2003, EMBO J, V22, P5036, DOI 10.1093/emboj/cdg503; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; Mitra SK, 2006, ONCOGENE, V25, P5969, DOI 10.1038/sj.onc.1209588; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Peng X, 2004, CARDIOVASC RES, V64, P421, DOI 10.1016/j.cardiores.2004.07.012; Ren XD, 2000, J CELL SCI, V113, P3673; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Smyth SS, 2002, J CELL BIOL, V158, P17, DOI 10.1083/jcb.200202100; Tanjoni I, 2010, CANCER BIOL THER, V9, P764, DOI 10.4161/cbt.9.10.11434; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; Walsh C, 2010, CANCER BIOL THER, V9, P776; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Zouq NK, 2009, J CELL SCI, V122, P357, DOI 10.1242/jcs.030478	69	85	89	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21526	21536		10.1074/jbc.M110.129999	http://dx.doi.org/10.1074/jbc.M110.129999			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442405	Green Published, hybrid			2022-12-25	WOS:000279516100039
J	O'Quin, JB; Bourassa, L; Zhang, DY; Shockey, JM; Gidda, SK; Fosnot, S; Chapman, KD; Mullen, RT; Dyer, JM				O'Quin, Jami B.; Bourassa, Linda; Zhang, Daiyuan; Shockey, Jay M.; Gidda, Satinder K.; Fosnot, Spencer; Chapman, Kent D.; Mullen, Robert T.; Dyer, John M.			Temperature-sensitive Post-translational Regulation of Plant Omega-3 Fatty-acid Desaturases Is Mediated by the Endoplasmic Reticulum-associated Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID DESATURASES; MEMBRANE LIPID-COMPOSITION; STEAROYL-COA DESATURASE; FLUORESCENT PROTEINS; GENE-EXPRESSION; ER; ARABIDOPSIS; STABILITY; ADAPTATION; COMPONENT	Changes in ambient temperature represent a major physiological challenge to membranes of poikilothermic organisms. In plants, the endoplasmic reticulum (ER)-localized omega-3 fatty-acid desaturases (Fad3) increase the production of polyunsaturated fatty acids at cooler temperatures, but the FAD3 genes themselves are typically not up-regulated during this adaptive response. Here, we expressed two closely related plant FAD3 genes in yeast cells and found that their enzymes produced significantly different amounts of omega-3 fatty acids and that these differences correlated to differences in rates of protein turnover. Domain-swapping and mutagenesis experiments revealed that each protein contained a degradation signal in its N terminus and that the charge density of a PEST-like sequence within this region was largely responsible for the differences in rates of protein turnover. The half-life of each Fad3 protein was increased at cooler temperatures, and protein degradation required specific components of the ER-associated degradation pathway including the Cdc48 adaptor proteins Doa1, Shp1, and Ufd2. Expression of the Fad3 proteins in tobacco cells incubated with the proteasomal inhibitor MG132 further confirmed that they were degraded via the proteasomal pathway in plants. Collectively, these findings indicate that Fad3 protein abundance is regulated by a combination of cis-acting degradation signals and the ubiquitin-proteasome pathway and that modulation of Fad3 protein amounts in response to temperature may represent one mechanism of homeoviscous adaptation in plants.	[O'Quin, Jami B.; Bourassa, Linda] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70124 USA; [Zhang, Daiyuan; Chapman, Kent D.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Zhang, Daiyuan; Fosnot, Spencer; Dyer, John M.] USDA ARS, US Arid Land Agr Res Ctr, Maricopa, AZ 85138 USA; [Shockey, Jay M.] USDA ARS, So Reg Res Ctr, New Orleans, LA 70124 USA; [Gidda, Satinder K.; Mullen, Robert T.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON NWG 2W1, Canada	University of Louisiana System; University of New Orleans; University of North Texas System; University of North Texas Denton; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Guelph	Dyer, JM (corresponding author), 21881 N Cardon Ln, Maricopa, AZ 85138 USA.	john.dyer@ars.usda.gov		Shockey, Jay/0000-0002-5057-5457; Chapman, Kent/0000-0003-0489-3072	United States Department of Agriculture (USDA); Current Research Information System (CRIS) [5347-21000-009-00D, 6435-41000-087-00D]; Natural Sciences and Engineering Research Council of Canada [217291]; Louisiana Board of Regents Governor's Biotechnology Initiative; University of Guelph Research Chair; USDA; University of North Texas; USDA through South Mountain Community College, Phoenix, AZ [2008-38422-19188]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Current Research Information System (CRIS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Louisiana Board of Regents Governor's Biotechnology Initiative; University of Guelph Research Chair; USDA(United States Department of Agriculture (USDA)); University of North Texas; USDA through South Mountain Community College, Phoenix, AZ	This work was supported by the United States Department of Agriculture (USDA), Current Research Information System (CRIS) Project 5347-21000-009-00D (to J.M.D.), CRIS Project 6435-41000-087-00D (to J.M.S.), Grant 217291 from the Natural Sciences and Engineering Research Council of Canada (to R. T. M.), Specific Cooperative Agreement 5347-21410-004-14S between the USDA and the University of North Texas, a grant from the Louisiana Board of Regents Governor's Biotechnology Initiative (to J.B. O'Q., L. B., and J.M.D.), and a University of Guelph Research Chair (to R. T. M.).; Supported by Cooperative State Research, Education, and Extension Service (CSREES) Grant 2008-38422-19188 from the USDA through the Undergraduate Bioscience Engagement Track (eUBET) program sponsored by South Mountain Community College, Phoenix, AZ.	Adachi S, 2006, PLANT CELL PHYSIOL, V47, P1683, DOI 10.1093/pcp/pcl034; Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Bachmair A, 2001, TRENDS PLANT SCI, V6, P463, DOI 10.1016/S1360-1385(01)02080-5; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Brachmann CB, 1998, YEAST, V14, P115; Brandizzi F, 2003, CURR PROTOC CELL BIO; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; BROWSE J, 1994, PORTL PR P, P141; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Costa V, 2007, IUBMB LIFE, V59, P293, DOI 10.1080/15216540701225958; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dyer JM, 2004, J AM OIL CHEM SOC, V81, P647, DOI 10.1007/s11746-004-956-x; Dyer JM, 2001, BIOCHEM BIOPH RES CO, V282, P1019, DOI 10.1006/bbrc.2001.4667; Dyer JM, 2001, FEBS LETT, V494, P44, DOI 10.1016/S0014-5793(01)02315-8; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Garcia-Alai MM, 2006, STRUCTURE, V14, P309, DOI 10.1016/j.str.2005.11.012; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Goder V, 2008, FEBS LETT, V582, P1575, DOI 10.1016/j.febslet.2008.03.056; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; Halter M, 2007, CYTOM PART A, V71A, P827, DOI 10.1002/cyto.a.20461; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Horiguchi G, 2000, PLANT J, V24, P805, DOI 10.1046/j.1365-313x.2000.00925.x; Horton R M, 1997, Methods Mol Biol, V67, P141; Huang DQ, 2002, MOL CELL BIOL, V22, P5076, DOI 10.1128/MCB.22.14.5076-5088.2002; Hwang YT, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-54; Jackson DD, 1997, J BIOL CHEM, V272, P25928, DOI 10.1074/jbc.272.41.25928; Jaenicke R, 2000, J BIOTECHNOL, V79, P193, DOI 10.1016/S0168-1656(00)00236-4; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kato H, 2006, J CELL SCI, V119, P2342, DOI 10.1242/jcs.02951; Kinner A, 2003, FEBS LETT, V549, P135, DOI 10.1016/S0014-5793(03)00801-9; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; KODAMA H, 1995, PLANT PHYSIOL, V107, P1177, DOI 10.1104/pp.107.4.1177; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Martz F, 2006, J EXP BOT, V57, P897, DOI 10.1093/jxb/erj075; Matsuda O, 2005, J BIOL CHEM, V280, P3597, DOI 10.1074/jbc.M407226200; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; MCCAMMON MT, 1990, J BACTERIOL, V172, P5816, DOI 10.1128/jb.172.10.5816-5827.1990; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; Mehlmer Norbert, 2009, V479, P235, DOI 10.1007/978-1-59745-289-2_15; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Muller J, 2005, PLANT CELL, V17, P149, DOI 10.1105/tpc.104.026625; Mziaut H, 2000, P NATL ACAD SCI USA, V97, P8883, DOI 10.1073/pnas.97.16.8883; Mziaut H, 2002, BBA-MOL CELL BIOL L, V1583, P45, DOI 10.1016/S1388-1981(02)00159-2; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; O'Quin JB, 2009, APPL MICROBIOL BIOT, V83, P117, DOI 10.1007/s00253-008-1826-2; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Routaboul JM, 2000, PLANT PHYSIOL, V124, P1697, DOI 10.1104/pp.124.4.1697; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; SOMERVILLE C, 1995, P NATL ACAD SCI USA, V92, P6215, DOI 10.1073/pnas.92.14.6215; Tang GQ, 2005, PLANT J, V44, P433, DOI 10.1111/j.1365-313X.2005.02535.x; Thompson AR, 2005, CURR OPIN PLANT BIOL, V8, P165, DOI 10.1016/j.pbi.2005.01.013; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; WILLIAMS JP, 1988, PLANT PHYSIOL, V87, P904, DOI 10.1104/pp.87.4.904; Winderickx J, 2008, BBA-MOL CELL RES, V1783, P1381, DOI 10.1016/j.bbamcr.2008.01.020; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Yu C, 2009, PLANT PHYSIOL BIOCH, V47, P1102, DOI 10.1016/j.plaphy.2009.07.008; Zeng G, 1998, BIOTECHNIQUES, V25, P206, DOI 10.2144/98252bm05; Zhang LJ, 2007, BIOTECHNIQUES, V42, P446, DOI 10.2144/000112453; Zhang LP, 2006, J AM CHEM SOC, V128, P4766, DOI 10.1021/ja0580439	81	55	57	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21781	21796		10.1074/jbc.M110.135236	http://dx.doi.org/10.1074/jbc.M110.135236			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452984	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000279516100063
J	Downie, MJ; El Bissati, K; Bobenchik, AM; Lochlainn, LN; Amerik, A; Zufferey, R; Kirk, K; Mamoun, CB				Downie, Megan J.; El Bissati, Kamal; Bobenchik, April M.; Lochlainn, Laura Nic; Amerik, Alexander; Zufferey, Rachel; Kirk, Kiaran; Mamoun, Choukri Ben			PfNT2, a Permease of the Equilibrative Nucleoside Transporter Family in the Endoplasmic Reticulum of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAERYTHROCYTIC MALARIA PARASITE; PLASMA-MEMBRANE; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR MEMBRANES; INFECTED ERYTHROCYTES; GENE ENCODES; PROTEIN; LOCALIZATION; YEAST	The survival and proliferation of the obligate intracellular malaria parasite Plasmodium falciparum require salvage of essential purines from the host. Genetic studies have previously shown that the parasite plasma membrane purine permease, PfNT1, plays an essential function in the transport of all naturally occurring purine nucleosides and nucleobases across the parasite plasma membrane. Here, we describe an intracellular permease, PfNT2. PfNT2 is, like PfNT1, a member of the equilibrative nucleoside transporter family. Confocal and immunoelectron microscopic analyses of transgenic parasites harboring green fluorescent protein- or hemagglutinin-tagged PfNT2 demonstrated endoplasmic reticulum localization. This localization was confirmed by colocalization with the endoplasmic reticulum marker PfBiP. Using yeast as a surrogate system, we show that targeting PfNT2 to the plasma membrane of fui1 Delta cells lacking the plasma membrane nucleoside transporter Fui1 confers sensitivity to the toxic nucleoside analog 5-fluorouridine. This study provides the first evidence of an intracellular purine permease in apicomplexan parasites and suggests a novel biological function for the parasite endoplasmic reticulum during malaria infection.	[Downie, Megan J.; Bobenchik, April M.; Lochlainn, Laura Nic; Amerik, Alexander; Mamoun, Choukri Ben] Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06512 USA; [Downie, Megan J.; Kirk, Kiaran] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [El Bissati, Kamal; Bobenchik, April M.; Zufferey, Rachel] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA	Yale University; Australian National University; University of Connecticut	Mamoun, CB (corresponding author), Yale Univ, Sch Med, Infect Dis Sect, WWW4,POB 208022, New Haven, CT 06520 USA.	choukri.benmamoun@yale.edu	Kirk, Kiaran/C-8299-2009; Amerik, Alexander/AAM-4167-2020	Kirk, Kiaran/0000-0002-5613-2622; EL BISSATI, KAMAL/0000-0001-9341-4162; Nic Lochlainn, Laura/0000-0001-8095-9892	National Institutes of Health through the NIAID [AI51507]; Department of Defense [PR033005]; Burroughs Wellcome Fund; Australian Research Council; National Health and Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051507] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense(United States Department of Defense); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI51507 through the NIAID (to C. B. M.), Department of Defense Grant PR033005 (to C. B. M.), by the Burroughs Wellcome Fund (to C. B. M), and by grants from the Australian Research Council and National Health and Medical Research Council (to K. K.).	Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683; Cliffe ST, 2009, HUM MOL GENET, V18, P2257, DOI 10.1093/hmg/ddp161; DESAI SA, 1993, NATURE, V362, P643, DOI 10.1038/362643a0; Downie MJ, 2008, INT J PARASITOL, V38, P203, DOI 10.1016/j.ijpara.2007.07.005; Downie MJ, 2006, MOL MICROBIOL, V60, P738, DOI 10.1111/j.1365-2958.2006.05125.x; El Bissati K, 2008, MOL BIOCHEM PARASIT, V161, P130, DOI 10.1016/j.molbiopara.2008.06.012; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Errasti-Murugarren E, 2009, FASEB J, V23, P172, DOI 10.1096/fj.08-113902; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GATI WP, 1990, BIOCHEM J, V272, P277, DOI 10.1042/bj2720277; GERO AM, 1988, MOL BIOCHEM PARASIT, V27, P159, DOI 10.1016/0166-6851(88)90035-7; Henry RI, 2007, BIOCHEM BIOPH RES CO, V363, P288, DOI 10.1016/j.bbrc.2007.08.116; KIRK K, 1994, J BIOL CHEM, V269, P3339; Kirk K, 2009, TRENDS PARASITOL, V25, P246, DOI 10.1016/j.pt.2009.03.006; Ko N, 2008, YEAST, V25, P155, DOI 10.1002/yea.1554; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; Lauer CM, 2008, FEMS MICROBIOL LETT, V285, P79, DOI 10.1111/j.1574-6968.2008.01214.x; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; Molho-Pessach V, 2008, AM J HUM GENET, V83, P529, DOI 10.1016/j.ajhg.2008.09.013; Mullin KA, 2006, P NATL ACAD SCI USA, V103, P9572, DOI 10.1073/pnas.0602293103; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Quashie NB, 2008, BIOCHEM J, V411, P287, DOI 10.1042/BJ20071460; Quashie NB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-36; Rager N, 2001, J BIOL CHEM, V276, P41095, DOI 10.1074/jbc.M107037200; Riegelhaupt PM, 2010, MOL BIOCHEM PARASIT, V169, P40, DOI 10.1016/j.molbiopara.2009.10.001; Saliba KJ, 2006, NATURE, V443, P582, DOI 10.1038/nature05149; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Tonkin CJ, 2006, CURR OPIN MICROBIOL, V9, P381, DOI 10.1016/j.mib.2006.06.015; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UPSTON JM, 1995, BBA-BIOMEMBRANES, V1236, P249, DOI 10.1016/0005-2736(95)00055-8; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Vickers MF, 2000, J BIOL CHEM, V275, P25931, DOI 10.1074/jbc.M000239200	39	23	23	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20827	20833		10.1074/jbc.M110.118489	http://dx.doi.org/10.1074/jbc.M110.118489			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439460	Green Published, hybrid			2022-12-25	WOS:000279228600046
J	Liu, J; Wang, XN; Cheng, F; Liou, YC; Deng, LW				Liu, Jie; Wang, Xiao Ning; Cheng, Fei; Liou, Yih-Cherng; Deng, Lih-Wen			Phosphorylation of Mixed Lineage Leukemia 5 by Cdc2 Affects Its Cellular Distribution and Is Required for Mitotic Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; CYCLIN-DEPENDENT KINASES; PROTO-ONCOPROTEIN MLL; HOX GENE-EXPRESSION; H3K4 METHYLATION; DROSOPHILA-TRITHORAX; MYELOID-LEUKEMIA; S-PHASE; MITOSIS; CHROMATIN	The human mixed lineage leukemia-5 (MLL5) gene is frequently deleted in myeloid malignancies. Emerging evidence suggests that MLL5 has important functions in adult hematopoiesis and the chromatin regulatory network, and it participates in regulating the cell cycle machinery. Here, we demonstrate that MLL5 is tightly regulated through phosphorylation on its central domain at the G(2)/M phase of the cell cycle. Upon entry into mitosis, the phosphorylated MLL5 delocalizes from condensed chromosomes, whereas after mitotic exit, MLL5 becomes dephosphorylated and re-associates with the relaxed chromatin. We further identify that the mitotic phosphorylation and subcellular localization of MLL5 are dependent on Cdc2 kinase activity, and Thr-912 is the Cdc2-targeting site. Overexpression of the Cdc2-targeting MLL5 fragment obstructs mitotic entry by competitive inhibition of the phosphorylation of endogenous MLL5. In addition, G(2) phase arrest caused by depletion of endogenous MLL5 can be compensated by exogenously overexpressed full-length MLL5 but not the phosphodomain deletion or MLL5-T912A mutant. Our data provide evidence that MLL5 is a novel cellular target of Cdc2, and the phosphorylation of MLL5 may have an indispensable role in the mitotic progression.	[Liu, Jie; Wang, Xiao Ning; Cheng, Fei; Deng, Lih-Wen] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Liou, Yih-Cherng] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore; National University of Singapore	Deng, LW (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, 8 Med Dr, Singapore 117597, Singapore.	bchdlw@nus.edu.sg		Deng, Lih-Wen/0000-0002-4985-7844	BMRC-A*STAR, Singapore [R-183-000-164-305]; NMRC-A*STAR, Singapore [R-183-000-149-213]; Ministry of Education [R-183-000-195-112]	BMRC-A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); NMRC-A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)National Medical Research Council, Singapore); Ministry of Education	This work was supported in part by BMRC-A*STAR, Singapore, Grant R-183-000-164-305, NMRC-A*STAR, Singapore, Grant R-183-000-149-213, and Ministry of Education Academic Research Fund Tier 2 Grant R-183-000-195-112.	Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Brezinova J, 2007, CANCER GENET CYTOGEN, V173, P10, DOI 10.1016/j.cancergencyto.2006.09.003; Chang F, 2008, INT J BIOCHEM CELL B, V40, P2472, DOI 10.1016/j.biocel.2008.04.012; Delcuve GP, 2008, J CELL BIOCHEM, V105, P1, DOI 10.1002/jcb.21806; Deng LW, 2004, P NATL ACAD SCI USA, V101, P757, DOI 10.1073/pnas.2036345100; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Georgatos SD, 2009, FRONT BIOSCI-LANDMRK, V14, P2017, DOI 10.2741/3360; Georgi AB, 2002, CURR BIOL, V12, P105, DOI 10.1016/S0960-9822(01)00662-5; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Hasle H, 1999, LEUKEMIA, V13, P376, DOI 10.1038/sj.leu.2401342; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Johnson EJ, 1996, BLOOD, V87, P3579, DOI 10.1182/blood.V87.9.3579.bloodjournal8793579; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; LeBeau MM, 1996, BLOOD, V88, P1930; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Liu H, 2009, BLOOD, V113, P1395, DOI 10.1182/blood-2008-11-185801; LUNAFINEMAN S, 1995, BLOOD, V85, P1985, DOI 10.1182/blood.V85.8.1985.bloodjournal8581985; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mishra BP, 2009, FEBS J, V276, P1629, DOI 10.1111/j.1742-4658.2009.06895.x; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; Moseley JB, 2009, CURR OPIN CELL BIOL, V21, P82, DOI 10.1016/j.ceb.2008.12.005; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; REYNOLDS JA, 1970, J BIOL CHEM, V245, P5161; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Sambasivan R, 2008, J BIOSCIENCES, V33, P27, DOI 10.1007/s12038-008-0019-6; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; YAMASHITA K, 1990, EMBO J, V9, P4331, DOI 10.1002/j.1460-2075.1990.tb07882.x; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zhou HL, 2001, NAT BIOTECHNOL, V19, P375, DOI 10.1038/86777	57	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20904	20914		10.1074/jbc.M109.098558	http://dx.doi.org/10.1074/jbc.M109.098558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439461	Green Published, hybrid			2022-12-25	WOS:000279228600055
J	McCoy, CE; Sheedy, FJ; Qualls, JE; Doyle, SL; Quinn, SR; Murray, PJ; O'Neill, LAJ				McCoy, Claire E.; Sheedy, Frederick J.; Qualls, Joseph E.; Doyle, Sarah L.; Quinn, Susan R.; Murray, Peter J.; O'Neill, Luke A. J.			IL-10 Inhibits miR-155 Induction by Toll-like Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING INOSITOL-5-PHOSPHATASE; B-CELL LYMPHOMAS; IMMUNE-RESPONSE; TRANSGENIC MICE; EXPRESSION; MICRORNA; TARGET; TRANSCRIPTION; ACTIVATION; PATHWAY	IL-10 is a potent anti-inflammatory cytokine that is crucial for down-regulating pro-inflammatory genes, which are induced by Toll-like receptor (TLR) signaling. In this study, we have examined whether modulation of microRNAs plays a role in the inhibitory effect of IL-10 on TLR4 signaling. Analyzing microRNAs known to be induced by TLR4, we found that IL-10 could inhibit the expression of miR-155 in response to lipopolysaccharide but had no effect on miR-21 or miR-146a. IL-10 inhibited miR-155 transcription from the BIC gene in a STAT3-dependent manner. This inhibitory effect of IL-10 on miR-155 led to an increase in the expression of the miR-155 target, SHIP1. This is the first example of IL-10 playing a role in microRNA function and suggests that through its inhibitory effect on miR-155, IL-10 has the ability to promote anti-inflammatory gene expression.	[McCoy, Claire E.; Sheedy, Frederick J.; Doyle, Sarah L.; Quinn, Susan R.; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Qualls, Joseph E.; Murray, Peter J.] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA	Trinity College Dublin; St Jude Children's Research Hospital	McCoy, CE (corresponding author), Monash Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	cmccoy@tcd.ie	Murray, Peter J/K-4725-2018; Doyle, Sarah/C-1453-2014	Murray, Peter J/0000-0001-6329-9802; Doyle, Sarah/0000-0002-6294-9380; Qualls, Joseph/0000-0002-0113-2166; Sheedy, Frederick/0000-0003-2645-8493; McCoy, Claire/0000-0001-8710-896X; Sheedy, Frederick/0000-0002-4722-3135; O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland; Health Research Board Ireland; Marie Curie Actions	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board Ireland; Marie Curie Actions(European Commission)	This work was supported by grants from the Science Foundation Ireland, Health Research Board Ireland, and Marie Curie Actions.	An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Gantier MP, 2007, IMMUNOL CELL BIOL, V85, P458, DOI 10.1038/sj.icb.7100091; Gantier MP, 2010, J INTERF CYTOK RES, V30, P283, DOI 10.1089/jir.2010.0037; Kanellopoulou C, 2008, SEMIN CANCER BIOL, V18, P79, DOI 10.1016/j.semcancer.2008.01.002; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu Z, 2008, INT J MOL SCI, V9, P978, DOI 10.3390/ijms9060978; Mccoy CE, 2008, J BIOL CHEM, V283, P14277, DOI 10.1074/jbc.M709731200; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	33	189	205	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20492	20498		10.1074/jbc.M110.102111	http://dx.doi.org/10.1074/jbc.M110.102111			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435894	Green Published, hybrid			2022-12-25	WOS:000279228600009
J	Wen, KK; McKane, M; Stokasimov, E; Fields, J; Rubenstein, PA				Wen, Kuo-Kuang; McKane, Melissa; Stokasimov, Ema; Fields, Jonathon; Rubenstein, Peter A.			A Potential Yeast Actin Allosteric Conduit Dependent on Hydrophobic Core Residues Val-76 and Trp-79	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; NASCENT MYOFIBRILS; MASS-SPECTROMETRY; BINDING PROTEINS; ARP2/3 COMPLEX; STRESS FIBERS; ALPHA-ACTIN; IN-VITRO; F-ACTIN; DYNAMICS	Intramolecular allosteric interactions responsible for actin conformational regulation are largely unknown. Previous work demonstrated that replacing yeast actin Val-76 with muscle actin Ile caused decreased nucleotide exchange. Residue 76 abuts Trp-79 in a six-residue linear array beginning with Lys-118 on the surface and ending with His-73 in the nucleotide cleft. To test if altering the degree of packing of these two residues would affect actin dynamics, we constructed V76I, W79F, and W79Y single mutants as well as the Ile-76/ Phe-79 and Ile-76/Tyr-79 double mutants. Tyr or Phe should decrease crowding and increase protein flexibility. Subsequent introduction of Ile should restore packing and dampen changes. All mutants showed decreased growth in liquid medium. W79Y alone was severely osmosensitive and exhibited vacuole abnormalities. Both properties were rescued by Ile-76. Phe-79 or Tyr decreased the thermostability of actin and increased its nucleotide exchange rate. These effects, generally greater for Tyr than for Phe, were reversed by introduction of Ile-76. HD exchange showed that the mutations caused propagated conformational changes to all four subdomains. Based on results from phosphate release and light-scattering assays, single mutations affected polymerization in the order of Ile, Phe, and Tyr from least to most. Introduction of Ile-76 partially rescued the polymerization defects caused by either Tyr-79 or Phe-79. Thus, alterations in crowding of the 76-79 residue pair can strongly affect actin conformation and behavior, and these results support the theory that the amino acid array in which they are located may play a central role in actin regulation.	[Wen, Kuo-Kuang; McKane, Melissa; Stokasimov, Ema; Fields, Jonathon; Rubenstein, Peter A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [GM33689]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33689 (to P.A.R.).	Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Carlier M F, 1990, Adv Biophys, V26, P51, DOI 10.1016/0065-227X(90)90007-G; CARLIER MF, 1991, J BIOL CHEM, V266, P1; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; COOK RK, 1992, J BIOL CHEM, V267, P9430; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; GREER C, 1982, MOL CELL BIOL, V2, P1270, DOI 10.1128/MCB.2.10.1270; Guan JQ, 2002, BIOCHEMISTRY-US, V41, P5765, DOI 10.1021/bi0121104; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Hasebe-Kishi F, 2000, J MUSCLE RES CELL M, V21, P717, DOI 10.1023/A:1010374424143; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; HITCHCOCK SE, 1980, J BIOL CHEM, V255, P5668; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; LATTERICH M, 1993, BIOCHEM BIOPH RES CO, V191, P1111, DOI 10.1006/bbrc.1993.1331; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Nwe TM, 1999, EXP CELL RES, V252, P33, DOI 10.1006/excr.1999.4611; Okamoto K, 2001, METHOD CELL BIOL, V65, P277, DOI 10.1016/S0091-679X(01)65017-9; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Shimada Y, 1997, CELL STRUCT FUNCT, V22, P59, DOI 10.1247/csf.22.59; SHU WP, 1992, BIOCHEM J, V283, P567, DOI 10.1042/bj2830567; Stokasimov E, 2009, J BIOL CHEM, V284, P25421, DOI 10.1074/jbc.M109.013078; Suzuki H, 1998, TISSUE CELL, V30, P274, DOI 10.1016/S0040-8166(98)80076-1; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Wang LT, 2002, MOL CELL PROTEOMICS, V1, P132, DOI 10.1074/mcp.M100009-MCP200; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	39	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21185	21194		10.1074/jbc.M110.121426	http://dx.doi.org/10.1074/jbc.M110.121426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20442407	hybrid, Green Published			2022-12-25	WOS:000279228600081
J	Rachakonda, G; Sekhar, KR; Jowhar, D; Samson, PC; Wikswo, JP; Beauchamp, RD; Datta, PK; Freeman, ML				Rachakonda, G.; Sekhar, K. R.; Jowhar, D.; Samson, P. C.; Wikswo, J. P.; Beauchamp, R. D.; Datta, P. K.; Freeman, M. L.			Increased cell migration and plasticity in Nrf2-deficient cancer cell lines	ONCOGENE			English	Article						Nrf2; TGF-beta; Smad; Cadherin; motility; oncogenesis	EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR NRF2; ACTIVATOR INHIBITOR-1 PROMOTER; GENE-EXPRESSION PROFILES; UBIQUITIN LIGASE COMPLEX; FACTOR-DEFICIENT MICE; TGF-BETA; OXIDATIVE STRESS; LUNG-CANCER; BREAST-CANCER	Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) expression is deregulated in many cancers. Genetic and biochemical approaches coupled with functional assays in cultured cells were used to explore the consequences of Nrf2 repression. Nrf2 suppression by Keap1-directed ubiquitylation or the expression of independent short hairpin RNA (shRNA)/siRNA sequences enhanced cellular levels of reactive oxygen species, Smad-dependent tumor cell motility and growth in soft agar. Loss of Nrf2 was accompanied by concomitant Smad linker region/C-terminus phosphorylation, induction of the E-cadherin transcriptional repressor Slug and suppression of the cell-cell adhesion protein E-cadherin. Ectopic expression of the wildtype but not dominant-negative Nrf2 suppressed the activity of a synthetic transforming growth factor-beta 1-responsive CAGA-directed luciferase reporter. shRNA knock-down of Nrf2 enhanced the activity of the synthetic CAGA reporter, as well as the expression of the endogenous Smad target gene plasminogen activator inhibitor-1. Finally, we found that Nrf2/Smad3/Smad4 formed an immunoprecipitable nuclear complex. Thus, loss of Nrf2 increased R-Smad phosphorylation and R-Smad signaling, supporting the hypothesis that loss of Nrf2 in an oncogenic context-dependent manner can enhance cellular plasticity and motility, in part by using transforming growth factor-beta/Smad signaling. Oncogene (2010) 29, 3703-3714; doi: 10.1038/onc.2010.118; published online 3 May 2010	[Freeman, M. L.] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37232 USA; [Jowhar, D.; Samson, P. C.; Wikswo, J. P.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37232 USA; [Jowhar, D.; Samson, P. C.; Wikswo, J. P.] Vanderbilt Univ, Vanderbilt Inst Integrat Biosyst Res & Educ, Nashville, TN 37232 USA; [Wikswo, J. P.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA; [Wikswo, J. P.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Beauchamp, R. D.; Datta, P. K.] Vanderbilt Univ, Dept Surg, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Freeman, ML (corresponding author), Vanderbilt Univ, Sch Med, Dept Radiat Oncol, B 902 TVC, Nashville, TN 37232 USA.	michael.freeman@vanderbilt.edu		Konjeti, Sekhar/0000-0003-2930-0739; Freeman, Michael/0000-0003-1881-366X; Beauchamp, Robert Daniel/0000-0002-8446-4114	NIH [RO1CA104590, RO1CA115556, RO1CA069457, R01DK052334, RO1CA095195, RO1CA113519, P50CA090949, U01AI061223]; Vanderbilt-Ingram Cancer Center [P30CA68485]; Vanderbilt Institute for Integrative Biosystems Research and Education; NATIONAL CANCER INSTITUTE [P50CA090949, R01CA104590, R01CA069457, R01CA115556, R01CA095195, P30CA068485, R01CA113519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052334] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center; Vanderbilt Institute for Integrative Biosystems Research and Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful for the assistance provided by Dr Swati Biswas. This research was supported in part by NIH Grants RO1CA104590, RO1CA115556, RO1CA069457, R01DK052334, RO1CA095195, RO1CA113519, P50CA090949 (Project# 4), U01AI061223, the Vanderbilt-Ingram Cancer Center grant P30CA68485, and the Vanderbilt Institute for Integrative Biosystems Research and Education.	Barve A, 2009, INT J CANCER, V124, P1693, DOI 10.1002/ijc.24106; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Brown SL, 2008, CANCER RES, V68, P364, DOI 10.1158/0008-5472.CAN-07-2170; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; CHAKRABORTY AK, 1992, MELANOMA RES, V2, P315, DOI 10.1097/00008390-199212000-00004; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Frohlich DA, 2008, ONCOGENE, V27, P4353, DOI 10.1038/onc.2008.79; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Grinberg AV, 2003, J BIOL CHEM, V278, P11227, DOI 10.1074/jbc.M211734200; Hayashi A, 2003, BIOCHEM BIOPH RES CO, V310, P824, DOI 10.1016/j.bbrc.2003.09.086; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Hirayama A, 2003, FREE RADICAL BIO MED, V34, P1236, DOI 10.1016/S0891-5849(03)00073-X; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; HUBER BE, 1987, CANCER RES, V47, P3414; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kusano Y, 2008, BIOCHEMISTRY-US, V47, P6169, DOI 10.1021/bi800199z; Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Liu JR, 2004, HUM GENE THER, V15, P239, DOI 10.1089/104303404322886093; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Loignon M, 2009, MOL CANCER THER, V8, P2432, DOI 10.1158/1535-7163.MCT-08-1186; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Mithani SK, 2004, J SURG RES, V117, P296, DOI 10.1016/S0022-4804(03)00335-4; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Muller N, 2002, ONCOGENE, V21, P6049, DOI 10.1038/sj.onc.1205766; Nioi P, 2007, BIOCHEM BIOPH RES CO, V362, P816, DOI 10.1016/j.bbrc.2007.08.051; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Safina AF, 2009, CELL CYCLE, V8, P284, DOI 10.4161/cc.8.2.7590; Sarsour EH, 2008, AGING CELL, V7, P405, DOI 10.1111/j.1474-9726.2008.00384.x; Sekhar KR, 2003, CANCER RES, V63, P5636; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Shiou SR, 2007, CANCER RES, V67, P1571, DOI 10.1158/0008-5472.CAN-06-1680; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Song CZ, 1998, J BIOL CHEM, V273, P29287, DOI 10.1074/jbc.273.45.29287; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Strachan GD, 2005, BIOCHEM BIOPH RES CO, V336, P490, DOI 10.1016/j.bbrc.2005.08.127; SUN Y, 1989, INT J CANCER, V44, P1028, DOI 10.1002/ijc.2910440615; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; VALENZUELA DM, 1986, NUCLEIC ACIDS RES, V14, P843, DOI 10.1093/nar/14.2.843; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; Weydert CJ, 2006, FREE RADICAL BIO MED, V41, P226, DOI 10.1016/j.freeradbiomed.2006.03.015; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yano T, 2001, CARCINOGENESIS, V22, P1593, DOI 10.1093/carcin/22.10.1593; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Yu SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008579; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang Y, 2002, CANCER RES, V62, P1205	78	70	71	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 24	2010	29	25					3703	3714		10.1038/onc.2010.118	http://dx.doi.org/10.1038/onc.2010.118			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	615CG	20440267	Green Accepted			2022-12-25	WOS:000279108600010
J	Kondratieva, E; Logunova, N; Majorov, K; Averbakh, M; Apt, A				Kondratieva, Elena; Logunova, Nadya; Majorov, Konstantin; Averbakh, Mikhail, Jr.; Apt, Alexander			Host Genetics in Granuloma Formation: Human-Like Lung Pathology in Mice with Reciprocal Genetic Susceptibility to M. tuberculosis and M. avium	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; NEUTROPHIL MOBILIZATION; NITRIC-OXIDE; RESISTANT; INFECTION; IMMUNITY; CELLS; I/ST; PROTECTION; TRANSPORT	Development of lung granulomata is a hallmark of infections caused by virulent mycobacteria, reflecting both protective host response that restricts infection spreading and inflammatory pathology. The role of host genetics in granuloma formation is not well defined. Earlier we have shown that mice of the I/St strain are extremely susceptible to Mycobacterium tuberculosis but resistant to M. avium infection, whereas B6 mice show a reversed pattern of susceptibility. Here, by directly comparing: (i) characteristics of susceptibility to two infections in vivo; (ii) architecture of lung granulomata assessed by immune staining; and (iii) expression of genes encoding regulatory factors of neutrophil influx in the lung tissue, we demonstrate that genetic susceptibility of the host largely determines the pattern of lung pathology. Necrotizing granuloma surrounded by hypoxic zones, as well as a massive neutrophil influx, develop in the lungs of M. avium-infected B6 mice and in the lungs of M. tuberculosis-infected I/St mice, but not in the lungs of corresponding genetically resistant counterparts. The mirror-type lung tissue responses to two virulent mycobacteria indicate that the level of genetic susceptibility of the host to a given mycobacterial species largely determines characteristics of pathology, and directly demonstrate the importance of host genetics in pathogenesis.	[Kondratieva, Elena; Logunova, Nadya; Majorov, Konstantin; Averbakh, Mikhail, Jr.; Apt, Alexander] Cent Inst TB, Immunogenet Lab, Moscow, Russia		Kondratieva, E (corresponding author), Cent Inst TB, Immunogenet Lab, Moscow, Russia.	asapt@aha.ru	Majorov, Konstantin Borisovich/AIE-6667-2022	Apt, Alexander/0000-0002-3683-3085	NIH [AI078864]; Russian Foundation for Basic Research [07-04-00988, 09-04-00159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078864] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financially supported by the NIH grant AI078864 and the Russian Foundation for Basic Research grants 07-04-00988 and 09-04-00159. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; APPELBERG R, 1990, CLIN EXP IMMUNOL, V80, P324, DOI 10.1111/j.1365-2249.1990.tb03288.x; APPELBERG R, 1995, INFECT IMMUN, V63, P3381, DOI 10.1128/IAI.63.9.3381-3387.1995; Apt A, 2009, TUBERCULOSIS, V89, P195, DOI 10.1016/j.tube.2009.02.002; Beisiegel M, 2009, J INFECT DIS, V199, P1222, DOI 10.1086/597421; Ehlers S, 2000, J IMMUNOL, V165, P483, DOI 10.4049/jimmunol.165.1.483; Ehlers S, 2001, J EXP MED, V194, P1847, DOI 10.1084/jem.194.12.1847; Ehlers S, 1999, FEMS IMMUNOL MED MIC, V23, P149, DOI 10.1111/j.1574-695X.1999.tb01234.x; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Eruslanov EB, 2004, CLIN EXP IMMUNOL, V135, P19, DOI 10.1111/j.1365-2249.2004.02328.x; Florido M, 2006, IMMUNOLOGY, V118, P122, DOI 10.1111/j.1365-2567.2006.02350.x; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Fulton SA, 2002, INFECT IMMUN, V70, P5322, DOI 10.1128/IAI.70.9.5322-5327.2002; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; Huang H, 2001, BIOCHEM BIOPH RES CO, V281, P378, DOI 10.1006/bbrc.2001.4363; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Keller C, 2006, INFECT IMMUN, V74, P4295, DOI 10.1128/IAI.00057-06; Kondratieva EV, 2007, INFECT IMMUN, V75, P4762, DOI 10.1128/IAI.00482-07; Kondratieva TK, 2010, J IMMUNOL, V184, P1227, DOI 10.4049/jimmunol.0902011; Kuhn DE, 2001, J LEUKOCYTE BIOL, V69, P43; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyadova IV, 2000, J IMMUNOL, V165, P5921, DOI 10.4049/jimmunol.165.10.5921; Majorov KB, 2003, INFECT IMMUN, V71, P697, DOI 10.1128/IAI.71.2.697-707.2003; Nikonenko BV, 2000, TUBERCLE LUNG DIS, V80, P15, DOI 10.1054/tuld.1999.0225; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; PEDROSA J, 1994, CLIN EXP IMMUNOL, V98, P210; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Radaeva TV, 2008, TUBERCULOSIS, V88, P576, DOI 10.1016/j.tube.2008.05.003; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Samoszuk MK, 2004, J HISTOCHEM CYTOCHEM, V52, P837, DOI 10.1369/jhc.4B6248.2004; SCHURR E, 2008, HDB TUBERCULOSIS IMM, P295; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; Wang CR, 2004, RHEUMATOLOGY, V43, P569, DOI 10.1093/rheumatology/keh147; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648	38	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10515	10.1371/journal.pone.0010515	http://dx.doi.org/10.1371/journal.pone.0010515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463893	Green Published, Green Submitted, gold			2022-12-25	WOS:000277379800010
J	Sundstrom, G; Dreborg, S; Larhammar, D				Sundstrom, Gorel; Dreborg, Susanne; Larhammar, Dan			Concomitant Duplications of Opioid Peptide and Receptor Genes before the Origin of Jawed Vertebrates	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROOPIOMELANOCORTIN GENE; CHROMOSOME DUPLICATIONS; EVOLUTION; GENOME; CLONING; IDENTIFICATION; PROENKEPHALIN; PRODYNORPHIN; ZEBRAFISH	Background: The opioid system is involved in reward and pain mechanisms and consists in mammals of four receptors and several peptides. The peptides are derived from four prepropeptide genes, PENK, PDYN, PNOC and POMC, encoding enkephalins, dynorphins, orphanin/nociceptin and beta-endorphin, respectively. Previously we have described how two rounds of genome doubling (2R) before the origin of jawed vertebrates formed the receptor family. Methodology/Principal Findings: Opioid peptide gene family members were investigated using a combination of sequence-based phylogeny and chromosomal locations of the peptide genes in various vertebrates. Several adjacent gene families were investigated similarly. The results show that the ancestral peptide gene gave rise to two additional copies in the genome doublings. The fourth member was generated by a local gene duplication, as the genes encoding POMC and PNOC are located on the same chromosome in the chicken genome and all three teleost genomes that we have studied. A translocation has disrupted this synteny in mammals. The PDYN gene seems to have been lost in chicken, but not in zebra finch. Duplicates of some peptide genes have arisen in the teleost fishes. Within the prepropeptide precursors, peptides have been lost or gained in different lineages. Conclusions/Significance: The ancestral peptide and receptor genes were located on the same chromosome and were thus duplicated concomitantly. However, subsequently genetic linkage has been lost. In conclusion, the system of opioid peptides and receptors was largely formed by the genome doublings that took place early in vertebrate evolution.	[Sundstrom, Gorel; Dreborg, Susanne; Larhammar, Dan] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Sundstrom, G (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	dan.larhammar@neuro.uu.se			Swedish Research Council; Carl Trygger's Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger's Foundation	This work was supported by grants from the Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) and Carl Trygger's Foundation (http://www.carltryggersstiftelse.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrubaian J, 2006, PEPTIDES, V27, P797, DOI 10.1016/j.peptides.2005.09.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bodnar RJ, 2009, PEPTIDES, V30, P2432, DOI 10.1016/j.peptides.2009.09.027; Braasch I, 2009, MOL BIOL EVOL, V26, P783, DOI 10.1093/molbev/msp015; Civelli Olivier, 2008, V46, P1, DOI 10.1007/400_2007_057; Collette Y, 2003, TRENDS IMMUNOL, V24, P387, DOI 10.1016/S1471-4906(03)00166-2; Conlon JM, 2005, GEN COMP ENDOCR, V142, P53, DOI 10.1016/j.ygcen.2004.11.016; Danielson P, 2002, NEUROENDOCRINOLOGY, V76, P55, DOI 10.1159/000063684; Danielson PB, 2001, J BIOL CHEM, V276, P22114, DOI 10.1074/jbc.M011741200; de Souza FSJ, 2005, MOL BIOL EVOL, V22, P2417, DOI 10.1093/molbev/msi236; DEEN PMT, 1992, MOL BIOL EVOL, V9, P483; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dores RM, 2002, MASS SPECTROM REV, V21, P220, DOI 10.1002/mas.10029; Dreborg S, 2008, P NATL ACAD SCI USA, V105, P15487, DOI 10.1073/pnas.0805590105; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Ewadinger NM, 1996, BRAIN RES, V737, P1, DOI 10.1016/0006-8993(96)00649-X; Gonzalez-Nunez V, 2003, BBA-GENE STRUCT EXPR, V1629, P114, DOI 10.1016/j.bbaexp.2003.08.001; Hurst LD, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-62; Hyndman KA, 2009, MOL PHYLOGENET EVOL, V52, P677, DOI 10.1016/j.ympev.2009.04.015; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Khalap A, 2005, ANN NY ACAD SCI, V1040, P22, DOI 10.1196/annals.1327.003; Kieffer BL, 2009, NEUROPHARMACOLOGY, V56, P205, DOI 10.1016/j.neuropharm.2008.07.033; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Larhammar D, 2004, HANDB EXP PHARM, V162, P75; Larsson TA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-184; LENNARD A, 1992, CYTOKINE, V4, P83, DOI 10.1016/1043-4666(92)90041-O; LUSCHEN W, 1991, P NATL ACAD SCI USA, V88, P8671, DOI 10.1073/pnas.88.19.8671; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Nunez VG, 2003, MOL BRAIN RES, V114, P31, DOI 10.1016/S0169-328X(03)00126-8; Okuda-Ashitaka E, 2000, PEPTIDES, V21, P1101, DOI 10.1016/S0196-9781(00)00247-3; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Pattee P, 2003, J BIOL CHEM, V278, P53098, DOI 10.1074/jbc.M306724200; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Roch GJ, 2009, GEN COMP ENDOCR, V161, P3, DOI 10.1016/j.ygcen.2008.10.017; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; STEFANO GB, 1993, P NATL ACAD SCI USA, V90, P11099, DOI 10.1073/pnas.90.23.11099; Sundstrom G, 2008, GEN COMP ENDOCR, V155, P705, DOI 10.1016/j.ygcen.2007.08.016; Takahashi A, 2006, GEN COMP ENDOCR, V148, P72, DOI 10.1016/j.ygcen.2005.09.003; Takahashi A, 2009, PEPTIDES, V30, P1374, DOI 10.1016/j.peptides.2009.04.014; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629	43	77	79	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10512	10.1371/journal.pone.0010512	http://dx.doi.org/10.1371/journal.pone.0010512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463905	Green Published, Green Submitted, gold			2022-12-25	WOS:000277379800008
J	Miller, JC; Danon, L; O'Hagan, JJ; Goldstein, E; Lajous, M; Lipsitch, M				Miller, Joel C.; Danon, Leon; O'Hagan, Justin J.; Goldstein, Edward; Lajous, Martin; Lipsitch, Marc			Student Behavior during a School Closure Caused by Pandemic Influenza A/H1N1	PLOS ONE			English	Article							TRANSMISSION	Background: Many schools were temporarily closed in response to outbreaks of the recently emerged pandemic influenza A/H1N1 virus. The effectiveness of closing schools to reduce transmission depends largely on student/family behavior during the closure. We sought to improve our understanding of these behaviors. Methodology/Principal Findings: To characterize this behavior, we surveyed students in grades 9-12 and parents of students in grades 5-8 about student activities during a weeklong closure of a school during the first months after the disease emerged. We found significant interaction with the community and other students-though less interaction with other students than during school-with the level of interaction increasing with grade. Conclusions: Our results are useful for the future design of social distancing policies and to improving the ability of modeling studies to accurately predict their impact.	[Miller, Joel C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Miller, Joel C.; Danon, Leon; O'Hagan, Justin J.; Goldstein, Edward; Lajous, Martin; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Danon, Leon] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Lajous, Martin] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Harvard University; Harvard T.H. Chan School of Public Health; University of Warwick; Instituto Nacional de Salud Publica; Harvard University; Harvard T.H. Chan School of Public Health	Miller, JC (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	joel.c.miller.research@gmail.com	Danon, Leon/AFV-8758-2022; Miller, Joel C./C-4229-2015; Danon, Leon/J-6324-2012	Danon, Leon/0000-0002-7076-1871; Miller, Joel C./0000-0003-4426-0405; Danon, Leon/0000-0002-7076-1871; Lipsitch, Marc/0000-0003-1504-9213	United States National Institutes of Health [5U01GM076497]; Mexican National Council for Science and Technology (CONACyT); Ministry of Health of Mexico; Department of Epidemiology, Harvard School of Public Health; Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Medical Research Council, United Kingdom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM076497] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministry of Health of Mexico; Department of Epidemiology, Harvard School of Public Health; Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States National Institutes of Health cooperative agreement 5U01GM076497 "Models of Infectious Disease Agent Study'' (M. Lipsitch, J.J.O'H. and E. G.), the Mexican National Council for Science and Technology (CONACyT), the Ministry of Health of Mexico (M.Lajous) and the Department of Epidemiology, Harvard School of Public Health (M.Lajous and J.J.O'H.), the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health (J.C.M.), and the Medical Research Council, United Kingdom (L. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AP, 2009, NYC SCH OFF DEATH TI; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; CDC (Centers for Disease Control and Prevention), 2009, CDC GUID STAT LOC PU; Cowling BJ, 2008, EMERG INFECT DIS, V14, P1660, DOI 10.3201/eid1410.080646; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; HALLORAN M, 2009, EPIDEMIOLOGY, V20; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; HEYMANN AD, 2009, EPIDEMIOL INFECT, P1; Mniszewski SM, 2008, P 2008 SPRING SIM MU, P556, DOI DOI 10.1145/1400549.1400636; Patrozou E, 2009, PUBLIC HEALTH REP, V124, P193, DOI 10.1177/003335490912400205	13	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10425	10.1371/journal.pone.0010425	http://dx.doi.org/10.1371/journal.pone.0010425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463960	Green Published, Green Submitted, gold			2022-12-25	WOS:000277379400007
J	Wang, Q; Symes, AJ; Kane, CA; Freeman, A; Nariculam, J; Munson, P; Thrasivoulou, C; Masters, JRW; Ahmed, A				Wang, Qin; Symes, Andrew J.; Kane, Corrina A.; Freeman, Alex; Nariculam, Joseph; Munson, Philippa; Thrasivoulou, Christopher; Masters, John R. W.; Ahmed, Aamir			A Novel Role for Wnt/Ca2+ Signaling in Actin Cytoskeleton Remodeling and Cell Motility in Prostate Cancer	PLOS ONE			English	Article							TYROSINE KINASE ROR2; WNT/BETA-CATENIN; BETA-CATENIN; TUMOR-SUPPRESSOR; TARGET GENES; WNT; EXPRESSION; IDENTIFICATION; PROLIFERATION; MECHANISMS	Wnt signaling is a critical regulatory pathway in development and disease. Very little is known about the mechanisms of Wnt signaling in prostate cancer, a leading cause of death in men. A quantitative analysis of the expression of Wnt5A protein in human tissue arrays, containing 600 prostate tissue cores, showed > 50% increase in malignant compared to benign cores (p < 0.0001). In a matched pair of prostate cancer and normal cell line, expression of Wnt5A protein was also increased. Calcium waves were induced in prostate cells in response to Wnt5A with a 3 fold increase in Flou-4 intensity. The activity of Ca2+/calmodulin dependent protein kinase (CaMKII), a transducer of the non-canonical Wnt/Ca2+ signaling, increased by 8 fold in cancer cells; no change was observed in beta-catenin expression, known to activate the canonical Wnt/beta-catenin pathway. Mining of publicly available human prostate cancer oligoarray datasets revealed that the expression of numerous genes (e.g., CCND1, CD44) under the control of beta-catenin transcription is down-regulated. Confocal and quantitative electron microscopy showed that specific inhibition of CaMKII in cancer cells causes remodeling of the actin cytoskeleton, irregular wound edges and loose intercellular architecture and a 6 and 8 fold increase in the frequency and length of filopodia, respectively. Conversely, untreated normal prostate cells showed an irregular wound edge and loose intercellular architecture; incubation of normal prostate cells with recombinant Wnt5A protein induced actin remodeling with a regular wound edge and increased wound healing capacity. Live cell imaging showed that a functional consequence of CaMKII inhibition was 80% decrease in wound healing capacity and reduced cell motility in cancer cells. We propose that non-canonical Wnt/Ca2+ signaling via CaMKII acts as a novel regulator of structural plasticity and cell motility in prostate cancer.	[Wang, Qin; Symes, Andrew J.; Kane, Corrina A.; Nariculam, Joseph; Masters, John R. W.; Ahmed, Aamir] UCL, Prostate Canc Res Ctr, London, England; [Wang, Qin; Symes, Andrew J.; Kane, Corrina A.; Nariculam, Joseph; Masters, John R. W.; Ahmed, Aamir] UCL, Div Surg, London, England; [Freeman, Alex] Univ Coll Hosp London Natl Hlth Serv Fdn Trust, Dept Histopathol, London, England; [Munson, Philippa] UCL, Univ Coll London Adv Diagnost, London, England; [Thrasivoulou, Christopher] UCL, Ctr Cell & Mol Dynam, London, England	University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Wang, Q (corresponding author), UCL, Prostate Canc Res Ctr, London, England.	aamir.ahmed@ucl.ac.uk	Thrasivoulou, Christopher/F-7087-2010; Masters, John R/C-5694-2011; Freeman, Alex/J-8344-2019	Thrasivoulou, Christopher/0000-0001-9425-8624; Ahmed, Aamir/0000-0001-7405-5336	National Cancer Research Institute; Prostate Cancer Research Center, United Kingdom; MRC [G0100116] Funding Source: UKRI; Medical Research Council [G0100116] Funding Source: researchfish	National Cancer Research Institute; Prostate Cancer Research Center, United Kingdom; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the National Cancer Research Institute and Prostate Cancer Research Center, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bright RK, 1997, CANCER RES, V57, P995; Chernyavsky AI, 2004, J CELL SCI, V117, P5665, DOI 10.1242/jcs.01492; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Constantinou Thecla, 2008, J Mol Signal, V3, P10, DOI 10.1186/1750-2187-3-10; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; IOZZO RV, 1995, CANCER RES, V55, P3495; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joesting MS, 2005, CANCER RES, V65, P10423, DOI 10.1158/0008-5472.CAN-05-0824; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nariculam J, 2009, ASIAN J ANDROL, V11, P109, DOI 10.1038/aja.2008.22; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Nusse R, 2007, SCIENCE, V316, P988, DOI 10.1126/science.1143337; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rasband W, 1997, IMAGEJ SOFTWARE VERS; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Wang Q, 2007, ONCOGENE, V26, P6560, DOI 10.1038/sj.onc.1210472; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; YAMAMOTO H, 2010, ONCOGENE; Zhu HN, 2004, CANCER RES, V64, P7918, DOI 10.1158/0008-5472.CAN-04-2704; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	47	86	94	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10456	10.1371/journal.pone.0010456	http://dx.doi.org/10.1371/journal.pone.0010456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454608	Green Submitted, gold, Green Published			2022-12-25	WOS:000277305300006
J	Bellemer, C; Chabosseau, P; Gallardo, F; Gleizes, PE; Stahl, G				Bellemer, Clement; Chabosseau, Pauline; Gallardo, Franck; Gleizes, Pierre-Emmanuel; Stahl, Guillaume			Genetic Interactions Show the Importance of rRNA Modification Machinery for the Role of Rps15p during Ribosome Biogenesis in S. cerevisiae	PLOS ONE			English	Article							EFFICIENT NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; SMALL-SUBUNIT; YEAST; PROTEIN; PRERIBOSOMES; PRECURSORS; MATURATION; PROCESSOME; VECTORS	Rps15p, an essential ribosomal protein, was previously shown to be critical for nuclear export of small subunit pre-particles. We have designed a synthetic lethal screen in Saccharomyces cerevisi to identify its genetic partners and further elucidate its role during ribosomal biogenesis. Our screen revealed interactions with mutants affected at various stages during ribosome biogenesis, from early nucleolar steps to nuclear export. Mutations were identified in genes encoding proteins involved in early ribosome biogenesis steps, like the small subunit processome component Utp15p, the 90S pre-ribosome factor Slx9p and the H/ACA snoRNP core protein Nhp2p. In addition, we found a synthetic lethality with BUD23, a gene encoding a methyltransferase involved both in rRNA modification and small subunit nuclear export. Interestingly, deletion of snR36 or snR85, two H/ACA snoRNAs that direct modifications close to Rps15p's binding site on the rRNA, produces mild and opposite effects on growth in an rps15 hypomorphic background. These data uncover an unreported link between a ribosomal protein and rRNA modification machinery.	[Bellemer, Clement; Chabosseau, Pauline; Gallardo, Franck; Gleizes, Pierre-Emmanuel; Stahl, Guillaume] Univ Toulouse, Lab Biol Mol Eucaryote, Toulouse, France; [Bellemer, Clement; Chabosseau, Pauline; Gallardo, Franck; Gleizes, Pierre-Emmanuel; Stahl, Guillaume] CNRS, Lab Biol Mol Eucaryote, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Bellemer, C (corresponding author), Univ Toulouse, Lab Biol Mol Eucaryote, Toulouse, France.	stahl@biotoul.fr	Stahl, Guillaume/O-1703-2014; Gleizes, Pierre-Emmanuel/ABB-9653-2021; Gallardo, Franck/H-1817-2011; Gleizes, Pierre-Emmanuel/H-3821-2014	Stahl, Guillaume/0000-0002-6703-3929; Gleizes, Pierre-Emmanuel/0000-0003-0830-7341; Gleizes, Pierre-Emmanuel/0000-0003-0830-7341	CNRS; Universite Paul Sabatier, ANR; Institut Universitaire de France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier, ANR(French National Research Agency (ANR)); Institut Universitaire de France	This work was supported by the CNRS, the Universite Paul Sabatier, ANR grants SNOSCA and RIBEUC and the Institut Universitaire de France ( to PEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Bax R, 2006, RNA, V12, P2005, DOI 10.1261/rna.159406; Bernstein KA, 2004, MOL BIOL CELL, V15, P5038, DOI 10.1091/mbc.E04-06-0515; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; DiMario PJ, 2004, INT REV CYTOL, V239, P99, DOI 10.1016/S0074-7696(04)39003-0; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gleizes PE, 2001, J CELL BIOL, V155, P923, DOI 10.1083/jcb.200108142; Henras A, 1998, EMBO J, V17, P7078, DOI 10.1093/emboj/17.23.7078; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Jakovljevic J, 2004, MOL CELL, V14, P331, DOI 10.1016/S1097-2765(04)00215-1; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liang XH, 2009, RNA, V15, P1716, DOI 10.1261/rna.1724409; MORITZ M, 1990, J CELL BIOL, V111, P2261, DOI 10.1083/jcb.111.6.2261; Oeffinger M, 2004, GENE DEV, V18, P196, DOI 10.1101/gad.285604; POWERS T, 1988, J MOL BIOL, V200, P309, DOI 10.1016/0022-2836(88)90243-4; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; SIKORSKI RS, 1989, GENETICS, V122, P19; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; Torchet C, 2005, RNA, V11, P928, DOI 10.1261/rna.2100905; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; White J, 2008, MOL CELL BIOL, V28, P3151, DOI 10.1128/MCB.01674-07	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10472	10.1371/journal.pone.0010472	http://dx.doi.org/10.1371/journal.pone.0010472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454621	Green Published, Green Submitted, gold			2022-12-25	WOS:000277240300031
J	Kramski, M; Matz-Rensing, K; Stahl-Hennig, C; Kaup, FJ; Nitsche, A; Pauli, G; Ellerbrok, H				Kramski, Marit; Maetz-Rensing, Kerstin; Stahl-Hennig, Christiane; Kaup, Franz-Josef; Nitsche, Andreas; Pauli, Georg; Ellerbrok, Heinz			A Novel Highly Reproducible and Lethal Nonhuman Primate Model for Orthopox Virus Infection	PLOS ONE			English	Article							MODIFIED VACCINIA VIRUS; TO-HUMAN TRANSMISSION; HUMAN MONKEYPOX; COWPOX; SMALLPOX; EXPRESSION; PROTECTION; CHALLENGE; PATHOLOGY; RESERVOIR	The intentional re-introduction of Variola virus (VARV), the agent of smallpox, into the human population is of great concern due its bio-terroristic potential. Moreover, zoonotic infections with Cowpox (CPXV) and Monkeypox virus (MPXV) cause severe diseases in humans. Smallpox vaccines presently available can have severe adverse effects that are no longer acceptable. The efficacy and safety of new vaccines and antiviral drugs for use in humans can only be demonstrated in animal models. The existing nonhuman primate models, using VARV and MPXV, need very high viral doses that have to be applied intravenously or intratracheally to induce a lethal infection in macaques. To overcome these drawbacks, the infectivity and pathogenicity of a particular CPXV was evaluated in the common marmoset (Callithrix jacchus). A CPXV named calpox virus was isolated from a lethal orthopox virus (OPV) outbreak in New World monkeys. We demonstrated that marmosets infected with calpox virus, not only via the intravenous but also the intranasal route, reproducibly develop symptoms resembling smallpox in humans. Infected animals died within 1-3 days after onset of symptoms, even when very low infectious viral doses of 5 x 10(2) pfu were applied intranasally. Infectious virus was demonstrated in blood, saliva and all organs analyzed. We present the first characterization of a new OPV infection model inducing a disease in common marmosets comparable to smallpox in humans. Intranasal virus inoculation mimicking the natural route of smallpox infection led to reproducible infection. In vivo titration resulted in an MID50 (minimal monkey infectious dose 50%) of 8.3 x 10(2) pfu of calpox virus which is approximately 10,000-fold lower than MPXV and VARV doses applied in the macaque models. Therefore, the calpox virus/marmoset model is a suitable nonhuman primate model for the validation of vaccines and antiviral drugs. Furthermore, this model can help study mechanisms of OPV pathogenesis.	[Kramski, Marit; Nitsche, Andreas; Pauli, Georg; Ellerbrok, Heinz] Robert Koch Inst, D-1000 Berlin, Germany; [Maetz-Rensing, Kerstin; Stahl-Hennig, Christiane; Kaup, Franz-Josef] German Primate Ctr DPZ, Gottingen, Germany	Robert Koch Institute; Deutsches Primatenzentrum (DPZ)	Kramski, M (corresponding author), Robert Koch Inst, D-1000 Berlin, Germany.	ellerbrokh@rki.de		Nitsche, Andreas/0000-0001-8185-3176	German Ministry of Health [1-121-42261]	German Ministry of Health	This work was supported by the German Ministry of Health (BMG-Erlass Foko 1-121-42261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ault A, 2003, LANCET, V361, P1626, DOI 10.1016/S0140-6736(03)13318-1; BAXBY D, 1994, BRIT J DERMATOL, V131, P598, DOI 10.1111/j.1365-2133.1994.tb04969.x; BAXBY D, 1994, LANCET, V343, P543, DOI 10.1016/S0140-6736(94)91498-2; Becker C, 2009, DTSCH ARZTEBL INT, V106, P329, DOI 10.3238/arztebl.2009.0329; Breman JG, 2000, EMERGING INFECTIONS 4, P45; CAREY GJ, 1991, PHARM BIOCH BEHAV, V42, P143; Carrion R, 2007, J VIROL, V81, P6482, DOI 10.1128/JVI.02876-06; Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423; CZERNY CP, 1991, J VET MED B, V38, P421, DOI 10.1111/j.1439-0450.1991.tb00891.x; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; DOWNIE AW, 1969, J HYG-CAMB, V67, P609, DOI 10.1017/S0022172400042066; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; FENNER F, 1988, HUMAN MONKEYPOX OTHE, P1287; FENNER F, 1988, CLIN FEATURES SMALLP, P1; FENNER F, 1988, PATHOGENESIS PATHOLO, P121; Genain CP, 1997, J MOL MED, V75, P187, DOI 10.1007/s001090050103; Guarner J, 2004, EMERG INFECT DIS, V10, P426, DOI 10.3201/eid1003.030878; Hazel SM, 2000, EPIDEMIOL INFECT, V124, P551, DOI 10.1017/S0950268899003799; Hooper JW, 2004, J VIROL, V78, P4433, DOI 10.1128/JVI.78.9.4433-4443.2004; Jahrling PB, 2004, P NATL ACAD SCI USA, V101, P15196, DOI 10.1073/pnas.0405954101; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; Jordan Robert, 2006, Expert Rev Anti Infect Ther, V4, P277, DOI 10.1586/14787210.4.2.277; Kern ER, 2003, ANTIVIR RES, V57, P35, DOI 10.1016/S0166-3542(02)00198-5; KETTLE S, 1995, VIROLOGY, V206, P136, DOI 10.1016/S0042-6822(95)80028-X; KLINGEBIEL T, 1988, PEDIATR INFECT DIS J, V7, P883, DOI 10.1097/00006454-198807120-00013; Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817; Kurth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006883; Lever MS, 2008, INT J EXP PATHOL, V89, P171, DOI 10.1111/j.1365-2613.2008.00581.x; Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003; MARENNIKOVA SS, 1976, ACTA VIROL, V20, P442; Matz-Rensing K, 2006, VET PATHOL, V43, P212, DOI 10.1354/vp.43-2-212; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; PILASKI J, 1986, ARCH VIROL, V88, P135, DOI 10.1007/BF01310898; Quenelle DC, 2003, ANTIMICROB AGENTS CH, V47, P3275, DOI 10.1128/AAC.47.10.3275-3280.2003; Qutaishat Salah S, 2003, Clin Med Res, V1, P85; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; RYLANDS AB, 1997, HDB MARMOSETS TAMARI, P1; Saijo M, 2006, J VIROL, V80, P5179, DOI 10.1128/JVI.02642-05; Smee DF, 2000, ANTIVIR RES, V47, P171, DOI 10.1016/S0166-3542(00)00105-4; Smee DF, 2003, ANTIVIR RES, V57, P41, DOI 10.1016/S0166-3542(02)00199-7; SPOUGE JL, 1992, P NATL ACAD SCI USA, V89, P7581, DOI 10.1073/pnas.89.16.7581; STAHLMANN R, 1995, HUM EXP TOXICOL, V14, P146, DOI 10.1177/096032719501400137; Staib C, 2006, J GEN VIROL, V87, P2917, DOI 10.1099/vir.0.82068-0; Stittelaar KJ, 2006, NATURE, V439, P745, DOI 10.1038/nature04295; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; van Vliet SAM, 2008, EUR NEUROPSYCHOPHARM, V18, P383, DOI 10.1016/j.euroneuro.2007.11.003; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; *WHO, 1980, GLOB ER SMALLP; Wolfs TFW, 2002, EMERG INFECT DIS, V8, P1495, DOI 10.3201/eid0812.020089; Woollard DJ, 2008, J VIROL, V82, P3054, DOI 10.1128/JVI.01153-07; Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	53	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10412	10.1371/journal.pone.0010412	http://dx.doi.org/10.1371/journal.pone.0010412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454688	Green Submitted, gold, Green Published			2022-12-25	WOS:000277240100020
J	Tchendjou, P; Same-Ekobo, C; Nga, A; Tejiokem, M; Kfutwah, A; Nlend, AN; Tsague, L; Bissek, AC; Ekoa, D; Orne-Gliemann, J; Rousset, D; Pouillot, R; Dabis, F				Tchendjou, Patrice; Same-Ekobo, Chantal; Nga, Annie; Tejiokem, Mathurin; Kfutwah, Anfumbom; Nlend, Anne Njom; Tsague, Landry; Bissek, Anne Cecile; Ekoa, Daniel; Orne-Gliemann, Joanna; Rousset, Dominique; Pouillot, Regis; Dabis, Francois			Effectiveness of Multidrug Antiretroviral Regimens to Prevent Mother-to-Child Transmission of HIV-1 in Routine Public Health Services in Cameroon	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED-TRIAL; COTE-DIVOIRE; FOLLOW-UP; ZIDOVUDINE; EFFICACY; INFANTS; INTRAPARTUM; PREGNANCY	Background: Multidrug antiretroviral (ARV) regimens including HAART and short-course dual antiretroviral (sc-dARV) regimens were introduced in 2004 to improve Prevention of Mother-to-Child Transmission (PMTCT) in Cameroon. We assessed the effectiveness of these regimens from 6-10 weeks and 12 months of age, respectively. Methodology/Findings: We conducted a retrospective cohort study covering the period from October 2004 to March 2008 in a reference hospital in Cameroon. HIV-positive pregnant women with CD4 <= 350 cells/mm(3) received first-line HAART [regimen 1] while the others received ARV prophylaxis including sc-dARV or single dose nevirapine (sd-NVP). Sc-dARV included at least two drugs according to different gestational ages: zidovudine (ZDV) from 28-32 weeks plus sd-NVP [regimen 2], ZDV and lamuvidine (3TC) from 33-36 weeks plus sd-NVP [regimen 3]. When gestational age was >= 37 weeks, women received sd-NVP during labour [regimen 4]. Infants received sd-NVP plus ZDV and 3TC for 7 days or 30 days. Early diagnosis (6-10 weeks) was done, using b-DNA and subsequently RT-PCR. We determined early MTCT rate and associated risk factors using logistic regression. The 12-month HIV-free survival was assessed using Cox regression. Among 418 mothers, 335 (80%) received multidrug ARV regimens (1, 2, and 3) and MTCT rate with multidrug regimens was 6.6% [95% CI: 4.3-9.6] at 6 weeks, without any significant difference between regimens. Duration of mother's ARV regimen <4 weeks [OR = 4.7, 95% CI: 1.3-17.6], mother's CD4 <350 cells/mm(3) [OR = 6.4, 95% CI: 1.8-22.5] and low birth weight [OR = 4.0, 95% CI: 1.4-11.3] were associated with early MTCT. By 12 months, mixed feeding [HR = 8.7, 95% CI: 3.6-20.6], prematurity [HR = 2.3, 95% CI: 1.2-4.3] and low birth weight were associated with children's risk of progressing to infection or death. Conclusions: Multidrug ARV regimens for PMTCT are feasible and effective in routine reference hospital. Early initiation of ARV during pregnancy and proper obstetrical care are essential to improve PMTCT.	[Tchendjou, Patrice; Tejiokem, Mathurin; Pouillot, Regis] Ctr Pasteur Cameroun, Lab Epidemiol, Yaounde, Cameroon; [Same-Ekobo, Chantal; Nga, Annie; Nlend, Anne Njom] Ctr Hosp Essos, Yaounde, Cameroon; [Kfutwah, Anfumbom; Rousset, Dominique] Ctr Pasteur Cameroun, Virol Lab, Yaounde, Cameroon; [Tsague, Landry; Bissek, Anne Cecile; Ekoa, Daniel] Minist Sante Publ Cameroun, Direct Lutte Malad, Yaounde, Cameroon; [Orne-Gliemann, Joanna; Dabis, Francois] Inst Sante Publ Epidemiol & Dev, INSERM, U897, Bordeaux, France	Centre Pasteur du Cameroun; Centre Pasteur du Cameroun; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Tchendjou, P (corresponding author), Ctr Pasteur Cameroun, Lab Epidemiol, Yaounde, Cameroon.	Tchendjou@pasteur-yaounde.org	DABIS, FRANCOIS/S-9298-2019; Pouillot, Regis/E-8103-2010; Rousset, Dominique/S-5400-2019; Orne-Gliemann, Joanna/T-2787-2019	DABIS, FRANCOIS/0000-0002-1614-8857; Pouillot, Regis/0000-0002-6107-5212; Rousset, Dominique/0000-0002-1473-3147; 	Centre Pasteur du Cameroun	Centre Pasteur du Cameroun	This is a retrospective study. It was sponsored by the Centre Pasteur du Cameroun as part of its public health mission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; ARMITAGE P, 2002, STAT METHODS MED RES, P488; Becquet R, 2005, JAIDS-J ACQ IMM DEF, V40, P600, DOI 10.1097/01.qai.0000171726.17436.82; Coutsoudis A, 2002, HEALTH POLICY PLANN, V17, P154, DOI 10.1093/heapol/17.2.154; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Creek T, 2008, PEDIATR INFECT DIS J, V27, P22, DOI 10.1097/INF.0b013e3181469050; Dabis F, 2005, AIDS, V19, P309; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Institut National de la Statistique (INS) et ORC Macro, 2004, ENQ DEM SANT CAM 200 ENQ DEM SANT CAM 200; Jackson DJ, 2007, AIDS, V21, P509, DOI 10.1097/QAD.0b013e32801424d2; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Leroy V, 2005, AIDS, V19, P1865, DOI 10.1097/01.aids.0000188423.02786.55; Leroy V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001645; Mandelbrot L, 2002, SEX TRANSM INFECT, V78, P267, DOI 10.1136/sti.78.4.267; Mofenson LM, 2000, LANCET, V355, P2237, DOI 10.1016/S0140-6736(00)02415-6; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Newell ML, 2001, B WORLD HEALTH ORGAN, V79, P1138; Nlend AN, 2007, J TROP PEDIATRICS, V53, P438, DOI 10.1093/tropej/fmm045; Piechulek H., 1996, Medecine d'Afrique Noire, V43, P67; Shapiro RL, 2006, AIDS, V20, P1281, DOI 10.1097/01.aids.0000232236.26630.35; Stanton CK, 2006, STUD FAMILY PLANN, V37, P41, DOI 10.1111/j.1728-4465.2006.00082.x; Taha TE, 2004, JAMA-J AM MED ASSOC, V292, P202, DOI 10.1001/jama.292.2.202; Tejiokem MC, 2004, MED MALADIES INFECT, V34, pS57, DOI 10.1016/S0399-077X(04)90019-4; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; TINDYEBWA D, 2006, HDB PAEDIAT AIDS AFR; Tonwe-Gold B, 2007, PLOS MED, V4, P1362, DOI 10.1371/journal.pmed.0040257; *UNAIDS, 2007, AIDS EP UPD DEC 207; *UNAIDS, 2005, AIDS EP UPD DEC 2005; WHO, 2022, ANT DRUGS TREAT PREG; *WHO, 2000, NEW DAT PREV MOTH TO	32	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10411	10.1371/journal.pone.0010411	http://dx.doi.org/10.1371/journal.pone.0010411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454459	gold, Green Published, Green Submitted			2022-12-25	WOS:000277240100019
J	Bandyopadhyay, A; Wang, L; Agyin, J; Tang, YP; Lin, S; Yeh, IT; De, K; Sun, LZ				Bandyopadhyay, Abhik; Wang, Long; Agyin, Joseph; Tang, Yuping; Lin, Shu; Yeh, I-Tien; De, Keya; Sun, Lu-Zhe			Doxorubicin in Combination with a Small TGF beta Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR KINASE INHIBITOR; IN-VIVO; STEM-CELLS; MAMMARY-CARCINOMA; TRANSFORMING GROWTH-FACTOR-BETA-1; DISEASE PROGRESSION; MDA-MB-231 CELLS; DRUG-RESISTANCE	Background: Recent studies suggested that induction of epithelial-mesenchymal transition (EMT) might confer both metastatic and self-renewal properties to breast tumor cells resulting in drug resistance and tumor recurrence. TGF beta is a potent inducer of EMT and has been shown to promote tumor progression in various breast cancer cell and animal models. Principal Findings: We report that chemotherapeutic drug doxorubicin activates TGF beta signaling in human and murine breast cancer cells. Doxorubicin induced EMT, promoted invasion and enhanced generation of cells with stem cell phenotype in murine 4T1 breast cancer cells in vitro, which were significantly inhibited by a TGF beta type I receptor kinase inhibitor (T beta RI-KI). We investigated the potential synergistic anti-tumor activity of T beta R1-KI in combination with doxorubicin in animal models of metastatic breast cancer. Combination of Doxorubicin and T beta RI-KI enhanced the efficacy of doxorubicin in reducing tumor growth and lung metastasis in the 4T1 orthotopic xenograft model in comparison to single treatments. Doxorubicin treatment alone enhanced metastasis to lung in the human breast cancer MDA-MB-231 orthotopic xenograft model and metastasis to bone in the 4T1 orthotopic xenograft model, which was significantly blocked when T beta R1-KI was administered in combination with doxorubicin. Conclusions: These observations suggest that the adverse activation of TGF beta pathway by chemotherapeutics in the cancer cells together with elevated TGF beta levels in tumor microenvironment may lead to EMT and generation of cancer stem cells resulting in the resistance to the chemotherapy. Our results indicate that the combination treatment of doxorubicin with a TGF beta inhibitor has the potential to reduce the dose and consequently the toxic side-effects of doxorubicin, and improve its efficacy in the inhibition of breast cancer growth and metastasis.	[Bandyopadhyay, Abhik; Wang, Long; Tang, Yuping; Lin, Shu; De, Keya; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Agyin, Joseph] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Yeh, I-Tien] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Bandyopadhyay, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	sunl@uthscsa.edu	Lin, Shu/C-3790-2013; , LuZhe/AAW-4095-2021		NIH [R01CA079683, R01CA075253, P01CA040035, P30CA054174]; Shelby Rae Tang Foundation; NATIONAL CANCER INSTITUTE [R01CA079683, R01CA075253, P01CA040035, P30CA054174] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shelby Rae Tang Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH Grants R01CA079683, R01CA075253, P01CA040035, and P30CA054174, and by Shelby Rae Tang Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2006, CURR OPIN GENET DEV, V16, P30, DOI 10.1016/j.gde.2005.12.009; Bandyopadhyay A, 2002, CANCER RES, V62, P4690; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Bandyopadhyay Abhik, 2008, V2, P723, DOI 10.1007/978-1-59745-293-9_44; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen JH, 2005, ENDOCR-RELAT CANCER, V12, P93, DOI 10.1677/erc.1.00871; DALAL BI, 1993, AM J PATHOL, V143, P381; Davies JA, 1996, ACTA ANAT, V156, P187; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; ELLIS MJ, 2004, TREATMENT METASTATIC, P749; Gamucci T, 2007, BRIT J CANCER, V97, P1040, DOI 10.1038/sj.bjc.6603982; Ge RR, 2006, CLIN CANCER RES, V12, P4315, DOI 10.1158/1078-0432.CCR-06-0162; GORSCH SM, 1992, CANCER RES, V52, P6949; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Ivanovic V, 2003, EUR J CANCER, V39, P454, DOI 10.1016/S0959-8049(02)00502-6; Kakonen SM, 2003, CANCER-AM CANCER SOC, V97, P834, DOI 10.1002/cncr.11132; Kolodziejski L, 1999, Pneumonol Alergol Pol, V67, P228; Lei XF, 2002, ONCOGENE, V21, P7514, DOI 10.1038/sj.onc.1205966; Lei XF, 2007, EXP CELL RES, V313, P1687, DOI 10.1016/j.yexcr.2007.02.016; Liu PC, 2000, INT J ONCOL, V16, P599; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin TJ, 2000, ENDOCR-RELAT CANCER, V7, P271, DOI 10.1677/erc.0.0070271; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Muraoka-Cook RS, 2006, ONCOGENE, V25, P3408, DOI 10.1038/sj.onc.1208964; Muraoka-Cook RS, 2004, CANCER RES, V64, P9002, DOI 10.1158/0008-5472.CAN-04-2111; Nikolic-Vukosavljevic D, 2004, CLIN EXP METASTAS, V21, P581; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Planchard D, 2004, CANCER-AM CANCER SOC, V100, P28, DOI 10.1002/cncr.11881; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh J, 2003, BIOORG MED CHEM LETT, V13, P4355, DOI 10.1016/j.bmcl.2003.09.028; Sledge GW, 2003, J CLIN ONCOL, V21, P588, DOI 10.1200/JCO.2003.08.013; SOSROSENO W, 1995, BRIT J BIOMED SCI, V52, P142; Sun LZ, 2004, FRONT BIOSCI, V9, P1925, DOI 10.2741/1382; Sun LZ, 1997, J BIOL CHEM, V272, P25367, DOI 10.1074/jbc.272.40.25367; Suzuki E, 2007, CANCER RES, V67, P2351, DOI 10.1158/0008-5472.CAN-06-2389; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Teicher BA, 1997, IN VIVO, V11, P453; Teicher BA, 1997, IN VIVO, V11, P463; Tsushima H, 2001, CLIN CANCER RES, V7, P1258; Verona EV, 2007, CANCER RES, V67, P5737, DOI 10.1158/0008-5472.CAN-07-0444; WALKER RA, 1995, J PATHOL, V177, P123, DOI 10.1002/path.1711770204; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yoneda Toshiyuki, 2000, Cancer, V88, P2979, DOI 10.1002/1097-0142(20000615)88:12+<2979::AID-CNCR13>3.0.CO;2-U	56	140	150	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10365	10.1371/journal.pone.0010365	http://dx.doi.org/10.1371/journal.pone.0010365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442777	Green Published, gold, Green Submitted			2022-12-25	WOS:000277154200007
J	Lesimple, C; Fureix, C; Menguy, H; Hausberger, M				Lesimple, Clemence; Fureix, Carole; Menguy, Herve; Hausberger, Martine			Human Direct Actions May Alter Animal Welfare, a Study on Horses (Equus caballus)	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; LOW-BACK-PAIN; MANIPULATION; KINEMATICS; DISORDERS; SPINE; WORK	Background: Back pain is the cause of bad welfare in humans and animals. Although vertebral problems are regularly reported on riding horses, these problems are not always identified nor noticed enough to prevent these horses to be used for work. Methodology/Principal Findings: Nineteen horses from two riding centres were submitted to chiropractic examinations performed by an experienced chiropractor and both horses' and riders' postures were observed during a riding lesson. The results show that 74% of horses were severely affected by vertebral problems, while only 26% were mildly or not affected. The degree of vertebral problems identified at rest was statistically correlated with horses' attitudes at work (neck height and curve), and horses' attitudes at work were clearly correlated with riders' positions. Clear differences appeared between schools concerning both riders' and horses' postures, and the analysis of the teachers' speech content and duration highlighted differences in the attention devoted to the riders' position. Conclusion/Significance: These findings are to our knowledge the first to underline the impact of riding on horses' back problems and the importance of teaching proper balance to beginner riders in order to increase animals' welfare.	[Lesimple, Clemence; Hausberger, Martine] Univ Rennes 1, Lab Ethol Anim & Humaine EthoS, CNRS, Stn Biol,UMR 6552, Paimpont, France; [Fureix, Carole; Hausberger, Martine] Univ Rennes 1, Lab Ethol Anim & Humaine EthoS, CNRS, UMR 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Lesimple, C (corresponding author), Univ Rennes 1, Lab Ethol Anim & Humaine EthoS, CNRS, Stn Biol,UMR 6552, Paimpont, France.	clemence.lesimple@univ-rennes1.fr		/0000-0003-0664-1151	Caisse Centrale de la Mutualite Sociale Agricole(MSA); CNRS; French Ministry of Research	Caisse Centrale de la Mutualite Sociale Agricole(MSA); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This study was supported by the Caisse Centrale de la Mutualite Sociale Agricole(MSA), the CNRS and the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIGOS SJ, 1991, SPINE, V16, P1, DOI 10.1097/00007632-199101000-00001; Castellan NJ, 1988, NONPARAMETRIC STAT B; Cauvin E, 1997, IN PRACTICE, V19, P522; Cook WR, 2002, J EQUINE VET SCI, V22, P7, DOI 10.1016/S0737-0806(02)70207-4; Denoix J.M., 1987, EQUINE EXERCISE PHYS, V2, P607; Faber M, 2000, AM J VET RES, V61, P399, DOI 10.2460/ajvr.2000.61.399; Fonseca BPA, 2006, J EQUINE VET SCI, V26, P507, DOI 10.1016/j.jevs.2006.09.007; Fureix C, 2009, ANIM COGN, V12, P643, DOI 10.1007/s10071-009-0223-2; Gillis C, 1999, VET CLIN N AM-EQUINE, V15, P97; Gomez Alvarez C B, 2006, Equine Vet J Suppl, P445; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; Haussler KK, 2006, EQUINE VET J, V38, P76, DOI 10.2746/042516406775374225; Haussler KK, 1999, AM J VET RES, V60, P143; Jeffcoat LB, 1999, VET J, V158, P113, DOI 10.1053/tvjl.1998.0334; JEFFCOTT LB, 1979, EQUINE VET J, V11, P129, DOI 10.1111/j.2042-3306.1979.tb01324.x; JEFFCOTT LB, 1980, EQUINE VET J, V12, P197, DOI 10.1111/j.2042-3306.1980.tb03427.x; KIRKALDYWILLIS WH, 1985, CAN FAM PHYSICIAN, V31, P535; Landman MAAM, 2004, VET REC, V155, P165, DOI 10.1136/vr.155.6.165; Licka T, 1998, EQUINE VET J, V30, P412, DOI 10.1111/j.2042-3306.1998.tb04511.x; Marras WS, 2000, ERGONOMICS, V43, P880, DOI 10.1080/001401300409080; McGreevy P, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P196; Odberg F O, 1999, Equine Vet J Suppl, P26; Popa T, 2007, EXP BRAIN RES, V177, P411, DOI 10.1007/s00221-006-0683-4; Rhodin M, 2005, EQUINE VET J, V37, P7, DOI 10.2746/0425164054406928; Ridgway K, 1999, VET CLIN N AM-EQUINE, V15, P263; Shearar KA, 2005, J MANIP PHYSIOL THER, V28, P493, DOI 10.1016/j.jmpt.2005.07.006; Sullivan KA, 2008, EQUINE VET J, V40, P14, DOI 10.2746/042516407X240456; Vieira ER, 2004, J OCCUP REHABIL, V14, P143, DOI 10.1023/B:JOOR.0000018330.46029.05; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; Wood TG, 2001, J MANIP PHYSIOL THER, V24, P260, DOI 10.1067/mmt.2001.114365; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	36	41	41	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10257	10.1371/journal.pone.0010257	http://dx.doi.org/10.1371/journal.pone.0010257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	589MV	20442766	Green Published, Green Submitted, gold			2022-12-25	WOS:000277154200001
J	Favaro, E; Ramachandran, A; McCormick, R; Gee, H; Blancher, C; Crosby, M; Devlin, C; Blick, C; Buffa, F; Li, JL; Vojnovic, B; das Neves, RP; Glazer, P; Iborra, F; Ivan, M; Ragoussis, J; Harris, AL				Favaro, Elena; Ramachandran, Anassuya; McCormick, Robert; Gee, Harriet; Blancher, Christine; Crosby, Meredith; Devlin, Cecilia; Blick, Christopher; Buffa, Francesca; Li, Ji-Liang; Vojnovic, Borivoj; das Neves, Ricardo Pires; Glazer, Peter; Iborra, Francisco; Ivan, Mircea; Ragoussis, Jiannis; Harris, Adrian L.			MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; INDUCIBLE FACTOR; MUTATION; HEAD; DEHYDROGENASE; RESPIRATION; BIOGENESIS; SIGNATURE; HELICASES	Background: Hypoxia in cancers results in the upregulation of hypoxia inducible factor 1 (HIF-1) and a microRNA, hsa-miR-210 (miR-210) which is associated with a poor prognosis. Methods and Findings: In human cancer cell lines and tumours, we found that miR-210 targets the mitochondrial iron sulfur scaffold protein ISCU, required for assembly of iron-sulfur clusters, cofactors for key enzymes involved in the Krebs cycle, electron transport, and iron metabolism. Down regulation of ISCU was the major cause of induction of reactive oxygen species (ROS) in hypoxia. ISCU suppression reduced mitochondrial complex 1 activity and aconitase activity, caused a shift to glycolysis in normoxia and enhanced cell survival. Cancers with low ISCU had a worse prognosis. Conclusions: Induction of these major hallmarks of cancer show that a single microRNA, miR-210, mediates a new mechanism of adaptation to hypoxia, by regulating mitochondrial function via iron-sulfur cluster metabolism and free radical generation.	[Favaro, Elena; Blancher, Christine; Ragoussis, Jiannis] Univ Oxford, Genom Grp, Wellcome Trust Ctr Human Genet, Oxford, England; [Favaro, Elena; Ramachandran, Anassuya; McCormick, Robert; Gee, Harriet; Blick, Christopher; Buffa, Francesca; Li, Ji-Liang; das Neves, Ricardo Pires; Iborra, Francisco; Harris, Adrian L.] Univ Oxford, John Radcliffe Hosp, Mol Oncol Labs, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Crosby, Meredith; Glazer, Peter] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Devlin, Cecilia; Ivan, Mircea] Indiana Univ, Indianapolis, IN 46204 USA; [Vojnovic, Borivoj] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Yale University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Oxford	Favaro, E (corresponding author), Univ Oxford, Genom Grp, Wellcome Trust Ctr Human Genet, Oxford, England.	mivan@iupui.edu; aharris.lab@imm.ox.ac.uk	Buffa, Francesca/D-2574-2013; Neves, Ricardo N Pires das/A-3322-2009; Ivan, Mircea/A-8109-2012; Vojnovic, Borivoj/AAV-4756-2021; iborra, francisco j/K-9313-2015; Harris, Adrian L/ABA-3343-2020; Ragoussis, Ioannis/AAD-9790-2022; Glazer, Peter/S-7651-2019; Favaro, Elena/Q-4566-2016; Gee, Harriet/I-5598-2017	Buffa, Francesca/0000-0003-0409-406X; Neves, Ricardo N Pires das/0000-0003-2291-6610; Vojnovic, Borivoj/0000-0001-9013-3816; iborra, francisco j/0000-0002-0692-3696; Harris, Adrian L/0000-0003-1376-8409; Favaro, Elena/0000-0001-5376-5515; Ivan, Mircea/0000-0003-3424-6642; Gee, Harriet/0000-0001-7397-8585; Glazer, Peter/0000-0003-4525-5560; Ramachandran, Anassuya/0000-0002-0123-6539; Ragoussis, Ioannis/0000-0002-8515-0934; Crosby, Meredith/0000-0002-3626-9445	Cancer Research UK; Friends of Kennington Cancer Research; Wellcome Trust; Royal College of Surgeons & British Urology Foundation; European Union; ACGT; Rhodes Scholarship; Nuffield Medical Fellowship; FIRC Studentship; NIHR Biomedical Research Centre Oxford; Elsa Pardee Foundation; American Cancer Society; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Medical Research Council [G1000801f] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Friends of Kennington Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); Royal College of Surgeons & British Urology Foundation; European Union(European Commission); ACGT; Rhodes Scholarship; Nuffield Medical Fellowship; FIRC Studentship(Fondazione AIRC per la ricerca sul cancro); NIHR Biomedical Research Centre Oxford(National Institute for Health Research (NIHR)); Elsa Pardee Foundation; American Cancer Society(American Cancer Society); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Cancer Research UK and Friends of Kennington Cancer Research Fund (EF, ALH, JL), The Wellcome Trust (CB1, CC, IR), Royal College of Surgeons & British Urology Foundation (CB2, RMcC), European Union, ACGT (FB), Rhodes Scholarship (HG), Nuffield Medical Fellowship (AR), FIRC Studentship (EF). Biobanking supported by NIHR Biomedical Research Centre Oxford; Elsa Pardee Foundation (MI), American Cancer Society (MC, MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bell EL, 2007, ESSAYS BIOCHEM, V43, P17, DOI 10.1042/bse0430017; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Iborra FJ, 2008, HISTOCHEM CELL BIOL, V129, P45, DOI 10.1007/s00418-007-0352-0; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; KIM HW, 2009, J BIOL CHEM; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; SEMENIUK C, 2007, WETLANDS ECOL CONSER, V1, P1; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wigfield SM, 2008, BRIT J CANCER, V98, P1975, DOI 10.1038/sj.bjc.6604356; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387	44	237	251	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10345	10.1371/journal.pone.0010345	http://dx.doi.org/10.1371/journal.pone.0010345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436681	Green Submitted, Green Published, gold			2022-12-25	WOS:000277079500015
J	Lira-Medeiros, CF; Parisod, C; Fernandes, RA; Mata, CS; Cardoso, MA; Ferreira, PCG				Lira-Medeiros, Catarina Fonseca; Parisod, Christian; Fernandes, Ricardo Avancini; Mata, Camila Souza; Cardoso, Monica Aires; Gomes Ferreira, Paulo Cavalcanti			Epigenetic Variation in Mangrove Plants Occurring in Contrasting Natural Environment	PLOS ONE			English	Article							DNA METHYLATION; POLYMORPHISM; INHERITANCE; POPULATION; HYBRIDIZATION; CONSEQUENCES; VARIABILITY; POLYPLOIDY; PATTERNS; DISPLAYS	Background: Epigenetic modifications, such as cytosine methylation, are inherited in plant species and may occur in response to biotic or abiotic stress, affecting gene expression without changing genome sequence. Laguncularia racemosa, a mangrove species, occurs in naturally contrasting habitats where it is subjected daily to salinity and nutrient variations leading to morphological differences. This work aims at unraveling how CpG-methylation variation is distributed among individuals from two nearby habitats, at a riverside (RS) or near a salt marsh (SM), with different environmental pressures and how this variation is correlated with the observed morphological variation. Principal Findings: Significant differences were observed in morphological traits such as tree height, tree diameter, leaf width and leaf area between plants from RS and SM locations, resulting in smaller plants and smaller leaf size in SM plants. Methyl-Sensitive Amplified Polymorphism (MSAP) was used to assess genetic and epigenetic (CpG-methylation) variation in L. racemosa genomes from these populations. SM plants were hypomethylated (14.6% of loci had methylated samples) in comparison to RS (32.1% of loci had methylated samples). Within-population diversity was significantly greater for epigenetic than genetic data in both locations, but SM also had less epigenetic diversity than RS. Frequency-based (G(ST)) and multivariate (beta(ST)) methods that estimate population structure showed significantly greater differentiation among locations for epigenetic than genetic data. Co-Inertia analysis, exploring jointly the genetic and epigenetic data, showed that individuals with similar genetic profiles presented divergent epigenetic profiles that were characteristic of the population in a particular environment, suggesting that CpG-methylation changes may be associated with environmental heterogeneity. Conclusions: In spite of significant morphological dissimilarities, individuals of L. racemosa from salt marsh and riverside presented little genetic but abundant DNA methylation differentiation, suggesting that epigenetic variation in natural plant populations has an important role in helping individuals to cope with different environments.	[Lira-Medeiros, Catarina Fonseca; Fernandes, Ricardo Avancini; Mata, Camila Souza; Cardoso, Monica Aires; Gomes Ferreira, Paulo Cavalcanti] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil; [Parisod, Christian] INRA Ctr Versailles, Inst JP Bourgin, Biol Cellulaire Lab, Versailles, France; [Gomes Ferreira, Paulo Cavalcanti] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil	Jardim Botanico do Rio de Janeiro; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal do Rio de Janeiro	Lira-Medeiros, CF (corresponding author), Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil.	paulof@bioqmed.ufrj.br	Parisod, Christian/A-1140-2010; Lira-Medeiros, Catarina F/G-1248-2012; Lira, Catarina F/S-3193-2019; Ferreira, Paulo C G/I-2836-2015	Parisod, Christian/0000-0001-8798-0897; Lira-Medeiros, Catarina F/0000-0001-8971-4226; Lira, Catarina F/0000-0001-8971-4226; Ferreira, Paulo C G/0000-0002-5510-999X	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientafico e Tecnolagico)	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientafico e Tecnolagico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientafico e Tecnolagico) for financial support for the molecular genetic studies and also scholarships for CFL-M and PCGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainouche ML, 2009, BIOL INVASIONS, V11, P1159, DOI 10.1007/s10530-008-9383-2; Araujo RJ, 1997, B MAR SCI, V60, P643; Barth OM, 2006, AN ACAD BRAS CIENC, V78, P227, DOI 10.1590/S0001-37652006000200004; Bender J, 2002, CURR BIOL, V12, pR412, DOI 10.1016/S0960-9822(02)00910-7; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Brooks RA, 2005, ESTUAR COAST SHELF S, V65, P440, DOI 10.1016/j.ecss.2005.06.019; Bussell JD, 1999, MOL ECOL, V8, P775, DOI 10.1046/j.1365-294X.1999.00627.x; Cardoso MA, 1998, MOL ECOL, V7, P601, DOI 10.1046/j.1365-294x.1998.00363.x; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Grant-Downton RT, 2006, ANN BOT-LONDON, V97, P11, DOI 10.1093/aob/mcj001; Hao YJ, 2004, J PLANT PHYSIOL, V161, P479, DOI 10.1078/0176-1617-01102; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Jablonka E, 1998, J EVOLUTION BIOL, V11, P159, DOI 10.1007/s000360050073; Jaligot E, 2004, GENOME, V47, P224, DOI 10.1139/G03-085; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Keyte AL, 2006, J HERED, V97, P444, DOI 10.1093/jhered/esl023; Landry CL, 2007, NEW PHYTOL, V176, P891, DOI 10.1111/j.1469-8137.2007.02228.x; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Lugo A. E., 1974, Annual Review of Ecology and Systematics, V5, P39, DOI 10.1146/annurev.es.05.110174.000351; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Marfil CF, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-21; PARISOD C, 2010, NEW PHYTOL IN PRESS; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Parisod C, 2009, NEW PHYTOL, V184, P1003, DOI 10.1111/j.1469-8137.2009.03029.x; Pavet V, 2006, MOL PLANT MICROBE IN, V19, P577, DOI 10.1094/MPMI-19-0577; Peraza-Echeverria S, 2001, PLANT SCI, V161, P359, DOI 10.1016/S0168-9452(01)00421-6; *R FDN STAT COMP, AUSTR R VERS 2 6 0; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richards EJ, 1997, TRENDS GENET, V13, P319, DOI 10.1016/S0168-9525(97)01199-2; Saenger P., 2003, MANGROVE ECOLOGY SIL; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Salmon A, 2008, PLANT SCI, V174, P61, DOI 10.1016/j.plantsci.2007.09.012; SCHAEFFERNOVELLI Y, 1990, ESTUARIES, V13, P204, DOI 10.2307/1351590; Schellenbaum P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-78; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; SCOTT R, 2006, CURR BIOL, V14, pR200; Takata M, 2005, BREEDING SCI, V55, P57, DOI 10.1270/jsbbs.55.57; Thioulouse J, 1997, STAT COMPUT, V7, P75, DOI 10.1023/A:1018513530268; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao XX, 2007, PLANT SCI, V172, P930, DOI 10.1016/j.plantsci.2007.01.002	56	249	267	4	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10326	10.1371/journal.pone.0010326	http://dx.doi.org/10.1371/journal.pone.0010326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436669	Green Published, gold			2022-12-25	WOS:000277079500010
J	Bourdin, B; Marger, F; Wall-Lacelle, S; Schneider, T; Klein, H; Sauve, R; Parent, L				Bourdin, Benoite; Marger, Fabrice; Wall-Lacelle, Sebastien; Schneider, Toni; Klein, Helene; Sauve, Remy; Parent, Lucie			Molecular Determinants of the Ca-V beta-induced Plasma Membrane Targeting of the Ca(V)1.2 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; I-II-LINKER; CA2+-ACTIVATED K+ CHANNELS; ENDOPLASMIC-RETICULUM; ALPHA(2)DELTA SUBUNIT; CA-V-BETA(2) SUBUNIT; INTERACTION DOMAIN; TERMINAL DOMAIN; MODULATION; CALMODULIN	Ca-V beta subunits modulate cell surface expression and voltage-dependent gating of high voltage-activated (HVA) Ca(V)1 and Ca(V)2 alpha 1 subunits. High affinity Ca-V beta binding onto the so-called alpha interaction domain of the I-II linker of the Ca-V alpha 1 subunit is required for Ca-V beta modulation of HVA channel gating. It has been suggested, however, that Ca-V beta-mediated plasma membrane targeting could be uncoupled from Ca-V beta-mediated modulation of channel gating. In addition to Ca-V beta, Ca-V alpha 2 delta and calmodulin have been proposed to play important roles in HVA channel targeting. Indeed we show that co-expression of Ca-V alpha 2 delta caused a 5-fold stimulation of the whole cell currents measured with Ca(V)1.2 and Ca-V beta 3. To gauge the synergetic role of auxiliary subunits in the steady-state plasma membrane expression of Ca(V)1.2, extracellularly tagged Ca(V)1.2 proteins were quantified using fluorescence-activated cell sorting analysis. Co-expression of Ca(V)1.2 with either Ca-V alpha 2 delta, calmodulin wild type, or apocalmodulin (alone or in combination) failed to promote the detection of fluorescently labeled Ca(V)1.2 subunits. In contrast, co-expression with Ca-V beta 3 stimulated plasma membrane expression of Ca(V)1.2 by a 10-fold factor. Mutations within the alpha interaction domain of Ca(V)1.2 or within the nucleotide kinase domain of Ca-V beta 3 disrupted the Ca-V beta 3-induced plasma membrane targeting of Ca(V)1.2. Altogether, these data support a model where high affinity binding of Ca-V beta to the I-II linker of Ca-V alpha 1 largely accounts for Ca-V beta-induced plasma membrane targeting of Ca(V)1.2.	[Parent, Lucie] Univ Montreal, Dept Physiol, Downtown Stn, Montreal, PQ H3C 3J7, Canada; [Parent, Lucie] Univ Montreal, Membrane Prot Res Grp, Montreal, PQ H3C 3J7, Canada; [Schneider, Toni] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Schneider, Toni] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany	Universite de Montreal; Universite de Montreal; University of Cologne; University of Cologne	Parent, L (corresponding author), Univ Montreal, Dept Physiol, Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca	Tuluc, Petronel/C-2527-2011		Canadian Institutes of Health Research [MOP13390]; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by Grant MOP13390 from the Canadian Institutes of Health Research and a grant from the Canadian Heart and Stroke Foundation (to L. P.).	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; Bell DC, 2001, J NEUROPHYSIOL, V85, P816, DOI 10.1152/jn.2001.85.2.816; Benmocha A, 2009, CHANNELS, V3, P337, DOI 10.4161/chan.3.5.9686; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Berrou L, 2005, J BIOL CHEM, V280, P494, DOI 10.1074/jbc.M410859200; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Butcher AJ, 2006, J PHYSIOL-LONDON, V574, P387, DOI 10.1113/jphysiol.2006.109744; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Cornet V, 2002, EUR J NEUROSCI, V16, P883, DOI 10.1046/j.1460-9568.2002.02168.x; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dalton S, 2005, J PHYSIOL-LONDON, V567, P757, DOI 10.1113/jphysiol.2005.093195; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; Gao TY, 2000, J BIOL CHEM, V275, P25436, DOI 10.1074/jbc.M003465200; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gao TY, 1999, J BIOL CHEM, V274, P2137, DOI 10.1074/jbc.274.4.2137; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074/jbc.M106231200; Gerster U, 1999, J PHYSIOL-LONDON, V517, P353, DOI 10.1111/j.1469-7793.1999.0353t.x; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; Harry JB, 2004, J BIOL CHEM, V279, P46367, DOI 10.1074/jbc.M409523200; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Jarvis SE, 2007, CURR OPIN CELL BIOL, V19, P474, DOI 10.1016/j.ceb.2007.04.020; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Jones LP, 1998, J GEN PHYSIOL, V112, P125, DOI 10.1085/jgp.112.2.125; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Klein H, 1999, J MEMBRANE BIOL, V167, P43, DOI 10.1007/s002329900470; Klugbauer N, 1999, J NEUROSCI, V19, P684; Lao QZ, 2008, J BIOL CHEM, V283, P15577, DOI 10.1074/jbc.M802035200; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Maltez JM, 2005, NAT STRUCT MOL BIOL, V12, P372, DOI 10.1038/nsmb909; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Parent L, 1997, J MEMBRANE BIOL, V160, P127, DOI 10.1007/s002329900302; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Platano D, 2000, BIOPHYS J, V78, P2959, DOI 10.1016/S0006-3495(00)76835-4; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795; Ravindran A, 2008, P NATL ACAD SCI USA, V105, P8154, DOI 10.1073/pnas.0711624105; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; Seu L, 2006, J GEN PHYSIOL, V128, P605, DOI 10.1085/jgp.200609631; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; Takahashi SX, 2005, J GEN PHYSIOL, V126, P365, DOI 10.1085/jgp.200509354; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Van Petegem F, 2006, BIOCHEM SOC T, V34, P887, DOI 10.1042/BST0340887; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; Wang HG, 2007, J NEUROSCI, V27, P9086, DOI 10.1523/JNEUROSCI.1720-07.2007; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	78	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22851	22861		10.1074/jbc.M110.111062	http://dx.doi.org/10.1074/jbc.M110.111062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20478999	Green Published, hybrid			2022-12-25	WOS:000279999900018
J	Jadali, A; Ghazizadeh, S				Jadali, Azadeh; Ghazizadeh, Soosan			Protein Kinase D Is Implicated in the Reversible Commitment to Differentiation in Primary Cultures of Mouse Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSING RECEPTOR; PLECKSTRIN HOMOLOGY DOMAIN; ACTIVATION LOOP SER(744); G(Q)-COUPLED RECEPTORS; MAP KINASE; C-MU; GROWTH ARREST; STEM-CELLS; KAPPA-B; EXPRESSION	Although commitment to epidermal differentiation is generally considered to be irreversible, differentiated keratinocytes (KCs) have been shown to maintain a regenerative potential and to reform skin epithelia when placed in a suitable environment. To obtain insights into the mechanism of reinitiation of this proliferative response in differentiated KCs, we examined the reversibility of commitment to Ca2+-induced differentiation. Lowering Ca2+ concentration to micromolar levels triggered culture-wide morphological and biochemical changes, as indicated by derepression of cyclin D1, reinitiation of DNA synthesis, and acquisition of basal cell-like characteristics. These responses were inhibited by Goedecke 6976, an inhibitor of protein kinaseD(PKD) and PKC alpha, but not with GF109203X, a general inhibitor of PKCs, suggesting PKD activation by a PKC-independent mechanism. PKD activation followed complex kinetics with a biphasic early transient phosphorylation within the first 6 h, followed by a sustained and progressive phosphorylation beginning at 24 h. The second phase of PKD activation was followed by prolonged ERK1/2 signaling and progression to DNA synthesis in response to the low Ca2+ switch. Specific knockdown of PKD-1 by RNA interference or expression of a dominant negative form of PKD-1 did not have a significant effect on normal KC proliferation and differentiation but did inhibit Ca2+-mediated reinitiation of proliferation and reversion in differentiated cultures. The present study identifies PKD as a major regulator of a proliferative response in differentiated KCs, probably through sustained activation of the ERK-MAPK pathway, and provides new insights into the process of epidermal regeneration and wound healing.	[Ghazizadeh, Soosan] SUNY Stony Brook, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA; [Jadali, Azadeh; Ghazizadeh, Soosan] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ghazizadeh, S (corresponding author), SUNY Stony Brook, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA.	sghazizadeh@notes.cc.sunysb.edu			National Institutes of Health [AR056013]; New York State Department of Health [C023053]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR056013 (to S. G.). This work was also supported by New York State Department of Health-New York Stem Cell Science Grant C023053.	Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bollag WB, 2004, DRUG NEWS PERSPECT, V17, P117, DOI 10.1358/dnp.2004.17.2.829045; Bourcier C, 2006, CANCER RES, V66, P2700, DOI 10.1158/0008-5472.CAN-05-3129; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; CABLE J, 1995, MECH DEVELOP, V50, P139, DOI 10.1016/0925-4773(94)00331-G; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Crish JF, 2000, CARCINOGENESIS, V21, P1031, DOI 10.1093/carcin/21.5.1031; Dodd ME, 2005, J INVEST DERMATOL, V125, P294, DOI 10.1111/j.0022-202X.2005.23780.x; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Elias PM, 2002, J INVEST DERMATOL, V119, P1128, DOI 10.1046/j.1523-1747.2002.19512.x; Ellwanger K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-47; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fuchs E, 1990, CURR OPIN CELL BIOL, V2, P1028, DOI 10.1016/0955-0674(90)90152-5; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hobson SA, 2003, MOL CELL ENDOCRINOL, V200, P189, DOI 10.1016/S0303-7207(01)00749-3; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jerome-Morais A, 2009, J INVEST DERMATOL, V129, P2365, DOI 10.1038/jid.2009.74; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Kolly C, 2005, J INVEST DERMATOL, V124, P1014, DOI 10.1111/j.0022-202X.2005.23655.x; Lemonnier J, 2004, J BIOL CHEM, V279, P259, DOI 10.1074/jbc.M308665200; Lu Z, 2005, EXP DERMATOL, V14, P727, DOI 10.1111/j.1600-0625.2005.00351.x; Mannik J, 2010, J INVEST DERMATOL, V130, P388, DOI 10.1038/jid.2009.244; MANSBRIDGE JN, 1987, J INVEST DERMATOL, V89, P253, DOI 10.1111/1523-1747.ep12471216; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MILLER DG, 1990, MOL CELL BIOL, V10, P4239, DOI 10.1128/MCB.10.8.4239; Morasso MI, 2005, BIOL CELL, V97, P173; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rutberg SE, 1996, ONCOGENE, V13, P167; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Saidak Z, 2009, ENDOCR REV, V30, P178, DOI 10.1210/er.2008-0041; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; Seitz CS, 2000, CANCER RES, V60, P4085; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Tu CL, 2008, J BIOL CHEM, V283, P3519, DOI 10.1074/jbc.M708318200; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Watt FM, 1983, J INVEST DERMATOL, V81, P100; YUSPA SH, 1982, CANCER RES, V42, P2344; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	57	27	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23385	23395		10.1074/jbc.M110.105619	http://dx.doi.org/10.1074/jbc.M110.105619			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20463010	hybrid, Green Published			2022-12-25	WOS:000279999900071
J	Schneider, JG; Yang, Z; Chakravarthy, MV; Lodhi, IJ; Wei, XC; Turk, J; Semenkovich, CF				Schneider, Jochen G.; Yang, Zhen; Chakravarthy, Manu V.; Lodhi, Irfan J.; Wei, Xiaochao; Turk, John; Semenkovich, Clay F.			Macrophage Fatty-acid Synthase Deficiency Decreases Diet-induced Atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTORS; MOUSE PERITONEAL-MACROPHAGES; LOW-DENSITY-LIPOPROTEIN; ACTIVATES PPAR-ALPHA; HUMAN AORTIC PLAQUES; PHOSPHOLIPID CONTENT; HYPERLIPIDEMIC MICE; INSULIN-RESISTANCE; BLOOD-PRESSURE; LXR	Fatty acid metabolism is perturbed in atherosclerotic lesions, but whether it affects lesion formation is unknown. To determine whether fatty acid synthesis affects atherosclerosis, we inactivated fatty-acid synthase (FAS) in macrophages of apoE-deficient mice. Serum lipids, body weight, and glucose metabolism were the same in FAS knock-out in macrophages (FASKOM) and control mice, but blood pressure was lower in FASKOM animals. Atherosclerotic extent was decreased 20-40% in different aortic regions of FASKOM as compared with control mice on Western diets. Foam cell formation was diminished in FASKOM as compared with wild type macrophages due to increased apoAI-specific cholesterol efflux and decreased uptake of oxidized low density lipoprotein. Expression of the anti-atherogenic nuclear receptor liver X receptor alpha (LXR alpha; Nr1h3) and its downstream targets, including Abca1, were increased in FASKOM macrophages, whereas expression of the potentially pro-atherogenic type B scavenger receptor CD36 was decreased. Peroxisome proliferator-activated receptor alpha (PPAR alpha) target gene expression was decreased in FASKOM macrophages. PPAR alpha agonist treatment of FASKOM and wild type macrophages normalized PPAR alpha target gene expression as well as Nr1h3 (LXR alpha). Atherosclerotic lesions were more extensive when apoE null mice were transplanted with LXR alpha-deficient/FAS-deficient bone marrow as compared with LXR alpha-replete/FAS-deficient marrow, consistent with anti-atherogenic effects of LXR alpha in the context of FAS deficiency. These results show that macrophage FAS deficiency decreases atherosclerosis through induction of LXR alpha and suggest that FAS, which is induced by LXR alpha, may generate regulatory lipids that cause feedback inhibition of LXR alpha in macrophages.	[Semenkovich, Clay F.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Med, St Louis, MO 63110 USA; [Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Semenkovich, CF (corresponding author), Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Med, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	csemenko@wustl.edu	Chakravarthy, Manu/AAD-7553-2021	Chakravarthy, Manu/0000-0002-3699-150X; Lodhi, Irfan/0000-0002-6246-9862; Semenkovich, Clay/0000-0003-1163-1871	National Institutes of Health [DK076729, HL083762, DK56341, DK20579, F32 DK083895, RR00954]; American Diabetes Association and American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076729, P30DK056341, P30DK020579, F32DK083895, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association and American Heart Association(American Heart AssociationAmerican Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK076729, HL083762, DK56341, DK20579, F32 DK083895, and RR00954. This work was also supported by fellowship awards from the American Diabetes Association and American Heart Association.	ARAI H, 1992, J BIOCHEM-TOKYO, V112, P482, DOI 10.1093/oxfordjournals.jbchem.a123925; Bernal-Mizrachi C, 2002, ARTERIOSCL THROM VAS, V22, P961, DOI 10.1161/01.ATV.0000019404.65403.71; Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Brunham LR, 2009, ARTERIOSCL THROM VAS, V29, P548, DOI 10.1161/ATVBAHA.108.182303; Chakravarthy MV, 2008, DIABETES, V57, P2698, DOI 10.2337/db08-0404; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2004, BIOCHEM BIOPH RES CO, V314, P151, DOI 10.1016/j.bbrc.2003.12.058; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Daugherty A, 2008, CIRC RES, V102, P1445, DOI 10.1161/CIRCRESAHA.108.178947; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; FELTON CV, 1994, LANCET, V344, P1195, DOI 10.1016/S0140-6736(94)90511-8; Felton CV, 1997, ARTERIOSCL THROM VAS, V17, P1337, DOI 10.1161/01.ATV.17.7.1337; HALLBERG A, 1984, BIOCHIM BIOPHYS ACTA, V796, P328, DOI 10.1016/0005-2760(84)90134-6; HOWARD CF, 1968, J LIPID RES, V9, P254; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; INSULL W, 1966, J CLIN INVEST, V45, P513, DOI 10.1172/JCI105365; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kalinowska A, 2009, FEBS LETT, V583, P2527, DOI 10.1016/j.febslet.2009.07.008; KANNEL WB, 1985, J AM COLL CARDIOL S6, V0005; Kridel SJ, 2007, EXPERT OPIN INV DRUG, V16, P1817, DOI 10.1517/13543784.16.11.1817; LANG PD, 1970, J CLIN INVEST, V49, P1479, DOI 10.1172/JCI106365; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; LOFLAND HB, 1965, J LIPID RES, V6, P112; LOFLAND HB, 1960, ARCH BIOCHEM BIOPHYS, V88, P105, DOI 10.1016/0003-9861(60)90203-4; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; PEKKANEN J, 1993, CARDIOLOGY, V82, P181, DOI 10.1159/000175867; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rudd JHF, 2008, J NUCL MED, V49, P871, DOI 10.2967/jnumed.107.050294; Schneider JG, 2007, ARTERIOSCL THROM VAS, V27, P2699, DOI 10.1161/ATVBAHA.107.153650; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; SEMENKOVICH CF, 1995, J LIPID RES, V36, P1507; Semenkovich CF, 1997, PROG LIPID RES, V36, P43, DOI 10.1016/S0163-7827(97)00003-9; Stachowska E, 2004, EUR J NUTR, V43, P313, DOI 10.1007/s00394-004-0479-x; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; TABAS I, 1987, J BIOL CHEM, V262, P12175; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Teupser D, 2008, ARTERIOSCL THROM VAS, V28, P2009, DOI 10.1161/ATVBAHA.108.175257; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; Traves PG, 2007, MOL PHARMACOL, V71, P1545, DOI 10.1124/mol.106.031906; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Whereat A F, 1971, Adv Lipid Res, V9, P119; WHEREAT AF, 1964, J ATHEROSCLER RES, V4, P272, DOI 10.1016/S0368-1319(64)80009-0; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	56	46	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23396	23407		10.1074/jbc.M110.100321	http://dx.doi.org/10.1074/jbc.M110.100321			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20479009	hybrid, Green Published			2022-12-25	WOS:000279999900072
J	Yang, LL; Latchoumycandane, C; McMullen, MR; Pratt, BT; Zhang, RL; Papouchado, BG; Nagy, LE; Feldstein, AE; McIntyre, TM				Yang, Lili; Latchoumycandane, Calivarathan; McMullen, Megan R.; Pratt, Brian T.; Zhang, Renliang; Papouchado, Bettina G.; Nagy, Laura E.; Feldstein, Ariel E.; McIntyre, Thomas M.			Chronic Alcohol Exposure Increases Circulating Bioactive Oxidized Phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; TAURINE SUPPLEMENTATION PREVENTS; HIGH-DENSITY-LIPOPROTEIN; TUMOR-NECROSIS-FACTOR; RAT KUPFFER CELLS; OXIDATIVE STRESS; FACTOR ACETYLHYDROLASE; LIPID-PEROXIDATION; REACTIVE OXYGEN; BLOOD-PLASMA	Ethanol metabolism by liver generates short lived reactive oxygen species that damage liver but also affects distal organs through unknown mechanisms. We hypothesized that dissemination of liver oxidative stress proceeds through release of biologically active oxidized lipids to the circulation. We searched for these by tandem mass spectrometry in plasma of rats fed a Lieber-DeCarli ethanol diet or in patients with established alcoholic liver inflammation, steatohepatitis. We found a several-fold increase in plasma peroxidized phosphatidylcholines, inflammatory and pro-apoptotic oxidatively truncated phospholipids, and platelet-activating factor, a remarkably potent and pleiotropic inflammatory mediator, in rats chronically ingesting ethanol. Circulating peroxidized phospholipids also increased in humans with established steatohepatitis. However, reactive oxygen species generated by liver ethanol catabolism were not directly responsible for circulating oxidized phospholipids because the delayed appearance of these lipids did not correlate with ethanol exposure, hepatic oxidative insult, nor plasma alanine transaminase marking hepatocyte damage. Rather, circulating oxidized lipids correlated with steatohepatitis and tumor necrosis factor-alpha deposition in liver. The organic osmolyte 2-aminoethylsulfonic acid (taurine), which reduces liver endoplasmic reticulum stress and inflammation, even though it is not an antioxidant, abolished liver damage and the increase in circulating oxidized phospholipids. Thus, circulating oxidized phospholipids are markers of developing steatohepatitis temporally distinct from oxidant stress associated with hepatic ethanol catabolism. Previously, circulating markers of the critical transition to pathologic steatohepatitis were unknown. Circulating oxidatively truncated phospholipids are pro-inflammatory and pro-apoptotic mediators with the potential to systemically distribute the effect of chronic ethanol exposure. Suppressing hepatic inflammation, not ethanol catabolism, reduces circulating inflammatory and apoptotic agonists.	[Yang, Lili; Latchoumycandane, Calivarathan; Zhang, Renliang; Feldstein, Ariel E.; McIntyre, Thomas M.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Lerner Res Inst,Dept Cell Biol, Cleveland, OH 44195 USA; [McMullen, Megan R.; Pratt, Brian T.; Nagy, Laura E.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Lerner Res Inst,Dept Pathobiol, Cleveland, OH 44195 USA; [Papouchado, Bettina G.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Lerner Res Inst,Dept Pathol, Cleveland, OH 44195 USA; [Nagy, Laura E.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Lerner Res Inst,Dept Gastroenterol, Cleveland, OH 44195 USA; [Feldstein, Ariel E.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Lerner Res Inst,Dept Pediat Endocrinol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	McIntyre, TM (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol NE 10, 9500 Euclid Ave, Cleveland, OH 44195 USA.	mcintyt@ccf.org	Latchoumycandane, Calivarathan/GPP-5175-2022	Latchoumycandane, Calivarathan/0000-0002-6637-369X	National Institutes of Health [AA017748, AA011876, AA011975, 1P20 AA017837, DK076852]; CTSA [1UL1RR024989]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grants AA017748 (to T.M.M.), AA011876 (to L.E.N.), AA011975 (to L.E.N.), 1P20 AA017837 (to L.E.N.), DK076852 (to A.E.F.), and CTSA 1UL1RR024989 (to Pamela Davis).	Adachi J, 2004, J LIPID RES, V45, P967, DOI 10.1194/jlr.M400008-JLR200; Bailey SM, 2002, FREE RADICAL BIO MED, V32, P11, DOI 10.1016/S0891-5849(01)00769-9; BEUTLER BA, 1985, J IMMUNOL, V135, P3972; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; Cahill A, 2002, ALCOHOL CLIN EXP RES, V26, P907, DOI 10.1097/00000374-200206000-00022; CAMUSSI G, 1987, J EXP MED, V166, P1390, DOI 10.1084/jem.166.5.1390; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chen R, 2009, J BIOL CHEM, V284, P26297, DOI 10.1074/jbc.M109.018978; Chen R, 2009, ARTERIOSCL THROM VAS, V29, P363, DOI 10.1161/ATVBAHA.108.178731; Chen XC, 2009, HEPATOLOGY, V49, P1554, DOI 10.1002/hep.22811; Czaja MJ, 2004, HEPATOLOGY, V40, P19, DOI 10.1002/hep.20328; Deaciuc IV, 1996, ALCOHOL CLIN EXP RES, V20, P293, DOI 10.1111/j.1530-0277.1996.tb01642.x; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; DIAGNE A, 1984, BIOCHIM BIOPHYS ACTA, V793, P221, DOI 10.1016/0005-2760(84)90324-2; ELSTAD MR, 1988, J IMMUNOL, V140, P1618; Frey B, 2000, J LIPID RES, V41, P1145; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Harada H, 2000, HYPERTENS RES, V23, P277, DOI 10.1291/hypres.23.277; Hoff HF, 2003, ARTERIOSCL THROM VAS, V23, P275, DOI 10.1161/01.ATV.0000051407.42536.73; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Horkko S, 1997, P NATL ACAD SCI USA, V94, P10356, DOI 10.1073/pnas.94.19.10356; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Itabe H, 1996, J BIOL CHEM, V271, P33208, DOI 10.1074/jbc.271.52.33208; ITABE H, 1988, BIOCHIM BIOPHYS ACTA, V962, P8; Johnson EF, 1996, ANN NY ACAD SCI, V804, P373, DOI 10.1111/j.1749-6632.1996.tb18629.x; Kato Y, 1998, ARCH BIOCHEM BIOPHYS, V351, P106, DOI 10.1006/abbi.1997.0519; Kriska T, 2007, J BIOL CHEM, V282, P100, DOI 10.1074/jbc.M608135200; Lehr HA, 1997, J CLIN INVEST, V99, P2358, DOI 10.1172/JCI119417; Marathe GK, 2003, J BIOL CHEM, V278, P3937, DOI 10.1074/jbc.M211126200; Marathe GK, 1999, J BIOL CHEM, V274, P28395, DOI 10.1074/jbc.274.40.28395; Meagher EA, 1999, J CLIN INVEST, V104, P805, DOI 10.1172/JCI5584; Moumtzi A, 2007, J LIPID RES, V48, P565, DOI 10.1194/jlr.M600394-JLR200; National Research Council, 1996, GUID CAR US LAB AN N; Nonaka H, 2001, CIRCULATION, V104, P1165, DOI 10.1161/hc3601.093976; NORDMANN R, 1990, ALCOHOL ALCOHOLISM, V25, P231, DOI 10.1093/oxfordjournals.alcalc.a044996; Owen JS, 2005, J LIPID RES, V46, P373, DOI 10.1194/jlr.D400029-JLR200; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Rhode S, 2009, J BIOL CHEM, V284, P2258, DOI 10.1074/jbc.M807591200; Roychowdhury S, 2009, HEPATOLOGY, V49, P1326, DOI 10.1002/hep.22776; Schroder H, 2006, FREE RADICAL BIO MED, V40, P1474, DOI 10.1016/j.freeradbiomed.2005.12.014; Shi XL, 1997, ANN CLIN LAB SCI, V27, P365; Smith WL, 2008, J BIOL CHEM, V283, P15513, DOI 10.1074/jbc.R800006200; Stafforini DM, 2009, CARDIOVASC DRUG THER, V23, P73, DOI 10.1007/s10557-008-6133-8; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Thakur V, 2006, J LEUKOCYTE BIOL, V79, P1348, DOI 10.1189/jlb.1005613; Thomas CP, 2010, J BIOL CHEM, V285, P6891, DOI 10.1074/jbc.M109.078428	51	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22211	22220		10.1074/jbc.M110.119982	http://dx.doi.org/10.1074/jbc.M110.119982			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460374	Green Published, hybrid			2022-12-25	WOS:000279702200034
J	Cheng, Q; Antholine, WE; Myers, JM; Kalyanaraman, B; Arner, ESJ; Myers, CR				Cheng, Qing; Antholine, William E.; Myers, Judith M.; Kalyanaraman, Balaraman; Arner, Elias S. J.; Myers, Charles R.			The Selenium-independent Inherent Pro-oxidant NADPH Oxidase Activity of Mammalian Thioredoxin Reductase and Its Selenium-dependent Direct Peroxidase Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXAVALENT CHROMIUM; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; REACTIVE OXYGEN; IN-VITRO; RADICAL GENERATION; HYDROXYL RADICALS; CELL-DEATH; SPIN-TRAP; SELENOCYSTEINE	Mammalian thioredoxin reductase (TrxR) is an NADPH-dependent homodimer with three redox-active centers per subunit: a FAD, an N-terminal domain dithiol (Cys(59)/Cys(64)), and a C-terminal cysteine/selenocysteine motif (Cys(497)/Sec(498)). TrxR has multiple roles in antioxidant defense. Opposing these functions, it may also assume a pro-oxidant role under some conditions. In the absence of its main electron-accepting substrates (e. g. thioredoxin), wild-type TrxR generates superoxide (O-2(raical anion)), which was here detected and quantified by ESR spin trapping with 5-diethoxyphosphoryl-5-methyl-1-pyrroline-N-oxide (DEPMPO). The peroxidase activity of wild-type TrxR efficiently converted the O2(radical anion). adduct (DEPMPO/HOO center dot) to the hydroxyl radical adduct(DEPMPO/HO center dot). This peroxidase activity was Sec-dependent, although multiple mutants lacking Sec could still generate O-2(radical anion). Variants of TrxR with C59S and/or C64S mutations displayed markedly reduced inherent NADPH oxidase activity, suggesting that the Cys59/Cys64 dithiol is required for O-2(radical anion) generation and that O-2(radical anion) is not derived directly from the FAD. Mutations in the Cys59/Cys64 dithiol also blocked the peroxidase and disulfide reductase activities presumably because of an inability to reduce the Cys497/Sec498 active site. Although the bulk of the DEPMPO/HO center dot signal generated by wild-type TrxR was due to its combined NADPH oxidase and Sec-dependent peroxidase activities, additional experiments showed that some free HO center dot could be generated by the enzyme in an H2O2-dependent and Sec-independent manner. The direct NADPH oxidase and peroxidase activities of TrxR characterized here give insights into the full catalytic potential of this enzyme and may have biological consequences beyond those solely related to its reduction of thioredoxin.	[Myers, Judith M.; Myers, Charles R.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Antholine, William E.; Kalyanaraman, Balaraman; Myers, Charles R.] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [Antholine, William E.; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Cheng, Qing; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Karolinska Institutet	Myers, CR (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	cmyers@mcw.edu	Arnér, Elias S.J./J-5832-2012; Arnér, Elias/K-6737-2019	Arnér, Elias S.J./0000-0002-4807-6114; Arnér, Elias/0000-0002-4807-6114; Myers, Charles/0000-0001-7956-3217; Cheng, Qing/0000-0002-3170-9333	National Institutes of Health [R01ES012707]; Swedish Research Council (Medicine); Swedish Cancer Society; Knut and Alice Wallenberg Foundation; Karolinska Institutet; National Institutes of Health National Biomedical ESR Center [EB001980]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council (Medicine)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet); National Institutes of Health National Biomedical ESR Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01ES012707 (to C. R. M.). This work was also supported by grants from the Swedish Research Council (Medicine), the Swedish Cancer Society, the Knut and Alice Wallenberg Foundation, and Karolinska Institutet (to E.S.J.A.). The EPR facilities of the Department of Biophysics of the Medical College of Wisconsin are supported by National Institutes of Health National Biomedical ESR Center Grant EB001980.	Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Anestal K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001846; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 2002, METHOD ENZYMOL, V347, P226; ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; Arner ESJ, 2001, FREE RADICAL BIO MED, V31, P1170, DOI 10.1016/S0891-5849(01)00698-0; Arteel GE, 1999, CHEM RES TOXICOL, V12, P264, DOI 10.1021/tx980223r; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; Borthiry GR, 2007, FREE RADICAL BIO MED, V42, P738, DOI 10.1016/j.freeradbiomed.2006.10.055; BRITIGAN BE, 1990, J BIOL CHEM, V265, P2650; Cenas N, 2004, J BIOL CHEM, V279, P2583, DOI 10.1074/jbc.M310292200; Chalier F, 2007, J ORG CHEM, V72, P7886, DOI 10.1021/jo071070s; Cheng Q, 2006, NAT PROTOC, V1, P604, DOI 10.1038/nprot.2006.87; Cheng Q, 2009, J BIOL CHEM, V284, P3998, DOI 10.1074/jbc.M807068200; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; Eriksson SE, 2009, FREE RADICAL BIO MED, V47, P1661, DOI 10.1016/j.freeradbiomed.2009.09.016; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; FINKELSTEIN E, 1982, MOL PHARMACOL, V21, P262; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HALLIWELL B, 1989, FREE RADICAL BIO MED, V7, P645, DOI 10.1016/0891-5849(89)90145-7; Hardy M, 2005, J ORG CHEM, V70, P2135, DOI 10.1021/jo0479516; Hardy M, 2007, CHEM RES TOXICOL, V20, P1053, DOI 10.1021/tx700101d; Hashemy SI, 2006, J BIOL CHEM, V281, P10691, DOI 10.1074/jbc.M511373200; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Johansson L, 2004, NAT METHODS, V1, P61, DOI 10.1038/NMETH707; Karoui H, 1996, J BIOL CHEM, V271, P6000, DOI 10.1074/jbc.271.11.6000; Khan N, 2003, FREE RADICAL BIO MED, V34, P1473, DOI 10.1016/S0891-5849(03)00182-5; KOSAKA H, 1992, ARCH BIOCHEM BIOPHYS, V293, P401, DOI 10.1016/0003-9861(92)90412-P; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; Lothrop AP, 2009, BIOCHEMISTRY-US, V48, P6213, DOI 10.1021/bi802146w; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Millet R, 2005, J MED CHEM, V48, P7024, DOI 10.1021/jm050256l; Myers CR, 2009, TOXICOLOGY, V257, P95, DOI 10.1016/j.tox.2008.12.013; Myers CR, 1998, CARCINOGENESIS, V19, P1029, DOI 10.1093/carcin/19.6.1029; Myers JM, 2008, TOXICOLOGY, V246, P222, DOI 10.1016/j.tox.2008.01.017; Myers JM, 2009, FREE RADICAL BIO MED, V47, P1477, DOI 10.1016/j.freeradbiomed.2009.08.015; Nordberg J, 1998, J BIOL CHEM, V273, P10835, DOI 10.1074/jbc.273.18.10835; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; PERKINS MJ, 1980, ADV PHYS ORG CHEM, V17, P1; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rengby O, 2007, APPL ENVIRON MICROB, V73, P432, DOI 10.1128/AEM.02019-06; Rengby O, 2009, FREE RADICAL BIO MED, V46, P893, DOI 10.1016/j.freeradbiomed.2008.12.017; Rhodes CJ, 2004, SPECTROCHIM ACTA A, V60, P1401, DOI 10.1016/j.saa.2003.10.038; Rigobello MP, 2004, J INORG BIOCHEM, V98, P1634, DOI 10.1016/j.jinorgbio.2004.04.020; Rigobello MP, 1998, FREE RADICAL BIO MED, V24, P370, DOI 10.1016/S0891-5849(97)00216-5; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shi HL, 2005, ARCH BIOCHEM BIOPHYS, V437, P59, DOI 10.1016/j.abb.2005.02.028; SHI XL, 1994, CARCINOGENESIS, V15, P2475, DOI 10.1093/carcin/15.11.2475; SHI XL, 1990, FREE RADICAL RES COM, V10, P17, DOI 10.3109/10715769009145929; SHI XL, 1990, ARCH BIOCHEM BIOPHYS, V277, P342, DOI 10.1016/0003-9861(90)90589-Q; SHI XL, 1992, ARCH BIOCHEM BIOPHYS, V293, P281, DOI 10.1016/0003-9861(92)90396-E; SHI XL, 1994, BBA-MOL BASIS DIS, V1226, P65, DOI 10.1016/0925-4439(94)90060-4; Szadkowski A, 2008, TOXICOLOGY, V243, P164, DOI 10.1016/j.tox.2007.10.004; TORDO P, 1998, ELECT PARAMAGN RESON, V16, P116, DOI DOI 10.1039/9781847553539-00116; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Vasquez-Vivar J, 1999, FREE RADICAL RES, V31, P607, DOI 10.1080/10715769900301181; Villamena FA, 2004, ANTIOXID REDOX SIGN, V6, P619, DOI 10.1089/152308604773934387; Watson WH, 2008, BIOCHEM BIOPH RES CO, V368, P832, DOI 10.1016/j.bbrc.2008.02.006; Witte AB, 2005, FREE RADICAL BIO MED, V39, P696, DOI 10.1016/j.freeradbiomed.2005.04.025; YAMAZAKI I, 1990, J BIOL CHEM, V265, P13589; Zhao HT, 2001, FREE RADICAL BIO MED, V31, P599, DOI 10.1016/S0891-5849(01)00619-0; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	72	50	51	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21708	21723		10.1074/jbc.M110.117259	http://dx.doi.org/10.1074/jbc.M110.117259			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20457604	Green Published, hybrid			2022-12-25	WOS:000279516100058
J	Hallows, KR; Bhalla, V; Oyster, NM; Wijngaarden, MA; Lee, JK; Li, H; Chandran, S; Xia, XY; Huang, ZR; Chalkley, RJ; Burlingame, AL; Pearce, D				Hallows, Kenneth R.; Bhalla, Vivek; Oyster, Nicholas M.; Wijngaarden, Marjolein A.; Lee, Jeffrey K.; Li, Hui; Chandran, Sindhu; Xia, Xiaoyu; Huang, Zhirong; Chalkley, Robert J.; Burlingame, Alma L.; Pearce, David			Phosphopeptide Screen Uncovers Novel Phosphorylation Sites of Nedd4-2 That Potentiate Its Inhibition of the Epithelial Na+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE NEDD4-2; CELL-SURFACE EXPRESSION; INDUCIBLE KINASE SGK; LIDDLES-SYNDROME; FUNCTIONAL REGULATION; SODIUM-TRANSPORT; ENAC REGULATION; PY MOTIF; SERUM; PROTEIN	The E3 ubiquitin ligase Nedd4-2 regulates several ion transport proteins, including the epithelial Na+ channel (ENaC). Nedd4-2 decreases apical membrane expression and activity of ENaC. Although it is subject to tight hormonal control, the mechanistic basis of Nedd4-2 regulation remains poorly understood. To characterize regulatory inputs to Nedd4-2 function, we screened for novel sites of Nedd4-2 phosphorylation using tandem mass spectrometry. Three of seven identified Xenopus Nedd4-2 Ser/Thr phosphorylation sites corresponded to previously identified target sites for SGK1, whereas four were novel, including Ser-293, which matched the consensus for a MAPK target sequence. Further in vitro and in vivo phosphorylation experiments revealed that Nedd4-2 serves as a target of JNK1, but not of p38 MAPK or ERK1/2. Additional rounds of tandem mass spectrometry identified two other phosphorylated residues within Nedd4-2, including Thr-899, which is present within the catalytic domain. Nedd4-2 with mutations at these sites had markedly inhibited JNK1-dependent phosphorylation, virtually no ENaC inhibitory activity, and significantly reduced ubiquitin ligase activity. These data identify phosphorylatable residues that activate Nedd4-2 and may work together with residues targeted by inhibitory kinases (e.g. SGK1 and protein kinase A) to govern Nedd4-2 regulation of epithelial ion transport.	[Hallows, Kenneth R.; Oyster, Nicholas M.; Lee, Jeffrey K.; Li, Hui] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Bhalla, Vivek; Chandran, Sindhu; Xia, Xiaoyu] Stanford Univ, Sch Med, Dept Med, Div Nephrol, Stanford, CA 94305 USA; [Wijngaarden, Marjolein A.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands; [Huang, Zhirong; Pearce, David] Univ Calif San Francisco, Sch Med, Dept Med, Div Nephrol, San Francisco, CA 94107 USA; [Chalkley, Robert J.; Burlingame, Alma L.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bhalla, V (corresponding author), Stanford Univ, Div Nephrol, 780 Welch Rd,Suite 106, Palo Alto, CA 94304 USA.	vbhalla@stanford.edu	Chandran, Sindhu/AAE-6783-2021; Wijngaarden, Marjolein A/F-9438-2010; Hallows, Kenneth/A-8477-2013	Chandran, Sindhu/0000-0003-4547-3381; Wijngaarden, Marjolein A/0000-0002-4697-0286; Bhalla, Vivek/0000-0002-5420-9657; Chalkley, Robert/0000-0002-9757-7302; Hallows, Kenneth/0000-0002-2964-2440	National Institutes of Health [P30 DK079307, R01 DK075048, K08 DK071648, R01 DK056695]; Dutch Kidney Foundation; National Center for Research Resources (NCRR); National Institutes of Health NCRR [RR01614, RR015804]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, S10RR015804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK071648, R01DK075048, R01DK056695, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Kidney Foundation; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 DK079307 (to the Pittsburgh Kidney Research Center), R01 DK075048 (to K. R. H.), K08 DK071648 (to V. B.), and R01 DK056695 (to D. P.). This work was also supported by a grant from the Dutch Kidney Foundation (to M. A. W.). Mass spectrometry analysis was provided by the University of California San Francisco Mass Spectrometry Facility (A. L. B. and R.J.C.), supported by the Biomedical Research Technology Program of the National Center for Research Resources (NCRR) and National Institutes of Health NCRR Grants RR01614 and RR015804.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Edinger RS, 2009, J BIOL CHEM, V284, P150, DOI 10.1074/jbc.M807358200; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Jiang QS, 1998, J CELL BIOL, V143, P645, DOI 10.1083/jcb.143.3.645; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014	35	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21671	21678		10.1074/jbc.M109.084731	http://dx.doi.org/10.1074/jbc.M109.084731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20466724	Green Published, hybrid			2022-12-25	WOS:000279516100054
J	Prapavorarat, A; Vatanavicharn, T; Soderhall, K; Tassanakajon, A				Prapavorarat, Adisak; Vatanavicharn, Tipachai; Soderhall, Kenneth; Tassanakajon, Anchalee			A Novel Viral Responsive Protein Is Involved in Hemocyte Homeostasis in the Black Tiger Shrimp, Penaeus monodon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE-SPOT SYNDROME; HEMATOPOIETIC-TISSUE; IN-VITRO; APOPTOSIS; CRAYFISH; IDENTIFICATION; ENCAPSULATION; EXPRESSION; MATURATION; CRUSTACEAN	A novel viral responsive protein, namely hemocyte homeostasis-associated protein (HHAP), was characterized for its role in the response of shrimp to white spot syndrome virus infection. The full-length cDNAs of HHAP from the black tiger shrimp (PmHHAP), Penaeus monodon, and the fresh water crayfish (PlHHAP), Pacifastacus leniusculus, were obtained and showed high sequence identity to a hypothetical protein from various organisms, with the highest identity to the hypothetical protein TcasGA2_TC006773 from the red flour beetle, Tribolium castaneum (54% amino acid sequence identity). Transcripts of PmHHAP were expressed in various shrimp tissues with the highest expression in hematopoietic tissue, whereas the transcripts of PlHHAP were found in the hematopoietic and nerve tissues. Upon white spot syndrome virus infection, a high up-regulation level of shrimp hemocytic HHAP mRNA and protein was observed by real-time reverse transcription-PCR and immunofluorescence microscopy, respectively. Gene silencing of PmHHAP by RNA interference resulted in a significant decrease in the number of circulating hemocytes and 100% shrimp mortality within 30 h of the double-stranded PmHHAP RNA injection (but not in control shrimp), indicating that HHAP is essential for shrimp survival. Interestingly, severe damage of hemocytes was observed in vivo in the PmHHAP knockdown shrimp and in vitro in shrimp primary hemocyte cell culture, suggesting that PmHHAP plays an important role in hemocyte homeostasis. Thus, it is speculated that the up-regulation of PmHHAP is an important mechanism to control circulating hemocyte levels in crustaceans during viral infection.	[Tassanakajon, Anchalee] Chulalongkorn Univ, Fac Sci, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Bangkok 10330, Thailand; [Soderhall, Kenneth] Uppsala Univ, Dept Comparat Physiol, S-75236 Uppsala, Sweden	Chulalongkorn University; Uppsala University	Tassanakajon, A (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Bangkok 10330, Thailand.	anchalee.k@chula.ac.th			Commission on Higher Education; Thailand National Center for Genetic Engineering and Biotechnology; Royal Golden Jubilee PhD Program, Thailand Research Fund; Thai Government [TKK2555]	Commission on Higher Education; Thailand National Center for Genetic Engineering and Biotechnology; Royal Golden Jubilee PhD Program, Thailand Research Fund; Thai Government	This work was supported by grants from The Commission on Higher Education, and the Thailand National Center for Genetic Engineering and Biotechnology and by a student fellowship (to A. P. and T. V.) from the Royal Golden Jubilee PhD Program, Thailand Research Fund. This work was also supported by the Thai Government Stimulus Package2 (TKK2555), under the Project for Establishment of Comprehensive Center for Innovative Food, Health Products, and Agriculture.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bangrak P, 2004, J BIOTECHNOL, V108, P219, DOI 10.1016/j.jbiotec.2003.12.007; Bauchau A.G., 1980, INVERTEBRATE BLOOD C, P385; Chaga Oleg, 1995, Animal Biology, V4, P59; Chang PS, 1996, DIS AQUAT ORGAN, V27, P131, DOI 10.3354/dao027131; Chou HY, 1995, DIS AQUAT ORGAN, V23, P165, DOI 10.3354/dao023165; Du HH, 2007, AQUACULTURE, V262, P532, DOI 10.1016/j.aquaculture.2006.11.002; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Flegel TW, 2006, AQUACULTURE, V258, P1, DOI 10.1016/j.aquaculture.2006.05.013; Granja CB, 2003, DIS AQUAT ORGAN, V54, P73, DOI 10.3354/dao054073; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hsiao CY, 2010, FISH SHELLFISH IMMUN, V28, P77, DOI 10.1016/j.fsi.2009.10.016; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; KOBAYASHI M, 1990, CELL TISSUE RES, V260, P13, DOI 10.1007/BF00297485; Lin XH, 2009, EXP CELL RES, V315, P1171, DOI 10.1016/j.yexcr.2009.01.001; Lin XH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-58; Liu HP, 2009, FISH SHELLFISH IMMUN, V27, P79, DOI 10.1016/j.fsi.2009.02.009; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Lorenzon S, 1999, FISH SHELLFISH IMMUN, V9, P31, DOI 10.1006/fsim.1998.0168; PATERSON WD, 1974, J FISH RES BOARD CAN, V31, P1051, DOI 10.1139/f74-119; Pech LL, 2000, J INSECT PHYSIOL, V46, P1565, DOI 10.1016/S0022-1910(00)00083-4; PERSSON M, 1987, CELL TISSUE RES, V247, P409; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SMITH VJ, 1983, CELL TISSUE RES, V233, P295; SMITH VJ, 1983, BIOL BULL, V164, P299, DOI 10.2307/1541146; Soderhall I, 2005, J IMMUNOL, V174, P6153, DOI 10.4049/jimmunol.174.10.6153; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Sung HH, 1998, J INVERTEBR PATHOL, V71, P26, DOI 10.1006/jipa.1997.4703; TSING A, 1989, J INVERTEBR PATHOL, V53, P64, DOI 10.1016/0022-2011(89)90075-X; van de Braak CBT, 2002, DIS AQUAT ORGAN, V51, P149, DOI 10.3354/dao051149; van de Braak CBT, 2002, FISH SHELLFISH IMMUN, V12, P253, DOI 10.1006/fsim.2001.0369; VLAK JM, 2004, 8 INT COMM TAX VIR; Wang CS, 1997, J FISH DIS, V20, P323, DOI 10.1046/j.1365-2761.1997.00301.x; Wang L, 2008, DEV COMP IMMUNOL, V32, P706, DOI 10.1016/j.dci.2007.10.010; Wang W, 2008, FISH SHELLFISH IMMUN, V25, P522, DOI 10.1016/j.fsi.2008.07.016; Wongprasert K, 2003, DIS AQUAT ORGAN, V55, P3, DOI 10.3354/dao055003; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001	40	26	27	5	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21467	21477		10.1074/jbc.M110.130526	http://dx.doi.org/10.1074/jbc.M110.130526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444692	Green Published, hybrid			2022-12-25	WOS:000279516100033
J	Van Horn, RD; Chu, SY; Fan, L; Yin, TG; Du, JA; Beckmann, R; Mader, M; Zhu, GX; Toth, J; Blanchard, K; Ye, XS				Van Horn, Robert D.; Chu, Shaoyou; Fan, Li; Yin, Tinggui; Du, Jian; Beckmann, Richard; Mader, Mary; Zhu, Guoxin; Toth, John; Blanchard, Kerry; Ye, Xiang S.			Cdk1 Activity Is Required for Mitotic Activation of Aurora A during G(2)/M Transition of Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE; SMALL-MOLECULE INHIBITOR; HISTONE H3 PHOSPHORYLATION; A KINASE; MAMMALIAN-CELLS; DNA-DAMAGE; CHROMOSOME ALIGNMENT; XENOPUS OOCYTES; B KINASE; S-PHASE	In mammalian cells entry into and progression through mitosis are regulated by multiple mitotic kinases. How mitotic kinases interact with each other and coordinately regulate mitosis remains to be fully understood. Here we employed a chemical biology approach using selective small molecule kinase inhibitors to dissect the relationship between Cdk1 and Aurora A kinases during G(2)/M transition. We find that activation of Aurora A first occurs at centrosomes at late G(2) and is required for centrosome separation independently of Cdk1 activity. Upon entry into mitosis, Aurora A then becomes fully activated downstream of Cdk1 activation. Inactivation of Aurora A or Plk1 individually during a synchronized cell cycle shows no significant effect on Cdk1 activation and entry into mitosis. However, simultaneous inactivation of both Aurora A and Plk1 markedly delays Cdk1 activation and entry into mitosis, suggesting that Aurora A and Plk1 have redundant functions in the feedback activation of Cdk1. Together, our data suggest that Cdk1, Aurora A, and Plk1 mitotic kinases participate in a feedback activation loop and that activation of Cdk1 initiates the feedback loop activity, leading to rapid and timely entry into mitosis in human cells. In addition, live cell imaging reveals that the nuclear cycle of cells becomes uncoupled from cytokinesis upon inactivation of both Aurora A and Aurora B kinases and continues to oscillate in a Cdk1-dependent manner in the absence of cytokinesis, resulting in multinucleated, polyploidy cells.	[Ye, Xiang S.] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Canc Res Div, Indianapolis, IN 46285 USA	Eli Lilly	Ye, XS (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Canc Res Div, Indianapolis, IN 46285 USA.	Ye_Xiang-s@Lilly.com						Abrieu A, 1998, J CELL SCI, V111, P1751; Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Cazales M, 2005, CELL CYCLE, V4, P1233, DOI 10.4161/cc.4.9.1964; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Du J, 2004, P NATL ACAD SCI USA, V101, P8975, DOI 10.1073/pnas.0308484101; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; Geddis AE, 2007, CELL CYCLE, V6, P455, DOI 10.4161/cc.6.4.3836; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gizatullin F, 2006, CANCER RES, V66, P7668, DOI 10.1158/0008-5472.CAN-05-3353; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Krystyniak A, 2006, ONCOGENE, V25, P338, DOI 10.1038/sj.onc.1209056; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Maton G, 2003, J BIOL CHEM, V278, P21439, DOI 10.1074/jbc.M300811200; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Osmani SA, 1996, BIOCHEM J, V317, P633, DOI 10.1042/bj3170633; Qian YW, 2001, MOL BIOL CELL, V12, P1791, DOI 10.1091/mbc.12.6.1791; Roshak AK, 2000, CELL SIGNAL, V12, P405, DOI 10.1016/S0898-6568(00)00080-2; Sardon T, 2008, EMBO J, V27, P2567, DOI 10.1038/emboj.2008.173; Sarg B, 2006, J BIOL CHEM, V281, P6573, DOI 10.1074/jbc.M508957200; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; WAHL AF, 2003, CURRENT PROTOCOLS CE; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5; Yang H, 2005, FEBS LETT, V579, P3385, DOI 10.1016/j.febslet.2005.04.080; YE XS, 1995, EMBO J, V14, P986, DOI 10.1002/j.1460-2075.1995.tb07079.x	40	51	51	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21849	21857		10.1074/jbc.M110.141010	http://dx.doi.org/10.1074/jbc.M110.141010			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444701	Green Published, hybrid			2022-12-25	WOS:000279516100069
J	Asano, R; Ikoma, K; Sone, Y; Kawaguchi, H; Taki, S; Hayashi, H; Nakanishi, T; Umetsu, M; Katayose, Y; Unno, M; Kudo, T; Kumagai, I				Asano, Ryutaro; Ikoma, Keiko; Sone, Yukiko; Kawaguchi, Hiroko; Taki, Shintaro; Hayashi, Hiroki; Nakanishi, Takeshi; Umetsu, Mitsuo; Katayose, Yu; Unno, Michiaki; Kudo, Toshio; Kumagai, Izumi			Highly Enhanced Cytotoxicity of a Dimeric Bispecific Diabody, the hEx3 Tetrabody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN FV; NEURAMINIDASE ANTIBODY NC10; V-L DOMAIN; CRYSTAL-STRUCTURE; TANDEM DIABODY; SCFV MULTIMERS; EFFICIENT INHIBITION; LINKER SEQUENCES; ANTIGEN-BINDING; TUMOR-CELLS	We previously reported the utility for cancer immunotherapy of a humanized bispecific diabody (hEx3) that targets epidermal growth factor receptor and CD3. Here, we used dynamic and static light scattering measurements to show that the multimer fraction observed in hEx3 in solution is a monodisperse tetramer. The multimerization into tetramers increased the inhibition of cancer cell growth by the hEx3 diabody. Furthermore, 1:2 stoichiometric binding for both antigens was observed in a thermodynamic analysis, indicating that the tetramer has bivalent binding activity for each target, and the structure may be in a circular configuration, as is the case for the single-chain Fv tetrabody. In addition to enhanced cytotoxicity, the functional affinity and stability of the hEx3 tetrabody were superior to those of the hEx3 diabody. The increase in molecular weight is also expected to improve the pharmacokinetics of the bispecific diabody, making the hEx3 tetrabody attractive as a therapeutic antibody fragment for cancer immunotherapy.	[Nakanishi, Takeshi; Umetsu, Mitsuo; Kumagai, Izumi] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Hayashi, Hiroki; Katayose, Yu; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg, Div Gastroenterol Surg, Sendai, Miyagi 9808574, Japan; [Kudo, Toshio] Tohoku Univ, Inst Dev Aging & Canc, Cell Resource Ctr Biomed Res, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University	Kumagai, I (corresponding author), Aoba 6-6-11-606,Aoba Ku, Sendai, Miyagi 9808579, Japan.	kmiz@kuma.che.tohoku.ac.jp	Asano, Ryutaro/G-7822-2016; Unno, Michiaki/AAX-5246-2020	Unno, Michiaki/0000-0002-2145-6416; Hayashi, Hiroki/0000-0001-9953-603X	Ministry of Education, Science, Sports, and Culture of Japan; New Energy and Industrial Technology Development Organization (NEDO) of Japan; National Institute of Biomedical Innovation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan (to R. A. and I. K.) and by grants from the New Energy and Industrial Technology Development Organization (NEDO) of Japan. This work was also supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation.	Adams GP, 1999, J IMMUNOL METHODS, V231, P249, DOI 10.1016/S0022-1759(99)00161-1; Arndt MAE, 1999, BLOOD, V94, P2562, DOI 10.1182/blood.V94.8.2562.420k20_2562_2568; Asano R, 2000, J BIOCHEM-TOKYO, V127, P673, DOI 10.1093/oxfordjournals.jbchem.a022656; Asano R, 2002, J BIOCHEM, V132, P903, DOI 10.1093/oxfordjournals.jbchem.a003303; Asano R, 2008, PROTEIN ENG DES SEL, V21, P597, DOI 10.1093/protein/gzn037; Asano R, 2008, J IMMUNOTHER, V31, P752, DOI 10.1097/CJI.0b013e3181849071; Asano R, 2007, J BIOL CHEM, V282, P27659, DOI 10.1074/jbc.M704719200; Asano R, 2006, CLIN CANCER RES, V12, P4036, DOI 10.1158/1078-0432.CCR-06-0059; Asano R, 2010, FEBS J, V277, P477, DOI 10.1111/j.1742-4658.2009.07499.x; Blanco B, 2003, J IMMUNOL, V171, P1070, DOI 10.4049/jimmunol.171.2.1070; Buhler P, 2008, CANCER IMMUNOL IMMUN, V57, P43, DOI 10.1007/s00262-007-0348-6; Cao Y, 2003, ADV DRUG DELIVER REV, V55, P171, DOI 10.1016/S0169-409X(02)00178-3; Cochlovius B, 2000, CANCER RES, V60, P4336; Dolezal O, 2000, PROTEIN ENG, V13, P565, DOI 10.1093/protein/13.8.565; Dolezal O, 2003, PROTEIN ENG, V16, P47, DOI 10.1093/proeng/gzg006; Gao Y, 2004, LEUKEMIA, V18, P513, DOI 10.1038/sj.leu.2403267; Hudson PJ, 1999, J IMMUNOL METHODS, V231, P177, DOI 10.1016/S0022-1759(99)00157-X; Kipriyanov SM, 1999, J MOL BIOL, V293, P41, DOI 10.1006/jmbi.1999.3156; Kipriyanov SM, 2003, J MOL BIOL, V330, P99, DOI 10.1016/S0022-2836(03)00526-6; Kipriyanov SM, 2002, J IMMUNOL, V169, P137, DOI 10.4049/jimmunol.169.1.137; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Kortt AA, 2001, BIOMOL ENG, V18, P95, DOI 10.1016/S1389-0344(01)00090-9; Kriangkum J, 2001, BIOMOL ENG, V18, P31, DOI 10.1016/S1389-0344(01)00083-1; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Le Gall F, 2004, PROTEIN ENG DES SEL, V17, P357, DOI 10.1093/protein/gzh039; Le Gall F, 2004, J IMMUNOL METHODS, V285, P111, DOI 10.1016/j.jim.2003.11.007; Makabe K, 2008, J BIOL CHEM, V283, P1156, DOI 10.1074/jbc.M706190200; Pei XY, 1997, P NATL ACAD SCI USA, V94, P9637, DOI 10.1073/pnas.94.18.9637; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; Power BE, 2003, PROTEIN SCI, V12, P734, DOI 10.1110/ps.0228503; RASO V, 1981, CANCER RES, V41, P2073; Ravn P, 2004, J MOL BIOL, V343, P985, DOI 10.1016/j.jmb.2004.08.052; Schlereth B, 2005, CANCER RES, V65, P2882, DOI 10.1158/0008-5472.CAN-04-2637; Shahied LS, 2004, J BIOL CHEM, V279, P53907, DOI 10.1074/jbc.M407888200; SURESH MR, 1986, METHOD ENZYMOL, V121, P210; Volkel T, 2001, PROTEIN ENG, V14, P815, DOI 10.1093/protein/14.10.815; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wu AM, 1996, IMMUNOTECHNOLOGY, V2, P21, DOI 10.1016/1380-2933(95)00027-5; Xiong DS, 2002, CANCER LETT, V177, P29, DOI 10.1016/S0304-3835(01)00758-3	39	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20844	20849		10.1074/jbc.M110.120444	http://dx.doi.org/10.1074/jbc.M110.120444			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20444691	Green Published, hybrid			2022-12-25	WOS:000279228600048
J	Chang, YI; Hua, WK; Yao, CL; Hwang, SM; Hung, YC; Kuan, CJ; Leou, JS; Lin, WJ				Chang, Yuan-I; Hua, Wei-Kai; Yao, Chao-Ling; Hwang, Shiaw-Min; Hung, Yi-Chi; Kuan, Chih-Jen; Leou, Jiun-Shyang; Lin, Wey-Jinq			Protein-arginine Methyltransferase 1 Suppresses Megakaryocytic Differentiation via Modulation of the p38 MAPK Pathway in K562 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE SIGNALING PATHWAYS; CYCLIN D1; TRANSCRIPTIONAL ACTIVATION; SUSTAINED ACTIVATION; STROMAL INHIBITION; METHYLATION SITES; ERK/MAPK PATHWAY; REGULATED KINASE; EXPRESSION; PROLIFERATION	Protein-arginine methyltransferase 1 (PRMT1) plays pivotal roles in various cellular processes. However, its role in megakaryocytic differentiation has yet to be investigated. Human leukemia K562 cells have been used as a model to study hematopoietic differentiation. In this study, we report that ectopic expression of HA-PRMT1 in K562 cells suppressed phorbol 12-myristate 13-acetate (PMA)-induced megakaryocytic differentiation as demonstrated by changes in cytological characteristics, adhesive properties, and CD41 expression, whereas knockdown of PRMT1 by small interference RNA promoted differentiation. Impairment of the methyltransferase activity of PRMT1 diminished the suppressive effect. These results provide evidence for a novel role of PRMT1 in negative regulation of megakaryocytic differentiation. Activation of ERK MAPK has been shown to be essential for megakaryocytic differentiation, although the role of p38 MAPK is still poorly understood. We show that knockdown of p38 alpha MAPK or treatment with the p38 inhibitor SB203580 significantly enhanced PMA-induced megakaryocytic differentiation. Further investigation revealed that PRMT1 promotes activation of p38 MAPK without inhibiting activation of ERK MAPK. In p38 alpha knockdown cells, PRMT1 could no longer suppress differentiation. In contrast, enforced expression of p38 alpha MAPK suppressed PMA-induced megakaryocytic differentiation of parental K562 as well as PRMT1-knockdown cells. We propose modulation of the p38 MAPK pathway by PRMT1 as a novel mechanism regulating megakaryocytic differentiation. This study thus provides a new perspective on the promotion of megakaryopoiesis.	[Chang, Yuan-I; Hua, Wei-Kai; Hung, Yi-Chi; Kuan, Chih-Jen; Leou, Jiun-Shyang; Lin, Wey-Jinq] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 11221, Taiwan; [Yao, Chao-Ling] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Chungli 32003, Taiwan; [Hwang, Shiaw-Min] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu 30062, Taiwan; [Lin, Wey-Jinq] Taipei City Hosp, Dept Educ & Res, Taipei 10341, Taiwan	National Yang Ming Chiao Tung University; Yuan Ze University; Taipei City Hospital	Lin, WJ (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, 155,Sect 2,Linong St, Taipei 11221, Taiwan.	wjlin@ym.edu.tw	Chang, Yuan-I/AAY-1711-2021; Yao, Chao-Ling/HDN-2709-2022	Yao, Chao-Ling/0000-0002-7196-5833	National Science Council, Taiwan [NSC 95-2311-B-010-002]; University System of Taiwan [97DFA2200014]; Ministry of Education	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); University System of Taiwan; Ministry of Education	This work was supported by National Science Council, Taiwan, Grant NSC 95-2311-B-010-002 (to W.-J.L.), University System of Taiwan Grant 97DFA2200014 (to W.-J.L.), and a grant from the Ministry of Education, Aim for the Top University Plan.	ALITALO R, 1990, LEUKEMIA RES, V14, P501, DOI 10.1016/0145-2126(90)90002-Q; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Blanchet F, 2005, J EXP MED, V202, P371, DOI 10.1084/jem.20050176; Chiou YY, 2007, PROTEIN J, V26, P87, DOI 10.1007/s10930-006-9049-9; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Conde I, 2010, EUR J HAEMATOL, V84, P430, DOI 10.1111/j.1600-0609.2010.01416.x; Delehanty LL, 2003, BLOOD, V101, P1744, DOI 10.1182/blood-2002-04-1278; Ding XZ, 2001, BIOCHEM BIOPH RES CO, V282, P447, DOI 10.1006/bbrc.2001.4595; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Eriksson M, 2005, EXP CELL RES, V304, P175, DOI 10.1016/j.yexcr.2004.10.017; Fichelson S, 1999, BLOOD, V94, P1601, DOI 10.1182/blood.V94.5.1601.417k19_1601_1613; Garcia J, 2001, MOL CELL BIOL, V21, P2659, DOI 10.1128/MCB.21.8.2659-2670.2001; Goldfarb AN, 2001, J BIOL CHEM, V276, P29526, DOI 10.1074/jbc.M103825200; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Herrera R, 1998, EXP CELL RES, V238, P407, DOI 10.1006/excr.1997.3847; Jacquel A, 2006, ONCOGENE, V25, P781, DOI 10.1038/sj.onc.1209119; Jiang F, 2002, BLOOD, V99, P3579, DOI 10.1182/blood.V99.10.3579; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Keeton AB, 2003, ENDOCRINOLOGY, V144, P5402, DOI 10.1210/en.2003-0592; Kirito K, 2003, BLOOD, V102, P3172, DOI 10.1182/blood-2003-03-0944; Klinge CM, 2004, J MOL ENDOCRINOL, V33, P387, DOI 10.1677/jme.1.01541; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lee CH, 1999, IUBMB LIFE, V48, P585, DOI 10.1080/152165499306450; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Mazharian A, 2009, EXP HEMATOL, V37, P1238, DOI 10.1016/j.exphem.2009.07.006; Meshkini A, 2008, TOXICOL IN VITRO, V22, P1503, DOI 10.1016/j.tiv.2008.05.005; Meyer R, 2007, J STEROID BIOCHEM, V107, P1, DOI 10.1016/j.jsbmb.2007.05.006; Miyata S, 2008, NEUROSCI LETT, V445, P162, DOI 10.1016/j.neulet.2008.08.065; Miyazaki R, 2001, ANN HEMATOL, V80, P284, DOI 10.1007/s002770000285; Navas TA, 2006, BLOOD, V108, P4170, DOI 10.1182/blood-2006-05-023093; Numazawa S, 2003, J BIOCHEM, V133, P599, DOI 10.1093/jb/mvg077; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Racke FK, 1997, J BIOL CHEM, V272, P23366, DOI 10.1074/jbc.272.37.23366; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Rouyez MC, 1997, MOL CELL BIOL, V17, P4991, DOI 10.1128/MCB.17.9.4991; Salojin KV, 1999, J IMMUNOL, V163, P844; Severin S, 2010, J THROMB HAEMOST, V8, P17, DOI 10.1111/j.1538-7836.2009.03658.x; Shahjahan M, 2008, AM J CLIN PATHOL, V130, P635, DOI 10.1309/2450EGK3V0XK8D9D; Stassen M, 2007, MOL IMMUNOL, V44, P926, DOI 10.1016/j.molimm.2006.03.019; Sun S, 2001, HAEMATOLOGICA, V86, P17; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tang YS, 2008, LEUKEMIA, V22, P1018, DOI 10.1038/leu.2008.20; Towatari M, 2004, HEMATOL J, V5, P262, DOI 10.1038/sj.thj.6200345; Tseng CP, 2001, BIOCHEM BIOPH RES CO, V285, P129, DOI 10.1006/bbrc.2001.5133; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yao CL, 2006, STEM CELLS DEV, V15, P70, DOI 10.1089/scd.2006.15.70; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	59	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20595	20606		10.1074/jbc.M109.092411	http://dx.doi.org/10.1074/jbc.M109.092411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20442406	Green Published, hybrid			2022-12-25	WOS:000279228600023
J	Oner, SS; Maher, EM; Breton, B; Bouvier, M; Blumer, JB				Oner, Sukru Sadik; Maher, Ellen M.; Breton, Billy; Bouvier, Michel; Blumer, Joe B.			Receptor-regulated Interaction of Activator of G-protein Signaling-4 and G alpha(i)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEROIN-SEEKING BEHAVIOR; G-BETA-GAMMA; GOLOCO MOTIF; INDEPENDENT ACTIVATORS; SURFACE EXPRESSION; AGS3; BINDING; IDENTIFICATION; DISSOCIATION; INHIBITION	Activator of G-protein signaling-4 (AGS4), via its three G-protein regulatory motifs, is well positioned to modulate G-protein signal processing by virtue of its ability to bind G alpha(i)-GDP subunits free of G beta gamma. Apart from initial observations on the biochemical activity of the G-protein regulatory motifs of AGS4, very little is known about the nature of the AGS4-G-protein interaction, how this interaction is regulated, or where the interaction takes place. As an initial approach to these questions, we evaluated the interaction of AGS4 with G alpha(i1) in living cells using bioluminescence resonance energy transfer (BRET). AGS4 and G alpha(i1) reciprocally tagged with either Renilla luciferase (RLuc) or yellow fluorescent protein (YFP) demonstrated saturable, specific BRET signals. BRET signals observed between AGS4-RLuc and G alpha(i1)-YFP were reduced by G-protein-coupled receptor activation, and this agonist-induced reduction in BRET was blocked by pertussis toxin. In addition, specific BRET signals were observed for AGS4-RLuc and alpha(2)-adrenergic receptor-Venus, which were G alpha(i)-dependent and reduced by agonist, indicating that AGS4-G alpha(i) complexes are receptor-proximal. These data suggest that AGS4-G alpha(i) complexes directly couple to a G-protein-coupled receptor and may serve as substrates for agonist-induced G-protein activation.	[Blumer, Joe B.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Breton, Billy; Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada	Medical University of South Carolina; Universite de Montreal	Blumer, JB (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol, 114 Doughty St,STB331, Charleston, SC 29425 USA.	blumerjb@musc.edu	Oner, Sukru/K-8032-2012; Bouvier, Michel/H-2758-2014	Oner, Sukru/0000-0002-8864-7356; Bouvier, Michel/0000-0003-1128-0100; Blumer, Joe/0000-0002-0020-3815	National Institutes of Health [GM086510, NS24821, DA025896]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS024821, R01NS024821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM086510 (to J.B.B.) and NS24821 and DA025896 (both to Stephen M. Lanier, Medical University of South Carolina). This work was also supported by grants from the Canadian Institutes of Health Research (to M.B.).	Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; DUZIC E, 1992, J BIOL CHEM, V267, P24045; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peterson YK, 2002, J BIOL CHEM, V277, P6767, DOI 10.1074/jbc.C100699200; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; SANS N, 2006, NAT CELL BIOL, V8, P100; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yao LN, 2006, P NATL ACAD SCI USA, V103, P7877, DOI 10.1073/pnas.0602661103	30	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20588	20594		10.1074/jbc.C109.088070	http://dx.doi.org/10.1074/jbc.C109.088070			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20452976	Green Published, hybrid			2022-12-25	WOS:000279228600022
J	Watari, A; Iwabe, N; Masuda, H; Okada, M				Watari, A.; Iwabe, N.; Masuda, H.; Okada, M.			Functional transition of Pak proto-oncogene during early evolution of metazoans	ONCOGENE			English	Article						evolution; metazoans; Pak; proto-oncogene	PROTEIN-TYROSINE KINASE; P21-ACTIVATED KINASES; MONOSIGA-BREVICOLLIS; SRC; ACTIVATION; CANCER; ONCOGENES; ANIMALS; PATHWAY; CELLS	Proto-oncogenes encode signaling molecular switches regulating cellular homeostasis in metazoans, and can be converted to oncogenes by gain-of-function mutations. To address the molecular basis for development of the regulatory system of proto-oncogenes during evolution, we screened for ancestral proto-oncogenes from the unicellular choanoflagellate Monosiga ovata by monitoring their transforming activities, and isolated a Pak gene ortholog encoding a serine/threonine kinase as a 'primitive oncogene'. We also cloned Pak orthologs from fungi and the multicellular sponge Ephydatia fluviatilis, and compared their regulatory features with that of M. ovata Pak (MoPak). MoPak is constitutively active and induces cell transformation in mammalian fibroblasts, although the Pak orthologs from multicellular animals are strictly regulated. Analyses of Pak mutants revealed that structural alteration of the auto-inhibitory domain (AID) of MoPak confers higher constitutive kinase activity, as well as greater binding ability to Rho family GTPases than the multicellular Paks, and this structural alteration is responsible for cell transformation and disruption of multicellular tissue organization. These results show that maturation of AID function was required for the development of the strict regulatory system of the Pak proto-oncogene, and suggest a potential link between the establishment of the regulatory system of proto-oncogenes and metazoan evolution. Oncogene (2010) 29, 3815-3826; doi: 10.1038/onc.2010.148; published online 10 May 2010	[Watari, A.; Masuda, H.; Okada, M.] Osaka Univ, Dept Oncogene Res, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Iwabe, N.] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan	Osaka University; Kyoto University	Okada, M (corresponding author), Osaka Univ, Dept Oncogene Res, Microbial Dis Res Inst, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	okadam@biken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Drs M Matsuda, T Akagi, T Hishida, M Yutsudo and S Morita for their generous gifts of reagents. This work was supported by Grants-in-Aids for Scientific Research on Priority Areas 'Cancer' and 'Comparative Genomics', from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; BISHOP JM, 1981, CELL, V23, P5; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Chung CY, 1999, J CELL BIOL, V147, P559, DOI 10.1083/jcb.147.3.559; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; HIBBERD DJ, 1975, J CELL SCI, V17, P191; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; JOHNSTON RN, 1992, BIOCHEM CELL BIOL, V70, P831, DOI 10.1139/o92-130; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li WQ, 2008, J BIOL CHEM, V283, P15491, DOI 10.1074/jbc.M800002200; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; O'Sullivan GC, 2007, INT J CANCER, V121, P1930, DOI 10.1002/ijc.22893; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Reeder MK, 2001, J BIOL CHEM, V276, P40606, DOI 10.1074/jbc.M103925200; Segawa Y, 2006, P NATL ACAD SCI USA, V103, P12021, DOI 10.1073/pnas.0600021103; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Suga H, 2001, GENE, V280, P195, DOI 10.1016/S0378-1119(01)00784-3; Suga H, 2008, FEBS LETT, V582, P815, DOI 10.1016/j.febslet.2008.02.002; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Todd R, 1999, ANTICANCER RES, V19, P4729; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200	38	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 1	2010	29	26					3815	3826		10.1038/onc.2010.148	http://dx.doi.org/10.1038/onc.2010.148			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	618VW	20453877				2022-12-25	WOS:000279385200009
J	Ahmed, K; Dehghani, H; Rugg-Gunn, P; Fussner, E; Rossant, J; Bazett-Jones, DP				Ahmed, Kashif; Dehghani, Hesam; Rugg-Gunn, Peter; Fussner, Eden; Rossant, Janet; Bazett-Jones, David P.			Global Chromatin Architecture Reflects Pluripotency and Lineage Commitment in the Early Mouse Embryo	PLOS ONE			English	Article							ZYGOTIC GENE ACTIVATION; STEM-CELLS; HISTONE H1; TRANSCRIPTION; METHYLATION; EXPRESSION; PROTEIN; GENOME; RNA; ORGANIZATION	An open chromatin architecture devoid of compact chromatin is thought to be associated with pluripotency in embryonic stem cells. Establishing this distinct epigenetic state may also be required for somatic cell reprogramming. However, there has been little direct examination of global structural domains of chromatin during the founding and loss of pluripotency that occurs in preimplantation mouse development. Here, we used electron spectroscopic imaging to examine large-scale chromatin structural changes during the transition from one-cell to early postimplantation stage embryos. In one-cell embryos chromatin was extensively dispersed with no noticeable accumulation at the nuclear envelope. Major changes were observed from one-cell to two-cell stage embryos, where chromatin became confined to discrete blocks of compaction and with an increased concentration at the nuclear envelope. In eight-cell embryos and pluripotent epiblast cells, chromatin was primarily distributed as an extended meshwork of uncompacted fibres and was indistinguishable from chromatin organization in embryonic stem cells. In contrast, lineage-committed trophectoderm and primitive endoderm cells, and the stem cell lines derived from these tissues, displayed higher levels of chromatin compaction, suggesting an association between developmental potential and chromatin organisation. We examined this association in vivo and found that deletion of Oct4, a factor required for pluripotency, caused the formation of large blocks of compact chromatin in putative epiblast cells. Together, these studies show that an open chromatin architecture is established in the embryonic lineages during development and is sufficient to distinguish pluripotent cells from tissue-restricted progenitor cells.	[Ahmed, Kashif; Fussner, Eden; Bazett-Jones, David P.] Hosp Sick Children, Genet & Genome Biol Program, Toronto, ON M5G 1X8, Canada; [Dehghani, Hesam] Ferdowsi Univ Mashhad, Dept Physiol, Sch Vet Med, Mashhad, Iran; [Dehghani, Hesam] Ferdowsi Univ Mashhad, Inst Biotechnol, Mashhad, Iran; [Rugg-Gunn, Peter; Rossant, Janet] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ferdowsi University Mashhad; Ferdowsi University Mashhad; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ahmed, K (corresponding author), Hosp Sick Children, Genet & Genome Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	david.bazett-jones@sickkids.ca	Dehghani, Hesam/D-1421-2010	Dehghani, Hesam/0000-0001-6750-0040; Rugg-Gunn, Peter/0000-0002-9601-5949	Canadian Institutes of Health Research [FRN14311, MOP77803]; Bisby Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bisby Fellowship	The research was funded by the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) through grants FRN14311 to DPB-J, MOP77803 to JR and a Bisby Fellowship to PR-G. DPB-J holds a Canada Research Chair in Molecular and Cellular Imaging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Kashif, 2008, V464, P415; Bazett-Jones DP, 2008, CHROMOSOME RES, V16, P397, DOI 10.1007/s10577-008-1237-3; Bazett-Jones DP, 1999, METHODS, V17, P188, DOI 10.1006/meth.1998.0729; Bazett-Jones DP, 1999, MICRON, V30, P151, DOI 10.1016/S0968-4328(99)00019-0; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; Beaujean N, 2004, CURR BIOL, V14, pR266, DOI 10.1016/j.cub.2004.03.019; Bourc'his D, 2001, CURR BIOL, V11, P1542, DOI 10.1016/S0960-9822(01)00480-8; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cao S, 2003, MOL CELL BIOL, V23, P5301, DOI 10.1128/MCB.23.15.5301-5307.2003; Chang CC, 2005, DEV BIOL, V278, P367, DOI 10.1016/j.ydbio.2004.11.032; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; CLARKE HJ, 1992, DEVELOPMENT, V115, P791; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Dehghani H, 2005, MICRON, V36, P95, DOI 10.1016/j.micron.2004.10.003; Dellaire G, 2004, METHOD ENZYMOL, V375, P456; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Eskiw CH, 2008, J CELL SCI, V121, P1999, DOI 10.1242/jcs.027250; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gilbert N, 2005, INT REV CYTOL, V242, P283; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; KORNBERG RD, 1991, CELL, V67, P833, DOI 10.1016/0092-8674(91)90354-2; KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cellbio.8.1.563; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Martin C, 2006, DEV BIOL, V292, P317, DOI 10.1016/j.ydbio.2006.01.009; MARTINEZSALAS E, 1989, GENE DEV, V3, P1493, DOI 10.1101/gad.3.10.1493; Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126; McGraw S, 2006, MOL REPROD DEV, V73, P692, DOI 10.1002/mrd.20448; Merico V, 2007, CHROMOSOME RES, V15, P341, DOI 10.1007/s10577-007-1130-5; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mohamed OA, 2001, DEV BIOL, V229, P237, DOI 10.1006/dbio.2000.9942; Nagy A., 2003, MANIPULATING MOUSE E; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; PIKO L, 1982, DEV BIOL, V89, P362, DOI 10.1016/0012-1606(82)90325-6; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; SCHULTZ GA, 1986, EXPT APPROACHES MAMM, P239; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Spada F, 1998, MECH DEVELOP, V76, P57, DOI 10.1016/S0925-4773(98)00095-1; Stein P, 2000, MOL REPROD DEV, V55, P241, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;241::AID-MRD1&gt;3.0.CO;2-T; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Teranishi T, 2004, DEV BIOL, V266, P76, DOI 10.1016/j.ydbio.2003.10.004; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; WIEKOWSKI M, 1991, DEV BIOL, V147, P403, DOI 10.1016/0012-1606(91)90298-H; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018	67	182	185	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10531	10.1371/journal.pone.0010531	http://dx.doi.org/10.1371/journal.pone.0010531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479880	Green Published, Green Submitted, gold			2022-12-25	WOS:000277467800013
J	Halterman, DA; Chen, Y; Sopee, J; Berduo-Sandoval, J; Sanchez-Perez, A				Halterman, Dennis A.; Chen, Yu; Sopee, Jiraphan; Berduo-Sandoval, Julio; Sanchez-Perez, Amilcar			Competition between Phytophthora infestans Effectors Leads to Increased Aggressiveness on Plants Containing Broad-Spectrum Late Blight Resistance	PLOS ONE			English	Article							IPIO GENE; R-GENE; AVIRULENCE; POTATO; SOLANUM; PROTEIN; FLAX; RUST; CELL; RECOGNITION	Background: The destructive plant disease potato late blight is caused by the oomycete pathogen Phytophthora infestans (Mont.) de Bary. This disease has remained particularly problematic despite intensive breeding efforts to integrate resistance into cultivated potato, largely because of the pathogen's ability to quickly evolve to overcome major resistance genes. The RB gene, identified in the wild potato species S. bulbocastanum, encodes a protein that confers broad-spectrum resistance to most P. infestans isolates through its recognition of highly conserved members of the corresponding pathogen effector family IPI-O. IpiO is a multigene family of effectors and while the majority of IPI-O proteins are recognized by RB to elicit host resistance, some variants exist that are able to elude detection (e. g. IPI-O4). Methods and Findings: In the present study, analysis of ipiO variants among 40 different P. infestans isolates collected from Guatemala, Thailand, and the United States revealed a high degree of complexity within this gene family. Isolate aggressiveness was correlated with increased ipiO diversity and especially the presence of the ipiO4 variant. Furthermore, isolates expressing IPI-O4 overcame RB-mediated resistance in transgenic potato plants even when the resistance-eliciting IPI-O1 variant was present. In support of this finding, we observed that expression of IPI-O4 via Agrobacterium blocked recognition of IPI-O1, leading to inactivation of RB-mediated programmed cell death in Nicotiana benthamiana. Conclusions: In this study we definitively demonstrate and provide the first evidence that P. infestans can defeat an R protein through inhibition of recognition of the corresponding effector protein.	[Halterman, Dennis A.; Chen, Yu] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Halterman, Dennis A.] ARS, USDA, Vegetable Crops Res Unit, Madison, WI USA; [Sopee, Jiraphan] Kasetsart Univ, Dept Plant Pathol, Bangkok, Thailand; [Berduo-Sandoval, Julio; Sanchez-Perez, Amilcar] Univ San Carlos, Fac Agron, San Carlos, Guatemala	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); Kasetsart University; Universidad de San Carlos de Guatemala	Halterman, DA (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	dennis.halterman@ars.usda.gov		Berduo Sandoval, Julio Ernesto/0000-0001-6043-9152	United States Department of Agriculture/Agricultural Research Service; Department of Plant Pathology at the University of Wisconsin-Madison; University of San Carlos; Kasetsart University	United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Department of Plant Pathology at the University of Wisconsin-Madison; University of San Carlos; Kasetsart University	Research funding was primarily provided by base funds from the United States Department of Agriculture/Agricultural Research Service. Salary support for Yu Chen was provided by the Department of Plant Pathology at the University of Wisconsin-Madison. Salary support for Julio Berduo and Amilcar Sanchez-Perez was provided by the University of San Carlos. Salary support for Jiraphan Sopee was provided by Kasetsart University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Bradeen JM, 2009, MOL PLANT MICROBE IN, V22, P437, DOI 10.1094/MPMI-22-4-0437; Champouret N, 2009, MOL PLANT MICROBE IN, V22, P1535, DOI 10.1094/MPMI-22-12-1535; CHEN Y, 2010, PHYTOPATHOLOGY UNPUB; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Flier WG, 2002, MYCOL RES, V106, P848, DOI 10.1017/S0953756202006123; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; GOODWIN SB, 1994, PHYTOPATHOLOGY, V84, P553, DOI 10.1094/Phyto-84-553; GOODWIN SB, 1992, CURR GENET, V22, P107, DOI 10.1007/BF00351469; Halterman DA, 2008, PLANT DIS, V92, P339, DOI 10.1094/PDIS-92-3-0339; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; JONES DA, 1988, PHYTOPATHOLOGY, V78, P342, DOI 10.1094/Phyto-78-342; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Kamoun S, 1998, PLANT CELL, V10, P1413, DOI 10.1105/tpc.10.9.1413; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kramer LC, 2009, MOL PLANT MICROBE IN, V22, P447, DOI 10.1094/MPMI-22-4-0447; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAWRENCE GJ, 1981, PHYTOPATHOLOGY, V71, P12, DOI 10.1094/Phyto-71-12; Liua Z, 2006, PHYSIOL MOL PLANT P, V69, P230, DOI 10.1016/j.pmpp.2007.05.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Marshall-Farrar KD, 1998, PLANT DIS, V82, P434, DOI 10.1094/PDIS.1998.82.4.434; MARTIN GB, 1994, PLANT CELL, V6, P1543, DOI 10.1105/tpc.6.11.1543; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; PIETERSE CMJ, 1994, GENE, V138, P67, DOI 10.1016/0378-1119(94)90784-6; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Spooner DM, 1998, AM J POTATO RES, V75, P3, DOI 10.1007/BF02883512; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; van West P, 1998, FUNGAL GENET BIOL, V23, P126, DOI 10.1006/fgbi.1998.1036; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wang M, 2008, THEOR APPL GENET, V116, P933, DOI 10.1007/s00122-008-0725-3; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	47	45	51	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10536	10.1371/journal.pone.0010536	http://dx.doi.org/10.1371/journal.pone.0010536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479869	Green Published, Green Submitted, gold			2022-12-25	WOS:000277467800018
J	Shin, HY; Hong, YH; Jang, SS; Chae, HG; Paek, SL; Moon, HE; Kim, DG; Kim, J; Paek, SH; Kim, SJ				Shin, Hye Young; Hong, Yun Hwa; Jang, Sung Soo; Chae, Hong Gu; Paek, Seung Leal; Moon, Hyo Eun; Kim, Dong Gyu; Kim, Jun; Paek, Sun Ha; Kim, Sang Jeong			A Role of Canonical Transient Receptor Potential 5 Channel in Neuronal Differentiation from A2B5 Neural Progenitor Cells	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; STEM-CELLS; PLASMA-MEMBRANE; CALCIUM-ENTRY; TRP CHANNELS; WHITE-MATTER; STORE; BRAIN; SENSOR; STIM1	Store-operated Ca2+ entry (SOCE) channels are the main pathway of Ca2+ entry in non-excitable cells such as neural progenitor cells (NPCs). However, the role of SOCE channels has not been defined in the neuronal differentiation from NPCs. Here, we show that canonical transient receptor potential channel (TRPC) as SOCE channel influences the induction of the neuronal differentiation of A2B5(+) NPCs isolated from postnatal-12-day rat cerebrums. The amplitudes of SOCE were significantly higher in neural cells differentiated from proliferating A2B5+ NPCs and applications of SOCE blockers, 2-aminoethoxy-diphenylborane (2-APB), and ruthenium red (RR), inhibited their rise of SOCE. Among TRPC subtypes (TRPC1-7), marked expression of TRPC5 and TRPC6 with turned-off TRPC1 expression was observed in neuronal cells differentiated from proliferating A2B5(+) NPCs. TRPC5 small interfering RNA (siRNA) blocked the neuronal differentiation from A2B5(+) NPCs and reduced the rise of SOCE. In contrast, TRPC6 siRNA had no significant effect on the neuronal differentiation from A2B5(+) NPCs. These results indicate that calcium regulation by TRPC5 would play a key role as a switch between proliferation and neuronal differentiation from NPCs.	[Shin, Hye Young; Paek, Seung Leal; Moon, Hyo Eun; Kim, Dong Gyu; Paek, Sun Ha] Seoul Natl Univ, Coll Med, Dept Neurosurg, Canc Res Inst,Ischem Hypox Dis Inst, Seoul, South Korea; [Hong, Yun Hwa; Jang, Sung Soo; Chae, Hong Gu; Kim, Jun; Kim, Sang Jeong] Seoul Natl Univ, Coll Med, Dept Brain & Cognit Sci, Dept Physiol,Neurosci Res Inst,Med Res Ctr, Seoul, South Korea; [Shin, Hye Young; Paek, Seung Leal; Moon, Hyo Eun; Kim, Dong Gyu; Paek, Sun Ha] Seoul Natl Univ Hosp, Clin Res Inst, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Shin, HY (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurosurg, Canc Res Inst,Ischem Hypox Dis Inst, Seoul, South Korea.	paeksh@snu.ac.kr; sangjkim@snu.ac.kr	Paek, Sun Ha/J-2760-2012; Kim, Sang Jeong/J-2740-2012; Kim, Dong Gyu/J-5388-2012	Shin, Hye Young/0000-0002-6827-3406; Kim, Sang Jeong/0000-0001-8931-3713	Republic of Korea [A04-0018-AY1204-08A5-00050B]; Seoul National University Hospital; Korea Research Foundation; ministry of Education, Science and Technology [2009-0080939, R32-10142]	Republic of Korea; Seoul National University Hospital; Korea Research Foundation(National Research Foundation of Korea); ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported in part by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A04-0018-AY1204-08A5-00050B), a grant of Seoul National University Hospital, and grants of Korea Research Foundation funded by the ministry of Education, Science and Technology (No. 2009-0080939 and WCU program R32-10142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Clarson LH, 2003, J PHYSIOL-LONDON, V550, P515, DOI 10.1113/jphysiol.2003.044149; Davare MA, 2009, J NEUROSCI, V29, P9794, DOI 10.1523/JNEUROSCI.1544-09.2009; Dietrich J, 2002, GLIA, V40, P65, DOI 10.1002/glia.10116; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Maric D, 2000, CEREB CORTEX, V10, P561, DOI 10.1093/cercor/10.6.561; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Meldolesi J, 1998, NATURE, V392, P863, DOI 10.1038/31804; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Pla AF, 2005, J NEUROSCI, V25, P2687, DOI 10.1523/JNEUROSCI.0951-04.2005; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; RAFF MC, 1983, J NEUROSCI, V3, P1289; SCHNITZER J, 1982, CELL TISSUE RES, V224, P625; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Uehara A, 2002, CELL CALCIUM, V31, P89, DOI 10.1054/ceca.2001.0257; Wu GS, 2007, J NEUROSCI, V27, P7447, DOI 10.1523/JNEUROSCI.4266-06.2007; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yanagida E, 2004, CELL CALCIUM, V36, P135, DOI 10.1016/j.ceca.2004.01.022; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	32	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10359	10.1371/journal.pone.0010359	http://dx.doi.org/10.1371/journal.pone.0010359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479868	Green Published, gold, Green Submitted			2022-12-25	WOS:000277467800002
J	Suominen-Taipale, AL; Partonen, T; Turunen, AW; Mannisto, S; Jula, A; Verkasalo, PK				Suominen-Taipale, Anna Liisa; Partonen, Timo; Turunen, Anu W.; Mannisto, Satu; Jula, Antti; Verkasalo, Pia K.			Fish Consumption and Omega-3 Polyunsaturated Fatty Acids in Relation to Depressive Episodes: A Cross-Sectional Analysis	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; CHOLESTERYL ESTERS; ADIPOSE-TISSUE; SERUM PHOSPHOLIPIDS; GENERAL-POPULATION; COMMUNITY SAMPLE; DIETARY-INTAKE; FOLATE INTAKE; 7 COUNTRIES; MOOD	High fish consumption and omega-3 polyunsaturated fatty acid (PUFA) intake are suggested to benefit mental well-being but the current evidence is conflicting. Our aim was to evaluate whether a higher level of fish consumption, a higher intake of omega-3 PUFAs, and a higher serum concentration of omega-3 PUFAs link to a lower 12-month prevalence of depressive episodes. We used data from the nationwide Health 2000 Survey (n = 5492) and the Fishermen Study on Finnish professional fishermen and their family members (n = 1265). Data were based on questionnaires, interviews, health examinations, and blood samples. Depressive episodes were assessed with the M-CIDI (the Munich version of the Composite International Diagnostic Interview) and a self-report of two CIDI probe questions, respectively. Fish consumption was measured by a food frequency questionnaire (g/day) and independent frequency questions (times/month). Dietary intake (g/day) and serum concentrations (% from fatty acids) of PUFAs were determined. Fish consumption was associated with prevalence of depressive episodes in men but not in women. The prevalence of depressive episodes decreased from 9% to 5% across the quartiles of fish consumption (g/day) in men of the Health 2000 Survey (p for linear trend = 0.01), and from 17% to 3% across the quartiles of fish consumption (times/month) in men of the Fishermen Study (p for linear trend = 0.05). This association was modified by lifestyle; in the Health 2000 Survey a higher level of fish consumption was related to a lower prevalence of depressive episodes in men who consumed the most alcohol, were occasional or former smokers, or had intermediate physical activity. The associations between depressive episodes and the intake or serum concentrations of omega-3 PUFAs were not consistent. In men, fish consumption appears as a surrogate for underlying but unidentified lifestyle factors that protect against depression.	[Suominen-Taipale, Anna Liisa; Turunen, Anu W.; Verkasalo, Pia K.] Natl Inst Hlth & Welf THL, Dept Environm Hlth, Kuopio, Finland; [Suominen-Taipale, Anna Liisa] Univ Turku, Inst Dent, Dept Publ Hlth Dent, Turku, Finland; [Partonen, Timo] Natl Inst Hlth & Welf THL, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Mannisto, Satu] Natl Inst Hlth & Welf THL, Dept Chron Dis Prevent, Helsinki, Finland; [Jula, Antti] Natl Inst Hlth & Welf THL, Dept Chron Dis Prevent, Turku, Finland	Finland National Institute for Health & Welfare; University of Turku; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Suominen-Taipale, AL (corresponding author), Natl Inst Hlth & Welf THL, Dept Environm Hlth, Kuopio, Finland.	liisa.suominen-taipale@thl.fi	Suominen, Anna L/AAE-6828-2021; Partonen, Timo/G-1105-2012	Partonen, Timo/0000-0003-1951-2455; Mannisto, Satu/0000-0002-8668-3046	Academy of Finland [52876, 206950, 107098, 100499, 205585]; Finnish Cancer Organisations; Yrjo Jahnsson Foundation; Juho Vainio Foundation	Academy of Finland(Academy of Finland); Finnish Cancer Organisations; Yrjo Jahnsson Foundation; Juho Vainio Foundation	This work was supported by the Academy of Finland (project numbers 52876, 206950, 107098, 100499; 205585); the Finnish Cancer Organisations; the Yrjo Jahnsson Foundation; and the Juho Vainio Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Appleton KM, 2008, NUTR RES REV, V21, P13, DOI 10.1017/S0954422408998620; Appleton KM, 2007, J AFFECT DISORDERS, V104, P217, DOI 10.1016/j.jad.2007.03.012; Appleton KM, 2007, SOC PSYCH PSYCH EPID, V42, P100, DOI 10.1007/s00127-006-0142-3; Appleton KM, 2006, AM J CLIN NUTR, V84, P1308, DOI 10.1093/ajcn/84.6.1308; Aromaa A., 2004, HLTH FUNCTIONAL CAPA; Astorg P, 2008, PROSTAG LEUKOTR ESS, V78, P171, DOI 10.1016/j.plefa.2008.01.003; Chiuve SE, 2005, AM J CLIN NUTR, V82, P155, DOI 10.1093/ajcn/82.1.155; Colangelo LA, 2009, NUTRITION, V25, P1011, DOI 10.1016/j.nut.2008.12.008; Freeman M P, 2000, Ann Clin Psychiatry, V12, P159, DOI 10.1023/A:1009069002816; Giltay EJ, 2004, AM J CLIN NUTR, V80, P1167, DOI 10.1093/ajcn/80.5.1167; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; Hakkarainen R, 2004, AM J PSYCHIAT, V161, P567, DOI 10.1176/appi.ajp.161.3.567; Hakkarainen R, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-14; HEISTARO S, 2008, HLTH 2000 SURVEY; Jacka FN, 2007, PSYCHOSOMATICS, V48, P54, DOI 10.1176/appi.psy.48.1.54; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Jula A, 2005, ARTERIOSCL THROM VAS, V25, P1952, DOI 10.1161/01.ATV.0000177812.84927.fa; Kamphuis MH, 2006, AM J CLIN NUTR, V84, P1513, DOI 10.1093/ajcn/84.6.1513; Katan MB, 1997, J LIPID RES, V38, P2012; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Koehler KM, 2001, AM J CLIN NUTR, V73, P628; Lin PY, 2007, J CLIN PSYCHIAT, V68, P1056, DOI 10.4088/JCP.v68n0712; Maes M, 1999, PSYCHIAT RES, V85, P275, DOI 10.1016/S0165-1781(99)00014-1; Maes M, 1996, J AFFECT DISORDERS, V38, P35, DOI 10.1016/0165-0327(95)00092-5; Mamalakis G, 2006, EUR J CLIN NUTR, V60, P882, DOI 10.1038/sj.ejcn.1602394; Mamalakis G, 2006, EUR J CLIN NUTR, V60, P1016, DOI 10.1038/sj.ejcn.1602413; Mamalakis G, 2004, PROSTAG LEUKOTR ESS, V70, P495, DOI 10.1016/j.plefa.2003.10.005; Mamalakis G, 2002, PROSTAG LEUKOTR ESS, V67, P311, DOI 10.1054/plef.2002.0435; Mamalakis G, 2008, PHARMACOL BIOCHEM BE, V89, P6, DOI 10.1016/j.pbb.2007.10.015; Mannisto S, 1996, J CLIN EPIDEMIOL, V49, P401, DOI 10.1016/0895-4356(95)00551-X; Murakami K, 2008, NUTRITION, V24, P140, DOI 10.1016/j.nut.2007.10.013; Nanri A, 2010, EUR J CLIN NUTR, V64, P289, DOI 10.1038/ejcn.2009.143; Paalanen L, 2006, J CLIN EPIDEMIOL, V59, P994, DOI 10.1016/j.jclinepi.2006.01.002; Paykel ES, 2005, EUR NEUROPSYCHOPHARM, V15, P411, DOI 10.1016/j.euroneuro.2005.04.008; Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7; REED V, 1998, INT J METH PSYCH RES, P142; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Sanchez-Villegas A, 2009, J HUM NUTR DIET, V22, P122, DOI 10.1111/j.1365-277X.2008.00931.x; Sanchez-Villegas A, 2007, EUR J NUTR, V46, P337, DOI 10.1007/s00394-007-0671-x; Silvers KM, 2002, PUBLIC HEALTH NUTR, V5, P427, DOI 10.1079/PHN2001308; Sontrop J, 2006, PREV MED, V42, P4, DOI 10.1016/j.ypmed.2005.11.005; Stahl LA, 2008, CURR OPIN INVEST DR, V9, P57; Suominen-Taipale AL, 2010, INT J EPIDEMIOL, V39, P494, DOI 10.1093/ije/dyp386; Tanskanen A, 2001, PSYCHIATR SERV, V52, P529, DOI 10.1176/appi.ps.52.4.529; Timonen M, 2004, J AFFECT DISORDERS, V82, P447, DOI 10.1016/j.jad.2004.02.002; Tolmunen T, 2004, PSYCHOTHER PSYCHOSOM, V73, P334, DOI 10.1159/000080385; Turunen AW, 2010, EUR J CLIN NUTR, V64, P313, DOI 10.1038/ejcn.2009.147; Turunen AW, 2008, INT J EPIDEMIOL, V37, P1008, DOI 10.1093/ije/dyn117; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Wittchen HU, 1998, ARCH GEN PSYCHIAT, V55, P1017, DOI 10.1001/archpsyc.55.11.1017	54	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10530	10.1371/journal.pone.0010530	http://dx.doi.org/10.1371/journal.pone.0010530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	593OI	20479881	Green Published, gold, Green Submitted			2022-12-25	WOS:000277467800012
J	Glas, J; Seiderer, J; Nagy, M; Fries, C; Beigel, F; Weidinger, M; Pfennig, S; Klein, W; Epplen, JT; Lohse, P; Folwaczny, M; Goke, B; Ochsenkuhn, T; Diegelmann, J; Muller-Myhsok, B; Roeske, D; Brand, S				Glas, Juergen; Seiderer, Julia; Nagy, Melinda; Fries, Christoph; Beigel, Florian; Weidinger, Maria; Pfennig, Simone; Klein, Wolfram; Epplen, Joerg T.; Lohse, Peter; Folwaczny, Matthias; Goeke, Burkhard; Ochsenkuehn, Thomas; Diegelmann, Julia; Mueller-Myhsok, Bertram; Roeske, Darina; Brand, Stephan			Evidence for STAT4 as a Common Autoimmune Gene: rs7574865 Is Associated with Colonic Crohn's Disease and Early Disease Onset	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; FRAMESHIFT MUTATION; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; HIGH-RISK; VARIANTS; CARD15; EXPRESSION	Background: Recent studies demonstrated an association of STAT4 variants with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), indicating that multiple autoimmune diseases share common susceptibility genes. We therefore investigated the influence of STAT4 variants on the susceptibility and phenotype of inflammatory bowel diseases (IBD) in a large patient and control cohort. Methodology/Principal Findings: Genomic DNA from 2704 individuals of Caucasian origin including 857 patients with Crohn's disease (CD), 464 patients with ulcerative colitis (UC), and 1383 healthy, unrelated controls was analyzed for seven SNPs in the STAT4 gene (rs11889341, rs7574865, rs7568275, rs8179673, rs10181656, rs7582694, rs10174238). In addition, a detailed genotype-phenotype analysis was performed. Our analysis revealed an association of the STAT4 SNP rs7574865 with overall decreased susceptibility to CD (p = 0.047, OR 0.86 [95% CI 0.74-0.99]). However, compared to CD patients carrying the wild type genotype, the STAT4 SNP rs7574865 was significantly associated with early CD onset (p = 0.021) and colonic CD (p = 0.008; OR = 4.60, 95% CI 1.63-12.96). For two other STAT4 variants, there was a trend towards protection against CD susceptibility (rs7568275, p = 0.058, OR 0.86 [95% CI 0.74-1.00]; rs10174238, p = 0.057, OR 0.86 [95% CI 0.75-1.00]). In contrast, we did not observe any association with UC susceptibility. Evidence for weak gene-gene interaction of STAT4 with the IL23R SNP rs11209026 was lost after Bonferroni correction. Conclusions/Significance: Our results identified the STAT4 SNP rs7574865 as a disease-modifying gene variant in colonic CD. However, in contrast to SLE and RA, the effect of rs7574865 on CD susceptibility is only weak.	[Glas, Juergen; Seiderer, Julia; Nagy, Melinda; Fries, Christoph; Beigel, Florian; Weidinger, Maria; Pfennig, Simone; Goeke, Burkhard; Ochsenkuehn, Thomas; Diegelmann, Julia; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Folwaczny, Matthias; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Inst Human Genet, Aachen, Germany; [Klein, Wolfram; Epplen, Joerg T.] Ruhr Univ Bochum, Dept Human Genet, Bochum, Germany; [Lohse, Peter] Univ Munich, Inst Clin Chem, Munich, Germany; [Mueller-Myhsok, Bertram; Roeske, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Munich; University of Munich; RWTH Aachen University; Ruhr University Bochum; University of Munich; Max Planck Society	Glas, J (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Müller-Myhsok, Bertram/A-3289-2013	Epplen, Joerg T./0000-0002-6087-3327	Broad Medical Foundation [IBD-0126R2]; Ludwig-Maximilians-University Munich [422]; Robert-Bosch-Foundation; Else Kroner-Fresenius-Stiftung [81/08//EKMS08/01, P50/05/EKMS05/62]; DFG [BR 1912/5-1]; DCCV e.V. [2007]	Broad Medical Foundation; Ludwig-Maximilians-University Munich; Robert-Bosch-Foundation; Else Kroner-Fresenius-Stiftung; DFG(German Research Foundation (DFG)); DCCV e.V.	J. Glas was supported by a grant from the Broad Medical Foundation (IBD-0126R2). J. Seiderer and J. Diegelmann were supported by grants from the Ludwig-Maximilians-University Munich (FoFoLe Nr. 422; Habilitationsstipendium, LMUExcellent to J. S. and Promotionsstipendium to J. D.); J. Seiderer was also supported by the Robert-Bosch-Foundation and the Else Kroner-Fresenius-Stiftung (81/08//EKMS08/01). S. Brand was supported by grants from the DFG (BR 1912/5-1), the Else Kroner-Fresenius-Stiftung (Else Kroner-Fresenius Memorial Stipendium 2005; P50/05/EKMS05/62), by the Ludwig-Demling Grant 2007 from DCCV e.V., and by grants of Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds 2008 and FoFoLe program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban Y, 2009, AUTOIMMUNITY, V42, P126, DOI 10.1080/08916930802422265; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Begue B, 2006, J CELL PHYSIOL, V209, P241, DOI 10.1002/jcp.20739; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Chang HC, 2009, BLOOD, V113, P5887, DOI 10.1182/blood-2008-09-179820; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; DIAZGALLO LM, 2010, HUM IMMUNOL     0307; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fedetz M, 2009, TISSUE ANTIGENS, V74, P244, DOI 10.1111/j.1399-0039.2009.01298.x; Frucht DM, 2000, J IMMUNOL, V164, P4659, DOI 10.4049/jimmunol.164.9.4659; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Huffmeier U, 2009, J INVEST DERMATOL, V129, P355, DOI 10.1038/jid.2008.233; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Ji JD, 2010, MOL BIOL REP, V37, P141, DOI 10.1007/s11033-009-9553-z; Kariuki SN, 2009, J IMMUNOL, V182, P34, DOI 10.4049/jimmunol.182.1.34; Korman BD, 2008, GENES IMMUN, V9, P267, DOI 10.1038/gene.2008.1; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Lankford CSR, 2003, J LEUKOCYTE BIOL, V73, P49, DOI 10.1189/jlb.0602326; Lee HS, 2008, ANN NY ACAD SCI, V1150, P93, DOI 10.1196/annals.1447.013; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Martinez A, 2008, ARTHRITIS RHEUM-US, V58, P2598, DOI 10.1002/art.23792; Massey DCO, 2007, AUTOPHAGY, V3, P649, DOI 10.4161/auto.5075; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402; Mo CQ, 2008, J IMMUNOL, V181, P5681, DOI 10.4049/jimmunol.181.8.5681; MOON CM, 2010, LIFE SCI       0220; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; O'Malley JT, 2008, J IMMUNOL, V181, P5062, DOI 10.4049/jimmunol.181.7.5062; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Orozco G, 2008, ARTHRITIS RHEUM-US, V58, P1974, DOI 10.1002/art.23549; Pang YH, 2007, CELL IMMUNOL, V248, P115, DOI 10.1016/j.cellimm.2007.10.003; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rueda B, 2009, HUM MOL GENET, V18, P2071, DOI 10.1093/hmg/ddp119; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2007, TISSUE ANTIGENS, V70, P238, DOI 10.1111/j.1399-0039.2007.00888.x; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Sigurdsson S, 2008, HUM MOL GENET, V17, P2868, DOI 10.1093/hmg/ddn184; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zervou MI, 2009, HUM IMMUNOL, V70, P738, DOI 10.1016/j.humimm.2009.05.008	55	41	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10373	10.1371/journal.pone.0010373	http://dx.doi.org/10.1371/journal.pone.0010373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454450	Green Submitted, Green Published, gold			2022-12-25	WOS:000277240100006
J	Montaudouin, C; Boucontet, L; Mailhe-Lembezat, MP; Mariotti-Ferrandiz, ME; Louise, A; Six, A; Freitas, AA; Garcia, S				Montaudouin, Caroline; Boucontet, Laurent; Mailhe-Lembezat, Marie-Pierre; Mariotti-Ferrandiz, Maria-Encarnita; Louise, Anne; Six, Adrien; Freitas, Antonio A.; Garcia, Sylvie			Endogenous TCR Recombination in TCR Tg Single RAG-Deficient Mice Uncovered by Robust In Vivo T Cell Activation and Selection	PLOS ONE			English	Article							ANTIGEN RECEPTOR; TRANSGENIC MICE; RAG-1-DEFICIENT MICE; V(D)J RECOMBINATION; POSITIVE SELECTION; LYMPHOCYTES-T; GENES; EXPRESSION; DELETION; REARRANGEMENT	Recombination activating gene (RAG)-deficient TCR (T Cell Receptor) Tg (transgenic) mice are routinely used as sources of monoclonal T cells. We found that after the transfer of T cells from a RAG-2-deficient 5CC7 TCR Tg mice into allogeneic hosts we recovered a population of T cells expressing diverse alpha beta-TCRs. In fact, in the thymus and spleen of the 5CC7 RAG-2deficient donor mice, we detected rare T cells expressing non-Tg TCR chains. Similar observations were obtained using T cells from two other TCR transgenic strains, namely RAG-2-deficient aHY and RAG-1-deficient OT-1 mice. The sequences of the endogenous TCR transcripts suggested that gene recombination could occur, albeit quite inefficiently, in the RAG-deficient mice we used. In agreement, we evidenced rare TCR V alpha and V beta-chain transcripts in non-Tg RAG-2-deficient mice. Since in these non-Tg RAG-deficient mice no mature T cells could ever be found, our findings suggested a role for the TCR Tg in rescuing rare recombined endogenous chains. Robust T-cell activation by the allogeneic environment favored the selection and expansion of the rare cells expressing endogenous TCRs. Potential mechanisms involved in the recombination of the endogenous TCR chains in the different strains of RAG-deficient mice used, and in particular the possibility of RAG-1 hypomorphism due to an incomplete knocking out procedure, are discussed. Our findings have important experimental implications for studies using TCR-Tg RAG-deficient cells as monoclonal T cell populations.	[Montaudouin, Caroline; Mailhe-Lembezat, Marie-Pierre; Freitas, Antonio A.; Garcia, Sylvie] Inst Pasteur, Dept Immunol, CNRS, Unite Biol Populat Lymphocytaires,URA 1961, F-75724 Paris, France; [Boucontet, Laurent] Inst Pasteur, INSERM, Dept Immunol, Unite Dev Lymphocytes,U668, F-75724 Paris, France; [Mariotti-Ferrandiz, Maria-Encarnita; Six, Adrien] Inst Pasteur, Dept Immunol, CNRS, Unite Physiopathol Infect,URA 1961, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Montaudouin, C (corresponding author), Inst Pasteur, Dept Immunol, CNRS, Unite Biol Populat Lymphocytaires,URA 1961, F-75724 Paris, France.	antonio.freitas@pasteur.fr; sylvie.garcia@pasteur.fr	Mariotti-Ferrandiz, Maria Encarnita/H-4788-2012; freitas, antonio/A-2482-2013; Mariotti-Ferrandiz, Encarnita/O-3262-2019	Mariotti-Ferrandiz, Encarnita/0000-0002-8770-0186; Garcia, Sylvie/0000-0002-7655-8911; freitas, antonio/0000-0001-6392-7178; Six, Adrien/0000-0001-5898-555X	French Ministry of Research; Pierre et Marie Curie University; Fond Inkermanns of Fondation de France; Institut Pasteur; Centre National de Recherche Scientifique; Agence Nationale de Recherche sur le SIDA; Agence Nationale de la Recherche; Association de Recherche sur le Cancer; Association Francaise contre les Myopathies	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Pierre et Marie Curie University; Fond Inkermanns of Fondation de France; Institut Pasteur(European Commission); Centre National de Recherche Scientifique; Agence Nationale de Recherche sur le SIDA(ANRSFrench National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association de Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	CM is supported by the French Ministry of Research; MEMF is supported by Pierre et Marie Curie University, Fond Inkermanns of Fondation de France. This work was supported by the Institut Pasteur, the Centre National de Recherche Scientifique and grants from Agence Nationale de Recherche sur le SIDA, Agence Nationale de la Recherche, Association de Recherche sur le Cancer & Association Francaise contre les Myopathies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEN B, 1985, NATURE, V316, P783, DOI 10.1038/316783a0; BLUTHMANN H, 1988, NATURE, V334, P156, DOI 10.1038/334156a0; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gilfillan S, 1995, IMMUNOL REV, V148, P201, DOI 10.1111/j.1600-065X.1995.tb00099.x; Golub R, 2001, EUR J IMMUNOL, V31, P2919, DOI 10.1002/1521-4141(2001010)31:10<2919::AID-IMMU2919>3.0.CO;2-N; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Koh WP, 1999, J IMMUNOL, V162, P7208; Legrand N, 2001, J IMMUNOL, V167, P6158, DOI 10.4049/jimmunol.167.11.6158; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; McMahan CJ, 1998, IMMUNITY, V9, P637, DOI 10.1016/S1074-7613(00)80661-5; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Sadofsky MJ, 2001, NUCLEIC ACIDS RES, V29, P1399, DOI 10.1093/nar/29.7.1399; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Veinotte LL, 2006, BLOOD, V107, P2673, DOI 10.1182/blood-2005-07-2797; XU B, 1994, SCIENCE, V265, P1590, DOI 10.1126/science.8079173; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287	27	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10238	10.1371/journal.pone.0010238	http://dx.doi.org/10.1371/journal.pone.0010238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454452	gold, Green Published			2022-12-25	WOS:000277240100001
J	Mihardja, SS; Gao, DW; Sievers, RE; Fang, QZ; Feng, JJ; Wang, JM; Vanbrocklin, HF; Larrick, JW; Huang, M; Dae, M; Lee, RJ				Mihardja, Shirley S.; Gao, Dongwei; Sievers, Richard E.; Fang, Qizhi; Feng, Jinjin; Wang, Jianming; Vanbrocklin, Henry F.; Larrick, James W.; Huang, Manley; Dae, Michael; Lee, Randall J.			Targeted In Vivo Extracellular Matrix Formation Promotes Neovascularization in a Rodent Model of Myocardial Infarction	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; LEFT-VENTRICULAR GEOMETRY; IV-COLLAGEN; SYNTHETIC PEPTIDE; ALPHA(V)BETA(3) INTEGRIN; GROWTH-FACTOR; ANGIOGENESIS; ADHESION; MIGRATION; FIBRONECTIN	Background: The extracellular matrix plays an important role in tissue regeneration. We investigated whether extracellular matrix protein fragments could be targeted with antibodies to ischemically injured myocardium to promote angiogenesis and myocardial repair. Methodology/Principal Findings: Four peptides, 2 derived from fibronectin and 2 derived from Type IV Collagen, were assessed for in vitro and in vivo tendencies for angiogenesis. Three of the four peptides-Hep I, Hep III, RGD-were identified and shown to increase endothelial cell attachment, proliferation, migration and cell activation in vitro. By chemically conjugating these peptides to an anti-myosin heavy chain antibody, the peptides could be administered intravenously and specifically targeted to the site of the myocardial infarction. When administered into Sprague-Dawley rats that underwent ischemia-reperfusion myocardial infarction, these peptides produced statistically significantly higher levels of angiogenesis and arteriogenesis 6 weeks post treatment. Conclusions/Significance: We demonstrated that antibody-targeted ECM-derived peptides alone can be used to sufficiently alter the extracellular matrix microenvironment to induce a dramatic angiogenic response in the myocardial infarct area. Our results indicate a potentially new non-invasive strategy for repairing damaged tissue, as well as a novel tool for investigating in vivo cell biology.	[Mihardja, Shirley S.; Gao, Dongwei; Fang, Qizhi; Dae, Michael; Lee, Randall J.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Sievers, Richard E.; Lee, Randall J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lee, Randall J.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA; [Gao, Dongwei; Feng, Jinjin; Vanbrocklin, Henry F.; Dae, Michael] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Lee, Randall J.] Univ Calif Berkeley, UCSF, Joint Bioengn Grad Grp, Berkeley, CA 94720 USA; [Wang, Jianming; Larrick, James W.; Huang, Manley] Panorama Res Inst, Sunnyvale, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California San Francisco	Mihardja, SS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	lee@medicine.ucsf.edu			NIH [R21 HL084121]; California Institute of Regenerative Medicine [RC1-00124-1]; American Heart Association; Margoes Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084121] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); American Heart Association(American Heart Association); Margoes Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NIH R21 HL084121 and by the California Institute of Regenerative Medicine (RC1-00124-1). SSM was supported by the American Heart Association Postdoctoral Fellowship and by the Margoes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Azarnoush K, 2005, J THORAC CARDIOV SUR, V130, P173, DOI 10.1016/j.jtcvs.2004.11.044; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Bonanno E, 2000, IN VITRO CELL DEV-AN, V36, P336; Bouchentouf M, 2008, GENE THER, V15, P404, DOI 10.1038/sj.gt.3303059; CAMERON JD, 1991, INVEST OPHTH VIS SCI, V32, P2766; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Corda S, 2000, Heart Fail Rev, V5, P119, DOI 10.1023/A:1009806403194; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; FORM DM, 1986, LAB INVEST, V55, P521; Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063; Heiss C, 2008, J CELL PHYSIOL, V215, P366, DOI 10.1002/jcp.21313; Huang NF, 2006, NAT PROTOC, V1, P1596, DOI 10.1038/nprot.2006.188; Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192; LITWIN SE, 1994, CIRCULATION, V89, P345, DOI 10.1161/01.CIR.89.1.345; Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com; MALDONADO BA, 1995, INVEST OPHTH VIS SCI, V36, P364; Manohar A, 2004, J CELL SCI, V117, P4043, DOI 10.1242/jcs.01277; MOORADIAN DL, 1993, INVEST OPHTH VIS SCI, V34, P153; Nam JO, 2003, J BIOL CHEM, V278, P25902, DOI 10.1074/jbc.M300358200; NICOSIA RF, 1987, AM J PATHOL, V128, P78; Nisato Riccardo E., 2003, Angiogenesis, V6, P105, DOI 10.1023/B:AGEN.0000011801.98187.f2; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Patel S, 2007, J BIOMED MATER RES A, V83A, P423, DOI 10.1002/jbm.a.31320; PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224; PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Senger DR, 1996, AM J PATHOL, V149, P293; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Setty S, 1998, J BIOL CHEM, V273, P12244, DOI 10.1074/jbc.273.20.12244; Simons M, 2004, MOL CELL BIOCHEM, V264, P99, DOI 10.1023/B:MCBI.0000044379.25823.03; Springer ML, 2000, MOL THER, V1, P82, DOI 10.1006/mthe.1999.0006; Springer ML, 2003, MOL THER, V7, P441, DOI 10.1016/S1525-0016(03)00010-8; Strauer BE, 2003, CIRCULATION, V107, P929, DOI 10.1161/01.CIR.0000057525.13182.24; SUDA T, 1981, CURRENT EYE RES, V1; Thiagarajan P, 1996, BIOCHEMISTRY-US, V35, P4169, DOI 10.1021/bi952532b; TSILIBARY EC, 1990, J CELL BIOL, V111, P1583, DOI 10.1083/jcb.111.4.1583; Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252; Vinals F, 1999, MOL CELL BIOL, V19, P2763; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; Vogel V, 2003, ANNU REV BIOMED ENG, V5, P441, DOI 10.1146/annurev.bioeng.5.040202.121615; WOODS A, 1993, MOL BIOL CELL, V4, P605, DOI 10.1091/mbc.4.6.605; Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036	44	19	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10384	10.1371/journal.pone.0010384	http://dx.doi.org/10.1371/journal.pone.0010384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442783	Green Submitted, Green Published, gold			2022-12-25	WOS:000277154200020
J	Romanuk, TN; Vogt, RJ; Young, A; Tuck, C; Carscallen, MW				Romanuk, Tamara N.; Vogt, Richard J.; Young, Angela; Tuck, Constance; Carscallen, Mather W.			Maintenance of Positive Diversity-Stability Relations along a Gradient of Environmental Stress	PLOS ONE			English	Article							SPECIES-DIVERSITY; COMMUNITY STRUCTURE; ECOSYSTEM FUNCTION; PLANT DIVERSITY; BIODIVERSITY; VARIABILITY; RICHNESS; DESICCATION	Background: Environmental stress is widely considered to be an important factor in regulating whether changes in diversity will affect the functioning and stability of ecological communities. Methodology/Principal Findings: We investigated the effects of a major environmental stressor (a decrease in water volume) on diversity-abundance and diversity-stability relations in laboratory microcosms composed of temperate multitrophic rock pool communities to identify differences in community and functional group responses to increasing functional group richness along a gradient of environmental stress (low, medium, and high water volume). When a greater number of functional groups were present, communities were less temporally variable and achieved higher abundances. The stabilizing effect of increased functional group richness was observed regardless of the level of environmental stress the community was subjected too. Despite the strong consistent stabilizing effect of increased functional group richness on abundance, the way that individual functional groups were affected by functional group richness differed along the stress gradient. Under low stress, communities with more functional groups present were more productive and showed evidence of strong facilitative interactions. As stress increased, the positive effect of functional group richness on community abundance was no longer observed and compensatory responses became more common. Responses of individual functional groups to functional group richness became increasing heterogeneous are stress increased, prompting shifts from linear diversity-variability/abundance relations under low stress to a mix of linear and non-linear responses under medium and high stress. The strength of relations between functional group richness and both the abundances and temporal variability of functional groups also increased as stress increased. Conclusions/Significance: While stress did not affect the relation between functional group richness and stability per se, the way in which functional groups responded to changes in functional group richness differed as stress increased. These differences, which include increases in the heterogeneity of responses of individual functional groups, increases in compensatory dynamics, and increases in the strength of richness-abundance and richness-variability relations, may be critical to maintaining stability under increasingly stressful environmental conditions.	[Romanuk, Tamara N.; Young, Angela; Tuck, Constance; Carscallen, Mather W.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Vogt, Richard J.] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	Dalhousie University; University of Quebec; University of Quebec Montreal	Romanuk, TN (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	tromanuk@gmail.com	Romanuk, t N/C-6493-2008		National Sciences and Engineering Research of Council Canada (NSERC)	National Sciences and Engineering Research of Council Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a National Sciences and Engineering Research of Council Canada (NSERC) Discovery Grant to TNR (http://www.nserccrsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004703; Barnett AJ, 2007, FRESHWATER BIOL, V52, P796, DOI 10.1111/j.1365-2427.2007.01733.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Franklin RB, 2001, APPL ENVIRON MICROB, V67, P702, DOI 10.1128/AEM.67.2.702-712.2001; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; Fukami T, 2004, POPUL ECOL, V46, P137, DOI 10.1007/s10144-004-0182-z; HEARD SB, 1994, ECOLOGY, V75, P1647, DOI 10.2307/1939625; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Paradise CJ, 1997, OECOLOGIA, V109, P303, DOI 10.1007/s004420050088; Petchey OL, 2002, OIKOS, V99, P231, DOI 10.1034/j.1600-0706.2002.990203.x; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Romanuk TN, 2006, BIOL LETT-UK, V2, P374, DOI 10.1098/rsbl.2006.0464; Romanuk TN, 2006, OIKOS, V114, P291, DOI 10.1111/j.2006.0030-1299.14739.x; Romanuk TN, 2009, OIKOS, V118, P819, DOI 10.1111/j.1600-0706.2008.17273.x; Romanuk TN, 2005, BIOL INVASIONS, V7, P711, DOI 10.1007/s10530-004-0997-8; Romanuk TN, 2004, ECOSCIENCE, V11, P455, DOI 10.1080/11956860.2004.11682855; Romanuk TN, 2002, ECOSCIENCE, V9, P55, DOI 10.1080/11956860.2002.11682690; ROMANUK TN, 2002, THESIS MCMASTER U HA; SCHLUTER D, 1984, ECOLOGY, V65, P998, DOI 10.2307/1938071; Solow AR, 2007, ECOSYSTEMS, V10, P1034, DOI 10.1007/s10021-007-9076-1; Srivastava DS, 2006, OECOLOGIA, V149, P493, DOI 10.1007/s00442-006-0467-3; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; *STATSOFT INC, 2004, STATISTICA DAT AN SO; Steiner CF, 2005, ECOL LETT, V8, P819, DOI 10.1111/j.1461-0248.2005.00785.x; Symstad AJ, 2000, ECOLOGY, V81, P99, DOI 10.1890/0012-9658(2000)081[0099:ATOTEO]2.0.CO;2; Symstad AJ, 2000, OIKOS, V89, P243, DOI 10.1034/j.1600-0706.2000.890204.x; Therriault TW, 2001, ISR J ZOOL, V47, P477, DOI 10.1560/BWWA-DTXB-LBJK-5GV5; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Valone TJ, 2003, OIKOS, V103, P519, DOI 10.1034/j.1600-0706.2003.12279.x; Vogt RJ, 2006, OIKOS, V113, P55, DOI 10.1111/j.0030-1299.2006.14494.x; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Williams D. D., 2006, ECOLOGY TEMPORARY WA; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Zhang QG, 2006, OIKOS, V112, P218, DOI 10.1111/j.0030-1299.2006.14220.x	44	12	12	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10378	10.1371/journal.pone.0010378	http://dx.doi.org/10.1371/journal.pone.0010378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436913	Green Published, gold			2022-12-25	WOS:000277079700012
J	Borderia, AV; Lorenzo-Redondo, R; Pernas, M; Casado, C; Alvaro, T; Domingo, E; Lopez-Galindez, C				Borderia, Antonio V.; Lorenzo-Redondo, Ramon; Pernas, Maria; Casado, Concepcion; Alvaro, Tamara; Domingo, Esteban; Lopez-Galindez, Cecilio			Initial Fitness Recovery of HIV-1 Is Associated with Quasispecies Heterogeneity and Can Occur without Modifications in the Consensus Sequence	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MISMATCH CLEAVAGE METHOD; MOUTH-DISEASE VIRUS; TYPE-1 INFECTION; CELL-CULTURE; RNA VIRUSES; MUTATIONS; POPULATION; EVOLUTION; PROGRESSION	Background: Fitness recovery of HIV-1 "in vitro" was studied using viral clones that had their fitness decreased as a result of plaque-to-plaque passages. Principal Findings: After ten large population passages, the viral populations showed an average increase of fitness, although with wide variations among clones. While 5 clones showed significant fitness increases, 3 clones showed increases that were only marginally significant (p<0.1), and 4 clones did not show any change. Fitness recovery was not accompanied by an increase in p24 production, but was associated with an increase in viral titer. Few mutations (an average of 2 mutations per genome) were detected in the consensus nucleotide sequence of the entire genome in all viral populations. Five of the populations did not fix any mutation, and three of them displayed marginally significant fitness increases, illustrating that fitness recovery can occur without detectable alterations of the consensus genomic sequence. The investigation of other possible viral factors associated with the initial steps of fitness recovery, showed that viral quasispecies heterogeneity increased between the initial clones and the passaged populations. A direct statistical correlation between viral heterogeneity and viral fitness was obtained. Conclusions: Thus, the initial fitness recovery of debilitated HIV-1 clones was mediated by an increase in quasispecies heterogeneity. This observation, together with the invariance of the consensus sequence despite fitness increases demonstrates the relevance of quasispecies heterogeneity in the evolution of HIV-1 in cell culture.	[Borderia, Antonio V.; Lorenzo-Redondo, Ramon; Pernas, Maria; Casado, Concepcion; Alvaro, Tamara; Lopez-Galindez, Cecilio] Inst Salud Carlos III, CNM, Madrid, Spain; [Domingo, Esteban] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Domingo, Esteban] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Microelectronica (CNM); Instituto de Salud Carlos III; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Borderia, AV (corresponding author), Inst Salud Carlos III, CNM, Madrid, Spain.	clopez@isciii.es	Pernas, Maria/E-3998-2018; Lopez-Galindez, Cecilio/A-3603-2008; Casado, Concepcion/F-3060-2016; Domingo, Esteban/K-3937-2014	Pernas, Maria/0000-0003-2966-0160; Lopez-Galindez, Cecilio/0000-0002-2324-9584; Casado, Concepcion/0000-0003-3412-2877; Domingo, Esteban/0000-0002-0573-1676; Lorenzo-Redondo, Ramon/0000-0002-5462-9483; Borderia, Antonio V./0000-0003-0623-1988	Plan Nacional del SIDA [SAF 2005/03833, SAF 2007/61036]; Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss); Fundacion para la Investigacion y la Prevencion del SIDA en Espana (FIPSE) [36558/06, 36641/07, 36779/08, 360766/09]; Ministerio de Ciencia e Innovacion [BFU 2008-02816/BMC]; Fundacion Ramon Areces; Instituto de Salud Carlos III	Plan Nacional del SIDA; Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss)(Instituto de Salud Carlos III); Fundacion para la Investigacion y la Prevencion del SIDA en Espana (FIPSE); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Ramon Areces; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Work in the Centro Nacional de Microbiologia was supported by grants, SAF 2005/03833, SAF 2007/61036 by the Plan Nacional del SIDA and in part by the Red Tematica Cooperativa de investigacion en SIDA (Red de grupos 173) of the Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss) and Fundacion para la Investigacion y la Prevencion del SIDA en Espana (FIPSE) grant 36558/06, 36641/07, 36779/08, 36641/07 and 360766/09. Work in the Centro de Biologia Molecular "Severo Ochoa" was supported by grant BFU 2008-02816/BMC from Ministerio de Ciencia e Innovacion, FIPSE 36558/06 and 360766/09 and Fundacion Ramon Areces. Centro de Investigaciones Biomedica en Red (CIBER): enfermedades hepaticas y digestivas (ehd) is funded by Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Baranowski E, 1998, J VIROL, V72, P6362, DOI 10.1128/JVI.72.8.6362-6372.1998; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brander C, 1999, CURR OPIN IMMUNOL, V11, P451, DOI 10.1016/S0952-7915(99)80076-4; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; DIEZ J, 1990, J VIROL, V64, P5519; Domingo E, 2005, ARCH VIROL, P59; DOMINGO E, 1985, GENE, V40, P1, DOI 10.1016/0378-1119(85)90017-4; DOMINGO E, ORIGIN EVOLUTION VIR; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1988, SEQUENCE SPACE QUASI, P211; EIGEN M, 1988, RNA GENETICS, P211; Escarmis C, 1999, J MOL BIOL, V285, P495, DOI 10.1006/jmbi.1998.2366; Gonzalez-Lopez Claudia, 2005, Infection Genetics and Evolution, V5, P366, DOI 10.1016/j.meegid.2005.05.001; GOONETILLEKE N, 2009, 1 T CELL RESPONSE TR; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; HOLLAND JJ, 1991, J VIROL, V65, P2960, DOI 10.1128/JVI.65.6.2960-2967.1991; Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; KUIKEN C, 2009, 0903280 LAUR; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; LOPEZGALINDEZ C, 1988, P NATL ACAD SCI USA, V85, P3522, DOI 10.1073/pnas.85.10.3522; LOPEZGALINDEZ C, 1991, P NATL ACAD SCI USA, V88, P4280, DOI 10.1073/pnas.88.10.4280; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Novella IS, 2004, J MOL BIOL, V342, P1423, DOI 10.1016/j.jmb.2004.08.004; NOVELLA IS, 1995, P NATL ACAD SCI USA, V92, P5841, DOI 10.1073/pnas.92.13.5841; Olivares I, 1997, AIDS RES HUM RETROV, V13, P979, DOI 10.1089/aid.1997.13.979; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SANCHEZPALOMINO S, 1993, J VIROL, V67, P2938; Sanz-Ramos M, 2008, J VIROL, V82, P10465, DOI 10.1128/JVI.00825-08; Sauder CJ, 2006, VIROLOGY, V350, P48, DOI 10.1016/j.virol.2006.01.035; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Thome KC, 1997, J VIROL, V71, P8149, DOI 10.1128/JVI.71.11.8149-8156.1997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Yuste E, 2005, J VIROL, V79, P5421, DOI 10.1128/JVi.79.9.5421-5427.2005; Yuste E, 2000, J VIROL, V74, P9546, DOI 10.1128/JVI.74.20.9546-9552.2000; Yuste E, 1999, J VIROL, V73, P2745, DOI 10.1128/JVI.73.4.2745-2751.1999	46	24	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10319	10.1371/journal.pone.0010319	http://dx.doi.org/10.1371/journal.pone.0010319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436678	Green Published, gold			2022-12-25	WOS:000277079500008
J	Maki, N; Suetsugu-Maki, R; Sano, S; Nakamura, K; Nishimura, O; Tarui, H; Del Rio-Tsonis, K; Ohsumi, K; Agata, K; Tsonis, PA				Maki, Nobuyasu; Suetsugu-Maki, Rinako; Sano, Shozo; Nakamura, Kenta; Nishimura, Osamu; Tarui, Hiroshi; Del Rio-Tsonis, Katia; Ohsumi, Keita; Agata, Kiyokazu; Tsonis, Panagiotis A.			Oocyte-type linker histone B4 is required for transdifferentiation of somatic cells in vivo	FASEB JOURNAL			English	Article						newt; lens regeneration; histone H1; gamma-crystallin	NUCLEAR TRANSFER; CRYSTALLIN GENE; SEA-URCHIN; H1; DIFFERENTIATION; REGENERATION; REPLACEMENT; ZEBRAFISH; VARIANTS; DYNAMICS	The ability to reprogram in vivo a somatic cell after differentiation is quite limited. One of the most impressive examples of such a process is transdifferentiation of pigmented epithelial cells (PECs) to lens cells during lens regeneration in newts. However, very little is known of the molecular events that allow newt cells to transdifferentiate. Histone B4 is an oocyte-type linker histone that replaces the somatic-type linker histone H1 during reprogramming mediated by somatic cell nuclear transfer (SCNT). We found that B4 is expressed and required during transdifferentiation of PECs. Knocking down of B4 decreased proliferation and increased apoptosis, which resulted in considerable smaller lens. Furthermore, B4 knockdown altered gene expression of key genes of lens differentiation and nearly abolished expression of gamma-crystallin. These data are the first to show expression of oocyte-type linker histone in somatic cells and its requirement in newt lens transdifferentiation and suggest that transdifferentiation in newts might share common strategies with reprogramming after SCNT.-Maki, N., Suetsugu-Maki, R., Sano, S., Nakamura, K., Nishimura, O., Tarui, H., Del Rio-Tsonis, K., Ohsumi, K., Agata, K., Tsonis, P. A. Oocyte-type linker histone B4 is required for transdifferentiation of somatic cells in vivo. FASEB J. 24, 3462-3467 (2010). www.fasebj.org	[Maki, Nobuyasu; Suetsugu-Maki, Rinako; Nakamura, Kenta; Tsonis, Panagiotis A.] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Maki, Nobuyasu; Suetsugu-Maki, Rinako; Nakamura, Kenta; Tsonis, Panagiotis A.] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton, Dayton, OH 45469 USA; [Maki, Nobuyasu; Sano, Shozo; Tarui, Hiroshi; Agata, Kiyokazu] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan; [Nishimura, Osamu; Agata, Kiyokazu] Kyoto Univ, Dept Biophys, Kyoto, Japan; [Del Rio-Tsonis, Katia] Miami Univ, Dept Zool, Oxford, OH 45056 USA; [Ohsumi, Keita] Nagoya Univ, Div Biol Sci, Nagoya, Aichi 4648601, Japan	University of Dayton; University of Dayton; RIKEN; Kyoto University; University System of Ohio; Miami University; Nagoya University	Maki, N (corresponding author), Univ Dayton, Dept Biol, 300 Coll Pk,SC46, Dayton, OH 45469 USA.	makinobu@notes.udayton.edu; panagiotis.tsonis@notes.udayton.edu	Nishimura, Osamu/AAC-1236-2020	Nishimura, Osamu/0000-0003-1969-2580; Agata, Kiyokazu/0000-0002-5195-2576	KAKENHI grant [17657068]; Naito Foundation; Japan Ministry of Education, Culture, Sports, Science, and Technology [17GS0318]; U.S. National Institutes of Health [EY10540]; NATIONAL EYE INSTITUTE [R01EY010540] Funding Source: NIH RePORTER	KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Naito Foundation(Naito Memorial Foundation); Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Y. Tanabe, and J. Hayashi for EST analysis. The authors are grateful to K. Ura for a helpful discussion. This work was supported by a KAKENHI grant (17657068) to N.M.; by the Naito Foundation and the Project for Realization of Regenerative Medicine as well as a Grant-in-Aid for Creative Research from the Japan Ministry of Education, Culture, Sports, Science, and Technology (17GS0318) to K. A., and by a U. S. National Institutes of Health grant (EY10540) to P. A. T.	ABE SI, 1977, DEV GROWTH DIFFER, V19, P309; Becker M, 2005, MOL BIOL CELL, V16, P3887, DOI 10.1091/mbc.E05-04-0350; CHO HS, 1994, GENE, V143, P233; CVEKL A, 1995, MOL CELL BIOL, V15, P653; EGUCHI G, 1973, P NATL ACAD SCI USA, V70, P1495, DOI 10.1073/pnas.70.5.1495; Gao SR, 2004, DEV BIOL, V266, P62, DOI 10.1016/j.ydbio.2003.10.003; Godde JS, 2009, INT J DEV BIOL, V53, P215, DOI 10.1387/ijdb.082644jg; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Maki N, 2007, DEV DYNAM, V236, P941, DOI 10.1002/dvdy.21027; Mandl B, 1997, MOL CELL BIOL, V17, P1189, DOI 10.1128/MCB.17.3.1189; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McGraw S, 2006, MOL REPROD DEV, V73, P692, DOI 10.1002/mrd.20448; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Muller K, 2002, MECH DEVELOP, V117, P253, DOI 10.1016/S0925-4773(02)00174-0; NEELIN JM, 1964, CAN J BIOCHEM PHYS, V42, P1743, DOI 10.1139/o64-185; Saeki H, 2005, P NATL ACAD SCI USA, V102, P5697, DOI 10.1073/pnas.0409824102; Tanaka M, 2005, BIOL REPROD, V72, P135, DOI 10.1095/biolreprod.104.032474; Tanaka M, 2001, DEVELOPMENT, V128, P655; Teranishi T, 2004, DEV BIOL, V266, P76, DOI 10.1016/j.ydbio.2003.10.004; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Wade PA, 2002, EUR J BIOCHEM, V269, P2284, DOI 10.1046/j.1432-1033.2002.02887.x; Wibrand K, 2002, MECH DEVELOP, V117, P249, DOI 10.1016/S0925-4773(02)00173-9; Yoshida T, 2002, GENES CELLS, V7, P693, DOI 10.1046/j.1365-2443.2002.00548.x	24	36	38	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2010	24	9					3462	3467		10.1096/fj.10-159285	http://dx.doi.org/10.1096/fj.10-159285			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20460584	Green Published			2022-12-25	WOS:000281446400033
J	Jeon, J; Kim, NY; Kim, S; Kang, NY; Novak, O; Ku, SJ; Cho, C; Lee, DJ; Lee, EJ; Strnad, M; Kim, J				Jeon, Jin; Kim, Nan Young; Kim, Sunmi; Kang, Na Young; Novak, Ondrej; Ku, Su-Jin; Cho, Chuloh; Lee, Dong Ju; Lee, Eun-Jung; Strnad, Miroslav; Kim, Jungmook			A Subset of Cytokinin Two-component Signaling System Plays a Role in Cold Temperature Stress Response in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE KINASE; GENE-EXPRESSION; NEGATIVE REGULATOR; ABSCISIC-ACID; ENVIRONMENTAL SIGNALS; MEMBRANE-FLUIDITY; MUTANTS REVEAL; RECEPTOR; PERCEPTION; TRANSDUCTION	Amultistep two-component signaling system is established as a key element of cytokinin signaling in Arabidopsis. Here, we provide evidence for a function of the two-component signaling system in cold stress response in Arabidopsis. Cold significantly induced the expression of a subset of A-type ARR genes and of GUS in Pro(ARR7):GUS transgenic Arabidopsis. AHK2 and AHK3 were found to be primarily involved in mediating cold to express A-type ARRs despite cytokinin deficiency. Cold neither significantly induced AHK2 and AHK3 expression nor altered the cytokinin contents of wild type within the 4 h during which the A-type ARR genes exhibited peak expression in response to cold, indicating that cold might induce ARR expression via the AHK2 and AHK3 proteins without alterations in cytokinin levels. The ahk2 ahk3 and ahk3 ahk4 mutants exhibited enhanced freezing tolerance compared with wild type. These ahk double mutants acclimated as efficiently to cold as did wild type. The overexpression of the cold-inducible ARR7 in Arabidopsis resulted in a hypersensitivity response to freezing temperatures under cold-acclimated conditions. The expression of C-repeat/dehydration- responsive element target genes was not affected by ARR7 overexpression as well as in ahk double mutants. By contrast, the arr7 mutants showed increased freezing tolerance. The ahk2 ahk3 and arr7 mutants showed hypersensitive response to abscisic acid (ABA) for germination, whereas ARR7 overexpression lines exhibited insensitive response to ABA. These results suggest that AHK2 and AHK3 and the cold-inducible A-type ARRs play a negative regulatory role in cold stress signaling via inhibition of ABA response, occurring independently of the cold acclimation pathway.	[Kang, Na Young; Cho, Chuloh; Kim, Jungmook] Chonnam Natl Univ, World Class Univ, Dept Bioenergy Sci & Technol, Kwangju 500757, South Korea; [Jeon, Jin; Kim, Nan Young; Kim, Sunmi; Ku, Su-Jin; Lee, Dong Ju; Lee, Eun-Jung] Chonnam Natl Univ, World Class Univ, Dept Plant Biotechnol, Kwangju 500757, South Korea; [Novak, Ondrej; Strnad, Miroslav] Palacky Univ, Lab Growth Regulators, CZ-78371 Olomouc, Czech Republic; [Novak, Ondrej; Strnad, Miroslav] Acad Sci Czech Republ, Inst Expt Bot, CZ-78371 Olomouc, Czech Republic	Chonnam National University; Chonnam National University; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Kim, J (corresponding author), Chonnam Natl Univ, World Class Univ, Dept Bioenergy Sci & Technol, Kwangju 500757, South Korea.	jungmkim@chonnam.ac.kr	NOVAK, Ondrej/F-7031-2014; Strnad, Miroslav/H-1858-2014	NOVAK, Ondrej/0000-0003-3452-0154; Strnad, Miroslav/0000-0002-2806-794X; Kim, Jungmook/0000-0003-1735-5564	Agricultural Plant Stress Research Center [R11-2001-092-04001-0]; World Class University [R31-2009-000-20025-0, PF06302-01]; Ministry of Education, Science and Technology of Korea	Agricultural Plant Stress Research Center; World Class University; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Agricultural Plant Stress Research Center Grant R11-2001-092-04001-0, by Plant Diversity Research Center of 21st Century Frontier Research Program Grant PF06302-01, and from the World Class University Project R31-2009-000-20025-0 funded by the Ministry of Education, Science and Technology of Korea (to J.K.).	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Craft J, 2005, PLANT J, V41, P899, DOI 10.1111/j.1365-313X.2005.02342.x; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Davies PJ, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P1; Desikan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002491; Faiss M, 1997, PLANT J, V12, P401, DOI 10.1046/j.1365-313X.1997.12020401.x; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Hejatko J, 2009, PLANT CELL, V21, P2008, DOI 10.1105/tpc.109.066696; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Hwang D, 2002, PLANT PHYSIOL, V129, P500, DOI 10.1104/pp.005504; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Ishitani M, 1998, PLANT CELL, V10, P1151, DOI 10.1105/tpc.10.7.1151; Iwama A, 2007, PLANT CELL PHYSIOL, V48, P375, DOI 10.1093/pcp/pcl065; Jefferson R. A., 1991, PLANT MOL BIOL MAN B, V14, P1; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kim HJ, 2002, PLANT J, V29, P693, DOI 10.1046/j.1365-313X.2002.01249.x; Kim J, 2007, J PLANT BIOL, V50, P139, DOI 10.1007/BF03030622; Lee DJ, 2008, PLANTA, V227, P577, DOI 10.1007/s00425-007-0640-x; Lee DJ, 2007, MOL GENET GENOMICS, V277, P115, DOI 10.1007/s00438-006-0177-x; Lohrmann J, 2002, PLANT PHYSIOL, V128, P363, DOI 10.1104/pp.010907; Los DA, 1997, MOL MICROBIOL, V25, P1167, DOI 10.1046/j.1365-2958.1997.5641912.x; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; Mikami K, 2003, PROG LIPID RES, V42, P527, DOI 10.1016/S0163-7827(03)00036-5; Murata N, 1997, PLANT PHYSIOL, V115, P875, DOI 10.1104/pp.115.3.875; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Novak O, 2003, ANAL CHIM ACTA, V480, P207, DOI 10.1016/S0003-2670(03)00025-4; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; Osakabe Y, 2002, BIOCHEM BIOPH RES CO, V293, P806, DOI 10.1016/S0006-291X(02)00286-3; Pischke MS, 2002, P NATL ACAD SCI USA, V99, P15800, DOI 10.1073/pnas.232580499; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Sangwan V, 2001, PLANT J, V27, P1, DOI 10.1046/j.1365-313x.2001.01052.x; Sharma P, 2005, BIOESSAYS, V27, P1048, DOI 10.1002/bies.20307; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Suzuki I, 2000, EMBO J, V19, P1327, DOI 10.1093/emboj/19.6.1327; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; To JPC, 2008, TRENDS PLANT SCI, V13, P85, DOI 10.1016/j.tplants.2007.11.005; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P751, DOI 10.1093/pcp/pce094; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P231, DOI 10.1093/pcp/pce015; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; Vaultier MN, 2006, FEBS LETT, V580, P4218, DOI 10.1016/j.febslet.2006.06.083; VIGH L, 1993, P NATL ACAD SCI USA, V90, P9090, DOI 10.1073/pnas.90.19.9090; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wohlbach DJ, 2008, PLANT CELL, V20, P1101, DOI 10.1105/tpc.107.055871; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251	63	207	221	7	79	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23369	23384		10.1074/jbc.M109.096644	http://dx.doi.org/10.1074/jbc.M109.096644			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20463025	Green Published, hybrid			2022-12-25	WOS:000279999900070
J	Ono, Y; Ojima, K; Torii, F; Takaya, E; Doi, N; Nakagawa, K; Hata, S; Abe, K; Sorimachi, H				Ono, Yasuko; Ojima, Koichi; Torii, Fukuyo; Takaya, Emi; Doi, Naoko; Nakagawa, Kazuhiro; Hata, Shoji; Abe, Keiko; Sorimachi, Hiroyuki			Skeletal Muscle-specific Calpain Is an Intracellular Na+-dependent Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; DYSTROPHY TYPE 2A; MUSCULAR-DYSTROPHY; BINDING-SITE; FACTOR XA; IN-VIVO; CALCIUM; SODIUM; P94; MUTATIONS	Because intracellular [Na+] is kept low by Na+/K+-ATPase, Na+ dependence is generally considered a property of extracellular enzymes. However, we found that p94/calpain 3, a skeletal-muscle-specific member of the Ca2+-activated intracellular "modulator proteases" that is responsible for a limb-girdle muscular dystrophy ("calpainopathy"), underwent Na+-dependent, but not Cs+-dependent, autolysis in the absence of Ca2+. Furthermore, Na+ and Ca2+ complementarily activated autolysis of p94 at physiological concentrations. By blocking Na+/K+-ATPase, we confirmed intracellular autolysis of p94 in cultured cells. This was further confirmed using inactive p94: C129S knock-in (p94CS-KI) mice as negative controls. Mutagenesis studies showed that much of the p94 molecule contributed to its Na+/Ca2+-dependent autolysis, which is consistent with the scattered location of calpainopathy-associated mutations, and that a conserved Ca2+-binding sequence in the protease acted as a Na+ sensor. Proteomic analyses using Cs+/Mg2+ and p94CS-KI mice as negative controls revealed that Na+ and Ca2+ direct p94 to proteolyze different substrates. We propose three roles for Na+ dependence of p94; 1) to increase sensitivity of p94 to changes in physiological [Ca2+], 2) to regulate substrate specificity of p94, and 3) to regulate contribution of p94 as a structural component in muscle cells. Finally, this is the first example of an intracellular Na+-dependent enzyme.	[Sorimachi, Hiroyuki] Tokyo Metropolitan Inst Med Sci Rinshoken, Calpain Project, Setagaya Ku, Tokyo 1568506, Japan; [Ojima, Koichi; Doi, Naoko; Sorimachi, Hiroyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Torii, Fukuyo; Nakagawa, Kazuhiro; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); University of Tokyo	Sorimachi, H (corresponding author), Tokyo Metropolitan Inst Med Sci Rinshoken, Calpain Project, Setagaya Ku, Kamikitazawa 2-1-6, Tokyo 1568506, Japan.	sorimachi-hr@igakuken.or.jp	Sorimachi, Hiroyuki/C-6448-2009; Sorimachi, Hiroyuki/Q-6956-2017	Sorimachi, Hiroyuki/0000-0001-9509-6727; Sorimachi, Hiroyuki/0000-0001-9509-6727; Ojima, Koichi/0000-0002-5973-1073	MEXT.KAKENHI [18076007, 22770139]; JSPS.KAKENHI [18700392, 20500369, 19658057, 20370055]; Ministry of Health, Labour, and Welfare [20B-13]; Takeda Science Foundation	MEXT.KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS.KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by MEXT.KAKENHI Grants 18076007 (to H. S.) and 22770139 (to Y.O.) and JSPS.KAKENHI Grants 18700392 and 20500369 (to K.O.) and 19658057 and 20370055 (to H. S.), by Research Grant 20B-13 for Nervous and Mental Disorders from the Ministry of Health, Labour, and Welfare (to H. S.), and by a Takeda Science Foundation research grant (to H. S.).	Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Bonagura CA, 1996, BIOCHEMISTRY-US, V35, P6107, DOI 10.1021/bi960122x; Bonagura CA, 1999, J BIOL CHEM, V274, P37827, DOI 10.1074/jbc.274.53.37827; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; Fanin M, 2007, J MED GENET, V44, P38, DOI 10.1136/jmg.2006.044859; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; HARAFUJI H, 1980, J BIOCHEM, V87, P1305, DOI 10.1093/oxfordjournals.jbchem.a132868; Hayashi C, 2008, J BIOL CHEM, V283, P14801, DOI 10.1074/jbc.M708262200; Herasse M, 1999, MOL CELL BIOL, V19, P4047; Huebsch KA, 2005, HUM MOL GENET, V14, P2801, DOI 10.1093/hmg/ddi313; Kamata K, 1998, P NATL ACAD SCI USA, V95, P6630, DOI 10.1073/pnas.95.12.6630; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Li HQ, 2004, BBA-MOL CELL RES, V1691, P91, DOI 10.1016/j.bbamcr.2003.12.006; Mizushima N, 2007, AUTOPHAGY, V3, P179, DOI 10.4161/auto.4051; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Yasuko, 2007, Biotechnology Journal, V2, P565, DOI 10.1002/biot.200700018; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P1817, DOI 10.1021/bi992006a; Richard I, 1999, AM J HUM GENET, V64, P1524, DOI 10.1086/302426; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; Saenz A, 2005, BRAIN, V128, P732, DOI 10.1093/brain/awh408; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; Silva FP, 2006, BIOPHYS CHEM, V119, P282, DOI 10.1016/j.bpc.2005.10.001; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Spencer MJ, 2002, P NATL ACAD SCI USA, V99, P8874, DOI 10.1073/pnas.132269299; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877	43	38	39	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22984	22996		10.1074/jbc.M110.126946	http://dx.doi.org/10.1074/jbc.M110.126946			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20460380	hybrid, Green Published			2022-12-25	WOS:000279999900033
J	Bankovich, AJ; Shiow, LR; Cyster, JG				Bankovich, Alexander J.; Shiow, Lawrence R.; Cyster, Jason G.			CD69 Suppresses Sphingosine 1-Phosophate Receptor-1 (S1P(1)) Function through Interaction with Membrane Helix 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; ACTIVATION ANTIGEN CD69; LYMPHOCYTE EGRESS; CALCITONIN RECEPTOR; CRYSTAL-STRUCTURE; EXPRESSION; 1-PHOSPHATE; INTERNALIZATION; TRAFFICKING; AGONISTS	Lymphocyte egress from lymph nodes requires the G-protein-coupled sphingosine 1-phosphate receptor-1 (S1P(1)). The activation antigen CD69 associates with and inhibits the function of S1P(1), inhibiting egress. Here we undertook biochemical characterization of the requirements for S1P(1)-CD69 complex formation. Domain swapping experiments between CD69 and the related type II transmembrane protein, NKRp1A, identified a requirement for the transmembrane and membrane proximal domains for specific interaction. Mutagenesis of S1P(1) showed a lack of requirement for N-linked glycosylation, tyrosine sulfation, or desensitization motifs but identified a requirement for transmembrane helix 4. Expression of CD69 led to a reduction of S1P(1) in cell lysates, likely reflecting degradation. Unexpectedly, the S1P(1)-CD69 complex exhibited a much longer half-life for binding of S1P than v alone. In contrast to wild-type CD69, a non-S1P(1) binding mutant of CD69 failed to inhibit T cell egress from lymph nodes. These findings identify an integral membrane interaction between CD69 and S1P(1) and suggest that CD69 induces an S1P(1) conformation that shares some properties of the ligand-bound state, thereby facilitating S1P(1) internalization and degradation.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), 513 Parnassus Ave,HSE 1001, San Francisco, CA 94143 USA.	Jason.Cyster@ucsf.edu		Bankovich, Alexander/0000-0003-2368-4479	National Institutes of Health [AI074847]; Irvington Institute Fellowship of the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute Fellowship of the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074847.; Supported by an Irvington Institute Fellowship of the Cancer Research Institute.	Armour SL, 1999, J PHARMACOL TOXICOL, V42, P217, DOI 10.1016/S1056-8719(00)00074-5; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Chu Peter, 2003, J Biol, V2, P21, DOI 10.1186/1475-4924-2-21; Cooray SN, 2009, MOL CELL ENDOCRINOL, V300, P17, DOI 10.1016/j.mce.2008.10.004; DeLano W., 2006, PYMOL MOL GRAPHICS S; ESWAR N, 2006, CURR PROT BIOINFORMA; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Fieger CB, 2005, FASEB J, V19, P1926, DOI 10.1096/fj.05-4476fje; HALL JG, 1965, BRIT J EXP PATHOL, V46, P450; HAMANN J, 1993, J IMMUNOL, V150, P4920; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; Llera AS, 2001, J BIOL CHEM, V276, P7312, DOI 10.1074/jbc.M008573200; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Nakayama T, 2002, J IMMUNOL, V168, P87, DOI 10.4049/jimmunol.168.1.87; Natarajan K, 2000, BIOCHEMISTRY-US, V39, P14779, DOI 10.1021/bi0018180; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sebag JA, 2009, J BIOL CHEM, V284, P610, DOI 10.1074/jbc.M804413200; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; SWIFT S, 1999, CURR PROT IMM; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; ZIEGLER SF, 1994, J IMMUNOL, V152, P1228; ZIEGLER SF, 1993, EUR J IMMUNOL, V23, P1643, DOI 10.1002/eji.1830230737	32	218	221	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22328	22337		10.1074/jbc.M110.123299	http://dx.doi.org/10.1074/jbc.M110.123299			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463015	Green Published, hybrid			2022-12-25	WOS:000279702200046
J	Kokhan, O; Shinkarev, VP; Wraight, CA				Kokhan, Oleksandr; Shinkarev, Vladimir P.; Wraight, Colin A.			Binding of Imidazole to the Heme of Cytochrome c(1) and Inhibition of the bc(1) Complex from Rhodobacter sphaeroides II. KINETICS AND MECHANISM OF BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; FERRICYTOCHROME-C; HORSE HEART; CONFORMATIONAL TRANSITION; ALKALINE ISOMERIZATION; ELECTRONIC-STRUCTURE; PROTEIN DYNAMICS; METHIONINE; EQUILIBRIUM; REACTIVITY	The kinetics of imidazole (Im) and N-methylimidazole (MeIm) binding to oxidized cytochrome (cyt) c(1) of detergent-solubilized bc(1) complex from Rhodobacter sphaeroides are described. The rate of formation of the cyt c(1)-Im complex exhibited three separated regions of dependence on the concentration of imidazole: (i) below 8 mM Im, the rate increased with concentration in a parabolic manner; (ii) above 20 mM, the rate leveled off, indicating a rate-limiting conformational step with lifetime similar to 1 s; and (iii) at Im concentrations above 100 mM, the rate substantially increased again, also parabolically. In contrast, binding of MeIm followed a simple hyperbolic concentration dependence. The temperature dependences of the binding and release kinetics of Im and MeIm were also measured and revealed very large activation parameters for all reactions. The complex concentration dependence of the Im binding rate is not consistent with the popular model for soluble c-type cytochromes in which exogenous ligand binding is preceded by spontaneous opening of the heme cleft, which becomes rate-limiting at high ligand concentrations. Instead, binding of ligand to the heme is explained by a model in which an initial and superficial binding facilitates access to the heme by disruption of hydrogen-bonded structures in the heme domain. For imidazole, two separate pathways of heme access are indicated by the distinct kinetics at low and high concentration. The structural basis for ligand entry to the heme cleft is discussed.	[Kokhan, Oleksandr; Wraight, Colin A.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Shinkarev, Vladimir P.; Wraight, Colin A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Wraight, CA (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, 156 Davenport Hall,607 S Mathews Ave, Urbana, IL 61801 USA.	cwraight@illinois.edu		Kokhan, Oleksandr/0000-0001-9867-8044	National Institutes of Health [R01GM053508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM053508.	Assfalg M, 2003, J AM CHEM SOC, V125, P2913, DOI 10.1021/ja027180s; AXELROD HL, 1994, ACTA CRYSTALLOGR D, V50, P596, DOI 10.1107/S0907444994001319; Banci L, 2001, J BIOL INORG CHEM, V6, P628, DOI 10.1007/s007750100240; Baymann F, 2004, P NATL ACAD SCI USA, V101, P17737, DOI 10.1073/pnas.0407442101; Cieluch E, 2010, BBA-BIOENERGETICS, V1797, P296, DOI 10.1016/j.bbabio.2009.11.003; CREUTZ C, 1974, J BIOL CHEM, V249, P6788; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Darrouzet E, 1999, BIOCHEMISTRY-US, V38, P7908, DOI 10.1021/bi990211k; DAVIS LA, 1974, J BIOL CHEM, V249, P2624; Dumortier C, 1998, J BIOL CHEM, V273, P25647, DOI 10.1074/jbc.273.40.25647; Dumortier C, 2004, BIOCHEMISTRY-US, V43, P7717, DOI 10.1021/bi0362370; Dumortier C, 1999, ARCH BIOCHEM BIOPHYS, V371, P142, DOI 10.1006/abbi.1999.1440; DYER C, 1979, BIOCHIM BIOPHYS ACTA, V579, P253, DOI 10.1016/0005-2795(79)90053-9; Elberry M, 2006, BIOCHEMISTRY-US, V45, P4991, DOI 10.1021/bi0522246; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101; GEORGE P, 1964, J BIOL CHEM, V239, P1504; GREENWOOD C, 1965, J BIOL CHEM, V240, P3660; Guergova-Kuras M, 1999, PROTEIN EXPRES PURIF, V15, P370, DOI 10.1006/prep.1998.1018; HARBURY HA, 1965, P NATL ACAD SCI USA, V54, P1658, DOI 10.1073/pnas.54.6.1658; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KIHARA H, 1976, BIOCHIM BIOPHYS ACTA, V430, P225, DOI 10.1016/0005-2728(76)90081-5; Kokhan O, 2010, J BIOL CHEM, V285, P22513, DOI 10.1074/jbc.M110.128058; Leskovac V., 2003, COMPREHENSIVE ENZYME, P111; Li J, 2002, BBA-BIOENERGETICS, V1556, P175, DOI 10.1016/S0005-2728(02)00360-2; Lu J, 1999, SPECTROSC LETT, V32, P519, DOI 10.1080/00387019909350003; MARGOLIASH E., 1966, ADVANCE PROTEIN CHEM, V21, P113, DOI 10.1016/S0065-3233(08)60128-X; Osyczka A, 2004, BBA-BIOENERGETICS, V1655, P71, DOI 10.1016/j.bbabio.2003.07.005; Osyczka A, 2001, BIOCHEMISTRY-US, V40, P14547, DOI 10.1021/bi011630w; PERRIN DD, 1972, DISSOCIATION CONST S, P190; Rosell FI, 1998, J AM CHEM SOC, V120, P11234, DOI 10.1021/ja971756+; SALEEM MMM, 1988, INORG CHIM A-BIOINOR, V153, P105, DOI 10.1016/S0020-1693(00)83867-0; SALEEM MMM, 1988, INORG CHIM A-BIOINOR, V153, P99, DOI 10.1016/S0020-1693(00)83866-9; SHAO WP, 1992, ACTA CHIM SINICA, V50, P1129; SHAO WP, 1995, J INORG BIOCHEM, V57, P103; Sivakolundu SG, 2000, J AM CHEM SOC, V122, P1513, DOI 10.1021/ja993225m; SUTIN N, 1972, J BIOL CHEM, V247, P6932; Varhac R, 2009, BIOPHYS CHEM, V144, P21, DOI 10.1016/j.bpc.2009.06.001; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yao Y, 2003, BIOPHYS CHEM, V104, P459, DOI 10.1016/S0301-4622(03)00031-0; Yao Y, 2002, J BIOL INORG CHEM, V7, P539, DOI 10.1007/s00775-001-0334-y; Zhang HB, 2006, BIOCHEMISTRY-US, V45, P14247, DOI 10.1021/bi061345i	42	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22522	22531		10.1074/jbc.M110.128082	http://dx.doi.org/10.1074/jbc.M110.128082			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20448037	hybrid, Green Published			2022-12-25	WOS:000279702200064
J	Whitney, M; Crisp, JL; Olson, ES; Aguilera, TA; Gross, LA; Ellies, LG; Tsien, RY				Whitney, Mike; Crisp, Jessica L.; Olson, Emilia S.; Aguilera, Todd A.; Gross, Larry A.; Ellies, Lesley G.; Tsien, Roger Y.			Parallel in Vivo and in Vitro Selection Using Phage Display Identifies Protease-dependent Tumor-targeting Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PENETRATING PEPTIDES; TYPE-1 MATRIX-METALLOPROTEINASE; POLYMORPHONUCLEAR LEUKOCYTE ELASTASE; ENDOGENOUS SERUM-ALBUMIN; PANCREATIC CYSTIC TUMORS; PRIMARY BREAST-CANCER; DRUG-DELIVERY; MOUSE MODEL; EXPRESSION; ACTIVATION	We recently developed activatable cell-penetrating peptides (ACPPs) that target contrast agents to in vivo sites of matrix metalloproteinase activity, such as tumors. Here we use parallel in vivo and in vitro selection with phage display to identify novel tumor-homing ACPPs with no bias for primary sequence or target protease. Specifically, phage displaying a library of ACPPs were either injected into tumor-bearing mice, followed by isolation of cleaved phage from dissected tumor, or isolated based on selective cleavage by extracts of tumor versus normal tissue. Selected sequences were synthesized as fluorescently labeled peptides, and tumor-specific cleavage was confirmed by digestion with tissue extracts. The most efficiently cleaved peptide contained the substrate sequence RLQLKL and labeled tumors and metastases from several cancer models with up to 5-fold contrast. This uniquely identified ACPP was not cleaved by matrix metalloproteinases or various coagulation factors but was efficiently cleaved by plasmin and elastases, both of which have been shown to be aberrantly overexpressed in tumors. The identification of an ACPP that targets tumor expressed proteases without rational design highlights the value of unbiased selection schemes for the development of potential therapeutic agents.	[Whitney, Mike; Olson, Emilia S.; Aguilera, Todd A.; Gross, Larry A.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Crisp, Jessica L.; Tsien, Roger Y.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ellies, Lesley G.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Gross, Larry A.; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Olson, Emilia S.; Aguilera, Todd A.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Tsien, RY (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	rtsien@ucsd.edu		Aguilera, Todd/0000-0002-3734-3758	National Institutes of Health, NCI [CA118182]; DOD [W81XWH-05-1-0183]; NATIONAL CANCER INSTITUTE [K22CA118182] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA118182 (to L. E.) and DOD grant W81XWH-05-1-0183 (to R. Y. T)	Aguilera TA, 2009, INTEGR BIOL, V1, P371, DOI 10.1039/b904878b; ALLES AJ, 1994, ANN SURG, V219, P131, DOI 10.1097/00000658-199402000-00004; Atwell S, 1999, P NATL ACAD SCI USA, V96, P9497, DOI 10.1073/pnas.96.17.9497; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Bremer C, 2001, RADIOLOGY, V221, P523, DOI 10.1148/radiol.2212010368; Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Cuevas BD, 2006, ONCOGENE, V25, P4998, DOI 10.1038/sj.onc.1209507; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Desmedt C, 2006, INT J CANCER, V119, P2539, DOI 10.1002/ijc.22149; Foekens JA, 2003, CANCER RES, V63, P337; Gammon ST, 2003, BIOCONJUGATE CHEM, V14, P368, DOI 10.1021/bc0256291; Goun EA, 2006, BIOCONJUGATE CHEM, V17, P787, DOI 10.1021/bc0503216; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; KOIVUNEN E, 1991, INT J CANCER, V47, P592, DOI 10.1002/ijc.2910470419; Koshikawa N, 1998, AM J PATHOL, V153, P937, DOI 10.1016/S0002-9440(10)65635-0; Kratz F, 2002, J MED CHEM, V45, P5523, DOI 10.1021/jm020276c; Kratz F, 2000, J MED CHEM, V43, P1253, DOI 10.1021/jm9905864; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; La Rocca G, 2004, BRIT J CANCER, V90, P1414, DOI 10.1038/sj.bjc.6601725; Laakkonen P, 2004, P NATL ACAD SCI USA, V101, P9381, DOI 10.1073/pnas.0403317101; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Maglione JE, 2001, CANCER RES, V61, P8298; Mi ZB, 2003, MOL THER, V8, P295, DOI 10.1016/S1525-0016(03)00181-3; Miyata S, 1999, J BIOCHEM, V125, P1067, DOI 10.1093/oxfordjournals.jbchem.a022388; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Paju A, 2004, CLIN CANCER RES, V10, P4761, DOI 10.1158/1078-0432.CCR-0204-03; Ratnikov BI, 2002, LAB INVEST, V82, P1583, DOI 10.1097/01.LAB.0000038555.67772.DB; Rothbard JB, 2002, J MED CHEM, V45, P3612, DOI 10.1021/jm0105676; Sabapathy KT, 1997, J CELL BIOL, V137, P953, DOI 10.1083/jcb.137.4.953; Sidhu SS, 2001, BIOMOL ENG, V18, P57, DOI 10.1016/S1389-0344(01)00087-9; Sounni NE, 2003, MATRIX BIOL, V22, P55, DOI 10.1016/S0945-053X(03)00003-9; Sperti C, 1996, CANCER, V78, P237, DOI 10.1002/(SICI)1097-0142(19960715)78:2<237::AID-CNCR8>3.0.CO;2-I; Talvensaari-Mattila A, 2003, BRIT J CANCER, V89, P1270, DOI 10.1038/sj.bjc.6601238; Thie JA, 2004, J NUCL MED, V45, P1431; Wright LR, 2003, CURR PROTEIN PEPT SC, V4, P105, DOI 10.2174/1389203033487252; YAMASHITA JI, 1994, BRIT J CANCER, V69, P72, DOI 10.1038/bjc.1994.11; Zhang Y, 2006, NANO LETT, V6, P1988, DOI 10.1021/nl0611586; Zou J, 2004, MOL BIOL REP, V31, P121, DOI 10.1023/B:MOLE.0000031459.14448.af	43	57	65	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22532	22541		10.1074/jbc.M110.138297	http://dx.doi.org/10.1074/jbc.M110.138297			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460372	hybrid, Green Published			2022-12-25	WOS:000279702200065
J	Li, M; Chen, CA; Davies, DR; Chiu, TK				Li, Min; Chen, Changqing; Davies, David R.; Chiu, Thang K.			Induced-fit Mechanism for Prolyl Endopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL-PEPTIDASE-IV; FIBROBLAST ACTIVATION PROTEIN; POSTPROLINE CLEAVING ENZYME; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; PORPHYROMONAS-GINGIVALIS; SERRATIA-MARCESCENS; GLYCEMIC CONTROL; STRUCTURAL BASIS; RAT-BRAIN	Prolyl peptidases cleave proteins at proline residues and are of importance for cancer, neurological function, and type II diabetes. Prolyl endopeptidase (PEP) cleaves neuropeptides and is a drug target for neuropsychiatric diseases such as post-traumatic stress disorder, depression, and schizophrenia. Previous structural analyses showing little differences between native and substrate-bound structures have suggested a lock-and-key catalytic mechanism. We now directly demonstrate from seven structures of Aeromonus punctata PEP that the mechanism is instead induced fit: the native enzyme exists in a conformationally flexible opened state with a large interdomain opening between the beta-propeller and alpha/beta-hydrolase domains; addition of substrate to preformed native crystals induces a large scale conformational change into a closed state with induced-fit adjustments of the active site, and inhibition of this conformational change prevents substrate binding. Absolute sequence conservation among 28 orthologs of residues at the active site and critical residues at the interdomain interface indicates that this mechanism is conserved in all PEPs. This finding has immediate implications for the use of conformationally targeted drug design to improve specificity of inhibition against this family of proline-specific serine proteases.	[Chiu, Thang K.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Li, Min; Davies, David R.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Chen, Changqing] Chinese Acad Sci, Shanghai Res Ctr Biotechnol, Shanghai 200233, Peoples R China	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Chinese Academy of Sciences	Chiu, TK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	tchiu@lsuhsc.edu			United States Department of Energy, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK034002] Funding Source: NIH RePORTER	United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The use of the Advanced Photon Source was supported by United States Department of Energy, Office of Basic Energy Sciences, Contract W-31-109-Eng-38.	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Ahren B, 2004, J CLIN ENDOCR METAB, V89, P2078, DOI 10.1210/jc.2003-031907; Ansorge S, 2009, CLIN CHEM LAB MED, V47, P253, DOI 10.1515/CCLM.2009.063; Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; ATACK JR, 1991, EUR J PHARMACOL, V205, P157, DOI 10.1016/0014-2999(91)90814-7; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Bellemere G, 2005, J NEUROENDOCRINOL, V17, P306, DOI 10.1111/j.1365-2826.2005.01308.x; Bellemere G, 2003, J NEUROCHEM, V84, P919, DOI 10.1046/j.1471-4159.2003.01536.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen WT, 2003, ADV EXP MED BIOL, V524, P197; Chiravuri M, 1999, J IMMUNOL, V163, P3092; Chiu TK, 2005, P NATL ACAD SCI USA, V102, P7517, DOI 10.1073/pnas.0502495102; DE MI, 2003, ADV EXP MED BIOL, V524, P3; Drucker DJ, 2003, EXPERT OPIN INV DRUG, V12, P87, DOI 10.1517/13543784.12.1.87; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Fuxreiter M, 2005, PROTEINS, V60, P504, DOI 10.1002/prot.20508; Geiss-Friedlander R, 2009, J BIOL CHEM, V284, P27211, DOI 10.1074/jbc.M109.041871; Hiramatsu H, 2003, BIOCHEM BIOPH RES CO, V302, P849, DOI 10.1016/S0006-291X(03)00258-4; Holst JJ, 2003, ADV EXP MED BIOL, V524, P263; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Irazusta J, 2002, NEUROCHEM INT, V40, P337, DOI 10.1016/S0197-0186(01)00078-X; Ito K, 2000, J BIOCHEM, V128, P673, DOI 10.1093/oxfordjournals.jbchem.a022800; Ito K, 2006, J MOL BIOL, V362, P228, DOI 10.1016/j.jmb.2006.06.083; Jones B, 2003, BLOOD, V102, P1641, DOI 10.1182/blood-2003-01-0208; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KOIDA M, 1976, J BIOL CHEM, V251, P7593; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Lambeir AM, 2002, BIOCHEM PHARMACOL, V64, P1753, DOI 10.1016/S0006-2952(02)01415-6; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Lee HJ, 2006, J BIOL CHEM, V281, P38653, DOI 10.1074/jbc.M603895200; Ludwig A, 2002, J LEUKOCYTE BIOL, V72, P183; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; Maes M, 2001, PSYCHONEUROENDOCRINO, V26, P17, DOI 10.1016/S0306-4530(00)00032-9; Maes M, 1999, J AFFECT DISORDERS, V53, P27, DOI 10.1016/S0165-0327(98)00086-X; MAES M, 1995, PSYCHIAT RES, V58, P217, DOI 10.1016/0165-1781(95)02698-V; Medrano FJ, 1998, EMBO J, V17, P1, DOI 10.1093/emboj/17.1.1; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Olsen C, 2002, GENE, V299, P185, DOI 10.1016/S0378-1119(02)01059-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pitman MR, 2009, FRONT BIOSCI-LANDMRK, V14, P3619, DOI 10.2741/3476; POLGAR L, 1993, FEBS LETT, V322, P227, DOI 10.1016/0014-5793(93)81575-K; POLGAR L, 1992, BIOCHEM J, V283, P647, DOI 10.1042/bj2830647; POLGAR L, 1991, EUR J BIOCHEM, V197, P441, DOI 10.1111/j.1432-1033.1991.tb15930.x; POLGAR L, 1991, BIOMED BIOCHIM ACTA, V50, P721; Portevin B, 1996, J MED CHEM, V39, P2379, DOI 10.1021/jm950858c; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Reinhold D, 2008, FRONT BIOSCI-LANDMRK, V13, P2356, DOI 10.2741/2849; Richard E, 2002, J BIOL CHEM, V277, P19720, DOI 10.1074/jbc.M111901200; Rigolet P, 2002, STRUCTURE, V10, P1383, DOI 10.1016/S0969-2126(02)00851-1; Ristic S, 2005, DIABETES OBES METAB, V7, P692, DOI 10.1111/j.1463-1326.2005.00539.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schrag JD, 1997, STRUCTURE, V5, P187, DOI 10.1016/S0969-2126(97)00178-0; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Szeltner Z, 2004, J MOL BIOL, V340, P627, DOI 10.1016/j.jmb.2004.05.011; Szeltner Z, 2002, J BIOL CHEM, V277, P42613, DOI 10.1074/jbc.M208043200; TAYLOR WL, 1980, BIOCHEM BIOPH RES CO, V94, P9, DOI 10.1016/S0006-291X(80)80179-3; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; WALTER R, 1978, BIOCHEMISTRY-US, V17, P4139, DOI 10.1021/bi00613a006; WELCHES WR, 1993, LIFE SCI, V52, P1461, DOI 10.1016/0024-3205(93)90108-F; Yoshimoto T, 1999, J BIOCHEM, V126, P559, DOI 10.1093/oxfordjournals.jbchem.a022486	67	60	60	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21487	21495		10.1074/jbc.M109.092692	http://dx.doi.org/10.1074/jbc.M109.092692			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444688	Green Published, hybrid			2022-12-25	WOS:000279516100035
J	Martel, G; Hamet, P; Tremblay, J				Martel, Guy; Hamet, Pavel; Tremblay, Johanne			GREBP, a cGMP-response Element-binding Protein Repressing the Transcription of Natriuretic Peptide Receptor 1 (NPR1/GCA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICULATE GUANYLATE-CYCLASE; VASCULAR ENDOTHELIAL-CELLS; MESSENGER-RNA DEGRADATION; NITRIC-OXIDE SYNTHASE; CYCLIC-GMP; ANGIOTENSIN-II; PHOSPHORYLATION SITES; GENE-EXPRESSION; PORCINE BRAIN; SMOOTH-MUSCLE	NPR1/GCA (natriuretic peptide receptor 1/guanylyl cyclase A) expression is controlled by several agents, including ANP (atrial natriuretic peptide). After ANP stimulation, NPR1/GCA down-regulates the transcriptional activity of its gene via a cGMP-dependent mechanism. Because we previously identified a cis-acting element responsible for this cGMP sensitivity, we proceed here to explore novel putative protein binding to cGMP-response element (cGMP-RE). Using the yeast one-hybrid technique with a human kidney cDNA library, we identified a strong positive clone able to bind cGMP-RE. The clone was derived from 1083-bp-long cDNA of a gene of yet unknown function localized on human chromosome 1 (1p33.36). We named this new protein GREBP (for cGMP-response element-binding protein). DNA binding assays showed 18-fold higher cGMP-RE binding capacity than the controls, whereas an electromobility shift assay indicated a specific binding for the cGMP-RE, and chromatin immunoprecipitation confirmed the binding of GREBP to the element under physiological conditions. By acting on cGMP-RE, GREBP inhibited the expression of a luciferase-coupled NPR1 promoter construct. In H295R cells, ANP heightened GREBP expression by 60% after just 3h of treatment while inhibiting NPR1/GCA expression by 30%. Silencing GREBP with specific small interfering RNA increased the activity of the luciferase-coupled NPR1 promoter and GCA/NPR1 mRNA levels. GREBP is a nuclear protein mainly expressed in the heart. We report here the existence of a human-specific gene that acts as a transcriptional repressor of the NPR1/GCA gene.	[Martel, Guy; Hamet, Pavel; Tremblay, Johanne] Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Montreal, PQ H1W 4A4, Canada	Universite de Montreal	Tremblay, J (corresponding author), CRCHUM, Technopole Angus,2901 Rue Rachel Est,Bur 314, Montreal, PQ H1W 4A4, Canada.	johanne.tremblay@umontreal.ca	Cossette, Suzanne/I-8008-2016; Tremblay, Johanne/E-2154-2013		Canadian Institutes of Health Research [MOP-11463]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-11463 (to J. T.).	Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BENNETT BD, 1991, J BIOL CHEM, V266, P23060; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; CAO L, 1995, J BIOL CHEM, V270, P24891, DOI 10.1074/jbc.270.42.24891; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chan SHH, 2004, MOL PHARMACOL, V65, P319, DOI 10.1124/mol.65.2.319; CHARTIER L, 1984, ENDOCRINOLOGY, V115, P2026, DOI 10.1210/endo-115-5-2026; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cheng HF, 2000, AM J PHYSIOL-RENAL, V279, pF122, DOI 10.1152/ajprenal.2000.279.1.F122; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; CURRIE MG, 1983, SCIENCE, V221, P71, DOI 10.1126/science.6857267; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Duttweiler HM, 1996, TRENDS GENET, V12, P340, DOI 10.1016/S0168-9525(96)80008-4; El Hader C, 2005, AM J PHYSIOL-RENAL, V289, pF1273, DOI 10.1152/ajprenal.00103.2005; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; GARBERS DL, 1992, CELL, V71, P1; Garg R, 2005, PEPTIDES, V26, P1009, DOI 10.1016/j.peptides.2004.09.022; Garg R, 2003, HYPERTENSION, V41, P730, DOI 10.1161/01.HYP.0000051890.68573.94; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; HAMET P, 1978, J CYCLIC NUCL PROT, V4, P281; HAMET P, 1984, BIOCHEM BIOPH RES CO, V123, P515, DOI 10.1016/0006-291X(84)90260-2; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; He B, 2003, EUR J BIOCHEM, V270, P2174, DOI 10.1046/j.1432-1033.2003.03574.x; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hum D, 2004, HYPERTENSION, V43, P1270, DOI 10.1161/01.HYP.0000126920.93207.53; Huo XW, 1999, BIOCHEMISTRY-US, V38, P16941, DOI 10.1021/bi9919448; INAGAMI T, 1989, J BIOL CHEM, V264, P3043; INOUE T, 1995, HYPERTENSION, V25, P711, DOI 10.1161/01.HYP.25.4.711; Isono K, 1999, NUCLEIC ACIDS RES, V27, P3728, DOI 10.1093/nar/27.18.3728; ITOH H, 1992, HYPERTENSION, V19, P758, DOI 10.1161/01.HYP.19.6.758; KATAFUCHI T, 1992, J BIOL CHEM, V267, P7624; Kiemer AK, 1998, J BIOL CHEM, V273, P13444, DOI 10.1074/jbc.273.22.13444; Kiemer AK, 2000, J IMMUNOL, V165, P175, DOI 10.4049/jimmunol.165.1.175; Kopp K, 2005, J CELL BIOCHEM, V95, P217, DOI 10.1002/jcb.20403; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LANIERSMITH KL, 1991, ENDOCRINOLOGY, V129, P2311, DOI 10.1210/endo-129-5-2311; Lee ES, 2007, FEBS LETT, V581, P4325, DOI 10.1016/j.febslet.2007.08.001; Martel G, 2010, MOL CELL BIOCHEM, V334, P53, DOI 10.1007/s11010-009-0326-8; NEYSES L, 1989, BIOCHEM BIOPH RES CO, V163, P1435, DOI 10.1016/0006-291X(89)91139-X; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; Perez-Sala D, 2001, AM J PHYSIOL-RENAL, V280, pF466, DOI 10.1152/ajprenal.2001.280.3.F466; Potter LR, 1999, METHODS, V19, P506, DOI 10.1006/meth.1999.0893; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058; Saeed M, 2007, CLIN GENET, V71, P238, DOI 10.1111/j.1399-0004.2007.00753.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sauzeau V, 2003, J BIOL CHEM, V278, P9472, DOI 10.1074/jbc.M212776200; Schmitzer AR, 2004, PROTEIN ENG DES SEL, V17, P809, DOI 10.1093/protein/gzh090; Sengenes C, 2003, J BIOL CHEM, V278, P48617, DOI 10.1074/jbc.M303713200; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Stein GS, 2000, J CELL SCI, V113, P2527; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; TREMBLAY J, 1986, FEBS LETT, V194, P210, DOI 10.1016/0014-5793(86)80086-2; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661; Wolf YI, 2009, P NATL ACAD SCI USA, V106, P7273, DOI 10.1073/pnas.0901808106; Yamamoto K, 1997, J MOL CELL CARDIOL, V29, P2375, DOI 10.1006/jmcc.1997.0472; Ye Q, 2003, HYPERTENSION, V41, P675, DOI 10.1161/01.HYP.0000047204.72286.34; Yu XP, 2005, J BIOL CHEM, V280, P35184, DOI 10.1074/jbc.M508138200; Zaragoza C, 2002, MOL PHARMACOL, V62, P927, DOI 10.1124/mol.62.4.927; ZEIDEL ML, 1990, ANNU REV PHYSIOL, V52, P747	63	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20926	20939		10.1074/jbc.M109.061622	http://dx.doi.org/10.1074/jbc.M109.061622			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20444705	Green Published, hybrid			2022-12-25	WOS:000279228600057
J	Guo, G; Qiu, X; Wang, S; Chen, Y; Rothman, PB; Wang, Z; Chen, Y; Wang, G; Chen, JL				Guo, G.; Qiu, X.; Wang, S.; Chen, Y.; Rothman, P. B.; Wang, Z.; Chen, Y.; Wang, G.; Chen, J-L			Oncogenic E17K mutation in the pleckstrin homology domain of AKT1 promotes v-Abl-mediated pre-B-cell transformation and survival of Pim-deficient cells	ONCOGENE			English	Article						AKT1; v-Abl; Pim; mutation; cancer	SERINE/THREONINE KINASE PIM-1; HEMATOPOIETIC-CELLS; LEUKEMIA-CELLS; HUMAN CANCER; DOWNSTREAM; APOPTOSIS; PATHWAY; GROWTH; PHOSPHORYLATION; LEUKEMOGENESIS	Abl-mediated transformation requires the activation of multiple pathways involved in the cellular proliferation and survival, including PI3K/AKT and JAK/STAT-dependent Pim kinases. Recently, the E17K mutation in the AKT1 has been associated with multiple human malignancies and leukemia in mice. However, this mutation has not been identified in Abl-transformed cells. We investigated the presence of the AKT1(E17K) mutation in v-Abl-transformed cell clones. AKT1(E17K) was detected in 3 (2.6%) of 116 specimens examined. To show the involvement of AKT1(E17K) directly in v-Abl-mediated tumorigenesis, we infected bone marrow cells from mice with bicistronic retroviruses encoding v-Abl and either wild-type or the mutant AKT1. Interestingly, we found that E17K mutant greatly increased the v-Abl transformation efficiency as compared with wild-type AKT1. Ectopic expression of E17K mutant increased the expression levels of antiapoptotic protein BCL2 and phosphorylation levels of proapoptotic protein BAD. This correlated with an increased protection from imatinib-induced apoptosis in Abl transformants. Furthermore, AKT1(E17K) promotes survival of the Pim-deficient cells, indicating a functional link between AKT and Pim in v-Abl transformation. In addition, AKT1(E17K) delays loss of Pim-1 and Pim-2 protein levels on v-Abl inactivation, which suggests that there exists reciprocal signaling between AKT and Pim in v-Abl transformants. Oncogene (2010) 29, 3845-3853; doi: 10.1038/onc.2010.149; published online 3 May 2010	[Guo, G.; Qiu, X.; Wang, S.; Chen, Y.; Chen, J-L] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Rothman, P. B.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Wang, Z.; Chen, Y.] China Agr Univ, Coll Anim Med, Dept Cell Biol & Anat, Beijing 100094, Peoples R China; [Wang, G.] Louisiana State Univ, Hlth Sci Ctr, Dept Med & Genet, Gene Therapy Program, New Orleans, LA USA	Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Iowa; China Agricultural University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Chen, JL (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, W Beichen Rd, Beijing 100101, Peoples R China.	chenjl@im.ac.cn	Chen, Ji-Long/AAJ-2134-2021	Chen, Ji-Long/0000-0002-4274-0563; Guo, Guijie/0000-0002-9031-1915	Natural Science Foundation of China [30971476]; National Basic Research Program (973) of China [2009CB918902, 2010CB534004]; Chinese Academy of Sciences	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973) of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank members of Chen laboratory for helpful discussions. This work was supported by Natural Science Foundation of China (30971476), National Basic Research Program (973) of China (2009CB918902, 2010CB534004) and Hundreds of Talents Program of Chinese Academy of Sciences 2009-2014.	AHMED NN, 1993, ONCOGENE, V8, P1957; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Banerjee A, 1998, J IMMUNOL, V161, P4611; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen JL, 2008, BLOOD, V111, P1677, DOI 10.1182/blood-2007-04-083808; Cheng GD, 2005, COLD REG SCI TECHNOL, V42, P169, DOI 10.1016/j.coldregions.2005.01.002; Danial NN, 2000, ONCOGENE, V19, P2523, DOI 10.1038/sj.onc.1203484; Deutsch AJA, 2007, BLOOD, V109, P3500, DOI 10.1182/blood-2006-06-030494; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Gong L, 2004, J VIROL, V78, P1636, DOI 10.1128/JVI.78.4.1636-1644.2004; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Horn S, 2008, ONCOGENE, V27, P4096, DOI 10.1038/onc.2008.40; Hu XF, 2009, J CLIN INVEST, V119, P362, DOI 10.1172/JCI33216; Kharas MG, 2008, J CLIN INVEST, V118, P3038, DOI 10.1172/JCI33337; Kharas NG, 2005, CANCER RES, V65, P2047, DOI 10.1158/0008-5472.CAN-04-3888; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; Klejman A, 2002, ONCOGENE, V21, P5868, DOI 10.1038/sj.onc.1205724; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P12260, DOI 10.1021/bi801683k; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Mahmoud IS, 2008, BRIT J CANCER, V99, P488, DOI 10.1038/sj.bjc.6604512; Malanga D, 2008, CELL CYCLE, V7, P665, DOI 10.4161/cc.7.5.5485; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mohamedali A, 2008, TECHNOL CANCER RES T, V7, P407, DOI 10.1177/153303460800700509; Muraski JA, 2007, NAT MED, V13, P1467, DOI 10.1038/nm1671; Nieborowska-Skorska M, 2002, BLOOD, V99, P4531, DOI 10.1182/blood.V99.12.4531; Oki S, 2002, BLOOD, V100, P966, DOI 10.1182/blood.V100.3.966; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Riener MO, 2008, BRIT J CANCER, V99, P836, DOI 10.1038/sj.bjc.6604498; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Tao WJ, 2008, ONCOGENE, V27, P3194, DOI 10.1038/sj.onc.1210979; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Zenz T, 2008, BRIT J HAEMATOL, V141, P742, DOI 10.1111/j.1365-2141.2008.07113.x; Zhang F, 2009, CANCER BIOL THER, V8, P846, DOI 10.4161/cbt.8.9.8210; Zilberman DE, 2009, CANCER GENET CYTOGEN, V191, P34, DOI 10.1016/j.cancergencyto.2009.01.009	41	32	33	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2010	29	26					3845	3853		10.1038/onc.2010.149	http://dx.doi.org/10.1038/onc.2010.149			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	618VW	20440266				2022-12-25	WOS:000279385200012
J	Hettiarachchi, G; Nguyen, D; Wu, J; Lucas, D; Ma, D; Isaacs, L; Briken, V				Hettiarachchi, Gaya; Nguyen, Duc; Wu, Jing; Lucas, Derick; Ma, Da; Isaacs, Lyle; Briken, Volker			Toxicology and Drug Delivery by Cucurbit[n]uril Type Molecular Containers	PLOS ONE			English	Article							NANOPARTICLES; CUCURBITURIL; TUBERCULOSIS; ENCAPSULATION; CYTOTOXICITY; RESISTANCE; DENDRIMERS; COMPLEXES; TOXICITY	Background: Many drug delivery systems are based on the ability of certain macrocyclic compounds - such as cyclodextrins (CDs) - to act as molecular containers for pharmaceutical agents in water. Indeed beta-CD and its derivatives have been widely used in the formulation of hydrophobic pharmaceuticals despite their poor abilities to act as a molecular container (e. g., weak binding (K-a < 10(4) M-1) and their challenges toward chemical functionalization. Cucurbit[n]urils (CB[n]) are a class of molecular containers that bind to a variety of cationic and neutral species with high affinity (K-a < 10(4) M-1) and therefore show great promise as a drug delivery system. Methodology: In this study we investigated the toxicology, uptake, and bioactivity of two cucurbit[n]urils (CB[5] and CB[7]) and three CB[n]-type containers (Pentamer 1, methyl hexamer 2, and phenyl hexamer 3). All five containers demonstrated high cell tolerance at concentrations of up to 1 mM in cell lines originating from kidney, liver or blood tissue using assays for metabolic activity and cytotoxicity. Furthermore, the CB[7] molecular container was efficiently internalized by macrophages indicating their potential for the intracellular delivery of drugs. Bioactivity assays showed that the first-line tuberculosis drug, ethambutol, was as efficient in treating mycobacteria infected macrophages when loaded into CB[7] as when given in the unbound form. This result suggests that CB[7]-bound drug molecules can be released from the container to find their intracellular target. Conclusion: Our study reveals very low toxicity of five members of the cucurbit[n]uril family of nanocontainers. It demonstrates the uptake of containers by cells and intracellular release of container-loaded drugs. These results provide initial proof-of-concept towards the use of CB[n] molecular containers as an advanced drug delivery system.	[Hettiarachchi, Gaya; Nguyen, Duc; Briken, Volker] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Wu, Jing; Lucas, Derick; Ma, Da; Isaacs, Lyle] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Hettiarachchi, G (corresponding author), Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA.	LIsaacs@umd.edu; vbriken@umd.edu	Isaacs, Lyle D/B-4472-2009	Isaacs, Lyle D/0000-0002-4079-332X; Briken, Volker/0000-0001-5830-6107	Maryland Department of Business and Economic Development (Nano-Bio Initiative); Maryland Technology Development Corporation	Maryland Department of Business and Economic Development (Nano-Bio Initiative); Maryland Technology Development Corporation	The authors thank the Maryland Department of Business and Economic Development (Nano-Bio Initiative) and the Maryland Technology Development Corporation for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlin G, 2009, DRUG METAB DISPOS, V37, P2275, DOI 10.1124/dmd.109.028654; BARANELLO L, 2009, NUCL ACIDS RES; Biagini CP, 2006, TOXICOL IN VITRO, V20, P1051, DOI 10.1016/j.tiv.2006.01.013; Cavagnaro JA, 2002, NAT REV DRUG DISCOV, V1, P469, DOI 10.1038/nrd822; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; Chaoui I, 2009, J INFECT DEV COUNTR, V3, P278; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Day A, 2001, J ORG CHEM, V66, P8094, DOI 10.1021/jo015897c; Delie F, 2005, MOLECULES, V10, P65, DOI 10.3390/10010065; Delogu G, 2009, J INFECT DEV COUNTR, V3, P5, DOI 10.3855/jidc.99; Dexheimer TS, 2009, J MED CHEM, V52, P7122, DOI 10.1021/jm901061s; Ge Z, 2008, ACTA PHARMACOL SIN, V29, P990, DOI 10.1111/j.1745-7254.2008.00825.x; Gelperina S, 2005, AM J RESP CRIT CARE, V172, P1487, DOI 10.1164/rccm.200504-613PP; He H, 2008, OPT LETT, V33, P2961, DOI 10.1364/OL.33.002961; HERRLING P, 2005, IMAGING DRUG DISCOVE; Huang WH, 2008, J AM CHEM SOC, V130, P8446, DOI 10.1021/ja8013693; Jeon YJ, 2005, ORG BIOMOL CHEM, V3, P2122, DOI 10.1039/b504487a; Jeon YM, 1996, J AM CHEM SOC, V118, P9790, DOI 10.1021/ja962071x; Jia J, 2005, BRIT J PHARMACOL, V144, P80, DOI 10.1038/sj.bjp.0705984; Kemp S, 2007, SUPRAMOL CHEM, V19, P475, DOI 10.1080/10610270601124019; Kim J, 2007, ANGEW CHEM INT EDIT, V46, P7393, DOI 10.1002/anie.200702540; Kim K, 2007, CHEM SOC REV, V36, P267, DOI 10.1039/b603088m; Kramer JA, 2007, NAT REV DRUG DISCOV, V6, P636, DOI 10.1038/nrd2378; Kuo JHS, 2005, J PHARM PHARMACOL, V57, P489, DOI 10.1211/0022357055803; Kuo JHS, 2005, COLLOID SURFACE B, V41, P189, DOI 10.1016/j.colsurfb.2004.12.008; Lagona J, 2005, ANGEW CHEM INT EDIT, V44, P4844, DOI 10.1002/anie.200460675; Liu SM, 2005, J AM CHEM SOC, V127, P15959, DOI 10.1021/ja055013x; MA D, 2010, J ORG CHEM UNPUB; MOCK WL, 1986, J ORG CHEM, V51, P4440, DOI 10.1021/jo00373a018; Montes-Navajas P, 2009, PHOTOCH PHOTOBIO SCI, V8, P1743, DOI 10.1039/b9pp00041k; Pandey R, 2003, J ANTIMICROB CHEMOTH, V52, P981, DOI 10.1093/jac/dkg477; Park KM, 2009, CHEM COMMUN, P71, DOI 10.1039/b815009e; Peck RW, 2007, DRUG DISCOV TODAY, V12, P289, DOI 10.1016/j.drudis.2007.02.004; Pritchard JF, 2003, NAT REV DRUG DISCOV, V2, P542, DOI 10.1038/nrd1131; Ralph AP, 2009, CLIN INFECT DIS, V49, P574, DOI 10.1086/600889; Sakagami H, 2009, ANTICANCER RES, V29, P343; Samad A, 2009, CURR PHARM DESIGN, V15, P2958, DOI 10.2174/138161209789058200; SCHOLFIELD C, 2009, LONZA RESOURCE NOTES, P6; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; SPATARO G, 2009, EUR J MED CHEM; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; VANDEWATERBEEMD HL, 2003, METHODS PRINCIPLES M; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Verma RK, 2002, J CONTROL RELEASE, V79, P7, DOI 10.1016/S0168-3659(01)00550-8; Wang RB, 2009, DALTON T, P3584, DOI 10.1039/b904028e; Wheate NJ, 2008, J INORG BIOCHEM, V102, P2060, DOI 10.1016/j.jinorgbio.2008.06.005; Wheate NJ, 2004, CHEM COMMUN, P1424, DOI 10.1039/b404358h; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zhao LB, 2009, J PHYS CHEM B, V113, P14172, DOI 10.1021/jp907437e; Zhao YJ, 2009, DALTON T, P5190, DOI 10.1039/b905112k; Zhao YJ, 2008, ORG BIOMOL CHEM, V6, P4509, DOI 10.1039/b813759e	53	201	203	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10514	10.1371/journal.pone.0010514	http://dx.doi.org/10.1371/journal.pone.0010514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463906	gold, Green Published, Green Submitted			2022-12-25	WOS:000277379800009
J	Malka, R; Shochat, E; Rom-Kedar, V				Malka, Roy; Shochat, Eliezer; Rom-Kedar, Vered			Bistability and Bacterial Infections	PLOS ONE			English	Article							ACUTE INFLAMMATORY RESPONSE; CHRONIC GRANULOMATOUS-DISEASE; REDUCED MATHEMATICAL-MODEL; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; NEUTROPHILS; DYNAMICS; QUANTITATION; NEUTROPENIA; HYSTERESIS	Bacterial infections occur when the natural host defenses are overwhelmed by invading bacteria. The main component of the host defense is impaired when neutrophil count or function is too low, putting the host at great risk of developing an acute infection. In people with intact immune systems, neutrophil count increases during bacterial infection. However, there are two important clinical cases in which they remain constant: a) in patients with neutropenic-associated conditions, such as those undergoing chemotherapy at the nadir (the minimum clinically observable neutrophil level); b) in ex vivo examination of the patient's neutrophil bactericidal activity. Here we study bacterial population dynamics under fixed neutrophil levels by mathematical modelling. We show that under reasonable biological assumptions, there are only two possible scenarios: 1) Bacterial behavior is monostable: it always converges to a stable equilibrium of bacterial concentration which only depends, in a gradual manner, on the neutrophil level (and not on the initial bacterial level). We call such a behavior type I dynamics. 2) The bacterial dynamics is bistable for some range of neutrophil levels. We call such a behavior type II dynamics. In the bistable case (type II), one equilibrium corresponds to a healthy state whereas the other corresponds to a fulminant bacterial infection. We demonstrate that published data of in vitro Staphylococcus epidermidis bactericidal experiments are inconsistent with both the type I dynamics and the commonly used linear model and are consistent with type II dynamics. We argue that type II dynamics is a plausible mechanism for the development of a fulminant infection.	[Malka, Roy; Rom-Kedar, Vered] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Estrin Family Chair Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Shochat, Eliezer] Hoffmann La Roche AG, Pharma Res & Early Dev, Basel, Switzerland	Weizmann Institute of Science; Roche Holding	Malka, R (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, Estrin Family Chair Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	vered.rom-kedar@weizmann.ac.il		Rom-Kedar, Vered/0000-0003-3855-6779; Malka, Roy/0000-0002-5091-8771	Israel Science Foundation [273/07]; Minerva Foundation	Israel Science Foundation(Israel Science Foundation); Minerva Foundation	This work was partially supported by the Israel Science Foundation (273/07), and the Minerva Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Asachenkov A., 1993, DIS DYNAMICS; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; BONGRAND P, 1976, J THEOR BIOL, V58, P197, DOI 10.1016/0022-5193(76)90147-8; CAPO C, 1974, J THEOR BIOL, V47, P177, DOI 10.1016/0022-5193(74)90108-8; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; CLAWSON CC, 1976, J LAB CLIN MED, V88, P316; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; D'Agata EMC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004036; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Detilleux J, 2006, J DAIRY SCI, V89, P3455, DOI 10.3168/jds.S0022-0302(06)72383-9; Detilleux JC, 2004, J DAIRY SCI, V87, P3716, DOI 10.3168/jds.S0022-0302(04)73510-9; FEIGIN RD, 1987, TXB PEDIAT INFECT DI; Gammack D, 2004, J MATH BIOL, V48, P218, DOI 10.1007/s00285-003-0232-8; GREEN JN, METHODS MOL BIOL, V412, P319; HAMERS MN, 1984, BLOOD, V64, P635, DOI 10.1182/blood.V64.3.635.635; HAMMER MC, 1981, J LAB CLIN MED, V98, P938; HERALD MC, 2009, B MATH BIOL; Huisman G, 1997, J THEOR BIOL, V185, P389, DOI 10.1006/jtbi.1996.0318; Imran M, 2007, DISCRETE CONT DYN-B, V8, P127; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; LEIJH PCJ, 1979, IMMUNOLOGY, V37, P453; Li YM, 2004, J EXP MED, V200, P613, DOI 10.1084/jem.20040725; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; Marchuk G.I., 1983, MATH MODELS IMMUNOLO; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Nasell I, 2001, J THEOR BIOL, V211, P11, DOI 10.1006/jtbi.2001.2328; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Popper, 1959, LOGIC SCI DISCOVERY; Pugliese A, 2008, MATH BIOSCI, V214, P73, DOI 10.1016/j.mbs.2008.04.004; Rahman Z, 1997, CANCER, V79, P1150, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1150::AID-CNCR13>3.0.CO;2-Z; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Roos D, 2001, BLOOD CELL MOL DIS, V27, P1000, DOI 10.1006/bcmd.2001.0473; Shochat E, 2008, CLIN CANCER RES, V14, P6354, DOI 10.1158/1078-0432.CCR-08-0807; Skalski GT, 2001, ECOLOGY, V82, P3083; SPIERS ASD, 1980, J HYG-CAMBRIDGE, V84, P457, DOI 10.1017/S0022172400026991; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Wolach B, 2008, CLIN IMMUNOL, V129, P103, DOI 10.1016/j.clim.2008.06.012; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	43	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10010	10.1371/journal.pone.0010010	http://dx.doi.org/10.1371/journal.pone.0010010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463954	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379400001
J	Cardoso, SC; Alves, VGL; da Rosa, LAR; Campos, LT; Batista, DVS; Facure, A				Cardoso, Simone C.; Alves, Victor Gabriel L.; da Rosa, Luiz Antonio R.; Campos, Luciana T.; Batista, Delano V. S.; Facure, Alessandro			Monte Carlo Simulation of Bony Heterogeneity Effects on Dose Profile for Small Irradiation Field in Radiotherapy	PLOS ONE			English	Article							CALCULATION ALGORITHMS; EQUIVALENT HETEROGENEITIES; STEREOTACTIC RADIOSURGERY; SMALL BEAMS; PHOTON; DISTRIBUTIONS; DOSIMETRY; PHANTOMS; ENERGY	In the radiotherapy treatment planning of a lesion located in the head region with small field radiation beams, the heterogeneity corrections play an important role. In this work, we investigated the influence of a bony heterogeneity on dose profile inside a soft tissue phantom containing a bony material. PDD curves were obtained by simulation using the Monte Carlo code EGSnrc and employing Eclipse (R) treatment planning system algorithms (Batho, Modified Batho, Equivalent TAR and Anisotropic Analytic Algorithm) for a 15 MV photon beam and field sizes of 2x2 and 10x10 cm(2). The Equivalent TAR method exhibited better agreement with Monte Carlo simulations for the 2x2 cm(2) field size. The magnitude of the effect on PDD due to the bony heterogeneity for 1x1, 2x2 and 10x10 cm(2) field sizes increases to 10, 5 and 3%, respectively.	[Cardoso, Simone C.; Alves, Victor Gabriel L.] Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil; [da Rosa, Luiz Antonio R.; Campos, Luciana T.] CNEN, IRD, Rio De Janeiro, Brazil; [Batista, Delano V. S.] Inst Nacl Canc INCA, Rio De Janeiro, Brazil; [Facure, Alessandro] Comissao Nacl Energia Nucl, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Radioprotecao e Dosimetria; National Cancer Institute (Inca); Comissao Nacional de Energia Nuclear (CNEN)	Cardoso, SC (corresponding author), Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil.	simone@if.ufrj.br	Metrologia das radiacoes, Inct/H-9981-2013; Cardoso, Simone/V-2514-2019; Cardoso, Simone/AAH-4274-2021; Alves, Victor Gabriel Leandro/AAO-5748-2021; Tourinho Campos, Luciana/O-1173-2017	Alves, Victor Gabriel Leandro/0000-0001-7982-2039; Tourinho Campos, Luciana/0000-0003-4751-129X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Funding was received from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AAPM, 2004, 85 AAPM RAD THER COM; [Anonymous], 1976, 24 ICRU; Attix F.H., 2008, INTRO RADIOLOGICAL P; BATHO H F, 1964, J Can Assoc Radiol, V15, P79; BJARNGARD BE, 1990, MED PHYS, V17, P794, DOI 10.1118/1.596475; Carrasco P, 2004, MED PHYS, V31, P2899, DOI 10.1118/1.1788932; Carrasco P, 2007, MED PHYS, V34, P3323, DOI 10.1118/1.2750972; Cheung JYC, 2001, APPL RADIAT ISOTOPES, V54, P461, DOI 10.1016/S0969-8043(00)00283-9; Fogliata A, 2007, PHYS MED BIOL, V52, P1363, DOI 10.1088/0031-9155/52/5/011; ICRU, 1984, 37 ICRU; Kawrakow I., 2000, PIRS701; Martens C, 2000, PHYS MED BIOL, V45, P2519, DOI 10.1088/0031-9155/45/9/306; MIJNHEER BJ, 1987, RADIOTHER ONCOL, V8, P237, DOI 10.1016/S0167-8140(87)80247-5; MOHAN R, 1985, MED PHYS, V12, P592, DOI 10.1118/1.595680; RICE RK, 1987, PHYS MED BIOL, V32, P1087, DOI 10.1088/0031-9155/32/9/002; Rogers D.W.O., 2021, NRC USER CODES EGSNR; Rustgi SN, 1995, MED PHYS, V22, P2117, DOI 10.1118/1.597655; Rustgi SN, 1998, PHYS MED BIOL, V43, P3509, DOI 10.1088/0031-9155/43/12/009; SONTAG M R, 1977, Medical Physics (Woodbury), V4, P431, DOI 10.1118/1.594329; SONTAG MR, 1978, RADIOLOGY, V129, P787, DOI 10.1148/129.3.787; Spirydovich S, 2006, RADIOTHER ONCOL, V81, P309, DOI 10.1016/j.radonc.2006.10.010; Ulmer W, 2005, PHYS MED BIOL, V50, P1767, DOI 10.1088/0031-9155/50/8/010; Ulmer W, 1995, Z MED PHYS, V5, P25; Verhaegen F, 1998, PHYS MED BIOL, V43, P2755, DOI 10.1088/0031-9155/43/10/006; Westermark M, 2000, PHYS MED BIOL, V45, P685, DOI 10.1088/0031-9155/45/3/308; WONG JW, 1990, MED PHYS, V17, P807, DOI 10.1118/1.596555	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10466	10.1371/journal.pone.0010466	http://dx.doi.org/10.1371/journal.pone.0010466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454675	Green Published, gold, Green Submitted			2022-12-25	WOS:000277240300027
J	Machida, RJ; Tsuda, A				Machida, Ryuji J.; Tsuda, Atsushi			Dissimilarity of Species and Forms of Planktonic Neocalanus Copepods Using Mitochondrial COI, 12S, Nuclear ITS, and 28S Gene Sequences	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; OYASHIO REGION; LIFE-CYCLE; CRISTATUS CRUSTACEA; CALANIDAE COPEPODA; EUCALANUS-BUNGII; GRAZING COPEPODS; DNA; PLUMCHRUS; FLEMINGERI	Background: A total of six Neocalanus species inhabit the oceans of the world. Of these, three species plus form variants (N. cristatus, N. plumchrus, N. flemingeri large form, and N. flemingeri small form), which constitute a monophyletic group among Neocalanus copepods, occur in the Northwestern Pacific off Japan. In the present study, we have tried to discriminate the three species plus form variants of Neocalanus copepods based on sequences of four DNA marker regions. Methodology/Principal Findings: Discrimination was performed based on the DNA sequence information from four genetic markers, including the mitochondrial COI, 12S, nuclear ITS, and 28S gene regions. Sequence dissimilarity was compared using both distance- and character-based approaches. As a result, all three species were confirmed to be distinct based on the four genetic marker regions. On the contrary, distinction of the form variants was only confirmed based on DNA sequence of the mitochondrial COI gene region. Conclusions/Significance: Although discrimination was not successful for the form variants based on the mitochondrial 12S, nuclear ITS, and 28S genes, diagnostic nucleotide sequence characters were observed in their mitochondrial COI gene sequences. Therefore, these form variants are considered to be an important unit of evolution below the species level, and constitute a part of the Neocalanus biodiversity.	[Machida, Ryuji J.; Tsuda, Atsushi] Univ Tokyo, Ocean Res Inst, Tokyo 164, Japan	University of Tokyo	Machida, RJ (corresponding author), Smithsonian Natl Museum Nat Hist, Washington, DC USA.	MachidaR@si.edu			Ministry of Education, Culture, Sports, Science and Technology of Japan [20241003]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors gratefully acknowledge the support of the Alfred P. Sloan Foundation. Additional support for this project was provided to R.J.M. and A. T. by a Grant-in-Aid for Scientific Research No. 20241003 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Data Integration & Analysis System from the Ministry of Education, Culture, Sports, Science and Technology of Japan provided funding to R.J.M. This study is a contribution from the Census of Marine Zooplankton (CMarZ), an ocean realm field project of the Census of Marine Life.	Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; BIRKY CW, 1989, GENETICS, V121, P613; Blaxter M, 2003, TRENDS ECOL EVOL, V18, P268, DOI 10.1016/S0169-5347(03)00102-2; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; BRADFORD JM, 1988, HYDROBIOLOGIA, V167, P73, DOI 10.1007/BF00026295; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Escorza-Trevino S, 2000, MOL ECOL, V9, P1049, DOI 10.1046/j.1365-294x.2000.00959.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kobari T, 2001, J PLANKTON RES, V23, P287, DOI 10.1093/plankt/23.3.287; Kobari T, 2001, MAR ECOL PROG SER, V209, P243, DOI 10.3354/meps209243; Kobari T, 1999, MAR BIOL, V134, P683, DOI 10.1007/s002270050584; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; Machida RJ, 2006, MAR BIOL, V148, P1071, DOI 10.1007/s00227-005-0140-0; Machida RJ, 2004, GENE, V332, P71, DOI 10.1016/j.gene.2004.01.019; Machida RJ, 2002, MAR BIOTECHNOL, V4, P406, DOI 10.1007/s10126-002-0033-x; Maddison DR, 2000, MACCLADE, V4; Mayr E., 1963, ANIMAL SPECIES EVOLU; MILLER CB, 1984, PROG OCEANOGR, V13, P201, DOI 10.1016/0079-6611(84)90009-0; MILLER CB, 1988, PROG OCEANOGR, V20, P293, DOI 10.1016/0079-6611(88)90044-4; MILLER CB, 1988, PROG OCEANOGR, V20, P223, DOI 10.1016/0079-6611(88)90042-0; MIYAMOTO H, 1904, CAECOSAGITTA M UNPUB; Norris RD, 2000, PALEOBIOLOGY, V26, P236, DOI 10.1666/0094-8373(2000)26[236:PSDBAE]2.0.CO;2; Pardini AT, 2001, NATURE, V412, P139, DOI 10.1038/35084125; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Tsuda A, 1999, MAR BIOL, V135, P533, DOI 10.1007/s002270050654; Tsuda Atsushi, 2001, Journal of Oceanography, V57, P341, DOI 10.1023/A:1012490730792	31	31	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10278	10.1371/journal.pone.0010278	http://dx.doi.org/10.1371/journal.pone.0010278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442767	Green Published, gold, Green Submitted			2022-12-25	WOS:000277154200002
J	Zhang, G; Karns, R; Narancic, NS; Sun, GY; Cheng, H; Missoni, S; Durakovic, Z; Rudan, P; Chakraborty, R; Deka, R				Zhang, Ge; Karns, Rebekah; Narancic, Nina Smolej; Sun, Guangyun; Cheng, Hong; Missoni, Sasa; Durakovic, Zijad; Rudan, Pavao; Chakraborty, Ranajit; Deka, Ranjan			Common SNPs in FTO Gene Are Associated with Obesity Related Anthropometric Traits in an Island Population from the Eastern Adriatic Coast of Croatia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTILOCUS GENOTYPE DATA; BODY-MASS INDEX; ADULT OBESITY; FRAME SIZE; QUANTITATIVE TRAITS; WAIST CIRCUMFERENCE; CHILDHOOD OBESITY; EARLY-ONSET; RISK LOCI	Background: Multiple studies have provided compelling evidence that the FTO gene variants are associated with obesity measures. The objective of the study was to investigate whether FTO variants are associated with a broad range of obesity related anthropometric traits in an island population. Methodology/Principal Findings: We examined genetic association between 29 FTO SNPs and a comprehensive set of anthropometric traits in 843 unrelated individuals from an island population in the eastern Adriatic coast of Croatia. The traits include 11 anthropometrics (height, weight, waist circumference, hip circumference, bicondilar upper arm width, upper arm circumference, and biceps, triceps, subscapular, suprailiac and abdominal skin-fold thicknesses) and two derived measures (BMI and WHR). Using single locus score tests, 15 common SNPs were found to be significantly associated with "body fatness'' measures such as weight, BMI, hip and waist circumferences with P-values ranging from 0.0004 to 0.01. Similar but less significant associations were also observed between these markers and bicondilar upper arm width and upper arm circumference. Most of these significant findings could be explained by a mediating effect of "body fatness''. However, one unique association signal between upper arm width and rs16952517 (P-value = 0.00156) could not be explained by this mediating effect. In addition, using a principle component analysis and conditional association tests adjusted for "body fatness'', two novel association signals were identified between upper arm circumference and rs11075986 (P-value = 0.00211) and rs16945088 (P-value = 0.00203). Conclusions/Significance: The current study confirmed the association of common variants of FTO gene with "body fatness'' measures in an isolated island population. We also observed evidence of pleiotropic effects of FTO gene on fat-free mass, such as frame size and muscle mass assessed by bicondilar upper arm width and upper arm circumference respectively and these pleiotropic effects might be influenced by variants that are different from the ones associated with "body fatness''.	[Zhang, Ge; Karns, Rebekah; Sun, Guangyun; Cheng, Hong; Deka, Ranjan] Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH 45221 USA; [Zhang, Ge] Univ Cincinnati, Dept Family & Community Med, Cincinnati, OH USA; [Narancic, Nina Smolej; Missoni, Sasa; Durakovic, Zijad; Rudan, Pavao] Inst Anthropol Res, Zagreb, Croatia; [Chakraborty, Ranajit] Univ N Texas, Hlth Sci Ctr, Ctr Computat Genom, Ft Worth, TX USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Institute for Anthropological Research Zagreb; University of North Texas System; University of North Texas Health Science Center	Zhang, G (corresponding author), Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH 45221 USA.	ranjan.deka@uc.edu	Missoni, Sasa/G-8821-2013; Zhang, Ge/F-1809-2011	Missoni, Sasa/0000-0002-6542-9970	National Institutes of Health, USA [R01 DK069845]; Croatian Ministry of Science, Education and Sports [196-1962766-2751, 196-1962766-2747, 196-0342282-0291]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069845] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by a grant from the National Institutes of Health, USA (R01 DK069845) and grants from the Croatian Ministry of Science, Education and Sports (196-1962766-2751 to PR, 196-1962766-2747 to NSN, 196-0342282-0291 to ZD). GZ was supported partially by a gift fund from Ellen and the late Dr. George Rieveschl Jr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Chumlea WC, 2002, AM J CLIN NUTR, V75, P1012, DOI 10.1093/ajcn/75.6.1012; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Clement K, 2008, OBESITY GENOMICS POS; COTSAPAS C, 2009, HUM MOL GENET; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Do R, 2008, DIABETES, V57, P1147, DOI 10.2337/db07-1267; Falush D, 2003, GENETICS, V164, P1567; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; FRISANCHO AR, 1983, AM J CLIN NUTR, V37, P311, DOI 10.1093/ajcn/37.2.311; FRISANCHO AR, 1984, AM J CLIN NUTR, V40, P808, DOI 10.1093/ajcn/40.4.808; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P680, DOI 10.1093/ajcn/36.4.680; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hubacek JA, 2008, OBESITY, V16, P2764, DOI 10.1038/oby.2008.421; JAMES WPT, 1994, EUR J CLIN NUTR, V48, P883; Jess T, 2008, INT J OBESITY, V32, P1388, DOI 10.1038/ijo.2008.110; Kring SII, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002958; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Mutch DM, 2006, PLOS GENET, V2, P1956, DOI 10.1371/journal.pgen.0020188; Pal P, 2007, HUM GENET, V122, P251, DOI 10.1007/s00439-007-0394-3; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Pritchard JK, 2000, GENETICS, V155, P945; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rudan I, 2003, J MED GENET, V40, P925, DOI 10.1136/jmg.40.12.925; Rudan P, 2004, COLLEGIUM ANTROPOL, V28, P321; RUDAN P, 1992, SOC ST HUM, V33, P204; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Weiner J.S., 1981, PRACTICAL HUMAN BIOL; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	52	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10375	10.1371/journal.pone.0010375	http://dx.doi.org/10.1371/journal.pone.0010375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442772	gold, Green Published, Green Submitted			2022-12-25	WOS:000277154200015
J	Muller, YD; Mai, G; Morel, P; Serre-Beinier, V; Gonelle-Gispert, C; Yung, GP; Ehirchiou, D; Wyss, JC; Bigenzahn, S; Irla, M; Heusser, C; Golshayan, D; Seebach, JD; Wekerle, T; Buhler, LH				Muller, Yannick D.; Mai, Gang; Morel, Philippe; Serre-Beinier, Veronique; Gonelle-Gispert, Carmen; Yung, Gisella Puga; Ehirchiou, Driss; Wyss, Jean-Christophe; Bigenzahn, Sinda; Irla, Magali; Heusser, Christoph; Golshayan, Dela; Seebach, Joerg D.; Wekerle, Thomas; Buehler, Leo H.			Anti-CD154 mAb and Rapamycin Induce T Regulatory Cell Mediated Tolerance in Rat-to-Mouse Islet Transplantation	PLOS ONE			English	Article							LONG-TERM SURVIVAL; COSTIMULATION BLOCKADE; ALLOGRAFT-REJECTION; KIDNEY ALLOGRAFTS; MIXED CHIMERISM; TYPE-1 CELLS; MODEL; MECHANISMS; EXPANSION; APOPTOSIS	Background: Anti-CD154 (MR1) monoclonal antibody (mAb) and rapamycin (RAPA) treatment both improve survival of ratto- mouse islet xenograft. The present study investigated the effect of combined RAPA/MR1 treatment on rat-to-mouse islet xenograft survival and analyzed the role of CD4(+)CD25(+)Foxp3(+) T regulatory cells (Treg) in the induction and maintenance of the ensuing tolerance. Methodology/Principal Findings: C57BL/6 mice were treated with MR1/RAPA and received additional monoclonal anti-IL2 mAb or anti CD25 mAb either early (0-28 d) or late (100-128 d) post-transplantation. Treg were characterised in the blood, spleen, draining lymph nodes and within the graft of tolerant and rejecting mice by flow cytometry and immunohistochemistry. Fourteen days of RAPA/MR1 combination therapy allowed indefinite islet graft survival in >80% of the mice. Additional administration of anti-IL-2 mAb or depleting anti-CD25 mAb at the time of transplantation resulted in rejection (100% and 89% respectively), whereas administration at 100 days post transplantation lead to lower rejection rates (25% and 40% respectively). Tolerant mice showed an increase of Treg within the graft and in draining lymph nodes early post transplantation, whereas 100 days post transplantation no significant increase of Treg was observed. Rejecting mice showed a transient increase of Treg in the xenograft and secondary lymphoid organs, which disappeared within 7 days after rejection. Conclusions/Significances: These results suggest a critical role for Treg in the induction phase of tolerance early after islet xenotransplantation. These encouraging data support the need of developing further Treg therapy for overcoming the species barrier in xenotransplantation.	[Muller, Yannick D.; Mai, Gang; Morel, Philippe; Serre-Beinier, Veronique; Gonelle-Gispert, Carmen; Buehler, Leo H.] Univ Hosp Geneva, Dept Surg, Surg Res Unit, Geneva, Switzerland; [Muller, Yannick D.; Yung, Gisella Puga; Ehirchiou, Driss; Seebach, Joerg D.] Univ Hosp & Med Fac, Dept Internal Med, Serv Clin Immunol & Allergol, Geneva, Switzerland; [Mai, Gang] Si Chuan Univ, W China Hosp, Hepatobiliopancreat Dept, Chengdu, Si Chuan, Peoples R China; [Wyss, Jean-Christophe; Golshayan, Dela] Univ Lausanne, Transplantat Immunopathol Lab, Dept Med, Lausanne, Switzerland; [Bigenzahn, Sinda; Wekerle, Thomas] Med Univ Vienna, Vienna Gen Hosp, Dept Surg, Div Transplantat, Vienna, Austria; [Heusser, Christoph] Novartis Inst Biomed Res, Basel, Switzerland; [Irla, Magali] Univ Geneva, Sch Med, CMU, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; Sichuan University; University of Lausanne; Medical University of Vienna; Novartis; University of Geneva	Muller, YD (corresponding author), Univ Hosp Geneva, Dept Surg, Surg Res Unit, Geneva, Switzerland.	leo.buhler@hcuge.ch	Seebach, Jörg/AAA-3746-2020; IRLA, Magali/AAH-7941-2019; Serre-Beinier, Véronique/T-8064-2019	IRLA, Magali/0000-0001-8803-9708; Serre-Beinier, Véronique/0000-0002-6016-1645; Golshayan, Dela/0000-0001-5631-6096; Buhler, Leo/0000-0002-9461-8498; mai, gang/0000-0002-5843-2821; Seebach, Jorg/0000-0001-5748-4577; Muller, Yannick/0000-0003-0513-7156; , Gisella/0000-0002-2283-7798; Wekerle, Thomas/0000-0001-5159-2796	Swiss National Research [3200BO-102134, 3200B0-109921]; Sir Jules Thorn Charitable Overseas Trust; Fondation Pierre Mercier Pour La Science	Swiss National Research; Sir Jules Thorn Charitable Overseas Trust; Fondation Pierre Mercier Pour La Science	This work was supported by Swiss National Research Fund grants #3200BO-102134 ( to P. M., D. B., T. B. and L. H. B.) and #3200B0-109921 ( to J. D. S.), and the Sir Jules Thorn Charitable Overseas Trust and Fondation Pierre Mercier Pour La Science. Novartis Pharma AG employed one of the authors of this study (Christoph Heusser, PhD) and provided several monoclonal antibodies (anti-CD25 mAb, anti-IL2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREFANIAN H, 2010, DIABETES; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.1.40; Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Bigenzahn S, 2005, AM J TRANSPLANT, V5, P1237, DOI 10.1111/j.1600-6143.2005.00862.x; Bucher P, 2005, TRANSPLANTATION, V79, P1545, DOI 10.1097/01.TP.0000163505.63159.69; Chauhan SK, 2009, J IMMUNOL, V182, P148, DOI 10.4049/jimmunol.182.1.148; Codarri L, 2007, J EXP MED, V204, P1533, DOI 10.1084/jem.20062120; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Dijke IE, 2008, HUM IMMUNOL, V69, P389, DOI 10.1016/j.humimm.2008.05.006; Dijke IE, 2007, TRANSPLANTATION, V83, P1477, DOI 10.1097/01.tp.0000264997.53153.8b; Ford ML, 2009, IMMUNOL REV, V229, P294, DOI 10.1111/j.1600-065X.2009.00776.x; Golshayan D, 2007, TRANSPL INT, V20, P12, DOI 10.1111/j.1432-2277.2006.00401.x; Golshayan D, 2007, BLOOD, V109, P827, DOI 10.1182/blood-2006-05-025460; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; Haanstra KG, 2007, AM J TRANSPLANT, V7, P2236, DOI 10.1111/j.1600-6143.2007.01917.x; Jaeckel E, 2005, DIABETES, V54, P306, DOI 10.2337/diabetes.54.2.306; Jarvinen LZ, 2003, TRANSPLANTATION, V76, P1375, DOI 10.1097/01.TP.0000093462.16309.73; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Jovanovic V, 2008, TRANSPL INT, V21, P199, DOI 10.1111/j.1432-2277.2007.00599.x; Kurtz J, 2004, TRENDS IMMUNOL, V25, P518, DOI 10.1016/j.it.2004.08.007; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Mai G, 2005, AM J TRANSPLANT, V5, P1021, DOI 10.1111/j.1600-6143.2005.00795.x; MONTI P, 2008, DIABETES; Muller YD, 2009, XENOTRANSPLANTATION, V16, P121, DOI 10.1111/j.1399-3089.2009.00531.x; Onizuka S, 1999, CANCER RES, V59, P3128; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2008, IMMUNOLOGY, V123, P3, DOI 10.1111/j.1365-2567.2007.02777.x; Snanoudj R, 2006, TRANSPLANT INT, V19, P693, DOI 10.1111/j.1432-2277.2006.00332.x; Waldmann H, 2008, J CLIN IMMUNOL, V28, P716, DOI 10.1007/s10875-008-9249-5; Wang S, 2008, TRANSPL IMMUNOL, V19, P93, DOI 10.1016/j.trim.2008.03.004; Wekerle T, 2002, CURR OPIN IMMUNOL, V14, P592, DOI 10.1016/S0952-7915(02)00378-3; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Xia G, 2008, AM J TRANSPLANT, V8, P298, DOI 10.1111/j.1600-6143.2007.02088.x; Zeiser R, 2008, CELL CYCLE, V7, P458, DOI 10.4161/cc.7.4.5454	39	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10352	10.1371/journal.pone.0010352	http://dx.doi.org/10.1371/journal.pone.0010352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436684	gold, Green Published, Green Submitted			2022-12-25	WOS:000277079500020
J	Tarantino, C; Paolella, G; Cozzuto, L; Minopoli, G; Pastore, L; Parisi, S; Russo, T				Tarantino, Carolina; Paolella, Gaetana; Cozzuto, Luca; Minopoli, Giuseppina; Pastore, Lucio; Parisi, Silvia; Russo, Tommaso			miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells	FASEB JOURNAL			English	Article						pluripotency; Sirt1; Smarca5; Jarid1b	SELF-RENEWAL; MICRORNAS; EXPRESSION; NANOG; PLURIPOTENCY; MIR-34A; CANCER; BIOGENESIS; OCT4; GENE	MicroRNAs (miRNAs) play an important role in proper function and differentiation of mouse embryonic stem cells (ESCs). We performed a systematic comparison of miRNA expression in undifferentiated vs. differentiating ESCs. We report that 138 miRNAs are increased on the induction of differentiation. We compared the entire list of candidate mRNA targets of up-regulated miRNAs with that of mRNA down-regulated in ESCs on induction of differentiation. Among the candidate targets emerging from this analysis, we found three genes, Smarca5, Jarid1b, and Sirt1, previously demonstrated to be involved in sustaining the undifferentiated phenotype in ESCs. On this basis, we first demonstrated that Smarca5 is a direct target of miR-100, Jarid1b of miR-137, and we also confirmed previously published data demonstrating that Sirt1 is a direct target of miR-34a in a different context. The suppression of these three miRNAs by anti-miRs caused the block of ESC differentiation induced by LIF withdrawal. On the other hand, the overexpression of the three miRNAs resulted in an altered expression of differentiation markers. These results demonstrate that miR-34a, miR-100, and miR-137 are required for proper differentiation of mouse ESCs, and that they function in part by targeting Sirt1, Smarca5, and Jarid1b mRNAs.-Tarantino, C., Paolella, G., Cozzuto, L., Minopoli, G., Pastore, L., Parisi, S., Russo, T. miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells. FASEB J. 24, 3255-3263 (2010). www.fasebj.org	[Tarantino, Carolina; Paolella, Gaetana; Cozzuto, Luca; Minopoli, Giuseppina; Pastore, Lucio; Parisi, Silvia; Russo, Tommaso] Ceinge Biotecnol Avanzate, I-80145 Naples, Italy; [Tarantino, Carolina; Parisi, Silvia] SEMM, Milan, Italy; [Paolella, Gaetana; Minopoli, Giuseppina; Pastore, Lucio; Russo, Tommaso] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II	Parisi, S (corresponding author), Ceinge Biotecnol Avanzate, Via Comunale Margherita 452, I-80145 Naples, Italy.	parisi@ceinge.unina.it; tommaso.russo@unina.it	Pastore, Lucio/AAF-3487-2019; Pastore, Lucio/F-4668-2010; Cozzuto, Luca/K-5385-2015; Russo, Tommaso/K-1331-2016	Pastore, Lucio/0000-0001-6894-9317; Cozzuto, Luca/0000-0003-3194-8892; Russo, Tommaso/0000-0003-4426-0106; PAOLELLA, Gaetana/0000-0003-2188-3829; Tarantino, Carolina/0000-0003-2470-3803	EC-Sirocco Consortium; Associazione Italiana Ricerca sul Cancro (AIRC); Italian Ministry of Health-Ricerca Finalizzata	EC-Sirocco Consortium; Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health-Ricerca Finalizzata(Ministry of Health, Italy)	This work was supported by grants from EC-Sirocco Consortium, Associazione Italiana Ricerca sul Cancro (AIRC), and the Italian Ministry of Health-Ricerca Finalizzata 2007.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Ciaudo C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000620; Dey BK, 2008, MOL CELL BIOL, V28, P5312, DOI 10.1128/MCB.00128-08; Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Li XK, 2008, STEM CELLS DEV, V17, P1043, DOI 10.1089/scd.2008.0036; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; ROGERS MB, 1991, DEVELOPMENT, V113, P815; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	44	103	108	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3255	3263		10.1096/fj.09-152207	http://dx.doi.org/10.1096/fj.09-152207			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20439489				2022-12-25	WOS:000281446400014
J	Vecchio, AJ; Simmons, DM; Malkowski, MG				Vecchio, Alex J.; Simmons, Danielle M.; Malkowski, Michael G.			Structural Basis of Fatty Acid Substrate Binding to Cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; MOLECULAR-DYNAMICS SIMULATIONS; ACTIVE-SITE RESIDUES; ARACHIDONIC-ACID; LINOLENIC ACID; ARGININE 120; PROSTAGLANDIN; OXYGENATION; CRYSTALLOGRAPHY; COMPLEXES	The cyclooxygenases (COX-1 and COX-2) are membrane-associated heme-containing homodimers that generate prostaglandin H-2 from arachidonic acid (AA). Although AA is the preferred substrate, other fatty acids are oxygenated by these enzymes with varying efficiencies. We determined the crystal structures of AA, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) bound to Co3+-protoporphyrin IX-reconstituted murine COX-2 to 2.1, 2.4, and 2.65 angstrom, respectively. AA, EPA, and docosahexaenoic acid bind in different conformations in each monomer constituting the homodimer in their respective structures such that one monomer exhibits nonproductive binding and the other productive binding of the substrate in the cyclooxygenase channel. The interactions identified between protein and substrate when bound to COX-1 are conserved in our COX-2 structures, with the only notable difference being the lack of interaction of the carboxylate of AA and EPA with the side chain of Arg-120. Leu-531 exhibits a different side chain conformation when the nonproductive and productive binding modes of AA are compared. Unlike COX-1, mutating this residue to Ala, Phe, Pro, or Thr did not result in a significant loss of activity or substrate binding affinity. Determination of the L531F:AA crystal structure resulted in AA binding in the same global conformation in each monomer. We speculate that the mobility of the Leu-531 side chain increases the volume available at the opening of the cyclooxygenase channel and contributes to the observed ability of COX-2 to oxygenate a broad spectrum of fatty acid and fatty ester substrates.	[Vecchio, Alex J.; Simmons, Danielle M.; Malkowski, Michael G.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Vecchio, Alex J.; Simmons, Danielle M.; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Malkowski, MG (corresponding author), SUNY Buffalo, Hauptman Woodward Med Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	malkowski@hwi.buffalo.edu	Malkowski, Michael G/G-4939-2011	Malkowski, Michael G/0000-0003-1025-0014; Malkowski, Michael/0000-0002-1203-7463; Vecchio, Alex/0000-0002-4222-7874	NIGMS, National Institutes of Health [R01 GM077176]; Arthritis Foundation; National Science Foundation [DMR-0225180]; NCRR, National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115386, R01GM077176] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Arthritis Foundation; National Science Foundation(National Science Foundation (NSF)); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM077176 (to M. G. M.) from the NIGMS. This work was also supported by an Arthritis Investigator award (to M. G. M.) from the Arthritis Foundation as part of the Segal Osteoarthritis Initiative. This work was based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation Award DMR-0225180, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by National Institutes of Health Award RR-01646 from NCRR.	Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Furse KE, 2006, BIOCHEMISTRY-US, V45, P3189, DOI 10.1021/bi052337p; Furse KE, 2006, BIOCHEMISTRY-US, V45, P3206, DOI 10.1021/bi052338h; Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129; Harman CA, 2004, J BIOL CHEM, V279, P42929, DOI 10.1074/jbc.M403013200; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; Kulmacz RJ, 2005, BIOCHEM BIOPH RES CO, V338, P25, DOI 10.1016/j.bbrc.2005.08.030; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Liu W, 2006, FASEB J, V20, P1097, DOI 10.1096/fj.05-5273com; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Malkowski MG, 2000, ARCH BIOCHEM BIOPHYS, V380, P39, DOI 10.1006/abbi.2000.1906; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OTTO JC, 1993, J BIOL CHEM, V268, P18234; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prusakiewicz JJ, 2002, BIOCHEM BIOPH RES CO, V296, P612, DOI 10.1016/S0006-291X(02)00915-4; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Rowlinson SW, 2000, J BIOL CHEM, V275, P6586, DOI 10.1074/jbc.275.9.6586; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHIMOKAWA T, 1992, J BIOL CHEM, V267, P12387; Smith T, 2000, ARCH BIOCHEM BIOPHYS, V375, P195, DOI 10.1006/abbi.1999.1659; Smith WL, 2008, TRENDS BIOCHEM SCI, V33, P27, DOI 10.1016/j.tibs.2007.09.013; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Turman MV, 2009, BIOCHEMISTRY-US, V48, P12233, DOI 10.1021/bi901181z; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	57	113	118	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22152	22163		10.1074/jbc.M110.119867	http://dx.doi.org/10.1074/jbc.M110.119867			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463020	Green Published, hybrid			2022-12-25	WOS:000279702200028
J	Dror, AA; Politi, Y; Shahin, H; Lenz, DR; Dossena, S; Nofziger, C; Fuchs, H; de Angelis, MH; Paulmichl, M; Weiner, S; Avraham, KB				Dror, Amiel A.; Politi, Yael; Shahin, Hashem; Lenz, Danielle R.; Dossena, Silvia; Nofziger, Charity; Fuchs, Helmut; de Angelis, Martin Hrabe; Paulmichl, Markus; Weiner, Steve; Avraham, Karen B.			Calcium Oxalate Stone Formation in the Inner Ear as a Result of an Slc26a4 Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAROXYSMAL POSITIONAL VERTIGO; PENDRED-SYNDROME GENE; TARGETED DISRUPTION; OTOCONIAL MEMBRANE; GLOBULAR SUBSTANCE; MAJOR PROTEIN; DEAFNESS; CELLS; TRPV5; CA2+	Calcium oxalate stone formation occurs under pathological conditions and accounts for more than 80% of all types of kidney stones. In the current study, we show for the first time that calcium oxalate stones are formed in the mouse inner ear of a genetic model for hearing loss and vestibular dysfunction in humans. The vestibular system within the inner ear is dependent on extracellular tiny calcium carbonate minerals for proper function. Thousands of these biominerals, known as otoconia, are associated with the utricle and saccule sensory maculae and are vital for mechanical stimulation of the sensory hair cells. We show that a missense mutation within the Slc26a4 gene abolishes the transport activity of its encoded protein, pendrin. As a consequence, dramatic changes in mineral composition, size, and shape occur within the utricle and saccule in a differential manner. Although abnormal giant carbonate minerals reside in the utricle at all ages, in the saccule, a gradual change in mineral composition leads to a formation of calcium oxalate in adult mice. By combining imaging and spectroscopy tools, we determined the profile of mineral composition and morphology at different time points. We propose a novel mechanism for the accumulation and aggregation of oxalate crystals in the inner ear.	[Avraham, Karen B.] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Politi, Yael; Weiner, Steve] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Dossena, Silvia; Nofziger, Charity; Paulmichl, Markus] Paracelsus Med Univ, Inst Pharmacol & Toxicol, A-5020 Salzburg, Austria; [Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, Inst Expt Genet, D-85764 Neuherberg, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany	Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Paracelsus Private Medical University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Avraham, KB (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	karena@post.tau.ac.il	Fuchs, Helmut/M-7347-2014; Dossena, Silvia/G-1437-2018; Dror, Amiel/AAD-3348-2022; Dror, Amiel/AAB-7522-2020; de Angelis, Martin Hrabe/F-5531-2012	Fuchs, Helmut/0000-0002-5143-2677; Dror, Amiel/0000-0002-7178-6771; de Angelis, Martin Hrabe/0000-0002-7898-2353; Avraham, Karen B/0000-0002-4913-251X	European Commission [LSHG-CT-2004-512063, 037188]; Fonds zur Forderung der Wissenschaftlichen Forschung (FWF) [P18608-B05, PIRSES-GA-2008-230661, M1108-B11]; Israel Council for Higher Education	European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds zur Forderung der Wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Israel Council for Higher Education	This work was supported by the European Commission FP6 Integrated Projects EuroHear LSHG-CT-2004-512063 and Eumodic 037188 (to K. B. A.) and the Fonds zur Forderung der Wissenschaftlichen Forschung (FWF) Grant P18608-B05 and Grant PIRSES-GA-2008-230661 (to M. P.).; Supported by a Levtzion Fellowship for outstanding doctoral students in the periphery through the Israel Council for Higher Education.; Supported by the Lise Meitner stipend of the Fonds zur Forderung der Wissenschaftlichen Forschung (FWF) (M1108-B11).	Anniko M, 1980, Am J Otolaryngol, V1, P400, DOI 10.1016/S0196-0709(80)80021-4; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; Beynon GJ, 1997, BRIT J AUDIOL, V31, P11, DOI 10.3109/03005364000000005; CARLSTROM DD, 1963, BIOL BULL, V125, P441, DOI 10.2307/1539358; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; Coyle B, 1996, NAT GENET, V12, P421, DOI 10.1038/ng0496-421; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; DiCiommo DP, 2004, INVEST OPHTH VIS SCI, V45, P3320, DOI 10.1167/iovs.04-0140; Dossena S, 2006, CELL PHYSIOL BIOCHEM, V18, P67, DOI 10.1159/000095164; Dossena S, 2009, J MOL ENDOCRINOL, V43, P93, DOI 10.1677/JME-08-0175; EPLEY JM, 1995, OTOLARYNG HEAD NECK, V112, P154, DOI 10.1016/S0194-5998(95)70315-2; EPLEY JM, 1992, OTOLARYNG HEAD NECK, V107, P399, DOI 10.1177/019459989210700310; ERWAY L C, 1986, Scanning Electron Microscopy, P1681; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Frische S, 2003, AM J PHYSIOL-RENAL, V284, pF584, DOI 10.1152/ajprenal.00254.2002; Fugazzola L, 2007, EUR J ENDOCRINOL, V157, P331, DOI 10.1530/EJE-07-0263; HARADA Y, 1977, ACTA OTO-LARYNGOL, V84, P65, DOI 10.3109/00016487709123943; Hertzano R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000207; House MG, 2003, AUDIOL NEURO-OTOL, V8, P91, DOI 10.1159/000068998; Hughes I, 2006, BRAIN RES, V1091, P58, DOI 10.1016/j.brainres.2006.01.074; HUNTERDUVAR IM, 1978, ACTA OTO-LARYNGOL, P3; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LIM DJ, 1983, AM J OTOLARYNG, V4, P33, DOI 10.1016/S0196-0709(83)80005-2; Lins U, 2000, J STRUCT BIOL, V131, P67, DOI 10.1006/jsbi.2000.4260; Lowenstam HA, 1989, BIOMINERALIZATION; Lundberg YXW, 2006, BRAIN RES, V1091, P47, DOI 10.1016/j.brainres.2006.02.083; Marquis RE, 1997, P NATL ACAD SCI USA, V94, P11923, DOI 10.1073/pnas.94.22.11923; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Nakaya K, 2007, AM J PHYSIOL-RENAL, V292, pF1314, DOI 10.1152/ajprenal.00432.2006; Oghalai JS, 2000, OTOLARYNG HEAD NECK, V122, P630, DOI 10.1016/S0194-5998(00)70187-2; Parnes LS, 2003, CAN MED ASSOC J, V169, P681; Pera A, 2008, P NATL ACAD SCI USA, V105, P18608, DOI 10.1073/pnas.0805831105; PIZZOLATO P, 1964, J HISTOCHEM CYTOCHEM, V12, P333, DOI 10.1177/12.5.333; POTE KG, 1993, BIOCHEMISTRY-US, V32, P5017, DOI 10.1021/bi00070a007; POTE KG, 1991, COMP BIOCHEM PHYS B, V98, P287, DOI 10.1016/0305-0491(91)90181-C; Ross M D, 1979, Adv Otorhinolaryngol, V25, P26; ROSS MD, 1976, ANN OTO RHINOL LARYN, V85, P310, DOI 10.1177/000348947608500302; ROSS MD, 1975, ANN OTO RHINOL LARYN, V84, P22, DOI 10.1177/000348947508400105; Royaux IE, 2003, JARO-J ASSOC RES OTO, V4, P394, DOI 10.1007/s10162-002-3052-4; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Scott DA, 1999, NAT GENET, V21, P440, DOI 10.1038/7783; Scott DA, 2000, AM J PHYSIOL-CELL PH, V278, pC207, DOI 10.1152/ajpcell.2000.278.1.C207; Sheffield VC, 1996, NAT GENET, V12, P424, DOI 10.1038/ng0496-424; Shiao JC, 2005, J COMP NEUROL, V488, P331, DOI 10.1002/cne.20578; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; SJOBERG EL, 1984, GEOCHIM COSMOCHIM AC, V48, P485, DOI 10.1016/0016-7037(84)90276-X; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Suzuki H, 1997, AM J PHYSIOL-CELL PH, V273, pC1533, DOI 10.1152/ajpcell.1997.273.5.C1533; SUZUKI H, 1995, HEARING RES, V90, P212, DOI 10.1016/0378-5955(95)00168-7; Takumida M, 1997, ACTA OTO-LARYNGOL, V117, P538, DOI 10.3109/00016489709113434; Takumida M, 2009, ACTA OTO-LARYNGOL, V129, P1340, DOI 10.3109/00016480902725254; Thalmann R, 2001, ANN NY ACAD SCI, V942, P162; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; Wang YX, 1998, P NATL ACAD SCI USA, V95, P15345, DOI 10.1073/pnas.95.26.15345; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Yamauchi D, 2005, BIOCHEM BIOPH RES CO, V331, P1353, DOI 10.1016/j.bbrc.2005.04.053; Yeh BI, 2003, J BIOL CHEM, V278, P51044, DOI 10.1074/jbc.M306326200; Zhao X, 2007, DEV BIOL, V304, P508, DOI 10.1016/j.ydbio.2007.01.013	63	57	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21724	21735		10.1074/jbc.M110.120188	http://dx.doi.org/10.1074/jbc.M110.120188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442411	hybrid, Green Published			2022-12-25	WOS:000279516100059
J	Shirai, R; Gotou, R; Hirano, F; Ikeda, K; Inoue, S				Shirai, Ryoichi; Gotou, Rikiya; Hirano, Fumiyasu; Ikeda, Kiyoshi; Inoue, Seiji			Autologous Extracellular Cytochrome c Is an Endogenous Ligand for Leucine-rich alpha(2)-Glycoprotein and beta-Type Phospholipase A(2) Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGKISTRODON-BLOMHOFFII-SINITICUS; HUMAN-SERUM; CHINESE MAMUSHI; BLOOD-PLASMA; PROTEIN; COMPLEX; EXPRESSION; APOPTOSIS; ALPHA-2-GLYCOPROTEIN; DIFFERENTIATION	beta-Type phospholipase A(2) inhibitory protein (PLI beta) from the serum of the venomous snake Gloydius brevicaudus neutralizes basic phospholipase A(2) (PLA(2)) from its own venom, and it has 33% sequence homology with human leucine-rich alpha(2)-glycoprotein (LRG), which has been recently reported to bind cytochrome c (Cyt c) (Cummings, C., Walder, J., Treeful, A., and Jemmerson, R. (2006) Apoptosis 11, 1121-1129). In the present study, PLI beta was found to bind Cyt c. The interactions of LRG and PLI beta with Cyt c were compared by surface plasmon resonance analysis. Human LRG bound horse and snake Cyt c with dissociation constants of 1.58 x 10(-13) M and 1.65 x 10(-10) M, respectively, but did not bind yeast Cyt c, while G. brevicaudus PLI beta bound horse, snake, and yeast Cyt c with dissociation constants of 1.05 x 10(-10) M, 2.37 x 10(-12) M, and 1.67 x 10(-6) M, respectively. On the other hand, LRG did not show any PLA(2) inhibitory activity and did not bind G. brevicaudus basic PLA(2), whereas PLI beta bound the basic PLA(2) with a dissociation constant of 1.21 x 10(-9) M, which is smaller than those with the Cyt c described above. The PLA(2) inhibitory activity of PLI beta was also found to be suppressed by the binding of Cyt c to PLI beta. These results suggest that autologous Cyt c is an endogeneous ligand for LRG and PLI beta and that these serum proteins neutralize the autologous Cyt c released from the dead cells.	[Shirai, Ryoichi; Gotou, Rikiya; Hirano, Fumiyasu; Ikeda, Kiyoshi; Inoue, Seiji] Osaka Univ Pharmaceut Sci, Biochem Lab, Osaka 5691094, Japan	Osaka University of Pharmaceutical Sciences	Inoue, S (corresponding author), Osaka Univ Pharmaceut Sci, Biochem Lab, 4-20-1 Nasahara, Osaka 5691094, Japan.	inoue@gly.oups.ac.jp	Inoue, Seiji/E-5128-2010	Inoue, Seiji/0000-0003-0760-1047				Ai J, 2008, J LEUKOCYTE BIOL, V83, P1277, DOI 10.1189/jlb.1107751; Codina R, 2010, APOPTOSIS, V15, P139, DOI 10.1007/s10495-009-0412-0; Cummings C, 2006, APOPTOSIS, V11, P1121, DOI 10.1007/s10495-006-8159-3; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HAUPT H, 1977, H-S Z PHYSIOL CHEM, V358, P639, DOI 10.1515/bchm2.1977.358.1.639; Hiraoka Y, 2004, P NATL ACAD SCI USA, V101, P6427, DOI 10.1073/pnas.0401631101; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; INOUE S, 1984, BIOCHIM BIOPHYS ACTA, V790, P188, DOI 10.1016/0167-4838(84)90223-1; Inoue S, 1997, BIOCHEM MOL BIOL INT, V41, P529; Jemmerson R, 2002, CELL DEATH DIFFER, V9, P538, DOI 10.1038/sj.cdd.4400981; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Johnson RJ, 2007, J MOL BIOL, V368, P434, DOI 10.1016/j.jmb.2007.02.005; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Kluck RM, 2000, J BIOL CHEM, V275, P16127, DOI 10.1074/jbc.275.21.16127; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lambeau G, 1999, TRENDS PHARMACOL SCI, V20, P162, DOI 10.1016/S0165-6147(99)01300-0; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; O'Donnell LC, 2002, J LEUKOCYTE BIOL, V72, P478; Ohkura N, 1997, BIOCHEM J, V325, P527, DOI 10.1042/bj3250527; Okumura K, 1998, J BIOL CHEM, V273, P19469, DOI 10.1074/jbc.273.31.19469; Okumura K, 2002, ARCH BIOCHEM BIOPHYS, V408, P124, DOI 10.1016/S0003-9861(02)00551-9; Okumura K, 1999, BBA-MOL CELL BIOL L, V1441, P51, DOI 10.1016/S1388-1981(99)00141-9; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; Pullerits R, 2005, RHEUMATOLOGY, V44, P32, DOI 10.1093/rheumatology/keh406; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; Renz A, 2001, BLOOD, V98, P1542, DOI 10.1182/blood.V98.5.1542; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shirai R, 2009, BIOCHEM BIOPH RES CO, V382, P776, DOI 10.1016/j.bbrc.2009.03.104; Shirai R, 2009, TOXICON, V53, P685, DOI 10.1016/j.toxicon.2009.02.001; Stumpp MT, 2003, J MOL BIOL, V332, P471, DOI 10.1016/S0022-2836(03)00897-0; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; Weivoda S, 2008, J IMMUNOL METHODS, V336, P22, DOI 10.1016/j.jim.2008.03.004; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	37	14	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21607	21614		10.1074/jbc.M110.122788	http://dx.doi.org/10.1074/jbc.M110.122788			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442399	Green Published, hybrid			2022-12-25	WOS:000279516100047
J	Wei, LL; Guo, JK; Ouyang, M; Sun, XW; Ma, JF; Chi, W; Lu, CM; Zhang, LX				Wei, Lili; Guo, Jinkui; Ouyang, Min; Sun, Xuwu; Ma, Jinfang; Chi, Wei; Lu, Congming; Zhang, Lixin			LPA19, a Psb27 Homolog in Arabidopsis thaliana, Facilitates D1 Protein Precursor Processing during PSII Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II REACTION-CENTER; PHOTOSYSTEM-II; CHLOROPHYLL-A; COMPLEXES; ACCUMULATION; ARCHITECTURE; RESOLUTION; REPAIR	The biogenesis and assembly of photosystem II (PSII) are mainly regulated by the nuclear-encoded factors. To further identify the novel components involved in PSII biogenesis, we isolated and characterized a high chlorophyll fluorescence low psii accumulation19 (lpa19) mutant, which is defective in PSII biogenesis. LPA19 encodes a Psb27 homolog (At1g05385). Interestingly, another Psb27 homolog (At1g03600) in Arabidopsis was revealed to be required for the efficient repair of photodamaged PSII. These results suggest that the Psb27 homologs play distinct functions in PSII biogenesis and repair in Arabidopsis. Chloroplast protein labeling assays showed that the C-terminal processing of D1 in the lpa19 mutant was impaired. Protein overlay assays provided evidence that LPA19 interacts with D1, and coimmunoprecipitation analysis demonstrated that LPA19 interacts with mature D1 (mD1) and precursor D1 (pD1). Moreover, LPA19 protein was shown to specifically interact with the soluble C terminus present in the precursor and mature D1 through yeast two-hybrid analyses. Thus, these studies suggest that LPA19 is involved in facilitating the D1 precursor protein processing in Arabidopsis.	[Wei, Lili; Guo, Jinkui; Ouyang, Min; Sun, Xuwu; Ma, Jinfang; Chi, Wei; Lu, Congming; Zhang, Lixin] Chinese Acad Sci, Inst Bot, Photosynthesis Res Ctr, Key Lab Photobiol, Beijing 100093, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, LX (corresponding author), Chinese Acad Sci, Inst Bot, Photosynthesis Res Ctr, Key Lab Photobiol, Beijing 100093, Peoples R China.	zhanglixin@ibcas.ac.cn	sun, xuwu/AGR-2370-2022	sun, xuwu/0000-0001-8462-6948	National Natural Science Foundation of China [30630007, 30725003]; Major State Basic Research Development Program [2009CB118500]; Knowledge Innovation Engineering of the Chinese Academy of Sciences [KSCX2-YW-N-042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China); Knowledge Innovation Engineering of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (30630007, 30725003), the Major State Basic Research Development Program (2009CB118500), the Frontier Project of the Knowledge Innovation Engineering of the Chinese Academy of Sciences (KSCX2-YW-N-042). We are grateful to the Arabidopsis Biological Resource Center for Arabidopsis seeds.	ADIR N, 1990, J BIOL CHEM, V265, P12563; ANBUDURAI PR, 1994, P NATL ACAD SCI USA, V91, P8082, DOI 10.1073/pnas.91.17.8082; Andersson B, 2001, ADV PHOTOSYNTH, V11, P377; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Bentley FK, 2008, BIOCHEMISTRY-US, V47, P11637, DOI 10.1021/bi800804h; Chen H, 2006, PLANT MOL BIOL, V61, P567, DOI 10.1007/s11103-006-0031-x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cormann KU, 2009, BIOCHEMISTRY-US, V48, P8768, DOI 10.1021/bi9012726; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Iwata S, 2004, CURR OPIN STRUC BIOL, V14, P447, DOI 10.1016/j.sbi.2004.07.002; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Kufryk GI, 2003, J BACTERIOL, V185, P6615, DOI 10.1128/JB.185.22.6615-6623.2003; Kufryk GI, 2001, BIOCHEMISTRY-US, V40, P9247, DOI 10.1021/bi0026526; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Ma JF, 2007, PLANT CELL, V19, P1980, DOI 10.1105/tpc.107.050526; Mabbitt PD, 2009, BIOCHEMISTRY-US, V48, P8771, DOI 10.1021/bi901309c; Mamedov F, 2007, BIOCHEMISTRY-US, V46, P5542, DOI 10.1021/bi7000399; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Meurer J, 1996, PLANTA, V198, P385, DOI 10.1007/BF00620055; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Peng LW, 2006, PLANT CELL, V18, P955, DOI 10.1105/tpc.105.037689; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rajalahti T, 2007, J PROTEOME RES, V6, P2420, DOI 10.1021/pr0605973; Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schottkowski M, 2009, J BIOL CHEM, V284, P1813, DOI 10.1074/jbc.M806116200; Sun XW, 2007, PLANT CELL, V19, P1347, DOI 10.1105/tpc.106.049510; Sun XW, 2010, PLANT J, V62, P240, DOI 10.1111/j.1365-313X.2010.04140.x; Suorsa M, 2004, EUR J BIOCHEM, V271, P96, DOI 10.1046/j.1432-1033.2003.03906.x; vanWijk KJ, 1997, BIOCHEMISTRY-US, V36, P6178, DOI 10.1021/bi962921l; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Yamamoto Y, 2001, J BIOL CHEM, V276, P7518, DOI 10.1074/jbc.M008877200; Zhang LX, 1999, J BIOL CHEM, V274, P16062, DOI 10.1074/jbc.274.23.16062; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	46	60	63	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21391	21398		10.1074/jbc.M110.105064	http://dx.doi.org/10.1074/jbc.M110.105064			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444695	Green Published, hybrid			2022-12-25	WOS:000279516100025
J	Brem, R; Li, F; Montaner, B; Reelfs, O; Karran, P				Brem, R.; Li, F.; Montaner, B.; Reelfs, O.; Karran, P.			DNA breakage and cell cycle checkpoint abrogation induced by a therapeutic thiopurine and UVA radiation	ONCOGENE			English	Article						thiopurines; UVA; skin cancer; DNA breakage; cell cycle checkpoints	DOUBLE-STRAND BREAKS; TRANSPLANT RECIPIENTS; MEDIATED DAMAGE; REPAIR; AZATHIOPRINE; SKIN; MECHANISMS; PROTECTION; MUTATIONS; CANCERS	The frequency of squamous cell skin carcinoma in organ transplant patients is around 100-fold higher than normal. This dramatic example of therapy-related cancer reflects exposure to sunlight and to immunosuppressive drugs. Here, we show that the interaction between low doses of UVA, the major ultraviolet component of incident sunlight, and 6-TG, a UVA chromophore that is introduced into DNA by one of the most widely prescribed immunosuppressive drugs, causes DNA single- and double-strand breaks (DSB). S phase cells are particularly vulnerable to this DNA breakage and cells defective in rejoining of S-phase DSB are hypersensitive to the combination of low-dose UVA and DNA 6-TG. 6-TG/UVA-induced DNA lesions provoke canonical DNA damage responses involving activation of the ATM/Chk2 and ATR/Chk1 pathways and appropriate cell cycle checkpoints. Higher levels of photochemical DNA damage induce a proteasome-mediated degradation of Chk1 and checkpoint abrogation that is consistent with persistent unrepaired DNA damage. These findings indicate that the interaction between UVA and an immunosuppressant drug causes photochemical DNA lesions, including DNA breaks, and can compromise cell cycle checkpoints. These two properties could contribute to the high risk of sunlight-related skin cancer in long-term immunosuppressed patients. Oncogene (2010) 29, 3953-3963; doi:10.1038/onc.2010.140; published online 3 May 2010	[Brem, R.; Li, F.; Montaner, B.; Karran, P.] Canc Res UK London Res Inst, Mammalian DNA Repair Lab, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Reelfs, O.] Guys Hosp, Kings Coll Sch Med, St Johns Inst Dermatol, London SE1 9RT, England	Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Karran, P (corresponding author), Canc Res UK London Res Inst, Mammalian DNA Repair Lab, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.	peter.karran@cancer.org.uk	/AAD-1866-2020	Montaner, Beatriz/0000-0001-9877-7317	Cancer Research UK [A3558] Funding Source: Medline; Cancer Research UK [11584] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)		Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Brem R, 2009, NUCLEIC ACIDS RES, V37, P1951, DOI 10.1093/nar/gkp070; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Cahill MA, 1996, BIOCHEM BIOPH RES CO, V229, P170, DOI 10.1006/bbrc.1996.1775; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P3084, DOI 10.1093/nar/26.13.3084; Cooke MS, 2008, DNA REPAIR, V7, P1982, DOI 10.1016/j.dnarep.2008.08.007; Daehn I, 2009, CANCER RES, V69, P2393, DOI 10.1158/0008-5472.CAN-08-4264; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Demple B, 2002, ONCOGENE, V21, P8926, DOI 10.1038/sj.onc.1206178; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Grosse Y, 2009, LANCET ONCOL, V10, P13, DOI 10.1016/S1470-2045(08)70286-9; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; Kerzendorfer C, 2009, DNA REPAIR, V8, P1139, DOI 10.1016/j.dnarep.2009.04.018; Koniaras K, 2001, ONCOGENE, V20, P7453, DOI 10.1038/sj.onc.1204942; Kumar SS, 2000, MUTAT RES-GEN TOX EN, V469, P207, DOI 10.1016/S1383-5718(00)00074-7; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; LENNARD L, 1985, BRIT J DERMATOL, V113, P723, DOI 10.1111/j.1365-2133.1985.tb02408.x; LIMOLI CL, 1993, RADIAT RES, V134, P160, DOI 10.2307/3578455; LJUNGMAN M, 1992, MOL CARCINOGEN, V5, P264, DOI 10.1002/mc.2940050406; LJUNGMAN M, 1991, RADIAT RES, V127, P171, DOI 10.2307/3577962; Montaner B, 2007, EMBO REP, V8, P1074, DOI 10.1038/sj.embor.7401084; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; ORMEROD MG, 2000, FLOW CYTOMETRY PRACT, P159; Penn I, 1994, Transplant Sci, V4, P23; Perrett CM, 2008, BRIT J DERMATOL, V159, P198, DOI 10.1111/j.1365-2133.2008.08610.x; Shiloh Y, 2001, BIOCHEM SOC T, V29, P661, DOI 10.1042/0300-5127:0290661; Smith CC, 1999, ENVIRON MOL MUTAGEN, V34, P131, DOI 10.1002/(SICI)1098-2280(1999)34:2/3<131::AID-EM12>3.3.CO;2-B; Toyooka T, 2006, ENVIRON MOL MUTAGEN, V47, P38, DOI 10.1002/em.20166; WARREN DJ, 1995, CANCER RES, V55, P1670; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhang XH, 2007, DNA REPAIR, V6, P344, DOI 10.1016/j.dnarep.2006.11.003; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	39	34	34	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2010	29	27					3953	3963		10.1038/onc.2010.140	http://dx.doi.org/10.1038/onc.2010.140			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	621SL	20440263	Green Accepted			2022-12-25	WOS:000279603200008
J	Hecker, RM; Amstutz, RA; Wachtel, M; Walter, D; Niggli, FK; Schafer, BW				Hecker, R. M.; Amstutz, R. A.; Wachtel, M.; Walter, D.; Niggli, F. K.; Schaefer, B. W.			p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment	ONCOGENE			English	Article						rhabdomyosarcoma; PAX3/FKHR; p21; combination treatment	HISTONE DEACETYLASE INHIBITOR; RHABDOMYOSARCOMA STUDY-GROUP; HUMAN COLON-CANCER; INTERGROUP RHABDOMYOSARCOMA; P21(WAF1/CIP1) EXPRESSION; TRANSCRIPTION FACTOR; CELL-LINES; GROWTH; ADOLESCENTS; EXPERIENCE	A number of drugs developed against cancer-specific molecular targets have been shown to offer survival benefits alone or in combination with standard treatments, especially for those cases in which tumor pathogenesis is dominated by a single molecular abnormality. One example for such a tumor type is alveolar rhabdomyosarcoma (aRMS), which is characterized by a specific translocation creating the oncogenic PAX3/FKHR transcription factor, believed to be the molecular basis of the disease. Recently, we were able to show that the small molecule inhibitor PKC412 (midostaurin) shows strong antitumor activity against aRMS by reducing the transcriptional activity of PAX3/FKHR. In this study, we screened for combination strategies that are superior to PKC412-only treatment and found that the combination of PKC412 with histone deacetylase inhibitors like valproic acid (VPA) synergistically induced apoptosis resulting in suppressed aRMS tumor growth in vivo. We provide evidence that the antitumor effect on combination treatment is achieved by VPA-induced reactivation of p21, which is downregulated in aRMS cells by destabilization of the transcriptional regulator EGR1 by PAX3/FKHR. Our study highlights a possible mechanism behind the increased efficacy and indicates that different arms of PAX3/FKHR oncogenicity can be exploited therapeutically by the specific combination of drugs to increase their therapeutic potential. Oncogene (2010) 29, 3942-3952; doi:10.1038/onc.2010.145; published online 10 May 2010	[Hecker, R. M.; Amstutz, R. A.; Wachtel, M.; Walter, D.; Niggli, F. K.; Schaefer, B. W.] Univ Childrens Hosp, Dept Oncol, CH-8032 Zurich, Switzerland	University Children's Hospital Zurich	Schafer, BW (corresponding author), Univ Childrens Hosp, Dept Oncol, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	beat.schaefer@kispi.uzh.ch	Niggli, Felix/L-6547-2017	Niggli, Felix/0000-0002-7553-3712; Wachtel, Marco/0000-0002-6077-3692; Schafer, Beat/0000-0001-5988-2915	Swiss National Science Foundation (SNF) [3100-109837, 3100-122562]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	We thank professor Soon Young Shin for providing constructs encoding EGR1 and p21 luciferase reporter plasmid, Silvia Behnke for her help with the stainings of tumor sections and Sarah Steinbacher for her graphical support in designing Figure 6. This work was supported by grants (3100-109837 and 3100-122562) from the Swiss National Science Foundation (SNF).	Amstutz R, 2008, CANCER RES, V68, P3767, DOI 10.1158/0008-5472.CAN-07-2447; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Bali P, 2004, CLIN CANCER RES, V10, P4991, DOI 10.1158/1078-0432.CCR-04-0210; Barlow JW, 2006, PEDIATR BLOOD CANCER, V47, P773, DOI 10.1002/pbc.20650; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Choi BH, 2008, CANCER RES, V68, P1369, DOI 10.1158/0008-5472.CAN-07-5222; Della Ragione F, 2003, J BIOL CHEM, V278, P23360, DOI 10.1074/jbc.M300771200; Ebauer M, 2007, ONCOGENE, V26, P7267, DOI 10.1038/sj.onc.1210525; Furukawa Y, 2007, LEUKEMIA, V21, P1005, DOI 10.1038/sj.leu.2404593; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Genini M, 1996, INT J CANCER, V66, P571; Kikuchi K, 2008, BIOCHEM BIOPH RES CO, V365, P568, DOI 10.1016/j.bbrc.2007.11.017; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim JS, 2001, BIOCHEM BIOPH RES CO, V281, P866, DOI 10.1006/bbrc.2001.4434; Kolb EA, 2008, PEDIATR BLOOD CANCER, V50, P1190, DOI 10.1002/pbc.21450; Liu CT, 1996, P NATL ACAD SCI USA, V93, P11831, DOI 10.1073/pnas.93.21.11831; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Meyer WH, 2004, CANCER TREAT REV, V30, P269, DOI 10.1016/j.ctrv.2003.11.001; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; Pappo AS, 1999, J CLIN ONCOL, V17, P3487, DOI 10.1200/JCO.1999.17.11.3487; Raney RB, 2001, J PEDIAT HEMATOL ONC, V23, P215, DOI 10.1097/00043426-200105000-00008; Roeb W, 2008, CELL CYCLE, V7, P837, DOI 10.4161/cc.7.7.5652; Roeb W, 2007, P NATL ACAD SCI USA, V104, P18085, DOI 10.1073/pnas.0708910104; Smith LM, 2001, J CLIN ONCOL, V19, P4058, DOI 10.1200/JCO.2001.19.20.4058; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200	28	20	21	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2010	29	27					3942	3952		10.1038/onc.2010.145	http://dx.doi.org/10.1038/onc.2010.145			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	621SL	20453878	Green Accepted			2022-12-25	WOS:000279603200007
J	Jackman, J; Chen, YM; Huang, A; Moffat, B; Scheer, JM; Leong, SR; Lee, WP; Zhang, JA; Sharma, N; Lu, YM; Iyer, S; Shields, RL; Chiang, N; Bauer, MC; Wadley, D; Roose-Girma, M; Vandlen, R; Yansura, DG; Wu, Y; Wu, LC				Jackman, Janet; Chen, Yongmei; Huang, Arthur; Moffat, Barbara; Scheer, Justin M.; Leong, Steven R.; Lee, Wyne P.; Zhang, Juan; Sharma, Navneet; Lu, Yanmei; Iyer, Suhasini; Shields, Robert L.; Chiang, Nancy; Bauer, Michele C.; Wadley, Diana; Roose-Girma, Merone; Vandlen, Richard; Yansura, Daniel G.; Wu, Yan; Wu, Lawren C.			Development of a Two-part Strategy to Identify a Therapeutic Human Bispecific Antibody That Inhibits IgE Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; GAMMA-RII; MONOCLONAL-ANTIBODIES; CELL ACTIVATION; CANCER-THERAPY; BINDING-SITE; HUMAN IGG1; ALLERGY; EXPRESSION; BASOPHILS	The development of bispecific antibodies as therapeutic agents for human diseases has great clinical potential, but broad application has been hindered by the difficulty of identifying bispecific antibody formats that exhibit favorable pharmacokinetic properties and ease of large-scale manufacturing. Previously, the development of an antibody technology utilizing heavy chain knobs-into-holes mutations and a single common light chain enabled the small-scale generation of human full-length bispecific antibodies. Here we have extended the technology by developing a two-part bispecific antibody discovery strategy that facilitates proof-of-concept studies and clinical candidate antibody generation. Our scheme consists of the efficient small-scale generation of bispecific antibodies lacking a common light chain and the hinge disulfides for proof-of-concept studies coupled with the identification of a common light chain bispecific antibody for large-scale production with high purity and yield. We have applied this technology to generate a bispecific antibody suitable for development as a human therapeutic. This antibody directly inhibits the activation of the high affinity IgE receptor Fc epsilon RI on mast cells and basophils by cross-linking Fc epsilon RI with the inhibitory receptor Fc gamma RIIb, an approach that has strong therapeutic potential for asthma and other allergic diseases. Our approach for producing human bispecific full-length antibodies enables the clinical application of bispecific antibodies to a validated therapeutic pathway in asthma.	[Jackman, Janet; Leong, Steven R.; Lee, Wyne P.; Zhang, Juan; Shields, Robert L.; Wu, Lawren C.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Chen, Yongmei; Huang, Arthur; Chiang, Nancy; Yansura, Daniel G.; Wu, Yan] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Moffat, Barbara; Scheer, Justin M.; Vandlen, Richard] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Sharma, Navneet; Iyer, Suhasini] Genentech Inc, Dept Pharmacokinet Pharmacodynam & Bioanalyt Sci, San Francisco, CA 94080 USA; [Lu, Yanmei] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Bauer, Michele C.; Wadley, Diana; Roose-Girma, Merone] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Wu, Lawren C.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Wu, LC (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way,MS 34, San Francisco, CA 94080 USA.	lawren@gene.com	Zhang, Juan/GRX-2638-2022		Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This work was fully supported by Genentech, Inc.	Asano R, 2007, J BIOL CHEM, V282, P27659, DOI 10.1074/jbc.M704719200; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Carter P, 2001, J IMMUNOL METHODS, V248, P7, DOI 10.1016/S0022-1759(00)00339-2; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chang TW, 2007, ADV IMMUNOL, V93, P63, DOI 10.1016/S0065-2776(06)93002-8; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Friend PJ, 1999, TRANSPLANTATION, V68, P1632, DOI 10.1097/00007890-199912150-00005; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Jung ST, 2010, P NATL ACAD SCI USA, V107, P604, DOI 10.1073/pnas.0908590107; Katz HR, 2002, CURR OPIN IMMUNOL, V14, P698, DOI 10.1016/S0952-7915(02)00400-4; Kepley CL, 2000, J ALLERGY CLIN IMMUN, V106, P337, DOI 10.1067/mai.2000.107931; Kriangkum J, 2001, BIOMOL ENG, V18, P31, DOI 10.1016/S1389-0344(01)00083-1; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Marvin JS, 2005, ACTA PHARMACOL SIN, V26, P649, DOI 10.1111/j.1745-7254.2005.00119.x; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Nakamura A, 2005, EXPERT OPIN THER TAR, V9, P169, DOI 10.1517/14728222.9.1.169; Poole JA, 2005, J ALLERGY CLIN IMMUN, V115, pS376, DOI 10.1016/j.jaci.2004.12.1124; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; RISKE F, 1991, J BIOL CHEM, V266, P11245; Saxon A, 2008, J ALLERGY CLIN IMMUN, V121, P320, DOI 10.1016/j.jaci.2007.10.017; Scharenberg AM, 1999, CURR OPIN IMMUNOL, V11, P621, DOI 10.1016/S0952-7915(99)00027-8; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; Tam SW, 2004, ALLERGY, V59, P772, DOI 10.1111/j.1398-9995.2004.00332.x; TAO MH, 1989, J IMMUNOL, V143, P2595; van Spriel AB, 2000, IMMUNOL TODAY, V21, P391, DOI 10.1016/S0167-5699(00)01659-5; WALKER MR, 1989, BIOCHEM J, V259, P347, DOI 10.1042/bj2590347; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219; Zhu DC, 2002, NAT MED, V8, P518, DOI 10.1038/nm0502-518	41	69	126	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20850	20859		10.1074/jbc.M110.113910	http://dx.doi.org/10.1074/jbc.M110.113910			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20444694	Green Published, hybrid			2022-12-25	WOS:000279228600049
J	Ohtake-Niimi, S; Kondo, S; Ito, T; Kakehi, S; Ohta, T; Habuchi, H; Kimata, K; Habuchi, O				Ohtake-Niimi, Shiori; Kondo, Sachiko; Ito, Tatsuro; Kakehi, Saori; Ohta, Tadayuki; Habuchi, Hiroko; Kimata, Koji; Habuchi, Osami			Mice Deficient in N-Acetylgalactosamine 4-Sulfate 6-O-Sulfotransferase Are Unable to Synthesize Chondroitin/Dermatan Sulfate containing N-Acetylgalactosamine 4,6-Bissulfate Residues and Exhibit Decreased Protease Activity in Bone Marrow-derived Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTES NEURITE OUTGROWTH; SIMPLEX-VIRUS INFECTIVITY; CONNECTIVE-TISSUE-TYPE; SECRETORY GRANULES; SERGLYCIN PROTEOGLYCAN; HEPARIN PROTEOGLYCANS; SQUID CARTILAGE; CRITICAL ROLES; GROWTH-FACTOR; MOUSE	Chondroitin sulfate (CS) and dermatan sulfate (DS) containing N-acetylgalactosamine 4,6-bissulfate (GalNAc(4,6-SO4)) show various physiological activities through interacting with numerous functional proteins. N-Acetylgalactosamine 4-sulfate 6-O-sulfotransferase (GalNAc4S-6ST) transfers sulfate from 3'-phosphoadenosine 5'-phosphosulfate to position 6 of N-acetylgalactosamine 4-sulfate in CS or DS to yield GalNAc(4,6-SO4) residues. We here report generation of transgenic mice that lack GalNAc4S-6ST. GalNAc4S-6ST-null mice were born normally and fertile. In GalNAc4S-6ST-null mice, GalNAc(4,6-SO4) residues in CS and DS disappeared completely, indicating that GalNAc4S-6ST should be a sole enzyme responsible for the synthesis of GalNAc(4,6-SO4) residues in both CS and DS. IdoA-GalNAc(4,6-SO4) units that account for similar to 40% of total disaccharide units of DS in the liver of the wild-type mice disappeared in the liver DS of GalNAc4S-6ST-null mice without reduction of IdoA content. Bone marrow-derived mast cells (BMMCs) derived from GalNAc4S-6ST-null mice contained CS without GlcA-GalNAc(4,6-SO4) units. Tryptase and carboxypeptidase A activities of BMMCs derived from GalNAc4S-6ST-null mice were lower than those activities of BMMCs derived from wild-type mice, although mRNA expression of these mast cell proteases was not altered. Disaccharide compositions of heparan sulfate/heparin contained in the mast cells derived from BMMCs in the presence of stem cell factor were much different from those of heparan sulfate/heparin in BMMCs but did not differ significantly between wildtype mice and GalNAc4S-6ST-null mice. These observations suggest that CS containing GalNAc(4,6-SO4) residues in BMMCs may contribute to retain the active proteases in the granules of BMMCs but not for the maturation of BMMCs into connective tissue-type mast cells.	[Ohtake-Niimi, Shiori; Kondo, Sachiko; Ito, Tatsuro; Kakehi, Saori; Habuchi, Osami] Aichi Univ Educ, Dept Chem, Aichi 4488542, Japan; [Ohta, Tadayuki] Aichi Univ Educ, Dept Biol, Aichi 4488542, Japan; [Habuchi, Hiroko; Kimata, Koji] Aichi Med Univ, Res Complex Med Frontiers, Aichi 4801195, Japan	Aichi University Education; Aichi University Education; Aichi Medical University	Habuchi, O (corresponding author), Aichi Univ Educ, Dept Chem, Igaya Cho, Aichi 4488542, Japan.	ohabuchi@auecc.aichi-edu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Seikagaku Corp.; YAMASA Corp.	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Seikagaku Corp.; YAMASA Corp.	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a special research fund from Seikagaku Corp. and YAMASA Corp.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; ANNO K, 1971, BIOCHIM BIOPHYS ACTA, V237, P173, DOI 10.1016/0304-4165(71)90046-8; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; BOURIN MC, 1990, J BIOL CHEM, V265, P15424; Bouton MC, 2007, CIRC RES, V100, P1174, DOI 10.1161/01.RES.0000265066.92923.ee; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DAVIDSON S, 1990, J BIOL CHEM, V265, P12324; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; DELFERT DM, 1985, ANAL BIOCHEM, V148, P303, DOI 10.1016/0003-2697(85)90233-7; Dudas J, 2001, AM J CLIN PATHOL, V115, P725; ELIAKIM R, 1986, P NATL ACAD SCI USA, V83, P461, DOI 10.1073/pnas.83.2.461; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Gallai M, 1996, AM J PATHOL, V148, P1463; HABUCHI O, 1993, J BIOL CHEM, V268, P21968; Habuchi O, 2002, ANAL BIOCHEM, V310, P129, DOI 10.1016/S0003-2697(02)00277-4; Halldorsdottir AM, 2006, GLYCOBIOLOGY, V16, P693, DOI 10.1093/glycob/cwj117; Hallgren J, 2000, BIOCHEMISTRY-US, V39, P13068, DOI 10.1021/bi000973b; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Hirose J, 2001, J BIOL CHEM, V276, P5228, DOI 10.1074/jbc.M007542200; Hogemann B, 1997, PATHOL RES PRACT, V193, P747; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Ishii M, 2008, J BIOL CHEM, V283, P32610, DOI 10.1074/jbc.M806331200; Ishii M, 2008, GLYCOBIOLOGY, V18, P602, DOI 10.1093/glycob/cwn040; Ito Y, 2000, J BIOL CHEM, V275, P34728, DOI 10.1074/jbc.M909633199; KATZ HR, 1986, J BIOL CHEM, V261, P3393; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; KIMATA K, 2007, COMPREHENSIVE GLYCOS, V3, P159; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; KOBAYASHI S, 1985, BIOCHIM BIOPHYS ACTA, V841, P71, DOI 10.1016/0304-4165(85)90275-2; Koshiishi I, 1999, ARCH BIOCHEM BIOPHYS, V370, P151, DOI 10.1006/abbi.1999.1396; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; MCGEE MP, 1995, J BIOL CHEM, V270, P26109, DOI 10.1074/jbc.270.44.26109; Miller HRP, 1999, BLOOD, V93, P3473, DOI 10.1182/blood.V93.10.3473.410k01_3473_3486; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Ohtake S, 2005, J BIOL CHEM, V280, P39115, DOI 10.1074/jbc.M508816200; Ohtake S, 2003, J BIOL CHEM, V278, P38443, DOI 10.1074/jbc.M306132200; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Ohtake S, 2008, BBA-GEN SUBJECTS, V1780, P687, DOI 10.1016/j.bbagen.2008.01.004; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Ra HJ, 2009, J BIOL CHEM, V284, P27924, DOI 10.1074/jbc.M109.035147; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; RAZIN E, 1984, J IMMUNOL, V132, P1479; RAZIN E, 1982, J BIOL CHEM, V257, P7229; Salgueiro AM, 2006, INT J DEV BIOL, V50, P705, DOI 10.1387/ijdb.062168as; SELZMAN HM, 1962, J CELL BIOL, V15, P136, DOI 10.1083/jcb.15.1.136; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Sotogaku N, 2007, J NEUROCHEM, V103, P749, DOI 10.1111/j.1471-4159.2007.04849.x; SPICER SS, 1967, J HISTOCHEM CYTOCHEM, V15, P225, DOI 10.1177/15.4.225; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; STEVENS RL, 1983, J BIOL CHEM, V258, P5977; STEVENS RL, 1988, P NATL ACAD SCI USA, V85, P2284, DOI 10.1073/pnas.85.7.2284; Takano H, 2008, FEBS LETT, V582, P1444, DOI 10.1016/j.febslet.2008.03.033; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja0484045; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Verkoczy LK, 1998, EUR J IMMUNOL, V28, P2839, DOI 10.1002/(SICI)1521-4141(199809)28:09<2839::AID-IMMU2839>3.0.CO;2-6; Yamaguchi T, 2007, GLYCOBIOLOGY, V17, P1365, DOI 10.1093/glycob/cwm103; YAOITA E, 1990, J BIOL CHEM, V265, P522	67	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20793	20805		10.1074/jbc.M109.084749	http://dx.doi.org/10.1074/jbc.M109.084749			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439988	hybrid, Green Published			2022-12-25	WOS:000279228600043
J	Sevova, ES; Goren, MA; Schwartz, KJ; Hsu, FF; Turk, J; Fox, BG; Bangs, JD				Sevova, Elitza S.; Goren, Michael A.; Schwartz, Kevin J.; Hsu, Fong-Fu; Turk, John; Fox, Brian G.; Bangs, James D.			Cell-free Synthesis and Functional Characterization of Sphingolipid Synthases from Parasitic Trypanosomatid Protozoa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL PHOSPHORYLCERAMIDE SYNTHASE; FREE TRANSLATION; MEMBRANE; IDENTIFICATION; METABOLISM; PROTEIN; CLONING; TARGET; GROWTH	The Trypanosoma brucei genome has four highly similar genes encoding sphingolipid synthases (TbSLS1-4). TbSLSs are polytopic membrane proteins that are essential for viability of the pathogenic bloodstream stage of this human protozoan parasite and, consequently, can be considered as potential drug targets. TbSLS4 was shown previously to be a bifunctional sphingomyelin/ethanolamine phosphorylceramide synthase, whereas functions of the others were not characterized. Using a recently described liposome-supplemented cell-free synthesis system, which eliminates complications from background cellular activities, we now unambiguously define the enzymatic specificity of the entire gene family. TbSLS1 produces inositol phosphorylceramide, TbSLS2 produces ethanolamine phosphorylceramide, and TbSLS3 is bifunctional, like TbSLS4. These findings indicate that TbSLS1 is uniquely responsible for synthesis of inositol phosphorylceramide in insect stage parasites, in agreement with published expression array data (17). This approach also revealed that the Trypanosoma cruzi ortholog (TcSLS1) is a dedicated inositol phosphorylceramide synthase. The cell-free synthesis system allowed rapid optimization of the reaction conditions for these enzymes and site-specific mutagenesis to alter end product specificity. A single residue at position 252 (TbSLS1, Ser(252); TbSLS3, Phe(252)) strongly influences enzymatic specificity. We also have used this system to demonstrate that aureobasidin A, a potent inhibitor of fungal inositol phosphorylceramide synthases, does not significantly affect any of the TbSLS activities, consistent with the phylogenetic distance of these two clades of sphingolipid synthases. These results represent the first application of cell-free synthesis for the rapid preparation and functional annotation of integral membrane proteins and thus illustrate its utility in studying otherwise intractable enzyme systems.	[Sevova, Elitza S.; Schwartz, Kevin J.; Bangs, James D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Goren, Michael A.; Fox, Brian G.] Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA; [Fox, Brian G.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Coll Agr & Life Sci, Madison, WI 53706 USA; [Hsu, Fong-Fu; Turk, John] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL)	Bangs, JD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	jdbangs@wisc.edu		Hsu, Fong-Fu/0000-0001-5368-0183	United States Public Health Service, NIAID, National Institutes of Health [R01 AI35739]; NIGMS, National Institutes of Health [RO1 GM50853]; NIGMS, National Institutes of Health Protein Structure Initiative [1 U54 GM074901]; United States Public Health Service [P41-RR00954, P60-DK20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035739, T32AI055397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074901, R01GM050853, U54GM094584] Funding Source: NIH RePORTER	United States Public Health Service, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)United States Public Health Service); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS, National Institutes of Health Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Service, NIAID, National Institutes of Health Grant R01 AI35739 (to J.D.B.), NIGMS, National Institutes of Health Grant RO1 GM50853 (to B.G.F.), and NIGMS, National Institutes of Health Protein Structure Initiative Grant 1 U54 GM074901 (to J.L. Markley, G.N. Phillips, Jr., and B.G.F.). The Washington University Department of Medicine Mass Spectroscopy Facility is supported by United States Public Health Service Grants P41-RR00954, P60-DK20579, and P30-DK56341.	Alexander DL, 2002, J CELL SCI, V115, P3253; ANDERSON RL, 1982, CLIN CHIM ACTA, V121, P111, DOI 10.1016/0009-8981(82)90216-9; BERTELLO LE, 1995, BIOCHEM J, V310, P255, DOI 10.1042/bj3100255; Blommel PG, 2006, PROTEIN EXPRES PURIF, V47, P562, DOI 10.1016/j.pep.2005.11.007; DASILVEIRA JF, 1981, BIOCHIM BIOPHYS ACTA, V644, P341, DOI 10.1016/0005-2736(81)90392-8; Denny PW, 2006, J BIOL CHEM, V281, P28200, DOI 10.1074/jbc.M600796200; Figueiredo JM, 2005, BIOCHEM J, V387, P519, DOI 10.1042/BJ20041842; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Goren MA, 2009, METHOD ENZYMOL, V463, P647, DOI 10.1016/S0076-6879(09)63037-8; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; KANESHIRO ES, 1986, J LIPID RES, V27, P1294; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; Mina JG, 2009, MOL BIOCHEM PARASIT, V168, P16, DOI 10.1016/j.molbiopara.2009.06.002; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; OLIVEIRA MM, 1977, COMP BIOCHEM PHYS B, V58, P195, DOI 10.1016/0305-0491(77)90109-2; Quinones W, 2004, EXP PARASITOL, V106, P135, DOI 10.1016/j.exppara.2004.03.006; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; Sato K, 2009, MOL BIOL CELL, V20, P4444, DOI 10.1091/mbc.E09-03-0235; Sawasaki T, 2000, Nucleic Acids Symp Ser, P9; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Sevova ES, 2009, MOL BIOL CELL, V20, P4739, DOI 10.1091/mbc.E09-07-0542; Shea JM, 2006, CURR OPIN MICROBIOL, V9, P352, DOI 10.1016/j.mib.2006.06.003; Sutterwala SS, 2008, MOL MICROBIOL, V70, P281, DOI 10.1111/j.1365-2958.2008.06393.x; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; TAKESAKO K, 1991, J ANTIBIOT, V44, P919, DOI 10.7164/antibiotics.44.919; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; Uhrig ML, 1996, BBA-LIPID LIPID MET, V1300, P233, DOI 10.1016/0005-2760(96)00021-5; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x; Zhang K, 2003, EMBO J, V22, P6016, DOI 10.1093/emboj/cdg584; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565	34	32	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20580	20587		10.1074/jbc.M110.127662	http://dx.doi.org/10.1074/jbc.M110.127662			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20457606	Green Published, hybrid			2022-12-25	WOS:000279228600021
J	Ratai, EM; Bombardier, JP; Joo, CG; Annamalai, L; Burdo, TH; Campbell, J; Fell, R; Hakimelahi, R; He, J; Autissier, P; Lentz, MR; Halpern, EF; Masliah, E; Williams, KC; Westmoreland, SV; Gonzalez, RG				Ratai, Eva-Maria; Bombardier, Jeffrey P.; Joo, Chan-Gyu; Annamalai, Lakshmanan; Burdo, Tricia H.; Campbell, Jennifer; Fell, Robert; Hakimelahi, Reza; He, Julian; Autissier, Patrick; Lentz, Margaret R.; Halpern, Elkan F.; Masliah, Eliezer; Williams, Kenneth C.; Westmoreland, Susan V.; Gonzalez, R. Gilberto			Proton Magnetic Resonance Spectroscopy Reveals Neuroprotection by Oral Minocycline in a Nonhuman Primate Model of Accelerated NeuroAIDS	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS DEMENTIA COMPLEX; NAIVE HIV PATIENTS; MICROGLIAL ACTIVATION; N-ACETYLASPARTATE; NEURONAL INJURY; SIV INFECTION; BRAIN-INJURY; HUNTINGTONS-DISEASE	Background: Despite the advent of highly active anti-retroviral therapy (HAART), HIV-associated neurocognitive disorders continue to be a significant problem. In efforts to understand and alleviate neurocognitive deficits associated with HIV, we used an accelerated simian immunodeficiency virus (SIV) macaque model of NeuroAIDS to test whether minocycline is neuroprotective against lentiviral-induced neuronal injury. Methodology/Principal Findings: Eleven rhesus macaques were infected with SIV, depleted of CD8+ lymphocytes, and studied until eight weeks post inoculation (wpi). Seven animals received daily minocycline orally beginning at 4 wpi. Neuronal integrity was monitored in vivo by proton magnetic resonance spectroscopy and post-mortem by immunohistochemistry for synaptophysin (SYN), microtubule-associated protein 2 (MAP2), and neuronal counts. Astrogliosis and microglial activation were quantified by measuring glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule 1 (IBA-1), respectively. SIV infection followed by CD8+ cell depletion induced a progressive decline in neuronal integrity evidenced by declining N-acetylaspartate/creatine (NAA/Cr), which was arrested with minocycline treatment. The recovery of this ratio was due to increases in NAA, indicating neuronal recovery, and decreases in Cr, likely reflecting downregulation of glial cell activation. SYN, MAP2, and neuronal counts were found to be higher in minocycline-treated animals compared to untreated animals while GFAP and IBA-1 expression were decreased compared to controls. CSF and plasma viral loads were lower in MN-treated animals. Conclusions/Significance: In conclusion, oral minocycline alleviates neuronal damage induced by the AIDS virus.	[Ratai, Eva-Maria; Bombardier, Jeffrey P.; Joo, Chan-Gyu; Fell, Robert; Hakimelahi, Reza; He, Julian; Lentz, Margaret R.; Gonzalez, R. Gilberto] Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Ratai, Eva-Maria; Bombardier, Jeffrey P.; Joo, Chan-Gyu; Fell, Robert; Hakimelahi, Reza; He, Julian; Lentz, Margaret R.; Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Neuroradiol Div, Charlestown, MA USA; [Ratai, Eva-Maria; Joo, Chan-Gyu; Annamalai, Lakshmanan; Hakimelahi, Reza; He, Julian; Lentz, Margaret R.; Westmoreland, Susan V.; Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Boston, MA USA; [Annamalai, Lakshmanan; Westmoreland, Susan V.] New England Reg Primate Res Ctr, Div Comparat Pathol, Southborough, MA 01772 USA; [Burdo, Tricia H.; Campbell, Jennifer; Autissier, Patrick; Williams, Kenneth C.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Halpern, Elkan F.] Massachusetts Gen Hosp, Dept Radiol, Inst Technol Assessment, Boston, MA 02114 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston College; Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego	Ratai, EM (corresponding author), Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Charlestown, MA USA.	ratai@nmr.mgh.harvard.edu	Gendelman, Howard E/G-8242-2012	Ratai, Eva-Maria/0000-0001-9476-6207	NIH [R21NS059331, R01NS050041, R01NS040237, R01NS37654, R01MH62962, MH59754, MH62512, RR00168]; NIH Nonhuman Primate Reagent Resource [R24 RR016001, N01 AI040101]; National Center for Research Resources [P41RR14075]; Mental Illness and Neuroscience Discovery (MIND) Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168, P41RR014075, R24RR016001, K26RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062962, P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059331, R01NS040237, R01NS050041, R01NS037654] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nonhuman Primate Reagent Resource; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mental Illness and Neuroscience Discovery (MIND) Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants R21NS059331 (EMR), R01NS050041 (RGG), R01NS040237 (KW), R01NS37654 (KW), R01MH62962 (EM), MH59754 (EM), MH62512 (EM), and RR00168 (NEPRC Base Grant). Depleting anti-CD8 (human recombinant, cM-807) used in these studies were provided by the NIH Nonhuman Primate Reagent Resource (R24 RR016001, N01 AI040101). The Massachusetts General Hospital A. A. Martinos Center for Biomedical Imaging is also supported by the National Center for Research Resources grant number P41RR14075 and the Mental Illness and Neuroscience Discovery (MIND) Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; BARKER PB, 1995, RADIOLOGY, V195, P58, DOI 10.1148/radiology.195.1.7892496; Bissel SJ, 2002, AM J PATHOL, V160, P927, DOI 10.1016/S0002-9440(10)64915-2; Blum D, 2004, NEUROBIOL DIS, V17, P359, DOI 10.1016/j.nbd.2004.07.012; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Burudi EME, 2001, ADV VIRUS RES, V56, P435, DOI 10.1016/S0065-3527(01)56035-2; Chang L, 2003, ANTIVIR THER, V8, P17; Chang L, 2002, NEUROIMAGE, V17, P1638, DOI 10.1006/nimg.2002.1254; Chang L, 1999, NEUROLOGY, V52, P100, DOI 10.1212/WNL.52.1.100; Cheng LL, 1997, P NATL ACAD SCI USA, V94, P6408, DOI 10.1073/pnas.94.12.6408; CHONG WK, 1993, RADIOLOGY, V188, P119, DOI 10.1148/radiology.188.1.8099750; DESROSIERS RC, 1990, ANNU REV IMMUNOL, V8, P557, DOI 10.1146/annurev.iy.08.040190.003013; DICKSON DW, 1991, LAB INVEST, V64, P135; Diguet E, 2004, EXP NEUROL, V189, P1, DOI 10.1016/j.expneurol.2004.05.016; Diguet E, 2004, EUR J NEUROSCI, V19, P3266, DOI 10.1111/j.0953-816X.2004.03372.x; Everall IP, 1997, J NEUROPATH EXP NEUR, V56, P1202, DOI 10.1097/00005072-199711000-00004; Follstaedt SC, 2008, J NEUROVIROL, V14, P376, DOI 10.1080/13550280802199898; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Gonzalez RG, 2000, AIDS, V14, P2841, DOI 10.1097/00002030-200012220-00005; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Greco JB, 2004, MAGN RESON MED, V51, P1108, DOI 10.1002/mrm.20073; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jenwitheesuk E, 2007, BIOINFORMATICS, V23, P2797, DOI 10.1093/bioinformatics/btm424; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kim JP, 2005, AM J NEURORADIOL, V26, P752; Lentz MR, 2008, NMR BIOMED, V21, P878, DOI 10.1002/nbm.1276; Lentz MR, 2005, RADIOLOGY, V235, P461, DOI 10.1148/radiol.2352040003; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lin SZ, 2001, NEUROSCI LETT, V315, P61, DOI 10.1016/S0304-3940(01)02324-2; Marcus CD, 1998, METAB BRAIN DIS, V13, P123, DOI 10.1023/A:1020609213664; MASLIAH E, 1992, ANN NEUROL, V32, P321, DOI 10.1002/ana.410320304; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Meyerhoff DJ, 1999, NEUROLOGY, V52, P995, DOI 10.1212/WNL.52.5.995; MOFFETT JR, 1991, NEUROREPORT, V2, P131, DOI 10.1097/00001756-199103000-00005; Moller HE, 1999, J MAGN RESON IMAGING, V9, P10, DOI 10.1002/(SICI)1522-2586(199901)9:1<10::AID-JMRI2>3.0.CO;2-W; Moore DJ, 2006, AIDS, V20, P879, DOI 10.1097/01.aids.0000218552.69834.00; Murata Y, 2008, STROKE, V39, P3372, DOI 10.1161/STROKEAHA.108.514026; MURRAY EA, 1992, SCIENCE, V255, P1246, DOI 10.1126/science.1546323; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; Nath A, 2002, J INFECT DIS, V186, pS193, DOI 10.1086/344528; Nath A, 2008, INT REV PSYCHIATR, V20, P25, DOI 10.1080/09540260701861930; NAVIA BA, 1986, ANN NEUROL, V19, P525, DOI 10.1002/ana.410190603; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; OGG RJ, 1994, J MAGN RESON SER B, V104, P1, DOI 10.1006/jmrb.1994.1048; Persidsky Y, 2003, J LEUKOCYTE BIOL, V74, P691, DOI 10.1189/jlb.0503205; Persidsky Y, 2000, J LEUKOCYTE BIOL, V68, P413; Popovic N, 2002, ANN NEUROL, V51, P215, DOI 10.1002/ana.10092; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; RATAI EM, 2009, 9 INT S NEUR MIAM BE; RATAI EM, 2009, 17 SCI M EXH HON HI; Ratai EM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-63; Sacktor N, 2002, J NEUROVIROL, V8, P115, DOI 10.1080/13550280290101094; Salvan AM, 1997, AIDS RES HUM RETROV, V13, P1055, DOI 10.1089/aid.1997.13.1055; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; SHARER LR, 1992, J NEUROPATH EXP NEUR, V51, P3, DOI 10.1097/00005072-199201000-00002; SHARER LR, 1988, ANN NEUROL, V23, pS108, DOI 10.1002/ana.410230727; Si QS, 2004, J NEUROVIROL, V10, P284, DOI 10.1080/13550280490499533; Smith DL, 2003, ANN NEUROL, V54, P186, DOI 10.1002/ana.10614; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Tracey I, 1996, NEUROLOGY, V46, P783, DOI 10.1212/WNL.46.3.783; Tsuji M, 2004, EXP NEUROL, V189, P58, DOI 10.1016/j.expneurol.2004.01.011; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; Weed MR, 2003, J NEUROVIROL, V9, P452, DOI 10.1080/13550280390218751; Westmoreland SV, 1998, J NEUROVIROL, V4, P260, DOI 10.3109/13550289809114527; Williams K, 2005, J CLIN INVEST, V115, P2534, DOI 10.1172/JCI22953; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zemke D, 2004, CLIN NEUROPHARMACOL, V27, P293, DOI 10.1097/01.wnf.0000150867.98887.3e; Zink M, 2000, NEUROAIDS, V3; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003; Zink MC, 1997, AM J PATHOL, V151, P793	82	43	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10523	10.1371/journal.pone.0010523	http://dx.doi.org/10.1371/journal.pone.0010523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479889	gold, Green Submitted, Green Published			2022-12-25	WOS:000277467800008
J	Srivastava, K; Field, DJ; Aggrey, A; Yamakuchi, M; Morrell, CN				Srivastava, Kalyan; Field, David J.; Aggrey, Angela; Yamakuchi, Munekazu; Morrell, Craig N.			Platelet Factor 4 Regulation of Monocyte KLF4 in Experimental Cerebral Malaria	PLOS ONE			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; ACTIVATED PLATELETS; IN-VIVO; PLASMODIUM-FALCIPARUM; SMOOTH-MUSCLE; T-CELLS; ATHEROSCLEROSIS; KRUPPEL-LIKE-FACTOR-4; DIFFERENTIATION; PATHOLOGY	Cerebral malaria continues to be a difficult to treat complication of Plasmodium falciparum infection in children. We have shown that platelets can have major deleterious immune functions in experimental cerebral malaria (ECM). One of the platelet derived mediators we have identified as particularly important is platelet factor 4/CXCL4. Our prior work demonstrated that PF4(-/-) mice are protected from ECM, have reduced plasma cytokines, and have reduced T-cell trafficking to the brain. We now show that PF4 drives monocyte cytokine production in a Kruppel like factor 4 (KLF4) dependent manner. Monocyte depleted Plasmodium berghei infected mice have improved survival, and KLF4 is greatly increased in control, but not monocyte depleted mice. PF4(-/-) mice have less cerebral monocyte trafficking and no change in KLF4 expression. These data indicate that PF4 induction of monocyte KLF4 expression may be an important step in the pathogenesis of ECM.	[Srivastava, Kalyan; Field, David J.; Aggrey, Angela; Yamakuchi, Munekazu; Morrell, Craig N.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA	University of Rochester	Srivastava, K (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA.	Craig_Morrell@URMC.Rochester.edu			National Institutes of Health (NIH) [R01HL093179, R01HL094547]; Johns Hopkins Malaria Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094547, R01HL093179] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants R01HL093179 and R01HL094547 and a Johns Hopkins Malaria Research Institute Pilot Project grant to C.N.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Atkins GB, 2008, CIRC RES, V103, P690, DOI 10.1161/CIRCRESAHA.108.184663; AZIZ KA, 1995, BRIT J HAEMATOL, V91, P846, DOI 10.1111/j.1365-2141.1995.tb05399.x; Bikfalvi A, 2004, SEMIN THROMB HEMOST, V30, P379, DOI 10.1055/s-2004-831051; Burger PC, 2003, BLOOD, V101, P2661, DOI 10.1182/blood-2002-07-2209; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; ENGSTAD CS, 1995, J LEUKOCYTE BIOL, V58, P575, DOI 10.1002/jlb.58.5.575; Eslin DE, 2004, BLOOD, V104, P3173, DOI 10.1182/blood-2003-11-3994; ESSIEN EM, 1983, ACTA HAEMATOL-BASEL, V70, P183, DOI 10.1159/000206720; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; GRAU GE, 1993, RES IMMUNOL, V144, P355, DOI 10.1016/S0923-2494(93)80080-I; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1993, EUR CYTOKINE NETW, V4, P415; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; HARPAZ R, 1992, J CLIN INVEST, V90, P515, DOI 10.1172/JCI115889; Hattori T, 2003, FEBS LETT, V541, P33, DOI 10.1016/S0014-5793(03)00283-7; Huo YQ, 2004, TRENDS CARDIOVAS MED, V14, P18, DOI 10.1016/j.tcm.2003.09.007; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kowalska MA, 2007, BLOOD, V110, P1903, DOI 10.1182/blood-2007-03-081901; Lambert MP, 2007, BLOOD, V110, P1153, DOI 10.1182/blood-2007-01-067116; Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001; Lou JN, 1997, AM J PATHOL, V151, P1397; McKenzie SE, 2004, SEMIN THROMB HEMOST, V30, P559, DOI 10.1055/s-2004-835676; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Poncz M, 2005, SEMIN THORAC CARDIOV, V17, P73, DOI 10.1053/j.semtcvs.2004.12.007; Poncz M, 2006, PATHOPHYSIOL HAEMO T, V35, P46, DOI 10.1159/000093543; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Sachais BS, 2007, THROMB HAEMOSTASIS, V98, P1108, DOI 10.1160/TH07-04-0271; Sachais BS, 2004, SEMIN THROMB HEMOST, V30, P351, DOI 10.1055/s-2004-831048; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; Smyth SS, 2009, J THROMB HAEMOST; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; van der Heyde HC, 2005, BLOOD, V105, P1956, DOI 10.1182/blood-2004-06-2206; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; von zur Muhlen C, 2008, J CLIN INVEST, V118, P1198, DOI 10.1172/JCI33314; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; Wassmer SC, 2006, INFECT IMMUN, V74, P645, DOI 10.1128/IAI.74.1.645-653.2006; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; Wassmer SC, 2003, ANN NY ACAD SCI, V992, P30, DOI 10.1111/j.1749-6632.2003.tb03135.x; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Woller G, 2008, J LEUKOCYTE BIOL, V83, P936, DOI 10.1189/jlb.0907592; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730; Yan FF, 2008, MED HYPOTHESES, V70, P845, DOI 10.1016/j.mehy.2007.07.031; Yusuf I, 2008, INT IMMUNOL, V20, P671, DOI 10.1093/intimm/dxn024; ZHENG B, IUBMB LIFE, V62, P132	55	24	24	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10413	10.1371/journal.pone.0010413	http://dx.doi.org/10.1371/journal.pone.0010413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454664	Green Submitted, Green Published, gold			2022-12-25	WOS:000277240300004
J	Bertrand, A; Ballon, M; Chaigneau, A				Bertrand, Arnaud; Ballon, Michael; Chaigneau, Alexis			Acoustic Observation of Living Organisms Reveals the Upper Limit of the Oxygen Minimum Zone	PLOS ONE			English	Article							HUMBOLDT CURRENT SYSTEM; HYPOXIA; WATER; ECOSYSTEM; SARDINE; ANCHOVY; ANOXIA; PERU	Background: Oxygen minimum zones (OMZs) are expanding in the World Ocean as a result of climate change and direct anthropogenic influence. OMZ expansion greatly affects biogeochemical processes and marine life, especially by constraining the vertical habitat of most marine organisms. Currently, monitoring the variability of the upper limit of the OMZs relies on time intensive sampling protocols, causing poor spatial resolution. Methodology/Principal Findings: Using routine underwater acoustic observations of the vertical distribution of marine organisms, we propose a new method that allows determination of the upper limit of the OMZ with a high precision. Applied in the eastern South-Pacific, this original sampling technique provides high-resolution information on the depth of the upper OMZ allowing documentation of mesoscale and submesoscale features (e. g., eddies and filaments) that structure the upper ocean and the marine ecosystems. We also use this information to estimate the habitable volume for the world's most exploited fish, the Peruvian anchovy (Engraulis ringens). Conclusions/Significance: This opportunistic method could be implemented on any vessel geared with multi-frequency echosounders to perform comprehensive high-resolution monitoring of the upper limit of the OMZ. Our approach is a novel way of studying the impact of physical processes on marine life and extracting valid information about the pelagic habitat and its spatial structure, a crucial aspect of Ecosystem-based Fisheries Management in the current context of climate change.	[Bertrand, Arnaud; Ballon, Michael] Inst Rech Dev, EME UMR212, CRH, Sete, France; [Bertrand, Arnaud; Ballon, Michael; Chaigneau, Alexis] Inst Mar Peru, Lima, Peru; [Chaigneau, Alexis] Inst Rech Dev, IPSL LOCEAN, UPMC CNRS IRD MNHN, Paris, France	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Instituto del Mar del Peru; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Bertrand, A (corresponding author), Inst Rech Dev, EME UMR212, CRH, Sete, France.	Arnaud.Bertrand@ird.fr	Bertrand, Arnaud/E-4251-2010; Chaigneau, Alexis/E-4324-2010	Bertrand, Arnaud/0000-0003-4723-179X; chaigneau, alexis/0000-0001-6770-0114	IRD	IRD	Funding: This work is a contribution to the cooperation agreement between the Instituto del Mar del Peru (IMARPE) and the Institut de Recherche pour le Developpement (IRD). Michael Ballon was supported by an individual predoctoral research grant (BSTD) proposed by the "Support and training of scientific communities of the South Department" (DSF) from IRD, managed by Egide. Myriax Software Pty. Ltd. kindly provided free access to Echoview. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayon P, 2008, PROG OCEANOGR, V79, P238, DOI 10.1016/j.pocean.2008.10.020; Bertrand A, 2004, FISH FISH, V5, P296, DOI 10.1111/j.1467-2679.2004.00165.x; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; Brewer PG, 2009, SCIENCE, V324, P347, DOI 10.1126/science.1170756; Capet X, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034736; CARRITT DE, 1966, J MAR RES, V24, P286; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Cressie N. A., 1980, MATH GEOL, V1, P115, DOI DOI 10.1007/BF01035243; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Farias L, 2007, DEEP-SEA RES PT I, V54, P164, DOI 10.1016/j.dsr.2006.11.003; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Foote K, 1987, 144 ICES; Freon P, 2009, PROG OCEANOGR, V83, P1, DOI 10.1016/j.pocean.2009.08.001; Fuenzalida R, 2009, DEEP-SEA RES PT II, V56, P1027, DOI 10.1016/j.dsr2.2008.11.001; Garcia-Castellano JM, 2005, EJC SUPPL, V3, P63; GUTIERREZ M, 1999, B I MAR PERU, V18, P77; Gutierrez M, 2007, FISH OCEANOGR, V16, P155, DOI 10.1111/j.1365-2419.2006.00422.x; Hazen EL, 2009, MAR ECOL PROG SER, V375, P195, DOI 10.3354/meps07791; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; ICES, 2007, 287 ICES; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Keister JE, 2000, MAR ECOL PROG SER, V205, P43, DOI 10.3354/meps205043; Kloser RJ, 2002, CAN J FISH AQUAT SCI, V59, P1065, DOI 10.1139/F02-076; Lau KM, 1995, B AM METEOROL SOC, V76, P2391, DOI 10.1175/1520-0477(1995)076<2391:CSDUWT>2.0.CO;2; LEBOURGESDHAUSS.A, 2010, ICES J MAR IN PRESS; Levi M., 2003, PERSPECT POLIT, V1, P45, DOI [10.1017/S1537592703000045, DOI 10.1017/S1537592703000045]; Liu YG, 2007, J ATMOS OCEAN TECH, V24, P2093, DOI 10.1175/2007JTECHO511.1; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Manriquez K, 2009, J PLANKTON RES, V31, P1075, DOI 10.1093/plankt/fbp053; McWilliams JC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039402; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Nevison CD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002110; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Oschlies A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003147; Paulmier A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026801; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; PRATHER M, 1995, SCI CLIMATE CHANGE I, P86; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Simmonds EJ, 2009, ICES J MAR SCI, V66, P1341, DOI 10.1093/icesjms/fsp118; Simmonds J., 2005, FISHERIES ACOUSTICS; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Swartzman G, 2008, PROG OCEANOGR, V79, P228, DOI 10.1016/j.pocean.2008.10.021; Taylor JC, 2003, AQUAT LIVING RESOUR, V16, P191, DOI 10.1016/S0990-7440(03)00012-3; THOMAS LN, 2008, EDDY RESOLVING OCEAN; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; WISHNER KF, 1995, DEEP-SEA RES PT I, V42, P93, DOI 10.1016/0967-0637(94)00021-J	50	105	110	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2010	5	4							e10330	10.1371/journal.pone.0010330	http://dx.doi.org/10.1371/journal.pone.0010330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PV	20442791	Green Submitted, Green Published, gold			2022-12-25	WOS:000277240200002
J	Satish, L; Johnson, S; Wang, JHC; Post, JC; Ehrlich, GD; Kathju, S				Satish, Latha; Johnson, Sandra; Wang, James H-C; Post, J. Christopher; Ehrlich, Garth D.; Kathju, Sandeep			Chaperonin Containing T-Complex Polypeptide Subunit Eta (CCT-eta) Is a Specific Regulator of Fibroblast Motility and Contractility	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; CYTOSOLIC CHAPERONIN; NITRIC-OXIDE; FETAL SKIN; SENSORY NEUROPATHY; EPSILON-SUBUNIT; CELL-MIGRATION; ADULT; EXPRESSION; GENES	Integumentary wounds in mammalian fetuses heal without scar; this scarless wound healing is intrinsic to fetal tissues and is notable for absence of the contraction seen in postnatal (adult) wounds. The precise molecular signals determining the scarless phenotype remain unclear. We have previously reported that the eta subunit of the chaperonin containing T-complex polypeptide (CCT-eta) is specifically reduced in healing fetal wounds in a rabbit model. In this study, we examine the role of CCT-eta in fibroblast motility and contractility, properties essential to wound healing and scar formation. We demonstrate that CCT-eta (but not CCT-beta) is underexpressed in fetal fibroblasts compared to adult fibroblasts. An in vitro wound healing assay demonstrated that adult fibroblasts showed increased cell migration in response to epidermal growth factor (EGF) and platelet derived growth factor (PDGF) stimulation, whereas fetal fibroblasts were unresponsive. Downregulation of CCT-eta in adult fibroblasts with short inhibitory RNA (siRNA) reduced cellular motility, both basal and growth factor-induced; in contrast, siRNA against CCT-beta had no such effect. Adult fibroblasts were more inherently contractile than fetal fibroblasts by cellular traction force microscopy; this contractility was increased by treatment with EGF and PDGF. CCT-eta siRNA inhibited the PDGF-induction of adult fibroblast contractility, whereas CCT-beta siRNA had no such effect. In each of these instances, the effect of downregulating CCT-eta was to modulate the behavior of adult fibroblasts so as to more closely approximate the characteristics of fetal fibroblasts. We next examined the effect of CCT-eta modulation on alpha-smooth muscle actin (alpha-SMA) expression, a gene product well known to play a critical role in adult wound healing. Fetal fibroblasts were found to constitutively express less alpha-SMA than adult cells. Reduction of CCT-eta with siRNA had minimal effect on cellular beta-actin but markedly decreased alpha-SMA; in contrast, reduction of CCT-beta had minimal effect on either actin isoform. Direct inhibition of alpha-SMA with siRNA reduced both basal and growth factor-induced fibroblast motility. These results indicate that CCT-eta is a specific regulator of fibroblast motility and contractility and may be a key determinant of the scarless wound healing phenotype by means of its specific regulation of alpha-SMA expression.	[Satish, Latha; Johnson, Sandra; Post, J. Christopher; Ehrlich, Garth D.; Kathju, Sandeep] Allegheny Gen Hosp, Ctr Genom Sci, Allegheny Singer Res Inst, Pittsburgh, PA 15212 USA; [Wang, James H-C] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15261 USA	Allegheny General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Satish, L (corresponding author), Allegheny Gen Hosp, Ctr Genom Sci, Allegheny Singer Res Inst, Pittsburgh, PA 15212 USA.	skathju@wpahs.org	Latha, Satish/AAH-4977-2019	Latha, Satish/0000-0003-0154-7094; Ehrlich, Garth/0000-0003-1140-6594	Allegheny Singer Research Institute; Allegheny General Hospital; Pittsburgh Tissue Engineering Institute (PTEI); United States Department of Defense [W81XWH-08-2-0032];  [K08 DE014780];  [DC 05659];  [DC04173];  [NIHR01 AR049921]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K08DE014780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005659, R01DC004173] Funding Source: NIH RePORTER	Allegheny Singer Research Institute; Allegheny General Hospital(General Electric); Pittsburgh Tissue Engineering Institute (PTEI); United States Department of Defense(United States Department of Defense); ; ; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: This study was supported by Allegheny Singer Research Institute, Allegheny General Hospital and Pittsburgh Tissue Engineering Institute (PTEI). This work was funded from the grants awarded to S. K. (K08 DE014780; United States Department of Defense, W81XWH-08-2-0032), J. C. P. (DC 05659), G. D. E. (DC04173) and to L. S. (3M Fellowship). Funding support for cellular traction force microscopy work was provided from the grant awarded to J. H- C. W. (NIHR01 AR049921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadeu TP, 2008, J SURG RES, V149, P84, DOI 10.1016/j.jss.2007.10.015; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Bouhouche A, 2006, J MED GENET, V43, P441, DOI 10.1136/jmg.2005.039230; BRIAN JB, 1999, ARCH OTOLARYNGOL, V125, P676; Brink HE, 2006, WOUND REPAIR REGEN, V14, P179, DOI 10.1111/j.1743-6109.2006.00108.x; Brink HE, 2005, IN VITRO CELL DEV-AN, V41, P252; Broker BJ, 1999, ARCH OTOLARYNGOL, V125, P676, DOI 10.1001/archotol.125.6.676; Burton K, 1999, MOL BIOL CELL, V10, P3745, DOI 10.1091/mbc.10.11.3745; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Cass DL, 1997, J PEDIATR SURG, V32, P1017, DOI 10.1016/S0022-3468(97)90390-0; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; Colwell AS, 2008, WOUND REPAIR REGEN, V16, P450, DOI 10.1111/j.1524-475X.2008.00383.x; Colwell AS, 2005, ADV BIOCHEM ENG BIOT, V93, P83, DOI 10.1007/b99972; Curran JN, 2006, WOUND REPAIR REGEN, V14, P376, DOI 10.1111/j.1743-6109.2006.00151.x; Cyrne L, 1996, FEBS LETT, V383, P277, DOI 10.1016/0014-5793(96)00240-2; Darden DL, 2000, J PEDIATR SURG, V35, P406, DOI 10.1016/S0022-3468(00)90204-5; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; DEPALMA RL, 1989, MATRIX, V9, P224; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; ELLIS I, 1992, J CELL SCI, V102, P447; ESTES JM, 1994, DIFFERENTIATION, V56, P173, DOI 10.1046/j.1432-0436.1994.5630173.x; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Hanafy KA, 2004, J BIOL CHEM, V279, P46946, DOI 10.1074/jbc.M404134200; Hantash BM, 2008, FRONT BIOSCI-LANDMRK, V13, P51, DOI 10.2741/2559; Himmelspach R, 1997, PLANT J, V12, P1299, DOI 10.1046/j.1365-313x.1997.12061299.x; HYNES G, 1995, FEBS LETT, V358, P129, DOI 10.1016/0014-5793(94)01408-S; Jain K, 2008, J SURG RES, V148, P45, DOI 10.1016/j.jss.2008.02.053; Kashuba E, 1999, J HUMAN VIROL, V2, P33; Kathju S, 2006, WOUND REPAIR REGEN, V14, P413, DOI 10.1111/j.1743-6109.2006.00140.x; KONDO H, 1995, EXP CELL RES, V220, P501, DOI 10.1006/excr.1995.1342; Kondo H, 2000, IN VITRO CELL DEV-AN, V36, P256; Koulikovska M, 2005, ACTA OPHTHALMOL SCAN, V83, P543, DOI 10.1111/j.1600-0420.2005.00482.x; Kubota H, 1999, EUR J BIOCHEM, V262, P492, DOI 10.1046/j.1432-1327.1999.00405.x; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; KUBOTA H, 1995, GENE, V154, P231, DOI 10.1016/0378-1119(94)00880-2; Landau L. D., 1986, COURSE THEORETICAL P, V7; Lee JS, 2005, AM J PATHOL, V166, P1861, DOI 10.1016/S0002-9440(10)62495-9; Lee MJ, 2003, HUM MOL GENET, V12, P1917, DOI 10.1093/hmg/ddg198; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; LORENZ HP, 1995, PLAST RECONSTR SURG, V96, P1251, DOI 10.1097/00006534-199511000-00001; Matsuda N, 2004, DEVELOPMENT, V131, P1913, DOI 10.1242/dev.01085; Park JC, 2001, YONSEI MED J, V42, P587, DOI 10.3349/ymj.2001.42.6.587; Rizk M, 2004, WORLD J SURG, V28, P301, DOI 10.1007/s00268-003-7396-7; ROMMELAERE H, 1993, P NATL ACAD SCI USA, V90, P11975, DOI 10.1073/pnas.90.24.11975; Roobol A, 1999, EUR J CELL BIOL, V78, P21, DOI 10.1016/S0171-9335(99)80004-1; Sandulache VC, 2005, CELL TRANSPLANT, V14, P331, DOI 10.3727/000000005783983025; Satish L, 2003, J INVEST DERMATOL, V120, P1110, DOI 10.1046/j.1523-1747.2003.12230.x; Satish L, 2008, CELL STRESS CHAPERON, V13, P527, DOI 10.1007/s12192-008-0040-6; SCHOR SL, 1985, J CELL SCI, V73, P221; Shiraha H, 1999, J CELL BIOL, V146, P243; Staykova MA, 2003, FASEB J, V17, P1337, DOI 10.1096/fj.02-0577fje; Stelnicki EJ, 1998, J INVEST DERMATOL, V110, P110, DOI 10.1046/j.1523-1747.1998.00092.x; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Tsai WC, 2003, J ORTHOPAED RES, V21, P265, DOI 10.1016/S0736-0266(02)00151-1; Tsai WC, 2008, CONNECT TISSUE RES, V49, P367, DOI 10.1080/03008200802325359; Webb Donna J., 2004, V294, P3; Wilgus TA, 2007, OSTOMY WOUND MANAG, V53, P16	59	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2010	5	4							e10063	10.1371/journal.pone.0010063	http://dx.doi.org/10.1371/journal.pone.0010063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PV	20442790	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000277240200001
J	Lambertini, C; Pantano, S; Dotto, GP				Lambertini, Chiara; Pantano, Serafino; Dotto, G. Paolo			Differential Control of Notch1 Gene Transcription by Klf4 and Sp3 Transcription Factors in Normal versus Cancer-Derived Keratinocytes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; SIGNALING PATHWAY; FACTOR FAMILY; CELL-GROWTH; EXPRESSION; P53; PROMOTER; INDUCTION; COMPLEX; TARGET	In specific cell types like keratinocytes, Notch signaling plays an important pro-differentiation and tumor suppressing function, with down-modulation of the Notch1 gene being associated with cancer development. Besides being controlled by p53, little else is known on regulation of Notch1 gene expression in this context. We report here that transcription of this gene is driven by a TATA-less "sharp peak'' promoter and that the minimal functional region of this promoter, which extends from the -342 bp position to the initiation codon, is differentially active in normal versus cancer cells. This GC rich region lacks p53 binding sites, but binds Klf4 and Sp3. This finding is likely to be of biological significance, as Klf4 and, to a lesser extent, Sp3 are up-regulated in a number of cancer cells where Notch1 expression is down-modulated, and Klf4 overexpression in normal cells is sufficient to down-modulate Notch1 gene transcription. The combined knock-down of Klf4 and Sp3 was necessary for the reverse effect of increasing Notch1 transcription, consistent with the two factors exerting an overlapping repressor function through their binding to the Notch1 promoter.	[Lambertini, Chiara; Pantano, Serafino; Dotto, G. Paolo] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Dotto, G. Paolo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA	University of Lausanne; Harvard University; Massachusetts General Hospital	Lambertini, C (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	Gian-Paolo.Dotto@unil.ch			Swiss National Foundation; European Union [LSHB-CT-2005-019067]; NIH [AR39190, AR054856]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054856, R01AR039190] Funding Source: NIH RePORTER	Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the Swiss National Foundation, a grant from the European Union (Epistem, Sixth Framework Program, LSHB-CT-2005-019067), and NIH Grants AR39190 and AR054856 and to G. P. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2007, NEOPLASIA, V9, P427, DOI 10.1593/neo.07211; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chen YJ, 2008, CANCER BIOL THER, V7, P777, DOI 10.4161/cbt.7.5.5768; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Dotto G. P., 2000, BIOCHIM BIOPHYS ACTA, V87483, P1; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Fasken MB, 2009, RNA BIOL, V6, P237, DOI 10.4161/rna.6.3.8330; Fischer DF, 1996, MOL CELL BIOL, V16, P5365, DOI 10.1128/mcb.16.10.5365; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Lewis BA, 2000, P NATL ACAD SCI USA, V97, P7172, DOI 10.1073/pnas.120181197; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Liu ZL, 2009, CANCER BIOL THER, V8, P1840, DOI 10.4161/cbt.8.19.9440; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Mandinova A, 2008, EMBO J, V27, P1243, DOI 10.1038/emboj.2008.45; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Prowse DM, 1997, J BIOL CHEM, V272, P1308, DOI 10.1074/jbc.272.2.1308; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Secchiero P, 2009, BLOOD, V113, P4300, DOI 10.1182/blood-2008-11-187708; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Song J, 2003, INT J MOL MED, V11, P547; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Thelu Jacques, 2002, BMC Dermatol, V2, P7, DOI 10.1186/1471-5945-2-7; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008	54	30	30	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10369	10.1371/journal.pone.0010369	http://dx.doi.org/10.1371/journal.pone.0010369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442780	Green Submitted, Green Published, gold			2022-12-25	WOS:000277154200011
J	Nguyen, M; Leuridan, E; Zhang, T; De Wit, D; Willems, F; Van Damme, P; Goldman, M; Goriely, S				Nguyen, Muriel; Leuridan, Elke; Zhang, Tong; De Wit, Dominique; Willems, Fabienne; Van Damme, Pierre; Goldman, Michel; Goriely, Stanislas			Acquisition of Adult-Like TLR4 and TLR9 Responses during the First Year of Life	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; CORD BLOOD; INNATE IMMUNITY; HUMAN NEWBORNS; MONONUCLEAR-CELLS; ALPHA PRODUCTION; DENDRITIC CELLS; LIPOPOLYSACCHARIDE; INTERLEUKIN-12; TRANSCRIPTION	Background: Characteristics of the human neonatal immune system are thought to be responsible for heightened susceptibility to infectious pathogens and poor responses to vaccine antigens. Using cord blood as a source of immune cells, many reports indicate that the response of neonatal monocytes and dendritic cells (DC) to Toll-like receptor (TLR) agonists differs significantly from that of adult cells. Herein, we analyzed the evolution of these responses within the first year of life. Methodology/Principal Findings: Blood samples from children (0, 3, 6, 9, 12 month old) and healthy adults were stimulated ex vivo with bacterial lipopolysaccharide (LPS, TLR4 agonist) or CpG oligonucleotides (TLR9 agonist). We determined phenotypic maturation of monocytes, myeloid (m) and plasmacytoid (p) DC and production of cytokines in the culture supernatants. We observed that surface expression of CD80 and HLA-DR reaches adult levels within the first 3 months of life for mDCs and 6-9 months of life for monocytes and pDCs. In response to LPS, production of TNF-alpha, IP-10 and IL-12p70 reached adult levels between 6-9 months of life. In response to CpG stimulation, production of type I IFN-dependent chemokines (IP-10 and CXCL9) gradually increased with age but was still limited in 1-year old infants as compared to adult controls. Finally, cord blood samples stimulated with CpG ODN produced large amounts of IL-6, IL-8, IL-1b and IL-10, a situation that was not observed for 3 month-old infants. Conclusions: The first year of life represents a critical period during which adult-like levels of TLR responses are reached for most but not all cytokine responses.	[Nguyen, Muriel; Zhang, Tong; De Wit, Dominique; Willems, Fabienne; Goldman, Michel; Goriely, Stanislas] Univ Libre Bruxelles, Inst Med Immunol, Gosselies, Belgium; [Leuridan, Elke; Van Damme, Pierre] Univ Antwerp, Ctr Evaluat Vaccinat, Vaccine & Infect Dis Inst, Antwerp, Belgium	Universite Libre de Bruxelles; University of Antwerp	Nguyen, M (corresponding author), Univ Libre Bruxelles, Inst Med Immunol, Gosselies, Belgium.	stgoriel@ulb.ac.be	van damme, pierre/I-4846-2013	Goriely, Stanislas/0000-0002-7005-6195; van damme, pierre/0000-0002-8642-1249; Leuridan, Elke/0000-0001-7482-799X	Fonds National de la Recherche Scientifique (FNRS, Belgium); Interuniversity Attraction Pole of the Belgian Federal Science Policy; University of Antwerp	Fonds National de la Recherche Scientifique (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Pole of the Belgian Federal Science Policy(Belgian Federal Science Policy Office); University of Antwerp	The Institute for Medical Immunology is sponsored by the government of the Walloon Region and GlaxoSmithKline Biologicals. This study was supported by the Fonds National de la Recherche Scientifique (FNRS, Belgium) and an Interuniversity Attraction Pole of the Belgian Federal Science Policy. S. G. is a research associate of the FRS-FNRS. E. L. received a research grant from the University of Antwerp for the conduction of the longitudinal study on maternal antibodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aksoy E, 2007, BLOOD, V109, P2887, DOI 10.1182/blood-2006-06-027862; Al-Hertani W, 2007, CLIN INVEST MED, V30, pE44; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Brown MA, 2003, PEDIATR ALLERGY IMMU, V14, P106, DOI 10.1034/j.1399-3038.2003.00015.x; COHEN L, 1995, J IMMUNOL, V155, P5337; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; De Wit D, 2004, BLOOD, V103, P1030, DOI 10.1182/blood-2003-04-1216; De Wit D, 2003, J AUTOIMMUN, V21, P277, DOI 10.1016/j.jaut.2003.08.003; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Malamitsi-Puchner A, 2005, EARLY HUM DEV, V81, P387, DOI 10.1016/j.earlhumdev.2004.10.017; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Rowe J, 2000, INFECT IMMUN, V68, P3873, DOI 10.1128/IAI.68.7.3873-3877.2000; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Siegrist C A, 2000, Int Rev Immunol, V19, P195, DOI 10.3109/08830180009088505; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; WEATHERSTONE KB, 1989, PEDIATR RES, V25, P342, DOI 10.1203/00006450-198904000-00006; WILSON CB, 1990, REV INFECT DIS, V12, pS410; Yan SR, 2004, INFECT IMMUN, V72, P1223, DOI 10.1128/IAI.72.3.1223-1229.2004; YERKOVICH ST, 2007, PEDIAT RES	27	109	115	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10407	10.1371/journal.pone.0010407	http://dx.doi.org/10.1371/journal.pone.0010407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442853	Green Submitted, Green Published, gold			2022-12-25	WOS:000277154200031
J	Mohamed, JS; Lopez, MA; Cox, GA; Boriek, AM				Mohamed, Junaith S.; Lopez, Michael A.; Cox, Gregory A.; Boriek, Aladin M.			Anisotropic regulation of Ankrd2 gene expression in skeletal muscle by mechanical stretch	FASEB JOURNAL			English	Article						diaphragm; NF-kappa B; AP-1; mdm mice; mechanotransduction	NF-KAPPA-B; MUSCULAR-DYSTROPHY; FIBER ARCHITECTURE; ECCENTRIC CONTRACTIONS; MAP KINASES; PROTEIN; TITIN; STRESS; ACTIVATION; PATHWAYS	The diaphragm muscles in vivo are subjected to mechanical forces both in the direction of the muscle fibers and in the direction transverse to the fibers. However, the effect of directional mechanical forces in skeletal muscle gene regulation is completely unknown. Here, we identified that stretch in the longitudinal and transverse directions to the diaphragm muscle fibers up-regulated Ankrd2 gene expression by two distinct signaling pathways in wild-type (WT) and mdm, a mouse model of muscular dystrophy with early-onset of progressive muscle-wasting. Stretch in the longitudinal direction activated both NF-kappa B and AP-1 transcription factors, whereas stretch in the transverse direction activated only AP-1 transcription factor. Interestingly, longitudinal stretch activated Ankrd2 promoter only by NF-kappa B, whereas transverse stretch activated Ankrd2 promoter by AP-1. Moreover, we found that longitudinal stretch activated Akt, which up-regulated Ankrd2 expression through NF-kappa B. However, transverse stretch activated Ras-GTP, Raf-1, and Erk1/2 proteins, which up-regulated Ankrd2 expression through AP-1. Surprisingly, the stretch-activated NF-kappa B and AP-1 signaling pathways was not involved in Ankrd2 regulation at the basal level, which was high in the mdm mouse diaphragm. Taken together, our data show the anisotropic regulation of Ankrd2 gene expression in the diaphragm muscles of WT and mdm mice via two distinct mechanosensitive signaling pathways.-Mohamed, J. S., Lopez, M. A., Cox, G. A., Boriek, A. M. Anisotropic regulation of Ankrd2 gene expression in skeletal muscle by mechanical stretch. FASEB J. 24, 3330-3340 (2010). www.fasebj.org	[Mohamed, Junaith S.; Lopez, Michael A.; Boriek, Aladin M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Cox, Gregory A.] Jackson Lab, Bar Harbor, ME 04609 USA	Baylor College of Medicine; Jackson Laboratory	Boriek, AM (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	boriek@bcm.tmc.edu	Mohamed, Junaith/AAC-4050-2020; Lopez, Michael A./AAT-2145-2021	Lopez, Michael A./0000-0002-3029-0761	National Heart, Lung and Blood Institute [HL-63134]; National Science Foundation [CBET-0650686]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063134] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung and Blood Institute grant HL-63134 and National Science Foundation grant CBET-0650686 supported this work.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barash IA, 2004, AM J PHYSIOL-CELL PH, V286, pC355, DOI 10.1152/ajpcell.00211.2003; Bean C, 2005, J MOL BIOL, V349, P349, DOI 10.1016/j.jmb.2005.03.063; Bean C, 2008, BBA-MOL CELL RES, V1783, P1023, DOI 10.1016/j.bbamcr.2008.01.027; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boriek AM, 2000, J APPL PHYSIOL, V89, P2187, DOI 10.1152/jappl.2000.89.6.2187; Boriek AM, 2002, J APPL PHYSIOL, V92, P725, DOI 10.1152/jappl.2002.92.2.725; Boriek AM, 2001, AM J PHYSIOL-REG I, V280, pR156, DOI 10.1152/ajpregu.2001.280.1.R156; Boriek AM, 1998, J APPL PHYSIOL, V84, P318; Boriek AM, 2001, AM J PHYSIOL-CELL PH, V280, pC46, DOI 10.1152/ajpcell.2001.280.1.C46; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHARU D, 2006, J CELL PHYSL, V208, P575; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GOLDSPINK G, 1992, AM J PHYSIOL, V262, pR356, DOI 10.1152/ajpregu.1992.262.3.R356; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Haravuori H, 2001, NEUROLOGY, V56, P869, DOI 10.1212/WNL.56.7.869; Hentzen ER, 2006, J PHYSIOL-LONDON, V570, P157, DOI 10.1113/jphysiol.2005.093005; Ishiguro N, 2002, AM J PATHOL, V160, P1767, DOI 10.1016/S0002-9440(10)61123-6; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Kojic S, 2004, J MOL BIOL, V339, P313, DOI 10.1016/j.jmb.2004.03.071; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kumar A, 2002, J BIOL CHEM, V277, P46493, DOI 10.1074/jbc.M203654200; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lehti TM, 2007, J MUSCLE RES CELL M, V28, P39, DOI 10.1007/s10974-007-9102-0; Lopez MA, 2008, AM J PHYSIOL-CELL PH, V295, pC1092, DOI 10.1152/ajpcell.16.2008; MARGULIES SS, 1994, J APPL PHYSIOL, V76, P2070, DOI 10.1152/jappl.1994.76.5.2070; Mckoy G, 2005, J APPL PHYSIOL, V98, P2337, DOI 10.1152/japplphysiol.01046.2004; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Moriyama M, 2001, BIOCHEM BIOPH RES CO, V285, P715, DOI 10.1006/bbrc.2001.5216; Pardo PS, 2008, AM J PHYSIOL-CELL PH, V294, pC1056, DOI 10.1152/ajpcell.00270.2007; Patel ND, 2003, AM J PHYSIOL-CELL PH, V284, pC962, DOI 10.1152/ajpcell.00326.2002; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Roy R R, 1991, Exerc Sport Sci Rev, V19, P269; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schramek H, 2002, NEWS PHYSIOL SCI, V17, P62, DOI 10.1152/nips.01365.2001; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Tsukamoto Y, 2002, LAB INVEST, V82, P645, DOI 10.1038/labinvest.3780459; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195	47	26	26	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3330	3340		10.1096/fj.10-158386	http://dx.doi.org/10.1096/fj.10-158386			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20442316	Green Published			2022-12-25	WOS:000281446400021
J	Pittel, I; Witt-Kehati, D; Degani-Katzav, N; Paas, Y				Pittel, Ilya; Witt-Kehati, Dvora; Degani-Katzav, Nurit; Paas, Yoav			Probing Pore Constriction in a Ligand-gated Ion Channel by Trapping a Metal Ion in the Pore upon Agonist Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CYS-LOOP RECEPTORS; X-RAY-STRUCTURE; BINDING-SITE; CRYSTAL-STRUCTURE; GLYCINE RECEPTOR; LOCAL-ANESTHETICS; GATING MECHANISM; NONCOMPETITIVE ANTAGONIST; ALPHA-BUNGAROTOXIN	Eukaryotic pentameric ligand-gated ion channels (pLGICs) are receptors activated by neurotransmitters to rapidly transport ions across cell membranes, down their electrochemical gradients. Recent crystal structures of two prokaryotic pLGICs were interpreted to imply that the extracellular side of the transmembrane pore constricts to close the channel (Hilf, R. J., and Dutzler, R. (2009) Nature 457, 115-118; Bocquet, N., Nury, H., Baaden, M., Le Poupon, C., Changeux, J. P., Delarue, M., and Corringer, P. J. (2009) Nature 457, 111-114). Here, we utilized a eukaryotic acetylcholine (ACh)-serotonin chimeric pLGIC that was engineered with histidines to coordinate a metal ion within the channel pore, at its cytoplasmic side. In a previous study, the access of Zn2+ ions to the engineered histidines had been explored when the channel was either at rest (closed) or active (open) (Paas, Y., Gibor, G., Grailhe, R., Savatier-Duclert, N., Dufresne, V., Sunesen, M., de Carvalho, L. P., Changeux, J. P., and Attali, B. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 1587715882). In this study, the interactions of Zn2+ with the pore were probed upon agonist (ACh) dissociation that triggers the transition of the receptor from the active conformation to the resting conformation (i.e. during deactivation). Application of Zn2+ onto ACh-bound open receptors obstructed their pore and prevented ionic flow. Removing ACh from its extracellular binding sites to trigger deactivation while Zn2+ is still bound led to tight trapping of Zn2+ within the pore. Together with single-channel recordings, made to explore single pore-blocking events, we show that dissociation of ACh causes the gate to shut on a Zn2+ ion that effectively acts as a "foot in the door." We infer that, upon deactivation, the cytoplasmic side of the pore of the ACh-serotonin receptor chimera constricts to close the channel.	[Pittel, Ilya; Witt-Kehati, Dvora; Degani-Katzav, Nurit; Paas, Yoav] Bar Ilan Univ, Inst Nanotechnol & Adv Mat, Mina & Everard Goodman Fac Life Sci, Lab Ion Channels, IL-52900 Ramat Gan, Israel	Bar Ilan University	Paas, Y (corresponding author), Bar Ilan Univ, Inst Nanotechnol & Adv Mat, Mina & Everard Goodman Fac Life Sci, Lab Ion Channels, IL-52900 Ramat Gan, Israel.	paasyo@mail.biu.ac.il			Wolfson Family Foundation; Israel Science Foundation [812/07, 1645/07]	Wolfson Family Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported by the Wolfson Family Foundation and the Israel Science Foundation Grants 812/07 and 1645/07.	AIDLEY DJ, 1996, ION CHANNELS MOL ACT, P225; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; ANAND R, 1993, FEBS LETT, V327, P241, DOI 10.1016/0014-5793(93)80177-V; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; BLANCHARD SG, 1979, BIOCHEMISTRY-US, V18, P5880, DOI 10.1021/bi00593a019; Blanton MP, 2000, J BIOL CHEM, V275, P3469, DOI 10.1074/jbc.275.5.3469; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; CHANG CC, 1966, BRIT J PHARM CHEMOTH, V28, P172, DOI 10.1111/j.1476-5381.1966.tb01883.x; Changeux JP, 2009, CR BIOL, V332, P421, DOI 10.1016/j.crvi.2009.02.005; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; Cheng MHY, 2007, PROTEINS, V68, P581, DOI 10.1002/prot.21435; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; Creighton T. E., 1993, PROTEINS STRUCTURES, P141; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2008, NAT STRUCT MOL BIOL, V15, P389, DOI 10.1038/nsmb.1407; Dang H, 2000, MOL PHARMACOL, V57, P1114; DAVIES NW, 1989, J PHYSIOL-LONDON, V413, P31, DOI 10.1113/jphysiol.1989.sp017640; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Diaz N, 2000, CHEM PHYS LETT, V326, P288, DOI 10.1016/S0009-2614(00)00744-2; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Gallagher MJ, 1999, MOL PHARMACOL, V56, P300, DOI 10.1124/mol.56.2.300; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; HIGAKI JN, 1992, TRENDS BIOCHEM SCI, V17, P100, DOI 10.1016/0968-0004(92)90245-5; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Ivanov I, 2007, J AM CHEM SOC, V129, P8217, DOI 10.1021/ja070778l; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KARLIN A, 1967, J THEOR BIOL, V16, P306, DOI 10.1016/0022-5193(67)90011-2; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lape R, 2009, J PHYSIOL-LONDON, V587, P5045, DOI 10.1113/jphysiol.2009.176305; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; LESTER HA, 1970, NATURE, V227, P727, DOI 10.1038/227727a0; Liu XL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040019; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mercado J, 2008, J BIOL CHEM, V283, P15250, DOI 10.1074/jbc.M708638200; Miller PS, 2008, NAT STRUCT MOL BIOL, V15, P1084, DOI 10.1038/nsmb.1492; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; OGDEN DC, 1981, NATURE, V289, P596, DOI 10.1038/289596a0; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; PAPKE RL, 1989, J GEN PHYSIOL, V93, P785, DOI 10.1085/jgp.93.5.785; Papke RL, 2001, MOL PHARMACOL, V60, P1365, DOI 10.1124/mol.60.6.1365; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Pascual JM, 1998, J GEN PHYSIOL, V112, P611, DOI 10.1085/jgp.112.5.611; Perkins DI, 2009, J BIOL CHEM, V284, P27304, DOI 10.1074/jbc.M109.023598; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Pless SA, 2009, J BIOL CHEM, V284, P15847, DOI 10.1074/jbc.M809343200; Purohit Y, 2006, J GEN PHYSIOL, V127, P703, DOI 10.1085/jgp.200509437; Rayes D, 2005, MOL PHARMACOL, V68, P1475, DOI 10.1124/mol.105.015438; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Samson AO, 2002, NEURON, V35, P319, DOI 10.1016/S0896-6273(02)00773-0; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Sunesen M, 2006, J BIOL CHEM, V281, P14875, DOI 10.1074/jbc.M511657200; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Taly A, 2006, P NATL ACAD SCI USA, V103, P16965, DOI 10.1073/pnas.0607477103; Taylor P, 2007, BIOCHEM PHARMACOL, V74, P1164, DOI 10.1016/j.bcp.2007.07.038; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Wiltfong RE, 2009, J NEUROSCI, V29, P1626, DOI 10.1523/JNEUROSCI.4121-08.2009	87	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26519	26531		10.1074/jbc.M110.102327	http://dx.doi.org/10.1074/jbc.M110.102327			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20466725	hybrid, Green Published			2022-12-25	WOS:000280921000069
J	Heilig, EA; Xia, WM; Shen, J; Kelleher, RJ				Heilig, Elizabeth A.; Xia, Weiming; Shen, Jie; Kelleher, Raymond J., III			A Presenilin-1 Mutation Identified in Familial Alzheimer Disease with Cotton Wool Plaques Causes a Nearly Complete Loss of gamma-Secretase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; TERMINAL PAL MOTIF; A-BETA; INTRACELLULAR DOMAINS; SPASTIC PARAPARESIS; MEMORY IMPAIRMENTS; CATALYTIC SITE; APP; DEPOSITION; STABILIZATION	Mutations in presenilin-1 and presenilin-2 (PS1 and PS2) are the most common cause of familial Alzheimer disease. PS1 and PS2 are the presumptive catalytic components of the multisub-unit gamma-secretase complex, which proteolyzes a number of type I transmembrane proteins, including the amyloid precursor protein (APP) and Notch. APP processing by gamma-secretase produces beta-amyloid peptides (A beta 40 and A beta 42) that accumulate in the Alzheimer disease brain. Here we identify a pathogenic L435F mutation in PS1 in two affected siblings with early-onset familial Alzheimer disease characterized by deposition of cerebral cotton wool plaques. The L435F mutation resides in a conserved C-terminal PAL sequence implicated in active site conformation and catalytic activity. The impact of PS1 mutations in and around the PAL motif on gamma-secretase activity was assessed by expression of mutant PS1 in mouse embryo fibroblasts lacking endogenous PS1 and PS2. Surprisingly, the L435F mutation caused a nearly complete loss of gamma-secretase activity, including > 90% reductions in the generation of A beta 40, A beta 42, and the APP and Notch intracellular domains. Two nonpathogenic PS1 mutations, P433L and L435R, caused essentially complete loss of gamma-secretase activity, whereas two previously identified pathogenic PS1 mutations, P436Q and P436S, caused partial loss of function with substantial reductions in production of A beta 40, A beta 42, and the APP and Notch intracellular domains. These results argue against overproduction of A beta 42 as an essential property of presenilin proteins bearing pathogenic mutations. Rather, our findings provide support for the hypothesis that pathogenic mutations cause a general loss of presenilin function.	[Heilig, Elizabeth A.; Kelleher, Raymond J., III] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Heilig, Elizabeth A.; Kelleher, Raymond J., III] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Xia, Weiming; Shen, Jie] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Heilig, Elizabeth A.; Xia, Weiming; Shen, Jie; Kelleher, Raymond J., III] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Heilig, Elizabeth A.; Xia, Weiming; Shen, Jie; Kelleher, Raymond J., III] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kelleher, RJ (corresponding author), MGH Simches Res Ctr, CPZN 6234,185 Cambridge St, Boston, MA 02114 USA.	kelleher@helix.mgh.harvard.edu	xia, weiming/E-5465-2016; Shen, Jie/GXH-9449-2022	xia, weiming/0000-0002-7463-3295; 	Alzheimer's Association; National Institutes of Health (NINDS) [R01 NS41783]; National Institutes of Health Training [T32 AG000222-18]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041783, R01NS075346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by grants from the Alzheimer's Association (to J.S. and R.J.K.) and by National Institutes of Health Grant R01 NS41783 (NINDS; to J.S.).; Supported by National Institutes of Health Training Grant T32 AG000222-18.	Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; Arduengo PM, 1998, J CELL SCI, V111, P3645; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Brunkan AL, 2005, J NEUROCHEM, V93, P769, DOI 10.1111/j.1471-4159.2005.03099.x; Campbell WA, 2002, BIOCHEMISTRY-US, V41, P3372, DOI 10.1021/bi015810h; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; Crook R, 1998, NAT MED, V4, P452, DOI 10.1038/nm0498-452; Dewachter I, 2002, J NEUROSCI, V22, P3445; Durkin JT, 1999, J BIOL CHEM, V274, P20499, DOI 10.1074/jbc.274.29.20499; Guo YQ, 1999, J NEUROSCI, V19, P8435; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Houlden H, 2000, ANN NEUROL, V48, P806, DOI 10.1002/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Karlstrom H, 2008, J NEUROCHEM, V104, P573, DOI 10.1111/j.1471-4159.2007.05038.x; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Kwok JBJ, 2003, J BIOL CHEM, V278, P6748, DOI 10.1074/jbc.M211827200; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Pardossi-Piquard R, 2006, J NEUROCHEM, V97, P1052, DOI 10.1111/j.1471-4159.2006.03822.x; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Rogaeva EA, 2001, NEUROLOGY, V57, P621, DOI 10.1212/WNL.57.4.621; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shimojo M, 2007, NEUROSCI RES, V57, P446, DOI 10.1016/j.neures.2006.12.005; Siman R, 2000, J NEUROSCI, V20, P8717; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Sun XY, 2005, NEURODEGENER DIS, V2, P6, DOI 10.1159/000086426; Tandon Anurag, 2000, Current Opinion in Neurology, V13, P377, DOI 10.1097/00019052-200008000-00003; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Uemura K, 2006, NEUROSCI LETT, V402, P278, DOI 10.1016/j.neulet.2006.04.018; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Wang J, 2004, NEUROBIOL DIS, V15, P654, DOI 10.1016/j.nbd.2003.12.008; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800	58	64	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22350	22359		10.1074/jbc.M110.116962	http://dx.doi.org/10.1074/jbc.M110.116962			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460383	hybrid, Green Published			2022-12-25	WOS:000279702200048
J	Lee, YS; Choi, JW; Hwang, I; Lee, JW; Lee, JH; Kim, AY; Huh, JY; Koh, YJ; Koh, GY; Son, HJ; Masuzaki, H; Hotta, K; Alfadda, AA; Kim, JB				Lee, Yun Sok; Choi, Jin Woo; Hwang, Injae; Lee, Joo Won; Lee, Jae Ho; Kim, A. Young; Huh, Jin Young; Koh, Young Jun; Koh, Gou Young; Son, Hee Jung; Masuzaki, Hiroaki; Hotta, Kikuko; Alfadda, Assim A.; Kim, Jae Bum			Adipocytokine Orosomucoid Integrates Inflammatory and Metabolic Signals to Preserve Energy Homeostasis by Resolving Immoderate Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ACUTE-PHASE PROTEIN; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ALPHA(1)-ACID GLYCOPROTEIN; 3T3-L1 ADIPOCYTES; OXIDATIVE STRESS; ALPHA-1-ACID GLYCOPROTEIN; GENE-EXPRESSION; BINDING-PROTEIN	Orosomucoid (ORM), also called alpha-1 acid glycoprotein, is an abundant plasma protein that is an immunomodulator induced by stressful conditions such as infections. In this study, we reveal that Orm is induced selectively in the adipose tissue of obese mice to suppress excess inflammation that otherwise disturbs energy homeostasis. Adipose Orm levels were elevated by metabolic signals, including insulin, high glucose, and free fatty acid, as well as by the proinflammatory cytokine tumor necrosis factor-alpha, which is found in increased levels in the adipose tissue of morbid obese subjects. In both adipocytes and macrophages, ORM suppressed proinflammatory gene expression and pathways such as NF-kappa B and mitogen-activated protein kinase signalings and reactive oxygen species generation. Concomitantly, ORM relieved hyperglycemia-induced insulin resistance as well as tumor necrosis factor-alpha-mediated lipolysis in adipocytes. Accordingly, ORM improved glucose and insulin tolerance in obese and diabetic db/db mice. Taken together, our results suggest that ORM integrates inflammatory and metabolic signals to modulate immune responses to protect adipose tissue from excessive inflammation and thereby from metabolic dysfunction.	[Lee, Yun Sok; Choi, Jin Woo; Hwang, Injae; Lee, Joo Won; Lee, Jae Ho; Kim, A. Young; Huh, Jin Young; Kim, Jae Bum] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151742, South Korea; [Lee, Yun Sok; Choi, Jin Woo; Hwang, Injae; Lee, Joo Won; Lee, Jae Ho; Kim, A. Young; Huh, Jin Young; Kim, Jae Bum] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Koh, Young Jun; Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Son, Hee Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul 135710, South Korea; [Son, Hee Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Hlth Promot, Seoul 135710, South Korea; [Masuzaki, Hiroaki] Univ Ryukyus, Grad Sch Med, Dept Internal Med 2, Okinawa 9030215, Japan; [Hotta, Kikuko] RIKEN, SNP Res Ctr, Kanagawa 2300045, Japan; [Alfadda, Assim A.] King Saud Univ, Coll Med, Obes Res Ctr, Riyadh 11461, Saudi Arabia; [Alfadda, Assim A.] King Saud Univ, Coll Med, Dept Med, Riyadh 11461, Saudi Arabia; [Kim, Jae Bum] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of the Ryukyus; RIKEN; King Saud University; King Saud University; Seoul National University (SNU)	Kim, JB (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, San 56-1, Seoul 151742, South Korea.	jaebkim@snu.ac.kr	Koh, Gou Young/C-1615-2011; Huh, Jin Young/AAN-5652-2020; Alfadda, Assim/AAF-4499-2020; Lee, Yun Sok/B-3265-2015; Alfadda, Assim/AAT-8023-2020; Lee, Yun Sok/ABC-9195-2021; Song, Minsun/I-5701-2015	Lee, Yun Sok/0000-0001-7967-4734; Alfadda, Assim/0000-0002-4792-5188; Lee, Yun Sok/0000-0001-7967-4734; Hotta, Kikuko/0000-0003-2427-6354; Huh, Jin Young/0000-0002-0980-7199; KIM, Jae Bum/0000-0003-2337-6935	Korea Science and Engineering Foundation; Ministry of Education, Science and Technology [SC-3230, 20090083340, 20090091913]; National Plan of Science and Technology, King Abdulaziz City of Science and Technology, Riyadh, Saudi Arabia	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Plan of Science and Technology, King Abdulaziz City of Science and Technology, Riyadh, Saudi Arabia	This work was supported in part by grants from the Korea Science and Engineering Foundation, Korean Research Foundation Grants SC-3230, 20090083340, and 20090091913 funded by the Ministry of Education, Science and Technology, and by the National Plan of Science and Technology, King Abdulaziz City of Science and Technology, Riyadh, Saudi Arabia.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Atemezem A, 2001, BIOCHEM J, V356, P121, DOI 10.1042/0264-6021:3560121; Boncela J, 2006, J BIOL CHEM, V281, P1066, DOI 10.1074/jbc.M506303200; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; CURRY FE, 1989, AM J PHYSIOL, V257, pH1354, DOI 10.1152/ajpheart.1989.257.5.H1354; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Ge XM, 2008, FREE RADICAL RES, V42, P582, DOI 10.1080/10715760802158448; Gunnarsson P, 2007, FASEB J, V21, P4059, DOI 10.1096/fj.07-8534com; HARALDSSON B, 1987, ACTA PHYSIOL SCAND, V129, P127, DOI 10.1111/j.1748-1716.1987.tb08047.x; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lee YS, 2003, NUCLEIC ACIDS RES, V31, P7165, DOI 10.1093/nar/gkg934; Lee YS, 2008, MOL ENDOCRINOL, V22, P2176, DOI 10.1210/me.2008-0023; Lee YS, 2007, MOL CELL BIOL, V27, P438, DOI 10.1128/MCB.00490-06; LIBERT C, 1994, J EXP MED, V180, P1571, DOI 10.1084/jem.180.4.1571; Libert C, 1998, TRANSGENIC RES, V7, P429, DOI 10.1023/A:1008810429645; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Lin Y, 2001, J BIOL CHEM, V276, P42077, DOI 10.1074/jbc.M107101200; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Ojala PJ, 2006, BIOCHEMISTRY-US, V45, P14021, DOI 10.1021/bi061657l; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Park SK, 2004, DIABETES, V53, P2757, DOI 10.2337/diabetes.53.11.2757; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; SCHONRICH G, 1992, EUR J IMMUNOL, V22, P1687, DOI 10.1002/eji.1830220704; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zsila F, 2008, BIOCHEM BIOPH RES CO, V372, P503, DOI 10.1016/j.bbrc.2008.05.090; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479	44	95	97	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22174	22185		10.1074/jbc.M109.085464	http://dx.doi.org/10.1074/jbc.M109.085464			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20442402	Green Published, hybrid			2022-12-25	WOS:000279702200030
J	Sakurai, A; Maruyama, F; Funao, J; Nozawa, T; Aikawa, C; Okahashi, N; Shintani, S; Hamada, S; Ooshima, T; Nakagawa, I				Sakurai, Atsuo; Maruyama, Fumito; Funao, Junko; Nozawa, Takashi; Aikawa, Chihiro; Okahashi, Nobuo; Shintani, Seikou; Hamada, Shigeyuki; Ooshima, Takashi; Nakagawa, Ichiro			Specific Behavior of Intracellular Streptococcus pyogenes That Has Undergone Autophagic Degradation Is Associated with Bacterial Streptolysin O and Host Small G Proteins Rab5 and Rab7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; FIBRONECTIN-BINDING PROTEIN; LISTERIA-MONOCYTOGENES; EPITHELIAL-CELLS; MAMMALIAN-CELLS; RECEPTOR; PATHWAYS; SURVIVAL; STRAINS; GROWTH	Streptococcus pyogenes (group A streptococcus (GAS)) is a pathogen that invades non-phagocytic host cells, and causes a variety of acute infections such as pharyngitis. Our group previously reported that intracellular GAS is effectively degraded by the host-cell autophagic machinery, and that a cholesterol-dependent cytolysin, streptolysin O (SLO), is associated with bacterial escape from endosomes in epithelial cells. However, the details of both the intracellular behavior of GAS and the process leading to its autophagic degradation remain unknown. In this study, we found that two host small G proteins, Rab5 and Rab7, were associated with the pathway of autophagosome formation and the fate of intracellular GAS. Rab5 was involved in bacterial invasion and endosome fusion. Rab7 was clearly multifunctional, with roles in bacterial invasion, endosome maturation, and autophagosome formation. In addition, this study showed that the bacterial cytolysin SLO supported the escape of GAS into the cytoplasm from endosomes, and surprisingly, a SLO-deficient mutant of GAS was viable longer than the wild-type strain although it failed to escape the endosomes. This intracellular behavior of GAS is unique and distinct from that of other types of bacterial invaders. Our results provide a new picture of GAS infection and host-cell responses in epithelial cells.	[Sakurai, Atsuo; Funao, Junko; Ooshima, Takashi] Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Suita, Osaka 5650871, Japan; [Sakurai, Atsuo; Shintani, Seikou] Tokyo Dent Coll, Dept Pediat Dent, Mihama Ku, Chiba 2618502, Japan; [Shintani, Seikou] Tokyo Dent Coll, Oral Hlth Sci Ctr, Hrc7, Mihama Ku, Chiba 2618502, Japan; [Maruyama, Fumito] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nozawa, Takashi; Aikawa, Chihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Bacterial Pathogenesis, Bunkyo Ku, Tokyo 1138510, Japan; [Nozawa, Takashi; Aikawa, Chihiro; Nakagawa, Ichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; [Okahashi, Nobuo] Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Suita, Osaka 5650871, Japan; [Hamada, Shigeyuki] Minist Publ Hlth, Res Collaborat Ctr Emerging & Reemerging Infect R, Dept Med Sci, Muang Nonthaburi 11000, Thailand	Osaka University; Tokyo Dental College; Tokyo Dental College; Tokyo Institute of Technology; Tokyo Medical & Dental University (TMDU); University of Tokyo; Osaka University; Ministry of Public Health - Thailand	Ooshima, T (corresponding author), Osaka Univ, Grad Sch Dent, Dept Pediat Dent, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ooshima@dent.osaka-u.ac.jp	okahashi, nobuo/A-4032-2010; Maruyama, Fumito/AAK-5928-2020	okahashi, nobuo/0000-0002-8045-7021; Maruyama, Fumito/0000-0003-2347-616X	Japan Society for the Promotion of Science [22390394, 22592032, 21792069]; Uehara Memorial Foundation; Takeda Foundation; Mitsubishi Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation	This work was supported in part by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (B) 22390394, for Scientific Research (C) 22592032, for young scientists (B) 21792069, the Uehara Memorial Foundation, the Takeda Foundation, and the Mitsubishi Foundation.	Amano A, 2006, J BIOCHEM, V140, P161, DOI 10.1093/jb/mvj162; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Ceresa BP, 2001, J BIOL CHEM, V276, P9649, DOI 10.1074/jbc.M010387200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; FALKOW S, 1991, CELL, V65, P1099, DOI 10.1016/0092-8674(91)90003-H; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Hara H, 2008, J IMMUNOL, V180, P7859, DOI 10.4049/jimmunol.180.12.7859; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; Jadoun J, 1998, J INFECT DIS, V178, P147, DOI 10.1086/515589; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; LI GP, 1993, J BIOL CHEM, V268, P24475; Limbago B, 2000, INFECT IMMUN, V68, P6384, DOI 10.1128/IAI.68.11.6384-6390.2000; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; MERESSE S, 1995, J CELL SCI, V108, P3349; Meyer-Morse N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008610; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Neeman R, 1998, LANCET, V352, P1974, DOI 10.1016/S0140-6736(97)12452-7; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ogawa M, 2006, CELL MICROBIOL, V8, P177, DOI 10.1111/j.1462-5822.2005.00652.x; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Prada-Delgado A, 2005, TRAFFIC, V6, P252, DOI 10.1111/j.1600-0854.2005.00265.x; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Pust S, 2005, EMBO J, V24, P1287, DOI 10.1038/sj.emboj.7600595; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Ruiz N, 1998, MOL MICROBIOL, V27, P337, DOI 10.1046/j.1365-2958.1998.00681.x; Sakurai A, 2003, INFECT IMMUN, V71, P6019, DOI 10.1128/IAI.71.10.6019-6026.2003; Sakurai A, 2008, BIOCHEM BIOPH RES CO, V373, P450, DOI 10.1016/j.bbrc.2008.06.061; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stassen M, 2003, INFECT IMMUN, V71, P6171, DOI 10.1128/IAI.71.11.6171-6177.2003; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Wilkowsky SE, 2002, BIOCHEM BIOPH RES CO, V291, P516, DOI 10.1006/bbrc.2002.6474; Yamaguchi H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000670; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	59	57	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22666	22675		10.1074/jbc.M109.100131	http://dx.doi.org/10.1074/jbc.M109.100131			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472552	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000279702200077
J	Singh, J; Aaronson, SA; Mlodzik, M				Singh, J.; Aaronson, S. A.; Mlodzik, M.			Drosophila Abelson kinase mediates cell invasion and proliferation through two distinct MAPK pathways	ONCOGENE			English	Article						Drosophila; Abl; Src; kinase; cell invasive behavior	ABL TYROSINE KINASE; BREAST-CANCER CELLS; BINDING PROTEIN RAC; C-ABL; SIGNALING PATHWAY; FAMILY KINASES; DISC EVERSION; BCR-ABL; SRC; JNK	The Abelson (Abl) family of non-receptor tyrosine kinases has an important role in cell morphogenesis, motility, and proliferation. Although the function of Abl has been extensively studied in leukemia, its role in epithelial cell invasion remains obscure. Using the Drosophila wing epithelium as an in vivo model system, we show that overexpression (activation) of Drosophila Abl (dAbl) causes loss of epithelial apical/basal cell polarity and secretion of matrix metalloproteinases, resulting in a cellular invasion and apoptosis. Our in vivo data indicate that dAbl acts downstream of the Src kinases, which are known regulators of cell adhesion and invasion. Downstream of dAbl, Rac GTPases activate two distinct MAPK pathways: c-Jun N-terminal kinase signaling (required for cell invasion and apoptosis) and ERK signaling (inducing cell proliferation). Activated Abl also increases the activity of Src members through a positive feedback loop leading to signal amplification. Thus, targeting Src-Abl, using available dual inhibitors, could be of therapeutic importance in tumor cell metastasis. Oncogene (2010) 29, 4033-4045; doi:10.1038/onc.2010.155; published online 10 May 2010	[Singh, J.; Mlodzik, M.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Aaronson, S. A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Mlodzik, M (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, 1 Gustave L Levy Pl, New York, NY 10029 USA.	marek.mlodzik@mssm.edu			NIH/NCI; NIH/National Eye Institute [R01 EY14597]; NATIONAL EYE INSTITUTE [R01EY014597, R01EY013256] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank the Bloomington Stock Center, DSHB, Ed Giniger, and Ross Cagan for fly stocks and antibodies. We are grateful to members of the Mlodzik lab for helpful suggestions, discussions, and criticism, Ross Cagan and members of the Cagan lab for discussion and reagents, in particular Tirtha Das. We also thank William Gault for critical reading of the manuscript, Nadinath Nillegoda, and Maneesha Chhikara for helpful comments and suggestions, and Joyce Lau, Sophy Okello, and Andrea Blitzer for technical help. Confocal laser microscopy was performed at the MSSM Microscopy SRF, supported by an NIH/NCI shared instrumentation grant. This research was supported by NIH/National Eye Institute Grant R01 EY14597 to MM.	Araujo J, 2010, CANCER TREAT REV, V36, P492, DOI 10.1016/j.ctrv.2010.02.015; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Boureux A, 2005, J CELL SCI, V118, P3717, DOI 10.1242/jcs.02491; BRAND AH, 1993, DEVELOPMENT, V118, P401; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Das J, 2006, J MED CHEM, V49, P6819, DOI 10.1021/jm060727j; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dolfi F, 1998, P NATL ACAD SCI USA, V95, P15394, DOI 10.1073/pnas.95.26.15394; Golas JM, 2003, CANCER RES, V63, P375; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARDEN N, 1995, DEVELOPMENT, V121, P903; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; NAVARRO P, 1991, J CELL BIOL, V115, P517, DOI 10.1083/jcb.115.2.517; Pastor-Pareja JC, 2004, DEV CELL, V7, P387, DOI 10.1016/j.devcel.2004.07.022; Pedraza LG, 2004, ONCOGENE, V23, P4754, DOI 10.1038/sj.onc.1207635; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Shindo M, 2008, DEVELOPMENT, V135, P1355, DOI 10.1242/dev.015982; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; Skorski T, 1998, P NATL ACAD SCI USA, V95, P11858, DOI 10.1073/pnas.95.20.11858; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Stevens TL, 2008, MOL BIOL CELL, V19, P378, DOI 10.1091/mbc.E07-01-0008; Sugimura M, 2000, JPN J CANCER RES, V91, P395, DOI 10.1111/j.1349-7006.2000.tb00958.x; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yang JH, 2008, BIOCHEM BIOPH RES CO, V374, P512, DOI 10.1016/j.bbrc.2008.07.057	48	21	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 15	2010	29	28					4033	4045		10.1038/onc.2010.155	http://dx.doi.org/10.1038/onc.2010.155			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	625JW	20453880	Green Accepted			2022-12-25	WOS:000279892400004
J	Egloff, S; Szczepaniak, SA; Dienstbier, M; Taylor, A; Knight, S; Murphy, S				Egloff, Sylvain; Szczepaniak, Sylwia Anna; Dienstbier, Martin; Taylor, Alice; Knight, Sophie; Murphy, Shona			The Integrator Complex Recognizes a New Double Mark on the RNA Polymerase II Carboxyl-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U2 SNRNA; PROTEIN-KINASE; GENE-EXPRESSION; KU-AUTOANTIGEN; TRANSCRIPTION; IICTD; ELONGATION; CODE; PHOSPHORYLATION; SERINE-7	The carboxyl-terminal domain (CTD) of the largest subunit of RNA polymerase II (pol II) comprises multiple tandem repeats of the heptapeptide Tyr(1)-Ser(2)-Pro(3)-Thr(4)-Ser(5)-Pro(6)-Ser(7). This unusual structure serves as a platform for the binding of factors required for expression of pol II-transcribed genes, including the small nuclear RNA (snRNA) gene-specific Integrator complex. The pol II CTD specifically mediates recruitment of Integrator to the promoter of snRNA genes to activate transcription and direct 3' end processing of the transcripts. Phosphorylation of the CTD and a serine in position 7 are necessary for Integrator recruitment. Here, we have further investigated the requirement of the serines in the CTD heptapeptide and their phosphorylation for Integrator binding. We show that both Ser(2) and Ser(7) of the CTD are required and that phosphorylation of these residues is necessary and sufficient for efficient binding. Using synthetic phosphopeptides, we have determined the pattern of the minimal Ser(2)/Ser(7) double phosphorylation mark required for Integrator to interact with the CTD. This novel double phosphorylation mark is a new addition to the functional repertoire of the CTD code and may be a specific signal for snRNA gene expression.	[Murphy, Shona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Knight, Sophie] Univ Oxford, Dept Biochem, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Murphy, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	shona.murphy@path.ox.ac.uk		EGLOFF, Sylvain/0000-0002-9798-125X; Murphy, Shona/0000-0001-5276-9645	Medical Research Council (UK); Wellcome Trust; MRC [G0400653] Funding Source: UKRI; Medical Research Council [G0400653] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Medical Research Council (UK) and Wellcome Trust grants (to S.M.).	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Corden JL, 2007, SCIENCE, V318, P1735, DOI 10.1126/science.1152624; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dominski Z, 2005, MOL CELL BIOL, V25, P1489, DOI 10.1128/MCB.25.4.1489-1500.2005; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2008, BIOCHEM SOC T, V36, P537, DOI 10.1042/BST0360537; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2009, MOL CELL BIOL, V29, P4002, DOI 10.1128/MCB.00189-09; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; HERNANDEZ N, 1985, EMBO J, V4, P1827, DOI 10.1002/j.1460-2075.1985.tb03857.x; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Izzard RA, 1999, CANCER RES, V59, P2581; Jacobs EY, 2004, MOL CELL BIOL, V24, P846, DOI 10.1128/MCB.24.2.846-855.2004; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Medlin JE, 2003, EMBO J, V22, P925, DOI 10.1093/emboj/cdg077; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769	29	78	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20564	20569		10.1074/jbc.M110.132530	http://dx.doi.org/10.1074/jbc.M110.132530			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20457598	hybrid, Green Published			2022-12-25	WOS:000279228600019
J	Rodriguez, HM; Vaysberg, M; Mikels, A; McCauley, S; Velayo, AC; Garcia, C; Smith, V				Rodriguez, Hector M.; Vaysberg, Maria; Mikels, Amanda; McCauley, Scott; Velayo, Arleene C.; Garcia, Carlos; Smith, Victoria			Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMINOPROPIONITRILE; MONOCLONAL-ANTIBODIES; TUMOR PROGRESSION; PROTEIN; DOMAIN; EXPRESSION; AFFINITY; COLLAGEN; ANCIENT; PATHWAY	In this report, we assessed the steady-state enzymatic activity of lysyl oxidase-like 2 (LOXL2) against the substrates 1,5-diaminopentane (DAP), spermine, and fibrillar type I collagen. We find that both DAP and spermine are capable of activating LOXL2 to the same extent and have similar Michaelis constants (K-m similar to 1 mM) and catalytic rates (k(cat) similar to 0.02 s(-1)). We also show that LOXL2 is capable of being inhibited by a known suicide inhibitor of lysyl oxidase (LOX), beta-aminopropionitrile, which we find is a potent inhibitor of LOXL2 activity. The modality of inhibition of beta-aminopropionitrile was also examined and found to be competitive with respect to the substrates DAP and spermine. In addition, we identified an antibody inhibitor (AB0023) of LOXL2 enzymatic function and have found that the inhibition occurs in a non-competitive manner with respect to both spermine and DAP. The binding epitope of AB0023 was mapped to the scavenger receptor cysteine-rich domain four of human LOXL2. AB0023 binds to a region remote from the catalytic domain making AB0023 an allosteric inhibitor of LOXL2. This affords AB0023 several advantages, because it is specific for LOXL2 and inhibits the enzymatic function of LOXL2 in a noncompetitive manner thereby allowing inhibition of LOXL2 regardless of substrate concentration. These results suggest that antibody allosteric modulators of enzymatic function represent a novel drug development strategy and, in the context of LOXL2, suggest that inhibitors such as these might be useful therapeutics in oncology, fibrosis, and inflammation.	[Rodriguez, Hector M.; Vaysberg, Maria; Mikels, Amanda; McCauley, Scott; Velayo, Arleene C.; Garcia, Carlos; Smith, Victoria] Arresto BioSci, Palo Alto, CA 94304 USA		Rodriguez, HM (corresponding author), Arresto BioSci, Palo Alto, CA 94304 USA.	hrodriguez@arresto.com		McCauley, Scott/0000-0003-4549-5599				Akiri G, 2003, CANCER RES, V63, P1657; BRENNAN C, 1994, PROTEIN ENG, V7, P509, DOI 10.1093/protein/7.4.509; CARROLL SB, 1982, P NATL ACAD SCI-BIOL, V79, P7233, DOI 10.1073/pnas.79.23.7233; CINADER B, 1964, IMMUNOLOGY, V7, P342; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; COPELAND RA, 2005, EVALUATION ENZYME IN, P95; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Fong SFT, 2007, GENE CHROMOSOME CANC, V46, P644, DOI 10.1002/gcc.20444; GACHERU SN, 1990, J BIOL CHEM, V265, P19022; GACHERU SN, 1988, J BIOL CHEM, V263, P16704; Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Jung ST, 2003, PROTEIN EXPRES PURIF, V31, P240, DOI 10.1016/S1046-5928(03)00217-1; KIM YM, MOL BIOL RE IN PRESS; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Leskovac, 2003, COMPREHENSIVE ENZYME; Martin F, 1997, PROTEIN ENG, V10, P607, DOI 10.1093/protein/10.5.607; McElroy KE, 2000, ANAL BIOCHEM, V284, P382, DOI 10.1006/abio.2000.4740; MINTZ KP, 1985, J NEUROCHEM, V45, P284, DOI 10.1111/j.1471-4159.1985.tb05505.x; Molnar J, 2003, BBA-PROTEINS PROTEOM, V1647, P220, DOI 10.1016/S1570-9639(03)00053-0; NARAYANAN AS, 1972, BIOCHEM BIOPH RES CO, V46, P745; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; PARK SS, 1982, CANCER RES, V42, P1798; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Siegel R C, 1979, Int Rev Connect Tissue Res, V8, P73; TANG SS, 1983, J BIOL CHEM, V258, P4331; TANG SS, 1984, J BIOL CHEM, V259, P975; TRACKMAN PC, 1979, J BIOL CHEM, V254, P7831; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; WILLIAMSON PR, 1986, J BIOL CHEM, V261, P9477	34	104	121	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20964	20974		10.1074/jbc.M109.094136	http://dx.doi.org/10.1074/jbc.M109.094136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439985	Green Published, hybrid			2022-12-25	WOS:000279228600060
J	Zheng, C; Fasken, MB; Marshall, NJ; Brockmann, C; Rubinson, ME; Wente, SR; Corbett, AH; Stewart, M				Zheng, Chao; Fasken, Milo B.; Marshall, Neil J.; Brockmann, Christoph; Rubinson, Max E.; Wente, Susan R.; Corbett, Anita H.; Stewart, Murray			Structural Basis for the Function of the Saccharomyces cerevisiae Gfd1 Protein in mRNA Nuclear Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; PORE COMPLEX; YEAST; DOMAIN; NAB2P; GLE1; DBP5; RAT8P/DBP5P; INTERACTS; LINK	Following transcription, mRNA is processed, packaged into messenger ribonucleoprotein (mRNP) particles, and transported through nuclear pores (NPCs) to the cytoplasm. At the NPC cytoplasmic face, Dbp5 mediates mRNP remodeling and mRNA export factor dissociation, releasing transcripts for translation. In Saccharomyces cerevisiae, the conserved poly(A) RNA-binding protein, Nab2, facilitates NPC targeting of transcripts and also modulates poly(A) tail length. Dbp5 removes Nab2 from mRNPs at the cytoplasmic face of the pore and, importantly, a Nab2 RNA-binding mutant suppresses the thermosensitive rat8-2 (dbp5) mutant. GFD1 is a multicopy suppressor of rat8-2 (dbp5), and Gfd1 interacts physically with both Dbp5 and the Nab2 N-terminal domain (Nab2-N). Here, we present a structural and functional analysis of the Gfd1/Nab2-N interaction. Crystallography, supported by solution NMR, shows that Gfd1 residues 126-150 form an alpha-helix when bound to Nab2-N. Engineered Nab2-N and Gfd1 mutants that inhibit this interaction in vitro were used to probe its function in vivo using the genetic interaction between GFD1 and NAB2. Although GFD1 is not essential for viability, its deletion severely impairs growth of rat8-2 (dbp5) cells. Moreover, although Gfd1 overexpression suppresses rat8-2 (dbp5), Gfd1 mutants that do not bind Nab2 only partially suppress rat8-2 (dbp5). Furthermore, rat8-2 (dbp5) cells that express nab2-Y34A, in which binding to Gfd1 is impaired, show a synthetic growth phenotype and nuclear accumulation of poly(A) RNA. These data support the importance of the Gfd1/Nab2 interaction for Dbp5 activity and provide further molecular details of the interactions that facilitate Dbp5-mediated mRNP remodeling in the terminal step of mRNA export.	[Stewart, Murray] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Fasken, Milo B.; Rubinson, Max E.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	MRC Laboratory Molecular Biology; Emory University; Vanderbilt University	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ms@mrc-lmb.cam.ac.uk	Fasken, Milo/K-2177-2019; Corbett, Anita/AAH-6106-2021	Fasken, Milo/0000-0003-4317-7909; Corbett, Anita/0000-0002-0461-6895	National Institutes of Health; Federation of the Societies of Biochemistry and Molecular Biology; Wellcome Trust; MRC [MC_U105178939] Funding Source: UKRI; Medical Research Council [MC_U105178939] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728, R01GM065442, R37GM051219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Federation of the Societies of Biochemistry and Molecular Biology; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants (to A. H. C. and S. R. W.). This work was also supported in part by a Federation of the Societies of Biochemistry and Molecular Biology Long Term Fellowship (to C. B.) and a Wellcome Trust Programme Grant (to M. S.).	Adams A, 1997, METHODS YEAST GENETI; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akker SA, 2001, J MOL ENDOCRINOL, V27, P123, DOI 10.1677/jme.0.0270123; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batisse J, 2009, J BIOL CHEM, V284, P34911, DOI 10.1074/jbc.M109.062034; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dower K, 2002, RNA, V8, P686, DOI 10.1017/S1355838202024068; Ellisdon AM, 2010, J BIOL CHEM, V285, P3850, DOI 10.1074/jbc.M109.070839; Estruch F, 2005, J BIOL CHEM, V280, P9691, DOI 10.1074/jbc.M413025200; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Fasken MB, 2008, J BIOL CHEM, V283, P27130, DOI 10.1074/jbc.M803649200; Goddard T.D., SPARKY 3; Grant RP, 2008, J MOL BIOL, V376, P1048, DOI 10.1016/j.jmb.2007.11.087; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Jensen TH, 2003, NAT STRUCT BIOL, V10, P10, DOI 10.1038/nsb0103-10; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Marfatia KA, 2003, J BIOL CHEM, V278, P6731, DOI 10.1074/jbc.M207571200; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Murphy R, 1996, MOL BIOL CELL, V7, P1921, DOI 10.1091/mbc.7.12.1921; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; SIKORSKI RS, 1989, GENETICS, V122, P19; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Stewart M, 2007, MOL CELL, V25, P327, DOI 10.1016/j.molcel.2007.01.016; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Stutz F, 2003, TRENDS CELL BIOL, V13, P319, DOI 10.1016/S0962-8924(03)00106-5; Suntharalingam M, 2004, J BIOL CHEM, V279, P35384, DOI 10.1074/jbc.M402044200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755	54	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20704	20715		10.1074/jbc.M110.107276	http://dx.doi.org/10.1074/jbc.M110.107276			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20463024	Green Published, hybrid			2022-12-25	WOS:000279228600034
J	Rowland, JG; Pang, X; Suzuki, I; Murata, N; Simon, WJ; Slabas, AR				Rowland, John G.; Pang, Xin; Suzuki, Iwane; Murata, Norio; Simon, William J.; Slabas, Antoni R.			Identification of Components Associated with Thermal Acclimation of Photosystem II in Synechocystis sp PCC6803	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; BLUE-GREEN-ALGAE; SP PCC 6803; HIGH-TEMPERATURE; GENE-EXPRESSION; MEMBRANE-LIPIDS; CHILLING SENSITIVITY; SP PCC-6803; ARABIDOPSIS-THALIANA; THYLAKOID MEMBRANES	Background: Photosystem II (PSII) is the most thermally sensitive component of photosynthesis. Thermal acclimation of this complex activity is likely to be critically important to the ability of photosynthetic organisms to tolerate temperature changes in the environment. Methodology/Findings: We have analysed gene expression using whole-genome microarrays and monitored alterations in physiology during acclimation of PSII to elevated growth temperature in Synechocystis sp. PCC 6803. PSII acclimation is complete within 480 minutes of exposure to elevated temperature and is associated with a highly dynamic transcriptional response. 176 genes were identified and classified into seven distinct response profile groups. Response profiles suggest the existence of an early transient phase and a sustained phase to the acclimation response. The early phase was characterised by induction of general stress response genes, including heat shock proteins, which are likely to influence PSII thermal stability. The sustained phase consisted of acclimation-specific alterations that are involved in other cellular processes. Sustained responses included genes involved in phycobillisome structure and modification, photosynthesis, respiration, lipid metabolism and motility. Approximately 60% of genes with sustained altered expression levels have no known function. The potential role of differentially expressed genes in thermotolerance and acclimation is discussed. We have characterised the acclimation physiology of selected gene 'knockouts' to elucidate possible gene function in the response. Conclusions/Significance: All mutants show lower PSII rates under normal growth conditions. Basal PSII thermotolerance was affected by mutations in clpB1, cpcC2, hspA, htpG and slr1674. Final PSII thermotolerance was affected by mutations in cpcC2, hik34, hspA and hypA1, suggesting that these gene products play roles in long-term thermal acclimation of PSII.	[Rowland, John G.; Pang, Xin; Simon, William J.; Slabas, Antoni R.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Suzuki, Iwane] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Murata, Norio] Natl Inst Basic Biol, Dept Regulat Biol, Okazaki, Japan	Durham University; University of Tsukuba; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Rowland, JG (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	a.r.slabas@durham.ac.uk	Murata, Norio/E-6569-2010; Rowland, John/B-5783-2008; Murata, Norio/O-7945-2019	Rowland, John/0000-0002-9819-1540; Murata, Norio/0000-0002-6605-5800	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C503946/1]; BBSRC [BB/H014241/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C503946/1, BB/H014241/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk) grant number BB/C503946/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal TK, 2005, J APPL MICROBIOL, V98, P114, DOI 10.1111/j.1365-2672.2004.02431.x; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Appel J, 1996, BBA-PROTEIN STRUCT M, V1298, P141, DOI 10.1016/S0167-4838(96)00176-8; Appel J, 1998, J PHOTOCH PHOTOBIO B, V47, P1, DOI 10.1016/S1011-1344(98)00179-1; ARNON DI, 1974, BIOCHIM BIOPHYS ACTA, V357, P231, DOI 10.1016/0005-2728(74)90063-2; Balogi Z, 2005, ARCH BIOCHEM BIOPHYS, V436, P346, DOI 10.1016/j.abb.2005.02.018; BARKER DF, 1981, J MOL BIOL, V146, P451, DOI 10.1016/0022-2836(81)90042-5; Chivasa S, 2006, J EXP BOT, V57, P1553, DOI 10.1093/jxb/erj149; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; Do JH, 2008, MOL CELLS, V25, P279; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eriksson MJ, 1996, J BACTERIOL, V178, P4839, DOI 10.1128/jb.178.16.4839-4846.1996; Exss-Sonne P, 2000, PHOTOSYNTH RES, V63, P145, DOI 10.1023/A:1006322925324; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P3584, DOI 10.1128/jb.170.8.3584-3592.1988; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GOMBOS Z, 1994, PLANT PHYSIOL, V104, P563, DOI 10.1104/pp.104.2.563; GRIGORIEVA G, 1982, FEMS MICROBIOL LETT, V13, P367, DOI 10.1111/j.1574-6968.1982.tb08289.x; Gross CA, 1996, ESCHERICHIA COLI SAL, P1382; HAGEMANN M, 1992, ARCH MICROBIOL, V158, P429; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Hong SW, 2000, P NATL ACAD SCI USA, V97, P4392, DOI 10.1073/pnas.97.8.4392; IshizakiNishizawa O, 1996, NAT BIOTECHNOL, V14, P1003, DOI 10.1038/nbt0896-1003; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kanesaki Y, 2002, BIOCHEM BIOPH RES CO, V290, P339, DOI 10.1006/bbrc.2001.6201; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P823, DOI 10.1093/pcp/pce106; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; KATOH S, 1967, ARCH BIOCHEM BIOPHYS, V122, P144, DOI 10.1016/0003-9861(67)90133-6; Kondo K, 2007, PLANT PHYSIOL, V144, P1200, DOI 10.1104/pp.107.099267; KOVACS E, 1994, PLANT PHYSIOL BIOCH, V32, P285; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Lee SY, 1998, CURR MICROBIOL, V37, P403, DOI 10.1007/s002849900400; Los DA, 1997, MOL MICROBIOL, V25, P1167, DOI 10.1046/j.1365-2958.1997.5641912.x; Luque I, 2003, MOL MICROBIOL, V50, P1043, DOI 10.1046/j.1365-2958.2003.03768.x; MAMEDOV M, 1993, BIOCHIM BIOPHYS ACTA, V1142, P1, DOI 10.1016/0005-2728(93)90077-S; Marin K, 2004, PLANT PHYSIOL, V136, P3290, DOI 10.1104/pp.104.045047; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; MOON BY, 1995, P NATL ACAD SCI USA, V92, P6219, DOI 10.1073/pnas.92.14.6219; MURATA N, 1992, NATURE, V356, P710, DOI 10.1038/356710a0; MURATA N, 1995, BIOCHEM J, V308, P1; Nefedova L. N., 2003, Genetika, V39, P478; Nishida I, 1996, ANNU REV PLANT PHYS, V47, P541, DOI 10.1146/annurev.arplant.47.1.541; NISHIYAMA Y, 1994, PLANT PHYSIOL, V105, P1313, DOI 10.1104/pp.105.4.1313; NISHIYAMA Y, 1993, PLANT CELL PHYSIOL, V34, P337; Nishiyama Y, 2006, PHOTOSYNTH RES, V90, P223, DOI 10.1007/s11120-007-9138-4; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Paithoonrangsarid K, 2004, J BIOL CHEM, V279, P53078, DOI 10.1074/jbc.M410162200; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Sakamoto T, 1997, MOL MICROBIOL, V23, P1281, DOI 10.1046/j.1365-2958.1997.3071676.x; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; SANTARIUS KA, 1976, J THERM BIOL, V1, P101, DOI 10.1016/0306-4565(76)90028-0; Singh AK, 2006, ARCH MICROBIOL, V186, P273, DOI 10.1007/s00203-006-0138-0; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; Suzuki I, 2005, PLANT PHYSIOL, V138, P1409, DOI 10.1104/pp.104.059097; Suzuki I, 2000, EMBO J, V19, P1327, DOI 10.1093/emboj/19.6.1327; Tanaka Y, 2000, PLANT PHYSIOL, V124, P441, DOI 10.1104/pp.124.1.441; Tolle J, 2002, MICROBIOL-SGM, V148, P3293, DOI 10.1099/00221287-148-10-3293; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Troshina O, 2002, INT J HYDROGEN ENERG, V27, P1283, DOI 10.1016/S0360-3199(02)00103-9; Tsvetkova NM, 2002, P NATL ACAD SCI USA, V99, P13504, DOI 10.1073/pnas.192468399; Tuominen I, 2006, FEBS LETT, V580, P319, DOI 10.1016/j.febslet.2005.11.082; WADA H, 1994, P NATL ACAD SCI USA, V91, P4273, DOI 10.1073/pnas.91.10.4273; WADA H, 1990, NATURE, V347, P200, DOI 10.1038/347200a0; Webb R., 1994, MOL BIOL CYANOBACTER, P751; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; WOLTER FP, 1992, EMBO J, V11, P4685, DOI 10.1002/j.1460-2075.1992.tb05573.x; Yamaguchi K, 2002, PLANT CELL, V14, P2901, DOI 10.1105/tpc.006262; Yamashita A, 2008, J BIOL CHEM, V283, P28380, DOI 10.1074/jbc.M710465200; YAMASHITA T, 1968, PLANT PHYSIOL, V43, P2037, DOI 10.1104/pp.43.12.2037; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3	71	27	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10511	10.1371/journal.pone.0010511	http://dx.doi.org/10.1371/journal.pone.0010511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463904	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000277379800007
J	Alexeyenko, A; Wassenberg, DM; Lobenhofer, EK; Yen, J; Linney, E; Sonnhammer, ELL; Meyer, JN				Alexeyenko, Andrey; Wassenberg, Deena M.; Lobenhofer, Edward K.; Yen, Jerry; Linney, Elwood; Sonnhammer, Erik L. L.; Meyer, Joel N.			Dynamic Zebrafish Interactome Reveals Transcriptional Mechanisms of Dioxin Toxicity	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; TROUT ONCORHYNCHUS-MYKISS; APOPTOTIC CELL-DEATH; CHICKEN-EMBRYO HEPATOCYTES; OXIDATIVE STRESS-RESPONSE; UP RAINBOW-TROUT; GENE-EXPRESSION; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; DEVELOPMENTAL TOXICITY; CYTOCHROME-P450 1A	Background: In order to generate hypotheses regarding the mechanisms by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) causes toxicity, we analyzed global gene expression changes in developing zebrafish embryos exposed to this potent toxicant in the context of a dynamic gene network. For this purpose, we also computationally inferred a zebrafish (Danio rerio) interactome based on orthologs and interaction data from other eukaryotes. Methodology/Principal Findings: Using novel computational tools to analyze this interactome, we distinguished between dioxin-dependent and dioxin-independent interactions between proteins, and tracked the temporal propagation of dioxin-dependent transcriptional changes from a few genes that were altered initially, to large groups of biologically coherent genes at later times. The most notable processes altered at later developmental stages were calcium and iron metabolism, embryonic morphogenesis including neuronal and retinal development, a variety of mitochondria-related functions, and generalized stress response (not including induction of antioxidant genes). Within the interactome, many of these responses were connected to cytochrome P4501A (cyp1a) as well as other genes that were dioxin-regulated one day after exposure. This suggests that cyp1a may play a key role initiating the toxic dysregulation of those processes, rather than serving simply as a passive marker of dioxin exposure, as suggested by earlier research. Conclusions/Significance: Thus, a powerful microarray experiment coupled with a flexible interactome and multi-pronged interactome tools (which are now made publicly available for microarray analysis and related work) suggest the hypothesis that dioxin, best known in fish as a potent cardioteratogen, has many other targets. Many of these types of toxicity have been observed in mammalian species and are potentially caused by alterations to cyp1a.	[Alexeyenko, Andrey; Sonnhammer, Erik L. L.] Stockholm Univ, Stockholm Bioinformat Ctr, S-10691 Stockholm, Sweden; [Wassenberg, Deena M.; Yen, Jerry; Linney, Elwood] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Lobenhofer, Edward K.] Cogenics, Morrisville, NC USA; [Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Stockholm University; Duke University; Duke University	Alexeyenko, A (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	joel.meyer@duke.edu	Alexeyenko, Andrey/F-1924-2016; Meyer, Joel/G-9836-2017	Alexeyenko, Andrey/0000-0001-8812-6481; Sonnhammer, Erik/0000-0002-9015-5588; Meyer, Joel/0000-0003-1219-0983	National Institutes of Health [ES011375, ES10356]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010356, U19ES011375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Institutes of Health ES011375 and ES10356. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyenko A, 2009, GENOME RES, V19, P1107, DOI 10.1101/gr.087528.108; Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; Antkiewicz DS, 2006, TOXICOL SCI, V94, P175, DOI 10.1093/toxsci/kfl093; Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073; Aragon AC, 2008, TOXICOL SCI, V101, P321, DOI 10.1093/toxsci/kfm272; Augspurger TP, 2008, ARCH ENVIRON CON TOX, V55, P659, DOI 10.1007/s00244-008-9198-2; Baccarelli A, 2002, ENVIRON HEALTH PERSP, V110, P1169, DOI 10.1289/ehp.021101169; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Belair CD, 2001, DEV DYNAM, V222, P581, DOI 10.1002/dvdy.1213; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Billiard SM, 2008, TOXICOL SCI, V105, P5, DOI 10.1093/toxsci/kfm303; Billiard SM, 2006, TOXICOL SCI, V92, P526, DOI 10.1093/toxsci/kfl011; Birnbaum LS, 2003, ENVIRON HEALTH PERSP, V111, P389, DOI 10.1289/ehp.5686; Biswas G, 2008, P NATL ACAD SCI USA, V105, P186, DOI 10.1073/pnas.0706183104; Blankenship AL, 2003, COMP BIOCHEM PHYS C, V136, P47, DOI 10.1016/S1532-0456(03)00166-2; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Cantrell SM, 1998, TOXICOL APPL PHARM, V148, P24, DOI 10.1006/taap.1997.8309; Cantrell SM, 1996, TOXICOL APPL PHARM, V141, P23; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; Carney SA, 2004, MOL PHARMACOL, V66, P512; Carney SA, 2006, MOL PHARMACOL, V70, P549, DOI 10.1124/mol.106.025304; Carvalho PSM, 2004, ENVIRON SCI TECHNOL, V38, P6300, DOI 10.1021/es034857i; Carvalho PSM, 2004, COMP BIOCHEM PHYS C, V137, P133, DOI 10.1016/j.cca.2003.12.005; Chen J, 2008, PHYSIOL GENOMICS, V33, P148, DOI 10.1152/physiolgenomics.00214.2007; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Dale YR, 2006, MOL PHARMACOL, V70, P1481, DOI 10.1124/mol.106.027474; Davies R, 2008, CHEM RES TOXICOL, V21, P330, DOI 10.1021/tx700176r; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Di Giulio Richard T., 2008, P273, DOI 10.1201/9780203647295.ch6; Dong W, 2002, TOXICOL SCI, V69, P191, DOI 10.1093/toxsci/69.1.191; Dragin N, 2008, MOL PHARMACOL, V73, P1844, DOI 10.1124/mol.108.045658; Dragin N, 2006, J BIOL CHEM, V281, P18591, DOI 10.1074/jbc.M601159200; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Frueh FW, 2001, TOXICOL LETT, V122, P189, DOI 10.1016/S0378-4274(01)00364-2; Genter MB, 2006, BIOCHEM BIOPH RES CO, V342, P1375, DOI 10.1016/j.bbrc.2006.02.121; Goldstone HMH, 2006, DRUG METAB REV, V38, P261, DOI 10.1080/03602530600570099; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hahn ME, 1996, ARCH BIOCHEM BIOPHYS, V329, P163, DOI 10.1006/abbi.1996.0205; Hahn ME, 2001, MAR BIOTECHNOL, V3, pS224, DOI 10.1007/s10126-001-0045-Y; Handley-Goldstone HM, 2005, TOXICOL SCI, V85, P683, DOI 10.1093/toxsci/kfi116; Henry TR, 1997, TOXICOL APPL PHARM, V142, P56, DOI 10.1006/taap.1996.8024; Hill A, 2003, TOXICOL SCI, V76, P392, DOI 10.1093/toxsci/kfg241; Hodson PV, 2007, AQUAT TOXICOL, V81, P275, DOI 10.1016/j.aquatox.2006.12.012; Hornug MW, 1999, TOXICOL SCI, V47, P40, DOI 10.1093/toxsci/47.1.40; HUITSON A, 1966, ANAL VARIANCE; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Humblet O, 2008, ENVIRON HEALTH PERSP, V116, P1443, DOI 10.1289/ehp.11579; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ivnitski I, 2001, TERATOLOGY, V64, P201, DOI 10.1002/tera.1065; Jonsson ME, 2007, TOXICOL SCI, V100, P180, DOI 10.1093/toxsci/kfm207; Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103; Knerr S, 2006, MOL NUTR FOOD RES, V50, P897, DOI 10.1002/mnfr.200600006; Lorenzen A, 1997, BIOCHEM PHARMACOL, V53, P373, DOI 10.1016/S0006-2952(96)00739-3; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mathew LK, 2008, FASEB J, V22, P3087, DOI 10.1096/fj.08-109009; Miettinen HM, 2004, TOXICOL LETT, V150, P285, DOI 10.1016/j.toxlet.2004.02.009; Monteiro P, 2008, MOL PHARMACOL, V73, P769, DOI 10.1124/mol.107.043125; Nebert DW, 2008, J BIOL CHEM, V283, P36061, DOI 10.1074/jbc.R800053200; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Park JYK, 1996, P NATL ACAD SCI USA, V93, P2322, DOI 10.1073/pnas.93.6.2322; Pelclova Daniela, 2006, Reviews on Environmental Health, V21, P119; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; PUGA A, 1992, DNA CELL BIOL, V11, P269, DOI 10.1089/dna.1992.11.269; Puga A, 2000, BIOCHEM PHARMACOL, V60, P1129, DOI 10.1016/S0006-2952(00)00403-2; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Rifkind AB, 2006, DRUG METAB REV, V38, P291, DOI 10.1080/03602530600570107; Schlezinger JJ, 2006, AQUAT TOXICOL, V77, P422, DOI 10.1016/j.aquatox.2006.01.012; Schlezinger JJ, 2001, AQUAT TOXICOL, V52, P101, DOI 10.1016/S0166-445X(00)00141-7; Senft AP, 2002, TOXICOL APPL PHARM, V178, P15, DOI 10.1006/taap.2001.9314; Shertzer HG, 1998, BIOCHEM BIOPH RES CO, V253, P44, DOI 10.1006/bbrc.1998.9753; Shertzer HG, 2004, FREE RADICAL BIO MED, V36, P618, DOI 10.1016/j.freeradbiomed.2003.11.014; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Sul D, 2009, TOXICOLOGY, V255, P65, DOI 10.1016/j.tox.2008.10.006; Teraoka H, 2003, BIOCHEM BIOPH RES CO, V304, P223, DOI 10.1016/S0006-291X(03)00576-X; Thackaberry EA, 2005, TOXICOL SCI, V88, P231, DOI 10.1093/toxsci/kfi301; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Tittlemier SA, 2003, ENVIRON TOXICOL CHEM, V22, P1622, DOI 10.1002/etc.5620220726; Toomey BH, 2001, AQUAT TOXICOL, V53, P127, DOI 10.1016/S0166-445X(00)00161-2; Uno S, 2004, TOXICOL APPL PHARM, V196, P410, DOI 10.1016/j.taap.2004.01.014; Urban P, 2007, EUR J NEUROL, V14, P213, DOI 10.1111/j.1468-1331.2006.01618.x; Vezina CM, 2009, BIOCHEM PHARMACOL, V77, P566, DOI 10.1016/j.bcp.2008.09.039; Volz DC, 2005, TOXICOL SCI, V85, P572, DOI 10.1093/toxsci/kfi109; Wassenberg DM, 2004, ENVIRON HEALTH PERSP, V112, P1658, DOI 10.1289/ehp.7168; Xiong KM, 2008, MOL PHARMACOL, V74, P1544, DOI 10.1124/mol.108.050435; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227; Yeager RL, 2006, REPROD TOXICOL, V22, P811, DOI 10.1016/j.reprotox.2006.07.004; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; [No title captured]	92	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10465	10.1371/journal.pone.0010465	http://dx.doi.org/10.1371/journal.pone.0010465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463971	gold, Green Submitted, Green Published			2022-12-25	WOS:000277379400014
J	Beck, J; Sieber, A				Beck, Jan; Sieber, Andrea			Is the Spatial Distribution of Mankind's Most Basic Economic Traits Determined by Climate and Soil Alone?	PLOS ONE			English	Article							SPECIES DISTRIBUTION; GEOGRAPHIC DISTRIBUTIONS; NEOLITHIC REVOLUTION; BIOGEOGRAPHY; CONSEQUENCES; BIODIVERSITY; EVOLUTION; FRAMEWORK; SELECTION; MODELS	Background: Several authors, most prominently Jared Diamond (1997, Guns, Germs and Steel), have investigated biogeographic determinants of human history and civilization. The timing of the transition to an agricultural lifestyle, associated with steep population growth and consequent societal change, has been suggested to be affected by the availability of suitable organisms for domestication. These factors were shown to quantitatively explain some of the current global inequalities of economy and political power. Here, we advance this approach one step further by looking at climate and soil as sole determining factors. Methodology/Principal Findings: As a simplistic 'null model', we assume that only climate and soil conditions affect the suitability of four basic landuse types - agriculture, sedentary animal husbandry, nomadic pastoralism and hunting-and-gathering. Using ecological niche modelling (ENM), we derive spatial predictions of the suitability for these four landuse traits and apply these to the Old World and Australia. We explore two aspects of the properties of these predictions, conflict potential and population density. In a calculation of overlap of landuse suitability, we map regions of potential conflict between landuse types. Results are congruent with a number of real, present or historical, regions of conflict between ethnic groups associated with different landuse traditions. Furthermore, we found that our model of agricultural suitability explains a considerable portion of population density variability. We mapped residuals from this correlation, finding geographically highly structured deviations that invite further investigation. We also found that ENM of agricultural suitability correlates with a metric of local wealth generation (Gross Domestic Product, Purchasing Power Parity). Conclusions/Significance: From simplified assumptions on the links between climate, soil and landuse we are able to provide good predictions on complex features of human geography. The spatial distribution of deviations from ENM predictions identifies those regions requiring further investigation of potential explanations. Our findings and methodological approaches may be of applied interest, e.g., in the context of climate change.	[Beck, Jan; Sieber, Andrea] Univ Basel, Dept Environm Sci, Basel, Switzerland	University of Basel	Beck, J (corresponding author), Univ Basel, Dept Environm Sci, Basel, Switzerland.	jan.beck@unibas.ch	Beck, Jan/L-5659-2015	Beck, Jan/0000-0003-1170-4751	Swiss National Science Foundation (SNF) [31003A_119879]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	JB is supported by the Swiss National Science Foundation (SNF Grant 31003A_119879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Brown C, 2006, NAT RESOUR FORUM, V30, P306, DOI 10.1111/j.1477-8947.2006.00118.x; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Collier P., 2007, BOTTOM BILLION WHY P; Dawkins R, 1976, SELFISH GENE; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Diamond J., 1997, GUNS GERMS STEEL SHO; DIAMOND JM, 2005, COLLAPSE SOC CHOOSE; Diniz JAF, 2008, GLOBAL ECOL BIOGEOGR, V17, P479, DOI 10.1111/j.1466-8238.2008.00395.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Easterly W, 2003, J MONETARY ECON, V50, P3, DOI 10.1016/S0304-3932(02)00200-3; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Erb KH, 2009, ECOL ECON, V69, P328, DOI 10.1016/j.ecolecon.2009.06.025; Gotelli NJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P337, DOI 10.1046/j.1466-822X.2001.00249.x; GOTELLI NJ, 2008, IBS NEWSLETTER, V6, P3; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hibbs DA, 2004, P NATL ACAD SCI USA, V101, P3715, DOI 10.1073/pnas.0305531101; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Koch NE, 1999, NEW FOREST, V17, P11, DOI 10.1023/A:1006520809425; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Munguia M, 2008, J BIOGEOGR, V35, P1879, DOI 10.1111/j.1365-2699.2008.01921.x; Newbold T, 2009, BIODIVERS CONSERV, V18, P3629, DOI 10.1007/s10531-009-9668-5; Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103; Olesen JE, 2002, EUR J AGRON, V16, P239, DOI 10.1016/S1161-0301(02)00004-7; Olsson O, 2005, EUR ECON REV, V49, P909, DOI 10.1016/j.euroecorev.2003.08.010; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Peterson AT, 2009, FRONTIERS BIOGEOGRAP, V1, P19, DOI DOI 10.21425/F5FBG12232; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Putterman L, 2008, ECONOMICA, V75, P729, DOI 10.1111/j.1468-0335.2007.00652.x; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Reader J., 1998, AFRICA BIOGRAPHY CON; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rogers DS, 2008, P NATL ACAD SCI USA, V105, P3416, DOI 10.1073/pnas.0711802105; Sachs J., 2001, GEOGRAPHY POVERTY WE, P71; Schwanghart W, 2008, GLOBAL ECOL BIOGEOGR, V17, P566, DOI 10.1111/j.1466-8238.2008.00390.x; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; STOCKWELL D, 2007, MATH COMPUTATIONAL B; TAYLOR M, 2003, REV INT ECON, V11, P436, DOI DOI 10.1016/J.JOEP.2006.04.003; WEISCHET W, 1977, OKOLOGISCHE BENACHTE; Weisdorf JL, 2005, J ECON SURV, V19, P561, DOI 10.1111/j.0950-0804.2005.00259.x; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104	47	21	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10416	10.1371/journal.pone.0010416	http://dx.doi.org/10.1371/journal.pone.0010416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	592LC	20463959	Green Published, Green Submitted, gold			2022-12-25	WOS:000277379400005
J	Weiser, SD; Tuller, DM; Frongillo, EA; Senkungu, J; Mukiibi, N; Bangsberg, DR				Weiser, Sheri D.; Tuller, David M.; Frongillo, Edward A.; Senkungu, Jude; Mukiibi, Nozmu; Bangsberg, David R.			Food Insecurity as a Barrier to Sustained Antiretroviral Therapy Adherence in Uganda	PLOS ONE			English	Article							HIV-POSITIVE INDIVIDUALS; INFECTED INDIVIDUALS; MEDICATION ADHERENCE; IMPROVE ADHERENCE; DRUG-RESISTANCE; ADULTS; FACILITATORS; SUPPRESSION; PROGRESSION; MORTALITY	Background: Food insecurity is emerging as an important barrier to antiretroviral (ARV) adherence in sub-Saharan Africa and elsewhere, but little is known about the mechanisms through which food insecurity leads to ARV non-adherence and treatment interruptions. Methodology: We conducted in-depth, open-ended interviews with 47 individuals (30 women, 17 men) living with HIV/AIDS recruited from AIDS treatment programs in Mbarara and Kampala, Uganda to understand how food insecurity interferes with ARV therapy regimens. Interviews were transcribed, coded for key themes, and analyzed using grounded theory. Findings: Food insecurity was common and an important barrier to accessing medical care and ARV adherence. Five mechanisms emerged for how food insecurity can contribute to ARV non-adherence and treatment interruptions or to postponing ARV initiation: 1) ARVs increased appetite and led to intolerable hunger in the absence of food; 2) Side effects of ARVs were exacerbated in the absence of food; 3) Participants believed they should skip doses or not start on ARVs at all if they could not afford the added nutritional burden; 4) Competing demands between costs of food and medical expenses led people either to default from treatment, or to give up food and wages to get medications; 5) While working for food for long days in the fields, participants sometimes forgot medication doses. Despite these obstacles, many participants still reported high ARV adherence and exceptional motivation to continue therapy. Conclusions: While reports from sub-Saharan Africa show excellent adherence to ARVs, concerns remain that these successes are not sustainable in the presence of widespread poverty and food insecurity. We provide further evidence on how food insecurity can compromise sustained ARV therapy in a resource-limited setting. Addressing food insecurity as part of emerging ARV treatment programs is critical for their long-term success.	[Weiser, Sheri D.] San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94110 USA; [Weiser, Sheri D.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Tuller, David M.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Frongillo, Edward A.] Univ S Carolina, Dept Hlth Promot Educ & Behav, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Senkungu, Jude; Mukiibi, Nozmu; Bangsberg, David R.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Bangsberg, David R.] Massachusetts Inst Technol & Harvard, Ragon Inst, Massachusetts Gen Hosp, Boston, MA USA; [Bangsberg, David R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Global Hlth, Cambridge, MA 02138 USA; [Bangsberg, David R.] Harvard Initiat Global Hlth, Boston, MA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Mbarara University of Science & Technology; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital; Harvard University	Weiser, SD (corresponding author), San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94110 USA.	Sheri.Weiser@ucsf.edu			National Institute of Mental Health [K23 MH079713-01]; NIMH [RO-1 54907, K24 87227]; Meyers Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907, K24MH087227, K23MH079713] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Meyers Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by National Institute of Mental Health K23 MH079713-01, NIMH RO-1 54907, and the Meyers Family Foundation. Dr. Bangsberg received support from NIMH K24 87227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Au JT, 2006, AIDS, V20, P2116, DOI 10.1097/01.aids.0000247580.16073.1b; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Crane JT, 2006, AIDS BEHAV, V10, P437, DOI 10.1007/s10461-006-9080-z; Danel C, 2009, J INFECT DIS, V199, P66, DOI 10.1086/595298; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Hadley C, 2008, SOC SCI MED, V66, P427, DOI 10.1016/j.socscimed.2007.08.025; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kadiyala S, 2009, J DEV EFFECT, V1, P470, DOI 10.1080/19439340903370469; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kumarasamy N, 2005, AIDS PATIENT CARE ST, V19, P526, DOI 10.1089/apc.2005.19.526; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; NASH D, 2008, CHARACTERISTICS FACI; *NAT AGR ADV SERV, 2003, IMP HIV AIDS AGR SEC; Normen L, 2005, J NUTR, V135, P820, DOI 10.1093/jn/135.4.820; Olupot-Olupot P, 2008, AIDS, V22, P1882, DOI 10.1097/QAD.0b013e3283112ba6; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Ramadhani HO, 2007, CLIN INFECT DIS, V45, P1492, DOI 10.1086/522991; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; SEUMEFOSSO E, 2004, FOOD NUTR TECHNICAL; Strauss A., 1990, BASICS QUALITATIVE R; TULLER DM, 2009, AIDS BEHAV; *UN ADM COMM COORD, 2001, NUTR HIV AIDS; van Sighem AI, 2003, AIDS, V17, P2227, DOI 10.1097/00002030-200310170-00011; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; WEISER SD, 2009, J AIDS IN PRESS; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; World Food Programme, 2003, PROGR ER AIDS WPFS R; World Health Organisation, 2003, NUTR REQ PEOPL LIV H	42	161	162	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10340	10.1371/journal.pone.0010340	http://dx.doi.org/10.1371/journal.pone.0010340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	589MV	20442769	Green Published, gold, Green Submitted			2022-12-25	WOS:000277154200004
J	Lohmann, G; Margulies, DS; Horstmann, A; Pleger, B; Lepsien, J; Goldhahn, D; Schloegl, H; Stumvoll, M; Villringer, A; Turner, R				Lohmann, Gabriele; Margulies, Daniel S.; Horstmann, Annette; Pleger, Burkhard; Lepsien, Joeran; Goldhahn, Dirk; Schloegl, Haiko; Stumvoll, Michael; Villringer, Arno; Turner, Robert			Eigenvector Centrality Mapping for Analyzing Connectivity Patterns in fMRI Data of the Human Brain	PLOS ONE			English	Article							RESTING-STATE FMRI; FUNCTIONAL CONNECTIVITY; CORTICAL HUBS; DEFAULT MODE; NETWORKS; FREQUENCY; DYNAMICS; IDENTIFICATION; ANATOMY; DISEASE	Functional magnetic resonance data acquired in a task-absent condition ("resting state'') require new data analysis techniques that do not depend on an activation model. In this work, we introduce an alternative assumption- and parameter-free method based on a particular form of node centrality called eigenvector centrality. Eigenvector centrality attributes a value to each voxel in the brain such that a voxel receives a large value if it is strongly correlated with many other nodes that are themselves central within the network. Google's PageRank algorithm is a variant of eigenvector centrality. Thus far, other centrality measures - in particular "betweenness centrality'' - have been applied to fMRI data using a pre-selected set of nodes consisting of several hundred elements. Eigenvector centrality is computationally much more efficient than betweenness centrality and does not require thresholding of similarity values so that it can be applied to thousands of voxels in a region of interest covering the entire cerebrum which would have been infeasible using betweenness centrality. Eigenvector centrality can be used on a variety of different similarity metrics. Here, we present applications based on linear correlations and on spectral coherences between fMRI times series. This latter approach allows us to draw conclusions of connectivity patterns in different spectral bands. We apply this method to fMRI data in task-absent conditions where subjects were in states of hunger or satiety. We show that eigenvector centrality is modulated by the state that the subjects were in. Our analyses demonstrate that eigenvector centrality is a computationally efficient tool for capturing intrinsic neural architecture on a voxel-wise level.	[Lohmann, Gabriele; Margulies, Daniel S.; Horstmann, Annette; Pleger, Burkhard; Lepsien, Joeran; Goldhahn, Dirk; Villringer, Arno; Turner, Robert] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Schloegl, Haiko; Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany	Max Planck Society; Leipzig University	Lohmann, G (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	lohmann@cbs.mpg.de	Stumvoll, Michael/ABE-1121-2021; Horstmann, Annette/C-9083-2011; Lohmann, Gabriele/C-3590-2008; Lohmann, Gabriele/AGE-9413-2022; Margulies, Daniel/L-4719-2016	Stumvoll, Michael/0000-0001-6225-8240; Horstmann, Annette/0000-0001-6184-8484; Lohmann, Gabriele/0000-0002-5922-9016; Villringer, Arno/0000-0003-2604-2404; Goldhahn, Dirk/0000-0003-1681-567X; Margulies, Daniel/0000-0002-8880-9204	Bundesministerium Bildung und Forschung (BMBF) [01GI0850, 934000-391]; European Union [223057]	Bundesministerium Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by the Bundesministerium Bildung und Forschung (BMBF), http://www.bmbf.de/, Foerderkennzeichen: 01GI0850, Projekt-Nr.: 934000-391; and the European Union's Seventh Framework Programme (Grant No. 223057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; BALLANGER B, ANN NEUROLO IN PRESS; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Bonacich P, 2004, SOC NETWORKS, V26, P331, DOI 10.1016/j.socnet.2004.08.007; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; CHATFIELD C, 1975, ANAL TIME SERIES THE; Comings DE, 2000, PROG BRAIN RES, V126, P325; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Fuehrer D, 2008, OBESITY, V16, P945, DOI 10.1038/oby.2008.33; Golub GH., 2013, MATRIX COMPUTATIONS; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; HE Y, 2009, PLOS ONE, V4, pE5526; Kiviniemi V, 2004, MAGN RESON IMAGING, V22, P197, DOI 10.1016/j.mri.2003.09.007; Langville A., 2006, GOOGLES PAGERANK SCI; Li KM, 2009, COMPUT MED IMAG GRAP, V33, P131, DOI 10.1016/j.compmedimag.2008.10.011; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Mezer A, 2009, NEUROIMAGE, V45, P1117, DOI 10.1016/j.neuroimage.2008.12.015; Muller K, 2007, J MAGN RESON IMAGING, V26, P1642, DOI 10.1002/jmri.21169; Muller K, 2003, J MAGN RESON IMAGING, V17, P375, DOI 10.1002/jmri.10268; Newman MEJ, 2008, NEW PALGRAVE ENCY EC; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Portas CM, 1998, J NEUROSCI, V18, P8979; Priestley M. B., 1981, SPECTRAL ANAL TIME S, V1; RAO TS, 1967, ANN MATH STAT, V38, P593, DOI 10.1214/aoms/1177698976; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; SAJONZ B, NEUROIMAGE; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; TATARANNI P, 2003, OBESITY REV; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; van Albada SJ, 2007, J NEUROSCI METH, V161, P205, DOI 10.1016/j.jneumeth.2006.11.004; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; ZUO X, NEUROIMAGE IN PRESS	48	321	327	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10232	10.1371/journal.pone.0010232	http://dx.doi.org/10.1371/journal.pone.0010232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436911	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079700003
J	Pothuri, B; Leitao, MM; Levine, DA; Viale, A; Olshen, AB; Arroyo, C; Bogomolniy, F; Olvera, N; Lin, O; Soslow, RA; Robson, ME; Offit, K; Barakat, RR; Boyd, J				Pothuri, Bhavana; Leitao, Mario M.; Levine, Douglas A.; Viale, Agnes; Olshen, Adam B.; Arroyo, Crispinita; Bogomolniy, Faina; Olvera, Narciso; Lin, Oscar; Soslow, Robert A.; Robson, Mark E.; Offit, Kenneth; Barakat, Richard R.; Boyd, Jeff			Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma	PLOS ONE			English	Article							PROPHYLACTIC OOPHORECTOMY; SURFACE EPITHELIUM; HUMAN-CELLS; INSTABILITY; PROTEIN; BRCA1; P53; PATHOGENESIS; EXPRESSION; MUTATION	Background: The high mortality rate associated with epithelial ovarian carcinoma (EOC) reflects diagnosis commonly at an advanced stage, but improved early detection is hindered by uncertainty as to the histologic origin and early natural history of this malignancy. Methodology/Principal Findings: Here we report combined molecular genetic and morphologic analyses of normal human ovarian tissues and early stage cancers, from both BRCA mutation carriers and the general population, indicating that EOCs frequently arise from dysplastic precursor lesions within epithelial inclusion cysts. In pathologically normal ovaries, molecular evidence of oncogenic stress was observed specifically within epithelial inclusion cysts. To further explore potential very early events in ovarian tumorigenesis, ovarian tissues from women not known to be at high risk for ovarian cancer were subjected to laser catapult microdissection and gene expression profiling. These studies revealed a quasineoplastic expression signature in benign ovarian cystic inclusion epithelium compared to surface epithelium, specifically with respect to genes affecting signal transduction, cell cycle control, and mitotic spindle formation. Consistent with this gene expression profile, a significantly higher cell proliferation index (increased cell proliferation and decreased apoptosis) was observed in histopathologically normal ovarian cystic compared to surface epithelium. Furthermore, aneuploidy was frequently identified in normal ovarian cystic epithelium but not in surface epithelium. Conclusions/Significance: Together, these data indicate that EOC frequently arises in ovarian cystic inclusions, is preceded by an identifiable dysplastic precursor lesion, and that increased cell proliferation, decreased apoptosis, and aneuploidy are likely to represent very early aberrations in ovarian tumorigenesis.	[Pothuri, Bhavana; Leitao, Mario M.; Levine, Douglas A.; Arroyo, Crispinita; Bogomolniy, Faina; Olvera, Narciso; Barakat, Richard R.; Boyd, Jeff] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Olshen, Adam B.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Lin, Oscar; Soslow, Robert A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Robson, Mark E.; Offit, Kenneth; Boyd, Jeff] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Boyd, Jeff] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Fox Chase Cancer Center	Pothuri, B (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	jeff.boyd@fccc.edu		Robson, Mark/0000-0002-3109-1692; Soslow, Robert/0000-0002-7269-5898; Levine, Douglas/0000-0003-1038-8232; Boyd, Jeff/0000-0002-3517-7637; Pothuri, Bhavana/0000-0003-4578-2061	National Institutes of Health [R01 CA71840]; W.M. Keck Foundation; NATIONAL CANCER INSTITUTE [R01CA071840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from the National Institutes of Health, R01 CA71840, and by a grant from the W.M. Keck Foundation, http://www.wmkeck.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Bunz F, 2002, CANCER RES, V62, P1129; Deligdisch L, 1999, CANCER-AM CANCER SOC, V86, P1544, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I; DELIGDISCH L, 1989, CANCER, V63, P748, DOI 10.1002/1097-0142(19890215)63:4<748::AID-CNCR2820630424>3.0.CO;2-8; Dubeau L, 1999, GYNECOL ONCOL, V72, P437, DOI 10.1006/gyno.1998.5275; Duesberg P, 2003, CELL CYCLE, V2, P202, DOI 10.4161/cc.2.3.382; Faire K, 1999, J CELL SCI, V112, P4243; Fleming GF, 2009, PRINCIPLES PRACTICE, P763; Flory MR, 2000, P NATL ACAD SCI USA, V97, P5919, DOI 10.1073/pnas.97.11.5919; Flory MR, 2002, CELL GROWTH DIFFER, V13, P47; GAJEWSKI WH, 1994, GYNECOL ONCOL, V53, P5, DOI 10.1006/gyno.1994.1078; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HOSACK DA, 2003, GENOME BIOL, V4, pP4, DOI DOI 10.1186/GB-2003-4-6-P4; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; HUTSON R, 1995, HISTOPATHOLOGY, V27, P367, DOI 10.1111/j.1365-2559.1995.tb01528.x; Kmet LM, 2003, CANCER, V97, P389, DOI 10.1002/cncr.11064; Kohn EC, 2007, DIS MARKERS, V23, P411, DOI 10.1155/2007/967023; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Leitao MM, 2004, GYNECOL ONCOL, V93, P301, DOI 10.1016/j.ygyno.2004.01.043; Lengauer C, 2005, SEMIN CANCER BIOL, V15, P1, DOI 10.1016/j.semcancer.2004.09.001; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; MASSON D, 1993, J CELL BIOL, V123, P357, DOI 10.1083/jcb.123.2.357; Michor F, 2005, SEMIN CANCER BIOL, V15, P43, DOI 10.1016/j.semcancer.2004.09.007; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Narod SA, 2002, CURR OPIN OBSTET GYN, V14, P19, DOI 10.1097/00001703-200202000-00004; Piek JMJ, 2004, AM J OBSTET GYNECOL, V191, P718, DOI 10.1016/j.ajog.2004.02.067; RADISAVLJEVIC SV, 1977, OBSTET GYNECOL, V49, P424; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; RESTA L, 1993, OBSTET GYNECOL, V82, P181; Rhei E, 1998, CANCER RES, V58, P3193; Rosenthal AN, 2006, CLIN OBSTET GYNECOL, V49, P433, DOI 10.1097/00003081-200609000-00004; Schlosshauer PW, 2003, CANCER, V98, P2599, DOI 10.1002/cncr.11848; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully RE, 1995, J CELL BIOCHEM, P208; Seidman JD, 2002, BLAUSTEINS PATHOLOGY, P791; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Werness BA, 1999, HUM PATHOL, V30, P151, DOI 10.1016/S0046-8177(99)90269-1; Werness BA, 2000, J NATL CANCER I, V92, P1088, DOI 10.1093/jnci/92.13.1088; Zanetta G, 1996, AM J OBSTET GYNECOL, V175, P1217, DOI 10.1016/S0002-9378(96)70031-5	45	78	83	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10358	10.1371/journal.pone.0010358	http://dx.doi.org/10.1371/journal.pone.0010358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436685	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000277079500022
J	Adinolfi, E; Cirillo, M; Woltersdorf, R; Falzoni, S; Chiozzi, P; Pellegatti, P; Callegari, MG; Sandona, D; Markwardt, F; Schmalzing, G; Di Virgilio, F				Adinolfi, Elena; Cirillo, Maria; Woltersdorf, Ronja; Falzoni, Simonetta; Chiozzi, Paola; Pellegatti, Patrizia; Callegari, Maria Giulia; Sandona, Doriana; Markwardt, Fritz; Schmalzing, Guenther; Di Virgilio, Francesco			Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor	FASEB JOURNAL			English	Article						extracellular ATP; purinergic receptors; cell growth; ion channels	P2X(7) ATP RECEPTOR; EXTRACELLULAR ATP; PLASMA-MEMBRANE; MOLECULAR PHYSIOLOGY; P-2Z RECEPTOR; CELLS; CHANNEL; PROLIFERATION; EXPRESSION; LYMPHOCYTES	P2X7 is the largest member of the P2X subfamily of purinergic receptors. A typical feature is the carboxyl tail, which allows formation of a large pore. Recently a naturally occurring truncated P2X7 splice variant, isoform B (P2X7B), has been identified. Here we show that P2X7B expression in HEK293 cells, a cell type lacking endogenous P2X receptors, mediated ATP-stimulated channel activity but not plasma membrane permeabilization, raised endoplasmic reticulum Ca(2+) content, activated the transcription factor NFATc1, increased the cellular ATP content, and stimulated growth. In addition, P2X7B-transfected HEK293 cells (HEK293-P2X7B), like most tumor cells, showed strong soft agar-infiltrating ability. When coexpressed with full-length P2X7 (P2X7A), P2X7B coassembled with P2X7A into a heterotrimer and potentiated all known responses mediated by this latter receptor. P2X7B mRNA was found to be widely distributed in human tissues, especially in the immune and nervous systems, and to a much higher level than P2X7A. Finally, P2X7B expression was increased on mitogenic stimulation of peripheral blood lymphocyte. Altogether, these data show that P2X7B is widely expressed in several human tissues, modulates P2X7A functions, participates in the control of cell growth, and may help understand the role of the P2X7 receptor in the control of normal and cancer cell proliferation.-Adinolfi, E., Cirillo, M., Woltersdorf, R., Falzoni, S., Chiozzi, P., Pellegatti, P., Callegari, M. G., Sandona, D., Markwardt, F., Schmalzing, G., Di Virgilio, F. Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor. FASEB J. 24, 3393-3404 (2010). www.fasebj.org	[Adinolfi, Elena; Cirillo, Maria; Falzoni, Simonetta; Chiozzi, Paola; Pellegatti, Patrizia; Callegari, Maria Giulia; Di Virgilio, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy; [Woltersdorf, Ronja; Schmalzing, Guenther] Rhein Westfal TH Aachen, Dept Mol Pharmacol, Aachen, Germany; [Sandona, Doriana] Univ Padua, Dept Biomed Sci, Padua, Italy; [Markwardt, Fritz] Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Halle, Germany	University of Ferrara; RWTH Aachen University; University of Padua; Martin Luther University Halle Wittenberg	Di Virgilio, F (corresponding author), Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, Interdisciplinary Ctr Study Inflammat, Via L Borsari 46, I-44100 Ferrara, Italy.	fdv@unife.it	Markwardt, Fritz/F-7693-2013; Adinolfi, Elena/F-9169-2010; Pellegatti, Patrizia/A-1891-2011; DI VIRGILIO, Francesco/O-4634-2019; Di Virgilio, Francesco/J-3754-2018; sandona, dorianna/AAB-9480-2020	Markwardt, Fritz/0000-0001-6761-2923; Adinolfi, Elena/0000-0001-8129-9929; DI VIRGILIO, Francesco/0000-0003-3566-1362; Di Virgilio, Francesco/0000-0003-3566-1362; Falzoni, Simonetta/0000-0002-6594-0357; Chiozzi, Paola/0000-0003-4952-334X	Italian Association for Cancer Research [IG 5354]; Telethon of Italy [GGP06070]; Italian Space Agency (ASI-OSMA); Commission of European Communities [HEALTH-F2-2007-202231]; Regione Emilia Romagna; University of Ferrara; Deutsche Forschungsgemeinschaft [Schm536/9-1, Ma1581/15-1]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon of Italy(Fondazione Telethon); Italian Space Agency (ASI-OSMA)(Agenzia Spaziale Italiana (ASI)); Commission of European Communities(European Commission); Regione Emilia Romagna(Regione Emilia Romagna); University of Ferrara; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by grants from the Italian Association for Cancer Research (IG 5354), Telethon of Italy (GGP06070), the Italian Space Agency (ASI-OSMA), the Commission of European Communities (7th Framework Program HEALTH-F2-2007-202231), the Regione Emilia Romagna (Research Programs "Innovative Approaches to the Diagnosis of Inflammatory Diseases" and "Monitor"), the Young Researchers Project of the University of Ferrara (to E. A.), the Deutsche Forschungsgemeinschaft (Schm536/9-1 to G. S. and Ma1581/15-1 to F. M.), and institutional funds from the University of Ferrara. F. D. V. acts as consultant to Cordex Pharma Inc. and Affectis Pharma AG, biotech companies involved in the development of ATP-based drugs.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2003, J BIOL CHEM, V278, P37344, DOI 10.1074/jbc.M301508200; Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Adinolfi E, 2009, J BIOL CHEM, V284, P10120, DOI 10.1074/jbc.M805805200; Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Becker D, 2008, J BIOL CHEM, V283, P25725, DOI 10.1074/jbc.M803855200; Bianco F, 2006, J NEUROCHEM, V99, P745, DOI 10.1111/j.1471-4159.2006.04101.x; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Denlinger LC, 2001, J IMMUNOL, V167, P1871, DOI 10.4049/jimmunol.167.4.1871; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Di Virgilio F, 2009, PURINERG SIGNAL, V5, P251, DOI 10.1007/s11302-009-9145-3; DIVIRGILIO F, 1989, J IMMUNOL, V143, P1955; Duckwitz W, 2006, J BIOL CHEM, V281, P39561, DOI 10.1074/jbc.M606113200; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Ferrari D, 2007, BRIT J PHARMACOL, V150, P445, DOI 10.1038/sj.bjp.0706994; GLOOR S, 1995, GENE, V160, P213, DOI 10.1016/0378-1119(95)00226-V; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Kim M, 2001, J BIOL CHEM, V276, P23262, DOI 10.1074/jbc.M102253200; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630	38	180	181	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2010	24	9					3393	3404		10.1096/fj.09-153601	http://dx.doi.org/10.1096/fj.09-153601			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20453110				2022-12-25	WOS:000281446400027
J	Hu, MC; Shi, MJ; Zhang, JN; Pastor, J; Nakatani, T; Lanske, B; Razzaque, MS; Rosenblatt, KP; Baum, MG; Kuro-o, M; Moe, OW				Hu, Ming Chang; Shi, Mingjun; Zhang, Jianning; Pastor, Johanne; Nakatani, Teruyo; Lanske, Beate; Razzaque, M. Shawkat; Rosenblatt, Kevin P.; Baum, Michel G.; Kuro-o, Makoto; Moe, Orson W.			Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule	FASEB JOURNAL			English	Article						renal brush border membrane; FGF23; NaPi-2a; beta-glucuronidase; proteolytic degradation	TRANSCRIPTS ENCODING MEMBRANE; FIBROBLAST GROWTH FACTOR-23; BONE-MINERAL DENSITY; NA/P-I COTRANSPORTER; HORMONE KLOTHO; TRPV5 CHANNEL; ALPHA-KLOTHO; NAPI-IIA; P-I; GENE	Klotho has profound effects on phosphate metabolism, but the mechanisms of how Klotho affects phosphate homeostasis is unknown. We detected Klotho in the proximal tubule cell, brush border, and urinary lumen, where phosphate homeostasis resides. Increasing Klotho in the kidney and urine chronically by transgenic overexpression or acutely by intravenous infusion caused hypophosphatemia, phosphaturia from decreased proximal phosphate reabsorption, and decreased activity and protein of the principal renal phosphate transporter NaPi-2a. The phosphaturic effect was present in FGF23-null mice, indicating a direct action distinct from Klotho's known role as a coreceptor for FGF23. Direct inhibition of NaPi-2a by Klotho was confirmed in cultured cells and in cell-free membrane vesicles characterized by acute inhibition of transport activity followed by decreased cell surface protein. Transport inhibition can be mimicked by recombinant beta-glucuronidase and is associated with proteolytic degradation and reduced surface NaPi-2a. The inhibitory effect of Klotho on NaPi-2a was blocked by beta-glucuronidase inhibitor but not by protease inhibitor. Klotho is a novel phosphaturic substance that acts as an enzyme in the proximal tubule urinary lumen by modifying glycans, which cause decreased transporter activity, followed by proteolytic degradation and possibly internalization of NaPi-2a from the apical membrane.-Hu, M. C., Shi, M., Zhang, J., Pastor, J., Nakatani, T., Lanske, B., Shawkat Razzaque, M., Rosenblatt, K. P., Baum, M. G., Kuro-o, M., Moe, O. W. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J. 24, 3438-3450 (2010). www.fasebj.org	[Hu, Ming Chang; Shi, Mingjun; Kuro-o, Makoto; Moe, Orson W.] Univ Texas SW Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA; [Hu, Ming Chang; Zhang, Jianning; Baum, Michel G.; Moe, Orson W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Hu, Ming Chang; Baum, Michel G.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Pastor, Johanne; Rosenblatt, Kevin P.; Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Moe, Orson W.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Nakatani, Teruyo; Lanske, Beate; Razzaque, M. Shawkat] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard School of Dental Medicine	Moe, OW (corresponding author), Univ Texas SW Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	orson.moe@utsouthwestern.edu	Razzaque, Mohammed S./K-4282-2019	Lanske, Beate/0000-0003-4638-804X	Simmons Family Foundation; National Institutes of Health [AG19712, AG25326, DK067158, DK41612, DK-48482, DK-20543, P30-DK-079328]; American Heart Association [0865235F]; Eisai Research Fund; Ellison Medical Foundation; Ted Nash Long Life Foundation; Charles and Jane Pak Center of Mineral Metabolism and Clinical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041612, R01DK067158, R01DK048482, R29DK048482, P30DK079328, P01DK020543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019712, R01AG025326] Funding Source: NIH RePORTER	Simmons Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Eisai Research Fund; Ellison Medical Foundation(Lawrence Ellison Foundation); Ted Nash Long Life Foundation; Charles and Jane Pak Center of Mineral Metabolism and Clinical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was primarily supported by the Simmons Family Foundation. The authors also received support from the National Institutes of Health (AG19712, AG25326, DK067158, DK41612, DK-48482, DK-20543, and P30-DK-079328), the American Heart Association (0865235F), the Eisai Research Fund, the Ellison Medical Foundation, the Ted Nash Long Life Foundation, and a Seed Grant from the Charles and Jane Pak Center of Mineral Metabolism and Clinical Research. Authors are grateful to Dr. O Bonny for valuable suggestions and discussions and to Drs. J. Biber and H. Murer (Institute of Physiology, University of Zurich, Zurich, Switzerland) for antisera against rat NaPi-2a.	Allred AJ, 2000, AM J PHYSIOL-RENAL, V279, pF841, DOI 10.1152/ajprenal.2000.279.5.F841; ARAR M, 1995, AM J PHYSIOL-RENAL, V268, pF309, DOI 10.1152/ajprenal.1995.268.2.F309; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Bacic D, 2005, AM J PHYSIOL-RENAL, V288, pF740, DOI 10.1152/ajprenal.00380.2004; Baum M, 2005, KIDNEY INT, V68, P1148, DOI 10.1111/j.1523-1755.2005.00506.x; Baum M, 2005, AM J PHYSIOL-RENAL, V288, pF363, DOI 10.1152/ajprenal.00217.2004; Baum M, 2003, P NATL ACAD SCI USA, V100, P11098, DOI 10.1073/pnas.1834060100; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Biber J, 1996, KIDNEY INT, V49, P981, DOI 10.1038/ki.1996.139; Brownstein CA, 2008, P NATL ACAD SCI USA, V105, P3455, DOI 10.1073/pnas.0712361105; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Diepens RJW, 2004, AM J PHYSIOL-RENAL, V286, pF483, DOI 10.1152/ajprenal.00231.2003; Friedman DJ, 2009, J BONE MINER RES, V24, P1847, DOI [10.1359/JBMR.090516, 10.1359/jbmr.090516]; Fuster DG, 2008, J AM SOC NEPHROL, V19, P1547, DOI 10.1681/ASN.2007111245; Girardi ACC, 2004, AM J PHYSIOL-CELL PH, V287, pC1238, DOI 10.1152/ajpcell.00186.2004; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Green J, 2001, KIDNEY INT, V60, P1182, DOI 10.1046/j.1523-1755.2001.0600031182.x; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; HAYES G, 1994, J BIOL CHEM, V269, P24143; Hilfiker H, 1998, P NATL ACAD SCI USA, V95, P14564, DOI 10.1073/pnas.95.24.14564; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Ichikawa S, 2007, J CLIN INVEST, V117, P2684, DOI 10.1172/JCI31330; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Kawano KI, 2002, J BONE MINER RES, V17, P1744, DOI 10.1359/jbmr.2002.17.10.1744; Khundmiri SJ, 2005, BBA-BIOMEMBRANES, V1716, P19, DOI 10.1016/j.bbamem.2005.08.009; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lanske B, 2007, AGEING RES REV, V6, P73, DOI 10.1016/j.arr.2007.02.002; Leung JC, 2005, HORM METAB RES, V37, P265, DOI 10.1055/s-2005-870096; LEVI M, 1991, AM J PHYSIOL, V261, pF767, DOI 10.1152/ajprenal.1991.261.5.F767; LEVINE DZ, 1971, AM J PHYSIOL, V221, P1164, DOI 10.1152/ajplegacy.1971.221.4.1164; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Madjdpour C, 2004, PFLUG ARCH EUR J PHY, V448, P402, DOI 10.1007/s00424-004-1253-x; MAGAGNIN S, 1993, P NATL ACAD SCI USA, V90, P5979, DOI 10.1073/pnas.90.13.5979; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Mizuno I, 2001, LIFE SCI, V68, P2917, DOI 10.1016/S0024-3205(01)01092-X; Moe OW, 2009, AM J PHYSIOL-RENAL, V296, pF689, DOI 10.1152/ajprenal.00007.2009; Murer H, 1996, ANNU REV PHYSIOL, V58, P607, DOI 10.1146/annurev.physiol.58.1.607; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Nolan VG, 2006, BRIT J HAEMATOL, V133, P570, DOI 10.1111/j.1365-2141.2006.06074.x; Nolan VG, 2005, BRIT J HAEMATOL, V128, P266, DOI 10.1111/j.1365-2141.2004.05295.x; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576; Pfister MF, 1998, P NATL ACAD SCI USA, V95, P1909, DOI 10.1073/pnas.95.4.1909; PREISIG PA, 1987, J CLIN INVEST, V80, P970, DOI 10.1172/JCI113190; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Rhee EJ, 2006, J ENDOCRINOL INVEST, V29, P613, DOI 10.1007/BF03344160; Riancho JA, 2007, BIOGERONTOLOGY, V8, P121, DOI 10.1007/s10522-006-9039-5; Roseman S, 2001, J BIOL CHEM, V276, P41527, DOI 10.1074/jbc.R100053200; SCHNERMANN J, 1971, PFLUG ARCH EUR J PHY, V329, P307, DOI 10.1007/BF00588002; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF769, DOI 10.1152/ajprenal.00248.2006; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shiraki-Iida T, 2000, J GENE MED, V2, P233, DOI 10.1002/1521-2254(200007/08)2:4<233::AID-JGM110>3.0.CO;2-5; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; SORRIBAS V, 1994, J BIOL CHEM, V269, P6615; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Villa-Bellosta R, 2009, AM J PHYSIOL-RENAL, V296, pF691, DOI 10.1152/ajprenal.90623.2008; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Xiao YS, 1997, BIOCHEM J, V323, P401, DOI 10.1042/bj3230401; Yamada Y, 2005, J MOL MED, V83, P50, DOI 10.1007/s00109-004-0578-4; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yu XJ, 2005, CYTOKINE GROWTH F R, V16, P221, DOI 10.1016/j.cytogfr.2005.01.002; Zhang F, 2007, OSTEOARTHR CARTILAGE, V15, P624, DOI 10.1016/j.joca.2006.12.002	71	418	438	0	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3438	3450		10.1096/fj.10-154765	http://dx.doi.org/10.1096/fj.10-154765			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20466874	Green Published			2022-12-25	WOS:000281446400031
J	Eylert, E; Herrmann, V; Jules, M; Gillmaier, N; Lautner, M; Buchrieser, C; Eisenreich, W; Heuner, K				Eylert, Eva; Herrmann, Vroni; Jules, Matthieu; Gillmaier, Nadine; Lautner, Monika; Buchrieser, Carmen; Eisenreich, Wolfgang; Heuner, Klaus			Isotopologue Profiling of Legionella pneumophila ROLE OF SERINE AND GLUCOSE AS CARBON SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-REQUIREMENTS; LIQUID-MEDIUM; METABOLISM; GROWTH; VIRULENCE; IDENTIFICATION	Legionella pneumophila (Lp) is commonly found in freshwater habitats but is also the causative agent of Legionnaires' disease when infecting humans. Although various virulence factors have been reported, little is known about the nutrition and the metabolism of the bacterium. Here, we report the application of isotopologue profiling for analyzing the metabolism of L. pneumophila. Cultures of Lp were supplied with [U-C-13(3)] serine, [U-C-13(6)] glucose, or [1,2-C-13(2)] glucose. After growth, C-13 enrichments and isotopologue patterns of protein-derived amino acids and poly-3-hydroxybutyrate were determined by mass spectrometry and/or NMR spectroscopy. The labeling patterns detected in the experiment with [U-C-13(3)] serine showed major carbon flux from serine to pyruvate and from pyruvate to acetyl-CoA, which serves as a precursor of poly-3-hydroxybutyrate or as a substrate of a complete citrate cycle with Si specificity of the citrate synthase. Minor carbon flux was observed between pyruvate and oxaloacetate/malate by carboxylation and decarboxylation, respectively. The apparent lack of label in Val, Ile, Leu, Pro, Phe, Met, Arg, and Tyr confirmed that L. pneumophila is auxotrophic for these amino acids. Experiments with [C-13] glucose showed that the carbohydrate is also used as a substrate to feed the central metabolism. The specific labeling patterns due to [1,2-C-13(2)] glucose identified the Entner-Doudoroff pathway as the predominant route for glucose utilization. In line with these observations, a mutant lacking glucose-6-phosphate dehydrogenase (Delta zwf) did not incorporate label from glucose at significant levels and was slowly outcompeted by the wild type strain in successive rounds of infection in Acanthamoeba castellanii, indicating the importance of this enzyme and of carbohydrate usage in general for the life cycle of Lp.	[Eylert, Eva; Gillmaier, Nadine; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, D-85747 Garching, Germany; [Herrmann, Vroni; Lautner, Monika; Heuner, Klaus] Robert Koch Inst, Res Grp Nosocomial Infect Elderly P26, D-13353 Berlin, Germany; [Jules, Matthieu; Buchrieser, Carmen] Inst Pasteur, F-75015 Paris, France; [Jules, Matthieu; Buchrieser, Carmen] CNRS, URA 2171, F-75015 Paris, France	Technical University of Munich; Robert Koch Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Eisenreich, W (corresponding author), Tech Univ Munich, Lehrstuhl Biochem, Lichtenbergstr 4, D-85747 Garching, Germany.	wolfgang.eisenreich@ch.tum.de; heunerk@rki.de	Jules, Matthieu/GVU-5315-2022; Eisenreich, Wolfgang/A-1258-2013	Jules, Matthieu/0000-0003-0817-8949; Eisenreich, Wolfgang/0000-0002-9832-8279; Buchrieser, Carmen/0000-0003-3477-9190	Deutsche Forschungsgemeinschaft DFG, Bonn, Germany [EI 384/4-1, HE 2845/6-1, SPP 1316]; Network of Excellence [LSHB-CT-2005-512061]; Institut Pasteur and Bio-Rad [PTR 185]	Deutsche Forschungsgemeinschaft DFG, Bonn, Germany(German Research Foundation (DFG)); Network of Excellence; Institut Pasteur and Bio-Rad	This work was supported by Grants EI 384/4-1 and HE 2845/6-1 from the Deutsche Forschungsgemeinschaft DFG SPP 1316, Bonn, Germany (to W.E. and K.H., respectively) and by the Network of Excellence "Euro-pathogenomics" Grant LSHB-CT-2005-512061 and the Grant PTR 185 from the Institut Pasteur and Bio-Rad (to C.B.). M.J. received support from the Institut Pasteur-Bio-Rad Grant PTR 185.	ANDERSON AJ, 1990, INT J BIOL MACROMOL, V12, P102, DOI 10.1016/0141-8130(90)90060-N; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Banerji S, 2008, INT J MED MICROBIOL, V298, P169, DOI 10.1016/j.ijmm.2007.11.004; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Flieger A, 2004, INFECT IMMUN, V72, P2648, DOI 10.1128/IAI.72.5.2648-2658.2004; Fonseca Maris V., 2008, P213; Garduno RA, 2002, INFECT IMMUN, V70, P6273, DOI 10.1128/IAI.70.11.6273-6283.2002; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Glockner G, 2008, INT J MED MICROBIOL, V298, P411, DOI 10.1016/j.ijmm.2007.07.012; Greub G, 2003, RES MICROBIOL, V154, P619, DOI 10.1016/j.resmic.2003.08.003; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Heuner K, 2002, INFECT IMMUN, V70, P1604, DOI 10.1128/IAI.70.3.1604-1608.2002; Hoffman PS, 2008, INFEC AGENT, P113; Hoffman PS, 1984, P 2 INT S LEG, P61; KEEN MG, 1984, CURR MICROBIOL, V11, P81, DOI 10.1007/BF01567708; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Pearce MM, 2009, FEMS MICROBIOL LETT, V300, P256, DOI 10.1111/j.1574-6968.2009.01801.x; PINE L, 1979, J CLIN MICROBIOL, V9, P615; REEVES MW, 1981, J CLIN MICROBIOL, V13, P688, DOI 10.1128/JCM.13.4.688-695.1981; RISTROPH JD, 1981, J CLIN MICROBIOL, V13, P115, DOI 10.1128/JCM.13.1.115-119.1981; RISTROPH JD, 1980, J CLIN MICROBIOL, V11, P19, DOI 10.1128/JCM.11.1.19-21.1980; Sauer JD, 2005, P NATL ACAD SCI USA, V102, P9924, DOI 10.1073/pnas.0502767102; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Schunder E, 2010, INT J MED MICROBIOL, V300, P313, DOI 10.1016/j.ijmm.2010.01.002; Steinert M, 1997, APPL ENVIRON MICROB, V63, P2047, DOI 10.1128/AEM.63.5.2047-2053.1997; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; TESH MJ, 1981, J CLIN MICROBIOL, V13, P865, DOI 10.1128/JCM.13.5.865-869.1981; TESH MJ, 1983, J BACTERIOL, V154, P1104, DOI 10.1128/JB.154.3.1104-1109.1983; TESH MJ, 1982, CAN J MICROBIOL, V28, P1055, DOI 10.1139/m82-158; WEISS E, 1984, APPL ENVIRON MICROB, V48, P380, DOI 10.1128/AEM.48.2.380-385.1984; WEISS E, 1980, CURR MICROBIOL, V4, P1, DOI 10.1007/BF02602882; Wieland H, 2005, MOL MICROBIOL, V55, P1528, DOI 10.1111/j.1365-2958.2005.04490.x; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	40	75	75	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22232	22243		10.1074/jbc.M110.128678	http://dx.doi.org/10.1074/jbc.M110.128678			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20442401	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000279702200036
J	Hilliard, M; Frohnert, C; Spillner, C; Marcone, S; Nath, A; Lampe, T; Fitzgerald, DJ; Kehlenbach, RH				Hilliard, Mark; Frohnert, Cornelia; Spillner, Christiane; Marcone, Simone; Nath, Annegret; Lampe, Tina; Fitzgerald, Desmond J.; Kehlenbach, Ralph H.			The Anti-inflammatory Prostaglandin 15-Deoxy-Delta(12,14)-PGJ(2) Inhibits CRM1-dependent Nuclear Protein Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOPENTENONE PROSTAGLANDINS; PORE COMPLEX; LEPTOMYCIN-B; CRM1; J(2); IMPORT; BINDING; SIGNAL; TRANSPORT; RECEPTOR	The signaling molecule 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) has been described as the "anti-inflammatory prostaglandin." Here we show that substrates of the nuclear export receptor CRM1 accumulate in the nucleus in the presence of 15d-PGJ(2), identifying this prostaglandin as a regulator of CRM1-dependent nuclear protein export that can be produced endogenously. Like leptomycin B (LMB), an established fungal CRM1-inhibitor, 15d-PGJ(2) reacts with a conserved cysteine residue in the CRM1 sequence. This covalent modification prevents the formation of nuclear export complexes. Cells that are transfected with mutant CRM1(C528S) are resistant to the inhibitory effects of LMB and 15d-PGJ(2), demonstrating that the same single amino acid is targeted by the two compounds. Inhibition of the CRM1 pathway by endogenously produced prostaglandin and/or exogenously applied 15d-PGJ(2) may contribute to its anti-inflammatory, anti-proliferative, and anti-viral effects.	[Frohnert, Cornelia; Spillner, Christiane; Nath, Annegret; Lampe, Tina; Kehlenbach, Ralph H.] Univ Gottingen, Fac Med, Dept Biochem 1, D-37073 Gottingen, Germany; [Hilliard, Mark; Marcone, Simone; Fitzgerald, Desmond J.] UCD Conway Inst, Dublin 4, Ireland	University of Gottingen; University College Dublin	Kehlenbach, RH (corresponding author), Univ Gottingen, Fac Med, Dept Biochem 1, Humboldtallee 23, D-37073 Gottingen, Germany.	rkehlen@gwdg.de		Kehlenbach, Ralph/0000-0003-4920-9916; Marcone, Simone/0000-0001-5516-4000	Faculty of Medicine, Georg-August-University, Gottingen; Health Research Board of Ireland; Cancer Research Ireland	Faculty of Medicine, Georg-August-University, Gottingen; Health Research Board of Ireland; Cancer Research Ireland	This work was funded in part by a Research Program Grant, Faculty of Medicine, Georg-August-University, Gottingen ( to R.H.K.) and by the Health Research Board of Ireland and the Cancer Research Ireland (to D.J.F.).	Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Chemnitz J, 2010, IMMUNOBIOLOGY, V215, P370, DOI 10.1016/j.imbio.2009.05.008; Cox B, 2002, BBA-MOL CELL BIOL L, V1584, P37, DOI 10.1016/S1388-1981(02)00267-6; Daelemans D, 2002, P NATL ACAD SCI USA, V99, P14440, DOI 10.1073/pnas.212285299; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Kahle J, 2009, J BIOL CHEM, V284, P9382, DOI 10.1074/jbc.M805694200; Kehlenbach Ralph H, 2002, Methods Mol Biol, V189, P231; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Kehlenbach RH, 2001, J BIOL CHEM, V276, P14524, DOI 10.1074/jbc.M011087200; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Kondo M, 2001, J BIOL CHEM, V276, P12076, DOI 10.1074/jbc.M009630200; Koster M, 2003, EXP CELL RES, V286, P321, DOI 10.1016/S0014-4827(03)00100-9; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Meissner T, 2004, FEBS LETT, V576, P27, DOI 10.1016/j.febslet.2004.08.056; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Richards SA, 1996, J CELL BIOL, V134, P1157, DOI 10.1083/jcb.134.5.1157; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Ryan AJ, 2008, J BIOL CHEM, V283, P24628, DOI 10.1074/jbc.M801167200; Scher JU, 2005, CLIN IMMUNOL, V114, P100, DOI 10.1016/j.clim.2004.09.008; Schutz S, 2006, J MOL BIOL, V358, P997, DOI 10.1016/j.jmb.2006.02.041; SMITH WL, 1989, BIOCHEM J, V259, P315, DOI 10.1042/bj2590315; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006.abs; Turner JG, 2009, CANCER RES, V69, P6899, DOI 10.1158/0008-5472.CAN-09-0484; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Wang P, 2009, J CELL SCI, V122, P3772, DOI 10.1242/jcs.057026; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X	53	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22202	22210		10.1074/jbc.M110.131821	http://dx.doi.org/10.1074/jbc.M110.131821			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20457605	Green Published, hybrid			2022-12-25	WOS:000279702200033
J	Shirai, A; Sadaie, M; Shinmyozu, K; Nakayama, J				Shirai, Atsuko; Sadaie, Mahito; Shinmyozu, Kaori; Nakayama, Jun-ichi			Methylation of Ribosomal Protein L42 Regulates Ribosomal Function and Stress-adapted Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SET DOMAIN METHYLTRANSFERASE; YEAST SCHIZOSACCHAROMYCES-POMBE; MASS-SPECTROMETRIC ANALYSIS; HISTONE LYSINE METHYLATION; LIFE-SPAN EXTENSION; FISSION YEAST; TRANSFER-RNA; CYCLOHEXIMIDE RESISTANCE; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION	Lysine methylation is one of the most common protein modifications. Although lysine methylation of histones has been extensively studied and linked to gene regulation, that of nonhistone proteins remains incompletely understood. Here, we show a novel regulatory role of ribosomal protein methylation. Using an in vitro methyltransferase assay, we found that Schizosaccharomyces pombe Set13, a SET domain protein encoded by SPAC688.14, specifically methylates lysine 55 of ribosomal protein L42 (Rpl42). Mass spectrometric analysis revealed that endogenous Rpl42 is monomethylated at lysine 55 in wild-type S. pombe cells and that the methylation is lost in Delta set13 mutant cells. Delta set13 and Rpl42 methylation-deficient mutant S. pombe cells showed higher cycloheximide sensitivity and defects in stress-responsive growth control compared with wild type. Genetic analyses suggested that the abnormal growth phenotype was distinct from the conserved stress-responsive pathway that modulates translation initiation. Furthermore, the Rpl42 methylation-deficient mutant cells showed a reduced ability to survive after entering stationary phase. These results suggest that Rpl42 methylation plays direct roles in ribosomal function and cell proliferation control independently of the general stress-response pathway.	[Nakayama, Jun-ichi] RIKEN Ctr Dev Biol, Lab Chromatin Dynam, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Shinmyozu, Kaori] RIKEN Ctr Dev Biol, Prote Support Unit, Kobe, Hyogo 6500047, Japan; [Sadaie, Mahito] Canc Res UK, Cambridge Res Inst, Cambridge CB2 0RE, England	RIKEN; RIKEN; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Nakayama, J (corresponding author), RIKEN Ctr Dev Biol, Lab Chromatin Dynam, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	jnakayam@cdb.riken.jp	shirai, atsuko/C-5406-2017; Nakayama, Jun-ichi/C-6003-2011	shirai, atsuko/0000-0003-1344-4746; Nakayama, Jun-ichi/0000-0002-5597-8239	Ministry of Education, Culture, Sports, Science, and Technology of Japan; RIKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.; Supported by a Special Postdoctoral Researchers Program of RIKEN. Both authors contributed equally to this work.	Aguilera J, 2007, FEMS MICROBIOL REV, V31, P327, DOI 10.1111/j.1574-6976.2007.00066.x; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Baouz S, 2009, BIOCHIMIE, V91, P1420, DOI 10.1016/j.biochi.2009.07.013; Blaha G, 2008, J MOL BIOL, V379, P505, DOI 10.1016/j.jmb.2008.03.075; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Chen D, 2007, AGING CELL, V6, P525, DOI 10.1111/j.1474-9726.2007.00305.x; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Clarke SG, 2006, ENZYMES, V24, P1; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dunand-Sauthier I, 2005, EUKARYOT CELL, V4, P1785, DOI 10.1128/EC.4.11.1785-1793.2005; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Houtz RL, 2003, ARCH BIOCHEM BIOPHYS, V414, P150, DOI 10.1016/S0003-9861(03)00122-X; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; KAUFER NF, 1983, NUCLEIC ACIDS RES, V11, P3123; Kim JH, 2004, HEPATOLOGY, V39, P129, DOI 10.1002/hep.20017; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; LHOEST J, 1984, EUR J BIOCHEM, V141, P585, DOI 10.1111/j.1432-1033.1984.tb08233.x; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Morris SA, 2005, EUKARYOT CELL, V4, P1446, DOI 10.1128/EC.4.8.1446-1454.2005; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Odintsova TI, 2003, J PROTEIN CHEM, V22, P249, DOI 10.1023/A:1025068419698; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Sergiev PV, 2005, NUCLEIC ACIDS RES, V33, P6048, DOI 10.1093/nar/gki910; Shirai A, 2008, J BIOL CHEM, V283, P10745, DOI 10.1074/jbc.M709211200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Takaku H, 2004, J BIOL CHEM, V279, P23030, DOI 10.1074/jbc.M400888200; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Webb KJ, 2008, J BIOL CHEM, V283, P35561, DOI 10.1074/jbc.M806006200; Yu YH, 2005, PROTEIN SCI, V14, P1438, DOI 10.1110/ps.041293005	59	18	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22448	22460		10.1074/jbc.M110.132274	http://dx.doi.org/10.1074/jbc.M110.132274			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20444689	hybrid, Green Published			2022-12-25	WOS:000279702200057
J	Merrick, WC				Merrick, William C.			Eukaryotic Protein Synthesis: Still a Mystery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRANSLATION INITIATION-FACTORS; RNA SECONDARY STRUCTURE; MESSENGER-RNA; RIBOSOME; VIRUS; REGION; ROLES; CODON		Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Merrick, WC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	wcm2@case.edu						Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; CIGAN AM, 1988, SCIENCE, V242, P93, DOI 10.1126/science.3051379; Dmitriev SE, 2003, FEBS LETT, V533, P99, DOI 10.1016/S0014-5793(02)03776-6; Elroy-Stein O., 2007, TRANSLATIONAL CONTRO, P155; GODEFROYCOLBURN T, 1985, EUR J BIOCHEM, V147, P541; GODEFROYCOLBURN T, 1981, J BIOL CHEM, V256, P1762; Herr AJ, 2001, J MOL BIOL, V309, P1029, DOI 10.1006/jmbi.2001.4717; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; KOZAK M, 1980, CELL, V19, P79, DOI 10.1016/0092-8674(80)90390-6; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRUSE C, 1985, P NATL ACAD SCI USA, V82, P7515, DOI 10.1073/pnas.82.22.7515; MATHEWS MB, 2007, TRANSLATIONAL CONTRO; Merrick WC, 2003, BIOCHEM MOL BIOL EDU, V31, P378, DOI 10.1002/bmb.2003.494031060274; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; PARKIN NT, 1988, EMBO J, V7, P2831, DOI 10.1002/j.1460-2075.1988.tb03139.x; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; PELLETIER J, 1987, BIOCHEM CELL BIOL, V65, P576, DOI 10.1139/o87-074; PELLETIER J, 1988, MOL CELL BIOL, V8, P1103, DOI 10.1128/MCB.8.3.1103; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Singh CR, 2006, EMBO J, V25, P4537, DOI 10.1038/sj.emboj.7601339; Svitkin YV, 2001, RNA, V7, P1743; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Yueh A, 2000, GENE DEV, V14, P414	25	44	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21197	21201		10.1074/jbc.R110.111476	http://dx.doi.org/10.1074/jbc.R110.111476			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444697	Green Published, hybrid			2022-12-25	WOS:000279516100002
J	Coffinier, C; Jung, HJ; Li, ZW; Nobumori, C; Yun, UJ; Farber, EA; Davies, BS; Weinstein, MM; Yang, SH; Lammerding, J; Farahani, JN; Bentolila, LA; Fong, LG; Young, SG				Coffinier, Catherine; Jung, Hea-Jin; Li, Ziwei; Nobumori, Chika; Yun, Ui Jeong; Farber, Emily A.; Davies, Brandon S.; Weinstein, Michael M.; Yang, Shao H.; Lammerding, Jan; Farahani, Javad N.; Bentolila, Laurent A.; Fong, Loren G.; Young, Stephen G.			Direct Synthesis of Lamin A, Bypassing Prelamin A Processing, Causes Misshapen Nuclei in Fibroblasts but No Detectable Pathology in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUTCHINSON-GILFORD PROGERIA; MUSCULAR-DYSTROPHY; ZMPSTE24-DEFICIENT MICE; RESTRICTIVE DERMOPATHY; DISEASE PHENOTYPES; SYNDROME MUTATION; A PRECURSOR; MOUSE MODEL; ZMPSTE24; GENE	Lamin A, a key component of the nuclear lamina, is generated from prelamin A by four post-translational processing steps: farnesylation, endoproteolytic release of the last three amino acids of the protein, methylation of the C-terminal farnesylcysteine, and finally, endoproteolytic release of the last 15 amino acids of the protein (including the farnesylcysteine methyl ester). The last cleavage step, mediated by ZMPSTE24, releases mature lamin A. This processing scheme has been conserved through vertebrate evolution and is widely assumed to be crucial for targeting lamin A to the nuclear envelope. However, its physiologic importance has never been tested. To address this issue, we created mice with a "mature lamin A-only" allele (Lmna(LAO)), which contains a stop codon immediately after the last codon of mature lamin A. Thus, Lmna(LAO/LAO) mice synthesize mature lamin A directly, bypassing prelamin A synthesis and processing. The levels of mature lamin A in Lmna(LAO/LAO) mice were indistinguishable from those in "prelamin A-only" mice (Lmna(PLAO/PLAO)), where all of the lamin A is produced from prelamin A. Lmna(LAO/LAO) exhibited normal body weights and had no detectable disease phenotypes. A higher frequency of nuclear blebs was observed in Lmna(LAO/LAO) embryonic fibroblasts; however, the mature lamin A in the tissues of Lmna(LAO/LAO) mice was positioned normally at the nuclear rim. We conclude that prelamin A processing is dispensable in mice and that direct synthesis of mature lamin A has little if any effect on the targeting of lamin A to the nuclear rim in mouse tissues.	[Coffinier, Catherine; Jung, Hea-Jin; Li, Ziwei; Nobumori, Chika; Yun, Ui Jeong; Farber, Emily A.; Davies, Brandon S.; Weinstein, Michael M.; Yang, Shao H.; Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Weinstein, Michael M.; Young, Stephen G.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Bentolila, Laurent A.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Farahani, Javad N.; Bentolila, Laurent A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Lammerding, Jan] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Cambridge, MA 02139 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital	Coffinier, C (corresponding author), 695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	coffinie@ucla.edu	Bentolila, Laurent/L-5535-2019; Lammerding, Jan/A-9498-2016	Lammerding, Jan/0000-0003-4335-8611; Young, Stephen/0000-0001-7270-3176; Davies, Brandon/0000-0002-7168-8522	National Institutes of Health [AG035626, HL76839, HL86683, GM66152, HL082792, NS059348]; March of Dimes [6-FY2007-1012]; Ellison Medical Foundation; American Heart Association [0835489N, 0635359N]; American Heart Association, Western States Affiliate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082792, R01HL076839, R01HL086683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Ellison Medical Foundation(Lawrence Ellison Foundation); American Heart Association(American Heart Association); American Heart Association, Western States Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG035626, HL76839, HL86683, GM66152, HL082792, and NS059348. This work was also supported by March of Dimes Grant 6-FY2007-1012, the Ellison Medical Foundation Senior Scholar Program, two American Heart Association Scientist Development Grants 0835489N and 0635359N, and a postdoctoral fellowship award from the American Heart Association, Western States Affiliate.	Ambroziak P., 2001, ENZYMES, P155; BECK LA, 1990, J CELL BIOL, V110, P1489, DOI 10.1083/jcb.110.5.1489; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Caron M, 2003, AIDS, V17, P2437, DOI 10.1097/00002030-200311210-00005; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; DAVIES BS, 2010, HUM MOL GEN IN PRESS; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; HENNEKES H, 1994, J CELL SCI, V107, P1019; HOLTZ D, 1989, CELL, V59, P969, DOI 10.1016/0092-8674(89)90753-8; JOYNER AL, 1989, NATURE, V338, P153, DOI 10.1038/338153a0; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lee R, 2010, HUM MOL GENET, V19, P1603, DOI 10.1093/hmg/ddq036; Leung GK, 2001, J BIOL CHEM, V276, P29051, DOI 10.1074/jbc.M102908200; LIN F, 1993, J BIOL CHEM, V268, P16321; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Muchir A, 2004, MUSCLE NERVE, V30, P444, DOI 10.1002/mus.20122; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Rusinol AE, 2006, J CELL SCI, V119, P3265, DOI 10.1242/jcs.03156; SINENSKY M, 1994, J CELL SCI, V107, P61; STEINERT P, 1982, METHOD CELL BIOL, V24, P399; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; VORBURGER K, 1989, EMBO J, V8, P4007, DOI 10.1002/j.1460-2075.1989.tb08583.x; Wang Y, 2008, HUM MOL GENET, V17, P2357, DOI 10.1093/hmg/ddn136; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2008, J BIOL CHEM, V283, P7094, DOI 10.1074/jbc.M708138200; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	43	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20818	20826		10.1074/jbc.M110.128835	http://dx.doi.org/10.1074/jbc.M110.128835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439468	Green Published, hybrid			2022-12-25	WOS:000279228600045
J	Kunderfranco, P; Mello-Grand, M; Cangemi, R; Pellini, S; Mensah, A; Albertini, V; Malek, A; Chiorino, G; Catapano, CV; Carbone, GM				Kunderfranco, Paolo; Mello-Grand, Maurizia; Cangemi, Romina; Pellini, Stefania; Mensah, Afua; Albertini, Veronica; Malek, Anastasia; Chiorino, Giovanna; Catapano, Carlo V.; Carbone, Giuseppina M.			ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer	PLOS ONE			English	Article							GROUP PROTEIN EZH2; MAMMARY EPITHELIAL-CELLS; TARGET GENES; STEM-CELLS; EXPRESSION; ACTIVATION; DIFFERENTIATION; METHYLATION; PROGRESSION; FUSIONS	Background: ETS transcription factors regulate important signaling pathways involved in cell differentiation and development in many tissues and have emerged as important players in prostate cancer. However, the biological impact of ETS factors in prostate tumorigenesis is still debated. Methodology/Principal Findings: We performed an analysis of the ETS gene family using microarray data and real-time PCR in normal and tumor tissues along with functional studies in normal and cancer cell lines to understand the impact in prostate tumorigenesis and identify key targets of these transcription factors. We found frequent dysregulation of ETS genes with oncogenic (i.e., ERG and ESE1) and tumor suppressor (i.e., ESE3) properties in prostate tumors compared to normal prostate. Tumor subgroups (i.e., ERG(high), ESE1(high), ESE3(low) and NoETS tumors) were identified on the basis of their ETS expression status and showed distinct transcriptional and biological features. ERG(high) and ESE3(low) tumors had the most robust gene signatures with both distinct and overlapping features. Integrating genomic data with functional studies in multiple cell lines, we demonstrated that ERG and ESE3 controlled in opposite direction transcription of the Polycomb Group protein EZH2, a key gene in development, differentiation, stem cell biology and tumorigenesis. We further demonstrated that the prostate-specific tumor suppressor gene Nkx3.1 was controlled by ERG and ESE3 both directly and through induction of EZH2. Conclusions/Significance: These findings provide new insights into the role of the ETS transcriptional network in prostate tumorigenesis and uncover previously unrecognized links between aberrant expression of ETS factors, deregulation of epigenetic effectors and silencing of tumor suppressor genes. The link between aberrant ETS activity and epigenetic gene silencing may be relevant for the clinical management of prostate cancer and design of new therapeutic strategies.	[Kunderfranco, Paolo; Cangemi, Romina; Pellini, Stefania; Mensah, Afua; Albertini, Veronica; Malek, Anastasia; Catapano, Carlo V.; Carbone, Giuseppina M.] Oncol Inst So Switzerland, Expt Oncol Lab, Bellinzona, Switzerland; [Mello-Grand, Maurizia; Chiorino, Giovanna] Fondo Edo Tempia, Lab Canc Genom, Biella, Italy	Institute of Oncology Research (IOR)	Kunderfranco, P (corresponding author), Oncol Inst So Switzerland, Expt Oncol Lab, Bellinzona, Switzerland.	pina.carbone@irb.unisi.ch	Malek, Anastasia V/R-8804-2016; Kunderfranco, Paolo/J-7636-2016; Chiorino, Giovanna/K-5037-2016; Kunderfranco, Paolo/GUQ-8968-2022; Kunderfranco, Paolo/ABH-9294-2020	Malek, Anastasia V/0000-0001-5334-7292; Kunderfranco, Paolo/0000-0003-3636-3391; Chiorino, Giovanna/0000-0002-9502-6400; Kunderfranco, Paolo/0000-0001-7477-8710; Kunderfranco, Paolo/0000-0001-7477-8710; Mensah, Afua Adjeiwaa/0000-0001-8113-3689; Catapano, Carlo V./0000-0002-7079-557X	Oncosuisse [OCS-01913-08]; Swiss National Science Foundation [FNS-31003A-118113]; Ticino Foundation for Cancer Research; Compagnia di San Paolo, Torino, Italy	Oncosuisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ticino Foundation for Cancer Research; Compagnia di San Paolo, Torino, Italy(Compagnia di San Paolo)	This work was supported by grants from Oncosuisse (OCS-01913-08), Swiss National Science Foundation (FNS-31003A-118113) and Ticino Foundation for Cancer Research to GMC. MGM and CG were supported by Compagnia di San Paolo, Torino, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Bryant RJ, 2008, PROSTATE, V68, P255, DOI 10.1002/pros.20705; Cangemi R, 2008, ONCOGENE, V27, P2877, DOI 10.1038/sj.onc.1210953; CAO Q, 2008, ONCOGENE; Carbone GM, 2003, NUCLEIC ACIDS RES, V31, P833, DOI 10.1093/nar/gkg198; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Ekins S, 2007, METH MOL B, V356, P319; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Gu XS, 2007, CANCER RES, V67, P4219, DOI 10.1158/0008-5472.CAN-06-3689; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Iljin K, 2006, CANCER RES, V66, P10242, DOI 10.1158/0008-5472.CAN-06-1986; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Markowski MC, 2008, CANCER RES, V68, P6896, DOI 10.1158/0008-5472.CAN-08-0578; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Napoli S, 2009, EMBO J, V28, P1708, DOI 10.1038/emboj.2009.139; Prescott JD, 2004, MOL CELL BIOL, V24, P5548, DOI 10.1128/MCB.24.12.5548-5564.2004; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Schedin PJ, 2004, ONCOGENE, V23, P1766, DOI 10.1038/sj.onc.1207391; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhang J, 2009, ANIMAL, V3, P1, DOI [10.1017/S1751731108003054, 10.1109/ISDRS.2009.5378133]; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	47	103	107	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10547	10.1371/journal.pone.0010547	http://dx.doi.org/10.1371/journal.pone.0010547			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479932	Green Submitted, gold, Green Published			2022-12-25	WOS:000277467900005
J	Lu, R; Wu, SP; Liu, XY; Xia, YL; Zhang, YG; Sun, J				Lu, Rong; Wu, Shaoping; Liu, Xingyin; Xia, Yinglin; Zhang, Yong-Guo; Sun, Jun			Chronic Effects of a Salmonella Type III Secretion Effector Protein AvrA In Vivo	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM COLITIS; NF-KAPPA-B; HOST-CELLS; MICE; INFECTION; BACTERIA; CANCER; INFLAMMATION; ACTIVATION; RESPONSES	Background: Salmonella infection is a common public health problem that can become chronic and increase the risk of inflammatory bowel diseases and cancer. AvrA is a Salmonella bacterial type III secretion effector protein. Increasing evidence demonstrates that AvrA is a multi-functional enzyme with critical roles in inhibiting inflammation, regulating apoptosis, and enhancing proliferation. However, the chronic effects of Salmonella and effector AvrA in vivo are still unknown. Moreover, alive, mutated, non-invasive Salmonella is used as a vector to specifically target cancer cells. However, studies are lacking on chronic infection with non-pathogenic or mutated Salmonella in the host. Methods/Principal Findings: We infected mice with Salmonella Typhimurium for 27 weeks and investigated the physiological effects as well as the role of AvrA in intestinal inflammation. We found altered body weight, intestinal pathology, and bacterial translocation in spleen, liver, and gallbladder in chronically Salmonella-infected mice. Moreover, AvrA suppressed intestinal inflammation and inhibited the secretion of cytokines IL-12, IFN-gamma, and TNF-alpha. AvrA expression in Salmonella enhanced its invasion ability. Liver abscess and Salmonella translocation in the gallbladder were observed and may be associated with AvrA expression in Salmonella. Conclusion/Significance: We created a mouse model with persistent Salmonella infection in vivo. Our study further emphasizes the importance of the Salmonella effector protein AvrA in intestinal inflammation, bacterial translocation, and chronic infection in vivo.	[Lu, Rong; Wu, Shaoping; Liu, Xingyin; Zhang, Yong-Guo; Sun, Jun] Univ Rochester, Dept Med, Rochester, NY 14627 USA; [Xia, Yinglin] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA; [Sun, Jun] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA; [Sun, Jun] Univ Rochester, Wilmot Canc Ctr, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Lu, R (corresponding author), Univ Rochester, Dept Med, Rochester, NY 14627 USA.	jun_sun@urmc.rochester.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133; Liu, Xingyin/0000-0001-8770-3494	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [KO1 DK075386]; American Cancer Society [RSG-09-075-01-MBC]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK075386] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) KO1 DK075386 and American Cancer Society Research Scholar Award RSG-09-075-01-MBC to Jun Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrach N, 2008, CANCER RES, V68, P4827, DOI 10.1158/0008-5472.CAN-08-0552; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Broberg CA, 2010, CURR OPIN MICROBIOL, V13, P34, DOI 10.1016/j.mib.2009.12.004; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Darveau R, 1999, NAT BIOTECHNOL, V17, P19, DOI 10.1038/5188; Du FY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000595; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 2007, CELL, V130, P192, DOI 10.1016/j.cell.2007.06.042; GAST RK, 2004, AVIAN DIS, V18, P863; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Grassl GA, 2008, GASTROENTEROLOGY, V134, P768, DOI 10.1053/j.gastro.2007.12.043; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; JEAMS AR, 2007, TRAVEL MED INFECT DI, V5, P144; Jimenez-Saenz M, 2001, EUR J GASTROEN HEPAT, V13, P587; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; Kumar S, 2006, J SURG ONCOL, V93, P633, DOI 10.1002/jso.20530; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; LIU X, FEBS LETT, V584, P911; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Okamura M, 2001, AVIAN DIS, V45, P61, DOI 10.2307/1593012; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Siccardi D, 2008, AM J PHYSIOL-GASTR L, V294, pG1392, DOI 10.1152/ajpgi.00599.2007; Sun J, 2005, AM J PHYSIOL-GASTR L, V289, pG129, DOI 10.1152/ajpgi.00515.2004; Sun J, 2004, AM J PHYSIOL-GASTR L, V287, pG220, DOI 10.1152/ajpgi.00498.2003; Valdez Y, 2008, CELL MICROBIOL, V10, P1646, DOI 10.1111/j.1462-5822.2008.01155.x; Vidal José E., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P115; Woo H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001603; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104	42	51	54	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10505	10.1371/journal.pone.0010505	http://dx.doi.org/10.1371/journal.pone.0010505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463922	Green Submitted, gold, Green Published			2022-12-25	WOS:000277379400036
J	Fadaee-Shohada, MJ; Hirst, RA; Rutman, A; Roberts, IS; O'Callaghan, C; Andrew, PW				Fadaee-Shohada, Mina J.; Hirst, Robert A.; Rutman, Andrew; Roberts, Ian S.; O'Callaghan, Chris; Andrew, Peter W.			The Behaviour of Both Listeria monocytogenes and Rat Ciliated Ependymal Cells Is Altered during Their Co-Culture	PLOS ONE			English	Article							VIRULENCE GENES; BEAT FREQUENCY; PRFA; BRAIN; MENINGOENCEPHALITIS; ULTRASTRUCTURE; IDENTIFICATION; HYDROCEPHALUS; PNEUMOLYSIN; INFECTIONS	Background: Ciliated ependymal cells line the cerebral ventricles and aqueducts separating the infected CSF from the brain parenchyma in meningitis. Principal Findings: Investigation of the interaction of Listeria monocytogenes with cultured rat brain ependymal cells showed that certain strains reduced the beat frequency of the cilia but all the strains studied significantly reduced the ciliary beat amplitude (the linear distance travelled by the tip of each cilium per beat cycle). Conclusion: The presence of the ependyma caused aggregation of some listeria strains and in some cases extracellular material also was seen in association with bacterial aggregates. These observations were dependent on the expression of genes required for invasion, intracellular survival and listerial cell to cell spread that are regulated by the transcriptional activator, positive regulatory factor A (PrfA).	[Fadaee-Shohada, Mina J.; Hirst, Robert A.; Rutman, Andrew; O'Callaghan, Chris; Andrew, Peter W.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Roberts, Ian S.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Leicester; University of Manchester	Fadaee-Shohada, MJ (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	sam20@le.ac.uk	Hirst, Robert/AAD-1649-2022; Andrew, Peter W/G-7526-2012	Hirst, Robert Anthony/0000-0003-1989-1790	Children's Research Fund; MRC [G0601205] Funding Source: UKRI; Medical Research Council [G0601205] Funding Source: researchfish	Children's Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was kindly supported by the Children's Research Fund (http://www.childrensresearchfund.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriao A, 2008, INT J FOOD MICROBIOL, V123, P142, DOI 10.1016/j.ijfoodmicro.2007.12.016; Allegrucci M, 2006, J BACTERIOL, V188, P2325, DOI 10.1128/JB.188.7.2325-2335.2006; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Borucki MK, 2003, APPL ENVIRON MICROB, V69, P7336, DOI 10.1128/AEM.69.12.7336-7342.2003; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chilvers MA, 2000, THORAX, V55, P314, DOI 10.1136/thorax.55.4.314; Chilvers MA, 2003, THORAX, V58, P333, DOI 10.1136/thorax.58.4.333; Deckert M, 2001, INFECT IMMUN, V69, P4561, DOI 10.1128/IAI.69.7.4561-4571.2001; DELBIGIO MR, 1995, GLIA, V14, P1, DOI 10.1002/glia.440140102; Drevets DA, 2004, CLIN MICROBIOL REV, V17, P323, DOI 10.1128/CMR.17.2.323-347.2004; Freitag NE, 2006, FUTURE MICROBIOL, V1, P89, DOI 10.2217/17460913.1.1.89; FREITAG NE, 1993, INFECT IMMUN, V61, P2537, DOI 10.1128/IAI.61.6.2537-2544.1993; FREITAG NE, 1992, J BACTERIOL, V174, P1293, DOI 10.1128/jb.174.4.1293-1298.1992; Glaser P, 2001, SCIENCE, V294, P849; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hirst RA, 2000, PEDIATR RES, V47, P381, DOI 10.1203/00006450-200003000-00016; HULTGREN SJ, 1985, INFECT IMMUN, V50, P370, DOI 10.1128/IAI.50.2.370-377.1985; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; JOHNSON NT, 1991, AM REV RESPIR DIS, V144, P1091, DOI 10.1164/ajrccm/144.5.1091; JURADO RL, 1993, CLIN INFECT DIS, V17, P224, DOI 10.1093/clinids/17.2.224; Kreft J, 2001, INT J MED MICROBIOL, V291, P145, DOI 10.1078/1438-4221-00111; LEIMEISTERWACHTER M, 1990, P NATL ACAD SCI USA, V87, P8336, DOI 10.1073/pnas.87.21.8336; Marr AK, 2006, J BACTERIOL, V188, P3887, DOI 10.1128/JB.01978-05; Marsh EJ, 2003, FEMS MICROBIOL LETT, V228, P203, DOI 10.1016/S0378-1097(03)00752-3; McLauchlin J, 1997, REV MED MICROBIOL, V8, P1; MENGAUD J, 1991, MOL MICROBIOL, V5, P2273, DOI 10.1111/j.1365-2958.1991.tb02158.x; Michelet C, 1999, ANTIMICROB AGENTS CH, V43, P1651, DOI 10.1128/AAC.43.7.1651; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Mohammed BJ, 1999, MICROB PATHOGENESIS, V27, P303, DOI 10.1006/mpat.1999.0306; Monkkonen KS, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-26; Mueller KJ, 2005, INFECT IMMUN, V73, P1917, DOI 10.1128/IAI.73.4.1917-1926.2005; Murray EGD, 1926, J PATHOL BACTERIOL, V29, P407, DOI 10.1002/path.1700290409; O'Callaghan CL, 2008, NEUROSCI LETT, V439, P56, DOI 10.1016/j.neulet.2008.04.095; PICCO P, 1993, EUR J PEDIATR SURG, V3, P20; Remer KA, 2001, INFECT IMMUN, V69, P4086, DOI 10.1128/IAI.69.6.4086-4093.2001; RUBINO S, 1993, INFECT IMMUN, V61, P1786, DOI 10.1128/IAI.61.5.1786-1792.1993; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; SEELIGER DJH, 1986, GENUS LISTERIA, P1235; SHIMIZU A, 1992, CHILD NERV SYST, V8, P25, DOI 10.1007/BF00316558; Stewart PS, 2001, TRENDS MICROBIOL, V9, P204, DOI 10.1016/S0966-842X(01)01983-7; WEIBEL M, 1986, DEV BRAIN RES, V25, P199, DOI 10.1016/0165-3806(86)90209-9	42	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10450	10.1371/journal.pone.0010450	http://dx.doi.org/10.1371/journal.pone.0010450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454610	Green Published, gold, Green Submitted			2022-12-25	WOS:000277305300003
J	Harma, V; Virtanen, J; Makela, R; Happonen, A; Mpindi, JP; Knuuttila, M; Kohonen, P; Lotjonen, J; Kallioniemi, O; Nees, M				Harma, Ville; Virtanen, Johannes; Makela, Rami; Happonen, Antti; Mpindi, John-Patrick; Knuuttila, Matias; Kohonen, Pekka; Lotjonen, Jyrki; Kallioniemi, Olli; Nees, Matthias			A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION SIGNATURE; TUMOR-CELL INVASION; STEM-CELLS; BREAST-CANCER; MAMMARY EPITHELIA; CULTURE MODEL; METASTASIS; LINES; DIFFERENTIATION	Prostate epithelial cells from both normal and cancer tissues, grown in three-dimensional (3D) culture as spheroids, represent promising in vitro models for the study of normal and cancer-relevant patterns of epithelial differentiation. We have developed the most comprehensive panel of miniaturized prostate cell culture models in 3D to date (n = 29), including many non-transformed and most currently available classic prostate cancer (PrCa) cell lines. The purpose of this study was to analyze morphogenetic properties of PrCa models in 3D, to compare phenotypes, gene expression and metabolism between 2D and 3D cultures, and to evaluate their relevance for pre-clinical drug discovery, disease modeling and basic research. Primary and non-transformed prostate epithelial cells, but also several PrCa lines, formed well-differentiated round spheroids. These showed strong cell-cell contacts, epithelial polarization, a hollow lumen and were covered by a complete basal lamina (BL). Most PrCa lines, however, formed large, poorly differentiated spheroids, or aggressively invading structures. In PC-3 and PC-3M cells, well-differentiated spheroids formed, which were then spontaneously transformed into highly invasive cells. These cell lines may have previously undergone an epithelial-to-mesenchymal transition (EMT), which is temporarily suppressed in favor of epithelial maturation by signals from the extracellular matrix (ECM). The induction of lipid and steroid metabolism, epigenetic reprogramming, and ECM remodeling represents a general adaptation to 3D culture, regardless of transformation and phenotype. In contrast, PI3-Kinase, AKT, STAT/interferon and integrin signaling pathways were particularly activated in invasive cells. Specific small molecule inhibitors targeted against PI3-Kinase blocked invasive cell growth more effectively in 3D than in 2D monolayer culture, or the growth of normal cells. Our panel of cell models, spanning a wide spectrum of phenotypic plasticity, supports the investigation of different modes of cell migration and tumor morphologies, and will be useful for predictive testing of anti-cancer and anti-metastatic compounds.	[Harma, Ville; Makela, Rami; Nees, Matthias] VTT Tech Res Ctr Finland, Med Biotechnol Knowledge Ctr, Turku, Finland; [Happonen, Antti; Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Knowledge Intens Serv, Turku, Finland; [Virtanen, Johannes; Mpindi, John-Patrick; Knuuttila, Matias; Kohonen, Pekka] Univ Turku, Ctr Biotechnol, Turku, Finland; [Kallioniemi, Olli] Univ Helsinki, FIMM, Helsinki, Finland	VTT Technical Research Center Finland; VTT Technical Research Center Finland; University of Turku; University of Helsinki	Harma, V (corresponding author), VTT Tech Res Ctr Finland, Med Biotechnol Knowledge Ctr, Turku, Finland.	matthias.nees@vtt.fi	Kohonen, Pekka/F-9596-2011; Nees, Matthias/AAT-5577-2020; Happonen, Antti/M-7644-2014; Nees, Matthias/W-6596-2018; Kallioniemi, Olli P/H-5111-2011	Kohonen, Pekka/0000-0002-7845-3611; Nees, Matthias/0000-0002-9034-301X; Kallioniemi, Olli P/0000-0002-3231-0332; Knuuttila, Matias/0000-0002-9953-5755; Harma, Ville/0000-0001-5767-5226	Finnish Academy [111597]; European commission	Finnish Academy(Academy of Finland); European commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by a grant of the Finnish Academy to MN (No. 111597). Additional funding to OK and JV was provided by FP6 and FP7 Integrated Projects PRIMA and EPITRON of the European commission. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz J, 2008, EMBO J, V27, P2829, DOI 10.1038/emboj.2008.206; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; Bissell Mina, 2009, J Cell Biol, V185, P374, DOI 10.1083/jcb.1853pi; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bjorkman M, 2008, INT J CANCER, V123, P2774, DOI 10.1002/ijc.23885; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; Carmona-Fontaine C, 2008, CELL ADHES MIGR, V2, P240, DOI 10.4161/cam.2.4.6747; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Chu JH, 2009, PROSTATE, V69, P428, DOI 10.1002/pros.20897; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Fournier MV, 2006, CANCER RES, V66, P7095, DOI 10.1158/0008-5472.CAN-06-0515; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Han J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000684; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kawano Y, 2009, BRIT J CANCER, V100, P1165, DOI 10.1038/sj.bjc.6604976; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Leivonen SK, 2009, ONCOGENE, V28, P3926, DOI 10.1038/onc.2009.241; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shah GV, 2009, J BIOL CHEM, V284, P1018, DOI 10.1074/jbc.M807823200; Simian M, 2001, DEVELOPMENT, V128, P3117; Spencer VA, 2010, J MAMMARY GLAND BIOL, V15, P65, DOI 10.1007/s10911-010-9163-3; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; Suzuki K, 2006, UROLOGY, V67, P647, DOI 10.1016/j.urology.2005.10.013; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Wallerand H, 2010, UROL ONCOL-SEMIN ORI, V28, P473, DOI 10.1016/j.urolonc.2008.12.018; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang SY, 2009, METHODS MOL BIOL, V568, P151, DOI 10.1007/978-1-59745-280-9_9; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850	65	248	256	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10431	10.1371/journal.pone.0010431	http://dx.doi.org/10.1371/journal.pone.0010431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454659	Green Published, gold			2022-12-25	WOS:000277240300008
J	Karner, CM; Dietrich, MF; Johnson, EB; Kappesser, N; Tennert, C; Percin, F; Wollnik, B; Carroll, TJ; Herz, J				Karner, Courtney M.; Dietrich, Martin F.; Johnson, Eric B.; Kappesser, Natalie; Tennert, Christian; Percin, Ferda; Wollnik, Bernd; Carroll, Thomas J.; Herz, Joachim			Lrp4 Regulates Initiation of Ureteric Budding and Is Crucial for Kidney Formation - A Mouse Model for Cenani-Lenz Syndrome	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; UROGENITAL SYSTEM; IN-VIVO; MICE; MUTATION; ORGANOGENESIS; EXPRESSION; RECEPTOR; PAX-2; GENE	Background: Development of the kidney is initiated when the ureteric bud (UB) branches from the Wolffian duct and invades the overlying metanephric mesenchyme (MM) triggering the mesenchymal/epithelial interactions that are the basis of organ formation. Multiple signaling pathways must be integrated to ensure proper timing and location of the ureteric bud formation. Methods and Principal Findings: We have used gene targeting to create an Lrp4 null mouse line. The mutation results in early embryonic lethality with a subpenetrant phenotype of kidney agenesis. Ureteric budding is delayed with a failure to stimulate the metanephric mesenchyme in a timely manner, resulting in failure of cellular differentiation and resulting absence of kidney formation in the mouse as well as comparable malformations in humans with Cenani-Lenz syndrome. Conclusion: Lrp4 is a multi-functional receptor implicated in the regulation of several molecular pathways, including Wnt and Bmp signaling. Lrp4(-/-) mice show a delay in ureteric bud formation that results in unilateral or bilateral kidney agenesis. These data indicate that Lrp4 is a critical regulator of UB branching and lack of Lrp4 results in congenital kidney malformations in humans and mice.	[Karner, Courtney M.; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Dietrich, Martin F.; Johnson, Eric B.; Kappesser, Natalie; Tennert, Christian; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Percin, Ferda] Gazi Univ, Fac Med, Dept Med Genet, Ankara, Turkey; [Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, CMMC, Cologne, Germany; [Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Inst Human Genet, Cologne, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Gazi University; University of Cologne; University of Cologne	Karner, CM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	joachim.herz@utsouthwestern.edu	Percin, Ferda E/H-6850-2016; Wollnik, Bernd/GRY-6062-2022	Percin, Ferda E/0000-0001-9317-8155; Wollnik, Bernd/0000-0003-2589-0364; Karner, Courtney/0000-0003-0387-4486	Boehringer Ingelheim Foundation; German Federal Ministry of Education and Research (BMBF) [01GM0880, 01GM0801]; National Institutes of Health; American Health Assistance Foundation; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER	Boehringer Ingelheim Foundation(Boehringer Ingelheim); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	M.F.D. is supported by a fellowship from the Boehringer Ingelheim Foundation. B. W. was supported by the German Federal Ministry of Education and Research (BMBF) by grant number 01GM0880 (SKELNET) and 01GM0801 (E-RARE network CRANIRARE). J.H. is supported by grants from the National Institutes of Health, the American Health Assistance Foundation, and the Perot Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates CM, 2000, MOL GENET METAB, V71, P391, DOI 10.1006/mgme.2000.3072; Blank U, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-86; Bridgewater D, 2009, PEDIATR NEPHROL, V24, P1611, DOI 10.1007/s00467-008-1048-y; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; DRESSLER GR, 1993, NATURE, V362, P65, DOI 10.1038/362065a0; Favor J, 1996, P NATL ACAD SCI USA, V93, P13870, DOI 10.1073/pnas.93.24.13870; Gluecksohn-Schoenheimer S, 1943, GENETICS, V28, P341; GLUECKSOHNSCHOENHEIMER S, 1945, GENETICS, V30, P29; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Johnson EB, 2006, GENOMICS, V88, P600, DOI 10.1016/j.ygeno.2006.08.005; Kispert A, 1996, DEVELOPMENT, V122, P3627; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; LI Y, 2010, AM J HUM GEN UNPUB; Lipschutz JH, 1998, AM J KIDNEY DIS, V31, P383, DOI 10.1053/ajkd.1998.v31.pm9506676; Lu PF, 2006, J MAMMARY GLAND BIOL, V11, P213, DOI 10.1007/s10911-006-9027-z; MAAS R, 1994, DEV DYNAM, V199, P214, DOI 10.1002/aja.1001990306; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; PHELPS DE, 1993, DEV BIOL, V157, P251, DOI 10.1006/dbio.1993.1129; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Sampogna RV, 2004, PHYSIOLOGY, V19, P339, DOI 10.1152/physiol.00025.2004; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; Shakya R, 2005, DEV BIOL, V283, P70, DOI 10.1016/j.ydbio.2005.04.008; Tomita Y, 1998, J BIOCHEM-TOKYO, V124, P784, DOI 10.1093/oxfordjournals.jbchem.a022180; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696	31	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10418	10.1371/journal.pone.0010418	http://dx.doi.org/10.1371/journal.pone.0010418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454682	Green Published, Green Submitted, gold			2022-12-25	WOS:000277240100024
J	Cool, BH; Chan, GCK; Lee, L; Oshima, J; Martin, GM; Hu, QB				Cool, Bethany H.; Chan, Guy C-K.; Lee, Lin; Oshima, Junko; Martin, George M.; Hu, Qubai			A Flanking Gene Problem Leads to the Discovery of a Gprc5b Splice Variant Predominantly Expressed in C57Bl/6J Mouse Brain and in Maturing Neurons	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; METABOTROPIC GLUTAMATE RECEPTORS; QUANTITATIVE TRAIT LOCI; ALZHEIMERS-DISEASE; RAT-BRAIN; FE65; COMPLEX; DOMAIN; CELLS; ORGANIZATION	Background: Gprc5b, a retinoic acid-inducible orphan G protein-coupled receptor (GPCR), is a member of the group C metabotropic glutamate receptor family proteins possibly involved in non-canonical Wnt signaling. Many GPCR transcripts are alternatively spliced, which diversifies this class of proteins in their cell-and tissue-specific signaling, regulatory and/or pharmacological properties. We previously generated p97FE65 isoform-specific knockout mice that showed learning/memory deficits. In this study, we further characterized the 97FE65 null mice using cDNA microarray and RT-PCR analyses. Methodology/Principal Findings: We discovered a novel brain-specific C-terminal splice variant of Gprc5b, Gprc5b_v2, which was differentially expressed in p97FE65 wild type and null mouse brains. The null mice were generated in 129/Sv ES cells, and backcrossed to C57Bl/6J for ten generations. We found that expression of Gprc5b_v2 mRNA in the brains of p97FE65 null mice was dramatically down-regulated (more than 20 fold) compared to their wild type littermates. However, expression profiles of Gprc5b variants and SNP analysis surrounding the FE65 locus suggest that the down-regulation is unlikely due to the altered FE65 function, but rather is caused by gene retention from the 129/Sv ES cells. Consistently, in contrast to ubiquitously expressed Gprc5b_v1, Gprc5b_v2 was predominantly expressed in the brain tissues of C57Bl/6J mice. The alternative splicing of the 39 terminal exon also altered the protein coding sequences, giving rise to the characteristic C-termini. Levels of Gprc5b_v2 mRNA were increased during neuronal maturation, paralleling the expression of synaptic proteins. Overexpression of both Gprc5b variants stimulated neurite-like outgrowth in a neuroblastoma cell line. Conclusions/Significance: Our results suggest that Gprc5b-v2 may play a role during brain maturation and in matured brain, possibly through the regulation of neuronal morphology and protein-protein interaction. This study also highlights the fact that unexpected gene retention following repeated backcrosses can lead to important biological consequences.	[Cool, Bethany H.; Lee, Lin; Oshima, Junko; Martin, George M.; Hu, Qubai] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Chan, Guy C-K.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cool, BH (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	gmmartin@u.washington.edu; qhu@u.washington.edu			National Institute on Aging, and National Institutes of Health (NIH) [R01 AG19711, T32 AG00057, NS20498]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057, R01AG019711] Funding Source: NIH RePORTER	National Institute on Aging, and National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported, in part, by R01 AG19711 and T32 AG00057 from the National Institute on Aging, and National Institutes of Health (NIH) grant NS20498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Bolivar VJ, 2001, GENOME RES, V11, P1549, DOI 10.1101/gr.194001; Brauner-Osborne H, 2000, GENOMICS, V65, P121, DOI 10.1006/geno.2000.6164; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chan GCK, 2005, J NEUROSCI, V25, P9913, DOI 10.1523/JNEUROSCI.2376-05.2005; CICCARONE V, 1989, CANCER RES, V49, P219; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Festing Michael F. W., 1992, V8, P17; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Harada Y, 2007, BIOCHEM BIOPH RES CO, V358, P968, DOI 10.1016/j.bbrc.2007.04.208; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hu QB, 1999, J NEUROSCI RES, V58, P632, DOI 10.1002/(SICI)1097-4547(19991201)58:5<632::AID-JNR4>3.0.CO;2-P; Hu QB, 2000, J NEUROSCI RES, V60, P73, DOI 10.1002/(SICI)1097-4547(20000401)60:1<73::AID-JNR8>3.0.CO;2-S; Kaur H, 2003, PROTEIN SCI, V12, P627, DOI 10.1110/ps.0228903; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Kreienkamp HJ, 2002, CURR OPIN PHARMACOL, V2, P581, DOI 10.1016/S1471-4892(02)00203-5; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; MARKOVIC D, 2009, CELL MOL LIFE SCI; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; MINAKAMI R, 1995, J NEUROCHEM, V65, P1536; Mirnics K, 2001, NAT REV NEUROSCI, V2, P444, DOI 10.1038/35077587; Mundell SJ, 2004, BIOCHEMISTRY-US, V43, P7541, DOI 10.1021/bi0359022; Owen EH, 1997, NEUROSCIENCE, V80, P1087, DOI 10.1016/S0306-4522(97)00165-6; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Robbins MJ, 2000, GENOMICS, V67, P8, DOI 10.1006/geno.2000.6226; Robbins MJ, 2002, MOL BRAIN RES, V106, P136, DOI 10.1016/S0169-328X(02)00420-5; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Strosberg AD, 1996, CANCER SURV, V27, P65; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Tohda C, 2000, NEUROREPORT, V11, P1981, DOI 10.1097/00001756-200006260-00035; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Wang Y, 2009, LEARN MEMORY, V16, P537, DOI 10.1101/lm.1499309; Wurmbach E, 2002, NEUROCHEM RES, V27, P1027, DOI 10.1023/A:1020900720328; Yang Z, 2006, J BIOL CHEM, V281, P4207, DOI 10.1074/jbc.M508445200	44	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10351	10.1371/journal.pone.0010351	http://dx.doi.org/10.1371/journal.pone.0010351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436672	Green Submitted, gold, Green Published			2022-12-25	WOS:000277079500019
J	Tatro, ET; Scott, ER; Nguyen, TB; Salaria, S; Banerjee, S; Moore, DJ; Masliah, E; Achim, CL; Everall, IP				Tatro, Erick T.; Scott, Erick R.; Nguyen, Timothy B.; Salaria, Shahid; Banerjee, Sugato; Moore, David J.; Masliah, Eliezer; Achim, Cristian L.; Everall, Ian P.			Evidence for Alteration of Gene Regulatory Networks through MicroRNAs of the HIV-Infected Brain: Novel Analysis of Retrospective Cases	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; GLIAL-CELL DENSITY; NEURONAL SIZE; RNA; EXPRESSION; CORTEX; DYSREGULATION; MICROARRAY; PATHWAY; PROTEIN	HIV infection disturbs the central nervous system (CNS) through inflammation and glial activation. Evidence suggests roles for microRNA (miRNA) in host defense and neuronal homeostasis, though little is known about miRNAs' role in HIV CNS infection. MiRNAs are non-coding RNAs that regulate gene translation through post-transcriptional mechanisms. Messenger-RNA profiling alone is insufficient to elucidate the dynamic dance of molecular expression of the genome. We sought to clarify RNA alterations in the frontal cortex (FC) of HIV-infected individuals and those concurrently infected and diagnosed with major depressive disorder (MDD). This report is the first published study of large-scale miRNA profiling from human HIV-infected FC. The goals of this study were to: 1. Identify changes in miRNA expression that occurred in the frontal cortex (FC) of HIV individuals, 2. Determine whether miRNA expression profiles of the FC could differentiate HIV from HIV/MDD, and 3. Adapt a method to meaningfully integrate gene expression data and miRNA expression data in clinical samples. We isolated RNA from the FC (n = 3) of three separate groups (uninfected controls, HIV, and HIV/MDD) and then pooled the RNA within each group for use in large-scale miRNA profiling. RNA from HIV and HIV/MDD patients (n = 4 per group) were also used for non-pooled mRNA analysis on Affymetrix U133 Plus 2.0 arrays. We then utilized a method for integrating the two datasets in a Target Bias Analysis. We found miRNAs of three types: A) Those with many dysregulated mRNA targets of less stringent statistical significance, B) Fewer dysregulated target-genes of highly stringent statistical significance, and C) unclear bias. In HIV/MDD, more miRNAs were downregulated than in HIV alone. Specific miRNA families at targeted chromosomal loci were dysregulated. The dysregulated miRNAs clustered on Chromosomes 14, 17, 19, and X. A small subset of dysregulated genes had many 3' untranslated region (3'UTR) target-sites for dysregulated miRNAs. We provide evidence that certain miRNAs serve as key elements in gene regulatory networks in HIV-infected FC and may be implicated in neurobehavioral disorder. Finally, our data indicates that some genes may serve as hubs of miRNA activity.	[Tatro, Erick T.; Salaria, Shahid; Moore, David J.; Achim, Cristian L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Tatro, Erick T.; Banerjee, Sugato; Moore, David J.; Masliah, Eliezer; Achim, Cristian L.] Univ Calif San Diego, HIV Neurobehav Res Ctr, San Diego, CA 92103 USA; [Scott, Erick R.; Banerjee, Sugato; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Everall, Ian P.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Melbourne	Tatro, ET (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	etatro@ucsd.edu	BANERJEE, SUGATO/M-7317-2017; BANERJEE, SUGATO/L-9012-2019	BANERJEE, SUGATO/0000-0002-4402-3066; 	National Institutes of Health [R21MH076681, R01MH062962, R01MH079881]; HIV Neurobehavioral Research Center [U01 MH83506]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083506, R01MH062962, R01MH079881, R21MH076681, U01MH083545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIV Neurobehavioral Research Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The following grants from the National Institutes of Health (nih.gov) funded this project: R21MH076681, R01MH062962, R01MH079881. The HIV Neurobehavioral Research Center is funded under grant number U01 MH83506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*APPL BIOS INC, 2005, APPL BIOS RQ MANG 1; Ashraf SI, 2006, CURR OPIN NEUROBIOL, V16, P535, DOI 10.1016/j.conb.2006.08.007; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bennasser Y, 2006, J BIOL CHEM, V281, P27674, DOI 10.1074/jbc.C600072200; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; Dogini DB, 2008, J MOL NEUROSCI, V35, P331, DOI 10.1007/s12031-008-9068-4; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; Eletto D, 2008, J CELL PHYSIOL, V216, P764, DOI 10.1002/jcp.21452; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Everall IP, 2001, J NEUROPATH EXP NEUR, V60, P293, DOI 10.1093/jnen/60.3.293; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; *ING SYST, 2009, ING PATHW AN; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kolbus A, 2003, BLOOD, V102, P3136, DOI 10.1182/blood-2003-03-0923; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; LANTOS PL, 1989, LANCET, V1, P309; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manakov SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-419; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Masliah E, 2004, J NEUROIMMUNOL, V157, P163, DOI 10.1016/j.jneuroim.2004.08.026; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Moore DJ, 2006, AIDS, V20, P879, DOI 10.1097/01.aids.0000218552.69834.00; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; O'Connor MF, 2009, NEUROIMAGE, V47, P891, DOI 10.1016/j.neuroimage.2009.05.049; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Salaria S, 2006, NEUROBIOL DIS, V23, P630, DOI 10.1016/j.nbd.2006.05.003; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; SPSS Inc, 2004, SPSS WIND REL 13 0; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; WANG X, 2008, BLOOD; White MG, 1999, CELL TRANSPLANT, V8, P59, DOI 10.1177/096368979900800115; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	51	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10337	10.1371/journal.pone.0010337	http://dx.doi.org/10.1371/journal.pone.0010337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436668	Green Submitted, Green Published, gold			2022-12-25	WOS:000277079500013
J	Wong, KKL				Wong, Kelvin Kian Loong			A Geometrical Perspective for the Bargaining Problem	PLOS ONE			English	Article								A new treatment to determine the Pareto-optimal outcome for a non-zero-sum game is presented. An equilibrium point for any game is defined here as a set of strategy choices for the players, such that no change in the choice of any single player will increase the overall payoff of all the players. Determining equilibrium for multi-player games is a complex problem. An intuitive conceptual tool for reducing the complexity, via the idea of spatially representing strategy options in the bargaining problem is proposed. Based on this geometry, an equilibrium condition is established such that the product of their gains over what each receives is maximal. The geometrical analysis of a cooperative bargaining game provides an example for solving multi-player and non-zero-sum games efficiently.	RMIT Univ, Sch Aerosp Mech & Mfg Engn, Bundoora, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Wong, KKL (corresponding author), RMIT Univ, Sch Aerosp Mech & Mfg Engn, Bundoora, Vic, Australia.	k.wong@rmit.edu.au	Wong, Kelvin Kian Loong/ABA-3915-2021; Wong, Kelvin/AAL-8636-2021	Wong, Kelvin Kian Loong/0000-0002-8600-1105; 				BARON R, 2002, 0219 U COP; Broom M, 1997, B MATH BIOL, V59, P931; Broom M., 2003, Comments on Theoretical Biology, V8, P103, DOI 10.1080/08948550302450; DASKALAKIS C, 2005, EL C COMP COMPL; Davis M., 1973, GAME THEORY NONTECHN; Hart S, 2002, HDB GAME THEORY; Hofbauer J., 1988, EVOLUTIONARY GAMES P; Iqbal A, 2008, PHYS LETT A, V372, P6564, DOI 10.1016/j.physleta.2008.09.026; Khan M., 2002, HDB GAME THEORY, V3; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; NASH JF, 1997, ESSAYS GAME THEORY; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; Owen G, 1995, GAME THEORY; RAPOPORT A, 1962, BEHAV SCI, V7, P38; Rasmusen E., 2001, GAMES INFORM INTRO G; VIOSSAT Y, 2006, PAPER SERIES EC FINA, V641; Von Neumann J, 1980, THEORY GAMES EC BEHA	17	27	29	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10331	10.1371/journal.pone.0010331	http://dx.doi.org/10.1371/journal.pone.0010331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436675	Green Published, gold, Green Submitted			2022-12-25	WOS:000277079500011
J	Huichalaf, C; Sakai, K; Jin, BW; Jones, K; Wang, GL; Schoser, B; Schneider-Gold, C; Sarkar, P; Pereira-Smith, OM; Timchenko, N; Timchenko, L				Huichalaf, Claudia; Sakai, Keiko; Jin, Bingwen; Jones, Karlie; Wang, Guo-Li; Schoser, Benedikt; Schneider-Gold, Christiane; Sarkar, Partha; Pereira-Smith, Olivia M.; Timchenko, Nikolai; Timchenko, Lubov			Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells	FASEB JOURNAL			English	Article						PKR; CUG-binding protein; CUGBP1; MRG15/MORF	BINDING PROTEIN-BETA; EXPANDED CTG REPEATS; TRIPLET REPEAT; MESSENGER-RNA; INCREASES TRANSLATION; OXIDATIVE STRESS; MOLECULAR-BASIS; REGION; DIFFERENTIATION; EXPRESSION	The purpose of this study was to investigate the role of the mutant CUGn RNA in the induction of stress in type 1 myotonic dystrophy (DM1) cells and in the stress-mediated inhibition of protein translation in DM1. To achieve our goals, we performed HPLC-based purification of stress granules (SGs), immunoanalysis of SGs with stress markers TIA-1, CUGBP1, and ph-eIF2, site-specific mutagenesis, and examinations of RNA-protein and protein-protein interactions in myoblasts from control and DM1 patients. The cause-and-effect relationships were addressed in stable cells expressing mutant CUG repeats. We found that the mutant CUGn RNA induces formation of SGs through the increase of the double-stranded RNA-dependent protein kinase (PKR) and following inactivation of eIF2 alpha, one of the substrates of PKR. We show that SGs trap mRNA coding for the DNA repair and remodeling factor MRG15 (MORF4L1), translation of which is regulated by CUGBP1. As the result of the trapping, the levels of MRG15 are reduced in DM1 cells and in CUG-expressing cells. These data show that CUG repeats cause stress in DM1 through the PKR-ph-eIF2 alpha pathway inhibiting translation of certain mRNAs, such as MRG15 mRNA. The repression of protein translation by stress might contribute to the progressive muscle loss in DM1.-Huichalaf, C., Sakai, K., Jin, B., Jones, K., Wang, G.-L., Schoser, B., Schneider-Gold, C., Sarkar, P., Pereira-Smith, O. M., Timchenko, N., Lubov, T. Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells. FASEB J. 24, 3706-3719 (2010). www.fasebj.org	[Huichalaf, Claudia; Sakai, Keiko; Jin, Bingwen; Jones, Karlie; Timchenko, Lubov] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Wang, Guo-Li; Timchenko, Nikolai] Baylor Coll Med, Dept Pathol & Immunol, Huffington Ctr Aging, Houston, TX 77030 USA; [Schoser, Benedikt] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; [Schneider-Gold, Christiane] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-4630 Bochum, Germany; [Sarkar, Partha] Univ Houston, Texas Med Branch, Galveston, TX USA; [Pereira-Smith, Olivia M.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	Baylor College of Medicine; Baylor College of Medicine; University of Munich; Ruhr University Bochum; University of Houston System; University of Houston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health San Antonio	Timchenko, L (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Room T424,1 Baylor Plaza, Houston, TX 77030 USA.	lubovt@bcm.tmc.edu	Schoser, Benedikt/AAH-6286-2020	Schneider-Gold, Christiane/0000-0002-9232-201X; Schoser, Benedikt/0000-0002-2757-8131	National Institutes of Health [AR052791, AR044387, AR044387-ARRA, NS063298, GM55188, CA100070, AG025477, AG032134]; Deutsche Gesellschaft fur Muskelkranke, Freiburg, Germany; German Ministry of Education and Research (BMBF, Bonn, Germany) [MD-NET/01GM0601]; EC [01/2003-03/2006]; NATIONAL CANCER INSTITUTE [R01CA100070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044387, R01AR052791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS063298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025477, R01AG032134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Gesellschaft fur Muskelkranke, Freiburg, Germany; German Ministry of Education and Research (BMBF, Bonn, Germany)(Federal Ministry of Education & Research (BMBF)); EC(European CommissionEuropean Commission Joint Research Centre); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AR052791, AR044387, AR044387-ARRA, NS063298 (to L.T.T.), GM55188, CA100070, AG025477 (to N.A.T.), and AG032134 (to O.M.P.-S.). B.S. has received research support from the Deutsche Gesellschaft fur Muskelkranke, Freiburg, Germany; he is a member of the German Muscular Dystrophy Network (MD-NET/01GM0601) funded by the German Ministry of Education and Research (BMBF, Bonn, Germany). MD-NET is a partner of TREAT-NMD (EC, 6th FP, proposal 036825). The authors thank the Muscle Tissue Culture Collection (MTCC) for providing the samples. MTCC is a partner of the EuroBioBank Network, established in 2001 thanks to EC funding (01/2003-03/2006).	Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; ARCHRAFI A, 2005, P NATL ACAD SCI USA, V102, P2180; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Fujimura K, 2008, EXP CELL RES, V314, P543, DOI 10.1016/j.yexcr.2007.10.024; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper PS, 2001, MYOTONIC DYSTROPHY; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Ikezoe K, 2007, ACTA NEUROPATHOL, V114, P527, DOI 10.1007/s00401-007-0267-9; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Onishi H, 2008, J NEUROSCI RES, V86, P1994, DOI 10.1002/jnr.21655; Ordway JM, 1996, BIOTECHNIQUES, V21, P609; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Paillard L, 1998, EMBO J, V17, P278, DOI 10.1093/emboj/17.1.278; Pardo PS, 2002, J BIOL CHEM, V277, P50860, DOI 10.1074/jbc.M203839200; Pena AAN, 2007, ANN NY ACAD SCI, V1100, P299, DOI 10.1196/annals.1395.031; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Salisbury E, 2008, EXP CELL RES, V314, P2266, DOI 10.1016/j.yexcr.2008.04.018; Salisbury E, 2009, AM J PATHOL, V175, P748, DOI 10.2353/ajpath.2009.090047; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko LT, 1996, HUM MOL GENET, V5, P115, DOI 10.1093/hmg/5.1.115; Timchenko LT, 1999, AM J HUM GENET, V64, P360, DOI 10.1086/302268; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Toscano A, 2005, FREE RADICAL RES, V39, P771, DOI 10.1080/10715760500138932; Usuki F, 2000, BIOCHEM BIOPH RES CO, V267, P739, DOI 10.1006/bbrc.1999.2026; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; Woeller CF, 2007, J BIOL CHEM, V282, P29927, DOI 10.1074/jbc.M706264200	48	69	69	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3706	3719		10.1096/fj.09-151159	http://dx.doi.org/10.1096/fj.09-151159			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20479119	Green Published			2022-12-25	WOS:000285005900011
J	Lantier, L; Mounier, R; Leclerc, J; Pende, M; Foretz, M; Viollet, B				Lantier, Louise; Mounier, Remi; Leclerc, Jocelyne; Pende, Mario; Foretz, Marc; Viollet, Benoit			Coordinated maintenance of muscle cell size control by AMP-activated protein kinase	FASEB JOURNAL			English	Article						muscle protein synthesis pathway; mTOR-p70S6K signaling; knockout mice	TWITCH SKELETAL-MUSCLE; MAMMALIAN TARGET; METABOLIC-RESPONSE; S6 KINASE; HYPERTROPHY; MTOR; GROWTH; PHOSPHORYLATION; ATROPHY; PATHWAY	Skeletal muscle mass is regulated by signaling pathways that govern protein synthesis and cell proliferation, and the mammalian target of rapamycin (mTOR) plays a key role in these processes. Recent studies suggested the crucial role of AMP-activated protein kinase (AMPK) in the inhibition of protein synthesis and cell growth. Here, we address the role of AMPK in the regulation of muscle cell size in vitro and in vivo. The size of AMPK-deficient myotubes was 1.5-fold higher than for controls. A marked increase in p70S6K Thr(389) and rpS6 Ser-235/236 phosphorylation was observed concomitantly with an up-regulation of protein synthesis rate. Treatment with rapamycin prevented p70S6K phosphorylation and rescued cell size control in AMPK-deficient cells. Importantly, myotubes lacking AMPK were resistant to further cell size increase beyond AMPK deletion alone, as MyrAkt-induced hypertrophy was absent in these cells. Moreover, in skeletal muscle-specific deficient AMPK alpha 1/alpha 2 KO mice, soleus muscle showed a higher mass with myofibers of larger size and was associated with increased p70S6K and rpS6 phosphorylation. Our results uncover the role of AMPK in the maintenance of muscle cell size control and highlight the crosstalk between AMPK and mTOR/p70S6K signaling pathways coordinating a metabolic checkpoint on cell growth.-Lantier, L., Mounier, R., Leclerc, J., Pende, M., Foretz, M., Viollet, B. Coordinated maintenance of muscle cell size control by AMP-activated protein kinase. FASEB J. 24, 3555-3561 (2010). www.fasebj.org	[Viollet, Benoit] INSERM, Inst Cochin, Dept Endocrinol Metab & Canc, U1016, F-75014 Paris, France; [Lantier, Louise; Mounier, Remi; Leclerc, Jocelyne; Foretz, Marc; Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Pende, Mario] INSERM, U845, Paris, France; [Pende, Mario] Univ Paris 05, UMRS 845, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Viollet, B (corresponding author), INSERM, Inst Cochin, Dept Endocrinol Metab & Canc, U1016, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	benoit.viollet@inserm.fr	Pende, Mario/AFR-1348-2022; Viollet, Benoit/N-2397-2019; FORETZ, Marc/O-7334-2017; Viollet, Benoit/O-6927-2017	Pende, Mario/0000-0002-7864-8937; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224	European Commission [LSHM-CT-2004-005272]; Agence Nationale pour la Recherche [PHYSIO 2006 R06428KS]; Association Francaise contre les Myopathies [14138]	European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	The authors thank Judith Melki (INSERM U788, Le Kremlin Bicetre, France) for kindly supplying the HSA-Cre transgenic mice for breeding, Kei Sakamoto (University of Dundee, Dundee, UK) for the kind gift of A-769662, and Grahame Hardie (University of Dundee) for providing anti-AMPK alpha 1 and alpha 2 antibodies. The authors are indebted to Dr. Luc Bertrand for the protein synthesis protocol. The authors also thank Athanassia Sotiropoulos for helpful and fruitful discussions. This work was supported by the European Commission integrated project (LSHM-CT-2004-005272), Agence Nationale pour la Recherche (PHYSIO 2006 R06428KS), and Association Francaise contre les Myopathies (grant 14138).	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gordon SE, 2008, EXERC SPORT SCI REV, V36, P179, DOI 10.1097/JES.0b013e3181877e13; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2008, MOL CELL, V30, P263, DOI 10.1016/j.molcel.2008.04.012; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Klein DK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1242, DOI 10.1152/ajpendo.00382.2007; Krause U, 2002, EUR J BIOCHEM, V269, P3751, DOI 10.1046/j.1432-1033.2002.03074.x; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Mounier R, 2009, FASEB J, V23, P2264, DOI 10.1096/fj.08-119057; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Thomson DM, 2008, J APPL PHYSIOL, V104, P625, DOI 10.1152/japplphysiol.00915.2007; Thomson DM, 2005, J APPL PHYSIOL, V98, P557, DOI 10.1152/japplphysiol.00811.2004; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zarrinpashneh E, 2006, AM J PHYSIOL-HEART C, V291, pH2875, DOI 10.1152/ajpheart.01032.2005; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	40	78	83	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3555	3561		10.1096/fj.10-155994	http://dx.doi.org/10.1096/fj.10-155994			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20460585	Green Submitted			2022-12-25	WOS:000281446400042
J	Twarock, S; Tammi, MI; Savani, RC; Fischer, JW				Twarock, Soeren; Tammi, Markku I.; Savani, Rashmin C.; Fischer, Jens W.			Hyaluronan Stabilizes Focal Adhesions, Filopodia, and the Proliferative Phenotype in Esophageal Squamous Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RECEPTOR RHAMM; CANCER-CELLS; OVEREXPRESSION; COLON; CD44; TRANSFORMATION; PROMOTES; MOTILITY; SURFACE	Hyaluronan (HA) is a polysaccharide component in the parenchyma and stroma of human esophageal squamous cell carcinoma (ESCC). Clinically, esophageal cancer represents a highly aggressive tumor type with poor prognosis resulting in a 5-year survival rate of 5%. The aim of the present study was the detailed analysis of the role of HA synthesis for ESCC phenotype in vitro using the ESCC cell line OSC1. In OSC1 cells, pericellular HA-matrix surrounding extended actin-dependent filopodia was detected. The small molecule inhibitor of HA synthesis, 4-methylumbelliferone (4-MU, 0.3 mM) caused loss of these filopodia and focal adhesions and inhibited proliferation and migration. In search of the underlying mechanism cleavage of focal adhesion kinase (FAK) was detected by immunoblotting. In addition, displacing HA by an HA-binding peptide (Pep-1, 500 mu g/ml) and digestion of pericellular HA by hyaluronidase resulted in cleavage of focal adhesions. Furthermore, real-time reverse transcription PCR revealed that HA synthase 3 (HAS3) > HAS2 are the predominant HA-synthases in OSC1. Lentiviral transduction with shHAS3, and to a lesser extent with shHAS2, reduced intact FAK protein and filopodia as well as proliferation and migration. Furthermore, down-regulation by lentiviral shRNA of RHAMM (receptor of HA-mediated motility) but not CD44 induced loss of filopodia and caused FAK cleavage. In contrast, knockdown of both HA receptors inhibited proliferation and migration of OSC1. In conclusion, HA synthesis and, in turn, RHAMM and CD44 signaling promoted an activated phenotype of OSC1. Because RHAMM appears to support both filopodia, FAK, and the proliferative and migratory phenotype, it may be promising to explore RHAMM as a potential therapeutic target in esophageal cancer.	[Twarock, Soeren; Fischer, Jens W.] Univ Duisburg Essen, Univ Klinikum Essen, Inst Pharmakol, D-45147 Essen, Germany; [Tammi, Markku I.] Univ Eastern Finland, Inst Biomed, FIN-70211 Kuopio, Finland; [Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Pulm & Vasc Biol, Dallas, TX 75390 USA; [Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Neonatal Perinatal Med, Dallas, TX 75390 USA	University of Duisburg Essen; University of Eastern Finland; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fischer, JW (corresponding author), Univ Duisburg Essen, Univ Klinikum Essen, Inst Pharmakol, Hufelandstr 55, D-45147 Essen, Germany.	j.fischer@uk-essen.de	Tammi, Markku/AAQ-7878-2021; Rashmin C. Savani, MBChB/AAG-2041-2021; Twarock, Sören/AAB-7705-2020	Rashmin C. Savani, MBChB/0000-0002-9533-5422; Twarock, Sören/0000-0001-9252-1353	Grunderstiftung zur Forderung von Forschung und wissenschaftlichen Nachwuchs an der Heinrich Heine Universitat Dusseldorf; National Institutes of Health [HL073896, HL079090, HL075930]; William Buchanan Chair in Pediatrics of the University of Texas Southwestern Medical Center, Dallas, TX; Academy of Finland; Sigrid Juselius Foundation; EVO Fund of Kuopio University Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079090, R01HL075930, R01HL073896] Funding Source: NIH RePORTER	Grunderstiftung zur Forderung von Forschung und wissenschaftlichen Nachwuchs an der Heinrich Heine Universitat Dusseldorf; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Buchanan Chair in Pediatrics of the University of Texas Southwestern Medical Center, Dallas, TX; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); EVO Fund of Kuopio University Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a fellowship from the Grunderstiftung zur Forderung von Forschung und wissenschaftlichen Nachwuchs an der Heinrich Heine Universitat Dusseldorf (to S. T.); National Institutes of Health Grants HL073896, HL079090, and HL075930 and the William Buchanan Chair in Pediatrics of the University of Texas Southwestern Medical Center, Dallas, TX (to R. C. S.); and the Academy of Finland, the Sigrid Juselius Foundation, and EVO Fund of Kuopio University Hospital (to M. I. T.).	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Amieva MR, 1999, J CELL SCI, V112, P111; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Carragher NO, 2001, J BIOL CHEM, V276, P4270, DOI 10.1074/jbc.M008972200; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Fujita Y, 2002, FEBS LETT, V528, P101, DOI 10.1016/S0014-5793(02)03262-3; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; LESLEY J, 1998, FRONT BIOSCI, V3, P616; Levkau B, 1998, J EXP MED, V187, P579, DOI 10.1084/jem.187.4.579; Liu NF, 2001, CANCER RES, V61, P5207; Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769; Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003; Nakazawa Hideaki, 2006, Cancer Chemother Pharmacol, V57, P165, DOI 10.1007/s00280-005-0016-5; OWENS LV, 1995, CANCER RES, V55, P2752; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Ropponen K, 1998, CANCER RES, V58, P342; Sarbia M, 1997, ANTICANCER RES, V17, P2185; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; Schmitt M, 2008, BLOOD, V111, P1357, DOI 10.1182/blood-2007-07-099366; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Sohara Y, 2001, MOL BIOL CELL, V12, P1859, DOI 10.1091/mbc.12.6.1859; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Tofuku K, 2006, INT J ONCOL, V29, P175; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Twarock S, 2009, BRIT J PHARMACOL, V157, P234, DOI 10.1111/j.1476-5381.2009.00138.x; UNDERHILL CB, 1979, J CELL BIOL, V82, P475, DOI 10.1083/jcb.82.2.475; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Wang C, 1998, CLIN CANCER RES, V4, P567; Wang C, 1996, AM J PATHOL, V148, P1861; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069; Yamano Y, 2008, INT J ONCOL, V32, P1001; Yoshihara S, 2005, FEBS LETT, V579, P2722, DOI 10.1016/j.febslet.2005.03.079; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	47	77	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23274	23282		10.1074/jbc.M109.093146	http://dx.doi.org/10.1074/jbc.M109.093146			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20463012	Green Published, hybrid			2022-12-25	WOS:000279999900061
J	Shima, F; Ijiri, Y; Muraoka, S; Liao, JL; Ye, M; Araki, M; Matsumoto, K; Yamamoto, N; Sugimoto, T; Yoshikawa, Y; Kumasaka, T; Yamamoto, M; Tamura, A; Kataoka, T				Shima, Fumi; Ijiri, Yuichi; Muraoka, Shin; Liao, Jingling; Ye, Min; Araki, Mitsugu; Matsumoto, Kousuke; Yamamoto, Naoki; Sugimoto, Takeshi; Yoshikawa, Yoko; Kumasaka, Takashi; Yamamoto, Masaki; Tamura, Atsuo; Kataoka, Tohru			Structural Basis for Conformational Dynamics of GTP-bound Ras Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MOLECULAR REPLACEMENT; ACTIVATING PROTEIN; P21 RAS; GAMMA-S; BINDING; PROGRAM; SPECTROSCOPY; M-RAS/R-RAS3; COMPLEXES	Ras family small GTPases assume two interconverting conformations, "inactive" state 1 and "active" state 2, in their GTP-bound forms. Here, to clarify the mechanism of state transition, we have carried out x-ray crystal structure analyses of a series of mutant H-Ras and M-Ras in complex with guanosine 5'-(beta,gamma-imido) triphosphate (GppNHp), representing various intermediate states of the transition. Crystallization of H-RasT35S-GppNHp enables us to solve the first complete tertiary structure of H-Ras state 1 possessing two surface pockets unseen in the state 2 or H-Ras-GDP structure. Moreover, determination of the two distinct crystal structures of H-RasT35S-GppNHp, showing prominent polysterism in the switch I and switch II regions, reveals a pivotal role of the guanine nucleotide-mediated interaction between the two switch regions and its rearrangement by a nucleotide positional change in the state 2 to state 1 transition. Furthermore, the P-31 NMR spectra and crystal structures of the GppNHp-bound forms of M-Ras mutants, carrying various H-Ras-type amino acid substitutions, also reveal the existence of a surface pocket in state 1 and support a similar mechanism based on the nucleotide-mediated interaction and its rearrangement in the state 1 to state 2 transition. Intriguingly, the conformational changes accompanying the state transition mimic those that occurred upon GDP/GTP exchange, indicating a common mechanistic basis inherent in the high flexibility of the switch regions. Collectively, these results clarify the structural features distinguishing the two states and provide new insights into the molecular basis for the state transition of Ras protein.	[Shima, Fumi; Ijiri, Yuichi; Muraoka, Shin; Liao, Jingling; Ye, Min; Matsumoto, Kousuke; Sugimoto, Takeshi; Yoshikawa, Yoko; Kataoka, Tohru] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Araki, Mitsugu; Yamamoto, Naoki] Kobe Univ, Grad Sch Med, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kumasaka, Takashi] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Muraoka, Shin; Yamamoto, Masaki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Kobe University; Kobe University; Japan Synchrotron Radiation Research Institute; RIKEN	Kataoka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kataoka@people.kobe-u.ac.jp	Kumasaka, Takashi/D-7428-2018; Yamamoto, Masaki/B-7844-2015; Araki, Mitsugu/C-7470-2016	Kumasaka, Takashi/0000-0001-9289-1557; Yamamoto, Masaki/0000-0002-1311-1768; Tamura, Atsuo/0000-0001-8238-8851	Ministry of Education, Science, Sports, and Culture of Japan [17014061, 18057014, A08]; National Institute of Biomedical Innovation [06-3]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by Grants-in-Aid for Scientific Research in Priority Areas 17014061 and 18057014, and Global Centers of Excellence Program A08 from the Ministry of Education, Science, Sports, and Culture of Japan and by National Institute of Biomedical Innovation Grant for the Program for Promotion of Fundamental Studies of Health Sciences 06-3.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bellew BF, 1996, BIOCHEMISTRY-US, V35, P12186, DOI 10.1021/bi960594b; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherfils J, 1997, EMBO J, V16, P5582, DOI 10.1093/emboj/16.18.5582; Corbett KD, 2001, TRENDS BIOCHEM SCI, V26, P710, DOI 10.1016/S0968-0004(01)01974-0; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabbro D, 2002, PHARMACOL THERAPEUT, V93, P79, DOI 10.1016/S0163-7258(02)00179-1; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Ford B, 2009, BIOCHEMISTRY-US, V48, P11449, DOI 10.1021/bi901479b; Geyer M, 1999, BIOCHEMISTRY-US, V38, P11250, DOI 10.1021/bi9904306; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Halkides CJ, 1996, BIOCHEMISTRY-US, V35, P12194, DOI 10.1021/bi9605954; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE AGW, 1992, JOINT CCP4 ESF EACBM; Liao JL, 2008, BIOCHEM BIOPH RES CO, V369, P327, DOI 10.1016/j.bbrc.2008.01.169; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Ye M, 2005, J BIOL CHEM, V280, P31267, DOI 10.1074/jbc.M505503200	35	99	102	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22696	22705		10.1074/jbc.M110.125161	http://dx.doi.org/10.1074/jbc.M110.125161			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20479006	Green Published, hybrid			2022-12-25	WOS:000279702200080
J	Olshina, MA; Angley, LM; Ramdzan, YM; Tang, JW; Bailey, MF; Hill, AF; Hatters, DM				Olshina, Maya A.; Angley, Lauren M.; Ramdzan, Yasmin M.; Tang, Jinwei; Bailey, Michael F.; Hill, Andrew F.; Hatters, Danny M.			Tracking Mutant Huntingtin Aggregation Kinetics in Cells Reveals Three Major Populations That Include an Invariant Oligomer Pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; FLUORESCENCE DETECTION; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; IN-VITRO; POLYGLUTAMINE; PROTEIN; HSP70; SUPPRESSION; HSP40	Huntington disease is caused by expanded polyglutamine sequences in huntingtin, which procures its aggregation into intracellular inclusion bodies (IBs). Aggregate intermediates, such as soluble oligomers, are predicted to be toxic to cells, yet because of a lack of quantitative methods, the kinetics of aggregation in cells remains poorly understood. We used sedimentation velocity analysis to define and compare the heterogeneity and flux of purified huntingtin with huntingtin expressed in mammalian cells under non-denaturing conditions. Non-pathogenic huntingtin remained as hydrodynamically elongated monomers in vitro and in cells. Purified polyglutamine-expanded pathogenic huntingtin formed elongated monomers (2.4 S) that evolved into a heterogeneous aggregate population of increasing size over time (100-6,000 S). However, in cells, mutant huntingtin formed three major populations: monomers (2.3 S), oligomers (mode s(20,w) = 140 S) and IBs (mode s(20,w) = 320,000 S). Strikingly, the oligomers did not change in size heterogeneity or in their proportion of total huntingtin over 3 days despite continued monomer conversion to IBs, suggesting that oligomers are rate-limiting intermediates to IB formation. We also determined how a chaperone known to modulate huntingtin toxicity, Hsc70, influences in-cell huntingtin partitioning. Hsc70 decreased the pool of 140 S oligomers but increased the overall flux of monomers to IBs, suggesting that Hsc70 reduces toxicity by facilitating transfer of oligomers into IBs. Together, our data suggest that huntingtin aggregation is streamlined in cells and is consistent with the 140 S oligomers, which remain invariant over time, as a constant source of toxicity to cells irrespective of total load of insoluble aggregates.	[Olshina, Maya A.; Angley, Lauren M.; Ramdzan, Yasmin M.; Tang, Jinwei; Bailey, Michael F.; Hill, Andrew F.; Hatters, Danny M.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Hill, Andrew F.; Hatters, Danny M.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3010, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Hatters, DM (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Parkville, Vic 3010, Australia.	dhatters@unimelb.edu.au	Hill, Andrew F/B-4527-2009; Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020	Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew F./0000-0001-5581-2354; Hatters, Danny/0000-0002-9965-2847	National Health and Medical Research Council (NHMRC) [566640]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by a National Health and Medical Research Council (NHMRC) program grant (to A. F. H.) and NHMRC Project Grant 566640 (to D. M. H.). A. F. H. is an NHMRC CDA (Level 2) Fellow.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dougan L, 2009, P NATL ACAD SCI USA, V106, P12605, DOI 10.1073/pnas.0900678106; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hatters DA, 2008, IUBMB LIFE, V60, P724, DOI 10.1002/iub.111; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; Hatters DM, 2000, BIOCHEMISTRY-US, V39, P8276, DOI 10.1021/bi000002w; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; JACOB L, 2002, PROTEIN SCI, V11, P2067; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kingsbury JS, 2008, J BIOL CHEM, V283, P11887, DOI 10.1074/jbc.M709638200; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Lide DR, 1996, CRC HDB CHEM PHYSICS, P8; Longinotti MP, 2008, J PHYS CHEM REF DATA, V37, P1503, DOI 10.1063/1.2932114; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; MacRaild CA, 2003, BIOPHYS J, V84, P2562, DOI 10.1016/S0006-3495(03)75061-9; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rosenow MA, 2004, BIOCHEMISTRY-US, V43, P4464, DOI 10.1021/bi0361315; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rujano MA, 2007, EXP CELL RES, V313, P3568, DOI 10.1016/j.yexcr.2007.07.034; Ryan TM, 2008, J BIOL CHEM, V283, P35118, DOI 10.1074/jbc.M804004200; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wang YS, 2009, J EUR ACAD DERMATOL, V23, P451, DOI 10.1111/j.1468-3083.2008.02895.x; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200	57	88	89	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21807	21816		10.1074/jbc.M109.084434	http://dx.doi.org/10.1074/jbc.M109.084434			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444706	Green Published, hybrid			2022-12-25	WOS:000279516100065
J	Tomasic, IB; Metcalf, MC; Guce, AI; Clark, NE; Garman, SC				Tomasic, Ivan B.; Metcalf, Matthew C.; Guce, Abigail I.; Clark, Nathaniel E.; Garman, Scott C.			Interconversion of the Specificities of Human Lysosomal Enzymes Associated with Fabry and Schindler Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-N-ACETYLGALACTOSAMINIDASE; 1.9 ANGSTROM STRUCTURE; REPLACEMENT THERAPY; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; GALACTOSIDASE; AGALSIDASE; SAFETY; ANTIBODY	The human lysosomal enzymes alpha-galactosidase (alpha-GAL, EC 3.2.1.22) and alpha-N-acetylgalactosaminidase (alpha-NAGAL, EC 3.2.1.49) share 46% amino acid sequence identity and have similar folds. The active sites of the two enzymes share 11 of 13 amino acids, differing only where they interact with the 2-position of the substrates. Using a rational protein engineering approach, we interconverted the enzymatic specificity of alpha-GAL and alpha-NAGAL. The engineered alpha-GAL (which we call alpha-GAL(SA)) retains the antigenicity of alpha-GAL but has acquired the enzymatic specificity of alpha-NAGAL. Conversely, the engineered alpha-NAGAL (which we call alpha-NAGAL(EL)) retains the antigenicity of alpha-NAGAL but has acquired the enzymatic specificity of the alpha-GAL enzyme. Comparison of the crystal structures of the designed enzyme alpha-GAL(SA) to the wild-type enzymes shows that active sites of alpha-GAL(SA) and alpha-NAGAL superimpose well, indicating success of the rational design. The designed enzymes might be useful as non-immunogenic alternatives in enzyme replacement therapy for treatment of lysosomal storage disorders such as Fabry disease.	[Garman, Scott C.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Guce, Abigail I.; Garman, Scott C.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Garman, SC (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St, Amherst, MA 01003 USA.	garman@biochem.umass.edu		Metcalf, Matthew/0000-0001-7705-4574	National Institutes of Health [R01 DK76877]; National Science Foundation [0654128]; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK76877 (to S. C. G.). This work was also supported by National Science Foundation Integrative Graduate Education and Research Traineeship 0654128 (to N. E. C.). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	[Anonymous], 2014, METABOLIC MOL BASES; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benichou B, 2009, MOL GENET METAB, V96, P4, DOI 10.1016/j.ymgme.2008.10.004; Bodensteiner D, 2008, GENET MED, V10, P353, DOI 10.1097/GIM.0b013e318170f868; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clark NE, 2009, J MOL BIOL, V393, P435, DOI 10.1016/j.jmb.2009.08.021; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2002, STRUCTURE, V10, P425, DOI 10.1016/S0969-2126(02)00726-8; Garman SC, 2006, BIOCATAL BIOTRANSFOR, V24, P129, DOI 10.1080/10242420600598194; Golubev AM, 2004, J MOL BIOL, V339, P413, DOI 10.1016/j.jmb.2004.03.062; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MAYES JS, 1981, CLIN CHIM ACTA, V112, P247, DOI 10.1016/0009-8981(81)90384-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERONA JJ, 1995, BIOCHEMISTRY-US, V34, P1489, DOI 10.1021/bi00005a004; Ries M, 2005, PEDIATRICS, V115, pE344, DOI 10.1542/peds.2004-1678; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2006, NEPHROL DIAL TRANSPL, V21, P345, DOI 10.1093/ndt/gfi152; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Starzyk K, 2007, MOL GENET METAB, V90, P157, DOI 10.1016/j.ymgme.2006.09.003; Tajima Y, 2009, AM J HUM GENET, V85, P569, DOI 10.1016/j.ajhg.2009.09.016; Toscano MD, 2007, ANGEW CHEM INT EDIT, V46, P3212, DOI 10.1002/anie.200604205; Vedder AC, 2008, MOL GENET METAB, V94, P319, DOI 10.1016/j.ymgme.2008.03.003; WANG AM, 1990, J BIOL CHEM, V265, P21859	30	17	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21560	21566		10.1074/jbc.M110.118588	http://dx.doi.org/10.1074/jbc.M110.118588			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444686	Green Published, hybrid			2022-12-25	WOS:000279516100042
J	Shouse, GP; Nobumori, Y; Liu, X				Shouse, G. P.; Nobumori, Y.; Liu, X.			A B56 gamma mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A	ONCOGENE			English	Article						p53; PP2A; B56 gamma; Thr55 phosphorylation; lung cancer	A-BETA-SUBUNIT; REGULATORY SUBUNIT; P53; GENE; HOLOENZYME; COMPLEXES; COLON	Earlier studies have shown both p53-dependent and -independent tumor-suppressive functions of B56 gamma-specific protein phosphatase 2A (B56 gamma-PP2A). In the absence of p53, B56 gamma-PP2A can inhibit cell proliferation and cell transformation by an unknown mechanism. In the presence of p53, on DNA damage, a complex including B56 gamma-PP2A and p53 is formed, which leads to Thr55 dephosphorylation of p53, induction of the p53 transcriptional target p21 and inhibition of cell proliferation. In spite of its significance in inhibition of cell proliferation, no B56 gamma mutations have been linked to human cancer to date. In this study, we first differentiate between the p53-dependent and -independent functions of B56 gamma-PP2A by identifying a domain of the B56 gamma protein required for interaction with p53. Within this region, we identify a B56 gamma mutation, F395C, in lung cancer that disrupts the B56 gamma-p53 interaction. More importantly, we show that F395C is unable to promote p53 Thr55 dephosphorylation, transcriptional activation of p21 and the p53-dependent tumor-suppressive function of PP2A. This finding provides a mechanistic basis for the p53-dependent and -independent functions of B56 gamma-PP2A and establishes a critical link between B56 gamma-PP2A p53-dependent tumor-suppressive function and tumorigenesis. Oncogene (2010) 29, 3933-3941; doi:10.1038/onc.2010.161; published online 17 May 2010	[Shouse, G. P.; Nobumori, Y.; Liu, X.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Liu, X (corresponding author), Univ Calif Riverside, Dept Biochem, 5414 Boyce Hall, Riverside, CA 92521 USA.	xuan.liu@ucr.edu		Shouse, Geoffrey/0000-0002-7917-5713	NIH, National Institute of Cancer [CA075180]; NATIONAL CANCER INSTITUTE [R01CA075180, R29CA075180] Funding Source: NIH RePORTER	NIH, National Institute of Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr B Shen at the City of Hope for assistance in searching public databases for mutations in the B56 gamma gene and to P Podlesny for generating B56 gamma mutant plasmid constructs. We thank all members of our laboratory for many helpful discussions. This work was supported by NIH grant CA075180 from the National Institute of Cancer.	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Esplin ED, 2006, GENE CHROMOSOME CANC, V45, P182, DOI 10.1002/gcc.20284; Forester CM, 2007, P NATL ACAD SCI USA, V104, P19867, DOI 10.1073/pnas.0709879104; Grochola LF, 2009, CLIN CANCER RES, V15, P6301, DOI 10.1158/1078-0432.CCR-09-0797; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; NETO E, 2006, P NATL ACAD SCI USA, V97, P3491; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Suzuki Y, 2004, GENOME RES, V14, P1711, DOI 10.1101/gr.2435604; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033	27	39	44	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 8	2010	29	27					3933	3941		10.1038/onc.2010.161	http://dx.doi.org/10.1038/onc.2010.161			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	621SL	20473327	Green Accepted			2022-12-25	WOS:000279603200006
J	Bhandari, DR; Seo, KW; Roh, KH; Jung, JW; Kang, SK; Kang, KS				Bhandari, Dilli Ram; Seo, Kwang-Won; Roh, Kyoung-Hwan; Jung, Ji-Won; Kang, Soo-Kyung; Kang, Kyung-Sun			REX-1 Expression and p38 MAPK Activation Status Can Determine Proliferation/Differentiation Fates in Human Mesenchymal Stem Cells	PLOS ONE			English	Article							FLOW-CYTOMETRIC DETECTION; UMBILICAL-CORD BLOOD; PROGENITOR CELLS; PHOSPHATIDYLSERINE EXPRESSION; PROTEIN-KINASES; BONE-MARROW; PPAR-GAMMA; ANNEXIN-V; IN-VITRO; ES CELLS	Background: REX1/ZFP42 is a well-known embryonic stem cell (ESC) marker. However, the role of REX1, itself, is relatively unknown because the function of REX1 has only been reported in the differentiation of ESCs via STAT signaling pathways. Human mesenchymal stem cells (hMSCs) isolated from young tissues and cancer cells express REX1. Methodology/Principal Finding: Human umbilical cord blood-derived MSCs (hUCB-MSCs) and adipose tissue-derived MSCs (hAD-MSCs) strongly express REX1 and have a lower activation status of p38 MAPK, but bone marrow-derived MSCs (hBM-MSCs) have weak REX1 expression and higher activation of p38 MAPK. These results indicated that REX1 expression in hMSCs was positively correlated with proliferation rates but inversely correlated with the phosphorylation of p38 MAPK. In hUCB-MSCs, the roles of REX1 and p38 MAPK were investigated, and a knockdown study was performed using a lentiviral vector-based small hairpin RNA (shRNA). After REX1 knockdown, decreased cell proliferation was observed. In REX1 knocked-down hUCB-MSCs, the osteogenic differentiation ability deteriorated, but the adipogenic potential increased or was similar to that observed in the controls. The phosphorylation of p38 MAPK in hUCB-MSCs significantly increased after REX1 knockdown. After p38 MAPK inhibitor treatment, the cell growth in REX1 knocked-down hUCB-MSCs almost recovered, and the suppressed expression levels of CDK2 and CCND1 were also restored. The expression of MKK3, an upstream regulator of p38 MAPK, significantly increased in REX1 knocked-down hUCB-MSCs. The direct binding of REX1 to the MKK3 gene was confirmed by a chromatin immunoprecipitation (ChIP) assay. Conclusions/Significance: These findings showed that REX1 regulates the proliferation/differentiation of hMSCs through the suppression of p38 MAPK signaling via the direct suppression of MKK3. Therefore, p38 MAPK and REX-1 status can determine the cell fate of adult stem cells (ASCs). These results were the first to show the role of REX1 in the proliferation/differentiation of ASCs.	[Bhandari, Dilli Ram; Seo, Kwang-Won; Roh, Kyoung-Hwan; Jung, Ji-Won; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, Lab Stem Cell & Tumor Biol, Dept Vet Publ Hlth, Seoul, South Korea; [Kang, Soo-Kyung] Seoul Natl Univ, Lab Vet Biotechnol, Coll Vet Med, Seoul, South Korea; [Kang, Soo-Kyung] Seoul Natl Univ, Program Vet Sci BK21, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Bhandari, DR (corresponding author), Seoul Natl Univ, Coll Vet Med, Lab Stem Cell & Tumor Biol, Dept Vet Publ Hlth, Seoul, South Korea.	kangpub@snu.ac.kr	Seo, Kwang Won/AAB-4821-2020; Kang, Kyung-Sun/G-6205-2013	Seo, Kwang Won/0000-0003-1025-6133; 	Korea Research Foundation; Korean government (MEST) [M1084000119-08N4100-11910]; Brain Korea 21 program	Korea Research Foundation(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the Korea Research Foundation funded by the Korean government (MEST, No. M1084000119-08N4100-11910) and Brain Korea 21 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino C, 2001, BIOL CELL, V93, P47, DOI 10.1016/S0248-4900(01)01124-8; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Chakraborty S, 2009, DIFFERENTIATION, V78, P143, DOI 10.1016/j.diff.2009.05.006; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Do Kim J, 2007, NUCLEIC ACIDS RES, V35, P3442, DOI 10.1093/nar/gkm235; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Gills JJ, 2007, J BIOL CHEM, V282, P27020, DOI 10.1074/jbc.M701108200; Grogan SP, 2008, ARTHRITIS RHEUM-US, V58, P2754, DOI 10.1002/art.23730; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Guarnaccia C, 2004, FEBS LETT, V574, P156, DOI 10.1016/j.febslet.2004.08.022; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; Hiraoka K, 2006, BIORHEOLOGY, V43, P447; HOSLER BA, 1989, MOL CELL BIOL, V9, P5623, DOI 10.1128/MCB.9.12.5623; Igura K, 2004, CYTOTHERAPY, V6, P543, DOI 10.1080/14653240410005366-1; Inoue T, 2005, J IMMUNOL, V174, P4301, DOI 10.4049/jimmunol.174.7.4301; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kawai M, 2007, BIOCHEM BIOPH RES CO, V363, P276, DOI 10.1016/j.bbrc.2007.08.088; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Li HW, 2006, BIOCHEM BIOPH RES CO, V341, P320, DOI 10.1016/j.bbrc.2005.12.182; Li YP, 2008, J IMMUNOL, V180, P1598, DOI 10.4049/jimmunol.180.3.1598; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Mittelstadt PR, 2005, CELL CYCLE, V4, P1189, DOI 10.4161/cc.4.9.2043; Mongan NP, 2006, MOL CARCINOGEN, V45, P887, DOI 10.1002/mc.20186; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Otto WR, 2004, CELL PROLIFERAT, V37, P97, DOI 10.1111/j.1365-2184.2004.00303.x; Pal R, 2009, CYTOTHERAPY, V11, P897, DOI 10.3109/14653240903253857; Park JR, 2008, CELL PROLIFERAT, V41, P859, DOI 10.1111/j.1365-2184.2008.00565.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peng J, 2009, IN VITRO CELL DEV-AN, V45, P558, DOI 10.1007/s11626-009-9223-4; Platt MO, 2009, STEM CELLS, V27, P2804, DOI 10.1002/stem.215; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Roche S, 2007, J CELL BIOCHEM, V101, P271, DOI 10.1002/jcb.21185; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Seo KW, 2009, BIOCHEM BIOPH RES CO, V384, P120, DOI 10.1016/j.bbrc.2009.04.094; SHI Y, 1997, BIOCHIM BIOPHYS ACTA, V1332, P49; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Xu J, 2008, J MOL BIOL, V377, P28, DOI 10.1016/j.jmb.2007.12.038; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130	65	50	52	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10493	10.1371/journal.pone.0010493	http://dx.doi.org/10.1371/journal.pone.0010493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463961	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379400027
J	Smith, DP; Kitner, JB; Norbeck, AD; Clauss, TR; Lipton, MS; Schwalbach, MS; Steindler, L; Nicora, CD; Smith, RD; Giovannoni, SJ				Smith, Daniel P.; Kitner, Joshua B.; Norbeck, Angela D.; Clauss, Therese R.; Lipton, Mary S.; Schwalbach, Michael S.; Steindler, Laura; Nicora, Carrie D.; Smith, Richard D.; Giovannoni, Stephen J.			Transcriptional and Translational Regulatory Responses to Iron Limitation in the Globally Distributed Marine Bacterium Candidatus Pelagibacter Ubique	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; EQUATORIAL PACIFIC-OCEAN; COLD-SHOCK PROTEINS; DNA-BINDING SITE; ESCHERICHIA-COLI; GENE-EXPRESSION; IRR PROTEIN; CSPA-FAMILY; BRADYRHIZOBIUM-JAPONICUM; MASS-SPECTROMETRY	Iron is recognized as an important micronutrient that limits microbial plankton productivity over vast regions of the oceans. We investigated the gene expression responses of Candidatus Pelagibacter ubique cultures to iron limitation in natural seawater media supplemented with a siderophore to chelate iron. Microarray data indicated transcription of the periplasmic iron binding protein sfuC increased by 16-fold, and iron transporter subunits, iron-sulfur center assembly genes, and the putative ferroxidase rubrerythrin transcripts increased to a lesser extent. Quantitative peptide mass spectrometry revealed that sfuC protein abundance increased 27-fold, despite an average decrease of 59% across the global proteome. Thus, we propose sfuC as a marker gene for indicating iron limitation in marine metatranscriptomic and metaproteomic ecological surveys. The marked proteome reduction was not directly correlated to changes in the transcriptome, implicating post-transcriptional regulatory mechanisms as modulators of protein expression. Two RNA-binding proteins, CspE and CspL, correlated well with iron availability, suggesting that they may contribute to the observed differences between the transcriptome and proteome. We propose a model in which the RNA-binding activity of CspE and CspL selectively enables protein synthesis of the iron acquisition protein SfuC during transient growth-limiting episodes of iron scarcity.	[Smith, Daniel P.] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA; [Kitner, Joshua B.; Schwalbach, Michael S.; Steindler, Laura; Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Norbeck, Angela D.; Clauss, Therese R.; Lipton, Mary S.; Nicora, Carrie D.; Smith, Richard D.] Pacific NW Natl Lab, Biol & Computat Sci Div, Richland, WA 99352 USA	Oregon State University; Oregon State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Smith, DP (corresponding author), Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	Smith, Daniel/L-6827-2019; Smith, Richard D/J-3664-2012; Lipton, Mary S/H-3913-2012	Smith, Daniel/0000-0002-2479-2044; Smith, Richard D/0000-0002-2381-2349; 	Gordon and Betty Moore Foundation [607_01]; U.S. Department of Energy's Office of Biological and Environmental Research, located at Pacific Northwest National Laboratory; DOE [DE-AC05-76RL01830]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); U.S. Department of Energy's Office of Biological and Environmental Research, located at Pacific Northwest National Laboratory; DOE(United States Department of Energy (DOE))	This work was supported by Marine Microbiology Initiative award number 607_01 from the Gordon and Betty Moore Foundation (http://www.moore.org/). Portions of this research were performed at the W. R. Wiley Environmental Molecular Science Laboratory, a national scientific user facility sponsored by the U.S. Department of Energy's Office of Biological and Environmental Research, located at Pacific Northwest National Laboratory (http://www.pnl.gov/). PNNL is operated by Battelle Memorial Institute under DOE contract DE-AC05-76RL01830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; Dubrac S, 2000, J BACTERIOL, V182, P3802, DOI 10.1128/JB.182.13.3802-3808.2000; Ducey TF, 2005, J BACTERIOL, V187, P4865, DOI 10.1128/JB.187.14.4865-4874.2005; Ermolenko DN, 2002, CELL MOL LIFE SCI, V59, P1902, DOI 10.1007/PL00012513; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Friedman YE, 2003, J BIOL CHEM, V278, P38395, DOI 10.1074/jbc.M306710200; Fuangthong M, 2003, J BACTERIOL, V185, P6348, DOI 10.1128/JB.185.21.6348-6357.2003; Fung IY, 2000, GLOBAL BIOGEOCHEM CY, V14, P281, DOI 10.1029/1999GB900059; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Geissmann T, 2009, RNA BIOL, V6, P153, DOI 10.4161/rna.6.2.8047; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; GOLDMAN JC, 1984, B MAR SCI, V35, P462; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Henkin TM, 2000, CURR OPIN MICROBIOL, V3, P149, DOI 10.1016/S1369-5274(00)00067-9; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Hofweber R, 2005, FEBS J, V272, P4691, DOI 10.1111/j.1742-4658.2005.04885.x; Hu KH, 1996, GENETICS, V143, P1521; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lavrrar JL, 2003, J BACTERIOL, V185, P2194, DOI 10.1128/JB.185.7.2194-2202.2003; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Malmstrom RR, 2005, APPL ENVIRON MICROB, V71, P2979, DOI 10.1128/AEM.71.6.2979-2986.2005; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MARTIN JH, 1990, NATURE, V345, P156, DOI 10.1038/345156a0; Martinez M, 2005, MICROBIOL-SGM, V151, P3427, DOI 10.1099/mic.0.28213-0; Marzi S, 2008, BIOL CHEM, V389, P585, DOI 10.1515/BC.2008.055; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Meyer MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-268; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Nie L, 2007, CRIT REV BIOTECHNOL, V27, P63, DOI 10.1080/07388550701334212; Phadtare S, 2003, METHOD ENZYMOL, V371, P460; Phadtare S, 1999, MOL MICROBIOL, V33, P1004, DOI 10.1046/j.1365-2958.1999.01541.x; Phadtare S, 2001, J BACTERIOL, V183, P1205, DOI 10.1128/JB.183.4.1205-1214.2001; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; SCHWALBACH MS, 2009, ENV MICROBIOL; Sowell SM, 2008, APPL ENVIRON MICROB, V74, P4091, DOI 10.1128/AEM.00599-08; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Stulke J, 2002, ARCH MICROBIOL, V177, P433, DOI 10.1007/s00203-002-0407-5; Tiss A, 2005, FEBS LETT, V579, P5454, DOI 10.1016/j.febslet.2005.08.067; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; Vecerek B, 2007, EMBO J, V26, P965, DOI 10.1038/sj.emboj.7601553; VENTURI V, 1995, MOL MICROBIOL, V15, P1081, DOI 10.1111/j.1365-2958.1995.tb02283.x; Vergara SV, 2008, BIOCHEM SOC T, V36, P1088, DOI 10.1042/BST0361088; Vraspir JM, 2009, ANNU REV MAR SCI, V1, P43, DOI 10.1146/annurev.marine.010908.163712; Wilhelm SW, 1996, LIMNOL OCEANOGR, V41, P89, DOI 10.4319/lo.1996.41.1.0089; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Wu G, 2008, CURR MICROBIOL, V57, P18, DOI 10.1007/s00284-008-9145-5; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200	72	34	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10487	10.1371/journal.pone.0010487	http://dx.doi.org/10.1371/journal.pone.0010487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463970	gold, Green Published, Green Submitted			2022-12-25	WOS:000277379400023
J	Rao, PK; Missiaglia, E; Shields, L; Hyde, G; Yuan, BB; Shepherd, CJ; Shipley, J; Lodish, HF				Rao, Prakash K.; Missiaglia, Edoardo; Shields, Lauren; Hyde, Greg; Yuan, Bingbing; Shepherd, Christopher J.; Shipley, Janet; Lodish, Harvey F.			Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells	FASEB JOURNAL			English	Article						microRNA; muscle; tumor	MUSCLE-SPECIFIC MICRORNA; SKELETAL-MUSCLE; EXPRESSION SIGNATURE; GENE-EXPRESSION; IDENTIFICATION; TARGET; MYOGENESIS; INDUCE; MYOD	Rhabdomyosarcoma is the most common soft tissue sarcoma in the pediatric population. As this tumor has an undifferentiated myogenic phenotype, agents that promote differentiation hold particular promise as part of a novel therapeutic approach to combat this type of cancer. In this report, we focus on the contribution of two microRNAs (miRNAs) in rhabdomyosarcomas. Levels of miR-1 and miR-133a are drastically reduced in representative cell lines from each major rhabdomyosarcoma subtype (embryonal and alveolar). Introduction of miR-1 and miR-133a into an embryonal rhabdomyosarcoma-derived cell line is cytostatic, thereby suggesting a tumor suppressor-like role for these myogenic miRNAs. Transcriptional profiling of cells after miR-1 and miR-133a expression reveals that miR-1 (but not miR-133a) exerts a strong promyogenic influence on these poorly differentiated tumor cells. We identify mRNAs that are down-regulated by these miRNAs and propose roles for miR-1 and miR-133a in repressing isoforms of genes that are normally not expressed in muscle. Finally, we show that mRNA targets of miR-1 and miR-133a are up-regulated in rhabdomyosarcomas, suggesting a causative role for these miRNAs in the development of rhabdomyosarcomas. More important, these results point to the promise of enhancing rhabdomyosarcoma therapy using miRNAs as agents that mediate cytostasis and promote muscle differentiation.-Rao, P. K., Missiaglia, E., Shields, L., Hyde, G., Yuan, B., Shepherd, C. J., Shipley, J., Lodish, H. F. Distinct roles for Mir-1 and Mir-133a in the proliferation and differentiation of rhabdomyosarcoma cells. FASEB J. 24, 3427-3437 (2010). www.fasebj.org	[Rao, Prakash K.; Shields, Lauren; Hyde, Greg; Yuan, Bingbing; Lodish, Harvey F.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Missiaglia, Edoardo; Shepherd, Christopher J.; Shipley, Janet] Inst Canc Res, Mol Cytogenet Team, Sutton, Surrey, England; [Shields, Lauren; Lodish, Harvey F.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of London; Institute of Cancer Research - UK; Massachusetts Institute of Technology (MIT)	Lodish, HF (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lodish@wi.mit.edu		missiaglia, edoardo/0000-0001-9221-0117; Shipley, Janet/0000-0001-6748-8678	National Institutes of Health [R01 DK068348]; Chris Lucas Trust; Cancer Research UK [C5066/A9541]; Muscular Dystrophy Association (MDA) [3882]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chris Lucas Trust; Cancer Research UK(Cancer Research UK); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work in H. F. L.'s laboratory was supported by National Institutes of Health grant R01 DK068348, and work in J.S.'s laboratory was supported by the Chris Lucas Trust and by Cancer Research UK (C5066/A9541). P. K. R. was supported by the Muscular Dystrophy Association (MDA grant 3882) and thanks members of the H. F. L. and David Bartel (Whitehead Institute for Biomedical Research, Cambridge, MA, USA) laboratories for their insightful comments.	Anderson J, 1999, GENE CHROMOSOME CANC, V26, P275, DOI 10.1002/(SICI)1098-2264(199912)26:4<275::AID-GCC1>3.0.CO;2-3; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; BOUCHE M, 1993, EXP CELL RES, V208, P209, DOI 10.1006/excr.1993.1239; Carey KA, 2006, PATHOL INT, V56, P246, DOI 10.1111/j.1440-1827.2006.01958.x; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; HORN RC, 1958, CANCER, V11, P181, DOI 10.1002/1097-0142(195801/02)11:1<181::AID-CNCR2820110130>3.0.CO;2-I; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Missiaglia E, 2009, GENE CHROMOSOME CANC, V48, P455, DOI 10.1002/gcc.20655; Morotti RA, 2006, AM J SURG PATHOL, V30, P962, DOI 10.1097/00000478-200608000-00005; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; Taniguchi E, 2008, ONCOGENE, V27, P6550, DOI 10.1038/onc.2008.255; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	39	108	112	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3427	3437		10.1096/fj.09-150698	http://dx.doi.org/10.1096/fj.09-150698			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20466878	Green Published			2022-12-25	WOS:000281446400030
J	Unsworth, H; Raguz, S; Edwards, HJ; Higgins, CF; Yague, E				Unsworth, H.; Raguz, S.; Edwards, H. J.; Higgins, C. F.; Yaguee, E.			mRNA escape from stress granule sequestration is dictated by localization to the endoplasmic reticulum	FASEB JOURNAL			English	Article						membrane proteins; RNA localization; drug resistance; P-glycoprotein; TIA-1	P-GLYCOPROTEIN; TRANSLATION; PROTEINS; CELLS; MEMBRANE; BINDING; CANCER; COMPARTMENT; EXPRESSION; INITIATION	In mammalian cells, cytotoxic stress triggers several signaling cascades that converge in the phosphorylation of translation initiation factor 2 alpha, shuttling of nuclear RNA-binding proteins such as TIA-1 to the cytoplasm, and aggregation of most cellular mRNAs into TIA-1-containing stress granules (SGs). As a result, protein synthesis is greatly impaired. Here we describe different dynamics of endogenous transcripts according to their cellular location, in response to stress. While cytosolic mRNAs aggregate into SGs, endoplasmic reticulum (ER) -bound transcripts escape sequestration. This has been specifically demonstrated using the multidrug resistance transporter gene (MDR1) as a model and showing that chimeric RNA constructs can be directed to the cytosol or tethered to the ER depending on the nature of the chimera, in response to stress. In addition, polysome profile analyses indicate that, on stress, ribosomes do not disengage from ER-associated transcripts (puromycin insensitive) and recover their translation status faster than SG-targeted cytosolic mRNAs once the stress is lifted. These findings have important implications for cell survival given that many membrane proteins, which are translated at the ER, have important roles in detoxification.-Unsworth, H., Raguz, S., Edwards, H. J., Higgins, C. F., Yague, E. mRNA escape from stress granule sequestration is dictated by localization to the endoplasmic reticulum. FASEB J. 24, 3370-3380 (2010). www.fasebj.org	[Yaguee, E.] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London W12 0NN, England; [Unsworth, H.; Raguz, S.; Edwards, H. J.; Higgins, C. F.; Yaguee, E.] MRC, Ctr Clin Sci, London, England	Imperial College London	Yague, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Oncol, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	ernesto.yague@imperial.ac.uk			UK Medical Research Council (MRC); MRC	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Tristan Rodriguez for his advice on FISH hybridization techniques, Ana Pombo and Sheila Quingchun Xie for their advice on confocal microscopy, and Anne Willis, Christopher Proud, Michael Clemens, Jeremy Brown, and John E. Hesketh for their helpful comments at various stages of the project. This work was funded by the UK Medical Research Council (MRC). H.U. was the recipient of an MRC Career Development Fellowship. The authors declare no conflict of interest.	Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anthony V, 2002, CURR PROTEIN PEPT SC, V3, P485, DOI 10.2174/1389203023380503; Blott EJ, 1999, EMBO J, V18, P6800, DOI 10.1093/emboj/18.23.6800; BONIFACINO JS, 1998, CURRENT PROTOCOLS MO; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Callaghan R, 2008, J CLIN PHARMACOL, V48, P365, DOI 10.1177/0091270007311568; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kostenko EV, 2000, FEBS LETT, V475, P181, DOI 10.1016/S0014-5793(00)01650-1; Lerner RS, 2006, RNA, V12, P775, DOI 10.1261/rna.2318906; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; Liscovitch M, 2007, CANCER LETT, V245, P350, DOI 10.1016/j.canlet.2006.01.013; Marnbula SS, 2007, METHODS, V43, P168, DOI 10.1016/j.ymeth.2007.06.009; Modok S, 2006, CURR OPIN PHARMACOL, V6, P350, DOI 10.1016/j.coph.2006.01.009; Nicchitta CV, 2005, BIOCHEM CELL BIOL, V83, P687, DOI 10.1139/O05-147; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Raguz S, 2008, INT J CANCER, V122, P1058, DOI 10.1002/ijc.23149; Randle RA, 2007, BIOCHEM J, V406, P445, DOI 10.1042/BJ20070235; Sivan G, 2007, MOL CELL BIOL, V27, P6639, DOI 10.1128/MCB.00798-07; SKACH WR, 1993, J BIOL CHEM, V268, P23552; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; Stohr N, 2006, J CELL BIOL, V175, P527, DOI 10.1083/jcb.200608071; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Yague E, 2003, J BIOL CHEM, V278, P10344, DOI 10.1074/jbc.M211093200; Zhang JT, 1996, MOL BIOL CELL, V7, P1709, DOI 10.1091/mbc.7.11.1709	34	49	51	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3370	3380		10.1096/fj.09-151142	http://dx.doi.org/10.1096/fj.09-151142			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20453113	Green Submitted			2022-12-25	WOS:000281446400025
J	Li, YR; Xu, W; Tang, Y				Li, Yanran; Xu, Wei; Tang, Yi			Classification, Prediction, and Verification of the Regioselectivity of Fungal Polyketide Synthase Product Template Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-CLUSTER; AROMATIC POLYKETIDES; ENZYMATIC-SYNTHESIS; MOLECULAR ANALYSIS; NATURAL-PRODUCTS; BIOSYNTHESIS; IDENTIFICATION; EXPRESSION; RADICICOL; MECHANISM	The fungal iterative nonreducing polyketide synthases (NRPKSs) synthesize aromatic polyketides, many of which have important biological activities. The product template domains (PT) embedded in the multidomain NRPKSs mediate the regio-selective cyclization of the highly reactive polyketide backbones and dictate the final structures of the products. Understanding the sequence-activity relationships of different PT domains is therefore an important step toward the prediction of polyketide structures from NRPKS sequences and can enable the genome mining of hundreds of cryptic NRPKSs uncovered via genome sequencing. In this work, we first performed phylogenetic analysis of PT domains from NRPKSs of known functions and showed that the PT domains can be classified into five groups, with each group corresponding to a unique product size or cyclization regioselectivity. Group V contains the formerly unverified PT domains that were identified as C6-C11 aldol cyclases. The regioselectivity of PTs from this group were verified by product-based assays using the PT domain excised from the asperthecin AptA NRPKS. When combined with dissociated PKS4 minimal PKS, or replaced the endogenous PKS4 C2-C7 PT domain in a hybrid NRPKS, AptA-PT directed the C6-C11 cyclization of the nonaketide backbone to yield a tetracyclic pyranoanthraquinone 4. Extensive NMR analysis verified that the backbone of 4 was indeed cyclized with the expected regioselectivity. The PT phylogenetic analysis was then expanded to include similar to 100 PT sequences from unverified NRPKSs. Using the assays developed for AptA-PT, the regioselectivities of additional PT domains were investigated and matched to those predicted by the phylogenetic classifications.	[Li, Yanran; Xu, Wei; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tang, Y (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.	yitang@ucla.edu		Li, Yanran/0000-0001-8709-3497	National Institutes of Health [1R01GM085128]; David and Lucile Packard Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM085128 and a David and Lucile Packard Fellowship (to Y.T.).	An JH, 1998, EUR J BIOCHEM, V257, P395, DOI 10.1046/j.1432-1327.1998.2570395.x; Awakawa T, 2009, CHEM BIOL, V16, P613, DOI 10.1016/j.chembiol.2009.04.004; Bailey AM, 2007, CHEM COMMUN, P4053, DOI 10.1039/b708614h; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Brakhage Axel A., 2008, V66; Breinholt J, 1997, ACTA CHEM SCAND, V51, P855, DOI 10.3891/acta.chem.scand.51-0855; Bringmann G, 2006, NAT CHEM BIOL, V2, P429, DOI 10.1038/nchembio805; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; Chen HQ, 2007, MOL MICROBIOL, V64, P755, DOI 10.1111/j.1365-2958.2007.05689.x; Chooi YH, 2010, CHEM BIOL, V17, P483, DOI 10.1016/j.chembiol.2010.03.015; Corre C, 2009, NAT PROD REP, V26, P977, DOI 10.1039/b713024b; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Crawford JM, 2008, SCIENCE, V320, P243, DOI 10.1126/science.1154711; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Crawford JM, 2009, NATURE, V461, P1139, DOI 10.1038/nature08475; Fujii I, 2001, CHEM BIOL, V8, P189, DOI 10.1016/S1074-5521(00)90068-1; Fujii I, 2004, J BIOL CHEM, V279, P44613, DOI 10.1074/jbc.M406758200; Fujii I, 2000, BIOCHEMISTRY-US, V39, P8853, DOI 10.1021/bi000644j; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; JESUS A, 1982, J CHEM SOC CHEM COMM, P902; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kim JE, 2005, APPL ENVIRON MICROB, V71, P1701, DOI 10.1128/AEM.71.4.1701-1708.2005; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linnemannstons P, 2002, FUNGAL GENET BIOL, V37, P134, DOI 10.1016/S1087-1845(02)00501-7; Ma SM, 2008, J AM CHEM SOC, V130, P38, DOI 10.1021/ja078091o; Ma SM, 2007, J AM CHEM SOC, V129, P10642, DOI 10.1021/ja074865p; Ma Y, 2006, CHEMBIOCHEM, V7, P1951, DOI 10.1002/cbic.200600341; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; MCDANIEL R, 1995, NATURE, V375, P549, DOI 10.1038/375549a0; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Rawlings BJ, 1999, NAT PROD REP, V16, P425, DOI 10.1039/a900566h; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Schumann J, 2006, J BIOTECHNOL, V124, P690, DOI 10.1016/j.jbiotec.2006.03.046; Szewczyk E, 2008, APPL ENVIRON MICROB, V74, P7607, DOI 10.1128/AEM.01743-08; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas R, 2001, CHEMBIOCHEM, V2, P612, DOI 10.1002/1439-7633(20010903)2:9<612::AID-CBIC612>3.0.CO;2-Z; Tominaga M, 2006, APPL ENVIRON MICROB, V72, P484, DOI 10.1128/AEM.72.1.484-490.2006; Tsai HF, 2001, J BIOL CHEM, V276, P29292, DOI 10.1074/jbc.M101998200; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Udwary DW, 2002, J MOL BIOL, V323, P585, DOI 10.1016/S0022-2836(02)00972-5; Wang SH, 2008, CHEM BIOL, V15, P1328, DOI 10.1016/j.chembiol.2008.10.006; Wattana-Amorn P, 2010, BIOCHEMISTRY-US, V49, P2186, DOI 10.1021/bi902176v; Yoder OC, 2001, CURR OPIN PLANT BIOL, V4, P315, DOI 10.1016/S1369-5266(00)00179-5; Zhang WJ, 2008, P NATL ACAD SCI USA, V105, P20683, DOI 10.1073/pnas.0809084105; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105; Zhou H, 2010, J AM CHEM SOC, V132, P4530, DOI 10.1021/ja100060k; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	54	73	82	1	39	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22762	22771		10.1074/jbc.M110.128504	http://dx.doi.org/10.1074/jbc.M110.128504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20479000	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000279999900008
J	Dresen, C; Lin, LYC; D'Angelo, I; Tocheva, EI; Strynadka, N; Eltis, LD				Dresen, Carola; Lin, Leo Y. -C.; D'Angelo, Igor; Tocheva, Elitza I.; Strynadka, Natalie; Eltis, Lindsay D.			A Flavin-dependent Monooxygenase from Mycobacterium tuberculosis Involved in Cholesterol Catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; ESCHERICHIA-COLI; 3-KETOSTEROID 9-ALPHA-HYDROXYLASE; CHLOROPHENOL 4-MONOOXYGENASE; FUNCTIONAL-CHARACTERIZATION; DIFFRACTION DATA; REDUCED FLAVIN; GENE-CLUSTER; 2-COMPONENT; PURIFICATION	Mycobacterium tuberculosis (Mtb) and Rhodococcus jostii RHA1 have similar cholesterol catabolic pathways. This pathway contributes to the pathogenicity of Mtb. The hsaAB cholesterol catabolic genes have been predicted to encode the oxygenase and reductase, respectively, of a flavin-dependent mono-oxygenase that hydroxylates 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17- dione (3-HSA) to a catechol. An hsaA deletion mutant of RHA1 did not grow on cholesterol but transformed the latter to 3-HSA and related metabolites in which each of the two keto groups was reduced: 3,9-dihydroxy-9,10-seconandrost-1,3,5(10)-triene- 17-one (3,9-DHSA) and 3,17-dihydroxy-9,10-seconandrost-1,3,5( 10)-triene-9-one (3,17-DHSA). Purified 3-hydroxy-9,10- seconandrost-1,3,5(10)-triene-9,17-dione 4-hydroxylase (HsaAB) from Mtb had higher specificity for 3-HSA than for 3,17-DHSA (apparent k(cat)/K-m =1000 +/- 100 M-1 s(-1) versus 700 +/- 100 M-1 s(-1)). However, 3,9-DHSA was a poorer substrate than 3-hydroxybiphenyl (apparent k(cat)/K-m = 80 +/- 40 M-1 s(-1)). In the presence of 3-HSA the K-mapp for O-2 was 100 +/- 10 mu M. The crystal structure of HsaA to 2.5-angstrom resolution revealed that the enzyme has the same fold, flavin-binding site, and catalytic residues as p-hydroxyphenyl acetate hydroxylase. However, HsaA has a much larger phenol-binding site, consistent with the enzyme's substrate specificity. In addition, a second crystal form of HsaA revealed that a C-terminal flap (Val(367)-Val(394)) could adopt two conformations differing by a rigid body rotation of 25 degrees around Arg(366). This rotation appears to gate the likely flavin entrance to the active site. In docking studies with 3-HSA and flavin, the closed conformation provided a rationale for the enzyme's substrate specificity. Overall, the structural and functional data establish the physiological role of HsaAB and provide a basis to further investigate an important class of monooxygenases as well as the bacterial catabolism of steroids.	[Dresen, Carola; Tocheva, Elitza I.; Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Lin, Leo Y. -C.; D'Angelo, Igor; Strynadka, Natalie; Eltis, Lindsay D.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Tocheva, Elitza I.] CALTECH, Pasadena, CA 91125 USA	University of British Columbia; University of British Columbia; California Institute of Technology	Eltis, LD (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@interchange.ubc.ca	Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158	Canadian Institute for Health Research; Michael Smith Foundation for Health Research (MSFHR); Emerging Team programs; Deutsche Forschungsgemeinschaft	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Emerging Team programs; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Canadian Institute for Health Research (to L. D. E. and N.S., respectively) and the Michael Smith Foundation for Health Research (MSFHR) Infrastructure (to N.S.) and Emerging Team programs.; Recipient of a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Becker D, 1997, EUR J BIOCHEM, V249, P739, DOI 10.1111/j.1432-1033.1997.t01-1-00739.x; Bhandari P, 1997, J BACTERIOL, V179, P4403, DOI 10.1128/jb.179.13.4403-4406.1997; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Clark-Curtiss JE, 2003, ANNU REV MICROBIOL, V57, P517, DOI 10.1146/annurev.micro.57.030502.090903; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; ELTIS LD, 1994, PROTEIN ENG, V7, P1145, DOI 10.1093/protein/7.9.1145; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Hunter RL, 2006, AM J PATHOL, V168, P1249, DOI 10.2353/ajpath.2006.050848; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kadiyala V, 1998, APPL ENVIRON MICROB, V64, P2479; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Lack NA, 2010, J BIOL CHEM, V285, P434, DOI 10.1074/jbc.M109.058081; Mathieu JM, 2010, APPL ENVIRON MICROB, V76, P352, DOI 10.1128/AEM.02538-09; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakashima N, 2004, APPL ENVIRON MICROB, V70, P5557, DOI 10.1128/AEM.70.9.5557-5568.2004; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Payne JW, 1998, J BACTERIOL, V180, P3823, DOI 10.1128/JB.180.15.3823-3827.1998; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; THIBAUT D, 1995, J BACTERIOL, V177, P5199, DOI 10.1128/jb.177.18.5199-5205.1995; Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; van der Geize R, 2004, CURR OPIN MICROBIOL, V7, P255, DOI 10.1016/j.mib.2004.04.001; van der Geize R, 2000, APPL ENVIRON MICROB, V66, P2029, DOI 10.1128/AEM.66.5.2029-2036.2000; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; van der Geize R, 2002, MICROBIOL-SGM, V148, P3285, DOI 10.1099/00221287-148-10-3285; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Xu YR, 1997, J BACTERIOL, V179, P1112, DOI 10.1128/jb.179.4.1112-1116.1997; Xun LY, 1996, J BACTERIOL, V178, P2645, DOI 10.1128/jb.178.9.2645-2649.1996; Xun LY, 2000, APPL ENVIRON MICROB, V66, P481, DOI 10.1128/AEM.66.2.481-486.2000; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x; Ying Z, 2005, ANNU REV PHARMACOL, V45, P529, DOI 10.1146/annurev.pharmtox.45.120403.100120	56	80	88	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22264	22275		10.1074/jbc.M109.099028	http://dx.doi.org/10.1074/jbc.M109.099028			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20448045	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000279702200039
J	Watanabe, R; Murai, MJ; Singh, CR; Fox, S; Ii, M; Asano, K				Watanabe, Ryosuke; Murai, Marcelo Jun; Singh, Chingakham Ranjit; Fox, Stephanie; Ii, Miki; Asano, Katsura			The Eukaryotic Initiation Factor (eIF) 4G HEAT Domain Promotes Translation Re-initiation in Yeast Both Dependent on and Independent of eIF4A mRNA Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START CODON SELECTION; 40S RIBOSOMAL-SUBUNIT; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; BINDING; GCN4; COMPLEX; ROLES; REINITIATION; REGION	Translation re-initiation provides the molecular basis for translational control of mammalian ATF4 and yeast GCN4 mediated by short upstream open reading (uORFs) in response to eIF2 phosphorylation. eIF4G is the major adaptor subunit of eIF4F that binds the cap-binding subunit eIF4E and the mRNA helicase eIF4A and is also required for re-initiation in mammals. Here we show that the yeast eIF4G2 mutations altering eIF4E-and eIF4A-binding sites increase re-initiation at GCN4 and impair recognition of the start codons of uORF1 or uORF4 located after uORF1. The increase in re-initiation at GCN4 was partially suppressed by increasing the distance between uORF1 and GCN4, suggesting that the mutations decrease the migration rate of the scanning ribosome in the GCN4 leader. Interestingly, eIF4E overexpression suppressed both the phenotypes caused by the mutation altering eIF4E-binding site. Thus, eIF4F is required for accurate AUG selection and re-initiation also in yeast, and the eIF4G interaction with the mRNA-cap appears to promote eIF4F re-acquisition by the re-initiating 40 S subunit. However, eIF4A overexpression suppressed the impaired AUG recognition but not the increase in re-initiation caused by the mutations altering eIF4A-binding site. These results not only provide evidence that mRNA unwinding by eIF4A stimulates start codon recognition, but also suggest that the eIF4A-binding site on eIF4G made of the HEAT domain stimulates the ribosomal scanning independent of eIF4A. Based on the RNA-binding activities identified within the unstructured segments flanking the eIF4G2 HEAT domain, we discuss the role of the HEAT domain in scanning beyond loading eIF4A onto the pre-initiation complex.	[Watanabe, Ryosuke; Murai, Marcelo Jun; Singh, Chingakham Ranjit; Fox, Stephanie; Ii, Miki; Asano, Katsura] Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA	Kansas State University	Asano, K (corresponding author), Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Ackert Hall, Manhattan, KS 66506 USA.	kasano@ksu.edu			National Institutes of Health [R01 GM64781]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM64781 (to K.A.).	ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Asano K, 2007, GENE DEV, V21, P1280, DOI 10.1101/gad.1562707; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; DONAHUE TF, 1988, MOL CELL BIOL, V8, P2955, DOI 10.1128/MCB.8.7.2955; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Laurino JP, 1999, MOL CELL BIOL, V19, P173; LAZAROWITZ SG, 1977, J BIOL CHEM, V252, P7842; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marintchev A, 2005, BIOCHEMISTRY-US, V44, P12265, DOI 10.1021/bi051271v; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Neff CL, 1999, MOL CELL BIOL, V19, P5557; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Prevot D, 2003, EMBO J, V22, P1909, DOI 10.1093/emboj/cdg175; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; Singh CR, 2006, EMBO J, V25, P4537, DOI 10.1038/sj.emboj.7601339; Singh CR, 2007, METHOD ENZYMOL, V429, P139, DOI 10.1016/S0076-6879(07)29007-X; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Szamecz B, 2008, GENE DEV, V22, P2414, DOI 10.1101/gad.480508; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tarun SZ, 1997, MOL CELL BIOL, V17, P6876, DOI 10.1128/MCB.17.12.6876; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; WEI CL, 1995, J BIOL CHEM, V270, P5764, DOI 10.1074/jbc.270.11.5764; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	45	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21922	21933		10.1074/jbc.M110.132027	http://dx.doi.org/10.1074/jbc.M110.132027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463023	Green Published, hybrid			2022-12-25	WOS:000279702200004
J	Zheng, H; Chu, J; Zeng, Y; Loh, HH; Law, PY				Zheng, Hui; Chu, Ji; Zeng, Yan; Loh, Horace H.; Law, Ping-Yee			Yin Yang 1 Phosphorylation Contributes to the Differential Effects of mu-Opioid Receptor Agonists on MicroRNA-190 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR YY1; F-ACTIN; DENDRITIC SPINE; MECHANISMS; NEUROGENESIS; TALIN2; BACE1	mu-Opioid receptor regulates microRNA-190 (miR-190) in an agonist-dependent manner; fentanyl, but not morphine, decreases the miR-190 level in rat primary hippocampal neuron cultures and in mouse hippocampi. In this study, the correlation between the cellular content of miR-190 and the mRNA level of its host gene, talin2, suggested that fentanyl decreases the miR-190 level by inhibiting the transcription of talin2. Fentanyl-induced beta-arrestin2-mediated ERK phosphorylation led to the phosphorylation of Yin Yang 1(YY1). In addition, YY1 phosphorylation impaired the association of YY1 with the -208 to -200 region on the Talin2 promoter, and this association was essential for YY1 to stimulate the transcription of talin2. Thus, fentanyl decreased the transcription of talin2 and subsequently the cellular level of miR-190 by inducing YY1 phosphorylation. In contrast, because morphine induces ERK phosphorylation via the protein kinase C pathway, morphine did not induce YY1 phosphorylation and had no effect on the transcription of talin2 and the cellular content of miR-190. This study therefore delineates a signaling pathway that mediates the effects of fentanyl on miR-190 expression.	[Zheng, Hui; Chu, Ji; Zeng, Yan; Loh, Horace H.; Law, Ping-Yee] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Zheng, H (corresponding author), 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	zhen0091@umn.edu		Law, Ping-Yee/0000-0002-5364-1093; Zheng, Hui/0000-0001-6801-0529	National Institutes of Health [DA007339, DA016674, DA000564, DA011806, K05-DA70544, K05-DA00513]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016674, K05DA000513, K05DA070554, R56DA000564, R01DA000564, R01DA007339, P50DA011806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA007339, DA016674, DA000564, and DA011806.; Recipient of National Institutes of Health Grant K05-DA70544.; Recipient of National Institutes of Health Grant K05-DA00513.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BECKER KG, 1994, GENE, V150, P259, DOI 10.1016/0378-1119(94)90435-9; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Liao D, 2005, P NATL ACAD SCI USA, V102, P1725, DOI 10.1073/pnas.0406797102; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Nishizaki T, 2007, NEW DIAM FRONT C TEC, V17, P21; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Senetar MA, 2007, CELL MOTIL CYTOSKEL, V64, P157, DOI 10.1002/cm.20173; Seo HM, 1996, J NEUROSCI, V16, P4102; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Stockley JH, 2008, CELL MOL LIFE SCI, V65, P3265, DOI 10.1007/s00018-008-8271-3; Tamada A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-29; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Tsuchiya S, 2006, J PHARMACOL SCI, V101, P267, DOI 10.1254/jphs.CPJ06013X; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Yue R, 2009, CELL, V139, P535, DOI 10.1016/j.cell.2009.08.038; Zeng Y, 2006, ONCOGENE, V25, P6156, DOI 10.1038/sj.onc.1209908; Zheng H, 2008, P NATL ACAD SCI USA, V105, P9421, DOI 10.1073/pnas.0802253105; Zheng H, 2010, IUBMB LIFE, V62, P112, DOI 10.1002/iub.293; Zheng H, 2010, MOL PHARMACOL, V77, P102, DOI 10.1124/mol.109.060848	37	55	63	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21994	22002		10.1074/jbc.M110.112607	http://dx.doi.org/10.1074/jbc.M110.112607			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20457614	Green Published, hybrid			2022-12-25	WOS:000279702200012
J	Juul, T; Malolepszy, A; Dybkaer, K; Kidmose, R; Rasmussen, JT; Andersen, GR; Johnsen, HE; Jorgensen, JE; Andersen, SU				Juul, Trine; Malolepszy, Anna; Dybkaer, Karen; Kidmose, Rune; Rasmussen, Jan Trige; Andersen, Gregers Rom; Johnsen, Hans Erik; Jorgensen, Jan-Elo; Andersen, Stig Uggerhoj			The in Vivo Toxicity of Hydroxyurea Depends on Its Direct Target Catalase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOTIDE REDUCTASE-ACTIVITY; RESISTANT HAMSTER-CELLS; ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; GENE-EXPRESSION; DRUG; MOUSE; OVERPRODUCTION; DISEASE; STATE	Hydroxyurea (HU) is a well tolerated ribonucleotide reductase inhibitor effective in HIV, sickle cell disease, and blood cancer therapy. Despite a positive initial response, however, most treated cancers eventually progress due to development of HU resistance. Although RNR properties influence HU resistance in cell lines, the mechanisms underlying cancer HU resistance in vivo remain unclear. To address this issue, we screened for HU resistance in the plant Arabidopsis thaliana and identified seventeen unique catalase mutants, thereby establishing that HU toxicity depends on catalase in vivo. We further demonstrated that catalase is a direct HU target by showing that HU acts as a competitive inhibitor of catalase-mediated hydrogen peroxide decomposition. Considering also that catalase can accelerate HU decomposition in vitro and that co-treatment with another catalase inhibitor alleviates HU effects in vivo, our findings suggests that HU could act as a catalase-activated pro-drug. Clinically, we found high catalase activity in circulating cells from untreated chronic myeloid leukemia, offering a possible explanation for the efficacy of HU against this malignancy.	[Jorgensen, Jan-Elo; Andersen, Stig Uggerhoj] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Dybkaer, Karen; Johnsen, Hans Erik] Aarhus Univ Hosp, Aalborg Hosp Sci & Innovat Ctr, Dept Hematol, DK-9000 Aalborg, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Andersen, SU (corresponding author), Aarhus Univ, Dept Mol Biol, Gustav Wieds Vej 10, DK-8000 Aarhus, Denmark.	sua@mb.au.dk		Rasmussen, Jan Trige/0000-0002-2809-7225; Andersen, Stig U./0000-0002-1096-1468; Dybkaer, Karen/0000-0003-2488-435X; Malolepszy, Anna/0000-0001-8862-9054; Andersen, Gregers Rom/0000-0001-6292-3319; Johnsen, Hans Erik/0000-0001-8253-2913	Danish Research Council for Technology and Production [274-06-0096]; K.E. Jensen Foundation; Proof-of-Concept grant	Danish Research Council for Technology and Production; K.E. Jensen Foundation; Proof-of-Concept grant(Luxembourg National Research Fund)	This work was supported by The Danish Research Council for Technology and Production (Grant 274-06-0096 to J.-E.J.), the K.E. Jensen Foundation (to H.E.J. and K. D.), and a Proof-of-Concept grant (to T.J., J.-E.J., and S. U. A.).	AKERBLOM L, 1981, P NATL ACAD SCI-BIOL, V78, P2159, DOI 10.1073/pnas.78.4.2159; Bachir D, 2007, HEMOGLOBIN, V31, P417, DOI 10.1080/03630260701587745; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bueso E, 2007, PLANT J, V52, P1052, DOI 10.1111/j.1365-313X.2007.03305.x; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHOY BK, 1988, CANCER RES, V48, P2029; Cokic VP, 2003, J CLIN INVEST, V111, P231, DOI 10.1172/JCI200316672; Dalziel K, 2004, HEALTH TECHNOL ASSES, V8, P1; ELFORD HL, 1968, BIOCHEM BIOPH RES CO, V33, P129, DOI 10.1016/0006-291X(68)90266-0; Elleingand E, 1998, EUR J BIOCHEM, V258, P485, DOI 10.1046/j.1432-1327.1998.2580485.x; GAO WY, 1994, MOL PHARMACOL, V46, P767; Gigon A, 2004, ANN BOT-LONDON, V94, P345, DOI 10.1093/aob/mch150; Hankins J, 2009, BRIT J HAEMATOL, V145, P296, DOI 10.1111/j.1365-2141.2009.07602.x; Ho YS, 2004, J BIOL CHEM, V279, P32804, DOI 10.1074/jbc.M404800200; Huang JM, 2004, J MED CHEM, V47, P3495, DOI 10.1021/jm030547z; HURTA RAR, 1990, BIOCHIM BIOPHYS ACTA, V1087, P165, DOI 10.1016/0167-4781(90)90201-C; Jong AY, 1998, J BIOMED SCI, V5, P62, DOI 10.1007/BF02253357; LEWIS WH, 1978, J CELL PHYSIOL, V97, P83; LEWIS WH, 1983, MOL CELL BIOL, V3, P1053, DOI 10.1128/MCB.3.6.1053; Lori F, 2007, CURR MED CHEM, V14, P233, DOI 10.2174/092986707779313336; MCCLARTY GA, 1986, SOMAT CELL MOLEC GEN, V12, P121, DOI 10.1007/BF01560659; Navarra P, 1999, CRIT REV ONCOL HEMAT, V29, P249, DOI 10.1016/S1040-8428(98)00032-8; Paton NI, 2002, LANCET, V359, P1667, DOI 10.1016/S0140-6736(02)08557-4; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Rodriguez GI, 1998, BLOOD, V91, P1533, DOI 10.1182/blood.V91.5.1533.1533_1533_1541; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; TAGGER AY, 1988, INT J CANCER, V42, P760, DOI 10.1002/ijc.2910420522; TAKAHARA S, 1952, LANCET, V263, P1101; TONIN PN, 1987, CYTOGENET CELL GENET, V45, P102, DOI 10.1159/000132438; WRIGHT JA, 1983, BIOSCIENCE REP, V3, P741, DOI 10.1007/BF01120985	30	39	39	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21411	21415		10.1074/jbc.M110.103564	http://dx.doi.org/10.1074/jbc.M110.103564			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452979	Green Published, hybrid			2022-12-25	WOS:000279516100027
J	Kumari, A; Minko, IG; Smith, RL; Lloyd, RS; McCullough, AK				Kumari, Anuradha; Minko, Irina G.; Smith, Rebecca L.; Lloyd, R. Stephen; McCullough, Amanda K.			Modulation of UvrD Helicase Activity by Covalent DNA-Protein Cross-links	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ESCHERICHIA-COLI; GENE-PRODUCT; DAMAGED DNA; BIOLOGICAL CONSEQUENCES; UNWINDING ENZYME-2; MAMMALIAN-CELLS; UVRABC NUCLEASE; POLYMERASE-I; REPLICATION	UvrD (DNA helicase II) has been implicated in DNA replication, DNA recombination, nucleotide excision repair, and methyl-directed mismatch repair. The enzymatic function of UvrD is to translocate along a DNA strand in a 3' to 5' direction and unwind duplex DNA utilizing a DNA-dependent ATPase activity. In addition, UvrD interacts with many other proteins involved in the above processes and is hypothesized to facilitate protein turnover, thus promoting further DNA processing. Although UvrD interactions with proteins bound to DNA have significant biological implications, the effects of covalent DNA-protein cross-links on UvrD helicase activity have not been characterized. Herein, we demonstrate that UvrD-catalyzed strand separation was inhibited on a DNA strand to which a 16-kDa protein was covalently bound. Our sequestration studies suggest that the inhibition of UvrD activity is most likely due to a translocation block and not helicase sequestration on the cross-link-containing DNA substrate. In contrast, no inhibition of UvrD-catalyzed strand separation was apparent when the protein was linked to the complementary strand. The latter result is surprising given the earlier observations that the DNA in this covalent complex is severely bent (similar to 70 degrees), with both DNA strands making multiple contacts with the cross-linked protein. In addition, UvrD was shown to be required for replication of plasmid DNAs containing covalent DNA-protein complexes. Combined, these data suggest a critical role for UvrD in the processing of DNA-protein cross-links.	[Kumari, Anuradha; Minko, Irina G.; Smith, Rebecca L.; Lloyd, R. Stephen; McCullough, Amanda K.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA	Oregon Health & Science University	McCullough, AK (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Ctr Res Occupat & Environm Toxicol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	mcculloa@ohsu.edu		Lloyd, R. Stephen/0000-0001-7273-372X	National Institutes of Health [R01 CA106858, PO1 ES05355]; Oregon Health & Science University Center for Research on Occupational & Environmental Toxicology; NATIONAL CANCER INSTITUTE [R01CA106858, P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Health & Science University Center for Research on Occupational & Environmental Toxicology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA106858 (to A. K. M. and R. S. L.) and PO1 ES05355 (to R. S. L.).; Supported by the Oregon Health & Science University Center for Research on Occupational & Environmental Toxicology Summer Internship Program.	ABDELMONEM M, 1977, EUR J BIOCHEM, V79, P33, DOI 10.1111/j.1432-1033.1977.tb11780.x; ABDELMONEM M, 1977, EUR J BIOCHEM, V79, P39, DOI 10.1111/j.1432-1033.1977.tb11781.x; Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Atkinson J, 2009, J BIOL CHEM, V284, P9612, DOI 10.1074/jbc.M808030200; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Bidnenko V, 2006, MOL MICROBIOL, V62, P382, DOI 10.1111/j.1365-2958.2006.05382.x; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; CARLSON KM, 1981, MUTAT RES, V84, P257, DOI 10.1016/0027-5107(81)90195-0; CARON PR, 1985, P NATL ACAD SCI USA, V82, P4925, DOI 10.1073/pnas.82.15.4925; Centore RC, 2009, J BACTERIOL, V191, P1429, DOI 10.1128/JB.01415-08; Choudhary S, 2006, J BIOL CHEM, V281, P6000, DOI 10.1074/jbc.M510122200; de Graaf B, 2009, DNA REPAIR, V8, P1207, DOI 10.1016/j.dnarep.2009.06.007; DODSON ML, 1993, BIOCHEMISTRY-US, V32, P8284, DOI 10.1021/bi00083a032; Douki T, 2003, BIOCHEMISTRY-US, V42, P9221, DOI 10.1021/bi034593c; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Golan G, 2006, J MOL BIOL, V362, P241, DOI 10.1016/j.jmb.2006.06.059; Hall MC, 1998, EMBO J, V17, P1535, DOI 10.1093/emboj/17.5.1535; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; JOYCE CM, 1984, J BACTERIOL, V158, P636, DOI 10.1128/JB.158.2.636-643.1984; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Khodursky AB, 1998, J BIOL CHEM, V273, P27668, DOI 10.1074/jbc.273.42.27668; KUEMMERLE NB, 1982, MUTAT RES, V94, P285, DOI 10.1016/0027-5107(82)90292-5; KUMURA K, 1985, NUCLEIC ACIDS RES, V13, P1483, DOI 10.1093/nar/13.5.1483; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LLOYD RS, 1978, CANCER RES, V38, P3191; MATSON SW, 1986, J BIOL CHEM, V261, P169; McCullough AK, 2001, BIOCHEMISTRY-US, V40, P561, DOI 10.1021/bi002404+; MENDONCA VM, 1993, J BACTERIOL, V175, P4641, DOI 10.1128/JB.175.15.4641-4651.1993; Minko IG, 2005, BIOCHEMISTRY-US, V44, P3000, DOI 10.1021/bi0478805; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Moolenaar GF, 2000, J BACTERIOL, V182, P5706, DOI 10.1128/JB.182.20.5706-5714.2000; MORIYA M, 1993, P NATL ACAD SCI USA, V90, P1122, DOI 10.1073/pnas.90.3.1122; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; OGAWA H, 1968, MOL GEN GENET, V101, P227, DOI 10.1007/BF00271625; OLINSKI R, 1981, RADIAT RES, V86, P102, DOI 10.2307/3575602; OLINSKI R, 1987, CANCER RES, V47, P201; OSSANNA N, 1989, J BACTERIOL, V171, P303, DOI 10.1128/jb.171.1.303-307.1989; Petit C, 1999, BIOCHIMIE, V81, P15, DOI 10.1016/S0300-9084(99)80034-0; Reardon JT, 2006, P NATL ACAD SCI USA, V103, P4056, DOI 10.1073/pnas.0600538103; RUNYON GT, 1989, J BIOL CHEM, V264, P17502; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; RUNYON GT, 1990, P NATL ACAD SCI USA, V87, P6383, DOI 10.1073/pnas.87.16.6383; Salem AMH, 2009, J BACTERIOL, V191, P5657, DOI 10.1128/JB.00417-09; SCHROCK RD, 1993, J BIOL CHEM, V268, P880; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; SIEGEL EC, 1983, MOL GEN GENET, V191, P397, DOI 10.1007/BF00425753; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; Sung JS, 2006, METHOD ENZYMOL, V408, P48, DOI 10.1016/S0076-6879(06)08004-9; VANHOUTEN B, 1988, J BIOL CHEM, V263, P16553; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Villani G, 2000, J BIOL CHEM, V275, P33185, DOI 10.1074/jbc.R000011200; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang G, 1998, J BACTERIOL, V180, P377, DOI 10.1128/JB.180.2.377-387.1998; ZWELLING LA, 1979, CANCER RES, V39, P365	61	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21313	21322		10.1074/jbc.M109.078964	http://dx.doi.org/10.1074/jbc.M109.078964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444702	Green Published, hybrid			2022-12-25	WOS:000279516100016
J	Moore, SA; Jia, YH				Moore, Stanley A.; Jia, Yunhua			Structure of the Cytoplasmic Domain of the Flagellar Secretion Apparatus Component FlhA from Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN EXPORT APPARATUS; CAMPYLOBACTER-JEJUNI; MEMBRANE COMPONENT; MOTOR PROTEIN; SALMONELLA; EXPRESSION; MUTATIONS; VIRULENCE; SYSTEM; FLIF	Using x-ray crystallography we have determined the structure of the cytoplasmic fragment (residues 384-732) of the flagellum secretion system protein FlhA from Helicobacter pylori at 2.4-angstrom resolution (r = 0.224; R-free = 0.263). FlhA proteins and their type III secretion homologues contain an N-terminal integral membrane domain (residues 1-350), a linker segment, and a globular C-terminal cytoplasmic region. The tertiary structure of the cytoplasmic fragment contains a thioredoxin-like domain, an RNA recognition motif-like domain inserted within the thioredoxin-fold, a helical domain, and a C-terminal beta/alpha-domain. Inter-domain contacts are extensive and the H. pylori FlhA structure appears to be in a closed conformation where the C-terminal domain closes against the RNA recognition motif-fold domain. Highly conserved surface residues in FlhA proteins are concentrated on a narrow surface strip comprising the thioredoxin-like and helical domains, possibly close to the export channel opening. The conformation of the FlhA N-terminal linker segment suggests a likely orientation for the FlhA cytoplasmic fragment relative to the membrane-embedded export pore. Comparison with the recently published structures of the Salmonella FlhA cytoplasmic fragment and its type III secretion counterpart InvA highlight a conformational change where the C-terminal beta/alpha domain in H. pylori FlhA moves 15 angstrom relative to Salmonella FlhA. The conformational change is complex but primarily involves hinge-like movements of the helical and C-terminal domains. Interpretation of previous mutational screens suggest that the C-terminal domain of FlhA(C) plays a regulatory role in substrate class switching in flagellum export.	[Moore, Stanley A.; Jia, Yunhua] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Moore, SA (corresponding author), A3 Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	stan.moore@usask.ca			Health Sciences Utilization and Research Committee of Saskatchewan; National Sciences and Engineering Research Council of Canada [RGPIN 262138-05]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; University of Saskatchewan	Health Sciences Utilization and Research Committee of Saskatchewan; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); University of Saskatchewan	This work was supported by a Health Sciences Utilization and Research Committee of Saskatchewan establishment grant and National Sciences and Engineering Research Council of Canada Discovery Grant RGPIN 262138-05.; Stacy McDonald carried out the cloning of the FlhA<INF>C</INF> domain. George Wong and Michael Lane contributed to early protein purification and crystallization efforts of a shorter FlhA<INF>C</INF> construct not presented in this study. Paul W. O'Toole generously provided H. pylori genomic DNA samples. We thank Michel Fojde, James Gorin, and Pawel Grochulski of the Canadian Macromolecular Crystallography (CMCF) beamline at the Canadian Light Source Synchrotron, Saskatoon, Canada, for timely access, advice, and assistance with x-ray data collection. The Canadian Light Source is funded by the Canadian Institutes for Health Research, the National Science and Engineering Research Council of Canada, the Canadian Foundation for Innovation, and the University of Saskatchewan. Many thanks to Dr. Paul W. O'Toole for providing support and encouragement, and for reading the manuscript.	Aizawa SI, 1996, MOL MICROBIOL, V19, P1, DOI 10.1046/j.1365-2958.1996.344874.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; Colland F, 2001, MOL MICROBIOL, V41, P477, DOI 10.1046/j.1365-2958.2001.02537.x; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Douillard FP, 2008, J BACTERIOL, V190, P7975, DOI 10.1128/JB.00879-08; EATON KA, 1992, J MED MICROBIOL, V37, P123, DOI 10.1099/00222615-37-2-123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghelardi E, 2002, J BACTERIOL, V184, P6424, DOI 10.1128/JB.184.23.6424-6433.2002; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grunenfelder B, 2003, J BACTERIOL, V185, P1624, DOI 10.1128/JB.185.5.1624-1633.2003; Hirano T, 2009, J BACTERIOL, V191, P3938, DOI 10.1128/JB.01811-08; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x; Josenhans C, 2002, MOL MICROBIOL, V43, P307, DOI 10.1046/j.1365-2958.2002.02765.x; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Kihara M, 2001, J BACTERIOL, V183, P1655, DOI 10.1128/JB.183.5.1655-1662.2001; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; McMurry JL, 2004, J BACTERIOL, V186, P7586, DOI 10.1128/JB.186.22.7586-7592.2004; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Minamino T, 2003, J BACTERIOL, V185, P3983, DOI 10.1128/JB.185.13.3983-3988.2003; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2010, J BACTERIOL, V192, P1929, DOI 10.1128/JB.01328-09; Minamino T, 2009, MOL MICROBIOL, V74, P1471, DOI 10.1111/j.1365-2958.2009.06946.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niehus E, 2004, MOL MICROBIOL, V52, P947, DOI 10.1111/j.1365-2958.2004.04006.x; O'Toole PW, 2000, MICROBES INFECT, V2, P1207, DOI 10.1016/S1286-4579(00)01274-0; OTOOLE PW, 1994, MOL MICROBIOL, V14, P691, DOI 10.1111/j.1365-2958.1994.tb01307.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; PLANO GV, 1995, J BACTERIOL, V177, P3843, DOI 10.1128/jb.177.13.3843-3854.1995; PLANO GV, 1993, J BACTERIOL, V175, P3536, DOI 10.1128/jb.175.11.3536-3545.1993; Rust M, 2009, J BACTERIOL, V191, P4824, DOI 10.1128/JB.00018-09; Saijo-Hamano Y, 2005, ACTA CRYSTALLOGR F, V61, P599, DOI 10.1107/S1744309105015745; Saijo-Hamano Y, 2004, J MOL BIOL, V343, P457, DOI 10.1016/j.jmb.2004.08.067; Saijo-Hamano Y, 2010, MOL MICROBIOL, V76, P260, DOI 10.1111/j.1365-2958.2010.07097.x; Schmitz A, 1997, J BACTERIOL, V179, P987, DOI 10.1128/jb.179.4.987-997.1997; Stone CB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-18; Suzuki H, 2004, J MOL BIOL, V337, P105, DOI 10.1016/j.jmb.2004.01.034; Suzuki H, 1998, J STRUCT BIOL, V124, P104, DOI 10.1006/jsbi.1998.4048; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; VANZANTEN SJOV, 1994, CAN MED ASSOC J, V150, P177; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Worrall LJ, 2010, PROTEIN SCI, V19, P1091, DOI 10.1002/pro.382	52	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21060	21069		10.1074/jbc.M110.119412	http://dx.doi.org/10.1074/jbc.M110.119412			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20442410	Green Published, hybrid			2022-12-25	WOS:000279228600069
J	Moriarty, CH; Pursell, B; Mercurio, AM				Moriarty, Charlotte H.; Pursell, Bryan; Mercurio, Arthur M.			miR-10b Targets Tiam1 IMPLICATIONS FOR Rac ACTIVATION AND CARCINOMA MIGRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA EXPRESSION; TUMOR INVASION; DEREGULATION; GTPASES; GENES; CELLS; ZEB1	Understanding the mechanisms by which specific microRNAs regulate cell migration and invasion is a timely and significant problem in cancer cell biology. miR-10b is of interest in this regard because its expression is altered in breast and other cancers. Our analysis of potential miR-10b targets identified Tiam1 (T lymphoma invasion and metastasis 1), a guanidine exchange factor for Rac. We demonstrate, using an miR-10b synthetic precursor, expression vector, and antisense oligonucleotide, that miR-10b represses Tiam1 expression in breast carcinoma cells and that it interacts with the 3'-UTR of Tiam1. Consistent with the involvement of Tiam1 in cell motility, we observed that miR-10b suppresses the ability of breast carcinoma cells to migrate and invade. Importantly, we demonstrate that miR-10b also inhibits Tiam1-mediated Rac activation. These data provide a mechanism for the regulation of Tiam1-mediated Rac activation in breast cancer cells and need to be considered in the context of other reported functions for miR-10b.	[Moriarty, Charlotte H.; Pursell, Bryan; Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Mercurio, AM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, 364 Plantat St, Worcester, MA 01605 USA.	arthur.mercurio@umassmed.edu			NCI NIH HHS [R01 CA080789] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080789] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	25	82	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20541	20546		10.1074/jbc.M110.121012	http://dx.doi.org/10.1074/jbc.M110.121012			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20444703	Green Published, hybrid			2022-12-25	WOS:000279228600016
J	Rios, JJ; Fleming, JGW; Bryant, UK; Carter, CN; Huber, JC; Long, MT; Spencer, TE; Adelson, DL				Rios, Jonathan J.; Fleming, JoAnn G. W.; Bryant, Uneeda K.; Carter, Craig N.; Huber, John C., Jr.; Long, Maureen T.; Spencer, Thomas E.; Adelson, David L.			OAS1 Polymorphisms Are Associated with Susceptibility to West Nile Encephalitis in Horses	PLOS ONE			English	Article							2'-5'-OLIGOADENYLATE SYNTHETASE GENE; MOLECULAR-WEIGHT INHIBITOR; INTERFERON-TREATED CELLS; FREE PROTEIN-SYNTHESIS; VIRUS-INFECTION; 2',5'-OLIGOADENYLATE SYNTHETASE; REGULATORY ELEMENTS; EXPRESSION; PATHOGENICITY; ACTIVATION	West Nile virus, first identified within the United States in 1999, has since spread across the continental states and infected birds, humans and domestic animals, resulting in numerous deaths. Previous studies in mice identified the Oas1b gene, a member of the OAS/RNASEL innate immune system, as a determining factor for resistance to West Nile virus (WNV) infection. A recent case-control association study described mutations of human OAS1 associated with clinical susceptibility to WNV infection. Similar studies in horses, a particularly susceptible species, have been lacking, in part, because of the difficulty in collecting populations sufficiently homogenous in their infection and disease states. The equine OAS gene cluster most closely resembles the human cluster, with single copies of OAS1, OAS3 and OAS2 in the same orientation. With naturally occurring susceptible and resistant sub-populations to lethal West Nile encephalitis, we undertook a case-control association study to investigate whether, similar to humans (OAS1) and mice (Oas1b), equine OAS1 plays a role in resistance to severe WNV infection. We identified naturally occurring single nucleotide mutations in equine (Equus caballus) OAS1 and RNASEL genes and, using Fisher's Exact test, we provide evidence that mutations in equine OAS1 contribute to host susceptibility. Virtually all of the associated OAS1 polymorphisms were located within the interferon-inducible promoter, suggesting that differences in OAS1 gene expression may determine the host's ability to resist clinical manifestations associated with WNV infection.	[Rios, Jonathan J.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Fleming, JoAnn G. W.; Spencer, Thomas E.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Bryant, Uneeda K.; Carter, Craig N.] Univ Kentucky, Livestock Dis Diagnost Ctr, Lexington, KY USA; [Huber, John C., Jr.] Texas A&M Univ, Sch Rural Publ Hlth, College Stn, TX USA; [Long, Maureen T.] Univ Florida, Coll Vet Med, Gainesville, FL USA; [Adelson, David L.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas A&M University System; Texas A&M University College Station; University of Kentucky; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; State University System of Florida; University of Florida; University of Adelaide	Rios, JJ (corresponding author), Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	david.adelson@adelaide.edu.au	Spencer, Thomas/AAD-6434-2020; Adelson, David L/E-5506-2011	Adelson, David L/0000-0003-2404-5636; Spencer, Thomas/0000-0003-2815-766X	Texas A&M University Patsy Link Endowment for Equine Research	Texas A&M University Patsy Link Endowment for Equine Research	This work was supported by the Texas A&M University Patsy Link Endowment for Equine Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGLIONI C, 1978, NATURE, V273, P684, DOI 10.1038/273684a0; BARNARD BJH, 1986, ONDERSTEPOORT J VET, V53, P235; BENECH P, 1987, MOL CELL BIOL, V7, P4498, DOI 10.1128/MCB.7.12.4498; BLACKBURN NK, 1989, J COMP PATHOL, V100, P59, DOI 10.1016/0021-9975(89)90090-X; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; DOHOO WMI, 2003, VET EPIDEMIOLOGIC RE; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Fleming JGW, 2006, ENDOCRINOLOGY, V147, P899, DOI 10.1210/en.2005-1120; Floyd-Smith G, 1999, EXP CELL RES, V246, P138, DOI 10.1006/excr.1998.4296; HOVANESSIAN AG, 1977, NATURE, V268, P537, DOI 10.1038/268537a0; Hovnanian A, 1998, GENOMICS, V52, P267, DOI 10.1006/geno.1998.5443; ILKAL MA, 1994, ACTA VIROL, V38, P157; JOHN J, 1991, MOL CELL BIOL, V11, P4189, DOI 10.1128/MCB.11.8.4189; Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; KERR IM, 1977, NATURE, V268, P540, DOI 10.1038/268540a0; Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; MCINTOSH B, 1982, ZOONOSES B; McLean RG, 2002, CURR TOP MICROBIOL, V267, P271; Naganuma A, 2000, J VIROL, V74, P8744, DOI 10.1128/JVI.74.18.8744-8750.2000; Ostlund EN, 2001, EMERG INFECT DIS, V7, P665; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Perelygin AA, 2005, CYTOGENET GENOME RES, V111, P51, DOI 10.1159/000085670; Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799; Perelygin AA, 2006, J MOL EVOL, V63, P562, DOI 10.1007/s00239-006-0073-3; R Core Team, 2022, R LANG ENV STAT COMP; Rios JJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-313; ROBERTS WK, 1976, NATURE, V264, P477, DOI 10.1038/264477a0; Scherbik SV, 2007, J VIROL, V81, P12005, DOI 10.1128/JVI.01359-07; StataCorp, 2005, STAT STAT SOFTW REL; Tnani M, 1998, BBA-MOL CELL RES, V1402, P139, DOI 10.1016/S0167-4889(97)00158-4; VanHeeke G, 1996, J INTERF CYTOK RES, V16, P119, DOI 10.1089/jir.1996.16.119; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yakub I, 2005, J INFECT DIS, V192, P1741, DOI 10.1086/497340	36	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10537	10.1371/journal.pone.0010537	http://dx.doi.org/10.1371/journal.pone.0010537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479874	Green Published, gold, Green Submitted			2022-12-25	WOS:000277467800019
J	Castilho, RM; Squarize, CH; Leelahavanichkul, K; Zheng, Y; Bugge, T; Gutkind, JS				Castilho, Rogerio M.; Squarize, Cristiane H.; Leelahavanichkul, Kantima; Zheng, Yi; Bugge, Thomas; Gutkind, J. Silvio			Rac1 Is Required for Epithelial Stem Cell Function during Dermal and Oral Mucosal Wound Healing but Not for Tissue Homeostasis in Mice	PLOS ONE			English	Article							HAIR FOLLICLE; HUMAN KERATINOCYTES; RHO-GTPASES; SKIN; EXPRESSION; EPIDERMIS; ACTIVATION; DIFFERENTIATION; TRANSFORMATION; MECHANISMS	Background: The regenerative capacity of the skin, including the continuous replacement of exfoliated cells and healing of injuries relies on the epidermal stem cells and their immediate cell descendants. The relative contribution of the hair follicle stem cells and the interfollicular stem cells to dermal wound healing is an area of active investigation. Recent studies have revealed that the small GTPase Rac1, which regulates cell migration and nuclear gene expression, is required for hair follicle stem function but not for the normal homeostasis of the interfollicular skin. Methodology/Principal Findings: Here we explored whether Rac1 contributes to wound healing in the skin and in the oral mucosa, the latter an anatomical site that presents similar architecture to that of the skin but is devoid of any hair follicle structures, and hence lacks hair follicle stem cells. Epidermal Rac1 gene excision led to the clearly delayed closure of cutaneous wounds. Remarkably, genetic ablation of Rac1 from the oral mucosa resulted in the complete inability of oral wounds to heal. We present evidence that the lack of oral mucosal re-epithelization may result from the reduced migratory capacity of cells lacking Rac1 together with altered expression of injury-induced proliferative and cellular stress-related expression programs. Conclusions/Significance: Together, these observations support that while the normal development and homeostasis of the interfollicular skin and oral mucosa do not require Rac1 function, the interfollicular and oral epithelial stem cells may require a Rac1-dependent program to orchestrate the tissue response to injury and ultimate for wound closure. Ultimately, these findings may enable the molecular characterization of the acute tissue regenerative response of these stem cell populations, thus facilitating the identification of novel molecular-targeted strategies aimed at accelerating wound closure.	[Castilho, Rogerio M.; Squarize, Cristiane H.; Leelahavanichkul, Kantima; Bugge, Thomas; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Zheng, Yi] Univ Cincinnati, Med Ctr, Div Expt Hematol, Childrens Hosp, Cincinnati, OH 45267 USA; [Castilho, Rogerio M.; Squarize, Cristiane H.] Univ Michigan, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan	Castilho, RM (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA.	sg39v@nih.gov	Castilho, Rogerio M/E-4987-2010; Gutkind, J. Silvio/J-1201-2016; Zheng, Yi/J-7235-2015; Gutkind, J. Silvio/A-1053-2009	Castilho, Rogerio M/0000-0001-5358-612X; Gutkind, J. Silvio/0000-0002-5150-4482; Zheng, Yi/0000-0001-7089-6074; Squarize, Cristiane/0000-0002-6782-3429	Program of the National Institutes of Health, National Institute of Dental and Craniofacial Research [Z01DE00558-18]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000558] Funding Source: NIH RePORTER	Program of the National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Dental and Craniofacial Research, project Z01DE00558-18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Bartkova J, 2003, ARCH ORAL BIOL, V48, P125, DOI 10.1016/S0003-9969(02)00202-9; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Castilho RM, 2007, ONCOGENE, V26, P5078, DOI 10.1038/sj.onc.1210322; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chrostek A, 2006, MOL CELL BIOL, V26, P6957, DOI 10.1128/MCB.00075-06; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Elias PM, 2005, EXP DERMATOL, V14, P719, DOI 10.1111/j.1600-0625.2005.00363.x; ELIAS PM, 1983, J INVEST DERMATOL, V80, P44, DOI DOI 10.1038/JID.1983.12); Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Fuchs E, 2008, COLD SH Q B, V73, P333, DOI 10.1101/sqb.2008.73.032; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; GRAFSTROM RC, 2002, CULTURE EPITHELIAL C; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; GUTKIND JS, 1991, P NATL ACAD SCI USA, V88, P4703, DOI 10.1073/pnas.88.11.4703; Haas AF, 1998, FREE RADICAL BIO MED, V25, P998, DOI 10.1016/S0891-5849(98)00135-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heath J, 2009, J INVEST DERMATOL, V129, P2358, DOI 10.1038/jid.2009.102; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kwei KA, 2006, CANCER LETT, V231, P326, DOI 10.1016/j.canlet.2005.02.031; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Neub A, 2007, J INVEST DERMATOL, V127, P2453, DOI 10.1038/sj.jid.5700864; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Shirai K, 2001, EXP EYE RES, V73, P461, DOI 10.1006/exer.2001.1052; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; TYNER AL, 1986, J CELL BIOL, V103, P1945, DOI 10.1083/jcb.103.5.1945; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; WOODLEY DT, 1993, DERMATOL CLIN, V11, P641, DOI 10.1016/S0733-8635(18)30217-1; Xu XW, 2003, AM J PATHOL, V163, P969, DOI 10.1016/S0002-9440(10)63456-6	39	77	78	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10503	10.1371/journal.pone.0010503	http://dx.doi.org/10.1371/journal.pone.0010503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463891	Green Submitted, Green Published, gold			2022-12-25	WOS:000277379800002
J	Birkenmeier, G; Stegemann, C; Hoffmann, R; Gunther, R; Huse, K; Birkemeyer, C				Birkenmeier, Gerd; Stegemann, Christin; Hoffmann, Ralf; Guenther, Robert; Huse, Klaus; Birkemeyer, Claudia			Posttranslational Modification of Human Glyoxalase 1 Indicates Redox-Dependent Regulation	PLOS ONE			English	Article							PROTEIN MIXED-DISULFIDES; S-GLUTATHIONYLATION; MASS-SPECTROMETRY; ESCHERICHIA-COLI; METHYLGLYOXAL; OXIDE; IDENTIFICATION; MECHANISM; ENZYME; EXPRESSION	Background: Glyoxalase 1 (Glo1) and glyoxalase 2 (Glo2) are ubiquitously expressed cytosolic enzymes that catalyze the conversion of toxic alpha-oxo-aldehydes into the corresponding alpha-hydroxy acids using L-glutathione (GSH) as a cofactor. Human Glo1 exists in various isoforms; however, the nature of its modifications and their distinct functional assignment is mostly unknown. Methodology/Principal Findings: We characterized native Glo1 purified from human erythrocytes by mass spectrometry. The enzyme was found to undergo four so far unidentified posttranslational modifications: (i) removal of the N-terminal methionine 1, (ii) N-terminal acetylation at alanine 2, (iii) a vicinal disulfide bridge between cysteine residues 19 and 20, and (iv) a mixed disulfide with glutathione on cysteine 139. Glutathionylation of Glo1 was confirmed by immunological methods. Both, N-acetylation and the oxidation state of Cys(19/20), did not impact enzyme activity. In contrast, glutathionylation strongly inhibited Glo1 activity in vitro. The discussed mechanism for enzyme inhibition by glutathionylation was validated by molecular dynamics simulation. Conclusion/Significance: It is shown for the first time that Glo1 activity directly can be regulated by an oxidative posttranslational modification that was found in the native enzyme, i. e., glutathionylation. Inhibition of Glo1 by chemical reaction with its co-factor and the role of its intramolecular disulfides are expected to be important factors within the context of redox-dependent regulation of glucose metabolism in cells.	[Birkenmeier, Gerd] Univ Leipzig, Inst Biochem, Fac Med, Leipzig, Germany; [Stegemann, Christin; Hoffmann, Ralf] Univ Leipzig, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, Fac Chem & Mineral, Leipzig, Germany; [Guenther, Robert] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, Leipzig, Germany; [Huse, Klaus] Fritz Lipmann Inst eV, Leibniz Inst Age Res, Jena, Germany; [Birkemeyer, Claudia] Univ Leipzig, Inst Analyt Chem, Fac Chem & Mineral, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Leipzig University	Birkenmeier, G (corresponding author), Univ Leipzig, Inst Biochem, Fac Med, Leipzig, Germany.	birkemeyer@chemie.uni-leipzig.de	Birkemeyer, Claudia S/L-8687-2015; Hoffmann, Ralf/ABD-8779-2020; Günther, Robert/B-5498-2008	Birkemeyer, Claudia S/0000-0002-8538-8838; Günther, Robert/0000-0002-3533-9747; Huse, Klaus/0000-0003-3854-1884; Birkenmeier, Gerd/0000-0001-7805-9924	BMBF, Germany [01GS0809]; University of Leipzig	BMBF, Germany(Federal Ministry of Education & Research (BMBF)); University of Leipzig	The study was partially supported by grant 01GS0809 from BMBF, Germany, and by the University of Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINS TW, 1989, DIABETES RES CLIN EX, V11, P125; AYOUB F, 1993, ANTICANCER RES, V13, P151; Cameron AD, 1997, EMBO J, V16, P3386, DOI 10.1093/emboj/16.12.3386; Cameron AD, 1999, BIOCHEMISTRY-US, V38, P13480, DOI 10.1021/bi990696c; Carugo O, 2003, PROTEIN ENG, V16, P637, DOI 10.1093/protein/gzg088; Chauhan SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006805; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; CLIFFE EE, 1961, BIOCHEM J, V79, P475, DOI 10.1042/bj0790475; Clugston SL, 1998, BIOCHEMISTRY-US, V37, P8754, DOI 10.1021/bi972791w; Cooper AJL, 1997, BIOL CHEM, V378, P793; de Arriba SG, 2007, NEUROBIOL AGING, V28, P1044, DOI 10.1016/j.neurobiolaging.2006.05.007; De Hemptinne V, 2007, BIOCHEM J, V407, P121, DOI 10.1042/BJ20070379; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2003, PROTEOMICS, V3, P1145, DOI 10.1002/pmic.200300435; Gilge JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004015; GRIMM LM, 1985, BIOCHIM BIOPHYS ACTA, V844, P50, DOI 10.1016/0167-4889(85)90232-0; GUY GR, 1993, J BIOL CHEM, V268, P2141; Hemptinne F, 2009, MOL CELL BIOCHEM, V325, P169; Hollenbach M, 2008, BIOCHEM PHARMACOL, V76, P631, DOI 10.1016/j.bcp.2008.06.006; Hurd TR, 2005, BIOCHEM SOC T, V33, P1390, DOI 10.1042/BST0331390; Klatt P, 2002, METHOD ENZYMOL, V348, P157, DOI 10.1016/S0076-6879(02)48635-1; Kuhla B, 2007, NEUROBIOL AGING, V28, P29, DOI 10.1016/j.neurobiolaging.2005.11.007; Laden BP, 2001, J LIPID RES, V42, P235; Laga M, 2007, BIOCHEM PHARMACOL, V74, P579, DOI 10.1016/j.bcp.2007.05.026; LAN Y, 1995, J BIOL CHEM, V270, P12957, DOI 10.1074/jbc.270.22.12957; Lee HJ, 2005, ANN NY ACAD SCI, V1043, P135, DOI 10.1196/annals.1333.017; MANNERVIK B, 1982, METHOD ENZYMOL, V90, P535; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2; Mitsumoto A, 2000, J BIOCHEM, V128, P647, DOI 10.1093/oxfordjournals.jbchem.a022797; Mitsumoto A, 1999, BIOCHEM J, V344, P837, DOI 10.1042/0264-6021:3440837; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; PRINS HK, 1966, BLOOD-J HEMATOL, V27, P145, DOI 10.1182/blood.V27.2.145.145; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Ralph Stephen John, 2008, Metal-Based Drugs, P260146, DOI 10.1155/2008/260146; RANGANATHAN S, 1993, J BIOL CHEM, V268, P5661; Ratliff DM, 1996, J CLIN ENDOCR METAB, V81, P488, DOI 10.1210/jc.81.2.488; Ridderstrom M, 1996, BIOCHEM J, V314, P463; Santel T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003508; SELLIN S, 1982, BIOCHEMISTRY-US, V21, P4850, DOI 10.1021/bi00263a004; Shelton MD, 2008, MOL CELLS, V25, P332; Staniszewska MM, 2006, MOL CELL BIOCHEM, V288, P29, DOI 10.1007/s11010-005-9115-1; Stokvis E, 2000, J PROTEIN CHEM, V19, P389, DOI 10.1023/A:1026439531005; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; Van Herreweghe F, 2002, P NATL ACAD SCI USA, V99, P949, DOI 10.1073/pnas.012432399; VANDERJAGT DL, 2001, CHEM-BIOL INTERACT, P130; Velu CS, 2007, BIOCHEMISTRY-US, V46, P7765, DOI 10.1021/bi700425y; Verspohl EJ, 2006, ENDOCR J, V53, P21, DOI 10.1507/endocrj.53.21; WHITTAKER VP, 1947, BIOCHEM J, V41, P56, DOI 10.1042/bj0410056; Wouters MA, 2007, CURR PROTEIN PEPT SC, V8, P484, DOI 10.2174/138920307782411464; Yen TY, 2000, J MASS SPECTROM, V35, P990, DOI 10.1002/1096-9888(200008)35:8<990::AID-JMS27>3.0.CO;2-K; Yen TY, 2002, J MASS SPECTROM, V37, P15, DOI 10.1002/jms.241	58	70	71	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10399	10.1371/journal.pone.0010399	http://dx.doi.org/10.1371/journal.pone.0010399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454679	gold, Green Published, Green Submitted			2022-12-25	WOS:000277240100011
J	Doherty, KE; Naugle, DE; Evans, JS				Doherty, Kevin E.; Naugle, David E.; Evans, Jeffrey S.			A Currency for Offsetting Energy Development Impacts: Horse-Trading Sage-Grouse on the Open Market	PLOS ONE			English	Article							WINTER HABITAT SELECTION; METHANE DEVELOPMENT; SAGEBRUSH HABITATS; CONSERVATION; VULNERABILITY; MOVEMENTS; PATTERNS; FIDELITY; BANKING; NESTS	Background: Biodiversity offsets provide a mechanism to compensate for unavoidable damages from new energy development as the U. S. increases its domestic production. Proponents argue that offsets provide a partial solution for funding conservation while opponents contend the practice is flawed because offsets are negotiated without the science necessary to backup resulting decisions. Missing in negotiations is a biologically-based currency for estimating sufficiency of offsets and a framework for applying proceeds to maximize conservation benefits. Methodology/Principal Findings: Here we quantify a common currency for offsets for greater sage-grouse (Centrocercus urophasianus) by estimating number of impacted birds at 4 levels of development commonly permitted. Impacts were indiscernible at 1-12 wells per 32.2 km(2). Above this threshold lek losses were 2-5 times greater inside than outside of development and bird abundance at remaining leks declined by -32 to -77%. Findings reiterated the importance of time-lags as evidenced by greater impacts 4 years after initial development. Clustering well locations enabled a few small leks to remain active inside of developments. Conclusions/Significance: Documented impacts relative to development intensity can be used to forecast biological tradeoffs of newly proposed or ongoing developments, and when drilling is approved, anticipated bird declines form the biological currency for negotiating offsets. Monetary costs for offsets will be determined by true conservation cost to mitigate risks such as sagebrush tillage to other populations of equal or greater number. If this information is blended with landscape level conservation planning, the mitigation hierarchy can be improved by steering planned developments away from conservation priorities, ensuring compensatory mitigation projects deliver a higher return for conservation that equate to an equal number of birds in the highest priority areas, provide on-site mitigation recommendations, and provide a biologically based cost for mitigating unavoidable impacts.	[Doherty, Kevin E.] Wyoming Audubon, Natl Audubon Soc Sci, Laramie, WY USA; [Naugle, David E.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Evans, Jeffrey S.] Nature Conservancy, N Amer Sci, Ft Collins, CO USA	University of Montana System; University of Montana; Nature Conservancy	Doherty, KE (corresponding author), Wyoming Audubon, Natl Audubon Soc Sci, Laramie, WY USA.	kdoherty@audubon.org		Evans, Jeffrey/0000-0002-5533-7044	United States Bureau of Land Management in Montana and Wyoming; Wolf Creek Charitable Foundation; Hewlett Foundation; Liz Claiborne and Art Ortenberg Foundation; University of Montana	United States Bureau of Land Management in Montana and Wyoming; Wolf Creek Charitable Foundation; Hewlett Foundation; Liz Claiborne and Art Ortenberg Foundation; University of Montana	Funding was provided by the state offices of the United States Bureau of Land Management in Montana and Wyoming, Wolf Creek Charitable Foundation, Hewlett Foundation, Liz Claiborne and Art Ortenberg Foundation and the University of Montana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbitt RJF, 2000, BIOL CONSERV, V96, P169, DOI 10.1016/S0006-3207(00)00064-1; Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; Baxter RJ, 2008, J WILDLIFE MANAGE, V72, P179, DOI 10.2193/2006-402; Bergquist E, 2007, ENVIRON MONIT ASSESS, V128, P381, DOI 10.1007/s10661-006-9321-7; BERRY JD, 1985, J WILDLIFE MANAGE, V49, P237, DOI 10.2307/3801877; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Burgin S, 2008, BIODIVERS CONSERV, V17, P807, DOI 10.1007/s10531-008-9319-2; CARROLL N, 2009, EARTHSCAN; Connelly J.W., 2004, CONSERVATION ASSESSM; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; CONNELLY JW, 2010, STUDIES AVI IN PRESS; Doherty K. E., 2008, THESIS U MONTANA MIS; DOHERTY KE, 2010, STUDIES AVI IN PRESS; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; DUNN PO, 1985, AUK, V102, P621, DOI 10.1093/auk/102.3.621; Gibbons Philip, 2007, Ecological Management & Restoration, V8, P26, DOI 10.1111/j.1442-8903.2007.00328.x; Green P.J., 1993, NONPARAMETRIC REGRES, DOI DOI 10.1201/B15710; Hastie TJ., 1990, GEN ADDITIVE MODELS; Holloran M., 2005, THESIS U WYOMING LAR; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Holloran MRJ, 2005, CONDOR, V107, P742, DOI 10.1650/7749.1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; International Energy Agency, 2008, WORLD EN OUTL 2008; JOHNSON G, 2009, GREATER SAGE GROUSE; KIESECKER JM, 2010, FRONT ECOL IN PRESS; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Mandel JT, 2010, FRONT ECOL ENVIRON, V8, P44, DOI 10.1890/070170; Naugle D. E., 2010, STUDIES AVI IN PRESS; NIEMUTH ND, 1995, CAN J ZOOL, V73, P819, DOI 10.1139/z95-096; Pruett CL, 2009, BIOSCIENCE, V59, P257, DOI 10.1525/bio.2009.59.3.10; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reese K. P., 2007, COLL NATURAL RESOURC, V88; Reese KP, 1997, WILDLIFE BIOL, V3, P235, DOI 10.2981/wlb.1997.029; Robertson MM, 2006, FRONT ECOL ENVIRON, V4, P297, DOI 10.1890/1540-9295(2006)4[297:EESMTI]2.0.CO;2; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Schroeder M.A., 2003, COLL NATURAL RESOURC, V80; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Stewart GB, 2007, ENVIRON CONSERV, V34, P1, DOI 10.1017/S0376892907003554; Stiver S. J., 2006, GREATER SAGE G UNPUB; ten Kate K., 2004, BIODIVERSITY OFFSETS; U. S. Department of Energy, 2008, 20 WIND EN 2030 INCR; *US BUR LAND MAN, 2008, FIN SUPPL MONT STAT, V1; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Wilson K, 2005, ENVIRON MANAGE, V35, P527, DOI 10.1007/s00267-004-0095-9; *WYOM GAM FISH DEP, 2003, WYOM GREAT SAG GROUS; *WYOM GAM FISH DEP, 2006, GREAT SAG GROUS JOB; Yates D., 1999, PRACTICE STAT; Zou L, 2006, J MED ENTOMOL, V43, P1034, DOI 10.1603/0022-2585(2006)43[1034:MLHMUR]2.0.CO;2	50	35	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10339	10.1371/journal.pone.0010339	http://dx.doi.org/10.1371/journal.pone.0010339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442770	Green Published, Green Submitted, gold			2022-12-25	WOS:000277154200003
J	Chang, G; Miao, YL; Zhang, Y; Liu, S; Kou, ZH; Ding, JJ; Chen, DY; Sun, QY; Gao, SR				Chang, Gang; Miao, Yi-Liang; Zhang, Yu; Liu, Sheng; Kou, Zhaohui; Ding, Junjun; Chen, Da-Yuan; Sun, Qing-Yuan; Gao, Shaorong			Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells	PLOS ONE			English	Article							NUCLEAR TRANSFER; TUMOR-SUPPRESSOR; SELF-RENEWAL; P53; GENERATION; MICE; INDUCTION; CLONING; CANCER; GENE	Somatic cell nuclear transfer (SCNT) has been proved capable of reprogramming various differentiated somatic cells into pluripotent stem cells. Recently, induced pluripotent stem cells (iPS) have been successfully derived from mouse and human somatic cells by the over-expression of a combination of transcription factors. However, the molecular mechanisms underlying the reprogramming mediated by either the SCNT or iPS approach are poorly understood. Increasing evidence indicates that many tumor pathways play roles in the derivation of iPS cells. Embryonal carcinoma (EC) cells have the characteristics of both stem cells and cancer cells and thus they might be the better candidates for elucidating the details of the reprogramming process. Although previous studies indicate that EC cells cannot be reprogrammed into real pluripotent stem cells, the reasons for this remain unclear. Here, nuclei from mouse EC cells (P19) were transplanted into enucleated oocytes and pluripotent stem cells (P19 NTES cells) were subsequently established. Interestingly, P19 NTES cells prolonged the development of tetraploid aggregated embryos compared to EC cells alone. More importantly, we found that the expression recovery of the imprinted H19 gene was dependent on the methylation state in the differential methylation region (DMR). The induction of Nanog expression, however, was independent of the promoter region DNA methylation state in P19 NTES cells. A whole-genome transcriptome analysis further demonstrated that P19 NTES cells were indeed the intermediates between P19 cells and ES cells and many interesting genes were uncovered that may be responsible for the failed reprogramming of P19 cells. To our knowledge, for the first time, we linked incomplete reprogramming to the improved pluripotency of EC cell-derived pluripotent stem cells. The candidate genes we discovered may be useful not only for understanding the mechanisms of reprogramming, but also for deciphering the transition between tumorigenesis and pluripotency.	[Chang, Gang; Miao, Yi-Liang; Chen, Da-Yuan; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Chang, Gang; Miao, Yi-Liang; Zhang, Yu; Liu, Sheng; Kou, Zhaohui; Ding, Junjun; Gao, Shaorong] Natl Inst Biol Sci, Beijing, Peoples R China; [Chang, Gang] Capital Med Univ, Dept Histol & Embryol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; National Institute of Biological Sciences, Beijing; Capital Medical University	Chang, G (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn; gaoshaorong@nibs.ac.cn	Ding, Junjun/C-4098-2012; Ding, Junjun/F-8618-2015	Ding, Junjun/0000-0002-9936-882X	National High Technology [2005AA210930, 2008AA022311]; National Basic Research Program of China [2006CB504004, 2006CB944004]; Chinese Academy of Sciences [KSCX2-YW-N-017]; National Natural Science Foundation of China [30430530]	National High Technology(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National High Technology Project 863 (2005AA210930 and 2008AA022311) to SG and the National Basic Research Program of China (2006CB504004 and 2006CB944004), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-N-017) and the National Natural Science Foundation of China (30430530) to QYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang G, 2009, GENOMICS, V93, P112, DOI 10.1016/j.ygeno.2008.09.011; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Curtin JC, 2005, ONCOGENE, V24, P1481, DOI 10.1038/sj.onc.1208130; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Guillou L, 1996, AM J PATHOL, V149, P1221; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; HOSACK DA, 2003, GENOME BIOL, V4, pP4, DOI DOI 10.1186/GB-2003-4-6-P4; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Li L, 2003, CANCER RES, V63, P2733; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; MARTIN GR, 1980, SCIENCE, V209, P768, DOI 10.1126/science.6250214; Moore BE, 2001, APPL IMMUNOHISTO M M, V9, P203, DOI 10.1097/00022744-200109000-00002; NAGY A, 1990, DEVELOPMENT, V110, P815; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; OREN M, 1982, MOL CELL BIOL, V2, P443, DOI 10.1128/MCB.2.4.443; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; REIK W, 1994, HUM MOL GENET, V3, P1297, DOI 10.1093/hmg/3.8.1297; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	51	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10320	10.1371/journal.pone.0010320	http://dx.doi.org/10.1371/journal.pone.0010320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436676	Green Submitted, Green Published, gold			2022-12-25	WOS:000277079500009
J	Namgoong, GM; Khanal, P; Cho, HG; Lim, SC; Oh, YK; Kang, BS; Shim, JH; Yoo, JC; Choi, HS				Namgoong, Gwang Mo; Khanal, Prem; Cho, Hae-Guk; Lim, Sung-Chul; Oh, Yoon Kyeong; Kang, Bong Seok; Shim, Jeong-Hyun; Yoo, Jin-Cheol; Choi, Hong Seok			The Prolyl Isomerase Pin1 Induces LC-3 Expression and Mediates Tamoxifen Resistance in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; ANTIESTROGEN RESISTANCE; REGULATES AUTOPHAGY; ENDOCRINE THERAPY; APOPTOTIC DEATH; CELL-DEATH; IN-VIVO; GROWTH; MACROAUTOPHAGY; INHIBITION	Endocrine therapies, which inhibit estrogen receptor signaling, are the most common and effective treatments for estrogen receptor alpha-positive breast cancer. However, the utility of these agents is limited by the frequent development of resistance, and the precise mechanisms underlying endocrine therapy resistance remain incompletely understood. Here, we demonstrate that peptidyl-prolyl isomerase Pin1 is an important determinant of resistance to tamoxifen and show that Pin1 increases E2F-4- and Egr-1-driven expression of LC-3 as a result of an increased interaction with and phosphorylation of MEK1/2. In human tamoxifen-resistant breast cancer, our results show a significant correlation between Pin1 overexpression and high levels of LC-3. Promoter activity as well as expression levels of Pin1 were drastically higher in tamoxifen-resistant MCF7 cells than control MCF7 cells, as were levels of LC-3 mRNA and protein, an autophagy marker. Pin1(-/-) mouse embryonic fibroblasts showed lower 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced MEK1/2 phosphorylation than Pin1(+/+) mouse embryonic fibroblasts. Silencing of Pin1 expression inhibited TPA-induced MEK1/2 phosphorylation in MCF7 cells. Moreover, PD98059, a specific inhibitor of MEK1/2, and juglone, a potent Pin1 inhibitor, significantly suppressed the TPA-induced expression of E2F-4 as well as Egr-1 transcription factors, which control LC-3 gene expression. Importantly, 4-hydroxy tamoxifen, when used in combination with silencing of Pin1 or LC-3, increased cleaved poly(ADP-ribose) polymerase and DNA fragmentation to inhibit cologenic growth of MCF7 cells. We therefore link the Pin1-MEK pathway and LC-3-mediated tamoxifen resistance and show the therapeutic potential of Pin1 in the treatment of tamoxifen-resistant breast cancer.	[Yoo, Jin-Cheol; Choi, Hong Seok] Chosun Univ, Project Team BK21, Coll Pharm, Kwangju 501759, South Korea; [Lim, Sung-Chul] Chosun Univ, Dept Pathol, Kwangju 501759, South Korea; [Oh, Yoon Kyeong] Chosun Univ, Dept Radiat Oncol, Sch Med, Kwangju 501759, South Korea; [Kang, Bong Seok] Kyungpook Natl Univ Hosp, Biomed Res Inst, Taegu 702701, South Korea; [Shim, Jeong-Hyun] Chonbuk Natl Univ, Sch Dent, Jeonju 561756, South Korea	Chosun University; Chosun University; Chosun University; Kyungpook National University; Kyungpook National University Hospital; Jeonbuk National University	Choi, HS (corresponding author), Chosun Univ, Project Team BK21, Coll Pharm, Kwangju 501759, South Korea.	chs@chosun.ac.kr		Yoo, Jin Cheol/0000-0002-0259-6237	Ministry of Education, Science, and Technology [2009-0066056]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (Grant 2009-0066056).	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chao SH, 2001, NUCLEIC ACIDS RES, V29, P767, DOI 10.1093/nar/29.3.767; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; ElAshry D, 1997, ONCOGENE, V15, P423, DOI 10.1038/sj.onc.1201198; Gaddy VT, 2004, CLIN CANCER RES, V10, P5215, DOI 10.1158/1078-0432.CCR-03-0637; Ghayad SE, 2010, INT J CANCER, V126, P545, DOI 10.1002/ijc.24750; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; John S, 2008, CANCER RES, V68, P7855, DOI 10.1158/0008-5472.CAN-07-5875; Joslyn SA, 2002, BREAST CANCER RES TR, V73, P45, DOI 10.1023/A:1015220420400; Lam PB, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-91; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Maddodi N, 2010, J INVEST DERMATOL, V130, P1657, DOI 10.1038/jid.2010.26; Mishima Y, 2008, CANCER SCI, V99, P2200, DOI 10.1111/j.1349-7006.2008.00932.x; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Oesterreich S, 2000, MOL ENDOCRINOL, V14, P369, DOI 10.1210/me.14.3.369; Oh AS, 2001, MOL ENDOCRINOL, V15, P1344, DOI 10.1210/me.15.8.1344; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Ryo A, 2003, J CELL SCI, V116, P773, DOI 10.1242/jcs.00276; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005	32	43	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23829	23841		10.1074/jbc.M109.092874	http://dx.doi.org/10.1074/jbc.M109.092874			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20479004	Green Published, hybrid			2022-12-25	WOS:000280291400033
J	Korasick, DA; McMichael, C; Walker, KA; Anderson, JC; Bednarek, SY; Heese, A				Korasick, David A.; McMichael, Colleen; Walker, Katie A.; Anderson, Jeffrey C.; Bednarek, Sebastian Y.; Heese, Antje			Novel Functions of Stomatal Cytokinesis-Defective 1 (SCD1) in Innate Immune Responses against Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; PLANT-DEFENSE; CELL-DEATH; SALICYLIC-ACID; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; DEPENDENT GROWTH; MPK4 ACTIVATION; PROTEIN; PERCEPTION	Eukaryotes employ complex immune mechanisms for protection against microbial pathogens. Here, we identified SCD1 (Stomatal Cytokinesis-Defective 1), previously implicated in growth and development through its role in cytokinesis and polarized cell expansion (Falbel, T. G., Koch, L. M., Nadeau, J.A., Segui-Simarro, J.M., Sack, F. D., and Bednarek, S.Y. (2003) Development 130, 4011-4024) as a novel component of innate immunity. In Arabidopsis, SCD1 is a unique gene encoding for the only protein containing a complete DENN (Differentially Expressed in Normal and Neoplastic cells) domain. The DENN domain is a largely uncharacterized tripartite protein motif conserved among eukaryotic proteins. We show that conditional scd1-1 plants containing a point mutation in a conserved DENN residue affected a subset of signaling responses to some bacterial pathogen-associated molecular patterns (PAMPs). Consistent with increased transcript accumulation of Pathogen-related (PR) genes, scd1-1 plants were more resistant to Pseudomonas syringae pathovar tomato (Pst) DC3000 infection implicating SCD1 as a negative regulator of basal resistance against bacteria. scd1-1 plants were different from known mutants exhibiting constitutive expressor of PR(cpr)-like phenotypes, in that growth impairment of scd1-1 plants was genetically independent of constitutive immune response activation. For scd1-1, shift to elevated temperature or introduction of a mutant allele in Salicylic acid Induction-Deficient 2 (SID2) suppressed constitutive defense response activation. sid2-2 also repressed the resistance phenotype of scd1-1. Temperature shift and sid2-2, however, did not rescue conditional growth and sterility defects of scd1-1. These results implicate SCD1 in multiple cellular pathways, possibly by affecting different proteins. Overall, our studies identified a novel role for eukaryotic DENN proteins in immunity against bacteria.	[Heese, Antje] Univ Missouri, Div Biochem, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [McMichael, Colleen; Bednarek, Sebastian Y.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison	Heese, A (corresponding author), Univ Missouri, Div Biochem, Interdisciplinary Plant Grp, 117 Schweitzer Hall, Columbia, MO 65211 USA.	heesea@missouri.edu	Anderson, Jeff/I-1316-2017; McMichael, Colleen/E-6679-2017	Anderson, Jeff/0000-0001-9446-7100; McMichael, Colleen/0000-0001-5371-9076; Korasick, David/0000-0002-6337-2085	University of Missouri; MU-Life Sciences Undergraduate Research Opportunity Program; Human Frontiers of Science Program [RGP22/2006]; National Science Foundation, Division of Molecular and Cellular Biosciences [0446157]	University of Missouri; MU-Life Sciences Undergraduate Research Opportunity Program; Human Frontiers of Science Program(Human Frontier Science Program); National Science Foundation, Division of Molecular and Cellular Biosciences(National Science Foundation (NSF))	This work was supported in part by start-up funds from the University of Missouri (to A. H.), MU-Life Sciences Undergraduate Research Opportunity Program (to D. A. K. and K. A. W.), Human Frontiers of Science Program Grant (RGP22/2006) (to J.C.A.), and the National Science Foundation, Division of Molecular and Cellular Biosciences (0446157) (to S.Y.B.).	Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Falbel TG, 2003, DEVELOPMENT, V130, P4011, DOI 10.1242/dev.00619; Fan J, 2008, PLANT J, V53, P393, DOI 10.1111/j.1365-313X.2007.03303.x; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Jambunathan N, 2001, PLANT CELL, V13, P2225, DOI 10.1105/tpc.13.10.2225; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Miyoshi J, 2004, TRENDS MOL MED, V10, P476, DOI 10.1016/j.molmed.2004.08.002; Mulherkar N, 2007, J BIOL CHEM, V282, P11715, DOI 10.1074/jbc.M701085200; Nakagami H, 2006, J BIOL CHEM, V281, P38697, DOI 10.1074/jbc.M605293200; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Su SH, 2007, FEBS LETT, V581, P3171, DOI 10.1016/j.febslet.2007.05.083; Suarez-Rodriguez MC, 2007, PLANT PHYSIOL, V143, P661, DOI 10.1104/pp.106.091389; Tanaka M, 2001, MOL BIOL CELL, V12, P1421, DOI 10.1091/mbc.12.5.1421; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	45	50	51	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23340	23348		10.1074/jbc.M109.090787	http://dx.doi.org/10.1074/jbc.M109.090787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20472560	hybrid, Green Published			2022-12-25	WOS:000279999900067
J	Wollers, S; Layer, G; Garcia-Serres, R; Signor, L; Clemancey, M; Latour, JM; Fontecave, M; de Choudens, SO				Wollers, Silke; Layer, Gunhild; Garcia-Serres, Ricardo; Signor, Luca; Clemancey, Martin; Latour, Jean-Marc; Fontecave, Marc; de Choudens, Sandrine Ollagnier			Iron-Sulfur (Fe-S) Cluster Assembly THE SufBCD COMPLEX IS A NEW TYPE OF Fe-S SCAFFOLD WITH A FLAVIN REDOX COFACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CYSTEINE DESULFURASE; CRYSTAL-STRUCTURE; PROTEINS; SUFE; BIOSYNTHESIS; BIOGENESIS; MACHINERY; REDUCTION; SYSTEM	Assembly of iron-sulfur (Fe-S) clusters and maturation of Fe-S proteins in vivo require complex machineries. In Escherichia coli, under adverse stress conditions, this process is achieved by the SUF system that contains six proteins as follows: SufA, SufB, SufC, SufD, SufS, and SufE. Here, we provide a detailed characterization of the SufBCD complex whose function was so far unknown. Using biochemical and spectroscopic analyses, we demonstrate the following: (i) the complex as isolated exists mainly in a 1:2:1 (B:C:D) stoichiometry; (ii) the complex can assemble a [4Fe-4S] cluster in vitro and transfer it to target proteins; and (iii) the complex binds one molecule of flavin adenine nucleotide per SufBC(2)D complex, only in its reduced form (FADH(2)), which has the ability to reduce ferric iron. These results suggest that the SufBC(2)D complex functions as a novel type of scaffold protein that assembles an Fe-S cluster through the mobilization of sulfur from the SufSE cysteine desulfurase and the FADH(2)-dependent reductive mobilization of iron.	[Latour, Jean-Marc; Fontecave, Marc; de Choudens, Sandrine Ollagnier] CEA, iRTSV LCBM, F-38054 Grenoble 09, France; [Wollers, Silke; Layer, Gunhild; Garcia-Serres, Ricardo; Clemancey, Martin; Latour, Jean-Marc; Fontecave, Marc; de Choudens, Sandrine Ollagnier] CNRS, UMR 5249, F-38054 Grenoble, France; [Wollers, Silke; Layer, Gunhild; Garcia-Serres, Ricardo; Clemancey, Martin; Latour, Jean-Marc; de Choudens, Sandrine Ollagnier] Univ Grenoble 1, F-38054 Grenoble, France; [Fontecave, Marc] Coll France, F-75231 Paris 05, France; [Signor, Luca] Univ Grenoble 1, CEA, CNRS, Inst Biol Struct,Lab Spectrometrie Masse Prot, F-38027 Grenoble 1, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Fontecave, M (corresponding author), CEA, iRTSV LCBM, F-38054 Grenoble 09, France.	mfontecave@cea.fr; sollagnier@cea.fr	Signor, Luca/O-7489-2014; García-Serres, Ricardo/E-4344-2012	Signor, Luca/0000-0003-3880-2466; García-Serres, Ricardo/0000-0001-5203-0568; Ollagnier de Choudens, Sandrine/0000-0002-0080-6659	Region Rhone-Alpes [CIBLE 07 016335]	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by the Region Rhone-Alpes, Contract CIBLE 07 016335.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Bedekovics T, 2007, FEMS YEAST RES, V7, P1276, DOI 10.1111/j.1567-1364.2007.00296.x; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; COVES J, 1993, J BIOL CHEM, V268, P18604; COVES J, 1993, EUR J BIOCHEM, V211, P635, DOI 10.1111/j.1432-1033.1993.tb17591.x; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Eccleston JF, 2006, J BIOL CHEM, V281, P8371, DOI 10.1074/jbc.M513455200; FONTECAVE M, 1994, BIOMETALS, V7, P3; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; HALLE F, 1992, EUR J BIOCHEM, V209, P621, DOI 10.1111/j.1432-1033.1992.tb17328.x; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Kitaoka S, 2006, FEBS LETT, V580, P137, DOI 10.1016/j.febslet.2005.11.058; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Lu JX, 2008, BIOCHEM J, V409, P535, DOI 10.1042/BJ20071166; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Mickowska B, 2000, J BIOCHEM BIOPH METH, V44, P95, DOI 10.1016/S0165-022X(00)00073-7; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Ollagnier-de Choudens S, 2003, J BIOL CHEM, V278, P17993, DOI 10.1074/jbc.M300285200; Ollagnier-de-Choudens S, 2004, J BIOL INORG CHEM, V9, P828, DOI 10.1007/s00775-004-0581-9; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Petrovic A, 2008, PROTEIN SCI, V17, P1264, DOI 10.1110/ps.034652.108; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Sendra M, 2007, FEBS LETT, V581, P1362, DOI 10.1016/j.febslet.2007.02.058; Song SH, 2007, J PHOTOCH PHOTOBIO B, V87, P37, DOI 10.1016/j.jphotobiol.2006.12.007; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tokumoto U, 2004, J BIOCHEM, V136, P199, DOI 10.1093/jb/mvh104; Valton J, 2004, J BIOL CHEM, V279, P44362, DOI 10.1074/jbc.M407722200; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Wada K, 2009, J MOL BIOL, V387, P245, DOI 10.1016/j.jmb.2009.01.054; Watanabe S, 2005, J MOL BIOL, V353, P1043, DOI 10.1016/j.jmb.2005.09.017	48	100	101	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23329	23339		10.1074/jbc.M110.127449	http://dx.doi.org/10.1074/jbc.M110.127449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20460376	Green Published, hybrid			2022-12-25	WOS:000279999900066
J	Porubsky, PR; Battaile, KP; Scott, EE				Porubsky, Patrick R.; Battaile, Kevin P.; Scott, Emily E.			Human Cytochrome P450 2E1 Structures with Fatty Acid Analogs Reveal a Previously Unobserved Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORZOXAZONE HYDROXYLATION; MACROMOLECULAR STRUCTURES; OMEGA-HYDROXYLATION; P450 2E1; PROTEIN; SUBSTRATE; INHIBITORS; MECHANISM; CAVITIES; INSIGHTS	Human microsomal cytochrome P450 (CYP) 2E1 is widely known for its ability to oxidize >70 different, mostly compact, low molecular weight drugs and other xenobiotic compounds. In addition CYP2E1 oxidizes much larger C9-C20 fatty acids that can serve as endogenous signaling molecules. Previously structures of CYP2E1 with small molecules revealed a small, compact CYP2E1 active site, which would be insufficient to accommodate medium and long chain fatty acids without conformational changes in the protein. In the current work we have determined how CYP2E1 can accommodate a series of fatty acid analogs by cocrystallizing CYP2E1 with omega-imidazolyl-octanoic fatty acid, omega-imidazolyl-decanoic fatty acid, and omega-imidazolyl-dodecanoic fatty acid. In each structure direct coordination of the imidazole nitrogen to the heme iron mimics the position required for native fatty acid substrates to yield the omega-1 hydroxylated metabolites that predominate experimentally. In each case rotation of a single Phe(298) side chain merges the active site with an adjacent void, significantly altering the active site size and topology to accommodate fatty acids. The binding of these fatty acid ligands is directly opposite the channel to the protein surface and the binding observed for fatty acids in the bacterial cytochrome P450 BM3 (CYP102A1) from Bacillus megaterium. Instead of the BM3-like binding mode in the CYP2E1 channel, these structures reveal interactions between the fatty acid carboxylates and several residues in the F, G, and B' helices at successive distances from the active site.	[Porubsky, Patrick R.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Battaile, Kevin P.] Argonne Natl Lab, Adv Photon Source, Ind Macromol Crystallog Assoc Collaborat Access T, Argonne, IL 60439 USA	University of Kansas; United States Department of Energy (DOE); Argonne National Laboratory	Scott, EE (corresponding author), 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	eescott@ku.edu		Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health [GM076343, RR017708]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health National Center for Research Resources Biomedical Technology Program; National Institute of General Medical Sciences; Center for Advanced Radiation Sources at the University of Chicago; Office of Basic Energy Sciences of the United States Department of Energy Office of Science [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076343, R37GM076343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Center for Advanced Radiation Sources at the University of Chicago(University of Chicago); Office of Basic Energy Sciences of the United States Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076343 (to E.E.S.).; Thanks are due to Jennifer Laurence for critical suggestions regarding protein stabilization, to Robert Hanzlik who provided initial samples of the imidazole ligands, and to group members Melanie Blevins and Andria Skinner who attempted to make the unstable CYP2E1 mutant proteins. Crystals were grown using the facilities of the Protein Structure Laboratory core facility at the University of Kansas (supported by National Institutes of Health Grant RR017708). Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the United States Department of Energy Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, the National Institutes of Health National Center for Research Resources Biomedical Technology Program, and the National Institute of General Medical Sciences. Use of the Industrial Macromolecular Crystallography Association Collaborative Access Team Beamline 17-BM at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Center for Advanced Radiation Sources at the University of Chicago. Use of the Advanced Photon Source was supported by the Office of Basic Energy Sciences of the United States Department of Energy Office of Science under Contract W-31-109-Eng-38.	Adas F, 1999, J LIPID RES, V40, P1990; ALTERMAN MA, 1995, ARCH BIOCHEM BIOPHYS, V320, P289, DOI 10.1016/0003-9861(95)90012-8; Bookser BC, 2001, J COMB CHEM, V3, P205, DOI 10.1021/cc000086s; Carroll MA, 1996, AM J PHYSIOL-REG I, V271, pR863, DOI 10.1152/ajpregu.1996.271.4.R863; Celik A, 2005, ORG BIOMOL CHEM, V3, P2688, DOI 10.1039/b506155e; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FUKUDA T, 1994, J BIOCHEM-TOKYO, V115, P338, DOI 10.1093/oxfordjournals.jbchem.a124339; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Haines DC, 2008, BIOCHEMISTRY-US, V47, P3662, DOI 10.1021/bi7023964; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; Leslie A. G., 1998, MOSFLM 6 0; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; Lu P, 1997, ARCH BIOCHEM BIOPHYS, V337, P1, DOI 10.1006/abbi.1996.9768; Lucas D, 1998, FUNDAM CLIN PHARM, V12, P553, DOI 10.1111/j.1472-8206.1998.tb00985.x; McCarver DG, 1998, TOXICOL APPL PHARM, V152, P276, DOI 10.1006/taap.1998.8532; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGiff JC, 1999, AM J PHYSIOL-REG I, V277, pR607, DOI 10.1152/ajpregu.1999.277.3.R607; Moran JH, 2000, TOXICOL APPL PHARM, V168, P268, DOI 10.1006/taap.2000.9053; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Roy U, 2005, BIOCHEM J, V390, P719, DOI 10.1042/BJ20050681; Smith SV, 2000, BIOCHEMISTRY-US, V39, P5731, DOI 10.1021/bi000129l	31	74	75	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22282	22290		10.1074/jbc.M110.109017	http://dx.doi.org/10.1074/jbc.M110.109017			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463018	hybrid, Green Published			2022-12-25	WOS:000279702200041
J	Pal, K; Kumar, S; Sharma, S; Garg, SK; Alam, MS; Xu, HE; Agrawal, P; Swaminathan, K				Pal, Kuntal; Kumar, Shiva; Sharma, Shikha; Garg, Saurabh Kumar; Alam, Mohammad Suhail; Xu, H. Eric; Agrawal, Pushpa; Swaminathan, Kunchithapadam			Crystal Structure of Full-length Mycobacterium tuberculosis H37Rv Glycogen Branching Enzyme INSIGHTS OF N-TERMINAL beta-SANDWICH IN SUBSTRATE SPECIFICITY AND ENZYMATIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; PROTEIN; POLYSACCHARIDES; BINDING; AMYLOSUCRASE; EXPRESSION; PATTERNS; SUCROSE; COMPLEX; SURFACE	The open reading frame Rv1326c of Mycobacterium tuberculosis (Mtb) H37Rv encodes for an alpha-1,4-glucan branching enzyme (MtbGlgB, EC 2.4.1.18, Uniprot entry Q10625). This enzyme belongs to glycoside hydrolase (GH) family 13 and catalyzes the branching of a linear glucose chain during glycogenesis by cleaving a 1 -> 4 bond and making a new 1 -> 6 bond. Here, we show the crystal structure of full-length MtbGlgB (MtbGlgBWT) at 2.33-angstrom resolution. MtbGlgBWT contains four domains: N1 beta-sandwich, N2 beta-sandwich, a central (beta/alpha)(8) domain that houses the catalytic site, and a C-terminal beta-sandwich. We have assayed the amylase activity with amylose and starch as substrates and the glycogen branching activity using amylose as a substrate for MtbGlgBWT and the N1 domain-deleted (the first 108 residues deleted) Mtb Delta 108GlgB protein. The N1 beta-sandwich, which is formed by the first 105 amino acids and superimposes well with the N2 beta-sandwich, is shown to have an influence in substrate binding in the amylase assay. Also, we have checked and shown that several GH13 family inhibitors are ineffective against MtbGlgBWT and Mtb Delta 108GlgB. We propose a two-step reaction mechanism, for the amylase activity (1 -> 4 bond breakage) and isomerization (1 -> 6 bond formation), which occurs in the same catalytic pocket. The structural and functional properties of MtbGlgB and Mtb Delta 108GlgB are compared with those of the N-terminal 112-amino acid-deleted Escherichia coli GlgB (EC Delta 112GlgB).	[Sharma, Shikha; Garg, Saurabh Kumar; Alam, Mohammad Suhail; Agrawal, Pushpa] Inst Microbial Technol, Council Sci & Ind Res, Chandigarh 160036, India; [Pal, Kuntal; Kumar, Shiva; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); National University of Singapore; Van Andel Institute	Agrawal, P (corresponding author), Inst Microbial Technol, Council Sci & Ind Res, Chandigarh 160036, India.	pushpa@imtech.res.in; dbsks@nus.edu.sg	Pal, Kuntal/W-6348-2019; Xu, H. Eric/ABD-7487-2021; sarkar, sabyasachi/A-9896-2010	sarkar, sabyasachi/0000-0002-8954-4375; Xu, H. Eric/0000-0002-6829-8144; PAL, KUNTAL/0000-0001-7094-2456	Ministry of Education and Biomedical Research Council, Singapore; Institute of Microbial Technology, India; National University of Singapore; Office of Science of the U.S. Dept. of Energy; CSIR-India [SIP-10]	Ministry of Education and Biomedical Research Council, Singapore(Ministry of Education, Singapore); Institute of Microbial Technology, India; National University of Singapore(National University of Singapore); Office of Science of the U.S. Dept. of Energy(United States Department of Energy (DOE)); CSIR-India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Ministry of Education and Biomedical Research Council, Singapore (to K. S.) and Institute of Microbial Technology, India (to P. A.) and scholarships from National University of Singapore (to K. P. and S. K.). Use of the Advanced Photon Source was supported by the Office of Science of the U.S. Dept. of Energy.; Supported by the CSIR-India Network (project SIP-10).; Supported by a fellowship from CSIR, India.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; ANDERSEN DH, 1956, LAB INVEST, V5, P11; BESRA GS, 1994, LIPIDS CARBOHYDRATES, P285; Binderup K, 2000, ARCH BIOCHEM BIOPHYS, V374, P73, DOI 10.1006/abbi.1999.1580; BROWN BI, 1966, P NATL ACAD SCI USA, V56, P725, DOI 10.1073/pnas.56.2.725; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHAPMAN GB, 1959, J BACTERIOL, V77, P205, DOI 10.1128/JB.77.2.205-211.1959; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Cywes C, 1997, INFECT IMMUN, V65, P4258, DOI 10.1128/IAI.65.10.4258-4266.1997; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Devillers CH, 2003, ARCH BIOCHEM BIOPHYS, V418, P34, DOI 10.1016/S0003-9861(03)00341-2; Dinadayala P, 2004, J BIOL CHEM, V279, P12369, DOI 10.1074/jbc.M308908200; Gagliardi MC, 2007, CELL MICROBIOL, V9, P2081, DOI 10.1111/j.1462-5822.2007.00940.x; Garg SK, 2007, PROTEIN EXPRES PURIF, V51, P198, DOI 10.1016/j.pep.2006.08.005; HANKS J H, 1961, Int J Lepr, V29, P74; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemassu A, 1996, MICROBIOL-UK, V142, P1513, DOI 10.1099/13500872-142-6-1513; LEMASSU A, 1994, BIOCHEM J, V297, P351, DOI 10.1042/bj2970351; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mirza O, 2001, BIOCHEMISTRY-US, V40, P9032, DOI 10.1021/bi010706l; ORTALOMAGNE A, 1995, MICROBIOL-UK, V141, P1609, DOI 10.1099/13500872-141-7-1609; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palomo M, 2009, APPL ENVIRON MICROB, V75, P1355, DOI 10.1128/AEM.02141-08; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sivakumar N, 2006, FEBS LETT, V580, P2646, DOI 10.1016/j.febslet.2006.04.017; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; Tan TC, 2008, J MOL BIOL, V378, P852, DOI 10.1016/j.jmb.2008.02.041; Tarling CA, 2008, CHEMBIOCHEM, V9, P433, DOI 10.1002/cbic.200700470; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Valberg SJ, 2001, J VET INTERN MED, V15, P572, DOI 10.1892/0891-6640(2001)015&lt;0572:GBEDIQ&gt;2.3.CO;2; Zhang DH, 2003, J BIOL CHEM, V278, P35428, DOI 10.1074/jbc.M302616200	43	53	55	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20897	20903		10.1074/jbc.M110.121707	http://dx.doi.org/10.1074/jbc.M110.121707			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20444687	hybrid, Green Published			2022-12-25	WOS:000279228600054
J	Lou, JJW; Chua, YL; Chew, EH; Gao, J; Bushell, M; Hagen, T				Lou, Jessica Jie Wei; Chua, Yee Liu; Chew, Eng Hui; Gao, Jie; Bushell, Martin; Hagen, Thilo			Inhibition of Hypoxia-Inducible Factor-1 alpha (HIF-1 alpha) Protein Synthesis by DNA Damage Inducing Agents	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SMALL-MOLECULE INHIBITOR; FACTOR 1-ALPHA; E-CADHERIN; FACTOR EXPRESSION; DOWN-REGULATION; PATHWAY; TRANSCRIPTION; TRANSLATION; ACTIVATION	Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor that is composed of a hypoxia-inducible alpha subunit (HIF-1 alpha and HIF-2 alpha) and a constitutively expressed beta subunit (HIF-1 beta). HIF mediates the adaptation of cells and tissues to low oxygen concentrations. It also plays an important role in tumorigenesis and constitutes an important therapeutic target in anti-tumor therapy. We have screened a number of reported HIF inhibitors for their effects on HIF-transcriptional activity and found that the DNA damage inducing agents camptothecin and mitomycin C produced the most robust effects. Camptothecin is a reported inhibitor of HIF-1 alpha translation, while mitomycin C has been reported to induce p53-dependent HIF-1 alpha degradation. In this study we demonstrate that the inhibitory effect of mitomycin C on HIF-1 alpha protein expression is not dependent on p53 and protein degradation, but also involves HIF-1 alpha translational regulation. Initiation of a DNA damage response with the small molecule p53 activator NSC-652287 (RITA) has been reported to inhibit HIF-1 alpha protein synthesis by increasing the phosphorylation of eIF2 alpha. However, we show here that even when eIF2 alpha phosphorylation is prevented, the DNA damage inducing drugs mitomycin C, camptothecin and NSC-652287 still inhibit HIF-1 alpha protein synthesis to the same extent. The inhibitory effects of camptothecin on HIF-1 alpha expression but not that of mitomycin C and NSC-652287 were dependent on cyclin-dependent kinase activity. In conclusion, specific types of DNA damage can bring about selective inhibition of HIF-1 alpha protein synthesis. Further characterization of the involved mechanisms may reveal important novel therapeutic targets.	[Lou, Jessica Jie Wei; Chua, Yee Liu; Chew, Eng Hui; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Gao, Jie; Bushell, Martin] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England	National University of Singapore; University of Nottingham	Lou, JJW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchth@nus.edu.sg			Office of the Deputy President (Research & Technology) of the National University of Singapore; University of Nottingham Biomedical Research Committee	Office of the Deputy President (Research & Technology) of the National University of Singapore; University of Nottingham Biomedical Research Committee	The work was supported through Cross-Faculty Research Grant funding from the Office of the Deputy President (Research & Technology) of the National University of Singapore and funding from the University of Nottingham Biomedical Research Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranello L, 2010, NUCLEIC ACIDS RES, V38, P159, DOI 10.1093/nar/gkp817; Blum R, 2005, CANCER RES, V65, P999; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chen RQ, 2009, J BIOL CHEM, V284, P16752, DOI 10.1074/jbc.M109.014316; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Chun YS, 2001, BIOCHEM PHARMACOL, V61, P947, DOI 10.1016/S0006-2952(01)00564-0; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Demidenko ZN, 2005, ONCOGENE, V24, P4829, DOI 10.1038/sj.onc.1208636; Emerling BM, 2005, MOL CELL BIOL, V25, P4853, DOI 10.1128/MCB.25.12.4853-4862.2005; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jin X, 2008, EUR J PHARMACOL, V592, P41, DOI 10.1016/j.ejphar.2008.06.104; Kaluzova M, 2004, MOL CELL BIOL, V24, P5757, DOI 10.1128/MCB.24.13.5757-5766.2004; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Louis N, 1997, VIROLOGY, V233, P423, DOI 10.1006/viro.1997.8597; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Moynahan ME, 2001, CANCER RES, V61, P4842; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Olenyuk BZ, 2004, P NATL ACAD SCI USA, V101, P16768, DOI 10.1073/pnas.0407617101; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Rapisarda A, 2004, CANCER RES, V64, P1475, DOI 10.1158/0008-5472.CAN-03-3139; Rapisarda A, 2002, CANCER RES, V62, P4316; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; STEEGENGA WT, 1995, VIROLOGY, V212, P543, DOI 10.1006/viro.1995.1512; Steegenga WT, 1996, MOL CELL BIOL, V16, P2101; Tan C, 2005, CANCER RES, V65, P605; Tang TTL, 2003, J BIOL CHEM, V278, P30125, DOI 10.1074/jbc.M302042200; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Xue ZH, 2005, BIOCHEM BIOPH RES CO, V332, P1140, DOI 10.1016/j.bbrc.2005.05.066; Yang J, 2009, MOL CELL BIOL, V29, P2243, DOI 10.1128/MCB.00959-08; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; Zhu KY, 2009, CANCER RES, V69, P1836, DOI 10.1158/0008-5472.CAN-08-4103	45	44	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10522	10.1371/journal.pone.0010522	http://dx.doi.org/10.1371/journal.pone.0010522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479887	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000277467800007
J	Danilov, SM; Kalinin, S; Chen, ZL; Vinokour, EI; Nesterovitch, AB; Schwartz, DE; Gribouval, O; Gubler, MC; Minshall, RD				Danilov, Sergei M.; Kalinin, Sergey; Chen, Zhenlong; Vinokour, Elena I.; Nesterovitch, Andrew B.; Schwartz, David E.; Gribouval, Olivier; Gubler, Marie-Claire; Minshall, Richard D.			Angiotensin I-Converting Enzyme Gln1069Arg Mutation Impairs Trafficking to the Cell Surface Resulting in Selective Denaturation of the C-Domain	PLOS ONE			English	Article							RENAL TUBULAR DYSGENESIS; ACE-DEFICIENT MICE; 2 ACTIVE-SITES; MONOCLONAL-ANTIBODIES; N-DOMAIN; CRYSTAL-STRUCTURE; KININASE-II; HUMAN BLOOD; INHIBITORS; DISEASE	Background: Angiotensin-converting enzyme (ACE; Kininase II; CD143) hydrolyzes small peptides such as angiotensin I, bradykinin, substance P, LH-RH and several others and thus plays a key role in blood pressure regulation and vascular remodeling. Complete absence of ACE in humans leads to renal tubular dysgenesis (RTD), a severe disorder of renal tubule development characterized by persistent fetal anuria and perinatal death. Methodology/Principal Findings: Patient with RTD in Lisbon, Portugal, maintained by peritoneal dialysis since birth, was found to have a homozygous substitution of Arg for Glu at position 1069 in the C-terminal domain of ACE (Q1069R) resulting in absence of plasma ACE activity; both parents and a brother who are heterozygous carriers of this mutation had exactly half-normal plasma ACE activity compared to healthy individuals. We hypothesized that the Q1069R substitution impaired ACE trafficking to the cell surface and led to accumulation of catalytically inactive ACE in the cell cytoplasm. CHO cells expressing wild-type (WT) vs. Q1069R-ACE demonstrated the mutant accumulates intracellularly and also that it is significantly degraded by intracellular proteases. Q1069R-ACE retained catalytic and immunological characteristics of WT-ACE N domain whereas it had 10-20% of the nativity of the WT-ACE C domain. A combination of chemical (sodium butyrate) or pharmacological (ACE inhibitor) chaperones with proteasome inhibitors (MG 132 or bortezomib) significantly restored trafficking of Q1069R-ACE to the cell surface and increased ACE activity in the cell culture media 4-fold. Conclusions/Significance: Homozygous Q1069R substitution results in an ACE trafficking and processing defect which can be rescued, at least in cell culture, by a combination of chaperones and proteasome inhibitors. Further studies are required to determine whether similar treatment of individuals with this ACE mutation would provide therapeutic benefits such as concentration of primary urine.	[Danilov, Sergei M.; Kalinin, Sergey; Vinokour, Elena I.; Nesterovitch, Andrew B.; Schwartz, David E.; Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, Chicago, IL 60607 USA; [Chen, Zhenlong; Minshall, Richard D.] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Gribouval, Olivier; Gubler, Marie-Claire] Univ Paris 05, INSERM, Hop Necker Enfants Malad, U574, Paris, France; [Danilov, Sergei M.] Natl Cardiol Res Ctr, Moscow, Russia	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Medical Research Center of Cardiology	Danilov, SM (corresponding author), Univ Illinois, Dept Anesthesiol, Chicago, IL 60607 USA.	danilov@uic.edu	Gribouval, Olivier/A-7689-2015; Chen, Zhenlong/AAQ-9578-2021	Gribouval, Olivier/0000-0003-0238-8224; Gubler, Marie-Claire/0000-0002-3526-5661	Department of Anesthesiology, University of Illinois at Chicago	Department of Anesthesiology, University of Illinois at Chicago	This work was supported by the Department of Anesthesiology, University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Balyasnikova IV, 2008, TISSUE ANTIGENS, V72, P354, DOI 10.1111/j.1399-0039.2008.01112.x; Balyasnikova IV, 2007, J PROTEOME RES, V6, P1580, DOI 10.1021/pr060658x; Balyasnikova IV, 2005, J PROTEOME RES, V4, P258, DOI 10.1021/pr049859w; Balyasnikova IV, 2005, HYBRIDOMA, V24, P14, DOI 10.1089/hyb.2005.24.14; Balyasnikova IV, 2005, TISSUE ANTIGENS, V65, P240, DOI 10.1111/j.1399-0039.2005.00364.x; Balyasnikova IV, 2003, TISSUE ANTIGENS, V61, P49, DOI 10.1034/j.1399-0039.2003.610104.x; Balyasnikova IV, 1999, TUMOR TARGET, V4, P70; Balyasnikova IV, 1998, IN VITRO CELL DEV-AN, V34, P545; Bernstein KE, 2005, CIRC RES, V96, P1135, DOI 10.1161/01.RES.0000169536.73576.66; Bernstein KE, 1998, NEPHROL DIAL TRANSPL, V13, P2991, DOI 10.1093/ndt/13.12.2991; BRUNEVAL P, 1986, HISTOCHEMISTRY, V85, P73, DOI 10.1007/BF00508656; CALDWELL PRB, 1976, SCIENCE, V191, P1050, DOI 10.1126/science.175444; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; CORVOL P, 2004, HDB PROTEOLYTIC ENZY, P332; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov SM, 2008, J CARDIOVASC PHARM, V52, P90, DOI 10.1097/FJC.0b013e31817fd3bc; Danilov SM, 2007, BIOCHEMISTRY-US, V46, P9019, DOI 10.1021/bi700489v; Danilov SM, 2005, CLIN CHEM, V51, P1040, DOI 10.1373/clinchem.2004.045633; Danilov SM, 2003, EXP HEMATOL, V31, P1301, DOI 10.1016/j.exphem.2003.08.018; Deddish PA, 1996, J PHARMACOL EXP THER, V279, P1582; DEFENDINI R, 1983, NEUROENDOCRINOLOGY, V37, P32, DOI 10.1159/000123512; Ehlers M R, 1991, Protein Expr Purif, V2, P1, DOI 10.1016/1046-5928(91)90001-Y; EHLERS MRW, 1989, BIOCHEMISTRY-US, V28, P5311, DOI 10.1021/bi00439a001; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P7118, DOI 10.1021/bi00243a012; Ermolenko DN, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1233, DOI 10.1007/s10541-005-0069-4; Franke FE., 1997, LEUCOCYTE TYPING, P749; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Georgiadis D, 2003, CIRC RES, V93, P148, DOI 10.1161/01.RES.0000081593.33848.FC; Gordon K, 2003, BIOCHEM J, V371, P437, DOI 10.1042/BJ20021842; Gordon K, 2010, TISSUE ANTIGENS, V75, P136, DOI 10.1111/j.1399-0039.2009.01416.x; Gribouval O, 2005, NAT GENET, V37, P964, DOI 10.1038/ng1623; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; IWATA K, 1983, ARCH BIOCHEM BIOPHYS, V227, P188, DOI 10.1016/0003-9861(83)90362-4; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Kishimoto, 1997, LEUCOCYTE TYPING, P746; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Lacoste M, 2006, J AM SOC NEPHROL, V17, P2253, DOI 10.1681/ASN.2005121303; Marcic B, 2000, HYPERTENSION, V36, P116, DOI 10.1161/01.HYP.36.1.116-a; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Montgomery H, 2002, EUR HEART J, V23, P1083, DOI 10.1053/euhj.2001.2980; Naperova IA, 2008, J PROTEOME RES, V7, P3396, DOI 10.1021/pr800142w; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; NONOTTE I, 1995, REGUL PEPTIDES, V59, P379, DOI 10.1016/0167-0115(95)00090-X; O'Neill HG, 2008, BIOL CHEM, V389, P1153, DOI 10.1515/BC.2008.131; PIQUILLO.Y, 1970, BIOCHIM BIOPHYS ACTA, V206, P136, DOI 10.1016/0005-2744(70)90090-2; PRYDE PG, 1993, J AM SOC NEPHROL, V3, P1575; Quan A, 2006, EARLY HUM DEV, V82, P23, DOI 10.1016/j.earlhumdev.2005.11.001; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sadhukhan R, 1996, J BIOL CHEM, V271, P6429, DOI 10.1074/jbc.271.11.6429; Sanders CR, 2000, CURR OPIN STRUC BIOL, V10, P438, DOI 10.1016/S0959-440X(00)00112-3; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; SILVERSTEIN E, 1978, ISRAEL J MED SCI, V14, P314; SKIDGEL RA, 1993, RENIN ANGIOTENSIN SY; Skirgello OE, 2006, BIOCHEMISTRY-US, V45, P4831, DOI 10.1021/bi052591h; Skirgello OE, 2005, BIOCHEM J, V391, P641, DOI 10.1042/BJ20050702; Sobolewski A, 2008, HUM MOL GENET, V17, P3180, DOI 10.1093/hmg/ddn214; SOLOMON B, 1995, J MOL RECOGNIT, V8, P72, DOI 10.1002/jmr.300080113; Solomon B, 2007, EXPERT OPIN INV DRUG, V16, P819, DOI 10.1517/13543784.16.6.819; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Staessen JA, 1997, J HYPERTENS, V15, P1579, DOI 10.1097/00004872-199715120-00059; Sturrock ED, 1996, BIOCHEMISTRY-US, V35, P9560, DOI 10.1021/bi960243x; Traynor T, 1999, AM J PHYSIOL-RENAL, V276, pF751, DOI 10.1152/ajprenal.1999.276.5.F751; Uematsu M, 2009, EUR J PEDIATR, V168, P207, DOI 10.1007/s00431-008-0743-9; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Voronov S, 2002, FEBS LETT, V522, P77, DOI 10.1016/S0014-5793(02)02888-0; Watermeyer JM, 2008, BIOCHEMISTRY-US, V47, P5942, DOI 10.1021/bi8002605; Watermeyer JM, 2006, BIOCHEMISTRY-US, V45, P12654, DOI 10.1021/bi061146z; WEI L, 1991, J BIOL CHEM, V266, P9002; Williams TA, 1996, BIOCHEM PHARMACOL, V51, P11, DOI 10.1016/0006-2952(95)02125-6; Woodman ZL, 2006, BIOL CHEM, V387, P1043, DOI 10.1515/BC.2006.129	75	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10438	10.1371/journal.pone.0010438	http://dx.doi.org/10.1371/journal.pone.0010438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454656	Green Published, gold			2022-12-25	WOS:000277240300014
J	Lind, EM; Parker, JD				Lind, Eric M.; Parker, John D.			Novel Weapons Testing: Are Invasive Plants More Chemically Defended than Native Plants?	PLOS ONE			English	Article							INCREASED COMPETITIVE ABILITY; ENEMY RELEASE HYPOTHESIS; BIOTIC RESISTANCE; NATURAL ENEMIES; GROWTH-RATE; LEAF-AREA; HERBIVORES; EVOLUTION; TRAITS; SUCCESS	Background: Exotic species have been hypothesized to successfully invade new habitats by virtue of possessing novel biochemistry that repels native enemies. Despite the pivotal long-term consequences of invasion for native food-webs, to date there are no experimental studies examining directly whether exotic plants are any more or less biochemically deterrent than native plants to native herbivores. Methodology/Principal Findings: In a direct test of this hypothesis using herbivore feeding assays with chemical extracts from 19 invasive plants and 21 co-occurring native plants, we show that invasive plant biochemistry is no more deterrent (on average) to a native generalist herbivore than extracts from native plants. There was no relationship between extract deterrence and length of time since introduction, suggesting that time has not mitigated putative biochemical novelty. Moreover, the least deterrent plant extracts were from the most abundant species in the field, a pattern that held for both native and exotic plants. Analysis of chemical deterrence in context with morphological defenses and growth-related traits showed that native and exotic plants had similar trade-offs among traits. Conclusions/Significance: Overall, our results suggest that particular invasive species may possess deterrent secondary chemistry, but it does not appear to be a general pattern resulting from evolutionary mismatches between exotic plants and native herbivores. Thus, fundamentally similar processes may promote the ecological success of both native and exotic species.	[Lind, Eric M.; Parker, John D.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA	Smithsonian Institution; Smithsonian Environmental Research Center	Lind, EM (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	linde@si.edu	Parker, John D/F-9761-2010	Parker, John D/0000-0002-3632-7625; Lind, Eric/0000-0003-3051-7724	Earthwatch Institute/HSBC Climate Partnership; George P. and Caroline V. S. Hachenberg and Charles D. and Mary Vaux Walcott Endowment Funds	Earthwatch Institute/HSBC Climate Partnership; George P. and Caroline V. S. Hachenberg and Charles D. and Mary Vaux Walcott Endowment Funds	Discussions with colleagues in the Global Invasions Network (NSF RCN DEB-0541673) inspired portions of this work. J.P.'s research on forest invasions is funded by the Earthwatch Institute/HSBC Climate Partnership, and the George P. and Caroline V. S. Hachenberg and Charles D. and Mary Vaux Walcott Endowment Funds to the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Ashton IW, 2008, DIVERS DISTRIB, V14, P169, DOI 10.1111/j.1472-4642.2007.00425.x; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bolser RC, 1996, ECOLOGY, V77, P2269, DOI 10.2307/2265730; Burns JH, 2006, ECOL APPL, V16, P1367, DOI 10.1890/1051-0761(2006)016[1367:RAEATA]2.0.CO;2; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Cappuccino N, 2006, BIOL LETTERS, V2, P189, DOI 10.1098/rsbl.2005.0433; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Craine JM, 2003, OECOLOGIA, V134, P471, DOI 10.1007/s00442-002-1155-6; Daehler CC, 1997, OECOLOGIA, V110, P99, DOI 10.1007/s004420050138; Davis M. A., 2009, INVASION BIOL; DUDT JF, 1994, ECOLOGY, V75, P86, DOI 10.2307/1939385; Frankfater C, 2005, J CHEM ECOL, V31, P2541, DOI 10.1007/s10886-005-7612-z; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Grotkopp E, 2007, AM J BOT, V94, P526, DOI 10.3732/ajb.94.4.526; Gulias J, 2003, ANN BOT-LONDON, V92, P215, DOI 10.1093/aob/mcg123; HAY M. E., 1998, METHODS CHEM ECOLOGY, V2, P39; HAY ME, 1987, ECOLOGY, V68, P1567, DOI 10.2307/1939849; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Higman D, 1968, ECOLOGICALLY ANNOTAT; HOKKANEN HMT, 1989, CAN ENTOMOL, V121, P829, DOI 10.4039/Ent121829-10; Inderjit, 2006, TRENDS PLANT SCI, V11, P574, DOI 10.1016/j.tplants.2006.10.004; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Lake JC, 2004, BIOL CONSERV, V117, P215, DOI 10.1016/S0006-3207(03)00294-5; Lee KP, 2002, J INSECT PHYSIOL, V48, P655, DOI 10.1016/S0022-1910(02)00088-4; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Leishman MR, 2010, J ECOL, V98, P28, DOI 10.1111/j.1365-2745.2009.01608.x; Li Jianhua, 2006, Harvard Papers in Botany, V11, P101, DOI 10.3100/1043-4534(2006)11[101:POAASB]2.0.CO;2; Mack RN, 1996, BIOL CONSERV, V78, P107, DOI 10.1016/0006-3207(96)00021-3; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; Martin JM, 1999, J NAT PROD, V62, P2, DOI 10.1021/np980308s; Martin PH, 2009, FRONT ECOL ENVIRON, V7, P142, DOI 10.1890/070096; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Murphy SM, 2006, ECOL MONOGR, V76, P399, DOI 10.1890/0012-9615(2006)076[0399:CFOANO]2.0.CO;2; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Parker JD, 2005, ECOL LETT, V8, P959, DOI 10.1111/j.1461-0248.2005.00799.x; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; PARKER JD, BIOL INVASI IN PRESS; Pattison RR, 1998, OECOLOGIA, V117, P449, DOI 10.1007/s004420050680; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; R Development Core Team, 2009, R FDN STAT COMP; Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1; Rosenthal GA., 1992, HERBIVORES THEIR INT; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Siska EL, 2002, ECOLOGY, V83, P3369, DOI 10.1890/0012-9658(2002)083[3369:LVIPOS]2.0.CO;2; Smith MD, 2001, INT J PLANT SCI, V162, P785, DOI 10.1086/320774; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Tecco PA, 2010, J ECOL, V98, P17, DOI 10.1111/j.1365-2745.2009.01592.x; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Verhoeven KJF, 2009, ECOL LETT, V12, P107, DOI 10.1111/j.1461-0248.2008.01248.x; WAGNER DL, 2005, CATERPILLARS E N AM, DOI DOI 10.1515/9781400838295, Patent No. [2203.04766, 220304766]; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452	60	48	48	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10429	10.1371/journal.pone.0010429	http://dx.doi.org/10.1371/journal.pone.0010429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454658	Green Published, gold, Green Submitted			2022-12-25	WOS:000277240300007
J	Lindshield, BL; Ford, NA; Canene-Adams, K; Diamond, AM; Wallig, MA; Erdman, JW				Lindshield, Brian L.; Ford, Nikki A.; Canene-Adams, Kirstie; Diamond, Alan M.; Wallig, Matthew A.; Erdman, John W., Jr.			Selenium, but Not Lycopene or Vitamin E, Decreases Growth of Transplantable Dunning R3327-H Rat Prostate Tumors	PLOS ONE			English	Article							GAMMA-TOCOPHEROL; ANDROGEN-RECEPTOR; CANCER PREVENTION; METHYLSELENINIC ACID; ALPHA-TOCOPHEROL; GENE-EXPRESSION; DOWN-REGULATION; MAMMARY-CANCER; ANTIOXIDANT SUPPLEMENTATION; ANTIGEN-EXPRESSION	Background: Lycopene, selenium, and vitamin E are three micronutrients commonly consumed and supplemented by men diagnosed with prostate cancer. However, it is not clear whether consumption of these compounds, alone or in combination, results in improved outcomes. Methodology/Principal Findings: We evaluated the effects of dietary lycopene (250 mg/kg diet), selenium (methylselenocysteine, 1 mg/kg diet), and vitamin E (gamma-tocopherol, 200 mg/kg diet) alone and in combination on the growth of androgen-dependent Dunning R3327-H rat prostate adenocarcinomas in male, Copenhagen rats. AIN-93G diets containing these micronutrients were prefed for 4 to 6 weeks prior to tumor implantation by subcutaneous injection. Tumors were allowed to grow for similar to 18 weeks. Across diet groups, methylselenocysteine consumption decreased final tumor area (P = 0.003), tumor weight (P = 0.003), and the tumor weight/body weight ratio (P = 0.003), but lycopene and gamma-tocopherol consumption intake did not alter any of these measures. There were no significant interactions among nutrient combinations on tumor growth. Methylselenocysteine consumption also led to small, but significant decreases in body weight (P = 0.007), food intake (P = 0.012), and body weight gain/food intake ratio (P = 0.022). However, neither body weight nor gain/food intake ratio was correlated with tumor weight. Methylselenocysteine, lycopene, and gamma-tocopherol consumed alone and in combination did not alter serum testosterone or dihydrotestosterone concentrations; tumor proliferation or apoptosis rates. In addition, the diets also did not alter tumor or prostate androgen receptor, probasin, selenoprotein 15, selenoprotein P, or selenium binding protein 2 mRNA expression. However, using castration and finasteride-treated tissues from a previous study, we found that androgen ablation altered expression of these selenium-associated proteins. Conclusions: Of the three micronutrients tested, only methylselenocysteine consumption reduced growth of transplantable Dunning R3327-H prostate tumors, albeit through an unresolved mechanism.	[Lindshield, Brian L.; Ford, Nikki A.; Canene-Adams, Kirstie; Diamond, Alan M.; Wallig, Matthew A.; Erdman, John W., Jr.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [Erdman, John W., Jr.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA; [Wallig, Matthew A.] Univ Illinois, Dept Pathobiol, Urbana, IL USA; [Diamond, Alan M.] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lindshield, BL (corresponding author), Kansas State Univ, Dept Human Nutr, Manhattan, KS 66506 USA.	jwerdman@illinois.edu	Ford, Nikki/G-7157-2011	Canene-Adams, Kirstie/0000-0003-4617-448X	American Institute for Cancer Research [05A021]; College of Agricultural, Consumer and Environmental Sciences at the University of Illinois at Urbana-Champaign	American Institute for Cancer Research; College of Agricultural, Consumer and Environmental Sciences at the University of Illinois at Urbana-Champaign	Supported in part by American Institute for Cancer Research (http://www.aicr.org/site/PageServer) Grant 05A021 and Jonathan Baldwin Turner Fellowships (to B.L.L and K.C-A) from the College of Agricultural, Consumer and Environmental Sciences at the University of Illinois at Urbana-Champaign. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2022, CANC FACTS FIGURES 2; BANSAL MP, 1990, CARCINOGENESIS, V11, P2071, DOI 10.1093/carcin/11.11.2071; Barve A, 2009, INT J CANCER, V124, P1693, DOI 10.1002/ijc.24106; Block KI, 2009, INTEGR CANCER THER, V8, P5, DOI 10.1177/1534735409332380; Boileau TWM, 2003, JNCI-J NATL CANCER I, V95, P1578, DOI 10.1093/jnci/djg081; Boileau TWM, 2001, J NUTR, V131, P1746, DOI 10.1093/jn/131.6.1746; Boileau TWM, 2000, J NUTR, V130, P1613, DOI 10.1093/jn/130.6.1613; Boon H, 2003, UROLOGY, V62, P849, DOI 10.1016/S0090-4295(03)00668-X; Bosland MC, 2009, JAMA-J AM MED ASSOC, V301, P1877, DOI 10.1001/jama.2009.628; BURK RF, 1994, J NUTR, V124, P1891, DOI 10.1093/jn/124.10.1891; Calvo A, 2002, CANCER RES, V62, P5325; Canene-Adams K, 2007, CANCER RES, V67, P836, DOI 10.1158/0008-5472.CAN-06-3462; Chang PWG, 1997, J CELL BIOCHEM, V64, P217, DOI 10.1002/(SICI)1097-4644(199702)64:2<217::AID-JCB5>3.0.CO;2-#; Cheetham PJ, 2001, PROSTATE CANCER P D, V4, P235, DOI 10.1038/sj.pcan.4500536; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Cho SD, 2004, MOL CANCER THER, V3, P605; Chun JY, 2006, MOL CANCER THER, V5, P913, DOI 10.1158/1535-7163.MCT-05-0389; Clement M, 1997, BBA-GEN SUBJECTS, V1334, P173, DOI 10.1016/S0304-4165(96)00090-6; CLINTON SK, 1988, J NUTR, V118, P908, DOI 10.1093/jn/118.7.908; Cohen J., 1983, APPL MULTIPLE REGRES; Corcoran NM, 2004, J UROLOGY, V171, P907, DOI 10.1097/01.ju.0000092859.16817.8e; COUNCIL NR, 1995, ANONYMOUS NUTR REQUI, P11; Craft NE, 2004, FASEB J, V18, pA534; Davis CD, 2002, J NUTR, V132, P307, DOI 10.1093/jn/132.2.307; Dong Y, 2004, CANCER RES, V64, P19, DOI 10.1158/0008-5472.CAN-03-2789; Dong Y, 2005, MOL CANCER THER, V4, P1047, DOI 10.1158/1535-7163.MCT-05-0124; El-Bayoumy K, 2009, NUTR CANCER, V61, P285, DOI 10.1080/01635580902892829; Finley JW, 2001, BIOFACTORS, V14, P191, DOI 10.1002/biof.5520140124; Finley JW, 2000, J NUTR, V130, P2384, DOI 10.1093/jn/130.9.2384; Fleshner N, 1999, J UROLOGY, V161, P1651, DOI 10.1016/S0022-5347(05)68998-7; Galli F, 2004, ARCH BIOCHEM BIOPHYS, V423, P97, DOI 10.1016/j.abb.2003.11.014; Gann PH, 2009, JAMA-J AM MED ASSOC, V301, P102, DOI 10.1001/jama.2008.863; Gann PH, 2003, JNCI-J NATL CANCER I, V95, P1563, DOI 10.1093/jnci/djg112; Gysin R, 2002, FASEB J, V16, P1952, DOI 10.1096/fj.02-0362fje; Helzlsouer KJ, 2000, J NATL CANCER I, V92, P2018, DOI 10.1093/jnci/92.24.2018; Huang HY, 2003, AM J EPIDEMIOL, V157, P335, DOI 10.1093/aje/kwf210; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Husbeck B, 2006, MOL CANCER THER, V5, P2078, DOI 10.1158/1535-7163.MCT-06-0056; IP C, 1995, CARCINOGENESIS, V16, P2649, DOI 10.1093/carcin/16.11.2649; IP C, 1992, NUTR CANCER, V17, P279, DOI 10.1080/01635589209514197; IP C, 1994, CARCINOGENESIS, V15, P1881, DOI 10.1093/carcin/15.9.1881; Ip C, 1996, CARCINOGENESIS, V17, P1979, DOI 10.1093/carcin/17.9.1979; Ip C, 2000, J AGR FOOD CHEM, V48, P2062, DOI 10.1021/jf000051f; Ip C, 1999, ANTICANCER RES, V19, P2875; IP C, 1992, CARCINOGENESIS, V13, P1167, DOI 10.1093/carcin/13.7.1167; Ip C, 2000, CANCER RES, V60, P2882; IP C, 1991, CANCER RES, V51, P595; IP C, 1994, CARCINOGENESIS, V15, P573, DOI 10.1093/carcin/15.4.573; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Ishida T, 2002, J HEALTH SCI, V48, P62, DOI 10.1248/jhs.48.62; Jiang Q, 2004, P NATL ACAD SCI USA, V101, P17825, DOI 10.1073/pnas.0408340102; Kasper S, 2000, BBA-PROTEIN STRUCT M, V1482, P249, DOI 10.1016/S0167-4838(00)00170-9; Kipp A, 2009, MOL NUTR FOOD RES, V53, P1561, DOI 10.1002/mnfr.200900105; Kumaraswamy E, 2000, J BIOL CHEM, V275, P35540, DOI 10.1074/jbc.M004014200; LANFEAR J, 1993, CARCINOGENESIS, V14, P335, DOI 10.1093/carcin/14.3.335; Lee SO, 2006, PROSTATE, V66, P1070, DOI 10.1002/pros.20329; Legg RL, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-57; Li GX, 2008, CARCINOGENESIS, V29, P1005, DOI 10.1093/carcin/bgn007; Li L, 2005, J BIOCHEM MOL TOXIC, V19, P396, DOI 10.1002/jbt.20105; Limpens J, 2006, J NUTR, V136, P1287, DOI 10.1093/jn/136.5.1287; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahn AV, 2009, J NUTR BIOCHEM, V20, P791, DOI 10.1016/j.jnutbio.2008.07.008; Mahn AV, 2009, BIOL RES, V42, P163, DOI [10.4067/S0716-97602009000200004, /S0716-97602009000200004]; Marshall JR, 2006, CANCER EPIDEM BIOMAR, V15, P1479, DOI 10.1158/1055-9965.EPI-05-0585; MCCORMICK D, 2010, CANC PREVENTION RES; McCormick DL, 1999, EUR UROL, V35, P464, DOI 10.1159/000019880; MCKOWN DM, 1978, J RADIOANAL CHEM, V43, P411, DOI 10.1007/BF02519502; Medina D, 2001, NUTR CANCER, V40, P12, DOI 10.1207/S15327914NC401_5; Morris JDH, 2006, CANCER LETT, V239, P111, DOI 10.1016/j.canlet.2005.07.037; Narayanan A, 1996, EXACT METHODS NPAR1W; Ni J, 2003, BIOCHEM BIOPH RES CO, V300, P357, DOI 10.1016/S0006-291X(02)02851-6; Novoselov SV, 2005, ONCOGENE, V24, P8003, DOI 10.1038/sj.onc.1208940; Pang ST, 2002, ENDOCRINOLOGY, V143, P4897, DOI 10.1210/en.2002-220327; Pinto JT, 2007, INT J CANCER, V120, P1410, DOI 10.1002/ijc.22500; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Riese C, 2006, ENDOCRINOLOGY, V147, P5883, DOI 10.1210/en.2006-0689; Sambrook J, 2001, MOL CLONING LAB MANU; SAMUELS BL, 1991, CANCER RES, V51, P521; Siler U, 2004, FASEB J, V18, P1019, DOI 10.1096/fj.03-1116fje; Takahashi S, 2009, PROSTATE, V69, P644, DOI 10.1002/pros.20915; Takahashi Y, 2006, MOL CARCINOGEN, V45, P18, DOI 10.1002/mc.20153; Tang LL, 2005, J NUTR, V135, P287, DOI 10.1093/jn/135.2.287; Tennant TR, 2000, PROSTATE, V43, P295, DOI 10.1002/1097-0045(20000601)43:4<295::AID-PROS9>3.0.CO;2-W; Unni E, 2004, BREAST CANCER RES, V6, pR586, DOI 10.1186/bcr914; VATASSERY GT, 1993, ANAL BIOCHEM, V214, P426, DOI 10.1006/abio.1993.1518; Velasco AM, 2004, ENDOCRINOLOGY, V145, P3913, DOI 10.1210/en.2004-0311; Venkateswaran V, 2004, CANCER RES, V64, P5891, DOI 10.1158/0008-5472.CAN-04-0690; Venkateswaran V, 2004, PROSTATE CANCER P D, V7, P54, DOI 10.1038/sj.pcan.4500707; Venkateswaran V, 2009, CANCER PREV RES, V2, P473, DOI 10.1158/1940-6207.CAPR-08-0124; Wang L, 2009, CANCER PREV RES, V2, P484, DOI 10.1158/1940-6207.CAPR-08-0173; WEIGEL RM, 1991, CONTROL CLIN TRIALS, V12, P378, DOI 10.1016/0197-2456(91)90018-H; Weinstein SJ, 2005, JNCI-J NATL CANCER I, V97, P396, DOI 10.1093/jnci/dji045; Whanger PD, 2004, BRIT J NUTR, V91, P11, DOI 10.1079/BJN20031015; Wright ME, 2007, CANCER EPIDEM BIOMAR, V16, P1128, DOI 10.1158/1055-9965.EPI-06-1071; Yang MH, 1998, CANCER RES, V58, P3150; Zhang X, 2008, CANCER PREV RES, V1, P119, DOI 10.1158/1940-6207.CAPR-08-0036; Zhao HJ, 2004, MOL BIOL CELL, V15, P506, DOI 10.1091/mbc.E03-07-0501; Zu K, 2003, CANCER RES, V63, P6988	100	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10423	10.1371/journal.pone.0010423	http://dx.doi.org/10.1371/journal.pone.0010423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454690	Green Published, gold, Green Submitted			2022-12-25	WOS:000277240100027
J	Sander, V; Eivers, E; Choi, RH; De Robertis, EM				Sander, Veronika; Eivers, Edward; Choi, Renee H.; De Robertis, Edward M.			Drosophila Smad2 Opposes Mad Signaling during Wing Vein Development	PLOS ONE			English	Article							BETA FAMILY-MEMBERS; RECEPTOR COMPLEXES; MORPHOGEN GRADIENT; PATTERN-FORMATION; I RECEPTORS; DPP; GENE; ACTIVATION; EXPRESSION; GROWTH	In the vertebrates, the BMP/Smad1 and TGF-b/Smad2 signaling pathways execute antagonistic functions in different contexts of development. The differentiation of specific structures results from the balance between these two pathways. For example, the gastrula organizer/node of the vertebrates requires a region of low Smad1 and high Smad2 signaling. In Drosophila, Mad regulates tissue determination and growth in the wing, but the function of dSmad2 in wing patterning is largely unknown. In this study, we used an RNAi loss-of-function approach to investigate dSmad2 signaling during wing development. RNAi-mediated knockdown of dSmad2 caused formation of extra vein tissue, with phenotypes similar to those seen in Dpp/Mad gain-of-function. Clonal analyses revealed that the normal function of dSmad2 is to inhibit the response of wing intervein cells to the extracellular Dpp morphogen gradient that specifies vein formation, as measured by expression of the activated phospho-Mad protein. The effect of dSmad2 depletion in promoting vein differentiation was dependent on Medea, the co-factor shared by Mad and dSmad2. Furthermore, double RNAi experiments showed that Mad is epistatic to dSmad2. In other words, depletion of Smad2 had no effect in Mad-deficient wings. Our results demonstrate a novel role for dSmad2 in opposing Mad-mediated vein formation in the wing. We propose that the main function of dActivin/dSmad2 in Drosophila wing development is to antagonize Dpp/Mad signaling. Possible molecular mechanisms for the opposition between dSmad2 and Mad signaling are discussed.	[Sander, Veronika; Eivers, Edward; Choi, Renee H.; De Robertis, Edward M.] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90024 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Sander, V (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90024 USA.	ederobertis@mednet.ucla.edu	Sander, Veronika/R-5190-2019	Sander, Veronika/0000-0002-2918-833X; De Robertis, Edward/0000-0002-7843-1869	NIH [HD21502-23S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502, R01HD021502] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	NIH HD21502-23S1 http://www.nih.gov HHMIhttp://www.hhmi.org. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Attisano L, 1998, CURR OPIN CELL BIOL, V10, P188, DOI 10.1016/S0955-0674(98)80141-5; Bengtsson L, 2009, J CELL SCI, V122, P1248, DOI 10.1242/jcs.039552; Bharathy S, 2008, CANCER RES, V68, P1656, DOI 10.1158/0008-5472.CAN-07-5089; Bickel D, 2008, MECH DEVELOP, V125, P117, DOI 10.1016/j.mod.2007.09.013; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; BLAIR SS, 1992, DEV BIOL, V152, P263, DOI 10.1016/0012-1606(92)90134-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Candia AF, 1997, DEVELOPMENT, V124, P4467; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; COUSO JP, 1994, DEVELOPMENT, V120, P621; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Das P, 1998, DEVELOPMENT, V125, P1519; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Eivers E, 2008, CURR OPIN GENET DEV, V18, P304, DOI 10.1016/j.gde.2008.06.001; Eivers E, 2009, CYTOKINE GROWTH F R, V20, P357, DOI 10.1016/j.cytogfr.2009.10.017; Eivers E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006543; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Garcia-Bellido A, 2009, INT J DEV BIOL, V53, P1291, DOI 10.1387/ijdb.072459ag; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Henderson KD, 1998, BIOCHEM BIOPH RES CO, V252, P195, DOI 10.1006/bbrc.1998.9562; Hudson JB, 1998, DEVELOPMENT, V125, P1407; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nicholls RE, 1998, GENETICS, V149, P203; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ralston A, 2005, DEV BIOL, V280, P187, DOI 10.1016/j.ydbio.2005.01.018; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Sander V, 2007, EMBO J, V26, P2955, DOI 10.1038/sj.emboj.7601705; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sotillos S, 2006, MECH DEVELOP, V123, P241, DOI 10.1016/j.mod.2005.12.002; Sotillos S, 2005, DEV DYNAM, V232, P738, DOI 10.1002/dvdy.20270; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Takaesu NT, 2005, DEVELOPMENT, V132, P4883, DOI 10.1242/dev.02048; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Yamamoto M, 2009, J CELL BIOL, V184, P323, DOI 10.1083/jcb.200808044; Yan SJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.35; Yu K, 2000, DEVELOPMENT, V127, P2143; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zheng XY, 2006, EMBO J, V25, P615, DOI 10.1038/sj.emboj.7600962; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhu CC, 2008, DEVELOPMENT, V135, P513, DOI 10.1242/dev.010876	58	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10383	10.1371/journal.pone.0010383	http://dx.doi.org/10.1371/journal.pone.0010383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442782	gold, Green Published			2022-12-25	WOS:000277154200019
J	Lee, WY; Hampson, P; Coulthard, L; Ali, F; Salmon, M; Lord, JM; Scheel-Toellner, D				Lee, Wing-yiu; Hampson, Peter; Coulthard, Lydia; Ali, Farrah; Salmon, Mike; Lord, Janet M.; Scheel-Toellner, Dagmar			Novel Antileukemic Compound Ingenol 3-Angelate Inhibits T Cell Apoptosis by Activating Protein Kinase C theta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; PKC-THETA; CENTRAL MEMORY; LYMPHOCYTES; SURVIVAL; FAMILY; BIM; COSTIMULATION; CHEMOTHERAPY; CD4(+)	Members of the protein kinase C (PKC) family of serine-threonine kinases are important regulators of immune cell survival. Ingenol 3-angelate (PEP005) activates a broad range of PKC isoforms and induces apoptosis in acute myeloid leukemia cells by activating the PKC isoform PKC delta. We show here that, in contrast to its effect on leukemic cells, PEP005 provides a strong survival signal to resting and activated human T cells. The antiapoptotic effect depends upon the activation of PKC theta. This PKC isoform is expressed in T cells but is absent in myeloid cells. Further studies of the mechanism involved in this process showed that PEP005 inhibited activated CD8(+) T cell apoptosis through the activation of NF kappa B downstream of PKC theta, leading to increased expression of the antiapoptotic proteins Mcl-1 and Bcl-x(L). Transfection of CD8(+) T cells with dominant-negative PKC theta diminished the prosurvival effect of PEP005 significantly. Ectopic expression of PKC theta in the acute myeloid leukemia cell line NB4 turned their response to PEP005 from an increased to decreased rate of apoptosis. Therefore, in contrast to myeloid leukemia cells, PEP005 provides a strong survival signal to T cells, and the expression of functional PKC theta influences whether PKC activation leads to an anti-or proapoptotic outcome in the cell types tested.	[Scheel-Toellner, Dagmar] Univ Birmingham, Rheumatol Res Grp, MRC,Inst Biomed Res, Ctr Immune Regulat,Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Coulthard, Lydia] Univ Leeds, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England	University of Birmingham; University of Leeds	Scheel-Toellner, D (corresponding author), Univ Birmingham, Rheumatol Res Grp, MRC,Inst Biomed Res, Ctr Immune Regulat,Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England.	d.scheel@bham.ac.uk	Lee, Wing-Yiu/AAC-8824-2019	Lee, Wing-Yiu/0000-0002-8524-3874; Lord, Janet/0000-0003-1030-6786; Johnson, Lydia/0000-0002-2122-3479	Arthritis Research UK; European Commission [LSHB-CT-2004-503467]; Peplin, Inc.; Birmingham University; Medical Research Council [G9818340B] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); European Commission(European CommissionEuropean Commission Joint Research Centre); Peplin, Inc.; Birmingham University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by an Arthritis Research UK Career Development Fellowship (to D.S.-T.), an Arthritis Research UK programme grant (to M.S. and J.M.L.), the European Commission (LSHB-CT-2004-503467), a project grant from Peplin, Inc., and a Birmingham University PhD studentship ( to W.-y.L.).	BAIER G, 1993, J BIOL CHEM, V268, P4997; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Barouch-Bentov R, 2005, J IMMUNOL, V175, P5126, DOI 10.4049/jimmunol.175.8.5126; Bosque A, 2007, MOL IMMUNOL, V44, P1446, DOI 10.1016/j.molimm.2006.04.029; Challacombe JM, 2006, J IMMUNOL, V177, P8123, DOI 10.4049/jimmunol.177.11.8123; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Deacon EM, 1997, J CLIN PATHOL-MOL PA, V50, P124, DOI 10.1136/mp.50.3.124; DUKE RC, 1986, LYMPHOKINE RES, V5, P289; Ersvaer E, 2007, CANCER IMMUNOL IMMUN, V56, P913, DOI 10.1007/s00262-006-0236-5; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Green A C, 1988, Australas J Dermatol, V29, P127, DOI 10.1111/j.1440-0960.1988.tb00383.x; Hampson P, 2005, BLOOD, V106, P1362, DOI 10.1182/blood-2004-10-4117; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Manicassamy S, 2006, J IMMUNOL, V176, P6709, DOI 10.4049/jimmunol.176.11.6709; MOHR H, 1987, IMMUNOBIOLOGY, V175, P420, DOI 10.1016/S0171-2985(87)80070-0; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; OSADA S, 1992, MOL CELL BIOL, V12, P3930, DOI 10.1128/MCB.12.9.3930; Saibil SD, 2007, J IMMUNOL, V178, P2932, DOI 10.4049/jimmunol.178.5.2932; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Scheel-Toellner D, 2008, APOPTOSIS, V13, P109, DOI 10.1007/s10495-007-0143-z; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thuille N, 2005, EMBO J, V24, P3869, DOI 10.1038/sj.emboj.7600856; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; WEEDON D, 1976, MED J AUSTRALIA, V1, P928, DOI 10.5694/j.1326-5377.1976.tb141173.x; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	33	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23889	23898		10.1074/jbc.M109.041962	http://dx.doi.org/10.1074/jbc.M109.041962			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20472553	Green Published, hybrid			2022-12-25	WOS:000280291400039
J	Li, G; Shi, Y; Huang, HS; Zhang, YP; Wu, KP; Luo, JS; Sun, Y; Lu, JX; Benovic, JL; Zhou, NM				Li, Guo; Shi, Ying; Huang, Haishan; Zhang, Yaping; Wu, Kuangpei; Luo, Jiansong; Sun, Yi; Lu, Jianxin; Benovic, Jeffrey L.; Zhou, Naiming			Internalization of the Human Nicotinic Acid Receptor GPR109A Is Regulated by G(i), GRK2, and Arrestin3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-GAMMA-SUBUNITS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; MOLECULAR-IDENTIFICATION; FATTY-ACIDS; DESENSITIZATION; KINASE; SEQUESTRATION; AGONIST; ENDOCYTOSIS	Nicotinic acid (niacin) has been widely used as a favorable lipid-lowering drug for several decades, and the orphan G protein-coupled receptor GPR109A has been identified to be a receptor for niacin. Mechanistic investigations have shown that as a G(i)-coupled receptor, GPR109A inhibits adenylate cyclase activity upon niacin activation, thereby inhibiting free fatty acid liberation. However, the underlying molecular mechanisms that regulate signaling and internalization of GPR109A remain largely unknown. To further characterize GPR109A internalization, we made a construct to express GPR109A fused with enhanced green fluorescent protein (EGFP) at its carboxyl-terminal end. In stable GPR109A-EGFP-expressing HEK-293 cells, GPR109A-EGFP was mainly localized at the plasma membrane and was rapidly internalized in a dose-and time-dependent manner upon agonist stimulation. GPR109A internalization was completely blocked by hypertonic sucrose, indicating that GPR109A internalizes via the clathrin-coated pit pathway. Further investigation demonstrated that internalized GPR109A was recycled to the cell surface after the removal of agonist, and recycling of the internalized receptors was not blocked by treatment with acidotropic agents, NH4Cl and monensin. Pertussis toxin pretreatment not only inhibited forskolin-induced cAMP accumulation and intracellular Ca2+ mobilization; it also significantly attenuated agonist-promoted GPR109A internalization. Moreover, RNA interference experiments showed that knockdown of GRK2 (G protein-coupled receptor kinase 2) and arrestin3 expression significantly impaired receptor internalization. Taken together, these results indicate that the agonist-induced internalization of GPR109A receptors is regulated by GRK2 and arrestin3 in a pertussis toxin-sensitive manner and that internalized receptor recycling is independent of endosomal acidification.	[Li, Guo; Shi, Ying; Huang, Haishan; Zhang, Yaping; Sun, Yi; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310058, Zhejiang, Peoples R China; [Wu, Kuangpei; Lu, Jianxin] Wenzhou Med Coll, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou 325035, Zhejiang, Peoples R China; [Luo, Jiansong; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Zhejiang University; Wenzhou Medical University; Jefferson University	Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus,388 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	znm2000@yahoo.com	Zhou, Naiming/AHC-1121-2022		National Institutes of Health [GM44944, GM47417]; National Natural Science Foundation of China [30670425]; Ministry of Science and Technology [2008AA02Z138]; Zhejiang Natural Science Foundation [Z2080207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944, R37GM047417, R01GM047417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM44944 and GM47417. This work was also supported by National Natural Science Foundation of China Grant 30670425, Ministry of Science and Technology Grant 2008AA02Z138, and Zhejiang Natural Science Foundation Grant Z2080207.	Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P4649, DOI 10.1210/jc.2004-0224; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; BLUM CB, 1977, J CLIN INVEST, V60, P795, DOI 10.1172/JCI108833; Boden G, 1998, DIABETES, V47, P1609, DOI 10.2337/diabetes.47.10.1609; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Chakrabarti S, 1997, MOL PHARMACOL, V52, P105, DOI 10.1124/mol.52.1.105; Daly CJ, 2003, PHARMACOL THERAPEUT, V100, P101, DOI 10.1016/j.pharmthera.2003.08.001; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; GRADY EF, 1995, MOL BIOL CELL, V6, P509, DOI 10.1091/mbc.6.5.509; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAGA K, 1992, J BIOL CHEM, V267, P2222; HARFORD J, 1983, J CELL BIOL, V96, P1824, DOI 10.1083/jcb.96.6.1824; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Kamanna VS, 2007, AM J CARDIOL, V100, p53N, DOI 10.1016/j.amjcard.2007.09.080; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Liang W, 2004, J CELL SCI, V117, P723, DOI 10.1242/jcs.00878; LippincottSchwartz J, 1997, CURR OPIN NEUROBIOL, V7, P631, DOI 10.1016/S0959-4388(97)80082-7; Lorenzen A, 2001, MOL PHARMACOL, V59, P349, DOI 10.1124/mol.59.2.349; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; MELLMAN I, 1984, J CELL BIOL, V98, P1163, DOI 10.1083/jcb.98.4.1163; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; MORO O, 1993, J BIOL CHEM, V268, P6862; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Olli-Lahdesmaki T, 2004, BIOCHEM BIOPH RES CO, V321, P226, DOI 10.1016/j.bbrc.2004.06.131; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; PALSRYLAARSDAM R, 1995, J BIOL CHEM, V270, P29004, DOI 10.1074/jbc.270.48.29004; Pheng LH, 2003, BRIT J PHARMACOL, V139, P695, DOI 10.1038/sj.bjp.0705306; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; RAY A, 1989, MOL CELL BIOL, V9, P5537, DOI 10.1128/MCB.9.12.5537; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Richman JG, 2007, J BIOL CHEM, V282, P18028, DOI 10.1074/jbc.M701866200; Santomauro ATMG, 1999, DIABETES, V48, P1836, DOI 10.2337/diabetes.48.9.1836; SCHVARTZ I, 1987, J BIOL CHEM, V262, P17046; Semple G, 2006, J MED CHEM, V49, P1227, DOI 10.1021/jm051099t; SHEPHERD J, 1979, J CLIN INVEST, V63, P858, DOI 10.1172/JCI109385; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; TSUGA H, 1994, J BIOL CHEM, V269, P32522; TSUKADA T, 1987, J BIOL CHEM, V262, P8743; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; VAAG A, 1991, J CLIN INVEST, V88, P1282, DOI 10.1172/JCI115432; VANEPPS DE, 1992, J LEUKOCYTE BIOL, V51, P393, DOI 10.1002/jlb.51.4.393; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Zhang YY, 2005, BIOCHEM BIOPH RES CO, V334, P729, DOI 10.1016/j.bbrc.2005.06.141	58	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22605	22618		10.1074/jbc.M109.087213	http://dx.doi.org/10.1074/jbc.M109.087213			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460384	Green Published, hybrid			2022-12-25	WOS:000279702200071
J	Askew, EB; Bai, SX; Blackwelder, AJ; Wilson, EM				Askew, Emily B.; Bai, Suxia; Blackwelder, Amanda J.; Wilson, Elizabeth M.			Transcriptional Synergy between Melanoma Antigen Gene Protein-A11 (MAGE-11) and p300 in Androgen Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; COOH-TERMINAL INTERACTION; ACTIVATION FUNCTION 2; HISTONE ACETYLTRANSFERASE; COREGULATOR MAGE-11; UBIQUITIN LIGASE; PROSTATE-CANCER; DNA-BINDING; CBP; DOMAIN	Androgen receptor (AR)-mediated gene regulation involves interactions with coregulatory proteins that include the melanoma antigen gene protein-A11 (MAGE-11). To understand the functional significance of sequence similarity between MAGE-11 and the adenovirus early protein E1A, we determined whether MAGE-11 contributes to AR transcriptional activity through an interaction with p300, a potent and ubiquitous transcriptional regulator. Here, we report that MAGE-11 interacts with the NH2-terminal region of p300 through the MAGE-11 MXXIF motif (MXXIF189)-M-185, with transcriptional activity depending on the MAGE-11 F-box and MAPK phosphorylation. The MAGE-11- and p300-dependent increase in AR transactivation required the NH2-terminal regions of AR and p300, p300 acetyltransferase activity, and the AR FXXLF motif (23)FQNLF(27) interaction with MAGE-11. MAGE-11 linked AR to p300 and the p160 coactivator, transcriptional intermediary protein 2 (TIF2). The p300 NH2-terminal FXXLF motif (33F)GSLF(37) was required for transcriptional activation by TIF2. Increased expression of p300 decreased the ubiquitinylation of MAGE-11 and transiently increased endogenous MAGE-11 levels. Auto-acetylation of p300 and decreased acetylation of TIF2 were evident in the MAGE-11, p300, and TIF2 complex. The studies suggest that MAGE-11 links NH2-terminal domains of AR and p300 to promote transcriptional synergy through a cadre of FXXLF-related interacting motifs.	[Askew, Emily B.; Bai, Suxia; Blackwelder, Amanda J.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Askew, Emily B.; Wilson, Elizabeth M.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA; [Askew, Emily B.; Bai, Suxia; Blackwelder, Amanda J.; Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bai, Suxia; Blackwelder, Amanda J.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Bai, Suxia; Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu	Askew, Eldon W/F-5347-2014		Eunice Kennedy Shriver NICHD [U54-HD35041]; NICHD (USPHS) [HD16910]; NCI [P01-CA77739]; Department of Defense [PC073586]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD035041, R01HD016910, R37HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD (USPHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)United States Public Health Service); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Cooperative Agreement U54-HD35041 from the Eunice Kennedy Shriver NICHD (Specialized Cooperative Centers Program in Reproduction and Infertility Research), Grant HD16910 from NICHD (USPHS), and by P01-CA77739 from the NCI. This work was also supported by Department of Defense PC073586 Fellowship Award.	Aarnisalo P, 1998, P NATL ACAD SCI USA, V95, P2122, DOI 10.1073/pnas.95.5.2122; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen YJ, 2007, J BIOL CHEM, V282, P27215, DOI 10.1074/jbc.M700264200; Debes JD, 2002, CANCER RES, V62, P5632; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Finlan L, 2004, J BIOL CHEM, V279, P49395, DOI 10.1074/jbc.M405974200; Fronsdal K, 1998, J BIOL CHEM, V273, P31853, DOI 10.1074/jbc.273.48.31853; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Galbiati L, 2005, CELL CYCLE, V4, P930, DOI 10.4161/cc.4.7.1784; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Goodman RH, 2000, GENE DEV, V14, P1553; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heemers HV, 2007, CANCER RES, V67, P3422, DOI 10.1158/0008-5472.CAN-06-2836; Hsu CL, 2003, J BIOL CHEM, V278, P23691, DOI 10.1074/jbc.M211908200; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Kim J, 2005, J MOL ENDOCRINOL, V34, P107, DOI 10.1677/jme.1.01701; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Matsuda S, 2004, J BIOL CHEM, V279, P14055, DOI 10.1074/jbc.M310188200; Muraoka M, 1996, ONCOGENE, V12, P1565; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; Rasti M, 2005, J VIROL, V79, P5594, DOI 10.1128/JVI.79.9.5594-5605.2005; Sheppard HM, 2001, MOL CELL BIOL, V21, P39, DOI 10.1128/MCB.21.1.39-50.2001; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Turnell AS, 2006, BRIT J CANCER, V95, P555, DOI 10.1038/sj.bjc.6603304; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wagner BL, 1998, MOL CELL BIOL, V18, P1369, DOI 10.1128/MCB.18.3.1369; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; Yuan LW, 2002, BBA-MOL CELL RES, V1592, P205, DOI 10.1016/S0167-4889(02)00327-0; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	63	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21824	21836		10.1074/jbc.M110.120600	http://dx.doi.org/10.1074/jbc.M110.120600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448036	Green Published, hybrid			2022-12-25	WOS:000279516100067
J	Hermans, SM; Kiragga, AN; Schaefer, P; Kambugu, A; Hoepelman, AIM; Manabe, YC				Hermans, Sabine M.; Kiragga, Agnes N.; Schaefer, Petra; Kambugu, Andrew; Hoepelman, Andy I. M.; Manabe, Yukari C.			Incident Tuberculosis during Antiretroviral Therapy Contributes to Suboptimal Immune Reconstitution in a Large Urban HIV Clinic in Sub-Saharan Africa	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; CD4 CELL COUNT; TERM IMMUNOLOGICAL RESPONSE; RESOURCE-LIMITED SETTINGS; INFECTED PATIENTS; SOUTH-AFRICA; TREATMENT FAILURE; PULMONARY TUBERCULOSIS; VIROLOGICAL RESPONSES; DISCORDANT RESPONSES	Background: Antiretroviral therapy (ART) effectively decreases tuberculosis (TB) incidence long-term, but is associated with high TB incidence rates in the first 6 months. We sought to determine the incidence and the long-term effects of TB during ART on HIV treatment outcome, and the risk factors for incident TB during ART in a large urban HIV clinic in Uganda. Methodology/Principal Findings: Routinely collected longitudinal clinical data from all patients initiated on first-line ART was retrospectively analysed. 5,982 patients were included with a median baseline CD4+ T cell count (CD4 count) of 117 cells/mm(3) (interquartile range [IQR]; 42, 182). In the first 2 years, there were 336 (5.6%) incident TB events in 10,710 person-years (py) of follow-up (3.14 cases/100pyar [95% CI 2.82-3.49]); incidence rates at 0-3, 3-6, 6-12 and 12-24 months were 11.25 (9.58-13.21), 6.27 (4.99-7.87), 2.47 (1.87-3.36) and 1.02 (0.80-1.31), respectively. Incident TB during ART was independently associated with baseline CD4 count of < 50 cells/mm(3) (hazard ratio [HR] 1.84 [1.25-2.70], P=0.002) and male gender (HR 1.68 [1.34-2.11], P < 0.001). After two years on ART, the patients who had developed TB in the first 12 months had a significantly lower median CD4 count increase (184 cells/mm(3) [IQR; 107, 258, n=118] vs 209 cells/mm(3) [124, 309, n=2166], P=0.01), a larger proportion of suboptimal immune reconstitution according to two definitions (increase in CD4 count < 200 cells/mm(3): 57.4% vs 46.9%, P=0.03, and absolute CD4 count < 200 cells/mm(3): 30.4 vs 19.9%, P=0.006), and a higher percentage of immunological failure according to the WHO criteria (13.6% vs 6.5%, P=0.003). Incident TB during ART was independently associated with poor CD4 count recovery and fulfilling WHO immunogical failure definitions. Conclusions/Significance: Incident TB during ART occurs most often within 3 months and in patients with CD4 counts less than 50 cells/mm(3). Incident TB during ART is associated with long-term impairment in immune recovery.	[Hermans, Sabine M.; Hoepelman, Andy I. M.] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Hermans, Sabine M.; Kiragga, Agnes N.; Schaefer, Petra; Kambugu, Andrew; Manabe, Yukari C.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA	Utrecht University; Utrecht University Medical Center; Makerere University; Johns Hopkins University	Hermans, SM (corresponding author), Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands.	shermans@idi.co.ug		Hermans, Sabine/0000-0001-5146-2932	Infectious Diseases Institute research department; Gilead IDSA Exchange Fellowship; University Medical Center Utrecht; Accordia Global Health Foundation; Wellcome Trust	Infectious Diseases Institute research department; Gilead IDSA Exchange Fellowship(Gilead Sciences); University Medical Center Utrecht; Accordia Global Health Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Infectious Diseases Institute research department core funding. S. H. was supported by a Gilead IDSA Exchange Fellowship as well as by the University Medical Center Utrecht. Y.M. receives salary support from Accordia Global Health Foundation. A. K. is supported by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin JF, 2004, INT J TUBERC LUNG D, V8, P435; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; Bonnet MMB, 2006, AIDS, V20, P1275, DOI 10.1097/01.aids.0000232235.26630.ee; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Breen RAM, 2006, J INFECT DIS, V193, P1437, DOI 10.1086/503437; Cassol E, 2005, J INFECT DIS, V191, P324, DOI 10.1086/427337; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Castelnuovo B, 2009, AIDS, V23, P1295, DOI 10.1097/QAD.0b013e32832cbd43; Chi BH, 2009, JAIDS-J ACQ IMM DEF, V52, P125, DOI 10.1097/QAI.0b013e3181ab6d8b; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Eggena MP, 2005, J INFECT DIS, V191, P694, DOI 10.1086/427516; Egger S, 2009, JAIDS-J ACQ IMM DEF, V50, P513, DOI 10.1097/QAI.0b013e31819906d3; Garcia F, 2004, JAIDS-J ACQ IMM DEF, V36, P702, DOI 10.1097/00126334-200406010-00007; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; Hansjee N, 2004, JAIDS-J ACQ IMM DEF, V36, P671, DOI 10.1097/00126334-200406010-00003; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Hirsch CS, 1999, J INFECT DIS, V179, P945, DOI 10.1086/314667; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Huttner AC, 2007, AIDS, V21, P939, DOI 10.1097/QAD.0b013e3280f00fd6; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Kassu A, 2001, CLIN DIAGN LAB IMMUN, V8, P1171, DOI 10.1128/CDLI.8.6.1171-1176.2001; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kigozi Brian K, 2009, AIDS Res Ther, V6, P17, DOI 10.1186/1742-6405-6-17; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Lawn SD, 2005, CLIN INFECT DIS, V41, P1783, DOI 10.1086/498308; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2004, J INFECTION, V48, P1, DOI 10.1016/j.jinf.2003.09.001; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Manabe YC, 2009, J INFECT DIS, V199, P437, DOI 10.1086/595985; Marchetti G, 2006, AIDS, V20, P1727, DOI 10.1097/01.aids.0000242819.72839.db; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Ministry of Health Uganda, 2008, NAT ANT TREATM CAR G; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Moore DM, 2009, JAIDS-J ACQ IMM DEF, V52, P357, DOI 10.1097/QAI.0b013e3181b62933; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Mussini C, 2008, AIDS, V22, P2461, DOI 10.1097/QAD.0b013e328314b5f1; MUWANGA A, 2008, C RETR OPP INF; Nakamura H, 2008, PHYS STATUS SOLIDI C, V5, P23, DOI 10.1002/pssc.200776546; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Patel A, 2004, JAIDS-J ACQ IMM DEF, V37, P1166, DOI 10.1097/01.qai.0000135956.96166.f0; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; Tuboi SH, 2010, JAIDS-J ACQ IMM DEF, V53, P70, DOI 10.1097/QAI.0b013e3181c22d19; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; *WHO, 2009, REP GLOB TUB CONTR; World Health Organization, 2006, ANT THER HIV INF AD	61	60	60	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10527	10.1371/journal.pone.0010527	http://dx.doi.org/10.1371/journal.pone.0010527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479873	Green Published, gold, Green Submitted			2022-12-25	WOS:000277467800011
J	Wolff, FH; Fuchs, SC; Barcellos, NNT; de Alencastro, PR; Ikeda, MLR; Brandao, ABM; Falavigna, M; Fuchs, FD				Wolff, Fernando H.; Fuchs, Sandra C.; Barcellos, Nemora N. T.; de Alencastro, Paulo Ricardo; Ikeda, Maria Leticia R.; Brandao, Ajacio B. M.; Falavigna, Maicon; Fuchs, Flavio D.			Co-Infection by Hepatitis C Virus in HIV-Infected Patients in Southern Brazil: Genotype Distribution and Clinical Correlates	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ALPHA-2A PLUS RIBAVIRIN; RISK-FACTORS; PREVALENCE; RESOLUTION; TIME	Background: Prevalence rates of Hepatitis C Virus (HCV) co-infection, the distribution of HCV genotypes, and the frequency of spontaneous resolution of hepatitis C in patients infected with the Human Immunodeficiency Virus (HIV) have a worldwide disparity. The purpose of this study is to investigate the prevalence of HCV antibodies (anti-HCV) in patients with HIV, the proportion and correlates of infection by different HCV genotypes, and rates of spontaneous resolution of HCV infection. Methods: A cross-sectional study was conducted among 1143 HIV patients under follow-up in a HIV/AIDS outpatient reference center of the Brazilian public health system. From 357 anti-HCV positive patients, a consecutive sample of 227 individuals HCV treatment-naive was interviewed and 207 was tested for HCV-RNA and genotypes. Results: Anti-HCV was detected in 357 patients (31.2%). HCV-RNA was undetectable in 16.4% of 207 anti-HCV positive individuals. Genotype 1 was diagnosed in 81.5% of the sample, genotype 2 in 1.7% and genotype 3 in 16.2%. Male gender was the unique characteristic associated with higher prevalence of genotype 1 HCV. Conclusions: Co-infection by HCV is frequent among patients with HIV in our State, and it is particularly high the infection by HCV genotype 1. Further investigation is necessary to explain the important regional variation in the proportion of infection by the different HCV genotypes and to better understand rates of spontaneous HCV clearance.	[Wolff, Fernando H.; Fuchs, Sandra C.; Barcellos, Nemora N. T.; Brandao, Ajacio B. M.; Fuchs, Flavio D.] Natl Inst Sci & Technol Hlth Technol Assessment I, Porto Alegre, RS, Brazil; [Wolff, Fernando H.; de Alencastro, Paulo Ricardo] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Sch Med, Porto Alegre, RS, Brazil; [Fuchs, Sandra C.; Barcellos, Nemora N. T.; Ikeda, Maria Leticia R.] Univ Fed Rio Grande do Sul, Postgrad Program Epidemiol, Sch Med, Porto Alegre, RS, Brazil; [Barcellos, Nemora N. T.; de Alencastro, Paulo Ricardo; Ikeda, Maria Leticia R.] Sanatorio Partenon Hosp, Therapeut Attent Serv, Porto Alegre, RS, Brazil; [Brandao, Ajacio B. M.] Fed Univ Hlth Sci Porto Alegre, Sch Med, Porto Alegre, RS, Brazil; [Falavigna, Maicon] CEARGS, Porto Alegre, RS, Brazil; [Fuchs, Flavio D.] Hosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Wolff, FH (corresponding author), Natl Inst Sci & Technol Hlth Technol Assessment I, Porto Alegre, RS, Brazil.	fhwolff@terra.com.br	Fuchs, Flávio D/L-5078-2016; Fuchs, Sandra C/T-2670-2019; Iats, Inct/K-2300-2013	Brandao, Ajacio/0000-0001-8411-5654; fuchs, flavio/0000-0002-1191-0523	Ministry of Health/Secretariat of Health Surveillance/Nacional STD and AIDS Programme (MOH/SHS/NAP); Coordinating Agency for Advanced Training of Graduate Personnel (CAPES); National Council for Scientific and Technological Development (CNPq); Universidade Federal do Rio Grande do Sul; National Institute of Science and Technology for Health Technology Assessment (IATS) - CNPq/Brazil	Ministry of Health/Secretariat of Health Surveillance/Nacional STD and AIDS Programme (MOH/SHS/NAP); Coordinating Agency for Advanced Training of Graduate Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do Rio Grande do Sul; National Institute of Science and Technology for Health Technology Assessment (IATS) - CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by a grant from the Ministry of Health/Secretariat of Health Surveillance/Nacional STD and AIDS Programme (MOH/SHS/NAP); Coordinating Agency for Advanced Training of Graduate Personnel (CAPES); the National Council for Scientific and Technological Development (CNPq); and Graduate Program in Medical Sciences, Universidade Federal do Rio Grande do Sul. This study was supported, in part, by the National Institute of Science and Technology for Health Technology Assessment (IATS) - CNPq/Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Amin J, 2004, HIV MED, V5, P174, DOI 10.1111/j.1468-1293.2004.00207.x; Barcellos NT, 2003, SEX TRANSM DIS, V30, P166, DOI 10.1097/00007435-200302000-00014; Bollepalli S, 2007, SEX TRANSM DIS, V34, P367, DOI 10.1097/01.olq.0000240295.35457.b1; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Busch MP, 2006, TRANSFUSION, V46, P469, DOI 10.1111/j.1537-2995.2006.00745.x; Caballero MR, 2005, MED CLIN-BARCELONA, V125, P56, DOI 10.1157/13076466; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Folgori A, 2006, GUT, V55, P1012, DOI 10.1136/gut.2005.080077; Fonseca ASK, 1999, XX WORLD CONGRESS OF PATHOLOGY AND LABORATORY MEDICINE, P69; Galperim Bruno, 2006, Arq. Gastroenterol., V43, P81, DOI 10.1590/S0004-28032006000200004; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Gonzalez SA, 2006, JAIDS-J ACQ IMM DEF, V41, P582, DOI 10.1097/01.qai.0000214806.90841.c8; Hyder Qurratulain, 2009, JPMA Journal of the Pakistan Medical Association, V59, P430; Karmochkine M, 2006, J VIRAL HEPATITIS, V13, P775, DOI 10.1111/j.1365-2893.2006.00742.x; Kim AY, 2006, PLOS MED, V3, P2324, DOI 10.1371/journal.pmed.0030492; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Krug LP, 1996, BRAZ J MED BIOL RES, V29, P1629; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Laguno M, 2004, AIDS, V18, pF27, DOI 10.1097/00002030-200409030-00003; Lock G, 2006, J VIRAL HEPATITIS, V13, P571, DOI 10.1111/j.1365-2893.2006.00735.x; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; Mendoza RJ, 2001, NEUROREHAB NEURAL RE, V15, P9, DOI 10.1177/154596830101500102; Merchante N, 2006, AIDS, V20, P49, DOI 10.1097/01.aids.0000198087.47454.e1; Monteiro Maria Rita de Cassia Costa, 2004, Rev. Soc. Bras. Med. Trop., V37, P40; Pavan Maria Helena P., 2003, Braz J Infect Dis, V7, P253, DOI 10.1590/S1413-86702003000400005; Pereira GAS, 2006, J MED VIROL, V78, P719, DOI 10.1002/jmv.20613; Quinn PG, 1999, AM J GASTROENTEROL, V94, P668, DOI 10.1111/j.1572-0241.1999.00934.x; Ramos B, 2007, J INFECTION, V54, P173, DOI 10.1016/j.jinf.2006.02.006; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Schott E, 2007, J HEPATOL, V46, P372, DOI 10.1016/j.jhep.2006.09.011; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Tovo CV, 2007, LIVER INT, V27, P40, DOI 10.1111/j.1478-3231.2006.01344.x; *UNAIDS, GLOB REP 2006; Wolff FH, 2008, DIGEST LIVER DIS, V40, P460, DOI 10.1016/j.dld.2007.11.010; Zocratto Keli Bahia Felicíssimo, 2006, Cad. Saúde Pública, V22, P839, DOI 10.1590/S0102-311X2006000400022; Zylberberg H, 1999, GUT, V45, P112, DOI 10.1136/gut.45.1.112	42	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10494	10.1371/journal.pone.0010494	http://dx.doi.org/10.1371/journal.pone.0010494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463962	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379400028
J	Bertrand-Vallery, V; Belot, N; Dieu, M; Delaive, E; Ninane, N; Demazy, C; Raes, M; Salmon, M; Poumay, Y; Debacq-Chainiaux, F; Toussaint, O				Bertrand-Vallery, Veronique; Belot, Nathalie; Dieu, Marc; Delaive, Edouard; Ninane, Noelle; Demazy, Catherine; Raes, Martine; Salmon, Michel; Poumay, Yves; Debacq-Chainiaux, Florence; Toussaint, Olivier			Proteomic Profiling of Human Keratinocytes Undergoing UVB-Induced Alternative Differentiation Reveals TRIpartite Motif Protein 29 as a Survival Factor	PLOS ONE			English	Article							D-COMPLEMENTING GENE; KINASE-C; ATAXIA-TELANGIECTASIA; INDUCED APOPTOSIS; EPIDERMAL DIFFERENTIATION; INDUCED SENESCENCE; DNA-DAMAGE; HUMAN SKIN; EXPRESSION; CANCER	Background: Repeated exposures to UVB of human keratinocytes lacking functional p16(INK-4a) and able to differentiate induce an alternative state of differentiation rather than stress-induced premature senescence. Methodology/Principal Findings: A 2D-DIGE proteomic profiling of this alternative state of differentiation was performed herein at various times after the exposures to UVB. Sixty-nine differentially abundant protein species were identified by mass spectrometry, many of which are involved in keratinocyte differentiation and survival. Among these protein species was TRIpartite Motif Protein 29 (TRIM29). Increased abundance of TRIM29 following UVB exposures was validated by Western blot using specific antibody and was also further analysed by immunochemistry and by RT-PCR. TRIM29 was found very abundant in keratinocytes and reconstructed epidermis. Knocking down the expression of TRIM29 by short-hairpin RNA interference decreased the viability of keratinocytes after UVB exposure. The abundance of involucrin mRNA, a marker of late differentiation, increased concomitantly. In TRIM29-knocked down reconstructed epidermis, the presence of picnotic cells revealed cell injury. Increased abundance of TRIM29 was also observed upon exposure to DNA damaging agents and PKC activation. The UVB-induced increase of TRIM29 abundance was dependent on a PKC signaling pathway, likely PKC delta. Conclusions/Significance: These findings suggest that TRIM29 allows keratinocytes to enter a protective alternative differentiation process rather than die massively after stress.	[Bertrand-Vallery, Veronique; Dieu, Marc; Delaive, Edouard; Ninane, Noelle; Demazy, Catherine; Raes, Martine; Debacq-Chainiaux, Florence; Toussaint, Olivier] Univ Namur FUNDP, Res Unit Cellular Biol, Namur, Belgium; [Belot, Nathalie; Salmon, Michel] StratiCELL SA, Isnes, Belgium; [Poumay, Yves] Univ Namur FUNDP, URPHYM, Cell & Tissue Lab, Namur, Belgium	University of Namur; University of Namur	Bertrand-Vallery, V (corresponding author), Univ Namur FUNDP, Res Unit Cellular Biol, Namur, Belgium.	olivier.toussaint@fundp.ac.be	Poumay, Yves/G-4525-2016	Poumay, Yves/0000-0001-5200-3367; Dieu, Marc/0000-0002-3902-542X; Debacq-Chainiaux, Florence/0000-0003-3949-395X	FRIA; FRFC (Belgium) [2.4506.01]; FNRS (Belgium) [1.5.033.06F]; European Commission [LSMH-CT-2005-518230, HEALTH-F4-2008-200880, HEALTH-F2-2009-223576, LSHM-CT-2005-513866, MTKI-CT-2006-042768]	FRIA(Fonds de la Recherche Scientifique - FNRS); FRFC (Belgium)(Fonds de la Recherche Scientifique - FNRS); FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre)	VB-V had a FRIA fellowship. FDC and OT are respectively Research Associate and Senior Research Associate of the Belgian FNRS. This work received financial support through FRFC Grant 2.4506.01 (Belgium) to YP and OT and FNRS Grant 1.5.033.06F (Belgium) to YP. The authors acknowledge the Region Wallonne/FSE for the 'Nanotoxico' projects. The authors also thank the European Commission for the Integrated Projects 'Proteomage' (LSMH-CT-2005-518230), 'Markage' (HEALTH-F4-2008-200880) and 'Myoage' (HEALTH-F2-2009-223576); Coordination Action Link-Age (LSHM-CT-2005-513866) and 'Matiss' Marie Curie Project (MTKI-CT-2006-042768). The funders and the StratiCELL SA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Armeni T, 2001, BIOL CHEM, V382, P1697, DOI 10.1515/BC.2001.205; Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001; Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465; BERTRANDVALLERY V, 2009, BIOGERONTOLOGY; Boxman ILA, 2002, BRIT J DERMATOL, V146, P777, DOI 10.1046/j.1365-2133.2002.04714.x; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; BRZOSKA PM, 1995, P NATL ACAD SCI USA, V92, P7824, DOI 10.1073/pnas.92.17.7824; D'Costa AM, 2005, CELL DEATH DIFFER, V12, P224, DOI 10.1038/sj.cdd.4401558; D'Errico M, 2003, CELL DEATH DIFFER, V10, P754, DOI 10.1038/sj.cdd.4401224; Decraene D, 2005, J INVEST DERMATOL, V125, P1026, DOI 10.1111/j.0022-202X.2005.23909.x; Del Bino S, 2004, BRIT J DERMATOL, V150, P658, DOI 10.1111/j.0007-0963.2004.05886.x; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Ernst T, 2002, VERH DEUT G, V86, P165; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Han JL, 2004, CANCER RES, V64, P3009, DOI 10.1158/0008-5472.CAN-04-0246; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hildesheim J, 2004, DNA REPAIR, V3, P567, DOI 10.1016/j.dnarep.2004.02.012; Huang CM, 2005, EXPERT REV PROTEOMIC, V2, P809, DOI 10.1586/14789450.2.5.809; Huang CM, 2003, J INVEST DERMATOL, V121, P51, DOI 10.1046/j.1523-1747.2003.12327.x; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; KAPP LN, 1989, INT J RADIAT BIOL, V56, P667, DOI 10.1080/09553008914551891; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Kosaka Y, 2007, ANN SURG ONCOL, V14, P2543, DOI 10.1245/s10434-007-9461-1; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2002, J BIOL CHEM, V277, P10775, DOI 10.1074/jbc.M107623200; Laderoute KR, 1996, INT J CANCER, V66, P772, DOI 10.1002/(SICI)1097-0215(19960611)66:6<772::AID-IJC11>3.0.CO;2-5; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; Li JL, 2007, J BIOMED SCI, V14, P303, DOI 10.1007/s11373-007-9148-4; MANFREDI JJ, 1984, PHARMACOL THERAPEUT, V25, P83, DOI 10.1016/0163-7258(84)90025-1; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matsumura M, 2003, BIOCHEM BIOPH RES CO, V303, P350, DOI 10.1016/S0006-291X(03)00345-0; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURNANE JP, 1993, SEMIN CANCER BIOL, V4, P93; Nacht M, 1999, CANCER RES, V59, P5464; Onoue S, 2003, J DERMATOL SCI, V33, P105, DOI 10.1016/j.jdermsci.2003.08.002; Papp H, 2003, EXP DERMATOL, V12, P811, DOI 10.1111/j.0906-6705.2003.00097.x; Pellieux C, 2003, J BIOL CHEM, V278, P29136, DOI 10.1074/jbc.M300598200; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; Sano T, 2009, ARCH DERMATOL RES, V301, P227, DOI 10.1007/s00403-008-0914-6; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; SUN HQ, 1995, J CELL BIOL, V129, P147, DOI 10.1083/jcb.129.1.147; Svobodova Alena, 2006, Biomedical Papers (Olomouc), V150, P25; Toivola DM, 2002, MOL BIOL CELL, V13, P1857, DOI 10.1091/mbc.01-12-0591; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Trautinger F, 2001, CLIN EXP DERMATOL, V26, P573, DOI 10.1046/j.1365-2230.2001.00893.x; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Weisfelner Michelle Emily, 2003, J Drugs Dermatol, V2, P385; Witke W, 2001, J CELL BIOL, V154, P775, DOI 10.1083/jcb.200101113; Wong JW, 2000, J INVEST DERMATOL, V115, P427, DOI 10.1046/j.1523-1747.2000.00077.x	57	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10462	10.1371/journal.pone.0010462	http://dx.doi.org/10.1371/journal.pone.0010462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454669	Green Published, gold			2022-12-25	WOS:000277240300026
J	Kim, MS; Kim, T; Kong, SY; Kwon, S; Bae, CY; Choi, J; Kim, CH; Lee, ES; Park, JK				Kim, Minseok S.; Kim, Taemin; Kong, Sun-Young; Kwon, Soim; Bae, Chae Yun; Choi, Jaekyu; Kim, Chul Hwan; Lee, Eun Sook; Park, Je-Kyun			Breast Cancer Diagnosis Using a Microfluidic Multiplexed Immunohistochemistry Platform	PLOS ONE			English	Article							SEMICONDUCTOR QUANTUM DOTS; GENE-EXPRESSION PATTERNS; TISSUE MICROARRAYS; PREOPERATIVE CHEMOTHERAPY; MOLECULAR PATHOLOGY; BIOMARKER ANALYSIS; CELLULAR TARGETS; PROSTATE-CANCER; QUANTIFICATION; CARCINOMAS	Background: Biomarkers play a key role in risk assessment, assessing treatment response, and detecting recurrence and the investigation of multiple biomarkers may also prove useful in accurate prediction and prognosis of cancers. Immunohistochemistry (IHC) has been a major diagnostic tool to identify therapeutic biomarkers and to subclassify breast cancer patients. However, there is no suitable IHC platform for multiplex assay toward personalized cancer therapy. Here, we report a microfluidics-based multiplexed IHC (MMIHC) platform that significantly improves IHC performance in reduction of time and tissue consumption, quantification, consistency, sensitivity, specificity and cost-effectiveness. Methodology/Principal Findings: By creating a simple and robust interface between the device and human breast tissue samples, we not only applied conventional thin-section tissues into on-chip without any additional modification process, but also attained perfect fluid control for various solutions, without any leakage, bubble formation, or cross-contamination. Four biomarkers, estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), progesterone receptor (PR) and Ki-67, were examined simultaneously on breast cancer cells and human breast cancer tissues. The MMIHC method improved immunoreaction, reducing time and reagent consumption. Moreover, it showed the availability of semi-quantitative analysis by comparing Western blot. Concordance study proved strong consensus between conventional whole-section analysis and MMIHC (n = 105, lowest Kendall's coefficient of concordance, 0.90). To demonstrate the suitability of MMIHC for scarce samples, it was also applied successfully to tissues from needle biopsies. Conclusions/Significance: The microfluidic system, for the first time, was successfully applied to human clinical tissue samples and histopathological diagnosis was realized for breast cancers. Our results showing substantial agreement indicate that several cancer-related proteins can be simultaneously investigated on a single tumor section, giving clear advantages and technical advances over standard immunohistochemical method. This novel concept will enable histopathological diagnosis using numerous specific biomarkers at a time even for small-sized specimens, thus facilitating the individualization of cancer therapy.	[Kim, Minseok S.; Bae, Chae Yun; Choi, Jaekyu; Park, Je-Kyun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Taemin] Korea Adv Inst Sci & Technol, Dept Elect Engn & Comp Sci, Taejon 305701, South Korea; [Kong, Sun-Young] Natl Canc Ctr, Res Inst & Hosp, Dept Lab Med, Goyang, South Korea; [Kwon, Soim; Lee, Eun Sook] Korea Univ, Coll Med, Dept Breast & Endocrine Surg, Seoul 136705, South Korea; [Kim, Chul Hwan] Korea Univ, Coll Med, Dept Pathol, Seoul 136705, South Korea; [Park, Je-Kyun] Korea Adv Inst Sci & Technol, Inst NanoCentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); National Cancer Center - Korea (NCC); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea Advanced Institute of Science & Technology (KAIST)	Kim, MS (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	eslee@korea.ac.kr; jekyun@kaist.ac.kr	Park, Je-Kyun/A-4911-2011; Kong, Sun-Young/ABB-7914-2021; Kim, Minseok S./AAJ-4797-2020	Park, Je-Kyun/0000-0003-4522-2574; 	Ministry of Education, Science and Technology (MEST) [R0A-2008-000-20109-0, 2008-00771]; Korea University [K0823791]	Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea University	This work was supported by the National Research Laboratory (NRL) Program grant (R0A-2008-000-20109-0) and by the Nano/Bio Science and Technology Program grant (2008-00771) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST), and by the Korea University grant (K0823791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Charpin C, 2009, INT J CANCER, V124, P2124, DOI 10.1002/ijc.24177; Dietel M, 2006, VIRCHOWS ARCH, V448, P744, DOI 10.1007/s00428-006-0189-2; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Fountaine TJ, 2006, MODERN PATHOL, V19, P1181, DOI 10.1038/modpathol.3800628; Garcia S, 2007, BRIT J CANCER, V96, P329, DOI 10.1038/sj.bjc.6603569; Guarneri V, 2009, ANN ONCOL, V20, P1193, DOI 10.1093/annonc/mdn761; Hahn YK, 2007, ANAL CHEM, V79, P2214, DOI 10.1021/ac061522l; Halushka MK, 2010, CARDIOVASC PATHOL, V19, P136, DOI 10.1016/j.carpath.2008.12.007; Hassan S, 2008, CURR OPIN BIOTECH, V19, P19, DOI 10.1016/j.copbio.2007.10.009; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim JE, 2007, J CLIN NEUROL, V3, P9, DOI 10.3988/jcn.2007.3.1.9; Kim MS, 2008, BIOTECHNOL BIOENG, V101, P1005, DOI 10.1002/bit.21962; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lakhani SR, 2001, NAT REV CANCER, V1, P151, DOI 10.1038/35101087; Laxman B, 2008, CANCER RES, V68, P645, DOI 10.1158/0008-5472.CAN-07-3224; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Liu GL, 2006, NAT MATER, V5, P27, DOI 10.1038/nmat1528; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Mulligan AM, 2008, CLIN CANCER RES, V14, P4168, DOI 10.1158/1078-0432.CCR-07-4543; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Netto GJ, 2006, ARCH PATHOL LAB MED, V130, P1157; Nocito A, 2001, INT J CANCER, V94, P1, DOI 10.1002/ijc.1385; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Regitnig P, 2002, VIRCHOWS ARCH, V441, P328, DOI 10.1007/s00428-002-0646-5; Rosen DG, 2004, MODERN PATHOL, V17, P790, DOI 10.1038/modpathol.3800120; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Rubin MA, 2002, AM J SURG PATHOL, V26, P312, DOI 10.1097/00000478-200203000-00004; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stearns V, 2006, NAT REV CANCER, V6, P886, DOI 10.1038/nrc1992; Sweeney E, 2008, BIOCHEM BIOPH RES CO, V374, P181, DOI 10.1016/j.bbrc.2008.06.127; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Walker RA, 2006, HISTOPATHOLOGY, V49, P406, DOI 10.1111/j.1365-2559.2006.02514.x; Wang HN, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/6/065101; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043; Xing Y, 2007, NAT PROTOC, V2, P1152, DOI 10.1038/nprot.2007.107; Yeon JH, 2007, BIOCHIP J, V1, P17; Yeon JH, 2009, ANAL CHEM, V81, P1944, DOI 10.1021/ac802351w; Yezhelyev MV, 2006, LANCET ONCOL, V7, P657, DOI 10.1016/S1470-2045(06)70793-8	44	52	57	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10441	10.1371/journal.pone.0010441	http://dx.doi.org/10.1371/journal.pone.0010441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454672	Green Published, Green Submitted, gold			2022-12-25	WOS:000277240300017
J	Christopher, DJ; Daley, P; Armstrong, L; James, P; Gupta, R; Premkumar, B; Michael, JS; Radha, V; Zwerling, A; Schiller, I; Dendukuri, N; Pai, M				Christopher, Devasahayam J.; Daley, Peter; Armstrong, Lois; James, Prince; Gupta, Richa; Premkumar, Beulah; Michael, Joy Sarojini; Radha, Vedha; Zwerling, Alice; Schiller, Ian; Dendukuri, Nandini; Pai, Madhukar			Tuberculosis Infection among Young Nursing Trainees in South India	PLOS ONE			English	Article							HEALTH-CARE WORKERS; DRUG-RESISTANT TUBERCULOSIS; RISK; PREVALENCE; DIAGNOSIS; TESTS; ASSAY	Background: Among healthcare workers in developing countries, nurses spend a large amount of time in direct contact with tuberculosis (TB) patients, and are at high risk for acquisition of TB infection and disease. To better understand the epidemiology of nosocomial TB among nurses, we recruited a cohort of young nursing trainees at Christian Medical College, a large, tertiary medical school hospital in Southern India. Methodology/Principal Findings: Among 535 nursing students enrolled in 2007, 468 gave consent to participate, and 436 underwent two-step tuberculin skin testing (TST). A majority (95%) were females, and almost 80% were under 22 years of age. Detailed TB exposure information was obtained using interviews and clinical log books. Prevalence of latent TB infection (LTBI) was estimated using Bayesian latent class analyses (LCA). Logistic regression analyses were done to determine the association between LTBI prevalence and TB exposure and risk factors. 219 of 436 students (50.2%, 95% CI: 45.4-55.0) were TST positive using the 10 mm or greater cut-off. Based on the LCA, the prevalence of LTBI was 47.8% (95% credible interval 17.8% to 65.6%). In the multivariate analysis, TST positivity was strongly associated with time spent in health care, after adjusting for age at entry into healthcare. Conclusions: Our study showed a high prevalence of LTBI even in young nursing trainees. With the recent TB infection control (TBIC) policy guidance from the World Health Organization as the reference, Indian healthcare providers and the Indian Revised National TB Control Programme will need to implement TBIC interventions, and enhance capacity for TBIC at the country level. Young trainees and nurses, in particular, will need to be targeted for TBIC interventions.	[Christopher, Devasahayam J.; James, Prince; Gupta, Richa] Christian Med Coll & Hosp, Dept Pulm Med, Vellore, Tamil Nadu, India; [Daley, Peter; Armstrong, Lois] Christian Med Coll & Hosp, Dept Med, Unit 1, Vellore, Tamil Nadu, India; [Premkumar, Beulah; Radha, Vedha] Christian Med Coll & Hosp, Coll Nursing, Vellore, Tamil Nadu, India; [Michael, Joy Sarojini] Christian Med Coll & Hosp, Dept Microbiol, Vellore, Tamil Nadu, India; [Zwerling, Alice; Dendukuri, Nandini; Pai, Madhukar] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Schiller, Ian; Dendukuri, Nandini] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada; [Pai, Madhukar] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; McGill University; McGill University; McGill University	Christopher, DJ (corresponding author), Christian Med Coll & Hosp, Dept Pulm Med, Vellore, Tamil Nadu, India.	madhukar.pai@mcgill.ca	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021; Daley, Peter/J-8908-2017	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Daley, Peter/0000-0001-7068-8056	Canadian Institutes of Health Research (CIHR) [MOP-81362, MOP-89857]; European Commission; Fonds de la recherche en sante du Quebec (FRSQ)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This study was funded by the Canadian Institutes of Health Research (CIHR) operating grants [MOP-81362 & MOP-89857], and European Commission (EU-FP7; TBSusgent grant). MP is a recipient of a CIHR New Investigator award and a Fonds de la recherche en sante du Quebec (FRSQ) establishment grant, and ND is a recipient of a FRSQ salary award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; Balaji V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009527; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; *CENTR TB DIV, 2009, TB IND 2009 RNTCP ST, P1; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P116; Corbett EL, 2007, CLIN INFECT DIS, V44, P317, DOI 10.1086/509926; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Gopinath KG, 2004, J HOSP INFECT, V57, P339, DOI 10.1016/j.jhin.2004.03.029; James P, 2009, INT J TUBERC LUNG D, V13, P795; Joshi R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000805; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2008, INT J TUBERC LUNG D, V12, P895; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, EMERG INFECT DIS, V12, P1311, DOI 10.3201/eid1209.051663; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Rao KG, 2004, INT J TUBERC LUNG D, V8, P1392; Roth VR, 2005, INT J TUBERC LUNG D, V9, P1335; Seidler A, 2005, RESPIRATION, V72, P431, DOI 10.1159/000086261; World Health Organization, 2009, WHO POL TB INF CONTR	24	45	49	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10408	10.1371/journal.pone.0010408	http://dx.doi.org/10.1371/journal.pone.0010408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454447	Green Published, gold, Green Submitted			2022-12-25	WOS:000277240100017
J	Sanchez-Vives, MV; Spanlang, B; Frisoli, A; Bergamasco, M; Slater, M				Sanchez-Vives, Maria V.; Spanlang, Bernhard; Frisoli, Antonio; Bergamasco, Massimo; Slater, Mel			Virtual Hand Illusion Induced by Visuomotor Correlations	PLOS ONE			English	Article							RUBBER HAND; BODY; OWNERSHIP	Background: Our body schema gives the subjective impression of being highly stable. However, a number of easily-evoked illusions illustrate its remarkable malleability. In the rubber-hand illusion, illusory ownership of a rubber-hand is evoked by synchronous visual and tactile stimulation on a visible rubber arm and on the hidden real arm. Ownership is concurrent with a proprioceptive illusion of displacement of the arm position towards the fake arm. We have previously shown that this illusion of ownership plus the proprioceptive displacement also occurs towards a virtual 3D projection of an arm when the appropriate synchronous visuotactile stimulation is provided. Our objective here was to explore whether these illusions (ownership and proprioceptive displacement) can be induced by only synchronous visuomotor stimulation, in the absence of tactile stimulation. Methodology/Principal Findings: To achieve this we used a data-glove that uses sensors transmitting the positions of fingers to a virtually projected hand in the synchronous but not in the asynchronous condition. The illusion of ownership was measured by means of questionnaires. Questions related to ownership gave significantly larger values for the synchronous than for the asynchronous condition. Proprioceptive displacement provided an objective measure of the illusion and had a median value of 3.5 cm difference between the synchronous and asynchronous conditions. In addition, the correlation between the feeling of ownership of the virtual arm and the size of the drift was significant. Conclusions/Significance: We conclude that synchrony between visual and proprioceptive information along with motor activity is able to induce an illusion of ownership over a virtual arm. This has implications regarding the brain mechanisms underlying body ownership as well as the use of virtual bodies in therapies and rehabilitation.	[Sanchez-Vives, Maria V.; Slater, Mel] Inst Catalana Recerca Estudis Avancats, Barcelona, Spain; [Sanchez-Vives, Maria V.] IDIBAPS, Barcelona, Spain; [Spanlang, Bernhard] Univ Politecn Cataluna, Barcelona, Spain; [Frisoli, Antonio; Bergamasco, Massimo] Scuola Super Sant Anna, CEIICP, PERCRO, Pisa, Italy; [Slater, Mel] Univ Barcelona, Barcelona, Spain; [Slater, Mel] UCL, London, England	ICREA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat Politecnica de Catalunya; Scuola Superiore Sant'Anna; University of Barcelona; University of London; University College London	Sanchez-Vives, MV (corresponding author), Inst Catalana Recerca Estudis Avancats, Barcelona, Spain.	msanche3@clinic.ub.es	Slater, Mel/M-5210-2014; Sanchez-Vives, Maria/J-8526-2014	Slater, Mel/0000-0002-6223-0050; Sanchez-Vives, Maria/0000-0002-8437-9083; BERGAMASCO, Massimo/0000-0002-7418-2332; Spanlang, Bernhard/0000-0002-9659-635X	EU Future and Emerging Technologies [27731]; ICREA Funding Source: Custom	EU Future and Emerging Technologies; ICREA(ICREA)	This project was funded under the EU Future and Emerging Technologies 6th Framework Integrated Project PRESENCCIA Contract Number 27731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; BERGAMASCO M, 2008, GONIOMETRIC SENSOR; BOTVINICK M, 1998, RUBBER HANDS FEEL TO; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; Kammers MPM, 2009, PERCEPTION, V38, P1804, DOI 10.1068/p6389; KAVAN L, 2007, SKINNING DUAL QUATER; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; NIELSEN TI, 1963, SCAND J PSYCHOL, V4, P225, DOI 10.1111/j.1467-9450.1963.tb01326.x; Raz L, 2008, LECT NOTES COMPUT SC, V5024, P367, DOI 10.1007/978-3-540-69057-3_47; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Slachevsky A, 2001, J COGNITIVE NEUROSCI, V13, P332, DOI 10.1162/08989290151137386; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Spanlang B., 2009, HALCA HARDWARE ACCEL; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2	19	234	237	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10381	10.1371/journal.pone.0010381	http://dx.doi.org/10.1371/journal.pone.0010381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	590PU	20454463	Green Published, gold, Green Submitted			2022-12-25	WOS:000277240100008
J	Verine, J; Lehmann-Che, J; Soliman, H; Feugeas, JP; Vidal, JS; Mongiat-Artus, P; Belhadj, S; Philippe, J; Lesage, M; Wittmer, E; Chanel, S; Couvelard, A; Ferlicot, S; Rioux-Leclercq, N; Vignaud, JM; Janin, A; Germain, S				Verine, Jerome; Lehmann-Che, Jacqueline; Soliman, Hany; Feugeas, Jean-Paul; Vidal, Jean-Sebastien; Mongiat-Artus, Pierre; Belhadj, Stephanie; Philippe, Josette; Lesage, Matthieu; Wittmer, Evelyne; Chanel, Stephane; Couvelard, Anne; Ferlicot, Sophie; Rioux-Leclercq, Nathalie; Vignaud, Jean-Michel; Janin, Anne; Germain, Stephane			Determination of Angptl4 mRNA as a Diagnostic Marker of Primary and Metastatic Clear Cell Renal-Cell Carcinoma	PLOS ONE			English	Article							HIPPEL-LINDAU-DISEASE; COILED-COIL DOMAIN; TUMOR-SUPPRESSOR; EPITHELIAL TUMORS; GENE; CLASSIFICATION; EXPRESSION; MUTATIONS; PROTEIN; UTILITY	Background: We have previously shown that angiopoietin-like 4 (angptl4) mRNA, a hypoxia-inducible gene, is highly expressed in clear cell renal-cell carcinoma (ccRCC), the most common subtype of RCC for which no specific marker is available. We here investigated whether angptl4 mRNA 1) could be a useful diagnostic and/or prognostic marker of ccRCC in a large and comprehensive retrospective series, 2) induction is dependent on the VHL status of tumors. Methodology/Principal Findings: Using in situ hybridization, we report that angptl4 mRNA is expressed in 100% of both sporadic (n = 102) and inherited (n = 6) primary ccRCCs, without any statistical association with nuclear grade (p = 0.39), tumor size (p = 0.09), stage grouping (p = 0.17), progression-free survival (p = 0.94), and overall survival (p = 0.80). Angptl4 mRNA was also expressed in 26 (87%) of 30 secondary ccRCCs but neither in any other secondary RCCs (n = 7). In contrast, angptl4 mRNA was neither expressed in 94% non-ccRCC renal tumors (papillary RCCs (n = 46), chromophobe RCCs (n = 28), and oncocytomas (n = 9)), nor in non-renal clear cell carcinomas (n = 39). Angptl4 expression was also examined in tumors associated (n = 23) or not associated (n = 66) with VHL disease. 40 (98%) hemangioblastomas expressed angptl4 whereas all pheochromocytomas (n = 23) and pancreatic tumors (n = 25) were angptl4-negative, whatever their VHL status. Conclusions/Significance: Angptl4 mRNA expression was highly associated with ccRCC (p = 1.5 10(-49), Chi square test) allowing to define its expression as a diagnosis marker for primary ccRCC. Moreover, angptl4 mRNA allows to discriminate the renal origin of metastases of clear-cell carcinomas arising from various organs. Finally, inactivation of VHL gene is neither necessary nor sufficient for angptl4 mRNA induction.	[Verine, Jerome; Philippe, Josette; Lesage, Matthieu; Germain, Stephane] INSERM, U833, Paris, France; [Verine, Jerome; Philippe, Josette; Lesage, Matthieu; Germain, Stephane] Coll France, Chaire Med Expt, F-75231 Paris, France; [Verine, Jerome; Belhadj, Stephanie; Janin, Anne] INSERM, U728, Paris, France; [Verine, Jerome; Lehmann-Che, Jacqueline; Feugeas, Jean-Paul; Mongiat-Artus, Pierre; Janin, Anne] Univ Paris Diderot Paris 7, Paris, France; [Verine, Jerome; Janin, Anne] Hop St Louis, AP HP, Pathol Lab, Paris, France; [Lehmann-Che, Jacqueline; Soliman, Hany; Feugeas, Jean-Paul; Wittmer, Evelyne] Hop St Louis, AP HP, Biochim Lab, Paris, France; [Lehmann-Che, Jacqueline; Soliman, Hany; Feugeas, Jean-Paul; Mongiat-Artus, Pierre] INSERM, U944, Paris, France; [Vidal, Jean-Sebastien] INSERM, U708, Paris, France; [Mongiat-Artus, Pierre] Hop St Louis, AP HP, Serv Urol, Paris, France; [Chanel, Stephane] Lab Pasteur Cerba, Cergy Pontoise, France; [Couvelard, Anne] Hop Beaujon, AP HP, Pathol Lab, Clichy, France; [Ferlicot, Sophie] Hop Bicetre, AP HP, Pathol Lab, Le Kremlin Bicetre, France; [Rioux-Leclercq, Nathalie] CHU Rennes, Pathol Lab, Rennes, France; [Vignaud, Jean-Michel] CHU Nancy, Pathol Lab, Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Rennes; CHU de Nancy	Verine, J (corresponding author), INSERM, U833, Paris, France.	stephane.germain@college-de-france.fr	Vidal, Jean-Sebastien/D-1941-2016; Germain, Stephane/E-2301-2016; rioux-leclercq, nathalie/I-2820-2015	Vidal, Jean-Sebastien/0000-0001-6770-0720; Germain, Stephane/0000-0001-5992-1275; Anne, Couvelard/0000-0002-6316-1210; FERLICOT, SOPHIE/0000-0003-4124-9227; Lehmann-Che, jacqueline/0000-0001-6685-3354	Programme Hospitalier de Recherche Clinique National 2006 [AOM 06 144]	Programme Hospitalier de Recherche Clinique National 2006	This work was supported by a grant from Programme Hospitalier de Recherche Clinique National 2006 (AOM 06 144). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allory Y, 2008, HISTOPATHOLOGY, V52, P158, DOI 10.1111/j.1365-2559.2007.02900.x; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Ficarra V, 2007, LANCET ONCOL, V8, P554, DOI 10.1016/S1470-2045(07)70173-0; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gokden N, 2008, AM J SURG PATHOL, V32, P1462, DOI 10.1097/PAS.0b013e318176dba7; Gupta R, 2009, AM J SURG PATHOL, V33, P241, DOI 10.1097/PAS.0b013e318181b828; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Lane BR, 2009, J UROLOGY, V181, P849, DOI 10.1016/j.juro.2008.10.069; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lopez-Beltran A, 2009, INT J UROL, V16, P432, DOI 10.1111/j.1442-2042.2009.02302.x; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Nyhan MJ, 2008, BIOCHEM SOC T, V36, P472, DOI 10.1042/BST0360472; Ortiz-Rey J A, 2006, Actas Urol Esp, V30, P281; OSUNKOYA AO, 2009, HUM PATHOL; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pan CC, 2004, HISTOPATHOLOGY, V45, P452, DOI 10.1111/j.1365-2559.2004.01962.x; Pascual D, 2008, ADV UROL, V2008, DOI 10.1155/2008/782381; Perigny M, 2009, AM J SURG PATHOL, V33, P739, DOI 10.1097/PAS.0b013e3181967992; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Schraml P, 2002, J PATHOL, V196, P186, DOI 10.1002/path.1034; Skinnider BF, 2005, SEMIN DIAGN PATHOL, V22, P51, DOI 10.1053/j.semdp.2005.11.004; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; van Nederveen FH, 2009, LANCET ONCOL, V10, P764, DOI 10.1016/S1470-2045(09)70164-0; Weinbreck N, 2008, AM J SURG PATHOL, V32, P1051, DOI 10.1097/PAS.0b013e3181609d7d; Wuttig D, 2009, INT J CANCER, V125, P474, DOI 10.1002/ijc.24353; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	33	26	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10421	10.1371/journal.pone.0010421	http://dx.doi.org/10.1371/journal.pone.0010421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454689	Green Published, Green Submitted, gold			2022-12-25	WOS:000277240100026
J	Nomellini, JF; Li, C; Lavallee, D; Shanina, I; Cavacini, LA; Horwitz, MS; Smit, J				Nomellini, John F.; Li, Carmen; Lavallee, Danielle; Shanina, Iryna; Cavacini, Lisa A.; Horwitz, Marc S.; Smit, John			Development of an HIV-1 Specific Microbicide Using Caulobacter crescentus S-Layer Mediated Display of CD4 and MIP1 alpha	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VAGINAL LACTOBACILLUS STRAIN; 2-DOMAIN CD4; FRESH-WATER; SURFACE; PROTEIN; MUTAGENESIS; INHIBITION; SECRETION; ENTRY	The development of alternative strategies to prevent HIV infection is a global public health priority. Initial efforts in anti-HIV microbicide development have met with poor success as the strategies have relied on a non-specific mechanism of action. Here, we report the development of a microbicide aimed at specifically blocking HIV entry by displaying molecular components of the HIV/host cell attachment complex on the surface of Caulobacter crescentus, a harmless aquatic bacterium. This bacterium can be readily manipulated to present heterologous proteins at high density on its surface by genetic insertion into its crystalline surface layer protein [1,2]. In separate constructions, we generated bacteria displaying domain 1 of CD4 and MIP1 alpha. Each moiety reacted with specific antibodies by Western immunoblot and immunofluorescence microscopy. Microbicide functionality was assessed using an HIV pseudotype virus assay system representing Clade B subtypes. Bacteria displaying MIP1 alpha reduced infectivity by 35-78% depending on the specific subtype while CD4 display reduced infection by as much as 56%. Combinations of both constructs reduced infectivity by nearly 98%. We demonstrated that HIV infection could be inhibited using a strategy aimed at HIV-specific molecular interactions with Caulobacter surface protein display, and that sufficient protein folding and conformation could be mimicked to bind and block entry. Further, this is the first demonstration that Caulobacter surface protein display may be a useful approach to preventing HIV infection or other viruses as a microbicide. We propose that this harmless bacterium, which is inexpensive to produce and formulate, might be suitable for topical applications as a viable alternative in the search for effective microbicides to counteract the world wide incidence of HIV infection.	[Nomellini, John F.; Li, Carmen; Lavallee, Danielle; Shanina, Iryna; Horwitz, Marc S.; Smit, John] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Cavacini, Lisa A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	University of British Columbia; Harvard University; Beth Israel Deaconess Medical Center	Nomellini, JF (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	jsmit@interchange.ubc.ca			Campbell Foundation and Harvard Center; University of British Columbia University-Industry Liaison Office Prototype Development Fund	Campbell Foundation and Harvard Center; University of British Columbia University-Industry Liaison Office Prototype Development Fund	This work was funded by grants from the Campbell Foundation and Harvard Center for AIDS Research to J. S., L. C. and M. S. H. and the University of British Columbia University-Industry Liaison Office Prototype Development Fund to J. S. and M. S. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASIMWEOKIROR G, 2007, HIV AIDS EPIDEMEOLOG; Awram P, 1998, J BACTERIOL, V180, P3062, DOI 10.1128/JB.180.12.3062-3069.1998; Bhatnagar PK, 2006, CANCER BIOL THER, V5, P485, DOI 10.4161/cbt.5.5.2553; Bingle WH, 1997, MOL MICROBIOL, V26, P277, DOI 10.1046/j.1365-2958.1997.5711932.x; Bingle WH, 1997, J BACTERIOL, V179, P601, DOI 10.1128/jb.179.3.601-611.1997; Bradley J, 2004, J BIOMOL SCREEN, V9, P516, DOI 10.1177/1087057104264577; Chang TLY, 2003, P NATL ACAD SCI USA, V100, P11672, DOI 10.1073/pnas.1934747100; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; GILCHRIST A, 1991, J BACTERIOL, V173, P921, DOI 10.1128/jb.173.2.921-925.1991; Graham GJ, 1996, EMBO J, V15, P6506, DOI 10.1002/j.1460-2075.1996.tb01041.x; Harrison PF, 2003, CLIN INFECT DIS, V36, P1290, DOI 10.1086/374834; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu JJ, 2007, CELL MICROBIOL, V9, P120, DOI 10.1111/j.1462-5822.2006.00772.x; Liu XM, 2008, APPL ENVIRON MICROB, V74, P4626, DOI 10.1128/AEM.00104-08; Liu XW, 2006, ANTIMICROB AGENTS CH, V50, P3250, DOI 10.1128/AAC.00493-06; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; Nomellini JF, 2007, APPL ENVIRON MICROB, V73, P3245, DOI 10.1128/AEM.02900-06; Samuelson P, 2002, J BIOTECHNOL, V96, P129, DOI 10.1016/S0168-1656(02)00043-3; Smit J, 2008, INNATE IMMUN-LONDON, V14, P25, DOI 10.1177/1753425907087588; *UNAIDS, 2008, 2008 REP GLOB AIDS E; WALKER SG, 1992, J BACTERIOL, V174, P1783, DOI 10.1128/jb.174.6.1783-1792.1992; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	22	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10366	10.1371/journal.pone.0010366	http://dx.doi.org/10.1371/journal.pone.0010366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442778	gold, Green Submitted, Green Published			2022-12-25	WOS:000277154200008
J	Talamini, LM; de Haan, L; Nieman, DH; Linszen, DH; Meeter, M				Talamini, Lucia M.; de Haan, Lieuwe; Nieman, Dorien H.; Linszen, Don H.; Meeter, Martijn			Reduced Context Effects on Retrieval in First-Episode Schizophrenia	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MEMORY IMPAIRMENT; HIPPOCAMPAL-FORMATION; RECOGNITION MEMORY; ENTORHINAL CORTEX; FALSE RECOGNITION; EPISODIC MEMORY; SPATIAL CONTEXT; NAIVE PATIENTS; VERBAL MEMORY	Background: A recent modeling study by the authors predicted that contextual information is poorly integrated into episodic representations in schizophrenia, and that this is a main cause of the retrieval deficits seen in schizophrenia. Methodology/Principal Findings: We have tested this prediction in patients with first-episode schizophrenia and matched controls. The benefit from contextual cues in retrieval was strongly reduced in patients. On the other hand, retrieval based on item cues was spared. Conclusions/Significance: These results suggest that reduced integration of context information into episodic representations is a core deficit in schizophrenia and one of the main causes of episodic memory impairment.	[Talamini, Lucia M.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [de Haan, Lieuwe; Nieman, Dorien H.; Linszen, Don H.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Meeter, Martijn] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Talamini, LM (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	L.M.Talamini@uva.nl	Meeter, Martijn/A-2926-2009	Meeter, Martijn/0000-0002-5112-6717; Nieman, Dorien/0000-0002-9846-4254	Dutch National Science Foundation (NWO) [051-04- 102, 402-01-635, 451-05-006]	Dutch National Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	Grant sponsor: Dutch National Science Foundation (NWO; http://www.nwo.nl). Grant numbers: 051-04- 102, 402-01-635 and 451-05-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim AM, 2003, BRAIN COGNITION, V53, P121, DOI 10.1016/S0278-2626(03)00092-7; Achim AM, 2007, ARCH GEN PSYCHIAT, V64, P999, DOI 10.1001/archpsyc.64.9.999; Aleman A, 1999, AM J PSYCHIAT, V156, P1358; [Anonymous], 1983, CANADIAN PSYCHOL; Arnold SE, 2000, ANN NY ACAD SCI, V911, P275; Bachevalier J, 2008, HIPPOCAMPUS, V18, P64, DOI 10.1002/hipo.20369; Bazin N, 2000, SCHIZOPHR RES, V45, P93, DOI 10.1016/S0920-9964(99)00167-X; Brebion G, 1997, J NERV MENT DIS, V185, P247, DOI 10.1097/00005053-199704000-00005; Brebion G, 1999, PSYCHIAT RES, V88, P15, DOI 10.1016/S0165-1781(99)00076-1; Brebion G, 2004, J CLIN EXP NEUROPSYC, V26, P1093, DOI 10.1080/13803390490515513; Brebion G, 1997, PSYCHOL MED, V27, P383, DOI 10.1017/S0033291796004448; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Danion JM, 1999, ARCH GEN PSYCHIAT, V56, P639, DOI 10.1001/archpsyc.56.7.639; DeLisi LE, 1997, PSYCHIAT RES-NEUROIM, V74, P129, DOI 10.1016/S0925-4927(97)00012-7; Diaz-Asper C, 2008, PSYCHIAT RES, V159, P259, DOI 10.1016/j.psychres.2007.02.018; Elvevag B, 2000, NEUROPSYCHOLOGIA, V38, P1565, DOI 10.1016/S0028-3932(00)00074-9; Elvevag B, 2000, PSYCHOL MED, V30, P885, DOI 10.1017/S003329179900255X; Elvevag B, 2004, NEUROPSYCHOLOGIA, V42, P546, DOI 10.1016/j.neuropsychologia.2003.08.013; Gold JM, 2000, J ABNORM PSYCHOL, V109, P534, DOI 10.1037//0021-843X.109.3.534; GOLD JM, 1992, J ABNORM PSYCHOL, V101, P487, DOI 10.1037/0021-843X.101.3.487; Goldberg TE, 1996, J CLIN PSYCHIAT, V57, P62; Harrison PJ, 2001, HIPPOCAMPUS, V11, P508, DOI 10.1002/hipo.1067.abs; Harvey PD, 2001, AM J PSYCHIAT, V158, P176, DOI 10.1176/appi.ajp.158.2.176; HARVEY PD, 1988, SCHIZOPHRENIA BULL, V14, P57, DOI 10.1093/schbul/14.1.57; Heckers S, 1998, NAT NEUROSCI, V1, P318, DOI 10.1038/1137; Heckers S, 2001, HIPPOCAMPUS, V11, P520, DOI 10.1002/hipo.1068; Hemby SE, 2002, ARCH GEN PSYCHIAT, V59, P631, DOI 10.1001/archpsyc.59.7.631; Hill SK, 2004, SCHIZOPHR RES, V68, P127, DOI 10.1016/S0920-9964(03)00125-7; Ho BC, 2003, ARCH GEN PSYCHIAT, V60, P585, DOI 10.1001/archpsyc.60.6.585; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; Keefe RSE, 1999, PSYCHOL MED, V29, P903, DOI 10.1017/S0033291799008673; Lee YS, 2007, PSYCHOL MED, V37, P559, DOI 10.1017/S0033291706009044; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Meeter M, 2002, NEUROCOMPUTING, V44, P929, DOI 10.1016/S0925-2312(02)00493-9; Moritz S, 2003, PSYCHOL MED, V33, P131, DOI 10.1017/S0033291702006852; Mortimer AM, 1997, PHARMACOL BIOCHEM BE, V56, P789, DOI 10.1016/S0091-3057(96)00425-X; Nuyen J, 2005, J INT NEUROPSYCH SOC, V11, P152, DOI 10.1017/S1355617705050162; Paulsen J S, 1995, J Int Neuropsychol Soc, V1, P88; Rizzo L, 1996, NEUROPSYCHOLOGY, V10, P376, DOI 10.1037/0894-4105.10.3.376; Rolls ET, 2005, J NEUROPHYSIOL, V94, P833, DOI 10.1152/jn.01063.2004; Rushe TM, 1999, SCHIZOPHR RES, V35, P85, DOI 10.1016/S0920-9964(98)00117-0; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Salisbury DF, 2000, PSYCHOPHYSIOLOGY, V37, P456, DOI 10.1017/S0048577200980028; Salisbury DF, 2002, CLIN NEUROPHYSIOL, V113, P383, DOI 10.1016/S1388-2457(02)00003-2; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; Sitnikova T, 2002, PSYCHOPHYSIOLOGY, V39, P851, DOI 10.1111/1469-8986.3960851; SPITZER RL, 1985, COMPREHENSIVE TXB PS; SPOHN HE, 1989, J ABNORM PSYCHOL, V98, P367, DOI 10.1037/0021-843X.98.4.367; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Talamini LM, 2005, ARCH GEN PSYCHIAT, V62, P485, DOI 10.1001/archpsyc.62.5.485; Talamini LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006505; Tendolkar I, 2002, PSYCHOL MED, V32, P1261, DOI 10.1017/S0033291702006335; Van Berkum JJA, 2008, J COGNITIVE NEUROSCI, V20, P580, DOI 10.1162/jocn.2008.20054; Vinogradov S, 1997, AM J PSYCHIAT, V154, P1530, DOI 10.1176/ajp.154.11.1530; Waters FAV, 2004, SCHIZOPHR RES, V68, P119, DOI 10.1016/S0920-9964(03)00221-4; Wechsler D., 1997, WECHSLER ADULT INTEL; Weickert Thomas W, 2005, Curr Psychiatry Rep, V7, P304, DOI 10.1007/s11920-005-0085-5; Weickert TW, 2000, ARCH GEN PSYCHIAT, V57, P907, DOI 10.1001/archpsyc.57.9.907; Weiss AP, 2002, AM J PSYCHIAT, V159, P1506, DOI 10.1176/appi.ajp.159.9.1506; Wood SJ, 2002, PSYCHOL MED, V32, P429, DOI 10.1017/S0033291702005275; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	61	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10356	10.1371/journal.pone.0010356	http://dx.doi.org/10.1371/journal.pone.0010356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	588NX	20436915	Green Submitted, gold, Green Published			2022-12-25	WOS:000277079700009
J	Schaedler, TA; van Veen, HW				Schaedler, Theresia A.; van Veen, Hendrik W.			A flexible cation binding site in the multidrug major facilitator superfamily transporter LmrP is associated with variable proton coupling	FASEB JOURNAL			English	Article						multidrug resistance; secondary-active transport; ligand binding; coupling stoichiometry	ESCHERICHIA-COLI; ABC TRANSPORTER; LACTOCOCCUS-LACTIS; LIGAND-BINDING; RESISTANCE; MECHANISM; RECOGNITION; PROTEINS; BACTERIA; EMRE	The multidrug major facilitator superfamily transporter LmrP from Lactococcus lactis mediates protonmotive-force dependent efflux of amphiphilic ligands from the cell. We compared the role of membrane-embedded carboxylates in transport and binding of divalent cationic propidium and monovalent cationic ethidium. D235N, E327Q, and D142N replacements each resulted in loss of electrogenicity in the propidium efflux reaction, pointing to electrogenic 3H(+)/propidium2(+) antiport. During ethidium efflux, single D142N and D235N replacements resulted in apparent loss of electrogenicity, whereas the E327Q substitution did not affect the energetics, consistent with electrogenic 2H(+)/ethidium(+) antiport. Different roles of carboxylates were also observed in fluorescence anisotropy-based ligand-binding assays. Whereas D235 and E327 were both involved in propidium binding, the loss of one of these carboxylates could be compensated for by the other in ethidium binding. The D142N replacement did not affect the binding of either ligand. These data point to the presence of a dedicated proton binding site containing D142, and a flexible proton/ligand binding site containing D235 and E327, the contributions to proton and ligand binding of which depend on the chemical structure of the bound ligand. Our findings provide the first evidence that multidrug transport by secondary-active transporters can be associated with variable ion coupling.-Schaedler, T. A., van Veen, H. W. A flexible cation binding site in the multidrug major facilitator superfamily transporter LmrP is associated with variable proton coupling. FASEB J. 24, 3653-3661(2010). www.fasebj.org	[Schaedler, Theresia A.; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008	van Veen, Hendrik W./0000-0002-9658-8077; Schaedler, Theresia/0000-0002-7247-4091	Cambridge European Trusts; Pembroke College; Kurt Hahn Trust	Cambridge European Trusts; Pembroke College; Kurt Hahn Trust	The authors thank Prof. Peter Henderson (Institute of membrane and Systems Biology, University of Leeds, Leeds, UK) for the gift of GalP vesicles. Theresia Schaedler is a recipient of awards from the Cambridge European Trusts, Pembroke College, and Kurt Hahn Trust.	Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104; Adler J, 2004, BIOCHEMISTRY-US, V43, P518, DOI 10.1021/bi035485t; Balakrishnan L, 2004, J BIOL CHEM, V279, P11273, DOI 10.1074/jbc.M308494200; Bapna A, 2007, J MOL MICROB BIOTECH, V12, P197, DOI 10.1159/000099641; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; KASHKET ER, 1980, J BACTERIOL, V143, P128, DOI 10.1128/JB.143.1.128-134.1980; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lewinson O, 2003, P NATL ACAD SCI USA, V100, P1667, DOI 10.1073/pnas.0435544100; Mazurkiewicz P, 2004, BBA-BIOENERGETICS, V1658, P252, DOI 10.1016/j.bbabio.2004.06.004; McKeegan KS, 2003, TRENDS MICROBIOL, V11, P21, DOI 10.1016/S0966-842X(02)00010-0; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Novo D, 1999, CYTOMETRY, V35, P55, DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Putman M, 2001, MICROBIOL-SGM, V147, P2873, DOI 10.1099/00221287-147-10-2873; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; SAWYER L, 1982, NATURE, V295, P79, DOI 10.1038/295079a0; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Shilling R, 2005, FASEB J, V19, P1698, DOI 10.1096/fj.04-3558fje; Sigal N, 2009, J BIOL CHEM, V284, P6966, DOI 10.1074/jbc.M808877200; Tamura N, 2003, CURR OPIN CHEM BIOL, V7, P570, DOI 10.1016/j.cbpa.2003.08.014; TENBRINK B, 1982, J BACTERIOL, V152, P682; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; Velamakanni S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006137; Venter H, 2003, NATURE, V426, P866, DOI 10.1038/nature02173; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Ward A, 2000, PRACT APPROACH SER, P141; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Wohlfahrt G, 2003, BIOCHEMISTRY-US, V42, P10095, DOI 10.1021/bi034954o	37	35	36	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3653	3661		10.1096/fj.10-156927	http://dx.doi.org/10.1096/fj.10-156927			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20472749				2022-12-25	WOS:000285005900006
J	Murad, JM; Place, CS; Ran, C; Hekmatyar, SKN; Watson, NP; Kauppinen, RA; Israel, MA				Murad, Joana M.; Place, Chelsea S.; Ran, Cong; Hekmatyar, Shahryar K. N.; Watson, Nathan P.; Kauppinen, Risto A.; Israel, Mark A.			Inhibitor of DNA Binding 4 (ID4) Regulation of Adipocyte Differentiation and Adipose Tissue Formation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; C/EBP-ALPHA; INSULIN-RESISTANCE; EXPRESSION; ADIPOGENESIS; LIPODYSTROPHY; PROTEINS	Inhibitor of DNA binding 4 (ID4) is a helix-loop-helix protein that heterodimerizes with basic helix-loop-helix transcription factors inhibiting their function. ID4 expression is important for adipogenic differentiation of the 3T3-L1 cell line, and inhibition of ID4 is associated with a concomitant decrease in CCAAT/enhancer-binding protein gamma and peroxisome proliferator-activated receptor gamma mRNA and protein expression. Mice with a homozygous deletion of Id4 (Id4(-/-)) have reduced body fat and gain much less weight compared with wild-type littermates when placed on diets with high fat content. Mouse embryonic fibroblasts (MEFs) isolated from Id4(-/-) mice have reduced adipogenic potential when compared with wild-type MEFs. In agreement with changes in morphological differentiation, the levels of CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma were also reduced in MEFs from Id4(-/-) mice. Our results demonstrate the importance of ID4 in adipocyte differentiation and the implications of this regulation for adipose tissue formation.	Norris Cotton Canc Ctr, Hanover, NH 03755 USA; [Israel, Mark A.] Dartmouth Med Sch, Dept Pediat, Hanover, NH 03755 USA; [Israel, Mark A.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Hekmatyar, Shahryar K. N.; Kauppinen, Risto A.] Dartmouth Med Sch, Dept Radiol, Hanover, NH 03755 USA	Norris Cotton Cancer Center; Dartmouth College; Dartmouth College; Dartmouth College	Israel, MA (corresponding author), Norris Cotton Canc Ctr, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Mark.A.Israel@Dartmouth.edu		Watson, Nathan/0000-0002-9913-5575	Theodora B. Betz Foundation	Theodora B. Betz Foundation	This work was supported by The Theodora B. Betz Foundation (to M. A. I.).	ABATE N, 1994, J LIPID RES, V35, P1490; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Carey JPW, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-173; Chen HC, 2002, J LIPID RES, V43, P986; Chen HP, 1999, BIOCHEM BIOPH RES CO, V256, P614, DOI 10.1006/bbrc.1999.0386; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Ciarapica R, 2009, ONCOGENE, V28, P1881, DOI 10.1038/onc.2009.56; Du Y, 2010, DIFFERENTIATION, V79, P84, DOI 10.1016/j.diff.2009.10.003; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Gronning LM, 2006, AM J PHYSIOL-ENDOC M, V290, pE599, DOI 10.1152/ajpendo.00242.2005; Gulbagci NT, 2009, EMBO REP, V10, P79, DOI 10.1038/embor.2008.207; HAASE A, 1985, PHYS MED BIOL, V30, P341, DOI 10.1088/0031-9155/30/4/008; Havrda MC, 2008, J NEUROSCI, V28, P14074, DOI 10.1523/JNEUROSCI.3188-08.2008; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hou TY, 2009, J BIOL CHEM, V284, P31735, DOI 10.1074/jbc.M109.013961; Imagawa M, 1999, BIOCHEM BIOPH RES CO, V254, P299, DOI 10.1006/bbrc.1998.9937; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Laclaustra M, 2007, NUTR METAB CARDIOVAS, V17, P125, DOI [10.1016/j.numecd.2006.10.005, 10.1038/ki.2008.517]; Liu CJ, 2002, MOL CELL BIOL, V22, P2893, DOI 10.1128/MCB.22.9.2893-2905.2002; Moldes M, 1997, MOL CELL BIOL, V17, P1796, DOI 10.1128/MCB.17.4.1796; Moldes M, 1999, BIOCHEM J, V344, P873, DOI 10.1042/0264-6021:3440873; Morrison RF, 1999, J CELL BIOCHEM, P59; Park KW, 2008, MOL ENDOCRINOL, V22, P2038, DOI 10.1210/me.2007-0454; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Rahmouni K, 2008, CIRC RES, V103, P565, DOI 10.1161/CIRCRESAHA.108.184366; Reue K, 2006, CURR OPIN CLIN NUTR, V9, P436, DOI 10.1097/01.mco.0000232904.82038.db; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sattler FR, 2001, AIDS, V15, P2001, DOI 10.1097/00002030-200110190-00013; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Tsai YS, 2004, J CLIN INVEST, V114, P240, DOI 10.1172/JCI200420964; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yun K, 2004, DEVELOPMENT, V131, P5441, DOI 10.1242/dev.01430; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	43	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24164	24173		10.1074/jbc.M110.128744	http://dx.doi.org/10.1074/jbc.M110.128744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20460371	Green Published, hybrid			2022-12-25	WOS:000280291400066
J	Dovas, A; Choi, Y; Yoneda, A; Multhaupt, HAB; Kwon, SH; Kang, D; Oh, ES; Couchman, JR				Dovas, Athanassios; Choi, Youngsil; Yoneda, Atsuko; Multhaupt, Hinke A. B.; Kwon, Seung-Hae; Kang, Dongmin; Oh, Eok-Soo; Couchman, John R.			Serine 34 Phosphorylation of Rho Guanine Dissociation Inhibitor (RhoGDI alpha) Links Signaling from Conventional Protein Kinase C to RhoGTPase in Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; CANINE KIDNEY-CELLS; PKC-ALPHA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; DEPENDENT ACTIVATION; CYTOPLASMIC DOMAIN; MEMBRANE-BINDING; PLASMA-MEMBRANE; PHOSPHOLIPASE-D; LIVING CELLS	Conventional protein kinase C (PKC) isoforms are essential serine/threonine kinases regulating many signaling networks. At cell adhesion sites, PKC alpha can impact the actin cytoskeleton through its influence on RhoGTPases, but the intermediate steps are not well known. One important regulator of RhoGTPase function is the multifunctional guanine nucleotide dissociation inhibitor RhoGDI alpha that sequesters several related RhoGTPases in an inactive form, but it may also target them through interactions with actin-associated proteins. Here, it is demonstrated that conventional PKC phosphorylates RhoGDI alpha on serine 34, resulting in a specific decrease in affinity for RhoA but not Rac1 or Cdc42. The mechanism of RhoGDI alpha phosphorylation is distinct, requiring the kinase and phosphatidylinositol 4,5-bisphosphate, consistent with recent evidence that the inositide can activate, localize, and orient PKC alpha in membranes. Phosphospecific antibodies reveal endogenous phosphorylation in several cell types that is sensitive to adhesion events triggered, for example, by hepatocyte growth factor. Phosphorylation is also sensitive to PKC inhibition. Together with fluorescence resonance energy transfer microscopy sensing GTP-RhoA levels, the data reveal a common pathway in cell adhesion linking two essential mediators, conventional PKC and RhoA.	[Dovas, Athanassios; Yoneda, Atsuko; Multhaupt, Hinke A. B.; Couchman, John R.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, London SW7 2AZ, England; [Choi, Youngsil; Kang, Dongmin; Oh, Eok-Soo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Kwon, Seung-Hae] Chuncheon Ctr, Korea Basic Sci Inst, Chunchon 210701, Gangwon Do, South Korea	Imperial College London; Ewha Womans University; Korea Basic Science Institute (KBSI)	Couchman, JR (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	john.couchman@bric.ku.dk		Kang, Dongmin/0000-0001-5997-625X	Wellcome Trust [065940]; Danish National Research Foundation; Haensch Fond; Wilhelm Pedersen Fond; University of Copenhagen; National Core Research Center, Ministry of Education, Science, and Technology Korea [R15-2006-020]; Korea Science and Engineering Foundation through Center for Cell Signaling and Drug Discovery at Ewha Woman's University	Wellcome Trust(Wellcome Trust); Danish National Research Foundation(Danmarks Grundforskningsfond); Haensch Fond; Wilhelm Pedersen Fond; University of Copenhagen; National Core Research Center, Ministry of Education, Science, and Technology Korea; Korea Science and Engineering Foundation through Center for Cell Signaling and Drug Discovery at Ewha Woman's University(Korea Science and Engineering Foundation)	The work was supported in part by Wellcome Trust Programme Grant 065940 (to J.R.C.), Danish National Research Foundation, Haensch Fond, Wilhelm Pedersen Fond, and University of Copenhagen (to J.R.C., H. A. B. M.).; Supported in part by Grant R15-2006-020 from the National Core Research Center program of the Ministry of Education, Science, and Technology Korea and Korea Science and Engineering Foundation through the Center for Cell Signaling and Drug Discovery at Ewha Woman's University.	AKTORIES K, 1995, METHOD ENZYMOL, V256, P184; Balboa MA, 1998, MOL PHARMACOL, V53, P221, DOI 10.1124/mol.53.2.221; Bass MD, 2008, J CELL BIOL, V181, P1013, DOI 10.1083/jcb.200711129; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Corbalan-Garcia S, 2003, J BIOL CHEM, V278, P4972, DOI 10.1074/jbc.M209385200; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Faure J, 1999, EUR J BIOCHEM, V262, P879, DOI 10.1046/j.1432-1327.1999.00458.x; Fujii M, 1999, BIOCHEM BIOPH RES CO, V254, P284, DOI 10.1006/bbrc.1998.9936; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Genth H, 2003, J BIOL CHEM, V278, P28523, DOI 10.1074/jbc.M301915200; Gentile A, 2008, ONCOGENE, V27, P5590, DOI 10.1038/onc.2008.173; Golovanov AP, 2001, EUR J BIOCHEM, V268, P2253, DOI 10.1046/j.1432-1327.2001.02100.x; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; HOCEVAR BA, 1992, J CELL SCI, V101, P671; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Horowitz A, 1998, J BIOL CHEM, V273, P25548, DOI 10.1074/jbc.273.40.25548; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Ivaska J, 2003, BIOCHEM SOC T, V31, P90, DOI 10.1042/bst0310090; JAKEN S, 1989, J CELL BIOL, V109, P697, DOI 10.1083/jcb.109.2.697; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; Kitajo H, 2003, ONCOL REP, V10, P1351; Knezevic N, 2007, MOL CELL BIOL, V27, P6323, DOI 10.1128/MCB.00523-07; KOCHS G, 1993, BIOCHEM J, V291, P627, DOI 10.1042/bj2910627; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lerm M, 2000, FEMS MICROBIOL LETT, V188, P1; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; Longley RL, 1999, J CELL SCI, V112, P3421; Lub M, 1997, MOL BIOL CELL, V8, P719, DOI 10.1091/mbc.8.4.719; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Marin-Vicente C, 2008, J MOL BIOL, V377, P1038, DOI 10.1016/j.jmb.2007.12.011; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mochly-Rosen D, 1998, FASEB J, V12, P35; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31; NISHIYAMA T, 1994, MOL CELL BIOL, V14, P2447, DOI 10.1128/MCB.14.4.2447; Oh ES, 1998, J BIOL CHEM, V273, P10624, DOI 10.1074/jbc.273.17.10624; Read PW, 2000, METHOD ENZYMOL, V325, P15; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Rodriguez P, 2005, BIOTECHNOL LETT, V27, P1869, DOI 10.1007/s10529-005-3895-y; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Sciorra VA, 1996, J BIOL CHEM, V271, P14226, DOI 10.1074/jbc.271.24.14226; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Son H, 2006, ARCH BIOCHEM BIOPHYS, V454, P1, DOI 10.1016/j.abb.2006.08.013; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TAKAISHI K, 1994, ONCOGENE, V9, P273; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Ziegler WH, 2002, J BIOL CHEM, V277, P7396, DOI 10.1074/jbc.M110008200	67	58	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23294	23306		10.1074/jbc.M109.098129	http://dx.doi.org/10.1074/jbc.M109.098129			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20472934	hybrid, Green Published			2022-12-25	WOS:000279999900063
J	Goddard, AD; Stevens, JM; Rao, F; Mavridou, DAI; Chan, WL; Richardson, DJ; Allen, JWA; Ferguson, SJ				Goddard, Alan D.; Stevens, Julie M.; Rao, Feng; Mavridou, Despoina A. I.; Chan, Weelee; Richardson, David J.; Allen, James W. A.; Ferguson, Stuart J.			c-Type Cytochrome Biogenesis Can Occur via a Natural Ccm System Lacking CcmH, CcmG, and the Heme-binding Histidine of CcmE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHAPERONE CCME; APOCYTOCHROME-C; ACTIVE-SITE; NITRITE REDUCTASE; COVALENT ATTACHMENT; MATURATION; PROTEIN; REVEALS; PATHWAY	The Ccm cytochrome c maturation System I catalyzes covalent attachment of heme to apocytochromes c in many bacterial species and some mitochondria. A covalent, but transient, bond between heme and a conserved histidine in CcmE along with an interaction between CcmH and the apocytochrome have been previously indicated as core aspects of the Ccm system. Here, we show that in the Ccm system from Desulfovibrio desulfuricans, no CcmH is required, and the holo-CcmE covalent bond occurs via a cysteine residue. These observations call for reconsideration of the accepted models of System I-mediated c-type cytochrome biogenesis.	[Goddard, Alan D.; Stevens, Julie M.; Rao, Feng; Mavridou, Despoina A. I.; Chan, Weelee; Allen, James W. A.; Ferguson, Stuart J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Richardson, David J.] Univ E Anglia, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	University of Oxford; University of East Anglia	Ferguson, SJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk	Richardson, David J/E-2275-2011; Mavridou, Despoina/ABG-5940-2020; Goddard, Alan/E-9328-2013	Mavridou, Despoina/0000-0002-7449-1151; Chan, Wee Lee/0000-0001-9672-3841; Goddard, Alan/0000-0003-4950-7470	Biotechnology and Biological Sciences Research Council [BB/D523019/1, BB/E004865/1, BB/D019753/1]; BBSRC [BB/D523019/1, BB/D019753/1, BB/E004865/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/D523019/1, BB/E004865/1, and BB/D019753/1.	Ahuja U, 2005, J BIOL CHEM, V280, P236, DOI 10.1074/jbc.M410912200; Allen JWA, 2008, FEBS J, V275, P2385, DOI 10.1111/j.1742-4658.2008.06380.x; Allen JWA, 2006, FEBS LETT, V580, P4827, DOI 10.1016/j.febslet.2006.07.073; Allen JWA, 2003, BIOCHEM J, V375, P721, DOI 10.1042/BJ20030752; Allen JWA, 2004, BIOCHEM J, V383, P537, DOI 10.1042/BJ20040832; Allen JWA, 2002, J BIOL CHEM, V277, P33559, DOI 10.1074/jbc.M204963200; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Bartsch R. G., 1971, METHODS ENZYMOL, V23, P344, DOI [10.1016/S0076-6879(71)23110-4, DOI 10.1016/S0076-6879(71)23110-4]; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; Christensen O, 2007, FEBS J, V274, P2322, DOI 10.1111/j.1742-4658.2007.05769.x; Cunha CA, 2003, J BIOL CHEM, V278, P17455, DOI 10.1074/jbc.M211777200; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P9703, DOI 10.1073/pnas.152120699; Di Matteo A, 2007, J BIOL CHEM, V282, P27012, DOI 10.1074/jbc.M702702200; Eaves DJ, 1998, MOL MICROBIOL, V28, P205, DOI 10.1046/j.1365-2958.1998.00792.x; Enggist E, 2003, J BACTERIOL, V185, P175, DOI 10.1128/JB.185.1.175-183.2003; Enggist E, 2002, STRUCTURE, V10, P1551, DOI 10.1016/S0969-2126(02)00885-7; Fabianek RA, 1999, ARCH MICROBIOL, V171, P92, DOI 10.1007/s002030050683; Fabianek RA, 1998, J BACTERIOL, V180, P1947, DOI 10.1128/JB.180.7.1947-1950.1998; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; Feissner RE, 2006, MOL MICROBIOL, V60, P563, DOI 10.1111/j.1365-2958.2006.05132.x; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; Ferguson SJ, 2008, BBA-BIOENERGETICS, V1777, P980, DOI 10.1016/j.bbabio.2008.03.020; Garcia-Rubio I, 2007, BIOPHYS J, V92, P1361, DOI 10.1529/biophysj.106.098277; GODDARD AD, 2010, J FEBS J, V277, P726; Goddard AD, 2008, MOL MICROBIOL, V70, P667, DOI 10.1111/j.1365-2958.2008.06436.x; GOODHEW CF, 1986, BIOCHIM BIOPHYS ACTA, V852, P288, DOI 10.1016/0005-2728(86)90234-3; Hamel P, 2009, BBA-MOL CELL RES, V1793, P125, DOI 10.1016/j.bbamcr.2008.06.017; Hartshorne RS, 2007, MOL MICROBIOL, V64, P1049, DOI 10.1111/j.1365-2958.2007.05712.x; Lee DH, 2005, J AM CHEM SOC, V127, P3716, DOI 10.1021/ja044658e; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Pattarkine MV, 2006, J MOL BIOL, V358, P1314, DOI 10.1016/j.jmb.2006.03.010; Reid E, 1998, FEMS MICROBIOL LETT, V166, P369, DOI 10.1016/S0378-1097(98)00357-7; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Richard-Fogal CL, 2008, J BACTERIOL, V190, P3489, DOI 10.1128/JB.00146-08; Robertson IB, 2008, FEBS LETT, V582, P3067, DOI 10.1016/j.febslet.2008.07.052; SAMBONGI Y, 1994, FEBS LETT, V340, P65, DOI 10.1016/0014-5793(94)80174-6; SAMBONGI Y, 1994, FEBS LETT, V353, P235, DOI 10.1016/0014-5793(94)01053-6; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; Setterdahl AT, 2000, BIOCHEMISTRY-US, V39, P10172, DOI 10.1021/bi000663t; Simon J, 2000, MOL MICROBIOL, V35, P686, DOI 10.1046/j.1365-2958.2000.01742.x; Spielewoy N, 2001, J BIOL CHEM, V276, P5491, DOI 10.1074/jbc.M008853200; Stevens JM, 2004, ACCOUNTS CHEM RES, V37, P999, DOI 10.1021/ar030266l; Stevens JM, 2003, J BIOL CHEM, V278, P20500, DOI 10.1074/jbc.M212925200; THONYMEYER L, 1995, J BACTERIOL, V177, P4321; ThroneHolst M, 1997, FEBS LETT, V410, P351, DOI 10.1016/S0014-5793(97)00656-X; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x; Uchida T, 2004, J BIOL CHEM, V279, P51981, DOI 10.1074/jbc.M408963200	48	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22880	22887		10.1074/jbc.M110.133421	http://dx.doi.org/10.1074/jbc.M110.133421			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20466730	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000279999900021
J	Ono, K; Condron, MM; Teplow, DB				Ono, Kenjiro; Condron, Margaret M.; Teplow, David B.			Effects of the English (H6R) and Tottori (D7N) Familial Alzheimer Disease Mutations on Amyloid beta-Protein Assembly and Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PHOTOINDUCED CROSS-LINKING; IN-VIVO; SYNAPTIC PLASTICITY; PROTOFIBRIL FORMATION; CEREBRAL-HEMORRHAGE; SECRETED OLIGOMERS; MTT REDUCTION; FIBRILLOGENESIS; GENE	Mutations in the amyloid beta-protein (A beta) precursor gene cause autosomal dominant Alzheimer disease in a number of kindreds. In two such kindreds, the English and the Tottori, the mutations produce amyloid beta-proteins containing amino acid substitutions, H6R and D7N, respectively, at the peptide N terminus. To elucidate the structural and biological effects of the mutations, we began by examining monomer conformational dynamics and oligomerization. Relative to their wild type homologues, and in both the A beta 40 and A beta 42 systems, the English and Tottori substitutions accelerated the kinetics of secondary structure change from statistical coil -> alpha/beta -> beta and produced oligomer size distributions skewed to higher order. This skewing was reflected in increases in average oligomer size, as measured using electron microscopy and atomic force microscopy. Stabilization of peptide oligomers using in situ chemical cross-linking allowed detailed study of their properties. Each substitution produced an oligomer that displayed substantial beta-strand (H6R) or alpha/beta (D7N) structure, in contrast to the predominately statistical coil structure of wild type A beta oligomers. Mutant oligomers functioned as fibril seeds, and with efficiencies significantly higher than those of their wild type homologues. Importantly, the mutant forms of both native and chemically stabilized oligomers were significantly more toxic in assays of cell physiology and death. The results show that the English and Tottori mutations alter A beta assembly at its earliest stages, monomer folding and oligomerization, and produce oligomers that are more toxic to cultured neuronal cells than are wild type oligomers.	[Ono, Kenjiro; Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Ono, Kenjiro] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol & Aging, Kanazawa, Ishikawa 9208640, Japan; [Teplow, David B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Teplow, David B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kanazawa University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Teplow, DB (corresponding author), 635 Charles E Young Dr S,Rm 445, Los Angeles, CA 90095 USA.	dteplow@ucla.edu			National Institutes of Health [AG027818]; Japan Human Science Foundation; Mochida Memorial Foundation; Eli Lilly Japan; NATIONAL INSTITUTE ON AGING [P01AG027818] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22790815] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Human Science Foundation; Mochida Memorial Foundation; Eli Lilly Japan(Eli Lilly); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant AG027818 and the Japan Human Science Foundation, a Pergolide Fellowship (Eli Lilly Japan), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research.	Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bugiani O., 1998, NEUROBIOL AGING, V19, pS238; Fancy DA, 2000, CHEM BIOL, V7, P697, DOI 10.1016/S1074-5521(00)00020-X; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Gardberg A, 2009, BIOCHEMISTRY-US, V48, P5210, DOI 10.1021/bi9001216; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KAMINO K, 1992, AM J HUM GENET, V51, P998; Khurana R, 2003, BIOPHYS J, V85, P1135, DOI 10.1016/S0006-3495(03)74550-0; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lazo ND, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P385; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Maji SK, 2009, J BIOL CHEM, V284, P23580, DOI 10.1074/jbc.M109.038133; Maji SK, 2005, BIOCHEMISTRY-US, V44, P13365, DOI 10.1021/bi0508284; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naiki H, 1996, LAB INVEST, V74, P374; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Ronicke R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003236; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Teplow DB, 2006, ACCOUNTS CHEM RES, V39, P635, DOI 10.1021/ar050063s; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Wakutani Y, 2004, J NEUROL NEUROSUR PS, V75, P1039, DOI 10.1136/jnnp.2003.010611; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039	57	123	125	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23184	23195		10.1074/jbc.M109.086496	http://dx.doi.org/10.1074/jbc.M109.086496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20452980	Green Published, hybrid			2022-12-25	WOS:000279999900053
J	Kapoor, GS; O'Rourke, DM				Kapoor, G. S.; O'Rourke, D. M.			SIRP alpha 1 receptors interfere with the EGFRvIII signalosome to inhibit glioblastoma cell transformation and migration	ONCOGENE			English	Article						SIRP alpha 1; EGFRvIII; SHP-2; glioblastoma; migration	GROWTH-FACTOR RECEPTOR; PROTEIN-TYROSINE-PHOSPHATASE; FOCAL ADHESION KINASE; ONCOGENIC TRANSFORMATION; LYSOPHOSPHATIDIC ACID; G(2)/M ARREST; IN-VIVO; SHP-2; ACTIVATION; PHOSPHORYLATION	EGFRvIII, a frequent genetic alteration of the epidermal growth factor receptor ( EGFR), has been shown to increase the migratory potential of tumor cells and normal fibroblasts. Previously, we showed that signal regulatory protein alpha 1 (SIRP alpha 1) receptors interact with SHP-2 to inhibit wild-type (wt) EGFR-mediated tumor migration, survival and cell transformation. However, the effects of SIRP alpha 1 inhibitory receptors on EGFRvIII-mediated phenotypes are unclear. The aim of this study was to investigate the effect of SIRP alpha 1 receptor on the EGFRvIII signalosome and phenotypes. Overexpression of SIRP alpha 1 in U87MG. EGFRvIII cells inhibited transformation and migration in a MAPK-dependent manner, and is independent of the phosphatidylinositol 3-kinase (PI3-K)/Akt pathway. We observed reduced EGFRvIII/SHP-2/Gab1/Grb2/Sos-1 interaction and enhanced SIRP/SHP-2 association in U87MG. EGFRvIII/SIRP alpha 1 cells when compared with empty vector control cells. Interestingly, SIRP alpha 1 overexpression differentially modulated SHP-2 phosphorylation at tyrosyl 542 and 580 residues, which may regulate Erk1/2 activity and the EGFRvIII phenotype. In addition, SIRP alpha 1-expressing cells exhibited reduced focal adhesion kinase (FAK) phosphorylation and its recruitment to the EGFRvIII/Grb2/Sos-1/Gab1/SHP-2 complex. Collectively, our data indicate that SIRP alpha 1 specifically affects the SHP-2/FAK/Grb2/Sos-1/MAPK activation loop to downmodulate EGFRvIII-mediated migration and transformation. Further understanding of the molecular interactions between the SIRP alpha 1 inhibitory receptor and the EGFRvIII signalosome may facilitate the identification of novel targets to inhibit the EGFRvIII glioblastoma phenotype. Oncogene (2010) 29, 4130-4144; doi: 10.1038/onc.2010.164; published online 17 May 2010	[Kapoor, G. S.; O'Rourke, D. M.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [O'Rourke, D. M.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	O'Rourke, DM (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA.	donald.orourke@uphs.upenn.edu	O'Rourke, Donald/AAC-3376-2021	O'Rourke, Donald/0000-0002-8479-7314	National Institutes of Health [R01 CA-90586, R01 2R56CA0905896-06A1]; Terri Ann for a Cure and For Pete's Sake Funds to the University of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA090586, T32CA009058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terri Ann for a Cure and For Pete's Sake Funds to the University of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to DMO from the National Institutes of Health R01 CA-90586, R01 2R56CA0905896-06A1 and from the Terri Ann for a Cure and For Pete's Sake Funds to the University of Pennsylvania.	Aponte M, 2008, CANCER RES, V68, P5839, DOI 10.1158/0008-5472.CAN-07-5771; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Boockvar JA, 2003, MOL CELL NEUROSCI, V24, P1116, DOI 10.1016/j.mcn.2003.09.011; Boudot C, 2002, CELL SIGNAL, V14, P869, DOI 10.1016/S0898-6568(02)00036-0; Cetin S, 2007, AM J PHYSIOL-GASTR L, V292, pG1347, DOI 10.1152/ajpgi.00375.2006; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Dai HY, 2008, MOL CARCINOGEN, V47, P956, DOI 10.1002/mc.20448; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Dong LW, 2008, MOL IMMUNOL, V45, P3025, DOI 10.1016/j.molimm.2008.03.012; Eminaga S, 2008, J BIOL CHEM, V283, P15328, DOI 10.1074/jbc.M801382200; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; GARCIA DP, 1993, CANCER RES, V53, P3217; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Kapoor GS, 2003, NEUROSURGERY, V52, P1425, DOI 10.1227/01.NEU.0000065135.28143.39; Kapoor GS, 2004, CANCER RES, V64, P6444, DOI 10.1158/0008-5472.CAN-04-0256; Kapoor GS, 2004, MOL CELL BIOL, V24, P823, DOI 10.1128/MCB.24.2.823-836.2004; Kapoor GS, 2007, CANCER BIOL THER, V6, P571, DOI 10.4161/cbt.6.4.3852; Keegan K, 1996, ONCOGENE, V12, P1537; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Learn CA, 2004, CLIN CANCER RES, V10, P3216, DOI 10.1158/1078-0432.CCR-03-0521; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Lorimer IAJ, 2001, BBA-MOL CELL RES, V1538, P1, DOI 10.1016/S0167-4889(00)00129-4; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; Luo Y, 2009, BIOCHEMISTRY-US, V48, P1838, DOI 10.1021/bi8020789; Madan R, 2006, HUM PATHOL, V37, P9, DOI 10.1016/j.humpath.2005.09.024; Malchinkhuu E, 2005, ONCOGENE, V24, P6676, DOI 10.1038/sj.onc.1208805; Minoo P, 2003, CELL SIGNAL, V15, P319, DOI 10.1016/S0898-6568(02)00122-5; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Moscatello DK, 1996, ONCOGENE, V13, P85; Motegi S, 2003, EMBO J, V22, P2634, DOI 10.1093/emboj/cdg278; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Pedersen MW, 2004, INT J CANCER, V108, P643, DOI 10.1002/ijc.11566; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Qi JH, 1999, J BIOL CHEM, V274, P14455, DOI 10.1074/jbc.274.20.14455; Qin Jian-Min, 2006, Hepatobiliary Pancreat Dis Int, V5, P246; Retta SF, 1996, EXP CELL RES, V229, P307, DOI 10.1006/excr.1996.0376; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sampaio C, 2008, MOL CELL BIOL, V28, P587, DOI 10.1128/MCB.01318-07; Sampson JH, 2008, SEMIN IMMUNOL, V20, P267, DOI 10.1016/j.smim.2008.04.001; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Takeda H, 1998, ONCOGENE, V16, P3019, DOI 10.1038/sj.onc.1201839; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Vadlamudi RK, 2002, J CELL PHYSIOL, V190, P189, DOI 10.1002/JCP.10054; Vogel W, 1996, CELL GROWTH DIFFER, V7, P1589; Wang FM, 2005, BREAST CANCER RES TR, V89, P5, DOI 10.1007/s10549-004-1002-z; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; Wu CJ, 2000, ONCOGENE, V19, P3999, DOI 10.1038/sj.onc.1203748; Yan HX, 2004, HEPATOLOGY, V40, P618, DOI 10.1002/hep.20360; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Yuan LP, 2005, J BIOL CHEM, V280, P42701, DOI 10.1074/jbc.M506768200; Yuan LP, 2003, J BIOL CHEM, V278, P15208, DOI 10.1074/jbc.M211327200; Zhan Y, 2004, CANCER RES, V64, P8292, DOI 10.1158/0008-5472.CAN-03-3143; Zhan Y, 2009, EXP CELL RES, V315, P2343, DOI 10.1016/j.yexcr.2009.05.001	64	9	10	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2010	29	29					4130	4144		10.1038/onc.2010.164	http://dx.doi.org/10.1038/onc.2010.164			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	628VL	20473329				2022-12-25	WOS:000280151500002
J	Litherland, GJ; Elias, MS; Hui, W; Macdonald, CD; Catterall, JB; Barter, MJ; Farren, MJ; Jefferson, M; Rowan, AD				Litherland, Gary J.; Elias, Martina S.; Hui, Wang; Macdonald, Christopher D.; Catterall, Jonathon B.; Barter, Matt J.; Farren, Matthew J.; Jefferson, Matthew; Rowan, Andrew D.			Protein Kinase C Isoforms zeta and iota Mediate Collagenase Expression and Cartilage Destruction via STAT3-and ERK-dependent c-fos Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; MATRIX-METALLOPROTEINASE EXPRESSION; BOVINE NASAL CARTILAGE; ONCOSTATIN-M; GENE-EXPRESSION; FACTOR-ALPHA; SIGNALING PATHWAYS; RETINOIC ACID; T-CELLS	The protein kinase C (PKC) signaling pathway is a major regulator of cellular functions and is implicated in pathologies involving extracellular matrix remodeling. Inflammatory joint disease is characterized by excessive extracellular matrix catabolism, and here we assess the role of PKC in the induction of the collagenases, matrix metalloproteinase (MMP)-1 and MMP-13, in human chondrocytes by the potent cytokine stimulus interleukin-1 (IL-1) in combination with oncostatin M(OSM). IL-1 + OSM-stimulated collagenolysis and gelatinase activity were ameliorated by pharmacological PKC inhibition in bovine cartilage, as was collagenase gene induction in human chondrocytes. Small interfering RNA-mediated silencing of PKC gene expression showed that both novel (nPKC delta, nPKC eta) and atypical (aPKC zeta, aPKC iota) isoforms were involved in collagenase induction by IL-1. However, MMP1 and MMP13 induction by IL-1 + OSM was inhibited only by aPKC silencing, suggesting that only atypical isoforms play a significant role in complex inflammatory milieus. Silencing of either aPKC led to diminished IL-1 + OSM-dependent extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription (STAT) 3 phosphorylation, and c-fos expression. STAT3 gene silencing or ERK pathway inhibition also resulted in loss of IL-1 + OSM-stimulated c-fos and collagenase expression. Silencing of c-fos and c-jun expression was sufficient to abrogate IL-1 + OSM-stimulated collagenase gene induction, and overexpression of both c-fos and c-jun was sufficient to drive transcription from the MMP1 promoter in the absence of a stimulus. Our data identify atypical PKC isozymes as STAT and ERK activators that mediate c-fos and collagenase expression during IL-1 + OSM synergy in human chondrocytes. aPKCs may constitute potential therapeutic targets for inflammatory joint diseases involving increased collagenase expression.	[Litherland, Gary J.; Elias, Martina S.; Hui, Wang; Macdonald, Christopher D.; Catterall, Jonathon B.; Barter, Matt J.; Farren, Matthew J.; Jefferson, Matthew; Rowan, Andrew D.] Newcastle Univ, Inst Cellular Med, Cell Signalling Injury & Repair Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Rowan, AD (corresponding author), Newcastle Univ, Inst Cellular Med, Cell Signalling Injury & Repair Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	a.d.rowan@ncl.ac.uk	Litherland, Gary J/K-9755-2015	Litherland, Gary/0000-0001-5264-0219; Elias, Martina S/0000-0003-3352-5391	Arthritis Research UK [18726]; Nuffield Foundation; Dunhill Medical Trust; John G. W. Patterson Foundation; UK National Institute of Health Research Biomedical Research Centre for Aging and Age-Related Disease	Arthritis Research UK(Versus Arthritis); Nuffield Foundation; Dunhill Medical Trust(Dunhill Medical Trust); John G. W. Patterson Foundation; UK National Institute of Health Research Biomedical Research Centre for Aging and Age-Related Disease	This work was supported by Arthritis Research UK Grant 18726, the Nuffield Foundation (Oliver Bird Fund), the Dunhill Medical Trust, the John G. W. Patterson Foundation, and a UK National Institute of Health Research Biomedical Research Centre for Aging and Age-Related Disease award to the Newcastle upon Tyne Hospitals National Health Service Foundation Trust.	Babu GJ, 2000, J MOL CELL CARDIOL, V32, P1447, DOI 10.1006/jmcc.2000.1185; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P540, DOI 10.1002/art.21574; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x; Boschelli DH, 2009, CURR TOP MED CHEM, V9, P640, DOI 10.2174/156802609789007372; Botelho FM, 1998, J BIOL CHEM, V273, P5211, DOI 10.1074/jbc.273.9.5211; Budhiraja S, 2008, FUND CLIN PHARMACOL, V22, P231, DOI 10.1111/j.1472-8206.2008.00583.x; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Caraglia M, 2006, ANN ONCOL, V17, pVII124, DOI 10.1093/annonc/mdl964; Carrozza ML, 1997, ONCOGENE, V14, P1083, DOI 10.1038/sj.onc.1200921; Cawston TE, 1998, ARTHRITIS RHEUM-US, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; Chockalingam PS, 2007, ARTHRITIS RHEUM, V56, P4074, DOI 10.1002/art.23043; Chu F, 2004, CARCINOGENESIS, V25, P585, DOI 10.1093/carcin/bgh041; Chu SC, 2004, CONNECT TISSUE RES, V45, P142, DOI 10.1080/03008200490506058; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; CLARK IM, 1992, MATRIX, V12, P475, DOI 10.1016/S0934-8832(11)80092-2; Cleaver CS, 2001, ANN RHEUM DIS, V60, P150, DOI 10.1136/ard.60.2.150; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guo Z, 2007, FASEB J, V21, P535, DOI 10.1096/fj.06-6739com; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hui W, 2003, ARTHRITIS RHEUM-US, V48, P3404, DOI 10.1002/art.11333; Hui W, 2003, ANN RHEUM DIS, V62, P172, DOI 10.1136/ard.62.2.172; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; JUBB RW, 1980, J PATHOL, V130, P159, DOI 10.1002/path.1711300304; Keller ET, 2004, BIOCHEM PHARMACOL, V68, P1049, DOI 10.1016/j.bcp.2004.04.024; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Korzus E, 1997, J BIOL CHEM, V272, P1188, DOI 10.1074/jbc.272.2.1188; Koshy PJ, 2002, ANN RHEUM DIS, V61, P704, DOI 10.1136/ard.61.8.704; Koshy PJT, 1999, ANAL BIOCHEM, V275, P202, DOI 10.1006/abio.1999.4310; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Lacreusette A, 2009, J PATHOL, V217, P665, DOI 10.1002/path.2490; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; Leaman DW, 1996, MOL CELL BIOL, V16, P369; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; Liu JF, 2002, BIOCHEM BIOPH RES CO, V293, P1174, DOI 10.1016/S0006-291X(02)00350-9; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Martelli AM, 2006, BBA-MOL CELL BIOL L, V1761, P542, DOI 10.1016/j.bbalip.2006.02.009; Martin P, 2005, P NATL ACAD SCI USA, V102, P9866, DOI 10.1073/pnas.0501202102; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Morgan TG, 2006, ANN RHEUM DIS, V65, P184, DOI 10.1136/ard.2004.033480; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Perez-Rodriguez R, 2009, J NEUROCHEM, V108, P1083, DOI 10.1111/j.1471-4159.2008.05862.x; Popa-Nita O, 2009, J IMMUNOL, V183, P2104, DOI 10.4049/jimmunol.0900906; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Robertson MJ, 2007, J CLIN ONCOL, V25, P1741, DOI 10.1200/JCO.2006.09.3146; Rowan AD, 2003, AM J PATHOL, V162, P1975, DOI 10.1016/S0002-9440(10)64330-1; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Scrivo R, 2007, ANN NY ACAD SCI, V1108, P312, DOI 10.1196/annals.1422.033; Shen Garry X., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P301, DOI 10.2174/1568006033481375; Shin OS, 2007, CELL MICROBIOL, V9, P1987, DOI 10.1111/j.1462-5822.2007.00929.x; Shingleton WD, 2006, RHEUMATOLOGY, V45, P958, DOI 10.1093/rheumatology/kel024; Shingleton WD, 2000, J CELL BIOCHEM, V79, P519, DOI 10.1002/1097-4644(20001215)79:4<519::AID-JCB10>3.0.CO;2-U; Skvara H, 2008, J CLIN INVEST, V118, P3151, DOI 10.1172/JCI35636; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Staunton D, 1998, PROTEIN ENG, V11, P1093, DOI 10.1093/protein/11.11.1093; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Tanaka S, 1998, SEMIN ARTHRITIS RHEU, V27, P392, DOI 10.1016/S0049-0172(98)80019-X; Tardif G, 1999, ARTHRITIS RHEUM, V42, P1147, DOI 10.1002/1529-0131(199906)42:6<1147::AID-ANR11>3.0.CO;2-Y; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Urtreger AJ, 2005, MOL CARCINOGEN, V42, P29, DOI 10.1002/mc.20066; Vincenti MP, 2007, J CELL PHYSIOL, V213, P355, DOI 10.1002/jcp.21208; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wierenga ATJ, 2003, EXP HEMATOL, V31, P398, DOI 10.1016/S0301-472X(03)00045-6	78	48	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22414	22425		10.1074/jbc.M110.120121	http://dx.doi.org/10.1074/jbc.M110.120121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463008	hybrid, Green Published			2022-12-25	WOS:000279702200054
J	Shanmugam, D; Wu, B; Ramirez, U; Jaffe, EK; Roos, DS				Shanmugam, Dhanasekaran; Wu, Bo; Ramirez, Ursula; Jaffe, Eileen K.; Roos, David S.			Plastid-associated Porphobilinogen Synthase from Toxoplasma gondii KINETIC AND STRUCTURAL PROPERTIES VALIDATE THERAPEUTIC POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURE; PLASMODIUM-FALCIPARUM; HEME-BIOSYNTHESIS; MALARIAL PARASITE; ESCHERICHIA-COLI; ACID DEHYDRATASE; TETRAPYRROLE BIOSYNTHESIS; PSEUDOMONAS-AERUGINOSA; INHIBITION; ASSEMBLIES	Apicomplexan parasites (including Plasmodium spp. and Toxoplasma gondii) employ a four-carbon pathway for de novo heme biosynthesis, but this pathway is distinct from the animal/fungal C4 pathway in that it is distributed between three compartments: the mitochondrion, cytosol, and apicoplast, a plastid acquired by secondary endosymbiosis of an alga. Parasite porphobilinogen synthase (PBGS) resides within the apicoplast, and phylogenetic analysis indicates a plant origin. The PBGS family exhibits a complex use of metal ions (Zn2+ and Mg2+) and oligomeric states (dimers, hexamers, and octamers). Recombinant T. gondii PBGS (TgPBGS) was purified as a stable similar to 320-kDa octamer, and low levels of dimers but no hexamers were also observed. The enzyme displays a broad activity peak (pH 7-8.5), with a K-m for aminolevulinic acid of similar to 150 mu M and specific activity of similar to 24 mu mol of porphobilinogen/mg of protein/h. Like the plant enzyme, TgPBGS responds to Mg2+ but not Zn2+ and shows two Mg2+ affinities, interpreted as tight binding at both the active and allosteric sites. Unlike other Mg2+ -binding PBGS, however, metal ions are not required for TgPBGS octamer stability. A mutant enzyme lacking the C-terminal 13 amino acids distinguishing parasite PBGS from plant and animal enzymes purified as a dimer, suggesting that the C terminus is required for octamer stability. Parasite heme biosynthesis is inhibited (and parasites are killed) by succinylacetone, an active site-directed suicide substrate. The distinct phylogenetic, enzymatic, and structural features of apicomplexan PBGS offer scope for developing selective inhibitors of the parasite enzyme based on its quaternary structure characteristics.	[Shanmugam, Dhanasekaran; Wu, Bo; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Ramirez, Ursula; Jaffe, Eileen K.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	University of Pennsylvania; Fox Chase Cancer Center	Roos, DS (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	droos@sas.upenn.edu		Roos, David Siker/0000-0001-6725-4089	National Institutes of Health Grants [AI28724, ES003654, T32CA00935, AI077577, CA006927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI028724, R01AI028724, R56AI077577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003654] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI28724 (to D.S.R.), ES003654 (to E.K.J.), T32CA00935 (to the Institute for Cancer Research), AI077577 (to E.K.J.), and CA006927 (to Fox Chase Cancer Center).	Bollivar David W., 2004, BMC Biochemistry, V5, P17, DOI 10.1186/1471-2091-5-17; Bonday ZQ, 1997, J BIOL CHEM, V272, P21839, DOI 10.1074/jbc.272.35.21839; Breinig S, 2003, NAT STRUCT BIOL, V10, P757, DOI 10.1038/nsb963; Canutescu AA, 2005, BIOINFORMATICS, V21, P2914, DOI 10.1093/bioinformatics/bti438; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Dhanasekaran S, 2004, J BIOL CHEM, V279, P6934, DOI 10.1074/jbc.M311409200; Erskine PT, 2001, FEBS LETT, V503, P196, DOI 10.1016/S0014-5793(01)02721-1; Erskine PT, 2001, J MOL BIOL, V312, P133, DOI 10.1006/jmbi.2001.4947; Frankenberg N, 1999, BIOCHEMISTRY-US, V38, P13976, DOI 10.1021/bi9906470; Gacond S, 2007, CHEM BIODIVERS, V4, P189, DOI 10.1002/cbdv.200790024; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Heinemann IU, 2010, ANTIMICROB AGENTS CH, V54, P267, DOI 10.1128/AAC.00553-09; Jaffe EK, 2007, AM J HUM GENET, V80, P329, DOI 10.1086/511444; Jaffe EK, 2004, BIOORG CHEM, V32, P316, DOI 10.1016/j.bioorg.2004.05.010; Jaffe EK, 2003, CHEM BIOL, V10, P25, DOI 10.1016/S1074-5521(02)00296-X; JAFFE EK, 1995, BIOCHEMISTRY-US, V34, P244, DOI 10.1021/bi00001a029; Jaffe EK, 2000, ACTA CRYSTALLOGR D, V56, P115, DOI 10.1107/S0907444999014894; JAFFE EK, 1995, J BIOENERG BIOMEMBR, V27, P169, DOI 10.1007/BF02110032; Jaffe EK, 2002, J BIOL CHEM, V277, P19792, DOI 10.1074/jbc.M201486200; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; Jarret C, 2000, CHEM BIOL, V7, P185, DOI 10.1016/S1074-5521(00)00089-2; Kervinen J, 2001, BIOCHEMISTRY-US, V40, P8227, DOI 10.1021/bi010656k; Kervinen J, 2000, BIOCHEMISTRY-US, V39, P9018, DOI 10.1021/bi000620c; Kokona B, 2008, BIOCHEMISTRY-US, V47, P10649, DOI 10.1021/bi801128d; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lawrence SH, 2008, CHEM BIOL, V15, P586, DOI 10.1016/j.chembiol.2008.04.012; Lawrence SH, 2009, J BIOL CHEM, V284, P35807, DOI 10.1074/jbc.M109.026294; Matrajt M, 2002, MOL BIOCHEM PARASIT, V120, P285, DOI 10.1016/S0166-6851(02)00014-2; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; Petrovich RM, 1996, J BIOL CHEM, V271, P8692, DOI 10.1074/jbc.271.15.8692; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Roos DS, 1999, CURR OPIN MICROBIOL, V2, P426, DOI 10.1016/S1369-5274(99)80075-7; Sato S, 2004, PROTIST, V155, P117, DOI 10.1078/1434461000169; Seeber F, 1997, PARASITOL RES, V83, P309, DOI 10.1007/s004360050254; Selwood T, 2008, BIOCHEMISTRY-US, V47, P3245, DOI 10.1021/bi702113z; Senior NM, 1996, BIOCHEM J, V320, P401; Srivastava P, 1998, EXP PARASITOL, V88, P60, DOI 10.1006/expr.1998.4193; SUROLIA N, 1992, BIOCHEM BIOPH RES CO, V187, P744, DOI 10.1016/0006-291X(92)91258-R; Tang L, 2005, J BIOL CHEM, V280, P15786, DOI 10.1074/jbc.M500218200; TSCHUDY DP, 1981, J BIOL CHEM, V256, P9915; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; WU B, 2006, THESIS U PENNSYLVANI; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699	44	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22122	22131		10.1074/jbc.M110.107243	http://dx.doi.org/10.1074/jbc.M110.107243			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20442414	hybrid, Green Published			2022-12-25	WOS:000279702200025
J	Wang, ZP; Bryan, J; Franz, C; Havlioglu, N; Sandell, LJ				Wang, Zhepeng; Bryan, Jennifer; Franz, Carl; Havlioglu, Necat; Sandell, Linda J.			Type IIB Procollagen NH2-propeptide Induces Death of Tumor Cells via Interaction with Integrins alpha(V)beta(3) and alpha(V)beta(5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-PROPEPTIDE; EXTRACELLULAR-MATRIX; NH2-TERMINAL PROPEPTIDE; C-PROTEINASE; GROWTH-PLATE; EXPRESSION; CARTILAGE; BONE; ANGIOGENESIS; ENDOCYTOSIS	Cartilage is resistant to tumor invasion. In the present study, we found that the NH2-propeptide of the cartilage-characteristic collagen, type IIB, PIIBNP, is capable of killing tumor cells. The NH2-propeptide is liberated into the extracellular matrix prior to deposition of the collagen fibrils. This peptide adheres to and kills cells from chondrosarcoma and cervical and breast cancer cell lines via the integrins alpha(v)beta(5) and alpha(v)beta(3). Adhesion is abrogated by blocking with anti alpha(v)beta(5) and alpha(v)beta(3) antibodies. When alpha(v) is suppressed by small intefering RNA, adhesion and cell killing are blocked. Normal chondrocytes from developing cartilage do not express alpha(v)beta(3) and alpha(v)beta(5) integrins and are thus protected from cell death. Morphological, DNA, and biochemical evidence indicates that the cell death is not by apoptosis but probably by necrosis. In an assay for invasion, PIIBNP reduced the number of cells crossing the membrane. In vivo, in a tumor model for breast cancer, PIIBNP was consistently able to reduce the size of the tumor.	Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Orthoped Surg, St Louis, MO 63110 USA; [Sandell, Linda J.] Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Sandell, LJ (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, 660 S Euclid Ave,Campus Box 8233, St Louis, MO 63110 USA.	sandelll@wustl.edu			National Institutes of Health [RO1 AR R01 036994]; Siteman Cancer Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR036994, R01AR050847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siteman Cancer Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AR R01 036994. This work was also supported by the Siteman Cancer Center Research Development Award.	Baker EA, 2002, J CLIN PATHOL-MOL PA, V55, P300; Borgne-Sanchez A, 2007, CELL DEATH DIFFER, V14, P422, DOI 10.1038/sj.cdd.4402018; Bornstein P, 2002, MATRIX BIOL, V21, P217, DOI 10.1016/S0945-053X(02)00008-2; BREM H, 1975, J EXP MED, V141, P427, DOI 10.1084/jem.141.2.427; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9; Chansky H, 1998, J ORTHOPAED RES, V16, P521, DOI 10.1002/jor.1100160502; CHEAH KSE, 1991, DEVELOPMENT, V111, P945; Cheresh DA, 2002, NAT MED, V8, P193, DOI 10.1038/nm0302-193; Choudhuri T, 2006, VIROLOGY, V351, P58, DOI 10.1016/j.virol.2006.03.031; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; FISHER LW, 1987, J BIOL CHEM, V262, P13457; Fukui N, 2002, J BIOL CHEM, V277, P2193, DOI 10.1074/jbc.M105485200; Graef Thorsten, 2005, Angiogenesis, V8, P361; Hartigan N, 2003, J BIOL CHEM, V278, P18045, DOI 10.1074/jbc.M211448200; Hausler G, 2002, CALCIFIED TISSUE INT, V71, P212, DOI 10.1007/s00223-001-2083-x; Herard AL, 1996, AM J PHYSIOL-LUNG C, V271, pL726, DOI 10.1152/ajplung.1996.271.5.L726; Hirbe AC, 2007, BLOOD, V109, P3424, DOI 10.1182/blood-2006-09-048686; Hirsch MS, 1997, DEV DYNAM, V210, P249, DOI 10.1002/(SICI)1097-0177(199711)210:3<249::AID-AJA6>3.0.CO;2-G; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Kim SY, 2007, ARCH BIOCHEM BIOPHYS, V459, P40, DOI 10.1016/j.abb.2006.11.001; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kubo T, 2006, J ORTHOP RES, V24, P1138, DOI 10.1002/jor.20177; Kusafuka K, 2002, ACTA HISTOCHEM, V104, P167, DOI 10.1078/0065-1281-00642; LANGER R, 1976, SCIENCE, V193, P70, DOI 10.1126/science.935859; Leavesley DI, 1999, NEPHROL DIAL TRANSPL, V14, P1208, DOI 10.1093/ndt/14.5.1208; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; McBrien NA, 2006, INVEST OPHTH VIS SCI, V47, P4674, DOI 10.1167/iovs.05-1150; McCarty MF, 2006, INTEGR CANCER THER, V5, P252, DOI 10.1177/1534735406291499; McCarty MF, 2006, INTEGR CANCER THER, V5, P150, DOI 10.1177/1534735406288443; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Moses MA, 1999, P NATL ACAD SCI USA, V96, P2645, DOI 10.1073/pnas.96.6.2645; Nah HD, 2001, DEV DYNAM, V220, P307, DOI 10.1002/dvdy.1109; NIKKARI L, 1995, J RHEUMATOL, V22, P16; Odrljin TM, 2001, AM J RESP CELL MOL, V24, P12, DOI 10.1165/ajrcmb.24.1.3992; Oganesian A, 1997, J HISTOCHEM CYTOCHEM, V45, P1469, DOI 10.1177/002215549704501104; Oganesian A, 2006, J BIOL CHEM, V281, P38507, DOI 10.1074/jbc.M607536200; Pande P, 2006, TOXICOL APPL PHARM, V210, P70, DOI 10.1016/j.taap.2005.07.017; PANETTI TS, 1995, J BIOL CHEM, V270, P18593, DOI 10.1074/jbc.270.31.18593; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Prockop DJ, 1998, MATRIX BIOL, V16, P399, DOI 10.1016/S0945-053X(98)90013-0; SALTER DM, 1992, BRIT J RHEUMATOL, V31, P231; SANDELL LJ, 1994, DEV DYNAM, V199, P129, DOI 10.1002/aja.1001990206; SANDELL LJ, 1991, J CELL BIOL, V114, P1307, DOI 10.1083/jcb.114.6.1307; Sanders R, 2008, J ORTHOP TRAUMA, V22, P1, DOI 10.1097/BOT.0b013e3181629441; Teitelbaum SL, 2000, J BONE MINER METAB, V18, P344, DOI 10.1007/s007740070007; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; VANDERREST M, 1986, BIOCHEM J, V237, P923, DOI 10.1042/bj2370923; Wang ZP, 2005, J BIOL CHEM, V280, P6840, DOI 10.1074/jbc.M405287200; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069	53	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20806	20817		10.1074/jbc.M110.118521	http://dx.doi.org/10.1074/jbc.M110.118521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439458	Green Published, hybrid			2022-12-25	WOS:000279228600044
J	Derkarabetian, S; Steinmann, DB; Hedin, M				Derkarabetian, Shahan; Steinmann, David B.; Hedin, Marshal			Repeated and Time-Correlated Morphological Convergence in Cave-Dwelling Harvestmen (Opiliones, Laniatores) from Montane Western North America	PLOS ONE			English	Article							EVOLUTION; DIVERGENCE; AUSTRALIA; PLANTHOPPERS; SPIDERS; ARANEAE; FAUNA; LONG	Background: Many cave-dwelling animal species display similar morphologies (troglomorphism) that have evolved convergent within and among lineages under the similar selective pressures imposed by cave habitats. Here we study such ecomorphological evolution in cave-dwelling Sclerobuninae harvestmen (Opiliones) from the western United States, providing general insights into morphological homoplasy, rates of morphological change, and the temporal context of cave evolution. Methodology/Principal Findings: We gathered DNA sequence data from three independent gene regions, and combined these data with Bayesian hypothesis testing, morphometrics analysis, study of penis morphology, and relaxed molecular clock analyses. Using multivariate morphometric analysis, we find that phylogenetically unrelated taxa have convergently evolved troglomorphism; alternative phylogenetic hypotheses involving less morphological convergence are not supported by Bayesian hypothesis testing. In one instance, this morphology is found in specimens from a high-elevation stony debris habitat, suggesting that troglomorphism can evolve in non-cave habitats. We discovered a strong positive relationship between troglomorphy index and relative divergence time, making it possible to predict taxon age from morphology. Most of our time estimates for the origin of highly-troglomorphic cave forms predate the Pleistocene. Conclusions/Significance: While several regions in the eastern and central United States are well-known hotspots for cave evolution, few modern phylogenetic studies have addressed the evolution of cave-obligate species in the western United States. Our integrative studies reveal the recurrent evolution of troglomorphism in a perhaps unexpected geographic region, at surprisingly deep time depths, and in sometimes surprising habitats. Because some newly discovered troglomorphic populations represent undescribed species, our findings stress the need for further biological exploration, integrative systematic research, and conservation efforts in western US cave habitats.	[Derkarabetian, Shahan; Hedin, Marshal] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Steinmann, David B.] Denver Museum Nat & Sci, Dept Zool, Denver, CO USA	California State University System; San Diego State University	Derkarabetian, S (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	mhedin@sciences.sdsu.edu			Cave Conservancy Foundation; Society for Integrative and Comparative Biology; American Arachnological Society; US National Science Foundation [0640173, 0640179]; Lloyd David and Carlye Cannon Wattis Foundation; Zocchi Foundation	Cave Conservancy Foundation; Society for Integrative and Comparative Biology; American Arachnological Society; US National Science Foundation(National Science Foundation (NSF)); Lloyd David and Carlye Cannon Wattis Foundation; Zocchi Foundation	This research was supported by the Cave Conservancy Foundation (Fellowship in Karst Studies), the Society for Integrative and Comparative Biology (Grants in Aid of Research), the American Arachnological Society (Vincent Roth Fund for Systematic Research), a collaborative US National Science Foundation grant awarded to M. Hedin (Award No. 0640173) and Dr. Jeff Shultz (Award No. 0640179), a grant from the Lloyd David and Carlye Cannon Wattis Foundation, and the Zocchi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Padilla F, 2009, CLADISTICS, V25, P109, DOI 10.1111/j.1096-0031.2008.00242.x; [Anonymous], 1995, ADAPTATION NATURAL S, DOI DOI 10.4159/HARVARD.9780674419070; Arnedo MA, 2007, INVERTEBR SYST, V21, P623, DOI 10.1071/IS07015; Bahlcke J., 2005, ENZYKLOP DIE NEUZEIT, V1; BARR TC, 1985, ANNU REV ECOL SYST, V16, P313, DOI 10.1146/annurev.es.16.110185.001525; BARR THOMAS C., 1968, P35; Briggs T. S., 1971, Occasional Papers Calif Acad Sci, VNo. 90, P1; BRIGGS TS, 1971, PAN-PAC ENTOMOL, V47, P165; Briggs TS, 1974, J ARACHNOL, V1, P205; Brunsfeld S. J., 2001, INTEGRATING ECOLOGY; Carstens BC, 2005, EVOLUTION, V59, P1639, DOI 10.1554/04-661.1; CHAMBERS SM, 1993, FED REGISTER, V56, P43818; CHRISTIANSEN KA, 1962, SPELUNCA, V2, P76; COKENDOLPHER JC, 2004, SPELEOLOGICAL MONOGR, V6, P143; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; Culver DC, 2003, BIODIVERS CONSERV, V12, P441, DOI 10.1023/A:1022425908017; DERKARABETIAN S, 2010, THESIS SAN DIEGO STA; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eberhard WG, 1985, SEXUAL SELECTION ANI; Faille A, 2010, MOL PHYLOGENET EVOL, V54, P97, DOI 10.1016/j.ympev.2009.10.008; Forster R. R., 1965, Rec Otago Mus, VNo. 2, P1; Giribet Gonzalo, 2007, P62; GONZALEZ AP, 2002, REV IBERICA ARACHNOL, V5, P43; GREELEY R, 1972, GEOL SOC AM BULL, V83, P2397, DOI 10.1130/0016-7606(1972)83[2397:LTOTCB]2.0.CO;2; Hedin M, 2010, J ARACHNOL, V38, P9, DOI 10.1636/HA09-49.1; Hedin M, 2010, MOL PHYLOGENET EVOL, V54, P107, DOI 10.1016/j.ympev.2009.08.020; HOCH H, 1989, SYST ENTOMOL, V14, P377, DOI 10.1111/j.1365-3113.1989.tb00291.x; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Juberthei C., 1981, Proceedings of the International Congress of Speleology, V8, P203; Karaman IM, 2005, REV SUISSE ZOOL, V112, P439, DOI 10.5962/bhl.part.80308; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Leys R, 2003, EVOLUTION, V57, P2819, DOI 10.1111/j.0014-3820.2003.tb01523.x; LONGACRE C, 2000, FED REGISTER, V65, P81419; Losos Jonathan B., 1994, P60; Luiszer FG, 2007, ACTA CARSOLOGICA, V36, P157; MADDISON DR, 2003, MACCLADE 4 RELEASE V; MARTENS J, 1986, 10 ACT C INT AR JAC, V1, P289; MAURY E A, 1988, Memoires de Biospeologie, V15, P117; Moore G., 1997, SPELEOLOGY CAVES CAV; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; NYLANDER JA, 2003, MRMODELTEST 1 1 B; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; OROMI P, 1986, C INT ESP, V2, P147; Page TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001618; PECK S B, 1981, Great Basin Naturalist, V41, P207; PECK S B, 1980, NSS Bulletin, V42, P53; PECK S B, 1978, Southwestern Naturalist, V23, P227, DOI 10.2307/3669771; Pinto-da-Rocha Ricardo, 2007, P88; Porter ML, 2007, ACTA CARSOLOGICA, V36, P173; Porter ML, 2007, J CAVE KARST STUD, V69, P179; RUZICKA J, 1998, CAVE ROCK DEBRIS DWE, P261; Ruzicka V, 1999, J NAT HIST, V33, P255, DOI 10.1080/002229399300407; Shear WA, 2009, ZOOTAXA, P47; SHULTZ JW, 2007, HARVESTMEN BIOL OPIL, P14; Thomas SM, 2008, MOL PHYLOGENET EVOL, V46, P645, DOI 10.1016/j.ympev.2007.10.013; Thomas SM, 2006, ZOOTAXA, P21; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ubick D, 2002, J ARACHNOL, V30, P435, DOI 10.1636/0161-8202(2002)030[0435:THFPAR]2.0.CO;2; UBICK D, 2004, SPELEOLOGICAL MONOGR, V6, P101; UBICK D, 1992, SPELEOLOGICAL MONOGR, V3, P155; Ubick Darrell, 2008, Proceedings of the California Academy of Sciences, V59, P1; Ubick Darrell, 2005, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V8, P75; Villacorta C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-7; Welbourn W. Calvin, 1999, Journal of Caves and Karst Studies, V61, P93; Wessel A, 2007, ACTA CARSOLOGICA, V36, P199; White W.B., 1988, GEOMORPHOLOGY HYDROL; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Wilcox TP, 2004, MOL PHYLOGENET EVOL, V31, P1101, DOI 10.1016/j.ympev.2003.11.006	71	62	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10388	10.1371/journal.pone.0010388	http://dx.doi.org/10.1371/journal.pone.0010388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479884	Green Published, gold			2022-12-25	WOS:000277467800003
J	Goicoechea, SM; Bednarski, B; Stack, C; Cowan, DW; Volmar, K; Thorne, L; Cukierman, E; Rustgi, AK; Brentnall, T; Hwang, RF; McCulloch, CAG; Yeh, JJ; Bentrem, DJ; Hochwald, SN; Hingorani, SR; Kim, HJ; Otey, CA				Goicoechea, Silvia M.; Bednarski, Brian; Stack, Christianna; Cowan, David W.; Volmar, Keith; Thorne, Leigh; Cukierman, Edna; Rustgi, Anil K.; Brentnall, Teresa; Hwang, Rosa F.; McCulloch, Christopher A. G.; Yeh, Jen Jen; Bentrem, David J.; Hochwald, Steven N.; Hingorani, Sunil R.; Kim, Hong Jin; Otey, Carol A.			Isoform-Specific Upregulation of Palladin in Human and Murine Pancreas Tumors	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; CARCINOMA-CELLS; CANCER; FIBROBLASTS; EXPRESSION; PROTEIN; STROMA; IDENTIFICATION; KRAS(G12D); COOPERATE	Pancreatic ductal adenocarcinoma (PDA) is a lethal disease with a characteristic pattern of early metastasis, which is driving a search for biomarkers that can be used to detect the cancer at an early stage. Recently, the actin-associated protein palladin was identified as a candidate biomarker when it was shown that palladin is mutated in a rare inherited form of PDA, and overexpressed in many sporadic pancreas tumors and premalignant precursors. In this study, we analyzed the expression of palladin isoforms in murine and human PDA and explored palladin's potential use in diagnosing PDA. We performed immunohistochemistry and immunoblot analyses on patient samples and tumor-derived cells using an isoform-selective monoclonal antibody and a pan-palladin polyclonal antibody. Immunoblot and real-time quantitative reverse transcription-PCR were used to quantify palladin mRNA levels in human samples. We show that there are two major palladin isoforms expressed in pancreas: 65 and 85-90 kDa. The 65 kDa isoform is expressed in both normal and neoplastic ductal epithelial cells. The 85-90 kDa palladin isoform is highly overexpressed in tumor-associated fibroblasts (TAFs) in both primary and metastatic tumors compared to normal pancreas, in samples obtained from either human patients or genetically engineered mice. In tumor-derived cultured cells, expression of palladin isoforms follows cell-type specific patterns, with the 85-90 kDa isoform in TAFs, and the 65 kDa isoform predominating in normal and neoplastic epithelial cells. These results suggest that upregulation of 85-90 kDa palladin isoform may play a role in the establishment of the TAF phenotype, and thus in the formation of a desmoplastic tumor microenvironment. Thus, palladin may have a potential use in the early diagnosis of PDA and may have much broader significance in understanding metastatic behavior.	[Goicoechea, Silvia M.; Stack, Christianna; Otey, Carol A.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA; [Bednarski, Brian; Yeh, Jen Jen; Kim, Hong Jin] Univ N Carolina, Dept Surg, Div Surg Oncol, Chapel Hill, NC USA; [Bednarski, Brian; Cowan, David W.; Thorne, Leigh; Yeh, Jen Jen; Kim, Hong Jin; Otey, Carol A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Volmar, Keith; Thorne, Leigh] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Cukierman, Edna] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Rustgi, Anil K.] Univ Penn, Dept Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Dept Genet, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Brentnall, Teresa] Univ Washington, Dept Med, Seattle, WA USA; [Hwang, Rosa F.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [McCulloch, Christopher A. G.] Univ Toronto, CIHR Grp Matrix Dynam, Toronto, ON, Canada; [Bentrem, David J.] NW Med Fac Fdn, Chicago, IL USA; [Hochwald, Steven N.] Univ Florida, Div Surg Oncol, Gainesville, FL USA; [Hingorani, Sunil R.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Fox Chase Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; State University System of Florida; University of Florida; Fred Hutchinson Cancer Center	Goicoechea, SM (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA.	sgoico@med.unc.edu	Core, UNC Microbiome/AAB-3304-2022; Cukierman, Edna/A-3951-2013; cukierman, edna/AAU-8932-2020	cukierman, edna/0000-0002-1452-9576; Hingorani, Sunil/0000-0002-3869-8729; Goicoechea, Silvia/0000-0003-1107-389X	Elsa U. Pardee Foundation; UNC Center for Gastrointestinal Biology and Disease; National Institutes of Health (NIH) [R01-GM081505, CA113451, K08-CA098240, T32-CA09688, CA15704, CA114028, CA129357, DK0606994]; Fox Chase Cancer Center's (FCCC) Kidney Keystone Program; Mead Foundation; Rosenzweig Foundation; PanCAN; CIHR [MOP-36332]; UNC SPORE in Gastrointestinal Cancers [P50-CA10699]; National Cancer Institute (NCI) [P50-CA106991]; NATIONAL CANCER INSTITUTE [K08CA138912, R21CA155650, K08CA098240, P30CA015704, T32CA009688, P50CA106991, R01CA113451, R01CA129357, K08CA114028] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081505] Funding Source: NIH RePORTER	Elsa U. Pardee Foundation; UNC Center for Gastrointestinal Biology and Disease; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Chase Cancer Center's (FCCC) Kidney Keystone Program; Mead Foundation; Rosenzweig Foundation; PanCAN; CIHR(Canadian Institutes of Health Research (CIHR)); UNC SPORE in Gastrointestinal Cancers; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Elsa U. Pardee Foundation, http://www.pardeefoundation.org/ (C. A. Otey and H.J. Kim), UNC Center for Gastrointestinal Biology and Disease, https://cgibd.med.unc.edu/index. php (C. A. Otey), National Institutes of Health (NIH) R01-GM081505 (C. A. Otey), National Cancer Institute (NCI)/NIH CA113451 and Fox Chase Cancer Center's (FCCC) Kidney Keystone Program Grant (E. Cukierman). Mead Foundation, http://gileswmeadfoundation.org/; Rosenzweig Foundation, http://jrpancan.org/; and PanCAN, http://www.pancan.org/ (S. Hingorani), NIH, http://www.nih.gov/ to H.J. Kim (K08-CA098240), B. Bednarski (T32-CA09688), S. Hingorani (CA15704, CA114028, CA129357) and A. Rustigi (DK0606994). CIHR, http://www.cihr-irsc.gc.ca/ operating grant MOP-36332 (C. A. G. McCulloch). UNC SPORE in Gastrointestinal Cancers, http://cancer.med.unc.edu/patient/programs/gi. asp P50-CA10699 (H.J. Kim). NCI SPORE in Gastrointestinal Cancers, http://spores.nci.nih.gov/current/gi/index. htm P50-CA106991 (Jen Jjen Yeh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PD, 1999, EXP CELL RES, V250, P155, DOI 10.1006/excr.1999.4521; Boukhelifa M, 2003, MOL CELL NEUROSCI, V23, P661, DOI 10.1016/S1044-7431(03)00127-1; Cleary SP, 2004, J AM COLL SURGEONS, V198, P722, DOI 10.1016/j.jamcollsurg.2004.01.008; Conlon KC, 1996, ANN SURG, V223, P273, DOI 10.1097/00000658-199603000-00007; Corsino P, 2007, CANCER RES, V67, P3135, DOI 10.1158/0008-5472.CAN-06-3815; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; JIN L, 2008, J BIOL CHEM; Jin L, 2007, CIRC RES, V100, P817, DOI 10.1161/01.RES.0000261351.54147.de; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; MCCULLOCH CAG, 1993, J CELL PHYSIOL, V155, P461, DOI 10.1002/jcp.1041550305; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Rozen P, 2009, ISR MED ASSOC J, V11, P710; Salaria SN, 2007, CANCER BIOL THER, V6, P324, DOI 10.4161/cbt.6.3.3904; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Tuveson DA, 2005, COLD SH Q B, V70, P65, DOI 10.1101/sqb.2005.70.040; Wang HV, 2008, DEV DYNAM, V237, P3342, DOI 10.1002/dvdy.21755; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136	34	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10347	10.1371/journal.pone.0010347	http://dx.doi.org/10.1371/journal.pone.0010347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436683	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079500017
J	Martel, J; Wu, CY; Young, JD				Martel, Jan; Wu, Cheng-Yeu; Young, John D.			Critical Evaluation of Gamma-Irradiated Serum Used as Feeder in the Culture and Demonstration of Putative Nanobacteria and Calcifying Nanoparticles	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; FETUIN-MINERAL COMPLEX; FETAL BOVINE SERUM; HUMAN-DERIVED NANOPARTICLES; CALCIUM-PHOSPHATE; STONE FORMATION; BIOLOGIC NANOPARTICLES; VASCULAR CALCIFICATION; SECONDARY STRUCTURE; FTIR SPECTROSCOPY	The culture and demonstration of putative nanobacteria (NB) and calcifying nanoparticles (CNP) from human and animal tissues has relied primarily on the use of a culture supplement consisting of FBS that had been gamma-irradiated at a dose of 30 kGy (gamma-FBS). The use of gamma-FBS is based on the assumption that this sterilized fluid has been rid entirely of any residual NB/CNP, while it continues to promote the slow growth in culture of NB/CNP from human/animal tissues. We show here that gamma-irradiation (5-50 kGy) produces extensive dose-dependent serum protein breakdown as demonstrated through UV and visible light spectrophotometry, fluorometry, Fourier-transformed infrared spectroscopy, and gel electrophoresis. Yet, both gamma-FBS and gamma-irradiated human serum (gamma-HS) produce NB/CNP in cell culture conditions that are morphologically and chemically indistinguishable from their normal serum counterparts. Contrary to earlier claims, gamma-FBS does not enhance the formation of NB/CNP from several human body fluids (saliva, urine, ascites, and synovial fluid) tested. In the presence of additional precipitating ions, both c-irradiated serum (FBS and HS) and c-irradiated proteins (albumin and fetuin-A) retain the inherent dual NB inhibitory and seeding capabilities seen also with their untreated counterparts. By gel electrophoresis, the particles formed from both gamma-FBS and gamma-HS are seen to have assimilated into their scaffold the same smeared protein profiles found in the gamma-irradiated sera. However, their protein compositions as identified by proteomics are virtually identical to those seen with particles formed from untreated serum. Moreover, particles derived from human fluids and cultured in the presence of gamma-FBS contain proteins derived from both gamma-FBS and the human fluid under investigation-a confusing and unprecedented scenario indicating that these particles harbor proteins from both the host tissue and the FBS used as feeder. Thus, the NB/CNP described in the literature clearly bear hybrid protein compositions belonging to different species. We conclude that there is no basis to justify the use of gamma-FBS as a feeder for the growth and demonstration of NB/CNP or any NB-like particles in culture. Moreover, our results call into question the validity of the entire body of literature accumulated to date on NB and CNP.	[Martel, Jan; Wu, Cheng-Yeu; Young, John D.] Chang Gung Univ, Lab Nanomat, Tao Yuan, Taiwan; [Martel, Jan] Chang Gung Univ, Dept Biochem & Mol Biol, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Wu, Cheng-Yeu] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Tao Yuan, Taiwan; [Young, John D.] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA; [Young, John D.] Mingchi Univ Technol, Biochem Engn Res Ctr, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Rockefeller University; Ming Chi University of Technology	Martel, J (corresponding author), Chang Gung Univ, Lab Nanomat, Tao Yuan, Taiwan.	dingeyoung@hotmail.com		Wu, Cheng-Yeu/0000-0002-1545-0835; Martel, Jan/0000-0003-0879-109X	Primordia Institute of New Sciences and Medicine; Chang Gung University [FMRPD2T02]; Mingchi University of Technology [0XB0]	Primordia Institute of New Sciences and Medicine; Chang Gung University; Mingchi University of Technology	This study was supported by Primordia Institute of New Sciences and Medicine and by grants from Chang Gung University (FMRPD2T02) and Mingchi University of Technology (0XB0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Akerman KK, 1997, P SOC PHOTO-OPT INS, V3111, P436, DOI 10.1117/12.278798; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; BESARAB A, 1981, J CLIN PATHOL, V34, P1361, DOI 10.1136/jcp.34.12.1361; Bjorklund M, 1998, P SOC PHOTO-OPT INS, V3441, P123, DOI 10.1117/12.319827; Bonucci E, 2002, J BONE MINER METAB, V20, P249, DOI 10.1007/s007740200037; BOSKEY AL, 1991, CRIT REV ORAL BIOL M, V2, P369, DOI 10.1177/10454411910020030501; BOSKEY AL, 2008, METAL IONS LIFE SCI, V4, P457; Bratos-Perez MA, 2008, EUR HEART J, V29, P371, DOI 10.1093/eurheartj/ehm592; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; Carson DA, 1998, P NATL ACAD SCI USA, V95, P7846, DOI 10.1073/pnas.95.14.7846; Cartellieri S, 2002, BIOTECHNOL APPL BIOC, V35, P83, DOI 10.1042/BA20010067; Charbonneau D, 2009, J PHYS CHEM B, V113, P1777, DOI 10.1021/jp8092012; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Ciftcioglu N, 2002, ANTIMICROB AGENTS CH, V46, P2077, DOI 10.1128/AAC.46.7.2077-2086.2002; Ciftcioglu N, 1999, PROC SPIE, V3755, P113, DOI 10.1117/12.375069; Ciftcioglu N, 1997, VACCINES, P99; Ciftcioglu N, 1998, PATHOPHYSIOLOGY, V4, P259, DOI DOI 10.1016/S0928-4680(97)10001-3; CIFTCIOGLU N, 2010, PEDIAT RES IN PRESS; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Ciftcioglu N, 2007, LANCET, V369, P2078, DOI 10.1016/S0140-6736(07)60977-5; Ciftcioglu N, 2008, INT J NANOMED, V3, P105; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Clarkson PM, 2000, AM J CLIN NUTR, V72, p637S, DOI 10.1093/ajcn/72.2.637S; CUERPO EG, 2000, ARCH ESP UROL, V53, P291; Dogan A, 2007, FOOD CHEM, V100, P1106, DOI 10.1016/j.foodchem.2005.11.017; Doherty TM, 2003, P NATL ACAD SCI USA, V100, P11201, DOI 10.1073/pnas.1932554100; Dorrell S, 1999, MOL MED TODAY, V5, P373, DOI 10.1016/S1357-4310(99)01553-1; Drancourt M, 2003, J CLIN MICROBIOL, V41, P368, DOI 10.1128/JCM.41.1.368-372.2003; Du J, 2004, INT J BIOCHEM CELL B, V36, P2334, DOI 10.1016/j.biocel.2004.05.012; Eftink M.R., 2000, TOPICS FLUORESCENCE, P1, DOI DOI 10.1007/0-306-47102-7_1; FOGHANDERSEN N, 1977, CLIN CHEM, V23, P2122; FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D; Frankenberg UM, 2009, EXP DERMATOL, V18, P275; GARNETT J, 1990, BIOCHEM J, V266, P863; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; GILMAN H, 1994, J INORG BIOCHEM, V55, P31, DOI 10.1016/0162-0134(94)85130-1; GILMAN H, 1994, J INORG BIOCHEM, V55, P21, DOI 10.1016/0162-0134(94)85129-8; Giroux M, 1998, FOOD RES INT, V31, P257, DOI 10.1016/S0963-9969(98)00092-1; GORNETSCHELNOKOW U, 1993, EUR J BIOCHEM, V213, P1235, DOI 10.1111/j.1432-1033.1993.tb17874.x; Grieb T, 2002, BIOLOGICALS, V30, P207, DOI 10.1006/biol.2002.0330; GRIEBENOW K, 1995, P NATL ACAD SCI USA, V92, P10969, DOI 10.1073/pnas.92.24.10969; Grootveld M, 1986, Free Radic Res Commun, V1, P243, DOI 10.3109/10715768609051634; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; HICKS M, 1986, FEBS LETT, V199, P92, DOI 10.1016/0014-5793(86)81230-3; Hjelle JT, 2000, KIDNEY INT, V57, P2360, DOI 10.1046/j.1523-1755.2000.00096.x; Hohling H J, 1997, Adv Dent Res, V11, P462; HU YR, 2009, CARDIOVASC IN PRESS; Iqbal MS, 2001, J RADIOANAL NUCL CH, V250, P397, DOI 10.1023/A:1017940906191; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Johansson JS, 1997, J BIOL CHEM, V272, P17961, DOI 10.1074/jbc.272.29.17961; Johansson L, 2003, CYTOTECHNOLOGY, V42, P67, DOI 10.1023/B:CYTO.0000009820.72920.cf; Jones JA, 2008, CURR CLIN UROL, P221, DOI 10.1007/978-1-59745-472-8_17; Jones JA, 2009, UROLOGY, V73, DOI 10.1016/j.urology.2008.01.033; Kajander EO, 2006, LETT APPL MICROBIOL, V42, P549, DOI 10.1111/j.1472-765X.2006.01945.x; Kajander EO, 1997, P SOC PHOTO-OPT INS, V3111, P420, DOI 10.1117/12.278796; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kajander EO, 1999, PROC SPIE, V3755, P106, DOI 10.1117/12.375068; KATO A, 1988, J AGR FOOD CHEM, V36, P1156, DOI 10.1021/jf00084a007; Kumar V, 2006, J INVEST MED, V54, P412, DOI 10.2310/6650.2006.06021; Lacroix M, 2000, FOOD RES INT, V33, P719, DOI 10.1016/S0963-9969(00)00085-5; Lee Y, 2002, J BIOCHEM MOL BIOL, V35, P590; Li Y, 2006, BIOORGAN MED CHEM, V14, P1431, DOI 10.1016/j.bmc.2005.09.066; Lieske JC, 2008, NAT CLIN PRACT NEPHR, V4, P308, DOI 10.1038/ncpneph0794; Loohuis KMO, 2010, KIDNEY INT, V77, P77, DOI 10.1038/ki.2009.407; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; Maruyama T, 2001, BIOTECHNOL BIOENG, V75, P233, DOI 10.1002/bit.10001; Matsui I, 2009, KIDNEY INT, V75, P915, DOI 10.1038/ki.2008.700; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Militello V, 2004, BIOPHYS CHEM, V107, P175, DOI 10.1016/j.bpc.2003.09.004; Miller VM, 2009, NANOMEDICINE-UK, V4, P725, DOI [10.2217/nnm.09.61, 10.2217/NNM.09.61]; Miller VM, 2004, AM J PHYSIOL-HEART C, V287, pH1115, DOI 10.1152/ajpheart.00075.2004; Naseem F, 2003, BBA-PROTEINS PROTEOM, V1649, P164, DOI 10.1016/S1570-9639(03)00169-9; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Pasteris JD, 2008, ELEMENTS, V4, P97, DOI 10.2113/GSELEMENTS.4.2.97; Pillay AE, 2003, ANAL BIOANAL CHEM, V375, P751, DOI 10.1007/s00216-003-1830-4; Price PA, 2004, J BIOL CHEM, V279, P1594, DOI 10.1074/jbc.M305199200; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Puskas LG, 2005, ACTA BIOL HUNG, V56, P233, DOI 10.1556/ABiol.56.2005.3-4.7; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Robinson C, 2007, J DENT RES, V86, P677, DOI 10.1177/154405910708600801; Sambrook J, 2001, MOL CLONING LAB MANU; SAROFF HA, 1963, J PHYS CHEM-US, V67, P1211, DOI 10.1021/j100800a011; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schwartz MAK, 2008, INT J NANOMED, V3, P243; Schwartz MK, 2009, NANOMEDICINE-UK, V4, P931, DOI 10.2217/NNM.09.72; Schwartz MK, 2009, AM J PHYSIOL-HEART C, V296, pH1434, DOI 10.1152/ajpheart.00993.2008; Shiekh FA, 2009, CLIN NEPHROL, V71, P1; Shiekh FA, 2006, UROL RES, V34, P53, DOI 10.1007/s00240-005-0034-0; Shroff RC, 2007, SEMIN DIALYSIS, V20, P103, DOI 10.1111/j.1525-139X.2007.00255.x; Sillitoe RH, 1996, SCIENCE, V272, P1153, DOI 10.1126/science.272.5265.1153; Smirnov GV, 2008, CONTEMP PROBL ECOL+, V1, P111, DOI 10.1134/S1995425508010128; Sommer AP, 2006, CRYST GROWTH DES, V6, P492, DOI 10.1021/cg050418e; Sommer AP, 2005, J PROTEOME RES, V4, P180, DOI 10.1021/pr0498382; Speer MY, 2004, CARDIOVASC PATHOL, V13, P63, DOI 10.1016/S1054-8807(03)00130-3; SUSI H, 1986, METHOD ENZYMOL, V130, P290; SUZUKI M, 1994, J EXP ZOOL, V270, P501, DOI 10.1002/jez.1402700603; Toyran N, 2004, EUR BIOPHYS J BIOPHY, V33, P549, DOI 10.1007/s00249-004-0396-1; Urbano P, 2007, PLOS PATHOG, V3, P567, DOI 10.1371/journal.ppat.0030055; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; Vitek L, 2009, CURR PHARM DESIGN, V15, P2869, DOI 10.2174/138161209789058237; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Vuckovic M, 2005, J SERB CHEM SOC, V70, P1255, DOI 10.2298/JSC0511255V; Wainwright M, 2004, MICROBIOL-SGM, V150, P756, DOI 10.1099/mic.0.26907-0; Wainwright M, 2003, FEMS MICROBIOL LETT, V218, P161, DOI 10.1111/j.1574-6968.2003.tb11513.x; Wang LM, 2006, DIGEST DIS SCI, V51, P1126, DOI 10.1007/s10620-006-8019-6; Wen Y, 2005, CHINESE MED J-PEKING, V118, P421; Wickramasinghe JT, 2006, ASTROPHYS SPACE SCI, V305, P411, DOI 10.1007/s10509-006-9181-1; Wong F, 2007, NAT CLIN PRACT GASTR, V4, P43, DOI 10.1038/ncpgasthep0680; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008058; Young JD, 2010, SCI AM, V302, P52, DOI 10.1038/scientificamerican0110-52; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005421; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004417; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; ZHANG QH, 2009, J ANDROL IN PRESS; Zhang QH, 2010, INT UROGYNECOL J, V21, P103, DOI 10.1007/s00192-009-0994-7; Zhang SM, 2008, BIOORGAN MED CHEM, V16, P7853, DOI 10.1016/j.bmc.2008.02.034; Zhang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007472; Zhang SM, 2009, J PERIODONTOL, V80, P1462, DOI 10.1902/jop.2009.080659; Zhou HD, 2006, MOL IMMUNOL, V43, P1864, DOI 10.1016/j.molimm.2005.10.021; Zhou ZS, 2008, UROLOGY, V71, P1091, DOI 10.1016/j.urology.2008.02.041	128	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10343	10.1371/journal.pone.0010343	http://dx.doi.org/10.1371/journal.pone.0010343			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436679	Green Published, gold, Green Submitted			2022-12-25	WOS:000277079500014
J	Cioffi, F; Zambad, SP; Chhipa, L; Senese, R; Busiello, RA; Tuli, D; Munshi, S; Moreno, M; Lombardi, A; Gupta, RC; Chauthaiwale, V; Dutt, C; de Lange, P; Silvestri, E; Lanni, A; Goglia, F				Cioffi, Federica; Zambad, Shitalkumar P.; Chhipa, Laxmikant; Senese, Rosalba; Busiello, Rosa Anna; Tuli, Davinder; Munshi, Siralee; Moreno, Maria; Lombardi, Assunta; Gupta, Ramesh C.; Chauthaiwale, Vijay; Dutt, Chaitanya; de Lange, Pieter; Silvestri, Elena; Lanni, Antonia; Goglia, Fernando			TRC150094, a novel functional analog of iodothyronines, reduces adiposity by increasing energy expenditure and fatty acid oxidation in rats receiving a high-fat diet	FASEB JOURNAL			English	Article						thyroid hormones; hepatic steatosis; mitochondria	METABOLIC SYNDROME; IN-VITRO; 3,5-DIIODO-L-THYRONINE; COA; OBESITY; HEART; DIIODOTHYRONINES; GLUCOSE; TISSUES; HUMANS	Chronic overnutrition and modern life-styles are causing a worldwide epidemic of obesity and associated comorbidities, which is creating a demand to identify underlying biological mechanisms and to devise effective treatments. In rats receiving a high-fat diet (HFD), we analyzed the effects of a 4-wk administration of a novel functional analog of iodothyronines, TRC150094 (TRC). HFD-TRC rats exhibited increased energy expenditure (+24% vs. HFD rats; P<0.05) and body weight (BW) gain comparable to that of standard chow-fed (N) rats [N, HFD, and HFD-TRC rats, +97 g, +140 g (P<0.05 vs. N), and +98 g (P<0.05 vs. HFD)]. HFD-TRC rats had significantly less visceral adipose tissue (vs. HFD rats) and exhibited altered metabolism in two major tissues that are very active metabolically. In liver, mitochondrial fatty acid import and oxidation were increased (+56 and +32%, respectively; P<0.05 vs. HFD rats), and consequently the hepatic triglyceride content was lower (-35%; P<0.05 vs. HFD rats). These effects were independent of the AMP-activated protein kinase-acetyl CoA-carboxylase-malonyl CoA pathway but involved sirtuin 1 activation. In skeletal muscle, TRC induced a fiber shift toward the oxidative type in tibialis anterior muscle, increasing its capacity to oxidize fatty acids. HFD-TRC rats had lower (vs. HFD rats) plasma cholesterol and triglyceride concentrations. If reproduced in humans, these results will open interesting possibilities regarding the counteraction of metabolic dysfunction associated with ectopic/visceral fat accumulation.-Cioffi, F., Zambad, S. P., Chhipa, L., Senese, R., Busiello, R. A., Tuli, D., Munshi, S., Moreno, M., Lombardi, A., Gupta, R. C., Chauthaiwale, V., Dutt, C., de Lange, P., Silvestri, E., Lanni, A., Goglia, F. TRC150094, a novel functional analog of iodothyronines, reduces adiposity by increasing energy expenditure and fatty acid oxidation in rats receiving a high-fat diet. FASEB J. 24, 3451-3461 (2010). www.fasebj.org	[Moreno, Maria; Silvestri, Elena; Goglia, Fernando] Univ Sannio, Dipartimento Sci Biol & Ambientali, I-82100 Benevento, Italy; [Cioffi, Federica; Senese, Rosalba; de Lange, Pieter; Lanni, Antonia] Univ Naples 2, Dipartimento Sci Vita, Caserta, Italy; [Zambad, Shitalkumar P.] Torrent Pharmaceut Ltd, Dept Pharmacol, Ahmadabad, Gujarat, India; [Chhipa, Laxmikant; Tuli, Davinder; Gupta, Ramesh C.] Torrent Pharmaceut Ltd, Med Drug Discovery, Ahmadabad, Gujarat, India; [Munshi, Siralee] Torrent Pharmaceut Ltd, Cellular & Mol Biol, Ahmadabad, Gujarat, India; [Chauthaiwale, Vijay] Torrent Pharmaceut Ltd, Discovery Res, Ahmadabad, Gujarat, India; [Dutt, Chaitanya] Torrent Pharmaceut Ltd, Clin Res, Torrent Res Ctr, Ahmadabad, Gujarat, India; [Busiello, Rosa Anna; Lombardi, Assunta] Univ Naples Federico 2, Dipartimento Biol, Naples, Italy	University of Sannio; Universita della Campania Vanvitelli; University of Naples Federico II	Goglia, F (corresponding author), Univ Sannio, Dipartimento Sci Biol & Ambientali, Via Port Arsa 11, I-82100 Benevento, Italy.	goglia@unisannio.it	Zambad, Shitalkumar/AIF-1927-2022; cioffi, federica/AAB-8161-2019; de Lange, Pieter/GXA-3052-2022	Zambad, Shitalkumar/0000-0002-4085-8613; cioffi, federica/0000-0002-1530-8556; SENESE, Rosalba/0000-0003-1571-0980; GOGLIA, Fernando/0000-0003-0468-9645; MORENO, Maria/0000-0002-6218-5501; Silvestri, Elena/0000-0002-0592-9033	Torrent Pharmaceuticals Ltd. (Ahmedabad, Gujarat, India)	Torrent Pharmaceuticals Ltd. (Ahmedabad, Gujarat, India)	The authors thank Dr. Onorato Goglia (Azienda Ospedaliera Rummo-Benevento) for performing cholesterol and triglycerides assays. This study was funded by Torrent Pharmaceuticals Ltd. (Ahmedabad, Gujarat, India). TRC150094 is a molecule patented under a patent owned by Torrent Pharmaceuticals Ltd. S.P.Z., L. C., D. T., S. M., R. C. G., V. C., and C. D. are employees of Torrent Pharmaceuticals Ltd. No other potential conflict of interest relevant to this article was reported.	Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Ball SG, 1997, J MOL ENDOCRINOL, V19, P137, DOI 10.1677/jme.0.0190137; Berkenstam A, 2008, P NATL ACAD SCI USA, V105, P663, DOI 10.1073/pnas.0705286104; BOSHOUWERS FMG, 1983, BRIT POULTRY SCI, V24, P273, DOI 10.1080/00071668308416739; BROWN GC, 1985, BIOCHEM J, V225, P399, DOI 10.1042/bj2250399; Chen K, 2008, DIABETES VASC DIS RE, V5, P96, DOI 10.3132/dvdr.2008.016; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; de Simone G, 2007, DIABETES CARE, V30, P1851, DOI 10.2337/dc06-2152; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Enas Enas A, 2007, J Cardiometab Syndr, V2, P267, DOI 10.1111/j.1559-4564.2007.07392.x; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; FOLCH J, 1957, J BIOL CHEM, V226, P497; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453, DOI 10.1152/ajpendo.1995.268.3.E453; Krotkiewski M, 2002, EUR J PHARMACOL, V440, P85, DOI 10.1016/S0014-2999(02)01420-6; Ladenson PW, 2010, NEW ENGL J MED, V362, P906, DOI 10.1056/NEJMoa0905633; Lanni A, 2005, FASEB J, V19, DOI 10.1096/fj.05.3977fje; LANNI A, 1992, MOL CELL ENDOCRINOL, V86, P143, DOI 10.1016/0303-7207(92)90138-V; Lanni A, 1996, J PHYSIOL-LONDON, V494, P831, DOI 10.1113/jphysiol.1996.sp021536; Lombardi A, 2009, AM J PHYSIOL-ENDOC M, V296, pE497, DOI 10.1152/ajpendo.90642.2008; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; Mollica MP, 2009, J HEPATOL, V51, P363, DOI 10.1016/j.jhep.2009.03.023; Moreno M, 1997, J PHYSIOL-LONDON, V505, P529, DOI 10.1111/j.1469-7793.1997.529bb.x; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; SADDIK M, 1993, J BIOL CHEM, V268, P25836; Tanner CJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1191, DOI 10.1152/ajpendo.00416.2001; Yu J, 2009, ANN NY ACAD SCI, V1173, P10	31	34	36	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3451	3461		10.1096/fj.10-157115	http://dx.doi.org/10.1096/fj.10-157115			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20453112				2022-12-25	WOS:000281446400032
J	Zhao, M; Valamanesh, F; Celerier, I; Savoldelli, M; Jonet, L; Jeanny, JC; Jaisser, F; Farman, N; Behar-Cohen, F				Zhao, Min; Valamanesh, Fatemeh; Celerier, Isabelle; Savoldelli, Michele; Jonet, Laurent; Jeanny, Jean-Claude; Jaisser, Frederic; Farman, Nicolette; Behar-Cohen, Francine			The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Muller glial cells	FASEB JOURNAL			English	Article						mineralocorticoid receptor; glucocorticoids; aquaporin 4; Kir 4.1 potassium channel; ENaC sodium channel	INTRAVITREAL TRIAMCINOLONE ACETONIDE; EPITHELIAL SODIUM-CHANNEL; CARDIOVASCULAR-DISEASE; RECEPTOR; EXPRESSION; RETINA; RAT; MICE; AQUAPORIN-4; DISRUPTION	Glucocorticoids reduce diabetic macular edema, but the mechanisms underlying glucocorticoid effects are imperfectly elucidated. Glucocorticoids may bind to glucocorticoid (GR) and mineralocorticoid (MR) receptors. We hypothesize that MR activation may influence retinal hydration. The effect of the MR agonist aldosterone (24 h) on ion/water channel expression (real-time PCR, Western blot, immunofluorescence) was investigated on cultured retinal Muller glial cells (RMGs, which contribute to fluid homeostasis in the retina), in Lewis rat retinal explants, and in retinas from aldosterone-injected eyes. We evidenced cell-specific expression of MR, GR, and 11-beta-hydroxysteroid dehydrogenase type II. Aldosterone significantly enhances expression of sodium and potassium channels ENaC-alpha (6.5-fold) and Kir4.1 (1.9-fold) through MR and GR occupancy, whereas aquaporin 4 (AQP4, 2.9-fold) up-regulation is MR-selective. Aldosterone intravitreous injection induces retinal swelling (24% increase compared to sham-injected eyes) and activation of RMGs. It promotes additional localization of Kir4.1 and AQP4 toward apical microvilli of RMGs. Our results highlight the mineralocorticoid-sensitivity of the neuroretina and show that aldosterone controls hydration of the healthy retina through regulation of ion/water channels expression in RMGs. These results provide a rationale for future investigations of abnormal MR signaling in the pathological retina.-Zhao, M., Valamanesh, F., Celerier, I., Savoldelli, M., Jonet, L., Jeanny, J.-C., Jaisser, F., Farman, N., Behar-Cohen, F. The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Muller glial cells. FASEB J. 24, 3405-3415 (2010). www.fasebj.org	[Zhao, Min; Valamanesh, Fatemeh; Jonet, Laurent; Jeanny, Jean-Claude; Behar-Cohen, Francine] Univ Paris 05, INSERM, Ctr Rech Cordeliers, U872,Team 17, F-75006 Paris, France; [Valamanesh, Fatemeh] Fdn Adolphe De Rothschild, Paris, France; [Savoldelli, Michele] Univ Paris 05, Hotel Dieu Univ Hosp, F-75006 Paris, France; [Celerier, Isabelle; Jaisser, Frederic; Farman, Nicolette] Univ Paris 06, INSERM, Ctr Rech Cordeliers, U872,Team 1, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Behar-Cohen, F (corresponding author), Univ Paris 05, INSERM, Ctr Rech Cordeliers, U872,Team 17, 15 Rue Ecole Med, F-75006 Paris, France.	francine.behar@gmail.com	Zhao, Min/AAX-7664-2020; Jaisser, Frederic/P-4287-2017	Zhao, Min/0000-0002-5418-7275; Jaisser, Frederic/0000-0001-9051-1901	Fondation Rothschild; Ministere de la Recherche; INSERM; Union National des Aveugles et Deficients Visuels (UNADEV) funds	Fondation Rothschild; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Union National des Aveugles et Deficients Visuels (UNADEV) funds	The authors thank Christophe Klein of the Research Center of Cordeliers for his help in confocal microscopy and Astrid Limb (University College London, London, UK) for providing the human RMG cell line. M.Z. and F. V. were supported by the Fondation Rothschild. I. C. is the recipient of a Ph.D. grant from the Ministere de la Recherche. This work has been supported by INSERM and Union National des Aveugles et Deficients Visuels (UNADEV) funds.	Baath J, 2007, J OCUL PHARMACOL TH, V23, P304, DOI 10.1089/jop.2006.125; Berger S, 1998, P NATL ACAD SCI USA, V95, P9424, DOI 10.1073/pnas.95.16.9424; Berka JLW, 2009, CIRC RES, V104, P124, DOI 10.1161/CIRCRESAHA.108.176008; Bhalla V, 2006, AM J PHYSIOL-RENAL, V291, pF714, DOI 10.1152/ajprenal.00061.2006; Boulkroun S, 2002, J BIOL CHEM, V277, P31506, DOI 10.1074/jbc.M200272200; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Brockway LM, 2002, AM J PHYSIOL-CELL PH, V283, pC126, DOI 10.1152/ajpcell.00457.2001; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; DEKOZAK Y, 1994, J NEUROIMMUNOL, V55, P1, DOI 10.1016/0165-5728(94)90141-4; DeRijk RH, 2008, EUR J PHARMACOL, V583, P303, DOI 10.1016/j.ejphar.2007.11.072; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; Farman N, 2010, EXP DERMATOL, V19, P100, DOI 10.1111/j.1600-0625.2009.01011.x; Fiebeler A, 2007, CURR OPIN NEPHROL HY, V16, P134; Funder JW, 2007, AM J CARDIOVASC DRUG, V7, P151, DOI 10.2165/00129784-200707030-00001; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Golestaneh N, 2001, GLIA, V33, P160, DOI 10.1002/1098-1136(200102)33:2<160::AID-GLIA1015>3.0.CO;2-4; Goodyear MJ, 2009, VISUAL NEUROSCI, V26, P159, DOI 10.1017/S0952523809090038; Guo C, 2006, ENDOCRINOLOGY, V147, P5363, DOI 10.1210/en.2006-0944; Iandiev L, 2008, NEUROSCI LETT, V434, P317, DOI 10.1016/j.neulet.2008.02.026; Joels M, 2008, TRENDS NEUROSCI, V31, P1, DOI 10.1016/j.tins.2007.10.005; Jonas JB, 2005, PROG RETIN EYE RES, V24, P587, DOI 10.1016/j.preteyeres.2005.01.004; Kaur C, 2007, J PATHOL, V212, P429, DOI 10.1002/path.2195; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Massin P, 2004, OPHTHALMOLOGY, V111, P218, DOI 10.1016/j.ophtha.2003.05.037; Mirshahi M, 1996, BIOCHEM BIOPH RES CO, V219, P150, DOI 10.1006/bbrc.1996.0197; MOSCONA AA, 1967, SCIENCE, V158, P496, DOI 10.1126/science.158.3800.496; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P2211, DOI 10.1210/me.2005-0089; Pippal JB, 2008, J MOL ENDOCRINOL, V41, P405, DOI 10.1677/JME-08-0093; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Revollo JR, 2009, ANN NY ACAD SCI, V1179, P167, DOI 10.1111/j.1749-6632.2009.04986.x; Rickard AJ, 2009, J MOL ENDOCRINOL, V42, P449, DOI 10.1677/JME-08-0144; Rozeboom AM, 2007, P NATL ACAD SCI USA, V104, P4688, DOI 10.1073/pnas.0606067104; Ruiz-Ederra J, 2007, J BIOL CHEM, V282, P21866, DOI 10.1074/jbc.M703236200; Valamanesh F, 2007, MOL VIS, V13, P1746; Verkman AS, 2008, PROG RETIN EYE RES, V27, P420, DOI 10.1016/j.preteyeres.2008.04.001; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Zennaro MC, 2009, TRENDS ENDOCRIN MET, V20, P444, DOI 10.1016/j.tem.2009.05.006	43	103	109	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3405	3415		10.1096/fj.09-154344	http://dx.doi.org/10.1096/fj.09-154344			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20466875				2022-12-25	WOS:000281446400028
J	Hsu, YH; Liao, LJ; Yu, CH; Chiang, CP; Jhan, JR; Chang, LC; Chen, YJ; Lou, PJ; Lin, JJ				Hsu, Yi-Hsin; Liao, Li-Jen; Yu, Chuan-Hang; Chiang, Chun-Pin; Jhan, Jing-Ru; Chang, Lien-Cheng; Chen, Yann-Jang; Lou, Pei-Jen; Lin, Jing-Jer			Overexpression of the Pituitary Tumor Transforming Gene Induces p53-dependent Senescence through Activating DNA Damage Response Pathway in Normal Human Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID SEPARATION; CELLULAR SENESCENCE; HUMAN SECURIN; HUMAN-CELLS; IN-VIVO; P53; TUMORIGENESIS; ARREST; GROWTH; CANCER	Pituitary tumor transforming gene (PTTG1, securin) is involved in cell-cycle control through inhibition of sister-chromatid separation. Elevated levels of PTTG1 were found to be associated with many different tumor types that might be involved in late stage tumor progression. However, the role of PTTG1 in early stage of tumorigenesis is unclear. Here we utilized the adenovirus expression system to deliver PTTG1 into normal human fibroblasts to evaluate the role of PTTG1 in tumorigenesis. Expressing PTTG1 in normal human fibroblasts inhibited cell proliferation. Several senescence-associated (SA) phenotypes including increased SA-beta-galactosidase activities, decreased bromodeoxyuridine incorporation, and increased SA-heterochromatin foci formation were also observed in PTTG1-expressing cells, indicating that PTTG1 overexpression induced a senescent phenotype in normal cells. Significantly, the PTTG1-induced senescence is p53-dependent and telomerase-independent, which is distinctively different from that of replicative senescence. The mechanism of PTTG1-induced senescence was also analyzed. Consistent with its role in regulating sister-chromatid separation, overexpression of PTTG1 inhibited the activation of separase. Consequently, the numbers of cells with abnormal nuclei morphologies and chromosome separations were increased, which resulted in activation of the DNA damage response. Thus, we concluded that PTTG1 overexpression in normal human fibroblasts caused chromosome instability, which subsequently induced p53-dependent senescence through activation of DNA-damage response pathway.	[Lou, Pei-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei 110, Taiwan; [Lou, Pei-Jen] Natl Taiwan Univ, Coll Med, Taipei 110, Taiwan; [Hsu, Yi-Hsin; Jhan, Jing-Ru; Chang, Lien-Cheng; Lin, Jing-Jer] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Liao, Li-Jen] Far Eastern Mem Hosp, Dept Otolaryngol, Taipei 110, Taiwan; [Liao, Li-Jen] Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 110, Taiwan; [Yu, Chuan-Hang; Chiang, Chun-Pin] Natl Taiwan Univ, Grad Inst Clin Dent, Taipei 110, Taiwan; [Chiang, Chun-Pin] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Dent, Taipei 110, Taiwan; [Chen, Yann-Jang] Natl Yang Ming Univ, Fac Life Sci, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University	Lou, PJ (corresponding author), Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei 110, Taiwan.	pjlou@ntu.edu.tw; jjlin@ym.edu.tw	Lin, Jing-Jer/G-8068-2015	Chiang, Chun-Pin/0000-0002-6190-7162; LOU, PEI-JEN/0000-0002-3383-8593; LIN, JING-JER/0000-0001-8250-7398	National Science Council [97-2311-B-010-005, 98-3112-B-010-006, 96-2627-B002-010]; National Health Research Institute [NHRI-EX98-9625SI]; Institute of Biopharmaceutical Science	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Institute of Biopharmaceutical Science	This work was supported by National Science Council Grants 97-2311-B-010-005 and 98-3112-B-010-006 (to J.-J. L.) and 96-2627-B002-010 (to P.-J. L.) and by the National Health Research Institute Grant NHRI-EX98-9625SI (to J.-J. L.).; We thank members of the Institute of Biopharmaceutical Science for help and support. We thank Y. Su for the adenoviral system, T. H. Cheng for the HCT116 cells, and the National RNAi core facility for the shRNAs.	BAUM P, 1988, MOL CELL BIOL, V8, P5386, DOI 10.1128/MCB.8.12.5386; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Escarpe P, 2003, MOL THER, V8, P332, DOI 10.1016/S1525-0016(03)00167-9; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Herzig A, 2002, GENE DEV, V16, P2443, DOI 10.1101/gad.242202; Ishikawa H, 2001, J CLIN ENDOCR METAB, V86, P867, DOI 10.1210/jc.86.2.867; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shepard JL, 2007, GENE DEV, V21, P55, DOI 10.1101/gad.1470407; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665; Yu R, 2003, ENDOCRINOLOGY, V144, P4991, DOI 10.1210/en.2003-0305; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	32	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22630	22638		10.1074/jbc.M109.096255	http://dx.doi.org/10.1074/jbc.M109.096255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20452981	hybrid, Green Published			2022-12-25	WOS:000279702200073
J	Maitra, M; Wang, YY; Gerard, RD; Mendelson, CR; Garcia, CK				Maitra, Meenakshi; Wang, Yongyu; Gerard, Robert D.; Mendelson, Carole R.; Garcia, Christine Kim			Surfactant Protein A2 Mutations Associated with Pulmonary Fibrosis Lead to Protein Instability and Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTITIAL LUNG-DISEASE; GENE TARGETED MICE; INNATE IMMUNITY; HUMAN SP-A1; SP-C; EXPRESSION; CELLS; OLIGOMERIZATION; TELOMERASE; MECHANISMS	Rare heterozygous mutations in the gene encoding surfactant protein A2 (SP-A2, SFTPA2) are associated with adult-onset pulmonary fibrosis and adenocarcinoma of the lung. We have previously shown that two recombinant SP-A2 mutant proteins (G231V and F198S) remain within the endoplasmic reticulum (ER) of A549 cells and are not secreted into the culture medium. The pathogenic mechanism of the mutant proteins is unknown. Here we analyze all common and rare variants of the surfactant protein A2, SP-A2, in both A549 cells and in primary type II alveolar epithelial cells. We show that, in contrast with all other SP-A2 variants, the mutant proteins are not secreted into the medium with wild-type SP-A isoforms, form fewer intracellular dimer and trimer oligomers, are partially insoluble in 0.5% Nonidet P-40 lysates of transfected A549 cells, and demonstrate greater protein instability in chymotrypsin proteolytic digestions. Both the G231V and F198S mutant SP-A2 proteins are destroyed via the ER-association degradation pathway. Expression of the mutant proteins increases the transcription of a BiP-reporter construct, expression of BiP protein, and production of an ER stress-induced XBP-1 spliced product. Human bronchoalveolar wash samples from individuals who are heterozygous for the G231V mutation have similar levels of total SP-A as normal family members, which suggests that the mechanism of disease does not involve an overt lack of secreted SP-A but instead involves an increase in ER stress of resident type II alveolar epithelial cells.	[Maitra, Meenakshi; Wang, Yongyu; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Mendelson, Carole R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garcia, CK (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Christine.garcia@utsouthwestern.edu	Wang, Yongyu/F-9039-2011	Wang, Yongyu/0000-0002-8804-3472; Mendelson, Carole Ruth/0000-0003-1696-9791; Wang, Yongyu/0000-0002-6088-8887	National Institutes of Health (NHLBI) [HL093096]; Doris Duke Charitable Foundation; National Institutes of Health [HL050022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093096, R37HL050022, R01HL050022] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093096 (NHLBI) (to C. K. G.) and HL050022 (to C. R. M.). This work was also supported by the Doris Duke Charitable Foundation.	Alcorn JL, 1997, AM J RESP CELL MOL, V17, P672, DOI 10.1165/ajrcmb.17.6.2858; Aoki K, 1999, MOL MED, V5, P224, DOI 10.1007/BF03402119; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Bridges JP, 2006, J CELL BIOL, V172, P395, DOI 10.1083/jcb.200508016; Bridges JP, 2003, J BIOL CHEM, V278, P52739, DOI 10.1074/jbc.M309599200; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Floros J, 1998, BBA-MOL BASIS DIS, V1408, P312, DOI 10.1016/S0925-4439(98)00077-5; Goss KL, 1998, AM J RESP CELL MOL, V19, P613, DOI 10.1165/ajrcmb.19.4.3155; HAAGSMAN HP, 1989, AM J PHYSIOL, V257, pL421, DOI 10.1152/ajplung.1989.257.6.L421; Han Chao, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P1409; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Korfhagen TR, 1998, BBA-MOL BASIS DIS, V1408, P296, DOI 10.1016/S0925-4439(98)00075-1; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; MCCORMICK SM, 1994, AM J PHYSIOL, V266, pL367, DOI 10.1152/ajplung.1994.266.4.L367; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Mulugeta S, 2007, AM J PHYSIOL-LUNG C, V293, pL720, DOI 10.1152/ajplung.00025.2007; Palaniyar N, 2001, COMP BIOCHEM PHYS A, V129, P109, DOI 10.1016/S1095-6433(01)00309-9; PETITOU M, 1978, ANAL BIOCHEM, V91, P350, DOI 10.1016/0003-2697(78)90849-7; Raghu G, 2004, BRIT J CANCER, V91, pS3, DOI 10.1038/sj.bjc.6602061; Saitoh H, 1998, AM J RESP CELL MOL, V19, P202, DOI 10.1165/ajrcmb.19.2.3239; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sanchez-Barbero F, 2007, BIOCHEM J, V406, P479, DOI 10.1042/BJ20070275; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Wang GR, 2004, BIOCHEMISTRY-US, V43, P4227, DOI 10.1021/bi036023i; Wang LQ, 2009, TRIBOL T, V52, P59, DOI 10.1080/10402000802105422; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Zeng XY, 2003, INFECT IMMUN, V71, P1306, DOI 10.1128/IAI.71.3.1306-1315.2003	36	106	108	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22103	22113		10.1074/jbc.M110.121467	http://dx.doi.org/10.1074/jbc.M110.121467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20466729	hybrid, Green Published			2022-12-25	WOS:000279702200023
J	Xu, Y; Yan, W; Chen, X				Xu, Y.; Yan, W.; Chen, X.			SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E	ONCOGENE			English	Article						p53; SNF5; chromatin remodeling; Mdm2; eIF4E; AMPK	CHROMATIN REMODELING COMPLEXES; MALIGNANT RHABDOID TUMORS; DNA-DAMAGE; CYCLE PROGRESSION; SUPPRESSOR; CANCER; MUTATIONS; FAMILY; TRANSCRIPTION; CHECKPOINT	SNF5, a core component of the SWI/SNF chromatin remodeling complex, is expressed as two isoforms, SNF5a and SNF5b. SNF5 is a tumor suppressor, as mutation of SNF5 leads to tumor formation and cooperates with p53 deficiency to enhance cancer susceptibility. Interestingly, lack of SNF5 inhibits cell survival and embryonic development, potentially through abnormal activation of p53. To further examine this, we generated cell lines in which SNF5a, SNF5b or both can be inducibly knocked down. We found that SNF5 knockdown leads to cell-cycle arrest in G1, and SNF5a and SNF5b are functionally redundant. We also showed that SNF5 knockdown impairs p53-dependent transcription of p21 and murine double minute 2. However, contrary to earlier reports that p53 is activated by SNF5 knockout in murine cells, SNF5 knockdown leads to decreased, but not increased, expression of both basal and stress-induced p53 in multiple human cell lines. In addition, we showed that SNF5 knockdown induces adenosine monophosphate-activated protein kinase activation and inhibits eIF4E expression. Finally, we showed that SNF5 knockdown inhibits p53 translation by eIF4E and replacement of eIF4E in SNF5 knockdown cells restores p53 expression and cell survival. Together, our study results suggest that the p53 pathway is regulated by, and mediates the activity of, SNF5 in tumor suppression and prosurvival. Oncogene (2010) 29, 4090-4100; doi:10.1038/onc.2010.159; published online 17 May 2010	[Xu, Y.; Yan, W.; Chen, X.] Univ Calif Davis, Ctr Comparat Oncol, VM Surg & Radiol Sci, Davis, CA 95616 USA; [Xu, Y.] Zhejiang Univ, Dept Hematol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	University of California System; University of California Davis; Zhejiang University	Chen, X (corresponding author), Univ Calif Davis, Ctr Comparat Oncol, VM Surg & Radiol Sci, 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			NIH [CA081237, CA076069, CA102188]; NATIONAL CANCER INSTITUTE [R01CA102188, R29CA076069, R01CA081237, R01CA121137, R01CA076069] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by NIH Grants CA081237, CA076069 and CA102188.	Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Caramel J, 2008, ONCOGENE, V27, P2035, DOI 10.1038/sj.onc.1210847; CARLSON M, 1994, CURR OPIN CELL BIOL, V6, P396, DOI 10.1016/0955-0674(94)90032-9; Chai JJ, 2007, CANCER RES, V67, P3002, DOI 10.1158/0008-5472.CAN-06-4207; CHEN XB, 1995, CANCER RES, V55, P4257; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Guidi CJ, 2004, J BIOL CHEM, V279, P4180, DOI 10.1074/jbc.M312043200; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Klochendler-Yeivin A, 2006, MOL CELL BIOL, V26, P2661, DOI 10.1128/MCB.26.7.2661-2674.2006; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; McKenna ES, 2008, MOL CELL BIOL, V28, P6223, DOI 10.1128/MCB.00658-08; Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200; Peters Charles R., 1996, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V6, P175; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Scoumanne A, 2008, HISTOL HISTOPATHOL, V23, P1143, DOI 10.14670/HH-23.1143; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Sevenet N, 1999, HUM MOL GENET, V8, P2359, DOI 10.1093/hmg/8.13.2359; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vries RGJ, 2005, GENE DEV, V19, P665, DOI 10.1101/gad.335805; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002	41	24	25	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 15	2010	29	28					4090	4100		10.1038/onc.2010.159	http://dx.doi.org/10.1038/onc.2010.159			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	625JW	20473326	Green Accepted			2022-12-25	WOS:000279892400009
J	Banski, P; Mahboubi, H; Kodiha, M; Shrivastava, S; Kanagaratham, C; Stochaj, U				Banski, Piotr; Mahboubi, Hicham; Kodiha, Mohamed; Shrivastava, Sanhita; Kanagaratham, Cynthia; Stochaj, Ursula			Nucleolar Targeting of the Chaperone Hsc70 Is Regulated by Stress, Cell Signaling, and a Composite Targeting Signal Which Is Controlled by Autoinhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; HEAT-SHOCK-PROTEIN-70 FAMILY; MOLECULAR CHAPERONES; OXIDATIVE STRESS; NUCLEAR IMPORT; PROTEIN; LOCALIZATION; MECHANISMS; KINASE; HSP70	Hsc70s are constitutively synthesized members of the 70-kDa chaperone family; they are essential for viability and conserved among all organisms. When eukaryotic cells recover from stress, hsc70s accumulate in nucleoli by an unknown mechanism. Our studies were undertaken to characterize the signaling events and the targeting sequence required to concentrate hsc70 in the nucleoli of human cells. Here, we show that pharmacological inhibitors of phosphatidylinositol (PI) 3-kinase and MEK kinases as well as protein-tyrosine phosphatases abolished the stress-dependent nucleolar accumulation of hsc70. Furthermore, to identify the hsc70 nucleolar targeting sequence, green fluorescent protein-tagged fusion proteins with defined segments of hsc70 were generated and their subcellular distribution was analyzed in growing cells. These studies demonstrated that residues 225 to 297 serve as a heat-inducible nucleolar targeting signal. This segment directs green fluorescent protein to nucleoli in response to stress, but fails to do so under nonstress conditions. Fine mapping of the nucleolar targeting signal revealed that it has two separable functions. First, residues 225 to 262 direct reporter proteins constitutively to nucleoli, even without stress. Second, segment 263 to 287 functions as an auto-inhibitory element that prevents hsc70 from concentrating in nucleoli when cells are not stressed. Taken together, PI 3-kinase and MEK kinase signaling as well as tyrosine dephosphorylation are essential for the accumulation of hsc70 in nucleoli of stressed cells. This process relies on a stress-dependent composite targeting signal that combines multiple functions.	[Banski, Piotr; Mahboubi, Hicham; Kodiha, Mohamed; Shrivastava, Sanhita; Kanagaratham, Cynthia; Stochaj, Ursula] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University	Stochaj, U (corresponding author), 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	ursula.stochaj@mcgill.ca	stochaj, ursula/AAC-1865-2021; Mahboubi, Hicham/E-4294-2015	Mahboubi, Hicham/0000-0001-7643-0769	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada; Fonds de la Recherche en Sante Quebec/Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fonds de la Recherche en Sante Quebec/Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of CanadaFonds de la Recherche en Sante du Quebec)	This work was supported in part by grants from Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Heart and Stroke Foundation of Canada (to U.S.).; Supported by a fellowship from Fonds de la Recherche en Sante Quebec/Heart and Stroke Foundation of Canada.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; BANSKI P, 2010, TRENDS BIOL IN PRESS; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Chu A, 2001, FASEB J, V15, P1478, DOI 10.1096/fj.00-0680fje; DANG CV, 1989, J BIOL CHEM, V264, P18019; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Giffard RG, 2004, J NEUROSURG ANESTH, V16, P53, DOI 10.1097/00008506-200401000-00010; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Hishiya A, 2008, ONCOGENE, V27, P6489, DOI 10.1038/onc.2008.314; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Kodiha M, 2005, AM J PHYSIOL-CELL PH, V289, pC1034, DOI 10.1152/ajpcell.00590.2004; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kodiha M, 2009, FEBS LETT, V583, P1987, DOI 10.1016/j.febslet.2009.05.011; Lam YW, 2010, MOL CELL PROTEOMICS, V9, P117, DOI 10.1074/mcp.M900338-MCP200; Lam YW, 2005, J CELL SCI, V118, P1335, DOI 10.1242/jcs.01736; Leung AKL, 2003, BIOCHEM J, V376, P553, DOI 10.1042/BJ20031169; Lo SJ, 2006, CELL RES, V16, P530, DOI 10.1038/sj.cr.7310070; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Marshall KS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-6; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; Mekhail K, 2007, MOL BIOL CELL, V18, P3966, DOI 10.1091/mbc.E07-03-0295; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Sale EM, 2008, CELL MOL LIFE SCI, V65, P113, DOI 10.1007/s00018-007-7274-9; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Tsukahara F, 2004, J BIOL CHEM, V279, P8867, DOI 10.1074/jbc.M308848200; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z	41	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21858	21867		10.1074/jbc.M110.117291	http://dx.doi.org/10.1074/jbc.M110.117291			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20457599	Green Published, hybrid			2022-12-25	WOS:000279516100070
J	Gines, S; Paoletti, P; Alberch, J				Gines, Silvia; Paoletti, Paola; Alberch, Jordi			Impaired TrkB-mediated ERK1/2 Activation in Huntington Disease Knock-in Striatal Cells Involves Reduced p52/p46 Shc Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; OXIDATIVE STRESS; TYROSINE PHOSPHORYLATION; FACTOR RECEPTORS; BRAIN; NEURONS; BDNF; PROTECTS; SURVIVAL	Altered neurotrophic support as a result of reduced brain-derived neurotrophic factor (BDNF) expression and trafficking has been revealed as a key factor in Huntington disease (HD) pathology. BDNF binds to and activates the tyrosine kinase receptor TrkB, leading to activation of intracellular signaling pathways to promote differentiation and cell survival. In order to design new neuroprotective therapies based on BDNF delivery, it is important to define whether BDNF-mediated TrkB signaling is affected in HD. Here, we demonstrate reduced TrkB-mediated Ras/MAPK/ERK1/2 signaling but unchanged phosphatidylinositol 3-kinase/Akt and phospholipase C gamma activation in knock-in HD striatal cells. Altered BDNF-mediated ERK1/2 activation in mutant huntingtin cells is associated with reduced expression of p52/p46 Shc docking proteins. Notably, reduced BDNF-induced ERK1/2 activation increases the sensitivity of mutant huntingtin striatal cells to oxidative damage. Accordingly, pharmacological activation of the MAPK pathway with PMA prevents cell death induced by oxidative stress. Taken together, our results suggest that in addition to reduced BDNF, diminished Ras/MAPK/ERK1/2 activation is involved in neurotrophic deficits associated with HD pathology. Therefore, pharmacological approaches aimed to directly modulate the MAPK/ERK1/2 pathway may represent a valuable therapeutic strategy in HD.	[Gines, Silvia; Paoletti, Paola; Alberch, Jordi] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, Fac Med, Dept Biol Cellular Immunol & Neurociencies, E-08036 Barcelona, Spain; [Gines, Silvia; Paoletti, Paola; Alberch, Jordi] Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-41013 Seville, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED	Gines, S (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, Fac Med, Dept Biol Cellular Immunol & Neurociencies, Casanova 143, E-08036 Barcelona, Spain.	silviagines@ub.edu	Alberch, Jordi/K-5702-2014; Gines, Silvia/L-1943-2015	Alberch, Jordi/0000-0002-8684-2721; Gines, Silvia/0000-0002-9479-8185	Ministerio de Ciencia e Innovacion [SAF2008-00644, SAF2009-7077, SAF2008-04360]; Centro de Investigaciones Biomedicas en Red sobre Enfermedades Neuro-degenerativas (CIBERNED) [CB06/05/0054]; Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III, RETICS) [RD06/0010/0006]; Fundacio La Marato de TV3	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Centro de Investigaciones Biomedicas en Red sobre Enfermedades Neuro-degenerativas (CIBERNED); Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III, RETICS)(Instituto de Salud Carlos III); Fundacio La Marato de TV3	This work was supported by Ministerio de Ciencia e Innovacion Grants SAF2008-00644 and SAF2009-7077 (to S. G.) and SAF2008-04360 (to J.A.), Centro de Investigaciones Biomedicas en Red sobre Enfermedades Neuro-degenerativas (CIBERNED) Grant CB06/05/0054, Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III, RETICS) Grant RD06/0010/0006, and the Fundacio La Marato de TV3.	Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Arany I, 2008, J BIOL CHEM, V283, P6110, DOI 10.1074/jbc.M708799200; Barettino D, 1999, BBA-GENE STRUCT EXPR, V1446, P24, DOI 10.1016/S0167-4781(99)00056-1; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; Butterworth NJ, 1998, NEUROSCIENCE, V87, P49, DOI 10.1016/S0306-4522(98)00129-8; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Deogracias R, 2004, MOL CELL NEUROSCI, V26, P470, DOI 10.1016/j.mcn.2004.03.007; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Fumagalli F, 2008, CNS DRUGS, V22, P1005, DOI 10.2165/0023210-200822120-00004; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gines S, 2006, EUR J NEUROSCI, V23, P649, DOI 10.1111/j.1460-9568.2006.04590.x; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Gotoh N, 1996, EMBO J, V15, P6197, DOI 10.1002/j.1460-2075.1996.tb01008.x; Gotoh N, 1997, MOL CELL BIOL, V17, P1824, DOI 10.1128/MCB.17.4.1824; Gotoh N, 1995, ONCOGENE, V11, P2525; Gu L, 2009, BIOCHEM BIOPH RES CO, V383, P469, DOI 10.1016/j.bbrc.2009.04.037; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Huang HY, 2007, NEUROBIOL AGING, V28, P1258, DOI 10.1016/j.neurobiolaging.2006.05.037; Jiang H, 2005, J MOL NEUROSCI, V25, P133, DOI 10.1385/JMN:25:2:133; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; OKADA S, 1995, J BIOL CHEM, V270, P20737, DOI 10.1074/jbc.270.35.20737; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Perez-Navarro E, 2000, J NEUROCHEM, V75, P2190, DOI 10.1046/j.1471-4159.2000.0752190.x; Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Rubio I, 2006, BIOCHEM J, V398, P243, DOI 10.1042/BJ20060160; Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174; Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Velazquez L, 2000, BLOOD, V96, P132, DOI 10.1182/blood.V96.1.132.013k13_132_138; Ventura A, 2002, J BIOL CHEM, V277, P22370, DOI 10.1074/jbc.M200280200; Wu ZL, 2002, J BIOL CHEM, V277, P44208, DOI 10.1074/jbc.M206890200; Yamada M, 1997, J BIOL CHEM, V272, P30334, DOI 10.1074/jbc.272.48.30334; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2008, BRAIN PATHOL, V18, P225, DOI 10.1111/j.1750-3639.2007.00111.x; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	44	48	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21537	21548		10.1074/jbc.M109.084202	http://dx.doi.org/10.1074/jbc.M109.084202			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442398	Green Published, hybrid			2022-12-25	WOS:000279516100040
J	Lucker, BF; Miller, MS; Dziedzic, SA; Blackmarr, PT; Cole, DG				Lucker, Ben F.; Miller, Mark S.; Dziedzic, Slawomir A.; Blackmarr, Philip T.; Cole, Douglas G.			Direct Interactions of Intraflagellar Transport Complex B Proteins IFT88, IFT52, and IFT46	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINESIN-LIKE PROTEIN; CHLAMYDOMONAS-REINHARDTII; CAENORHABDITIS-ELEGANS; CYTOPLASMIC DYNEIN; SENSORY NEURONS; PRIMARY CILIUM; GENE; FLAGELLA; DISEASE; DISORDERS	Intraflagellar transport (IFT) particles of Chlamydomonas reinhardtii contain two distinct protein complexes, A and B, composed of at least 6 and 15 protein subunits, respectively. As isolated from C. reinhardtii flagella, IFT complex B can be further reduced to a similar to 500-kDa core that contains IFT88, 2 x IFT81, 2 x IFT74/72, IFT52, IFT46, IFT27, IFT25, and IFT22. In this study, yeast-based two-hybrid analysis was combined with bacterial coexpression to show that three of the core B subunits, IFT88, IFT52, and IFT46, interact directly with each other and, together, are capable of forming a ternary complex. Chemical cross-linking results support the IFT52-IFT88 interaction and provide additional evidence of an association between IFT27 and IFT81. With previous studies showing that IFT81 and IFT74/72 interact to form a (IFT81)(2)(IFT74/72)(2) heterotetramer and that IFT27 and IFT25 form a heterodimer, the architecture of complex B is revealing itself. Last, electroporation of recombinant IFT46 was used to rescue flagellar assembly of a newly identified ift46 mutant and to monitor in vivo localization and movement of the IFT particles.	[Cole, Douglas G.] Univ Idaho, Dept Microbiol Mol Biol & Biochem, Moscow, ID 83844 USA; Univ Idaho, Ctr Reprod Biol, Moscow, ID 83844 USA	Idaho; University of Idaho; Idaho; University of Idaho	Cole, DG (corresponding author), Univ Idaho, Dept Microbiol Mol Biol & Biochem, MMBB LSS142, Moscow, ID 83844 USA.	dcole@uidaho.edu	Dziedzic, Slawomir/I-3200-2012	Dziedzic, Slawomir/0000-0003-1721-8594	National Institutes of Health [R01-GM61920]; National Center for Research Resources [P20-RR016454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM61920 (to D. G. C.) and P20-RR016454 from the Idea Networks of Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Asamiziu E, 2000, DNA RES, V7, P305, DOI 10.1093/dnares/7.5.305; Asamizu E, 1999, DNA Res, V6, P369, DOI 10.1093/dnares/6.6.369; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Bell LR, 2006, GENETICS, V173, P1275, DOI 10.1534/genetics.106.056721; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; BRAY D, 2001, CELL MOVEMENTS MOL M, P3; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; COLE D, 2009, CHLAMYDOMONAS SOURCE, V3, P71; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Collet J, 1998, GENETICS, V148, P187; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; HARLOW E, 1999, USING ANTIBODIES LAB, P276; Hayashi M, 2002, CELL MOTIL CYTOSKEL, V53, P273, DOI 10.1002/cm.10075; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lechtreck KF, 2009, CELL MOTIL CYTOSKEL, V66, P469, DOI 10.1002/cm.20369; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 2000, METHODS, V22, P285, DOI 10.1006/meth.2000.1081; Pedersen LB, 2005, CURR BIOL, V15, P262, DOI 10.1016/j.cub.2005.01.037; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; Signor D, 1999, MOL BIOL CELL, V10, P345, DOI 10.1091/mbc.10.2.345; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Watanabe Y, 2004, CELL STRUCT FUNCT, V29, P67, DOI 10.1247/csf.29.67; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001	57	53	58	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21508	21518		10.1074/jbc.M110.106997	http://dx.doi.org/10.1074/jbc.M110.106997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20435895	hybrid, Green Published			2022-12-25	WOS:000279516100037
J	Kim, M; Williamson, CT; Prudhomme, J; Bebb, DG; Riabowol, K; Lee, PWK; Lees-Miller, SP; Mori, Y; Rahman, MM; McFadden, G; Johnston, RN				Kim, M.; Williamson, C. T.; Prudhomme, J.; Bebb, D. G.; Riabowol, K.; Lee, P. W. K.; Lees-Miller, S. P.; Mori, Y.; Rahman, M. M.; McFadden, G.; Johnston, R. N.			The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status	ONCOGENE			English	Article						reovirus; myxoma virus; tumor suppressor; oncolytic virus; anticancer therapy	ACTIVATED RAS PATHWAY; SIGNALING PATHWAY; CANCER-THERAPY; PHASE-I; CELLS; P53; INFECTION; INTERFERON; REPLICATION; VIROTHERAPY	Replication-competent oncolytic viruses hold great potential for the clinical treatment of many cancers. Importantly, many oncolytic virus candidates, such as reovirus and myxoma virus, preferentially infect cancer cells bearing abnormal cellular signaling pathways. Reovirus and myxoma virus are highly responsive to activated Ras and Akt signaling pathways, respectively, for their specificity for viral oncolysis. However, considering the complexity of cancer cell populations, it is possible that other tumor-specific signaling pathways may also contribute to viral discrimination between normal versus cancer cells. Because carcinogenesis is a multistep process involving the accumulation of both oncogene activations and the inactivation of tumor suppressor genes, we speculated that not only oncogenes but also tumor suppressor genes may have an important role in determining the tropism of these viruses for cancer cells. It has been previously shown that many cellular tumor suppressor genes, such as p53, ATM and Rb, are important for maintaining genomic stability; dysfunction of these tumor suppressors may disrupt intact cellular antiviral activity due to the accumulation of genomic instability or due to interference with apoptotic signaling. Therefore, we speculated that cells with dysfunctional tumor suppressors may display enhanced susceptibility to challenge with these oncolytic viruses, as previously seen with adenovirus. We report here that both reovirus and myxoma virus preferentially infect cancer cells bearing dysfunctional or deleted p53, ATM and Rb tumor suppressor genes compared to cells retaining normal counterparts of these genes. Thus, oncolysis by these viruses may be influenced by both oncogenic activation and tumor suppressor status. Oncogene (2010) 29, 3990-3996; doi:10.1038/onc.2010.137; published online 17 May 2010	[Kim, M.; Williamson, C. T.; Prudhomme, J.; Riabowol, K.; Lees-Miller, S. P.; Mori, Y.; Johnston, R. N.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Kim, M.; Rahman, M. M.; McFadden, G.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Bebb, D. G.] Univ Calgary, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Lee, P. W. K.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada	University of Calgary; State University System of Florida; University of Florida; University of Calgary; Dalhousie University	Johnston, RN (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Room HMRB 307,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	rnjohnst@ucalgary.ca	Johnston, Randal/B-9247-2009	Lees-Miller, Susan/0000-0001-5809-2516; McFadden, Grant/0000-0002-2556-3526	Canadian Institutes of Health Research; Canadian Breast Cancer Foundation; University of Florida College of Medicine; NIH [R01 CA138541]; NATIONAL CANCER INSTITUTE [R01CA138541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080607] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); University of Florida College of Medicine(University of Florida); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the Canadian Institutes of Health Research and the Canadian Breast Cancer Foundation (to RNJ) and a start-up grant from the University of Florida College of Medicine and NIH grant R01 CA138541 (to GM). GM is an International Scholar of the Howard Hughes Medical Institute.	Abou El Hassan MAI, 2004, J VIROL, V78, P12243, DOI 10.1128/JVI.78.22.12243-12251.2004; Alain T, 2002, BLOOD, V100, P4146, DOI 10.1182/blood-2002-02-0503; Bea S, 2009, BLOOD, V113, P3059, DOI 10.1182/blood-2008-07-170183; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Dharel N, 2008, HEPATOLOGY, V47, P1136, DOI 10.1002/hep.22176; DUNCAN MR, 1978, J VIROL, V28, P444, DOI 10.1128/JVI.28.2.444-449.1978; Duursma AM, 2003, SEMIN CANCER BIOL, V13, P267, DOI 10.1016/S1044-579X(03)00040-3; Forsyth P, 2008, MOL THER, V16, P627, DOI 10.1038/sj.mt.6300403; HASHIRO G, 1977, ARCH VIROL, V54, P307, DOI 10.1007/BF01314776; Huang S, 2004, CELL CYCLE, V3, P1043; Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003; Kim M, 2007, ONCOGENE, V26, P4124, DOI 10.1038/sj.onc.1210189; Kim M, 2009, LEUKEMIA, V23, P2313, DOI 10.1038/leu.2009.219; KIM M, 2007, AM SOC VIR ASV 2007; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Kozlov S, 2003, J BIOL CHEM, V278, P9309, DOI 10.1074/jbc.M300003200; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Lun XQ, 2007, CANCER RES, V67, P8818, DOI 10.1158/0008-5472.CAN-07-1214; McCormick F, 2005, ONCOGENE, V24, P7817, DOI 10.1038/sj.onc.1209064; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; Morris SM, 2002, MUTAT RES-REV MUTAT, V511, P45, DOI 10.1016/S1383-5742(01)00075-8; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Norman KL, 2005, DRUG DISCOV TODAY, V10, P847, DOI 10.1016/S1359-6446(05)03483-5; Norman KL, 2004, P NATL ACAD SCI USA, V101, P11099, DOI 10.1073/pnas.0404310101; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Royds JA, 2006, ONCOGENE, V25, P1509, DOI 10.1038/sj.onc.1209185; Shmulevitz M, 2010, CANCER GENE THER, V17, P69, DOI 10.1038/cgt.2009.46; Song L, 2009, CANCER GENE THER, V16, P382, DOI 10.1038/cgt.2008.84; Stanford MM, 2008, MOL THER, V16, P52, DOI 10.1038/sj.mt.6300348; Stanford MM, 2007, EXPERT OPIN BIOL TH, V7, P1415, DOI 10.1517/14712598.7.9.1415; Strong JE, 1996, J VIROL, V70, P612, DOI 10.1128/JVI.70.1.612-616.1996; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; STRONG JE, 1993, VIROLOGY, V197, P405, DOI 10.1006/viro.1993.1602; Sypula J., 2004, GENE THER MOL BIOL, V8, P103; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tucker CA, 2006, LEUKEMIA RES, V30, P449, DOI 10.1016/j.leukres.2005.08.016; Vidal L, 2008, CLIN CANCER RES, V14, P7127, DOI 10.1158/1078-0432.CCR-08-0524; Wang F, 2009, J VIROL, V83, P5928, DOI 10.1128/JVI.02587-08; Wang G, 2006, P NATL ACAD SCI USA, V103, P4640, DOI 10.1073/pnas.0509341103; WHITE E, 1994, NATURE, V371, P21, DOI 10.1038/371021a0	44	45	47	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 8	2010	29	27					3990	3996		10.1038/onc.2010.137	http://dx.doi.org/10.1038/onc.2010.137			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	621SL	20473328	Green Accepted			2022-12-25	WOS:000279603200011
J	GuezGuez, A; Prod'homme, V; Mouska, X; Baudot, A; Blin-Wakkach, C; Rottapel, R; Deckert, M				GuezGuez, Amel; Prod'homme, Virginie; Mouska, Xavier; Baudot, Alice; Blin-Wakkach, Claudine; Rottapel, Robert; Deckert, Marcel			3BP2 Adapter Protein Is Required for Receptor Activator of NF kappa B Ligand (RANKL)-induced Osteoclast Differentiation of RAW264.7 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SRC; REGULATES OSTEOCLASTOGENESIS; SIGNALING PATHWAY; ANTIGEN RECEPTOR; T-CELLS; BONE; EXPRESSION; SH3BP2; NFATC1; KINASE	The adapter protein 3BP2 (also known as SH3BP2 and Abl SH3-binding protein 2) has been involved in leukocyte signaling and activation downstream immunoreceptors. Genetic studies have further associated 3BP2 mutations to the human disease cherubism and to inflammation and bone dysfunction in mouse. However, how wild type 3BP2 functions in macrophage differentiation remains poorly understood. In this study, using small interfering RNA-mediated silencing of 3BP2 in the RAW264.7 monocytic cell line, we show that 3BP2 was required for receptor activator of NF kappa B ligand (RANKL)-induced differentiation of RAW264.7 cells into multinucleated mature osteoclasts but not for granulocyte macrophage-colony stimulating factor/interleukin-4-induced differentiation into dendritic cells. 3BP2 silencing was associated with impaired activation of multiple signaling events downstream of RANK, including actin reorganization; Src, ERK, and JNK phosphorylation; and up-regulation of osteoclastogenic factors. In addition, 3BP2 knockdown cells induced to osteoclast by RANKL displayed a reduced increase of Src and nuclear factor of activated T cells (NFATc1) mRNA and protein expression. Importantly, 3BP2 interacted with Src, Syk, Vav, and Cbl in monocytic cells, and the introduction of constitutively active mutants of Src and NFATc1 in 3BP2-deficient cells restored osteoclast differentiation. Finally, the expression of a 3BP2 cherubism mutant was found to promote increased Src activity and NFAT-dependent osteoclast formation. Together, this study demonstrates that wild type 3BP2 is a key regulator of RANK-mediated macrophage differentiation into osteoclast through Src and NFATc1 activation.	[GuezGuez, Amel; Prod'homme, Virginie; Mouska, Xavier; Baudot, Alice] Hop Archet 1, INSERM, UMR576, F-06202 Nice, France; [GuezGuez, Amel; Prod'homme, Virginie; Baudot, Alice; Blin-Wakkach, Claudine; Deckert, Marcel] Univ Nice Sophia Antipolis, F-06103 Nice, France; [Blin-Wakkach, Claudine] CNRS, Fac Med, FRE2943, F-06107 Nice, France; [Rottapel, Robert] Ontario Canc Inst, Toronto, ON M5G 1L7, Canada	CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Deckert, M (corresponding author), Hop Archet 1, INSERM, UMR576, Route St Antoine Ginestiere, F-06202 Nice, France.	deckert@unice.fr	Deckert, Marcel/M-4998-2016; Deckert, Marcel/T-3566-2019; Blin-Wakkach, Claudine/I-1263-2016; WAKKACH, Abdelilah/J-6584-2016; Prod'homme, Virginie/A-3948-2012	Deckert, Marcel/0000-0003-2094-559X; Blin-Wakkach, Claudine/0000-0002-2621-3907; WAKKACH, Abdelilah/0000-0002-6658-8009; Prod'homme, Virginie/0000-0002-9664-4710; Mouska, Xavier/0000-0002-4263-543X; Rottapel, Robert/0000-0002-6024-5558	INSERM; ANR (Agence Nationale pour la Recherche); l'Association pour la Recherche sur le Cancer; Ligue Nationale Contre le Cancer; Fondation pour la Recherche Medicale; Contrat d'Interface Clinique with the Department of Clinical Hematology, Centre Hospitalier Universitaire de Nice (France)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); l'Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Contrat d'Interface Clinique with the Department of Clinical Hematology, Centre Hospitalier Universitaire de Nice (France)	This work was supported by INSERM, ANR (Agence Nationale pour la Recherche), and l'Association pour la Recherche sur le Cancer.; Recipient of a fellowship from the Ligue Nationale Contre le Cancer.; Supported by the Fondation pour la Recherche Medicale.; Recipient of a Contrat d'Interface Clinique with the Department of Clinical Hematology, Centre Hospitalier Universitaire de Nice (France). To whom correspondence should be addressed: INSERM UMR576, Hopital de l'Archet 1, Route Saint-Antoine de Ginestiere, F-06202, Nice Cedex 3, France. Tel.: 33-492-157-700; Fax: 33-492-157-709; E-mail: deckert@unice.fr.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bailet O, 2009, CANCER RES, V69, P2748, DOI 10.1158/0008-5472.CAN-08-2690; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; de la Fuente MA, 2006, MOL CELL BIOL, V26, P5214, DOI 10.1128/MCB.00087-06; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Deckert M, 2006, ADV EXP MED BIOL, V584, P107; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Foucault I, 2005, BLOOD, V105, P1106, DOI 10.1182/blood-2003-08-2965; Hatani T, 2008, CURR MED CHEM, V15, P549; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; Jevremovic D, 2001, J IMMUNOL, V166, P7219, DOI 10.4049/jimmunol.166.12.7219; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P2325, DOI 10.1073/pnas.0806963106; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Le Bras S, 2007, FEBS LETT, V581, P967, DOI 10.1016/j.febslet.2007.01.084; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Lietman SA, 2008, BIOCHEM BIOPH RES CO, V371, P644, DOI 10.1016/j.bbrc.2008.04.080; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Munugalavadla V, 2008, MOL CELL BIOL, V28, P7182, DOI 10.1128/MCB.00920-08; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Southgate J, 1998, J CLIN PATHOL, V51, P831, DOI 10.1136/jcp.51.11.831; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	51	30	34	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20952	20963		10.1074/jbc.M109.091124	http://dx.doi.org/10.1074/jbc.M109.091124			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439986	Green Published, hybrid			2022-12-25	WOS:000279228600059
J	Li, L; Kim, E; Yuan, HX; Inoki, K; Goraksha-Hicks, P; Schiesher, RL; Neufeld, TP; Guan, KL				Li, Li; Kim, Eunjung; Yuan, Haixin; Inoki, Ken; Goraksha-Hicks, Pankuri; Schiesher, Rachel L.; Neufeld, Thomas P.; Guan, Kun-Liang			Regulation of mTORC1 by the Rab and Arf GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE; DIRECT TARGET; CELL-GROWTH; BREFELDIN-A; S6 KINASE; RHEB; TSC2; PHOSPHORYLATION; AUTOPHAGY; PROTEINS	The mammalian target of rapamycin ( mTOR) is a key cell growth regulator, which forms two distinct functional complexes (mTORC1 and mTORC2). mTORC1, which is directly inhibited by rapamycin, promotes cell growth by stimulating protein synthesis and inhibiting autophagy. mTORC1 is regulated by a wide range of extra- and intracellular signals, including growth factors, nutrients, and energy levels. Precise regulation of mTORC1 is important for normal cellular physiology and development, and dysregulation of mTORC1 contributes to hypertrophy and tumorigenesis. In this study, we screened Drosophila small GTPases for their function in TORC1 regulation and found that TORC1 activity is regulated by members of the Rab and Arf family GTPases, which are key regulators of intracellular vesicle trafficking. In mammalian cells, uncontrolled activation of Rab5 and Arf1 strongly inhibit mTORC1 activity. Interestingly, the effect of Rab5 and Arf1 on mTORC1 is specific to amino acid stimulation, whereas glucose-induced mTORC1 activation is not blocked by Rab5 or Arf1. Similarly, active Rab5 selectively inhibits mTORC1 activation by Rag GTPases, which are involved in amino acid signaling, but does not inhibit the effect of Rheb, which directly binds and activates mTORC1. Our data demonstrate a key role of Rab and Arf family small GTPases and intracellular trafficking in mTORC1 activation, particularly in response to amino acids.	[Li, Li; Yuan, Haixin; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Li, Li; Yuan, Haixin; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Li, Li] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Inoki, Ken] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Kim, Eunjung] Catholic Univ Daegu, Dept Food Sci & Nutr, Gyongsan 712702, South Korea; [Goraksha-Hicks, Pankuri; Schiesher, Rachel L.; Neufeld, Thomas P.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Catholic University of Daegu; University of Minnesota System; University of Minnesota Twin Cities	Guan, KL (corresponding author), Univ Calif San Diego, Moores Canc Ctr, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022	Neufeld, Thomas/0000-0001-5659-4811	National Institutes of Health [GM62694, GM51586]; United States Department of Defense [DOD W81XWH-09-1-0279]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062694, R01GM062509, R01GM051586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62694 and GM51586 (to K.-L.G.). This work was also supported by Grant DOD W81XWH-09-1-0279 from the United States Department of Defense (to K.-L.G.).	Arsham AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006068; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Lodhi IJ, 2008, MOL BIOL CELL, V19, P2718, DOI 10.1091/mbc.E08-01-0105; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Merithew E, 2001, J BIOL CHEM, V276, P13982, DOI 10.1074/jbc.M009771200; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thomas G, 2002, BIOL RES, V35, P305, DOI 10.4067/S0716-97602002000200022; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yudin D, 2009, J CELL SCI, V122, P587, DOI 10.1242/jcs.015289; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	30	104	110	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19705	19709		10.1074/jbc.C110.102483	http://dx.doi.org/10.1074/jbc.C110.102483			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20457610	hybrid, Green Published			2022-12-25	WOS:000279012000002
J	Wang, MJ; Larsen, MV; Nielsen, M; Harndahl, M; Justesen, S; Dziegiel, MH; Buus, S; Tang, ST; Lund, O; Claesson, MH				Wang, Mingjun; Larsen, Mette V.; Nielsen, Morten; Harndahl, Mikkel; Justesen, Sune; Dziegiel, Morten H.; Buus, Soren; Tang, Sheila T.; Lund, Ole; Claesson, Mogens H.			HLA Class I Binding 9mer Peptides from Influenza A Virus Induce CD4(+) T Cell Responses	PLOS ONE			English	Article							TAP TRANSPORT EFFICIENCY; CTL EPITOPES; MOLECULES; LIGATION; VARIOLA; H5N1	Background: Identification of human leukocyte antigen class I (HLA-I) restricted cytotoxic T cell (CTL) epitopes from influenza virus is of importance for the development of new effective peptide-based vaccines. Methodology/Principal Findings: In the present work, bioinformatics was used to predict 9mer peptides derived from available influenza A viral proteins with binding affinity for at least one of the 12 HLA-I supertypes. The predicted peptides were then selected in a way that ensured maximal coverage of the available influenza A strains. One hundred and thirty one peptides were synthesized and their binding affinities for the HLA-I supertypes were measured in a biochemical assay. Influenza-specific T cell responses towards the peptides were quantified using IFN gamma ELISPOT assays with peripheral blood mononuclear cells (PBMC) from adult healthy HLA-I typed donors as responder cells. Of the 131 peptides, 21 were found to induce T cell responses in 19 donors. In the ELISPOT assay, five peptides induced responses that could be totally blocked by the pan-specific anti-HLA-I antibody W6/32, whereas 15 peptides induced responses that could be completely blocked in the presence of the pan-specific anti-HLA class II (HLA-II) antibody IVA12. Blocking of HLA-II subtype reactivity revealed that 8 and 6 peptide responses were blocked by anti-HLA-DR and -DP antibodies, respectively. Peptide reactivity of PBMC depleted of CD4(+) or CD8(+) T cells prior to the ELISPOT culture revealed that effectors are either CD4(+) (the majority of reactivities) or CD8(+) T cells, never a mixture of these subsets. Three of the peptides, recognized by CD4(+) T cells showed binding to recombinant DRA1*0101/DRB1*0401 or DRA1*0101/DRB5*0101 molecules in a recently developed biochemical assay. Conclusions/Significance: HLA-I binding 9mer influenza virus-derived peptides induce in many cases CD4(+) T cell responses restricted by HLA-II molecules.	[Wang, Mingjun; Harndahl, Mikkel; Justesen, Sune; Buus, Soren; Claesson, Mogens H.] Univ Copenhagen, Fac Heath Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Larsen, Mette V.; Nielsen, Morten; Tang, Sheila T.; Lund, Ole] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Dziegiel, Morten H.] Copenhagen Univ Hosp, H S Blood Bank KI 2034, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; University of Copenhagen	Wang, MJ (corresponding author), Univ Copenhagen, Fac Heath Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	mwang429@gmail.com; claesson@sund.ku.dk	Buus, Soren/F-5446-2010; Nielsen, Morten/AAL-8700-2020; Nielsen, Morten/E-7754-2011; Lund, Ole/F-4437-2014	Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Dziegiel, Morten Hanefeld/0000-0001-8034-1523; Buus, Soren/0000-0001-8363-1999; WANG, MINGJUN/0000-0002-5848-0444	National Institutes of Health [HHSN266200400083C, HHSN266200400025C]; EU [6FP 503231]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission)	This work was supported by National Institutes of Health contracts HHSN266200400083C, HHSN266200400025C and EU 6FP 503231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Berkhoff EGM, 2007, J GEN VIROL, V88, P530, DOI 10.1099/vir.0.82120-0; Bragstad K, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-40; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Harndahl M, 2009, J BIOMOL SCREEN, V14, P173, DOI 10.1177/1087057108329453; Justesen Sune, 2009, Immunome Res, V5, P2, DOI 10.1186/1745-7580-5-2; KUWANO K, 1988, J IMMUNOL, V140, P1264; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pedersen LO, 2001, EUR J IMMUNOL, V31, P2986, DOI 10.1002/1521-4141(2001010)31:10<2986::AID-IMMU2986>3.0.CO;2-R; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Skov S, 1997, J CELL BIOL, V139, P1523, DOI 10.1083/jcb.139.6.1523; Skov S, 1997, J IMMUNOL, V158, P3189; Tang ST, 2008, ARCH VIROL, V153, P1833, DOI 10.1007/s00705-008-0194-7; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Wang M, 2009, CLIN EXP IMMUNOL, V155, P441, DOI 10.1111/j.1365-2249.2008.03856.x; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x	27	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10533	10.1371/journal.pone.0010533	http://dx.doi.org/10.1371/journal.pone.0010533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479886	Green Published, Green Submitted, gold			2022-12-25	WOS:000277467800015
J	Yang, LC; Zhang, QG; Zhou, CF; Yang, F; Zhang, YD; Wang, RM; Brann, DW				Yang, Li-cai; Zhang, Quan-Guang; Zhou, Cai-feng; Yang, Fang; Zhang, Yi-dong; Wang, Rui-min; Brann, Darrell W.			Extranuclear Estrogen Receptors Mediate the Neuroprotective Effects of Estrogen in the Rat Hippocampus	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; FOCAL BRAIN ISCHEMIA; PLASMA-MEMBRANE; NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; CEREBRAL-ISCHEMIA; MOUSE HIPPOCAMPUS; NEURONAL SURVIVAL; GLOBAL-ISCHEMIA	Background: 17 beta-estradiol (E2) has been implicated to exert neuroprotective effects in the brain following cerebral ischemia. Classically, E2 is thought to exert its effects via genomic signaling mediated by interaction with nuclear estrogen receptors. However, the role and contribution of extranuclear estrogen receptors (ER) is unclear and was the subject of the current study. Methodology/Principal Findings: To accomplish this goal, we employed two E2 conjugates (E2 dendrimer, EDC, and E2-BSA) that can interact with extranuclear ER and exert rapid nongenomic signaling, but lack the ability to interact with nuclear ER due to their inability to enter the nucleus. EDC or E2-BSA (10 mu M) was injected icv 60 min prior to global cerebral ischemia (GCI). FITC-tagged EDC or E2-BSA revealed high uptake in the hippocampal CA1 region after icv injection, with a membrane (extranuclear) localization pattern in cells. Both EDC and E2-BSA exerted robust neuroprotection in the CA1 against GCI, and the effect was blocked by the ER antagonist, ICI182,780. EDC and E2-BSA both rapidly enhanced activation of the prosurvival kinases, ERK and Akt, while attenuating activation of the proapoptotic kinase, JNK following GCI, effects that were blocked by ICI182,780. Administration of an MEK or PI3K inhibitor blocked the neuroprotective effects of EDC and E2-BSA. Further studies showed that EDC increased p-CREB and BDNF in the CA1 region in an ERK- and Akt-dependent manner, and that cognitive outcome after GCI was preserved by EDC in an ER-dependent manner. Conclusions/Significance: In conclusion, the current study demonstrates that activation of extranuclear ER results in induction of ERK-Akt-CREB-BDNF signaling in the hippocampal CA1 region, which significantly reduces ischemic neuronal injury and preserves cognitive function following GCI. The study adds to a growing literature that suggests that extranuclear ER can have important actions in the brain.	[Yang, Li-cai; Zhou, Cai-feng; Yang, Fang; Zhang, Yi-dong; Wang, Rui-min] N China Coal Med Univ, Expt & Res Ctr, Tangshan, Hebei, Peoples R China; [Zhang, Quan-Guang; Brann, Darrell W.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA	North China University of Science & Technology; University System of Georgia; Augusta University	Yang, LC (corresponding author), N China Coal Med Univ, Expt & Res Ctr, Tangshan, Hebei, Peoples R China.	rmwang1213@yahoo.com.cn; dbrann@mcg.edu			National Institute of Neurological Diseases and Stroke (NINDS), NIH, USA [NS050730]; National Natural Science Foundation of China [30970664]; Natural Science Foundation of Hebei Provinces of China [C2008000997]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050730] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke (NINDS), NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Provinces of China(Natural Science Foundation of Hebei Province); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a research grant (NS050730) (to DWB) from the National Institute of Neurological Diseases and Stroke (NINDS), NIH, USA, and a research grant (to RMW) from the National Natural Science Foundation (30970664) (to RMW) of China and the Natural Science Foundation (C2008000997) (to RMW) of Hebei Provinces of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, REPRODUCTION, V131, P763, DOI 10.1530/rep.1.00807; Alkayed NJ, 2001, J NEUROSCI, V21, P7543, DOI 10.1523/JNEUROSCI.21-19-07543.2001; Azcoitia I, 1999, GLIA, V26, P260; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bondar G, 2009, J NEUROSCI, V29, P15323, DOI 10.1523/JNEUROSCI.2107-09.2009; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Chaban VV, 2004, ENDOCRINOLOGY, V145, P3788, DOI 10.1210/en.2004-0149; Choi YC, 2004, FUND CLIN PHARMACOL, V18, P547, DOI 10.1111/j.1472-8206.2004.00284.x; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dhandapani KM, 2005, ENDOCRINOLOGY, V146, P2749, DOI 10.1210/en.2005-0014; Dhandapani KM, 2007, EXP GERONTOL, V42, P70, DOI 10.1016/j.exger.2006.06.032; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Elzer J.G., 2009, J CEREB BLOOD FLOW M; Evinger AJ, 2005, STEROIDS, V70, P361, DOI 10.1016/j.steroids.2005.02.015; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Gorosito SV, 2008, NEUROSCIENCE, V154, P1173, DOI 10.1016/j.neuroscience.2008.05.001; Guan QH, 2005, BRAIN RES, V1035, P51, DOI 10.1016/j.brainres.2004.11.050; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Jover-Mengual T, 2007, ENDOCRINOLOGY, V148, P1131, DOI 10.1210/en.2006-1137; Kalita K, 2005, HIPPOCAMPUS, V15, P404, DOI 10.1002/hipo.20066; Kelly MJ, 2009, MOL CELL ENDOCRINOL, V308, P17, DOI 10.1016/j.mce.2009.03.008; Kow LM, 2004, P NATL ACAD SCI USA, V101, P12354, DOI 10.1073/pnas.0404889101; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Marin R, 2009, J STEROID BIOCHEM, V114, P2, DOI 10.1016/j.jsbmb.2008.12.014; Matsuda KI, 2008, NEUROSCI LETT, V441, P94, DOI 10.1016/j.neulet.2008.05.108; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; Merchenthaler I, 2003, ANN NY ACAD SCI, V1007, P89, DOI 10.1196/annals.1286.009; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Milner TA, 2001, J COMP NEUROL, V429, P355; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murphy SJ, 2004, ILAR J, V45, P147, DOI 10.1093/ilar.45.2.147; Nakajo Y, 2008, BRAIN RES, V1241, P103, DOI 10.1016/j.brainres.2008.08.080; Niewada M, 2005, NEUROEPIDEMIOLOGY, V24, P123, DOI 10.1159/000082999; Nishio M, 2004, NEUROSCI LETT, V355, P109, DOI 10.1016/j.neulet.2003.10.064; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Porte Y, 2008, LEARN MEMORY, V15, P885, DOI 10.1101/lm.1094208; Raval AP, 2009, NEUROSCIENCE, V160, P307, DOI 10.1016/j.neuroscience.2009.02.065; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Roquer J, 2003, STROKE, V34, P1581, DOI 10.1161/01.STR.0000078562.82918.F6; Shughrue PJ, 2003, NEUROSCIENCE, V116, P851, DOI 10.1016/S0306-4522(02)00790-X; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Singer CA, 1999, J NEUROSCI, V19, P2455; Singh M, 1999, J NEUROSCI, V19, P1179; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Soderstrom I, 2009, EUR J NEUROSCI, V29, P1215, DOI 10.1111/j.1460-9568.2009.06662.x; Taguchi Yasuto, 2004, Nucl Recept, V2, P5, DOI 10.1186/1478-1336-2-5; Vasudevan N, 2007, ENDOCR REV, V28, P1, DOI 10.1210/er.2005-0021; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang QG, 2006, J NEUROCHEM, V98, P1886, DOI 10.1111/j.1471-4159.2006.04020.x; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092	70	143	157	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e9851	10.1371/journal.pone.0009851	http://dx.doi.org/10.1371/journal.pone.0009851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479872	Green Published, Green Submitted, gold			2022-12-25	WOS:000277467800001
J	Gandhi, KS; Mckay, FC; Diefenbach, E; Crossett, B; Schibeci, SD; Heard, RN; Stewart, GJ; Booth, DR; Arthur, JW				Gandhi, Kaushal S.; Mckay, Fiona C.; Diefenbach, Eve; Crossett, Ben; Schibeci, Stephen D.; Heard, Robert N.; Stewart, Graeme J.; Booth, David R.; Arthur, Jonathan W.			Novel Approaches to Detect Serum Biomarkers for Clinical Response to Interferon-beta Treatment in Multiple Sclerosis	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; PROTEOMIC ANALYSIS; ENDOTHELIAL-CELLS; T-LYMPHOCYTES; NEUTRALIZING ANTIBODIES; EXPERIMENTAL-DESIGN; EARLY INTERVENTION; CHEMOKINE	Interferon beta (IFN beta) is the most common immunomodulatory treatment for relapsing-remitting multiple sclerosis (RRMS). However, some patients fail to respond to treatment. In this study, we identified putative clinical response markers in the serum and plasma of people with multiple sclerosis (MS) treated with IFN beta. In a discovery-driven approach, we use 2D-difference gel electrophoresis (DIGE) to identify putative clinical response markers and apply power calculations to identify the sample size required to further validate those markers. In the process we have optimized a DIGE protocol for plasma to obtain cost effective and high resolution gels for effective spot comparison. APOA1, A2M, and FIBB were identified as putative clinical response markers. Power calculations showed that the current DIGE experiment requires a minimum of 10 samples from each group to be confident of 1.5 fold difference at the p<0.05 significance level. In a complementary targeted approach, Cytometric Beadarray (CBA) analysis showed no significant difference in the serum concentration of IL-6, IL-8, MIG, Eotaxin, IP-10, MCP-1, and MIP-1 alpha, between clinical responders and non-responders, despite the association of these proteins with IFN beta treatment in MS.	[Gandhi, Kaushal S.; Mckay, Fiona C.; Diefenbach, Eve; Schibeci, Stephen D.; Heard, Robert N.; Stewart, Graeme J.; Booth, David R.] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Gandhi, Kaushal S.; Arthur, Jonathan W.] Univ Sydney, Sydney Med Sch, Discipline Med, Sydney, NSW 2006, Australia; [Crossett, Ben] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney	Gandhi, KS (corresponding author), Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia.	jonathan.arthur@sydney.edu.au	Arthur, Jonathan/A-5367-2009; Crossett, Ben/G-2316-2011	Arthur, Jonathan/0000-0003-3615-7352; McKay, Fiona Catherine/0000-0002-9610-0668	Australian Research Council [LP0668335]	Australian Research Council(Australian Research Council)	This work was funded by an Australian Research Council (www.arc.gov.au) Linkage Grant (LP0668335), partnered by Biogen Idec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Alexander JS, 2007, J MOL NEUROSCI, V32, P169, DOI 10.1007/s12031-007-0018-3; Baker PW, 1999, J LIPID RES, V40, P345; Boz C, 2006, CLIN NEUROL NEUROSUR, V108, P124, DOI 10.1016/j.clineuro.2005.01.005; Buttmann M, 2004, J NEUROIMMUNOL, V156, P195, DOI 10.1016/j.jneuroim.2004.07.016; Calabresi PA, 2001, J NEUROIMMUNOL, V115, P161, DOI 10.1016/S0165-5728(01)00253-3; Comabella M, 2002, J NEUROIMMUNOL, V126, P205, DOI 10.1016/S0165-5728(02)00064-4; Comabella M, 2009, CLIN IMMUNOL, V130, P145, DOI 10.1016/j.clim.2008.09.010; Conroy DM, 2001, RESP RES, V2, P150, DOI 10.1186/rr52; Dumont D, 2004, PROTEOMICS, V4, P2117, DOI 10.1002/pmic.200300715; Durelli L, 2001, NEUROL SCI, V22, P201, DOI 10.1007/s100720170024; Flachenecker P, 2003, DRUGS, V63, P1525, DOI 10.2165/00003495-200363150-00001; Franciotta D, 2006, J NEUROL SCI, V247, P202, DOI 10.1016/j.jns.2006.05.049; Galvani M, 2001, ELECTROPHORESIS, V22, P2066, DOI 10.1002/1522-2683(200106)22:10<2066::AID-ELPS2066>3.0.CO;2-8; Gez S, 2007, BBA-PROTEINS PROTEOM, V1774, P1173, DOI 10.1016/j.bbapap.2007.06.011; Gneiss C, 2004, MULT SCLER J, V10, P507, DOI 10.1191/1352458504ms1074oa; Granger J, 2005, PROTEOMICS, V5, P4713, DOI 10.1002/pmic.200401331; Gunnarsson M, 2003, ACTA NEUROL SCAND, V108, P16, DOI 10.1034/j.1600-0404.2003.00079.x; Gutierrez-Ramos JC, 1999, IMMUNOL TODAY, V20, P500, DOI 10.1016/S0167-5699(99)01522-4; Hammack BN, 2004, MULT SCLER, V10, P245, DOI 10.1191/1352458504ms1023oa; Hartung HP, 2005, EUR J NEUROL, V12, P588, DOI 10.1111/j.1468-1331.2005.01104.x; Horgan GW, 2007, J PROTEOME RES, V6, P2884, DOI 10.1021/pr070114a; Hunt SMN, 2005, J PROTEOME RES, V4, P809, DOI 10.1021/pr049758y; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Irani DN, 2006, ANN NEUROL, V59, P237, DOI 10.1002/ana.20786; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jeffery DR, 2002, J NEUROL SCI, V197, P1, DOI 10.1016/S0022-510X(02)00039-4; Jensen PEH, 2004, BBA-MOL BASIS DIS, V1690, P203, DOI 10.1016/j.bbadis.2004.06.010; Jungo F, 2001, CYTOKINE, V14, P272, DOI 10.1006/cyto.2001.0884; Kappos L, 2004, NEUROLOGY, V63, P1779, DOI 10.1212/01.WNL.0000145561.08973.4F; Karp NA, 2005, J PROTEOME RES, V4, P1867, DOI 10.1021/pr050084g; Khan A, 2005, CLIN CHIM ACTA, V358, P119, DOI 10.1016/j.cccn.2005.03.013; Kozovska ME, 1999, NEUROLOGY, V53, P1692, DOI 10.1212/WNL.53.8.1692; Liu SL, 2009, J CELL MOL MED, V13, P1586, DOI 10.1111/j.1582-4934.2009.00850.x; Lund BT, 2004, J NEUROIMMUNOL, V155, P161, DOI 10.1016/j.jneuroim.2004.06.008; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Muller D, 2000, VIRCHOWS ARCH, V437, P521, DOI 10.1007/s004280000271; Muller Diane M., 2004, Current Drug Targets - Inflammation and Allergy, V3, P279, DOI 10.2174/1568010043343732; Nakatsuji Y, 2006, CYTOKINE, V36, P69, DOI 10.1016/j.cyto.2006.10.013; Nicoletti F, 2000, CYTOKINE, V12, P682, DOI 10.1006/cyto.1999.0616; Qin ZY, 2009, CELL MOL NEUROBIOL, V29, P203, DOI 10.1007/s10571-008-9312-z; Sena A, 2000, CLIN CHEM LAB MED, V38, P209, DOI 10.1515/CCLM.2000.030; Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2; Szczucinski A, 2004, FOLIA NEUROPATHOL, V42, P15; TARLORI C, 2002, J NEUROIMMUNOL, V123, P170; Timms JF, 2008, PROTEOMICS, V8, P4886, DOI 10.1002/pmic.200800298; Tumani H, 2009, NEUROSCI LETT, V452, P214, DOI 10.1016/j.neulet.2009.01.057; Tumani H, 2010, EXPERT REV PROTEOMIC, V7, P29, DOI 10.1586/EPR.09.99; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; Veldhuis TB, 2003, J CEREBR BLOOD F MET, V23, P1060, DOI 10.1097/01.WCB.0000080701.47016.24; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Waubant E, 2003, NEUROLOGY, V61, P184, DOI 10.1212/01.WNL.0000078888.07196.0B; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zang YCQ, 2001, J NEUROIMMUNOL, V112, P174, DOI 10.1016/S0165-5728(00)00397-0	54	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10484	10.1371/journal.pone.0010484	http://dx.doi.org/10.1371/journal.pone.0010484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463963	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379400020
J	Mader, S; Lutterotti, A; Di Pauli, F; Kuenz, B; Schanda, K; Aboul-Enein, F; Khalil, M; Storch, MK; Jarius, S; Kristoferitsch, W; Berger, T; Reindl, M				Mader, Simone; Lutterotti, Andreas; Di Pauli, Franziska; Kuenz, Bettina; Schanda, Kathrin; Aboul-Enein, Fahmy; Khalil, Michael; Storch, Maria K.; Jarius, Sven; Kristoferitsch, Wolfgang; Berger, Thomas; Reindl, Markus			Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; DIAGNOSTIC-CRITERIA; PATHOGENESIS; IGG; DISTINCTION; PREDICTORS; RITUXIMAB; MARKER; NMO	Background: Neuromyelitis optica (NMO), a severe demyelinating disease, represents itself with optic neuritis and longitudinally extensive transverse myelitis. Serum NMO-IgG autoantibodies (Abs), a specific finding in NMO patients, target the water channel protein aquaporin-4 (AQP4), which is expressed as a long (M-1) or a short (M-23) isoform. Methodology/Principal Findings: The aim of this study was to analyze serum samples from patients with NMO and controls for the presence and epitope specificity of IgG and IgM anti-AQP4 Abs using an immunofluorescence assay with HEK293 cells expressing M-1 or M-23 human AQP4. We included 56 patients with definite NMO (n = 30) and high risk NMO (n = 26), 101 patients with multiple sclerosis, 27 patients with clinically isolated syndromes (CIS), 30 patients with systemic lupus erythematosus (SLE) or Sjogren's syndrome, 29 patients with other neurological diseases and 47 healthy controls. Serum anti-AQP4 M-23 IgG Abs were specifically detected in 29 NMO patients, 17 patients with high risk NMO and two patients with myelitis due to demyelination (CIS) and SLE. In contrast, IgM anti-AQP4 Abs were not only found in some NMO and high risk patients, but also in controls. The sensitivity of the M-23 AQP4 IgG assay was 97% for NMO and 65% for high risk NMO, with a specificity of 100% compared to the controls. Sensitivity with M-1 AQP4 transfected cells was lower for NMO (70%) and high risk NMO (39%). The conformational epitopes of M-23 AQP4 are the primary targets of NMO-IgG Abs, whereas M-1 AQP4 Abs are developed with increasing disease duration and number of relapses. Conclusions: Our results confirm M-23 AQP4-IgG Abs as reliable biomarkers in patients with NMO and high risk syndromes. M-1 and M-23 AQP4-IgG Abs are significantly associated with a higher number of relapses and longer disease duration.	[Mader, Simone; Lutterotti, Andreas; Di Pauli, Franziska; Kuenz, Bettina; Schanda, Kathrin; Berger, Thomas; Reindl, Markus] Innsbruck Med Univ, Dept Clin Neurol, Innsbruck, Austria; [Aboul-Enein, Fahmy; Kristoferitsch, Wolfgang] SMZ Ost Donauspital, Dept Neurol, Vienna, Austria; [Khalil, Michael; Storch, Maria K.] Med Univ Graz, Dept Neurol, Graz, Austria; [Jarius, Sven] Univ Heidelberg, Dept Neurol, Div Mol Neuroimmunol, Heidelberg, Germany	Medical University of Innsbruck; Donauspital; Medical University of Graz; Ruprecht Karls University Heidelberg	Mader, S (corresponding author), Innsbruck Med Univ, Dept Clin Neurol, Innsbruck, Austria.	markus.reindl@i-med.ac.at	Reindl, Markus/ABE-5880-2020	Reindl, Markus/0000-0003-2817-1402; Mader, Simone/0000-0002-2844-9091; Berger, Thomas/0000-0001-5626-1144; Khalil, Michael/0000-0002-5350-3328	European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) [2007104]	European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)	Research grant (no. 2007104) of the interdisciplinary center for research and treatment (IFTZ), Innsbruck Medical University, Research Fellowship from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) to S.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; CRANE JM, 2009, NEUROSCIENCE; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; Cree B, 2008, CURR NEUROL NEUROSCI, V8, P427, DOI 10.1007/s11910-008-0066-2; Elkon K, 2008, NAT CLIN PRACT RHEUM, V4, P491, DOI 10.1038/ncprheum0895; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Graber DJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-22; Jacob A, 2008, ARCH NEUROL-CHICAGO, V65, P1443, DOI 10.1001/archneur.65.11.noc80069; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Jarius S, 2007, NEUROLOGY, V68, P1076, DOI 10.1212/01.wnl.0000256822.01222.bd; Jarius S, 2008, NAT CLIN PRACT NEURO, V4, P202, DOI 10.1038/ncpneuro0764; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Keegan M, 2002, NEUROLOGY, V58, P143, DOI 10.1212/WNL.58.1.143; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Takahashi T, 2006, TOHOKU J EXP MED, V210, P307, DOI 10.1620/tjem.210.307; Waters P, 2008, Int MS J, V15, P99; Weinshenker BG, 2006, ANN NEUROL, V59, P566, DOI 10.1002/ana.20770; Weinshenker BG, 2007, ARCH NEUROL-CHICAGO, V64, P899, DOI 10.1001/archneur.64.6.899; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, NEUROLOGIST, V13, P2, DOI 10.1097/01.nrl.0000250927.21903.f8; Wingerchuk DM, 2003, NEUROLOGY, V60, P848, DOI 10.1212/01.WNL.0000049912.02954.2C; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	31	122	128	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10455	10.1371/journal.pone.0010455	http://dx.doi.org/10.1371/journal.pone.0010455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463974	Green Published, Green Submitted, gold			2022-12-25	WOS:000277379400010
J	Pohjoismaki, JLO; Goffart, S; Taylor, RW; Turnbull, DM; Suomalainen, A; Jacobs, HT; Karhunen, PJ				Pohjoismaki, Jaakko L. O.; Goffart, Steffi; Taylor, Robert W.; Turnbull, Douglas M.; Suomalainen, Anu; Jacobs, Howard T.; Karhunen, Pekka J.			Developmental and Pathological Changes in the Human Cardiac Muscle Mitochondrial DNA Organization, Replication and Copy Number	PLOS ONE			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MULTIPLE MTDNA DELETIONS; TRANSCRIPTION FACTOR-A; AUTOSOMAL-DOMINANT; HELICASE TWINKLE; MUTATIONS; HEART; EXPRESSION; SKELETAL; FAILURE	Adult human heart mitochondrial DNA (mtDNA) has recently been shown to have a complex organization with abundant dimeric molecules, branched structures and four-way junctions. In order to understand the physiological significance of the heart-specific mtDNA maintenance mode and to find conditions that modify human heart mtDNA structure and replication, we analyzed healthy human heart of various ages as well as several different heart diseases, including ischemic heart disease, dilated as well as hypertrophic cardiomyopathies, and several mitochondrial disorders. By using one-and two-dimensional agarose gel electrophoresis, various enzymatic treatments and quantitative PCR we found that in human newborns heart mtDNA has a simple organization, lacking junctional forms and dimers. The adult-type branched forms are acquired in the early childhood, correlating with an increase in mtDNA copy number. Mitochondrial disorders involving either mutations in the mtDNA polymerase gamma (PolG alpha) or mtDNA helicase Twinkle, while having no obvious cardiac manifestation, show distinct mtDNA maintenance phenotypes, which are not seen in various types of diseased heart or in mitochondrial disorders caused by point mutations or large-scale deletions of mtDNA. The findings suggest a link between cardiac muscle development, mtDNA copy number, replication mode and topological organization. Additionally, we show that Twinkle might have a direct role in the maintenance of four-way junctions in human heart mtDNA.	[Pohjoismaki, Jaakko L. O.; Karhunen, Pekka J.] Univ Tampere, Sch Med, Dept Forens Med, FIN-33101 Tampere, Finland; [Goffart, Steffi; Jacobs, Howard T.] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Taylor, Robert W.; Turnbull, Douglas M.] Univ Newcastle, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Suomalainen, Anu] Univ Helsinki, Res Program Mol Neurol, Helsinki, Finland	Tampere University; Tampere University; Newcastle University - UK; University of Helsinki	Pohjoismaki, JLO (corresponding author), Univ Tampere, Sch Med, Dept Forens Med, FIN-33101 Tampere, Finland.	Jaakko.Pohjoismaki@uta.fi	Pohjoismaeki, Jaakko L. O./AAC-7995-2019; Goffart, Steffi/N-3597-2015; Jacobs, Howard T/G-2434-2011	Pohjoismaeki, Jaakko L. O./0000-0002-1185-3610; Goffart, Steffi/0000-0001-8491-1458; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Jacobs, Howard/0000-0003-1895-6003; Turnbull, Doug/0000-0002-8878-9901	EU; Wellcome Trust; Newcastle upon Tyne Hospitals NHS Trust; UK National Comissioning Group; Medical Research Council [G0700718B] Funding Source: researchfish	EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Newcastle upon Tyne Hospitals NHS Trust; UK National Comissioning Group; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JLP was funded by the EU's 7th Framework Program Collaborative Project, AtheroRemo. RWT and DMT acknowledge the continuing financial support of a Wellcome Trust Programme Grant and the Newcastle upon Tyne Hospitals NHS Trust. Mitochondrial diagnostic testing in Newcastle is funded by the UK National Comissioning Group to provide the "Rare Mitochondrial Disorders of Adults and Children'' Diagnostics Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backert S, 2000, CURR GENET, V37, P304, DOI 10.1007/s002940050532; Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x; BOGENHAGEN D, 1981, J MOL BIOL, V148, P77, DOI 10.1016/0022-2836(81)90236-9; Brunetti-Pierri N, 2008, NEUROPEDIATRICS, V39, P179, DOI 10.1055/s-0028-1093334; Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498; Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008; Goffart S, 2004, CARDIOVASC RES, V64, P198, DOI 10.1016/j.cardiores.2004.06.030; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Hyvarinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676; Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835; Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; Leipe DD, 2000, GENOME RES, V10, P5; Ling F, 2007, MOL CELL BIOL, V27, P1133, DOI 10.1128/MCB.00770-06; McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004; McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Pohjoismaki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Russell LK, 2005, J MOL CELL CARDIOL, V38, P81, DOI 10.1016/j.yjmcc.2004.10.010; Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SWALWELL H, 2008, EUR J HUM GENET, V18, P63; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392	36	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10426	10.1371/journal.pone.0010426	http://dx.doi.org/10.1371/journal.pone.0010426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454654	Green Published, gold, Green Submitted			2022-12-25	WOS:000277240300006
J	Sayre, EC; Li, LC; Kopec, JA; Esdaile, JM; Bar, S; Cibere, J				Sayre, Eric C.; Li, Linda C.; Kopec, Jacek A.; Esdaile, John M.; Bar, Sherry; Cibere, Jolanda			The Effect of Disease Site (Knee, Hip, Hand, Foot, Lower Back or Neck) on Employment Reduction Due to Osteoarthritis	PLOS ONE			English	Article							PREVALENCE; DISABILITY; PAIN; POPULATION; ARTHRITIS; WORK; DETERMINANTS; INDIVIDUALS; ASSOCIATION; PERSPECTIVE	Background: Osteoarthritis (OA) has a significant impact on individuals' ability to work. Our goal was to investigate the effects of the site of OA (knee, hip, hand, foot, lower back or neck) on employment reduction due to OA (EROA). Methods and Findings: This study involved a random sample of 6,000 patients with OA selected from the Medical Service Plan database in British Columbia, Canada. A total of 5,491 were alive and had valid addresses, and of these, 2,259 responded (response rate = 41%), from which 2,134 provided usable data. Eligible participants were 19 or older with physician diagnosed OA based on administrative data between 1992 and 2006. Data of 688 residents were used (mean age 62.1 years (27 to 86); 60% women). EROA had three levels: no reduction; reduced hours; and total cessation due to OA. The (log) odds of EROA was regressed on OA sites, adjusting for age, sex, education and comorbidity. Odds ratios (ORs) represented the effect predicting total cessation and reduced hours/total cessation. The strongest effect was found in lower back OA, with OR = 2.08 (95% CI: 1.47, 2.94), followed by neck (OR = 1.59; 95% CI: 1.11, 2.27) and knee (OR = 1.43; 95% CI: 1.02, 2.01). We found an interaction between sex and foot OA (men: OR = 1.94; 95% CI: 1.05, 3.59; women: OR = 0.89; 95% CI = 0.57, 1.39). No significant effect was found for hip OA (OR = 1.33) or hand OA (OR = 1.11). Limitations of this study included a modest response rate, the lack of an OA negative group, the use of administrative databases to identify eligible participants, and the use of patient self-reported data. Conclusions: After adjusting for socio-demographic variables, comorbidity, and other OA disease sites, we find that OA of the lower back, neck and knee are significant predictors for EROA. Foot OA is only significantly associated with EROA in males. For multi-site combinations, ORs are multiplicative. These findings may be used to guide resource allocation for future development/improvement of vocational rehabilitation programs for site-specific OA.	[Sayre, Eric C.; Li, Linda C.; Kopec, Jacek A.; Esdaile, John M.; Cibere, Jolanda] Arthrit Res Ctr Canada, Vancouver, BC, Canada; [Sayre, Eric C.; Kopec, Jacek A.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Esdaile, John M.; Cibere, Jolanda] Univ British Columbia, Dept Med, Div Rheumatol, Vancouver, BC V5Z 1M9, Canada; [Li, Linda C.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Bar, Sherry] British Columbia Minist Hlth Serv, Victoria, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Sayre, EC (corresponding author), Arthrit Res Ctr Canada, Vancouver, BC, Canada.	esayre@arthritisresearch.ca	Li, Linda C./P-8485-2015	Li, Linda C./0000-0001-6280-0511	Canadian Arthritis Network (CAN); Canadian Institutes of Health Research (CIHR); American College of Rheumatology Research and Education Foundation; Arthritis Society British Columbia; Yukon Division	Canadian Arthritis Network (CAN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); American College of Rheumatology Research and Education Foundation; Arthritis Society British Columbia; Yukon Division	Dr. Sayre is supported by a Canadian Arthritis Network (CAN) Postdoctoral Fellowship Award. Dr. Li is supported by a Canadian Institutes of Health Research (CIHR) New Investigator Award, and an American College of Rheumatology Research and Education Foundation Health Professional New Investigator Award. This study was supported by funding from the Arthritis Society British Columbia and Yukon Division (TAS;http://www.arthritis.ca/) and the Healthy Heart Society (http://www.healthyheart.bc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo L, 2008, ARTHRIT RHEUM-ARTHR, V59, P489, DOI 10.1002/art.23537; BADLEY EM, 1995, J RHEUMATOL, V43, pS19; Besse JL, 2006, REV CHIR ORTHOP, V92, P175, DOI 10.1016/S0035-1040(06)75703-8; Botha-Scheepers SA, 2004, ANN RHEUM DIS, V63, P72; BROSSEAU L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004259; Brosseau L, 2003, COCHRANE DB SYST REV, V2003, DOI DOI 10.1002/14651858.CD004522; Carreira AG, 2007, ANN RHEUM DIS, V66, P659; Chen JC, 2007, OCCUP ENVIRON MED, V64, P798, DOI 10.1136/oem.2006.030148; Dahaghin S, 2005, ANN RHEUM DIS, V64, P99, DOI 10.1136/ard.2003.017087; Gignac MAM, 2008, ARTHRIT RHEUM-ARTHR, V59, P1805, DOI 10.1002/art.24085; Gobelet C, 2007, DISABIL REHABIL, V29, P1331, DOI 10.1080/09638280701315094; Gravlee JR, 2007, AM FAM PHYSICIAN, V75, P342; Gupta S, 2005, RHEUMATOLOGY, V44, P1531, DOI 10.1093/rheumatology/kei049; Hammond A, 2008, BEST PRACT RES CL RH, V22, P435, DOI 10.1016/j.berh.2008.02.003; Heijbel B, 2005, J OCCUP REHABIL, V15, P167, DOI 10.1007/s10926-005-1216-x; Hirata S, 2006, J RHEUMATOL, V33, P939; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hostler D, 2009, PREHOSP EMERG CARE, V13, P256, DOI 10.1080/10903120802706195; JENNINGS MB, 1994, J AM PODIAT MED ASSN, V84, P348, DOI 10.7547/87507315-84-7-348; Kaptein SA, 2009, ARTHRIT RHEUM-ARTHR, V61, P605, DOI 10.1002/art.24427; Klobas L, 2006, ACTA ODONTOL SCAND, V64, P341, DOI 10.1080/00016350600825310; Lacaille D, 2005, ARTHRIT RHEUM-ARTHR, V53, P241, DOI 10.1002/art.21077; Levine B, 2009, CLIN ORTHOP RELAT R, V467, P1468, DOI 10.1007/s11999-009-0779-9; Li L, 2008, BRIT COLUMBIA OSTEOA; Menz HB, 2005, J AM PODIAT MED ASSN, V95, P573, DOI 10.7547/0950573; Min JL, 2005, ARTHRITIS RHEUM-US, V52, P1077, DOI 10.1002/art.20993; Muraki S, 2007, CALCIFIED TISSUE INT, V80, pS67; Palmer KT, 2005, OCCUP ENVIRON MED, V62, P54, DOI 10.1136/oem.2004.014977; Roos E, 2006, FOOT ANKLE INT, V27, P606, DOI 10.1177/107110070602700807; Rytter S, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-93; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; Viieland TPMV, 2009, CURR OPIN RHEUMATOL, V21, P183, DOI 10.1097/BOR.0b013e328324e6eb; Wilder FV, 2006, OSTEOARTHR CARTILAGE, V14, P953, DOI 10.1016/j.joca.2006.04.013	33	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10470	10.1371/journal.pone.0010470	http://dx.doi.org/10.1371/journal.pone.0010470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454665	Green Published, Green Submitted, gold			2022-12-25	WOS:000277240300030
J	Wolters, JC; Berntsson, RPA; Gul, N; Karasawa, A; Thunnissen, AMWH; Slotboom, DJ; Poolman, B				Wolters, Justina C.; Berntsson, Ronnie P-A.; Gul, Nadia; Karasawa, Akira; Thunnissen, Andy-Mark W. H.; Slotboom, Dirk-Jan; Poolman, Bert			Ligand Binding and Crystal Structures of the Substrate-Binding Domain of the ABC Transporter OpuA	PLOS ONE			English	Article							SOLUTES GLYCINE BETAINE; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; BACILLUS-SUBTILIS; CORYNEBACTERIUM-GLUTAMICUM; COMPATIBLE SOLUTES; IONIC-STRENGTH; PROLINE BETAINE; PROTEIN OPUAC; SPECIFICITY	The ABC transporter OpuA from Lactococcus lactis transports glycine betaine upon activation by threshold values of ionic strength. In this study, the ligand binding characteristics of purified OpuA in a detergent-solubilized state and of its substrate-binding domain produced as soluble protein (OpuAC) was characterized. Principal Findings: The binding of glycine betaine to purified OpuA and OpuAC (K(D) = 4-6 mu M) did not show any salt dependence or cooperative effects, in contrast to the transport activity. OpuAC is highly specific for glycine betaine and the related proline betaine. Other compatible solutes like proline and carnitine bound with affinities that were 3 to 4 orders of magnitude lower. The low affinity substrates were not noticeably transported by membrane-reconstituted OpuA. OpuAC was crystallized in an open (1.9 angstrom) and closed-liganded (2.3 angstrom) conformation. The binding pocket is formed by three tryptophans (Trp-prism) coordinating the quaternary ammonium group of glycine betaine in the closed-liganded structure. Even though the binding site of OpuAC is identical to that of its B. subtilis homolog, the affinity for glycine betaine is 4-fold higher. Conclusions: Ionic strength did not affect substrate binding to OpuA, indicating that regulation of transport is not at the level of substrate binding, but rather at the level of translocation. The overlap between the crystal structures of OpuAC from L. lactis and B. subtilis, comprising the classical Trp-prism, show that the differences observed in the binding affinities originate from outside of the ligand binding site.	[Wolters, Justina C.; Berntsson, Ronnie P-A.; Gul, Nadia; Karasawa, Akira; Slotboom, Dirk-Jan; Poolman, Bert] Univ Groningen, Dept Biochem, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst,Netherland, Groningen, Netherlands; [Thunnissen, Andy-Mark W. H.] Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	University of Groningen; University of Groningen	Wolters, JC (corresponding author), Univ Groningen, Dept Biochem, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst,Netherland, Groningen, Netherlands.	b.poolman@rug.nl	Berntsson, Ronnie/J-3535-2019; Institute, Zernike/W-7033-2019; Karasawa, Akira/ABF-4128-2021; Thunnissen, Andy-Mark/A-1777-2010; Berntsson, Ronnie/K-1326-2012; Poolman, Bert/D-1882-2012; Karasawa, Akira/ABC-9782-2021	Berntsson, Ronnie/0000-0001-6848-322X; Thunnissen, Andy-Mark/0000-0002-1915-9850; 	Marie Curie Early Stage Training (EST); Netherlands Organisation for Scientific research (NWO) [700-56-302]; Vidi grant; EU; Netherlands Proteomics Centre (NPC)	Marie Curie Early Stage Training (EST)(European Commission); Netherlands Organisation for Scientific research (NWO)(Netherlands Organization for Scientific Research (NWO)); Vidi grant; EU(European Commission); Netherlands Proteomics Centre (NPC)	This work was supported by grants from Marie Curie Early Stage Training (EST, to RB), The Netherlands Organisation for Scientific research (NWO, Chemical Sciences Top Subsidy to BP; grant number 700-56-302; Vidi grant to DJS), EU (EMEP and EDICT programs) and the Netherlands Proteomics Centre (NPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Biemans-Oldehinkel E, 2003, EMBO J, V22, P5983, DOI 10.1093/emboj/cdg581; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; BOCH J, 1994, J BACTERIOL, V176, P5364; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chen CL, 2007, J BACTERIOL, V189, P6901, DOI 10.1128/JB.00763-07; Culham DE, 2003, BIOCHEMISTRY-US, V42, P11815, DOI 10.1021/bi034939j; Culham DE, 2008, BIOCHEMISTRY-US, V47, P8176, DOI 10.1021/bi800794z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horn C, 2006, J MOL BIOL, V357, P592, DOI 10.1016/j.jmb.2005.12.085; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Kappes RM, 1998, MICROBIOL-UK, V144, P83, DOI 10.1099/00221287-144-1-83; Lanfermeijer FC, 1999, BIOCHEMISTRY-US, V38, P14440, DOI 10.1021/bi9914715; MacMillan SV, 1999, BBA-BIOMEMBRANES, V1420, P30, DOI 10.1016/S0005-2736(99)00085-1; Magnusson U, 2004, J BIOL CHEM, V279, P8747, DOI 10.1074/jbc.M311890200; Mahmood NABN, 2006, J BIOL CHEM, V281, P29830, DOI 10.1074/jbc.M604907200; Mahmood NABN, 2009, J BIOL CHEM, V284, P14368, DOI 10.1074/jbc.M901238200; MAO B, 1982, J BIOL CHEM, V257, P1131; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monnet V, 2003, CELL MOL LIFE SCI, V60, P2100, DOI 10.1007/s00018-003-3054-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oswald C, 2008, J BIOL CHEM, V283, P32848, DOI 10.1074/jbc.M806021200; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Peter H, 1996, J BACTERIOL, V178, P5229, DOI 10.1128/jb.178.17.5229-5234.1996; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V742, P16, DOI 10.1016/0167-4838(83)90353-9; Romeo Y, 2007, FEBS LETT, V581, P3387, DOI 10.1016/j.febslet.2007.06.037; Schiefner A, 2004, J BIOL CHEM, V279, P48270, DOI 10.1074/jbc.M403540200; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Schiller D, 2004, FEBS LETT, V563, P108, DOI 10.1016/S0014-5793(04)00279-0; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Smits SHJ, 2008, J BACTERIOL, V190, P5663, DOI 10.1128/JB.00346-08; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Van der Heide T, 2000, J BACTERIOL, V182, P203, DOI 10.1128/JB.182.1.203-206.2000; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	47	34	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10361	10.1371/journal.pone.0010361	http://dx.doi.org/10.1371/journal.pone.0010361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454456	gold, Green Published, Green Submitted			2022-12-25	WOS:000277240100004
J	Jeong, H; Bae, S; An, SY; Byun, MR; Hwang, JH; Yaffe, MB; Hong, JH; Hwang, ES				Jeong, Hana; Bae, Sujung; An, Su Yeon; Byun, Mi Ran; Hwang, Jun-Ha; Yaffe, Michael B.; Hong, Jeong-Ho; Hwang, Eun Sook			TAZ as a novel enhancer of MyoD-mediated myogenic differentiation	FASEB JOURNAL			English	Article						myogenin; myoblast; mesenchymal stem cells; MCK	MUSCLE SATELLITE CELLS; MESENCHYMAL STEM-CELLS; HELIX-LOOP-HELIX; MOUSE SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; WW DOMAIN; HISTONE DEACETYLASES; TEMPORAL EXPRESSION; GENE-EXPRESSION; PROTEINS	Myoblast differentiation is indispensable for skeletal muscle formation and is governed by the precisely coordinated regulation of a series of transcription factors, including MyoD and myogenin, and transcriptional coregulators. TAZ (transcriptional coactivator with PDZ-binding motif) has been characterized as a modulator of mesenchymal stem cell differentiation into osteoblasts and adipocytes through its regulation of lineage-specific master transcription factors. In this study, we investigated whether TAZ affects myoblast differentiation, which is one of the differentiated lineages of mesenchymal stem cells. Ectopic overexpression of TAZ in myoblasts increases myogenic gene expression in a MyoD-dependent manner and hastens myofiber formation, whereas TAZ knockdown delays myogenic differentiation. In addition, enforced coexpression of TAZ and MyoD in fibroblasts accelerates MyoD-induced myogenic differentiation. TAZ physically interacts with MyoD through the WW domain and activates MyoD-dependent gene transcription. TAZ additionally enhances the interaction of MyoD with the myogenin gene promoter. These results strongly suggest that TAZ functions as a novel transcriptional modulator of myogenic differentiation by promoting MyoD-mediated myogenic gene expression.-Jeong, H., Bae, S., An, S. Y., Byun, M. R., Hwang, J.-H., Yaffe, M. B., Hong, J.-H., Hwang, E. S. TAZ as a novel enhancer of MyoD-mediated myogenic differentiation. FASEB J. 24, 3310-3320 (2010). www.fasebj.org	[Jeong, Hana; Bae, Sujung; An, Su Yeon; Hong, Jeong-Ho; Hwang, Eun Sook] Ewha Womans Univ, Coll Pharm, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Jeong, Hana; Bae, Sujung; An, Su Yeon; Hong, Jeong-Ho; Hwang, Eun Sook] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea; [Byun, Mi Ran; Hwang, Jun-Ha] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Yaffe, Michael B.] MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Ewha Womans University; Ewha Womans University; Korea University; Massachusetts Institute of Technology (MIT)	Hwang, ES (corresponding author), Ewha Womans Univ, Coll Pharm, Div Life & Pharmaceut Sci, Sci Bldg C206,11-1 Daehyun Dong, Seoul 120750, South Korea.	jh_hong@korea.ac.kr; eshwang@ewha.ac.kr			Ministry of Education, Science, and Technology (MEST) [2009-0073324, R01-2007-000-11173-0, R15-2006-020]; MEST [M10748000286-07N4800-28610]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Andrew B. Lassar (Harvard University, Boston, MA, USA) for generous gifts of MCK-Luc, myogenin-Luc, MyoD, and myogenin expression plasmids. The authors also thank Dr. Thomas Benjamin (Harvard University) for sharing TAZ KO MEFs. This work was supported by the Basic Science Research Program (2009-0073324 to E. S. H., R01-2007-000-11173-0 to J.H.H.) and the National Core Research Center program (R15-2006-020 to E. S. H.) funded by the Ministry of Education, Science, and Technology (MEST) and also supported by a grant from the Research Program for New Drug Target Discovery (M10748000286-07N4800-28610 to J.H.H.) funded by MEST. The authors declare that they have no conflict of interest.	Arnold HH, 2000, CURR TOP DEV BIOL, V48, P129; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; BISCHOFF R, 1990, DEVELOPMENT, V109, P943; BISCHOFF R, 1994, DEV DYNAM, V201, P41, DOI 10.1002/aja.1002010105; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Cooper RN, 1999, J CELL SCI, V112, P2895; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Di Palma T, 2009, EXP CELL RES, V315, P162, DOI 10.1016/j.yexcr.2008.10.016; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; Jeon ES, 2006, J CELL SCI, V119, P4994, DOI 10.1242/jcs.03281; Jung H, 2009, BIOCHEM PHARMACOL, V78, P1323, DOI 10.1016/j.bcp.2009.07.001; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; KARPATI G, 1982, MUSCLE NERVE, V5, P369, DOI 10.1002/mus.880050506; Kim MR, 2009, STEM CELLS, V27, P191, DOI 10.1634/stemcells.2008-0363; Kitagawa M, 2007, BIOCHEM BIOPH RES CO, V361, P1022, DOI 10.1016/j.bbrc.2007.07.129; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MCGEACHIE JK, 1987, CELL TISSUE RES, V248, P125, DOI 10.1007/BF01239972; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; PRICE HM, 1964, LAB INVEST, V13, P1264; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; SMITH CK, 1994, J CELL PHYSIOL, V159, P379, DOI 10.1002/jcp.1041590222; SMITH TH, 1994, J CELL BIOL, V127, P95, DOI 10.1083/jcb.127.1.95; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Tan MY, 2009, BIOMATERIALS, V30, P3234, DOI 10.1016/j.biomaterials.2009.02.013; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Warren GL, 2007, J PHYSIOL-LONDON, V582, P825, DOI 10.1113/jphysiol.2007.132373; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Yoon YS, 2005, BIOL CELL, V97, P253, DOI 10.1042/BC20040099; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3	64	80	84	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2010	24	9					3310	3320		10.1096/fj.09-151324	http://dx.doi.org/10.1096/fj.09-151324			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20466877				2022-12-25	WOS:000281446400019
J	Mirza, S; Chen, JL; Wen, B; Ewens, CL; Dai, J; Murphy, JM; Young, IG				Mirza, Shamaruh; Chen, Jinglong; Wen, Bin; Ewens, Cameron L.; Dai, Jin; Murphy, James M.; Young, Ian G.			Two Modes of beta-Receptor Recognition Are Mediated by Distinct Epitopes on Mouse and Human Interleukin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; HUMAN GM-CSF; COMPLETE EXTRACELLULAR DOMAIN; HIGH-AFFINITY BINDING; IL-5 RECEPTORS; ALPHA-CHAIN; EXPRESSION CLONING; LIGAND-BINDING; SUBUNIT; ACTIVATION	The cytokine interleukin-3 (IL-3) is a critical regulator of inflammation and immune responses in mammals. IL-3 exerts its effects on target cells via receptors comprising an IL-3-specific alpha-subunit and common beta-subunit (beta c; shared with IL-5 and granulocyte-macrophage colony-stimulating factor) or a beta-subunit that specifically binds IL-3 (beta(IL-3); present in mice but not humans). We recently identified two splice variants of the alpha-subunit of the IL-3 receptor (IL-3R alpha) that are relevant to hematopoietic progenitor cell differentiation or proliferation: the full length ("SP1" isoform) and a novel isoform (denoted "SP2") lacking the N-terminal Ig-like domain. Although our studies demonstrated that each mouse IL-3 (mIL-3) R alpha isoform can direct mIL-3 binding to two distinct sites on the beta(IL-3) sub-unit, it has remained unclear which residues in mIL-3 itself are critical to the two modes of beta(IL-3) recognition and whether the human IL-3R alpha SP1 and SP2 orthologs similarly instruct human IL-3 binding to two distinct sites on the human beta c subunit. Herein, we describe the identification of residues clustering around the highly conserved A-helix residue, Glu(23), in the mIL-3 A- and C-helices as critical for receptor binding and growth stimulation via the beta(IL-3) and mIL-3R alpha SP2 subunits, whereas an overlapping cluster was required for binding and activation of beta(IL-3) in the presence of mIL-3R alpha SP1. Similarly, our studies of human IL-3 indicate that two different modes of beta c binding are utilized in the presence of the hIL-3R alpha SP1 or SP2 isoforms, suggesting a possible conserved mechanism by which the relative orientations of receptor subunits are modulated to achieve distinct signaling outcomes.	[Murphy, James M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Mirza, Shamaruh; Chen, Jinglong; Wen, Bin; Ewens, Cameron L.; Dai, Jin; Young, Ian G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Biol Struct, Canberra, ACT 0200, Australia	Walter & Eliza Hall Institute; Australian National University; John Curtin School of Medical Research	Murphy, JM (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	jamesm@wehi.edu.au; Ian.Young@anu.edu.au	Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia.	Bagley CJ, 1996, J BIOL CHEM, V271, P31922, DOI 10.1074/jbc.271.50.31922; BARRY SC, 1994, J BIOL CHEM, V269, P8488; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Chen JL, 2009, J BIOL CHEM, V284, P5763, DOI 10.1074/jbc.M808197200; CORNELIS S, 1995, EMBO J, V14, P3395, DOI 10.1002/j.1460-2075.1995.tb07345.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; GRABER P, 1995, J BIOL CHEM, V270, P15762, DOI 10.1074/jbc.270.26.15762; Gustin SE, 2001, EUR J BIOCHEM, V268, P2905, DOI 10.1046/j.1432-1327.2001.02178.x; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; LOPEZ AF, 1992, EMBO J, V11, P909, DOI 10.1002/j.1460-2075.1992.tb05129.x; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; Mirza S, 2010, BIOCHEM J, V426, P307, DOI 10.1042/BJ20091745; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Murphy JM, 2008, CYTOKINE, V42, P234, DOI 10.1016/j.cyto.2008.02.010; Murphy JM, 2010, GROWTH FACTORS, V28, P104, DOI 10.3109/08977190903443048; Murphy JM, 2004, J BIOL CHEM, V279, P26500, DOI 10.1074/jbc.M402705200; Murphy JM, 2003, J BIOL CHEM, V278, P10572, DOI 10.1074/jbc.M211664200; OLINS PO, 1995, J BIOL CHEM, V270, P23754, DOI 10.1074/jbc.270.40.23754; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; TAKAKI S, 1993, J EXP MED, V177, P1523, DOI 10.1084/jem.177.6.1523; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; TAVERNIER J, 1995, P NATL ACAD SCI USA, V92, P5194, DOI 10.1073/pnas.92.11.5194; Vollmer P, 1999, EUR J BIOCHEM, V263, P438, DOI 10.1046/j.1432-1327.1999.00511.x; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; WOODCOCK JM, 1994, EMBO J, V13, P5176, DOI 10.1002/j.1460-2075.1994.tb06848.x; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999; Yao SG, 2010, BIOMOL NMR ASSIGN, V4, P73, DOI 10.1007/s12104-010-9213-1; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	41	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22370	22381		10.1074/jbc.M110.117465	http://dx.doi.org/10.1074/jbc.M110.117465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472554	Green Published, hybrid			2022-12-25	WOS:000279702200050
J	Nguyen, TT; Ogbi, M; Yu, QL; Fishman, JB; Thomas, W; Harvey, BJ; Fulton, D; Johnson, JA				Nguyen, Tiffany T.; Ogbi, Mourad; Yu, Qilin; Fishman, Jordan B.; Thomas, Warren; Harvey, Brian J.; Fulton, David; Johnson, John A.			Modulation of the Protein Kinase C delta Interaction with the "d" Subunit of F1F0-ATP Synthase in Neonatal Cardiac Myocytes DEVELOPMENT OF CELL-PERMEABLE, MITOCHONDRIALLY TARGETED INHIBITOR AND FACILITATOR PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY-METABOLISM; IN-VIVO; INTRACELLULAR RECEPTOR; EPSILON INTERACTS; OXIDASE ACTIVITY; HEART; PKC; REPERFUSION; ISCHEMIA; DOMAIN	The F1F0-ATP synthase provides similar to 90% of cardiac ATP, yet little is known regarding its regulation under normal or pathological conditions. Previously, we demonstrated that protein kinase C delta(PKC delta) inhibits F1F0 activity via an interaction with the "d" subunit of F1F0-ATP synthase (dF(1)F(0)) in neonatal cardiac myocytes (NCMs) (Nguyen, T., Ogbi, M., and Johnson, J.A. (2008) J. Biol. Chem. 283, 29831-29840). We have now identified a dF(1)F(0)-derived peptide (NH2-(2)AGRKLALKTIDWVSF(16-)COOH) that inhibits PKC delta binding to dF(1)F(0) in overlay assays. We have also identified a second dF(1)F(0)-derived peptide (NH2-(111)RVREYEKQLEKIKNMI(126)-COOH) that facilitates PKC delta binding to dF(1)F(0). Incubation of NCMs with versions of these peptides containing HIV-Tat protein transduction and mammalian mitochondrial targeting sequences resulted in their delivery into mitochondria. Preincubation of NCMs, with 10 nM extracellular concentrations of the mitochondrially targeted PKC delta-dF(1)F(0) interaction inhibitor, decreased 100 nM 4 beta-phorbol 12-myristate 13-acetate (4 beta-PMA)-induced co-immuno-precipitation of PKC delta with dF(1)F(0) by 50 +/- 15% and abolished the 30 nM 4 beta-PMA-induced inhibition of F1F0-ATPase activity. A scrambled sequence (inactive) peptide, which contained HIV-Tat and mitochondrial targeting sequences, was without effect. In contrast, the cell-permeable, mitochondrially targeted PKC delta-dF(1)F(0) facilitator peptide by itself induced the PKC delta-dF(1)F(0) co-immunoprecipitation and inhibited F1F0-ATPase activity. In in vitro PKC add-back experiments, the PKC delta-F1F0 inhibitor blocked PKC delta-mediated inhibition of F1F0-ATPase activity, whereas the facilitator induced inhibition. We have developed the first cell-permeable, mitochondrially targeted modulators of the PKC delta-dF(1)F(0) interaction in NCMs. These novel peptides will improve our understanding of cardiac F1F0 regulation and may have potential as therapeutics to attenuate cardiac injury.	[Nguyen, Tiffany T.; Ogbi, Mourad; Yu, Qilin; Fulton, David; Johnson, John A.] Med Coll Georgia, Sch Med, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Nguyen, Tiffany T.; Ogbi, Mourad; Yu, Qilin; Fulton, David; Johnson, John A.] Med Coll Georgia, Program Regenerat Med, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Fulton, David] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Fishman, Jordan B.] 21st Century Biochem Inc, Marlborough, MA 01752 USA; [Thomas, Warren; Harvey, Brian J.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Mol Med, Dublin 9, Ireland	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Royal College of Surgeons - Ireland	Johnson, JA (corresponding author), 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	jjohnson@mail.mcg.edu	Thomas, Warren/A-5477-2010; Harvey, Brian J/A-5120-2010; Harvey, Brian/AAJ-4085-2020	Harvey, Brian J/0000-0002-7388-8034; Harvey, Brian/0000-0002-7388-8034; Thomas, Warren/0000-0003-2706-1770	NHLBI, National Institutes of Health [R01HL76805]; American Heart Association [GSE0855285E, PRE2060572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076805] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL76805 from NHLBI. This work was also supported by The American Heart Association Grant GSE0855285E ( to J.A.J.) and American Heart Association Greater Southeast Affiliate Predoctoral Fellowship PRE2060572 ( to T.T.N.).	Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Buchanan SK, 1996, BIOCHEM J, V318, P343, DOI 10.1042/bj3180343; Carbajo RJ, 2005, J MOL BIOL, V351, P824, DOI 10.1016/j.jmb.2005.06.012; Chauhan A, 2007, J CONTROL RELEASE, V117, P148, DOI 10.1016/j.jconrel.2006.10.031; Chen L, 2001, CHEM BIOL, V8, P1123, DOI 10.1016/S1074-5521(01)00076-X; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; Churchill EN, 2009, TRENDS ENDOCRIN MET, V20, P25, DOI 10.1016/j.tem.2008.10.002; Das AM, 2003, MOL GENET METAB, V79, P71, DOI 10.1016/S1096-7192(03)00069-6; Di Pancrazio F, 2004, BBA-BIOENERGETICS, V1659, P52, DOI 10.1016/j.bbabio.2004.07.009; Gaballo A, 2002, CURR PROTEIN PEPT SC, V3, P451, DOI 10.2174/1389203023380558; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Green DW, 2000, BBA-BIOENERGETICS, V1458, P343, DOI 10.1016/S0005-2728(00)00085-2; Guo DH, 2007, AM J PHYSIOL-HEART C, V293, pH2219, DOI 10.1152/ajpheart.01306.2006; Gustafsson AB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; Inagaki K, 2003, CIRCULATION, V108, P2304, DOI 10.1161/01.CIR.0000101682.24138.36; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; JOHNSON JA, 1995, CIRC RES, V76, P654, DOI 10.1161/01.RES.76.4.654; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; Liang BT, 1997, AM J PHYSIOL-HEART C, V273, pH847, DOI 10.1152/ajpheart.1997.273.2.H847; Malhotra A, 2005, AM J PHYSIOL-HEART C, V289, pH1343, DOI 10.1152/ajpheart.01200.2004; Mangat R, 2006, AM J PHYSIOL-HEART C, V291, pH854, DOI 10.1152/ajpheart.01205.2005; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH946, DOI 10.1152/ajpheart.00878.2003; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH937, DOI 10.1152/ajpheart.00877.2003; Mochly-Rosen D, 2000, CIRC RES, V86, P1173; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; MOCHLYROSEN D, 1987, J BIOL CHEM, V262, P2291; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Murriel CL, 2004, J BIOL CHEM, V279, P47985, DOI 10.1074/jbc.M405071200; Murriel CL, 2003, ARCH BIOCHEM BIOPHYS, V420, P246, DOI 10.1016/j.abb.2003.08.038; Neubauer S, 1999, J MOL CELL CARDIOL, V31, P1845, DOI 10.1006/jmcc.1999.1016; NGUYEN T, 2007, CURR ENZ INHIB, V3, P143; Nguyen T, 2008, J BIOL CHEM, V283, P29831, DOI 10.1074/jbc.M801642200; Ogbi M, 2006, BIOCHEM J, V393, P191, DOI 10.1042/BJ20050757; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; Roe MT, 2008, CIRCULATION, V117, P886, DOI 10.1161/CIRCULATIONAHA.107.759167; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Schechtman D, 2002, METHOD ENZYMOL, V345, P470; Schechtman Deborah, 2003, Methods Mol Biol, V233, P345; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006; Takeo S, 1999, CARDIOVASC RES, V43, P32, DOI 10.1016/S0008-6363(99)00079-6; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Vogt AM, 2005, MOL CELL BIOCHEM, V278, P223, DOI 10.1007/s11010-005-7576-x; VUORINEN K, 1995, CIRCULATION, V91, P2810, DOI 10.1161/01.CIR.91.11.2810; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Wang YG, 2001, CIRCULATION, V104, P85, DOI 10.1161/01.CIR.104.1.85; Ylitalo K, 2001, BBA-BIOENERGETICS, V1504, P329, DOI 10.1016/S0005-2728(00)00261-9; Zanotti F, 2004, J BIOENERG BIOMEMBR, V36, P447, DOI 10.1023/B:JOBB.0000047327.68173.9b	53	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22164	22173		10.1074/jbc.M109.077578	http://dx.doi.org/10.1074/jbc.M109.077578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460381	Green Published, hybrid			2022-12-25	WOS:000279702200029
J	Sanggaard, KW; Scavenius, C; Rasmussen, AJ; Wisniewski, HG; Thgersen, IB; Enghild, JJ				Sanggaard, Kristian W.; Scavenius, Carsten; Rasmussen, Anna Julie; Wisniewski, Hans-Georg; Thgersen, Ida B.; Enghild, Jan J.			The TSG-6/HC2-mediated Transfer Is a Dynamic Process Shuffling Heavy Chains between Glycosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; HYALURONAN-BINDING PROTEINS; COVALENTLY CROSS-LINKS; TRYPSIN-INHIBITOR; EXTRACELLULAR-MATRIX; STIMULATED GENE-6; BIKUNIN PROTEINS; TSG-6; ARTHRITIS; COMPLEX	The heavy chain (HC) subunits of the bikunin proteins are covalently attached to a single chondroitin sulfate (CS) chain originating from bikunin and can be transferred to different hyaluronan (HA) molecules by TSG-6/HC2. In the present study, we demonstrate that HCs transferred to HA may function as HC donors in subsequent transfer reactions, and we show that the CS of bikunin may serve as an HC acceptor, analogous to HA. Our data suggest that TSG-6/HC2 link HCs randomly on the CS chain of bikunin, in contrast to the ordered attachment observed during the biosynthesis. Moreover, the results show that the transfer activity is indifferent to the new HC position, and the relocated HCs are thus prone to further TSG-6/HC2 induced transfer reactions. The data suggest that HCs may be transferred directly from HA to HA without the involvement of the bikunin CS chain. The results demonstrate reversibility of the interactions between HCs and glycosaminoglycans and suggest that a dynamic shuffling of the HCs occur in vivo.	[Sanggaard, Kristian W.; Scavenius, Carsten; Rasmussen, Anna Julie; Thgersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark; [Sanggaard, Kristian W.; Scavenius, Carsten; Rasmussen, Anna Julie; Thgersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Wisniewski, Hans-Georg] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Aarhus University; Aarhus University; New York University	Enghild, JJ (corresponding author), Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Gustav Wiedsvej 10C, DK-8000 Aarhus C, Denmark.	jje@mb.au.dk	Scavenius, Carsten/Q-5941-2017	Scavenius, Carsten/0000-0002-4304-0681; Enghild, Jan Johannes/0000-0001-9292-9172	Carlsberg Foundation; Danish Council for Independent Research, Medical Science	Carlsberg Foundation(Carlsberg Foundation); Danish Council for Independent Research, Medical Science(Det Frie Forskningsrad (DFF))	This work was supported by grants from The Carlsberg Foundation and grants from the Danish Council for Independent Research, Medical Science.	AKO H, 1972, BIOCHEM BIOPH RES CO, V47, P1402, DOI 10.1016/0006-291X(72)90228-8; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Chi LL, 2008, J AM CHEM SOC, V130, P2617, DOI 10.1021/ja0778500; Colon E, 2009, J BIOL CHEM, V284, P2320, DOI 10.1074/jbc.M807183200; Day AJ, 1999, BIOCHEM SOC T, V27, P115, DOI 10.1042/bst0270115; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; GEBHARD W, 1990, BIOL CHEM H-S, V371, P13; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; MORELLE W, 1994, EUR J BIOCHEM, V221, P881, DOI 10.1111/j.1432-1033.1994.tb18803.x; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; SAYERS CA, 1980, BIOCHEM J, V189, P255, DOI 10.1042/bj1890255; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; THOGERSEN IB, 1995, J BIOL CHEM, V270, P18700; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	37	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21988	21993		10.1074/jbc.M109.041046	http://dx.doi.org/10.1074/jbc.M109.041046			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463016	hybrid, Green Published			2022-12-25	WOS:000279702200011
J	Beilke, S; Oswald, F; Genze, F; Wirth, T; Adler, G; Wagner, M				Beilke, S.; Oswald, F.; Genze, F.; Wirth, T.; Adler, G.; Wagner, M.			The zinc-finger protein KCMF1 is overexpressed during pancreatic cancer development and downregulation of KCMF1 inhibits pancreatic cancer development in mice	ONCOGENE			English	Article						cancer; pancreas; KCMF1; gene trap mice; mouse model; tumor progression	TRANSFORMING-GROWTH-FACTOR; EWINGS-SARCOMA; FACTOR-ALPHA; CYCLIN D1; IN-VIVO; CELLS; MOUSE; EXPRESSION; ADENOCARCINOMA; TUMORIGENESIS	Potassium channel modulatory factor 1 (KCMF1) was found upregulated in a differential screen in the metaplastic epithelium in the pancreas of transforming growth factor (TGF)-alpha transgenic mice. Expression analysis indicated broad overexpression in human cancer tissues. Therefore, we investigated the hypothesis that KCMF1 promotes metaplastic changes and tumor development. KCMF1 represents an evolutionarily highly conserved protein with a 95% identity between human and zebrafish. KCMF1 is expressed during embryonic development and in the majority of adult tissues investigated. Upregulation of nuclear KCMF1 expression is evident in preneoplastic lesions and in several epithelial malignancies, such as pancreatic cancer in mice and humans. In cell culture and in the chicken chorioallantoic membrane model, KCMF1 enhances proliferation, migration and invasion of HEK-293 and Panc1 cells. In crossbreeding experiments, KCMF1-knockdown gene trap mice showed a reduced number and size of premalignant lesions and absence of pancreatic cancer formation in TGF-alpha transgenic mice. This effect is related to the decreased expression of G1 to S cell-cycle regulators such as cyclin D and cyclin-dependent kinase (CDK) 4. Our data support the hypothesis that KCMF1 mediates pro-oncogenic functions in vitro and in vivo and downregulation of KCMF1 results in the inhibition of pancreatic cancer formation in mice. These effects are mediated through downregulation of cell-cycle control genes such as cyclin D and CDK4. Oncogene (2010) 29, 4058-4067; doi:10.1038/onc.2010.156; published online 17 May 2010	[Beilke, S.; Oswald, F.; Adler, G.; Wagner, M.] Univ Hosp Ulm, Dept Internal Med 1, Ctr Internal Med, D-89083 Ulm, Baden Wuerttemb, Germany; [Genze, F.] Univ Ulm, Inst Pharmacol Nat Prod, Ulm, Germany; [Wirth, T.] Univ Ulm, Dept Physiol Chem, Ulm, Germany	Ulm University; Ulm University; Ulm University	Wagner, M (corresponding author), Univ Hosp Ulm, Dept Internal Med 1, Ctr Internal Med, Albert Einstein Allee 23, D-89083 Ulm, Baden Wuerttemb, Germany.	martin.wagner@uni-ulm.de	Oswald, Franz/AAO-9584-2020; Wirth, Thomas/X-7172-2019		Deutsche Forschungsgemeinschaft [SFB518: A10, A18, B23]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Jessica Wegele and Uschi Mohnle for excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (SFB518: A10 to MW, A18 to FO and B23 to TW). We thank all the participating members of the SFB518 for helpful discussions, advices and materials.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; AMBROS IM, 1991, CANCER, V67, P1886, DOI 10.1002/1097-0142(19910401)67:7<1886::AID-CNCR2820670712>3.0.CO;2-U; BARTON CM, 1991, J PATHOL, V163, P111, DOI 10.1002/path.1711630206; CALDAS C, 1994, CANCER RES, V54, P3568; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; de Alava E, 2007, CLIN TRANSL ONCOL, V9, P130, DOI 10.1007/s12094-007-0027-2; Ghaneh P, 2006, BEST PRACT RES CL GA, V20, P383, DOI 10.1016/j.bpg.2005.11.008; Gillett C, 1996, INT J CANCER, V69, P92, DOI 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.3.CO;2-I; Hahn SA, 1996, CANCER RES, V56, P490; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Jang JH, 2004, FEBS LETT, V578, P21, DOI 10.1016/j.febslet.2004.10.071; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Khasawneh J, 2009, P NATL ACAD SCI USA, V106, P3354, DOI 10.1073/pnas.0802864106; Kreppel M, 2006, ONCOGENE, V25, P2795, DOI 10.1038/sj.onc.1209300; Kuefer R, 2004, BRIT J CANCER, V90, P535, DOI 10.1038/sj.bjc.6601510; Li ZX, 2003, BIOCHEM BIOPH RES CO, V306, P623, DOI 10.1016/S0006-291X(03)00875-1; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Mendez J, 2009, CRIT REV BIOCHEM MOL, V44, P343, DOI 10.1080/10409230903232618; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Nakhai LA, 2007, EVID-BASED COMPL ALT, V4, P43, DOI 10.1093/ecam/nel051; SANDGREN EP, 1993, MOL CELL BIOL, V13, P320, DOI 10.1128/MCB.13.1.320; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tosh D, 2002, NAT REV MOL CELL BIO, V3, P187, DOI 10.1038/nrm761; Wagner M, 1998, GASTROENTEROLOGY, V115, P1254, DOI 10.1016/S0016-5085(98)70098-8; Wagner M, 1998, GASTROENTEROLOGY, V114, P798, DOI 10.1016/S0016-5085(98)70594-3; Wagner M, 2002, GASTROENTEROLOGY, V122, P1898, DOI 10.1053/gast.2002.33594; Wagner M, 2001, GENE DEV, V15, P286, DOI 10.1101/gad.184701; Yamamoto M, 2006, MOL CARCINOGEN, V45, P901, DOI 10.1002/mc.20204	33	13	16	3	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 15	2010	29	28					4058	4067		10.1038/onc.2010.156	http://dx.doi.org/10.1038/onc.2010.156			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	625JW	20473331				2022-12-25	WOS:000279892400006
J	Dean, JL; Thangavel, C; McClendon, AK; Reed, CA; Knudsen, ES				Dean, J. L.; Thangavel, C.; McClendon, A. K.; Reed, C. A.; Knudsen, E. S.			Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure	ONCOGENE			English	Article						breast cancer; CDK4/6; RB; PD-0332991; cyclin D; E2F	CELL-CYCLE; RETINOBLASTOMA GENE; ESTROGEN-RECEPTOR; DEPENDENT KINASES; LUNG-CANCER; EXPRESSION; PROTEIN; RB; PHOSPHORYLATION; OVEREXPRESSION	A hallmark of cancer is the deregulation of cell-cycle machinery, ultimately facilitating aberrant proliferation that fuels tumorigenesis and disease progression. Particularly, in breast cancers, cyclin D1 has a crucial role in the development of disease. Recently, a highly specific inhibitor of CDK4/6 activity (PD-0332991) has been developed that may have efficacy in the treatment of breast cancer. To interrogate the utility of PD-0332991 in treating breast cancers, therapeutic response was evaluated on a panel of breast cancer cell lines. These analyses showed that the chronic loss of Rb is specifically associated with evolution to a CDK4/6-independent state and, ultimately, resistance to PD-0332991. However, to interrogate the functional consequence of Rb directly, knockdown experiments were performed in models that represent immortalized mammary epithelia and multiple subtypes of breast cancer. These studies showed a highly specific role for Rb in mediating the response to CDK4/6 inhibition that was dependent on transcriptional repression manifest through E2F, and the ability to attenuate CDK2 activity. Acquired resistance to PD-03322991 was specifically associated with attenuation of CDK2 inhibitors, indicating that redundancy in CDK functions represents a determinant of therapeutic failure. Despite these caveats, in specific models, PD-0332991 was a particularly effective therapy, which induced Rb-dependent cytostasis. Combined, these findings indicate the critical importance of fully understanding cell-cycle regulatory pathways in directing the utilization of CDK inhibitors in the clinic. Oncogene (2010) 29, 4018-4032; doi:10.1038/onc.2010.154; published online 17 May 2010	[Dean, J. L.; Thangavel, C.; McClendon, A. K.; Reed, C. A.; Knudsen, E. S.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA	Jefferson University	Knudsen, ES (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, BLSB Room 1002,233 S 10th St, Philadelphia, PA 19107 USA.	eknudsen@kimmelcancercenter.org						Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Alle KM, 1998, CLIN CANCER RES, V4, P847; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P181, DOI 10.2174/156802606776173483; Barker Stewart, 2003, Curr Opin Investig Drugs, V4, P652; BORG A, 1992, CANCER RES, V52, P2991; Brenner AJ, 1996, CLIN CANCER RES, V2, P1993; Buzdar AU, 2009, ANN ONCOL, V20, P993, DOI 10.1093/annonc/mdn739; Dannenberg Jan-Hermen, 2006, V42, P183, DOI 10.1007/002; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Donovan JCH, 2001, J BIOL CHEM, V276, P40888, DOI 10.1074/jbc.M106448200; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; ENCARNACION CA, 1993, BREAST CANCER RES TR, V26, P237, DOI 10.1007/BF00665801; Fry DW, 2004, MOL CANCER THER, V3, P1427; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; GILLETT C, 1994, CANCER RES, V54, P1812; Halaban R, 1998, INT J MOL MED, V1, P419; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jensen EV, 2003, CLIN CANCER RES, V9, P1980; KEYOMARSI K, 1994, CANCER RES, V54, P380; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Loden M, 2002, ONCOGENE, V21, P4680, DOI 10.1038/sj.onc.1205578; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Nielsen NH, 1997, ONCOGENE, V14, P295, DOI 10.1038/sj.onc.1200833; OKAMOTO A, 1994, COLD SPRING HARB SYM, V59, P49, DOI 10.1101/SQB.1994.059.01.008; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; OTTERSON GA, 1994, ONCOGENE, V9, P3375; PIETILAINEN T, 1995, EUR J CANCER, V31A, P329, DOI 10.1016/0959-8049(94)00463-F; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; POON RYC, 1995, MOL BIOL CELL, V6, P1197, DOI 10.1091/mbc.6.9.1197; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Rizzi F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003617; Robertson JFR, 1996, BRIT J CANCER, V73, P5, DOI 10.1038/bjc.1996.2; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Santamaria D, 2006, FRONT BIOSCI-LANDMRK, V11, P1164, DOI 10.2741/1871; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; SHAPIRO GI, 1995, CANCER RES, V55, P505; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stengel KR, 2009, J BIOL CHEM, V284, P19265, DOI 10.1074/jbc.M808740200; SUTHERLAND RL, 1983, CANCER RES, V43, P3998; Swarbrick A, 2000, MOL CELL BIOL, V20, P2581, DOI 10.1128/MCB.20.7.2581-2591.2000; Takano Y, 1999, J CANCER RES CLIN, V125, P505, DOI 10.1007/s004320050309; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Vaughn DJ, 2009, NEW ENGL J MED, V360, P423, DOI 10.1056/NEJMc0808558; Vivar OI, 2009, BIOCHEM PHARMACOL, V78, P469, DOI 10.1016/j.bcp.2009.05.008; Wakimoto N, 2008, CANCER RES, V68, P6978, DOI 10.1158/0008-5472.CAN-07-5675; Wang L, 2007, BLOOD, V110, P2075, DOI 10.1182/blood-2007-02-071266; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WATTS CKW, 1995, MOL ENDOCRINOL, V9, P1804, DOI 10.1210/me.9.12.1804; YEAGER T, 1995, CANCER RES, V55, P493; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zagorski WA, 2007, CANCER RES, V67, P8264, DOI 10.1158/0008-5472.CAN-06-4753	60	269	275	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 15	2010	29	28					4018	4032		10.1038/onc.2010.154	http://dx.doi.org/10.1038/onc.2010.154			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	625JW	20473330	Bronze			2022-12-25	WOS:000279892400003
J	Kaspar, JW; Jaiswal, AK				Kaspar, James W.; Jaiswal, Anil K.			An Autoregulatory Loop between Nrf2 and Cul3-Rbx1 Controls Their Cellular Abundance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; UBIQUITIN-PROTEASOME PATHWAY; TRANSCRIPTION FACTOR NRF2; GENE-EXPRESSION; OXIDOREDUCTASE-1 GENE; MEDIATED EXPRESSION; NUCLEAR IMPORT; ACTIVATION; DEGRADATION; PROTEIN	The INrf2 (Keap1)/Cul3-Rbx1 complex constantly degrades Nrf2 under normal conditions. When a cell encounters oxidative or electrophilic stress, Nrf2 dissociates from the INrf2/Cul3-Rbx1 complex and translocates into the nucleus. In the nucleus, Nrf2 activates a myriad of antioxidant and defensive genes that protect cells. Nrf2 is then exported out of the nucleus and degraded. INrf2 serves as a substrate adaptor to link Nrf2 to Cul3 and Rbx1. Cul3 and Rbx1 make up the ubiquitin ligase complex that is responsible for the ubiquitination and degradation of Nrf2. Previously we have shown a feedback autoregulatory loop between Nrf2 and INrf2 indicating that Nrf2 regulates INrf2 by controlling its transcription. Here we are extending this research by demonstrating the presence of another feedback autoregulatory loop between Cul3-Rbx1 and Nrf2. Experiments using Hepa-1 and HepG2 cells indicate that Nrf2 controls its own degradation by regulating expression and induction of Cul3-Rbx1 genes. Treatment with the antioxidant tert-Butylhydroquinone (t-BHQ) leads to induction of Cul3-Rbx1 genes. Mutagenesis and transfection experiments identified an antioxidant response element in the forward and reverse strands of the proximal Cul3 and Rbx1 promoters, respectively, that Nrf2 binds and regulates expression and antioxidant induction of the Cul3-Rbx1 genes. In addition, short interfering RNA inhibition and overexpression of Nrf2 led to a respective decrease and increase in Cul3-Rbx1 gene expression. The increase in Cul3-Rbx1 leads to ubiquitination and degradation of Nrf2. These data suggest that Nrf2 regulates Cul3-Rbx1 by controlling regulation of expression and induction of Cul3-Rbx1. The induction of Cul3-Rbx1 control Nrf2 by increasing degradation.	[Kaspar, James W.; Jaiswal, Anil K.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu			National Institutes of Health [R01 ES012265]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 ES012265.	Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Ikeda H, 2004, BIOCHEM J, V380, P515, DOI 10.1042/BJ20031948; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Maher JM, 2007, HEPATOLOGY, V46, P1597, DOI 10.1002/hep.21831; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; MOHLER J, 1991, MECH DEVELOP, V34, P3, DOI 10.1016/0925-4773(91)90086-L; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Sekhar KR, 2002, ONCOGENE, V21, P6829, DOI 10.1038/sj.onc.1205905; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; THELEN M, 1993, PHYSIOL REV, V73, P797, DOI 10.1152/physrev.1993.73.4.797; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang W, 2006, FREE RADICAL BIO MED, V40, P1119, DOI 10.1016/j.freeradbiomed.2005.10.063; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	34	48	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21349	21358		10.1074/jbc.M110.121863	http://dx.doi.org/10.1074/jbc.M110.121863			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452971	hybrid, Green Published			2022-12-25	WOS:000279516100020
J	Pfister, CA; Meyer, F; Antonopoulos, DA				Pfister, Catherine A.; Meyer, Folker; Antonopoulos, Dionysios A.			Metagenomic Profiling of a Microbial Assemblage Associated with the California Mussel: A Node in Networks of Carbon and Nitrogen Cycling	PLOS ONE			English	Article							DIVERSITY; COASTAL; ECOLOGY; REGENERATION; COMPETITION; INCREASES; ENDOLITHS; ECOSYSTEM; PATTERNS; PLANKTON	Mussels are conspicuous and often abundant members of rocky shores and may constitute an important site for the nitrogen cycle due to their feeding and excretion activities. We used shotgun metagenomics of the microbial community associated with the surface of mussels (Mytilus californianus) on Tatoosh Island in Washington state to test whether there is a nitrogen-based microbial assemblage associated with mussels. Analyses of both tidepool mussels and those on emergent benches revealed a diverse community of Bacteria and Archaea with approximately 31 million bp from 6 mussels in each habitat. Using MG-RAST, between 22.5-25.6% were identifiable using the SEED non-redundant database for proteins. Of those fragments that were identifiable through MG-RAST, the composition was dominated by Cyanobacteria and Alpha and Gamma-proteobacteria. Microbial composition was highly similar between the tidepool and emergent bench mussels, suggesting similar functions across these different microhabitats. One percent of the proteins identified in each sample were related to nitrogen cycling. When normalized to protein discovery rate, the high diversity and abundance of enzymes related to the nitrogen cycle in mussel-associated microbes is as great or greater than that described for other marine metagenomes. In some instances, the nitrogen-utilizing profile of this assemblage was more concordant with soil metagenomes in the Midwestern U. S. than for open ocean system. Carbon fixation and Calvin cycle enzymes further represented 0.65 and 1.26% of all proteins and their abundance was comparable to a number of open ocean marine metagenomes. In sum, the diversity and abundance of nitrogen and carbon cycle related enzymes in the microbes occupying the shells of Mytilus californianus suggest these mussels provide a node for microbial populations and thus biogeochemical processes.	[Pfister, Catherine A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Meyer, Folker] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Meyer, Folker; Antonopoulos, Dionysios A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Antonopoulos, Dionysios A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Pfister, CA (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	cpfister@uchicago.edu	Antonopoulos, Dionysios/ABE-6212-2020	Antonopoulos, Dionysios/0000-0002-2238-5031; Meyer, Folker/0000-0003-1112-2284	National Science Foundation [OCE-0928232]; Argonne National Labs; Division Of Ocean Sciences [0928232] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Argonne National Labs(United States Department of Energy (DOE)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by National Science Foundation OCE-0928232 to CAP and Argonne National Labs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agawin NSR, 2007, LIMNOL OCEANOGR, V52, P2233, DOI 10.4319/lo.2007.52.5.2233; Aquilino KM, 2009, LIMNOL OCEANOGR, V54, P309, DOI 10.4319/lo.2009.54.1.0309; BARBER RT, 2001, EXCELLENCE ECOLOGY, V13; BAYNE BL, 1976, OECOLOGIA, V22, P211, DOI 10.1007/BF00344793; Bode A, 2004, J PLANKTON RES, V26, P11, DOI 10.1093/plankt/fbh003; Bracken MES, 2004, J PHYCOL, V40, P1032, DOI 10.1111/j.1529-8817.2004.03106.x; Bracken MES, 2004, ECOLOGY, V85, P2828, DOI 10.1890/03-0651; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; EPPLEY RW, 1973, LIMNOL OCEANOGR, V18, P534, DOI 10.4319/lo.1973.18.4.0534; FIELD D, 2009, NAT BIOTECHNOL, V26, P541; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Hansen J. E., 1981, NATURAL HIST ANO NUE, P183; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Hillebrand H, 2002, ECOLOGY, V83, P2205, DOI 10.1890/0012-9658(2002)083[2205:COMCBG]2.0.CO;2; Howarth R. W., 2000, ISSUES ECOLOGY, V7, P1; Jensen Susan L., 1994, Pacific Science, V48, P32; Kaehler S, 1999, MAR BIOL, V135, P505, DOI 10.1007/s002270050651; Kaehler S, 1999, MAR BIOL, V135, P497, DOI 10.1007/s002270050650; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kottmann R, 2008, OMICS, V12, P115, DOI 10.1089/omi.2008.0A10; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Paerl HW, 2000, MICROBIAL ECOLOGY OC, P387; PAINE RT, 1984, ECOLOGY, V65, P1339, DOI 10.2307/1939114; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pfister CA, 2007, LIMNOL OCEANOGR, V52, P1767, DOI 10.4319/lo.2007.52.5.1767; Pfister CA, 2007, ECOLOGY, V88, P1647, DOI 10.1890/06-1913.1; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Suchanek T. H., 1979, THESIS U WASHINGTON; Thauer RK, 2007, SCIENCE, V318, P1732, DOI 10.1126/science.1152209; Trainer VL, 2009, LIMNOL OCEANOGR, V54, P289, DOI 10.4319/lo.2009.54.1.0289; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward B.B., 2000, MICROBIAL ECOLOGY OC, P427; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Wootton JT, 2005, NATURE, V433, P309, DOI 10.1038/nature03211; WOOTTON JT, 1991, J EXP MAR BIOL ECOL, V151, P139, DOI 10.1016/0022-0981(91)90121-C	51	36	38	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10518	10.1371/journal.pone.0010518	http://dx.doi.org/10.1371/journal.pone.0010518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463896	gold, Green Published, Green Submitted			2022-12-25	WOS:000277379800012
J	Bachstetter, AD; Jernberg, J; Schlunk, A; Vila, JL; Hudson, C; Cole, MJ; Shytle, RD; Tan, J; Sanberg, PR; Sanberg, CD; Boriongan, C; Kaneko, Y; Tajiri, N; Gemma, C; Bickford, PC				Bachstetter, Adam D.; Jernberg, Jennifer; Schlunk, Andrea; Vila, Jennifer L.; Hudson, Charles; Cole, Michael J.; Shytle, R. Douglas; Tan, Jun; Sanberg, Paul R.; Sanberg, Cyndy D.; Boriongan, Cesario; Kaneko, Yuji; Tajiri, Naoki; Gemma, Carmelina; Bickford, Paula C.			Spirulina Promotes Stem Cell Genesis and Protects against LPS Induced Declines in Neural Stem Cell Proliferation	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; DIETARY SUPPLEMENTATION; PLATENSIS; POLYSACCHARIDE; BRAIN; RAT; LIPOPOLYSACCHARIDE; INFLAMMATION; ACTIVATION; IL-1-BETA	Adult stem cells are present in many tissues including, skin, muscle, adipose, bone marrow, and in the brain. Neuroinflammation has been shown to be a potent negative regulator of stem cell and progenitor cell proliferation in the neurogenic regions of the brain. Recently we demonstrated that decreasing a key neuroinflammatory cytokine IL-1 beta in the hippocampus of aged rats reversed the age-related cognitive decline and increased neurogenesis in the age rats. We also have found that nutraceuticals have the potential to reduce neuroinflammation, and decrease oxidative stress. The objectives of this study were to determine if spirulina could protect the proliferative potential of hippocampal neural progenitor cells from an acute systemic inflammatory insult of lipopolysaccharide (LPS). To this end, young rats were fed for 30 days a control diet or a diet supplemented with 0.1% spirulina. On day 28 the rats were given a single i.p. injection of LPS (1 mg/kg). The following day the rats were injected with BrdU (50 mg/kg b.i.d. i.p.) and were sacrificed 24 hours after the first injection of BrdU. Quantification of the BrdU positive cells in the subgranular zone of the dentate gyrus demonstrated a decrease in proliferation of the stem/progenitor cells in the hippocampus as a result of the LPS insult. Furthermore, the diet supplemented with spirulina was able to negate the LPS induced decrease in stem/progenitor cell proliferation. In a second set of studies we examined the effects of spirulina either alone or in combination with a proprietary formulation (NT-020) of blueberry, green tea, vitamin D3 and carnosine on the function of bone marrow and CD34(+) cells in vitro. Spirulina had small effects on its own and more than additive effects in combination with NT-020 to promote mitochondrial respiration and/or proliferation of these cells in culture. When examined on neural stem cells in culture spirulina increased proliferation at baseline and protected against the negative influence of TNF alpha to reduce neural stem cell proliferation. These results support the hypothesis that a diet enriched with spirulina and other nutraceuticals may help protect the stem/progenitor cells from insults.	[Bachstetter, Adam D.; Gemma, Carmelina; Bickford, Paula C.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Bachstetter, Adam D.; Jernberg, Jennifer; Schlunk, Andrea; Vila, Jennifer L.; Cole, Michael J.; Shytle, R. Douglas; Sanberg, Paul R.; Boriongan, Cesario; Kaneko, Yuji; Tajiri, Naoki; Gemma, Carmelina; Bickford, Paula C.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL USA; [Hudson, Charles; Boriongan, Cesario; Gemma, Carmelina; Bickford, Paula C.] James A Haley Vet Adm Hosp, Res Serv, Tampa, FL USA; [Tan, Jun] Univ S Florida, Coll Med, Dept Psychiat, Tampa, FL USA; [Sanberg, Cyndy D.] NaturaTherapeutics Inc, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida	Bachstetter, AD (corresponding author), Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	pbickfor@health.usf.edu	Tan, Jun/I-5339-2012; Tajiri, Naoki/K-1230-2012; Shytle, Roland D/J-4249-2012; Bickford, Paula C/J-5970-2012	Tajiri, Naoki/0000-0003-2189-662X; Bickford, Paula C/0000-0001-9657-7725; Bachstetter, Adam/0000-0003-4646-6757; Gemma, Carmelina/0000-0002-4480-0056; Sanberg, Paul/0000-0001-9130-4592; Borlongan, Cesar/0000-0002-2966-9782	National Institutes of Health (NIH) [R21AG024165, PO1AG04418]; United States Veterans Administration Medical Research Service; NATIONAL INSTITUTE ON AGING [P01AG004418, R21AG024165] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Veterans Administration Medical Research Service; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants R21AG024165 (CG) and PO1AG04418 (PCB), and the United States Veterans Administration Medical Research Service (PCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Balachandran P, 2006, INT IMMUNOPHARMACOL, V6, P1808, DOI 10.1016/j.intimp.2006.08.001; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Bickford PC, 2006, STEM CELLS DEV, V15, P118, DOI 10.1089/scd.2006.15.118; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Gemma C, 2002, J NEUROSCI, V22, P6114; Gordon MN, 1997, J COMP NEUROL, V388, P106; Hansen MK, 2000, AM J PHYSIOL-REG I, V278, pR331, DOI 10.1152/ajpregu.2000.278.2.R331; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; LEE SC, 1993, J IMMUNOL, V150, P2659; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Lobner M, 2008, J MED FOOD, V11, P313, DOI 10.1089/jmf.2007.564; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; NARAYANAN N, 1975, AUST J EXP BIOL MED, V53, P59, DOI 10.1038/icb.1975.6; Pugh N, 2001, PLANTA MED, V67, P737, DOI 10.1055/s-2001-18358; Qureshi MA, 1996, IMMUNOPHARM IMMUNOT, V18, P465, DOI 10.3109/08923979609052748; Qureshi MA, 1996, IMMUNOPHARM IMMUNOT, V18, P457, DOI 10.3109/08923979609052747; Reddy CM, 2000, BIOCHEM BIOPH RES CO, V277, P599, DOI 10.1006/bbrc.2000.3725; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sheng WS, 2005, J LEUKOCYTE BIOL, V78, P1233, DOI 10.1189/jlb.0405221; Shytle RD, 2007, REJUV RES, V10, P173, DOI 10.1089/rej.2006.0515; Stromberg I, 2005, EXP NEUROL, V196, P298, DOI 10.1016/j.expneurol.2005.08.013; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Trushina E. N., 2007, Voprosy Pitaniya, V76, P21; Wang Y, 2005, EXP NEUROL, V193, P75, DOI 10.1016/j.expneurol.2004.12.014; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yasuhara T, 2008, REJUV RES, V11, P201, DOI 10.1089/rej.2007.0608	32	43	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10496	10.1371/journal.pone.0010496	http://dx.doi.org/10.1371/journal.pone.0010496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463965	Green Published, Green Submitted, gold			2022-12-25	WOS:000277379400029
J	Tian, W; Qin, LL; Song, QL; He, L; Ai, MD; Jin, Y; Zhou, ZY; You, S; Long, YQ; Yu, Q				Tian, Wei; Qin, Lili; Song, Qiaoling; He, Li; Ai, Midan; Jin, Yi; Zhou, Zuyu; You, Song; Long, Yaqiu; Yu, Qiang			A Novel Synthetic Analog of 5, 8-Disubstituted Quinazolines Blocks Mitosis and Induces Apoptosis of Tumor Cells by Inhibiting Microtubule Polymerization	PLOS ONE			English	Article							BREAST-CANCER CELLS; IN-VITRO; ANTIMITOTIC ACTIVITY; DESTABILIZING DRUGS; CENTROMERE DYNAMICS; SPINDLE CHECKPOINT; AGENTS; TAXOL; TUBULIN; BINDING	Many mitosis inhibitors are powerful anticancer drugs. Tremendous efforts have been made to identify new anti-mitosis compounds for developing more effective and less toxic anti-cancer drugs. We have identified LJK-11, a synthetic analog of 5, 8-disubstituted quinazolines, as a novel mitotic blocker. LJK-11 inhibited growth and induced apoptosis of many different types of tumor cells. It prevented mitotic spindle formation and arrested cells at early phase of mitosis. Detailed in vitro analysis demonstrated that LJK-11 inhibited microtubule polymerization. In addition, LJK-11 had synergistic effect with another microtubule inhibitor colchicine on blocking mitosis, but not with vinblastine or nocodazole. Therefore, LJK-11 represents a novel anti-microtubule structure. Understanding the function and mechanism of LJK-11 will help us to better understand the action of anti-microtubule agents and to design better anti-cancer drugs.	[Tian, Wei; Qin, Lili; You, Song] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China; [Song, Qiaoling; He, Li; Ai, Midan; Jin, Yi; Zhou, Zuyu; Long, Yaqiu; Yu, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Shenyang Pharmaceutical University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Tian, W (corresponding author), Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China.	qyu@sibs.ac.cn			China National Natural Science Foundation [30672481, 30771097]; Shanghai Science and Technology [03XD14002]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology(Shanghai Science & Technology Committee)	This work was supported by China National Natural Science Foundation grants 30672481 and 30771097 and the Shanghai Science and Technology grant 03XD14002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blajeski AL, 2002, J CLIN INVEST, V110, P91, DOI 10.1172/JCI200213275; Chen JG, 2002, CANCER RES, V62, P1935; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gupta S, 2003, MOL CELL BIOCHEM, V253, P41, DOI 10.1023/A:1026045100219; Hong FD, 1999, CARCINOGENESIS, V20, P1161, DOI 10.1093/carcin/20.7.1161; Jin Y, 2005, BIOORGAN MED CHEM, V13, P5613, DOI 10.1016/j.bmc.2005.05.045; Jin Y, 2006, BIOORG MED CHEM LETT, V16, P5864, DOI 10.1016/j.bmcl.2006.08.058; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; JORDAN MA, 1992, J CELL SCI, V102, P401; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Karbowski M, 2001, J CELL SCI, V114, P281; Kelling J, 2003, CANCER RES, V63, P2794; Kovacs P, 2006, CELL BIOCHEM FUNCT, V24, P419, DOI 10.1002/cbf.1238; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Lee EA, 2004, MOL CANCER THER, V3, P661; Leoni LM, 2000, JNCI-J NATL CANCER I, V92, P217, DOI 10.1093/jnci/92.3.217; Mani S, 2004, ANTI-CANCER DRUG, V15, P553, DOI 10.1097/01.cad.0000131681.21637.b2; Margolis RL, 1998, BIOESSAYS, V20, P830, DOI 10.1002/(SICI)1521-1878(199810)20:10<830::AID-BIES8>3.0.CO;2-N; Martello LA, 2000, CLIN CANCER RES, V6, P1978; Martin JHJ, 2002, ONCOL REP, V9, P379; Masuda A, 2003, AM J PATHOL, V163, P1109, DOI 10.1016/S0002-9440(10)63470-0; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Okouneva T, 2003, MOL CANCER THER, V2, P427; Panda D, 1997, P NATL ACAD SCI USA, V94, P10560, DOI 10.1073/pnas.94.20.10560; Photiou A, 1997, EUR J CANCER, V33, P463, DOI 10.1016/S0959-8049(96)00451-0; Rowinsky EK, 2001, CANC PRINCIPLES PRAC, P431; Sasaki J, 2002, MOL CANCER THER, V1, P1201; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Shin DY, 2004, J REPROD DEVELOP, V50, P647, DOI 10.1262/jrd.50.647; Tahir SK, 2001, CANCER RES, V61, P5480; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Wall ME, 1996, J ETHNOPHARMACOL, V51, P239, DOI 10.1016/0378-8741(95)01367-9; Weiderhold KN, 2006, INT J CANCER, V118, P1032, DOI 10.1002/ijc.21424; Wilson L, 1999, CELL STRUCT FUNCT, V24, P329, DOI 10.1247/csf.24.329; Yoshida D, 2000, J NEURO-ONCOL, V47, P133, DOI 10.1023/A:1006393705560; Zanelli GD, 1997, EUR J CANCER, V33, P486, DOI 10.1016/S0959-8049(96)00478-9	38	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10499	10.1371/journal.pone.0010499	http://dx.doi.org/10.1371/journal.pone.0010499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463925	Green Published, Green Submitted, gold			2022-12-25	WOS:000277379400032
J	Angelakis, E; Raoult, D				Angelakis, Emmanouil; Raoult, Didier			The Increase of Lactobacillus Species in the Gut Flora of Newborn Broiler Chicks and Ducks Is Associated with Weight Gain	PLOS ONE			English	Article							FED DIETS; GROWTH-PERFORMANCE; MICROBIOTA; OBESITY; STRAINS; PROBIOTICS; CULTURES; MICE	Background: A bacterial role in the obesity pandemic has been suspected based on the ingestion of probiotics that can modify the gut flora. The objective of our study was to determine if increased Lactobacillus sp. in the gut flora of newborn broiler chicks and ducks could result in weight gain increase. Methodology: Female broiler chicks (Gallus gallus domesticus) and ducks (Anas platyrhynchos domestica) were separated into one control and two experimental groups, and inoculated once or twice with 4610 10 Lactobacillus spp. per animal in PBS, or with PBS alone. Fecal samples were collected before and at 24 hours, 2, 4, 8, 16 and 30 days after the inoculation. DNA was extracted from the stools, and qPCR assays were performed on a MX3000 (TM) system for the detection and quantification of Lactobacillus sp., Bacteroidetes and Firmicutes, using a quantification plasmid. Animals were measured and sacrificed 60 days after the beginning of the experiment, and livers were collected and measured. Principal Findings: Chicks inoculated once and twice with Lactobacillus weighed 10.2% (p = 0.0162) and 13.5% (p = 0.0064) more than the control group animals, respectively. Similarly, ducks inoculated once and twice weighed 7.7% (p = 0.05) and 14% (p = 0.035) more than those in the control group, respectively. Liver mass was also significantly higher in inoculated animals compared to the control group. Inoculation with Lactobacillus sp. increased the DNA copies of Lactobacillus spp. and Firmicutes in the stools. Bacteroidetes remained stable, and only the second Lactobacillus sp. inoculation significantly decreased its population in chicks. The ratio of DNA copies of Firmicutes to those of Bacteroidetes increased to as much as 6,4 in chicks and 8,3 in ducks. Conclusions: Differences in the intestinal microbiota may precede weight increase, as we found that an increase of Lactobacillus sp. in newborn ducks and chicks preceded the development of weight gain.	[Angelakis, Emmanouil; Raoult, Didier] Univ Mediterranee, Unite Rickettsies, CNRS UMR 6020, Fac Med,IFR 48, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Angelakis, E (corresponding author), Univ Mediterranee, Unite Rickettsies, CNRS UMR 6020, Fac Med,IFR 48, Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Angelakis, Emmanouil/A-9873-2015; Angelakis, Emmanouil/D-8039-2013	RAOULT, Didier/0000-0002-0633-5974; Angelakis, Emmanouil/0000-0001-7327-5441				Anadon A, 2006, REGUL TOXICOL PHARM, V45, P91, DOI 10.1016/j.yrtph.2006.02.004; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Bailey JS, 2000, J FOOD PROTECT, V63, P867, DOI 10.4315/0362-028X-63.7.867; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Carcopino X, 2006, J MED VIROL, V78, P1131, DOI 10.1002/jmv.20673; Chang YH, 2001, ANTON LEEUW INT J G, V80, P193, DOI 10.1023/A:1012213728917; Craven SE, 1999, AVIAN DIS, V43, P484, DOI 10.2307/1592646; Bernardez PF, 2008, J FOOD PROTECT, V71, P1797, DOI 10.4315/0362-028X-71.9.1797; Jin LZ, 1998, POULTRY SCI, V77, P1259, DOI 10.1093/ps/77.9.1259; Jin LZ, 2000, POULTRY SCI, V79, P886, DOI 10.1093/ps/79.6.886; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Khan M, 2007, BRIT POULTRY SCI, V48, P732, DOI 10.1080/00071660701716222; Lan PTN, 2004, MICROBIOL IMMUNOL, V48, P917, DOI 10.1111/j.1348-0421.2004.tb03620.x; Lan PTN, 2003, J GEN APPL MICROBIOL, V49, P29; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Liu JR, 2007, BRIT POULTRY SCI, V48, P507, DOI 10.1080/00071660701485034; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Mountzouris KC, 2007, POULTRY SCI, V86, P309, DOI 10.1093/ps/86.2.309; Raoult D, 2008, EUR J CLIN MICROBIOL, V27, P631, DOI 10.1007/s10096-008-0490-x; Raoult D, 2008, NATURE, V454, P690, DOI 10.1038/454690c; Raoult D, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2209-c3; Raoult D, 2009, NAT REV MICROBIOL, V7, P616, DOI 10.1038/nrmicro2209; Saulnier DMA, 2009, CURR OPIN BIOTECH, V20, P135, DOI 10.1016/j.copbio.2009.01.002; Thuny F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009074; Vanderhoof JA, 2008, CLIN INFECT DIS, V46, pS67, DOI 10.1086/523339; Yeo J, 1997, POULTRY SCI, V76, P381, DOI 10.1093/ps/76.2.381; Zulkifli I, 2000, BRIT POULTRY SCI, V41, P593, DOI 10.1080/713654979	30	101	114	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10463	10.1371/journal.pone.0010463	http://dx.doi.org/10.1371/journal.pone.0010463			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454557	Green Published, Green Submitted, gold			2022-12-25	WOS:000277305300008
J	Weiller, D; Martin, R; Dahne, S; Engel, AK; Konig, P				Weiller, Daniel; Maertin, Robert; Daehne, Sven; Engel, Andreas K.; Koenig, Peter			Involving Motor Capabilities in the Formation of Sensory Space Representations	PLOS ONE			English	Article							STATISTICS	A goal of sensory coding is to capture features of sensory input that are behaviorally relevant. Therefore, a generic principle of sensory coding should take into account the motor capabilities of an agent. Up to now, unsupervised learning of sensory representations with respect to generic coding principles has been limited to passively received sensory input. Here we propose an algorithm that reorganizes an agent's representation of sensory space by maximizing the predictability of sensory state transitions given a motor action. We applied the algorithm to the sensory spaces of a number of simple, simulated agents with different motor parameters, moving in two-dimensional mazes. We find that the optimization algorithm generates compact, isotropic representations of space, comparable to hippocampal place fields. As expected, the size and spatial distribution of these place fields-like representations adapt to the motor parameters of the agent as well as to its environment. The representations prove to be well suited as a basis for path planning and navigation. They not only possess a high degree of state-transition predictability, but also are temporally stable. We conclude that the coding principle of predictability is a promising candidate for understanding place field formation as the result of sensorimotor reorganization.	[Weiller, Daniel; Maertin, Robert; Daehne, Sven; Koenig, Peter] Univ Osnabruck, Dept Neurobiopsychol, Inst Cognit Sci, Osnabruck, Germany; [Engel, Andreas K.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany	University Osnabruck; University of Hamburg; University Medical Center Hamburg-Eppendorf	Weiller, D (corresponding author), Univ Osnabruck, Dept Neurobiopsychol, Inst Cognit Sci, Osnabruck, Germany.	dweiller@uos.de	Engel, Andreas K/C-7781-2012; König, Peter/ABB-2380-2020; Engel, Andreas K./AAH-6384-2019	Engel, Andreas K/0000-0003-4899-8466; König, Peter/0000-0003-3654-5267; Engel, Andreas K./0000-0003-4899-8466	European Commission [FP7-ICT-2007-1, 217148]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission FP7-ICT-2007-1 (Grant Agreement Number 217148 (PK)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Bellman R., 1957, DYNAMIC PROGRAMMING; Berkes P, 2005, J VISION, V5, P579, DOI 10.1167/5.6.9; Betsch BY, 2004, BIOL CYBERN, V90, P41, DOI 10.1007/s00422-003-0434-6; CHRISMAN L, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P183; Creutzig F, 2008, NEURAL COMPUT, V20, P1026, DOI 10.1162/neco.2008.01-07-455; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Franzius M, 2007, PLOS COMPUT BIOL, V3, P1605, DOI 10.1371/journal.pcbi.0030166; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; JAHNE B, 2002, DIGITALE BILDVERARBE; KARVANEN J, 2003, P 4 INT S IND COMP A, P125; Konig P, 2006, BIOL CYBERN, V94, P325, DOI [10.1007/s00422-006-0050-3, 10.1007/S00422-006-0050-3]; Kording KP, 2004, J NEUROPHYSIOL, V91, P206, DOI 10.1152/jn.00149.2003; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; MCCALLUM AK, 1996, P SAB96; McCallum R. A., 1993, P 10 INT C MACH LEAR, P190, DOI DOI 10.1016/B978-1-55860-307-3.50031-9; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MOORE AW, 1991, P IWML 1991; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Reynolds S. I., 2000, P 17 INT C MACH LEAR, P783; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SINGH SP, 1995, 7 NIPS; Sprekeler H, 2007, PLOS COMPUT BIOL, V3, P1136, DOI 10.1371/journal.pcbi.0030112; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; WEILLER D, 2007, UNSUPERVISED LEARNIN; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; Wyss R, 2006, PLOS BIOL, V4, P836, DOI 10.1371/journal.pbio.0040120	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10377	10.1371/journal.pone.0010377	http://dx.doi.org/10.1371/journal.pone.0010377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442849	Green Published, gold, Green Submitted			2022-12-25	WOS:000277154200017
J	Caubet, C; Bousset, L; Clemmensen, O; Sourigues, Y; Bygum, A; Chavanas, S; Coudane, F; Hsu, CY; Betz, RC; Melki, R; Simon, M; Serre, G				Caubet, Cecile; Bousset, Luc; Clemmensen, Ole; Sourigues, Yannick; Bygum, Anette; Chavanas, Stephane; Coudane, Fanny; Hsu, Chiung-Yueh; Betz, Regina C.; Melki, Ronald; Simon, Michel; Serre, Guy			A new amyloidosis caused by fibrillar aggregates of mutated corneodesmosin	FASEB JOURNAL			English	Article						skin; keratinocytes; adhesion; conformational disease; protein misfolding	HEREDITARY HYPOTRICHOSIS SIMPLEX; LOCALIZED CUTANEOUS AMYLOIDOSIS; EPIDERMOLYSIS-BULLOSA SIMPLEX; PALMOPLANTAR KERATODERMA; COMMON MECHANISM; V2 DOMAIN; IN-VITRO; PROTEIN; MUTATIONS; SCALP	Heterozygous nonsense mutations in the CDSN gene encoding corneodesmosin (CDSN), an adhesive protein expressed in cornified epithelia and hair follicles, cause hypotrichosis simplex of the scalp (HSS), a nonsyndromic form of alopecia. Truncated mutants of CDSN ((CDSN)-C-mut), which bear the N-terminal adhesive Gly/Ser-rich domain (GS domain) of the protein, abnormally accumulate as amorphous deposits at the periphery of hair follicles and in the papillary dermis of the patient skin. Here, we present evidence that the (CDSN)-C-mut deposits display an affinity for amyloidophilic dyes, namely Congo red and thioflavin T. We also detected the serum amyloid protein component in the dermis of HSS patients. We demonstrated that recombinant forms of (CDSN)-C-mut and of the GS domain assemble in vitro into ring-shaped oligomeric structures and fibrils. The amyloid-like nature of the fibrils was demonstrated by dye binding and Fourier transform infrared spectrometry measurements. We showed that the ring-shaped oligomers of (CDSN)-C-mut, but not the fibrillar forms, are toxic to cultured keratinocytes. Finally, online algorithms predicted the GS domain to be a particularly disordered region of CDSN in agreement with circular dichroism measurements. This identifies HSS as a human amyloidosis related to the aggregation of natively unfolded (CDSN)-C-mut polypeptides into amyloid fibrils.-Caubet, C., Bousset, L., Clemmensen, O., Sourigues, Y., Bygum, A., Chavanas, S., Coudane, F., Hsu, C.-Y., Betz, R. C., Melki, R., Simon, M., Serre, G. A new amyloidosis caused by fibrillar aggregates of mutated corneodesmosin. FASEB J. 24, 3416-3426 (2010). www.fasebj.org	[Bousset, Luc; Sourigues, Yannick; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, UPR3082, F-91198 Gif Sur Yvette, France; [Caubet, Cecile; Chavanas, Stephane; Coudane, Fanny; Hsu, Chiung-Yueh; Simon, Michel; Serre, Guy] Univ Toulouse 3, Inst Fed Rech IFR150, Ctr Hosp Univ, INSERM,CNRS,UMR5165, Toulouse, France; [Clemmensen, Ole] Odense Univ Hosp, Dept Clin Pathol, Odense, Denmark; [Bygum, Anette] Odense Univ Hosp, Dept Dermatol, Odense, Denmark; [Betz, Regina C.] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Bonn	Melki, R (corresponding author), CNRS, Lab Enzymol & Biochim Struct, UPR3082, Batiment 34,Ave Terrasse, F-91198 Gif Sur Yvette, France.	melki@lebs.cnrs-gif.fr; serre@udear.cnrs.fr	Simon, Michel/B-7308-2011; Chavanas, stephane/K-1183-2014; Betz, Regina C/E-8591-2011	Simon, Michel/0000-0003-3655-6329; Betz, Regina C/0000-0001-5024-3623; bousset, luc/0000-0002-0433-4337; chavanas, stephane/0000-0003-4323-2656; HSU, Chiung-Yueh/0000-0002-4671-0919; Bygum, Anette/0000-0002-3004-0180	CNRS; INSERM; Toulouse III University; Toulouse University Hospital; Alopecia Areata Association; ANR [ANR-06-BLAN-0266]; German Research Foundation (DFG)	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Toulouse III University; Toulouse University Hospital; Alopecia Areata Association; ANR(French National Research Agency (ANR)); German Research Foundation (DFG)(German Research Foundation (DFG))	The authors thank Peter Faller (Laboratoire de Chimie de Coordination, CNRS UPR8241, Toulouse, France) for putting the Safas SP 2000 spectrofluorimeter at our disposal, Bruno Payre (Centre de Microscopie Electronique Appliquee a la Biologie, University of Toulouse III) for the use of the electron microscope, the IMAGIF facility for the use of the Jeol 1400 TEM, and Sophie Allard from the confocal microscopy facility (INSERM, IFR150). This work was supported by grants from CNRS, INSERM, Toulouse III University, Toulouse University Hospital, and the Alopecia Areata Association. L. B., Y.S., and R. M. are supported by CNRS and ANR (contract ANR-06-BLAN-0266). R. C. B. is a recipient of an Emmy Noether Grant from the German Research Foundation (DFG).	Apaydin R, 2004, J EUR ACAD DERMATOL, V18, P305, DOI 10.1111/j.1468-3083.2004.00905.x; Arita K, 2008, AM J HUM GENET, V82, P73, DOI 10.1016/j.ajhg.2007.09.002; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Bousset L, 2004, BIOCHEMISTRY-US, V43, P5022, DOI 10.1021/bi049828e; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buxbaum JN, 2003, TRENDS BIOCHEM SCI, V28, P585, DOI 10.1016/j.tibs.2003.09.009; Caubet C, 2004, J INVEST DERMATOL, V122, P747, DOI 10.1111/j.0022-202X.2004.22331.x; Chang YT, 2004, ARCH DERMATOL RES, V296, P83, DOI 10.1007/s00403-004-0474-3; Chiang YY, 2008, BRIT J DERMATOL, V159, P1370, DOI 10.1111/j.1365-2133.2008.08801.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Davalos NO, 2005, BRIT J DERMATOL, V153, P1216, DOI 10.1111/j.1365-2133.2005.06958.x; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fox Jeffrey D, 2003, Methods Mol Biol, V205, P99; Gu LH, 2003, J INVEST DERMATOL, V121, P482, DOI 10.1046/j.1523-1747.2003.12424.x; Guerrin M, 1998, J BIOL CHEM, V273, P22640, DOI 10.1074/jbc.273.35.22640; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Jonca N, 2002, J BIOL CHEM, V277, P5024, DOI 10.1074/jbc.M108438200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khurana R, 2001, J BIOL CHEM, V276, P22715, DOI 10.1074/jbc.M011499200; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; KOBAYASHI H, 1983, J INVEST DERMATOL, V80, P66, DOI 10.1111/1523-1747.ep12531130; KOHN G, 1987, CLIN GENET, V32, P120; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Leclerc EA, 2009, J CELL SCI, V122, P2699, DOI 10.1242/jcs.050302; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; Lugassy J, 2006, AM J HUM GENET, V79, P724, DOI 10.1086/507792; Lutz ME, 2002, J AM ACAD DERMATOL, V46, P434, DOI 10.1067/mjd.2002.110660; MASU SI, 1981, ACTA DERM-VENEREOL, V61, P381; Matsumoto M, 2008, P NATL ACAD SCI USA, V105, P6720, DOI 10.1073/pnas.0709345105; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Richardson ES, 2006, J INVEST DERMATOL, V126, P79, DOI 10.1038/sj.jid.5700025; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SERRE G, 1991, J INVEST DERMATOL, V97, P1061, DOI 10.1111/1523-1747.ep12492589; Seshadri S, 1999, METHOD ENZYMOL, V309, P559; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; Terrinoni A, 2000, J INVEST DERMATOL, V114, P1136, DOI 10.1046/j.1523-1747.2000.00983.x; TORIBIO J, 1974, BRIT J DERMATOL, V91, P687, DOI 10.1111/j.1365-2133.1974.tb12455.x; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Whittock NV, 2002, J INVEST DERMATOL, V118, P838, DOI 10.1046/j.1523-1747.2002.01750.x	45	20	22	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3416	3426		10.1096/fj.10-155622	http://dx.doi.org/10.1096/fj.10-155622			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20448140				2022-12-25	WOS:000281446400029
J	Gilio, K; Harper, MT; Cosemans, JMEM; Konopatskaya, O; Munnix, ICA; Prinzen, L; Leitges, M; Liu, QH; Molkentin, JD; Heemskerk, JWM; Poole, AW				Gilio, Karen; Harper, Matthew T.; Cosemans, Judith M. E. M.; Konopatskaya, Olga; Munnix, Imke C. A.; Prinzen, Lenneke; Leitges, Michael; Liu, Qinghang; Molkentin, Jeffery D.; Heemskerk, Johan W. M.; Poole, Alastair W.			Functional Divergence of Platelet Protein Kinase C (PKC) Isoforms in Thrombus Formation on Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED HUMAN PLATELETS; GLYCOPROTEIN-VI; TYROSINE KINASE; SERINE/THREONINE KINASES; PROCOAGULANT ACTIVITY; FIBRINOGEN RECEPTOR; GRANULE SECRETION; ALPHA-GRANULE; EX-VIVO; THETA	Arterial thrombosis, a major cause of myocardial infarction and stroke, is initiated by activation of blood platelets by subendothelial collagen. The protein kinase C (PKC) family centrally regulates platelet activation, and it is becoming clear that the individual PKC isoforms play distinct roles, some of which oppose each other. Here, for the first time, we address all four of the major platelet-expressed PKC isoforms, determining their comparative roles in regulating platelet adhesion to collagen and their subsequent activation under physiological flow conditions. Using mouse gene knock-out and pharmacological approaches in human platelets, we show that collagen-dependent alpha-granule secretion and thrombus formation are mediated by the conventional PKC isoforms, PKC alpha and PKC beta, whereas the novel isoform, PKC theta, negatively regulates these events. PKC delta also negatively regulates thrombus formation but not alpha-granule secretion. In addition, we demonstrate for the first time that individual PKC isoforms differentially regulate platelet calcium signaling and exposure of phosphatidylserine under flow. Although platelet deficient in PKC alpha or PKC beta showed reduced calcium signaling and phosphatidylserine exposure, these responses were enhanced in the absence of PKC theta. In summary therefore, this direct comparison between individual subtypes of PKC, by standardized methodology under flow conditions, reveals that the four major PKCs expressed in platelets play distinct non-redundant roles, where conventional PKCs promote and novel PKCs inhibit thrombus formation on collagen.	[Heemskerk, Johan W. M.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, Lab Cellular Thrombosis & Haemostasis, NL-6200 MD Maastricht, Netherlands; [Harper, Matthew T.; Konopatskaya, Olga; Poole, Alastair W.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Liu, Qinghang; Molkentin, Jeffery D.] Cincinnati Childrens Hosp, Med Ctr, Dept Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	Maastricht University; University of Bristol; University of Oslo; Cincinnati Children's Hospital Medical Center	Heemskerk, JWM (corresponding author), Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, Lab Cellular Thrombosis & Haemostasis, POB 616, NL-6200 MD Maastricht, Netherlands.	jwm.heemskerk@bioch.unimaas.nl; a.poole@bris.ac.uk	Leitges, Michael/AAN-1953-2021; Heemskerk, Johan/AAM-8323-2021; Cosemans, Judith MEM/C-8161-2016; Harper, Matthew T/G-5630-2013	Heemskerk, Johan/0000-0002-2848-5121; Cosemans, Judith MEM/0000-0001-7429-0109; Harper, Matthew T/0000-0002-4740-637X; Leitges, Michael/0000-0003-4203-6995; Poole, Alastair/0000-0002-0868-297X; Molkentin, Jeffery/0000-0002-3558-6529; Liu, Qinghang/0000-0003-0638-6509	British Heart Foundation [RG/05/015]; Marie Curie program [2005-020706-2, ZonMW 11.400.0076]	British Heart Foundation(British Heart Foundation); Marie Curie program(European Commission)	This work was supported by the Marie Curie program Early Stage Research Training Grant 2005-020706-2 and ZonMW 11.400.0076 (to J.W.M.H.) and by the British Heart Foundation for program grant support, Grant RG/05/015 (to A. W. P.).	Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; BALDASSARE JJ, 1992, J BIOL CHEM, V267, P15585; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; CAVALLINI L, 1994, EUR J BIOCHEM, V222, P693, DOI 10.1111/j.1432-1033.1994.tb18914.x; Chari R, 2009, ARTERIOSCL THROM VAS, V29, P699, DOI 10.1161/ATVBAHA.109.184010; Cohen S, 2009, BIOCHEM BIOPH RES CO, V385, P22, DOI 10.1016/j.bbrc.2009.05.021; CRABOS M, 1991, BIOCHEM BIOPH RES CO, V178, P878, DOI 10.1016/0006-291X(91)90973-B; Crosby D, 2003, J BIOL CHEM, V278, P24533, DOI 10.1074/jbc.M301847200; Crosby D, 2002, J BIOL CHEM, V277, P9958, DOI 10.1074/jbc.M108965200; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Giuliano S, 2003, BIOCHEM J, V372, P163, DOI 10.1042/BJ20020868; GRABAREK J, 1992, J BIOL CHEM, V267, P10011; Hall KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003277; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Harper MT, 2006, J THROMB HAEMOST, V4, P2695, DOI 10.1111/j.1538-7836.2006.02207.x; Harper MT, 2009, BLOOD, V114, P489, DOI 10.1182/blood-2009-03-208454; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; Heemskerk JWM, 2001, J PHYSIOL-LONDON, V535, P625, DOI 10.1111/j.1469-7793.2001.00625.x; Hers I, 1998, ARTERIOSCL THROM VAS, V18, P404, DOI 10.1161/01.ATV.18.3.404; Kahn ML, 2004, SEMIN THROMB HEMOST, V30, P419, DOI 10.1055/s-2004-833477; KHAN WA, 1993, J BIOL CHEM, V268, P5063; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Lecut C, 2004, ARTERIOSCL THROM VAS, V24, P1727, DOI 10.1161/01.ATV.0000137974.85068.93; Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; MURPHY CT, 1991, BIOCHEM J, V278, P255, DOI 10.1042/bj2780255; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; ORR JW, 1992, J BIOL CHEM, V267, P15263; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Pears CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003793; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Pula G, 2006, BLOOD, V108, P4035, DOI 10.1182/blood-2006-05-023739; Quinton TM, 2002, BIOCHEM J, V368, P535, DOI 10.1042/BJ20020226; RINK TJ, 1990, ANNU REV PHYSIOL, V52, P431, DOI 10.1146/annurev.ph.52.030190.002243; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Standaert ML, 1999, ENDOCRINOLOGY, V140, P4470, DOI 10.1210/en.140.10.4470; Strehl A, 2007, J BIOL CHEM, V282, P7046, DOI 10.1074/jbc.M611367200; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tabuchi A, 2003, J BIOL CHEM, V278, P26374, DOI 10.1074/jbc.M212407200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; van der Meijden PEJ, 2008, FEBS J, V275, P371, DOI 10.1111/j.1742-4658.2007.06207.x; WALKER TR, 1993, BIOCHEM J, V289, P277, DOI 10.1042/bj2890277; WANG F, 1993, BIOCHEM BIOPH RES CO, V191, P240, DOI 10.1006/bbrc.1993.1208; Yoshioka A, 2001, J BIOL CHEM, V276, P39379, DOI 10.1074/jbc.M102933200	53	80	82	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23408	23417		10.1074/jbc.M110.136176	http://dx.doi.org/10.1074/jbc.M110.136176			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20479008	Green Published, hybrid			2022-12-25	WOS:000279999900073
J	Sugden, C; Ross, S; Bloomfield, G; Ivens, A; Skelton, J; Mueller-Taubenberger, A; Williams, JG				Sugden, Christopher; Ross, Susan; Bloomfield, Gareth; Ivens, Alasdair; Skelton, Jason; Mueller-Taubenberger, Annette; Williams, Jeffrey G.			Two Novel Src Homology 2 Domain Proteins Interact to Regulate Dictyostelium Gene Expression during Growth and Early Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH2 DOMAIN; MITOCHONDRIAL MORPHOLOGY; DISCOIDEUM; STAT	There are 13 Dictyostelium Src homology 2 (SH2) domain proteins, almost 10-fold fewer than in mammals, and only three are functionally unassigned. One of these, LrrB, contains a novel combination of protein interaction domains: an SH2 domain and a leucine-rich repeat domain. Growth and early development appear normal in the mutant, but expression profiling reveals that three genes active at these stages are greatly under-expressed: the ttdA metallohydrolase, the abcG10 small molecule transporter, and the cinB esterase. In contrast, the multi-gene family encoding the lectin discoidin 1 is overexpressed in the disruptant strain. LrrB binds to 14-3-3 protein, and the level of binding is highest during growth and decreases during early development. Comparative tandem affinity purification tagging shows that LrrB also interacts, via its SH2 domain and in a tyrosine phosphorylation-dependent manner, with two novel proteins: CldA and CldB. Both of these proteins contain a Clu domain, a > 200-amino acid sequence present within highly conserved eukaryotic proteins required for correct mitochondrial dispersal. A functional interaction of LrrB with CldA is supported by the fact that a cldA disruptant mutant also under-expresses ttdA, abcG10, and cinB. Significantly, CldA is itself one of the three functionally unassigned SH2 domain proteins. Thus, just as in metazoa, but on a vastly reduced numerical scale, an interacting network of SH2 domain proteins regulates specific Dictyostelium gene expression.	[Sugden, Christopher; Ross, Susan; Williams, Jeffrey G.] Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland; [Bloomfield, Gareth] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Ivens, Alasdair; Skelton, Jason] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Mueller-Taubenberger, Annette] Univ Munich, Inst Cell Biol, D-80336 Munich, Germany; [Mueller-Taubenberger, Annette] Univ Munich, Ctr Integrated Prot Sci, D-80336 Munich, Germany	University of Dundee; Wellcome Trust Sanger Institute; MRC Laboratory Molecular Biology; University of Munich; University of Munich	Williams, JG (corresponding author), Univ Dundee, Sch Life Sci, Dow St, Dundee DD1 5EH, Scotland.	j.g.williams@dundee.ac.uk	Müller-Taubenberger, Annette/AAM-3671-2021	Ivens, Al/0000-0002-0112-3876; Bloomfield, Gareth/0000-0003-4269-8059; Muller-Taubenberger, Annette/0000-0003-1163-9232	Biotechnology and Biological Sciences Research Council [BB/C500428/1]; Wellcome Trust [06724]; Medical Research Council [MC_U105115237] Funding Source: researchfish; MRC [MC_U105115237] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council Project Grant BB/C500428/1 and by Wellcome Trust Program Grant 06724.	Abe T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng095; Araki T, 2008, DEVELOPMENT, V135, P1347, DOI 10.1242/dev.009936; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Cox RT, 2009, DIS MODEL MECH, V2, P490, DOI 10.1242/dmm.002378; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fields SD, 1998, J CELL SCI, V111, P1717; Gao Q, 2004, MOL CELL PROTEOMICS, V3, P704, DOI 10.1074/mcp.M300131-MCP200; Kibler K, 2003, DEV BIOL, V259, P193, DOI 10.1016/S0012-1606(03)00204-5; Kim L, 1999, CELL, V99, P399, DOI 10.1016/S0092-8674(00)81526-3; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; Knetsch MLW, 1997, BBA-MOL CELL RES, V1357, P243, DOI 10.1016/S0167-4889(97)00060-8; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Langenick J, 2008, J CELL SCI, V121, P3524, DOI 10.1242/jcs.036798; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Logan DC, 2003, PLANT J, V36, P500, DOI 10.1046/j.1365-313X.2003.01894.x; LOOMIS WF, 1990, P NATL ACAD SCI USA, V87, P9093, DOI 10.1073/pnas.87.23.9093; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Meima ME, 2007, PROTEIN EXPRES PURIF, V53, P283, DOI 10.1016/j.pep.2007.01.001; Moniakis J, 2001, GENE DEV, V15, P687, DOI 10.1101/gad.871001; Olsen R, 2005, J MOL EVOL, V61, P659, DOI 10.1007/s00239-005-0060-0; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; SINGLETON CK, 1987, DEV BIOL, V119, P433, DOI 10.1016/0012-1606(87)90047-9; SINGLETON CK, 1989, NUCLEIC ACIDS RES, V17, P9679, DOI 10.1093/nar/17.23.9679; SINGLETON CK, 1991, DEV GENET, V12, P88, DOI 10.1002/dvg.1020120116; Strmecki L, 2007, EUKARYOT CELL, V6, P245, DOI 10.1128/EC.00204-06; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Williams JG, 2004, TRENDS PLANT SCI, V9, P161, DOI 10.1016/j.tplants.2004.02.001; WILLIAMS JG, 2003, SIGNAL TRANSDUCERS A, P105; Zhu QL, 1997, P NATL ACAD SCI USA, V94, P7308, DOI 10.1073/pnas.94.14.7308; Zhukovskaya NV, 2004, DEVELOPMENT, V131, P447, DOI 10.1242/dev.00927	31	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22925	22933		10.1074/jbc.M110.139733	http://dx.doi.org/10.1074/jbc.M110.139733			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20457612	Green Published, hybrid			2022-12-25	WOS:000279999900026
J	Sanchez, R; Pantoja-Uceda, D; Prieto, J; Diercks, T; Marcaida, MJ; Montoya, G; Campos-Olivas, R; Blanco, FJ				Sanchez, Ricardo; Pantoja-Uceda, David; Prieto, Jesus; Diercks, Tammo; Marcaida, Maria J.; Montoya, Guillermo; Campos-Olivas, Ramon; Blanco, Francisco J.			Solution Structure of Human Growth Arrest and DNA Damage 45 alpha (Gadd45 alpha) and Its Interactions with Proliferating Cell Nuclear Antigen (PCNA) and Aurora A Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53-REGULATED PROTEIN; GADD45A; ACTIVATION; DEMETHYLATION; GADD45-GAMMA; MTK1/MEKK4; ASSIGNMENT; COMPLEX	Gadd45 alpha is a nuclear protein encoded by a DNA damage-inducible gene. Through its interactions with other proteins, Gadd45 alpha participates in the regulation of DNA repair, cell cycle, cell proliferation, and apoptosis. The NMR structure of human Gadd45 alpha has been determined and shows an alpha/beta fold with two long disordered and flexible regions at the N terminus and one of the loops. Human Gadd45 alpha is predominantly monomeric in solution but exists in equilibrium with dimers and other oligomers whose population increases with protein concentration. NMR analysis shows that Aurora A interacts through its N-terminal domain with a region of human Gadd45 alpha encompassing the site of dimerization, suggesting that the oligomerization of Gadd45 alpha could be a regulatory mechanism to modulate its interactions with Aurora A, and possibly with other proteins too. However, Gadd45 alpha appears to interact only weakly with PCNA through its flexible loop, in contrast with previous and contradictory reports.	[Prieto, Jesus; Marcaida, Maria J.; Montoya, Guillermo; Campos-Olivas, Ramon] CNIO, Struct & Computat Biol Programme, E-28029 Madrid, Spain; [Sanchez, Ricardo; Diercks, Tammo; Blanco, Francisco J.] CIC bioGUNE, Struct Biol Unit, E-48160 Derio, Spain; [Pantoja-Uceda, David] CSIC, Inst Quim Fis Rocasolano, Mol Struct & Spect Dept, E-28006 Madrid, Spain; [Blanco, Francisco J.] Basque Fdn Sci, IKERBASQUE, E-48011 Bilbao, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); CIC bioGUNE; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Basque Foundation for Science	Campos-Olivas, R (corresponding author), CNIO, Struct & Computat Biol Programme, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	rcampos@cnio.es; fblanco@cicbiogune.es	Pantoja-Uceda, David/J-8097-2014; cancer, biogune/H-7276-2012; Diercks, Tammo/G-1167-2011; Sánchez, Ricardo/AAB-1516-2019; Campos-Olivas, Ramón/L-9173-2014; Marcaida, Maria Jose/I-1644-2017; Blanco, Francisco J/D-4401-2009; Diercks, Tammo/AAT-3731-2021	Diercks, Tammo/0000-0002-5200-0905; Campos-Olivas, Ramón/0000-0002-5743-2221; Marcaida, Maria Jose/0000-0003-0663-5309; Blanco, Francisco J/0000-0003-2545-4319; Diercks, Tammo/0000-0002-5200-0905; Pantoja-Uceda, David/0000-0003-4390-6972	Spanish Ministerio de Ciencia e Innovacion [CTQ2008-03115/BQU, BFU2008-01344, CSD2006-00023]; Consejeria de Educacion of the Basque Government [PI2009-4]; Comunidad Auto noma de Madrid [CAM-P2006/Gen-0166, ETORTEK-2008]; ETORTEK	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejeria de Educacion of the Basque Government; Comunidad Auto noma de Madrid(Comunidad de Madrid); ETORTEK	This work was supported by the Spanish Ministerio de Ciencia e Innovacion Grants CTQ2008-03115/BQU (to F.J.B.) and BFU2008-01344 and CSD2006-00023 (to G. M.), Consejeria de Educacion of the Basque Government Grant PI2009-4 (to F.J.B.), Comunidad Auto noma de Madrid Grant CAM-P2006/Gen-0166 (to G. M.), and ETORTEK-2008 Grant to the Structural Biology Unit of CIC bioGUNE.	Azam N, 2001, J BIOL CHEM, V276, P2766, DOI 10.1074/jbc.M005626200; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Carrier F, 1999, MOL CELL BIOL, V19, P1673; CARRIER F, 1994, J BIOL CHEM, V269, P32672; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; HALL PA, 1995, ONCOGENE, V10, P2427; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Kovalsky O, 2001, J BIOL CHEM, V276, P39330, DOI 10.1074/jbc.M105115200; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Sanchez R, 2007, BIOMOL NMR ASSIGN, V1, P245, DOI 10.1007/s12104-007-9068-2; Sanchez R, 2008, BIOMOL NMR ASSIGN, V2, P139, DOI 10.1007/s12104-008-9105-9; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Schrag JD, 2008, P NATL ACAD SCI USA, V105, P6566, DOI 10.1073/pnas.0800086105; Shao SJ, 2006, J BIOL CHEM, V281, P28943, DOI 10.1074/jbc.M600235200; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tornatore L, 2008, J MOL BIOL, V378, P97, DOI 10.1016/j.jmb.2008.01.074; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Wang X, 2008, PROTEIN SCI, V17, P899, DOI 10.1110/ps.073395108; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R	28	21	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22196	22201		10.1074/jbc.M109.069344	http://dx.doi.org/10.1074/jbc.M109.069344			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460379	Green Published, hybrid			2022-12-25	WOS:000279702200032
J	Chinnakkannu, P; Samanna, V; Cheng, GM; Ablonczy, Z; Baicu, CF; Bethard, JR; Menick, DR; Kuppuswamy, D; Cooper, G				Chinnakkannu, Panneerselvam; Samanna, Venkatesababa; Cheng, Guangmao; Ablonczy, Zsolt; Baicu, Catalin F.; Bethard, Jennifer R.; Menick, Donald R.; Kuppuswamy, Dhandapani; Cooper, George			Site-specific Microtubule-associated Protein 4 Dephosphorylation Causes Microtubule Network Densification in Pressure Overload Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULIN MESSENGER-RNAS; CONTRACTILE DYSFUNCTION; ADULT CARDIOCYTES; TAU-PROTEIN; BETA-TUBULIN; TRANSLATIONAL INITIATION; RECEPTOR TRAFFICKING; PHOSPHORYLATION SITE; PROJECTION DOMAIN; ALZHEIMER-DISEASE	In severe pressure overload-induced cardiac hypertrophy, a dense, stabilized microtubule network forms that interferes with cardiocyte contraction and microtubule-based transport. This is associated with persistent transcriptional up-regulation of cardiac alpha- and beta-tubulin and microtubule-stabilizing microtubule-associated protein 4 (MAP4). There is also extensive microtubule decoration by MAP4, suggesting greater MAP4 affinity for microtubules. Because the major determinant of this affinity is site-specific MAP4 dephosphorylation, we characterized this in hypertrophied myocardium and then assessed the functional significance of each dephosphorylation site found by mimicking it in normal cardiocytes. We first isolated MAP4 from normal and pressure overload-hypertrophied feline myocardium; volume-overloaded myocardium, which has an equal degree and duration of hypertrophy but normal functional and cytoskeletal properties, served as a control for any nonspecific growth-related effects. After cloning cDNA-encoding feline MAP4 and obtaining its deduced amino acid sequence, we characterized by mass spectrometry any site-specific MAP4 dephosphorylation. Solely in pressure overload-hypertrophied myocardium, we identified striking MAP4 dephosphorylation at Ser-472 in the MAP4 N-terminal projection domain and at Ser-924 and Ser-1056 in the assembly-promoting region of the C-terminal microtubule-binding domain. Site-directed mutagenesis of MAP4 cDNA was then used to switch each serine to non-phosphorylatable alanine. Wild-type and mutated cDNAs were used to construct adenoviruses; microtubule network density, stability, and MAP4 decoration were assessed in normal cardiocytes following an equivalent level of MAP4 expression. The Ser-924 -> Ala MAP4 mutant produced a microtubule phenotype indistinguishable from that seen in pressure overload hypertrophy, such that Ser-924 MAP4 dephosphorylation during pressure overload hypertrophy may be central to this cytoskeletal abnormality.	[Chinnakkannu, Panneerselvam; Samanna, Venkatesababa; Cheng, Guangmao; Baicu, Catalin F.; Menick, Donald R.; Kuppuswamy, Dhandapani; Cooper, George] Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Charleston, SC 29403 USA; [Ablonczy, Zsolt] Med Univ S Carolina, Storm Eye Inst, Dept Ophthalmol, Charleston, SC 29403 USA; [Bethard, Jennifer R.] Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29403 USA; [Kuppuswamy, Dhandapani; Cooper, George] Dept Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Cooper, G (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, POB 250773,114 Doughty St, Charleston, SC 29403 USA.	cooperge@musc.edu			National Institutes of Health [HL094545, HL104287, HL48788]; Dept. of Veterans Affairs; NATIONAL EYE INSTITUTE [R01EY019065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104287, R01HL094545, P01HL048788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094545 and HL104287 (to G. C.) and NIH Program Project Grant HL48788 (to G. C., D. K., and D. M.). This work was also supported by a Dept. of Veterans Affairs Merit Review Grant (to G. C.).	Ablonczy Z, 2005, PHOTOCHEM PHOTOBIOL, V81, P541, DOI 10.1562/2004-08-27-RA-294.1; Ablonczy Z, 2002, J BIOL CHEM, V277, P40491, DOI 10.1074/jbc.M205507200; AIZAWA H, 1991, J BIOL CHEM, V266, P9841; AIZAWA H, 1990, J BIOL CHEM, V265, P13849; BACHURSKI CJ, 1994, MOL CELL BIOL, V14, P4076, DOI 10.1128/MCB.14.6.4076; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BLALOCK A, 1950, SURG GYNECOL OBSTET, V90, P1; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Casey LM, 2003, CELL MOTIL CYTOSKEL, V54, P317, DOI 10.1002/cm.10105; Chang W, 2001, J CELL SCI, V114, P2879; CHAPIN SJ, 1991, J CELL SCI, V98, P27; Chen XW, 2007, CIRC RES, V100, P536, DOI 10.1161/01.RES.0000259560.39234.99; Cheng GM, 2005, AM J PHYSIOL-HEART C, V288, pH1193, DOI 10.1152/ajpheart.00109.2004; Cheng GM, 2002, AM J PHYSIOL-HEART C, V283, pH2379, DOI 10.1152/ajpheart.00410.2002; Cheng G, 2008, AM J PHYSIOL-HEART C, V294, pH2231, DOI 10.1152/ajpheart.91515.2007; COOPER G, 1973, CIRC RES, V32, P140, DOI 10.1161/01.RES.32.2.140; COOPER G, 1986, CIRC RES, V58, P692, DOI 10.1161/01.RES.58.5.692; COOPER G, 1973, CIRC RES, V33, P213, DOI 10.1161/01.RES.33.2.213; COOPER G, 1981, CIRC RES, V48, P488, DOI 10.1161/01.RES.48.4.488; COOPER G, 2007, CONGESTIVE HEART FAI, P52; Cooper G, 2006, AM J PHYSIOL-HEART C, V291, pH1003, DOI 10.1152/ajpheart.00132.2006; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Ferrer I, 2002, ACTA NEUROPATHOL, V104, P658, DOI 10.1007/s00401-002-0600-2; HAGESTEDT T, 1989, J CELL BIOL, V109, P1643, DOI 10.1083/jcb.109.4.1643; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Hein S, 2008, AM J PHYSIOL-HEART C, V294, pH1130, DOI 10.1152/ajpheart.91528.2007; Iida J, 2002, J MOL BIOL, V320, P97, DOI 10.1016/S0022-2836(02)00402-3; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; IRMINGERFINGER I, 1990, J CELL BIOL, V111, P2563, DOI 10.1083/jcb.111.6.2563; IVESTER CT, 1995, J BIOL CHEM, V270, P21950, DOI 10.1074/jbc.270.37.21950; Kitazawa H, 2000, CELL STRUCT FUNCT, V25, P33, DOI 10.1247/csf.25.33; Knapp DR, 2002, METHOD ENZYMOL, V343, P157; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; Mangan ME, 1996, DEVELOPMENT, V122, P771; Narishige T, 1999, J BIOL CHEM, V274, P9692, DOI 10.1074/jbc.274.14.9692; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; OSTLUND RE, 1979, ANAL BIOCHEM, V96, P155, DOI 10.1016/0003-2697(79)90568-2; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; PARDEE AB, 1985, BIOESSAYS, V2, P37, DOI 10.1002/bies.950020112; Permana S, 2005, CELL STRUCT FUNCT, V29, P147, DOI 10.1247/csf.29.147; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Scholz D, 2008, AM J PHYSIOL-HEART C, V294, pH1135, DOI 10.1152/ajpheart.01275.2007; Schwab C, 2000, NEUROBIOL AGING, V21, P503, DOI 10.1016/S0197-4580(00)00110-X; Tagawa H, 1996, P ASSOC AM PHYSICIAN, V108, P218; Tagawa H, 1996, CIRCULATION, V93, P1230, DOI 10.1161/01.CIR.93.6.1230; Takahashi M, 2003, AM J PHYSIOL-HEART C, V285, pH2072, DOI 10.1152/ajpheart.00396.2003; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; TSUTSUI H, 1993, SCIENCE, V260, P682, DOI 10.1126/science.8097594; TSUTSUI H, 1994, CIRCULATION, V90, P533, DOI 10.1161/01.CIR.90.1.533; Wada H, 1996, J BIOL CHEM, V271, P8359, DOI 10.1074/jbc.271.14.8359; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; WEST RR, 1991, J BIOL CHEM, V266, P21886; YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0	59	24	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21837	21848		10.1074/jbc.M110.120709	http://dx.doi.org/10.1074/jbc.M110.120709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20436166	Green Published, hybrid			2022-12-25	WOS:000279516100068
J	Kim, KS; Park, JY; Jou, I; Park, SM				Kim, Kwang Soo; Park, Ji-Young; Jou, Ilo; Park, Sang Myun			Regulation of Weibel-Palade Body Exocytosis by alpha-Synuclein in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; FAMILIAL PARKINSONS-DISEASE; CHAPERONE-LIKE ACTIVITY; PROTEIN-KINASE-C; IN-VITRO; ALZHEIMERS-DISEASE; MEDIATED RELEASE; PHORBOL ESTERS; LEWY BODIES; WILD-TYPE	alpha-Synuclein is a small presynaptic protein implicated in the pathogenesis of Parkinson disease. Nevertheless, its physiological roles and mechanisms remain incompletely understood. alpha-Synuclein is not only expressed in neurons but also in the vascular endothelium, which contains intracellular granules called Weibel-Palade bodies (WPBs) that contain a number of chemokines, adhesive molecules, and inflammatory cytokines. This study explored whether the exocytosis of WPB is regulated by alpha-synuclein. Phorbol 12-myristate 13-acetate-, thrombin-, or forskolin-induced von Willebrand factor release or translocation of P-selectin from endothelial cells were inhibited by alpha-and alpha-synuclein but not alpha-synuclein. Three point mutants (A30P, A53T, and E46K) found in familial Parkinson disease also inhibited WPB exocytosis similar to that of wild-type alpha-synuclein. Furthermore, the negative regulation of WPB exocytosis required the N terminus or the nonamyloid beta-component of Alzheimer disease amyloid region of alpha-synuclein, but not the C-terminal acidic tail, and alpha-synuclein affected WPB exocytosis through interference with RalA activation by enhancing the interaction of RalGDS-beta-arrestin complexes. Immuno-EM analysis revealed that alpha-synuclein was localized close to WPBs. These findings imply that alpha-synuclein plays as a negative regulator in WPB exocytosis in endothelial cells.	[Park, Sang Myun] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 442721, South Korea; [Kim, Kwang Soo; Park, Ji-Young; Jou, Ilo; Park, Sang Myun] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 442721, South Korea	Ajou University; Ajou University	Park, SM (corresponding author), Ajou Univ, Sch Med, Dept Pharmacol, San 5, Suwon 442721, South Korea.	sangmyun@ajou.ac.kr			Korean Government [KRF-2008-331-E00016]; Korea Science and Engineering Foundation through Chronic Inflammatory Disease Research Center Ajou University [R13-2003-019]	Korean Government(Korean Government); Korea Science and Engineering Foundation through Chronic Inflammatory Disease Research Center Ajou University	This work was supported in part by National Research Foundation of Korea Grant KRF-2008-331-E00016 funded by the Korean Government and the Korea Science and Engineering Foundation through Chronic Inflammatory Disease Research Center Ajou University Grant R13-2003-019.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahn BH, 2002, J BIOL CHEM, V277, P12334, DOI 10.1074/jbc.M110414200; Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Baba M, 1998, AM J PATHOL, V152, P879; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Bouley DM, 2001, INFECT IMMUN, V69, P7820, DOI 10.1128/IAI.69.12.7820-7831.2001; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; de Leeuw HPJC, 2001, ARTERIOSCL THROM VAS, V21, P899, DOI 10.1161/01.ATV.21.6.899; Disse J, 2009, BLOOD, V113, P973, DOI 10.1182/blood-2008-06-165282; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; HAMILTON KK, 1987, J CLIN INVEST, V79, P600, DOI 10.1172/JCI112853; Hashimoto M, 1997, BIOCHEM BIOPH RES CO, V237, P611, DOI 10.1006/bbrc.1997.6978; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SB, 2009, BIOCHEM BIOPH RES CO, V381, P39, DOI 10.1016/j.bbrc.2009.02.002; Lee SJ, 2008, ACTA NEUROBIOL EXP, V68, P509; LEVINE JD, 1982, BLOOD, V60, P531; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Matsushita K, 2005, J CELL BIOL, V170, P73, DOI 10.1083/jcb.200502031; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Parihar MS, 2009, INT J BIOCHEM CELL B, V41, P2015, DOI 10.1016/j.biocel.2009.05.008; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Park SM, 2002, BLOOD, V100, P2506, DOI 10.1182/blood.V100.7.2506; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; Rondaij MG, 2004, ARTERIOSCL THROM VAS, V24, P1315, DOI 10.1161/01.ATV.0000131267.13425.45; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Saha AR, 2000, EUR J NEUROSCI, V12, P3073, DOI 10.1046/j.1460-9568.2000.00210.x; Shin EC, 2000, MOL CELLS, V10, P65, DOI 10.1007/s100590070011; Silinsky EM, 2003, BRIT J PHARMACOL, V138, P1191, DOI 10.1038/sj.bjp.0705213; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Surguchov A, 1999, MOL CELL NEUROSCI, V13, P95, DOI 10.1006/mcne.1999.0735; Tamo W, 2002, NEUROSCI LETT, V326, P5, DOI 10.1016/S0304-3940(02)00297-5; Vischer UM, 1997, THROMB HAEMOSTASIS, V77, P1182; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	59	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21416	21425		10.1074/jbc.M110.103499	http://dx.doi.org/10.1074/jbc.M110.103499			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448034	Green Published, hybrid			2022-12-25	WOS:000279516100028
J	Rah, SY; Mushtaq, M; Nam, TS; Kim, SH; Kim, UH				Rah, So-Young; Mushtaq, Mazhar; Nam, Tae-Sik; Kim, Suhn Hee; Kim, Uh-Hyun			Generation of Cyclic ADP-ribose and Nicotinic Acid Adenine Dinucleotide Phosphate by CD38 for Ca2+ Signaling in Interleukin-8-treated Lymphokine-activated Killer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CALCIUM-MOBILIZING METABOLITE; PANCREATIC-ACINAR-CELLS; CADP-RIBOSE; NANOMOLAR SENSITIVITY; CYCLASE ACTIVATION; INTRACELLULAR CA2+; HUMAN ERYTHROCYTES; HUMAN NEUTROPHILS; CARDIAC MYOCYTES	We have previously demonstrated that cyclic ADP-ribose (cADPR) is a calcium signaling messenger in interleukin 8 (IL-8)-induced lymphokine-activated killer (LAK) cells. In this study we examined the possibility that IL-8 activates CD38 to produce another messenger, nicotinic acid adenine dinucleotide phosphate (NAADP), in LAK cells, and we showed that IL-8 induced NAADP formation after cADPR production. These calcium signaling messengers were not produced when LAK cells prepared from CD38 knock-out mice were treated with IL-8, indicating that the synthesis of both NAADP and cADPR is catalyzed by CD38 in LAK cells. Application of cADPR to LAK cells induced NAADP production, where as NAADP failed to increase intracellular cADPR levels, confirming that the production of cADPR precedes that of NAADP in IL-8-treated LAK cells. Moreover, NAADP increased intracellular Ca2+ signaling as well as cell migration, which was completely blocked by bafilomycin A1, suggesting that NAADP is generated in lysosome-related organelles after cADPR production. IL-8 or exogenous cADPR, but not NAADP, increased intracellularc AMP levels. cGMP analog, 8-(4-chlorophenylthio)-guanosine 3',5'-cyclic monophosphate, increased both cADPR and NAADP production, whereas the cAMP analog, 8-(4-chlorophenylthio)-cAMP, increased only NAADP production, suggesting that cAMP is essential for IL-8-induced NAADP formation. Furthermore, activation of Rap1, a downstream molecule of Epac, was required for IL-8-induced NAADP formation in LAK cells. Taken together, our data suggest that IL-8-induced NAADP production is mediated by CD38 activation through the actions of cAMP/Epac/proteinkinase A/Rap1 in LAK cells and that NAADP plays a key role in Ca2+ signaling of IL-8-induced LAK cell migration.	[Rah, So-Young; Mushtaq, Mazhar; Nam, Tae-Sik; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea; [Kim, Suhn Hee] Chonbuk Natl Univ, Sch Med, Dept Physiol, Jeonju 561182, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Inst Cardiovasc Res, Jeonju 561182, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr	Mushtaq, Mazhar/L-3366-2019	Mushtaq, Mazhar/0000-0002-2126-924X; Kim, Uh-Hyun/0000-0003-3304-7190; Rah, So-Young/0000-0002-0255-1960	Korea Science and Engineering Foundation [R0A-2007-000-20121-0]; Korea Research Foundation [KRF-2008-359-E00004]; Chonbuk National University [2007]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea); Chonbuk National University	This work was supported by Korea Science and Engineering Foundation Grant R0A-2007-000-20121-0 (to U.-H. K.) and by Korea Research Foundation Grant KRF-2008-359-E00004 (to S.-Y.R.).; Supported by the Chonbuk National University Postdoctoral Fellowship Program (2007).	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; BASSE P, 1991, J EXP MED, V174, P479, DOI 10.1084/jem.174.2.479; Billington RA, 2006, FASEB J, V20, P521, DOI 10.1096/fj.05-5058fje; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Chu H, 2008, J IMMUNOL, V181, P3373, DOI 10.4049/jimmunol.181.5.3373; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; DAGNINO L, 1991, J BIOL CHEM, V266, P6308; Franco L, 1998, FASEB J, V12, P1507; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R, 2002, BIOCHEM J, V367, P163, DOI 10.1042/BJ20020644; Graeff RM, 1998, J BIOL CHEM, V273, P118, DOI 10.1074/jbc.273.1.118; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Gul R, 2008, AM J PHYSIOL-HEART C, V295, pH77, DOI 10.1152/ajpheart.01355.2007; Guo FF, 2001, J BIOL CHEM, V276, P25568, DOI 10.1074/jbc.M101277200; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Harmer AR, 2001, BIOCHEM J, V353, P555, DOI 10.1042/0264-6021:3530555; Higashida H, 1997, J BIOL CHEM, V272, P31272, DOI 10.1074/jbc.272.50.31272; Higashida H, 1999, J BIOL CHEM, V274, P33348, DOI 10.1074/jbc.274.47.33348; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Institute of Laboratory Animal Resources Commission on Life Sciences National Research Council, 1996, GUIDE CARE USE LAB A, P8; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; Kim SY, 2008, AM J PHYSIOL-RENAL, V294, pF982, DOI 10.1152/ajprenal.00483.2007; KIM UH, 1993, BIOCHIM BIOPHYS ACTA, V1178, P121, DOI 10.1016/0167-4889(93)90001-6; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1995, J BIOL CHEM, V270, P9060, DOI 10.1074/jbc.270.16.9060; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; LUND F, 1995, IMMUNOL TODAY, V16, P469, DOI 10.1016/0167-5699(95)80029-8; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Podesta M, 2005, J BIOL CHEM, V280, P5343, DOI 10.1074/jbc.M408085200; QUILLIAM LA, 1991, J IMMUNOL, V147, P1628; Rah SY, 2007, J BIOL CHEM, V282, P5653, DOI 10.1074/jbc.M609478200; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; SEBOK K, 1993, J IMMUNOL, V150, P1524; Shimomura H, 2004, ARCH BIOCHEM BIOPHYS, V431, P124, DOI 10.1016/j.abb.2004.07.021; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Somekawa S, 2005, CIRC RES, V97, P655, DOI 10.1161/01.RES.0000183880.49270.f9; Steen M, 2007, J BIOL CHEM, V282, P18864, DOI 10.1074/jbc.M610925200; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Wilson HL, 1998, BIOCHEM J, V331, P837, DOI 10.1042/bj3310837; Xie GH, 2003, BIOCHEM BIOPH RES CO, V307, P713, DOI 10.1016/S0006-291X(03)01240-3; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	60	54	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21877	21887		10.1074/jbc.M109.066290	http://dx.doi.org/10.1074/jbc.M109.066290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442403	hybrid, Green Published			2022-12-25	WOS:000279516100072
J	Wang, HS; Kim, SS; Zhuo, M				Wang, Hansen; Kim, Susan S.; Zhuo, Min			Roles of Fragile X Mental Retardation Protein in Dopaminergic Stimulation-induced Synapse-associated Protein Synthesis and Subsequent alpha-Amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; PREFRONTAL CORTEX NEURONS; MAMMALIAN TARGET; SIGNALING PATHWAY; GENETIC-EVIDENCE; D1 RECEPTORS; TRANSLATIONAL CONTROL; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS	Fragile X syndrome, the most common form of inherited mental retardation, is caused by the absence of the RNA-binding protein fragile X mental retardation protein (FMRP). FMRP regulates local protein synthesis in dendritic spines. Dopamine (DA) is involved in the modulation of synaptic plasticity. Activation of DA receptors can regulate higher brain functions in a protein synthesis-dependent manner. Our recent study has shown that FMRP acts as a key messenger for DA modulation in forebrain neurons. Here, we demonstrate that FMRP is critical for DA D1 receptor-mediated synthesis of synapse-associated protein 90/PSD-95-associated protein 3 (SAPAP3) in the prefrontal cortex (PFC). DA D1 receptor stimulation induced dynamic changes of FMRP phosphorylation. The changes in FMRP phosphorylation temporally correspond with the expression of SAPAP3 after D1 receptor stimulation. Protein phosphatase 2A, ribosomal protein S6 kinase, and mammalian target of rapamycin are the key signaling molecules for FMRP linking DA D1 receptors to SAPAP3. Knockdown of SAPAP3 did not affect surface expression of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) GluR1 receptors induced by D1 receptor activation but impaired their subsequent internalization in cultured PFC neurons; the subsequent internalization of GluR1 was also impaired in Fmr1 knock-out PFC neurons, suggesting that FMRP may be involved in subsequent internalization of GluR1 through regulating the abundance of SAPAP3 after DA D1 receptor stimulation. Our study thus provides further insights into FMRP involvement in DA modulation and may help to reveal the molecular mechanisms underlying impaired learning and memory in fragile X syndrome.	[Wang, Hansen; Kim, Susan S.; Zhuo, Min] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Zhuo, M (corresponding author), Univ Toronto, Fac Med, Dept Physiol, Med Sci Bldg,Rm 3342,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	min.zhuo@utoronto.ca	Zhuo, Min/A-2072-2008; wang, hansen/I-2510-2019; Cabrera, Mariel/GMX-2706-2022	Zhuo, Min/0000-0001-9062-3241; wang, hansen/0000-0003-4414-3372; 	EJLB Canadian Institutes of Health Research Michael Smith Chair in Neurosciences and Mental Health; Canada Research Chair; NeuroCanada; Canadian Institutes of Health [CIHR66975, CIHR81086]; Fragile X Research Foundation of Canada	EJLB Canadian Institutes of Health Research Michael Smith Chair in Neurosciences and Mental Health(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NeuroCanada; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Fragile X Research Foundation of Canada	This work was supported by grants from the EJLB Canadian Institutes of Health Research Michael Smith Chair in Neurosciences and Mental Health, Canada Research Chair, and NeuroCanada and by Canadian Institutes of Health Research Operating Grants CIHR66975 and CIHR81086 (to M. Z.). 1 Supported by a postdoctoral fellowship from the Fragile X Research Foundation of Canada.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Bingol B, 2004, NEUROPHARMACOLOGY, V47, P755, DOI 10.1016/j.neuropharm.2004.07.028; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Chen L, 2007, J NEUROPHYSIOL, V97, P2448, DOI 10.1152/jn.00317.2006; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008; Dounay AB, 2002, CURR MED CHEM, V9, P1939, DOI 10.2174/0929867023368791; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Gong B, 2007, EUR J NEUROSCI, V26, P275, DOI 10.1111/j.1460-9568.2007.05669.x; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huang YY, 2007, LEARN MEMORY, V14, P497, DOI 10.1101/lm.593407; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; Nagai T, 2007, LEARN MEMORY, V14, P117, DOI 10.1101/lm.461407; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Paspalas CD, 2005, J NEUROSCI, V25, P1260, DOI 10.1523/JNEUROSCI.3436-04.2005; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Polakiewicz RD, 1998, J BIOL CHEM, V273, P23534, DOI 10.1074/jbc.273.36.23534; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Ronesi JA, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.15pe6; Saitoh M, 2002, J BIOL CHEM, V277, P20104, DOI 10.1074/jbc.M201745200; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Schicknick H, 2008, CEREB CORTEX, V18, P2646, DOI 10.1093/cercor/bhn026; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Shang YZ, 2009, J NEUROCHEM, V111, P635, DOI 10.1111/j.1471-4159.2009.06314.x; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; SLOBODYANSKY E, 1995, AM J PHYSIOL-RENAL, V268, pF279, DOI 10.1152/ajprenal.1995.268.2.F279; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Snyder SH, 2006, NEURON, V49, P484, DOI 10.1016/j.neuron.2006.02.002; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Swayze RD, 2004, NEUROPHARMACOLOGY, V47, P764, DOI 10.1016/j.neuropharm.2004.07.014; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Terracciano A, 2005, AM J MED GENET C, V137C, P32, DOI 10.1002/ajmg.c.30062; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; Wang HS, 2008, J NEUROSCI, V28, P4385, DOI 10.1523/JNEUROSCI.0646-08.2008; Wang HS, 2007, J BIOL CHEM, V282, P1507, DOI 10.1074/jbc.M607291200; Wang HS, 2009, J BIOL CHEM, V284, P18953, DOI 10.1074/jbc.M109.019141; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Weinshenker D, 2008, NATURE, V455, P607, DOI 10.1038/455607a; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Welch JM, 2004, J COMP NEUROL, V472, P24, DOI 10.1002/cne.20060; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Wolf ME, 2003, ANN NY ACAD SCI, V1003, P241, DOI 10.1196/annals.1300.015; Yan Z, 1999, P NATL ACAD SCI USA, V96, P11607, DOI 10.1073/pnas.96.20.11607; Yang CR, 1996, J NEUROSCI, V16, P1922; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005	80	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21888	21901		10.1074/jbc.M110.116293	http://dx.doi.org/10.1074/jbc.M110.116293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20457613	hybrid, Green Published			2022-12-25	WOS:000279516100073
J	Sauzeau, V; Berenjeno, IM; Citterio, C; Bustelo, XR				Sauzeau, V.; Berenjeno, I. M.; Citterio, C.; Bustelo, X. R.			A transcriptional cross-talk between RhoA and c-Myc inhibits the RhoA/Rock-dependent cytoskeleton	ONCOGENE			English	Article						RhoA; c-Myc; Pak; integrin; stress fibers; gene expression	GTP-BINDING PROTEINS; ROCK-I; KINASE; ACTIVATION; GTPASES; DEGRADATION; DISTINCT; MYOSIN; FAMILY; TARGET	The GTPase RhoA participates in a number of cellular processes, including cytoskeletal organization, mitogenesis and tumorigenesis. We have previously shown that the transforming activity of an oncogenic version of RhoA (Q63L mutant) was highly dependent on the transcriptional factor c-Myc. In contrast to these positive effects in the RhoA route, we show here that c-Myc affects negatively the F-actin cytoskeleton induced by RhoA(Q63L) and its downstream effector, the serine/threonine kinase Rock. This effect entails the activation of a transcriptional program that requires synergistic interactions with RhoA-derived signals and that includes the upregulation of the GTPase Cdc42 and its downstream element Pak1 as well as the repression of specific integrin subunits. The negative effects of c-Myc in the F-actin cytoskeleton are eliminated by the establishment of cell-to-cell contacts, an effect associated with the rescue of Pak1 and integrin levels at the post-transcriptional and transcriptional levels, respectively. These results reveal the presence of a hitherto unknown signaling feed-back loop between RhoA and c-Myc oncogenes that can contribute to maintain fluid cytoskeletal dynamics in cancer cells. Oncogene (2010) 29, 3781-3792; doi: 10.1038/onc.2010.134; published online 10 May 2010	[Sauzeau, V.; Berenjeno, I. M.; Citterio, C.; Bustelo, X. R.] Univ Salamanca, CSIC, Ctr Invest Canc, E-37007 Salamanca, Spain; [Sauzeau, V.; Berenjeno, I. M.; Citterio, C.; Bustelo, X. R.] Univ Salamanca, CSIC, IBMCC, E-37007 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Bustelo, XR (corresponding author), Univ Salamanca, CSIC, Ctr Invest Canc, Campus Unamuno, E-37007 Salamanca, Spain.	xbustelo@usal.es	Sauzeau, Vincent/D-3548-2015; Bustelo, Xose R./A-9526-2010; Bustelo, Xose R./AAD-2081-2022	Bustelo, Xose R./0000-0001-9398-6072; Bustelo, Xose R./0000-0001-9398-6072; Sauzeau, Vincent/0000-0002-6187-0312	NIH [5R01CA73735]; Spanish Ministry of Science and Innovation [SAF2006-01789, GEN2003-20239-C06-01]; Red Tematica de Investigacion Cooperativa en Cancer [RD06/0020/0001]; Castilla y Leon Autonomous Government [GR97]; European Union [FP7-HEALTH-2007-A-201862]; NATIONAL CANCER INSTITUTE [R01CA073735] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer; Castilla y Leon Autonomous Government; European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M Blazquez for technical help. XRB work is supported by grants from the NIH (5R01CA73735), the Spanish Ministry of Science and Innovation (SAF2006-01789, GEN2003-20239-C06-01), the Red Tematica de Investigacion Cooperativa en Cancer (RD06/0020/0001), the Castilla y Leon Autonomous Government (GR97), and the 7th Framework European Union Program (FP7-HEALTH-2007-A-201862).	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Berenjeno IM, 2007, ONCOGENE, V26, P4295, DOI 10.1038/sj.onc.1210194; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Guo FK, 2004, ONCOGENE, V23, P5577, DOI 10.1038/sj.onc.1207752; Hatzoglou A, 2007, MOL BIOL CELL, V18, P1242, DOI 10.1091/mbc.E06-06-0510; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lee HH, 2008, J CELL BIOL, V181, P999, DOI 10.1083/jcb.200710187; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 1999, CURR BIOL, V9, P136, DOI 10.1016/S0960-9822(99)80067-0; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8	30	17	18	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2010	29	26					3781	3792		10.1038/onc.2010.134	http://dx.doi.org/10.1038/onc.2010.134			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	618VW	20453885	Green Accepted, Green Submitted			2022-12-25	WOS:000279385200006
J	Pimiento, C; Ehret, DJ; MacFadden, BJ; Hubbell, G				Pimiento, Catalina; Ehret, Dana J.; MacFadden, Bruce J.; Hubbell, Gordon			Ancient Nursery Area for the Extinct Giant Shark Megalodon from the Miocene of Panama	PLOS ONE			English	Article							SPHYRNA-LEWINI GRIFFITH; OFFSHORE FORAGING AREA; CARCHARODON-CARCHARIAS; WHITE SHARK; ONTOGENIC CHANGES; SOUTH-CAROLINA; KANEOHE BAY; CALIFORNIA; MIGRATION; BEHAVIOR	Background: As we know from modern species, nursery areas are essential shark habitats for vulnerable young. Nurseries are typically highly productive, shallow-water habitats that are characterized by the presence of juveniles and neonates. It has been suggested that in these areas, sharks can find ample food resources and protection from predators. Based on the fossil record, we know that the extinct Carcharocles megalodon was the biggest shark that ever lived. Previous proposed paleo-nursery areas for this species were based on the anecdotal presence of juvenile fossil teeth accompanied by fossil marine mammals. We now present the first definitive evidence of ancient nurseries for C. megalodon from the late Miocene of Panama, about 10 million years ago. Methodology/Principal Findings: We collected and measured fossil shark teeth of C. megalodon, within the highly productive, shallow marine Gatun Formation from the Miocene of Panama. Surprisingly, and in contrast to other fossil accumulations, the majority of the teeth from Gatun are very small. Here we compare the tooth sizes from the Gatun with specimens from different, but analogous localities. In addition we calculate the total length of the individuals found in Gatun. These comparisons and estimates suggest that the small size of Gatun's C. megalodon is neither related to a small population of this species nor the tooth position within the jaw. Thus, the individuals from Gatun were mostly juveniles and neonates, with estimated body lengths between 2 and 10.5 meters. Conclusions/Significance: We propose that the Miocene Gatun Formation represents the first documented paleo-nursery area for C. megalodon from the Neotropics, and one of the few recorded in the fossil record for an extinct selachian. We therefore show that sharks have used nursery areas at least for 10 millions of years as an adaptive strategy during their life histories.	[Pimiento, Catalina] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Pimiento, Catalina; Ehret, Dana J.; MacFadden, Bruce J.] Univ Florida, Florida Museum Nat Hist, Div Vertebrate Paleontol, Gainesville, FL 32611 USA; [Pimiento, Catalina] Smithsonian Trop Res Inst, Ctr Paleoecol & Archaeol, Panama City, Panama; [Ehret, Dana J.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA; [MacFadden, Bruce J.] Natl Sci Fdn, Div Res Learning Educ & Human Resources, Arlington, VA 22230 USA; [Hubbell, Gordon] Jaws Int, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian Tropical Research Institute; State University System of Florida; University of Florida; National Science Foundation (NSF)	Pimiento, C (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.	pimientoc@ufl.edu	Pimiento, Catalina/ABF-1204-2020	Pimiento, Catalina/0000-0002-5320-7246; Ehret, Dana/0000-0002-5041-5699	NSF [EAR 0418042]; Sigma [Xi G2009100426]; Florida Museum of Natural History; Smithsonian Tropical Research Institute; Mitchell Hope Scholarship; Ken Ericson Scholarship	NSF(National Science Foundation (NSF)); Sigma; Florida Museum of Natural History; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Mitchell Hope Scholarship; Ken Ericson Scholarship	This project was funded by NSF EAR 0418042 (http://www.nsf.gov/funding), Sigma Xi G2009100426 (http://www.sigmaxi.org/programs/giar/index.shtml), The Florida Museum of Natural History (www.flmnh.ufl.edu), The Smithsonian Tropical Research Institute (www.stri.org), The Mitchell Hope Scholarship(http://www.southwestfloridafossilclub.com/) and the Ken Ericson Scholarship(http://www.flmnh.ufl.edu/vertpaleo/kenericsonscholarship.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA O, 1996, PALCOBIOTIC SURVEY C, P251; AINLEY DG, 1985, S CALIF ADAC SCI MEM, V8, P109; Alejo-Plata C, 2007, REV BIOL MAR OCEANOG, V42, P403; Applegate SP, 1996, GREAT WHITE SHARKS, P19, DOI 10.1016/B978-012415031-7/50005-7; Blake S.F., 1862, GEOLOGIST, V5, P316; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; Bush A, 2002, J EXP MAR BIOL ECOL, V278, P157, DOI 10.1016/S0022-0981(02)00332-5; Cappetta H., 1987, HDB PALEOICHTHYOLO B, V3B; Casier E., 1960, Ann Mus Congo belge A III, V1, P1; CASTRO JI, 1993, ENVIRON BIOL FISH, V38, P37, DOI 10.1007/BF00842902; CLIFF G, 1989, SHARKS CAUGHT PROTEC, V2, P131; COATES AG, 1996, B PALEONTOLOGICAL RE, V357, P17; Coates Anthony G., 1996, P21; Collins LS, 1996, GEOLOGY, V24, P687, DOI 10.1130/0091-7613(1996)024<0687:TLMPIS>2.3.CO;2; Dewar H, 2004, ENVIRON BIOL FISH, V70, P133, DOI 10.1023/B:EBFI.0000029343.54027.6a; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Ebert DA, 2002, MAR FRESHWATER RES, V53, P517, DOI 10.1071/MF01143; Ehret DJ, 2009, J VERTEBR PALEONTOL, V29, P1; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Ferreira CA, 1996, GREAT WHITE SHARKS, P381, DOI 10.1016/B978-012415031-7/50036-7; Gillette D.D., 1984, Journal of Vertebrate Paleontology, V4, P172; GLUCKMAN LS, 1964, SHARKS PALEOGENE STR; Goldman KJ, 1999, ENVIRON BIOL FISH, V56, P351, DOI 10.1023/A:1007520931105; Gottfried MD, 1996, GREAT WHITE SHARKS, P55, DOI 10.1016/B978-012415031-7/50008-2; Gussone N, 2004, EARTH PLANET SC LETT, V227, P201, DOI 10.1016/j.epsl.2004.09.004; Haug GH, 2001, GEOLOGY, V29, P207, DOI 10.1130/0091-7613(2001)029<0207:ROPUOO>2.0.CO;2; Heihaus Michael R., 2007, V50, P3; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; Hubbell G, 1996, GREAT WHITE SHARKS, P9, DOI 10.1016/B978-012415031-7/50004-5; Jordan D. S., 1923, Bulletin of the Southern California Academy of Sciences, V22, P27; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Lowe CG, 2002, J EXP MAR BIOL ECOL, V278, P141, DOI 10.1016/S0022-0981(02)00331-3; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; MacFadden B.J., 1992, FOSSIL HORSES SYSTEM; MCCANDLESS CT, 2007, AM FISHERIES SOC S, V50, P1; McElroy WD, 2006, ENVIRON BIOL FISH, V76, P81, DOI 10.1007/s10641-006-9010-y; MORGAN GS, 1994, CONTRIBUTIONS MARINE, P239; Nasby-Lucas N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008163; Nyberg KG, 2006, J VERTEBR PALEONTOL, V26, P806, DOI 10.1671/0272-4634(2006)26[806:TTAOTG]2.0.CO;2; PIMIENTO C, 2010, SYSTEMATICS PALEOBIO; Purdy RW, 1996, GREAT WHITE SHARKS, P67, DOI 10.1016/B978-012415031-7/50009-4; Purdy RW, 2001, SM C PALEOB, V90, P71; Purdy RW, 1998, T AM PHILOS SOC, V88, P122, DOI 10.2307/1006671; Shimada K., 2003, J FOSSIL RES, V35, P28; Teranes Jane L., 1996, P105; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; Voorhies M.R., 2004, LATE CRETACEOUS CENO; Ward David J., 2001, Central Mediterranean Naturalist, V3, P131; Ward Lauck W., 2008, Virginia Museum of Natural History Special Publication, V14, P325; Yamaguchi A, 2000, FISHERIES SCI, V66, P1039, DOI 10.1046/j.1444-2906.2000.00166.x; ZHELEZKO V, 1999, ELASMOBRANCHII PALEO, V3	52	64	69	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10552	10.1371/journal.pone.0010552	http://dx.doi.org/10.1371/journal.pone.0010552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479893	gold, Green Published, Green Submitted			2022-12-25	WOS:000277467900008
J	Sun, JJ; Collier, RJ				Sun, Jianjun; Collier, R. John			Disulfide Bonds in the Ectodomain of Anthrax Toxin Receptor 2 Are Required for the Receptor-Bound Protective-Antigen Pore to Function	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; INFANTILE SYSTEMIC HYALINOSIS; CRYSTAL-STRUCTURE; MUTATIONS; CELLS; FORMS; TRANSLOCATION; FIBROMATOSIS; GENE; EXPRESSION	Background: Cell-surface receptors play essential roles in anthrax toxin action by providing the toxin with a high-affinity anchor and self-assembly site on the plasma membrane, mediating the toxin entry into cells through endocytosis, and shifting the pH threshold for prepore-to-pore conversion of anthrax toxin protective antigen (PA) to a more acidic pH, thereby inhibiting premature pore formation. Each of the two known anthrax toxin receptors, ANTXR1 and ANTXR2, has an ectodomain comprised of an N-terminal von Willebrand factor A domain (VWA), which binds PA, and an uncharacterized immunoglobulin-like domain (Ig) that connects VWA to the membrane-spanning domain. Potential roles of the receptor Ig domain in anthrax toxin action have not been investigated heretofore. Methodology/Principal Findings: We expressed and purified the ANTXR2 ectodomain (R2-VWA-Ig) in E. coli and showed that it contains three disulfide bonds: one in R2-VWA and two in R2-Ig. Reduction of the ectodomain inhibited functioning of the pore, as measured by K(+) release from liposomes or Chinese hamster ovary cells or by PA-mediated translocation of a model substrate across the plasma membrane. However, reduction did not affect binding of the ectodomain to PA or the transition of ectodomain-bound PA prepore to the pore conformation. The inhibitory effect depended specifically on reduction of the disulfides within R2-Ig. Conclusions/Significance: We conclude that disulfide integrity within R2-Ig is essential for proper functioning of receptor-bound PA pore. This finding provides a novel venue to investigate the mechanism of anthrax toxin action and suggests new strategies for inhibiting toxin action.	[Sun, Jianjun; Collier, R. John] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sun, JJ (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	jsun@utep.edu		Collier, R John/0000-0002-2427-4239	NIAID [RO1-AI022021]; UTEP-New faculty Start-UP fund; NIH [5G12RR008124]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022021] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UTEP-New faculty Start-UP fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIAID grant RO1-AI022021 (to R.J.C.), UTEP-New faculty Start-UP fund (to J.S.) and NIH Grant #5G12RR008124 (To UTEP-BBRC DNA Analysis core facility and Biomolecule Analysis core facility). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antaya RJ, 2007, AM J DERMATOPATH, V29, P99, DOI 10.1097/01.dad.0000245636.39098.e5; Austin CD, 2005, P NATL ACAD SCI USA, V102, P17987, DOI 10.1073/pnas.0509035102; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bell SE, 2001, J CELL SCI, V114, P2755; Bonuccelli G, 2005, AM J PHYSIOL-CELL PH, V288, pC1402, DOI 10.1152/ajpcell.00582.2004; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Dowling O, 2003, AM J HUM GENET, V73, P957, DOI 10.1086/378781; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; HA SD, 2009, J BIOL CHEM; Hanks S, 2003, AM J HUM GENET, V73, P791, DOI 10.1086/378418; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Lee JYY, 2005, CLIN EXP DERMATOL, V30, P176, DOI 10.1111/j.1365-2230.2004.01698.x; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Sun J, 2008, P NATL ACAD SCI USA, V105, P4346, DOI 10.1073/pnas.0800701105; Sun JJ, 2007, J BIOL CHEM, V282, P1059, DOI 10.1074/jbc.M609869200; van der Goot G, 2009, MOL ASPECTS MED, V30, P406, DOI 10.1016/j.mam.2009.08.007; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wolfe JT, 2005, J BIOL CHEM, V280, P39417, DOI 10.1074/jbc.M509049200; Yan M, 2003, MOL MED, V9, P46, DOI 10.1007/BF03402106; Yang J, 2006, P NATL ACAD SCI USA, V103, P13872, DOI 10.1073/pnas.0601455103	36	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2010	5	5							e10553	10.1371/journal.pone.0010553	http://dx.doi.org/10.1371/journal.pone.0010553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OJ	20479891	Green Published, gold, Green Submitted			2022-12-25	WOS:000277467900009
J	Formann, AK				Formann, Anton K.			The Newcomb-Benford Law in Its Relation to Some Common Distributions	PLOS ONE			English	Article							SIGNIFICANT-DIGIT; 1ST DIGIT; RANDOM-VARIABLES; NUMBERS; RATIO; ZIPF	An often reported, but nevertheless persistently striking observation, formalized as the Newcomb-Benford law (NBL), is that the frequencies with which the leading digits of numbers occur in a large variety of data are far away from being uniform. Most spectacular seems to be the fact that in many data the leading digit 1 occurs in nearly one third of all cases. Explanations for this uneven distribution of the leading digits were, among others, scale-and base-invariance. Little attention, however, found the interrelation between the distribution of the significant digits and the distribution of the observed variable. It is shown here by simulation that long right-tailed distributions of a random variable are compatible with the NBL, and that for distributions of the ratio of two random variables the fit generally improves. Distributions not putting most mass on small values of the random variable (e. g. symmetric distributions) fail to fit. Hence, the validity of the NBL needs the predominance of small values and, when thinking of real-world data, a majority of small entities. Analyses of data on stock prices, the areas and numbers of inhabitants of countries, and the starting page numbers of papers from a bibliography sustain this conclusion. In all, these findings may help to understand the mechanisms behind the NBL and the conditions needed for its validity. That this law is not only of scientific interest per se, but that, in addition, it has also substantial implications can be seen from those fields where it was suggested to be put into practice. These fields reach from the detection of irregularities in data (e. g. economic fraud) to optimizing the architecture of computers regarding number representation, storage, and round-off errors.	Univ Vienna, Dept Psychol Basic Res, Vienna, Austria	University of Vienna	Formann, AK (corresponding author), Univ Vienna, Dept Psychol Basic Res, Vienna, Austria.	anton.formann@univie.ac.at						Adhikari A. K., 1968, SANKHYA B, V30, P47; ADHIKARI AK, 1969, SANKHYA SER B, V31, P413; [Anonymous], 1994, CONTINUOUS UNIVARIAT; Beer TW, 2009, J CLIN PATHOL, V62, P192, DOI 10.1136/jcp.2008.061721; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; BERGER A, 2010, BENFORD ONLINE BIBLI; Brown A, 1998, IMECHE SEM, V1998, P1; Diekmann A, 2007, J APPL STAT, V34, P321, DOI 10.1080/02664760601004940; Duembgen L, 2008, ELECTRON COMMUN PROB, V13, P99; el Sehity T, 2005, INT J RES MARK, V22, P471, DOI 10.1016/j.ijresmar.2005.09.002; Engel HA, 2003, STAT PROBABIL LETT, V63, P361, DOI 10.1016/S0167-7152(03)00101-9; FURRY WH, 1945, NATURE, V155, P52, DOI 10.1038/155052a0; Giles DE, 2007, APPL ECON LETT, V14, P157, DOI 10.1080/13504850500425667; Gottwald GA, 2002, PHYSICA A, V303, P387, DOI 10.1016/S0378-4371(01)00497-6; Hales DN, 2008, EUR J OPER RES, V189, P583, DOI 10.1016/j.ejor.2006.09.092; Hill TP, 1995, STAT SCI, V10, P354, DOI 10.1214/ss/1177009869; HILL TP, 1995, P AM MATH SOC, V123, P887, DOI 10.2307/2160815; Hill TP, 1998, AM SCI, V86, P358, DOI 10.1511/1998.4.358; HILL TP, 1995, AM MATH MON, V102, P322, DOI 10.2307/2974952; HINKLEY DV, 1969, BIOMETRIKA, V56, P635, DOI 10.1093/biomet/56.3.635; Hurlimann W., 2006, BENFORDS LAW 1881 20; Irmay S, 1997, J APPL STAT, V24, P383, DOI 10.1080/02664769723594; Janvresse T, 2004, J APPL PROBAB, V41, P1203, DOI 10.1239/jap/1101840566; Judge G, 2009, J HUM RESOUR, V44, P1; Kim HJ, 2006, COMMUN STAT-THEOR M, V35, P965, DOI 10.1080/03610920600672229; Knuth D E, 1997, ART COMPUTER PROGRAM, V2; Leemis LM, 2000, AM STAT, V54, P236, DOI 10.2307/2685773; Ley E, 1996, AM STAT, V50, P311, DOI 10.2307/2684926; Lolbert T, 2008, MATH SOC SCI, V55, P103, DOI 10.1016/j.mathsocsci.2007.09.001; Luque B, 2009, P ROY SOC A-MATH PHY, V465, P2197, DOI 10.1098/rspa.2009.0126; MILLER SJ, 2008, ARXIVMATH0601344V5; Newcomb S., 1881, AM J MATH, V4, P39, DOI [10.2307/2369148, DOI 10.2307/2369148]; Nigrini Mark John, 2000, DIGITAL ANAL USING B; Pietronero L, 2001, PHYSICA A, V293, P297, DOI 10.1016/S0378-4371(00)00633-6; PINKHAM RS, 1961, ANN MATH STAT, V32, P1223, DOI 10.1214/aoms/1177704862; RAIMI RA, 1976, AM MATH MON, V83, P521, DOI 10.2307/2319349; Rodriguez RJ, 2004, AM STAT, V58, P64, DOI 10.1198/0003130042782; Schatte P, 1998, STAT PROBABIL LETT, V37, P391, DOI 10.1016/S0167-7152(97)00142-9; Torres J, 2007, EUR J PHYS, V28, pL17, DOI 10.1088/0143-0807/28/3/N04	39	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10541	10.1371/journal.pone.0010541	http://dx.doi.org/10.1371/journal.pone.0010541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	593OI	20479878	Green Published, Green Submitted, gold			2022-12-25	WOS:000277467800022
J	Martinez, O; Reyes-Valdes, MH; Herrera-Estrella, L				Martinez, Octavio; Humberto Reyes-Valdes, M.; Herrera-Estrella, Luis			Cancer Reduces Transcriptome Specialization	PLOS ONE			English	Article							GENE-EXPRESSION; CELL; DIVERSITY; SIGNATURE; ORIGIN	A central goal of cancer biology is to understand how cells from this family of genetic diseases undergo specific morphological and physiological changes and regress to a de-regulated state of the cell cycle. The fact that tumors are unable to perform most of the specific functions of the original tissue led us to hypothesize that the degree of specialization of the transcriptome of cancerous tissues must be less than their normal counterparts. With the aid of information theory tools, we analyzed four datasets derived from transcriptomes of normal and tumor tissues to quantitatively test the hypothesis that cancer reduces transcriptome specialization. Here, we show that the transcriptional specialization of a tumor is significantly less than the corresponding normal tissue and comparable with the specialization of dedifferentiated embryonic stem cells. Furthermore, we demonstrate that the drop in specialization in cancerous tissues is largely due to a decrease in expression of genes that are highly specific to the normal organ. This approach gives us a better understanding of carcinogenesis and offers new tools for the identification of genes that are highly influential in cancer progression.	[Martinez, Octavio; Herrera-Estrella, Luis] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Humberto Reyes-Valdes, M.] Univ Autonoma Agr Antonio Narro, Dept Plant Breeding, Saltillo, Coahuila, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Martinez, O (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.	omartine@ira.cinvestav.mx	Herrera-Estrella, Luis/ABC-7431-2020; Herrera-Estrella, Luis/AAL-2472-2020; Martinez, Octavio/F-3951-2014; Estrella, Luis R Herrera/G-7351-2011	Herrera-Estrella, Luis/0000-0001-7936-3856; Martinez, Octavio/0000-0002-7590-0041; Estrella, Luis R Herrera/0000-0001-7936-3856	Consejo Nacional de Ciencia y Tecnologia (Conacyt); Consejo de Ciencia y Tecnologia del Estado de Guanajuato (Concyteg); Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (Cinvestav); Universidad Autonoma Agraria Antonio Narro (UAAAN)	Consejo Nacional de Ciencia y Tecnologia (Conacyt)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo de Ciencia y Tecnologia del Estado de Guanajuato (Concyteg); Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (Cinvestav); Universidad Autonoma Agraria Antonio Narro (UAAAN)	This work was supported by Consejo Nacional de Ciencia y Tecnologia (Conacyt), Consejo de Ciencia y Tecnologia del Estado de Guanajuato (Concyteg), Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (Cinvestav) and Universidad Autonoma Agraria Antonio Narro (UAAAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Brentani H, 2003, P NATL ACAD SCI USA, V100, P13418, DOI 10.1073/pnas.1233632100; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; CROSBIE RE, 1993, EUROSIM 92 - SIMULATION CONGRESS, P1; Di CH, 2005, CANCER RES, V65, P919; EVERITT BS, 1992, ANAL CONTINGENCY TAB, P1; Ewens W.J., 2001, STAT METHODS BIOINFO; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Inamura K, 2007, HUM PATHOL, V38, P702, DOI 10.1016/j.humpath.2006.11.019; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Klausner RD, 2002, CANCER CELL, V1, P3, DOI 10.1016/S1535-6108(02)00020-X; Lee S, 2007, AM J PATHOL, V171, P252, DOI 10.2353/ajpath.2007.061010; MAJETI R, 2009, P NATL ACAD SCI; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Martinez O, 2008, P NATL ACAD SCI USA, V105, P9709, DOI 10.1073/pnas.0803479105; Mihich E, 2002, CANCER RES, V62, P3883; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Park JC, 2008, BIOCHEM BIOPH RES CO, V365, P221, DOI 10.1016/j.bbrc.2007.10.144; Porter D, 2003, EXPERT OPIN THER TAR, V7, P759; R Development Core Team, 2005, R LANG ENV STAT COMP; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reyes I, 2007, BIOMEDICA, V27, P190; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Riggins GJ, 2001, HUM MOL GENET, V10, P663, DOI 10.1093/hmg/10.7.663; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; SELL S, 1993, ENVIRON HEALTH PERSP, V101, P15, DOI 10.2307/3431838; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Wodarz D, 2005, COMPUTATIONAL BIOLOGY OF CANCER: LECTURE NOTES AND MATHEMATICAL MODELING, P1, DOI 10.1142/9789812701367; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200	33	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10398	10.1371/journal.pone.0010398	http://dx.doi.org/10.1371/journal.pone.0010398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454660	Green Submitted, Green Published, gold			2022-12-25	WOS:000277240300003
J	Kvennefors, ECE; Sampayo, EM; Ridgway, T; Barnes, AC; Hoegh-Guldberg, O				Kvennefors, E. Charlotte E.; Sampayo, Eugenia M.; Ridgway, Tyrone; Barnes, Andrew C.; Hoegh-Guldberg, Ove			Bacterial Communities of Two Ubiquitous Great Barrier Reef Corals Reveals Both Site- and Species-Specificity of Common Bacterial Associates	PLOS ONE			English	Article							BLACK BAND DISEASE; GRADIENT GEL-ELECTROPHORESIS; ACROPORID WHITE SYNDROME; RIBOSOMAL-RNA GENES; PLAGUE-LIKE DISEASE; MICROBIAL COMMUNITIES; CAUSATIVE AGENT; INDO-PACIFIC; SP-NOV.; SCLERACTINIAN CORALS	Background: Coral-associated bacteria are increasingly considered to be important in coral health, and altered bacterial community structures have been linked to both coral disease and bleaching. Despite this, assessments of bacterial communities on corals rarely apply sufficient replication to adequately describe the natural variability. Replicated data such as these are crucial in determining potential roles of bacteria on coral. Methodology/Principal Findings: Denaturing Gradient Gel Electrophoresis (DGGE) of the V3 region of the 16S ribosomal DNA was used in a highly replicated approach to analyse bacterial communities on both healthy and diseased corals. Although site-specific variations in the bacterial communities of healthy corals were present, host species-specific bacterial associates within a distinct cluster of gamma-proteobacteria could be identified, which are potentially linked to coral health. Corals affected by "White Syndrome" (WS) underwent pronounced changes in their bacterial communities in comparison to healthy colonies. However, the community structure and bacterial ribotypes identified in diseased corals did not support the previously suggested theory of a bacterial pathogen as the causative agent of the syndrome. Conclusions/Significance: This is the first study to employ large numbers of replicated samples to assess the bacterial communities of healthy and diseased corals, and the first culture-independent assessment of bacterial communities on WS affected Acroporid corals on the GBR. Results indicate that a minimum of 6 replicate samples are required in order to draw inferences on species, spatial or health-related changes in community composition, as a set of clearly distinct bacterial community profiles exist in healthy corals. Coral bacterial communities may be both site and species specific. Furthermore, a cluster of gamma-proteobacterial ribotypes may represent a group of specific common coral and marine invertebrate associates. Finally, the results did not support the contention that a single bacterial pathogen may be the causative agent of WS Acroporids on the GBR.	[Kvennefors, E. Charlotte E.; Sampayo, Eugenia M.; Ridgway, Tyrone; Barnes, Andrew C.; Hoegh-Guldberg, Ove] Univ Queensland, Ctr Marine Studies, Brisbane, Qld, Australia; [Kvennefors, E. Charlotte E.; Sampayo, Eugenia M.; Hoegh-Guldberg, Ove] Univ Queensland, Australian Res Council, Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia; [Barnes, Andrew C.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Kvennefors, E. Charlotte E.; Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland	Kvennefors, ECE (corresponding author), Univ Queensland, Ctr Marine Studies, Brisbane, Qld, Australia.	c.kvennefors@uq.edu.au	Barnes, Andrew/J-9012-2014; Barnes, Andrew C/G-7334-2012; Kvennefors, Eva Charlotte E/B-9585-2013; Hoegh-Guldberg, Ove/H-6169-2011; Hoegh-Guldberg, Ove/ABA-5420-2020	Barnes, Andrew/0000-0002-3990-8070; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713	Australian Research Council Centre of Excellence for Coral Reef Studies; Coral Reef Targeted Research Project; Centre for Marine Studies and Global Change Institute (The University of Queensland); Australian Coral Reef Society	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Coral Reef Targeted Research Project; Centre for Marine Studies and Global Change Institute (The University of Queensland)(University of Queensland); Australian Coral Reef Society	This project was funded by the Australian Research Council Centre of Excellence for Coral Reef Studies (to OHG), Coral Reef Targeted Research Project to (OHG), Centre for Marine Studies and Global Change Institute (The University of Queensland) and the Australian Coral Reef Society. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2007, MAR BIOL, V151, P19, DOI 10.1007/s00227-006-0449-3; Ainsworth T, 2008, ISME J, V2, P67, DOI 10.1038/ismej.2007.88; Ainsworth TD, 2006, APPL ENVIRON MICROB, V72, P3016, DOI 10.1128/AEM.72.4.3016-3020.2006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Arboleda M, 2009, MICROB ECOL, V57, P117, DOI 10.1007/s00248-008-9400-0; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2005, CORAL REEFS, V24, P304, DOI 10.1007/s00338-005-0479-1; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Brons JK, 2008, APPL ENVIRON MICROB, V74, P2717, DOI 10.1128/AEM.02195-07; Bythell JC, 2002, LETT APPL MICROBIOL, V34, P359, DOI 10.1046/j.1472-765X.2002.01097.x; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Chimetto LA, 2008, SYST APPL MICROBIOL, V31, P312, DOI 10.1016/j.syapm.2008.06.001; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Frias-Lopez J, 2003, APPL ENVIRON MICROB, V69, P2409, DOI 10.1128/AEM.69.4.2409-2413.2003; Frias-Lopez J, 2004, APPL ENVIRON MICROB, V70, P5955, DOI 10.1128/AEM.70.10.5955-5962.2004; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Gloess S, 2008, APPL ENVIRON MICROB, V74, P4231, DOI 10.1128/AEM.02545-07; Guppy R, 2006, MAR ECOL PROG SER, V328, P133, DOI 10.3354/meps328133; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hirst CN, 2007, DIVERS DISTRIB, V13, P361, DOI 10.1111/j.1472-4642.2007.00307.x; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Johnston IS, 2007, CORAL REEFS, V26, P375, DOI 10.1007/s00338-007-0208-z; Kellogg CA, 2004, MAR ECOL PROG SER, V273, P81, DOI 10.3354/meps273081; Kelman D, 2006, MAR BIOL, V149, P357, DOI 10.1007/s00227-005-0218-8; Klaus JS, 2007, ENVIRON MICROBIOL, V9, P1291, DOI 10.1111/j.1462-2920.2007.01249.x; Klaus JS, 2005, CORAL REEFS, V24, P129, DOI 10.1007/s00338-004-0447-1; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Koh EGL, 1997, J CHEM ECOL, V23, P379, DOI 10.1023/B:JOEC.0000006366.58633.f4; Kurahashi M, 2007, SYST APPL MICROBIOL, V30, P202, DOI 10.1016/j.syapm.2006.07.003; Kushmaro A, 2004, CORAL HEALTH AND DISEASE, P231; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Kushmaro A, 1996, NATURE, V380, P396, DOI 10.1038/380396a0; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; Lampert Y, 2006, FEMS MICROBIOL ECOL, V58, P99, DOI 10.1111/j.1574-6941.2006.00136.x; Lane D.J., 1991, 16S 23S RRNA SEQUENC; Lesser MP, 2007, MAR ECOL PROG SER, V346, P143, DOI 10.3354/meps07008; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Quinn G. P., 2002, EXPT DESIGN DATA ANA, P1; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Rincon-Rosales R, 2009, FEMS MICROBIOL ECOL, V67, P103, DOI 10.1111/j.1574-6941.2008.00590.x; Ritchie KB, 2004, CORAL HEALTH AND DISEASE, P259; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; Ritchie KB, 1994, PROCEEDINGS OF THE FIFTH SYMPOSIUM ON THE NATURAL HISTORY OF THE BAHAMAS, P75; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Ritchie Kim B., 1995, Journal of Marine Biotechnology, V3, P105; Roff G, 2008, CORAL REEFS, V27, P373, DOI 10.1007/s00338-007-0339-2; Roff G, 2006, CORAL REEFS, V25, P255, DOI 10.1007/s00338-006-0099-4; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rohwer F, 2004, CORAL HEALTH AND DISEASE, P265; SANTAVY DL, 1995, MICROBIAL DIVERSITY AND ECOSYSTEM FUNCTION, P211; Schuett C, 2007, HELGOLAND MAR RES, V61, P211, DOI 10.1007/s10152-007-0069-4; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SHASHAR N, 1994, MAR ECOL PROG SER, V111, P259, DOI 10.3354/meps111259; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Stamper DM, 2003, APPL ENVIRON MICROB, V69, P852, DOI 10.1128/AEM.69.2.852-860.2003; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Suzuki MT, 1997, APPL ENVIRON MICROB, V63, P983, DOI 10.1128/AEM.63.3.983-989.1997; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; SWOFFORD L, 2000, PAUP PHYLOGENETIC AN; Theron J, 2000, CRIT REV MICROBIOL, V26, P37, DOI 10.1080/10408410091154174; Thompson FL, 2006, INT J SYST EVOL MICR, V56, P365, DOI 10.1099/ijs.0.63800-0; Voss JD, 2007, MICROB ECOL, V54, P730, DOI 10.1007/s00248-007-9234-1; Wang GCY, 1997, APPL ENVIRON MICROB, V63, P4645, DOI 10.1128/AEM.63.12.4645-4650.1997; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Wegley L, 2004, MAR ECOL PROG SER, V273, P89, DOI 10.3354/meps273089; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69	89	97	100	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10401	10.1371/journal.pone.0010401	http://dx.doi.org/10.1371/journal.pone.0010401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454460	Green Published, Green Submitted, gold			2022-12-25	WOS:000277240100013
J	Antunes, DA; Vieira, GF; Rigo, MM; Cibulski, SP; Sinigaglia, M; Chies, JAB				Antunes, Dinler A.; Vieira, Gustavo F.; Rigo, Mauricio M.; Cibulski, Samuel P.; Sinigaglia, Marialva; Chies, Jose A. B.			Structural Allele-Specific Patterns Adopted by Epitopes in the MHC-I Cleft and Reconstruction of MHC:peptide Complexes to Cross-Reactivity Assessment	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INFLUENZA-A VIRUS; PEPTIDE LIGANDS; DNA PRIME; BINDING; PROTEIN; PREDICTION; VACCINE; CTL; VISUALIZATION	The immune system is engaged in a constant antigenic surveillance through the Major Histocompatibility Complex (MHC) class I antigen presentation pathway. This is an efficient mechanism for detection of intracellular infections, especially viral ones. In this work we describe conformational patterns shared by epitopes presented by a given MHC allele and use these features to develop a docking approach that simulates the peptide loading into the MHC cleft. Our strategy, to construct in silico MHC: peptide complexes, was successfully tested by reproducing four different crystal structures of MHC-I molecules available at the Protein Data Bank (PDB). An in silico study of cross-reactivity potential was also performed between the wildtype complex HLA-A2-NS31073 and nine MHC: peptide complexes presenting alanine exchange peptides. This indicates that structural similarities among the complexes can give us important clues about cross reactivity. The approach used in this work allows the selection of epitopes with potential to induce cross-reactive immune responses, providing useful tools for studies in autoimmunity and to the development of more comprehensive vaccines.	[Antunes, Dinler A.; Vieira, Gustavo F.; Rigo, Mauricio M.; Cibulski, Samuel P.; Sinigaglia, Marialva; Chies, Jose A. B.] Univ Fed Rio Grande do Sul, Nucleo Bioinformat, Lab Imunogenet, Dept Genet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Antunes, DA (corresponding author), Univ Fed Rio Grande do Sul, Nucleo Bioinformat, Lab Imunogenet, Dept Genet, Porto Alegre, RS, Brazil.	jabchies@terra.com.br	vieira, gustavo F/G-4846-2012; Rigo, Mauricio Menegatti/N-8532-2018; Sinigaglia, Marialva/AAG-3172-2020; Antunes, Dinler Amaral/Z-4437-2019; Cibulski, Samuel P/G-5190-2017; Chies, Jose/K-9664-2015	vieira, gustavo F/0000-0002-2380-8059; Rigo, Mauricio Menegatti/0000-0002-1584-6194; Antunes, Dinler Amaral/0000-0001-7947-6455; Chies, Jose/0000-0001-7025-0660; Cibulski, Samuel/0000-0003-0503-8692	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Bill & Melinda Gates Foundation	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	DAA and JABC received a CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) grant and GFV received a CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) grant. Funded by a grant from Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Apostolopoulos V, 1998, NAT BIOTECHNOL, V16, P276, DOI 10.1038/nbt0398-276; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; Buslepp J, 2001, J BIOL CHEM, V276, P47320, DOI 10.1074/jbc.M109231200; Cavasotto CN, 2007, CURR TOP MED CHEM, V7, P1006, DOI 10.2174/156802607780906753; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Cucchiarini M, 2000, CELL IMMUNOL, V203, P111, DOI 10.1006/cimm.2000.1683; *DEL SCI LLC, PYMOL; DIBROV A, 2009, ACTA BIOTHEOR; Frankild S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001831; Fytili P, 2008, VACCINE, V26, P3818, DOI 10.1016/j.vaccine.2008.05.045; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Kmiecik S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-43; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Madurga S, 2005, PROTEIN SCI, V14, P2069, DOI 10.1110/ps.051351605; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; MORRIS GM, 1998, J COMPUTATIONAL CHEM, V19; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reali E, 1999, J IMMUNOL, V162, P106; Rigo MM, 2009, LECT N BIOINFORMAT, V5676, P160, DOI 10.1007/978-3-642-03223-3_17; Sandalova T, 2005, J BIOL CHEM, V280, P27069, DOI 10.1074/jbc.M500927200; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Sieker F, 2009, CURR PROTEIN PEPT SC, V10, P286, DOI 10.2174/138920309788452191; Tian FF, 2008, PROTEIN PEPTIDE LETT, V15, P1033, DOI 10.2174/092986608786071120; Todman SJ, 2008, J MOL GRAPH MODEL, V26, P957, DOI 10.1016/j.jmgm.2007.07.005; Tong JC, 2004, PROTEIN SCI, V13, P2523, DOI 10.1110/ps.04631204; Trott O., 2009, J COMPUT CHEM; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Velloso LM, 2004, J IMMUNOL, V172, P5504, DOI 10.4049/jimmunol.172.9.5504; Wang S, 2008, VACCINE, V26, P1098, DOI 10.1016/j.vaccine.2007.12.024; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; Welsh RM, 2007, NAT REV MICROBIOL, V5, P555, DOI 10.1038/nrmicro1709; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Wulf M, 2009, METHODS MOL BIOL, V524, P361, DOI 10.1007/978-1-59745-450-6_26; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zeng J, 2001, J COMPUT AID MOL DES, V15, P573, DOI 10.1023/A:1011145123635; Zhang C, 1998, J MOL BIOL, V281, P929, DOI 10.1006/jmbi.1998.1982; Zhang H, 2009, BIOINFORMATICS, V25, P1293, DOI 10.1093/bioinformatics/btp137; Zhao R, 1999, J EXP MED, V189, P359, DOI 10.1084/jem.189.2.359	47	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10353	10.1371/journal.pone.0010353	http://dx.doi.org/10.1371/journal.pone.0010353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20442757	gold, Green Submitted, Green Published			2022-12-25	WOS:000277079500021
J	Goltermann, L; Larsen, MSY; Banerjee, R; Joerger, AC; Ibba, M; Bentin, T				Goltermann, Lise; Larsen, Marie Sofie Yoo; Banerjee, Rajat; Joerger, Andreas C.; Ibba, Michael; Bentin, Thomas			Protein Evolution via Amino Acid and Codon Elimination	PLOS ONE			English	Article							GREEN-FLUORESCENT PROTEIN; DIRECTED EVOLUTION; GENE-EXPRESSION; MUTATIONS; STABILITY; DESIGN; INTERMEDIATE	Background: Global residue-specific amino acid mutagenesis can provide important biological insight and generate proteins with altered properties, but at the risk of protein misfolding. Further, targeted libraries are usually restricted to a handful of amino acids because there is an exponential correlation between the number of residues randomized and the size of the resulting ensemble. Using GFP as the model protein, we present a strategy, termed protein evolution via amino acid and codon elimination, through which simplified, native-like polypeptides encoded by a reduced genetic code were obtained via screening of reduced-size ensembles. Methodology/Principal Findings: The strategy involves combining a sequential mutagenesis scheme to reduce library size with structurally stabilizing mutations, chaperone complementation, and reduced temperature of gene expression. In six steps, we eliminated a common buried residue, Phe, from the green fluorescent protein (GFP), while retaining activity. A GFP variant containing 11 Phe residues was used as starting scaffold to generate 10 separate variants in which each Phe was replaced individually (in one construct two adjacent Phe residues were changed simultaneously), while retaining varying levels of activity. Combination of these substitutions to generate a Phe-free variant of GFP abolished fluorescence. Combinatorial re-introduction of five Phe residues, based on the activities of the respective single amino acid replacements, was sufficient to restore GFP activity. Successive rounds of mutagenesis generated active GFP variants containing, three, two, and zero Phe residues. These GFPs all displayed progenitor-like fluorescence spectra, temperature-sensitive folding, a reduced structural stability and, for the least stable variants, a reduced steady state abundance. Conclusions/Significance: The results provide strategies for the design of novel GFP reporters. The described approach offers a means to enable engineering of active proteins that lack certain amino acids, a key step towards expanding the functional repertoire of uniquely labeled proteins in synthetic biology.	[Goltermann, Lise; Larsen, Marie Sofie Yoo; Bentin, Thomas] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark; [Banerjee, Rajat; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Joerger, Andreas C.] Ctr Prot Engn, MRC, Cambridge, England	University of Copenhagen; University System of Ohio; Ohio State University; University of Cambridge	Goltermann, L (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark.	bentin@sund.ku.dk		Larsen, Marie Sofie Yoo/0000-0003-1046-5277; Joerger, Andreas/0000-0002-1232-0138; Goltermann, Lise/0000-0002-6679-9762	Danish Agency for Science, Technology, and Innovation [272-06-0553]; Lundbeck Foundation; National Science Foundation [MCB-0344002]	Danish Agency for Science, Technology, and Innovation; Lundbeck Foundation(Lundbeckfonden); National Science Foundation(National Science Foundation (NSF))	TB was supported by grant 272-06-0553 from the Danish Agency for Science, Technology, and Innovation and by the Lundbeck Foundation. MI was supported by grant MCB-0344002 from the National Science Foundation. LG received travel support from The Faculty of Health Sciences, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Branden C., 1999, INTRO PROTEIN STRUCT; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Hayes RJ, 2002, P NATL ACAD SCI USA, V99, P15926, DOI 10.1073/pnas.212627499; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Huang JR, 2007, J MOL BIOL, V370, P356, DOI 10.1016/j.jmb.2007.04.039; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Link AJ, 2005, METHODS, V36, P291, DOI 10.1016/j.ymeth.2005.04.005; Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sasidharan R, 2007, P NATL ACAD SCI USA, V104, P10080, DOI 10.1073/pnas.0703737104; Steiner T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001680; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Treynor TP, 2007, P NATL ACAD SCI USA, V104, P48, DOI 10.1073/pnas.0609647103; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Walter KU, 2005, J BIOL CHEM, V280, P37742, DOI 10.1074/jbc.M507210200; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Yoo TH, 2007, P NATL ACAD SCI USA, V104, P13887, DOI 10.1073/pnas.0701904104	39	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10104	10.1371/journal.pone.0010104	http://dx.doi.org/10.1371/journal.pone.0010104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436666	Green Published, gold, Green Submitted			2022-12-25	WOS:000277079500002
J	Wang, Y; Barakat, A; Zhou, HW				Wang, Yun; Barakat, Amey; Zhou, Hongwei			Electrotonic Coupling between Pyramidal Neurons in the Neocortex	PLOS ONE			English	Article							CONNEXIN 36-DEFICIENT MICE; CORTEX IN-VITRO; GAP-JUNCTIONS; ELECTRICAL SYNAPSES; NETWORK OSCILLATIONS; FREQUENCY OSCILLATIONS; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL SLICES; PREFRONTAL CORTEX; MAMMALIAN BRAIN	Electrotonic couplings (i.e., electrical synapses or gap junctions) are fundamental to neuronal synchronization, and thus essential for many physiological functions and pathological disorders. Interneuron electrical synapses have been studied intensively. Although studies on electrotonic couplings between pyramidal cells (PCs) are emerging, particularly in the hippocampus, evidence is still rare in the neocortex. The electrotonic coupling of PCs in the neocortex is therefore largely unknown in terms of electrophysiological, anatomical and synaptological properties. Using multiple patch-clamp recording with differential interference contrast infrared videomicroscopy (IR-DIC) visualization, histochemical staining, and 3D-computer reconstruction, electrotonic coupling was recorded between close PCs, mainly in the medial prefrontal cortex as well as in the visual cortical regions of ferrets and rats. Compared with interneuron gap junctions, these electrotonic couplings were characterized by several special features. The recording probability of an electrotonic coupling between PCs is extremely low; but the junctional conductance is notably high, permitting the direct transmission of action potentials (APs) and even tonic firing between coupled neurons. AP firing is therefore perfectly synchronized between coupled PCs; Postjunctional APs and spikelets alternate following slight changes of membrane potentials; Postjunctional spikelets, especially at high frequencies, are summated and ultimately reach AP-threshold to fire. These properties of pyramidal electrotonic couplings largely fill the needs, as predicted by simulation studies, for the synchronization of a neuronal assembly. It is therefore suggested that the electrotonic coupling of PCs plays a unique role in the generation of neuronal synchronization in the neocortex.	[Wang, Yun; Barakat, Amey; Zhou, Hongwei] Tufts Univ, Caritas St Elizabeths Med Ctr, Boston, MA 02135 USA; [Wang, Yun] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou 325027, Zhejiang, Peoples R China	St. Elizabeth's Medical Center; Tufts University; Wenzhou Medical University	Wang, Y (corresponding author), Tufts Univ, Caritas St Elizabeths Med Ctr, Boston, MA 02135 USA.	yun.wang@tufts.edu			NIMH-RO1; NIH/NEI-RO1; Natalie V Zucker Award; Charlton Research Grants at Tufts University School of Medicine	NIMH-RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH/NEI-RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natalie V Zucker Award; Charlton Research Grants at Tufts University School of Medicine	This work was supported by a NIMH-RO1 and a NIH/NEI-RO1, by Natalie V Zucker Award and by Charlton Research Grants at Tufts University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bennett M., 1977, HDB PHYSL          1, P357; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Buhl DL, 2003, J NEUROSCI, V23, P1013; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Devor A, 2002, ANN NY ACAD SCI, V978, P508, DOI 10.1111/j.1749-6632.2002.tb07594.x; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Epsztein J, 2010, SCIENCE, V327, P474, DOI 10.1126/science.1182773; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P289, DOI 10.1113/jphysiol.1959.sp006143; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; Hormuzdi SG, 2004, BBA-BIOMEMBRANES, V1662, P113, DOI 10.1016/j.bbamem.2003.10.023; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Jedlicka P, 2006, PHYSIOL RES, V55, P139, DOI 10.33549/physiolres.930764; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Long MA, 2002, J NEUROSCI, V22, P10898; MACVICAR BA, 1982, J NEUROPHYSIOL, V47, P579, DOI 10.1152/jn.1982.47.4.579; MACVICAR BA, 1981, SCIENCE, V213, P782, DOI 10.1126/science.6266013; Maier N, 2002, J PHYSIOL-LONDON, V541, P521, DOI 10.1113/jphysiol.2002.017624; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1991, J NEUROSCI, V11, P72; Mercer A, 2006, BRAIN CELL BIOL, V35, P13, DOI 10.1007/s11068-006-9005-9; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Simon A, 2005, J NEUROSCI, V25, P6278, DOI 10.1523/JNEUROSCI.1431-05.2005; SLOPER JJ, 1972, BRAIN RES, V44, P640, DOI 10.1016/0006-8993(72)90327-7; SLOPER JJ, 1978, PROC R SOC SER B-BIO, V203, P39, DOI 10.1098/rspb.1978.0089; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Traub RD, 2002, REV NEUROSCIENCE, V13, P1; TRAUB RD, 1985, NEUROSCIENCE, V14, P1033, DOI 10.1016/0306-4522(85)90274-X; Traub RD, 1999, NEUROSCIENCE, V92, P407, DOI 10.1016/S0306-4522(98)00755-6; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008366	43	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10253	10.1371/journal.pone.0010253	http://dx.doi.org/10.1371/journal.pone.0010253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436674	gold, Green Published, Green Submitted			2022-12-25	WOS:000277079500003
J	Tossidou, I; Teng, B; Drobot, L; Meyer-Schwesinger, C; Worthmann, K; Haller, H; Schiffer, M				Tossidou, Irini; Teng, Beina; Drobot, Lyudmyla; Meyer-Schwesinger, Catherine; Worthmann, Kirstin; Haller, Hermann; Schiffer, Mario			CIN85/Ruk(L) Is a Novel Binding Partner of Nephrin and Podocin and Mediates Slit Diaphragm Turnover in Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; MEMBRANE CURVATURE; DOWN-REGULATION; BAR DOMAINS; PROTEIN; EXPRESSION; UBIQUITIN; KINASE; FAMILY; MONOUBIQUITINATION	Podocyte damage is the basis of many glomerular diseases with ultrastructural changes and decreased expression of components of the slit diaphragm such as nephrin and podocin. Under physiological conditions it is likely that the slit diaphragm underlies permanent renewal processes to indemnify its stability in response to changes in filtration pressure. This would require constant reorganization of the podocyte foot process and the renewal of slit diaphragm components. Thus far, the mechanisms underlying the turnover of slit diaphragm proteins are largely unknown. In this manuscript we examined a mechanism of nephrin endocytosis via CIN85/Ruk(L)-mediated ubiquitination. We can demonstrate that the loss of nephrin expression and onset of the proteinuria in CD2AP(-/-) mice correlates with an increased accumulation of ubiquitinated proteins and expression of CIN85/Ruk(L) in podocytes. In cultured murine podocytes CD2AP deficiency leads to an early ubiquitination of nephrin and podocin after stimulation with fibroblast growth factor-4. Binding assays with different CIN85/Ruk iso-forms and mutants showed that nephrin and podocin are binding to the coiled-coil domain of CIN85/Ruk(L). We found that in the presence of CIN85/Ruk(L), which is involved in down-regulation of receptor-tyrosine kinases, nephrin is internalized after stimulation with fibroblast growth factor-4. Interestingly, co-expression of CIN85/Ruk(L) with CD2AP led to a decreased binding of CIN85/Ruk(L) to nephrin and podocin, which indicates a functional competition between CD2AP and CIN85/Ruk(L). Our results support a novel role for CIN85/Ruk(L) in slit diaphragm turnover and proteinuria.	[Tossidou, Irini; Teng, Beina; Worthmann, Kirstin; Haller, Hermann; Schiffer, Mario] Hannover Med Sch, Div Nephrol, D-30625 Hannover, Germany; [Drobot, Lyudmyla] Palladin Inst Biochem, Inst Cell Biol, UA-01601 Kiev, Ukraine; [Meyer-Schwesinger, Catherine] Univ Hosp Hamburg Eppendorf, Dept Internal Med, D-20251 Hamburg, Germany	Hannover Medical School; National Academy of Sciences Ukraine; Institute of Cell Biology & Genetic Engineering of the National Academy of Sciences of Ukraine; Palladin Institute of Biochemistry of NASU; University of Hamburg; University Medical Center Hamburg-Eppendorf	Tossidou, I (corresponding author), Hannover Med Sch, Div Nephrol, Carl Neuberg St 1, D-30625 Hannover, Germany.	tossidou.irini@mh-hannover.de	Drobot, Liudmyla B/J-8642-2017; Schiffer, Mario/U-7050-2019	Schiffer, Mario/0000-0002-8414-1470	Deutsche Forschungsgemeinschaft [SCHI 587/2-2, SFB 566, B16]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by an Emmy-Noether fellowship from the Deutsche Forschungsgemeinschaft (SCHI 587/2-2) and SFB 566, Project B16 (to M.S.).	Buchman VL, 2002, GENE, V295, P13, DOI 10.1016/S0378-1119(02)00821-1; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Endlich K, 2001, CURR OPIN NEPHROL HY, V10, P331, DOI 10.1097/00041552-200105000-00006; Gagliardini E, 2003, AM J NEPHROL, V23, P277, DOI 10.1159/000072281; Gaidos G, 2007, J CELL SCI, V120, P2366, DOI 10.1242/jcs.004333; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Grunkemeyer JA, 2005, J BIOL CHEM, V280, P29677, DOI 10.1074/jbc.M504004200; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2002, P NATL ACAD SCI USA, V99, P12191, DOI 10.1073/pnas.192462299; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Havrylov S, 2008, TRAFFIC, V9, P798, DOI 10.1111/j.1600-0854.2008.00724.x; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 2001, YEAST, V18, pS28; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2002, J AM SOC NEPHROL, V13, p124A; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Ikezumi Y, 2008, BIOCHEM BIOPH RES CO, V376, P706, DOI 10.1016/j.bbrc.2008.09.049; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2005, CELL STRUCT FUNCT, V30, P24; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; Meyer-Schwesinger C, 2009, J PATHOL, V217, P452, DOI 10.1002/path.2446; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Ryan PJ, 1998, BIOCHEM BIOPH RES CO, V244, P763, DOI 10.1006/bbrc.1998.8326; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schiffer M, 2002, J AM SOC NEPHROL, V13, p43A; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Shmuel M, 2006, J BIOL CHEM, V281, P13300, DOI 10.1074/jbc.M513723200; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tossidou I, 2007, J BIOL CHEM, V282, P7457, DOI 10.1074/jbc.M608519200; Tryggvason K, 2001, CURR OPIN NEPHROL HY, V10, P543, DOI 10.1097/00041552-200107000-00009; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Xavier S, 2009, J AM SOC NEPHROL, V20, P2127, DOI 10.1681/ASN.2008070806; Zhang J, 2009, CELL RES, V19, P733, DOI 10.1038/cr.2009.51; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	42	47	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25285	25295		10.1074/jbc.M109.087239	http://dx.doi.org/10.1074/jbc.M109.087239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20457601	hybrid, Green Published			2022-12-25	WOS:000280682400021
J	Mandal, PK; Seiler, A; Perisic, T; Kolle, P; Canak, AB; Forster, H; Weiss, N; Kremmer, E; Lieberman, MW; Bannai, S; Kuhlencordt, P; Sato, H; Bornkamm, GW; Conrad, M				Mandal, Pankaj Kumar; Seiler, Alexander; Perisic, Tamara; Koelle, Pirkko; Canak, Ana Banjac; Foerster, Heidi; Weiss, Norbert; Kremmer, Elisabeth; Lieberman, Michael W.; Bannai, Shiro; Kuhlencordt, Peter; Sato, Hideyo; Bornkamm, Georg W.; Conrad, Marcus			System x(c)(-) and Thioredoxin Reductase 1 Cooperatively Rescue Glutathione Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTINE/GLUTAMATE EXCHANGE TRANSPORTER; EARLY EMBRYONIC LETHALITY; OXIDATIVE STRESS; PROTEIN GLUTATHIONYLATION; PLASMA-MEMBRANE; CELL-DEATH; CYSTINE; GROWTH; RESISTANCE; GLUTAMATE	GSH is the major antioxidant and detoxifier of xenobiotics in mammalian cells. A strong decrease of intracellular GSH has been frequently linked to pathological conditions like ischemia/reperfusion injury and degenerative diseases including diabetes, atherosclerosis, and neurodegeneration. Although GSH is essential for survival, the deleterious effects of GSH deficiency can often be compensated by thiol-containing antioxidants. Using three genetically defined cellular systems, we show here that forced expression of xCT, the substrate-specific subunit of the cystine/glutamate antiporter, in gamma-glutamylcysteine synthetase knock-out cells rescues GSH deficiency by increasing cellular cystine uptake, leading to augmented intracellular and surprisingly high extracellular cysteine levels. Moreover, we provide evidence that under GSH deprivation, the cytosolic thioredoxin/thioredoxin reductase system plays an essential role for the cells to deal with the excess amount of intracellular cystine. Our studies provide first evidence that GSH deficiency can be rescued by an intrinsic genetic mechanism to be considered when designing therapeutic rationales targeting specific redox enzymes to combat diseases linked to GSH deprivation.	[Mandal, Pankaj Kumar; Seiler, Alexander; Perisic, Tamara; Canak, Ana Banjac; Foerster, Heidi; Bornkamm, Georg W.; Conrad, Marcus] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Clin Mol Biol & Tumor Genet, D-81377 Munich, Germany; [Koelle, Pirkko; Weiss, Norbert; Kuhlencordt, Peter] Univ Munich, Med Poliklin Innenstadt, D-80336 Munich, Germany; [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Lieberman, Michael W.] Methodist Hosp, Res Inst, Dept Pathol, Houston, TX 77030 USA; [Bannai, Shiro; Sato, Hideyo] Yamagata Univ, Dept Bioresource Engn, Yamagata 9978555, Japan	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; The Methodist Hospital System; The Methodist Hospital - Houston; Yamagata University	Conrad, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Clin Mol Biol & Tumor Genet, Marchioninistr 25, D-81377 Munich, Germany.	marcus.conrad@helmholtz-muenchen.de	mandal, pankaj/B-4885-2016; Conrad, Marcus/E-8792-2015	Conrad, Marcus/0000-0003-1140-5612; Mandal, Pankaj/0000-0003-1993-9918	Deutsche Forschungsgemeinschaft [SPP 1089, CO 291/2-2]; Deutsche Krebshilfe e.V.; Japan Society for the Promotion of Science (JSPS)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Deutsche Forschungsgemeinschaft Grants SPP 1089 (to M.C. and G.W.B.) and CO 291/2-2 (to M.C.), funds from Deutsche Krebshilfe e.V. (to G.W.B.), a JSPS Bilateral Joint Research Project (to H.S. and G.W.B.), and a Japan Society for the Promotion of Science (JSPS) travel fellowship (to M.C.).	Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; BANNAI S, 1980, J BIOL CHEM, V255, P2372; BANNAI S, 1986, J BIOL CHEM, V261, P2256; Camier S, 2007, FREE RADICAL BIO MED, V42, P1008, DOI 10.1016/j.freeradbiomed.2006.12.027; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; FAHEY RC, 1984, SCIENCE, V224, P70, DOI 10.1126/science.6322306; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Jones DP, 2004, FASEB J, V18, P1246, DOI 10.1096/fj.03-0971fje; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Loscalzo J, 2008, CELL METAB, V8, P182, DOI 10.1016/j.cmet.2008.08.004; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; May JM, 1998, J BIOL CHEM, V273, P23039, DOI 10.1074/jbc.273.36.23039; May JM, 2002, METHOD ENZYMOL, V347, P327; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Niwa T, 2007, J CHROMATOGR B, V855, P59, DOI 10.1016/j.jchromb.2006.12.029; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; NOVOGRODSKY A, 1979, P NATL ACAD SCI USA, V76, P4932, DOI 10.1073/pnas.76.10.4932; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Qiang W, 2004, J VIROL, V78, P11926, DOI 10.1128/JVI.78.21.11926-11938.2004; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; SATO H, 1995, BIOCHEM J, V310, P547, DOI 10.1042/bj3100547; Sato H, 2002, J NEUROSCI, V22, P8028; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shi S, 2007, CYTOM PART A, V71A, P686, DOI 10.1002/cyto.a.20434; Shi ZZ, 2000, P NATL ACAD SCI USA, V97, P5101, DOI 10.1073/pnas.97.10.5101; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200	44	129	134	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22244	22253		10.1074/jbc.M110.121327	http://dx.doi.org/10.1074/jbc.M110.121327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463017	Green Published, hybrid			2022-12-25	WOS:000279702200037
J	Oh, W; Lee, EW; Lee, D; Yang, MR; Ko, A; Yoon, CH; Lee, HW; Bae, YS; Choi, CY; Song, J				Oh, W.; Lee, E-W; Lee, D.; Yang, M-R; Ko, A.; Yoon, C-H; Lee, H-W; Bae, Y-S; Choi, C. Y.; Song, J.			Hdm2 negatively regulates telomerase activity by functioning as an E3 ligase of hTERT	ONCOGENE			English	Article						Hdm2; telomerase; hTERT; p53; ubiquitination	HUMAN TUMOR-CELLS; DOWN-REGULATION; LIFE-SPAN; P53; CANCER; APOPTOSIS; EXPRESSION; DEGRADATION; GROWTH; MDM2	In this study, we identified posttranslational regulation of human telomerase reverse-transcriptase (hTERT) by the E3 ligase Hdm2. The telomerase activity generated by exogenous hTERT in U2OS cells was reduced on adriamycin treatment. The overexpressed levels of hTERT were also decreased under the same conditions. These processes were reversed by treatment with a proteasome inhibitor or depletion of Hdm2. Furthermore, intrinsic telomerase activity was increased in HCT116 cells with ablation of Hdm2. Immunoprecipitation analyses showed that hTERT and Hdm2 bound to each other in multiple domains. Ubiquitination analyses showed that Hdm2 could polyubiquitinate hTERT principally at the N-terminus, which was further degraded in a proteasome-dependent manner. An hTERT mutant with all five lysine residues at the N-terminus of hTERT that mutated to arginine became resistant to Hdm2-mediated ubiquitination and degradation. In U2OS cells, depletion of Hdm2 or addition of the Hdm2-resistant hTERT mutant strengthened the cellular protective effects against apoptosis. Similar results were obtained with the Hdm2-stable H1299 cell line. These observations indicate that Hdm2 is an E3 ligase of hTERT. Oncogene (2010) 29, 4101-4112; doi:10.1038/onc.2010.160; published online 10 May 2010	[Oh, W.; Lee, E-W; Yang, M-R; Ko, A.; Song, J.] Sungkyunkwan Univ, Dept Biotechnol & Bioengn, Suwon 440746, South Korea; [Lee, D.; Yoon, C-H; Bae, Y-S; Choi, C. Y.] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Lee, H-W] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Yonsei University	Song, J (corresponding author), Sungkyunkwan Univ, Dept Biotechnol & Bioengn, Suwon 440746, South Korea.	jso678@skku.edu	Lee, Eun-Woo/AAP-9603-2020	Song, Jaewhan/0000-0001-8152-9210; Ko, Aram/0000-0003-4997-3092; Lee, Eun-Woo/0000-0002-5156-0003	Ministry of Health and Welfare, Republic of Korea [0820110, A080333]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (0820110) and by a grant of the Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A080333).	Akiyama M, 2002, CANCER RES, V62, P3876; Blackburn EH, 2000, NAT STRUCT BIOL, V7, P847, DOI 10.1038/79594; Blasco MA, 2003, CURR OPIN GENET DEV, V13, P70, DOI 10.1016/S0959-437X(02)00011-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bouska A, 2009, TRENDS BIOCHEM SCI, V34, P279, DOI 10.1016/j.tibs.2009.02.006; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Cao Y, 2002, ONCOGENE, V21, P3130, DOI 10.1038/sj.onc.1205419; Carroll VA, 2008, CANCER RES, V68, P545, DOI 10.1158/0008-5472.CAN-06-4738; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; Dairkee SH, 2007, ONCOGENE, V26, P6269, DOI 10.1038/sj.onc.1210452; Dalla Torre CA, 2002, BRAZ J MED BIOL RES, V35, P65, DOI 10.1590/S0100-879X2002000100009; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dimri GP, 2002, CANCER RES, V62, P4736; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Froment P, 2008, CELL CYCLE, V7, P3098, DOI 10.4161/cc.7.19.6807; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Kanaya T, 2000, CLIN CANCER RES, V6, P1239; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Kusumoto M, 1999, CLIN CANCER RES, V5, P2140; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Luiten RM, 2003, BLOOD, V101, P4512, DOI 10.1182/blood-2002-07-2018; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Oh W, 2009, J CELL SCI, V122, P2613, DOI 10.1242/jcs.048066; Rahman R, 2005, ONCOGENE, V24, P1320, DOI 10.1038/sj.onc.1208232; Roth A, 2003, BLOOD, V102, P849, DOI 10.1182/blood-2002-07-2015; Saller E, 1999, EMBO J, V18, P4424, DOI 10.1093/emboj/18.16.4424; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Teng LS, 2003, J CLIN ENDOCR METAB, V88, P1362, DOI 10.1210/jc.2002-021222; Urquidi V, 2000, ANNU REV MED, V51, P65, DOI 10.1146/annurev.med.51.1.65; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wu YL, 2006, J CELL SCI, V119, P2797, DOI 10.1242/jcs.03001; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618	44	21	22	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 15	2010	29	28					4101	4112		10.1038/onc.2010.160	http://dx.doi.org/10.1038/onc.2010.160			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	625JW	20453884				2022-12-25	WOS:000279892400010
J	Salem, H; Rachmin, I; Yissachar, N; Cohen, S; Amiel, A; Haffner, R; Lavi, L; Motro, B				Salem, H.; Rachmin, I.; Yissachar, N.; Cohen, S.; Amiel, A.; Haffner, R.; Lavi, L.; Motro, B.			Nek7 kinase targeting leads to early mortality, cytokinesis disturbance and polyploidy	ONCOGENE			English	Article						NIMA; kinase; gene targeting; early lethality; cytokinesis; mitosis	NIMA-FAMILY KINASE; POLYCYSTIC KIDNEY-DISEASE; MITOTIC SPINDLE FORMATION; CELL-CYCLE; PROTEIN-KINASES; ASPERGILLUS-NIDULANS; MAMMALIAN-CELLS; MURINE KINASES; PRIMARY CILIA; CENTROSOME	The mammalian NIMA-related kinases (Neks) are commonly referred to as mitotic kinases, although a definitive in vivo verification of this definition is largely missing. Reduction in the activity of Nek7 or its close paralog, Nek6, has previously been shown to arrest cells in mitosis, mainly at metaphase. In this study, we investigate the developmental and cellular roles of Nek7 kinase through the generation and analysis of Nek7-deficient mice. We show that absence of Nek7 leads to lethality in late embryogenesis or at early post-natal stages and to severe growth retardation. Mouse embryonic fibroblasts (MEFs) derived from Nek7(-/-) embryos show increase tendency for chromosomal lagging, micronuclei formation and cytokinesis failure. Tetraploidy and aneuploidy were commonly observed and their prevalence arises with MEFs passages. The frequency of multicentrosomal cells in the mutant's MEF cells was higher, and it commonly occurred concurrently with a binuclear phenotype, suggesting cytokinesis failure etiology. Lastly, the percentage of mutant MEF cells bearing primary cilia (PC) was low, whereas a cell population having two cilia appeared in the mutant MEFs. Taken together, these results confirm Nek7 as a regulator of cell division, and reveal it as an essential component for mammalian growth and survival. The intimate connection between tetraploidy, aneuploidy and cancer development suggests that Nek7 deregulation can induce oncogenesis. Oncogene (2010) 29, 4046-4057; doi:10.1038/onc.2010.162; published online 17 May 2010	[Salem, H.; Rachmin, I.; Yissachar, N.; Cohen, S.; Amiel, A.; Lavi, L.; Motro, B.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Amiel, A.] Meir Med Ctr, Genet Inst, Kefar Sava, Israel; [Haffner, R.] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel	Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	Motro, B (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	motro@mail.biu.ac.il	/ABF-8487-2022	Yissachar, Nissan/0000-0002-7647-9754	Bar-Ilan Rector	Bar-Ilan Rector	We thank G Damari and A Berkovitz from the Transgenic Unit of the Weizmann Institute for generation of chimeras. We also thank S Madar, Weizmann Institute, for real time RT-PCR analyses; R Palmiter, University of Washington, for providing the pNeoZTK2 vector. This study is supported by funds from Bar-Ilan Rector.	Akhter S, 2004, MOL CELL BIOL, V24, P10448, DOI 10.1128/MCB.24.23.10448-10455.2004; Aleem Eiman, 2006, V42, P271, DOI 10.1007/023; Alieva IB, 2004, CELL BIOL INT, V28, P139, DOI 10.1016/j.cellbi.2003.11.013; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489; Castillo A, 2007, CANCER RES, V67, P10138, DOI 10.1158/0008-5472.CAN-07-0326; De Souza CPC, 2003, GENETICS, V165, P1071; EPSTEIN CJ, 1967, P NATL ACAD SCI USA, V57, P327, DOI 10.1073/pnas.57.2.327; Feige E, 2002, MECH DEVELOP, V110, P219, DOI 10.1016/S0925-4773(01)00573-1; FRY AM, 1995, CURR BIOL, V5, P1122, DOI 10.1016/S0960-9822(95)00227-2; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Kandli M, 2000, GENOMICS, V68, P187, DOI 10.1006/geno.2000.6293; Kim S, 2007, BIOCHEM BIOPH RES CO, V360, P56, DOI 10.1016/j.bbrc.2007.05.206; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lee MY, 2008, CELL CYCLE, V7, P2705, DOI 10.4161/cc.7.17.6551; Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173; Mahjoub MR, 2005, J AM SOC NEPHROL, V16, P3485, DOI 10.1681/ASN.2005080824; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; OSMANI AH, 1991, CELL, V67, P283, DOI 10.1016/0092-8674(91)90180-7; Parker JDK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001076; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Roig J, 2005, MOL BIOL CELL, V16, P4827, DOI 10.1091/mbc.E05-04-0315; Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Shalom O, 2008, FEBS LETT, V582, P1465, DOI 10.1016/j.febslet.2008.03.036; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smith LA, 2006, J AM SOC NEPHROL, V17, P2821, DOI 10.1681/ASN.2006020136; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Upadhya P, 2000, P NATL ACAD SCI USA, V97, P217, DOI 10.1073/pnas.97.1.217; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; White MC, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-29; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069	45	53	56	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 15	2010	29	28					4046	4057		10.1038/onc.2010.162	http://dx.doi.org/10.1038/onc.2010.162			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	625JW	20473324				2022-12-25	WOS:000279892400005
J	Uriu, Y; Kiyonaka, S; Miki, T; Yagi, M; Akiyama, S; Mori, E; Nakao, A; Beedle, AM; Campbell, KP; Wakamori, M; Mori, Y				Uriu, Yoshitsugu; Kiyonaka, Shigeki; Miki, Takafumi; Yagi, Masakuni; Akiyama, Satoshi; Mori, Emiko; Nakao, Akito; Beedle, Aaron M.; Campbell, Kevin P.; Wakamori, Minoru; Mori, Yasuo			Rab3-interacting Molecule gamma Isoforms Lacking the Rab3-binding Domain Induce Long Lasting Currents but Block Neurotransmitter Vesicle Anchoring in Voltage-dependent P/Q-type Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL; BETA-SUBUNIT; ACTIVE ZONE; N-TYPE; SYNAPTIC-TRANSMISSION; SKELETAL-MUSCLE; PC12 CELLS; FUNCTIONAL EXPRESSION; INTERACTING MOLECULE; NERVE-TERMINALS	Assembly of voltage-dependent Ca2+ channels (VDCCs) with their associated proteins regulates the coupling of VDCCs with upstream and downstream cellular events. Among the four isoforms of the Rab3-interacting molecule (RIM1 to -4), we have previously reported that VDCC beta-subunits physically interact with the long alpha isoform of the presynaptic active zone scaffolding protein RIM1 (RIM1 alpha) via its C terminus containing the C2B domain. This interaction cooperates with RIM1 alpha-Rab3 interaction to support neurotransmitter exocytosis by anchoring vesicles in the vicinity of VDCCs and by maintaining depolarization-triggered Ca2+ influx as a result of marked inhibition of voltage-dependent inactivation of VDCCs. However, physiological functions have not yet been elucidated for RIM3 and RIM4, which exist only as short gamma isoforms (gamma-RIMs), carrying the C-terminal C2B domain common to RIMs but not the Rab3-binding region and other structural motifs present in the alpha-RIMs, including RIM1 alpha. Here, we demonstrate that gamma-RIMs also exert prominent suppression of VDCC inactivation via direct binding to beta-subunits. In the pheochromocytoma PC12 cells, this common functional feature allows native RIMs to enhance acetylcholine secretion, whereas gamma-RIMs are uniquely different from alpha-RIMs in blocking localization of neurotransmitter-containing vesicles near the plasma membrane. gamma-RIMs as well as alpha-RIMs show wide distribution in central neurons, but knockdown of gamma-RIMs attenuated glutamate release to a lesser extent than that of alpha-RIMs in cultured cerebellar neurons. The results suggest that sustained Ca2+ influx through suppression of VDCC inactivation by RIMs is a ubiquitous property of neurons, whereas the extent of vesicle anchoring to VDCCs at the plasma membrane may depend on the competition of alpha-RIMs with gamma-RIMs for VDCC beta-subunits.	[Uriu, Yoshitsugu; Kiyonaka, Shigeki; Miki, Takafumi; Yagi, Masakuni; Akiyama, Satoshi; Mori, Emiko; Nakao, Akito; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan; [Beedle, Aaron M.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Beedle, Aaron M.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Beedle, Aaron M.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Beedle, Aaron M.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Wakamori, Minoru] Tohoku Univ, Grad Sch Dent, Dept Oral Biol, Sendai, Miyagi 9808575, Japan	Kyoto University; Japan Science & Technology Agency (JST); Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Tohoku University	Mori, Y (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Katsura Campus, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp	Beedle, Aaron/AAI-7014-2020; Beedle, Aaron M/K-1902-2015; Wakamori, Minoru/AAE-2661-2019; Nakao, Akito/AER-2812-2022; Kiyonaka, Shigeki/AAM-7303-2021	Beedle, Aaron M/0000-0002-1019-3235; Wakamori, Minoru/0000-0001-8574-3310; Campbell, Kevin/0000-0003-2066-5889; Nakao, Akito/0000-0002-2296-8245	Ministry of Education, Culture, Sport, Science and Technology of Japan; Grants-in-Aid for Scientific Research [22681033] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sport, Science and Technology of Japan.	Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Craig PJ, 1998, J COMP NEUROL, V397, P251; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Gebhart M, 2010, MOL CELL NEUROSCI, V44, P246, DOI 10.1016/j.mcn.2010.03.011; Gracheva EO, 2008, NEUROSCI LETT, V444, P137, DOI 10.1016/j.neulet.2008.08.026; Hanson JE, 2002, J COMP NEUROL, V442, P89, DOI 10.1002/cne.10075; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kaeser PS, 2008, J NEUROSCI, V28, P13435, DOI 10.1523/JNEUROSCI.3235-08.2008; KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1; Kang MG, 2006, P NATL ACAD SCI USA, V103, P5561, DOI 10.1073/pnas.0601289103; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Koga T, 2002, BRAIN RES, V952, P282, DOI 10.1016/S0006-8993(02)03253-5; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; Lachamp PM, 2009, J NEUROSCI, V29, P381, DOI 10.1523/JNEUROSCI.2354-08.2009; Liang F, 2007, J COMP NEUROL, V503, P501, DOI 10.1002/cne.21403; Liu HY, 1996, J NEUROSCI, V16, P7557; Liu TT, 2005, J PHYSIOL-LONDON, V568, P917, DOI 10.1113/jphysiol.2005.094011; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; Maximov A, 2002, J NEUROSCI, V22, P6939; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Miki Takafumi, 2007, Channels (Austin), V1, P144; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; NIIDOME T, 1994, BIOCHEM BIOPH RES CO, V203, P1821, DOI 10.1006/bbrc.1994.2399; Nishida M, 1999, BIOCHEM BIOPH RES CO, V262, P350, DOI 10.1006/bbrc.1999.1218; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Patzel V, 2005, NAT BIOTECHNOL, V23, P1440, DOI 10.1038/nbt1151; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANDALL A, 1995, J NEUROSCI, V15, P2995; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; Saegusa H, 2007, MOL CELL NEUROSCI, V34, P261, DOI 10.1016/j.mcn.2006.11.006; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; STANLEY EF, 1991, J NEUROSCI, V11, P985; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Toru S, 2000, J BIOL CHEM, V275, P10893, DOI 10.1074/jbc.275.15.10893; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; Vendel AC, 2006, J NEUROSCI, V26, P2635, DOI 10.1523/JNEUROSCI.0067-06.2006; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Wong FK, 2010, J NEUROCHEM, V112, P463, DOI 10.1111/j.1471-4159.2009.06466.x; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028	84	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21750	21767		10.1074/jbc.M110.101311	http://dx.doi.org/10.1074/jbc.M110.101311			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452978	Green Published, hybrid			2022-12-25	WOS:000279516100061
J	Yang, J; Bachrati, CZ; Ou, JW; Hickson, ID; Brown, GW				Yang, Jay; Bachrati, Csanad Z.; Ou, Jiongwen; Hickson, Ian D.; Brown, Grant W.			Human Topoisomerase III alpha Is a Single-stranded DNA Decatenase That Is Stimulated by BLM and RMI1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOMS-SYNDROME HELICASE; HOLLIDAY JUNCTION DISSOLVASOME; SISTER-CHROMATID EXCHANGES; SYNDROME GENE-PRODUCT; HOMOLOGOUS RECOMBINATION; GENOME STABILITY; SYNDROME PROTEIN; ESSENTIAL COMPONENT; COMPLEX; REPLICATION	Human topoisomerase III alpha is a type IA DNA topoisomerase that functions with BLM and RMI1 to resolve DNA replication and recombination intermediates. BLM, human topoisomerase III alpha, and RMI1 catalyze the dissolution of double Holliday junctions into noncrossover products via a strand-passage mechanism. We generated single-stranded catenanes that resemble the proposed dissolution intermediate recognized by human topoisomerase III alpha. We demonstrate that human topoisomerase III alpha is a single-stranded DNA decatenase that is specifically stimulated by the BLM-RMI1 pair. In addition, RMI1 interacts with human topoisomerase III alpha, and the interaction is required for the stimulatory effect of RMI1 on decatenase activity. Our data provide direct evidence that human topoisomerase III alpha functions as a decatenase with the assistance of BLM and RMI1 to facilitate the processing of homologous recombination intermediates without crossing over as a mechanism to preserve genome integrity.	[Brown, Grant W.] Univ Toronto, Dept Biochem, Donnelly CCBR, Toronto, ON M5S 3E1, Canada; [Bachrati, Csanad Z.; Hickson, Ian D.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK Labs, Oxford OX3 9DS, England	University of Toronto; Cancer Research UK; University of Oxford	Brown, GW (corresponding author), Univ Toronto, Dept Biochem, Donnelly CCBR, Rm 1230,160 Coll St, Toronto, ON M5S 3E1, Canada.	grant.brown@utoronto.ca	Bachrati, Csanad/ABF-2020-2021; Hickson, Ian/AAJ-7548-2020	Bachrati, Csanad/0000-0003-1703-5894; Hickson, Ian/0000-0002-0583-566X; Brown, Grant/0000-0002-9002-5003	Canadian Institute of Health [MOP-79368]; Cancer Research United Kingdom; Bloom Syndrome Foundation	Canadian Institute of Health(Canadian Institutes of Health Research (CIHR)); Cancer Research United Kingdom(Cancer Research UK); Bloom Syndrome Foundation	This work was supported by the Canadian Institute of Health Research Grant MOP-79368 (to G. W. B.), by Cancer Research United Kingdom, and the Bloom Syndrome Foundation (to I. D. H. and C.Z.B.).	Bachrati CZ, 2009, METHODS MOL BIOL, V582, P91, DOI 10.1007/978-1-60761-340-4_8; Broberg K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-140; Bucka A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e24; Burgers PMJ, 1999, METHODS, V18, P349, DOI 10.1006/meth.1999.0796; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Bylund GO, 2006, METHOD ENZYMOL, V409, P1, DOI 10.1016/S0076-6879(05)09001-4; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chelysheva L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000309; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; GERMAN J, 1995, DERMATOL CLIN, V13, P7, DOI 10.1016/S0733-8635(18)30101-3; Goodwin A, 1999, NUCLEIC ACIDS RES, V27, P4050, DOI 10.1093/nar/27.20.4050; Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443; Hartung F, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000285; HIASA H, 1994, J BIOL CHEM, V269, P32655; HIASA H, 1994, J BIOL CHEM, V269, P2093; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hu P, 2001, HUM MOL GENET, V10, P1287, DOI 10.1093/hmg/10.12.1287; Johnson FB, 2000, CANCER RES, V60, P1162; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Liu Y, 2008, GENE DEV, V22, P2737, DOI 10.1101/gad.1732808; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Raynard S, 2008, J BIOL CHEM, V283, P15701, DOI 10.1074/jbc.M802127200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Seki M, 2006, MOL CELL BIOL, V26, P6299, DOI 10.1128/MCB.00702-06; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wu L, 2002, NUCLEIC ACIDS RES, V30, P4823, DOI 10.1093/nar/gkf611; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	42	54	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21426	21436		10.1074/jbc.M110.123216	http://dx.doi.org/10.1074/jbc.M110.123216			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20445207	Green Published, hybrid			2022-12-25	WOS:000279516100029
J	Hatton, BA; Villavicencio, EH; Pritchard, J; LeBlanc, M; Hansen, S; Ulrich, M; Ditzler, S; Pullar, B; Stroud, MR; Olson, JM				Hatton, B. A.; Villavicencio, E. H.; Pritchard, J.; LeBlanc, M.; Hansen, S.; Ulrich, M.; Ditzler, S.; Pullar, B.; Stroud, M. R.; Olson, J. M.			Notch signaling is not essential in sonic hedgehog-activated medulloblastoma	ONCOGENE			English	Article						medulloblastoma; notch; sonic hedgehog; gamma secretase inhibitor	GAMMA-SECRETASE INHIBITORS; EMBRYONAL BRAIN-TUMORS; PATHWAY; CELLS; GROWTH; MODEL; CORE; MICE	Dysregulated signal transduction through the notch pathway has been noted in human and mouse medulloblastoma studies. Gamma secretase inhibitors (GSIs) impair notch signaling by preventing the cleavage of transmembrane notch proteins into their active intracellular domain fragments. Previous studies have shown that GSI treatment caused apoptosis and impaired medulloblastoma cell engraftment in xenograft systems. In this study, we used in vivo genetic and pharmacologic approaches to quantify the contribution of notch signaling to sonic hedgehog (shh)-activated mouse medulloblastoma models. In contrast to prior in vitro studies, pharmacologic inhibition of notch pathways did not reduce the efficiency of medulloblastoma xenotransplantation nor did systemic therapy impact tumor size, proliferation, or apoptosis in genetically engineered mouse medulloblastoma models. The incidence and pathology of medulloblastomas driven by the SmoA1 transgene was unchanged by the bi-allelic absence of Notch1, Notch2, or Hes5 genes. These data show that notch signaling is not essential for the initiation, engraftment, or maintenance of sonic hedgehog pathway-driven medulloblastomas. Oncogene (2010) 29, 3865-3872; doi: 10.1038/onc.2010.142; published online 3 May 2010	[Hatton, B. A.; Villavicencio, E. H.; Pritchard, J.; LeBlanc, M.; Hansen, S.; Ulrich, M.; Ditzler, S.; Pullar, B.; Stroud, M. R.; Olson, J. M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Olson, JM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N,Mailstop D4-100, Seattle, WA 98109 USA.	jolson@fhcrc.org			NIH [5R01CA112350-04, 5R01CA114567-04, 5T32CA009351, 5K12CA076930]; NATIONAL CANCER INSTITUTE [R01CA114567, T32CA009351, K12CA076930, R01CA112350] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr Francois Guillemot for providing the Hes5-null mice, to Freddy Radtke for the notch1 conditional knockout mice, to Thomas Gridley for the notch2 conditional knockout mice, and to Dr Irwin Bernstein for providing the 18G anti-Notch antibody and advice. The gamma secretase inhibitor MRK-003 was provided by Merck Research Laboratories, which also provided partial funding for the studies. This work was supported by NIH Grants 5R01CA112350-04, 5R01CA114567-04, 5T32CA009351, and 5K12CA076930.	Cau E, 2000, DEVELOPMENT, V127, P2323; Eberhart CG, 2007, NEUROSURG CLIN N AM, V18, P59, DOI 10.1016/j.nec.2006.10.005; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Ingram WJ, 2008, ONCOGENE, V27, P1489, DOI 10.1038/sj.onc.1210767; Julian E, 2010, ONCOGENE, V29, P3465, DOI 10.1038/onc.2010.101; Lewis SJ, 2005, BIOORG MED CHEM LETT, V15, P373, DOI 10.1016/j.bmcl.2004.10.062; McCright B, 2006, GENESIS, V44, P29, DOI 10.1002/gene.20181; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Sasai K, 2006, CANCER RES, V66, P4215, DOI 10.1158/0008-5472.CAN-05-4505; Schouwey K, 2008, HISTOL HISTOPATHOL, V23, P609, DOI 10.14670/HH-23.609; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Sparey T, 2005, BIOORG MED CHEM LETT, V15, P4212, DOI 10.1016/j.bmcl.2005.06.084; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Weiner HL, 2002, CANCER RES, V62, P6385; Zeltzer PM, 1999, J CLIN ONCOL, V17, P832, DOI 10.1200/JCO.1999.17.3.832	22	16	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 1	2010	29	26					3865	3872		10.1038/onc.2010.142	http://dx.doi.org/10.1038/onc.2010.142			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	618VW	20440271	Green Accepted			2022-12-25	WOS:000279385200014
J	Vizioli, MG; Sensi, M; Miranda, C; Cleris, L; Formelli, F; Anania, MC; Pierotti, MA; Greco, A				Vizioli, M. G.; Sensi, M.; Miranda, C.; Cleris, L.; Formelli, F.; Anania, M. C.; Pierotti, M. A.; Greco, A.			IGFBP7: an oncosuppressor gene in thyroid carcinogenesis	ONCOGENE			English	Article						IGFBP7; thyroid tumors; PTC	EXPRESSION PROFILES; COLORECTAL-CANCER; TUMOR-GROWTH; PAPILLARY; PROTEIN; CARCINOMA; SENESCENCE; BRAF	Insulin-like growth factor-binding protein 7 (IGFBP7) is a secreted protein involved in several cellular processes, including proliferation, senescence and apoptosis. Loss of IGFBP7 expression is a critical step in the development of human tumors, including melanoma and colon cancer. By microarray gene expression studies, we have detected downregulation of IGFBP7 gene expression in follicular and papillary thyroid tumors in comparison with normal thyroid tissue. Evaluation of publicly available PTC microarray gene expression data sets confirmed, in a consistent fraction of tumors, the downregulation of IGFBP7 transcript levels. The functional consequence of IGFBP7 downregulation was addressed in the PTC-derived NIM1 cell line in which IGFBP7 expression is repressed by promoter hypermethylation. Exposure to soluble IGFBP7 protein or restoration of IGFBP7 expression by complementary DNA transfection reduced growth rate, migration, anchorage-independent growth and tumorigenicity of NIM1 cells. We show that the effects of IGFBP7 are related to apoptosis. Our data suggest that loss of IGFBP7 expression has a functional role in thyroid carcinogenesis, and it may represent a possible basis for therapeutic strategies. Oncogene (2010) 29, 3835-3844; doi: 10.1038/onc.2010.136; published online 3 May 2010	[Vizioli, M. G.; Miranda, C.; Anania, M. C.; Greco, A.] Ist Nazl Tumori, IRCCS Fdn, Dept Expt Oncol & Mol Med, Mol Mech Unit, I-20133 Milan, Italy; [Sensi, M.] Ist Nazl Tumori, IRCCS Fdn, Dept Expt Oncol & Mol Med, Human Tumors Immunobiol Unit, I-20133 Milan, Italy; [Cleris, L.; Formelli, F.] Ist Nazl Tumori, IRCCS Fdn, Dept Expt Oncol & Mol Med, Chemoprevent Unit, I-20133 Milan, Italy; [Pierotti, M. A.] Ist Nazl Tumori, IRCCS Fdn, Dept Expt Oncol & Mol Med, Sci Directorate, I-20133 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Greco, A (corresponding author), Ist Nazl Tumori, IRCCS Fdn, Dept Expt Oncol & Mol Med, Mol Mech Unit, Via Venezian 1, I-20133 Milan, Italy.	angela.greco@istitutotumori.mi.it	Anania, Maria Chiara/N-4853-2019; Cleris, Loredana/T-3144-2018; Greco, Angela/C-1953-2017; Sensi, Marialuisa/K-5631-2014; Anania, Maria Chiara/B-9339-2017; Pierotti, Marco Alessandro/AAC-4728-2022	Anania, Maria Chiara/0000-0003-4012-1870; Cleris, Loredana/0000-0001-8778-7931; Greco, Angela/0000-0003-2994-0349; Sensi, Marialuisa/0000-0002-7643-0248; Anania, Maria Chiara/0000-0003-4012-1870; Pierotti, Marco Alessandro/0000-0002-7431-8332	AIRC [4472]; ACC; Ministry of Health	AIRC(Fondazione AIRC per la ricerca sul cancro); ACC; Ministry of Health	The authors thank Mrs Sonia Pagliardini for technical assistance and Mrs Cristina Mazzadi for editing and secretarial help. This work was supported by AIRC grant N. 4472, ACC and Ministry of Health.	Ahmed S, 2003, BIOCHEM BIOPH RES CO, V310, P612, DOI 10.1016/j.bbrc.2003.09.058; Akaogi K, 1996, P NATL ACAD SCI USA, V93, P8384, DOI 10.1073/pnas.93.16.8384; Aldred MA, 2004, J CLIN ONCOL, V22, P3531, DOI 10.1200/JCO.2004.08.127; [Anonymous], 1988, BRIT J CANCER, V58, P109, DOI 10.1038/bjc.1988.174; Burger AM, 2005, EUR J CANCER, V41, P1515, DOI 10.1016/j.ejca.2005.04.023; Chen Y, 2007, J PATHOL, V211, P431, DOI 10.1002/path.2132; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Ferrario C, 2008, LAB INVEST, V88, P474, DOI 10.1038/labinvest.2008.17; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; Greco A, 2009, Q J NUCL MED MOL IM, V53, P440; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hinoue T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008357; Huang Y, 2001, P NATL ACAD SCI USA, V98, P15044, DOI 10.1073/pnas.251547398; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Kanemitsu N, 2000, BIOCHEM BIOPH RES CO, V279, P251, DOI 10.1006/bbrc.2000.3944; Latini FRM, 2008, ENDOCR-RELAT CANCER, V15, P787, DOI 10.1677/ERC-08-0079; Lin J, 2007, J PATHOL, V212, P83, DOI 10.1002/path.2144; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; Ruan Wen-jing, 2006, J Zhejiang Univ Sci B, V7, P929, DOI 10.1631/jzus.2006.B0929; Ruan WJ, 2007, CANCER BIOL THER, V6, P354, DOI 10.4161/cbt.6.3.3702; Sato Y, 2007, CANCER SCI, V98, P1055, DOI 10.1111/j.1349-7006.2007.00502.x; Schrama D, 2010, J INVEST DERMATOL, V130, P897, DOI 10.1038/jid.2009.304; Sprenger CC, 1999, CANCER RES, V59, P2370; Suzuki H, 2010, CARCINOGENESIS, V31, P342, DOI 10.1093/carcin/bgp179; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wajapeyee N, 2009, MOL CANCER THER, V8, P3009, DOI 10.1158/1535-7163.MCT-09-0470; Wilson HMP, 2002, CELL GROWTH DIFFER, V13, P205; Yamanaka Y, 1997, J BIOL CHEM, V272, P30729, DOI 10.1074/jbc.272.49.30729; ZEKI K, 1993, J CLIN ENDOCR METAB, V76, P127, DOI 10.1210/jc.76.1.127	31	65	66	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2010	29	26					3835	3844		10.1038/onc.2010.136	http://dx.doi.org/10.1038/onc.2010.136			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	618VW	20440262				2022-12-25	WOS:000279385200011
J	Liu, F; Killian, JK; Yang, M; Walker, RL; Hong, JA; Zhang, M; Davis, S; Zhang, Y; Hussain, M; Xi, S; Rao, M; Meltzer, PA; Schrump, DS				Liu, F.; Killian, J. K.; Yang, M.; Walker, R. L.; Hong, J. A.; Zhang, M.; Davis, S.; Zhang, Y.; Hussain, M.; Xi, S.; Rao, M.; Meltzer, P. A.; Schrump, D. S.			Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate	ONCOGENE			English	Article						tobacco smoke; lung cancer; epigenetics; respiratory epithelial cells	CELL LUNG-CANCER; MODIFICATIONS PREDICT PROGNOSIS; IN-VITRO; METHYLTRANSFERASES CONTRIBUTES; MAINSTREAM SMOKE; POOR-PROGNOSIS; UP-REGULATION; MAGE-A; METHYLATION; ACTIVATION	Limited information is available regarding epigenomic events mediating initiation and progression of tobacco-induced lung cancers. In this study, we established an in vitro system to examine epigenomic effects of cigarette smoke in respiratory epithelia. Normal human small airway epithelial cells and cdk-4/hTERT-immortalized human bronchial epithelial cells (HBEC) were cultured in normal media with or without cigarette smoke condensate (CSC) for up to 9 months under potentially relevant exposure conditions. Western blot analysis showed that CSC mediated dose- and time-dependent diminution of H4K16Ac and H4K20Me3, while increasing relative levels of H3K27Me3; these histone alterations coincided with decreased DNA methyltransferase 1 (DNMT1) and increased DNMT3b expression. Pyrosequencing and quantitative RT-PCR experiments revealed time-dependent hypomethylation of D4Z4, NBL2, and LINE-1 repetitive DNA sequences; up-regulation of H19, IGF2, MAGE-A1, and MAGE-A3; activation of Wnt signaling; and hypermethylation of tumor suppressor genes such as RASSF1A and RAR-beta, which are frequently silenced in human lung cancers. Array-based DNA methylation profiling identified additional novel DNA methylation targets in soft-agar clones derived from CSC-exposed HBEC; a CSC gene expression signature was also identified in these cells. Progressive genomic hypomethylation and locoregional DNA hypermethylation induced by CSC coincided with a dramatic increase in soft-agar clonogenicity. Collectively, these data indicate that cigarette smoke induces 'cancer-associated' epigenomic alterations in cultured respiratory epithelia. This in vitro model may prove useful for delineating early epigenetic mechanisms regulating gene expression during pulmonary carcinogenesis. Oncogene ( 2010) 29, 3650-3664; doi: 10.1038/onc.2010.129; published online 3 May 2010	[Liu, F.; Yang, M.; Hong, J. A.; Zhang, M.; Zhang, Y.; Hussain, M.; Xi, S.; Rao, M.; Schrump, D. S.] NCI, Thorac Oncol Sect, Surg Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Killian, J. K.; Walker, R. L.; Davis, S.; Meltzer, P. A.] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schrump, DS (corresponding author), NCI, Thorac Oncol Sect, Surg Branch, Ctr Canc Res, 10 Ctr Dr,Bldg 10,Room 4-3940, Bethesda, MD 20892 USA.	David_Schrump@nih.gov	Davis, Sean/AAD-1801-2021	Davis, Sean/0000-0002-8991-6458; Walker, Robert/0000-0001-8235-4686	NATIONAL CANCER INSTITUTE [ZIABC011122, ZICBC011040, ZIABC011091] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA BC011115-09, ZIA BC011122-06] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; Cho Hearn J, 2006, Cancer Immun, V6, P12; D'Alessio AC, 2006, BIOCHEM CELL BIOL, V84, P463, DOI 10.1139/O06-090; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Fields WR, 2005, TOXICOL SCI, V86, P84, DOI 10.1093/toxsci/kfi179; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Ho YS, 2005, TOXICOL APPL PHARM, V205, P133, DOI 10.1016/j.taap.2004.09.019; Hoogeboom D, 2009, BBA-REV CANCER, V1796, P63, DOI 10.1016/j.bbcan.2009.02.002; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Jensen TJ, 2009, TOXICOL APPL PHARM, V235, P39, DOI 10.1016/j.taap.2008.10.013; Jin Q, 2008, CARCINOGENESIS, V29, P1614, DOI 10.1093/carcin/bgm234; Jorgensen ED, 2004, CELL CYCLE, V3, P1154; Kang Y, 2007, ONCOGENE, V26, P4394, DOI 10.1038/sj.onc.1210218; Kaplan R, 2003, CANCER RES, V63, P1475; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Killian JK, 2009, CANCER RES, V69, P758, DOI 10.1158/0008-5472.CAN-08-2984; Kim HJ, 2006, CANCER, V107, P1042, DOI 10.1002/cncr.22087; LE FN, 2005, FASEB J, V19, P144; Lee SJ, 2005, CARCINOGENESIS, V26, P403, DOI 10.1093/carcin/bgh307; Licchesi JDF, 2008, CARCINOGENESIS, V29, P895, DOI 10.1093/carcin/bgn017; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Malusecka E, 2008, ANTICANCER RES, V28, P501; Mathews LA, 2009, DIFFERENTIATION, V78, P1, DOI 10.1016/j.diff.2009.04.002; McCabe MT, 2009, CANCER RES, V69, P282, DOI 10.1158/0008-5472.CAN-08-3274; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Narayan S, 2004, ONCOGENE, V23, P5880, DOI 10.1038/sj.onc.1207792; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Schrump DS, 2007, CANCER J, V13, P56, DOI 10.1097/PPO.0b013e31803c74cf; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Seng TJ, 2008, BRIT J CANCER, V99, P375, DOI 10.1038/sj.bjc.6604452; Sexton K, 2008, PHARMACOGENET GENOM, V18, P853, DOI 10.1097/FPC.0b013e328307bddf; Shin HJ, 2009, FOOD CHEM TOXICOL, V47, P192, DOI 10.1016/j.fct.2008.10.028; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smith CJ, 2003, FOOD CHEM TOXICOL, V41, P807, DOI 10.1016/S0278-6915(03)00021-8; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Toyooka S, 2006, CANCER RES, V66, P1371, DOI 10.1158/0008-5472.CAN-05-2625; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Vrzalikova K, 2008, J CANCER RES CLIN, V134, P1037, DOI 10.1007/s00432-008-0361-y; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200; Wu JP, 2009, TOXICOL SCI, V107, P385, DOI 10.1093/toxsci/kfn239; Xing J, 2008, BRIT J CANCER, V98, P1716, DOI 10.1038/sj.bjc.6604343; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Zhou X, 2009, TOXICOL APPL PHARM, V236, P78, DOI 10.1016/j.taap.2009.01.009	51	202	218	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 24	2010	29	25					3650	3664		10.1038/onc.2010.129	http://dx.doi.org/10.1038/onc.2010.129			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	615CG	20440268	Green Accepted			2022-12-25	WOS:000279108600006
J	Wilson, JJ				Wilson, John James			Assessing the Value of DNA Barcodes and Other Priority Gene Regions for Molecular Phylogenetics of Lepidoptera	PLOS ONE			English	Article							NOCTUOIDEA INSECTA; UTILITY; BUTTERFLIES; MITOCHONDRIAL; DIVERGENCE; CHARACTERS; MORPHOLOGY; EVOLUTION; SEQUENCES; PATTERNS	Background: Despite apparently abundant amounts of observable variation and species diversity, the order Lepidoptera exhibits a morphological homogeneity that has provided only a limited number of taxonomic characters and led to widespread use of nucleotides for inferring relationships. This study aims to characterize and develop methods to quantify the value of priority gene regions designated for Lepidoptera molecular systematics. In particular, I assess how the DNA barcode segment of the mitochondrial COI gene performs across a broad temporal range given its number one position of priority, most sequenced status, and the conflicting opinions on its phylogenetic performance. Methodology/Principal Findings: Gene regions commonly sequenced for Lepidoptera phylogenetics were scored using multiple measures across three categories: practicality, which includes universality of primers and sequence quality; phylogenetic utility; and phylogenetic signal. I found that alternative measures within a category often appeared correlated, but high scores in one category did not necessarily translate into high scores in another. The DNA barcode was easier to sequence than other genes, and had high scores for utility but low signal above the genus level. Conclusions/Significance: Given limited financial resources and time constraints, careful selection of gene regions for molecular phylogenetics is crucial to avoid wasted effort producing partially informative data. This study introduces an approach to assessing the value of gene regions prior to the initiation of new studies and presents empirical results to help guide future selections.	Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Wilson, JJ (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	jwilso04@uoguelph.ca	Wilson, John-James/C-4656-2012	Wilson, John-James/0000-0002-3583-3550	NSERC; Genome Canada through the Ontario Genomics Institute	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada through the Ontario Genomics Institute(Genome Canada)	This study was funded by grants from NSERC and Genome Canada through the Ontario Genomics Institute to Paul D. N. Hebert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Baker RH, 2001, SYST BIOL, V50, P87, DOI 10.1080/106351501750107512; Bapteste E, 2002, MOL BIOL EVOL, V19, P972, DOI 10.1093/oxfordjournals.molbev.a004156; Brower AVZ, 1998, INSECT MOL BIOL, V7, P73, DOI 10.1046/j.1365-2583.1998.71052.x; Brower AVZ, 1996, ANNU REV ECOL SYST, V27, P423, DOI 10.1146/annurev.ecolsys.27.1.423; Brower AVZ, 2000, P ROY SOC B-BIOL SCI, V267, P1201, DOI 10.1098/rspb.2000.1129; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Caterino MS, 2000, ANNU REV ENTOMOL, V45, P1, DOI 10.1146/annurev.ento.45.1.1; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Floyd Robin M., 2009, P417, DOI 10.1002/9781444308211.ch17; Gatesy J, 2007, SYSTEMATIC BIOL, V56, P355, DOI 10.1080/10635150701294733; Goloboff PA, 2009, CLADISTICS, V25, P211, DOI 10.1111/j.1096-0031.2009.00255.x; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heath TA, 2008, SYST BIOL, V57, P160, DOI 10.1080/10635150701884640; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Kandul NP, 2004, SYST BIOL, V53, P278, DOI 10.1080/10635150490423692; Kitching I. J., 1998, CLADISTICS THEORY PR; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Mitchell A, 2000, SYST BIOL, V49, P202, DOI 10.1093/sysbio/49.2.202; Mitchell A, 1997, MOL BIOL EVOL, V14, P381, DOI 10.1093/oxfordjournals.molbev.a025774; Mitchell A, 2008, AUST J ENTOMOL, V47, P169, DOI 10.1111/j.1440-6055.2008.00645.x; Monaghan MT, 2007, MOL PHYLOGENET EVOL, V45, P674, DOI 10.1016/j.ympev.2007.06.009; Nazari V, 2007, MOL PHYLOGENET EVOL, V42, P131, DOI 10.1016/j.ympev.2006.06.022; Phillips AJ, 2006, J BIOMED INFORM, V39, P18, DOI 10.1016/j.jbi.2005.11.005; POGUE MG, 2009, INSECT BIODIVERSITY, P263; Purvis A, 1997, TRENDS ECOL EVOL, V12, P49, DOI 10.1016/S0169-5347(96)30066-9; Reed RD, 1999, MOL BIOL EVOL, V16, P286, DOI 10.1093/oxfordjournals.molbev.a026110; Regier JC, 1998, MOL BIOL EVOL, V15, P1172, DOI 10.1093/oxfordjournals.molbev.a026024; Regier JC, 2008, SYST ENTOMOL, V33, P219, DOI 10.1111/j.1365-3113.2007.00416.x; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Rosenberg MS, 2003, SYST BIOL, V52, P119, DOI 10.1080/10635150390132894; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; SCOBLE MJ, 1992, LEPIDOPTERA FUNCTION; Shull VL, 2001, SYST BIOL, V50, P945, DOI 10.1080/106351501753462894; Solis M. Alma, 1999, American Entomologist, V45, P206; Sperling Felix, 2003, P431; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Vane-Wright Richard I., 2003, P477; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; WAHLBERG N, 2006, ESF LESC EXPL WORKSH; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Warren AD, 2008, CLADISTICS, V24, P642, DOI 10.1111/j.1096-0031.2008.00218.x; Wenzel JW, 1999, CLADISTICS, V15, P51, DOI 10.1006/clad.1999.0084; Whinnett A, 2005, P ROY SOC B-BIOL SCI, V272, P2525, DOI 10.1098/rspb.2005.3247; Wiegmann BM, 2000, MOL PHYLOGENET EVOL, V15, P242, DOI 10.1006/mpev.1999.0746; Wortley AH, 2006, TAXON, V55, P431, DOI 10.2307/25065589; Zhang Min, 2008, Agricultural Sciences in China, V7, P731, DOI 10.1016/S1671-2927(08)60108-X	55	35	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10525	10.1371/journal.pone.0010525	http://dx.doi.org/10.1371/journal.pone.0010525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479871	Green Published, gold			2022-12-25	WOS:000277467800010
J	Chen, PL; O'Neal, JF; Ebelt, ND; Cantrell, MA; Mitra, S; Nasrazadani, A; Vandenbroek, TL; Heasley, LE; Van Den Berg, CL				Chen, Peila; O'Neal, Jamye F.; Ebelt, Nancy D.; Cantrell, Michael A.; Mitra, Shreya; Nasrazadani, Azadeh; Vandenbroek, Tracy L.; Heasley, Lynn E.; Van Den Berg, Carla L.			Jnk2 Effects on Tumor Development, Genetic Instability and Replicative Stress in an Oncogene-Driven Mouse Mammary Tumor Model	PLOS ONE			English	Article							DNA-LIGASE-I; DEPENDENT PHOSPHORYLATION; CHECKPOINT; DAMAGE; ACTIVATION; REQUIREMENT; PATHWAY; CELLS; IDENTIFICATION; TRANSFORMATION	Oncogenes induce cell proliferation leading to replicative stress, DNA damage and genomic instability. A wide variety of cellular stresses activate c-Jun N-terminal kinase (JNK) proteins, but few studies have directly addressed the roles of JNK isoforms in tumor development. Herein, we show that jnk2 knockout mice expressing the Polyoma Middle T Antigen transgene developed mammary tumors earlier and experienced higher tumor multiplicity compared to jnk2 wildtype mice. Lack of jnk2 expression was associated with higher tumor aneuploidy and reduced DNA damage response, as marked by fewer pH2AX and 53BP1 nuclear foci. Comparative genomic hybridization further confirmed increased genomic instability in PyV MT/jnk22/2 tumors. In vitro, PyV MT/jnk22/2 cells underwent replicative stress and cell death as evidenced by lower BrdU incorporation, and sustained chromatin licensing and DNA replication factor 1 (CDT1) and p21(Waf1) protein expression, and phosphorylation of Chk1 after serum stimulation, but this response was not associated with phosphorylation of p53 Ser15. Adenoviral overexpression of CDT1 led to similar differences between jnk2 wildtype and knockout cells. In normal mammary cells undergoing UV induced single stranded DNA breaks, JNK2 localized to RPA (Replication Protein A) coated strands indicating that JNK2 responds early to single stranded DNA damage and is critical for subsequent recruitment of DNA repair proteins. Together, these data support that JNK2 prevents replicative stress by coordinating cell cycle progression and DNA damage repair mechanisms.	[Chen, Peila; O'Neal, Jamye F.; Mitra, Shreya; Nasrazadani, Azadeh; Vandenbroek, Tracy L.; Van Den Berg, Carla L.] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA; [Heasley, Lynn E.] Univ Colorado Denver, Dept Craniofacial Biol, Aurora, CO USA; [Ebelt, Nancy D.; Cantrell, Michael A.] Univ Texas Austin, Sch Biol Sci, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Austin	Chen, PL (corresponding author), Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA.	cvandenberg@mail.utexas.edu		Ebelt, Nancy/0000-0002-1998-3719	National Institutes of Health [CA100238]; NATIONAL CANCER INSTITUTE [R01CA116527, R01CA100238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA100238 (to C. L. V. D. B.). The content of this information does not necessarily reflect the position or the policy of the government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bentley AM, 2002, J CELL SCI, V115, P949; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bogoyevitch MA, 2006, BIOESSAYS, V28, P923, DOI 10.1002/bies.20458; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Chen NY, 2001, CANCER RES, V61, P3908; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Downey M, 2006, CELL CYCLE, V5, P1376, DOI 10.4161/cc.5.13.2899; Farrants AKO, 2008, FEBS LETT, V582, P2041, DOI 10.1016/j.febslet.2008.04.032; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Li YH, 2002, J INFRARED MILLIM W, V21, P1; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; Machida YJ, 2005, J BIOL CHEM, V280, P27624, DOI 10.1074/jbc.M502615200; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Rampakakis E, 2008, J CELL SCI, V121, P590, DOI 10.1242/jcs.021352; Rodrigues GA, 1997, EMBO J, V16, P2634, DOI 10.1093/emboj/16.10.2634; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; She QB, 2002, CANCER RES, V62, P1343; Shen Q, 2006, DEV BIOL, V295, P589, DOI 10.1016/j.ydbio.2006.03.042; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; Song W, 2007, J BIOL CHEM, V282, P22721, DOI 10.1074/jbc.M703774200; Squires S, 2004, CELL CYCLE, V3, P1543, DOI 10.4161/cc.3.12.1272; SRINIVAS S, 1994, P NATL ACAD SCI USA, V91, P10064, DOI 10.1073/pnas.91.21.10064; Stuart SA, 2009, J BIOL CHEM, V284, P15061, DOI 10.1074/jbc.M808810200; Sun DY, 2001, CLIN CANCER RES, V7, P4143; Sun DY, 2002, CLIN CANCER RES, V8, P1189; Tapia-Alveal C, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-8; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Wang WS, 2006, J BIOL CHEM, V281, P20865, DOI 10.1074/jbc.M602289200; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100	52	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10443	10.1371/journal.pone.0010443	http://dx.doi.org/10.1371/journal.pone.0010443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454618	Green Published, gold, Green Submitted			2022-12-25	WOS:000277240300019
J	Hajdin, K; D'Alessandro, V; Niggli, FK; Schafer, BW; Bernasconi, M				Hajdin, Katarina; D'Alessandro, Valentina; Niggli, Felix K.; Schaefer, Beat W.; Bernasconi, Michele			Furin Targeted Drug Delivery for Treatment of Rhabdomyosarcoma in a Mouse Model	PLOS ONE			English	Article							PROPROTEIN CONVERTASES FURIN; PRO-PROTEIN CONVERTASES; CANCER-THERAPY; PHAGE DISPLAY; MONOCLONAL-ANTIBODIES; HOMING PEPTIDE; TUMOR-CELLS; HUMAN HEAD; GROWTH; INHIBITION	Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Improvement of treatment efficacy and decreased side effects through tumor-targeted drug delivery would be desirable. By panning with a phage-displayed cyclic random peptide library we selected a peptide with strong affinity for RMS in vitro and in vivo. The peptide minimal binding motif Arg-X-(Arg/Lys)(Arg/Lys) identified by alanine-scan, suggested the target receptor to be a proprotein convertase (PC). Expression profiling of all PCs in RMS biopsies and cell lines revealed consistent high expression levels for the membrane-bound furin and PC7. Direct binding of RMS-P3 peptide to furin was demonstrated by affinity chromatography and supported by activity and colocalization studies. Treatment of RMS in mice with doxorubicin coupled to the targeting peptide resulted in a two-fold increase in therapeutic efficacy compared to doxorubicin treatment alone. Our findings indicate surface-furin binding as novel mechanism for therapeutic cell penetration which needs to be further investigated. Furthermore, this work demonstrates that specific targeting of membrane-bound furin in tumors is possible for and suggests that RMS and other tumors might benefit from proprotein convertases targeted drug delivery.	[Hajdin, Katarina; D'Alessandro, Valentina; Niggli, Felix K.; Schaefer, Beat W.; Bernasconi, Michele] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland	University Children's Hospital Zurich	Hajdin, K (corresponding author), Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland.	michele.bernasconi@kispi.uzh.ch	Bernasconi, Michele/GOH-1815-2022; Bernasconi, Michele/CAG-2492-2022; Bernasconi, Michele/C-6734-2008; Niggli, Felix/L-6547-2017	Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Niggli, Felix/0000-0002-7553-3712; Schafer, Beat/0000-0001-5988-2915	Swiss Bridge Foundation; Schweizer Forschungstiftung Kind und Krebs	Swiss Bridge Foundation; Schweizer Forschungstiftung Kind und Krebs	This work was supported by the Swiss Bridge Foundation, the Schweizer Forschungstiftung Kind und Krebs (http://www.kindundkrebs.ch/) and the Zurcher Krebsliga (http://www.krebsliga-zh.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; AINA O, 2007, MOL PHARM; Aina OH, 2002, BIOPOLYMERS, V66, P184, DOI 10.1002/bip.10257; Basak A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007700; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bassi DE, 2003, AM J PATHOL, V162, P439, DOI 10.1016/S0002-9440(10)63838-2; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; Bergeron F, 2000, J MOL ENDOCRINOL, V24, P1, DOI 10.1677/jme.0.0240001; Breitfeld PP, 2005, ONCOLOGIST, V10, P518, DOI 10.1634/theoncologist.10-7-518; Chretien M, 2008, EXPERT OPIN THER TAR, V12, P1289, DOI 10.1517/14728222.12.10.1289 ; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; De Giovanni C, 2009, FUTURE ONCOL, V5, P1449, DOI 10.2217/fon.09.97; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Enback J, 2007, BIOCHEM SOC T, V35, P780, DOI 10.1042/BST0350780; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; Futaki S, 2006, BIOPOLYMERS, V84, P241, DOI 10.1002/bip.20421; HOFFMAN JA, 2004, PHAGE DISPLAY PRACTI, P169; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; KIDO H, 1993, J BIOL CHEM, V268, P13406; KOMADA M, 1993, FEBS LETT, V328, P25, DOI 10.1016/0014-5793(93)80958-W; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Lapierre M, 2007, CANCER RES, V67, P9030, DOI 10.1158/0008-5472.CAN-07-0807; Laprise MH, 2002, BLOOD, V100, P3578, DOI 10.1182/blood.V100.10.3578; Levene AP, 2005, J ROY SOC MED, V98, P146, DOI 10.1258/jrsm.98.4.146; Mbikay M, 1997, BRIT J CANCER, V75, P1509, DOI 10.1038/bjc.1997.258; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; NELSEN SM, 2009, J BIOL CHEM; NISHIMURA S, 2008, J BIOL CHEM; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; REMACLE AG, 2010, INT J BIOCH CELL BIO; Ruoslahti E, 2004, BIOCHEM SOC T, V32, P397, DOI 10.1042/BST0320397; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Scholl FA, 2000, BRIT J CANCER, V82, P1239; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; Stawowy P, 2004, BIOCHEM BIOPH RES CO, V321, P531, DOI 10.1016/j.bbrc.2004.07.001; Stern M, 2005, CRIT REV ONCOL HEMAT, V54, P11, DOI 10.1016/j.critrevonc.2004.10.011; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Sun XW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-73; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Wick W, 2004, J NEUROCHEM, V91, P1275, DOI 10.1111/j.1471-4159.2004.02806.x; Witt H, 2009, INT J CANCER, V124, P2026, DOI 10.1002/ijc.24170; Zurita AJ, 2003, J CONTROL RELEASE, V91, P183, DOI 10.1016/S0168-3659(03)00236-0	58	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10445	10.1371/journal.pone.0010445	http://dx.doi.org/10.1371/journal.pone.0010445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454619	gold, Green Published, Green Submitted			2022-12-25	WOS:000277240300020
J	Cohen, TS; Lawrence, GG; Khasgiwala, A; Margulies, SS				Cohen, Taylor S.; Lawrence, Gladys Gray; Khasgiwala, Amit; Margulies, Susan S.			MAPk Activation Modulates Permeability of Isolated Rat Alveolar Epithelial Cell Monolayers Following Cyclic Stretch	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INDUCED LUNG INJURY; PROTEIN-KINASE; VENTILATION; PATHWAYS; STRESS; INHIBITION; EXPRESSION; PREVENTION; MECHANISM	We cultured (5 days) rat alveolar epithelial cells to investigate the role of mitogen-activated protein kinase (MAPk) signaling in ventilator induced epithelial barrier dysfunction. Cells were stretched to a magnitude of 12% or 37% change in surface area at a rate of 0.25 Hz with and without pretreatment with either the JNK inhibitor SP600125 or the ERK inhibitor U0126. Following stretch (0, 10, 30, or 60 min), MAPk phosphorylation was examined, monolayer permeability to the uncharged tracer carboxyfluorescein measured (0, 10, 60 min of stretch), and occludin expression determined (0 and 60 min of stretch). Stretch to 12%, previously shown not to increase monolayer permeability, did not alter phosphorylation of any MAPk or occludin expression at any time point. Following stretch to 37%, phosphorylation of JNK, ERK, and p38 was significantly higher by 10 minutes than in unstretched monolayers. Phosphorylation of JNK and p38 subsided as stretch continued, and by 30 minutes returned to unstretched levels. Phosphorylation of ERK remained significantly elevated compared to unstretched levels at all stretch durations. Epithelial permeability increased significantly by 10 minutes of stretch compared to unstretched controls, with further significant increases by 60 minutes. Inhibition with U0126 and SP600125 prevented stretch-induced phosphorylation increases of ERK and JNK, respectively, however neither prevented increases in permeability following 10 minutes. Separately, inhibition of JNK or ERK prevented subsequent additional permeability increases as stretch continued to 60 minute time points. Inhibition of JNK, not ERK, prevented loss of occludin, and minimized loss of cell-cell contact following 60 minutes of stretch. These data suggest that stretch-induced JNK signaling modulates epithelial permeability through regulation tight junction protein expression, and is a potential target for clinical treatments during mechanical ventilation.	[Cohen, Taylor S.; Lawrence, Gladys Gray; Khasgiwala, Amit; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania	Cohen, TS (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	margulies@seas.upenn.edu	Cohen, Taylor/C-9927-2016	Cohen, Taylor/0000-0001-9368-0903	NIH [RO1-HL57204]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057204] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by the NIH: RO1-HL57204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Boncoeur E, 2008, INT J BIOCHEM CELL B, V40, P432, DOI 10.1016/j.biocel.2007.08.013; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carrozzino F, 2009, AM J PHYSIOL-CELL PH, V297, pC775, DOI 10.1152/ajpcell.00084.2009; Cavanaugh KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1179, DOI 10.1152/ajpcell.00355.2004; Cavanaugh KJ, 2001, AM J RESP CELL MOL, V25, P584, DOI 10.1165/ajrcmb.25.5.4486; Chen CY, 2008, ARTERIOSCL THROM VAS, V28, P906, DOI 10.1161/ATVBAHA.108.163667; Cohen TS, 2008, EUR RESPIR J, V32, P854, DOI 10.1183/09031936.00141007; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; EGAN EA, 1976, J PHYSIOL-LONDON, V260, P409, DOI 10.1113/jphysiol.1976.sp011522; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; HAAKE R, 1987, CHEST, V91, P608, DOI 10.1378/chest.91.4.608; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hsieh MH, 2005, INT REV CYTOL, V245, P45, DOI 10.1016/S0074-7696(05)45003-2; KIM KJ, 1985, J APPL PHYSIOL, V59, P1290, DOI 10.1152/jappl.1985.59.4.1290; KIM KJ, 1982, J APPL PHYSIOL, V52, P1498, DOI 10.1152/jappl.1982.52.6.1498; KIM KJ, 1983, J APPL PHYSIOL, V54, P140, DOI 10.1152/jappl.1983.54.1.140; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Li LF, 2004, AM J RESP CRIT CARE, V169, P518, DOI 10.1164/rccm.200305-660OC; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Ning QM, 2007, MED HYPOTHESES, V68, P356, DOI 10.1016/j.mehy.2006.06.053; Oswari J, 2001, AM J PHYSIOL-LUNG C, V281, pL1068, DOI 10.1152/ajplung.2001.281.5.L1068; PARKER JC, 1993, CRIT CARE MED, V21, P131, DOI 10.1097/00003246-199301000-00024; Pedram A, 2002, J BIOL CHEM, V277, P44385, DOI 10.1074/jbc.M202391200; Petecchia L, 2009, CHEST, V135, P1502, DOI 10.1378/chest.08-1780; ROQUE T, 2008, J PHARM EXP THER; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Uhlig U, 2002, EUR RESPIR J, V20, P946, DOI 10.1183/09031936.02.01612001; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; White SR, 2005, AM J RESP CELL MOL, V32, P301, DOI 10.1165/rcmb.2004-0118OC; Zar JH, 1999, BIOSTATISTICAL ANAL	37	48	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10385	10.1371/journal.pone.0010385	http://dx.doi.org/10.1371/journal.pone.0010385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442784	Green Submitted, gold, Green Published			2022-12-25	WOS:000277154200021
J	Govorunova, EG; Moussaif, M; Kullyev, A; Nguyen, KCQ; McDonald, TV; Hall, DH; Sze, JY				Govorunova, Elena G.; Moussaif, Mustapha; Kullyev, Andrey; Nguyen, Ken C. Q.; McDonald, Thomas V.; Hall, David H.; Sze, Ji Y.			A Homolog of FHM2 Is Involved in Modulation of Excitatory Neurotransmission by Serotonin in C. elegans	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; NERVOUS-SYSTEM; MISSENSE MUTATION; PLC-BETA; CAENORHABDITIS; GENE; MIGRAINE; NA,K-ATPASE; BEHAVIOR; RECEPTORS	The C. elegans eat-6 gene encodes a Na+, K+-ATPase a subunit and is a homolog of the familial hemiplegic migraine candidate gene FHM2. Migraine is the most common neurological disorder linked to serotonergic dysfunction. We sought to study the pathophysiological mechanisms of migraine and their relation to serotonin (5-HT) signaling using C. elegans as a genetic model. In C. elegans, exogenous 5-HT inhibits paralysis induced by the acetylcholinesterase inhibitor aldicarb. We found that the eat-6(ad467) mutation or RNAi of eat-6 increases aldicarb sensitivity and causes complete resistance to 5-HT treatment, indicating that EAT-6 is a component of the pathway that couples 5-HT signaling and ACh neurotransmission. While a postsynaptic role of EAT-6 at the bodywall NMJs has been well established, we found that EAT-6 may in addition regulate presynaptic ACh neurotransmission. We show that eat-6 is expressed in ventral cord ACh motor neurons, and that cell-specific RNAi of eat-6 in the ACh neurons leads to hypersensitivity to aldicarb. Electron microscopy showed an increased number of synaptic vesicles in the ACh neurons in the eat-6(ad467) mutant. Genetic analyses suggest that EAT-6 interacts with EGL-30 G alpha q, EGL-8 phospholipase C and SLO-1 BK channel signaling to modulate ACh neurotransmission and that either reduced or excessive EAT-6 function may lead to increased ACh neurotransmission. Study of the interaction between eat-6 and 5-HT receptors revealed both stimulatory and inhibitory 5-HT inputs to the NMJs. We show that the inhibitory and stimulatory 5-HT signals arise from distinct 5-HT neurons. The role of eat-6 in modulation of excitatory neurotransmission by 5-HT may provide a genetic explanation for the therapeutic effects of the drugs targeting 5-HT receptors in the treatment of migraine patients.	[Govorunova, Elena G.; Moussaif, Mustapha; Kullyev, Andrey; McDonald, Thomas V.; Sze, Ji Y.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [McDonald, Thomas V.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Nguyen, Ken C. Q.; Hall, David H.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Govorunova, EG (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	jiying.sze@einstein.yu.edu	Kullyev, Andrey/A-1673-2017	Kullyev, Andrey/0000-0002-3547-4041; Govorunova, Elena/0000-0003-0522-9683	National Institutes of Mental Health; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064747, R01MH083982] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by an award from the Department of Defense Autism Spectrum Disorder Research Program and grants from the National Institutes of Mental Health (to J.Y.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; AVERY L, 1993, GENETICS, V133, P897; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bastiani CA, 2003, GENETICS, V165, P1805; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Carre-Pierrat Maite, 2006, Invertebrate Neuroscience, V6, P189, DOI 10.1007/s10158-006-0033-z; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Davis MW, 1995, J NEUROSCI, V15, P8408; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Doi M, 2008, MOL CELL NEUROSCI, V38, P548, DOI 10.1016/j.mcn.2008.05.003; EDGLEY M, 2006, WORMBOOK C ELEGANS R; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Estevez M, 2006, HEADACHE, V46, pS25, DOI 10.1111/j.1526-4610.2006.00487.x; FRAZER A, 1990, ANNU REV PHARMACOL, V30, P307; Gargus JJ, 2009, ANN NY ACAD SCI, V1151, P133, DOI 10.1111/j.1749-6632.2008.03572.x; Goadsby PJ, 2007, TRENDS MOL MED, V13, P39, DOI 10.1016/j.molmed.2006.11.005; Goldstein I, 2009, BIOL PSYCHIAT, V65, P985, DOI 10.1016/j.biopsych.2008.10.033; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; HALL D, 1995, ELECT MICROSCOPY 3D, P395; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hamel E, 2007, Cephalalgia, V27, P1293, DOI 10.1111/j.1468-2982.2007.01476.x; Harris GP, 2009, J NEUROSCI, V29, P1446, DOI 10.1523/JNEUROSCI.4585-08.2009; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Montagna P, 2004, NEUROL SCI, V25, pS93, DOI 10.1007/s10072-004-0261-0; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Okamura H, 2003, J MEMBRANE BIOL, V191, P13, DOI 10.1007/s00232-002-1041-5; OKKEMA PG, 1993, GENETICS, V135, P385; Perez-Mansilla B, 2009, ADV GENET, V65, P145, DOI 10.1016/S0065-2660(09)65004-5; Peters MA, 2007, CURR BIOL, V17, P1601, DOI 10.1016/j.cub.2007.08.031; Pietrobon D, 2007, NEUROTHERAPEUTICS, V4, P274, DOI 10.1016/j.nurt.2007.01.008; RAIZEN DM, 1995, GENETICS, V141, P1365; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Sandoval GM, 2006, NAT NEUROSCI, V9, P599, DOI 10.1038/nn1685; Segall L, 2005, P NATL ACAD SCI USA, V102, P11106, DOI 10.1073/pnas.0504323102; Segall L, 2004, J BIOL CHEM, V279, P43692, DOI 10.1074/jbc.M407471200; Shima Y, 1998, BIOCHEM BIOPH RES CO, V248, P778, DOI 10.1006/bbrc.1998.8981; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tavraz NN, 2008, J BIOL CHEM, V283, P31097, DOI 10.1074/jbc.M802771200; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; TRENT C, 1983, GENETICS, V104, P619; van de Ven RCG, 2007, ARCH NEUROL-CHICAGO, V64, P643, DOI 10.1001/archneur.64.5.643; van den Maagdenberg AMJM, 2007, CURR OPIN NEUROL, V20, P299, DOI 10.1097/WCO.0b013e3281338d1f; Vanmolkot KR, 2006, EUR J HUM GENET, V14, P555, DOI 10.1038/sj.ejhg.5201607; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Weimer Robby M., 2006, V351, P203; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang SY, 2004, DEVELOPMENT, V131, P1629, DOI 10.1242/dev.01047; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	65	16	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10368	10.1371/journal.pone.0010368	http://dx.doi.org/10.1371/journal.pone.0010368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442779	Green Published, gold, Green Submitted			2022-12-25	WOS:000277154200010
J	Kumasaka, N; Nakamura, Y; Kamatani, N				Kumasaka, Natsuhiko; Nakamura, Yusuke; Kamatani, Naoyuki			The Textile Plot: A New Linkage Disequilibrium Display of Multiple-Single Nucleotide Polymorphism Genotype Data	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; HUMAN GENOME; HAPLOTYPE MAP; ASSOCIATION; POPULATION; VISUALIZATION	Linkage disequilibrium (LD) is a major concern in many genetic studies because of the markedly increased density of SNP (Single Nucleotide Polymorphism) genotype markers. This dramatic increase in the number of SNPs may cause problems in statistical analyses, such as by introducing multiple comparisons in hypothesis testing and colinearity in logistic regression models, because of the presence of complex LD structures. Inferences must be made about the underlying genetic variation through the LD structure before applying statistical models to the data. Therefore, we introduced the textile plot to provide a visualization of LD to improve the analysis of the genetic variation present in multiple-SNP genotype data. The plot can accentuate LD by displaying specific geometrical shapes, and allowing for the underlying haplotype structure to be inferred without any haplotype-phasing algorithms. Application of this technique to simulated and real data sets illustrated the potential usefulness of the textile plot as an aid to the interpretation of LD in multiple-SNP genotype data. The initial results of LD mapping and haplotype analyses of disease genes are encouraging, indicating that the textile plot may be useful in disease association studies.	[Kumasaka, Natsuhiko; Nakamura, Yusuke; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Tokyo, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Tokyo, Japan	RIKEN; University of Tokyo	Kumasaka, N (corresponding author), RIKEN, Ctr Genom Med, Tokyo, Japan.	kumasaka@stat.math.keio.ac.jp			Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; CALSON CS, 2004, AM J HUM GENET, V74, P106; Chambers JM., 1992, STAT MODELS S; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fry B.J, 2004, COMPUTATIONAL INFORM; Gifi A., 1990, NONLINEAR MULTIVARIA; Greenacre M.J., 1984, THEORY APPL CORRES A; Hurley CB, 2004, J COMPUT GRAPH STAT, V13, P788, DOI 10.1198/106186004X12425; Inselberg A, 1985, VISUAL COMPUT, V1, P69, DOI 10.1007/BF01898350; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kumasaka N, 2008, COMPUT STAT DATA AN, V52, P3616, DOI 10.1016/j.csda.2007.11.016; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Smith LP, 2009, GENET EPIDEMIOL, V33, P344, DOI 10.1002/gepi.20387; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Wadman M, 2006, NATURE, V444, P256, DOI 10.1038/444256a; WEGMAN EJ, 1990, J AM STAT ASSOC, V85, P664, DOI 10.2307/2290001	29	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10207	10.1371/journal.pone.0010207	http://dx.doi.org/10.1371/journal.pone.0010207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436909	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079700002
J	Walter, A; Etienne-Selloum, N; Brasse, D; Khallouf, H; Bronner, C; Rio, MC; Beretz, A; Schini-Kerth, VB				Walter, Allison; Etienne-Selloum, Nelly; Brasse, David; Khallouf, Hadeel; Bronner, Christian; Rio, Marie-Christine; Beretz, Alain; Schini-Kerth, Valerie B.			Intake of grape-derived polyphenols reduces C26 tumor growth by inhibiting angiogenesis and inducing apoptosis	FASEB JOURNAL			English	Article						colon cancer; red wine polyphenols; neovascularization; tumor suppressor gene; metastasis; aberrant crypt foci	ABERRANT CRYPT FOCI; CELL-CYCLE ARREST; COLORECTAL-CANCER; (-)-EPIGALLOCATECHIN GALLATE; CYCLOOXYGENASE-2 EXPRESSION; GENE-EXPRESSION; ANGIOTENSIN-II; COLON; P53; CARCINOGENESIS	This study evaluated the in vivo antitumor activity of grape-derived polyphenols. BALB/c mice were subcutaneously implanted with C26 colon carcinoma cells, and 2 d later they received either solvent or red wine polyphenols (RWPs) (100 mg/kg/d, human equivalent dose approximate to 500 mg/d) in the drinking water for 25 d. Wistar rats received either solvent or RWPs (100 mg/kg/d, human equivalent dose approximate to 1000 mg/d) in the drinking water 1 wk before injection of azoxymethane and were studied 10 wk later. In mice, RWPs inhibited tumor growth by 31%, reduced tumor vascularization and the number of lung metastases, decreased proliferation as indicated by down-regulation of Ki67, cyclin D1, and UHRF1, and increased apoptosis as indicated by TUNEL staining and active caspase-3 levels in tumor cells. RWPs reduced expression of VEGF, matrix metalloproteinase (MMP)-2, MMP-9, and cyclooxygenase-2 and increased expression of tumor suppressor genes p16(INK4A), p53, and p73 in tumor cells. In rats, RWPs reduced by 49% the number of azoxymethane-induced aberrant crypt foci (preneoplastic lesions) in colon. Thus, RWPs effectively reduced the development of colon carcinoma tumors in vivo by blunting tumor vascularization and by inhibiting proliferation and promoting apoptosis of tumor cells subsequent to an up-regulation of tumor suppressor genes.-Walter, A., Etienne-Selloum, N., Brasse, D., Khallouf, H., Bronner, C., Rio, M.-C., Beretz, A., Schini-Kerth, V. B. Intake of grape-derived polyphenols reduces C26 tumor growth by inhibiting angiogenesis and inducing apoptosis. FASEB J. 24, 3360-3369 (2010). www.fasebj.org	[Walter, Allison; Etienne-Selloum, Nelly; Khallouf, Hadeel; Bronner, Christian; Beretz, Alain; Schini-Kerth, Valerie B.] Univ Strasbourg, CNRS, UMR 7213, Lab Biophoton & Pharmacol,Fac Pharm, F-67401 Illkirch Graffenstaden, France; [Brasse, David] UDS, IN2P3, CNRS, Inst Pluridisciplinaire Hubert Curien,UMR 7178, Strasbourg, France; [Rio, Marie-Christine] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, INSERM, CNRS,UMR 7104,U964, F-67401 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schini-Kerth, VB (corresponding author), Univ Strasbourg, CNRS, UMR 7213, Lab Biophoton & Pharmacol,Fac Pharm, 74 Route Rhin, F-67401 Illkirch Graffenstaden, France.	valerie.schini-kerth@unistra.fr	Bronner, Christian/R-8488-2016; Brasse, David/AAU-3671-2020; Beretz, Alain/ABA-3589-2020	Bronner, Christian/0000-0002-3101-9279; Beretz, Alain/0000-0002-1479-1697	Ligue Nationale Francaise contre le Cancer; Comite du Haut-Rhin de la Ligue contre le Cancer; Association pour la Recherche contre le Cancer; VINIFLHOR (Ministry of Agriculture, France)	Ligue Nationale Francaise contre le Cancer(Ligue nationale contre le cancer); Comite du Haut-Rhin de la Ligue contre le Cancer; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); VINIFLHOR (Ministry of Agriculture, France)	The authors thank Isabelle Stoll and Sara Zgheib for providing valuable technical help. This work was supported by Ligue Nationale Francaise contre le Cancer, Comite du Haut-Rhin de la Ligue contre le Cancer, Association pour la Recherche contre le Cancer, and VINIFLHOR (Ministry of Agriculture, France).	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Bouvet M, 1998, ANN SURG ONCOL, V5, P681, DOI 10.1007/BF02303477; Boyle P, 2000, BRIT MED J, V321, P805, DOI 10.1136/bmj.321.7264.805; Brasse D, 2005, PHYS MED BIOL, V50, P5799, DOI 10.1088/0031-9155/50/24/003; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Calbo J, 2001, CANCER GENE THER, V8, P740, DOI 10.1038/sj.cgt.7700374; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CORBETT TH, 1975, CANCER RES, V35, P2434; Dashwood RH, 1998, CANCER RES, V58, P1127; Des Guetz G, 2006, BRIT J CANCER, V94, P1823, DOI 10.1038/sj.bjc.6603176; Dolara P, 2005, MUTAT RES-FUND MOL M, V591, P237, DOI 10.1016/j.mrfmmm.2005.04.022; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Fini L, 2007, J NUTR, V137, P2622, DOI 10.1093/jn/137.12.2622; Fresco P, 2006, MED RES REV, V26, P747, DOI 10.1002/med.20060; Glade M.J., 1997, AM I CANC RES CANC R, V15, P523, DOI [10.1016/s0899-9007(99)00021-0, DOI 10.1016/S0899-9007(99)00021-0]; Gosse F, 2005, CARCINOGENESIS, V26, P1291, DOI 10.1093/carcin/bgi074; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Hilska M, 2005, DIS COLON RECTUM, V48, P2197, DOI 10.1007/s10350-005-0202-x; Hoensch H, 2008, WORLD J GASTROENTERO, V14, P2187, DOI 10.3748/wjg.14.2187; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Izawa H, 2005, INT J ONCOL, V27, P69; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Kim KC, 2006, ARCH PHARM RES, V29, P152, DOI 10.1007/BF02974277; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li H, 2001, HUM GENE THER, V12, P515, DOI 10.1089/104303401300042429; Lu YP, 2002, P NATL ACAD SCI USA, V99, P12455, DOI 10.1073/pnas.182429899; Marques-Vidal P, 2006, CLIN NUTR, V25, P14, DOI 10.1016/j.clnu.2005.09.008; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; Oak MH, 2004, CIRCULATION, V110, P1861, DOI 10.1161/01.CIR.0000142617.52881.F4; Oak MH, 2003, ARTERIOSCL THROM VAS, V23, P1001, DOI 10.1161/01.ATV.0000070101.70534.38; Ohishi T, 2002, CANCER LETT, V177, P49, DOI 10.1016/S0304-3835(01)00767-4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Potter JD, 1996, CANCER CAUSE CONTROL, V7, P127, DOI 10.1007/BF00115644; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Rahman I, 2006, BIOCHEM PHARMACOL, V72, P1439, DOI 10.1016/j.bcp.2006.07.004; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Sasaki Y, 2001, GENE THER, V8, P1401, DOI 10.1038/sj.gt.3301538; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Sengottuvelan M, 2006, CARCINOGENESIS, V27, P1038, DOI 10.1093/carcin/bgi286; Shapiro GI, 2000, CELL BIOCHEM BIOPHYS, V33, P189, DOI 10.1385/CBB:33:2:189; SHARIF T, EUR J CANC, V46, P983; Sheng HM, 1998, CANCER RES, V58, P362; Tseng SH, 2004, CLIN CANCER RES, V10, P2190, DOI 10.1158/1078-0432.CCR-03-0105; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Uefuji K, 2000, CLIN CANCER RES, V6, P135; Walter A, 2008, J VASC RES, V45, P386, DOI 10.1159/000121408; Walter A, 2009, J PHARMACOL EXP THER, V329, P699, DOI 10.1124/jpet.108.148080; Wiese FW, 2001, CARCINOGENESIS, V22, P5, DOI 10.1093/carcin/22.1.5; Xiao H, 2008, CARCINOGENESIS, V29, P113, DOI 10.1093/carcin/bgm204; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6	58	43	45	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3360	3369		10.1096/fj.09-149419	http://dx.doi.org/10.1096/fj.09-149419			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20442318				2022-12-25	WOS:000281446400024
J	Brown, CR; Hung, GC; Dunton, D; Chiang, HL				Brown, C. Randell; Hung, Guo-Chiuan; Dunton, Danielle; Chiang, Hui-Ling			The TOR Complex 1 Is Distributed in Endosomes and in Retrograde Vesicles That Form from the Vacuole Membrane and Plays an Important Role in the Vacuole Import and Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CATABOLITE INACTIVATION; MOLECULAR MACHINERY; PROTEIN-TRANSPORT; PICHIA-PASTORIS; VID VESICLES; BETA-COP; FRUCTOSE-1,6-BISPHOSPHATASE; AUTOPHAGY; BIOGENESIS	The key gluconeogenic enzyme fructose-1,6-bisphosphatase (FBPase) is induced when Saccharomyces cerevisiae are starved of glucose. However, when glucose is added to cells that have been starved for 3 days, FBPase is degraded in the vacuole. FBPase is first imported to Vid (vacuole import and degradation) vesicles, and these vesicles then merge with the endocytic pathway. In this report we show that two additional gluconeogenic enzymes, isocitrate lyase and phosphoenolpyruvate carboxykinase, were also degraded in the vacuole via the Vid pathway. These new cargo proteins and FBPase interacted with the TORC1 complex during glucose starvation. However, Tor1p was dissociated from FBPase after the addition of glucose. FBPase degradation was inhibited in cells overexpressing TOR1, suggesting that excessive Tor1p is inhibitory. Both Tco89p and Tor1p were found in endosomes coming from the plasma membrane as well as in retrograde vesicles forming from the vacuole membrane. When TORC1 was inactivated by rapamycin, FBPase degradation was inhibited. We suggest that TORC1 interacts with multiple cargo proteins destined for the Vid pathway and plays an important role in the degradation of FBPase in the vacuole.	[Brown, C. Randell; Chiang, Hui-Ling] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Hung, Guo-Chiuan] US FDA, Div Cellular & Gene Therapy, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; US Food & Drug Administration (FDA)	Chiang, HL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	hxc32@psu.edu			National Institutes of Health [R01GM 59480]; Pennsylvania Tobacco Settlement Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Settlement Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM 59480. This work was also supported by a grant from the Pennsylvania Tobacco Settlement Fund (to H.-L. C.).	Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Brown CR, 2008, J BIOL CHEM, V283, P26116, DOI 10.1074/jbc.M709922200; Brown CR, 2001, J BIOL CHEM, V276, P48017, DOI 10.1074/jbc.M109222200; Brown CR, 2002, J CELL SCI, V115, P655; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Chiang HL, 1996, J BIOL CHEM, V271, P9934, DOI 10.1074/jbc.271.17.9934; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Cui DY, 2004, J BIOL CHEM, V279, P9713, DOI 10.1074/jbc.M310793200; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; Gabriely G, 2007, MOL CELL BIOL, V27, P526, DOI 10.1128/MCB.00577-06; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Hammerle M, 1998, J BIOL CHEM, V273, P25000, DOI 10.1074/jbc.273.39.25000; Hoffman M, 1996, GENETICS, V143, P1555; HOLZER H, 1989, RBC-CELL BIOL REV, V21, P305; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; JONES EW, 1991, J BIOL CHEM, V266, P7963; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; SCHORK SM, 1995, J BIOL CHEM, V270, P26446, DOI 10.1074/jbc.270.44.26446; Shieh HL, 1998, J BIOL CHEM, V273, P3381, DOI 10.1074/jbc.273.6.3381; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; TUTTLE DL, 1995, J CELL SCI, V108, P25; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; WHITNEY JA, 1995, CELL, V83, P703; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5; Yuan WP, 1999, MOL BIOL CELL, V10, P1353, DOI 10.1091/mbc.10.5.1353	49	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23357	23368		10.1074/jbc.M109.075143	http://dx.doi.org/10.1074/jbc.M109.075143			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20457600	Green Published, hybrid			2022-12-25	WOS:000279999900069
J	Gorbea, C; Makar, KA; Pauschinger, M; Pratt, G; Bersola, JLF; Varela, J; David, RM; Banks, L; Huang, CH; Li, H; Schultheiss, HP; Towbin, JA; Vallejo, JG; Bowles, NE				Gorbea, Carlos; Makar, Kimberly A.; Pauschinger, Matthias; Pratt, Gregory; Bersola, Jeathrina L. F.; Varela, Jacquelin; David, Ryan M.; Banks, Lori; Huang, Chien-Hua; Li, Hua; Schultheiss, Heinz-Peter; Towbin, Jeffrey A.; Vallejo, Jesus G.; Bowles, Neil E.			A Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; ISOLATED RAT HEPATOCYTES; BECLIN 1; PHOSPHATIDYLINOSITOL 3-KINASE; MULTIVESICULAR BODIES; AUTOPHAGIC VACUOLES; FUNCTIONAL ANALYSES; PROTEIN LIPIDATION; ENDOCYTIC PATHWAYS; SIGNALING PATHWAYS	The innate antiviral response is mediated, at least in part, by Toll-like receptors (TLRs). TLR3 signaling is activated in response to viral infection, and the absence of TLR3 in mice significantly increases mortality after infection with enteroviruses that cause myocarditis and/or dilated cardiomyopathy. We screened TLR3 in patients diagnosed with enteroviral myocarditis/cardiomyopathy and identified a rare variant in one patient as well as a significantly increased occurrence of a common polymorphism compared with controls. Expression of either variant resulted in significantly reduced TLR3-mediated signaling after stimulation with synthetic double-stranded RNA. Furthermore, Coxsackievirus B3 infection of cell lines expressing mutated TLR3 abrogated activation of the type I interferon pathway, leading to increased viral replication. TLR3-mediated type I interferon signaling required cellular autophagy and was suppressed by 3-methyladenine and bafilomycin A1, by inhibitors of lysosomal proteolysis, and by reduced expression of Beclin 1, Atg5, or microtubule-associated protein 1 light chain 3 beta (MAP1LC3 beta). However, TLR3-mediated signaling was restored upon exogenous expression of Beclin 1 or a variant MAP1LC3 beta fusion protein refractory to RNA interference. These data suggest that individuals harboring these variants may have a blunted innate immune response to enteroviral infection, leading to reduced viral clearance and an increased risk of cardiac pathology.	Univ Utah, Sch Med, Dept Pediat, Div Cardiol, Salt Lake City, UT 84112 USA; [Pratt, Gregory] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Makar, Kimberly A.; Towbin, Jeffrey A.] Baylor Coll Med, Dept Med, Cardiovasc Sci Sect, Houston, TX 77030 USA; [Bersola, Jeathrina L. F.; Varela, Jacquelin; David, Ryan M.; Li, Hua; Towbin, Jeffrey A.] Baylor Coll Med, Dept Pediat, Cardiol Sect, Houston, TX 77030 USA; [Banks, Lori; Huang, Chien-Hua] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA; [Towbin, Jeffrey A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pauschinger, Matthias; Schultheiss, Heinz-Peter] Charite, Med Clin 2, D-12203 Berlin, Germany	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bowles, NE (corresponding author), Univ Utah, Sch Med, Eccles Inst Human Genet, Dept Pediat Cardiol, 15 North 2030 East,Rm 7110B, Salt Lake City, UT 84112 USA.	neil.bowles@hsc.utah.edu	Gorbea, Carlos/L-4406-2019; Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X; HUANG, CHIEN-HUA/0000-0003-2981-4537; Banks, Lori/0000-0003-4684-8763	National Institutes of Health, NHLBI [R21-HL091223]; American Heart Association (National Center; Dept. of Human Genetics, University of Utah; Dept. of Pathology, University of Utah; Dept. of Biochemistry, University of Utah; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091223] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (National Center(American Heart Association); Dept. of Human Genetics, University of Utah; Dept. of Pathology, University of Utah; Dept. of Biochemistry, University of Utah; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R21-HL091223 (NHLBI, to N. E. B. and J. G. V.). This work was supported by the American Heart Association (National Center and Texas Affiliate (to N. E. B.).; We are grateful to Dr. Mark Leppert (Dept. of Human Genetics, University of Utah), Dr. Robert Fujinami (Dept. of Pathology, University of Utah), and Dr. Martin Rechsteiner (Dept. of Biochemistry, University of Utah) for support and assistance.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bowles KR, 2000, GENOMICS, V67, P109, DOI 10.1006/geno.2000.6242; Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X; Bowles NE, 2003, CURR OPIN CARDIOL, V18, P182, DOI 10.1097/00001573-200305000-00002; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Drose S, 1997, J EXP BIOL, V200, P1; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; GOODWIN JF, 1983, MYOCARDITIS CARDIOMY, P7; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Itoh K, 2008, J IMMUNOL, V181, P5522, DOI 10.4049/jimmunol.181.8.5522; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kuhl U, 1996, HEART, V75, P295, DOI 10.1136/hrt.75.3.295; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; Muzio M, 2000, J LEUKOCYTE BIOL, V67, P450, DOI 10.1002/jlb.67.4.450; Negishi H, 2008, P NATL ACAD SCI USA, V105, P20446, DOI 10.1073/pnas.0810372105; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pauschinger M, 1999, CIRCULATION, V99, P1348, DOI 10.1161/01.CIR.99.10.1348; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Richer MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004127; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shoji-Kawata S, 2009, BBA-MOL CELL RES, V1793, P1478, DOI 10.1016/j.bbamcr.2009.02.008; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yajima T, 2009, CIRCULATION, V119, P2615, DOI 10.1161/CIRCULATIONAHA.108.766022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	66	122	133	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23206	23221		10.1074/jbc.M109.047464	http://dx.doi.org/10.1074/jbc.M109.047464			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20472559	Green Published, hybrid			2022-12-25	WOS:000279999900055
J	Lazer, G; Pe'er, L; Farago, M; Machida, K; Mayer, BJ; Katzav, S				Lazer, Galit; Pe'er, Liron; Farago, Marganit; Machida, Kazuya; Mayer, Bruce J.; Katzav, Shulamit			Tyrosine Residues at the Carboxyl Terminus of Vav1 Play an Important Role in Regulation of Its Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; SIGNAL TRANSDUCER VAV1; ADAPTER PROTEIN; EXCHANGE FACTOR; RHO-FAMILY; PROTOONCOGENE VAV; HUMAN GENOME; LUNG-CANCER; SH2 DOMAINS; ACTIVATION	The guanine nucleotide exchange factor (GEF) Vav1 is an essential signal transducer protein in the hematopoietic system, where it is expressed physiologically. It is also involved in several human malignancies. Tyrosine phosphorylation at the Vav1 amino terminus plays a central role in regulating its activity; however, the role of carboxyl terminal tyrosine residues is unknown. We found that mutation of either Tyr-826 (Y826F) or Tyr-841 (Y841F) to phenylalanine led to loss of Vav1 GEF activity. When these Vav1 mutants were ectopically expressed in pancreatic cancer cells lacking Vav1, they failed to induce growth in agar, indicating loss of transforming potential. Furthermore, although Y841F had no effect on Vav1-stimulated nuclear factor of activated T cells (NFAT) activity, Y826F doubled NFAT activity when compared with Vav1, suggesting that Tyr-826 mediates an autoinhibitory effect on NFAT activity. SH2 profiling revealed that Shc, Csk, Abl, and Sap associate with Tyr-826, whereas SH2-B, Src, Brk, GTPase-activating protein, and phospholipase C-gamma associate with Tyr-841. Although the mutations in the Tyr-826 and Tyr-841 did not affect the binding of the carboxyl SH3 of Vav1 to other proteins, binding to several of the proteins identified by the SH2 profiling was lost. Of interest is Csk, which associates with wild-type Vav1 and Y841F, yet it fails to associate with Y826F, suggesting that loss of binding between Y826F and Csk might relieve an autoinhibitory effect, leading to increased NFAT. Our data indicate that GEF activity is critical for the function of Vav1 as a transforming protein but not for NFAT stimulation. The association of Vav1 with other proteins, detected by SH2 profiling, might affect other Vav1-dependent activities, such as NFAT stimulation.	[Lazer, Galit; Pe'er, Liron; Farago, Marganit; Katzav, Shulamit] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Machida, Kazuya; Mayer, Bruce J.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Raymond & Beverly Sackler Lab Genet & Mol Med, Farmington, CT 06030 USA	Hebrew University of Jerusalem; University of Connecticut	Katzav, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Dev Biol & Canc Res, POB 12272, IL-91120 Jerusalem, Israel.	shulamitk@ekmd.huji.ac.il			National Institutes of Health [CA107785]; Israel Academy of Sciences; Israel Cancer Research Foundation; Connecticut Breast Health Initiative; NATIONAL CANCER INSTITUTE [R21CA107785, R01CA082258, R33CA107785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Academy of Sciences; Israel Cancer Research Foundation; Connecticut Breast Health Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA107785 (to B.J.M.). This work was also partially supported by grants from the Israel Academy of Sciences (to S. K.), Israel Cancer Research Foundation (to S. K.), and Connecticut Breast Health Initiative (to K.M.).	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bassermann F, 2002, J BIOL CHEM, V277, P12437, DOI 10.1074/jbc.M112397200; Bertagnolo V, 2010, J PROTEOME RES, V9, P752, DOI 10.1021/pr900581y; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Cui LL, 2009, J IMMUNOL, V182, P3233, DOI 10.4049/jimmunol.0802621; Dierck Kevin, 2009, V527, P131, DOI 10.1007/978-1-60327-834-8_11; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fumagalli L, 2007, J IMMUNOL, V178, P3874, DOI 10.4049/jimmunol.178.6.3874; Groysman M, 2002, J BIOL CHEM, V277, P50121, DOI 10.1074/jbc.M204299200; Groysman M, 1998, ONCOGENE, V17, P1597, DOI 10.1038/sj.onc.1202074; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harnois T, 2003, ONCOGENE, V22, P6445, DOI 10.1038/sj.onc.1206626; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Hornstein I, 2003, J PATHOL, V199, P526, DOI 10.1002/path.1314; Huang JY, 2000, P NATL ACAD SCI USA, V97, P10923, DOI 10.1073/pnas.97.20.10923; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Kaminuma O, 2001, MOL CELL BIOL, V21, P3126, DOI 10.1128/MCB.21.9.3126-3136.2001; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; KATZAV S, 1993, ONCOGENE, V8, P1757; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Lazer G, 2007, CELL SIGNAL, V19, P2479, DOI 10.1016/j.cellsig.2007.07.022; Lazer G, 2009, J PATHOL, V219, P25, DOI 10.1002/path.2579; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Liu HH, 2006, ACTA PHYS-CHIM SIN, V22, P868, DOI 10.3866/PKU.WHXB20060720; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Machida K, 2005, BBA-PROTEINS PROTEOM, V1747, P1, DOI 10.1016/j.bbapap.2004.10.005; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Maures TJ, 2007, TRENDS ENDOCRIN MET, V18, P38, DOI 10.1016/j.tem.2006.11.007; Michel F, 1998, J BIOL CHEM, V273, P31932, DOI 10.1074/jbc.273.48.31932; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Patrussi L, 2007, BLOOD, V110, P1730, DOI 10.1182/blood-2007-01-068411; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Peterson ME, 2008, IMMUNITY, V29, P578, DOI 10.1016/j.immuni.2008.07.014; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saborit-Villarroya I, 2008, MOL IMMUNOL, V45, P3446, DOI 10.1016/j.molimm.2008.03.021; Saborit-Villarroya IN, 2005, J IMMUNOL, V175, P4226, DOI 10.4049/jimmunol.175.7.4226; Saveliev A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000420; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smit L, 1996, J BIOL CHEM, V271, P8564, DOI 10.1074/jbc.271.15.8564; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; Walters DK, 2006, LEUKEMIA RES, V30, P1097, DOI 10.1016/j.leukres.2006.01.001; WU J, 1995, MOL CELL BIOL, V15, P4337; Yabana N, 2002, ONCOGENE, V21, P7720, DOI 10.1038/sj.onc.1205927; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	63	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23073	23083		10.1074/jbc.M109.094508	http://dx.doi.org/10.1074/jbc.M109.094508			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20457609	hybrid, Green Published			2022-12-25	WOS:000279999900042
J	Matsuda, JJ; Filali, MS; Moreland, JG; Miller, FJ; Lamb, FS				Matsuda, James J.; Filali, Mohammed S.; Moreland, Jessica G.; Miller, Francis J.; Lamb, Fred S.			Activation of Swelling-activated Chloride Current by Tumor Necrosis Factor-alpha Requires ClC-3-dependent Endosomal Reactive Oxygen Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; SENSITIVE CL-CHANNEL; NADPH OXIDASE; ANION CHANNELS; VOLUME REGULATION; PLASMA-MEMBRANE; VENTRICULAR MYOCYTES; SIGNALING ENDOSOMES; RABBIT VENTRICLE; CLC-3 CHANNELS	ClC-3 is a Cl-/H+ antiporter required for cytokine-induced intraendosomal reactive oxygen species (ROS) generation by Nox1. ClC-3 current is distinct from the swelling-activated chloride current (IClswell), but overexpression of ClC-3 can activate currents that resemble IClswell. Because H2O2 activates IClswell directly, we hypothesized that ClC-3-dependent, endosomal ROS production activates IClswell. Whole-cell perforated patch clamp methods were used to record Cl- currents in cultured aortic vascular smooth muscle cells from wild type (WT) and ClC-3 null mice. Under isotonic conditions, tumor necrosis factor-alpha (TNF-alpha) (10 ng/ml) activated outwardly rectifying Cl- currents with time-dependent inactivation in WT but not ClC-3 null cells. Inhibition by tamoxifen (10 mu M) and by hypertonicity (340 mosM) identified them as IClswell. IClswell was also activated by H2O2 (500 mu M), and the effect of TNF-alpha was completely inhibited by polyethylene glycol-catalase. ClC-3 expression induced IClswell in ClC-3 null cells in the absence of swelling or TNF-alpha, and this effect was also blocked by catalase. IClswell activation by hypotonicity (240 mosM) was only partially inhibited by catalase, and the size of these currents did not differ between WT and ClC-3 null cells. Disruption of endosome trafficking with either mutant Rab5 (S34N) or Rab11 (S25N) inhibited TNF-alpha-mediated activation of IClswell. Thrombin also activates ROS production by Nox1 but not in endosomes. Thrombin caused H2O2-dependent activation of IClswell, but this effect was not ClC-3- or Rab5-dependent. Thus, activation of IClswell by TNF-alpha requires ClC-3-dependent endosomal H2O2 production. This demonstrates a functional link between two distinct anion currents, ClC-3 and IClswell.	Univ Iowa, Dept Pediat, Childrens Hosp, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Childrens Hosp, Iowa City, IA 52242 USA; Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Lamb, FS (corresponding author), Univ Iowa, Dept Pediat, 7770-F JPP, Iowa City, IA 52242 USA.	fred-lamb@uiowa.edu	Miller Jr, Francis/N-7312-2015	Miller Jr, Francis/0000-0001-5822-0549; Lamb, Fred/0000-0003-2955-5133	National Institutes of Health [HL62483, HL081750, AI067533, DK07690-15]; American Heart Association; Department of Veterans Affairs Office of Research and Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081750, R56HL062483, R01HL062483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62483 (to F.S.L.), HL081750 (to F.J.M.), AI067533 (to J.G.M.), and DK07690-15 (to J.J.M.). This work was also supported by grants from the American Heart Association (to F.S.L.), and the Department of Veterans Affairs Office of Research and Development (to F.J.M.).	Arreola J, 2002, J PHYSIOL-LONDON, V545, P207, DOI 10.1113/jphysiol.2002.021980; Browe DM, 2006, J GEN PHYSIOL, V127, P237, DOI 10.1085/jgp.200509366; Browe DM, 2004, J GEN PHYSIOL, V124, P273, DOI 10.1085/jgp.200409040; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Dai YP, 2005, BRIT J PHARMACOL, V145, P5, DOI 10.1038/sj.bjp.0706135; Dinneen JL, 2004, EXP CELL RES, V294, P509, DOI 10.1016/j.yexcr.2003.12.006; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Duan DY, 2001, J PHYSIOL-LONDON, V531, P437, DOI 10.1111/j.1469-7793.2001.0437i.x; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Friis MB, 2008, AM J PHYSIOL-CELL PH, V294, pC1552, DOI 10.1152/ajpcell.00571.2007; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Gong WQ, 2004, CELL PHYSIOL BIOCHEM, V14, P213, DOI 10.1159/000080330; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; JENTSCH TJ, 1995, J PHYSIOL-LONDON, V482, P19; Lamb FS, 2009, ANTIOXID REDOX SIGN, V11, P1335, DOI [10.1089/ars.2008.2448, 10.1089/ARS.2009.2448]; Lambert S, 2005, J PHYSIOL-LONDON, V567, P191, DOI 10.1113/jphysiol.2005.089888; Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5; Lemonnier L, 2005, ENDOCR-RELAT CANCER, V12, P335, DOI 10.1677/erc.1.00898; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Luo SF, 2009, TOXICOL APPL PHARM, V237, P8, DOI 10.1016/j.taap.2009.02.025; Mao JW, 2008, BIOCHEM PHARMACOL, V75, P1706, DOI 10.1016/j.bcp.2008.01.008; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; Matsuda JJ, 2010, J BIOL CHEM, V285, P2569, DOI 10.1074/jbc.M109.018002; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Moreland JG, 2007, J BIOL CHEM, V282, P33958, DOI 10.1074/jbc.M705289200; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Mumbengegwi DR, 2008, MOL CELL BIOL, V28, P3700, DOI 10.1128/MCB.02038-07; Ogura T, 2002, FASEB J, V16, P863, DOI 10.1096/fj.01-0845fje; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Qian JS, 2009, CELL PHYSIOL BIOCHEM, V24, P461, DOI 10.1159/000257485; Reinehr R, 2007, GLIA, V55, P758, DOI 10.1002/glia.20504; Ren ZJ, 2005, AM J PHYSIOL-HEART C, V288, pH2628, DOI 10.1152/ajpheart.00992.2004; Ren Z, 2008, CARDIOVASC RES, V77, P73, DOI 10.1093/cvr/cvm031; Robinson NC, 2004, J PHYSIOL-LONDON, V556, P353, DOI 10.1113/jphysiol.2003.058032; Rossow CF, 2006, ACTA PHYSIOL, V187, P5, DOI 10.1111/j.1748-1716.2006.01550.x; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Shimada K, 2000, AM J PHYSIOL-GASTR L, V279, pG268, DOI 10.1152/ajpgi.2000.279.2.G268; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Tang YB, 2008, CELL PROLIFERAT, V41, P775, DOI 10.1111/j.1365-2184.2008.00551.x; Trebak M, 2010, ANTIOXID REDOX SIGN, V12, P657, DOI 10.1089/ars.2009.2842; Varela D, 2004, J BIOL CHEM, V279, P13301, DOI 10.1074/jbc.C400020200; Varela D, 2007, CELL PHYSIOL BIOCHEM, V20, P773, DOI 10.1159/000110437; Volk APD, 2008, J BIOL CHEM, V283, P34315, DOI 10.1074/jbc.M803141200; Wang GL, 2002, CIRC RES, V91, pE28, DOI 10.1161/01.RES.0000042062.69653.E4; Wang GX, 2003, AM J PHYSIOL-HEART C, V285, pH1453, DOI 10.1152/ajpheart.00244.2003; Wang J, 2005, JPN J PHYSIOL, V55, P379, DOI 10.2170/jjphysiol.S655; Wang Li-Wei, 2004, Shengli Xuebao, V56, P230; Wang XQ, 2006, NEURON, V52, P321, DOI 10.1016/j.neuron.2006.08.035; Weinberg F, 2009, CELL MOL LIFE SCI, V66, P3663, DOI 10.1007/s00018-009-0099-y; Weylandt KH, 2001, J BIOL CHEM, V276, P17461, DOI 10.1074/jbc.M011667200; Yamamoto-Mizuma S, 2004, J PHYSIOL-LONDON, V557, P439, DOI 10.1113/jphysiol.2003.059261; Yin ZH, 2008, AM J PHYSIOL-CELL PH, V294, pC535, DOI 10.1152/ajpcell.00291.2007; Zhang HN, 2006, APOPTOSIS, V11, P327, DOI 10.1007/s10495-006-3980-2; Zhou JG, 2005, J BIOL CHEM, V280, P7301, DOI 10.1074/jbc.M412813200	66	49	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22862	22871		10.1074/jbc.M109.099838	http://dx.doi.org/10.1074/jbc.M109.099838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20479003	Green Published, hybrid			2022-12-25	WOS:000279999900019
J	Xu, K; Zhang, H; Blumwald, E; Xia, T				Xu, Kai; Zhang, Hui; Blumwald, Eduardo; Xia, Tao			A Novel Plant Vacuolar Na+/H+ Antiporter Gene Evolved by DNA Shuffling Confers Improved Salt Tolerance in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; CATION SELECTIVITY; ION HOMEOSTASIS; C-TERMINUS; IN-VITRO; EXCHANGER; ATNHX1	Plant vacuolar Na+/H+ antiporters play important roles in maintaining cellular ion homeostasis and mediating the transport of Na+ out of the cytosol and into the vacuole. Vacuolar antiporters have been shown to play significant roles in salt tolerance; however the relatively low V-max of the Na+/H+ exchange of the Na+/H+ antiporters identified could limit its application in the molecular breeding of salt tolerant crops. In this study, we applied DNA shuffling methodology to generate and recombine the mutations of Arabidopsis thaliana vacuolar Na+/H+ antiporter gene AtNHX1. Screening using a large scale yeast complementation system identified AtNHXS1, a novel Na+/H+ antiporter. Expression of AtNHXS1 in yeast showed that the antiporter localized to the vacuolar membrane and that its expression improved the tolerance of yeast to NaCl, KCl, LiCl, and hygromycin B. Measurements of the ion transport activity across the intact yeast vacuole demonstrated that the AtNHXS1 protein showed higher Na+/H+ exchange activity and a slightly improved K+/H+ exchange activity.	[Xu, Kai; Zhang, Hui; Xia, Tao] E China Normal Univ, Sch Life Sci, Dept Biochem & Mol Biol, Shanghai 200062, Peoples R China; [Blumwald, Eduardo] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	East China Normal University; University of California System; University of California Davis	Xia, T (corresponding author), B809 Sci Bldg,3663 N Zhongshan Rd, Shanghai, Peoples R China.	txia@bio.ecnu.edu.cn	Blumwald, Eduardo/Y-2751-2019	Xia, Tao/0000-0002-3712-8468	National Natural Science Foundation of China [30671336]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30671336).	Apse MP, 2007, FEBS LETT, V581, P2247, DOI 10.1016/j.febslet.2007.04.014; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Darley CP, 2000, BIOCHEM J, V351, P241, DOI 10.1042/0264-6021:3510241; Dibrov P, 1998, BIOCHEMISTRY-US, V37, P8282, DOI 10.1021/bi9801457; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hamada A, 2001, PLANT PHYSIOL, V125, P437, DOI 10.1104/pp.125.1.437; Hernandez A, 2009, J BIOL CHEM, V284, P14276, DOI 10.1074/jbc.M806203200; Kamauchi S, 2002, J BIOCHEM, V131, P821, DOI 10.1093/oxfordjournals.jbchem.a003171; Kemp G, 2008, CHANNELS, V2, P329, DOI 10.4161/chan.2.5.6898; Kinclova O, 2001, MOL MICROBIOL, V40, P656, DOI 10.1046/j.1365-2958.2001.02412.x; Kinclova-Zimmermannova O, 2006, MOL MEMBR BIOL, V23, P349, DOI 10.1080/09687860600738908; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; Mitsui K, 2004, J BIOCHEM, V135, P139, DOI 10.1093/jb/mvh016; Montiel V, 2007, FEMS YEAST RES, V7, P102, DOI 10.1111/j.1567-1364.2006.00115.x; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; RODRIGUEZNAVARRO A, 1984, J BACTERIOL, V159, P940; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Simon E, 2003, FEBS LETT, V545, P239, DOI 10.1016/S0014-5793(03)00557-X; Sottosanto JB, 2004, PLANT J, V40, P752, DOI 10.1111/j.1365-313X.2004.02253.x; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; Wiebe CA, 2003, MOL CELL BIOCHEM, V254, P117, DOI 10.1023/A:1027311916247; Wiebe CA, 2001, BIOCHEM J, V357, P1, DOI 10.1042/0264-6021:3570001; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Yamaguchi T, 2003, P NATL ACAD SCI USA, V100, P12510, DOI 10.1073/pnas.2034966100; Yamaguchi T, 2001, PLANT CELL PHYSIOL, V42, P451, DOI 10.1093/pcp/pce080; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Zhao HM, 1997, NUCLEIC ACIDS RES, V25, P1307, DOI 10.1093/nar/25.6.1307	42	16	23	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22997	23004		10.1074/jbc.M109.073783	http://dx.doi.org/10.1074/jbc.M109.073783			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20457597	hybrid, Green Published			2022-12-25	WOS:000279999900034
J	Dolan, PJ; Johnson, GVW				Dolan, Philip J.; Johnson, Gail V. W.			A Caspase Cleaved Form of Tau Is Preferentially Degraded through the Autophagy Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMER-DISEASE; QUALITY-CONTROL; HYPERPHOSPHORYLATED TAU; PHOSPHORYLATED TAU; CARBOXYL-TERMINUS; UBIQUITIN LIGASE; PROTEIN CHIP; MOUSE MODEL; CATHEPSIN-D	The microtubule-associated protein tau plays a central role in the pathogenesis of Alzheimer disease (AD) and abnormally accumulates as neurofibrillary tangles; therefore, the pathways by which tau is degraded have been examined extensively. In AD brain tau is abnormally truncated at Asp(421) (tau Delta C), which increases its fibrillogenic properties and results in compromised neuronal function. Given the fact that the accumulation of tau Delta C is a pathogenic process in AD, in this study we examined whether full-length tau and tau Delta Care degraded through similar or different mechanisms. To this end a tetracycline-inducible model was used to show that tau Delta C was degraded significantly faster than full-length tau (FL-tau). Pharmacological inhibition of the proteasome or autophagy pathways demonstrated that although FL-tau is degraded by the proteasome, tau Delta C is cleared predominantly by macroautophagy. We also found that tau Delta C binds C terminus of Hsp70-interacting protein more efficiently than tau. This interaction leads to an increased ubiquitylation of tau Delta C in a reconstituted in vitro assay, but surprisingly, tau (full-length or truncated) was not ubiquitylated in situ. The finding that tau Delta C and FL-tau are differentially processed by these degradation systems provides important insights for the development of therapeutic strategies, which are focused on modulating degradation systems to preferentially clear pathological forms of the proteins.	[Johnson, Gail V. W.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Dolan, Philip J.; Johnson, Gail V. W.] Univ Rochester, Dept Pharmacol Physiol, Rochester, NY 14642 USA; [Dolan, Philip J.; Johnson, Gail V. W.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	University of Rochester; University of Rochester; University of Alabama System; University of Alabama Birmingham	Johnson, GVW (corresponding author), Univ Rochester, Med Ctr, Dept Anesthesiol, 601 Elmwood Ave,Box 604,Courier Rm4-6314, Rochester, NY 14642 USA.	gail_johnsonvoll@urmc.rochester.edu	Johnson, Gail V.W./K-4723-2012	Johnson, Gail V.W./0000-0003-3464-0404	National Institutes of Health [NS051279]; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS051279. This work was also supported by a grant from the Alzheimer's Association.	AHLBERG J, 1982, LAB INVEST, V47, P523; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Alzheimer A, 1995, Clin Anat, V8, P429; Arnaud LT, 2009, J NEUROCHEM, V110, P328, DOI 10.1111/j.1471-4159.2009.06142.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bednarski E, 1996, J NEUROCHEM, V67, P1846, DOI 10.1046/j.1471-4159.1996.67051846.x; Berry RW, 2003, BIOCHEMISTRY-US, V42, P8325, DOI 10.1021/bi027348m; Bi XN, 2000, J NEUROCHEM, V74, P1469, DOI 10.1046/j.1471-4159.2000.0741469.x; Bongarzone ER, 1998, J NEUROSCI RES, V54, P309, DOI 10.1002/(SICI)1097-4547(19981101)54:3<309::AID-JNR2>3.0.CO;2-5; Brady NR, 2007, FEBS J, V274, P3184, DOI 10.1111/j.1742-4658.2007.05849.x; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DeTure M, 2002, AM J PATHOL, V161, P1711, DOI 10.1016/S0002-9440(10)64448-3; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; DRUBIN D, 1988, J CELL BIOL, V106, P1583, DOI 10.1083/jcb.106.5.1583; Grelle G, 2006, MOL CELL PROTEOMICS, V5, P234, DOI 10.1074/mcp.M500198-MCP200; GRUNE T, 2010, ARCH BIOCH IN PRESS; Hamano T, 2008, EUR J NEUROSCI, V27, P1119, DOI 10.1111/j.1460-9568.2008.06084.x; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; HENELL F, 1987, EXP MOL PATHOL, V46, P1, DOI 10.1016/0014-4800(87)90026-8; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; KAWASAKI H, 1987, ACTA NEUROPATHOL, V75, P156, DOI 10.1007/BF00687076; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Li B, 2007, ACTA NEUROPATHOL, V113, P501, DOI 10.1007/s00401-007-0207-8; Li L, 2002, J BIOL CHEM, V277, P41390, DOI 10.1074/jbc.M206334200; Matthews-Roberson TA, 2008, BRAIN RES, V1234, P206, DOI 10.1016/j.brainres.2008.07.111; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Quintanilla RA, 2009, J BIOL CHEM, V284, P18754, DOI 10.1074/jbc.M808908200; Rankin CA, 2005, MOL BRAIN RES, V138, P84, DOI 10.1016/j.molbrainres.2005.04.012; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; SCHWORER CM, 1981, J BIOL CHEM, V256, P7652; SELKOE DJ, 1986, NEUROBIOL AGING, V7, P425, DOI 10.1016/0197-4580(86)90055-2; Shelton SB, 2004, J NEUROSCI RES, V76, P110, DOI 10.1002/jnr.20051; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; THORPE GHG, 1986, METHOD ENZYMOL, V133, P331; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Zhang CL, 2005, AM J PHYSIOL-HEART C, V288, pH2836, DOI 10.1152/ajpheart.01122.2004	65	111	113	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21978	21987		10.1074/jbc.M110.110940	http://dx.doi.org/10.1074/jbc.M110.110940			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20466727	Green Published, hybrid			2022-12-25	WOS:000279702200010
J	Rey, FE; Faith, JJ; Bain, J; Muehlbauer, MJ; Stevens, RD; Newgard, CB; Gordon, JI				Rey, Federico E.; Faith, Jeremiah J.; Bain, James; Muehlbauer, Michael J.; Stevens, Robert D.; Newgard, Christopher B.; Gordon, Jeffrey I.			Dissecting the in Vivo Metabolic Potential of Two Human Gut Acetogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATE-REDUCING BACTERIA; FATTY-ACID PRODUCTION; HUMAN LARGE-INTESTINE; HUMAN FECES; CLOSTRIDIUM-THERMOACETICUM; ANAEROBIC-BACTERIA; MICROBIAL-FLORA; HUMAN COLON; SP-NOV; FERMENTATION	Fermenting microbial communities generate hydrogen; its removal through the production of acetate, methane, or hydrogen sulfide modulates the efficiency of energy extraction from available nutrients in many ecosystems. We noted that pathway components for acetogenesis are more abundantly and consistently represented in the gut microbiomes of monozygotic twins and their mothers than components for methanogenesis or sulfate reduction and subsequently analyzed the metabolic potential of two sequenced human gut acetogens, Blautia hydrogenotrophica and Marvinbryantia formatexigens in vitro and in the intestines of gnotobiotic mice harboring a prominent saccharolytic bacterium. To do so, we developed a generally applicable method for multiplex sequencing of expressed microbial mRNAs (microbial RNA-Seq) and, together with mass spectrometry of metabolites, showed that these organisms have distinct patterns of substrate utilization. B. hydrogenotrophica targets aliphatic and aromatic amino acids. It increases the efficiency of fermentation by consuming reducing equivalents, thereby maintaining a high NAD(+)/NADH ratio and boosting acetate production. In contrast, M. formatexigens consumes oligosaccharides, does not impact the redox state of the gut, and boosts the yield of succinate. These findings have strategic implications for those who wish to manipulate the hydrogen economy of gut microbial communities in ways that modulate energy harvest.	[Rey, Federico E.; Faith, Jeremiah J.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; [Bain, James; Muehlbauer, Michael J.; Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Bain, James; Muehlbauer, Michael J.; Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27704 USA	Washington University (WUSTL); Duke University; Duke University	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA.	jgordon@wustl.edu		Bain, James R./0000-0002-8917-9187	National Institutes of Health [DK70977, DK078669, DK30292]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, R01DK070977, R01DK030292, R37DK030292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK70977, DK078669, and DK30292. This work was also supported by the Crohn's and Colitis Foundation of America.	Arendsen AF, 1999, J BACTERIOL, V181, P1489, DOI 10.1128/JB.181.5.1489-1495.1999; Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126; Bernalier A, 1996, ARCH MICROBIOL, V166, P176, DOI 10.1007/s002030050373; BLAXTER KL, 1965, BRIT J NUTR, V19, P511, DOI 10.1079/BJN19650046; BOONE DR, 1989, APPL ENVIRON MICROB, V55, P1735, DOI 10.1128/AEM.55.7.1735-1741.1989; Breznak J.A., 1994, ACETOGENESIS, P303; BREZNAK JA, 1986, APPL ENVIRON MICROB, V52, P623, DOI 10.1128/AEM.52.4.623-630.1986; BREZNAK JA, 1991, ARCH MICROBIOL, V156, P105, DOI 10.1007/BF00290981; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHRISTL SU, 1992, GUT, V33, P1234, DOI 10.1136/gut.33.9.1234; CORDRUWISCH R, 1988, ARCH MICROBIOL, V149, P350, DOI 10.1007/BF00411655; DORE J, 1995, FEMS MICROBIOL LETT, V130, P7, DOI 10.1016/0378-1097(95)00176-6; DORE J, 1995, FEMS MICROBIOL ECOL, V17, P279, DOI 10.1016/0168-6496(95)00033-7; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ferchaud-Roucher V, 2005, AM J PHYSIOL-ENDOC M, V289, pE716, DOI 10.1152/ajpendo.00430.2004; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Fonty G, 2007, APPL ENVIRON MICROB, V73, P6391, DOI 10.1128/AEM.00181-07; Frostl JM, 1996, J BACTERIOL, V178, P4597; GIBSON GR, 1988, J APPL BACTERIOL, V65, P241, DOI 10.1111/j.1365-2672.1988.tb01891.x; GIBSON GR, 1988, J APPL BACTERIOL, V65, P103, DOI 10.1111/j.1365-2672.1988.tb01498.x; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Graber JR, 2004, APPL ENVIRON MICROB, V70, P1307, DOI 10.1128/AEM.70.3.1307-1314.2004; HAROLD KKD, 2006, PROKARYOTES, P354; Havlikova M, 2008, SCI TOTAL ENVIRON, V396, P121, DOI 10.1016/j.scitotenv.2008.02.027; KERBY R, 1983, CURR MICROBIOL, V8, P27, DOI 10.1007/BF01567310; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Leclerc M, 1997, ANAEROBE, V3, P307, DOI 10.1006/anae.1997.0117; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; MAI XH, 1994, J BIOL CHEM, V269, P16726; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Miller TL, 1996, APPL ENVIRON MICROB, V62, P1589, DOI 10.1128/AEM.62.5.1589-1592.1996; Nakamura N, 2010, ANNU REV FOOD SCI T, V1, P363, DOI 10.1146/annurev.food.102308.124101; ODELSON DA, 1983, APPL ENVIRON MICROB, V45, P1602, DOI 10.1128/AEM.45.5.1602-1613.1983; OUWERKERK D, 2007, ADV ANIM NUTR AUSTR, V16, P101; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; PRINS RA, 1977, FEMS MICROBIOL LETT, V1, P255, DOI 10.1111/j.1574-6968.1977.tb00627.x; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stewart JA, 2006, LETT APPL MICROBIOL, V43, P58, DOI 10.1111/j.1472-765X.2006.01906.x; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Williams YJ, 2009, APPL ENVIRON MICROB, V75, P1860, DOI 10.1128/AEM.02453-08; Wolin MJ, 2003, APPL ENVIRON MICROB, V69, P6321, DOI 10.1128/AEM.69.10.6321-6326.2003; WOLIN MJ, 1993, APPL ENVIRON MICROB, V59, P3551, DOI 10.1128/AEM.59.11.3551-3556.1993; WOLIN MJ, 1983, FED PROC, V42, P109; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106	49	222	248	1	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22082	22090		10.1074/jbc.M110.117713	http://dx.doi.org/10.1074/jbc.M110.117713			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20444704	Green Published, hybrid			2022-12-25	WOS:000279702200021
J	Choi, YJ; Im, E; Pothoulakis, C; Rhee, SH				Choi, Yoon Jeong; Im, Eunok; Pothoulakis, Charalabos; Rhee, Sang Hoon			TRIF Modulates TLR5-dependent Responses by Inducing Proteolytic Degradation of TLR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; COLONIC EPITHELIAL-CELLS; HEPATITIS-C VIRUS; ADAPTER PROTEIN; TOLL-LIKE-RECEPTOR-5 ENGAGEMENT; NECROTIZING ENTEROCOLITIS; BACTERIAL FLAGELLIN; NEGATIVE REGULATION	Proteolytic modification of pattern recognition receptors and their signaling adaptor molecules has recently emerged as an essential cellular event to regulate immune and inflammatory responses. Here we show that the TIR domain containing adaptor-inducing interferon-beta (TRIF), an adaptor molecule mediating TLR3 signaling and MyD88-independent signaling of TLR4, plays an inhibitory role in TLR5-elicited responses by inducing proteolytic degradation of TLR5. TRIF overexpression in human embryonic kidney (HEK293) and human colonic epithelial (NCM460) cells abolishes the cellular protein level of TLR5, whereas it does not alter TLR5 mRNA level. Thus, TRIF overexpression dramatically suppresses flagellin/TLR5-deriven NF kappa B activation in NCM460 cells. TRIF-induced TLR5 protein degradation is completely inhibited in the presence of pan-caspase inhibitor (benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone), whereas several specific inhibitors against cathepsin B, reactive oxygen species, or ubiquitin-mediated proteasome activity fail to suppress this degradation. These results indicate that TRIF-induced caspase activity causes TLR5 protein degradation. In addition, we identify that the C terminus of TRIF and extracellular domain of TLR5 are required for TRIF-induced TLR5 degradation. Furthermore, TRIF-induced proteolytic degradation is extended to TLR3, TLR6, TLR7, TLR8, TLR9, and TLR10, whereas the cellular level of TLR1, TLR2, and TLR4 is not affected by TRIF overexpression. These results suggest that, in addition to mediating TLR3- or TLR4-induced signaling as an adaptor molecule, TRIF can participate in proteolytic modification of certain members of TLRs to modulate the functionality of TLRs at post-translational level. Collectively, our findings propose a potential inhibitory role of TRIF at least in regulating host-microbial communication via TLR5 in colonic epithelial cells.	[Choi, Yoon Jeong; Im, Eunok; Pothoulakis, Charalabos; Rhee, Sang Hoon] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rhee, SH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, MRL 1240,675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	shrhee@mednet.ucla.edu	Lee, Kee-Joon/AAA-4090-2022		NIDDK, National Institutes of Health [DK072471, DK083336, DK079015]; Flight Attendant Medical Research Institute, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK079015, K01DK083336] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Flight Attendant Medical Research Institute, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK072471 (NIDDK, to C. P.), DK083336 (NIDDK, to E. I.), and DK079015 (NIDDK, to S. H. R.). This work was also supported by a Young Clinical Scientist Award (to S. H. R. and E. I.) from Flight Attendant Medical Research Institute, Inc.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Barrie A, 2006, GASTROENTEROL CLIN N, V35, P883, DOI 10.1016/j.gtc.2006.09.001; Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Carvalho FA, 2008, INFLAMM BOWEL DIS, V14, P1051, DOI 10.1002/ibd.20423; Chan KL, 2009, WORLD J GASTROENTERO, V15, P4745, DOI 10.3748/wjg.15.4745; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Hoshimaru M, 1996, P NATL ACAD SCI USA, V93, P1518, DOI 10.1073/pnas.93.4.1518; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pan MH, 2008, P NATL ACAD SCI USA, V105, P5862, DOI 10.1073/pnas.0707460104; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Rebsamen M, 2008, CELL DEATH DIFFER, V15, P1804, DOI 10.1038/cdd.2008.119; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Rhee SH, 2006, J BIOL CHEM, V281, P18560, DOI 10.1074/jbc.M513861200; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rhee SH, 2004, J BIOL CHEM, V279, P25179, DOI 10.1074/jbc.M400967200; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622	46	28	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21382	21390		10.1074/jbc.M110.115022	http://dx.doi.org/10.1074/jbc.M110.115022			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452988	Green Published, hybrid			2022-12-25	WOS:000279516100024
J	Merrick, WC				Merrick, William C.			Introduction to the Thematic Minireview Series on Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Merrick, WC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	wcm2@case.edu							0	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21195	21196		10.1074/jbc.R110.140012	http://dx.doi.org/10.1074/jbc.R110.140012			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444699	hybrid, Green Published			2022-12-25	WOS:000279516100001
J	Mutschler, H; Reinstein, J; Meinhart, A				Mutschler, Hannes; Reinstein, Jochen; Meinhart, Anton			Assembly Dynamics and Stability of the Pneumococcal Epsilon Zeta Antitoxin Toxin (PezAT) System from Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN ASSOCIATION; MEDIATED CELL-DEATH; ESCHERICHIA-COLI; MULTIDRUG TOLERANCE; COMPLEX-FORMATION; PLASMID; BINDING; ENERGY; DEGRADATION; ENHANCEMENT	The pneumococcal epsilon zeta antitoxin toxin (PezAT) system is a chromosomally encoded, class II toxin antitoxin system from the human pathogen Streptococcus pneumnoniae. Neutralization of the bacteriotoxic protein PezT is carried out by complex formation with its cognate antitoxin PezA. Here we study the stability of the inhibitory complex in vivo and in vitro. We found that toxin release is impeded in Escherichia coli and Bacillus subtilis due to the proteolytic resistance of PezA once bound to PezT. These findings are supported by in vitro experiments demonstrating a strong thermodynamic stabilization of both proteins upon binding. A detailed kinetic analysis of PezAT assembly revealed that these particular features of PezAT are based on a strong, electrostatically guided binding mechanism leading to a stable toxin antitoxin complex with femtomolar affinity. Our data show that PezAT complex formation is distinct to all other conventional toxin antitoxin modules and a controlled mode of toxin release is required for activation.	[Mutschler, Hannes; Reinstein, Jochen; Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Max Planck Society	Meinhart, A (corresponding author), Jahnstr 29, D-69120 Heidelberg, Germany.	anton.meinhart@mpimf-heidelberg.mpg.de	Meinhart, Anton/M-9647-2014; Mutschler, Hannes/K-5148-2015; Mutschler, Hannes/T-1390-2019	Mutschler, Hannes/0000-0001-8005-1657; Mutschler, Hannes/0000-0001-8005-1657				Alsallaq R, 2007, STRUCTURE, V15, P215, DOI 10.1016/j.str.2007.01.005; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bernasconi C. F., 1976, RELAXATION KINETICS; Brown JS, 2004, INFECT IMMUN, V72, P1587, DOI 10.1128/IAI.72.3.1587-1593.2004; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Camacho AG, 2002, BIOL CHEM, V383, P1701, DOI 10.1515/BC.2002.191; CEGLOWSKI P, 1993, MOL GEN GENET, V241, P579, DOI 10.1007/BF00279900; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Debye P., 1942, T ELECTROCHEM SOC, V82, P265, DOI [10.1149/1.3071413, DOI 10.1149/1.3071413]; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Gabdoulline RR, 1999, J MOL RECOGNIT, V12, P226, DOI 10.1002/(SICI)1099-1352(199907/08)12:4<226::AID-JMR462>3.0.CO;2-P; Gazit E, 1999, J BIOL CHEM, V274, P16813, DOI 10.1074/jbc.274.24.16813; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Harrison JJ, 2009, ANTIMICROB AGENTS CH, V53, P2253, DOI 10.1128/AAC.00043-09; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LEE FS, 1989, BIOCHEMISTRY-US, V28, P225, DOI 10.1021/bi00427a031; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lewis K, 2005, BIOCHEMISTRY-MOSCOW+, V70, P267, DOI 10.1007/s10541-005-0111-6; Li W, 2004, J MOL BIOL, V337, P743, DOI 10.1016/j.jmb.2004.02.005; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; Lioy VS, 2010, PLASMID, V63, P31, DOI 10.1016/j.plasmid.2009.09.005; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; MCLENDON G, 1978, J BIOL CHEM, V253, P6335; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Nieto C, 2006, MOL MICROBIOL, V59, P1280, DOI 10.1111/j.1365-2958.2006.05027.x; O'Connor EB, 2007, PLASMID, V58, P115, DOI 10.1016/j.plasmid.2007.02.002; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Sat B, 2003, J BACTERIOL, V185, P1803, DOI 10.1128/JB.185.6.1803-1807.2003; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Selzer T, 1999, J MOL BIOL, V287, P409, DOI 10.1006/jmbi.1999.2615; Sletvold H, 2008, PLASMID, V60, P75, DOI 10.1016/j.plasmid.2008.04.002; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; TSUCHIMOTO S, 1992, J BACTERIOL, V174, P4205, DOI 10.1128/JB.174.13.4205-4211.1992; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13743, DOI 10.1021/bi00042a004; Werbeck ND, 2009, BIOCHEMISTRY-US, V48, P7240, DOI 10.1021/bi900880c; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000439; Zielenkiewicz U, 2005, J BACTERIOL, V187, P6094, DOI 10.1128/JB.187.17.6094-6105.2005	56	20	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21797	21806		10.1074/jbc.M110.126250	http://dx.doi.org/10.1074/jbc.M110.126250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442221	hybrid, Green Published			2022-12-25	WOS:000279516100064
J	Sun, WJ; Wang, H; Zhao, XM; Yu, Y; Fan, YH; Wang, H; Wang, XS; Lu, XB; Zhang, GY; Fu, SB; Yang, JH				Sun, Wenjing; Wang, Hao; Zhao, Xiumei; Yu, Yang; Fan, Yihui; Wang, Hao; Wang, Xishan; Lu, Xiongbin; Zhang, Guiyin; Fu, Songbin; Yang, Jianhua			Protein Phosphatase 2A Acts as a Mitogen-activated Protein Kinase Kinase Kinase 3 (MEKK3) Phosphatase to Inhibit Lysophosphatidic Acid-induced I kappa B Kinase beta/Nuclear Factor-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-BETA; NEGATIVE REGULATION; S6 KINASE; PHOSPHORYLATION; ALPHA; COMPLEX; DEPHOSPHORYLATION; IDENTIFICATION; SUBUNIT; AKT	MEKK3 is a central intermediate signaling component in lysophosphatidic acid (LPA)-induced activation of the nuclear factor-kappa B (NF-kappa B). However, the precise mechanism for the termination of MEKK3 kinase activity is not fully understood. Using a functional genomic approach, we have identified a protein serine/threonine phosphatase, protein phosphatase 2A (PP2A), as a MEKK3 phosphatase. Overexpression of PP2A catalytic subunit (PP2Ac) beta-isoform results in dephosphorylation of MEKK3 at Thr-516 and Ser-520 and termination of MEKK3-mediated NF-kappa B activation. PP2Ac associates with the phosphorylated form of MEKK3 and the interaction between PP2Ac and MEKK3 is induced by LPA in a transient fashion in the cells. Furthermore, knockdown of PP2Ac expression enhances LPA-induced MEKK3-mediated I kappa B kinase beta (IKK beta) phosphorylation and NF-kappa B activation. These data suggest that PP2A plays an important role in the termination of LPA-mediated NF-kappa B activation through dephosphorylating and inactivating MEKK3.	[Sun, Wenjing; Zhang, Guiyin; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin 150081, Peoples R China; [Sun, Wenjing; Zhao, Xiumei; Yu, Yang; Fan, Yihui; Wang, Hao; Yang, Jianhua] Baylor Coll Med, Dept Pediat, Texas Childrens Canc Ctr, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Wang, Hao] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin 150086, Peoples R China; [Zhao, Xiumei] Harbin Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Harbin 150001, Peoples R China; [Wang, Xishan] Harbin Med Univ, Affiliated Tumor Hosp, Dept Abdominal Surg, Harbin 150086, Peoples R China; [Lu, Xiongbin] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	Harbin Medical University; Baylor College of Medicine; Texas Children's Cancer Center; Harbin Medical University; Harbin Medical University; Harbin Medical University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Fu, SB (corresponding author), Harbin Med Univ, Med Genet Lab, 157 Baojian Rd, Harbin 150081, Peoples R China.	fusb@ems.hrbmu.edu.cn; jianhuay@bcm.edu			National Institutes of Health/NCI [1R21CA106513-01A2, 5P30CA125123-03]; National Cancer Institute [RSG-06-070-01-TBE]; American Cancer Society; Virginia and L. E. Simmons Family Foundation; National Natural Science Foundation of China [30771198, 30971583]; NATIONAL CANCER INSTITUTE [R21CA106513, P30CA125123] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Virginia and L. E. Simmons Family Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health/NCI Grant 1R21CA106513-01A2 (to J.Y.) from the National Cancer Institute, a research scholar grant RSG-06-070-01-TBE (to J.Y.) from the American Cancer Society, the Virginia and L. E. Simmons Family Foundation Collaborative Research Fund (to J.Y.), the DLDCC pilot study from National Institutes of Health/NCI Grant 5P30CA125123-03(to J.Y.), and the National Natural Science Foundation of China Grants 30771198 and 30971583 (to S. F.).	Adams DG, 2002, ARCH BIOCHEM BIOPHYS, V407, P103, DOI 10.1016/S0003-9861(02)00464-2; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barr RK, 2008, J BIOL CHEM, V283, P34994, DOI 10.1074/jbc.M804658200; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Chen D, 1999, MOL CELL BIOL, V19, P4684; Cohen PTW, 2003, METHOD ENZYMOL, V366, P135; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fritz A, 2006, J BIOL CHEM, V281, P6236, DOI 10.1074/jbc.M509249200; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Jang YJ, 2007, J BIOL CHEM, V282, P2473, DOI 10.1074/jbc.M605480200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim TS, 2009, J BIOL CHEM, V284, P21201, DOI 10.1074/jbc.M109.018168; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Kolupaeva V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003447; Lee T, 2003, J CELL PHYSIOL, V194, P349, DOI 10.1002/jcp.10211; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Ma J, 2007, ONCOGENE, V26, P5145, DOI 10.1038/sj.onc.1210323; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Sun WJ, 2010, J BIOL CHEM, V285, P7911, DOI 10.1074/jbc.M109.051219; Sun WJ, 2009, CELL SIGNAL, V21, P1488, DOI 10.1016/j.cellsig.2009.05.007; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Ye RD, 2001, J LEUKOCYTE BIOL, V70, P839; Yellaturu CR, 2002, J BIOL CHEM, V277, P40148, DOI 10.1074/jbc.M206376200; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913	48	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21341	21348		10.1074/jbc.M110.104224	http://dx.doi.org/10.1074/jbc.M110.104224			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448038	hybrid, Green Published			2022-12-25	WOS:000279516100019
J	Vignola, MJ; Kashatus, DF; Taylor, GA; Counter, CM; Valdivia, RH				Vignola, Mark J.; Kashatus, David F.; Taylor, Gregory A.; Counter, Christopher M.; Valdivia, Raphael H.			cPLA(2) Regulates the Expression of Type I Interferons and Intracellular Immunity to Chlamydia trachomatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-RESISTANCE; INTERLEUKIN-8 PRODUCTION; INCLUSION MEMBRANE; IFN-BETA; RAS; ACTIVATION; INFECTION; PROTEIN; GTPASE; PATHWAY	Infection with the obligate bacterial intracellular pathogen Chlamydia trachomatis leads to the sustained activation of the small GTPase RAS and many of its downstream signaling components. In particular, the mitogen-activated protein kinase ERK and the calcium-dependent phospholipase cPLA(2) are activated and are important for the onset of inflammatory responses. In this study we tested if activation of ERK and cPLA(2) occurred as a result of RAS signaling during infection and determined the relative contribution of these signaling components to chlamydial replication and survival. We provide genetic and pharmacological evidence that during infection RAS, ERK, and, to a lesser extent, cPLA(2) activation are uncoupled, suggesting that Chlamydia activates individual components of this signaling pathway in a non-canonical manner. In human cell lines, inhibition of ERK or cPLA(2) signaling did not adversely impact C. trachomatis replication. In contrast, in murine cells, inhibition of ERK and cPLA(2) played a significant protective role against C. trachomatis. We determined that cPLA(2)-deficient murine cells are permissive for C. trachomatis replication because of their impaired expression of beta interferon and the induction of immunity-related GTPases (IRG) important for the containment of intracellular pathogens. Furthermore, the MAPK p38 was primarily responsible for cPLA(2) activation in Chlamydia-infected cells and IRG expression. Overall, these findings define a previously unrecognized role for cPLA(2) in the induction of cell autonomous cellular immunity to Chlamydia and highlight the many non-canonical signaling pathways engaged during infection.	[Taylor, Gregory A.; Valdivia, Raphael H.] Duke Univ, Med Ctr, Ctr Microbial Pathogenesis, Durham, NC 27710 USA; Vet Affairs Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Kashatus, David F.; Counter, Christopher M.] Vet Affairs Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Taylor, Gregory A.] Vet Affairs Med Ctr, Dept Med, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Taylor, Gregory A.] Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Durham, NC 27710 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Valdivia, RH (corresponding author), Duke Univ, Med Ctr, Ctr Microbial Pathogenesis, 272 Jones Bldg,Res Dr, Durham, NC 27710 USA.	valdi001@mc.duke.edu	Kashatus, David F/D-8299-2012; Valdivia, Raphael/R-5377-2019	Kashatus, David F/0000-0001-8007-0612; Valdivia, Raphael/0000-0003-0961-073X; Counter, Christopher M/0000-0003-0748-3079	National Institutes of Health [AI068032]; Burroughs Wellcome Program on the Pathogenesis of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057831, R01AI068032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Program on the Pathogenesis of Infectious Diseases(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI068032 and an award from the Burroughs Wellcome Program on the Pathogenesis of Infectious Diseases.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Al-Zeer MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004588; Bannantine JP, 1998, INFECT IMMUN, V66, P6017, DOI 10.1128/IAI.66.12.6017-6021.1998; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Bivona TG, 2006, METHOD ENZYMOL, V407, P128, DOI 10.1016/S0076-6879(05)07012-6; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Buchholz KR, 2008, INFECT IMMUN, V76, P3150, DOI 10.1128/IAI.00104-08; Buchholz KR, 2007, INFECT IMMUN, V75, P5924, DOI 10.1128/IAI.01029-07; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Cheng W, 2008, INFECT IMMUN, V76, P942, DOI 10.1128/IAI.01313-07; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Collazo CM, 2002, INFECT IMMUN, V70, P6933, DOI 10.1128/IAI.70.12.6933-6939.2002; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Derbigny WA, 2007, INFECT IMMUN, V75, P1280, DOI 10.1128/IAI.01525-06; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Devitt A, 1996, INFECT IMMUN, V64, P3951, DOI 10.1128/IAI.64.10.3951-3956.1996; Donovan S, 2002, BBA-REV CANCER, V1602, P23, DOI 10.1016/S0304-419X(01)00041-5; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gurumurthy RK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000651; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Howard J, 2008, IMMUNOBIOLOGY, V213, P367, DOI 10.1016/j.imbio.2007.11.005; Johnson RM, 2004, INFECT IMMUN, V72, P3951, DOI 10.1128/IAI.72.7.3951-3960.2004; Krull M, 2004, INFECT IMMUN, V72, P6615, DOI 10.1128/IAI.72.11.6615-6621.2004; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; Lad SP, 2005, J IMMUNOL, V174, P7186, DOI 10.4049/jimmunol.174.11.7186; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nagarajan UM, 2005, J IMMUNOL, V175, P450, DOI 10.4049/jimmunol.175.1.450; NAKAFUKU M, 1992, J BIOL CHEM, V267, P19448; Navarini AA, 2006, P NATL ACAD SCI USA, V103, P15535, DOI 10.1073/pnas.0607325103; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; PETERSON EM, 1988, J BACTERIOL, V170, P1389, DOI 10.1128/jb.170.3.1389-1392.1988; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; QUILLIAM LA, 1994, MOL CELL BIOL, V14, P1113, DOI 10.1128/MCB.14.2.1113; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Rzomp KA, 2006, INFECT IMMUN, V74, P5362, DOI 10.1128/IAI.00539-06; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194; Schachter J, 2001, INT J SYST EVOL MICR, V51, P249, DOI 10.1099/00207713-51-1-249; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Taylor GA, 2007, MICROBES INFECT, V9, P1644, DOI 10.1016/j.micinf.2007.09.004; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Tiwari Sangeeta, 2008, V445, P407, DOI 10.1007/978-1-59745-157-4_26; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288	71	30	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21625	21635		10.1074/jbc.M110.103010	http://dx.doi.org/10.1074/jbc.M110.103010			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452986	Green Published, hybrid			2022-12-25	WOS:000279516100049
J	Lee, SC; Corradi, N; Doan, S; Dietrich, FS; Keeling, PJ; Heitman, J				Lee, Soo Chan; Corradi, Nicolas; Doan, Sylvia; Dietrich, Fred S.; Keeling, Patrick J.; Heitman, Joseph			Evolution of the sex-Related Locus and Genomic Features Shared in Microsporidia and Fungi	PLOS ONE			English	Article							MATING-TYPE LOCUS; ENCEPHALITOZOON-CUNICULI; CRYPTOCOCCUS-NEOFORMANS; PHYLOGENETIC ANALYSIS; CANDIDA-ALBICANS; INTRACELLULAR PARASITES; BALANCING SELECTION; ALPHA-TUBULIN; POLAR TUBE; GENES	Background: Microsporidia are obligate intracellular, eukaryotic pathogens that infect a wide range of animals from nematodes to humans, and in some cases, protists. The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it. Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes. Methodology/Principal Findings: Here we expanded this analysis and also examined a putative sex-locus for variability between microsporidian populations. Whole genome inspection reveals a unique syntenic gene pair (RPS9-RPL21) present in the vast majority of fungi and the microsporidians but not in other eukaryotic lineages. Two other unique gene fusions (glutamyl-prolyl tRNA synthetase and ubiquitin-ribosomal subunit S30) that are present in metazoans, choanoflagellates, and filasterean opisthokonts are unfused in the fungi and microsporidians. One locus previously found to be conserved in many microsporidian genomes is similar to the sex locus of zygomycetes in gene order and architecture. Both sex-related and sex loci harbor TPT, HMG, and RNA helicase genes forming a syntenic gene cluster. We sequenced and analyzed the sex-related locus in 11 different Encephalitozoon cuniculi isolates and the sibling species E. intestinalis (3 isolates) and E. hellem (1 isolate). There was no evidence for an idiomorphic sex-related locus in this Encephalitozoon species sample. According to sequence-based phylogenetic analyses, the TPT and RNA helicase genes flanking the HMG genes are paralogous rather than orthologous between zygomycetes and microsporidians. Conclusion/Significance: The unique genomic hallmarks between microsporidia and fungi are independent of sequence based phylogenetic comparisons and further contribute to define the borders of the fungal kingdom and support the classification of microsporidia as unusual derived fungi. And the sex/sex-related loci appear to have been subject to frequent gene conversion and translocations in microsporidia and zygomycetes.	[Lee, Soo Chan; Dietrich, Fred S.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Corradi, Nicolas; Doan, Sylvia; Keeling, Patrick J.] Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada; [Dietrich, Fred S.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA	Duke University; Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Duke University	Lee, SC (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	heitm001@duke.edu	Heitman, Joseph/ABC-6006-2021	Corradi, Nicolas/0000-0002-7932-7932; Keeling, Patrick/0000-0002-7644-0745	National Institutes of Health (NIH) [AI50113, AI052080]; Canadian Institute for Health Research; Swiss National Science Foundation [PA00P3_124166]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085331, R01AI050113, T32AI052080] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant AI50113 to J.H., a grant from the Canadian Institute for Health Research to P.J.K., the Molecular Mycology Pathogenesis Training Program fellowship (AI052080) from the NIH to S. C. L., and a senior postdoctoral fellowship from the Swiss National Science Foundation (PA00P3_124166) to N.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000261; Alby K, 2009, NATURE, V460, P890, DOI 10.1038/nature08252; Badrane H, 1999, MOL BIOL EVOL, V16, P975, DOI 10.1093/oxfordjournals.molbev.a026187; Berthonneau E, 2000, FEBS LETT, V470, P300, DOI 10.1016/S0014-5793(00)01343-0; Burglin TR, 2003, DEV GENES EVOL, V213, P50, DOI 10.1007/s00427-002-0287-3; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Butler G, 2010, CLIN MICROBIOL REV, V23, P140, DOI 10.1128/CMR.00053-09; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Casselton LA, 2008, BIOESSAYS, V30, P711, DOI 10.1002/bies.20782; CAVALIERSMITH T, 1986, NATURE, V324, P416, DOI 10.1038/324416a0; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Corradi Nicolas, 2009, Fungal Biology Reviews, V23, P1, DOI 10.1016/j.fbr.2009.05.001; Corradi N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r106; Daniels KJ, 2006, EMBO J, V25, P2240, DOI 10.1038/sj.emboj.7601099; Didier Elizabeth S, 2005, Expert Rev Anti Infect Ther, V3, P419, DOI 10.1586/14787210.3.3.419; Didier ES, 1996, J EUKARYOT MICROBIOL, V43, P34, DOI 10.1111/j.1550-7408.1996.tb02470.x; DIDIER ES, 1995, PARASITOLOGY, V111, P411, DOI 10.1017/S0031182000065914; DIDIER PJ, 1991, J PROTOZOOL, V38, P502, DOI 10.1111/j.1550-7408.1991.tb04824.x; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dyer PS, 2008, CURR BIOL, V18, pR1012, DOI 10.1016/j.cub.2008.09.034; Dyer PS, 2008, CURR BIOL, V18, pR207, DOI 10.1016/j.cub.2008.01.014; Edlind TD, 1996, MOL PHYLOGENET EVOL, V5, P359; Fraser JA, 2004, PLOS BIOL, V2, P2243, DOI 10.1371/journal.pbio.0020384; Fraser James A., 2007, P19, DOI 10.1037/11499-002; Fraser JA, 2007, EUKARYOT CELL, V6, P622, DOI 10.1128/EC.00018-07; Gill EE, 2006, GENE, V375, P103, DOI 10.1016/j.gene.2006.02.023; Green LC, 1999, J EUKARYOT MICROBIOL, V46, P434, DOI 10.1111/j.1550-7408.1999.tb04624.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAZARD EI, 1984, J INVERTEBR PATHOL, V44, P3, DOI 10.1016/0022-2011(84)90039-9; Heitman J, 2009, NATURE, V460, P807, DOI 10.1038/460807a; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Hull CM, 2005, EUKARYOT CELL, V4, P526, DOI 10.1128/EC.4.3.526-535.2005; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; Ironside JE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-48; Iwase M, 2003, P NATL ACAD SCI USA, V100, P5258, DOI 10.1073/pnas.0635848100; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Kahmann Regine, 2007, P377; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000489; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Keeling PJ, 2003, FUNGAL GENET BIOL, V38, P298, DOI 10.1016/S1087-1845(02)00537-6; Keeling PJ, 1996, MOL BIOL EVOL, V13, P1297, DOI 10.1093/oxfordjournals.molbev.a025576; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; LEE SC, 2010, MICROBIOL M IN PRESS; Lee SC, 2008, CURR BIOL, V18, P1675, DOI 10.1016/j.cub.2008.09.030; Lee Soo Chan, 2009, Commun Integr Biol, V2, P414; Lengeler KB, 2002, EUKARYOT CELL, V1, P704, DOI 10.1128/EC.1.5.704-718.2002; Lengeler KB, 2000, P NATL ACAD SCI USA, V97, P14455, DOI 10.1073/pnas.97.26.14455; Lin X., 2007, SEX FUNGI; Lin X, 2007, PLOS GENET, V3, P1975, DOI 10.1371/journal.pgen.0030186; Lin XR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000283; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-272; MACKAY VL, 1988, P NATL ACAD SCI USA, V85, P55, DOI 10.1073/pnas.85.1.55; Malik SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002879; May G, 1999, P NATL ACAD SCI USA, V96, P9172, DOI 10.1073/pnas.96.16.9172; Morrow CA, 2009, FEMS YEAST RES, V9, P161, DOI 10.1111/j.1567-1364.2008.00475.x; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Peyretaillade E, 1998, NUCLEIC ACIDS RES, V26, P3513, DOI 10.1093/nar/26.15.3513; Polonais V, 2005, FUNGAL GENET BIOL, V42, P791, DOI 10.1016/j.fgb.2005.05.005; Reedy JL, 2009, CURR BIOL, V19, P891, DOI 10.1016/j.cub.2009.04.058; Schaefer D, 2007, EUKARYOT CELL, V6, P907, DOI 10.1128/EC.00090-07; Schurko AM, 2008, BIOESSAYS, V30, P579, DOI 10.1002/bies.20764; Schurko AM, 2009, TRENDS ECOL EVOL, V24, P208, DOI 10.1016/j.tree.2008.11.010; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Stajich JE, 2009, CURR BIOL, V19, pR840, DOI 10.1016/j.cub.2009.07.004; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; SWEENEY AW, 1988, J INVERTEBR PATHOL, V51, P46, DOI 10.1016/0022-2011(88)90087-0; Thomarat F, 2004, J MOL EVOL, V59, P780, DOI 10.1007/s00239-004-2673-0; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; VOSSBRINCK CR, 1987, NATURE, V326, P411, DOI 10.1038/326411a0; Weiss LM, 1999, J EUKARYOT MICROBIOL, V46, p17S, DOI 10.1111/j.1550-7408.1999.tb06055.x; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; Wittner M., 1999, MICROSPORIDIA MICROS; Wu J, 1998, P NATL ACAD SCI USA, V95, P12398, DOI 10.1073/pnas.95.21.12398; Xiao LH, 2001, J CLIN MICROBIOL, V39, P2248, DOI 10.1128/JCM.39.6.2248-2253.2001; Xu YJ, 2005, INT J PARASITOL, V35, P941, DOI 10.1016/j.ijpara.2005.04.003; Xu YJ, 2006, INFECT IMMUN, V74, P239, DOI 10.1128/IAI.74.1.239-247.2006	79	49	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10539	10.1371/journal.pone.0010539	http://dx.doi.org/10.1371/journal.pone.0010539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479876	Green Submitted, gold, Green Published			2022-12-25	WOS:000277467800020
J	Mishra, AC; Chadha, MS; Choudhary, ML; Potdar, VA				Mishra, Akhilesh C.; Chadha, Mandeep S.; Choudhary, Manohar L.; Potdar, Varsha A.			Pandemic Influenza (H1N1) 2009 Is Associated with Severe Disease in India	PLOS ONE			English	Article							SWINE; VIRUS; EPIDEMIOLOGY; TRANSMISSION; PATHOGENESIS; FERRETS	Background: Pandemic influenza A (H1N1) 2009 has posed a serious public health challenge world-wide. In absence of reliable information on severity of the disease, the nations are unable to decide on the appropriate response against this disease. Methods: Based on the results of laboratory investigations, attendance in outpatient department, hospital admissions and mortality from the cases of influenza like illness from 1 August to 31 October 2009 in Pune urban agglomeration, risk of hospitalization and case fatality ratio were assessed to determine the severity of pandemic H1N1 and seasonal influenza-A infections. Results: Prevalence of pandemic H1N1 as well as seasonal-A cases were high in Pune urban agglomeration during the study period. The cases positive for pandemic H1N1 virus had significantly higher risk of hospitalization than those positive for seasonal influenza-A viruses (OR: 1.7). Of 93 influenza related deaths, 57 and 8 deaths from Pune (urban) and 27 and 1 death from Pune (rural) were from pandemic H1N1 positive and seasonal-A positive cases respectively. The case fatality ratio 0.86% for pandemic H1N1 was significantly higher than that of seasonal-A (0.13%) and it was in category 3 of the pandemic severity index of CDC, USA. The data on the cumulative fatality of rural and urban Pune revealed that with time the epidemic is spreading to rural areas. Conclusions: The severity of the H1N1 influenza pandemic is less than that reported for 'Spanish flu 1918' but higher than other pandemics of the 20(th) century. Thus, pandemic influenza should be considered as serious health threat and unprecedented global response seems justified.	[Mishra, Akhilesh C.; Chadha, Mandeep S.; Choudhary, Manohar L.; Potdar, Varsha A.] Natl Inst Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Mishra, AC (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	acm1750@rediffmail.com	Jadhav, Santoshkumar/AAB-7634-2021; Potdar, Varsha/ABA-3799-2021; Choudhary, Manohar Lal/ABA-6120-2021; Choudhary, Manohar Lal/K-2055-2019	Potdar, Varsha/0000-0002-7535-7878; Choudhary, Manohar Lal/0000-0001-9968-8957; 	Indian Council of Medical Research, Government of India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	The study was supported by the Indian Council of Medical Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER M, 2009, EUROSURVEILLANCE, V14, P42; Baker MG, 2009, EUROSURVEILLANCE, V14, P2; Beckett CG, 2004, CLIN INFECT DIS, V39, P443, DOI 10.1086/422314; *CDC, 2007, COMM STRAT PAND INFL; CDC, 2009, CDC PROT REALT RTPCR; Chan M., WORLD NOW START 2009; Collignon P, 2009, AUSTRALAS EMERG NURS, V12, P71, DOI 10.1016/j.aenj.2009.06.001; de Silva UC, 2009, EUROSURVEILLANCE, V14, P11; Enserink M, 2009, SCIENCE, V325, P17, DOI 10.1126/science.325_17; FOX M, 2009, SWINE FLU DEATH RATE; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hampson AW, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00100-0; Nguyen HLK, 2007, J INFECTION, V55, P58, DOI 10.1016/j.jinf.2006.12.001; Hasegawa G, 2006, J CLIN VIROL, V37, P233, DOI 10.1016/j.jcv.2006.08.003; Lee VJ, 2007, EMERG INFECT DIS, V13, P1052, DOI 10.3201/eid1307.061313; Leo YS, 2010, EMERG INFECT DIS, V16, P103, DOI 10.3201/eid1601.091164; Leo YS, 2009, LANCET INFECT DIS, V9, P457, DOI 10.1016/S1473-3099(09)70182-3; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; McConnell J, 2009, LANCET INFECT DIS, V9, P590, DOI 10.1016/S1473-3099(09)70242-7; Michaelis M, 2009, MED MICROBIOL IMMUN, V198, P175, DOI 10.1007/s00430-009-0118-5; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Nishiura H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006852; *NY CIT DEP HLTH H, 2009, COMM TRANSM H1N1 FLU; Rao BL, 2003, NATL MED J INDIA, V16, P143; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; World Health Organisation, WHO PAND H1N1 2009 U; World Health Organization (WHO), 2002, MAN AN INFL DIAGN SU	31	66	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10540	10.1371/journal.pone.0010540	http://dx.doi.org/10.1371/journal.pone.0010540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479875	Green Published, gold, Green Submitted			2022-12-25	WOS:000277467800021
J	Patrick, SM; White, E; Shiels, HA				Patrick, Simon M.; White, Ed; Shiels, Holly A.			Mechano-Electric Feedback in the Fish Heart	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; MONOPHASIC ACTION-POTENTIALS; RAINBOW-TROUT; VENTRICULAR MYOCYTES; OXYGEN-CONSUMPTION; MECHANICAL PERFORMANCE; ATRIAL-FIBRILLATION; CLINICAL-RELEVANCE; DEPENDENT CHANGES; CARDIAC MYOCYTES	Background: Mechanoelectric feedback (MEF) describes the modulation of electrical activity by mechanical activity. This may occur via the activation of mechanosensitive ion channels (MSCs). MEF has not previously been investigated in fish ventricular tissue even though fish can greatly increase ventricular end diastolic volume during exercise which should therefore provide a powerful mechanical stimulus for MEF. Methodology/Principal Finding: When the ventricles of extrinsically paced, isolated working trout hearts were dilated by increasing afterload, monophasic action potential (MAP) duration was significantly shortened at 25% repolarisation, unaltered at 50% repolarisation and significantly lengthened at 90% repolarisation. This observation is consistent with the activation of cationic non-selective MSCs (MSC(NS)s). We then cloned the trout ortholog of TRPC1, a candidate MSC(NS) and confirmed its presence in the trout heart. Conclusions/Significance: Our results have validated the use of MAP technology for the fish heart and suggest that, in common with amphibians and mammals, MEF operates in fish ventricular myocardium, possibly via the activation of mechanosensitive TRPC1 ion channels.	[Patrick, Simon M.; Shiels, Holly A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [White, Ed] Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England; [White, Ed] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England	University of Manchester; University of Leeds; University of Leeds	Patrick, SM (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	simon.patrick@postgrad.manchester.ac.uk			Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberra A, 2001, EXP PHYSIOL, V86, P27, DOI 10.1113/eph8602051; Agnisola C, 2003, J EXP BIOL, V206, P4003, DOI 10.1242/jeb.00623; Bainbridge FA, 1915, J PHYSIOL-LONDON, V50, P65; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Belus A, 2003, J PHYSIOL-LONDON, V546, P501, DOI 10.1113/jphysiol.2002.027573; Bode F, 2001, NATURE, V409, P35, DOI 10.1038/35051165; Bode F, 2000, CIRCULATION, V101, P2200, DOI 10.1161/01.CIR.101.18.2200; Burggren W., 1997, HDB PHYSL, P215; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Cousins KL, 1996, CAN J ZOOL, V74, P380, DOI 10.1139/z96-044; Dyachenko V, 2009, CELL CALCIUM, V45, P38, DOI 10.1016/j.ceca.2008.06.003; Farrell Anthony P., 1992, P1; Farrell AP, 2000, PHYSIOL BIOCHEM ZOOL, V73, P1, DOI 10.1086/316727; Farrell AP, 1996, J EXP BIOL, V199, P663; Frank O., 1895, Z BIOL, V32, P370; Franz MR, 1999, CARDIOVASC RES, V41, P25, DOI 10.1016/S0008-6363(98)00268-5; Franz MR, 1996, CARDIOVASC RES, V32, P15, DOI 10.1016/0008-6363(96)00074-0; GRAHAM MS, 1990, PHYSIOL ZOOL, V63, P536, DOI 10.1086/physzool.63.3.30156227; GRAHAM MS, 1989, PHYSIOL ZOOL, V62, P38, DOI 10.1086/physzool.62.1.30159997; Greve G, 2001, EXP PHYSIOL, V86, P651, DOI 10.1113/eph8602225; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hansen J, 2002, J COMP PHYSIOL B, V172, P477, DOI 10.1007/s00360-002-0270-3; Harwood CL, 2000, J EXP BIOL, V203, P493; Hondeghem LM, 2001, CIRCULATION, V103, P2004; JENSEN D, 1969, COMP BIOCHEM PHYSIOL, V30, P685, DOI 10.1016/0010-406X(69)92147-1; JENSEN D, 1970, Comparative and General Pharmacology, V1, P254, DOI 10.1016/0010-4035(70)90061-3; Kamkin A, 2000, CARDIOVASC RES, V48, P409, DOI 10.1016/S0008-6363(00)00208-X; KAUFMANN RL, 1971, PFLUG ARCH EUR J PHY, V324, P100, DOI 10.1007/BF00592656; KICENIUK JW, 1977, J EXP BIOL, V69, P247; Knollmann BC, 2001, J CARDIOVASC ELECTR, V12, P1286, DOI 10.1046/j.1540-8167.2001.01286.x; Kohl P, 1998, CAN J CARDIOL, V14, P111; LAB MJ, 1978, CARDIOVASC RES, V12, P555, DOI 10.1093/cvr/12.9.555; LAB MJ, 1982, CIRC RES, V50, P757, DOI 10.1161/01.RES.50.6.757; LAB MJ, 1978, CIRC RES, V42, P519, DOI 10.1161/01.RES.42.4.519; Lab MJ, 1996, CARDIOVASC RES, V32, P3, DOI 10.1016/S0008-6363(96)00088-0; LAB MJ, 1984, CIRC RES, V55, P825, DOI 10.1161/01.RES.55.6.825; Martinac B, 2003, PROG BIOPHYS MOL BIO, V82, P11, DOI 10.1016/S0079-6107(03)00002-6; Moeller CC, 2008, GENE EXPR PATTERNS, V8, P291, DOI 10.1016/j.gep.2008.02.002; Nazir SA, 1996, CARDIOVASC RES, V32, P112, DOI 10.1016/0008-6363(96)00077-6; Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020; Patterson SW, 1914, J PHYSIOL-LONDON, V48, P357; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Ravens U, 2003, PROG BIOPHYS MOL BIO, V82, P255, DOI 10.1016/S0079-6107(03)00026-9; RUNNALLS ME, 1987, AM J PHYSIOL, V253, pH1315, DOI 10.1152/ajpheart.1987.253.5.H1315; Rytter D, 2007, COMP BIOCHEM PHYS A, V147, P1083, DOI 10.1016/j.cbpa.2007.03.031; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Shiels HA, 2000, J EXP BIOL, V203, P2771; Shiels HA, 2006, J GEN PHYSIOL, V128, P37, DOI 10.1085/jgp.200609543; Shiels HA, 2008, J EXP BIOL, V211, P2005, DOI 10.1242/jeb.003145; Taggart P, 1996, CARDIOVASC RES, V32, P38; Taggart P, 1999, PROG BIOPHYS MOL BIO, V71, P139, DOI 10.1016/S0079-6107(98)00039-X; Vassort G, 2009, CAN J PHYSIOL PHARM, V87, P100, DOI 10.1139/Y08-112; Ward ML, 2008, PROG BIOPHYS MOL BIO, V97, P232, DOI 10.1016/j.pbiomolbio.2008.02.009; WHITE E, 2005, CARDIAC MECHANO ELEC, P83; White E, 2006, CURR PHARM DESIGN, V12, P3645, DOI 10.2174/138161206778522083; Zabel M, 1996, CARDIOVASC RES, V32, P120, DOI 10.1016/0008-6363(96)00089-2; Zeng T, 2000, AM J PHYSIOL-HEART C, V278, pH548, DOI 10.1152/ajpheart.2000.278.2.H548	58	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10548	10.1371/journal.pone.0010548	http://dx.doi.org/10.1371/journal.pone.0010548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479879	gold, Green Published, Green Submitted			2022-12-25	WOS:000277467800026
J	Mitchell, P; Mould, R; Dillon, J; Glautier, S; Andrianakis, I; James, C; Pugh, A; Holden-Dye, L; O'Connor, V				Mitchell, Philippa; Mould, Richard; Dillon, James; Glautier, Steven; Andrianakis, Ioannis; James, Christopher; Pugh, Amanda; Holden-Dye, Lindy; O'Connor, Vincent			A Differential Role for Neuropeptides in Acute and Chronic Adaptive Responses to Alcohol: Behavioural and Genetic Analysis in Caenorhabditis elegans	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; ETHANOL TOLERANCE; PHARMACOLOGICAL EVIDENCE; POTASSIUM CHANNEL; NEURAL MECHANISMS; NATURAL VARIATION; OPIOID SYSTEMS; ANIMAL-MODELS; DARK SIDE; NEMATODE	Prolonged alcohol consumption in humans followed by abstinence precipitates a withdrawal syndrome consisting of anxiety, agitation and in severe cases, seizures. Withdrawal is relieved by a low dose of alcohol, a negative reinforcement that contributes to alcohol dependency. This phenomenon of 'withdrawal relief' provides evidence of an ethanol-induced adaptation which resets the balance of signalling in neural circuits. We have used this as a criterion to distinguish between direct and indirect ethanol-induced adaptive behavioural responses in C. elegans with the goal of investigating the genetic basis of ethanol-induced neural plasticity. The paradigm employs a 'food race assay' which tests sensorimotor performance of animals acutely and chronically treated with ethanol. We describe a multifaceted C. elegans 'withdrawal syndrome'. One feature, decrease reversal frequency is not relieved by a low dose of ethanol and most likely results from an indirect adaptation to ethanol caused by inhibition of feeding and a food-deprived behavioural state. However another aspect, an aberrant behaviour consisting of spontaneous deep body bends, did show withdrawal relief and therefore we suggest this is the expression of ethanol-induced plasticity. The potassium channel, slo-1, which is a candidate ethanol effector in C. elegans, is not required for the responses described here. However a mutant deficient in neuropeptides, egl-3, is resistant to withdrawal (although it still exhibits acute responses to ethanol). This dependence on neuropeptides does not involve the NPY-like receptor npr-1, previously implicated in C. elegans ethanol withdrawal. Therefore other neuropeptide pathways mediate this effect. These data resonate with mammalian studies which report involvement of a number of neuropeptides in chronic responses to alcohol including corticotrophin-releasing-factor (CRF), opioids, tachykinins as well as NPY. This suggests an evolutionarily conserved role for neuropeptides in ethanol-induced plasticity and opens the way for a genetic analysis of the effects of alcohol on a simple model system.	[Mitchell, Philippa; Mould, Richard; Dillon, James; Pugh, Amanda; Holden-Dye, Lindy; O'Connor, Vincent] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Glautier, Steven] Univ Southampton, Sch Psychol, Southampton, Hants, England; [Andrianakis, Ioannis; James, Christopher] Univ Southampton, Inst Sound & Vibrat Res, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton	Mitchell, P (corresponding author), Univ Southampton, Sch Biol Sci, Southampton, Hants, England.	lmhd@soton.ac.uk	James, Christopher/AAV-4770-2020; Glautier, Steven/H-5444-2011	Glautier, Steven/0000-0001-8852-3268; O'Connor, Vincent/0000-0003-3185-5709; Dillon, James/0000-0003-3244-7483; Holden-Dye, Lindy/0000-0002-9704-1217	Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom; Medical Research Council (MRC); British Pharmacological Society; National Institutes of Health (NIH) National Center for Research Resources (NCRR); BBSRC [BB/E022251/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E022251/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Pharmacological Society; National Institutes of Health (NIH) National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Richard Mould, James Dillon and Yiannis Andrianakis were funded by the Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom, through a joint Medical Research Council (MRC) and BBSRC, UK, Initiative in the Neurobiological Basis of Mental Health and Behaviour; Philippa Mitchell was funded by a BBSRC Priority Studentship in Interdisciplinary Brain Science. Amanda Pugh was funded by a vacation scholarship from the British Pharmacological Society. Some nematode strains used in this work were provided by the Caenorhabditis elegans Genetics Center, which is funded by the National Institutes of Health (NIH) National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, DIAGNOSTIC STAT MANU; Berger KH, 2004, ALCOHOL CLIN EXP RES, V28, P1469, DOI 10.1097/01.ALC.0000141817.15993.98; BRENNER S, 1974, GENETICS, V77, P71; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Cowmeadow RB, 2006, ALCOHOL CLIN EXP RES, V30, P745, DOI 10.1111/j.1530-0277.2006.00087.x; Cowmeadow RB, 2005, ALCOHOL CLIN EXP RES, V29, P1777, DOI 10.1097/01.alc.0000183232.56788.62; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Davis JR, 2008, ALCOHOL CLIN EXP RES, V32, P853, DOI 10.1111/j.1530-0277.2008.00639.x; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; EDWARDS G, 1976, BRIT MED J, V1, P1058, DOI 10.1136/bmj.1.6017.1058; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Faingold CL, 2004, ALCOHOL CLIN EXP RES, V28, P268, DOI 10.1097/01.ALC.0000113421.41962.8D; Gehlert DR, 2007, J NEUROSCI, V27, P2718, DOI 10.1523/JNEUROSCI.4985-06.2007; George DT, 2008, SCIENCE, V319, P1536, DOI 10.1126/science.1153813; Graham ME, 2009, MOL BIOL CELL, V20, P43, DOI 10.1091/mbc.E08-07-0689; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guest M, 2007, INT J PARASITOL, V37, P1577, DOI 10.1016/j.ijpara.2007.05.006; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Heinz A, 2003, PHARMACOPSYCHIATRY, V36, pS255; Herz A, 1997, PSYCHOPHARMACOLOGY, V129, P99, DOI 10.1007/s002130050169; Hokfelt T, 2003, LANCET NEUROL, V2, P463, DOI 10.1016/S1474-4422(03)00482-4; Husson SJ, 2007, PROG NEUROBIOL, V82, P33, DOI 10.1016/j.pneurobio.2007.01.006; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Kapfhamer D, 2008, GENES BRAIN BEHAV, V7, P669, DOI 10.1111/j.1601-183X.2008.00404.x; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Keating CD, 2003, CURR BIOL, V13, P1715, DOI 10.1016/j.cub.2003.09.003; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Koob GF, 2008, P NATL ACAD SCI USA, V105, P8809, DOI 10.1073/pnas.0804354105; Koob GF, 2010, CURR OPIN INVEST DR, V11, P63; Koob GF, 2009, NEUROPHARMACOLOGY, V56, P18, DOI 10.1016/j.neuropharm.2008.07.043; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Koob GF, 2006, NEUR ADD; Kwon JY, 2004, GENOMICS, V83, P600, DOI 10.1016/j.ygeno.2003.10.008; Lovinger DM, 2005, NAT NEUROSCI, V8, P1471, DOI 10.1038/nn1581; Mitchell PH, 2007, PHARMACOGENOMICS J, V7, P411, DOI 10.1038/sj.tpj.6500440; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Morgan PG, 1995, ALCOHOL CLIN EXP RES, V19, P1423, DOI 10.1111/j.1530-0277.1995.tb01002.x; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Pastor R, 2008, P NATL ACAD SCI USA, V105, P9070, DOI 10.1073/pnas.0710181105; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Roberts AJ, 1998, ALCOHOL CLIN EXP RES, V22, P1564, DOI 10.1111/j.1530-0277.1998.tb03950.x; Rodd ZA, 2004, PHARMACOL BIOCHEM BE, V79, P439, DOI 10.1016/j.pbb.2004.08.018; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Scholz H, 2005, NATURE, V436, P845, DOI 10.1038/nature03864; Scholz H, 2009, J NEUROGENET, V23, P111, DOI 10.1080/01677060802471676; Schuckit MA, 2000, AM J ADDICTION, V9, P103, DOI 10.1080/10550490050173172; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; Stewart J, 2008, PHILOS T R SOC B, V363, P3147, DOI 10.1098/rstb.2008.0084; Thorsell A, 2007, PEPTIDES, V28, P480, DOI 10.1016/j.peptides.2006.11.017; Thorsell A, 2010, PSYCHOPHARMACOLOGY, V209, P103, DOI 10.1007/s00213-010-1775-1; Thorsell A, 2008, ANN NY ACAD SCI, V1148, P136, DOI 10.1196/annals.1410.083; TRENT C, 1983, GENETICS, V104, P619; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Walker BM, 2008, NEUROPSYCHOPHARMACOL, V33, P643, DOI 10.1038/sj.npp.1301438; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166	60	39	41	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10422	10.1371/journal.pone.0010422	http://dx.doi.org/10.1371/journal.pone.0010422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454655	Green Published, gold			2022-12-25	WOS:000277240300005
J	Schartau, JM; Kroger, RHH; Sjogreen, B				Schartau, J. Marcus; Kroger, Ronald H. H.; Sjogreen, Bodil			Dopamine Induces Optical Changes in the Cichlid Fish Lens	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; MULTIFOCAL LENSES; EPITHELIAL-CELLS; RETINA; PERMEABILITY; VERTEBRATES; VISUALIZATION; MOVEMENTS; RECEPTOR; RELEASE	The crystalline lens in the cichlid fish Aequidens pulcher undergoes a transformation of its optical properties every dawn and dusk as the eye adapts to changes in light conditions. During dusk the transformation result in an increase of the refractive power in the lens cortex, the outermost 40 percent. The change is thought to match the optical properties of the lens to the requirements of the retina. Using a short term in vitro lens culturing system together with optical measurements we here present data that confirm that the optical properties of the lens can change within hours and that dopamine influences the optical properties of the lens. Dopamine yields dose-dependent decrease of the refractive power in the lens cortex. The D1-agonist SKF-38393 induces a similar decrease of the refractive power in the cortex, while the D2-agonist quinpirole has no effect. The effect of dopamine can be blocked by using the D1-antagonist SCH 23390. Our results suggest that dopamine alone could be responsible for the light/dark adaptive optical changes in the lens, but the involvement of other signaling substances cannot be ruled out.	[Schartau, J. Marcus; Kroger, Ronald H. H.; Sjogreen, Bodil] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Schartau, JM (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	marcus.schartau@cob.lu.se	Kroger, Ronald/L-2090-2016	Kroger, Ronald/0000-0002-6006-6728	Swedish Research Council [2005-2852]; Royal Physiographic Society in Lund; Lars Hierta Memorial Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund; Lars Hierta Memorial Foundation	The study was supported by grant 2005-2852 from the Swedish Research Council to R. H. H. K. and grants from the Royal Physiographic Society in Lund and the Lars Hierta Memorial Foundation to J.M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge WH, 1998, SEMIN CELL DEV BIOL, V9, P311, DOI 10.1006/scdb.1998.0235; Burnside B, 2001, Prog Brain Res, V131, P477; Burnside B., 1983, PROG RETIN RES, V2, P67, DOI [10.1016/0278-4327(83)90004-4, DOI 10.1016/0278-4327(83)90004-4]; Cardinaud B, 1997, J BIOL CHEM, V272, P2778, DOI 10.1074/jbc.272.5.2778; Churchill GC, 1999, AM J PHYSIOL-CELL PH, V276, pC426, DOI 10.1152/ajpcell.1999.276.2.C426; DEARRY A, 1989, J NEUROCHEM, V53, P870, DOI 10.1111/j.1471-4159.1989.tb11785.x; Delgado MJ, 2001, NEUROSCI LETT, V300, P129, DOI 10.1016/S0304-3940(01)01560-9; DOUGLAS RH, 1982, J EXP BIOL, V96, P389; FRAIL DE, 1993, MOL PHARMACOL, V44, P1113; Goldberg GS, 2004, BBA-BIOMEMBRANES, V1662, P96, DOI 10.1016/j.bbamem.2003.11.022; Gustafsson OSE, 2008, J EXP BIOL, V211, P1559, DOI 10.1242/jeb.016048; Kanaporis G, 2008, J GEN PHYSIOL, V131, P293, DOI 10.1085/jgp.200709934; Karpestam B, 2007, J EXP BIOL, V210, P2923, DOI 10.1242/jeb.002956; KOLBINGER W, 1990, VISUAL NEUROSCI, V5, P143, DOI 10.1017/S0952523800000183; Kroger RHH, 1999, J COMP PHYSIOL A, V184, P361, DOI 10.1007/s003590050335; Lamb Trevor D., 2008, Evolution Education and Outreach, V1, P415, DOI 10.1007/s12052-008-0091-2; Lind OE, 2008, J EXP BIOL, V211, P2752, DOI 10.1242/jeb.018630; Lurtz MM, 2003, AM J PHYSIOL-CELL PH, V285, pC1475, DOI 10.1152/ajpcell.00361.2002; Malkki PE, 2005, J OPT A-PURE APPL OP, V7, P691, DOI 10.1088/1464-4258/7/11/012; Malmstrom T, 2006, J EXP BIOL, V209, P18, DOI 10.1242/jeb.01959; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; MATTHIESSEN L, 1882, PFLUG ARCH GES PHYS, V38, P521; MCCORMACK CA, 1994, J GEN PHYSIOL, V103, P487, DOI 10.1085/jgp.103.3.487; Nguyen TA, 2003, EXP EYE RES, V76, P565, DOI 10.1016/S0014-4835(03)00049-6; Ohngemach S, 1997, VISUAL NEUROSCI, V14, P493, DOI 10.1017/S0952523800012153; Schartau JM, 2009, CURR BIOL, V19, P122, DOI 10.1016/j.cub.2008.11.062; SROCZYNSKI S, 1977, J COMP PHYSIOL, V121, P135, DOI 10.1007/BF00614185; Vaghefi E, 2009, PHYSIOL MEAS, V30, P1061, DOI 10.1088/0967-3334/30/10/007; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; VOORTER CEM, 1989, BIOCHIM BIOPHYS ACTA, V986, P8, DOI 10.1016/0005-2736(89)90265-4; WITKOVSKY P, 1993, P NATL ACAD SCI USA, V90, P5667, DOI 10.1073/pnas.90.12.5667	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10402	10.1371/journal.pone.0010402	http://dx.doi.org/10.1371/journal.pone.0010402			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454461	gold, Green Published, Green Submitted			2022-12-25	WOS:000277240100014
J	Wang, B; Ling, SY; Lin, WC				Wang, Bing; Ling, Shiyun; Lin, Weei-Chin			14-3-3 tau Regulates Beclin 1 and Is Required for Autophagy	PLOS ONE			English	Article							BREAST-CANCER; CELL INVASION; EXPRESSION; INDUCTION; APOPTOSIS; PROTEIN; TOPBP1; E2F1; TUMORIGENESIS; INHIBITION	Background: Beclin 1 plays an essential role in autophagy; however, the regulation of Beclin 1 expression remains largely unexplored. An earlier ChIP-on-chip study suggested Beclin 1 could be an E2F target. Previously, we also reported that 14-3-3 tau regulates E2F1 stability, and is required for the expression of several E2F1 target genes. 14-3-3 proteins mediate many cellular signaling processes, but its role in autophagy has not been investigated. We hypothesize that 14-3-3 tau could regulate Beclin 1 expression through E2F1 and thus regulate autophagy. Methods and Findings: Using the RNAi technique we demonstrate a novel role for one of 14-3-3 isoforms, 14-3-3 tau, in the regulation of Beclin 1 expression and autophagy. Depletion of 14-3-3 tau inhibits the expression of Beclin 1 in many different cell lines; whereas, upregulation of 14-3-3 tau induces Beclin 1. The regulation is physiologically relevant as an extracellular matrix protein tenascin-C, a known 14-3-3 tau inducer, can induce Beclin 1 through 14-3-3 tau. Moreover, rapamycin-induced, serum free-induced and amino acid starvation-induced autophagy depends on 14-3-3 tau. We also show the expression of Beclin 1 depends on E2F, and E2F can transactivate the Beclin 1 promoter in a promoter reporter assay. Upregulation of Beclin 1 by 14-3-3 tau requires E2F1. Depletion of E2F1, like 14-3-3 tau, also inhibits autophagy. Conclusion: Taken together, this study uncovers a role for 14-3-3 tau in Beclin 1 and autophagy regulation probably through regulation of E2F1.	[Wang, Bing; Ling, Shiyun; Lin, Weei-Chin] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Ling, Shiyun; Lin, Weei-Chin] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, B (corresponding author), Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA.	weeichil@bcm.edu	Ling, Shiyun/P-2242-2014		National Institutes of Health [CA 100857, CA138641]; Department of Defense [W81XWH-09-1-0338]; NATIONAL CANCER INSTITUTE [R01CA100857, R01CA138641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by grants from National Institutes of Health (CA 100857, CA138641) and Department of Defense Breast Cancer Research Program (W81XWH-09-1-0338). W-C. L. is a Leukemia and Lymphoma Society Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN Y, 2009, PATHOL ONCOL RES; Chiquet-Ehrismann R, 1991, CURR OPIN CELL BIOL, V3, P800, DOI 10.1016/0955-0674(91)90053-2; Copetti T, 2009, AUTOPHAGY, V5, P858, DOI 10.4161/auto.8822; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Hancox RA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2251; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; Jahkola T, 1998, BRIT J CANCER, V78, P1507, DOI 10.1038/bjc.1998.714; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KUSAMA Y, 2009, APOPTOSIS; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li BX, 2009, AUTOPHAGY, V5, P303, DOI 10.4161/auto.5.3.7491; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Liu K, 2009, MOL CELL BIOL, V29, P2673, DOI 10.1128/MCB.01140-08; Martin D, 2003, J CELL BIOL, V160, P171, DOI 10.1083/jcb.200206109; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Miracco C, 2007, INT J ONCOL, V30, P429; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pirtoli L, 2009, AUTOPHAGY, V5, P930, DOI 10.4161/auto.5.7.9227; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sarkar S, 2006, CANCER RES, V66, P11771, DOI 10.1158/0008-5472.CAN-05-0470; Shi YH, 2009, AUTOPHAGY, V5, P380, DOI 10.4161/auto.5.3.7658; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001	37	33	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10409	10.1371/journal.pone.0010409	http://dx.doi.org/10.1371/journal.pone.0010409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454448	Green Submitted, Green Published, gold			2022-12-25	WOS:000277240100018
J	Miyazaki, JI; Martins, LD; Fujita, Y; Matsumoto, H; Fujiwara, Y				Miyazaki, Jun-Ichi; de Oliveira Martins, Leonardo; Fujita, Yuko; Matsumoto, Hiroto; Fujiwara, Yoshihiro			Evolutionary Process of Deep-Sea Bathymodiolus Mussels	PLOS ONE			English	Article							HYDROTHERMAL VENT MUSSELS; NORTH FIJI BASIN; COLD-SEEP; PHYLOGENETIC-RELATIONSHIPS; BIVALVIA MYTILIDAE; WOODEN STEPS; NEW-ZEALAND; RATES; ENDOSYMBIONTS; POPULATIONS	Background: Since the discovery of deep-sea chemosynthesis-based communities, much work has been done to clarify their organismal and environmental aspects. However, major topics remain to be resolved, including when and how organisms invade and adapt to deep-sea environments; whether strategies for invasion and adaptation are shared by different taxa or unique to each taxon; how organisms extend their distribution and diversity; and how they become isolated to speciate in continuous waters. Deep-sea mussels are one of the dominant organisms in chemosynthesis-based communities, thus investigations of their origin and evolution contribute to resolving questions about life in those communities. Methodology/Principal Finding: We investigated worldwide phylogenetic relationships of deep-sea Bathymodiolus mussels and their mytilid relatives by analyzing nucleotide sequences of the mitochondrial cytochrome c oxidase subunit I (COI) and NADH dehydrogenase subunit 4 (ND4) genes. Phylogenetic analysis of the concatenated sequence data showed that mussels of the subfamily Bathymodiolinae from vents and seeps were divided into four groups, and that mussels of the subfamily Modiolinae from sunken wood and whale carcasses assumed the outgroup position and shallow-water modioline mussels were positioned more distantly to the bathymodioline mussels. We provisionally hypothesized the evolutionary history of Bathymodilolus mussels by estimating evolutionary time under a relaxed molecular clock model. Diversification of bathymodioline mussels was initiated in the early Miocene, and subsequently diversification of the groups occurred in the early to middle Miocene. Conclusions/Significance: The phylogenetic relationships support the "Evolutionary stepping stone hypothesis,'' in which mytilid ancestors exploited sunken wood and whale carcasses in their progressive adaptation to deep-sea environments. This hypothesis is also supported by the evolutionary transition of symbiosis in that nutritional adaptation to the deep sea proceeded from extracellular to intracellular symbiotic states in whale carcasses. The estimated evolutionary time suggests that the mytilid ancestors were able to exploit whales during adaptation to the deep sea.	[Miyazaki, Jun-Ichi] Univ Yamanashi, Fac Educ & Human Sci, Yamanashi, Japan; [de Oliveira Martins, Leonardo] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain; [Fujita, Yuko; Matsumoto, Hiroto] Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan; [Fujiwara, Yoshihiro] Japan Agcy Marine Earth Sci & Technol, Res Program Marine Biol & Ecol, Kanagawa, Japan	University of Yamanashi; Universidade de Vigo; University of Tsukuba; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Miyazaki, JI (corresponding author), Univ Yamanashi, Fac Educ & Human Sci, Yamanashi, Japan.	miyazaki@yamanashi.ac.jp	de Oliveira Martins, Leonardo/I-4606-2013	de Oliveira Martins, Leonardo/0000-0001-5247-1320	Ministry of Education, Culture, Sports, Science and Technology of Japan [21570093]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 21570093, http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Burton KW, 1997, NATURE, V386, P382, DOI 10.1038/386382a0; CAVANAUGH CM, 1987, NATURE, V325, P346, DOI 10.1038/325346a0; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; Collins LS, 1996, P NATL ACAD SCI USA, V93, P6069, DOI 10.1073/pnas.93.12.6069; COLLINS TM, 1989, THESIS YALE U NEW HA; CRADDOCK C, 1995, MAR BIOL, V121, P477, DOI 10.1007/BF00349456; CRADDOCK C, 1995, MAR BIOL, V124, P137, DOI 10.1007/BF00349155; DISTEL DL, 1995, P NATL ACAD SCI USA, V92, P9598, DOI 10.1073/pnas.92.21.9598; DISTEL DL, 1988, J BACTERIOL, V170, P2506, DOI 10.1128/jb.170.6.2506-2510.1988; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Dubilier N, 1998, MAR ECOL PROG SER, V165, P187, DOI 10.3354/meps165187; DUQUECARO H, 1990, PALAEOGEOGR PALAEOCL, V77, P203, DOI 10.1016/0031-0182(90)90178-A; Fiala-Medioni A, 2002, MAR BIOL, V141, P1035, DOI 10.1007/s00227-002-0903-9; FISHER CR, 1993, PSZNI MAR ECOL, V14, P277; Fujita Yuko, 2009, Venus (Tokyo), V67, P123; Fujiwara Y, 2000, MAR ECOL PROG SER, V208, P147, DOI 10.3354/meps208147; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Gros O, 2007, CAH BIOL MAR, V48, P103; Gustafson RG, 1998, MALACOLOGIA, V40, P63; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hasegawa M, 2003, GENES GENET SYST, V78, P267, DOI 10.1266/ggs.78.267; Hashimoto Jun, 2005, Venus (Tokyo), V64, P1; Hashimoto Jun, 2001, Venus (Tokyo), V60, P141; Hashimoto Jun, 2007, Venus (Tokyo), V66, P57; Hashimoto Jun, 1994, Venus the Japanese Journal of Malacology, V53, P61; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Iwasaki H, 2006, MAR BIOL, V149, P1111, DOI 10.1007/s00227-006-0268-6; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; KENK VC, 1985, MALACOLOGIA, V26, P253; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kyuno Akiko, 2009, Journal of Marine Biology, V2009, P1; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; Lorion J, 2009, P ROY SOC B-BIOL SCI, V276, P177, DOI 10.1098/rspb.2008.1101; Miyazaki JI, 2004, MAR BIOL, V144, P527, DOI 10.1007/s00227-003-1208-3; OKUTANI T, 2004, VENUS, V63, P97; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Page R.D.M., 1998, MOL EVOLUTION PHYLOG; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Samadi S, 2007, CR BIOL, V330, P446, DOI 10.1016/j.crvi.2007.04.001; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Smith PJ, 2004, MAR BIOL, V144, P537, DOI 10.1007/s00227-003-1207-4; SQUIRES RL, 1991, NATURE, V349, P574, DOI 10.1038/349574a0; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; von Cosel R, 2003, NAUTILUS, V117, P31; Von Cosel R, 1999, VELIGER, V42, P218; von Cosel R, 1998, CR ACAD SCI III-VIE, V321, P655, DOI 10.1016/S0764-4469(98)80005-X; von Cosel Rudo, 2002, Zoosystema, V24, P259; von Cosel R, 2008, RAFFLES B ZOOL, P105; von Cosel R, 2008, ARCH MOLLUSKENKD, V137, P195, DOI 10.1127/arch.moll/0003-9284/137/195-224; VONCOSEL R, 1994, VELIGER, V37, P374; Yamanaka T, 2003, J MAR BIOL ASSOC UK, V83, P841, DOI 10.1017/S0025315403007872h; Yamanaka Toshiro, 2000, Benthos Research, V55, P63; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	59	60	65	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10363	10.1371/journal.pone.0010363	http://dx.doi.org/10.1371/journal.pone.0010363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436906	Green Published, gold, Green Submitted			2022-12-25	WOS:000277079700011
J	de Boussac, H; Ratajewski, M; Sachrajda, I; Koblos, G; Tordai, A; Pulaski, L; Buday, L; Varadi, A; Aranyi, T				de Boussac, Hugues; Ratajewski, Marcin; Sachrajda, Iwona; Koblos, Gabriella; Tordai, Attila; Pulaski, Lukasz; Buday, Laszlo; Varadi, Andras; Aranyi, Tamas			The ERK1/2-Hepatocyte Nuclear Factor 4 alpha Axis Regulates Human ABCC6 Gene Expression in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAUSE PSEUDOXANTHOMA ELASTICUM; CORONARY-ARTERY-DISEASE; TRANSCRIPTION FACTORS; DNA METHYLATION; PROTEIN; GROWTH; PROMOTER; RECEPTOR; LIVER; IDENTIFICATION	ABCC6 mutations are responsible for the development of pseudoxanthoma elasticum, a rare recessive disease characterized by calcification of elastic fibers. Although ABCC6 is mainly expressed in the liver the disease has dermatologic, ocular, and cardiovascular symptoms. We investigated the transcriptional regulation of the gene and observed that hepatocyte growth factor (HGF) inhibits its expression in HepG2 cells via the activation of ERK1/2. Similarly, other factors activating the cascade also inhibited ABCC6 expression. We identified the ERK1/2 response element in the proximal promoter by luciferase reporter gene assays. This site overlapped with a region conferring the tissue-specific expression pattern to the gene and with a putative hepatocyte nuclear factor 4 alpha (HNF4 alpha) binding site. We demonstrated that HNF4 alpha regulates the expression of ABCC6, acts through the putative binding site, and determines its cell type-specific expression. We also showed that HNF4 alpha is inhibited by the activation of the ERK1/2 cascade. In conclusion we describe here the first regulatory pathway of ABCC6 expression showing that the ERK1/2-HNF4 alpha axis has an important role in regulation of the gene.	[Buday, Laszlo; Varadi, Andras; Aranyi, Tamas] Hungarian Acad Sci, Inst Enzymol, H-1113 Budapest, Hungary; [Ratajewski, Marcin; Sachrajda, Iwona; Pulaski, Lukasz] Polish Acad Sci, Inst Med Biol, Lab Transcript Regulat, PL-93232 Lodz, Poland; [Tordai, Attila] Hungarian Natl Blood Transfus Serv, Lab Mol Diagnost, H-1113 Budapest, Hungary; [Buday, Laszlo] Semmelweis Univ, Dept Med Chem, H-1094 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Semmelweis University	Aranyi, T (corresponding author), Hungarian Acad Sci, Inst Enzymol, Karolina Ut 29, H-1113 Budapest, Hungary.	aranyi@enzim.hu	Varadi, Andras/A-2055-2012; Aranyi, Tamas/AAJ-9629-2021; Ratajewski, Marcin/I-4657-2019	Aranyi, Tamas/0000-0002-2087-6275; Ratajewski, Marcin/0000-0001-5391-5843; Pulaski, Lukasz/0000-0001-8063-801X	National Research Fund of Hungary [NI68950, PD79183]; National Development Agency [KMOP-1.1.2-07/1-2008-0003]; Hungarian Academy of Sciences [KFKT-1-2006-0006]; Polish-Hungarian academic cooperation grant	National Research Fund of Hungary; National Development Agency; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Polish-Hungarian academic cooperation grant	This work was supported in part by National Research Fund of Hungary Grants NI68950 and PD79183, National Development Agency Grant KMOP-1.1.2-07/1-2008-0003, Polanyi Mihaly Grant KFKT-1-2006-0006, a grant called "Lendulet" from the Hungarian Academy of Sciences, and a Polish-Hungarian academic cooperation grant.	Aranyi T, 2005, J BIOL CHEM, V280, P18643, DOI 10.1074/jbc.M501139200; Aranyi T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-431; Bacchelli B, 1999, MODERN PATHOL, V12, P1112; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bors A, 2008, ANAL BIOCHEM, V372, P261, DOI 10.1016/j.ab.2007.08.024; Borst P, 2008, CELL CYCLE, V7, P1575, DOI 10.4161/cc.7.11.6005; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Cai L, 2001, J MOL MED, V79, P536, DOI 10.1007/s001090100275; Czaja MJ, 2003, HEPATOLOGY, V37, P1405, DOI 10.1053/jhep.2003.50233; Douet V, 2007, BIOCHEM BIOPH RES CO, V354, P66, DOI 10.1016/j.bbrc.2006.12.151; Douet V, 2006, BBA-GENE STRUCT EXPR, V1759, P426, DOI 10.1016/j.bbaexp.2006.08.002; Gujdar A, 2004, CELL SIGNAL, V16, P505, DOI 10.1016/j.cellsig.2003.09.009; Hamlin N, 2003, BRIT J HAEMATOL, V122, P852, DOI 10.1046/j.1365-2141.2003.04484.x; Hatzis P, 2006, MOL CELL BIOL, V26, P7017, DOI 10.1128/MCB.00297-06; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; Hendig D, 2008, CLIN BIOCHEM, V41, P407, DOI 10.1016/j.clinbiochem.2007.12.023; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Jiang QJ, 2006, J INVEST DERMATOL, V126, P325, DOI 10.1038/sj.jid.5700065; Jiang QJ, 2009, J INVEST DERMATOL, V129, P348, DOI 10.1038/jid.2008.212; Kermorgant S, 2005, CELL CYCLE, V4, P352, DOI 10.4161/cc.4.3.1519; Koblos G, 2010, GENET TEST MOL BIOMA, V14, P75, DOI 10.1089/gtmb.2009.0094; Kool M, 1999, CANCER RES, V59, P175; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Li QL, 2009, EXP DERMATOL, V18, P1, DOI 10.1111/j.1600-0625.2008.00795.x; Lian ZR, 2001, HEPATOLOGY, V34, P146, DOI 10.1053/jhep.2001.25545; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pasquali-Ronchetti I, 2006, J PATHOL, V208, P54, DOI 10.1002/path.1867; Pfendner Ellen G, 2008, Expert Opin Med Diagn, V2, P63, DOI 10.1517/17530059.2.1.63; Qadri I, 2006, MOL PHARMACOL, V70, P627, DOI 10.1124/mol.106.023499; Qadri I, 2009, TOXICOL APPL PHARM, V234, P281, DOI 10.1016/j.taap.2008.10.005; Ratajewski M, 2006, BIOCHEM BIOPH RES CO, V350, P1082, DOI 10.1016/j.bbrc.2006.10.007; Ratajewski M, 2009, BIOCHEM BIOPH RES CO, V383, P73, DOI 10.1016/j.bbrc.2009.03.131; Ratajewski M, 2008, HUM GENET, V124, P451, DOI 10.1007/s00439-008-0570-0; Reddy S, 1999, J BIOL CHEM, V274, P33050, DOI 10.1074/jbc.274.46.33050; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Ringpfeil F, 2000, P NATL ACAD SCI USA, V97, P6001, DOI 10.1073/pnas.100041297; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Schulz V, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9444; Sipeki S, 1999, CELL SIGNAL, V11, P885, DOI 10.1016/S0898-6568(99)00060-1; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Symmons O, 2008, MOL BIOL EVOL, V25, P2601, DOI 10.1093/molbev/msn202; Trip MD, 2002, CIRCULATION, V106, P773, DOI 10.1161/01.CIR.0000028420.27813.C0; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833	48	25	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22798	22806		10.1074/jbc.M110.105593	http://dx.doi.org/10.1074/jbc.M110.105593			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20463007	Green Published, hybrid			2022-12-25	WOS:000279999900012
J	Jacquot, G; Maidou-Peindara, P; Benichou, S				Jacquot, Guillaume; Maidou-Peindara, Priscilla; Benichou, Serge			Molecular and Functional Basis for the Scaffolding Role of the p50/Dynamitin Subunit of the Microtubule-associated Dynactin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-RELATED PROTEIN; CYTOPLASMIC DYNEIN; CENTROSOMES; COMPONENT; SPINDLE; CELLS; END; OVEREXPRESSION; PROCESSIVITY; ORIENTATION	p50/dynamitin (DM) is a major subunit of the microtubule-associated dynactin complex that is required for stabilization and attachment of its two distinct structural domains, namely the Arp1 rod and the shoulder/sidearm. Here, we define the determinants of p50/DM required for self-oligomerization of the protein and for interactions with other subunits of the dynactin complex. Whereas the N-terminal 1-91-amino acid region of the protein is required and sufficient for binding to the Arp1 rod, additional determinants contained within the first half of the protein are required for optimal recruitment of the p150(Glued) subunit of the shoulder/sidearm. Overexpression experiments confirmed that the N-terminal 1-91-amino acid region of p50/DM is critical for dynactin functionality, because this fragment acts as a dominant negative to inhibit both dynein-dependent and -independent functions of the complex. Furthermore, the first two predicted coiled-coil motifs of p50/DM contain determinants that mediate self-association of the protein. Interestingly, p50/DM self-association does not contribute to p50/DM-induced disruption of the dynactin complex, but most likely participates in the stabilization of the complex.	[Jacquot, Guillaume; Maidou-Peindara, Priscilla; Benichou, Serge] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Jacquot, Guillaume; Maidou-Peindara, Priscilla; Benichou, Serge] INSERM, U1016, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Benichou, S (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	serge.benichou@inserm.fr		Benichou, Serge/0000-0003-3602-3530	INSERM; CNRS; Universite Paris-Descartes; French National Agency for AIDS Research; Sidaction Fondation de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Descartes; French National Agency for AIDS Research; Sidaction Fondation de France	This work was supported in part by INSERM, CNRS, Universite Paris-Descartes, the French National Agency for AIDS Research, and Sidaction Fondation de France (to S.B.).	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Berezuk MA, 2007, TRAFFIC, V8, P124, DOI 10.1111/j.1600-0854.2006.00517.x; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; CLARK SW, 1994, J CELL BIOL, V127, P129, DOI 10.1083/jcb.127.1.129; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; HARTE PJ, 1982, GENETICS, V101, P477; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Maier KC, 2008, TRAFFIC, V9, P481, DOI 10.1111/j.1600-0854.2008.00702.x; Melkonian KA, 2007, J BIOL CHEM, V282, P19355, DOI 10.1074/jbc.M700003200; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; MUHUA L, 1994, CELL, V78, P669, DOI 10.1016/0092-8674(94)90531-2; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; PLAMANN M, 1994, J CELL BIOL, V127, P139, DOI 10.1083/jcb.127.1.139; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Selig L, 1999, J VIROL, V73, P592, DOI 10.1128/JVI.73.1.592-600.1999; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Uetake Y, 2004, CELL MOTIL CYTOSKEL, V58, P53, DOI 10.1002/cm.10175; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; Yue LL, 2000, J BIOL CHEM, V275, P23948, DOI 10.1074/jbc.M001845200	33	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23017	23029		10.1074/jbc.M110.100602	http://dx.doi.org/10.1074/jbc.M110.100602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20463029	Green Published, hybrid			2022-12-25	WOS:000279999900036
J	Rowley, PA; Kachroo, AH; Ma, CH; Maciaszek, AD; Guga, P; Jayaram, M				Rowley, Paul A.; Kachroo, Aashiq H.; Ma, Chien-Hui; Maciaszek, Anna D.; Guga, Piotr; Jayaram, Makkuni			Electrostatic Suppression Allows Tyrosine Site-specific Recombination in the Absence of a Conserved Catalytic Arginine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION COMPLEX; FLP RECOMBINASE; ACTIVE-SITE; DNA RECOMBINATION; RIBONUCLEASE-ACTIVITIES; FUNCTIONAL-ANALYSIS; INTEGRASE FAMILY; TOPOISOMERASE-I; SIMILARITIES; SUBSTRATE	The active site of the tyrosine family site-specific recombinase Flp contains a conserved catalytic pentad that includes two arginine residues, Arg-191 and Arg-308. Both arginines are essential for the transesterification steps of strand cleavage and strand joining in DNA substrates containing a phosphate group at the scissile position. During strand cleavage, the active site tyrosine supplies the nucleophile to form a covalent 3'-phosphotyrosyl intermediate. The 5'-hydroxyl group produced by cleavage provides the nucleophile to re-form a 3'-5' phosphodiester bond in a recombinant DNA strand. In previous work we showed that substitution of the scissile phosphate (P) by the charge neutral methylphosphonate (MeP) makes Arg-308 dispensable during the catalytic activation of the MeP diester bond. However, in the Flp(R308A) reaction, water out-competes the tyrosine nucleophile (Tyr-343) to cause direct hydrolysis of the MeP diester bond. We now report that for MeP activation Arg-191 is also not required. In contrast to Flp(R308A), Flp(R191A) primarily mediates normal cleavage by Tyr-343 but also exhibits a weaker direct hydrolytic activity. The cleaved MeP-tyrosyl intermediate formed by Flp(R191A) can be targeted for nucleophilic attack by a 5'-hydroxyl or water and channeled toward strand joining or hydrolysis, respectively. In collaboration with wild type Flp, Flp(R191A) promotes strand exchange between MeP- and P-DNA partners. Loss of a catalytically crucial positively charged side chain can thus be suppressed by a compensatory modification in the DNA substrate that neutralizes the negative charge on the scissile phosphate.	[Rowley, Paul A.; Kachroo, Aashiq H.; Ma, Chien-Hui; Jayaram, Makkuni] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Maciaszek, Anna D.; Guga, Piotr] Polish Acad Sci, Dept Bioorgan Chem, Ctr Mol & Macromol Studies, PL-90363 Lodz, Poland	University of Texas System; University of Texas Austin; Polish Academy of Sciences; Centre of Molecular & Macromolecular Studies of the Polish Academy of Sciences	Jayaram, M (corresponding author), 1 Univ Stn A5000,NMS 2-210, Austin, TX 78712 USA.	Jayaram@icmb.utexas.edu	Kachroo, Aashiq/Z-2505-2019; Guga, Piotr J/Y-5582-2018; Rowley, Paul/I-1265-2019	Kachroo, Aashiq/0000-0001-9770-778X; Rowley, Paul/0000-0002-3590-5139	National Institutes of Health [GM035654]; Robert F. Welch Foundation [F-1274]; University of Texas at Austin; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert F. Welch Foundation(The Welch Foundation); University of Texas at Austin; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM035654 (to M.J.). This work was also supported in part by Robert F. Welch Foundation Award F-1274 and by a University of Texas at Austin faculty research award.	ARGOS P, 1986, EMBO J, V5, P433, DOI 10.1002/j.1460-2075.1986.tb04229.x; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; CHEN JW, 1992, MOL CELL BIOL, V12, P3757, DOI 10.1128/MCB.12.9.3757; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chen Y, 2003, ANNU REV BIOPH BIOM, V32, P135, DOI 10.1146/annurev.biophys.32.110601.141732; Chen Y, 2003, J BIOL CHEM, V278, P24800, DOI 10.1074/jbc.M300853200; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Conway AB, 2003, J MOL BIOL, V326, P425, DOI 10.1016/S0022-2836(02)01370-0; Davies DR, 2006, J MOL BIOL, V357, P1202, DOI 10.1016/j.jmb.2006.01.022; FRIESEN H, 1992, J MOL BIOL, V225, P313, DOI 10.1016/0022-2836(92)90924-9; Ghosh K, 2005, J BIOL CHEM, V280, P8290, DOI 10.1074/jbc.M411668200; Grainge I, 1999, MOL MICROBIOL, V33, P449, DOI 10.1046/j.1365-2958.1999.01493.x; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Lee J, 1999, EMBO J, V18, P784, DOI 10.1093/emboj/18.3.784; Ma CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007248; Ma CH, 2009, EMBO J, V28, P1745, DOI 10.1038/emboj.2009.131; PARSONS RL, 1988, MOL CELL BIOL, V8, P3303, DOI 10.1128/MCB.8.8.3303; PARSONS RL, 1990, J BIOL CHEM, V265, P4527; Perry K, 2006, MOL CELL, V23, P343, DOI 10.1016/j.molcel.2006.06.015; PRASAD PV, 1987, P NATL ACAD SCI USA, V84, P2189, DOI 10.1073/pnas.84.8.2189; SERRE MC, 1993, J BIOL CHEM, V268, P455; Tian LG, 2005, STRUCTURE, V13, P513, DOI 10.1016/j.str.2005.02.001; Tian LG, 2003, MOL CELL, V12, P199, DOI 10.1016/S1097-2765(03)00263-6; Xu CJ, 1998, MOL CELL, V1, P729, DOI 10.1016/S1097-2765(00)80072-6; Xu CJ, 1998, J BIOL CHEM, V273, P30591, DOI 10.1074/jbc.273.46.30591	26	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22974	22983		10.1074/jbc.M110.112292	http://dx.doi.org/10.1074/jbc.M110.112292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20448041	Green Published, hybrid			2022-12-25	WOS:000279999900032
J	Oelkrug, R; Kutschke, M; Meyer, CW; Heldmaier, G; Jastroch, M				Oelkrug, Rebecca; Kutschke, Maria; Meyer, Carola W.; Heldmaier, Gerhard; Jastroch, Martin			Uncoupling Protein 1 Decreases Superoxide Production in Brown Adipose Tissue Mitochondria.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE PRODUCTION; NONSHIVERING THERMOGENESIS; FATTY-ACIDS; PROTON CONDUCTANCE; OXIDATIVE STRESS; COMPLEX-I; DEHYDROGENASE; ANTIPORTER; EXPRESSION; GENERATION	In thermogenic brown adipose tissue, uncoupling protein 1 (UCP1) catalyzes the dissipation of mitochondrial proton motive force as heat. In a cellular environment of high oxidative capacity such as brown adipose tissue (BAT), mitochondrial uncoupling could also reduce deleterious reactive oxygen species, but the specific involvement of UCP1 in this process is disputed. By comparing brown adipose tissue mitochondria of wild type mice and UCP1-ablated litter mates, we show that UCP1 potently reduces mitochondrial superoxide production after cold acclimation and during fatty acid oxidation. We address the sites of superoxide production and suggest diminished probability of "reverse electron transport" facilitated by uncoupled respiration as the underlying mechanism of reactive oxygen species suppression in BAT. Furthermore, ablation of UCP1 represses the cold-stimulated increase of substrate oxidation normally seen in active BAT, resulting in lower superoxide production, presumably avoiding deleterious oxidative damage. We conclude that UCP1 allows high oxidative capacity without promoting oxidative damage by simultaneously lowering superoxide production.	[Oelkrug, Rebecca; Kutschke, Maria; Meyer, Carola W.; Heldmaier, Gerhard; Jastroch, Martin] Univ Marburg, Fac Biol, Dept Anim Physiol, D-35043 Marburg, Germany	Philipps University Marburg	Jastroch, M (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.	mjastroch@buckinstitute.org	Heldmaier, Gerhard/AAI-3286-2020; Meyer, Carola/N-5874-2014; Jastroch, Martin/I-7494-2017	Meyer, Carola/0000-0001-7959-1218; 	Deutsche Forschungsgemeinschaft [HE 990/15-1, JA 1884/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants HE 990/15-1 (to G.H. and C.W.M.) and JA 1884/2-1.	ANDREYEV AY, 1988, FEBS LETT, V226, P265, DOI 10.1016/0014-5793(88)81436-4; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Aydin J, 2008, FASEB J, V22, P3919, DOI 10.1096/fj.08-113712; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CANNON B, 1977, FEBS LETT, V76, P284, DOI 10.1016/0014-5793(77)80169-5; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Drahota Z, 2002, J BIOENERG BIOMEMBR, V34, P105, DOI 10.1023/A:1015123908918; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARMAN D, 1972, AM J CLIN NUTR, V25, P839; HELDMAIER G, 1990, SEASONAL ADAPTATION; HITTELMAN KJ, 1969, EUR J BIOCHEM, V11, P183, DOI 10.1111/j.1432-1033.1969.tb00759.x; Jastroch M, 2005, PHYSIOL GENOMICS, V22, P150, DOI 10.1152/physiolgenomics.00070.2005; Khailova LS, 2006, BBA-BIOENERGETICS, V1757, P1324, DOI 10.1016/j.bbabio.2006.04.024; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Klingenspor M, 1996, BIOCHEM J, V316, P607, DOI 10.1042/bj3160607; Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOCKE RM, 1982, EUR J BIOCHEM, V129, P373, DOI 10.1111/j.1432-1033.1982.tb07060.x; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Mzilikazi N, 2007, AM J PHYSIOL-REG I, V293, pR2120, DOI 10.1152/ajpregu.00427.2007; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; RATNER PL, 1981, J BIOL CHEM, V256, P3576; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; ROTHWELL NJ, 1983, ADV NUTR RES, V5, P201; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Shabalina IG, 2006, J BIOL CHEM, V281, P13882, DOI 10.1074/jbc.M601387200; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972	48	63	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21961	21968		10.1074/jbc.M110.122861	http://dx.doi.org/10.1074/jbc.M110.122861			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20466728	Green Published, hybrid			2022-12-25	WOS:000279702200008
J	Yeom, J; Imlay, JA; Park, W				Yeom, Jinki; Imlay, James A.; Park, Woojun			Iron Homeostasis Affects Antibiotic-mediated Cell Death in Pseudomonas Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLO-BETA-LACTAMASE; OXIDATIVE STRESS; DNA-DAMAGE; RESISTANCE; AERUGINOSA; MEMBRANE; VIRULENCE	Antibiotics can induce cell death via a variety of action modes, including the inhibition of transcription, ribosomal function, and cell wall biosynthesis. In this study, we demonstrated directly that iron availability is important to the action of antibiotics, and the ferric reductases of Pseudomonas putida and Pseudomonas aeruginosa could accelerate antibiotic-mediated cell death by promoting the Fenton reaction. The modulation of reduced nicotinamide-adenine dinucleotide (NADH) levels and iron chelation affected the actions of antibiotics. Interestingly, the deletion of the ferric reductase gene confers more antibiotic resistance upon cells, and its overexpression accelerates antibiotic-mediated cell death. The results of transcriptome analysis showed that both Pseudomonas species induce many oxidative stress genes under antibiotic conditions, which could not be observed in ferric reductase mutants. Our results indicate that iron homeostasis is crucial for bacterial cell survival under antibiotics and should constitute a significant target for boosting the action of antibiotics.	[Imlay, James A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Yeom, Jinki; Park, Woojun] Korea Univ, Div Environm Sci & Ecol Engn, Seoul 136713, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; Korea University	Imlay, JA (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	jimlay@illinois.edu; wpark@korea.ac.kr		Yeom, Jinki/0000-0002-5332-2658	MEST/NRF, South Korea [20090091491, 2009-0076488]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049640] Funding Source: NIH RePORTER	MEST/NRF, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 20090091491 from the MEST/NRF to the Environment Biotechnology National Core Research Center and Grant 2009-0076488 from the MEST/NRF program, South Korea.	Albesa I, 2004, BIOCHEM BIOPH RES CO, V317, P605, DOI 10.1016/j.bbrc.2004.03.085; Angrave FE, 2001, ANTIMICROB AGENTS CH, V45, P2939, DOI 10.1128/AAC.45.10.2939-2942.2001; Banerjee R., 2008, REDOX BIOCH; BEERS RF, 1952, J BIOL CHEM, V195, P133; Cabiscol E, 2002, J BIOL CHEM, V277, P44531, DOI 10.1074/jbc.M206525200; Cornelis Pierre, 2008, P213; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Docquier JD, 2003, ANTIMICROB AGENTS CH, V47, P1522, DOI 10.1128/AAC.47.5.1522-1528.2003; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; ECKERT B, 1989, J BACTERIOL, V171, P3557, DOI 10.1128/JB.171.6.3557-3559.1989; Gomez MI, 2007, CURR OPIN PHARMACOL, V7, P244, DOI 10.1016/j.coph.2006.12.005; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Hassett DJ, 2007, ACS CHEM BIOL, V2, P708, DOI 10.1021/cb700232k; Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796; HEYM B, 1992, RES MICROBIOL, V143, P721, DOI 10.1016/0923-2508(92)90067-X; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jeannot K, 2008, ANTIMICROB AGENTS CH, V52, P2455, DOI 10.1128/AAC.01107-07; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; MICHEAHAMZEHPOUR M, 1991, ANTIMICROB AGENTS CH, V35, P2091, DOI 10.1128/AAC.35.10.2091; NORRIS MJ, 1985, LETT APPL MICROBIOL, V1, P3, DOI 10.1111/j.1472-765X.1985.tb01476.x; Page MGP, 2009, CURR OPIN PHARMACOL, V9, P558, DOI 10.1016/j.coph.2009.08.006; Perz JF, 2005, J CLIN MICROBIOL, V43, P5316, DOI 10.1128/JCM.43.10.5316-5318.2005; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P2889, DOI 10.1128/AAC.00398-06; Rolston KVI, 2005, DIAGN MICR INFEC DIS, V51, P215, DOI 10.1016/j.diagmicrobio.2004.11.002; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Singh NP, 1999, MUTAT RES-FUND MOL M, V429, P159, DOI 10.1016/S0027-5107(99)00124-4; THOMAS CM, 1998, PSEUDOMONAS, P133; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Yeom J, 2009, J BIOCHEM, V145, P481, DOI 10.1093/jb/mvn185; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08	35	85	89	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22689	22695		10.1074/jbc.M110.127456	http://dx.doi.org/10.1074/jbc.M110.127456			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20479007	Green Published, hybrid			2022-12-25	WOS:000279702200079
J	Alibaud, L; Alahari, A; Trivelli, X; Ojha, AK; Hatfull, GF; Guerardel, Y; Kremer, L				Alibaud, Laeticia; Alahari, Anuradha; Trivelli, Xavier; Ojha, Anil K.; Hatfull, Graham F.; Guerardel, Yann; Kremer, Laurent			Temperature-dependent Regulation of Mycolic Acid Cyclopropanation in Saprophytic Mycobacteria ROLE OF THE MYCOBACTERIUM SMEGMATIS 1351 GENE (MSMEG_1351) IN CIS-CYCLOPROPANATION OF alpha-MYCOLATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBERCULOSIS; BIOSYNTHESIS; DRUG; GENE; VIRULENCE; METHYLTRANSFERASE; IDENTIFICATION; THIACETAZONE; ADAPTATION; SMEGMATIS	The cell envelope is a crucial determinant of virulence and drug resistance in Mycobacterium tuberculosis. Several features of pathogenesis and immunomodulation of host responses are attributable to the structural diversity in cell wall lipids, particularly in the mycolic acids. Structural modification of the alpha-mycolic acid by introduction of cyclopropane rings as catalyzed by the methyltransferase, PcaA, is essential for a lethal, persistent infection and the cording phenotype in M. tuberculosis. Here, we demonstrate the presence of cyclopropanated cell wall mycolates in the nonpathogenic strain Mycobacterium smegmatis and identify MSMEG_1351 as a gene encoding a PcaA homologue. Interestingly, alpha-mycolic acid cyclopropanation was inducible in cultures grown at 25 degrees C. The growth temperature modulation of the cyclopropanating activity was determined by high resolution magic angle spinning NMR analyses on whole cells. In parallel, quantitative reverse transcription-PCR analysis showed that MSMEG_1351 gene expression is up-regulated at 25 degrees C compared with 37 degrees C. An MSMEG_1351 knock-out strain of M. smegmatis, generated by recombineering, exhibited a deficiency in cyclopropanation of alpha-mycolates. The functional equivalence of PcaA and MSMEG_1351 was established by cross-complementation in the MSMEG_1351 knock-out mutant and also in a Delta pcaA strain of Mycobacterium bovis BCG. Overexpression of MSMEG_1351 restored the wild-type mycolic acid profile and the cording phenotype in BCG. Although the biological significance of mycolic acid cyclopropanation in nonpathogenic mycobacteria remains unclear, it likely represents a mechanism of adaptation of cell wall structure and composition to cope with environmental factors.	[Alibaud, Laeticia; Alahari, Anuradha; Kremer, Laurent] Univ Montpellier II & I, CNRS, Lab Dynam Interact Membranaires Normales & Pathol, UMR 5235, F-34095 Montpellier 05, France; [Kremer, Laurent] INSERM, F-34095 Montpellier 05, France; [Trivelli, Xavier; Guerardel, Yann] Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, F-59650 Villeneuve Dascq, France; [Trivelli, Xavier; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Ojha, Anil K.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Hatfull, Graham F.] Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kremer, L (corresponding author), Univ Montpellier II & I, CNRS, Lab Dynam Interact Membranaires Normales & Pathol, UMR 5235, Case 107,Pl Eugene Bataillon, F-34095 Montpellier 05, France.	laurent.kremer@univ-montp2.fr	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Guerardel, Yann/0000-0003-4967-9512; Trivelli, Xavier/0000-0001-6775-9650	Tres Grands Equipements Resonnance Magnetique Nucleaire Tres Haut Champs [Fr3050]; CNRS; European Union (FEDER); Ministere Francais de l'Enseignement Superieur et de la Recherche; Region Nord-Pas de Calais; Universite Lille1-Sciences et Technologies	Tres Grands Equipements Resonnance Magnetique Nucleaire Tres Haut Champs; CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union (FEDER)(European Commission); Ministere Francais de l'Enseignement Superieur et de la Recherche; Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); Universite Lille1-Sciences et Technologies	This work was supported in part by Tres Grands Equipements Resonnance Magnetique Nucleaire Tres Haut Champs Fr3050.; Supported by a grant from the CNRS (Action Thematique Incitative sur Programme "Microbiologie Fondamentale").; We thank W. R. Jacobs and M. Glickman for the kind gift of BCG mc<SUP>2</SUP>2801. We also thank Christophe Biot for help in structural analyses and Benedicte Gauriat-Deroy from Thermo Fisher Scientific Electron for EI analyses of pyrolysis fragments. The 800 MHz NMR spectrometer was funded by European Union (FEDER), Ministere Francais de l'Enseignement Superieur et de la Recherche, Region Nord-Pas de Calais, Universite Lille1-Sciences et Technologies, and CNRS.	Alahari A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001343; Alahari A, 2009, MOL MICROBIOL, V71, P1263, DOI 10.1111/j.1365-2958.2009.06604.x; BABA T, 1989, J BIOCHEM-TOKYO, V106, P81, DOI 10.1093/oxfordjournals.jbchem.a122825; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Behr MA, 2000, J BACTERIOL, V182, P3394, DOI 10.1128/JB.182.12.3394-3399.2000; Bhowruth V, 2008, BIOCHEM SOC T, V36, P555, DOI 10.1042/BST0360555; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cronan JE, 2002, CURR OPIN MICROBIOL, V5, P202, DOI 10.1016/S1369-5274(02)00297-7; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; GEORGE KM, 1995, J BIOL CHEM, V270, P27292, DOI 10.1074/jbc.270.45.27292; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; Houben ENG, 2009, MOL MICROBIOL, V72, P41, DOI 10.1111/j.1365-2958.2009.06612.x; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Iivanainen E, 1999, J APPL MICROBIOL, V86, P673, DOI 10.1046/j.1365-2672.1999.00711.x; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; LARSEN MH, 2007, CURR PROTOC MICROBIO, P1; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Laval F, 2008, J BIOL CHEM, V283, P1419, DOI 10.1074/jbc.M708859200; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; LORIAN V, 1969, APPL MICROBIOL, V17, P559, DOI 10.1128/AEM.17.4.559-562.1969; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; MINNIKIN DE, 1972, LIPIDS, V7, P398, DOI 10.1007/BF02531510; Mitchison DA, 2004, FRONT BIOSCI-LANDMRK, V9, P1059, DOI 10.2741/1293; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Rao M, 2001, MICROBIOL-UK, V147, P1017, DOI 10.1099/00221287-147-4-1017; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Stratton HM, 2003, SYST APPL MICROBIOL, V26, P165, DOI 10.1078/072320203322345994; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; TOMIYASU I, 1982, J BACTERIOL, V151, P828, DOI 10.1128/JB.151.2.828-837.1982; TORIYAMA S, 1978, FEBS LETT, V95, P111, DOI 10.1016/0014-5793(78)80063-5; TORIYAMA S, 1980, J BIOCHEM-TOKYO, V88, P211; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; Zhang Y, 2006, DRUG DISCOV TODAY, V11, P21, DOI 10.1016/S1359-6446(05)03626-3	45	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21698	21707		10.1074/jbc.M110.125724	http://dx.doi.org/10.1074/jbc.M110.125724			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20457615	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000279516100057
J	Mittendorf, EA; Liu, Y; Tucker, SL; McKenzie, T; Qiao, N; Akli, S; Biernacka, A; Liu, Y; Meijer, L; Keyomarsi, K; Hunt, KK				Mittendorf, E. A.; Liu, Y.; Tucker, S. L.; McKenzie, T.; Qiao, N.; Akli, S.; Biernacka, A.; Liu, Y.; Meijer, L.; Keyomarsi, K.; Hunt, K. K.			A novel interaction between HER2/neu and cyclin E in breast cancer	ONCOGENE			English	Article						breast cancer; HER2/neu; cell cycle regulation; cyclin E	MOLECULAR-WEIGHT FORMS; RECEPTOR STATUS; EXPRESSION; OVEREXPRESSION; AMPLIFICATION; TRASTUZUMAB; INHIBITION; HER-2/NEU; C-ERBB-2; ANTIBODY	HER2/neu (HER2) and cyclin E are important prognostic indicators in breast cancer. As both are involved in cell cycle regulation we analyzed whether there was a direct interaction between the two. HER2 and cyclin E expression levels were determined in 395 breast cancer patients. Patients with HER2-overexpression and high levels of cyclin E had decreased 5-year disease-specific survival compared with low levels of cyclin E (14% versus 89%, P < 0.0001). In vitro studies were performed in which HER2-mediated activity in HER2-overexpressing breast cancer cell lines was downregulated by transfection with HER2 small interfering RNA or treatment with trastuzumab. Cyclin E expression levels were determined by western blot analysis, and functional effects analyzed using kinase assays, MTT assays were used to assess cell viability as a marker of proliferation and fluorescence-activated cell sorting analysis was used to determine cell cycle profiles. Decreased HER2-mediated signaling resulted in decreased expression of cyclin E, particularly the low molecular weight (LMW) isoforms. Decreased HER2 and LMW cyclin E expression had functional consequences, including decreased cyclin E-associated kinase activity and decreased proliferation, because of increased apoptosis and an increased accumulation of cells in the G1 phase. In vivo studies performed in a HER2-overexpressing breast cancer xenograft model confirmed the effects of trastuzumab on cyclin E expression. Given the relationship between HER2 and cyclin E, in vitro clonogenic assays were performed to assess combination therapy targeting both proteins. Isobologram analysis showed a synergistic interaction between the two agents (trastuzumab targeting HER2 and roscovitine targeting cyclin E). Taken together, these studies show that HER2-mediated signaling effects LMW cyclin E expression, which in turn deregulates the cell cycle. LMW cyclin E has prognostic and predictive roles in HER2-overexpressing breast cancer, warranting further study of its potential as a therapeutic target. Oncogene (2010) 29, 3896-3907; doi:10.1038/onc.2010.151; published online 10 May 2010	[Hunt, K. K.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Unit 444, Houston, TX 77030 USA; [Tucker, S. L.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat, Houston, TX 77030 USA; [Tucker, S. L.] Univ Texas MD Anderson Canc Ctr, Dept Computat Biol, Houston, TX 77030 USA; [Akli, S.; Biernacka, A.; Liu, Y.; Keyomarsi, K.; Hunt, K. K.] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Meijer, L.] CNRS, Biol Stn, Roscoff, France	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Centre National de la Recherche Scientifique (CNRS)	Hunt, KK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Unit 444, 1515 Holcombe Blvd, Houston, TX 77030 USA.	kkeyomar@mdanderson.org; khunt@mdanderson.org	Keyomarsi, Khandan/H-2716-2016	Keyomarsi, Khandan/0000-0002-5440-0849; , laurent/0000-0003-3511-4916	NIH [T32 CA009599, CA87458, 1K99CA133244-01]; AACR; Susan G Komen for the Cure [PDF0707621]; Clayton Foundation for Research; NCI [P50CA116199]; Susan G Komen Breast Cancer Foundation [BCTR0504200]; NATIONAL CANCER INSTITUTE [R01CA087548, R01CA152228, K99CA133244, T32CA009599, P50CA116199] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AACR; Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Clayton Foundation for Research; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH T32 CA009599 (Mittendorf); AACR (Mittendorf); Susan G Komen for the Cure PDF0707621 (Keyomarsi and Mittendorf); Clayton Foundation for Research (Keyomarsi); NIH CA87458 (Keyomarsi); NCI P50CA116199 (Keyomarsi); Susan G Komen Breast Cancer Foundation BCTR0504200 (Hunt) and NIH 1K99CA133244-01 (Mittendorf).	Akli S, 2004, CANCER RES, V64, P3198, DOI 10.1158/0008-5472.CAN-03-3672; Akli S, 2003, CANCER BIOL THER, V2, pS38; Akli S, 2007, CANCER RES, V67, P7212, DOI 10.1158/0008-5472.CAN-07-0599; BACUS SS, 1992, CANCER RES, V52, P2580; Brockhoff G, 2007, CELL PROLIFERAT, V40, P488, DOI 10.1111/j.1365-2184.2007.00449.x; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; DULIC V, 1993, P NATL ACAD SCI USA, V90, P11034, DOI 10.1073/pnas.90.23.11034; GUSTERSON BA, 1992, J CLIN ONCOL, V10, P1049, DOI 10.1200/JCO.1992.10.7.1049; Harwell RM, 2000, CANCER RES, V60, P481; KEYOMARSI K, 1994, CANCER RES, V54, P380; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Keyomarsi K, 1997, Prog Cell Cycle Res, V3, P171; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333; Le XF, 2006, CELL CYCLE, V5, P1654, DOI 10.4161/cc.5.15.3007; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; MCCANN AH, 1991, CANCER RES, V51, P3296; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Potemski P, 2006, J EXP CLIN CANC RES, V25, P59; Rao S, 1998, ONCOGENE, V17, P2393, DOI 10.1038/sj.onc.1202322; Roh H, 2000, CANCER RES, V60, P560; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Timms JF, 2002, ONCOGENE, V21, P6573, DOI 10.1038/sj.onc.1205847; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wingate H, 2005, J BIOL CHEM, V280, P15148, DOI 10.1074/jbc.M409789200; WRIGHT C, 1989, CANCER RES, V49, P2087; Yakes FM, 2002, CANCER RES, V62, P4132; Yang HY, 2000, J BIOL CHEM, V275, P24735, DOI 10.1074/jbc.C000147200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	36	40	45	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2010	29	27					3896	3907		10.1038/onc.2010.151	http://dx.doi.org/10.1038/onc.2010.151			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	621SL	20453888	Green Accepted			2022-12-25	WOS:000279603200003
J	George, EM; Izard, T; Anderson, SD; Brown, DT				George, Eric M.; Izard, Tina; Anderson, Stephen D.; Brown, David T.			Nucleosome Interaction Surface of Linker Histone H1c Is Distinct from That of H1(0)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-STRUCTURE; GLOBULAR DOMAIN; CRYSTAL-STRUCTURE; IN-VIVO; BINDING; DNA; LOCATION; FAMILY; FIBER; H5	The fully organized structure of the eukaryotic nucleosome remains unsolved, in part due to limited information regarding the binding site of the H1 or linker histone. The central globular domain of H1 is believed to interact with the nucleosome core at or near the dyad and to bind at least two strands of DNA. We utilized site-directed mutagenesis and in vivo photobleaching to identify residues that contribute to the binding of the globular domain of the somatic H1 subtype H1c to the nucleosome. As was previously observed for the H1(0) subtype, the binding residues for H1c are clustered on the surface of one face of the domain. Despite considerable structural conservation between the globular domains of these two subtypes, the locations of the binding sites identified for H1c are distinct from those of H1(0). We suggest that the globular domains of these two linker histone subtypes will bind to the nucleosome with distinct orientations that may contribute to higher order chromatin structure heterogeneity or to differences in dynamic interactions with other DNA or chromatin-binding proteins.	[George, Eric M.; Anderson, Stephen D.; Brown, David T.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Izard, Tina] Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL 33458 USA	University of Mississippi; University of Mississippi Medical Center; Scripps Research Institute	Brown, DT (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, 2500 N State St, Jackson, MS 39216 USA.	dbrown@umc.edu	George, Eric/ABE-2767-2020	George, Eric/0000-0002-6622-7369	Mississippi Functional Genomics Network, National Institutes of Health [RR016476]; National Center for Research Resources; National Science Foundation [MCB0235800]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Mississippi Functional Genomics Network, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant RR016476 from the Mississippi Functional Genomics Network, IDeA Networks of Biomedical Research Excellence Program of the National Center for Research Resources. This work was also supported by National Science Foundation Grant MCB0235800 (to D. T. B.).	ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; Becker M, 2005, MOL BIOL CELL, V16, P3887, DOI 10.1091/mbc.E05-04-0350; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Brown DT, 1996, NUCLEIC ACIDS RES, V24, P486, DOI 10.1093/nar/24.3.486; Brown DT, 1997, NUCLEIC ACIDS RES, V25, P5003, DOI 10.1093/nar/25.24.5003; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; CERF C, 1994, BIOCHEMISTRY-US, V33, P11079, DOI 10.1021/bi00203a004; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; COLE RD, 1987, INT J PEPT PROT RES, V30, P433; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Duggan MM, 2000, J MOL BIOL, V304, P21, DOI 10.1006/jmbi.2000.4205; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Grigoryev SA, 2009, P NATL ACAD SCI USA, V106, P13317, DOI 10.1073/pnas.0903280106; Haab BB, 2001, GENOME BIOL, V2; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Kepper N, 2008, BIOPHYS J, V95, P3692, DOI 10.1529/biophysj.107.121079; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MCBRYANT SJ, 2010, CELL RES, DOI DOI 10.1038/CR2010.35; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Ramakrishnan V, 1997, CRIT REV EUKAR GENE, V7, P215, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.20; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; STAYNOV DZ, 1988, EMBO J, V7, P3685, DOI 10.1002/j.1460-2075.1988.tb03250.x; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THOMAS H, 1999, ENTREP REGION DEV, V11, P317; Travers A, 1999, TRENDS BIOCHEM SCI, V24, P4, DOI 10.1016/S0968-0004(98)01339-5; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; van Holde KE., 1989, SPRINGER SERIES MOL; Wolffe A., 1998, CHROMATIN STRUCTURE; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Woodcock CL, 2005, NAT STRUCT MOL BIOL, V12, P639, DOI 10.1038/nsmb0805-639; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Yellajoshyula D, 2006, P NATL ACAD SCI USA, V103, P18568, DOI 10.1073/pnas.0606478103; Zhou YB, 1998, NATURE, V395, P402, DOI 10.1038/26521; Zlatanova J, 2008, TRENDS BIOCHEM SCI, V33, P247, DOI 10.1016/j.tibs.2008.04.001	56	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20891	20896		10.1074/jbc.M110.108639	http://dx.doi.org/10.1074/jbc.M110.108639			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20444700	Green Published, hybrid			2022-12-25	WOS:000279228600053
J	Krejci, P; Murakami, S; Prochazkova, J; Trantirek, L; Chlebova, K; Ouyang, ZF; Aklian, A; Smutny, J; Bryja, V; Kozubik, A; Wilcox, WR				Krejci, Pavel; Murakami, Shunichi; Prochazkova, Jirina; Trantirek, Lukas; Chlebova, Katarina; Ouyang, Zhufeng; Aklian, Anie; Smutny, Jiri; Bryja, Vitezslav; Kozubik, Alois; Wilcox, William R.			NF449 Is a Novel Inhibitor of Fibroblast Growth Factor Receptor 3 (FGFR3) Signaling Active in Chondrocytes and Multiple Myeloma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERK MAP KINASE; ACTIVATING MUTATIONS; PROLIFERATION; SURAMIN; PATHWAY; DIFFERENTIATION; ACHONDROPLASIA; ASSOCIATION; ANTAGONIST; EXPRESSION	The FGFR3 receptor tyrosine kinase represents an attractive target for therapy due to its role in several human disorders, including skeletal dysplasias, multiple myeloma, and cervical and bladder carcinomas. By using molecular library screening, we identified a compound named NF449 with inhibitory activity toward FGFR3 signaling. In cultured chondrocytes and murine limb organ culture, NF449 rescued FGFR3-mediated extracellular matrix loss and growth inhibition, which represent two major cellular phenotypes of aberrant FGFR3 signaling in cartilage. Similarly, NF449 antagonized FGFR3 action in the multiple myeloma cell lines OPM2 and KMS11, as evidenced by NF449-mediated reversal of ERK MAPK activation and transcript accumulation of CCL3 and CCL4 chemokines, both of which are induced by FGFR3 activation. In cell-free kinase assays, NF449 inhibited the kinase activity of both wild type and a disease-associated FGFR3 mutant (K650E) in a fashion that appeared non-competitive with ATP. Our data identify NF449 as a novel antagonist of FGFR3 signaling, useful for FGFR3 inhibition alone or in combination with inhibitors that target the ATP binding site.	[Krejci, Pavel; Aklian, Anie; Wilcox, William R.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Krejci, Pavel; Prochazkova, Jirina; Chlebova, Katarina; Smutny, Jiri; Bryja, Vitezslav; Kozubik, Alois] Masaryk Univ, Inst Expt Biol, Dept Anim Physiol & Immunol, CS-61137 Brno, Czech Republic; [Krejci, Pavel; Bryja, Vitezslav; Kozubik, Alois] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, CS-61265 Brno, Czech Republic; [Murakami, Shunichi; Ouyang, Zhufeng] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA; [Trantirek, Lukas] Univ Utrecht, Dept Chem, NL-3584 CH Utrecht, Netherlands; [Wilcox, William R.] UCLA Sch Med, Dept Pediat, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Case Western Reserve University; Utrecht University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Krejci, P (corresponding author), Cedars Sinai Med Ctr, Inst Med Genet, 8727 W 3rd St,Rm 203, Los Angeles, CA 90048 USA.	pavel.krejci@cshs.org	Medalova, Jirina/D-7528-2012; Bryja, Vít?zslav/H-1925-2014; Krejčí, Pavel/I-4285-2014; Trantirek, Lukas/F-9923-2014; Kozubík, Alois/H-1954-2014; Bryja, Vítězslav/P-4217-2019	Bryja, Vít?zslav/0000-0002-9136-5085; Bryja, Vítězslav/0000-0002-9136-5085; Krejci, Pavel/0000-0003-0618-9134	National Institutes of Health [5P01HD022657-21A, 1R01AR055556-01A209]; Multiple Myeloma Research Foundation; Ministry of Education, Youth, and Sports of the Czech Republic [MSM0021622430]; Grant Agency of the Czech Republic [301/09/0587, 204/09/H058]; Academy of Sciences of the Czech Republic [AVOZ50040507, AVOZ50040702]; Winnick Family Research Scholars Award; European Molecular Biology Organization; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE017406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Winnick Family Research Scholars Award; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P01HD022657-21A and 1R01AR055556-01A209 (to S. M.). This work was also supported by the Multiple Myeloma Research Foundation; Ministry of Education, Youth, and Sports of the Czech Republic Grant MSM0021622430; Grant Agency of the Czech Republic Grants 301/09/0587 and 204/09/H058; Academy of Sciences of the Czech Republic Grants AVOZ50040507 and AVOZ50040702; a Winnick Family Research Scholars Award (to W. R. W.); and a European Molecular Biology Organization Installation Grant (to V. B.).	Aikawa T, 2001, J BIOL CHEM, V276, P29347, DOI 10.1074/jbc.M101859200; Aviezer D, 2003, CURR DRUG TARGETS, V4, P353, DOI 10.2174/1389450033490993; Braun K, 2001, N-S ARCH PHARMACOL, V364, P285, DOI 10.1007/s002100100463; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Dailey L, 2003, J CELL BIOL, V161, P1053, DOI 10.1083/jcb.200302075; FIRSCHING A, 1995, CANCER RES, V55, P4957; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; Guzman-Aranguez A, 2008, EUR J PHARMACOL, V584, P72, DOI 10.1016/j.ejphar.2008.02.002; Hafner C, 2010, BRIT J DERMATOL, V162, P508, DOI 10.1111/j.1365-2133.2009.09488.x; Hafner C, 2006, J CLIN INVEST, V116, P2201, DOI 10.1172/JCI28163; Hausmann R, 2006, MOL PHARMACOL, V69, P2058, DOI 10.1124/mol.106.022665; Hernandez S, 2009, MODERN PATHOL, V22, P848, DOI 10.1038/modpathol.2009.46; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Intini D, 2001, BRIT J HAEMATOL, V114, P362, DOI 10.1046/j.1365-2141.2001.02957.x; Kassack MU, 2004, EUR J MED CHEM, V39, P345, DOI 10.1016/j.ejmech.2004.01.007; Kathir KM, 2006, BIOCHEMISTRY-US, V45, P899, DOI 10.1021/bi051389b; Krejci P, 2006, LEUKEMIA, V20, P1165, DOI 10.1038/sj.leu.2404202; Krejci P, 2005, J CELL SCI, V118, P5089, DOI 10.1242/jcs.02618; Krejci P, 2004, EXP CELL RES, V297, P152, DOI 10.1016/j.yexcr.2004.03.011; Krejci P, 2008, J CELL SCI, V121, P272, DOI 10.1242/jcs.017160; Krejci P, 2007, INVEST NEW DRUG, V25, P391, DOI 10.1007/s10637-007-9054-7; Krejci P, 2007, J BIOL CHEM, V282, P2929, DOI 10.1074/jbc.M606144200; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Lozano RM, 1998, J MOL BIOL, V281, P899, DOI 10.1006/jmbi.1998.1977; Manetti F, 2000, CURR PHARM DESIGN, V6, P1897, DOI 10.2174/1381612003398528; Masih-Khan E, 2006, BLOOD, V108, P3465, DOI 10.1182/blood-2006-04-017087; Meyer AN, 2008, CANCER RES, V68, P7362, DOI 10.1158/0008-5472.CAN-08-0575; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Muenke M, 1997, AM J HUM GENET, V60, P555; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; Plowright EE, 2000, BLOOD, V95, P992, DOI 10.1182/blood.V95.3.992.003k29_992_998; Qing J, 2009, J CLIN INVEST, V119, P1216, DOI 10.1172/JCI38017; Ronchetti D, 2001, ONCOGENE, V20, P3553, DOI 10.1038/sj.onc.1204465; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sola F, 1999, CANCER CHEMOTH PHARM, V43, P241, DOI 10.1007/s002800050890; Soto F, 1999, NEUROPHARMACOLOGY, V38, P141, DOI 10.1016/S0028-3908(98)00158-0; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yeh BK, 2002, MOL CELL BIOL, V22, P7184, DOI 10.1128/MCB.22.20.7184-7192.2002; Zamai M, 2002, BIOPHYS J, V82, P2652, DOI 10.1016/S0006-3495(02)75607-5	43	33	57	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20644	20653		10.1074/jbc.M109.083626	http://dx.doi.org/10.1074/jbc.M109.083626			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439987	Green Published, hybrid			2022-12-25	WOS:000279228600028
J	Yoshida, T; Gan, QO; Franke, AS; Ho, RY; Zhang, JF; Chen, YE; Hayashi, M; Majesky, MW; Somlyo, AV; Owens, GK				Yoshida, Tadashi; Gan, Qiong; Franke, Aaron S.; Ho, Ruoya; Zhang, Jifeng; Chen, Y. Eugene; Hayashi, Matsuhiko; Majesky, Mark W.; Somlyo, Avril V.; Owens, Gary K.			Smooth and Cardiac Muscle-selective Knock-out of Kruppel-like Factor 4 Causes Postnatal Death and Growth Retardation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL DIFFERENTIATION MARKERS; PLURIPOTENT STEM-CELLS; IN-VIVO; OXIDIZED PHOSPHOLIPIDS; CONDITIONAL DELETION; GOBLET CELLS; ALPHA-ACTIN; TRANSCRIPTION; KLF4; KRUPPEL-LIKE-FACTOR-4	Kruppel-like factor 4 (Klf4) is a transcription factor involved in differentiation and proliferation in multiple tissues. We demonstrated previously that tamoxifen-induced deletion of the Klf4 gene in mice accelerated neointimal formation but delayed down-regulation of smooth muscle cell differentiation markers in carotid arteries following injury. To further determine the role of Klf4 in the cardiovascular system, we herein derived mice deficient for the Klf4 gene in smooth and cardiac muscle using the SM22 alpha promoter (SM22 alpha-CreKI(+)/Klf4(loxP/loxP) mice). SM22 alpha-CreKI(+)/Klf4(loxP/loxP) mice were born at the expected Mendelian ratio, but they gradually died after birth. Although similar to 40% of SM22 alpha-CreKI(+)/Klf4(loxP/loxP) mice survived beyond postnatal day 28, they exhibited marked growth retardation. In wild-type mice, Klf4 was expressed in the heart from late embryonic development through adulthood, whereas it was not expressed in smooth muscle. No changes were observed in morphology or expression of smooth muscle cell differentiation markers in vessels of SM22 alpha-CreKI(+)/Klf4(loxP/loxP) mice. Of interest, cardiac output was significantly decreased in SM22 alpha-CreKI(+)/Klf4(loxP/loxP) mice, as determined by magnetic resonance imaging. Moreover, a lack of Klf4 in the heart resulted in the reduction in expression of multiple cardiac genes, including Gata4. In vivo chromatin immunoprecipitation assays on the heart revealed that Klf4 bound to the promoter region of the Gata4 gene. Results provide novel evidence that Klf4 plays a key role in late fetal and/or postnatal cardiac development.	[Yoshida, Tadashi; Hayashi, Matsuhiko] Keio Univ, Apheresis & Dialysis Ctr, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Somlyo, Avril V.; Owens, Gary K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Ctr Cardiovasc, Dept Internal Med, Med Ctr, Ann Arbor, MI 48109 USA; [Majesky, Mark W.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Majesky, Mark W.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	Keio University; University of Virginia; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Yoshida, T (corresponding author), Keio Univ, Apheresis & Dialysis Ctr, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan.	tayoshida-npr@umin.ac.jp	Hayashi, Matsuhiko/J-4748-2013		National Institutes of Health [P01HL19242, R01HL38854, R01HL57353]; American Heart Association [0635253N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093594, R01HL038854, P01HL019242, R01HL057353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL19242, R01HL38854, and R01HL57353 (to G. K. O.). This work was also supported by American Heart Association National Scientist Development Grant 0635253N (to T. Y.)	Adam PJ, 2000, J BIOL CHEM, V275, P37798, DOI 10.1074/jbc.M006323200; BRAUNWALD E, 1997, HEART DIS ATEXTBOOK; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Guittot SM, 2007, BIOL REPROD, V76, P85, DOI 10.1095/biolreprod.106.055137; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; Isbell DC, 2007, AM J PHYSIOL-HEART C, V293, pH3372, DOI 10.1152/ajpheart.00997.2007; JONES AW, 1973, J PHYSIOL-LONDON, V232, P247, DOI 10.1113/jphysiol.1973.sp010268; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Katz JP, 2002, DEVELOPMENT, V129, P2619; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu Y, 2003, J BIOL CHEM, V278, P48004, DOI 10.1074/jbc.M301902200; Ohara Y, 2006, BIOL PHARM BULL, V29, P410, DOI 10.1248/bpb.29.410; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; SOMLYO AP, 1974, J CELL BIOL, V61, P723, DOI 10.1083/jcb.61.3.723; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zhang JF, 2006, ARTERIOSCL THROM VAS, V26, pE23, DOI 10.1161/01.ATV.0000202661.61837.93; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200	36	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21175	21184		10.1074/jbc.M110.112482	http://dx.doi.org/10.1074/jbc.M110.112482			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439457	Green Published, hybrid			2022-12-25	WOS:000279228600080
J	Kuzontkoski, PM; Mulligan-Kehoe, MJ; Harris, BT; Israel, MA				Kuzontkoski, P. M.; Mulligan-Kehoe, M. J.; Harris, B. T.; Israel, M. A.			Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels	ONCOGENE			English	Article						ID4; MGP; angiogenesis; glioblastoma; vascularization	HUMAN-ENDOTHELIAL-CELLS; LOOP-HELIX PROTEINS; ID PROTEINS; TUMOR ANGIOGENESIS; ASTROCYTIC TUMORS; MESSENGER-RNA; BREAST-CANCER; IN-VITRO; EXPRESSION; DIFFERENTIATION	Inhibitor of differentiation-4 is highly expressed in glioblastoma multiforme (GBM). We report a novel pro-angiogenic function for inhibitor of differentiation-4 in the growth of glioblastoma xenografts. Tumor-derived cell cultures expressing elevated levels of ID4 produced enlarged xenografts in immunosuppressed mice that were better vascularized than corresponding control tumors and expressed elevated matrix GLA protein (MGP) that mediated enhanced tumor angiogenesis. Inhibition of MGP resulted in smaller and less vascularized xenografts. Our finding shows a novel function for ID4 in tumor angiogenesis, and identifies ID4 and MGP as possible therapeutic targets for GBM. Oncogene (2010) 29, 3793-3802; doi: 10.1038/onc.2010.147; published online 10 May 2010	[Kuzontkoski, P. M.; Israel, M. A.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Pediat, Lebanon, NH 03756 USA; [Kuzontkoski, P. M.; Israel, M. A.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Genet, Lebanon, NH 03756 USA; [Mulligan-Kehoe, M. J.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Surg, Vasc Sect, Lebanon, NH 03756 USA; [Harris, B. T.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Pathol, Lebanon, NH 03756 USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center	Israel, MA (corresponding author), Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Pediat, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Mark.A.Israel@Dartmouth.edu			Theodora B. Betz Foundation; Jordan & Kyra Foundation	Theodora B. Betz Foundation; Jordan & Kyra Foundation	Many thanks to Dr Kristina I Bostrom for lending her expertise, sharing reagents, and fielding generously many questions about MGP. This work was supported by funding from the Theodora B. Betz Foundation (MAI) and the Jordan & Kyra Foundation (MAI).	AndresBarquin PJ, 1997, CANCER RES, V57, P215; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Bellido M, 2003, HAEMATOLOGICA, V88, P994; Benezra R, 2001, ONCOGENE, V20, P8334, DOI 10.1038/sj.onc.1205160; Benezra R, 2001, TRENDS CARDIOVAS MED, V11, P237, DOI 10.1016/S1050-1738(01)00117-7; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Chan ASW, 2003, ONCOGENE, V22, P6946, DOI 10.1038/sj.onc.1206799; CHEN L, 1990, ONCOGENE, V5, P1391; de Candia P, 2006, HUM PATHOL, V37, P1032, DOI 10.1016/j.humpath.2006.03.004; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fontemaggi G, 2009, NAT STRUCT MOL BIOL, V16, P1086, DOI 10.1038/nsmb.1669; Havrda MC, 2008, J NEUROSCI, V28, P14074, DOI 10.1523/JNEUROSCI.3188-08.2008; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itahana Y, 2003, CANCER RES, V63, P7098; Jeon HM, 2008, GENE DEV, V22, P2028, DOI 10.1101/gad.1668708; Kargiotis O, 2006, J NEURO-ONCOL, V78, P281, DOI 10.1007/s11060-005-9097-6; Kleihues P., 1997, PATHOLOGY GENETICS T; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Lampugnani MG, 1999, METH MOL B, V96, P177; LEVEDAKOU EN, 1992, INT J CANCER, V52, P534, DOI 10.1002/ijc.2910520406; Liang Y, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-6; Ling MT, 2005, CARCINOGENESIS, V26, P1668, DOI 10.1093/carcin/bgi128; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Newman B, 2001, J CELL BIOL, V154, P659, DOI 10.1083/jcb.200106040; Ozawa T, 1998, IN VIVO, V12, P369; Proudfoot D, 2006, NEPHROLOGY, V11, P455, DOI 10.1111/j.1440-1797.2006.00660.x; Russell RG, 2004, CANCER RES, V64, P7220, DOI 10.1158/0008-5472.CAN-04-2095; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Sakurai D, 2004, J IMMUNOL, V173, P5801, DOI 10.4049/jimmunol.173.9.5801; Shan L, 2003, AM J PATHOL, V163, P2495, DOI 10.1016/S0002-9440(10)63604-8; Sikder H, 2003, CANCER CELL, V4, P291, DOI 10.1016/S1535-6108(03)00245-9; St Croix B, 2000, SCIENCE, V289, P1197; Umetani N, 2004, CLIN CANCER RES, V10, P7475, DOI 10.1158/1078-0432.CCR-04-0689; Umetani N, 2005, ONCOGENE, V24, P4721, DOI 10.1038/sj.onc.1208538; Vandeputte DAA, 2002, GLIA, V38, P329, DOI 10.1002/glia.10076; VERMEER C, 2001, PATENT COOPERATION T, P1; Volpert OV, 2002, CANCER CELL, V2, P473, DOI 10.1016/S1535-6108(02)00209-X; Wu QO, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-16; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Yun K, 2004, DEVELOPMENT, V131, P5441, DOI 10.1242/dev.01430	49	34	34	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 1	2010	29	26					3793	3802		10.1038/onc.2010.147	http://dx.doi.org/10.1038/onc.2010.147			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	618VW	20453881				2022-12-25	WOS:000279385200007
J	Lu, Y; Bertran, S; Samuels, TA; Mira-y-Lopez, R; Farias, EF				Lu, Y.; Bertran, S.; Samuels, T-A; Mira-y-Lopez, R.; Farias, E. F.			Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RAR alpha agonist AM580	ONCOGENE			English	Article						RAR alpha; RAR gamma; AM580; MMTV-neu; MMTV-wnt1; breast cancer	HUMAN-BREAST-CANCER; ACID RECEPTOR-ALPHA; CHANGES FOLLOWING DEPRIVATION; SQUAMOUS-CELL CARCINOMA; RETINOIC ACID; BETA-CATENIN; SIGNAL-TRANSDUCTION; TRANSGENIC MICE; EXPRESSION; GAMMA	We hypothesized that specific activation of a single retinoic acid receptor-alpha (RAR alpha), without direct and concurrent activation of RAR beta and gamma, will inhibit mammary tumor oncogenesis in murine models relevant to human cancer. A total of 50 uniparous mouse mammary tumor virus (MMTV)-neu and 50 nuliparous MMTV-wnt1 transgenic mice were treated with RAR alpha agonist (retinobenzoic acid, Am580) that was added to the diet for 40 (neu) and 35 weeks (wnt1), respectively. Among the shared antitumor effects was the inhibition of epithelial hyperplasia, a significant increase (P<0.05) in tumor-free survival and a reduction in tumor incidence and in the growth of established tumors. In both models, the mechanisms responsible for these effects involved inhibition of proliferation and survival pathways, and induction of apoptosis. The treatment was more effective in the MMTV-wnt1 model in which Am580 also induced differentiation, in both in vivo and three-dimensional (3D) cultures. In these tumors Am580 inhibited the wnt pathway, measured by loss of nuclear beta-catenin, suggesting partial oncogene dependence of therapy. Am580 treatment increased RAR beta and lowered the level of RAR gamma, an isotype whose expression we linked with tumor proliferation. The anticancer effect of RAR alpha, together with the newly discovered pro-proliferative role of RAR gamma, suggests that specific activation of RAR alpha and inhibition of RAR gamma might be effective in breast cancer therapy. Oncogene (2010) 29, 3665-3676; doi: 10.1038/onc.2010.119; published online 10 May 2010	[Lu, Y.; Bertran, S.; Samuels, T-A; Mira-y-Lopez, R.; Farias, E. F.] Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, Tisch Canc Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Farias, EF (corresponding author), Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, Tisch Canc Ctr, 1 Gustave Levy Pl, New York, NY 10029 USA.	Eduardo.farias@mssm.edu			NCI [R01-CA119018]; Samuel Waxman Cancer Research Foundation (SWCRF); NIH-NCI [5R24-CA095823-04]; NSF [DBI-972404]; NIH [1S10-RR0-9145-01]; NATIONAL CANCER INSTITUTE [R01CA119018, R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Samuel Waxman Cancer Research Foundation (SWCRF); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Drs W Muller and HE Varmus, respectively, for the gift of MMTV-neu and MMTV-wnt1 mice, Dr K Shudo for generous gift of AM580 in amounts sufficient to complete these extensive in vivo studies, and Drs L Ossowski, S Waxman and J Aguirre-Ghiso for helpful advice. This work was supported by the NCI Grant R01-CA119018, the Samuel Waxman Cancer Research Foundation (SWCRF) and the NIH-NCI shared resources Grant 5R24-CA095823-04, NSF Major Research Instrumentation Grant DBI-972404, the NIH shared instrumentation Grant 1S10-RR0-9145-01 to MSSM's Microscopy Shared Resources Facility.	ASTROM A, 1990, BIOCHEM BIOPH RES CO, V173, P339, DOI 10.1016/S0006-291X(05)81062-9; Berry DC, 2007, PPAR RES, V2007, DOI 10.1155/2007/73256; Borriello A, 2006, CANCER RES, V66, P4240, DOI 10.1158/0008-5472.CAN-05-2759; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Bukholm IK, 2000, J PATHOL, V190, P15; Cardiff RD, 1999, J MAMMARY GLAND BIOL, V4, P105, DOI 10.1023/A:1018712905244; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collins SJ, 2008, CURR OPIN HEMATOL, V15, P346, DOI 10.1097/MOH.0b013e3283007edf; Dankort DL, 2000, ONCOGENE, V19, P1038, DOI 10.1038/sj.onc.1203272; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DELESCLUSE C, 1991, MOL PHARMACOL, V40, P556; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Gantenbein-Ritter B, 2008, TISSUE ENG PART C-ME, V14, P353, DOI 10.1089/ten.tec.2008.0313; Gianni M, 2002, J BIOL CHEM, V277, P24859, DOI 10.1074/jbc.C200230200; HONG WK, 1990, NEW ENGL J MED, V323, P795, DOI 10.1056/NEJM199009203231205; KAGECHIKA H, 1988, J MED CHEM, V31, P2182, DOI 10.1021/jm00119a021; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Klaassen I, 2001, BRIT J CANCER, V85, P630, DOI 10.1054/bjoc.2001.1952; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; LOTAN R, 1995, J NATL CANCER I, V87, P1655, DOI 10.1093/jnci/87.22.1655; Marcotte R, 2008, J MAMMARY GLAND BIOL, V13, P323, DOI 10.1007/s10911-008-9087-3; MOON RC, 1990, METHOD ENZYMOL, V190, P395; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Noy N, 2007, BIOCHEMISTRY-US, V46, P13461, DOI 10.1021/bi7018699; Osanai M, 2005, MOL PHARMACOL, V67, P1808, DOI 10.1124/mol.104.005769; Ozpolat B, 2002, AM J HEMATOL, V70, P39, DOI 10.1002/ajh.10099; Paik J, 2003, CANCER INVEST, V21, P304, DOI 10.1081/CNV-120016425; Patatanian E, 2008, J CLIN PHARM THER, V33, P331, DOI 10.1111/j.1365-2710.2008.00935.x; Polakis P, 2000, GENE DEV, V14, P1837; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Radu M, 2008, J CELL PHYSIOL, V217, P558, DOI 10.1002/jcp.21532; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schneider SM, 2000, CANCER RES, V60, P5479; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shin DM, 2001, J CLIN ONCOL, V19, P3010, DOI 10.1200/JCO.2001.19.12.3010; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SPORN MB, 1976, FED PROC, V35, P1332; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Van heusden J, 1998, BRIT J CANCER, V77, P26, DOI 10.1038/bjc.1998.5; Veeck J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2151; Veeck J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-83; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; WARRELL RP, 1993, NEW ENGL J MED, V329, P177, DOI 10.1056/NEJM199307153290307; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; WOLBACH SB, 1978, NUTR REV, V36, P16; Wolf G, 2000, NUTR REV, V58, P211, DOI 10.1111/j.1753-4887.2000.tb01865.x; Wu JM, 2001, APOPTOSIS, V6, P377, DOI 10.1023/A:1011342220621	55	22	22	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2010	29	25					3665	3676		10.1038/onc.2010.119	http://dx.doi.org/10.1038/onc.2010.119			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	615CG	20453882	Green Accepted			2022-12-25	WOS:000279108600007
J	Dai, E; Liu, LY; Wang, H; McIvor, D; Sun, YM; Macaulay, C; King, E; Munuswamy-Ramanujam, G; Bartee, MY; Williams, J; Davids, J; Charo, I; McFadden, G; Esko, JD; Lucas, AR				Dai, Erbin; Liu, Li-Ying; Wang, Hao; McIvor, Dana; Sun, Yun Ming; Macaulay, Colin; King, Elaine; Munuswamy-Ramanujam, Ganesh; Bartee, Mee Yong; Williams, Jennifer; Davids, Jennifer; Charo, Israel; McFadden, Grant; Esko, Jeffrey D.; Lucas, Alexandra R.			Inhibition of Chemokine-Glycosaminoglycan Interactions in Donor Tissue Reduces Mouse Allograft Vasculopathy and Transplant Rejection	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INTERFERON-GAMMA RECEPTOR; HEPARAN-SULFATE; RENAL-TRANSPLANTATION; BINDING PROTEIN; CARDIAC GRAFTS; M-T7; HOMOLOG; ATHEROSCLEROSIS; OLIGOMERIZATION	Background: Binding of chemokines to glycosaminoglycans (GAGs) is classically described as initiating inflammatory cell migration and creating tissue chemokine gradients that direct local leukocyte chemotaxis into damaged or transplanted tissues. While chemokine-receptor binding has been extensively studied during allograft transplantation, effects of glycosaminoglycan (GAG) interactions with chemokines on transplant longevity are less well known. Here we examine the impact of interrupting chemokine-GAG interactions and chemokine-receptor interactions, both locally and systemically, on vascular disease in allografts. Methodology/Principal Findings: Analysis of GAG or CC chemokine receptor 2 (CCR2) deficiency were coupled with the infusion of viral chemokine modulating proteins (CMPs) in mouse aortic allograft transplants (n = 239 mice). Inflammatory cell invasion and neointimal hyperplasia were significantly reduced in N-deacetylase-N-sulfotransferase-1 (Ndst1(f/f)TekCre(+)) heparan sulfate (GAG)-deficient (Ndst1(-/-), p < 0.044) and CCR2-deficient (Ccr2(-/-), p < 0.04) donor transplants. Donor tissue GAG or CCR2 deficiency markedly reduced inflammation and vasculopathy, whereas recipient deficiencies did not. Treatment with three CMPs was also investigated; Poxviral M-T1 blocks CC chemokine receptor binding, M-T7 blocks C, CC, and CXC GAG binding, and herpesviral M3 binds receptor and GAG binding for all classes. M-T7 reduced intimal hyperplasia in wild type (WT) (Ccr2(+/+), p <= 0.003 and Ccr2(-/-), p <= 0.027) aortic allografts, but not in Ndst1(-/-) aortic allografts (p = 0.933). M-T1 and M3 inhibited WT (Ccr2(+/+) and Ndst1(+/+), p <= 0.006) allograft vasculopathy, but did not block vasculopathy in Ccr2(-/-) (p = 0.61). M-T7 treatment alone, even without immunosuppressive drugs, also significantly prolonged survival of renal allograft transplants (p <= 0.001). Conclusions/Significance: Interruption of chemokine-GAG interactions, even in the absence of chemokine-receptor blockade, is a highly effective approach to reduction of allograft rejection, reducing vascular inflammation and prolonging allograft survival. Although chemokines direct both local and systemic cell migration, interruption of inherent chemokine responses in the donor tissue unexpectedly had a greater therapeutic impact on allograft vasculopathy.	[Dai, Erbin; Liu, Li-Ying; Sun, Yun Ming; Munuswamy-Ramanujam, Ganesh; Lucas, Alexandra R.] Univ Western Ontario, Vasc Biol Res Grp, Robarts Res Inst, London, ON, Canada; [Wang, Hao; McIvor, Dana; McFadden, Grant; Lucas, Alexandra R.] Univ Western Ontario, Dept Med & Surg, London, ON, Canada; [Wang, Hao; McIvor, Dana; McFadden, Grant; Lucas, Alexandra R.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Dai, Erbin; Liu, Li-Ying; Munuswamy-Ramanujam, Ganesh; Bartee, Mee Yong; Williams, Jennifer; Lucas, Alexandra R.] Univ Florida, Div Cardiovasc Med, Gainesville, FL USA; [Dai, Erbin; Liu, Li-Ying; Munuswamy-Ramanujam, Ganesh; Bartee, Mee Yong; Williams, Jennifer; Davids, Jennifer; McFadden, Grant; Lucas, Alexandra R.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Sun, Yun Ming; Macaulay, Colin; King, Elaine] Viron Therapeut Inc, London, ON, Canada; [Charo, Israel] Gladstone Inst, San Francisco, CA USA; [Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Diego	Dai, E (corresponding author), Univ Western Ontario, Vasc Biol Res Grp, Robarts Res Inst, London, ON, Canada.	alexandra.lucas@medicine.ufl.edu	Munuswamy-Ramanujam, Ganesh/ABE-7225-2021	Munuswamy-Ramanujam, Ganesh/0000-0001-8021-601X; McFadden, Grant/0000-0002-2556-3526; Macaulay, Colin/0000-0003-0118-7674	National Institutes of Health American Recovery Act (ARRA, RC1) [1RC1HL100202-01]; Canadian Institutes of Health Research (CIHR) [MOP 577578]; American Heart Association Grant In Aid (GIA) [0855421 E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100202] Funding Source: NIH RePORTER	National Institutes of Health American Recovery Act (ARRA, RC1)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); American Heart Association Grant In Aid (GIA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was received from the National Institutes of Health American Recovery Act (ARRA, RC1) Grant # 1RC1HL100202-01, Canadian Institutes of Health Research (CIHR) - Grant # MOP 577578, and the American Heart Association Grant In Aid (GIA) Grant # 0855421 E. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2004, J IMMUNOL, V172, P767, DOI 10.4049/jimmunol.172.2.767; Alexis JD, 2008, J VASC RES, V45, P538, DOI 10.1159/000129688; Ali S, 2005, TRANSPLANTATION, V79, P672, DOI 10.1097/01.TP.0000155961.57664.DB; Bedard ELR, 2003, TRANSPLANTATION, V76, P249, DOI 10.1097/01.TP.0000061604.57432.E3; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Cheng O, 2006, AM J TRANSPLANT, V6, P2292, DOI 10.1111/j.1600-6143.2006.01493.x; Christopher K, 2002, J IMMUNOL, V169, P522, DOI 10.4049/jimmunol.169.1.522; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Cripps JG, 2005, INT IMMUNOPHARMACOL, V5, P1622, DOI 10.1016/j.intimp.2005.04.010; Da Silva CC, 2009, IMMUNOLOGY, V126, P394, DOI 10.1111/j.1365-2567.2008.02906.x; Dai EB, 2006, J BIOL CHEM, V281, P8041, DOI 10.1074/jbc.M509454200; David G, 1995, ATHEROSCLEROSIS, V118, pS57, DOI 10.1016/0021-9150(95)90074-8; Deng SP, 1996, TRANSPLANTATION, V61, P1300, DOI 10.1097/00007890-199605150-00003; Eefting D, 2009, J VASC SURG, V50, P152, DOI 10.1016/j.jvs.2009.03.027; Fairchild RL, 1997, TRANSPLANTATION, V63, P1807, DOI 10.1097/00007890-199706270-00018; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; Hancock WW, 2002, TRANSPLANTATION, V73, P1392, DOI 10.1097/00007890-200205150-00006; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Horiguchi K, 2002, J HEART LUNG TRANSPL, V21, P1090, DOI 10.1016/S1053-2498(02)00443-6; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Lalani AS, 1998, VIROLOGY, V250, P173, DOI 10.1006/viro.1998.9340; Lalani AS, 1997, J VIROL, V71, P4356, DOI 10.1128/JVI.71.6.4356-4363.1997; Libby P, 2001, IMMUNITY, V14, P387, DOI 10.1016/S1074-7613(01)00119-4; Lindow M, 2003, TRENDS PHARMACOL SCI, V24, P126, DOI 10.1016/S0165-6147(03)00033-6; Liu D, 2004, TRANSPLANTATION, V77, P1652, DOI 10.1097/01.TP.0000131173.52424.84; Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934; Lucas A, 2004, J IMMUNOL, V173, P4765, DOI 10.4049/jimmunol.173.8.4765; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Morita K, 2001, J IMMUNOL, V167, P2979, DOI 10.4049/jimmunol.167.5.2979; MOSSMAN K, 1995, J BIOL CHEM, V270, P3031, DOI 10.1074/jbc.270.7.3031; Mossman K, 1996, VIROLOGY, V215, P17, DOI 10.1006/viro.1996.0003; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Nickerson MM, 2009, ARTERIOSCL THROM VAS, V29, P1794, DOI 10.1161/ATVBAHA.109.194019; Papaioannou EG, 2004, SURG TODAY, V34, P668, DOI 10.1007/s00595-004-2795-4; Peters W, 2001, CURR OPIN LIPIDOL, V12, P175, DOI 10.1097/00041433-200104000-00011; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; RAMANUJAM GM, 2010, THROMB HAEMOSTASIS, V103, P545; Rivas-Caicedo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007066; RUSSELL ME, 1993, P NATL ACAD SCI USA, V90, P6086, DOI 10.1073/pnas.90.13.6086; Seet BT, 2001, P NATL ACAD SCI USA, V98, P9008, DOI 10.1073/pnas.171069398; STEVENS RR, 1993, TRANSPLANT P, V25, P382; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; van Berkel V, 2002, J CLIN INVEST, V109, P905, DOI 10.1172/JCI14358; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Zhao DXM, 2002, J IMMUNOL, V169, P1556, DOI 10.4049/jimmunol.169.3.1556	48	36	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10510	10.1371/journal.pone.0010510	http://dx.doi.org/10.1371/journal.pone.0010510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463901	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379800006
J	Kover, H; Bao, SW				Koever, Hania; Bao, Shaowen			Cortical Plasticity as a Mechanism for Storing Bayesian Priors in Sensory Perception	PLOS ONE			English	Article							EXPERIENCE; REPRESENTATION; VARIABILITY; INTEGRATION; MODULATION; CATEGORIES; DYNAMICS; INFANTS	Human perception of ambiguous sensory signals is biased by prior experiences. It is not known how such prior information is encoded, retrieved and combined with sensory information by neurons. Previous authors have suggested dynamic encoding mechanisms for prior information, whereby top-down modulation of firing patterns on a trial-by-trial basis creates short-term representations of priors. Although such a mechanism may well account for perceptual bias arising in the short-term, it does not account for the often irreversible and robust changes in perception that result from long-term, developmental experience. Based on the finding that more frequently experienced stimuli gain greater representations in sensory cortices during development, we reasoned that prior information could be stored in the size of cortical sensory representations. For the case of auditory perception, we use a computational model to show that prior information about sound frequency distributions may be stored in the size of primary auditory cortex frequency representations, read-out by elevated baseline activity in all neurons and combined with sensory-evoked activity to generate a percept that conforms to Bayesian integration theory. Our results suggest an alternative neural mechanism for experience-induced long-term perceptual bias in the context of auditory perception. They make the testable prediction that the extent of such perceptual prior bias is modulated by both the degree of cortical reorganization and the magnitude of spontaneous activity in primary auditory cortex. Given that cortical over-representation of frequently experienced stimuli, as well as perceptual bias towards such stimuli is a common phenomenon across sensory modalities, our model may generalize to sensory perception, rather than being specific to auditory perception.	[Koever, Hania; Bao, Shaowen] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kover, H (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	sbao@berkeley.edu			NIH [DC007883, DC009259]; Boehringer Ingelheim Fonds, Germany; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC007883, R01DC009259] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds, Germany(Boehringer Ingelheim); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study was supported by NIH grants DC007883 and DC009259. H. K. was supported by a predoctoral fellowship from Boehringer Ingelheim Fonds, Germany (http://www.bifonds.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BARLOW H, 2001, NETWORK, V12; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Feldman N. H., 2007, P 29 ANN C COGN SCI; FELDMAN NH, 2009, PSYCHOL REV IN PRESS; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; GRISHICK AR, 2010, COSYNE ABSTR 2010; Guenther FH, 1996, J ACOUST SOC AM, V100, P1111, DOI 10.1121/1.416296; Han YK, 2007, NAT NEUROSCI, V10, P1191, DOI 10.1038/nn1941; Insanally MN, 2009, J NEUROSCI, V29, P5456, DOI 10.1523/JNEUROSCI.5311-08.2009; Iverson P, 2003, COGNITION, V87, pB47, DOI 10.1016/S0010-0277(02)00198-1; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kim H, 2008, J COMPUT NEUROSCI, V24, P277, DOI 10.1007/s10827-007-0055-5; Kim H, 2009, J NEUROSCI, V29, P5163, DOI 10.1523/JNEUROSCI.0365-09.2009; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kossut M, 1998, EXP BRAIN RES, V123, P110, DOI 10.1007/s002210050551; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; KUHL PK, 1991, PERCEPT PSYCHOPHYS, V50, P93, DOI 10.3758/BF03212211; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; POWELL M J D, 1977, FAST ALGORITHM NONLI; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; SIMONCELLI E, 2009, OPTIMAL ESTIMA UNPUB; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	31	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10497	10.1371/journal.pone.0010497	http://dx.doi.org/10.1371/journal.pone.0010497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463967	Green Submitted, gold, Green Published			2022-12-25	WOS:000277379400030
J	Gomez-Diaz, E; Gonzalez-Solis, J				Gomez-Diaz, Elena; Gonzalez-Solis, Jacob			Trophic Structure in a Seabird Host-Parasite Food Web: Insights from Stable Isotope Analyses	PLOS ONE			English	Article							FEATHER MITES; DIET; SHEARWATERS; DISCRIMINATION; NITROGEN; BEHAVIOR; ECOLOGY; MODELS; CARBON; BIRDS	Ecological studies on food webs rarely include parasites, partly due to the complexity and dimensionality of host-parasite interaction networks. Multiple co-occurring parasites can show different feeding strategies and thus lead to complex and cryptic trophic relationships, which are often difficult to disentangle by traditional methods. We analyzed stable isotope ratios of C (C-13/C-12, delta C-13) and N (N-15/N-14, delta N-15) of host and ectoparasite tissues to investigate trophic structure in 4 co-occurring ectoparasites: three lice and one flea species, on two closely related and spatially segregated seabird hosts (Calonectris shearwaters). delta C-13 isotopic signatures confirmed feathers as the main food resource for the three lice species and blood for the flea species. All ectoparasite species showed a significant enrichment in delta N-15 relatively to the host tissue consumed (discrimination factors ranged from 2 to 5% depending on the species). Isotopic differences were consistent across multiple host-ectoparasite locations, despite of some geographic variability in baseline isotopic levels. Our findings illustrate the influence of both ectoparasite and host trophic ecology in the isotopic structuring of the Calonectris ectoparasite community. This study highlights the potential of stable isotope analyses in disentangling the nature and complexity of trophic relationships in symbiotic systems.	[Gomez-Diaz, Elena] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain; Univ Barcelona, Dept Biol Anim Vertebrats, Barcelona, Spain	University of Barcelona; University of Barcelona	Gomez-Diaz, E (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain.	elegomez@ub.edu	Gómez-Díaz, Elena/G-2503-2011; Gómez-Díaz, Elena/AAA-9141-2019; Gonzalez-Solis, Jacob/C-3942-2008; González-Solís, Jacob/AAB-1161-2019; Gonzalez-Solis, Jacob/AAZ-5338-2021	Gómez-Díaz, Elena/0000-0002-4146-9003; Gómez-Díaz, Elena/0000-0002-4146-9003; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gonzalez-Solis, Jacob/0000-0002-8691-9397	Generalitat de Catalunya; Ministerio de Educacion y Ciencia (MEyC); Ministerio de Ciencia e Innovacion and Fondo Europeo de Desarrollo Regional (FEDER) [CGL2006-01315/BOS]	Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Educacion y Ciencia (MEyC)(Spanish Government); Ministerio de Ciencia e Innovacion and Fondo Europeo de Desarrollo Regional (FEDER)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	E. G.-D. was supported by a postgraduate grant from the Generalitat de Catalunya and J.G.-S. was supported by the Program Ramon y Cajal funded by the Ministerio de Educacion y Ciencia (MEyC). Financial support was provided by the project CGL2006-01315/BOS from the Ministerio de Ciencia e Innovacion and Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 1999, J STAT COMPUT SIM, V62, P271, DOI 10.1080/00949659908811936; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Blanco G, 1997, J AVIAN BIOL, V28, P197, DOI 10.2307/3676970; Boag B, 1997, ISOT ENVIRON HEALT S, V33, P81, DOI 10.1080/10256019708036335; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; CLAYTON DH, 1995, PARASITOLOGY, V110, P195, DOI 10.1017/S0031182000063964; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Deudero S, 2002, DIS AQUAT ORGAN, V52, P77, DOI 10.3354/dao052077; Gomez-Diaz E, 2006, MOL PHYLOGENET EVOL, V41, P322, DOI 10.1016/j.ympev.2006.05.006; Gomez-Diaz E, 2008, ECOGRAPHY, V31, P477, DOI 10.1111/j.0906-7590.2008.05330.x; Gomez-Diaz E, 2007, ECOL APPL, V17, P1484, DOI 10.1890/06-1232.1; Hobson KA, 2005, DIVERS DISTRIB, V11, P157, DOI 10.1111/j.1366-9516.2005.00149.x; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hood-Nowotny R, 2007, ENTOMOL EXP APPL, V124, P3, DOI 10.1111/j.1570-7458.2007.00572.x; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; JANOVY J, 1997, PROTOZOA HELMINTHS A; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Magalhaes MC, 2008, MAR ECOL PROG SER, V359, P283, DOI 10.3354/meps07340; MARSHALL AG, 1981, ECOLOGY ECTOPARASITI; MEY E, 2006, B CHILENO ORNITOLOGI, V12, P30; MOLLER A, 2010, OECOLOGIA IN PRESS; Navarro J, 2009, BIOL LETTERS, V5, P545, DOI 10.1098/rsbl.2009.0150; Neilson R, 2005, PARASITOLOGY, V131, P279, DOI 10.1017/S0031182005007717; O'Grady SP, 2006, OECOLOGIA, V150, P355, DOI 10.1007/s00442-006-0487-z; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinnegar JK, 2001, J FISH BIOL, V59, P494, DOI 10.1006/jfbi.2001.1660; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Poulin R, 2008, TRENDS PARASITOL, V24, P24, DOI 10.1016/j.pt.2007.10.002; Price R. D., 2003, CHEWING LICE WORLD C; Proctor H, 2000, TRENDS ECOL EVOL, V15, P358, DOI 10.1016/S0169-5347(00)01924-8; Proctor HC, 2003, ANNU REV ENTOMOL, V48, P185, DOI 10.1146/annurev.ento.48.091801.112725; Raffel TR, 2008, TRENDS ECOL EVOL, V23, P610, DOI 10.1016/j.tree.2008.06.015; Weber DC, 2009, BIOL CONTROL, V51, P199, DOI 10.1016/j.biocontrol.2009.05.013	41	21	24	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10454	10.1371/journal.pone.0010454	http://dx.doi.org/10.1371/journal.pone.0010454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454612	Green Published, gold, Green Submitted			2022-12-25	WOS:000277305300005
J	Berny, MA; Munnix, ICA; Auger, JM; Schols, SEM; Cosemans, JMEM; Panizzi, P; Bock, PE; Watson, SP; McCarty, OJT; Heemskerk, JWM				Berny, Michelle A.; Munnix, Imke C. A.; Auger, Jocelyn M.; Schols, Saskia E. M.; Cosemans, Judith M. E. M.; Panizzi, Peter; Bock, Paul E.; Watson, Steve P.; McCarty, Owen J. T.; Heemskerk, Johan W. M.			Spatial Distribution of Factor Xa, Thrombin, and Fibrin(ogen) on Thrombi at Venous Shear	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FLOWING HUMAN BLOOD; IN-VIVO; PLATELET ACTIVATION; GAMMA-CHAIN; ANNEXIN-V; FIBRINOGEN; COMPLEX; COLLAGEN; BINDING	Background: The generation of thrombin is a critical process in the formation of venous thrombi. In isolated plasma under static conditions, phosphatidylserine (PS)-exposing platelets support coagulation factor activation and thrombin generation; however, their role in supporting coagulation factor binding under shear conditions remains unclear. We sought to determine where activated factor X (FXa), (pro) thrombin, and fibrin(ogen) are localized in thrombi formed under venous shear. Methodology/Principal Findings: Fluorescence microscopy was used to study the accumulation of platelets, FXa, (pro) thrombin, and fibrin(ogen) in thrombi formed in vitro and in vivo. Co-perfusion of human blood with tissue factor resulted in formation of visible fibrin at low, but not at high shear rate. At low shear, platelets demonstrated increased Ca(2+) signaling and PS exposure, and supported binding of FXa and prothrombin. However, once cleaved, (pro) thrombin was observed on fibrin fibers, covering the whole thrombus. In vivo, wild-type mice were injected with fluorescently labeled coagulation factors and venous thrombus formation was monitored in mesenteric veins treated with FeCl(3). Thrombi formed in vivo consisted of platelet aggregates, focal spots of platelets binding FXa, and large areas binding (pro) thrombin and fibrin(ogen). Conclusions/Significance: FXa bound in a punctate manner to thrombi under shear, while thrombin and fibrin(ogen) distributed ubiquitously over platelet-fibrin thrombi. During thrombus formation under venous shear, thrombin may relocate from focal sites of formation (on FXa-binding platelets) to dispersed sites of action (on fibrin fibers).	[Berny, Michelle A.; Munnix, Imke C. A.; Schols, Saskia E. M.; Cosemans, Judith M. E. M.; Heemskerk, Johan W. M.] Maastricht Univ, CARIM, Dept Biochem, Maastricht, Netherlands; [Berny, Michelle A.; McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Auger, Jocelyn M.; Watson, Steve P.] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Panizzi, Peter] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Panizzi, Peter; Bock, Paul E.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA	Maastricht University; Maastricht University Medical Centre (MUMC); Oregon Health & Science University; University of Birmingham; Harvard University; Massachusetts General Hospital; Vanderbilt University	Berny, MA (corresponding author), Maastricht Univ, CARIM, Dept Biochem, Maastricht, Netherlands.	mccartyo@ohsu.edu; jwm.heemskerk@biochem.unimaas.nl	Watson, Stephen P/Q-6292-2016; Panizzi, Peter/A-6072-2019; Heemskerk, Johan/AAM-8323-2021; Cosemans, Judith MEM/C-8161-2016	Watson, Stephen P/0000-0002-7846-7423; Panizzi, Peter/0000-0003-0141-8807; Heemskerk, Johan/0000-0002-2848-5121; Cosemans, Judith MEM/0000-0001-7429-0109; Berny-Lang, Michelle/0000-0001-5889-4295	American Heart Association [09PRE2230117, 09GRNT2150003]; Netherlands Organization for Scientific Research [11-400-0076]; Wellcome Trust [073107]; National Institutes of Health [R37HL071544, RO1HL038779]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038779, R37HL071544, R00HL094533] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association (http://www.americanheart.org; M. A. B. - 09PRE2230117 and O.J.T.M. - 09GRNT2150003), the Netherlands Organization for Scientific Research (http://www.nwo.nl; J.W.M.H. and J.M.E.M.C. - 11-400-0076), the Wellcome Trust (http://www.wellcome.ac.uk; J.M.A. and S. P. W. - 073107), and the National Institutes of Health (http://www.nih.gov; P. E. B. - R37HL071544 and RO1HL038779 from the National Heart, Lung, and Blood Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2006, ARTERIOSCL THROM VAS, V26, P1738, DOI 10.1161/01.ATV.0000228844.65168.d1; Ahmad SS, 2003, J THROMB HAEMOST, V1, P2348, DOI 10.1046/j.1538-7836.2003.00428.x; Ahmad SS, 2003, J THROMB HAEMOST, V1, P48, DOI 10.1046/j.1538-7836.2003.00020.x; Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Beguin S, 1997, THROMB HAEMOSTASIS, V78, P590; Berny MA, 2008, ARTERIOSCL THROM VAS, V28, P329, DOI 10.1161/ATVBAHA.107.156273; BOCK PE, 1992, J BIOL CHEM, V267, P14974; Butenas S, 2001, THROMB HAEMOSTASIS, V86, P660, DOI 10.1055/s-0037-1616110; Celi A, 2003, J THROMB HAEMOST, V1, P60, DOI 10.1046/j.1538-7836.2003.t01-1-00033.x; COLLER BS, 1980, BLOOD, V55, P169; DACHARYPRIGENT J, 1995, BIOCHEMISTRY-US, V34, P11625, DOI 10.1021/bi00036a039; Dubois C, 2007, J CLIN INVEST, V117, P953, DOI 10.1172/JCI30537; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Furie B, 2007, J THROMB HAEMOST, V5, P12, DOI 10.1111/j.1538-7836.2007.02482.x; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Hemker HC, 2000, THROMB HAEMOSTASIS, V83, P589; INAUEN W, 1990, ARTERIOSCLEROSIS, V10, P607, DOI 10.1161/01.ATV.10.4.607; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kalia N, 2008, MICROCIRCULATION, V15, P325, DOI 10.1080/10739680701728822; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; Kaneko N, 1996, CLIN CHIM ACTA, V251, P65, DOI 10.1016/0009-8981(96)06294-8; Kuijpers MJE, 2008, MICROCIRCULATION, V15, P269, DOI 10.1080/10739680701653517; Leon C, 2004, BLOOD, V103, P594, DOI 10.1182/blood-2003-05-1385; Lovely RS, 2002, THROMB HAEMOSTASIS, V88, P26; Masuda J, 2004, THROMB HAEMOSTASIS, V91, P1129, DOI 10.1160/TH03-12-0778; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; MOSESSON MW, 1972, J BIOL CHEM, V247, P5223; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; NACHMAN RL, 1982, J CLIN INVEST, V69, P263, DOI 10.1172/JCI110448; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Ni HY, 2003, BLOOD, V102, P3609, DOI 10.1182/blood-2003-03-0850; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; TRACY PB, 1985, J BIOL CHEM, V260, P2119; van Lier M, 2008, THROMB HAEMOSTASIS, V99, P1068, DOI 10.1160/TH07-08-0528; Vanschoonbeek K, 2004, J THROMB HAEMOST, V2, P476, DOI 10.1111/j.1538-7933.2004.00618.x; WEISS HJ, 1986, J CLIN INVEST, V78, P1072, DOI 10.1172/JCI112663; Weitz JI, 1998, CIRCULATION, V97, P544; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	43	62	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10415	10.1371/journal.pone.0010415	http://dx.doi.org/10.1371/journal.pone.0010415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454680	gold, Green Published, Green Submitted			2022-12-25	WOS:000277240100022
J	Rodriguez-Calvo, T; Ojosnegros, S; Sanz-Ramos, M; Garcia-Arriaza, J; Escarmis, C; Domingo, E; Sevilla, N				Rodriguez-Calvo, Teresa; Ojosnegros, Samuel; Sanz-Ramos, Marta; Garcia-Arriaza, Juan; Escarmis, Cristina; Domingo, Esteban; Sevilla, Noemi			New Vaccine Design Based on Defective Genomes That Combines Features of Attenuated and Inactivated Vaccines	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; RECOMBINANT MEASLES VIRUSES; BINARY ETHYLENIMINE; IMMUNE-RESPONSES; CELL-CULTURES; IN-VIVO; FOOT; CATTLE; INFECTION; SWINE	Background: New vaccine designs are needed to control diseases associated with antigenically variable RNA viruses. Foot-and-mouth disease (FMD) is a highly contagious disease of livestock that inflicts severe economic losses. Although the current whole-virus chemically inactivated vaccine has proven effective, it has led to new outbreaks of FMD because of incomplete inactivation of the virus or the escape of infectious virus from vaccine production premises. We have previously shown that serial passages of FMD virus (FMDV) C-S8c1 at high multiplicity of infection in cell culture resulted in virus populations consisting of defective genomes that are infectious by complementation (termed C-S8p260). Principal Finding: Here we evaluate the immunogenicity of C-S8p260, first in a mouse model system to establish a proof of principle, and second, in swine, the natural host of FMDV C-S8c1. Mice were completely protected against a lethal challenge with FMDV C-S8c1, after vaccination with a single dose of C-S8p260. Pigs immunized with different C-S8p260 doses and challenged with FMDV C-S8c1 either did not develop any clinical signs or showed delayed and mild disease symptoms. C-S8p260 induced high titers of both FMDV-specific, neutralizing antibodies and activated FMDV-specific T cells in swine, that correlated with solid protection against FMDV. Conclusions: The defective virus-based vaccine did not produce detectable levels of transmissible FMDV. Therefore, a segmented, replication-competent form of a virus, such as FMDV C-S8p260, can provide the basis of a new generation of attenuated antiviral vaccines with two safety barriers. The design can be extended to any viral pathogen that encodes transacting gene products, allowing complementation between replication-competent, defective forms.	[Rodriguez-Calvo, Teresa; Sanz-Ramos, Marta; Sevilla, Noemi] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain; [Ojosnegros, Samuel; Sanz-Ramos, Marta; Garcia-Arriaza, Juan; Escarmis, Cristina; Domingo, Esteban] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Domingo, Esteban] CIBERehd, Barcelona, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Rodriguez-Calvo, T (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain.	sevilla@inia.es	GARCIA-ARRIAZA, JUAN/Q-6243-2017; Sevilla, Noemi/K-8648-2014; Rodriguez-Calvo, Teresa/A-6831-2010; Rodriguez-Calvo, Teresa/AAH-2365-2019; Domingo, Esteban/K-3937-2014	GARCIA-ARRIAZA, JUAN/0000-0002-5167-5724; Sevilla, Noemi/0000-0003-0118-0376; Domingo, Esteban/0000-0002-0573-1676; Ojosnegros, Samuel/0000-0002-9562-3264	Ministerio de Ciencia e Innovacion, Spain [AGL2004-0049, AGL2007-61374, CSD2006-07, BFU2008-02816/BMC]; European Union [FOOD-CT-2006-016236]; Instituto de Salud Carlos III; Fundacion Ramon Areces; Comunidad Autonoma de Madrid; Ministerio de Educacion y Ciencia	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Ramon Areces; Comunidad Autonoma de Madrid(Comunidad de Madrid); Ministerio de Educacion y Ciencia(Spanish Government)	This research was supported by grants AGL2004-0049, AGL2007-61374, CSD2006-07 and BFU2008-02816/BMC from Ministerio de Ciencia e Innovacion, Spain, and European Union, Network of Excellence, EPIZONE (Contract # FOOD-CT-2006-016236). CIBERehd (Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas) is funded by Instituto de Salud Carlos III. Work at Centro de Biologia Molecular "Severo Ochoa" (CISC-UAM) was supported by an institutional grant from Fundacion Ramon Areces. T.R-C. was supported by a contract from Comunidad Autonoma de Madrid; S.O. and M.S-R were supported by a predoctoral fellowship from the Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHNEMANN HG, 1975, ARCH VIROL, V47, P47, DOI 10.1007/BF01315592; BAHNEMANN HG, 1990, VACCINE, V8, P299, DOI 10.1016/0264-410X(90)90083-X; Barteling SJ, 2004, DEV BIOLOGICALS, V119, P449; BECK E, 1987, J VIROL, V61, P1621, DOI 10.1128/JVI.61.5.1621-1629.1987; Billeter MA, 2009, CURR TOP MICROBIOL, V329, P129; BUDOWSKY EI, 1991, VACCINE, V9, P319, DOI 10.1016/0264-410X(91)90057-D; Chinsangaram J, 1998, VACCINE, V16, P1516, DOI 10.1016/S0264-410X(98)00029-2; Chinsangaram J, 2003, J VIROL, V77, P1621, DOI 10.1128/JVI.77.2.1621-1625.2003; Collen T, 1998, VIRUS RES, V56, P125, DOI 10.1016/S0168-1702(98)00035-5; COLLEN T, 1991, J IMMUNOL, V146, P749; del Valle JR, 2007, J VIROL, V81, P10597, DOI 10.1128/JVI.00923-07; DIEZ J, 1990, VIRUS RES, V18, P3, DOI 10.1016/0168-1702(90)90084-O; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; Domingo E, 2004, FOOT AND MOUTH DISEASE: CURRENT PERSPECTIVES, P261; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Domingo E, 2003, VIRUS RES, V91, P47, DOI 10.1016/S0168-1702(02)00259-9; DOMINGO E, 1990, APPL VIROLOGY RES; DOUGHERTY E, 1968, AM J VET RES, V29, P693; Eble PL, 2007, VACCINE, V25, P1043, DOI 10.1016/j.vaccine.2006.09.066; Emonet SF, 2009, P NATL ACAD SCI USA, V106, P3473, DOI 10.1073/pnas.0900088106; EVANS DMA, 1985, NATURE, V314, P548, DOI 10.1038/314548a0; FRANCIS MJ, 1983, J HYG-CAMBRIDGE, V91, P329, DOI 10.1017/S0022172400060344; Galloway I. A., 1962, Bulletin de l'Office International des Epizooties, V57, P748; Garcia-Arriaza J, 2005, VIROLOGY, V335, P155, DOI 10.1016/j.virol.2005.02.012; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Garcia-Arriaza J, 2006, J MOL BIOL, V360, P558, DOI 10.1016/j.jmb.2006.05.027; Gonzalez-Lopez C, 2004, J VIROL, V78, P3319, DOI 10.1128/JVI.78.7.3319-3324.2004; Kitching RP, 2005, VET J, V169, P197, DOI 10.1016/j.tvjl.2004.06.001; KLEID DG, 1981, SCIENCE, V214, P1125, DOI 10.1126/science.6272395; KUPPER H, 1981, NATURE, V289, P555, DOI 10.1038/289555a0; Liniger M, 2009, VACCINE, V27, P3299, DOI 10.1016/j.vaccine.2009.01.057; Manrubia SC, 2006, EUROPHYS LETT, V74, P547, DOI 10.1209/epl/i2005-10560-9; Mason PW, 2003, VIRUS RES, V91, P9, DOI 10.1016/S0168-1702(02)00257-5; Mason PW, 1997, VIROLOGY, V227, P96, DOI 10.1006/viro.1996.8309; MATEU MG, 1988, VIROLOGY, V167, P113, DOI 10.1016/0042-6822(88)90060-8; MATEU MG, 1989, P NATL ACAD SCI USA, V86, P5883, DOI 10.1073/pnas.86.15.5883; MATEU MG, 1987, VIRUS RES, V8, P261, DOI 10.1016/0168-1702(87)90020-7; MCCULLOUGH KC, 1992, J VIROL, V66, P1835, DOI 10.1128/JVI.66.4.1835-1840.1992; McInerney GM, 2000, J GEN VIROL, V81, P1699, DOI 10.1099/0022-1317-81-7-1699; Minor PD, 2004, NAT REV MICROBIOL, V2, P473, DOI 10.1038/nrmicro906; Moraes MP, 2003, VACCINE, V22, P268, DOI 10.1016/S0264-410X(03)00560-7; MURPHY BR, 1996, VIROLOGY, P467; NICHOLSON, 1994, SYNTHETIC VACCINES; Pereira H. G., 1981, Virus diseases of food animals. Volume II, P333; Pluimers FH, 2002, REV SCI TECH OIE, V21, P711, DOI 10.20506/rst.21.3.1371; PORTER AG, 1993, J VIROL, V67, P6917, DOI 10.1128/JVI.67.12.6917-6921.1993; Rowlands DJ, 2003, VIRUS RES, V91, P1, DOI 10.1016/S0168-1702(02)00264-2; Rweyemamu MM, 1999, ADV VIRUS RES, V53, P111, DOI 10.1016/S0065-3527(08)60345-0; Salguero FJ, 2005, VIROLOGY, V332, P384, DOI 10.1016/j.virol.2004.11.005; Salt JS, 1996, EPIDEMIOL INFECT, V117, P349, DOI 10.1017/S0950268800001539; SALT JS, 1993, BRIT VET J, V149, P207, DOI 10.1016/S0007-1935(05)80168-X; Sanz-Ramos M, 2008, J VIROL, V82, P10465, DOI 10.1128/JVI.00825-08; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; SOBRINO F, 1983, VIROLOGY, V128, P310, DOI 10.1016/0042-6822(83)90258-1; SOBRINO F, 2004, FOOT AND MOUTH DIS C; Taboga O, 1997, J VIROL, V71, P2606, DOI 10.1128/JVI.71.4.2606-2614.1997; Tami C, 2003, J VIROL, V77, P1219, DOI 10.1128/JVI.77.2.1219-1226.2003; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Yang CF, 2005, J VIROL, V79, P12623, DOI 10.1128/JVI.79.20.12623-12634.2005; Zuniga A, 2007, VACCINE, V25, P2974, DOI 10.1016/j.vaccine.2007.01.064	61	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10414	10.1371/journal.pone.0010414	http://dx.doi.org/10.1371/journal.pone.0010414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454676	Green Published, gold			2022-12-25	WOS:000277240100021
J	Kasaragod, P; Venkatesan, R; Kiema, TR; Hiltunen, JK; Wierenga, RK				Kasaragod, Prasad; Venkatesan, Rajaram; Kiema, Tiila R.; Hiltunen, J. Kalervo; Wierenga, Rik K.			Crystal Structure of Liganded Rat Peroxisomal Multifunctional Enzyme Type 1 A FLEXIBLE MOLECULE WITH TWO INTERCONNECTED ACTIVE SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENOYL-COA HYDRATASE; BETA-OXIDATION; DELTA(3)-DELTA(2)-ENOYL-COA ISOMERASE; DELTA-3,DELTA-2-ENOYL-COA ISOMERASE; 3-HYDROXYACYL-COA DEHYDROGENASE; CROTONASE SUPERFAMILY; 2-ENOYL-COA HYDRATASE; ANGSTROM RESOLUTION; BIFUNCTIONAL ENZYME; LIVER PEROXISOMES	The crystal structure of the full-length rat peroxisomal multifunctional enzyme, type 1 (rpMFE1), has been determined at 2.8 angstrom resolution. This enzyme has three catalytic activities and two active sites. The N-terminal part has the crotonase fold, which builds the active site for the Delta(3),Delta(2)-enoyl-CoA isomerase and the Delta(2)-enoyl-CoA hydratase-1 catalytic activities, and the C-terminal part has the (3S)-hydroxyacyl-CoA dehydrogenase fold and makes the (3S)-hydroxyacyl-CoA dehydrogenase active site. rpMFE1 is a multidomain protein having five domains (A-E). The crystal structure of full-length rpMFE1 shows a flexible arrangement of the A-domain with respect to the B-E-domains. Because of a hinge region near the end of the A-domain, two different positions of the A-domain were observed for the two protein molecules (A and B) of the asymmetric unit. In the most closed conformation, the mode of binding of CoA is stabilized by domains A and B (helix-10), as seen in other crotonase fold members. Domain B, although functionally belonging to the N-terminal part, is found tightly associated with the C-terminal part, i.e. fixed to the E-domain. The two active sites of rpMFE1 are similar to 40 angstrom apart, separated by a tunnel, characterized by an excess of positively charged side chains. Comparison of the structures of rpMFE1 with the monofunctional crotonase and (3S)-hydroxyacyl-CoA dehydrogenase superfamily enzymes, as well as with the bacterial alpha(2)beta(2)-fatty acid oxidation multienzyme complex, reveals that this tunnel could be important for substrate channeling, as observed earlier on the basis of the kinetics of rpMFE1 purified from rat liver.	[Wierenga, Rik K.] Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland	University of Oulu; Finland National Institute for Health & Welfare; University of Oulu	Wierenga, RK (corresponding author), Univ Oulu, Bioctr Oulu, POB 3000, FI-90014 Oulu, Finland.	rik.wierenga@oulu.fi		Venkatesan, Rajaram/0000-0002-7257-1211	Academy of Finland; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work has been supported by a grant from the Academy of Finland and the Sigrid Juselius Foundation.	Atreya CE, 2003, J BIOL CHEM, V278, P28901, DOI 10.1074/jbc.M212689200; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barycki JJ, 1999, PROTEIN SCI, V8, P2010, DOI 10.1110/ps.8.10.2010; Barycki JJ, 2000, J BIOL CHEM, V275, P27186; Bhaumik P, 2005, CURR OPIN STRUC BIOL, V15, P621, DOI 10.1016/j.sbi.2005.10.010; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elcock AH, 1996, J MOL BIOL, V262, P370, DOI 10.1006/jmbi.1996.0520; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferdinandusse S, 2004, J LIPID RES, V45, P1104, DOI 10.1194/jlr.M300512-JLR200; Filppula SA, 1998, J BIOL CHEM, V273, P349, DOI 10.1074/jbc.273.1.349; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gurvitz A, 1998, J BIOL CHEM, V273, P31366, DOI 10.1074/jbc.273.47.31366; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; Hiltunen JK, 2000, BBA-MOL CELL BIOL L, V1484, P117, DOI 10.1016/S1388-1981(00)00013-5; Hofstein HA, 1999, BIOCHEMISTRY-US, V38, P9508, DOI 10.1021/bi990506y; Holden HM, 1998, CURR OPIN STRUC BIOL, V8, P679, DOI 10.1016/S0959-440X(98)80086-9; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Kiema TR, 1999, BIOCHEMISTRY-US, V38, P2991, DOI 10.1021/bi981646v; Kiema TR, 2002, BIOCHEM J, V367, P433, DOI 10.1042/BJ20020292; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kurosawa T, 2001, STEROIDS, V66, P107, DOI 10.1016/S0039-128X(00)00217-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mursula AM, 2004, FEBS LETT, V557, P81, DOI 10.1016/S0014-5793(03)01450-9; Nguyen SD, 2008, BBA-MOL CELL BIOL L, V1781, P400, DOI 10.1016/j.bbalip.2008.06.004; PALOSAARI PM, 1990, J BIOL CHEM, V265, P2446; PALOSAARI PM, 1991, J BIOL CHEM, V266, P10750; Partanen ST, 2004, J MOL BIOL, V342, P1197, DOI 10.1016/j.jmb.2004.07.039; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; Savolainen K, 2004, HUM MOL GENET, V13, P955, DOI 10.1093/hmg/ddh107; Taskinen JP, 2006, J MOL BIOL, V355, P734, DOI 10.1016/j.jmb.2005.10.085; Taskinen JP, 2002, ACTA CRYSTALLOGR D, V58, P690, DOI 10.1107/S0907444902001890; Tsuchiya D, 2006, STRUCTURE, V14, P237, DOI 10.1016/j.str.2005.10.011; Xu RF, 1996, BIOCHEM BIOPH RES CO, V221, P271, DOI 10.1006/bbrc.1996.0585; YANG SY, 1986, J BIOL CHEM, V261, P5390; Zhang DY, 2002, J BIOL CHEM, V277, P9127, DOI 10.1074/jbc.M112228200	47	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24089	24098		10.1074/jbc.M110.117606	http://dx.doi.org/10.1074/jbc.M110.117606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20463028	Green Published, hybrid			2022-12-25	WOS:000280291400059
J	Foti, JJ; DeLucia, AM; Joyce, CM; Walker, GC				Foti, James J.; DeLucia, Angela M.; Joyce, Catherine M.; Walker, Graham C.			UmuD(2) Inhibits a Non-covalent Step during DinB-mediated Template Slippage on Homopolymeric Nucleotide Runs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY DNA-POLYMERASE; ERROR-FREE BYPASS; Y-FAMILY; ESCHERICHIA-COLI; FRAMESHIFT MUTATION; ABASIC LESION; MUTAGENESIS; FIDELITY; MISALIGNMENT; REPLICATION	Escherichia coli DinB (DNA polymerase IV) possesses an enzyme architecture resulting in specialized lesion bypass function and the potential for creating -1 frameshifts in homopolymeric nucleotide runs. We have previously shown that the mutagenic potential of DinB is regulated by the DNA damage response protein UmuD(2). In the current study, we employ a pre-steady-state fluorescence approach to gain a mechanistic understanding of DinB regulation by UmuD(2). Our results suggest that DinB, like its mammalian and archaeal orthologs, uses a template slippage mechanism to create single base deletions on homopolymeric runs. With 2-aminopurine as a fluorescent reporter in the DNA substrate, the template slippage reaction results in a prechemistry fluorescence change that is inhibited by UmuD(2). We propose a model in which DNA templates containing homopolymeric nucleotide runs, when bound to DinB, are in an equilibrium between non-slipped and slipped conformations. UmuD(2), when bound to DinB, displaces the equilibrium in favor of the non-slipped conformation, thereby preventing frameshifting and potentially enhancing DinB activity on non-slipped substrates.	[Foti, James J.; Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA; [DeLucia, Angela M.; Joyce, Catherine M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Massachusetts Institute of Technology (MIT); Yale University	Walker, GC (corresponding author), MIT, Dept Biol, 68-633,77 Massachusetts Ave, Cambridge, MA 02139 USA.	gwalker@mit.edu		/0000-0001-7243-8261	National Institutes of Health [R01 GM28550, R01 CA021615, F32 GM079885, P30 ES002019]; NATIONAL CANCER INSTITUTE [R01CA021615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028550, F32GM079885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM28550 (to C.M.J.), R01 CA021615 (to G. C. W.), F32 GM079885 (to J.J.F.), and P30 ES002019 (to the MIT Center for Environmental Health Sciences).	Bauer J, 2007, P NATL ACAD SCI USA, V104, P14905, DOI 10.1073/pnas.0700717104; BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946; Bebenek K, 2008, EMBO REP, V9, P459, DOI 10.1038/embor.2008.33; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; Boudsocq F, 2004, J BIOL CHEM, V279, P32932, DOI 10.1074/jbc.M405249200; CAIRNS J, 1991, GENETICS, V128, P695; CUPPLES CG, 1990, GENETICS, V125, P275; DeLucia AM, 2007, BIOCHEMISTRY-US, V46, P10790, DOI 10.1021/bi7006756; Efrati E, 1997, J BIOL CHEM, V272, P2559; FRIEDBERG EC, 2005, DNA REPAIR MUTAGENES, P509; Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Jarosz DF, 2009, P NATL ACAD SCI USA, V106, P21137, DOI 10.1073/pnas.0907257106; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Jia L, 2008, NUCLEIC ACIDS RES, V36, P6571, DOI 10.1093/nar/gkn719; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Ogi T, 1999, GENES CELLS, V4, P607, DOI 10.1046/j.1365-2443.1999.00289.x; Ohashi E, 2000, GENE DEV, V14, P1589; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Potapova O, 2002, J BIOL CHEM, V277, P28157, DOI 10.1074/jbc.M202607200; Rachofsky EL, 2001, BIOCHEMISTRY-US, V40, P946, DOI 10.1021/bi001664o; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Shen X, 2002, J BIOL CHEM, V277, P5265, DOI 10.1074/jbc.M109575200; SIMMONS LA, 2008, ECOSAL ESCHERICHIA C; Simon SM, 2008, P NATL ACAD SCI USA, V105, P1152, DOI 10.1073/pnas.0706067105; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Sutton MD, 2001, P NATL ACAD SCI USA, V98, P8342, DOI 10.1073/pnas.111036998; Tippin B, 2004, J BIOL CHEM, V279, P45360, DOI 10.1074/jbc.M408600200; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Wilson RC, 2008, MOL CELL, V29, P767, DOI 10.1016/j.molcel.2008.01.014; Wolfle WT, 2003, GENE DEV, V17, P2191, DOI 10.1101/gad.1108603; WOODGATE R, 1991, MOL GEN GENET, V229, P10, DOI 10.1007/BF00264207; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147	42	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23084	23093		10.1074/jbc.M110.115774	http://dx.doi.org/10.1074/jbc.M110.115774			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20467052	hybrid, Green Published			2022-12-25	WOS:000279999900043
J	Berube, J; Roussel, L; Nattagh, L; Rousseau, S				Berube, Julie; Roussel, Lucie; Nattagh, Leila; Rousseau, Simon			Loss of Cystic Fibrosis Transmembrane Conductance Regulator Function Enhances Activation of p38 and ERK MAPKs, Increasing Interleukin-6 Synthesis in Airway Epithelial Cells Exposed to Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE PRODUCTION; SIGNALING PATHWAYS; KINASE CASCADE; PHOSPHORYLATION; MYD88; INFECTIONS; GENERATION; EXPRESSION; TRANSPORT; TARGETS	In cystic fibrosis (CF), the absence of functional cystic fibrosis transmembrane conductance regulator (CFTR) translates into chronic bacterial infection, excessive inflammation, tissue damage, impaired lung function and eventual death. Understanding the mechanisms underlying this vicious circle of inflammation is important to design better therapies for CF. We found in CF lung biopsies increased immunoreactivity for p38 MAPK activity markers. Moreover, when compared with their non-CF counterpart, airway epithelial cells expressing the most common mutation in CF (CFTR Delta F508) were more potent at inducing neutrophil chemotaxis through increased interleukin (IL)-6 synthesis when challenged with Pseudomonas aeruginosa diffusible material. We then discovered that in CFTR Delta F508cells, the p38 and ERK MAPKs are hyperactivated in response to P. aeruginosa diffusible material, leading to increased IL-6 mRNA expression and stability. Moreover, although TLR5 contributes to p38 MAPK activation upon P. aeruginosa challenge, it only played a weak role in IL-6 synthesis. Instead, we found that the production of reactive oxygen species is essential for IL-6 synthesis in response to P. aeruginosa diffusible material. Finally, we uncovered that in CFTR Delta F508 cells, the extracellular glutathione levels are decreased, leading to a greater sensitivity to reactive oxygen species, providing an explanation for the hyperactivation of the p38 and ERK MAPKs and increased IL-6 synthesis. Taken together, our study has characterized a mechanism whereby the CFTR Delta F508 mutation in airway epithelial cells contributes to increase inflammation of the airways.	[Berube, Julie; Roussel, Lucie; Nattagh, Leila; Rousseau, Simon] McGill Univ, Meakins Christie Labs, Heath Ctr, Res Inst, Montreal, PQ H2X 2P2, Canada	McGill University	Rousseau, S (corresponding author), McGill Univ, Meakins Christie Labs, Heath Ctr, Res Inst, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.	simon.rousseau@mcgill.ca	Rousseau, Simon/A-1800-2009	Rousseau, Simon/0000-0002-8773-575X	Canadian Cystic Fibrosis Foundation; Department of Medicine, McGill University; McGill University Health Centre Research Institute (MUHC-RI); Canadian Foundation for Innovation-leaders; Les Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Cystic Fibrosis Foundation; Department of Medicine, McGill University; McGill University Health Centre Research Institute (MUHC-RI); Canadian Foundation for Innovation-leaders; Les Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a Canadian Cystic Fibrosis Foundation research grant (to S.R.); the Department of Medicine, McGill University; the McGill University Health Centre Research Institute (MUHC-RI); and the Canadian Foundation for Innovation-leaders opportunities funds. The Meakins-Christie Laboratories, MUHC-RI, are supported by a Centre grant from Les Fonds de la Recherche en Sante du Quebec (FRSQ).; Recipient of a postdoctoral fellowship from the FRSQ.; Recipient of a salary award from the FRSQ. To whom correspondence should be addressed: Meakins-Christie Laboratories, 3626 St-Urbain, Montreal, Quebec H2X 2P2, Canada. Tel.: 514-398-3864; Fax: 514-398-7483; E-mail: simon.rousseau@mcgill.ca.	Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Berube J, 2009, CELL SIGNAL, V21, P448, DOI 10.1016/j.cellsig.2008.12.001; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bonfield TL, 1999, J ALLERGY CLIN IMMUN, V104, P72, DOI 10.1016/S0091-6749(99)70116-8; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kelley TJ, 1998, J CLIN INVEST, V102, P1200, DOI 10.1172/JCI2357; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ratner AJ, 2001, J BIOL CHEM, V276, P19267, DOI 10.1074/jbc.M007703200; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Schwiebert LM, 1999, AM J PHYSIOL-CELL PH, V276, pC700, DOI 10.1152/ajpcell.1999.276.3.C700; Shapiro L, 1995, P NATL ACAD SCI USA, V92, P12230, DOI 10.1073/pnas.92.26.12230; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wedzicha JA, 2002, CHEST, V121, p136S, DOI 10.1378/chest.121.5_suppl.136S; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Wu Q, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-26; Yan FG, 2008, BIOCHEM BIOPH RES CO, V366, P513, DOI 10.1016/j.bbrc.2007.11.172; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025	47	62	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22299	22307		10.1074/jbc.M109.098566	http://dx.doi.org/10.1074/jbc.M109.098566			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460375	Green Published, hybrid			2022-12-25	WOS:000279702200043
J	Chou, S; Jensen, BC; Parsons, M; Alber, T; Grundner, C				Chou, Seemay; Jensen, Bryan C.; Parsons, Marilyn; Alber, Tom; Grundner, Christoph			The Trypanosoma brucei Life Cycle Switch TbPTP1 Is Structurally Conserved and Dephosphorylates the Nucleolar Protein NOPP44/46	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHORYLATED PROTEINS; RIBOSOME BIOGENESIS; KINASE; PHOSPHATASE; PESCADILLO; BINDING; DIFFERENTIATION; LOCALIZATION; PURIFICATION; SPECIFICITY	Trypanosoma brucei adapts to changing environments as it cycles through arrested and proliferating stages in the human and tsetse fly hosts. Changes in protein tyrosine phosphorylation of several proteins, including NOPP44/46, accompany T. brucei development. Moreover, inactivation of T. brucei protein-tyrosine phosphatase 1 (TbPTP1) triggers differentiation of bloodstream stumpy forms into tsetse procyclic forms through unknown downstream effects. Here, we link these events by showing that NOPP44/46 is a major substrate of TbPTP1. TbPTP1 substrate-trapping mutants selectively enrich NOPP44/46 from procyclic stage cell lysates, and TbPTP1 efficiently and selectively dephosphorylates NOPP44/46 in vitro. To provide insights into the mechanism of NOPP44/46 recognition, we determined the crystal structure of TbPTP1. The TbPTP1 structure, the first of a kinetoplastid protein-tyrosine phosphatase (PTP), emphasizes the conservation of the PTP fold, extending to one of the most diverged eukaryotes. The structure reveals surfaces that may mediate substrate specificity and affords a template for the design of selective inhibitors to interfere with T. brucei transmission.	[Chou, Seemay; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chou, Seemay; Alber, Tom] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Jensen, Bryan C.; Parsons, Marilyn; Grundner, Christoph] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Parsons, Marilyn; Grundner, Christoph] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Grundner, C (corresponding author), 307 Westlake Ave N,Ste 500, Seattle, WA 98109 USA.	christoph.grundner@sbri.org		Parsons, Marilyn/0000-0003-3994-8096	National Institutes of Health [R01 AI31077]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI31077 (to M. P.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Das A, 1996, J BIOL CHEM, V271, P15675, DOI 10.1074/jbc.271.26.15675; Das A, 1998, J CELL SCI, V111, P2615; Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014; Fevre EM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000333; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Garcia-Salcedo JA, 2002, MOL MICROBIOL, V45, P307, DOI 10.1046/j.1365-2958.2002.03019.x; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hellman K, 2007, EUKARYOT CELL, V6, P2206, DOI 10.1128/EC.00176-07; Inder KL, 2009, J BIOL CHEM, V284, P28410, DOI 10.1074/jbc.M109.001537; Jensen BC, 2005, EUKARYOT CELL, V4, P30, DOI 10.1128/EC.4.1.30-35.2005; Jensen BC, 2007, MOL BIOCHEM PARASIT, V151, P28, DOI 10.1016/j.molbiopara.2006.10.002; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Maiorana A, 2004, ONCOGENE, V23, P7116, DOI 10.1038/sj.onc.1207916; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; Muller IB, 2002, MOL BIOL CELL, V13, P3787, DOI 10.1091/mbc.E02-02-0093; Nett IRE, 2009, EUKARYOT CELL, V8, P617, DOI 10.1128/EC.00366-08; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Park JH, 2002, MOL BIOCHEM PARASIT, V119, P97, DOI 10.1016/S0166-6851(01)00407-8; Park JH, 2001, J CELL SCI, V114, P173; PARSONS M, 1991, MOL BIOCHEM PARASIT, V45, P241, DOI 10.1016/0166-6851(91)90091-J; PARSONS M, 1994, MOL BIOCHEM PARASIT, V63, P69, DOI 10.1016/0166-6851(94)90009-4; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Szoor B, 2006, J CELL BIOL, V175, P293, DOI 10.1083/jcb.200605090; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Worthen C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000678; ZHANG ZY, 1992, J BIOL CHEM, V267, P23759; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	44	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22075	22081		10.1074/jbc.M110.108860	http://dx.doi.org/10.1074/jbc.M110.108860			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20444707	Green Published, hybrid			2022-12-25	WOS:000279702200020
J	Cogoi, S; Paramasivam, M; Membrino, A; Yokoyama, KK; Xodo, LE				Cogoi, Susanna; Paramasivam, Manikandan; Membrino, Alexandro; Yokoyama, Kazunari K.; Xodo, Luigi E.			The KRAS Promoter Responds to Myc-associated Zinc Finger and Poly(ADP-ribose) Polymerase 1 Proteins, Which Recognize a Critical Quadruplex-forming GA-element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEASE HYPERSENSITIVE ELEMENT; C-MYC; DNA-STRUCTURE; GENE-EXPRESSION; P2 PROMOTER; G4 DNA; BINDING; MAZ; TRANSCRIPTION; PARP-1	The murine KRAS promoter contains a G-rich nuclease hypersensitive element (GA-element) upstream of the transcription start site that is essential for transcription. Pulldown and chromatin immunoprecipitation assays demonstrate that this GA-element is bound by the Myc-associated zinc finger (MAZ) and poly(ADP-ribose) polymerase 1 (PARP-1) proteins. These proteins are crucial for transcription, because when they are knocked down by short hairpin RNA, transcription is down-regulated. This is also the case when the poly(ADP-ribosyl) ation activity of PARP-1 is inhibited by 3,4-dihydro-5-[ 4-(1-piperidinyl) butoxyl]-1(2H) isoquinolinone. We found that MAZ specifically binds to the duplex and quadruplex conformations of the GA-element, whereas PARP-1 shows specificity only for the G-quadruplex. On the basis of fluorescence resonance energy transfer melting and polymerase stop assays we saw that MAZ stabilizes the KRAS quadruplex. When the capacity of folding in the GA-element is abrogated by specific G -> T or G -> A point mutations, KRAS transcription is down-regulated. Conversely, guanidine-modified phthalocyanines, which specifically interact with and stabilize the KRAS G-quadruplex, push the promoter activity up to more than double. Collectively, our data support a transcription mechanism for murine KRAS that involves MAZ, PARP-1 and duplex-quadruplex conformational changes in the promoter GA-element.	[Cogoi, Susanna; Paramasivam, Manikandan; Membrino, Alexandro; Xodo, Luigi E.] Univ Udine, Sch Med, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung 80708, Taiwan	University of Udine; Kaohsiung Medical University	Xodo, LE (corresponding author), Univ Udine, Sch Med, Dept Biomed Sci & Technol, Piazzale Kolbe 4, I-33100 Udine, Italy.	luigi.xodo@uniud.it	Xodo, Luigi/W-6350-2019	Xodo, Luigi/0000-0003-3344-7207	Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Scientific Research [PRIN 2007]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Scientific Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by Associazione Italiana per la Ricerca sul Cancro 2008 and Italian Ministry of Scientific Research (PRIN 2007).	Alzeer J, 2009, CHEM COMMUN, P1970, DOI 10.1039/b822985f; Bonicalzi ME, 2005, CELL MOL LIFE SCI, V62, P739, DOI 10.1007/s00018-004-4505-1; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Caiafa P, 2009, J CELL PHYSIOL, V219, P265, DOI 10.1002/jcp.21691; Chasovskikh S, 2005, CYTOM PART A, V68A, P21, DOI 10.1002/cyto.a.20187; Choi EW, 2010, NUCLEIC ACIDS RES, V38, P1623, DOI 10.1093/nar/gkp1088; Choi HS, 2009, BIOCHEM BIOPH RES CO, V380, P431, DOI 10.1016/j.bbrc.2009.01.136; Cogoi S, 2008, NUCLEIC ACIDS RES, V36, P3765, DOI 10.1093/nar/gkn120; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Freyer MW, 2007, BIOPHYS J, V92, P2007, DOI 10.1529/biophysj.106.097246; Green JJ, 2003, J AM CHEM SOC, V125, P3763, DOI 10.1021/ja029149w; Her S, 2003, MOL PHARMACOL, V64, P1180, DOI 10.1124/mol.64.5.1180; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Himeda CL, 2008, MOL CELL BIOL, V28, P6521, DOI 10.1128/MCB.00306-08; HOFFMAN EK, 1990, P NATL ACAD SCI USA, V87, P2705, DOI 10.1073/pnas.87.7.2705; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Izzo MW, 1999, J BIOL CHEM, V274, P19498, DOI 10.1074/jbc.274.27.19498; Jordan-Sciutto KL, 2000, BIOCHEMISTRY-US, V39, P3206, DOI 10.1021/bi992211q; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Leroy C, 2004, J MOL ENDOCRINOL, V32, P99, DOI 10.1677/jme.0.0320099; Lew A, 2000, P NATL ACAD SCI USA, V97, P12508, DOI 10.1073/pnas.97.23.12508; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Martin-Oliva D, 2006, CANCER RES, V66, P5744, DOI 10.1158/0008-5472.CAN-05-3050; Membrino A, 2010, CHEM COMMUN, V46, P625, DOI 10.1039/b918964e; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Parks CL, 1997, J VIROL, V71, P9600, DOI 10.1128/JVI.71.12.9600-9607.1997; Parks CL, 1996, J BIOL CHEM, V271, P4417; PESTOV DG, 1991, NUCLEIC ACIDS RES, V19, P6527, DOI 10.1093/nar/19.23.6527; Potaman VN, 2005, J MOL BIOL, V348, P609, DOI 10.1016/j.jmb.2005.03.010; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Soldatenkov VA, 2008, ACS CHEM BIOL, V3, P214, DOI 10.1021/cb700234f; Song J, 1998, J BIOL CHEM, V273, P20603, DOI 10.1074/jbc.273.32.20603; Song J, 2001, J BIOL CHEM, V276, P19897, DOI 10.1074/jbc.M010658200; Sun D, 2008, MOL CANCER THER, V7, P880, DOI 10.1158/1535-7163.MCT-07-2119; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Tsutsui H, 1996, BIOCHEM BIOPH RES CO, V226, P801, DOI 10.1006/bbrc.1996.1432; Tsutsui H, 1999, BIOCHEM BIOPH RES CO, V262, P198, DOI 10.1006/bbrc.1999.1130; Ugai H, 2001, BIOCHEM BIOPH RES CO, V286, P1087, DOI 10.1006/bbrc.2001.5469; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07	58	97	98	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22003	22016		10.1074/jbc.M110.101923	http://dx.doi.org/10.1074/jbc.M110.101923			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20457603	Green Published, hybrid			2022-12-25	WOS:000279702200013
J	Han, SJ; Makareeva, E; Kuznetsova, NV; DeRidder, AM; Sutter, MB; Losert, W; Phillips, CL; Visse, R; Nagase, H; Leikin, S				Han, Sejin; Makareeva, Elena; Kuznetsova, Natalia V.; DeRidder, Angela M.; Sutter, Mary Beth; Losert, Wolfgang; Phillips, Charlotte L.; Visse, Robert; Nagase, Hideaki; Leikin, Sergey			Molecular Mechanism of Type I Collagen Homotrimer Resistance to Mammalian Collagenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL COLLAGEN; PEPTIDE-BOND HYDROLYSIS; EHLERS-DANLOS-SYNDROME; C-TERMINAL DOMAIN; OSTEOGENESIS IMPERFECTA; FIBROBLAST COLLAGENASE; EXTRACELLULAR-MATRIX; ALPHA-2(I) CHAIN; OSTEO-SARCOMA; GELATINASE-A	Type I collagen cleavage is crucial for tissue remodeling, but its homotrimeric isoform is resistant to all collagenases. The homotrimers occur in fetal tissues, fibrosis, and cancer, where their collagenase resistance may play an important physiological role. To understand the mechanism of this resistance, we studied interactions of alpha 1(I)(3) homotrimers and normal alpha 1(I)(2)alpha 2(I) heterotrimers with fibroblast collagenase (MMP-1). Similar MMP-1 binding to the two isoforms and similar cleavage efficiency of unwound alpha 1(I) and alpha 2(I) chains suggested increased stability and less efficient unwinding of the homotrimer triple helix at the collagenase cleavage site. The unwinding, necessary for placing individual chains inside the catalytic cleft of the enzyme, was the rate-limiting cleavage step for both collagen isoforms. Comparative analysis of the homo-and heterotrimer cleavage kinetics revealed that MMP-1 binding promotes stochastic helix unwinding, resolving the controversy between different models of collagenase action.	[Han, Sejin; Makareeva, Elena; Kuznetsova, Natalia V.; DeRidder, Angela M.; Sutter, Mary Beth; Leikin, Sergey] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Han, Sejin; Losert, Wolfgang] Univ Maryland, Inst Phys Sci & Technol, Dept Phys, College Pk, MD 20742 USA; [Han, Sejin; Losert, Wolfgang] Univ Maryland, Inst Res Elect & Appl Phys, College Pk, MD 20742 USA; [Phillips, Charlotte L.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Visse, Robert; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, London W6 8LH, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Missouri System; University of Missouri Columbia; Imperial College London; University of Oxford	Leikin, S (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bldg 9,Rm 1E-127, Bethesda, MD 20892 USA.	leikins@mail.nih.gov	Makareeva, Elena/F-5183-2011; Leikin, Sergey/A-5518-2008	Makareeva, Elena/0000-0002-5815-0760; Leikin, Sergey/0000-0001-7095-0739; Phillips, Charlotte/0000-0002-7761-3783	National Institutes of Health NICHD; NIDDK [DK069522]; National Science Foundation [PHY-0750371]; Wellcome Trust [075473]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000256] Funding Source: NIH RePORTER	National Institutes of Health NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health NICHD Intramural Research Program grant (to S.L.) and NIDDK Grant DK069522 (to C.L.P.). This work was also supported by National Science Foundation Grant PHY-0750371 (to W.L.) and Wellcome Trust Program Grant 075473 (to H.N.).	ASOKAN R, 1993, MOL CELL BIOCHEM, V121, P99, DOI 10.1007/BF00925968; Bailey AJ, 2002, INT J BIOCHEM CELL B, V34, P176, DOI 10.1016/S1357-2725(01)00107-8; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Beare AHM, 2003, J INVEST DERMATOL, V120, P153, DOI 10.1046/j.1523-1747.2003.12019.x; Brodeur AC, 2007, KIDNEY INT, V71, P985, DOI 10.1038/sj.ki.5002173; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; Collier IE, 2001, BIOPHYS J, V81, P2370, DOI 10.1016/S0006-3495(01)75883-3; DECLERCK YA, 1987, CANCER RES, V47, P6505; EHRLICH HP, 1982, BIOCHEM MED METAB B, V28, P273, DOI 10.1016/0006-2944(82)90080-1; Han S, 2008, J MOL BIOL, V383, P122, DOI 10.1016/j.jmb.2008.08.008; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; JIMENEZ SA, 1977, BIOCHEM BIOPH RES CO, V78, P1354, DOI 10.1016/0006-291X(77)91441-3; Kuznetsova NV, 2003, J MOL BIOL, V331, P191, DOI 10.1016/S0022-2836(03)00715-0; LEHEUP BP, 1989, LAB INVEST, V60, P791; LESOT H, 1981, BIOCHIM BIOPHYS ACTA, V656, P206, DOI 10.1016/0005-2787(81)90088-5; LITTLE CD, 1977, CELL, V10, P287, DOI 10.1016/0092-8674(77)90222-7; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227; Makareeva E, 2006, J BIOL CHEM, V281, P6463, DOI 10.1074/jbc.M511830200; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Makareeva E, 2010, CANCER RES, V70, P4366, DOI 10.1158/0008-5472.CAN-09-4057; Malfait F, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.038224; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; Miles CA, 2002, J MOL BIOL, V321, P797, DOI 10.1016/S0022-2836(02)00703-9; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; MINAFRA IP, 1985, CELL BIOL INT REP, V9, P291, DOI 10.1016/0309-1651(85)90047-5; MINAFRA S, 1988, CELL BIOL INT REP, V12, P895, DOI 10.1016/0309-1651(88)90053-7; MORO L, 1977, ARCH BIOCHEM BIOPHYS, V182, P33, DOI 10.1016/0003-9861(77)90280-6; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NARAYANAN AS, 1984, COLLAGEN REL RES, V4, P289; NARAYANAN AS, 1980, BIOCHEMISTRY-US, V19, P5037, DOI 10.1021/bi00563a016; Nerenberg PS, 2008, J MOL BIOL, V382, P246, DOI 10.1016/j.jmb.2008.07.009; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Pace JM, 2008, J BIOL CHEM, V283, P16061, DOI 10.1074/jbc.M801982200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; ROJKIND M, 1979, GASTROENTEROLOGY, V76, P710; RUPARD JH, 1988, AM J PATHOL, V133, P316; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Schwarze U, 2004, AM J HUM GENET, V74, P917, DOI 10.1086/420794; SHAPIRO FD, 1982, J NATL CANCER I, V69, P1009; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; UITTO J, 1979, ARCH BIOCHEM BIOPHYS, V192, P371, DOI 10.1016/0003-9861(79)90105-X; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; YAMAGATA S, 1984, J BIOCHEM-TOKYO, V96, P17, DOI 10.1093/oxfordjournals.jbchem.a134809; Zhao WG, 2000, J CLIN INVEST, V106, P941, DOI 10.1172/JCI10158	48	83	88	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22276	22281		10.1074/jbc.M110.102079	http://dx.doi.org/10.1074/jbc.M110.102079			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463013	Green Published, hybrid			2022-12-25	WOS:000279702200040
J	Tadevosyan, A; Maguy, A; Villeneuve, LR; Babin, J; Bonnefoy, A; Allen, BG; Nattel, S				Tadevosyan, Artavazd; Maguy, Ange; Villeneuve, Louis R.; Babin, Judith; Bonnefoy, Arnaud; Allen, Bruce G.; Nattel, Stanley			Nuclear-delimited Angiotensin Receptor-mediated Signaling Regulates Cardiomyocyte Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SMOOTH-MUSCLE-CELLS; END-POINT REDUCTION; II-BINDING SITES; NF-KAPPA-B; CARDIAC MYOCYTES; ANG-II; CARDIOVASCULAR MORBIDITY; LOSARTAN INTERVENTION; TRANSCRIPTION FACTOR	Angiotensin-II (Ang-II) from extracardiac sources and intra-cardiac synthesis regulates cardiac homeostasis, with mitogenic and growth-promoting effects largely due to altered gene expression. Here, we assessed the possibility that angiotensin-1 (AT1R) or angiotensin-2 (AT2R) receptors on the nuclear envelope mediate effects on cardiomyocyte gene expression. Immunoblots of nucleus-enriched fractions from isolated cardiomyocytes indicated the presence of AT1R and AT2R proteins that copurified with the nuclear membrane marker nucleoporin-62 and histone-3, but not markers of plasma (calpactin-I), Golgi (GRP-78), or endoplasmic reticulum (GM130) membranes. Confocal microscopy revealed AT1R and AT2R proteins on nuclear membranes. Microinjected Ang-II preferentially bound to nuclear sites of isolated cardiomyocytes. AT1R and AT2R ligands enhanced de novo RNA synthesis in isolated cardiomyocyte nuclei incubated with [alpha-P-32]UTP (e.g. 36.0 +/- 6.0 cpm/ng of DNA control versus 246.4 +/- 15.4 cpm/ng of DNA Ang-II, 390.1 +/- 15.5 cpm/ng of DNA L-162313 (AT1), 180.9 +/- 7.2 cpm/ng of DNA CGP42112A (AT2), p < 0.001). Ang-II application to cardiomyocyte nuclei enhanced NF kappa B mRNA expression, a response that was suppressed by co-administration of AT1R (valsartan) and/or AT2R (PD123177) blockers. Dose-response experiments with Ang-II applied to purified cardiomyocyte nuclei versus intact cardiomyocytes showed greater increases in NF kappa B mRNA levels at saturating concentrations with similar to 2-fold greater affinity upon nuclear application, suggesting preferential nuclear signaling. AT1R, but not AT2R, stimulation increased [Ca2+] in isolated cardiomyocyte nuclei. Inositol 1,4,5-trisphosphate receptor blockade by 2-aminoethoxydiphenyl borate prevented AT1R-mediated Ca2+ release and attenuated AT1R-mediated transcription initiation responses. We conclude that cardiomyocyte nuclear membranes possess angiotensin receptors that couple to nuclear signaling pathways and regulate transcription. Signaling within the nuclear envelope (e.g. from intracellularly synthesized Ang-II) may play a role in Ang-II-mediated changes in cardiac gene expression, with potentially important mechanistic and therapeutic implications.	[Tadevosyan, Artavazd; Babin, Judith; Bonnefoy, Arnaud; Allen, Bruce G.; Nattel, Stanley] Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; [Allen, Bruce G.] Montreal Heart Inst, Dept Biochem, Montreal, PQ H1T 1C8, Canada; [Bonnefoy, Arnaud] Univ Montreal, INSERM, U743, Montreal, PQ H3T 1J4, Canada; [Allen, Bruce G.; Nattel, Stanley] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; McGill University	Nattel, S (corresponding author), 5000 Belanger St E, Montreal, PQ H1T 1C8, Canada.	stanley.nattel@icm-mhi.org	Maguy, Ange/ABG-9298-2021; Allen, Bruce G/B-4693-2008	Allen, Bruce G/0000-0001-9000-9495; Maguy, Ange/0000-0003-0170-7430; Nattel, Stanley/0000-0002-5565-3311	Canadian Institutes of Health Research [MGP 6957]; Fondation Leducq	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation Leducq(Leducq Foundation)	This work was supported by Canadian Institutes of Health Research Grant MGP 6957 and the European-North American Atrial Fibrillation Research Alliance (ENAFRA) award from Fondation Leducq.	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Baker KM, 2004, REGUL PEPTIDES, V120, P5, DOI 10.1016/j.regpep.2004.04.004; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BATTLE T, 1994, TISSUE CELL, V26, P943, DOI 10.1016/0040-8166(94)90043-4; Bezin S, 2008, J BIOL CHEM, V283, P27859, DOI 10.1074/jbc.M804701200; Bhattacharya M, 1998, P NATL ACAD SCI USA, V95, P15792, DOI 10.1073/pnas.95.26.15792; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Boivin B, 2003, J BIOL CHEM, V278, P29153, DOI 10.1074/jbc.M301738200; Boivin B, 2006, CARDIOVASC RES, V71, P69, DOI 10.1016/j.cardiores.2006.03.015; BOOZ GW, 1992, ENDOCRINOLOGY, V130, P3641, DOI 10.1210/en.130.6.3641; CHEN L, 1991, P SOC EXP BIOL MED, V196, P280; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; De Mello WC, 2006, REGUL PEPTIDES, V133, P10, DOI 10.1016/j.regpep.2005.09.020; De Mello WC, 1998, HYPERTENSION, V32, P976, DOI 10.1161/01.HYP.32.6.976; Filipeanu CM, 2001, BRIT J PHARMACOL, V132, P1590, DOI 10.1038/sj.bjp.0703984; Gerasimenko O, 2004, J CELL SCI, V117, P3087, DOI 10.1242/jcs.01295; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Groth W, 2003, J HYPERTENS, V21, P2175, DOI 10.1097/00004872-200311000-00028; Haller H, 1996, CIRC RES, V79, P765, DOI 10.1161/01.RES.79.4.765; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Juillerat-Jeanneret L, 2004, BRIT J CANCER, V90, P1059, DOI 10.1038/sj.bjc.6601646; Kang NL, 2002, J MOL MED, V80, P359, DOI 10.1007/s00109-002-0326-6; Kusnier C, 2006, BIOL RES, V39, P541, DOI 10.4067/S0716-97602006000300015; Li XC, 2008, AM J PHYSIOL-CELL PH, V294, pC1034, DOI 10.1152/ajpcell.00432.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malviya AN, 1998, CELL, V92, P17, DOI 10.1016/S0092-8674(00)80895-8; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; Peters J, 2002, CIRC RES, V90, P1135, DOI 10.1161/01.RES.0000019242.51541.99; Re RN, 2008, J CLIN PHARMACOL, V48, P344, DOI 10.1177/0091270007312155; Re RN, 2007, NAT CLIN PRACT CARD, V4, P549, DOI 10.1038/ncpcardio0985; Reudelhuber TL, 2007, HYPERTENSION, V49, P1196, DOI 10.1161/HYPERTENSIONAHA.106.075085; ROBERTSON AL, 1971, SCIENCE, V172, P1138, DOI 10.1126/science.172.3988.1138; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; Shao J, 2007, J HYPERTENS, V25, P1643, DOI 10.1097/HJH.0b013e328165d159; Singh VP, 2007, AM J PHYSIOL-HEART C, V293, pH939, DOI 10.1152/ajpheart.00391.2007; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Sorriento D, 2008, P NATL ACAD SCI USA, V105, P17818, DOI 10.1073/pnas.0804446105; TANG SS, 1992, ENDOCRINOLOGY, V131, P374, DOI 10.1210/en.131.1.374; Wachtell K, 2005, J AM COLL CARDIOL, V45, P705, DOI 10.1016/j.jacc.2004.06.080; Willard FS, 2000, IMMUNOL CELL BIOL, V78, P387, DOI 10.1046/j.1440-1711.2000.00927.x; Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024; Xu J, 2007, AM J PHYSIOL-HEART C, V293, pH1900, DOI 10.1152/ajpheart.00379.2007; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731	44	89	89	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22338	22349		10.1074/jbc.M110.121749	http://dx.doi.org/10.1074/jbc.M110.121749			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463030	hybrid, Green Published			2022-12-25	WOS:000279702200047
J	Daniels, C; Daddaoua, A; Lu, D; Zhang, XD; Ramos, JL				Daniels, Craig; Daddaoua, Abdelali; Lu, Duo; Zhang, Xiaodong; Ramos, Juan-Luis			Domain Cross-talk during Effector Binding to the Multidrug Binding TTGR Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-PUTIDA DOT-T1E; EFFLUX PUMPS; ESCHERICHIA-COLI; RESISTANCE; EXPRESSION; TOLERANCE; BACTERIA; PROTEIN; TTGABC	A major mechanism of antibiotic resistance in bacteria is the active extrusion of toxic compounds through membrane-bound efflux pumps. The TtgR protein represses transcription of ttgABC, a key efflux pump in Pseudomonas putida DOT-T1E capable of extruding antibiotics, solvents, and flavonoids. TtgR contains two distinct and overlapping ligand binding sites, one is broad and contains mainly hydrophobic residues, whereas the second is deep and contains polar residues. Mutants in the ligand binding pockets were generated and characterized using electrophoretic mobility shift assays, isothermal titration calorimetry, and promoter expression. Several mutants were affected in their response to effectors in vitro: mutants H70A, H72A, and R75A did not dissociate from promoter DNA in the presence of chloramphenicol. Other mutants exhibited altered binding to the operator: L66A and L66AV96A mutants bound 3- and 15-fold better than the native protein, whereas the H67A mutant bound with 3- fold lower affinity. In vivo expression assays using a fusion of the promoter of ttgA to lacZ and antibiotic tolerance correlated with the in vitro observations, namely that mutant H67A leads to increased basal expression levels and enhances antibiotic tolerance, whereas mutants L66A and L66AV96A exhibit lower basal expression levels and decreased resistance to antibiotics. The crystal structure of TtgR H67A was resolved. The data provide evidence for the inter-domain communication that is predicted to be required for the transmission of the effector binding signal to the DNA binding domain and provide important information to understand TtgR/DNA/effector interactions.	[Ramos, Juan-Luis] CSIC, EEZ, Environm Protect Dept, E-18008 Granada, Spain; [Lu, Duo; Zhang, Xiaodong] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Imperial College London	Ramos, JL (corresponding author), CSIC, EEZ, Environm Protect Dept, C Prof Albareda 1, E-18008 Granada, Spain.	jlramos@eez.csic.es	Daddaoua, Abdelali/D-6930-2014	Zhang, Xiaodong/0000-0001-9786-7038; Ramos, Juan L./0000-0002-8731-7435; Daddaoua, Abdelali/0000-0002-7348-6393	Junta de Andalucia FEDER Proyecto de Excelencia [CVI1912]; FEDER [BIO2006-05668]; Spanish Ministry of Science and Innovation [PSYSMO GEN2006-27750-C5-5-E/SYS]; Consejo Superior de Investigaciones Cientificas; MRC [G0501723] Funding Source: UKRI; Medical Research Council [G0501723] Funding Source: researchfish	Junta de Andalucia FEDER Proyecto de Excelencia; FEDER(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Junta de Andalucia FEDER Proyecto de Excelencia Grant CVI1912, FEDER Consolider C Grant BIO2006-05668, and Grant PSYSMO GEN2006-27750-C5-5-E/SYS from the Spanish Ministry of Science and Innovation.; Recipient of an I3P fellowship from Consejo Superior de Investigaciones Cientificas.	Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Amsterdam D., 1991, ANTIBIOTICS LAB MED, P72; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1658, DOI 10.1111/j.1462-2920.2007.01283.x; Chuanchuen R, 2002, J BACTERIOL, V184, P5036, DOI 10.1128/JB.184.18.5036-5044.2002; Duque E, 2001, MOL MICROBIOL, V39, P1100, DOI 10.1046/j.1365-2958.2001.02310.x; Grkovic S, 1998, J BIOL CHEM, V273, P18665, DOI 10.1074/jbc.273.29.18665; Kieboom J, 2001, MICROBIOL-SGM, V147, P43, DOI 10.1099/00221287-147-1-43; Krell T, 2007, J MOL BIOL, V369, P1188, DOI 10.1016/j.jmb.2007.04.025; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; MILLER JH, 1972, EXPT MOL GENETICS, pCH48; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Nikaido H, 2001, SEMIN CELL DEV BIOL, V12, P215, DOI 10.1006/scdb.2000.0247; POOLE K, 2003, PSEUDOMONAS; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; Ramos JL, 1998, J BACTERIOL, V180, P3323, DOI 10.1128/JB.180.13.3323-3329.1998; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Teran W, 2003, ANTIMICROB AGENTS CH, V47, P3067, DOI 10.1128/AAC.47.10.3067-3072.2003; Teran W, 2006, J BIOL CHEM, V281, P7102, DOI 10.1074/jbc.M511095200	19	22	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21372	21381		10.1074/jbc.M110.113282	http://dx.doi.org/10.1074/jbc.M110.113282			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20435893	Green Published, hybrid			2022-12-25	WOS:000279516100023
J	Peng, FW; Yao, HH; Bai, XT; Zhu, XH; Reiner, BC; Beazely, M; Funa, K; Xiong, HG; Buch, S				Peng, Fuwang; Yao, Honghong; Bai, Xuetao; Zhu, Xuhui; Reiner, Benjamin C.; Beazely, Michael; Funa, Keiko; Xiong, Huangui; Buch, Shilpa			Platelet-derived Growth Factor-mediated Induction of the Synaptic Plasticity Gene Arc/Arg3.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; METABOTROPIC GLUTAMATE RECEPTORS; PROTEASE-ACTIVATED LIGAND; CENTRAL-NERVOUS-SYSTEM; PDGF B-CHAIN; HIPPOCAMPAL-NEURONS; MESSENGER-RNA; IN-VITRO; INTRACELLULAR CALCIUM	Platelet-derived growth factor (PDGF) is a pleiotropic protein with critical roles in both developmental as well as pathogenic processes. In the central nervous system specifically, PDGF is critical for neuronal proliferation and differentiation and has also been implicated as a neuroprotective agent. Whether PDGF also plays a role in synaptic plasticity, however, remains poorly understood. In the present study we demonstrated that in the rat hippocampal neurons PDGF regulated the expression of Arc/Arg3.1 gene that has been implicated in both synapse plasticity and long term potentiation. Relevance of these findings was further confirmed in vivo by injecting mice with intracerebral inoculations of PDGF, which resulted in a rapid induction of Arc in the hippocampus of the injected mice. PDGF induced long term potentiation in rat hippocampal slices, which was abolished by PDGF receptor-tyrosine kinase inhibitor STI-571. We also present evidence that PDGF-mediated induction of Arc/Arg3.1 involved activation of the MAPK/ERK (MEK) pathway. Additionally, induction of Arc/Arg3.1 also involved the upstream release of intracellular calcium stores, an effect that could be blocked by thapsigargin but not by EGTA. Pharmacological approach using inhibitors specific for either MAPK/ERK phosphorylation or calcium release demonstrated that the two pathways converged downstream at a common point involving activation of the immediate early gene Egr-1. Chromatin immunoprecipitation assays demonstrated the binding of Egr-1, but not Egr-3, to the Arc promoter. These findings for the first time, thus, suggest an additional role of PDGF, that of induction of Arc.	[Xiong, Huangui; Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Bai, Xuetao] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66160 USA; [Beazely, Michael] Univ Waterloo, Sch Pharm, Kitchener, ON N2G 1C5, Canada; [Funa, Keiko] Gothenburg Univ, SE-40530 Gothenburg, Sweden	University of Nebraska System; University of Nebraska Medical Center; University of Kansas; University of Kansas Medical Center; University of Waterloo; University of Gothenburg	Buch, S (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, 985880 Nebraska Med Ctr,DRC 8011, Omaha, NE 68198 USA.	sbuch@unmc.edu	Reiner, Benjamin/ABG-1618-2020	Reiner, Benjamin/0000-0001-7796-587X; Beazely, Michael/0000-0002-8722-460X; Buch, Shilpa/0000-0002-3103-6685	National Institutes of Health [MH-068212, DA020392, DA023397, DA024442, DA027729]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068212, P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020392, R21DA023397, R01DA027729, R01DA024442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants MH-068212, DA020392, DA023397, DA024442, and DA027729 (to S. B.).	ABRAHAM WC, 1991, MOL NEUROBIOL, V5, P297, DOI 10.1007/BF02935553; Beazely MA, 2009, J BIOL CHEM, V284, P8054, DOI 10.1074/jbc.M805384200; BENITO M, 1993, GROWTH REGULAT, V3, P172; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CHENG B, 1995, J NEUROSCI, V15, P7095; Coogan AN, 1999, NEUROSCIENCE, V93, P57, DOI 10.1016/S0306-4522(99)00100-1; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Egawa-Tsuzuki T, 2004, EXP NEUROL, V186, P89, DOI 10.1016/j.expneurol.2003.11.001; Enarsson M, 2002, MOL CANCER RES, V1, P147; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gozal D, 2000, J NEUROCHEM, V74, P310, DOI 10.1046/j.1471-4159.2000.0740310.x; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Heldin CH, 2002, ARCH BIOCHEM BIOPHYS, V398, P284, DOI 10.1006/abbi.2001.2707; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hynds DL, 1997, J NEUROSCI RES, V47, P617, DOI 10.1002/(SICI)1097-4547(19970315)47:6<617::AID-JNR7>3.0.CO;2-G; Iihara K, 1997, J CEREBR BLOOD F MET, V17, P1097, DOI 10.1097/00004647-199710000-00012; Ishii Y, 2006, J NEUROCHEM, V98, P588, DOI 10.1111/j.1471-4159.2006.03922.x; Kuhl D, 1998, CURR OPIN NEUROBIOL, V8, P600, DOI 10.1016/S0959-4388(98)80087-1; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Machado HB, 2008, J NEUROSCI RES, V86, P593, DOI 10.1002/jnr.21529; Mayer SI, 2009, EUR J CELL BIOL, V88, P19, DOI 10.1016/j.ejcb.2008.07.002; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; Mohapel P, 2005, NEUROSCIENCE, V132, P767, DOI 10.1016/j.neuroscience.2004.11.056; Moon Y, 2007, TOXICOL APPL PHARM, V223, P155, DOI 10.1016/j.taap.2007.04.018; Nunes-de-Souza RL, 2002, BRAIN RES, V927, P87, DOI 10.1016/S0006-8993(01)03335-2; Oak JN, 2001, MOL PHARMACOL, V60, P92, DOI 10.1124/mol.60.1.92; OTHBERG A, 1995, EXP BRAIN RES, V105, P111; Peng FW, 2008, J NEUROVIROL, V14, P62, DOI 10.1080/13550280701809084; Pietz K, 1996, NEUROSCI LETT, V204, P101, DOI 10.1016/0304-3940(96)12326-0; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Pratsinis H, 2007, EUR SPINE J, V16, P1858, DOI 10.1007/s00586-007-0408-9; Rosenblum K, 2000, J NEUROSCI, V20, P977, DOI 10.1523/JNEUROSCI.20-03-00977.2000; Rosengart MR, 2000, SHOCK, V13, P183, DOI 10.1097/00024382-200003000-00003; RUPPRECHT HD, 1993, AM J PHYSIOL, V265, pF351, DOI 10.1152/ajprenal.1993.265.3.F351; Saqr HE, 1999, NEUROCHEM INT, V35, P411, DOI 10.1016/S0197-0186(99)00092-3; SASAHARA A, 1992, DEV BRAIN RES, V68, P41, DOI 10.1016/0165-3806(92)90246-S; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Steward O, 2002, NEUROBIOL LEARN MEM, V78, P508, DOI 10.1006/nlme.2002.4102; Sung JY, 2001, J NEUROCHEM, V78, P1044, DOI 10.1046/j.1471-4159.2001.00491.x; Tseng HC, 2005, NEUROBIOL DIS, V19, P77, DOI 10.1016/j.nbd.2004.11.007; Tsui CC, 1996, J NEUROSCI, V16, P2463; Valenzuela CF, 1995, MOL PHARMACOL, V48, P1099; Valenzuela CF, 1997, BRAIN RES REV, V24, P77; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; Xiong HG, 1996, BRAIN RES, V737, P188, DOI 10.1016/0006-8993(96)00731-7; Yao HH, 2005, J NEUROCHEM, V92, P948, DOI 10.1111/j.1471-4159.2004.02937.x; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zheng F, 2009, J NEUROSCI RES, V87, P380, DOI 10.1002/jnr.21863	65	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21615	21624		10.1074/jbc.M110.107003	http://dx.doi.org/10.1074/jbc.M110.107003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452974	Green Published, hybrid			2022-12-25	WOS:000279516100048
J	Wang, Z; Ginnan, R; Abdullaev, IF; Trebak, M; Vincent, PA; Singer, HA				Wang, Zhen; Ginnan, Roman; Abdullaev, Iskandar F.; Trebak, Mohamed; Vincent, Peter A.; Singer, Harold A.			Calcium/Calmodulin-dependent Protein Kinase II Delta 6 (CaMKII delta(6)) and RhoA Involvement in Thrombin-induced Endothelial Barrier Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; CELL PROLIFERATION; ISOFORM REGULATION; ERK ACTIVATION; TRP CHANNELS; HEART-TISSUE; PERMEABILITY; CAMKII; MECHANISM; ENTRY	Multiple Ca2+ release and entry mechanisms and potential cytoskeletal targets have been implicated in vascular endothelial barrier dysfunction; however, the immediate downstream effectors of Ca2+ signals in the regulation of endothelial permeability still remain unclear. In the present study, we evaluated the contribution of multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) as a mediator of thrombin-stimulated increases in human umbilical vein endothelial cell (HUVEC) monolayer permeability. For the first time, we identified the CaMKII delta(6) isoform as the predominant CaMKII isoform expressed in endothelium. As little as 2.5 nM thrombin maximally increased CaMKII delta(6) activation assessed by Thr(287) autophosphorylation. Electroporation of siRNA targeting endogenous CaMKII delta (siCaMKII delta) suppressed expression of the kinase by >80% and significantly inhibited 2.5 nM thrombin-induced increases in monolayer permeability assessed by electrical cell-substrate impedance sensing (ECIS). siCaMKII delta inhibited 2.5 nM thrombin-induced activation of RhoA, but had no effect on thrombin-induced ERK1/2 activation. Although Rho kinase inhibition strongly suppressed thrombin-induced HUVEC hyperpermeability, inhibiting ERK1/2 activation had no effect. In contrast to previous reports, these results indicate that thrombin-induced ERK1/2 activation in endothelial cells is not mediated by CaMKII and is not involved in endothelial barrier hyperpermeability. Instead, CaMKII delta(6) mediates thrombin-induced HUVEC barrier dysfunction through RhoA/Rho kinase as downstream intermediates. Moreover, the relative contribution of the CaMKII delta(6)/RhoA pathway(s) diminished with increasing thrombin stimulation, indicating recruitment of alternative signaling pathways mediating endothelial barrier dysfunction, dependent upon thrombin concentration.	[Wang, Zhen; Ginnan, Roman; Abdullaev, Iskandar F.; Trebak, Mohamed; Vincent, Peter A.; Singer, Harold A.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Singer, HA (corresponding author), Albany Med Coll MC8, Ctr Cardiovasc Sci, 47 New Scotland Ave, Albany, NY 12208 USA.	singerh@mail.amc.edu	Abdullaev, Iskandar/AAH-2478-2021; Trebak, Mohamed/E-7405-2014		National Institutes of Health [R01 HL-049426, RO1 HL-077870]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111, R01HL049426, R01HL077870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL-049426 (to H. A. S.) and RO1 HL-077870 (to P. A. V.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Abraham ST, 1996, J BIOL CHEM, V271, P2506, DOI 10.1074/jbc.271.5.2506; Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Birnbaumer L, 2002, CIRC RES, V91, P1, DOI 10.1161/01.RES.0000026600.67226.92; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Borbiev T, 2003, AM J PHYSIOL-LUNG C, V285, pL43, DOI 10.1152/ajplung.00460.2001; Borbiev T, 2001, AM J PHYSIOL-LUNG C, V280, pL983, DOI 10.1152/ajplung.2001.280.5.L983; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; Chew CS, 2008, AM J PHYSIOL-GASTR L, V295, pG1159, DOI 10.1152/ajpgi.90345.2008; Chiasson CM, 2009, MOL BIOL CELL, V20, P1970, DOI 10.1091/mbc.E08-07-0735; Cioffi DL, 2009, ANTIOXID REDOX SIGN, V11, P765, DOI 10.1089/ARS.2008.2221; Clements RT, 2005, AM J PHYSIOL-LUNG C, V288, pL294, DOI 10.1152/ajplung.00213.2004; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Gavard J, 2008, J BIOL CHEM, V283, P29888, DOI 10.1074/jbc.M803880200; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Lu KK, 2005, AM J PHYSIOL-CELL PH, V289, pC1343, DOI 10.1152/ajpcell.00064.2005; MAYER P, 1995, BASIC RES CARDIOL, V90, P372, DOI 10.1007/BF00788498; MAYER P, 1994, BIOCHEM J, V298, P757, DOI 10.1042/bj2980757; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Pfleiderer PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1238, DOI 10.1152/ajpcell.00536.2003; Rezazadeh S, 2006, J PHARMACOL EXP THER, V317, P292, DOI 10.1124/jpet.105.097618; Rokolya A, 2000, AM J PHYSIOL-CELL PH, V278, pC537, DOI 10.1152/ajpcell.2000.278.3.C537; Sandoval R, 2001, AM J PHYSIOL-LUNG C, V280, pL239, DOI 10.1152/ajplung.2001.280.2.L239; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; SHUMAN MA, 1976, J CLIN INVEST, V58, P1249, DOI 10.1172/JCI108579; SHUMAN MA, 1978, J CLIN INVEST, V61, P1102, DOI 10.1172/JCI109010; Singer HA, 1997, J BIOL CHEM, V272, P9393; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Van Riper DA, 2000, MOL CELL BIOCHEM, V213, P83, DOI 10.1023/A:1007116231678; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343	41	41	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21303	21312		10.1074/jbc.M110.120790	http://dx.doi.org/10.1074/jbc.M110.120790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442409	Green Published, hybrid			2022-12-25	WOS:000279516100015
J	Zhang, JD; Qian, XS; Ning, HA; Yang, JJ; Xiong, HB; Liu, JG				Zhang, Jidong; Qian, Xuesong; Ning, Huan; Yang, Jianjun; Xiong, Huabao; Liu, Jianguo			Activation of IL-27 p28 Gene Transcription by Interferon Regulatory Factor 8 in Cooperation with Interferon Regulatory Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BINDING-PROTEIN; CENTRAL-NERVOUS-SYSTEM; NATURAL-KILLER-CELLS; CD4(+) T-CELLS; NF-KAPPA-B; FACTOR-I; DENDRITIC CELLS; LEISHMANIA-MAJOR; CARCINOMA-CELLS; TH1 RESPONSES	Interferon regulatory factor (IRF) family members, especially interferon regulatory factor-1 (IRF-1) and interferon regulatory factor-8 (IRF-8 or ICSBP), play important roles in interferon signaling in a wide range of host responses to infection and tumor growth. Interleukin-27 (IL-27), as a member of the IL-12 cytokine family, not only acts as a proinflammatory cytokine that regulates the differentiation of naive T helper cells but also possesses anti-inflammatory properties. IL-27 consists of EBI3 (Epstein-Barr virus-induced gene 3) and p28 subunits. Our previous work has shown that IRF-1 regulates IL-27 p28 gene transcription by specifically binding to the IRF-1 response element in the p28 promoter. In this study, we found that IRF-8-deficient macrophages were highly defective in the production of IL-27 p28 at both mRNA and protein levels. Circulating IL-27 p28 in serum was also decreased in IRF-8(-/-) mice in a septic shock model. Lipopolysaccharide, as a potent inducer of IL-27 p28 expression, could activate IRF-8 expression in a MyD88-dependent pathway, which in turn induced p28 gene transcription through NF-kappa B and/or IRF-8. Transcriptional analyses revealed that IRF-8 activated p28 gene transcription through binding to a site located at -57 to -48 in the p28 promoter overlapping the IRF-1 binding site. Consistent with this observation, overexpression of both IRF-8 and IRF-1 additively activated IL-27 p28 promoter. This study provides further mechanistic information regarding how signals initiated during innate and adaptive immune responses synergize to yield greater IL-27 production and sustained cellular immunity.	[Zhang, Jidong; Qian, Xuesong; Ning, Huan; Liu, Jianguo] St Louis Univ, Sch Med, Dept Internal Med, Div Immunobiol, St Louis, MO 63104 USA; [Yang, Jianjun; Xiong, Huabao] Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA	Saint Louis University; Icahn School of Medicine at Mount Sinai	Liu, JG (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, Div Immunobiol, 1100 S Grand Blvd,DRC Rm 811, St Louis, MO 63104 USA.	jliu9@slu.edu	NING, HUAN/R-4786-2018; yang, jian/HIK-0188-2022		Vasculitis Foundation	Vasculitis Foundation	This work was supported in part by the Vasculitis Foundation.	Artis D, 2004, J IMMUNOL, V172, P4672, DOI 10.4049/jimmunol.172.8.4672; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Chiyo M, 2004, ANTICANCER RES, V24, P3763; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Duncan GS, 1996, J EXP MED, V184, P2043, DOI 10.1084/jem.184.5.2043; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Levi BZ, 2002, J INTERF CYTOK RES, V22, P153, DOI 10.1089/107999002753452764; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Liu JG, 2007, J EXP MED, V204, P141, DOI 10.1084/jem.20061440; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Lohoff M, 2000, J EXP MED, V192, P325, DOI 10.1084/jem.192.3.325; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Miyazaki Y, 2005, J IMMUNOL, V175, P2401, DOI 10.4049/jimmunol.175.4.2401; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; Nozawa H, 1999, GENE DEV, V13, P1240, DOI 10.1101/gad.13.10.1240; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pirhonen J, 2007, J LEUKOCYTE BIOL, V82, P1185, DOI 10.1189/jlb.0307157; Remoli ME, 2007, EUR J IMMUNOL, V37, P3499, DOI 10.1002/eji.200737566; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tsujimura H, 2004, J IMMUNOL, V172, P6820, DOI 10.4049/jimmunol.172.11.6820; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Zahn S, 2005, EUR J IMMUNOL, V35, P1106, DOI 10.1002/eji.200425926; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	56	47	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21269	21281		10.1074/jbc.M110.100818	http://dx.doi.org/10.1074/jbc.M110.100818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20435892	Green Published, hybrid			2022-12-25	WOS:000279516100012
J	Favre, C; Zhdanov, A; Leahy, M; Papkovsky, D; O'Connor, R				Favre, C.; Zhdanov, A.; Leahy, M.; Papkovsky, D.; O'Connor, R.			Mitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells	ONCOGENE			English	Article						PNC1; IGF-I; mitochondria; ROS; EMT in cancer; metabolism	ACTIVATED PROTEIN-KINASE; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-I; AEROBIC GLYCOLYSIS; SKELETAL-MUSCLE; OXIDATIVE STRESS; DNA-REPLICATION; INSULIN; METABOLISM; OXYGEN	The insulin-like growth factor (IGF-I) signalling pathway is essential for metabolism, cell growth and survival. It induces expression of the mitochondrial pyrimidine nucleotide carrier 1 (PNC1) in transformed cells, but the consequences of this for cell phenotype are unknown. Here we show that PNC1 is necessary to maintain mitochondrial function by controlling mitochondrial DNA replication and the ratio of transcription of mitochondrial genes relative to nuclear genes. PNC1 suppression causes reduced oxidative phosphorylation and leakage of reactive oxygen species (ROS), which activates the AMPK-PGC1 alpha signalling pathway and promotes mitochondrial biogenesis. Overexpression of PNC1 suppresses mitochondrial biogenesis. Suppression of PNC1 causes a profound ROS-dependent epithelial-mesenchymal transition (EMT), whereas overexpression of PNC1 suppresses both basal EMT and induction of EMT by TGF-beta. Overall, our findings indicate that PNC1 is essential for mitochondria maintenance and suggest that its induction by IGF-I facilitates cell growth whereas protecting cells from an ROS-promoted differentiation programme that arises from mitochondrial dysfunction. Oncogene (2010) 29, 3964-3976; doi:10.1038/onc.2010.146; published online 10 May 2010	[Favre, C.; Leahy, M.; O'Connor, R.] Univ Coll Cork, BioSci Inst, Dept Biochem, Cell Biol Lab, Cork, Ireland; [Zhdanov, A.; Papkovsky, D.] Univ Coll Cork, Dept Biochem, Lab Biophys & Bioanal, Cork, Ireland	University College Cork; University College Cork	O'Connor, R (corresponding author), Univ Coll Cork, BioSci Inst, Dept Biochem, Cell Biol Lab, Coll Rd, Cork, Ireland.	r.oconnor@ucc.ie	O'Connor, Rosemary/B-7902-2014	O'Connor, Rosemary/0000-0002-0687-3422; Zhdanov, Alexander/0000-0001-5787-2035; Papkovsky, Dmitri/0000-0003-1556-1145	Science Foundation Ireland; Health Research Board	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board	We thank Kurt Tidmore for assistance with illustrations and to our colleagues in the Cell Biology Laboratory for helpful discussions. This work was funded by Science Foundation Ireland and the Health Research Board.	Ayllon V, 2007, ONCOGENE, V26, P3451, DOI 10.1038/sj.onc.1210142; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Ferraro D, 2006, ONCOGENE, V25, P3689, DOI 10.1038/sj.onc.1209409; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Hynes J, 2009, ANAL BIOCHEM, V390, P21, DOI 10.1016/j.ab.2009.04.016; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200; Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Marshall Stephen, 2006, Sci STKE, V2006, pre7; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Naito A, 2008, CANCER SCI, V99, P1584, DOI 10.1111/j.1349-7006.2008.00879.x; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Pankratz SL, 2009, J BIOL CHEM, V284, P2031, DOI 10.1074/jbc.M804776200; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Perez R, 2008, WORLD J GASTROENTERO, V14, P2731, DOI 10.3748/wjg.14.2731; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; QUON MJ, 1995, MOL CELL BIOL, V15, P5403; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Unterluggauer Hermann, 2008, Biotechnology Journal, V3, P813, DOI 10.1002/biot.200700254; VANDYCK E, 1995, MOL GEN GENET, V246, P426, DOI 10.1007/BF00290446; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Will Y, 2006, NAT PROTOC, V1, P2563, DOI 10.1038/nprot.2006.351; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Zhdanov AV, 2008, J BIOL CHEM, V283, P5650, DOI 10.1074/jbc.M706439200	46	58	60	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 8	2010	29	27					3964	3976		10.1038/onc.2010.146	http://dx.doi.org/10.1038/onc.2010.146			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	621SL	20453889				2022-12-25	WOS:000279603200009
J	Nagano, M; Hoshino, D; Sakamoto, T; Kawasaki, N; Koshikawa, N; Seiki, M				Nagano, Makoto; Hoshino, Daisuke; Sakamoto, Takeharu; Kawasaki, Noritaka; Koshikawa, Naohiko; Seiki, Motoharu			ZF21 Protein Regulates Cell Adhesion and Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE SHP-2; FOCAL ADHESION; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; EXTRACELLULAR-MATRIX; ALPHA-ACTININ; FYVE FINGER; MIGRATION; KINASE; CYTOSKELETON; INTEGRINS	Cell migration on an extracellular matrix (ECM) requires continuous formation and turnover of focal adhesions (FAs) along the direction of cell movement. However, our knowledge of the components of FAs and the mechanism of their regulation remains limited. Here, we identify ZF21, a member of a protein family characterized by the presence of a phosphatidylinositol 3-phosphate-binding FYVE domain, to be a new regulator of FAs and cell movement. Knockdown of ZF21 expression in cells increased the number of FAs and suppressed cell migration. Knockdown of ZF21 expression also led to a significant delay in FA disassembly following induction of synchronous disassembly of FAs by nocodazole treatment. ZF21 bound to focal adhesion kinase, localized to FAs, and was necessary for dephosphorylation of FAK at Tyr(397), which is important for disassembly of FAs. Thus, ZF21 represents a new component of FAs, mediates disassembly of FAs, and thereby regulates cell motility.	[Nagano, Makoto; Hoshino, Daisuke; Sakamoto, Takeharu; Kawasaki, Noritaka; Koshikawa, Naohiko] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Seiki, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Koshikawa, Naohiko/S-7306-2017; Nagano, Makoto/J-7050-2015; Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015	Koshikawa, Naohiko/0000-0002-4539-888X; Nagano, Makoto/0000-0002-1948-1591; Sakamoto, Takeharu/0000-0002-1225-1902; 	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Specific Coordination Fund for Promoting Science (to T. S.), by a grant-in-aid for scientific research on priority areas ("Integrative Research toward the Conquest of Cancer") (to M. S.), and by Global COE Program (to T. S. and M. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Carlucci A, 2008, J BIOL CHEM, V283, P10919, DOI 10.1074/jbc.M707248200; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; GLUCK U, 1994, J CELL SCI, V107, P1773; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; ILIAE D, 1995, NATURE, V377, P539; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Iwahara T, 2004, P NATL ACAD SCI USA, V101, P17693, DOI 10.1073/pnas.0408413102; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Liu SC, 2000, J CELL SCI, V113, P3563; Manes S, 1999, MOL CELL BIOL, V19, P3125; Meighan CM, 2008, CURR OPIN CELL BIOL, V20, P520, DOI 10.1016/j.ceb.2008.05.010; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Uekita T, 2004, J BIOL CHEM, V279, P12734, DOI 10.1074/jbc.M309957200; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	42	16	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21013	21022		10.1074/jbc.M110.106443	http://dx.doi.org/10.1074/jbc.M110.106443			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439989	Green Published, hybrid			2022-12-25	WOS:000279228600065
J	Wernimont, SA; Simonson, WTN; Greer, PA; Seroogy, CM; Huttenlocher, A				Wernimont, Sarah A.; Simonson, William T. N.; Greer, Peter A.; Seroogy, Christine M.; Huttenlocher, Anna			Calpain 4 Is Not Necessary for LFA-1-Mediated Function in CD4+T Cells	PLOS ONE			English	Article							PERIPHERAL T-CELLS; UBIQUITOUS CALPAINS; CYTOPLASMIC DOMAIN; ACTIVATION; LFA-1; APOPTOSIS; MIGRATION; DEATH; DISRUPTION; INHIBITORS	Background: T cell activation and immune synapse formation require the appropriate activation and clustering of the integrin, LFA-1. Previous work has reported that the calpain family of calcium-dependent proteases are important regulators of integrin activation and modulate T cell adhesion and migration. However, these studies have been limited by the use of calpain inhibitors, which have known off-target effects. Methodology/Principal Findings: Here, we used a LoxP/CRE system to specifically deplete calpain 4, a small regulatory calpain subunit required for expression and activity of ubiquitously expressed calpains 1 and 2, in CD4+ T cells. CD4+ and CD8+ T cells developed normally in Capn4(F/F): CD4-CRE mice and had severely diminished expression of Calpain 1 and 2, diminished talin proteolysis and impaired casein degradation. Calpain 4-deficient T cells showed no difference in adhesion or migration on the LFA-1 ligand ICAM-1 compared to control T cells. Moreover, there was no impairment in conjugation between Capn4(F/F):CD4-CRE T cells and antigen presenting cells, and the conjugates were still capable of polarizing LFA-1, PKC-theta and actin to the immune synapse. Furthermore, T cells from Capn4(F/F):CD4-CRE mice showed normal proliferation in response to either anti-CD3/CD28 coated beads or cognate antigen-loaded splenocytes. Finally, there were no differences in the rates of apoptosis following extrinsic and intrinsic apoptotic stimuli. Conclusion/Significance: Our findings demonstrate that calpain 4 is not necessary for LFA-1-mediated adhesion, conjugation or migration. These results challenge previous reports that implicate a central role for calpains in the regulation of T cell LFA-1 function.	[Wernimont, Sarah A.; Simonson, William T. N.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Greer, Peter A.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Seroogy, Christine M.; Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Seroogy, Christine M.; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; McMaster University; Queens University - Canada; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wernimont, SA (corresponding author), Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA.	huttenlocher@wisc.edu		Wernimont, Sarah/0000-0002-6894-7837	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [AI068062]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) R01 to A. H. [AI068062]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Bleijs DA, 2001, J BIOL CHEM, V276, P10338, DOI 10.1074/jbc.M008967200; Butler JT, 2009, J NEUROSCI RES, V87, P626, DOI 10.1002/jnr.21882; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Cooper KM, 2008, MOL BIOL CELL, V19, P3180, DOI 10.1091/mbc.E08-02-0225; CRAWFORD C, 1988, BIOCHEM J, V253, P751, DOI 10.1042/bj2530751; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dreolini L, 2007, BIOCHEM BIOPH RES CO, V356, P207, DOI 10.1016/j.bbrc.2007.02.100; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; Kandula S, 2004, J IMMUNOL, V173, P4443, DOI 10.4049/jimmunol.173.7.4443; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; Noma H, 2009, IMMUNOLOGY, V128, pe487, DOI 10.1111/j.1365-2567.2008.03012.x; RASER KJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P211, DOI 10.1006/abbi.1995.1284; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock MT, 2000, EXP CELL RES, V261, P260, DOI 10.1006/excr.2000.5048; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; SARIN A, 1993, J EXP MED, V178, P1693, DOI 10.1084/jem.178.5.1693; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Simonson WTN, 2006, J IMMUNOL, V177, P7707, DOI 10.4049/jimmunol.177.11.7707; Squier MKT, 1997, J IMMUNOL, V158, P3690; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Tan Y, 2006, GENESIS, V44, P297, DOI 10.1002/dvg.20216; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Varghese J, 2001, EUR J IMMUNOL, V31, P2035, DOI 10.1002/1521-4141(200107)31:7<2035::AID-IMMU2035>3.0.CO;2-Y; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Yang YL, 1997, BLOOD, V89, P550, DOI 10.1182/blood.V89.2.550	34	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10513	10.1371/journal.pone.0010513	http://dx.doi.org/10.1371/journal.pone.0010513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479866	Green Submitted, gold, Green Published			2022-12-25	WOS:000277467800005
J	Bagaitkar, J; Demuth, DR; Daep, CA; Renaud, DE; Pierce, DL; Scott, DA				Bagaitkar, Juhi; Demuth, Donald R.; Daep, Carlo Amorin; Renaud, Diane E.; Pierce, Deanne L.; Scott, David A.			Tobacco Upregulates P. gingivalis Fimbrial Proteins Which Induce TLR2 Hyposensitivity	PLOS ONE			English	Article							CIGARETTE-SMOKE EXTRACT; CREVICULAR FLUID LEVELS; INNATE IMMUNE-RESPONSE; PORPHYROMONAS-GINGIVALIS; EPITHELIAL-CELLS; CYTOKINE PRODUCTION; TNF-ALPHA; IN-VIVO; ACTIVATION; VIRULENCE	Background: Tobacco smokers are more susceptible to periodontitis than non-smokers but exhibit reduced signs of clinical inflammation. The underlying mechanisms are unknown. We have previously shown that cigarette smoke extract (CSE) represents an environmental stress to which P. gingivalis adapts by altering the expression of several virulence factors including major and minor fimbrial antigens (FimA and Mfa1, respectively) and capsule - concomitant with a reduced pro-inflammatory potential of intact P. gingivalis. Methodology/Principal Findings: We hypothesized that CSE-regulation of capsule and fimbrial genes is reflected at the ultrastructural and functional levels, alters the nature of host-pathogen interactions, and contributes to the reduced pro-inflammatory potential of smoke exposed P. gingivalis. CSE induced ultrastructural alterations were determined by electron microscopy, confirmed by Western blot and physiological consequences studied in open-flow biofilms. Inflammatory profiling of specific CSE-dysregulated proteins, rFimA and rMfa1, was determined by quantifying cytokine induction in primary human innate and OBA-9 cells. CSE up-regulates P. gingivalis FimA at the protein level, suppresses the production of capsular polysaccharides at the ultrastructural level, and creates conditions that promote biofilm formation. We further show that while FimA is recognized by TLR2/6, it has only minimal inflammatory activity in several cell types. Furthermore, FimA stimulation chronically abrogates the pro-inflammatory response to subsequent TLR2 stimulation by other TLR-2-specific agonists (Pam3CSK4, FSL, Mfa1) in an IkB alpha- and IRAK-1-dependent manner. Conclusions/Significance: These studies provide some of the first information to explain, mechanistically, how tobacco smoke changes the P. gingivalis phenotype in a manner likely to promote P. gingivalis colonization and infection while simultaneously reducing the host response to this major mucosal pathogen.	[Bagaitkar, Juhi; Demuth, Donald R.; Daep, Carlo Amorin; Scott, David A.] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Demuth, Donald R.; Renaud, Diane E.; Pierce, Deanne L.; Scott, David A.] Univ Louisville, Sch Dent, Oral Hlth & Syst Dis Res Grp, Dept Oral Hlth & Rehabil, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Bagaitkar, J (corresponding author), Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	dascot07@louisville.edu	Scott, David/GYU-8656-2022	Scott, David A./0000-0003-1007-2756	National Institute of Environmental Health Sciences (NIEHS); Integrative Biology at the University of Louisville [1P30ES014443-01A1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Integrative Biology at the University of Louisville; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by a National Institute of Environmental Health Sciences (NIEHS) pilot grant awarded to the Center for Environmental Genomics and Integrative Biology at the University of Louisville (1P30ES014443-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the investigators had any direct or indirect tobacco funding for their salaries.	Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; Andreou V, 2004, J PERIODONTOL, V75, P939, DOI 10.1902/jop.2004.75.7.939; BAGAITKAR J, 2009, ENV MICROBIOL; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Bagaitkar J, 2009, ENVIRON MICROBIOL, V11, P1242, DOI 10.1111/j.1462-2920.2008.01852.x; Bergstrom J, 2000, J CLIN PERIODONTOL, V27, P61, DOI 10.1034/j.1600-051x.2000.027001061.x; Bergstrom Jan, 2006, J Evid Based Dent Pract, V6, P33, DOI 10.1016/j.jebdp.2005.12.018; Billips BK, 2008, INFECT IMMUN, V76, P3891, DOI 10.1128/IAI.00069-08; Bostrom L, 1999, J CLIN PERIODONTOL, V26, P352, DOI 10.1034/j.1600-051X.1999.260604.x; Calsina G, 2002, J CLIN PERIODONTOL, V29, P771; Chamekh M, 2008, J IMMUNOL, V180, P4292, DOI 10.4049/jimmunol.180.6.4292; d'Empaire G, 2006, INFECT IMMUN, V74, P6236, DOI 10.1128/IAI.00519-06; Daep CA, 2006, INFECT IMMUN, V74, P5756, DOI 10.1128/IAI.00813-06; Davey ME, 2006, J BACTERIOL, V188, P5510, DOI 10.1128/JB.01685-05; de Heens GLT, 2009, J PERIODONTAL RES, V44, P28, DOI 10.1111/j.1600-0765.2007.01047.x; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Eggert FM, 2001, J PERIODONTOL, V72, P1210, DOI 10.1902/jop.2000.72.9.1210; Erdemir EO, 2004, J CLIN PERIODONTOL, V31, P99, DOI 10.1111/j.0303-6979.2004.00454.x; Eskan MA, 2007, INFECT IMMUN, V75, P892, DOI 10.1128/IAI.01604-06; Fraser HS, 2001, J DENT RES, V80, P1643, DOI 10.1177/00220345010800070901; Gensch E, 2004, J BIOL CHEM, V279, P39085, DOI 10.1074/jbc.M406866200; Graves DT, 2005, J ENDOTOXIN RES, V11, P13, DOI 10.1179/096805105225006722; Haffajee AD, 2001, J CLIN PERIODONTOL, V28, P377, DOI 10.1034/j.1600-051x.2001.028005377.x; Hajishengallis G, 2006, CELL MICROBIOL, V8, P1557, DOI 10.1111/j.1462-5822.2006.00730.x; Hamada N, 2002, ORAL MICROBIOL IMMUN, V17, P197, DOI 10.1034/j.1399-302X.2002.170311.x; Hamada S, 1998, ORAL MICROBIOL IMMUN, V13, P129, DOI 10.1111/j.1399-302X.1998.tb00724.x; Harokopakis E, 2005, EUR J IMMUNOL, V35, P1201, DOI 10.1002/eji.200425883; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Kamma JJ, 1999, J PERIODONTAL RES, V34, P25, DOI 10.1111/j.1600-0765.1999.tb02218.x; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kuboniwa M, 2009, ORAL MICROBIOL IMMUN, V24, P260, DOI 10.1111/j.1399-302X.2009.00511.x; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Laine ML, 1998, ORAL MICROBIOL IMMUN, V13, P322, DOI 10.1111/j.1399-302X.1998.tb00714.x; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Maeda K, 2004, INFECT IMMUN, V72, P1341, DOI 10.1128/IAI.72.3.1341-1348.2004; Murakami Y, 2006, ARCH BIOCHEM BIOPHYS, V449, P171, DOI 10.1016/j.abb.2006.02.005; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; Nair P, 2003, J CLIN PERIODONTOL, V30, P435, DOI 10.1034/j.1600-051X.2003.20039.x; Nakagawa I, 2006, INFECT IMMUN, V74, P3773, DOI 10.1128/IAI.01902-05; Neumann D, 2007, BIOCHEM BIOPH RES CO, V354, P1089, DOI 10.1016/j.bbrc.2007.01.104; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; Nouri-Shirazi M, 2007, IMMUNOL LETT, V109, P155, DOI 10.1016/j.imlet.2007.02.005; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Palmer RM, 2005, J CLIN PERIODONTOL, V32, P180, DOI 10.1111/j.1600-051X.2005.00786.x; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Petropoulos G, 2004, J CLIN PERIODONTOL, V31, P390, DOI 10.1111/j.1600-051X.2004.00489.x; Pierce DL, 2009, INFECT IMMUN, V77, P3294, DOI 10.1128/IAI.00262-09; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Robbins CS, 2008, J IMMUNOL, V180, P6623, DOI 10.4049/jimmunol.180.10.6623; Sayers NM, 1999, J PERIODONTOL, V70, P1269, DOI 10.1902/jop.1999.70.11.1269; Sayers NM, 1997, J CLIN PATHOL, V50, P245, DOI 10.1136/jcp.50.3.245; Scott D A, 2004, Int J Dent Hyg, V2, P104, DOI 10.1111/j.1601-5037.2004.00079.x; Scott DA, 2006, WORLD J GASTROENTERO, V12, P7451, DOI 10.3748/wjg.v12.i46.7451; Shirodaria S, 2000, J DENT RES, V79, P1864, DOI 10.1177/00220345000790110801; Siedlar M, 2004, J IMMUNOL, V173, P2736, DOI 10.4049/jimmunol.173.4.2736; Stringer KA, 2007, AM J PHYSIOL-LUNG C, V292, pL1572, DOI 10.1152/ajplung.00325.2006; Umeda JE, 2006, ORAL MICROBIOL IMMUN, V21, P415, DOI 10.1111/j.1399-302X.2006.00312.x; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wolfe DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004280; Xu MQ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-19; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006; Zambon JJ, 1996, J PERIODONTOL, V67, P1050, DOI 10.1902/jop.1996.67.10s.1050; Zappacosta B, 2001, LUMINESCENCE, V16, P315, DOI 10.1002/bio.661; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005; Zhou QD, 2007, J IMMUNOL, V179, P7777, DOI 10.4049/jimmunol.179.11.7777	67	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e9323	10.1371/journal.pone.0009323	http://dx.doi.org/10.1371/journal.pone.0009323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454607	Green Submitted, Green Published, gold			2022-12-25	WOS:000277305300001
J	Dutta, S; Rittinger, K				Dutta, Sujit; Rittinger, Katrin			Regulation of NOXO1 Activity through Reversible Interactions with p22(phox) and NOXA1	PLOS ONE			English	Article							PHAGOCYTE NADPH OXIDASE; PHOSPHORYLATION-INDUCED ACTIVATION; PROTEIN-KINASE-C; SH3 DOMAINS; NAD(P)H OXIDASE-1; SUPEROXIDE; P47(PHOX); BINDING; P67(PHOX); FAMILY	Reactive oxygen species (ROS) have been known for a long time to play important roles in host defense against microbial infections. In addition, it has become apparent that they also perform regulatory roles in signal transduction and cell proliferation. The source of these chemicals are members of the NOX family of NADPH oxidases that are found in a variety of tissues. NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1) and NOXA1 (NOX activating protein 1), as well as the flavocytochrome component p22(phox) for maximal activity. Unlike NOX2, the phagocytic NADPH oxidase whose activity is tightly repressed in the resting state, NOX1 produces superoxide constitutively at low levels. These levels can be further increased in a stimulus-dependent manner, yet the molecular details regulating this activity are not fully understood. Here we present the first quantitative characterization of the interactions made between the cytosolic regulators NOXO1 and NOXA1 and membrane-bound p22(phox). Using isothermal titration calorimetry we show that the isolated tandem SH3 domains of NOXO1 bind to p22(phox) with high affinity, most likely adopting a superSH3 domain conformation. In contrast, complex formation is severely inhibited in the presence of the C-terminal tail of NOXO1, suggesting that this region competes for binding to p22(phox) and thereby contributes to the regulation of superoxide production. Furthermore, we provide data indicating that the molecular details of the interaction between NOXO1 and NOXA1 is significantly different from that between the homologous proteins of the phagocytic oxidase, suggesting that there are important functional differences between the two systems. Taken together, this study provides clear evidence that the assembly of the NOX1 oxidase complex can be regulated through reversible protein-protein interactions.	[Dutta, Sujit; Rittinger, Katrin] Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Dutta, S (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	katrin.rittinger@nimr.mrc.ac.uk	Rittinger, Katrin/N-3344-2019; Rittinger, Katrin/D-2586-2014	Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435	Medical Research Council, UK; Medical Research Council [MC_U117565398] Funding Source: researchfish; MRC [MC_U117565398] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; CHENG G, 2006, J BIOL CHEM; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Huang J, 1999, J BIOL CHEM, V274, P19731, DOI 10.1074/jbc.274.28.19731; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kawahara T, 2004, J IMMUNOL, V172, P3051, DOI 10.4049/jimmunol.172.5.3051; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-178; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lambeth JD, 2002, CURR OPIN HEMATOL, V9, P11, DOI 10.1097/00062752-200201000-00003; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Perisic O, 2004, ADV ENZYME REGUL, V44, P279, DOI 10.1016/j.advenzreg.2003.11.003; Pires JR, 2003, J MOL BIOL, V326, P1427, DOI 10.1016/S0022-2836(03)00039-1; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Rokutan K, 2006, ANTIOXID REDOX SIGN, V8, P1573, DOI 10.1089/ars.2006.8.1573; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Yamamoto A, 2007, BIOCHEM BIOPH RES CO, V352, P560, DOI 10.1016/j.bbrc.2006.11.060; Yuzawa S, 2004, GENES CELLS, V9, P443, DOI 10.1111/j.1356-9597.2004.00733.x	44	40	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10478	10.1371/journal.pone.0010478	http://dx.doi.org/10.1371/journal.pone.0010478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454568	Green Published, Green Submitted, gold			2022-12-25	WOS:000277305300012
J	Faghiri, Z; Camargo, SMR; Huggel, K; Forster, IC; Ndegwa, D; Verrey, F; Skelly, PJ				Faghiri, Zahra; Camargo, Simone M. R.; Huggel, Katja; Forster, Ian C.; Ndegwa, David; Verrey, Francois; Skelly, Patrick J.			The Tegument of the Human Parasitic Worm Schistosoma mansoni as an Excretory Organ: The Surface Aquaporin SmAQP Is a Lactate Transporter	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; WATER CHANNELS; FUNCTIONAL EXPRESSION; METABOLISM; CLONING; SELECTIVITY; APPEARANCE; PROTEINS; GLYCEROL; GLYCOGEN	Adult schistosomes are intravascular parasites that metabolize imported glucose largely via glycolysis. How the parasites get rid of the large amounts of lactic acid this generates is unknown at the molecular level. Here, we report that worms whose aquaporin gene (SmAQP) has been suppressed using RNAi fail to rapidly acidify their culture medium and excrete less lactate compared to controls. Functional expression of SmAQP in Xenopus oocytes demonstrates that this protein can transport lactate following Michaelis-Menten kinetics with low apparent affinity (Km = 41+/-5.8 mM) and with a low energy of activation (E-a = 7.18+/-0.7 kcal/mol). Phloretin, a known inhibitor of lactate release from schistosomes, also inhibits lactate movement in SmAQP-expressing oocytes. In keeping with the substrate promiscuity of other aquaporins, SmAQP is shown here to be also capable of transporting water, mannitol, fructose and alanine but not glucose. Using immunofluorescent and immuno-EM, we confirm that SmAQP is localized in the tegument of adult worms. These findings extend the proposed functions of the schistosome tegument beyond its known capacity as an organ of nutrient uptake to include a role in metabolic waste excretion.	[Faghiri, Zahra; Ndegwa, David; Skelly, Patrick J.] Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, Mol Helminthol Lab,Div Infect Dis, Grafton, MA USA; [Camargo, Simone M. R.; Huggel, Katja; Forster, Ian C.; Verrey, Francois] Univ Zurich, Inst Physiol, Zurich, Switzerland	Tufts University; University of Zurich	Faghiri, Z (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, Mol Helminthol Lab,Div Infect Dis, Grafton, MA USA.	Patrick.Skelly@Tufts.edu		Forster, Ian/0000-0003-3087-9952; Camargo, Simone/0000-0003-0091-7380; Verrey, Francois/0000-0003-3250-9824	NIH-NIAID [AI-056273]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056273] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH-NIAID grant AI-056273. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Bacconi A, 2007, J MEMBRANE BIOL, V215, P81, DOI 10.1007/s00232-007-9008-1; Braschi S, 2006, PROTEOMICS, V6, P1471, DOI 10.1002/pmic.200500368; Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200; BUEDING E, 1950, J GEN PHYSL, V33; Correnti JA, 2005, MOL BIOCHEM PARASIT, V143, P209, DOI 10.1016/j.molbiopara.2005.06.007; DA'Dara AA, 2003, PARASITE IMMUNOL, V25, P429, DOI 10.1111/j.1365-3024.2003.00651.x; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Echevarria M, 1996, J BIOL CHEM, V271, P25079, DOI 10.1074/jbc.271.41.25079; Faghiri Z, 2009, FASEB J, V23, P2780, DOI 10.1096/fj.09-130757; Githui E. K., 2006, Journal of Tropical Microbiology and Biotechnology, V2, P31; Githui EK, 2006, EXP PARASITOL, V114, P180, DOI 10.1016/j.exppara.2006.03.007; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; HOREMANS AMC, 1991, PARASITOLOGY, V102, P259, DOI 10.1017/S0031182000062570; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; KATSURA T, 1995, P NATL ACAD SCI USA, V92, P7212, DOI 10.1073/pnas.92.16.7212; Krautz-Peterson G, 2007, J BIOL CHEM, V282, P21767, DOI 10.1074/jbc.M703512200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Meredith D, 2008, XENOBIOTICA, V38, P1072, DOI [10.1080/00498250802010868, 10.1080/00498250802010868 ]; Merezhinskaya N, 2009, HISTOL HISTOPATHOL, V24, P243, DOI 10.14670/HH-24.243; Ohgusu Y, 2008, DRUG METAB PHARMACOK, V23, P279, DOI 10.2133/dmpk.23.279; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; SHAPIRO TA, 1982, EXP PARASITOL, V54, P379, DOI 10.1016/0014-4894(82)90047-9; Skelly PJ, 2006, ADV PARASIT, V63, P185, DOI 10.1016/S0065-308X(06)63003-0; Skelly PJ, 1996, P NATL ACAD SCI USA, V93, P3642, DOI 10.1073/pnas.93.8.3642; SKELLY PJ, 1994, J BIOL CHEM, V269, P4247; Skelly PJ, 2000, INT J PARASITOL, V30, P625, DOI 10.1016/S0020-7519(00)00031-X; Skelly PJ, 2001, PARASITOLOGY, V123, P277, DOI 10.1017/S0031182001008484; Skelly PJ, 2001, PARASITOLOGY, V122, P67, DOI 10.1017/S0031182000007071; Skelly PJ, 1998, PARASITOL TODAY, V14, P402, DOI 10.1016/S0169-4758(98)01319-2; THOMPSON DP, 1984, MOL BIOCHEM PARASIT, V13, P39, DOI 10.1016/0166-6851(84)90100-2; TIELENS AGM, 1990, MOL BIOCHEM PARASIT, V39, P195, DOI 10.1016/0166-6851(90)90058-T; TIELENS AGM, 1989, EXP PARASITOL, V68, P235, DOI 10.1016/0014-4894(89)90103-3; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; Yukutake Y, 2008, BIOL CELL, V100, P355, DOI 10.1042/BC20070132; ZHANG R, 1990, J BIOL CHEM, V265, P15375	38	62	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10451	10.1371/journal.pone.0010451	http://dx.doi.org/10.1371/journal.pone.0010451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454673	Green Published, Green Submitted, gold			2022-12-25	WOS:000277240300023
J	Gulliford, MC; Dodhia, H; Sivaprasad, S; Ashworth, M				Gulliford, Martin C.; Dodhia, Hiten; Sivaprasad, Sobha; Ashworth, Mark			Family Practices' Achievement of Diabetes Quality of Care Targets and Risk of Screen-Detected Diabetic Retinopathy	PLOS ONE			English	Article							MICROVASCULAR COMPLICATIONS; SOCIOECONOMIC-STATUS; SOCIAL DEPRIVATION; OUTCOMES; PAY; PERFORMANCE; ENGLAND; INEQUALITIES; INCENTIVES; ILLNESS	Background: We aimed to determine whether family practices' achievement of diabetes quality of care targets is associated with diabetic retinal disease in registered patients. Methods: Data for achievement of diabetes quality of care targets, including the proportion of patients with HbA1c <= 7.5%, for 144 family practices in London UK, for the years 2004/5 to 2007/8, were linked to data from a population-based diabetes eye screening programme collected from September 2007 to February 2009. Analyses were adjusted for age, sex, duration and type of diabetes, unadjusted diabetes prevalence, ethnicity and deprivation category. Results: Data were analysed for 24,458 participants with one or more eye screening results in the period. There were 9,332 (38%) with any diabetic retinopathy and 2,819 (11.5%) with sight threatening diabetic retinopathy (STDR), including 2,654 (10.9%) with maculopathy. Among participants registered at 13 family practices that were in the highest quartile for achievement of the HbA1c quality of care target for all four years of study, the relative odds of any diabetic retinopathy were 0.78 (0.69 to 0.88) P<0.001. For participants at 12 practices consistently in the lowest quartile of HbA1c achievement, the relative odds of any diabetic retinopathy were 1.16 (1.03 to 1.30), P = 0.015. In the highest achieving practices, the relative odds of maculopathy were 0.74 (0.62 to 0.89), P = 0.001 and STDR 0.77 (0.65 to 0.92), P = 0.004. Conclusions: The risk of diabetic retinopathy might be lower at family practices that consistently achieve highly on diabetes quality of care targets for HbA1c.	[Gulliford, Martin C.; Ashworth, Mark] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England; [Dodhia, Hiten] Lambeth NHS Primary Care Trust, Dept Publ Hlth, London, England; [Sivaprasad, Sobha] Kings Coll Hosp London, Dept Ophthalmol, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Gulliford, MC (corresponding author), Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England.	martin.gulliford@kcl.ac.uk	Sivaprasad, S./D-6876-2015; Gulliford, Martin C/I-8606-2018	Sivaprasad, S./0000-0001-8952-0659; Gulliford, Martin C/0000-0003-1898-9075; Ashworth, Mark/0000-0001-6514-9904	Lambeth NHS Primary Care Trusts, London UK; Southwark NHS Primary Care Trusts, London UK; Lewisham NHS Primary Care Trusts, London UK	Lambeth NHS Primary Care Trusts, London UK; Southwark NHS Primary Care Trusts, London UK; Lewisham NHS Primary Care Trusts, London UK	The study was supported by Lambeth, Southwark and Lewisham NHS Primary Care Trusts, London UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth M, 2008, MED J AUSTRALIA, V189, P60, DOI 10.5694/j.1326-5377.2008.tb01916.x; Ashworth M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2030; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Edwards R, 2003, DIABETOLOGIA, V46, P750, DOI 10.1007/s00125-003-1102-z; Epstein AM, 2006, NEW ENGL J MED, V355, P406, DOI 10.1056/NEJMe068131; Gulliford MC, 2007, DIABETIC MED, V24, P505, DOI 10.1111/j.1464-5491.2007.02090.x; Gulliford MC, 2010, DIABETIC MED, V27, P282, DOI 10.1111/j.1464-5491.2010.02946.x; HAFFNER SM, 1989, DIABETES CARE, V12, P128, DOI 10.2337/diacare.12.2.128; Hart JT, 2000, BRIT MED J, V320, P18; *I MED, 2005, COMM QUAL HLTH CAR A; KELLY WF, 1993, BRIT MED J, V307, P1115, DOI 10.1136/bmj.307.6912.1115; Khunti K, 2001, FAM PRACT, V18, P27, DOI 10.1093/fampra/18.1.27; KLEIN R, 1988, JAMA-J AM MED ASSOC, V260, P2864, DOI 10.1001/jama.260.19.2864; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; Millett C, 2006, J MED SCREEN, V13, P152, DOI 10.1258/096914106778440608; *NAT SCREEN PROGR, 2009, NAT PROGR; *OFF NAT STAT, 2009, NEIGHB STAT; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Scanlon PH, 2008, J MED SCREEN, V15, P118, DOI 10.1258/jms.2008.008013; Scanlon PH, 2008, J MED SCREEN, V15, P1, DOI 10.1258/jms.2008.008015; Stata Corporation, 2009, STAT STAT SOFTW REL; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Vaghela P, 2009, DIABETES CARE, V32, P427, DOI 10.2337/dc08-1999; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10424	10.1371/journal.pone.0010424	http://dx.doi.org/10.1371/journal.pone.0010424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454691	Green Published, gold, Green Submitted			2022-12-25	WOS:000277240100028
J	Melzi, R; Antonioli, B; Mercalli, A; Battaglia, M; Valle, A; Pluchino, S; Galli, R; Sordi, V; Bosi, E; Martino, G; Bonifacio, E; Doglioni, C; Piemonti, L				Melzi, Raffaella; Antonioli, Barbara; Mercalli, Alessia; Battaglia, Manuela; Valle, Andrea; Pluchino, Stefano; Galli, Rossella; Sordi, Valeria; Bosi, Emanuele; Martino, Gianvito; Bonifacio, Ezio; Doglioni, Claudio; Piemonti, Lorenzo			Co-Graft of Allogeneic Immune Regulatory Neural Stem Cells (NPC) and Pancreatic Islets Mediates Tolerance, while Inducing NPC-Derived Tumors in Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-I; T-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; TRANSPLANTATION; INSULIN; TRANSFORMATION; NEUROSPHERES; INSTABILITY; EXPRESSION	Background: Data available on the immunomodulatory properties of neural stem/precursor cells (NPC) support their possible use as modulators for immune-mediated process. The aim of this study was to define whether NPC administered in combination with pancreatic islets prevents rejection in a fully mismatched allograft model. Methodology/Principal Finding: Diabetic Balb/c mice were co-transplanted under the kidney capsule with pancreatic islets and GFP(+) NPC from fully mismatched C57BL/6 mice. The following 4 groups of recipients were used: mice receiving islets alone; mice receiving islets alone and treated with standard immunosuppression (IL-2R alpha chain mAbs + FK506 + Rapamycin); mice receiving a mixed islet/NPC graft under the same kidney capsule (Co-NPC-Tx); mice receiving the islet graft under the left kidney capsule and the NPC graft under the right kidney capsule (NPC-Tx). Our results demonstrate that only the co-transplantation and co-localization of NPC and islets (Co-NPC-Tx) induce stable long-term graft function in the absence of immunosuppression. This condition is associated with an expansion of CD4(+)CD25(+)FoxP3(+) T regulatory cells in the spleen. Unfortunately, stable graft function was accompanied by constant and reproducible development of NPC-derived cancer mainly sustained by insulin secretion. Conclusion: These data demonstrate that the use of NPC in combination with islets prevents graft rejection in a fully mismatched model. However, the development of NPC-derived cancer raises serious doubts about the safety of using adult stem cells in combination with insulin-producing cells outside the original microenvironment.	[Melzi, Raffaella; Antonioli, Barbara; Mercalli, Alessia; Battaglia, Manuela; Valle, Andrea; Sordi, Valeria; Piemonti, Lorenzo] Ist Sci San Raffaele, San Raffaele Diabet Res Inst HSR, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Pluchino, Stefano] Ist Sci San Raffaele, CNS Repair Unit, Inst Expt Neurol INSPE, Div Neurosci, I-20132 Milan, Italy; [Galli, Rossella] Ist Sci San Raffaele, Neural Stem Cell Biol Unit, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy; [Bosi, Emanuele] Ist Sci San Raffaele, Dept Internal Med, Diabet & Endocrinol Unit, I-20132 Milan, Italy; [Martino, Gianvito] Ist Sci San Raffaele, Neuroimmunol Unit, Inst Expt Neurol INSPE, Div Neurosci, I-20132 Milan, Italy; [Bonifacio, Ezio] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-8027 Dresden, Germany; [Doglioni, Claudio] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy; [Doglioni, Claudio] Univ Vita Salute, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Technische Universitat Dresden; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Melzi, R (corresponding author), Ist Sci San Raffaele, San Raffaele Diabet Res Inst HSR, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy.	piemonti.lorenzo@hsr.it	Sordi, Valeria/AAN-3913-2020; Galli, Rossella/AAI-8028-2020; Mercalli, Alessia/AAN-3811-2020; martino, gianvito/AAL-2682-2020; Piemonti, Lorenzo/P-7605-2017; Melzi, Raffaella/AAN-3825-2020; Pluchino, Stefano/AAE-9037-2019; Bonifacio, Ezio/E-7700-2010	Galli, Rossella/0000-0001-9023-7033; martino, gianvito/0000-0003-1295-9131; Piemonti, Lorenzo/0000-0002-2172-2198; Pluchino, Stefano/0000-0002-6267-9472; Bonifacio, Ezio/0000-0002-8704-4713; Sordi, Valeria/0000-0003-0179-1679; DOGLIONI, Claudio/0000-0002-4969-5216; Battaglia, Manuela/0000-0003-4535-3152	EU [HEALTH-F2-2008-202013]; Fondazione Cariplo [2007-5165]; Fondazione Siemens Italia (Milan, Italy); MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish	EU(European Commission); Fondazione Cariplo(Fondazione Cariplo); Fondazione Siemens Italia (Milan, Italy); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by EU (DIAPREPP Project, HEALTH-F2-2008-202013), by an award from Fondazione Cariplo (2007-5165) and by an award from Fondazione Siemens Italia (Milan, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONIADES HN, 1992, INT J CANCER, V50, P215, DOI 10.1002/ijc.2910500210; Arcaro A, 2007, BIOCHEM J, V406, P57, DOI 10.1042/BJ20070309; Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.1.40; Ben-Hur T, 2003, GLIA, V41, P73, DOI 10.1002/glia.10159; Beyer M, 2009, CURR PHARM DESIGN, V15, P1879, DOI 10.2174/138161209788453211; Burns JS, 2005, CANCER RES, V65, P3126, DOI 10.1158/0008-5472.CAN-04-2218; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Escolar ML, 2005, NEW ENGL J MED, V352, P2069, DOI 10.1056/NEJMoa042604; Fainstein N, 2008, MOL CELL NEUROSCI, V39, P335, DOI 10.1016/j.mcn.2008.07.007; Fecci PE, 2006, CANCER RES, V66, P3294, DOI 10.1158/0008-5472.CAN-05-3773; Foroni C, 2007, CANCER RES, V67, P3725, DOI 10.1158/0008-5472.CAN-06-4577; Gritti A, 1996, J NEUROSCI, V16, P1091; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Lu ZQ, 2009, J NEUROIMMUNOL, V206, P58, DOI 10.1016/j.jneuroim.2008.10.014; MARTIN DM, 1992, MOL BRAIN RES, V15, P241, DOI 10.1016/0169-328X(92)90114-Q; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Marzorati S, 2007, EXPERT OPIN BIOL TH, V7, P1627, DOI 10.1517/14712598.7.11.1627; Melzi R, 2007, TRANSPLANTATION, V83, P167, DOI 10.1097/01.tp.0000250659.24286.43; Miller RH, 2006, BRAIN RES, V1091, P258, DOI 10.1016/j.brainres.2006.01.073; Mineo D, 2008, AM J TRANSPLANT, V8, P1262, DOI 10.1111/j.1600-6143.2008.02230.x; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005959; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shiras A, 2007, STEM CELLS, V25, P1478, DOI 10.1634/stemcells.2006-0585; Solari MG, 2009, J AUTOIMMUN, V32, P116, DOI 10.1016/j.jaut.2009.01.003; Sordi V, 2010, STEM CELLS, V28, P140, DOI 10.1002/stem.259; TROJAN J, 1993, SCIENCE, V259, P94, DOI 10.1126/science.8418502; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Wang L, 2009, EXP NEUROL, V216, P177, DOI 10.1016/j.expneurol.2008.11.017; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	39	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10357	10.1371/journal.pone.0010357	http://dx.doi.org/10.1371/journal.pone.0010357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436918	Green Submitted, gold, Green Published			2022-12-25	WOS:000277079700010
J	Chen, WH; Gao, F; Chu, FL; Zhang, JH; Gao, GF; Xia, C				Chen, Weihong; Gao, Feng; Chu, Fuliang; Zhang, Jianhua; Gao, George F.; Xia, Chun			Crystal Structure of a Bony Fish beta(2)-Microglobulin INSIGHTS INTO THE EVOLUTIONARY ORIGIN OF IMMUNOGLOBULIN SUPERFAMILY CONSTANT MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; 3-DIMENSIONAL STRUCTURE; T-CELL; BETA-2-MICROGLOBULIN; SYSTEM; GENES; CRYSTALLOGRAPHY; RECOGNITION; AMPHIOXUS; RECEPTOR	Three-dimensional structures of beta(2)-microglobulin (beta 2m) from chicken and various mammals have been described previously, but aside from genomic sequences, very little is known about the three-dimensional structures of beta 2m in species other than warm-blooded vertebrates. Here, we present the first three-dimensional structure of beta 2m from bony fish grass carp (Ctid-beta 2m), resolved at 2.1 angstrom. The key structural differences between this new structure and previously published structures are two new hydrogen bonds at positions Ile(37) and Glu(38) in strand C and Lys(66) in strand E, and a hydrophobic pocket around the center of the protein found in Ctid-beta 2m. Importantly, Ctid-beta 2m has a short D strand and a long loop between stands C and D, rather than the flexible region found in other beta 2m structures that serves as a putative binding region for the major histocompatibility complex heavy chain. Comparing the Ctid-beta 2m structure with those of bovine and human beta 2ms, the C alpha root mean square deviation of the latter are 1.3 angstrom and 1.8 angstrom, respectively. Compared with the constant domains of Lamprey T cell receptor-like receptor (Lamp-TCRLC) and Amphioxus V and C domain-bearing protein (Amphi-VCPC), Ctid-beta 2m exhibits very different topology. The three-dimensional structures of domains predicted from Amphi-VCPC/Lamp-TCRLC are distinctly lacking in strand A of beta 2ms. There are 18 amino acids at the N terminus of Amphi-VCPC that may have evolved into strand A of beta 2ms. A mutation in the BC loops of Amphi-VCPC may have led to the novel topology found in beta 2m. Based on these results, Ctid-beta 2m may well reflect evolutionary characteristics of ancestral C set molecules.	[Chen, Weihong; Zhang, Jianhua; Xia, Chun] China Agr Univ, Coll Vet Med, Dept Microbiol & Immunol, Beijing 100094, Peoples R China; [Chen, Weihong; Gao, Feng; Chu, Fuliang; Zhang, Jianhua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Gao, George F.] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Microbiol & Mol Immunol, Beijing 100101, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing 100101, Peoples R China; [Xia, Chun] Minist Agr China, Key Lab Prevent Vet Med, Beijing 100094, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Ministry of Agriculture & Rural Affairs	Xia, C (corresponding author), China Agr Univ, Coll Vet Med, Dept Microbiol & Immunol, Beijing 100094, Peoples R China.	xiachun@cau.edu.cn	Gao, George Fu/ABD-5229-2021; Chu, Fuliang/F-6925-2011		National Basic Research Program of China [2007CB815805]; National Natural Science Foundation of China [30371098]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program (Project 973) of China (2007CB815805) and the National Natural Science Foundation of China (Grant 30371098).	Achour A, 1998, IMMUNITY, V9, P199, DOI 10.1016/S1074-7613(00)80602-0; BECKER JW, 1985, P NATL ACAD SCI USA, V82, P4225, DOI 10.1073/pnas.82.12.4225; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen WH, 2008, ACTA CRYSTALLOGR F, V64, P200, DOI 10.1107/S1744309107068388; Chu FL, 2007, J IMMUNOL, V178, P944, DOI 10.4049/jimmunol.178.2.944; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Criscitiello MF, 1998, IMMUNOGENETICS, V48, P339, DOI 10.1007/s002510050441; DIXON B, 1993, IMMUNOGENETICS, V38, P27, DOI 10.1007/BF00216387; Hao HF, 2006, FISH SHELLFISH IMMUN, V20, P118, DOI 10.1016/j.fsi.2005.04.003; Hao HF, 2007, PROTEIN EXPRES PURIF, V51, P120, DOI 10.1016/j.pep.2006.08.003; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; LANCET D, 1979, P NATL ACAD SCI USA, V76, P3844, DOI 10.1073/pnas.76.8.3844; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lundqvist ML, 1999, IMMUNOGENETICS, V50, P79, DOI 10.1007/s002510050690; Magor KE, 2004, J IMMUNOL, V172, P3635, DOI 10.4049/jimmunol.172.6.3635; Michaelsson J, 2001, J IMMUNOL, V166, P7327, DOI 10.4049/jimmunol.166.12.7327; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; ONO H, 1993, IMMUNOGENETICS, V38, P1, DOI 10.1007/BF00216384; Pancer Z, 2004, P NATL ACAD SCI USA, V101, P13273, DOI 10.1073/pnas.0405529101; Persson AC, 1999, IMMUNOGENETICS, V50, P49, DOI 10.1007/s002510050685; Prada JAH, 2006, NAT IMMUNOL, V7, P875, DOI 10.1038/ni1359; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rosano C, 2005, BBA-PROTEINS PROTEOM, V1753, P85, DOI 10.1016/j.bbapap.2005.07.010; Smith KJ, 1996, IMMUNITY, V4, P215, DOI 10.1016/S1074-7613(00)80430-6; Trinh CH, 2002, P NATL ACAD SCI USA, V99, P9771, DOI 10.1073/pnas.152337399; Yu CL, 2005, J IMMUNOL, V174, P3493, DOI 10.4049/jimmunol.174.6.3493; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	30	22	22	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22505	22512		10.1074/jbc.M109.095000	http://dx.doi.org/10.1074/jbc.M109.095000			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20444690	hybrid, Green Published			2022-12-25	WOS:000279702200062
J	Kabil, O; Banerjee, R				Kabil, Omer; Banerjee, Ruma			Redox Biochemistry of Hydrogen Sulfide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYSTATHIONINE BETA-SYNTHASE; MERCAPTOPYRUVATE SULFURTRANSFERASE; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; RAT-LIVER; H2S; OXIDATION; CYSTEINE; SULFUR; SUBSTRATE; OXIDASE	H2S, the most recently discovered gasotransmitter, might in fact be the evolutionary matriarch of this family, being both ancient and highly reduced. Disruption of gamma-cystathionase in mice leads to cardiovascular dysfunction and marked hypertension, suggesting a key role for this enzyme in H2S production in the vasculature. However, patients with inherited deficiency in gamma-cystathionase apparently do not present vascular pathology. A mitochondrial pathway disposes sulfide and couples it to oxidative phosphorylation while also exposing cytochrome c oxidase to this metabolic poison. This report focuses on the biochemistry of H2S biogenesis and clearance, on the molecular mechanisms of its action, and on its varied biological effects.	[Kabil, Omer; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Kabil, Omer/AAJ-1435-2020		National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984 (to R.B.). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Abe K, 1996, J NEUROSCI, V16, P1066; Agrawal N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004032; AKAGI R, 1982, ACTA MED OKAYAMA, V36, P187; BARTHOLOMEW TC, 1980, BIOCHEM PHARMACOL, V29, P2431, DOI 10.1016/0006-2952(80)90346-9; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Celano L, 2009, ARCH BIOCHEM BIOPHYS, V491, P96, DOI 10.1016/j.abb.2009.08.022; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Collman J, 2009, P NATL ACAD SCI USA, V106, P22090, DOI 10.1073/pnas.0904082106; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; CRAWHALL JC, 1968, SCIENCE, V160, P419, DOI 10.1126/science.160.3826.419; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Eto K, 2002, J BIOL CHEM, V277, P42680, DOI 10.1074/jbc.M205835200; Flores JF, 2005, P NATL ACAD SCI USA, V102, P2713, DOI 10.1073/pnas.0407455102; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; GADALLA MM, 2010, J NEUROCHEM IN PRESS; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Grice K, 2005, SCIENCE, V307, P706, DOI 10.1126/science.1104323; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; JARABAK R, 1978, ARCH BIOCHEM BIOPHYS, V185, P458, DOI 10.1016/0003-9861(78)90189-3; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; Li L, 2008, TRENDS PHARMACOL SCI, V29, P84, DOI 10.1016/j.tips.2007.11.003; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Mudd S., 2001, METABOLIC MOL BASES, P2007; MUDD SH, 1967, SCIENCE, V156, P1599, DOI 10.1126/science.156.3782.1599; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Nagahara N, 2005, J BIOL CHEM, V280, P34569, DOI 10.1074/jbc.M505643200; NAGAHARA N, 1995, J BIOL CHEM, V270, P16230, DOI 10.1074/jbc.270.27.16230; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nandi DL, 1998, INT J BIOCHEM CELL B, V30, P973, DOI 10.1016/S1357-2725(98)00050-8; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Nicoletti FP, 2010, BIOCHEMISTRY-US, V49, P2269, DOI 10.1021/bi901671d; Olson KR, 2009, BBA-BIOENERGETICS, V1787, P856, DOI 10.1016/j.bbabio.2009.03.019; Pietri R, 2009, BIOCHEMISTRY-US, V48, P4881, DOI 10.1021/bi801738j; POWELL MA, 1986, SCIENCE, V233, P563, DOI 10.1126/science.233.4763.563; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Vorobets VS, 2002, RUSS J APPL CHEM+, V75, P229, DOI 10.1023/A:1016152117662; Wang J, 2003, HUM GENET, V112, P404, DOI 10.1007/s00439-003-0906-8; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Westrop GD, 2009, J BIOL CHEM, V284, P33485, DOI 10.1074/jbc.M109.054320; Whitfield NL, 2008, AM J PHYSIOL-REG I, V294, pR1930, DOI 10.1152/ajpregu.00025.2008; Williams RAM, 2003, J BIOL CHEM, V278, P1480, DOI 10.1074/jbc.M209395200; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	54	581	603	3	131	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21903	21907		10.1074/jbc.R110.128363	http://dx.doi.org/10.1074/jbc.R110.128363			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20448039	hybrid, Green Published			2022-12-25	WOS:000279702200001
J	Lee, SM; Vasishtha, M; Prywes, R				Lee, Seung-Min; Vasishtha, Mansi; Prywes, Ron			Activation and Repression of Cellular Immediate Early Genes by Serum Response Factor Cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ELK-1; TERNARY COMPLEX FACTORS; C-FOS GENE; GROWTH-FACTOR; HISTONE DEACETYLASES; BINDING PROTEIN; ACTIN DYNAMICS; MAP KINASES; DOMAIN; MYOCARDIN	The induction of expression of many cellular immediate early genes (IEG) involves the transcription factor serum response factor (SRF). Two families of SRF coactivators have also been implicated in IEG induction, the ternary complex factors (TCFs), ELK1, Sap1, and Net, and the myocardin-related factors, MKL1 and MKL2. We found that serum induction of some SRF target genes is preferentially regulated by MKL1/2, whereas others are redundantly activated by both TCFs and MKL1/2. Yet ELK1 can also repress transcription. Binding of ELK1 and MKL1 to SRF has been found to be mutually exclusive in vitro, suggesting that ELK1 could repress expression of IEGs by blocking MKL1 binding. We characterized the in vivo binding of MKL1 and ELK1 to target genes and found an inverse relationship of serum-induced MKL1 binding and serum-decreased ELK1 binding. However, experiments with short hairpin RNA-mediated MKL1/2 depletion and expression of a nuclear MKL1 (N100) variant in stably transfected cells failed to alter ELK1 binding, suggesting that ELK1 binding to target genes is regulated independently of MKL1/2. Nevertheless, we found that short interfering RNA-mediated depletion of TCFs increased target gene expression in cells containing the N100 MKL1 activator, most notably in cells under continuous growth conditions. These results indicate that the TCFs can function both as activators and repressors of target gene expression depending upon the cellular growth conditions.	[Lee, Seung-Min; Vasishtha, Mansi; Prywes, Ron] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Prywes, R (corresponding author), Columbia Univ, Dept Biol Sci, Fairchild 813A,MC 2420,1212 Amsterdam Ave, New York, NY 10027 USA.	mrp6@columbia.edu			National Institutes of Health [CA50329]; NATIONAL CANCER INSTITUTE [R01CA050329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA50329 (to R. P.).	ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; BRAVO R, 1990, CELL GROWTH DIFFER, V1, P305; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Cesari F, 2004, MOL CELL BIOL, V24, P294, DOI 10.1128/MCB.24.1.294-305.2004; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; Criqui-Filipe P, 1999, EMBO J, V18, P3392, DOI 10.1093/emboj/18.12.3392; Descot A, 2008, MOL CELL BIOL, V28, P6171, DOI 10.1128/MCB.00303-08; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Ducret C, 2000, ONCOGENE, V19, P5063, DOI 10.1038/sj.onc.1203892; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hassler M, 2001, EMBO J, V20, P3018, DOI 10.1093/emboj/20.12.3018; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; JANKNECHT R, 1994, ONCOGENE, V9, P1273; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; Kasza A, 2005, J BIOL CHEM, V280, P1149, DOI 10.1074/jbc.M411161200; Li QJ, 2003, EMBO J, V22, P281, DOI 10.1093/emboj/cdg028; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Maira SM, 1996, EMBO J, V15, P5849, DOI 10.1002/j.1460-2075.1996.tb00972.x; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; Nakagawa K, 2005, GENES CELLS, V10, P835, DOI 10.1111/j.1365-2443.2005.00880.x; Nissen LJ, 2001, J BIOL CHEM, V276, P5213, DOI 10.1074/jbc.M007824200; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Shore P, 1996, MOL CELL BIOL, V16, P3338; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Spencer JA, 1999, MOL CELL BIOL, V19, P3977; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Wang Y, 1998, CELL GROWTH DIFFER, V9, P513; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yang SH, 2002, MOL CELL BIOL, V22, P5036, DOI 10.1128/MCB.22.14.5036-5046.2002; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200	78	51	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22036	22049		10.1074/jbc.M110.108878	http://dx.doi.org/10.1074/jbc.M110.108878			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20466732	Green Published, hybrid			2022-12-25	WOS:000279702200016
J	Qamar, I; Gong, EY; Kim, Y; Song, CH; Lee, HJ; Chun, SY; Lee, K				Qamar, Imteyaz; Gong, Eun-Yeung; Kim, Yeawon; Song, Chin-Hee; Lee, Hyun Joo; Chun, Sang-Young; Lee, Keesook			Anti-steroidogenic Factor ARR19 Inhibits Testicular Steroidogenesis through the Suppression of Nur77 Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR NUR77; PROTEIN-KINASE-A; P450C17 GENE-TRANSCRIPTION; NECROSIS-FACTOR-ALPHA; RAT LEYDIG-CELLS; NGFI-B; COACTIVATOR RECRUITMENT; ANDROGEN RECEPTOR; MEDIATES TRANSACTIVATION; INDEPENDENT MECHANISMS	ARR19 (androgen receptor corepressor-19 kDa), a leucine-rich protein whose expression is down-regulated by luteinizing hormone and cAMP, is differentially expressed during the development of Leydig cells and inhibits testicular steroidogenesis by reducing the expression of steroidogenic enzymes. However, the molecular events behind the suppression of testicular steroidogenesis are unknown. In the present study, we demonstrate that ARR19 inhibits the transactivation of orphan nuclear receptor Nur77, which is one of the major transcription factors that regulate the expression of steroidogenic enzyme genes in Leydig cells. ARR19 physically interacts with Nur77 and suppresses Nur77-induced promoter activity of steroidogenic enzyme genes including StAR, P450c17, and 3 beta-HSD in Leydig cells. Transient transfection and chromatin immunoprecipitation assays revealed that ARR19-mediated reduced expression of steroidogenic enzyme genes was likely due to the interference of SRC-1 recruitment to Nur77 protein on the promoter of steroidogenic enzyme genes. These findings suggest that ARR19 acts as a novel coregulator of Nur77, in turn regulating Nur77-induced testicular steroidogenesis, and may play an important role in the development and function of testicular Leydig cells.	[Qamar, Imteyaz; Gong, Eun-Yeung; Kim, Yeawon; Song, Chin-Hee; Lee, Hyun Joo; Chun, Sang-Young; Lee, Keesook] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea	Chonnam National University	Lee, K (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	klee@chonnam.ac.kr		Qamar, Imteyaz/0000-0003-2390-1808	Ministry of Education, Science and Technology [2009-0065629]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant 2009-0065629.	Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Cooke BA, 1999, MOL CELL ENDOCRINOL, V151, P25, DOI 10.1016/S0303-7207(98)00255-X; COOKE BA, 1996, LEYDIG CELL, P352; DAVIS IJ, 1993, MOL ENDOCRINOL, V7, P953, DOI 10.1210/me.7.8.953; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Haddad JJ, 2002, CYTOKINE, V17, P301, DOI 10.1006/cyto.2002.1017; HAIDER S, 1986, GEN COMP ENDOCR, V64, P321, DOI 10.1016/0016-6480(86)90065-1; Han YQ, 1997, J BIOL CHEM, V272, P9825; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HAZEL TG, 1991, MOL CELL BIOL, V11, P3239, DOI 10.1128/MCB.11.6.3239; HIRATA Y, 1993, J BIOL CHEM, V268, P24808; Hong CY, 2004, MOL CELL BIOL, V24, P2593, DOI 10.1128/MCB.24.7.2593-2604.2004; Jeong BC, 2004, MOL ENDOCRINOL, V18, P13, DOI 10.1210/me.2003-0065; Kim JY, 2004, MOL ENDOCRINOL, V18, P2880, DOI 10.1210/me.2004-0211; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Li T, 2006, INT J BIOCHEM CELL B, V38, P420, DOI 10.1016/j.biocel.2005.10.003; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Manna P. R., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P93, DOI 10.2174/1568008053174714; Mellon SH, 1998, ENDOCR RES, V24, P505, DOI 10.3109/07435809809032639; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; Moraga PF, 1997, J ENDOCRINOL, V154, P201, DOI 10.1677/joe.0.1540201; Park JI, 2001, ENDOCRINOLOGY, V142, P3051, DOI 10.1210/en.142.7.3051; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Payne A., 1996, LEYDIG CELL PP, P259; Pekarsky Y, 2001, P NATL ACAD SCI USA, V98, P3690, DOI 10.1073/pnas.051003198; Qamar I, 2009, J BIOL CHEM, V284, P18021, DOI 10.1074/jbc.M900896200; Sadie H, 2003, ENDOCRINOLOGY, V144, P1958, DOI 10.1210/en.2002-220874; Sadovsky Y, 2000, REV REPROD, V5, P136; Sohn YC, 2001, J BIOL CHEM, V276, P43734, DOI 10.1074/jbc.M107208200; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Steinmetz ACU, 2001, ANNU REV BIOPH BIOM, V30, P329, DOI 10.1146/annurev.biophys.30.1.329; Stocco CO, 2000, J BIOL CHEM, V275, P37202, DOI 10.1074/jbc.M006016200; Teerds KJ, 2007, J ENDOCRINOL, V194, P579, DOI 10.1677/JOE-06-0084; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; Wansa KDSA, 2003, J BIOL CHEM, V278, P24776, DOI 10.1074/jbc.M300088200; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; WILSON TE, 1993, MOL CELL BIOL, V13, P861, DOI 10.1128/MCB.13.2.861; Zhang PL, 1997, MOL ENDOCRINOL, V11, P891, DOI 10.1210/me.11.7.891; Zhang PL, 1996, MOL ENDOCRINOL, V10, P147, DOI 10.1210/me.10.2.147	47	28	30	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22360	22369		10.1074/jbc.M109.059949	http://dx.doi.org/10.1074/jbc.M109.059949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472563	Green Published, hybrid			2022-12-25	WOS:000279702200049
J	Halterman, MW; Gill, M; DeJesus, C; Ogihara, M; Schor, NF; Federoff, HJ				Halterman, Marc W.; Gill, Molly; DeJesus, Chris; Ogihara, Mitsunori; Schor, Nina F.; Federoff, Howard J.			The Endoplasmic Reticulum Stress Response Factor CHOP-10 Protects against Hypoxia-induced Neuronal Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; PROGRAMMED CELL-DEATH; TRANSCRIPTION FACTOR; UP-REGULATION; BRAIN; EXPRESSION; ACTIVATION; PROMOTES; GADD153; PATHWAY	Hypoxia-induced gene expression is a critical determinant of neuron survival after stroke. Understanding the cell autonomous genetic program controlling adaptive and pathological transcription could have important therapeutic implications. To identify the factors that modulate delayed neuronal apoptosis after hypoxic injury, we developed an in vitro culture model that recapitulates these divergent responses and characterized the sequence of gene expression changes using microarrays. Hypoxia induced a disproportionate number of bZIP transcription factors and related targets involved in the endoplasmic reticulum stress response. Although the temporal and spatial aspects of ATF4 expression correlated with neuron loss, our results did not support the anticipated pathological role for delayed CHOP expression. Rather, CHOP deletion enhanced neuronal susceptibility to both hypoxic and thapsigargin-mediated injury and attenuated brain-derived neurotrophic factor-induced neuroprotection. Also, enforced expression of CHOP prior to the onset of hypoxia protected wild-type cultures against subsequent injury. Collectively, these findings indicate CHOP serves a more complex role in the neuronal response to hypoxic stress with involvement in both ischemic preconditioning and delayed neuroprotection.	[Halterman, Marc W.; Gill, Molly; Schor, Nina F.] Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Halterman, Marc W.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Halterman, Marc W.; DeJesus, Chris; Schor, Nina F.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Ogihara, Mitsunori] Univ Miami, Dept Comp Sci, Coral Gables, FL 33124 USA; [Federoff, Howard J.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA	University of Rochester; University of Rochester; University of Rochester; University of Miami; Georgetown University	Halterman, MW (corresponding author), Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, 601 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	marc_halterman@urmc.rochester.edu	Ogihara, Mitsunori/AAB-8275-2020	Ogihara, Mitsunori/0000-0002-5690-7854; Schor, Nina/0000-0002-3817-7376	NINDS NIH HHS [R00 NS060764-04, R00 NS060764] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS060764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Bert AG, 2006, RNA, V12, P1074, DOI 10.1261/rna.2320506; Bredesen DE, 2007, STROKE, V38, P652, DOI 10.1161/01.STR.0000257802.82826.a7; Chen G, 2007, J NEUROSCI RES, V85, P1674, DOI 10.1002/jnr.21292; Dave KR, 2004, BRAIN RES, V1024, P89, DOI 10.1016/j.brainres.2004.07.050; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; GESCHWIND MD, 1994, METH NEUROSCI, V21, P462; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Halterman MW, 2008, MOL CELL NEUROSCI, V38, P125, DOI 10.1016/j.mcn.2008.01.014; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Jin KL, 2001, ANN NEUROL, V50, P93, DOI 10.1002/ana.1073; Khot S, 2006, SEMIN NEUROL, V26, P422, DOI 10.1055/s-2006-948323; Kim JB, 2004, J NEUROCHEM, V89, P1271, DOI 10.1111/j.1471-4159.2004.02429.x; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; Konaka Kuni, 2007, J Stroke Cerebrovasc Dis, V16, P82, DOI 10.1016/j.jstrokecerebrovasdis.2006.10.007; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu SM, 2004, J CEREBR BLOOD F MET, V24, P343, DOI 10.1097/01.WCB.0000110047.43905.01; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oida Y, 2008, NEUROSCIENCE, V151, P111, DOI 10.1016/j.neuroscience.2007.10.047; ROSENBAUM DM, 1994, ANN NEUROL, V36, P864, DOI 10.1002/ana.410360610; ROSS DT, 1993, J CEREBR BLOOD F MET, V13, P558, DOI 10.1038/jcbfm.1993.73; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHIGENO T, 1990, NEUROSCI LETT, V120, P117, DOI 10.1016/0304-3940(90)90182-9; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Tajiri S, 2006, FEBS LETT, V580, P3462, DOI 10.1016/j.febslet.2006.05.021; Teschendorf P, 2008, NEUROSCI LETT, V448, P194, DOI 10.1016/j.neulet.2008.10.030; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Zhu Y, 2008, J NEUROSCI, V28, P2168, DOI 10.1523/JNEUROSCI.5232-07.2008; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	41	50	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21329	21340		10.1074/jbc.M109.095299	http://dx.doi.org/10.1074/jbc.M109.095299			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448044	Green Published, hybrid			2022-12-25	WOS:000279516100018
J	Loomis, WF; Behrens, MM; Williams, ME; Anjard, C				Loomis, William F.; Behrens, M. Margarita; Williams, Megan E.; Anjard, Christophe			Pregnenolone Sulfate and Cortisol Induce Secretion of Acyl-CoA-binding Protein and Its Conversion into Endozepines from Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED RAT ASTROCYTES; TERMINAL DIFFERENTIATION; UNCONVENTIONAL SECRETION; OCTADECANEUROPEPTIDE ODN; PROCESSING PRODUCTS; CEREBROSPINAL-FLUID; PRESYNAPTIC ACTION; INHIBITOR DBI; DICTYOSTELIUM; MECHANISMS	Acyl-CoA-binding protein (ACBP) functions both intracellularly as part of fatty acid metabolism and extracellularly as diazepam binding inhibitor, the precursor of endozepine peptides. Two of these peptides, ODN and TTN, bind to the GABA(A) receptor and modulate its sensitivity to gamma-aminobutyric acid (GABA). We have found that depolarization of mouse primary astrocytes induces the rapid release and processing of ACBP to the active peptides. We previously showed that ODN can trigger the rapid sporulation of the social amoeba Dictyostelium. Using this bioassay, we now show that astrocytes release the endozepine peptides within 10 min of exposure to the steroids cortisol, pregnenolone, pregnenolone sulfate, or progesterone. ACBP lacks a signal sequence for secretion through the endoplasmic reticulum/Golgi pathway and its secretion is not affected by addition of brefeldin A, a well known inhibitor of the classical secretion pathway, suggesting that it follows an unconventional pathway for secretion. Moreover, induction of autophagy by addition of rapamycin also resulted in rapid release of ACBP indicating that this protein uses components of the autophagy pathway for secretion. Following secretion, ACBP is proteolytically cleaved to the active neuropeptides by protease activity on the surface of astrocytes. Neurosteroids, such as pregnenolone sulfate, were previously shown to modulate the excitatory/inhibitory balance in brain through increased release of glutamate and decreased release of GABA. These effects of steroids in neurons will be reinforced by the release of endozepines from astrocytes shown here, and suggest an orchestrated astrocyte-neuron cross-talk that can affect a broad spectrum of behavioral functions.	[Loomis, William F.; Williams, Megan E.; Anjard, Christophe] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Behrens, M. Margarita] Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Salk Institute	Loomis, WF (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	wloomis@UCSD.edu; canjard@ucsd.edu	Behrens, M. Margarita/K-2576-2014; Anjard, Christophe/H-5012-2017	Anjard, Christophe/0000-0002-6905-1493	National Institutes of Health [GM78175]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM78175.	ANJARD C, 1992, DEVELOPMENT, V115, P785; Anjard C, 2005, P NATL ACAD SCI USA, V102, P7607, DOI 10.1073/pnas.0501820102; Anjard C, 1998, DEV BIOL, V193, P146, DOI 10.1006/dbio.1997.8804; Anjard C, 2008, DEVELOPMENT, V135, P819, DOI 10.1242/dev.018051; Anjard C, 2006, DEVELOPMENT, V133, P2253, DOI 10.1242/dev.02399; Anjard C, 2009, DEVELOPMENT, V136, P803, DOI 10.1242/dev.032607; BERKOVICH A, 1990, MOL PHARMACOL, V37, P164; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; CABRAL M, 2010, EUKARYOTIC IN PRESS; Cuervo P, 2009, J PROTEOMICS, V73, P79, DOI 10.1016/j.jprot.2009.08.006; Do-Rego JL, 2001, J NEUROCHEM, V76, P128, DOI 10.1046/j.1471-4159.2001.00053.x; Dong Y, 2005, CELL MOL LIFE SCI, V62, P1003, DOI 10.1007/s00018-005-5004-8; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Faergeman NJ, 2007, MOL CELL BIOCHEM, V299, P55, DOI 10.1007/s11010-005-9040-3; FERRERO P, 1986, P NATL ACAD SCI USA, V83, P827, DOI 10.1073/pnas.83.3.827; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Gibbs TT, 2006, PHARMACOL BIOCHEM BE, V84, P555, DOI 10.1016/j.pbb.2006.07.031; GUARNERI P, 1990, NEUROPHARMACOLOGY, V29, P419, DOI 10.1016/0028-3908(90)90162-K; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; Hwang J, 2010, BRIT J PHARMACOL, V159, P586, DOI 10.1111/j.1476-5381.2009.00563.x; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; KNUDSEN J, 1993, MOL CELL BIOCHEM, V123, P129, DOI 10.1007/BF01076484; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; MAJEWSKA MD, 1988, NEUROSCI LETT, V90, P279, DOI 10.1016/0304-3940(88)90202-9; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; Masmoudi O, 2005, J NEUROCHEM, V94, P561, DOI 10.1111/j.1471-4159.2005.03076.x; Masmoudi O, 2003, FASEB J, V17, P17, DOI 10.1096/fj.02-0317com; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Mtchedlishvili Z, 2003, MOL PHARMACOL, V64, P857, DOI 10.1124/mol.64.4.857; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nitz I, 2005, INT J BIOCHEM CELL B, V37, P2395, DOI 10.1016/j.biocel.2005.06.008; PAPADOPOULOS V, 1991, NEUROPHARMACOLOGY, V30, P1417, DOI 10.1016/S0028-3908(11)80011-0; Prager EM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286re5; Qian ZY, 2008, J NEUROCHEM, V105, P1287, DOI 10.1111/j.1471-4159.2008.05229.x; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SLOBODYANSKY E, 1989, J NEUROCHEM, V53, P1276, DOI 10.1111/j.1471-4159.1989.tb07425.x; Smith JL, 2008, STEROIDS, V73, P1160, DOI 10.1016/j.steroids.2008.05.003; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Teschemacher A, 1997, BRAIN RES, V772, P226, DOI 10.1016/S0006-8993(97)00872-X; TONON MC, 1990, NEUROPEPTIDES, V15, P17, DOI 10.1016/0143-4179(90)90155-R; Wang N, 1999, MOL CELL BIOL, V19, P4750; Yanase H, 2002, ARCH HISTOL CYTOL, V65, P27, DOI 10.1679/aohc.65.27; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Zheng P, 2009, PROG NEUROBIOL, V89, P134, DOI 10.1016/j.pneurobio.2009.07.001; Zinder O, 1999, ACTA PHYSIOL SCAND, V167, P181	48	42	42	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21359	21365		10.1074/jbc.M110.105858	http://dx.doi.org/10.1074/jbc.M110.105858			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452969	hybrid, Green Published			2022-12-25	WOS:000279516100021
J	Hanson, HH; Kang, S; Fernandez-Monreal, M; Oung, T; Yildirim, M; Lee, R; Suyama, K; Hazan, RB; Phillips, GR				Hanson, Hugo H.; Kang, Semie; Fernandez-Monreal, Monica; Oung, Twethida; Yildirim, Murat; Lee, Rebecca; Suyama, Kimita; Hazan, Rachel B.; Phillips, Greg R.			LC3-dependent Intracellular Membrane Tubules Induced by gamma-Protocadherins A3 and B2 A ROLE FOR INTRALUMINAL INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; CORRELATIVE LIGHT; CELL-ADHESION; N-CADHERIN; LC3; PROTEIN; ALPHA; REVEALS; FAMILY; ULTRASTRUCTURE	Clustered protocadherins (Pcdhs) are a family of cadherin-like molecules arranged in gene clusters (alpha, beta, and gamma). gamma-Protocadherins (Pcdh-gamma s) are involved in cell-cell interactions, but their prominent intracellular distribution in vivo and different knock-out phenotypes suggest that these molecules participate in still unidentified processes. We found using correlative light and electron microscopy that Pcdh-gamma A3 and -gamma B2, but not -gamma C4, -alpha 1, or N-cadherin, generate intracellular juxtanuclear membrane tubules when expressed in cells. These tubules recruit the autophagy marker MAP1A/1B LC3 (LC3) but are not associated with autophagic vesicles. Lipidation of LC3 is required for its coclustering with Pcdh-gamma tubules, suggesting the involvement of an autophagic-like molecular cascade. Expression of wild-type LC3 with Pcdh-gamma A3 increased tubule length whereas expression of lipidation-defective LC3 decreased tubule length relative to Pcdh-gamma A3 expressed alone. The tubules were found to emanate from lysosomes. Deletion of the luminal/extracellular domain of Pcdh-gamma A3 preserved lysosomal targeting but eliminated tubule formation whereas cytoplasmic deletion eliminated both lysosomal targeting and tubule formation. Deletion of the membrane-proximal three cadherin repeats resulted in tubes that were narrower than those produced by full-length molecules. These results suggest that Pcdh-gamma A and -gamma B families can influence the shape of intracellular membranes by mediating intraluminal interactions within organelles.	[Hanson, Hugo H.; Kang, Semie; Fernandez-Monreal, Monica; Oung, Twethida; Yildirim, Murat; Lee, Rebecca; Phillips, Greg R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Suyama, Kimita; Hazan, Rachel B.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine	Phillips, GR (corresponding author), Mt Sinai Sch Med, Dept Neurosci, Box 1065,1 Gustave L Levy Pl, New York, NY 10029 USA.	greg.phillips@mssm.edu	Monreal, Monica Fernandez/P-6685-2019; Fernandez-Monreal, Mónica/I-7954-2012	Monreal, Monica Fernandez/0000-0001-7278-448X; Fernandez-Monreal, Mónica/0000-0001-7278-448X	National Institutes of Health [NS051238]; Irma T. Hirschl award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS051238 and an Irma T. Hirschl award (to G. R. P.).	Baisamy L, 2009, J BIOL CHEM, V284, P28232, DOI 10.1074/jbc.M109.054668; Chen ZW, 2007, J NEUROSCI, V27, P6655, DOI 10.1523/JNEUROSCI.0919-07.2007; Elazar Z, 2003, BBA-MOL CELL RES, V1641, P145, DOI 10.1016/S0167-4889(03)00086-7; Emond MR, 2008, DEV BIOL, V321, P175, DOI 10.1016/j.ydbio.2008.06.011; Fernandez-Monreal M, 2009, MOL CELL NEUROSCI, V40, P344, DOI 10.1016/j.mcn.2008.12.002; Frank M, 2005, MOL CELL NEUROSCI, V29, P603, DOI 10.1016/j.mcn.2005.05.001; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; Garrett AM, 2009, J NEUROSCI, V29, P11723, DOI 10.1523/JNEUROSCI.2818-09.2009; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Jontes JD, 2006, TRENDS NEUROSCI, V29, P186, DOI 10.1016/j.tins.2006.02.002; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Koch AW, 2004, STRUCTURE, V12, P793, DOI 10.1016/j.str.2004.02.034; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; KUZNETSOV SA, 1987, FEBS LETT, V212, P145, DOI 10.1016/0014-5793(87)81574-0; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Lingwood D, 2009, J BIOL CHEM, V284, P12041, DOI 10.1074/jbc.M900220200; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Mutoh T, 2004, EXP CELL RES, V294, P494, DOI 10.1016/j.yexcr.2003.11.019; OBATA S, 1995, J CELL SCI, V108, P3765; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Phillips GR, 2003, J NEUROSCI, V23, P5096; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Razi M, 2009, METHOD ENZYMOL, V452, P261, DOI 10.1016/S0076-6879(08)03617-3; Scherz-Shouval R, 2003, J BIOL CHEM, V278, P14053, DOI 10.1074/jbc.M212108200; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Su H, 2010, DEV BIOL, V339, P38, DOI 10.1016/j.ydbio.2009.12.010; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Triana-Baltzer GB, 2006, J NEUROBIOL, V66, P393, DOI 10.1002/neu.20228; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Wang Y, 2006, NEUROSCIENCE, V140, P1265, DOI 10.1016/j.neuroscience.2006.03.013; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xie ZP, 2009, AUTOPHAGY, V5, P217, DOI 10.4161/auto.5.2.7201	49	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20982	20992		10.1074/jbc.M109.092031	http://dx.doi.org/10.1074/jbc.M109.092031			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439459	hybrid, Green Published			2022-12-25	WOS:000279228600062
J	Shirogane, Y; Takeda, M; Tahara, M; Ikegame, S; Nakamura, T; Yanagi, Y				Shirogane, Yuta; Takeda, Makoto; Tahara, Maino; Ikegame, Satoshi; Nakamura, Takanori; Yanagi, Yusuke			Epithelial-Mesenchymal Transition Abolishes the Susceptibility of Polarized Epithelial Cell Lines to Measles Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; MEDIATED EXPRESSION CLONING; E-CADHERIN; TIGHT JUNCTION; CLONED CDNA; ADENOVIRUS RECEPTOR; RECYCLING ENDOSOMES; SYNCYTIUM FORMATION; GENE-EXPRESSION; TUMOR-CELLS	Measles virus (MV), an enveloped negative-strand RNA virus, remains a major cause of morbidity and mortality in developing countries. MV predominantly infects immune cells by using signaling lymphocyte activation molecule (SLAM; also called CD150) as a receptor, but it also infects polarized epithelial cells, forming tight junctions in a SLAM-independent manner. Although the ability of MV to infect polarized epithelial cells is thought to be important for its transmission, the epithelial cell receptor for MV has not been identified. A transcriptional repressor, Snail, induces epithelial-mesenchymal transition (EMT), in which epithelial cells lose epithelial cell phenotypes, such as adherens and tight junctions. In this study, EMT was induced by expressing Snail in a lung adenocarcinoma cell line, II-18, which is highly susceptible to wild-type MV. Snail-expressing II-18 cells lost adherens and tight junctions. Microarray analysis confirmed the induction of EMT in II-18 cells and suggested a novel function of Snail in protein degradation and distribution. Importantly, wild-type MV no longer entered EMT-induced II-18 cells, suggesting that the epithelial cell receptor is down-regulated by the induction of EMT. Other polarized cell lines, NCI-H358 and HT-29, also lost susceptibility to wild-type MV when EMT was induced. However, the complete formation of tight junctions rather reduced MV entry into HT-29 cells. Taken together, these data suggest that the unidentified epithelial cell receptor for MV is involved in the formation of epithelial intercellular junctions.	[Shirogane, Yuta] Kyushu Univ, Fac Med, Dept Virol, Higashi Ku, Fukuoka 8128582, Japan; [Nakamura, Takanori] Kyushu Univ, Res Support Ctr, Fac Med, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Shirogane, Y (corresponding author), Kyushu Univ, Fac Med, Dept Virol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yuuta@virology.med.kyushu-u.ac.jp	Shirogane, Yuta/AAO-1073-2021; Takeda, Makoto/J-2550-2018; ikegame, satoshi/AAC-6305-2022	Shirogane, Yuta/0000-0002-4284-0310; Takeda, Makoto/0000-0002-8194-7727; Yanagi, Yusuke/0000-0001-7815-1667	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology and the Ministry of Health, Labor, and Welfare of Japan.	Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BROWER M, 1986, CANCER RES, V46, P798; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Craighead J. E., 2000, PATHOLOGY PATHOGENES, P397; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; de Marco MC, 2002, J CELL BIOL, V159, P37, DOI 10.1083/jcb.200206033; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Fogh J., 1975, HUMAN TUMOR CELLS IN, VVolume 1, P115, DOI [10.1007/978-1-4757-1647-4_5, DOI 10.1007/978-1-4757-1647-4_5]; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; Hashimoto K, 2002, J VIROL, V76, P6743, DOI 10.1128/JVI.76.13.6743-6749.2002; Hunziker W, 1998, J BIOL CHEM, V273, P15734, DOI 10.1074/jbc.273.25.15734; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Janda E, 2006, ONCOGENE, V25, P7117, DOI 10.1038/sj.onc.1209701; KIMURA A, 1975, ARCH VIROL, V47, P295, DOI 10.1007/BF01347970; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitamura T, 2000, METH MOL B, V134, P143; KOBAYASHI S, 1990, KOKENSHI, V42, P73; Lacher MD, 2006, CANCER RES, V66, P1648, DOI 10.1158/0008-5472.CAN-05-2328; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; LIGHTWOOD R, 1970, J PEDIATR-US, V77, P59, DOI 10.1016/S0022-3476(70)80045-2; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mee CJ, 2008, J VIROL, V82, P461, DOI 10.1128/JVI.01894-07; MOENCH TR, 1988, J INFECT DIS, V158, P433, DOI 10.1093/infdis/158.2.433; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakatsu Y, 2006, J VIROL METHODS, V137, P152, DOI 10.1016/j.jviromet.2006.05.029; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; NII S, 1964, BIKEN J, V6, P271; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOMMENSEN FE, 1981, J MED VIROL, V7, P157, DOI 10.1002/jmv.1890070210; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; OLDINGSTENKVIST E, 1976, J INFECT DIS, V134, P463, DOI 10.1093/infdis/134.5.463; Onishi M, 1996, EXP HEMATOL, V24, P324; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; RICHARDSON CD, 1980, VIROLOGY, V105, P205, DOI 10.1016/0042-6822(80)90168-3; Rodriguez-Gabin AG, 2004, J NEUROSCI RES, V76, P758, DOI 10.1002/jnr.20121; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; SAKAGUCHI M, 1986, MICROBIOL IMMUNOL, V30, P1067, DOI 10.1111/j.1348-0421.1986.tb03036.x; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; SILICIANO JD, 1988, J CELL BIOL, V107, P2389, DOI 10.1083/jcb.107.6.2389; Tahara M, 2008, J VIROL, V82, P4630, DOI 10.1128/JVI.02691-07; Tahara M, 2007, J VIROL, V81, P2564, DOI 10.1128/JVI.02449-06; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; Takeda M, 2000, J VIROL, V74, P6643, DOI 10.1128/JVI.74.14.6643-6647.2000; Takeda M, 2005, VIRUS RES, V108, P161, DOI 10.1016/j.virusres.2004.09.002; Takeda M, 2007, J VIROL, V81, P12091, DOI 10.1128/JVI.01264-07; Takeuchi K, 2003, VIRUS RES, V94, P11, DOI 10.1016/S0168-1702(03)00117-5; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Vetter G, 2009, BIOCHEM BIOPH RES CO, V385, P485, DOI 10.1016/j.bbrc.2009.05.025; Whiteman EL, 2008, ONCOGENE, V27, P3875, DOI 10.1038/onc.2008.9; Yanagi Y, 2009, CURR TOP MICROBIOL, V329, P13; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	65	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20882	20890		10.1074/jbc.M110.102590	http://dx.doi.org/10.1074/jbc.M110.102590			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435897	hybrid, Green Published			2022-12-25	WOS:000279228600052
J	Wiles, KG; Panizzi, P; Kroh, HK; Bock, PE				Wiles, Karen G.; Panizzi, Peter; Kroh, Heather K.; Bock, Paul E.			Skizzle Is a Novel Plasminogen- and Plasmin-binding Protein from Streptococcus agalactiae That Targets Proteins of Human Fibrinolysis to Promote Plasmin Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE-CATALYZED ACTIVATION; ANTIFIBRINOLYTIC AMINO-ACIDS; EPSILON-AMINOCAPROIC ACID; SITE-SPECIFIC MUTAGENESIS; ACTIVE-SITE; LIGAND-BINDING; CONFORMATIONAL ACTIVATION; STREPTOKINASE BINDS; FLUORESCENCE PROBES; KINETIC MECHANISM	Skizzle (SkzL), secreted by Streptococcus agalactiae, has moderate sequence identity to streptokinase and staphylokinase, bacterial activators of human plasminogen (Pg). SkzL binds [Glu]Pg with low affinity (K-D 3-16 mu M) and [Lys]Pg and plasmin (Pm) with indistinguishable high affinity (K-D 80 and 50 nM, respectively). Binding of SkzL to Pg and Pm is completely lysine-binding site-dependent, as shown by the effect of the lysine analog, 6-aminohexanoic acid. Deletion of the COOH-terminal SkzL Lys(415) residue reduces affinity for [Lys] Pg and active site-blocked Pm 30-fold, implicating Lys(415) in a lysine-binding site interaction with a Pg/Pm kringle. SkzL binding to active site fluorescein-labeled Pg/Pm analogs demonstrates distinct high and low affinity interactions. High affinity binding is mediated by Lys(415), whereas the source of low affinity binding is unknown. SkzL enhances the activation of [Glu] Pg by urokinase (uPA) similar to 20-fold, to a maximum rate indistinguishable from that for [Lys]Pg and [Glu]Pg activation in the presence of 6-aminohexanoic acid. SkzL binds preferentially to the partially extended beta-conformation of [Glu] Pg, which is in unfavorable equilibrium with the compact alpha-conformation, thereby converting [Glu]Pg to the fully extended gamma-conformation and accelerating the rate of its activation by uPA. SkzL enhances [Lys]Pg and [Glu]Pg activation by single-chain tissue-type Pg activator, similar to 42- and similar to 650-fold, respectively. SkzL increases the rate of plasma clot lysis by uPA and single-chain tissue-type Pg activator similar to 2-fold, confirming its cofactor activity in a physiological model system. The results suggest a role for SkzL in S. agalactiae pathogenesis through fibrinolytic enhancement.	[Wiles, Karen G.; Panizzi, Peter; Kroh, Heather K.; Bock, Paul E.] Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Bock, PE (corresponding author), Vanderbilt Univ, Dept Pathol, Sch Med, C3321A Med Ctr N, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu	Panizzi, Peter/A-6072-2019	Panizzi, Peter/0000-0003-0141-8807	NHLBI [RO1 HL056181]; American Heart Association [0715393B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056181, R00HL094533] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole or in part by National Institutes of Health Grant RO1 HL056181 from the NHLBI (to P. E. B.).; Supported in part by Predoctoral Fellowship 0715393B from the American Heart Association, Greater SE Affiliate.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bachmann F., 1994, HEMOSTASIS THROMBOSI, V3rd, P1592; Bean RR, 2005, J BIOL CHEM, V280, P7504, DOI 10.1074/jbc.M411637200; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Blumberg HM, 1996, J INFECT DIS, V173, P365, DOI 10.1093/infdis/173.2.365; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; CASTELLINO FJ, 1973, BIOCHEMISTRY-US, V12, P2787, DOI 10.1021/bi00739a002; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; Cockell CS, 1998, BIOCHEM J, V333, P99, DOI 10.1042/bj3330099; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; CUMMINGS HS, 1985, ARCH BIOCHEM BIOPHYS, V236, P612, DOI 10.1016/0003-9861(85)90665-4; DEMUNK GAW, 1993, THROMB HAEMOSTASIS, V70, P481; DEMUNK GAW, 1989, BIOCHEMISTRY-US, V28, P7318, DOI 10.1021/bi00444a026; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Esmon CT, 1998, NAT STRUCT BIOL, V5, P933, DOI 10.1038/2906; Fluegge K, 2004, EUR J CLIN MICROBIOL, V23, P818, DOI 10.1007/s10096-004-1229-y; FREDENBURGH JC, 1992, J BIOL CHEM, V267, P26150; Grella DK, 1997, BLOOD, V89, P1585, DOI 10.1182/blood.V89.5.1585.1585_1585_1589; HENKIN J, 1991, PROG CARDIOVASC DIS, V34, P135, DOI 10.1016/0033-0620(91)90010-J; HOCHSCHWENDER SM, 1981, J BIOL CHEM, V256, P1172; Jespers L, 1999, THROMB HAEMOSTASIS, V81, P479; Johnsen LB, 2000, BIOCHEMISTRY-US, V39, P6440, DOI 10.1021/bi9922502; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LERCH PG, 1980, EUR J BIOCHEM, V107, P7, DOI 10.1111/j.1432-1033.1980.tb04617.x; LIJNEN HR, 1988, EUR J BIOCHEM, V177, P575, DOI 10.1111/j.1432-1033.1988.tb14409.x; LIJNEN HR, 1990, J BIOL CHEM, V265, P5232; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P567, DOI 10.1111/j.1432-1033.1994.00567.x; Magalhaes V, 2007, MICROBES INFECT, V9, P1276, DOI 10.1016/j.micinf.2007.06.001; Markus G, 1996, FIBRINOLYSIS, V10, P75, DOI 10.1016/S0268-9499(96)80082-8; MARKUS G, 1979, J BIOL CHEM, V254, P1211; MARKUS G, 1978, J BIOL CHEM, V253, P727; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; MCCANCE SG, 1995, BIOCHEMISTRY-US, V34, P9581, DOI 10.1021/bi00029a035; NELLES L, 1987, J BIOL CHEM, V262, P5682; NOVOKHATNY V, 1995, J BIOL CHEM, V270, P8680, DOI 10.1074/jbc.270.15.8680; NOVOKHATNY VV, 1989, THROMB RES, V53, P243, DOI 10.1016/0049-3848(89)90099-6; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Panizzi P, 2004, CELL MOL LIFE SCI, V61, P2793, DOI 10.1007/s00018-004-4285-7; Panizzi P, 2006, J BIOL CHEM, V281, P26774, DOI 10.1074/jbc.C600171200; PETROS AM, 1989, BIOCHEMISTRY-US, V28, P1368, DOI 10.1021/bi00429a064; Pietrocola G, 2005, BLOOD, V105, P1052, DOI 10.1182/blood-2004-06-2149; PLOPLIS VA, 1982, BIOCHEMISTRY-US, V21, P5891, DOI 10.1021/bi00266a025; PLOW EF, 1981, J BIOL CHEM, V256, P864; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Rajamohan G, 2002, BIOCHEM J, V365, P379, DOI 10.1042/BJ20011647; ROBBINS KC, 1975, J BIOL CHEM, V250, P4044; Sazonova IY, 2001, J BIOL CHEM, V276, P12609, DOI 10.1074/jbc.M009265200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schuchat A, 1999, LANCET, V353, P51, DOI 10.1016/S0140-6736(98)07128-1; SJOHOLM I, 1973, EUR J BIOCHEM, V39, P471, DOI 10.1111/j.1432-1033.1973.tb03146.x; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Tharp AC, 2009, J BIOL CHEM, V284, P19511, DOI 10.1074/jbc.M109.005512; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; URANO T, 1987, J BIOL CHEM, V262, P15959; URANO T, 1987, P NATL ACAD SCI USA, V84, P4031, DOI 10.1073/pnas.84.12.4031; URANO T, 1988, BIOCHEMISTRY-US, V27, P6522, DOI 10.1021/bi00417a049; VALI Z, 1982, J BIOL CHEM, V257, P2104; VIOLAND BN, 1976, J BIOL CHEM, V251, P3906; VIOLAND BN, 1978, J BIOL CHEM, V253, P5395; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Ward PN, 2004, INDIAN J MED RES, V119, P136; Ward PN, 2004, J MOL BIOL, V342, P1101, DOI 10.1016/j.jmb.2004.07.079; Ward PN, 2002, J BACTERIOL, V184, P119, DOI 10.1128/JB.184.1.119-125.2002; WEISEL JW, 1994, J MOL BIOL, V235, P1117, DOI 10.1006/jmbi.1994.1061; Whiting GC, 2002, J MED MICROBIOL, V51, P837, DOI 10.1099/0022-1317-51-10-837	80	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21153	21164		10.1074/jbc.M110.107730	http://dx.doi.org/10.1074/jbc.M110.107730			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435890	Green Published, hybrid			2022-12-25	WOS:000279228600078
J	Majumder, S; Ilayaraja, M; Seerapu, HR; Sinha, S; Siamwala, JH; Chatterjee, S				Majumder, Syamantak; Ilayaraja, M.; Seerapu, Himabindu Reddy; Sinha, Swaraj; Siamwala, Jamila H.; Chatterjee, Suvro			Chick Embryo Partial Ischemia Model: A New Approach to Study Ischemia Ex Vivo	PLOS ONE			English	Article							TRANSIENT FOREBRAIN ISCHEMIA; CREATINE-KINASE ISOENZYME; LIPID-PEROXIDATION; REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; N-ACETYLCYSTEINE; FILAMENT MODEL; NITRIC-OXIDE; EGG-YOLK; HYPOXIA	Background: Ischemia is a pathophysiological condition due to blockade in blood supply to a specific tissue thus damaging the physiological activity of the tissue. Different in vivo models are presently available to study ischemia in heart and other tissues. However, no ex vivo ischemia model has been available to date for routine ischemia research and for faster screening of anti-ischemia drugs. In the present study, we took the opportunity to develop an ex vivo model of partial ischemia using the vascular bed of 4(th) day incubated chick embryo. Methodology/Principal Findings: Ischemia was created in chick embryo by ligating the right vitelline artery using sterile surgical suture. Hypoxia inducible factor-1 alpha (HIF-1 alpha), creatine phospho kinase-MB and reactive oxygen species in animal tissues and cells were measured to confirm ischemia in chick embryo. Additionally, ranolazine, N-acetyl cysteine and trimetazidine were administered as an anti-ischemic drug to validate the present model. Results from the present study depicted that blocking blood flow elevates HIF-1 alpha, lipid peroxidation, peroxynitrite level in ischemic vessels while ranolazine administration partially attenuates ischemia driven HIF-1 alpha expression. Endothelial cell incubated on ischemic blood vessels elucidated a higher level of HIF-1 alpha expression with time while ranolazine treatment reduced HIF-1 alpha in ischemic cells. Incubation of caprine heart strip on chick embryo ischemia model depicted an elevated creatine phospho kinase-MB activity under ischemic condition while histology of the treated heart sections evoked edema and disruption of myofibril structures. Conclusions/Significance: The present study concluded that chick embryo partial ischemia model can be used as a novel ex vivo model of ischemia. Therefore, the present model can be used parallel with the known in vivo ischemia models in understanding the mechanistic insight of ischemia development and in evaluating the activity of anti-ischemic drug.	[Majumder, Syamantak; Ilayaraja, M.; Seerapu, Himabindu Reddy; Sinha, Swaraj; Siamwala, Jamila H.; Chatterjee, Suvro] Anna Univ, Vasc Biol Lab, AU KBC Res Ctr, Chennai 600025, Tamil Nadu, India	Anna University; Anna University Chennai	Majumder, S (corresponding author), Anna Univ, Vasc Biol Lab, AU KBC Res Ctr, Chennai 600025, Tamil Nadu, India.	soovro@yahoo.ca	Siamwala, Jamila/AGN-8667-2022; Muthuramu, Ilayaraja/R-2199-2018	Muthuramu, Ilayaraja/0000-0003-3550-7672; Majumder, Syamantak/0000-0001-8957-9810; Siamwala, Jamila/0000-0001-9482-9183	KB Chandrasekhar- Research Foundation	KB Chandrasekhar- Research Foundation	This work was supported by a grant from KB Chandrasekhar- Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLELY MC, 1990, BRIT J PHARMACOL, V99, P5, DOI 10.1111/j.1476-5381.1990.tb14641.x; ALLELY MC, 1988, BRIT J PHARMACOL, V93, P375, DOI 10.1111/j.1476-5381.1988.tb11444.x; AOKI N, 1988, BRIT J PHARMACOL, V95, P735, DOI 10.1111/j.1476-5381.1988.tb11699.x; Ay H, 2002, STROKE, V33, P286, DOI 10.1161/hs0102.101544; Baines CP, 1997, J MOL CELL CARDIOL, V29, P207, DOI 10.1006/jmcc.1996.0265; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; BROMONT C, 1989, STROKE, V20, P918, DOI 10.1161/01.STR.20.7.918; CLARKE B, 1993, BRIT J PHARMACOL, V109, P748, DOI 10.1111/j.1476-5381.1993.tb13637.x; Dittmar M, 2003, STROKE, V34, P2252, DOI 10.1161/01.STR.0000083625.54851.9A; Dittmar MS, 2006, J NEUROSCI METH, V156, P50, DOI 10.1016/j.jneumeth.2006.02.003; FABINYI G, 1977, J NEUROL NEUROSUR PS, V40, P818, DOI 10.1136/jnnp.40.8.818; FUJII DK, 1983, IN VITRO CELL DEV B, V19, P811, DOI 10.1007/BF02618160; GRALINSKI MR, 1994, CARDIOVASC RES, V28, P1231, DOI 10.1093/cvr/28.8.1231; Groenendijk BCW, 2007, PHYSIOLOGY, V22, P380, DOI 10.1152/physiol.00023.2007; HACKENBERRY LE, 1982, CRIT CARE MED, V10, P641; Hamrick SEG, 2005, NEUROSCI LETT, V379, P96, DOI 10.1016/j.neulet.2004.12.080; Hartmann C, 2001, WORLD POULTRY SCI J, V57, P13, DOI 10.1079/WPS20010003; Hasenfuss G, 2008, CLIN RES CARDIOL, V97, P222, DOI 10.1007/s00392-007-0612-y; Hauet T, 1998, CRYOBIOLOGY, V37, P231, DOI 10.1006/cryo.1998.2120; Hayashi T, 2008, TRANSPL P, V40, P2139, DOI 10.1016/j.transproceed.2008.07.083; Hogers B, 1999, CARDIOVASC RES, V41, P87, DOI 10.1016/S0008-6363(98)00218-1; Iqbal S, 2002, BRAIN RES, V928, P1, DOI 10.1016/S0006-8993(01)03095-5; KASTE M, 1978, BRIT HEART J, V40, P802; Kaufmann PA, 2000, CORONARY ARTERY DIS, V11, P363, DOI 10.1097/00019501-200006000-00011; KEHRER JP, 1991, ADV EXP MED BIOL, V283, P299; Klawitter PF, 2002, AM J PHYSIOL-HEART C, V283, pH1656, DOI 10.1152/ajpheart.00041.2002; KNUCKEY NW, 1995, STROKE, V26, P305, DOI 10.1161/01.STR.26.2.305; Koksal C, 2003, J SURG RES, V111, P236, DOI 10.1016/S0022-4804(03)00094-5; Kwak KH, 2009, ACTA ANAESTH SCAND, V53, P648, DOI 10.1111/j.1399-6576.2009.01937.x; Laake JH, 1999, BRAIN RES PROTOC, V4, P173, DOI 10.1016/S1385-299X(99)00021-5; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510; Majumder S, 2008, BIOCHEM CELL BIOL, V86, P1, DOI 10.1139/o07-146; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; Marshall RC, 2003, AM J PHYSIOL-HEART C, V284, pH654, DOI 10.1152/ajpheart.00594.2002; Matsumura H, 1998, JPN J PHARMACOL, V77, P31, DOI 10.1254/jjp.77.31; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; McCormack JG, 1996, CIRCULATION, V93, P135, DOI 10.1161/01.CIR.93.1.135; Miller MJ, 2001, CAN J CARDIOL, V17, P1075; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; OSHINO N, 1975, BIOCHEM J, V146, P53, DOI 10.1042/bj1460053; PULEO PR, 1990, CIRCULATION, V82, P759, DOI 10.1161/01.CIR.82.3.759; SCADUTO RC, 1988, AM J PHYSIOL, V255, pF911, DOI 10.1152/ajprenal.1988.255.5.F911; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; VOS SS, 2003, J EXP BIOL, V206, P1051; Wang YJ, 2009, ANN BIOMED ENG, V37, P1069, DOI 10.1007/s10439-009-9682-5; WIELOCH T, 2003, Patent No. 2003091405; Yada T, 2006, AM J PHYSIOL-HEART C, V291, pH1138, DOI 10.1152/ajpheart.00187.2006; YAMAMOTO M, 1983, STROKE, V14, P977, DOI 10.1161/01.STR.14.6.977; Zhai PY, 2000, AM J PHYSIOL-HEART C, V279, pH2766, DOI 10.1152/ajpheart.2000.279.6.H2766	56	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10524	10.1371/journal.pone.0010524	http://dx.doi.org/10.1371/journal.pone.0010524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479865	gold, Green Published, Green Submitted			2022-12-25	WOS:000277467800009
J	Balhoff, JP; Dahdul, WM; Kothari, CR; Lapp, H; Lundberg, JG; Mabee, P; Midford, PE; Westerfield, M; Vision, TJ				Balhoff, James P.; Dahdul, Wasila M.; Kothari, Cartik R.; Lapp, Hilmar; Lundberg, John G.; Mabee, Paula; Midford, Peter E.; Westerfield, Monte; Vision, Todd J.			Phenex: Ontological Annotation of Phenotypic Diversity	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; OSTARIOPHYSI; SILURIFORMES; GENOMICS	Background: Phenotypic differences among species have long been systematically itemized and described by biologists in the process of investigating phylogenetic relationships and trait evolution. Traditionally, these descriptions have been expressed in natural language within the context of individual journal publications or monographs. As such, this rich store of phenotype data has been largely unavailable for statistical and computational comparisons across studies or integration with other biological knowledge. Methodology/Principal Findings: Here we describe Phenex, a platform-independent desktop application designed to facilitate efficient and consistent annotation of phenotypic similarities and differences using Entity-Quality syntax, drawing on terms from community ontologies for anatomical entities, phenotypic qualities, and taxonomic names. Phenex can be configured to load only those ontologies pertinent to a taxonomic group of interest. The graphical user interface was optimized for evolutionary biologists accustomed to working with lists of taxa, characters, character states, and character-by-taxon matrices. Conclusions/Significance: Annotation of phenotypic data using ontologies and globally unique taxonomic identifiers will allow biologists to integrate phenotypic data from different organisms and studies, leveraging decades of work in systematics and comparative morphology.	[Balhoff, James P.; Dahdul, Wasila M.; Kothari, Cartik R.; Lapp, Hilmar; Midford, Peter E.; Vision, Todd J.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Balhoff, James P.; Kothari, Cartik R.; Vision, Todd J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Dahdul, Wasila M.; Mabee, Paula] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Lundberg, John G.] Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; [Westerfield, Monte] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	The National Evolutionary Synthesis Center; University of North Carolina; University of North Carolina Chapel Hill; University of South Dakota; Drexel University; University of Oregon	Balhoff, JP (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC USA.	balhoff@nescent.org	Midford, Peter E./B-5946-2008; Lapp, Hilmar/A-8275-2009; Vision, Todd/B-4867-2010	Midford, Peter E./0000-0001-6512-3296; Mabee, Paula/0000-0002-8455-3213; Balhoff, James/0000-0002-8688-6599; Lapp, Hilmar/0000-0001-9107-0714; Saravanamuthu, Cartik Kothari/0000-0002-0195-950X; Dahdul, Wasila/0000-0003-3162-7490; Vision, Todd/0000-0002-6133-2581	NSF [DBI 0641025]; NIH [HG002659]; National Evolutionary Synthesis Center [NSF EF-0423641]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG002659, U41HG002659] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1062542] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Evolutionary Synthesis Center; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank NSF (DBI 0641025), http://www.nsf.gov/; NIH (HG002659), http://www.nih.gov/; and the National Evolutionary Synthesis Center (NSF EF-0423641), https://www.nescent.org/, for the support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuaje F, 2006, METH MOL B, V316, P67; Bodenreider O, 2006, BRIEF BIOINFORM, V7, P256, DOI 10.1093/bib/bbl027; BORNBUSCH AH, 1995, ZOOL J LINN SOC-LOND, V115, P1; Buckup Paulo Andreas, 1998, P123; DAHDUL W, 2010, PLOS ONE IN PRESS; DAHDUL WM, 2010, SYSTEMATIC IN PRESS; DALLWITZ MJ, 1980, TAXON, V29, P41, DOI 10.2307/1219595; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8; Goble C, 2008, J BIOMED INFORM, V41, P687, DOI 10.1016/j.jbi.2008.01.008; Grande T, 1999, ZOOL J LINN SOC-LOND, V125, P197; Hagedorn G., 2005, STRUCTURED DESCRIPTI; Lundberg J.G., 1993, P392; Mabee PM, 2007, J EXP ZOOL PART B, V308B, P655, DOI 10.1002/jez.b.21181; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Maddison, 2019, MESQUITE MODULAR SYS; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Nadkarni PM, 1999, J AM MED INFORM ASSN, V6, P478, DOI 10.1136/jamia.1999.0060478; Prosdocimi F, 2009, EVOL BIOINFORM, V5, P47; Ramirez MJ, 2007, SYST BIOL, V56, P283, DOI 10.1080/10635150701313848; ROYERO R, 1999, STUDIES SYSTEMATICS; Ruttenberg A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S3-S2; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith G.R., 1993, P778; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; Toledo-Piza M, 2007, ZOOL J LINN SOC-LOND, V151, P691, DOI 10.1111/j.1096-3642.2007.00355.x; Vigliotta TR, 2008, P ACAD NAT SCI PHILA, V157, P73, DOI 10.1635/0097-3157(2008)157[73:APSOTA]2.0.CO;2; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247	33	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10500	10.1371/journal.pone.0010500	http://dx.doi.org/10.1371/journal.pone.0010500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463926	Green Submitted, Green Published, gold			2022-12-25	WOS:000277379400033
J	Martin, AJ; Vazquez-Prokopec, GM; Page, M				Martin, Anthony J.; Vazquez-Prokopec, Gonzalo M.; Page, Michael			First Known Feeding Trace of the Eocene Bottom-Dwelling Fish Notogoneus osculus and Its Paleontological Significance	PLOS ONE			English	Article							GREEN RIVER FORMATION; NEW-ENGLAND; UNDICHNA; FOSSIL; EXAMPLES; TRAILS; LAKES; USA	Background: The Green River Formation (early Eocene, about 42-53 Ma) at and near Fossil Butte National Monument in Wyoming, USA, is world famous for its exquisitely preserved freshwater teleost fish in the former Fossil Lake. Nonetheless, trace fossils attributed to fish interacting with the lake bottom are apparently rare, and have not been associated directly with any fish species. Here we interpret the first known feeding and swimming trace fossil of the teleost Notogoneus osculus Cope (Teleostei: Gonorynchidae), which is also represented as a body fossil in the same stratum. Methodology/Principal Findings: A standard description of the trace fossil, identified as Undichna cf. U. simplicatas, was augmented by high-resolution digital images and spatial and mathematical analyses, which allowed for detailed interpretations of the anatomy, swimming mode, feeding behavior, and body size of the tracemaker. Our analysis indicates that the tracemaker was about 45 cm long; used its caudal, anal, and pelvic fins (the posterior half of its body) to make the swimming traces; and used a ventrally oriented mouth to make overlapping feeding marks. We hypothesize that the tracemaker was an adult Notogoneus osculus. Conclusions/Significance: Our results are the first to link a specific teleost tracemaker with a trace fossil from the Green River Formation, while also interpreting the size and relative age of the tracemaker. The normal feeding and swimming behaviors indicated by the trace fossil indicate temporarily oxygenated benthic conditions in the deepest part of Fossil Lake, counter to most paleoecological interpretations of this deposit. Lastly, our spatial and mathematical analyses significantly update and advance previous approaches to the study of teleost trace fossils.	[Martin, Anthony J.; Vazquez-Prokopec, Gonzalo M.; Page, Michael] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA	Emory University	Martin, AJ (corresponding author), Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA.	geoam@learnlink.emory.edu			Department of Environmental Studies (Emory University)	Department of Environmental Studies (Emory University)	The only funding was internal travel money from the Department of Environmental Studies (Emory University) provided to AJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON A M, 1976, Palaeontology (Oxford), V19, P397; BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; BAINBRIDGE R, 1963, J EXP BIOL, V40, P23; Benner JS, 2008, PALAEOGEOGR PALAEOCL, V260, P375, DOI 10.1016/j.palaeo.2007.12.004; Benner JS, 2009, PALAEOGEOGR PALAEOCL, V272, P212, DOI 10.1016/j.palaeo.2008.10.029; BIAGGI RE, 2002, GEOL SOC AM ABSTR, V34, P557; BOYER BW, 1982, GEOLOGY, V10, P321, DOI 10.1130/0091-7613(1982)10<321:GRLDTP>2.0.CO;2; Buchheim H. P., 1994, CONTRIBUTIONS GEOLOG, V30, P3; Buchheim H.P., 1998, UTAH GEOLOGICAL ASS, P1; BUCHHEIM HP, 2002, GEOL SOC AM ABSTR, V34, P479; De Carvalho MR, 2004, B AM MUS NAT HIST, P1; de Gibert JM, 1999, PALAEONTOLOGY, V42, P409, DOI 10.1111/1475-4983.00079; de Gibert Jordi M., 2001, Ichnos, V8, P15; EDWARDS P, 1976, Contributions to Geology University of Wyoming, V14, P115; FERBER CT, 1995, PALAEOGEOGR PALAEOCL, V117, P185, DOI 10.1016/0031-0182(94)00127-T; Grande L, 2001, T GEOBIOL, V18, P1; GRANDE L, 1982, COPEIA, P523; GRANDE L, 1984, GEOLOGICAL SURVEY WY, V63; Grande L, 2008, J PALEONTOL, V82, P1, DOI 10.1666/0022-3360(2008)82[1:ROTTSF]2.0.CO;2; Grande Lance, 1994, Contributions to Geology University of Wyoming, V30, P33; Loewen Mark A., 1999, Journal of Vertebrate Paleontology, V19, p59A; Lu ZS, 2004, SCI CHINA SER D, V47, P272, DOI 10.1360/02yd0273; Martin Anthony J., 2005, P59; Minter NJ, 2006, PALAEONTOLOGY, V49, P1123, DOI 10.1111/j.1475-4983.2006.00588.x; Morrissey LB, 2004, GEOL J, V39, P337, DOI 10.1002/gj.998; Russ J. C., 2002, IMAGE PROCESSING HDB, V4th, DOI DOI 10.1201/9781420040760; Seilacher A., 2007, TRACE FOSSIL ANAL; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Smith ME, 2008, GEOL SOC AM BULL, V120, P54, DOI 10.1130/B26073.1; Trewin NH, 2000, PALAEONTOLOGY, V43, P979, DOI 10.1111/1475-4983.00158; Trigub R.M., 2004, FOURIER ANAL APPROXI; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; WARDLE CS, 1995, J EXP BIOL, V198, P1629	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10420	10.1371/journal.pone.0010420	http://dx.doi.org/10.1371/journal.pone.0010420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463969	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379400006
J	Choo, YM; Lee, KS; Yoon, HJ; Kim, BY; Sohn, MR; Roh, JY; Je, YH; Kim, NJ; Kim, I; Woo, SD; Sohn, HD; Jin, BR				Choo, Young Moo; Lee, Kwang Sik; Yoon, Hyung Joo; Kim, Bo Yeon; Sohn, Mi Ri; Roh, Jong Yul; Je, Yeon Ho; Kim, Nam Jung; Kim, Iksoo; Woo, Soo Dong; Sohn, Hung Dae; Jin, Byung Rae			Dual Function of a Bee Venom Serine Protease: Prophenoloxidase-Activating Factor in Arthropods and Fibrin(ogen)olytic Enzyme in Mammals	PLOS ONE			English	Article							SNAKE-VENOM; HYMENOPTERA VENOM; PHOSPHOLIPASE A(2); BIOCHEMICAL-CHARACTERIZATION; PRO-PHENOLOXIDASE; BLOOD-COAGULATION; MOLECULAR-CLONING; BOMBYX-MORI; BUMBLEBEE; PURIFICATION	Bee venom contains a variety of peptides and enzymes, including serine proteases. While the presence of serine proteases in bee venom has been demonstrated, the role of these proteins in bee venom has not been elucidated. Furthermore, there is currently no information available regarding the melanization response or the fibrin(ogen)olytic activity of bee venom serine protease, and the molecular mechanism of its action remains unknown. Here we show that bee venom serine protease (Bi-VSP) is a multifunctional enzyme. In insects, Bi-VSP acts as an arthropod prophenoloxidase (proPO)-activating factor (PPAF), thereby triggering the phenoloxidase (PO) cascade. Bi-VSP injected through the stinger induces a lethal melanization response in target insects by modulating the innate immune response. In mammals, Bi-VSP acts similarly to snake venom serine protease, which exhibits fibrin(ogen) olytic activity. Bi-VSP activates prothrombin and directly degrades fibrinogen into fibrin degradation products, defining roles for Bi-VSP as a prothrombin activator, a thrombin-like protease, and a plasmin-like protease. These findings provide a novel view of the mechanism of bee venom in which the bee venom serine protease kills target insects via a melanization strategy and exhibits fibrin(ogen) olytic activity.	[Choo, Young Moo; Lee, Kwang Sik; Kim, Bo Yeon; Sohn, Mi Ri; Sohn, Hung Dae; Jin, Byung Rae] Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea; [Yoon, Hyung Joo; Kim, Nam Jung] Natl Acad Agr Sci, Dept Agr Biol, Suwon, South Korea; [Roh, Jong Yul; Je, Yeon Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Iksoo] Chonnam Natl Univ, Dept Agr Biol, Kwangju, South Korea; [Woo, Soo Dong] Chungbuk Natl Univ, Dept Plant Med, Cheongju, South Korea	Dong A University; Seoul National University (SNU); Chonnam National University; Chungbuk National University	Choo, YM (corresponding author), Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea.	brjin@dau.ac.kr			Rural Development Administration [10-29-66]; Ministry of Education, Science and Technology, Republic of Korea	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Agenda Project (10-29-66), the Rural Development Administration, and the BK21 Project, from the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGIOLAS A, 1985, J BIOL CHEM, V260, P1437; Asano T, 2001, J BIOL CHEM, V276, P11100, DOI 10.1074/jbc.M008426200; ASHIDA M, 1983, BIOCHEM BIOPH RES CO, V113, P562, DOI 10.1016/0006-291X(83)91762-X; ASHIDA M, 1990, EUR J BIOCHEM, V188, P507, DOI 10.1111/j.1432-1033.1990.tb15429.x; ASTRUP T, 1952, ARCH BIOCHEM BIOPHYS, V40, P346, DOI 10.1016/0003-9861(52)90121-5; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Choo YM, 2008, MOL CELL NEUROSCI, V38, P224, DOI 10.1016/j.mcn.2008.02.011; Choo YM, 2010, COMP BIOCHEM PHYS B, V156, P168, DOI 10.1016/j.cbpb.2010.03.007; DATTA G, 1995, ARCH BIOCHEM BIOPHYS, V317, P365, DOI 10.1006/abbi.1995.1176; Fitzgerald KT, 2006, CLIN TECH SMALL AN P, V21, P194, DOI 10.1053/j.ctsap.2006.10.002; GAULDIE J, 1976, EUR J BIOCHEM, V61, P369, DOI 10.1111/j.1432-1033.1976.tb10030.x; GOH H G, 1990, Korean Journal of Applied Entomology, V29, P180; Golden DBK, 2007, IMMUNOL ALLERGY CLIN, V27, P261, DOI 10.1016/j.iac.2007.03.008; Golden DBK, 2009, J ALLERGY CLIN IMMUN, V123, P1371, DOI 10.1016/j.jaci.2009.03.017; Gui ZZ, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-49; He JY, 2007, FEBS LETT, V581, P2965, DOI 10.1016/j.febslet.2007.05.047; HIDER RC, 1988, ENDEAVOUR, V12, P60, DOI 10.1016/0160-9327(88)90082-8; Hoffman DR, 2006, CLIN REV ALLERG IMMU, V30, P109, DOI 10.1385/CRIAI:30:2:109; HOFFMAN DR, 1984, ANN ALLERGY, V52, P276; Hoffman DR, 2001, J ALLERGY CLIN IMMUN, V108, P855, DOI 10.1067/mai.2001.119029; Hoffman DR, 1996, J ALLERGY CLIN IMMUN, V97, P812, DOI 10.1016/S0091-6749(96)80159-X; Inceoglu B, 2003, P NATL ACAD SCI USA, V100, P922, DOI 10.1073/pnas.242735499; Je YH, 2001, BIOTECHNOL LETT, V23, P575; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Joseph JS, 2001, HAEMOSTASIS, V31, P234; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; KAWABATA T, 1995, P NATL ACAD SCI USA, V92, P7774, DOI 10.1073/pnas.92.17.7774; Kini RM, 2005, PATHOPHYSIOL HAEMO T, V34, P200, DOI 10.1159/000092424; Koh YS, 2001, TOXICON, V39, P555, DOI 10.1016/S0041-0101(00)00169-0; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Matsui T, 1998, EUR J BIOCHEM, V252, P569, DOI 10.1046/j.1432-1327.1998.2520569.x; Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Mirshafiey A, 2007, NEUROPHARMACOLOGY, V53, P353, DOI 10.1016/j.neuropharm.2007.05.002; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; Ownby CL, 1997, TOXICON, V35, P67, DOI 10.1016/S0041-0101(96)00078-5; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Silva MB, 2003, BIOCHEM J, V369, P129, DOI 10.1042/BJ20020449; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Son DJ, 2007, PHARMACOL THERAPEUT, V115, P246, DOI 10.1016/j.pharmthera.2007.04.004; SPEIJER H, 1986, J BIOL CHEM, V261, P3258; Swenson S, 2005, TOXICON, V45, P1021, DOI 10.1016/j.toxicon.2005.02.027; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Winningham KM, 2004, J ALLERGY CLIN IMMUN, V114, P928, DOI 10.1016/j.jaci.2004.07.043; Xin Y, 2009, COMP BIOCHEM PHYS B, V154, P195, DOI 10.1016/j.cbpb.2009.06.003; Yoon HJ, 2002, APPL ENTOMOL ZOOL, V37, P419, DOI 10.1303/aez.2002.419; ZHANG Y, 1995, J BIOL CHEM, V270, P10246, DOI 10.1074/jbc.270.17.10246; Zhao MY, 2005, J BIOL CHEM, V280, P24744, DOI 10.1074/jbc.M504173200	55	73	75	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10393	10.1371/journal.pone.0010393	http://dx.doi.org/10.1371/journal.pone.0010393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454652	Green Submitted, gold, Green Published			2022-12-25	WOS:000277240300002
J	Morueta-Holme, N; Flojgaard, C; Svenning, JC				Morueta-Holme, Naia; Flojgaard, Camilla; Svenning, Jens-Christian			Climate Change Risks and Conservation Implications for a Threatened Small-Range Mammal Species	PLOS ONE			English	Article							ASSISTED MIGRATION; DISTRIBUTIONS; PREDICTION; DIVERSITY; IMPACTS; DETERMINANTS; EXTINCTION; RESPONSES; PATTERNS; FUTURE	Background: Climate change is already affecting the distributions of many species and may lead to numerous extinctions over the next century. Small-range species are likely to be a special concern, but the extent to which they are sensitive to climate is currently unclear. Species distribution modeling, if carefully implemented, can be used to assess climate sensitivity and potential climate change impacts, even for rare and cryptic species. Methodology/Principal Findings: We used species distribution modeling to assess the climate sensitivity, climate change risks and conservation implications for a threatened small-range mammal species, the Iberian desman (Galemys pyrenaicus), which is a phylogenetically isolated insectivore endemic to south-western Europe. Atlas data on the distribution of G. pyrenaicus was linked to data on climate, topography and human impact using two species distribution modeling algorithms to test hypotheses on the factors that determine the range for this species. Predictive models were developed and projected onto climate scenarios for 2070-2099 to assess climate change risks and conservation possibilities. Mean summer temperature and water balance appeared to be the main factors influencing the distribution of G. pyrenaicus. Climate change was predicted to result in significant reductions of the species' range. However, the severity of these reductions was highly dependent on which predictor was the most important limiting factor. Notably, if mean summer temperature is the main range determinant, G. pyrenaicus is at risk of near total extinction in Spain under the most severe climate change scenario. The range projections for Europe indicate that assisted migration may be a possible long-term conservation strategy for G. pyrenaicus in the face of global warming. Conclusions/Significance: Climate change clearly poses a severe threat to this illustrative endemic species. Our findings confirm that endemic species can be highly vulnerable to a warming climate and highlight the fact that assisted migration has potential as a conservation strategy for species threatened by climate change.	[Morueta-Holme, Naia; Flojgaard, Camilla; Svenning, Jens-Christian] Aarhus Univ, Dept Biol Sci, Ecoinformat & Biodivers Grp, Aarhus, Denmark; [Flojgaard, Camilla] Aarhus Univ, Natl Environm Res Inst, Dept Wildlife Ecol & Biodivers, Ronde, Denmark	Aarhus University; Aarhus University	Morueta-Holme, N (corresponding author), Aarhus Univ, Dept Biol Sci, Ecoinformat & Biodivers Grp, Aarhus, Denmark.	morueta.holme@biology.au.dk	Svenning, Jens-Christian/C-8977-2012; Morueta-Holme, Naia/J-4952-2013	Svenning, Jens-Christian/0000-0002-3415-0862; Morueta-Holme, Naia/0000-0002-0776-4092; Flojgaard, Camilla/0000-0002-5829-8503	Danish Natural Science Research Council [272-07-0242]	Danish Natural Science Research Council(Danish Natural Science Research Council)	This work received economic support from the Danish Natural Science Research Council (Grant 272-07-0242 to JCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P541; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Aublet JF, 2009, OECOLOGIA, V159, P237, DOI 10.1007/s00442-008-1198-4; AYMERICH P, 2004, B INFORM SOC ESPANOL, V16, P83; Aymerich P., 2004, HABITATS, V9, P26; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Buermann W, 2008, J BIOGEOGR, V35, P1160, DOI 10.1111/j.1365-2699.2007.01858.x; Cabria MT, 2006, GENE, V375, P1, DOI 10.1016/j.gene.2006.01.038; CASTEL E, 2003, HABITATS, V7, P22; *CIESIN CIAT, 2005, POP WORLD VERS 3 GWP; Degerbol M., 1964, Journal of Animal Ecology (Suppl), V33, P71, DOI 10.2307/2431; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fischlin A., 2007, CONTRIBUTION WORKING, P211; Flojgaard C, 2009, J BIOGEOGR, V36, P1152, DOI 10.1111/j.1365-2699.2009.02089.x; GASTON JK, 1994, RARITY; GISBERT J, 2003, VER354 MIN MED AMB; Grayson DK, 2000, J BIOGEOGR, V27, P181, DOI 10.1046/j.1365-2699.2000.00383.x; Grayson DK, 2005, CONSERV BIOL, V19, P557; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; IUCN, 2007, EUR MAMM ASS; IUCN, 2014, IUCN RED LIST THREAT; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Levinsky I, 2007, BIODIVERS CONSERV, V16, P3803, DOI 10.1007/s10531-007-9181-7; MARRIS E, 2008, CLIMATE CHANGE, V2, P112; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mira A, 2008, MAMM BIOL, V73, P102, DOI 10.1016/j.mambio.2006.11.003; Mitchell T. D., 2004, TYNDALL CTR CLIMATE, V55, P25; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; Nogues-Bravo D, 2008, PLOS BIOL, V6, P685, DOI 10.1371/journal.pbio.0060079; NORES C, 1999, SEM CONS MARG MARG G; NORES C, 1992, APROXIMACIO METODOLO; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Palmeirim J.M., 1983, MAMMALIAN SPECIES, V207, P1; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Pearman PB, 2008, ECOL LETT, V11, P357, DOI 10.1111/j.1461-0248.2007.01150.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schreuder A., 1940, ARCH NEERLAND ZOOL, V4, P201; Seddon PJ, 2009, CONSERV BIOL, V23, P788, DOI 10.1111/j.1523-1739.2009.01200.x; Skov F, 2004, ECOGRAPHY, V27, P366, DOI 10.1111/j.0906-7590.2004.03823.x; Smirnov N G, 2007, Dokl Biol Sci, V414, P219, DOI 10.1134/S0012496607030143; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Svenning JC, 2003, ECOL LETT, V6, P646, DOI 10.1046/j.1461-0248.2003.00477.x; SVENNING JC, 2009, IOP C SER EARTH ENV, V8; Svenning JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P234, DOI 10.1111/j.1466-8238.2006.00280.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Tinoco BA, 2009, BIRD CONSERV INT, V19, P63, DOI 10.1017/S0959270908007703; Vitt P, 2009, TRENDS ECOL EVOL, V24, P473, DOI 10.1016/j.tree.2009.05.007; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Willis SG, 2009, CONSERV LETT, V2, P45, DOI 10.1111/j.1755-263X.2008.00043.x	77	105	111	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10360	10.1371/journal.pone.0010360	http://dx.doi.org/10.1371/journal.pone.0010360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454451	gold, Green Published, Green Submitted			2022-12-25	WOS:000277240100003
J	Paladino, P; Collins, SE; Mossman, KL				Paladino, Patrick; Collins, Susan E.; Mossman, Karen L.			Cellular Localization of the Herpes Simplex Virus ICP0 Protein Dictates Its Ability to Block IRF3-Mediated Innate Immune Responses	PLOS ONE			English	Article							INTERFERON REGULATORY FACTOR-3; NF-KAPPA-B; EARLY POLYPEPTIDE VMW110; IMMEDIATE-EARLY GENE-1; DOUBLE-STRANDED-RNA; ANTIVIRAL RESPONSE; TYPE-1 ICP0; STIMULATED GENES; PARTICLE ENTRY; POSTTRANSLATIONAL MODIFICATION	Interferon regulatory factor 3 (IRF3) is important for innate antiviral responses; accordingly, many viruses target and inactivate IRF3. The ability of the Herpes simplex virus type 1 (HSV-1) immediate early protein ICP0 to inhibit IRF3 is controversial and has not been studied solely in the context of a wild type HSV-1 infection. Discrepancies in the literature surround the mechanism by which ICP0 antagonizes the IRF3 pathway, the cellular localization of ICP0 inhibitory activity and the ability of ICP0 to interfere with interferon and interferon-stimulated gene induction. In this study, we set out to investigate the role of ICP0 localization and the requirement of the proteasome during the inhibition of IRF3 activation within the context of an HSV-1 infection. Collectively, the results presented herein demonstrate that incoming wild type HSV-1 activates IRF3 and that de novo produced ICP0 prevents sustained IRF3 activation following its translocation from the nucleus to the cytoplasm. While previous studies implicate the E3 ubiquitin ligase domain of ICP0 in mediating its biological functions, including the inhibition of IRF3, we show that cytoplasmic ICP0 does not require the proteasome for this activity. Instead, proteasome function is required to localize ICP0 to the cytoplasm where it mediates its inhibitory effect independent of E3 ubiquitin ligase activity. The importance of these findings is discussed within the context of an HSV-1 infection.	[Paladino, Patrick; Collins, Susan E.; Mossman, Karen L.] McMaster Univ, Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University	Paladino, P (corresponding author), McMaster Univ, Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada.	mossk@mcmaster.ca	Collins, Susan/AAD-1390-2020		Canadian Institutes for Health Research [FRN 57669]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by an operating grant from the Canadian Institutes for Health Research (FRN 57669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani SJ, 2001, J VIROL, V75, P7904, DOI 10.1128/JVI.75.17.7904-7912.2001; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BECKER Y, 1977, ANTIMICROB AGENTS CH, V11, P919, DOI 10.1128/AAC.11.5.919; BLAHO JA, 1993, J VIROL, V67, P3891, DOI 10.1128/JVI.67.7.3891-3900.1993; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; Boutell C, 2008, J VIROL, V82, P10647, DOI 10.1128/JVI.01063-08; CAI WZ, 1992, J VIROL, V66, P2904, DOI 10.1128/JVI.66.5.2904-2915.1992; CAI WZ, 1989, J VIROL, V63, P4579, DOI 10.1128/JVI.63.11.4579-4589.1989; CIUFO DM, 1994, J VIROL, V68, P3267, DOI 10.1128/JVI.68.5.3267-3282.1994; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; Davido DJ, 2005, J VIROL, V79, P1232, DOI 10.1128/JVI.79.2.1232-1243.2005; Davido DJ, 2002, J VIROL, V76, P1077, DOI 10.1128/JVI.76.3.1077-1088.2002; DeFilippis V, 2005, J VIROL, V79, P6419, DOI 10.1128/JVI.79.10.6419-6431.2005; Ehlers B, 2007, J VIROL, V81, P8091, DOI 10.1128/JVI.00255-07; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; Everett RD, 2000, J VIROL, V74, P9994, DOI 10.1128/JVI.74.21.9994-10005.2000; EVERETT RD, 1991, NUCLEIC ACIDS RES, V19, P6155, DOI 10.1093/nar/19.22.6155; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; EVERETT RD, 1988, J MOL BIOL, V202, P87, DOI 10.1016/0022-2836(88)90521-9; Everett RD, 1998, EMBO J, V17, P7161, DOI 10.1093/emboj/17.24.7161; EVERETT RD, 1989, J GEN VIROL, V70, P1185, DOI 10.1099/0022-1317-70-5-1185; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; Everett RD, 2008, J VIROL, V82, P8871, DOI 10.1128/JVI.00613-08; Everett RD, 2009, J VIROL, V83, P4963, DOI 10.1128/JVI.02593-08; Everett RD, 2009, J VIROL, V83, P4978, DOI 10.1128/JVI.02595-08; Fridman AL, 2006, J GERONTOL A-BIOL, V61, P879, DOI 10.1093/gerona/61.9.879; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Guo JJ, 2000, VIROLOGY, V267, P209, DOI 10.1006/viro.1999.0135; Hagglund R, 2004, J VIROL, V78, P2169, DOI 10.1128/JVI.78.5.2169-2178.2004; HAY J, 1977, J ANTIMICROB CHEMOTH, V3, P63, DOI 10.1093/jac/3.suppl_A.63; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Kalaravoki M, 2008, J VIROL, V82, P1701, DOI 10.1128/JVI.02157-07; Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x; Kawaguchi Y, 1997, J VIROL, V71, P1019, DOI 10.1128/JVI.71.2.1019-1024.1997; Kawaguchi Y, 1997, J VIROL, V71, P7328, DOI 10.1128/JVI.71.10.7328-7336.1997; KILLINGTON RA, 1977, J GEN VIROL, V37, P297, DOI 10.1099/0022-1317-37-2-297; LEINBACH SS, 1976, BIOCHEMISTRY-US, V15, P426, DOI 10.1021/bi00647a029; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lopez P, 2001, J VIROL, V75, P3832, DOI 10.1128/JVI.75.8.3832-3840.2001; Lu G, 2006, CELL MOL BIOL, V52, P29, DOI 10.1170/T695; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; MAUL GG, 1993, J GEN VIROL, V74, P2679, DOI 10.1099/0022-1317-74-12-2679; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Mossman KL, 2000, J VIROL, V74, P2052, DOI 10.1128/JVI.74.4.2052-2056.2000; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Nicholl MJ, 2000, J GEN VIROL, V81, P2215, DOI 10.1099/0022-1317-81-9-2215; Noyce RS, 2006, J VIROL, V80, P226, DOI 10.1128/JVI.80.1.226-235.2006; Noyce RS, 2009, J VIROL, V83, P4013, DOI 10.1128/JVI.02069-08; Ogle WO, 1997, VIROLOGY, V235, P406, DOI 10.1006/viro.1997.8710; PALADINO P, 2009, J INTERFERON CYTOKIN; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Preston CM, 2001, J VIROL, V75, P8909, DOI 10.1128/JVI.75.19.8909-8916.2001; Ranjan P, 2009, TRENDS MOL MED, V15, P359, DOI 10.1016/j.molmed.2009.06.003; Reimer T, 2008, J LEUKOCYTE BIOL, V83, P1249, DOI 10.1189/jlb.0607412; Reimer T, 2007, J IMMUNOL, V179, P1166, DOI 10.4049/jimmunol.179.2.1166; Roizman B, 2005, CELL CYCLE, V4, P1019, DOI 10.4161/cc.4.8.1902; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Sobol PT, 2006, J VIROL, V80, P218, DOI 10.1128/JVI.80.1.218-225.2006; STOW ND, 1986, J GEN VIROL, V67, P2571, DOI 10.1099/0022-1317-67-12-2571; Tsitoura E, 2009, J GEN VIROL, V90, P2209, DOI 10.1099/vir.0.012203-0; Van Sant C, 1999, P NATL ACAD SCI USA, V96, P8184, DOI 10.1073/pnas.96.14.8184; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	73	79	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10428	10.1371/journal.pone.0010428	http://dx.doi.org/10.1371/journal.pone.0010428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454685	Green Published, Green Submitted, gold			2022-12-25	WOS:000277240100030
J	Safavi-Hemami, H; Young, ND; Doyle, J; Llewellyn, L; Klueter, A				Safavi-Hemami, Helena; Young, Neil D.; Doyle, Jason; Llewellyn, Lyndon; Klueter, Anke			Characterisation of Nitric Oxide Synthase in Three Cnidarian-Dinoflagellate Symbioses	PLOS ONE			English	Article								Background: Nitric oxide synthase (NOS) is an enzyme catalysing the conversion of L-arginine to L-citrulline and nitric oxide (NO), the latter being an essential messenger molecule for a range of biological processes. Whilst its role in higher vertebrates is well understood little is known about the role of this enzyme in early metazoan groups. For instance, NOS-mediated signalling has been associated with Cnidaria-algal symbioses, however controversy remains about the contribution of enzyme activities by the individual partners of these mutualistic relationships. Methodology/Principal Findings: Using a modified citrulline assay we successfully measured NOS activity in three cnidarian-algal symbioses: the sea anemone Aiptasia pallida, the hard coral Acropora millepora, and the soft coral Lobophytum pauciflorum, so demonstrating a wide distribution of this enzyme in the phylum Cnidaria. Further biochemical (citrulline assay) and histochemical (NADPH-diaphorase) investigations of NOS in the host tissue of L. pauciflorum revealed the cytosolic and calcium dependent nature of this enzyme and its in situ localisation within the coral's gastrodermal tissue, the innermost layer of the body wall bearing the symbiotic algae. Interestingly, enzyme activity could not be detected in symbionts freshly isolated from the cnidarians, or in cultured algal symbionts. Conclusions/Significance: These results suggest that NOS-mediated NO release may be host-derived, a finding that has the potential to further refine our understanding of signalling events in cnidarian-algal symbioses.	[Safavi-Hemami, Helena] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Young, Neil D.] Univ Melbourne, Fac Vet Sci, Melbourne, Vic, Australia; [Doyle, Jason; Llewellyn, Lyndon; Klueter, Anke] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Klueter, Anke] Univ Maine, Sch Marine Sci, Orono, ME USA	University of Melbourne; University of Melbourne; Australian Institute of Marine Science; University of Maine System; University of Maine Orono	Safavi-Hemami, H (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.	a.klueter@aims.gov.au	Young, Neil David/AAU-4572-2020; Safavi-Hemami, Helena/E-7624-2015; Llewellyn, Lyndon E/F-6030-2011	Young, Neil David/0000-0001-8756-229X; Safavi-Hemami, Helena/0000-0002-1984-2721; Llewellyn, Lyndon E/0000-0003-1680-1796	Cooperative Research Centre for the Great Barrier Reef World Heritage Area	Cooperative Research Centre for the Great Barrier Reef World Heritage Area(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research was funded by the Cooperative Research Centre for the Great Barrier Reef World Heritage Area (CRC Reef Research). URL: http//www.rrrc.org.au/crcreef/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard JN, 2008, PLANT CELL PHYSIOL, V49, P641, DOI 10.1093/pcp/pcn037; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; COLASANTI M, 1995, NATURE, V374, P505, DOI 10.1038/374505a0; Fabricius K, 2001, SOFT CORALS SEA FANS; Giovine M, 2001, NITRIC OXIDE-BIOL CH, V5, P427, DOI 10.1006/niox.2001.0366; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; Kuzin B. A., 2005, Ontogenez, V36, P343; Moroz LL, 2004, J COMP NEUROL, V471, P26, DOI 10.1002/cne.20023; Morrall CE, 2000, COMP BIOCHEM PHYS B, V125, P483, DOI 10.1016/S0305-0491(00)00157-7; Owen R, 2002, MAR POLLUT BULL, V44, P623, DOI 10.1016/S0025-326X(01)00303-4; Perez S, 2006, J EXP BIOL, V209, P2804, DOI 10.1242/jeb.02309; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Trapido-Rosenthal H, 2005, BIOL BULL-US, V208, P3, DOI 10.2307/3593094; Trapido-Rosenthal HG, 2001, AM ZOOL, V41, P247, DOI 10.1668/0003-1569(2001)041[0247:NOACDS]2.0.CO;2; von der Leyen HE, 2001, CIRCULATION, V103, P2760; Weinberg JB, 1998, ENVIRON HEALTH PERSP, V106, P1131, DOI 10.2307/3433975; Yamasaki H, 1999, TRENDS PLANT SCI, V4, P128, DOI 10.1016/S1360-1385(99)01393-X; [No title captured]	21	40	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10379	10.1371/journal.pone.0010379	http://dx.doi.org/10.1371/journal.pone.0010379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442851	Green Published, gold			2022-12-25	WOS:000277154200018
J	Sarmah, S; Barrallo-Gimeno, A; Melville, DB; Topczewski, J; Solnica-Krezel, L; Knapik, EW				Sarmah, Swapnalee; Barrallo-Gimeno, Alejandro; Melville, David B.; Topczewski, Jacek; Solnica-Krezel, Lilianna; Knapik, Ela W.			Sec24D-Dependent Transport of Extracellular Matrix Proteins Is Required for Zebrafish Skeletal Morphogenesis	PLOS ONE			English	Article							CONTROLS CELL POLARITY; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; TRANSGENIC MICE; COPII; CARTILAGE; BINDING; MUTATIONS; PERLECAN; GENE	Protein transport from endoplasmic reticulum ( ER) to Golgi is primarily conducted by coated vesicular carriers such as COPII. Here, we describe zebrafish bulldog mutations that disrupt the function of the cargo adaptor Sec24D, an integral component of the COPII complex. We show that Sec24D is essential for secretion of cartilage matrix proteins, whereas the preceding development of craniofacial primordia and pre-chondrogenic condensations does not depend on this isoform. Bulldog chondrocytes fail to secrete type II collagen and matrilin to extracellular matrix (ECM), but membrane bound receptor beta 1-Integrin and Cadherins appear to leave ER in Sec24D-independent fashion. Consequently, Sec24D-deficient cells accumulate proteins in the distended ER, although a subset of ER compartments and Golgi complexes as visualized by electron microscopy and NBD C6-ceramide staining appear functional. Consistent with the backlog of proteins in the ER, chondrocytes activate the ER stress response machinery and significantly upregulate BiP transcription. Failure of ECM secretion hinders chondroblast intercalations thus resulting in small and malformed cartilages and severe craniofacial dysmorphology. This defect is specific to Sec24D mutants since knockdown of Sec24C, a close paralog of Sec24D, does not result in craniofacial cartilage dysmorphology. However, craniofacial development in double Sec24C/Sec24D-deficient animals is arrested earlier than in bulldog/sec24d, suggesting that Sec24C can compensate for loss of Sec24D at initial stages of chondrogenesis, but Sec24D is indispensable for chondrocyte maturation. Our study presents the first developmental perspective on Sec24D function and establishes Sec24D as a strong candidate for cartilage maintenance diseases and craniofacial birth defects.	[Sarmah, Swapnalee; Barrallo-Gimeno, Alejandro; Melville, David B.; Knapik, Ela W.] Vanderbilt Univ, Med Ctr, Dept Med, Div Med Genet, Nashville, TN 37235 USA; [Sarmah, Swapnalee; Barrallo-Gimeno, Alejandro; Melville, David B.; Knapik, Ela W.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA; [Barrallo-Gimeno, Alejandro; Knapik, Ela W.] Univ Freiburg, Inst Biol 1, D-7800 Freiburg, Germany; [Topczewski, Jacek; Solnica-Krezel, Lilianna] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA	Vanderbilt University; Vanderbilt University; University of Freiburg; Vanderbilt University	Sarmah, S (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Med Genet, Nashville, TN 37235 USA.	ela.knapik@vanderbilt.edu	Barrallo-Gimeno, Alejandro/L-1952-2013; Knapik, Ela W./J-6172-2014; Topczewski, Jacek/D-5895-2016	Barrallo-Gimeno, Alejandro/0000-0003-2086-8926; Knapik, Ela W./0000-0002-2977-3619; Topczewski, Jacek/0000-0001-6023-9556	National Institute of Dental and Craniofacial Research [R01 DE018477]; Vanderbilt University Academic Venture Capital Fund (EWK); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018477] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Vanderbilt University Academic Venture Capital Fund (EWK); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work has been supported in part by the National Institute of Dental and Craniofacial Research grant R01 DE018477 and the Zebrafish Initiative of the Vanderbilt University Academic Venture Capital Fund (EWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Bosserhoff AK, 2004, GENE EXPR PATTERNS, V4, P473, DOI 10.1016/j.modgep.2003.12.002; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hall BK, 1995, INT J DEV BIOL, V39, P881; HALL BK, 1992, ANAT EMBRYOL, V186, P107; Henrotin Y, 2007, CURR OPIN RHEUMATOL, V19, P444, DOI 10.1097/BOR.0b013e32829fb3b5; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Ko YP, 2005, BIOCHEM J, V386, P367, DOI 10.1042/BJ20041486; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Kvist AJ, 2006, J BIOL CHEM, V281, P33127, DOI 10.1074/jbc.M607892200; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; Li SW, 2001, DEV DYNAM, V222, P141, DOI 10.1002/dvdy.1178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; MASUDA H, 1994, J CLIN INVEST, V94, P2481, DOI 10.1172/JCI117617; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Olsen BR, 1999, J CELL BIOL, V147, P909, DOI 10.1083/jcb.147.5.909; Pace JM, 1997, DEV DYNAM, V208, P25; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Schilling TF, 1997, DEVELOPMENT, V124, P2945; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Tang BL, 1999, BIOCHEM BIOPH RES CO, V258, P679, DOI 10.1006/bbrc.1999.0574; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110	52	90	93	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10367	10.1371/journal.pone.0010367	http://dx.doi.org/10.1371/journal.pone.0010367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442775	gold, Green Published, Green Submitted			2022-12-25	WOS:000277154200009
J	Coppo, P; Schwarzinger, M; Buffet, M; Wynckel, A; Clabault, K; Presne, C; Poullin, P; Malot, S; Vanhille, P; Azoulay, E; Galicier, L; Lemiale, V; Mira, JP; Ridel, C; Rondeau, E; Pourrat, J; Girault, S; Bordessoule, D; Saheb, S; Ramakers, M; Hamidou, M; Vernant, JP; Guidet, B; Wolf, M; Veyradier, A				Coppo, Paul; Schwarzinger, Michael; Buffet, Marc; Wynckel, Alain; Clabault, Karine; Presne, Claire; Poullin, Pascale; Malot, Sandrine; Vanhille, Philippe; Azoulay, Elie; Galicier, Lionel; Lemiale, Virginie; Mira, Jean-Paul; Ridel, Christophe; Rondeau, Eric; Pourrat, Jacques; Girault, Stephane; Bordessoule, Dominique; Saheb, Samir; Ramakers, Michel; Hamidou, Mohamed; Vernant, Jean-Paul; Guidet, Bertrand; Wolf, Martine; Veyradier, Agnes		French Reference Ctr Thrombotic Mi	Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; HEMOLYTIC-UREMIC-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; LOGISTIC-REGRESSION ANALYSIS; THROMBOCYTOPENIC-PURPURA; PLASMA-EXCHANGE; PROGNOSTIC VALUE; ANTIBODIES; RITUXIMAB	Severe ADAMTS13 deficiency occurs in 13% to 75% of thrombotic microangiopathies (TMA). In this context, the early identification of a severe, antibody-mediated, ADAMTS13 deficiency may allow to start targeted therapies such as B-lymphocytes-depleting monoclonal antibodies. To date, assays exploring ADAMTS13 activity require skill and are limited to only some specialized reference laboratories, given the very low incidence of the disease. To identify clinical features which may allow to predict rapidly an acquired ADAMTS13 deficiency, we performed a cross-sectional analysis of our national registry from 2000 to 2007. The clinical presentation of 160 patients with TMA and acquired ADAMTS13 deficiency was compared with that of 54 patients with detectable ADAMTS13 activity. ADAMTS13 deficiency was associated with more relapses during treatment and with a good renal prognosis. Patients with acquired ADAMTS13 deficiency had platelet count <30x10(-9)/L (adjusted odds ratio [OR] 9.1, 95% confidence interval [CI] 3.4-24.2, P<.001), serum creatinine level <= 200 mu mol/L (OR 23.4, 95% CI 8.8-62.5, P<.001), and detectable antinuclear antibodies (OR 2.8, 95% CI 1.0-8.0, P<.05). When at least 1 criteria was met, patients with a severe acquired ADAMTS13 deficiency were identified with positive predictive value of 85%, negative predictive value of 93.3%, sensitivity of 98.8%, and specificity of 48.1%. Our criteria should be useful to identify rapidly newly diagnosed patients with an acquired ADAMTS13 deficiency to better tailor treatment for different pathophysiological groups.	[Coppo, Paul; Buffet, Marc; Malot, Sandrine] Hop St Antoine, AP HP, Serv Hematol & Therapie Cellulaire, F-75571 Paris, France; [Coppo, Paul; Schwarzinger, Michael; Buffet, Marc; Malot, Sandrine; Guidet, Bertrand] Univ Paris 06, Paris, France; [Schwarzinger, Michael] INSERM, UMR S 707, Paris, France; [Wynckel, Alain] Hop Maison Blanche, Serv Nephrol, Reims, France; [Clabault, Karine] Hop Charles Nicolle, Serv Reanimat Med, Rouen, France; [Presne, Claire] Hop Sud, Serv Nephrol Med Interne, Amiens, France; [Poullin, Pascale] Hop Conception, Serv Hemapherese, Marseille, France; [Vanhille, Philippe] Ctr Hosp Valenciennes, Serv Nephrol, Valenciennes, France; [Azoulay, Elie] Univ Paris 07, Hop St Louis, AP HP, Serv Reanimat Polyvalente, Paris, France; [Galicier, Lionel] Univ Paris 07, Hop St Louis, AP HP, Serv Immunopathol, Paris, France; [Lemiale, Virginie; Mira, Jean-Paul] Univ Paris 05, Hop Cochin, AP HP, Serv Reanimat Polyvalente, Paris, France; [Ridel, Christophe; Rondeau, Eric] Univ Paris 06, Hop Tenon, AP HP, Serv Nephrol, Paris, France; [Pourrat, Jacques] CHU Rangueil, Serv Nephrol, F-31054 Toulouse, France; [Pourrat, Jacques] CHU Rangueil, Immunol Clin, F-31054 Toulouse, France; [Girault, Stephane; Bordessoule, Dominique] CHU Dupuytren, Serv Hematol Clin & Therapie Cellulaire, Limoges, France; [Saheb, Samir; Vernant, Jean-Paul] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Serv Hematol Clin & Therapie Cellulaire, Paris, France; [Ramakers, Michel] CHU Caen, Serv Reanimat Med, F-14000 Caen, France; [Hamidou, Mohamed] Hop Hotel Dieu, Serv Med Interne A, Nantes, France; [Guidet, Bertrand] Hop St Antoine, AP HP, Serv Reanimat Med, F-75571 Paris, France; [Wolf, Martine; Veyradier, Agnes] Univ Paris 11, INSERM, U770, Le Kremlin Bicetre, France; [Wolf, Martine; Veyradier, Agnes] Hop Antoine Beclere, AP HP, Serv Hematol Biol, Clamart, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Rouen; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CH de Valenciennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; CHU de Toulouse; CHU Limoges; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Coppo, P (corresponding author), Hop St Antoine, AP HP, Serv Hematol & Therapie Cellulaire, F-75571 Paris, France.	paul.coppo@sat.aphp.fr	vigneau, cecile/I-3178-2015; Schwarzinger, Michael/F-7367-2011	Schwarzinger, Michael/0000-0002-0573-6856; IFRAH, Norbert/0000-0003-3063-850X; Saheb, Samir/0000-0002-7764-6016; deschenes, georges/0000-0002-5158-2915; gruson, didier/0000-0002-1199-5125; Ojeda-Uribe, Mario/0000-0001-6881-6055	Etablissement Francais du Sang [CS/2002/009]; GIS Maladies Rares [GIS MR0428]	Etablissement Francais du Sang; GIS Maladies Rares	This work was funded by grants from the Etablissement Francais du Sang (CS/2002/009) and the GIS Maladies Rares (GIS MR0428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asherson RA, 2008, AUTOIMMUN REV, V7, P164, DOI 10.1016/j.autrev.2007.11.009; Bianchi V, 2002, BLOOD, V100, P710, DOI 10.1182/blood-2002-02-0344; Coppo P, 2006, BRIT J HAEMATOL, V132, P66, DOI 10.1111/j.1365-2141.2005.05837.x; Coppo P, 2004, MEDICINE, V83, P233, DOI 10.1097/01.md.0000133622.03370.07; Coppo P, 2003, MEDICINE, V82, P27, DOI 10.1097/00005792-200301000-00003; Elliott MA, 2009, EUR J HAEMATOL, V83, P365, DOI 10.1111/j.1600-0609.2009.01292.x; Fakhouri F, 2005, BLOOD, V106, P1932, DOI 10.1182/blood-2005-03-0848; Ferrari S, 2007, BLOOD, V109, P2815, DOI 10.1182/blood-2006-02-006064; Francavilla R, 2008, HELICOBACTER, V13, P127, DOI 10.1111/j.1523-5378.2008.00593.x; Froissart A, 2009, BLOOD, V114, P366; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Hovinga JAK, 2010, BLOOD, V115, P1500, DOI 10.1182/blood-2009-09-243790; Howard MA, 2006, TRANSFUSION, V46, P154, DOI 10.1111/j.1537-2995.2006.00687.x; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Letchumanan P, 2009, RHEUMATOLOGY, V48, P399, DOI 10.1093/rheumatology/ken510; Mannucci PM, 2003, HAEMATOLOGICA, V88, P914; Mannucci PM, 2001, BLOOD, V98, P2730, DOI 10.1182/blood.V98.9.2730; Matsumoto M, 2004, SEMIN HEMATOL, V41, P68, DOI 10.1053/j.seminhematol.2003.10.009; Mori Y, 2002, TRANSFUSION, V42, P572, DOI 10.1046/j.1537-2995.2002.00100.x; Raife T, 2004, TRANSFUSION, V44, P146, DOI 10.1111/j.1537-2995.2004.00626.x; Rieger M, 2005, BLOOD, V106, P1262, DOI 10.1182/blood-2004-11-4490; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Scully M, 2007, BRIT J HAEMATOL, V136, P451, DOI 10.1111/j.1365-2141.2006.06448.x; Shelat SG, 2006, J THROMB HAEMOST, V4, P1707, DOI 10.1111/j.1538-7836.2006.02025.x; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Vesely SK, 2003, BLOOD, V102, P60, DOI 10.1182/blood-2003-01-0193; Veyradier A, 2001, BLOOD, V98, P1765, DOI 10.1182/blood.V98.6.1765; Zheng XL, 2004, BLOOD, V103, P4043, DOI 10.1182/blood-2003-11-4035	30	209	215	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10208	10.1371/journal.pone.0010208	http://dx.doi.org/10.1371/journal.pone.0010208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20436664	Green Published, gold, Green Submitted			2022-12-25	WOS:000277079300001
J	Lam, CKL; Chari, M; Su, BB; Cheung, GWC; Kokorovic, A; Yang, CS; Wang, PYT; Lai, TYY; Lam, TKT				Lam, Carol K. L.; Chari, Madhu; Su, Brenda B.; Cheung, Grace W. C.; Kokorovic, Andrea; Yang, Clair S.; Wang, Penny Y. T.; Lai, Teresa Y. Y.; Lam, Tony K. T.			Activation of N-Methyl-D-aspartate (NMDA) Receptors in the Dorsal Vagal Complex Lowers Glucose Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOOD-INTAKE; INSULIN ACTION; GLYCINE RECEPTORS; NR1 SUBUNIT; BRAIN; HOMEOSTASIS; HORN; INHIBITION; METABOLISM; MECHANISMS	Diabetes is characterized by hyperglycemia due partly to increased hepatic glucose production. The hypothalamus regulates hepatic glucose production in rodents. However, it is currently unknown whether other regions of the brain are sufficient in glucose production regulation. The N-methyl-D-aspartate (NMDA) receptor is composed of NR1 and NR2 subunits, which are activated by co-agonist glycine and glutamate or aspartate, respectively. Here we report that direct administration of either co-agonist glycine or NMDA into the dorsal vagal complex (DVC), targeting the nucleus of the solitary tract, lowered glucose production in vivo. Direct infusion of the NMDA receptor blocker MK-801 into the DVC negated the metabolic effect of glycine. To evaluate whether NR1 subunit of the NMDA receptor mediates the effect of glycine, NR1 in the DVC was inhibited by DVC NR1 antagonist 7-chlorokynurenic acid or DVC shRNA-NR1. Pharmacological and molecular inhibition of DVC NR1 negated the metabolic effect of glycine. To evaluate whether the NMDA receptors mediate the effects of NR2 agonist NMDA, DVC NMDA receptors were inhibited by antagonist D-2-amino-5-phosphonovaleric acid (D-APV). DVC D-APV fully negated the ability of DVC NMDA to lower glucose production. Finally, hepatic vagotomy negated the DVC glycine ability to lower glucose production. These findings demonstrate that activation of NR1 and NR2 subunits of the NMDA receptors in the DVC is sufficient to trigger a brain-liver axis to lower glucose production, and suggest that DVC NMDA receptors serve as a therapeutic target for diabetes and obesity.	[Lam, Tony K. T.] Univ Hlth Network, Toronto Gen Res Inst, MaRS Ctr, Toronto, ON M5G 1L7, Canada; [Lam, Carol K. L.; Chari, Madhu; Cheung, Grace W. C.; Kokorovic, Andrea; Yang, Clair S.; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Lam, TKT (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, MaRS Ctr, Toronto Med Discovery Tower,Rm 10-705,101 Coll St, Toronto, ON M5G 1L7, Canada.	tony.lam@uhnres.utoronto.ca		Lam, Carol/0000-0002-9736-3347	Canadian Institute of Health Research [MOP-86554]; Ontario Graduate Scholarship; Banting and Best Diabetes Centre at the University of Toronto (BBDC)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Banting and Best Diabetes Centre at the University of Toronto (BBDC)	This work was supported by a research grant (to T.K.T.L.) from the Canadian Institute of Health Research (MOP-86554).; Supported by the Canadian Institute of Health Research graduate scholarship.; Supported by the Ontario Graduate Scholarship and a graduate scholarship from the Banting and Best Diabetes Centre at the University of Toronto (BBDC).; Supported by the Canadian Institute of Health Research and BBDC graduate scholarships.	Baptista V, 2005, J NEUROPHYSIOL, V94, P147, DOI 10.1152/jn.00927.2004; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; BUDAI D, 1992, NEUROSCI LETT, V135, P265, DOI 10.1016/0304-3940(92)90452-D; Caspi L, 2007, CELL METAB, V6, P99, DOI 10.1016/j.cmet.2007.07.005; Chari M, 2008, DIABETES, V57, P836, DOI 10.2337/db07-1464; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Cheung GWC, 2009, CELL METAB, V10, P99, DOI 10.1016/j.cmet.2009.07.005; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Garraway SM, 2007, J PHARMACOL EXP THER, V322, P982, DOI 10.1124/jpet.107.123125; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Lam CKL, 2009, PHYSIOLOGY, V24, P159, DOI 10.1152/physiol.00003.2009; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Morton GJ, 2005, J CLIN INVEST, V115, P703, DOI 10.1172/JCI200522081; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Ross R, 2008, DIABETES, V57, P2061, DOI 10.2337/db08-0206; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shimoyama N, 2005, J PHARMACOL EXP THER, V312, P834, DOI 10.1124/jpet.104.074856; South SM, 2003, J NEUROSCI, V23, P5031; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Whitehead KJ, 2001, BRAIN RES, V910, P192, DOI 10.1016/S0006-8993(01)02684-1	40	57	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21913	21921		10.1074/jbc.M109.087338	http://dx.doi.org/10.1074/jbc.M109.087338			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20448042	Green Published, hybrid			2022-12-25	WOS:000279702200003
J	Li, TB; Yang, YS; Canessa, CM				Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.			Leu(85) in the beta 1-beta 2 Linker of ASIC1 Slows Activation and Decreases the Apparent Proton Affinity by Stabilizing a Closed Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION-CHANNEL; ION-CHANNEL-1; PH	Acid-sensing ion channels (ASICs) are proton-activated channels expressed in neurons of the central and peripheral nervous systems where they modulate neuronal activity in response to external increases in proton concentration. The size of ASIC1 currents evoked by a given local acidification is determined by the number of channels in the plasma membrane and by the apparent proton affinities for activation and steady-state desensitization of the channel. Thus, the magnitude of the pH drop and the value of the baseline pH both are functionally important. Recent characterization of ASIC1s from an increasing number of species has made evident that proton affinities of these channels vary across vertebrates. We found that in species with high baseline plasma pH, e. g. frog, shark, and fish, ASIC1 has high proton affinity compared with the mammalian channel. The beta 1-beta 2 linker in the extracellular domain, specifically by the substitution M85L, determines the interspecies differences in proton affinities and also the time course of ASIC1 macroscopic currents. The mechanism underlying these observations is a delay in channel opening after application of protons, most likely by stabilizing a closed conformation that decreases the apparent affinity to protons and also slows the rise and decay phases of the current. Together, the results suggest evolutionary adaptation of ASIC1 to match the value of the species-specific plasma pH. At the molecular level, adaptation is achieved by substitutions of nonionizable residues rather than by modification of the channel proton sensor.	[Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Canessa, CM (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	Cecilia.canessa@yale.edu	Li, Tianbo/C-6118-2012					Burton RF, 2002, J EXP BIOL, V205, P641; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HUGHES MK, 1993, MOL BIOL EVOL, V10, P1360; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; LI T, 2010, AM J PHYSL IN PRESS; Springauf A, 2010, J PHYSIOL-LONDON, V588, P809, DOI 10.1113/jphysiol.2009.182931; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	14	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22706	22712		10.1074/jbc.M110.134114	http://dx.doi.org/10.1074/jbc.M110.134114			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20479002	Green Published, hybrid			2022-12-25	WOS:000279702200081
J	Wang, Q; Rajshankar, D; Laschinger, C; Talior-Volodarsky, I; Wang, YQ; Downey, GP; McCulloch, CA				Wang, Qin; Rajshankar, Dhaarmini; Laschinger, Carol; Talior-Volodarsky, Ilana; Wang, Yongqiang; Downey, Gregory P.; McCulloch, Christopher A.			Importance of Protein-tyrosine Phosphatase-alpha Catalytic Domains for Interactions with SHP-2 and Interleukin-1-induced Matrix Metalloproteinase-3 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; FOCAL ADHESIONS; PTP-ALPHA; ENDOPLASMIC-RETICULUM; HUMAN FIBROBLASTS; DOWN-REGULATION; ERK ACTIVATION; RPTP-ALPHA; PHOSPHORYLATION; INTEGRIN	Interleukin-1 (IL-1) induces extracellular matrix degradation as a result of increased expression of matrix metalloproteinases (MMPs). We examined adhesion-restricted signaling pathways that enable IL-1-induced MMP release in human gingival and murine fibroblasts. Of the seven MMPs and three tissue inhibitors of MMPs screened, IL-1 enhanced release only of MMP3 when cells formed focal adhesions. Inhibition of protein-tyrosine phosphatases (PTPs), which are enriched in focal adhesions, blocked IL-1-induced MMP3 release. Accordingly, in contrast to wild-type cells, fibroblasts null for PTP alpha did not exhibit IL-1-induced MMP3 release. IL-1 treatment enhanced the recruitment of SHP-2 and PTP alpha to focal adhesions and the association of PTP alpha with SHP-2. Pulldown assays confirmed a direct interaction between PTP alpha and SHP-2, which was dependent on the intact, membrane-proximal phosphatase domain of PTP alpha. Interactions between SHP-2 and PTP alpha, recruitment of SHP-2 to focal adhesions, IL-1-induced ERK activation, and MMP3 expression were all blocked by point mutations in the phosphatase domains of PTP alpha. These data indicate that IL-1-induced signaling through focal adhesions leading to MMP3 release and interactions between SHP-2 and PTP alpha are dependent on the integrity of the catalytic domains of PTP alpha.	[Wang, Qin; Rajshankar, Dhaarmini; Laschinger, Carol; Talior-Volodarsky, Ilana; Wang, Yongqiang; McCulloch, Christopher A.] Univ Toronto, Matrix Dynam Grp, Toronto, ON M5S 3E2, Canada; [Downey, Gregory P.] Natl Jewish Hlth, Div Pulm & Crit Care Med, Dept Med, Denver, CO 80206 USA; [Downey, Gregory P.] Natl Jewish Hlth, Div Pulm & Crit Care Med, Dept Pediat, Denver, CO 80206 USA; [Downey, Gregory P.] Univ Colorado Denver, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO 80045 USA; [Downey, Gregory P.] Univ Colorado Denver, Integrated Dept Immunol, Aurora, CO 80045 USA	University of Toronto; National Jewish Health; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	McCulloch, CA (corresponding author), Univ Toronto, Matrix Dynam Grp, Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca		Downey, Gregory P/0000-0003-3253-5862	Canadian Institutes of Health Research [MOP 84254]; National Institutes of Health [HL090669]; Harold and Mary Zirin Chair in Pulmonary Biology at National Jewish Health; Canada Research Chair [Tier 1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090669] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Mary Zirin Chair in Pulmonary Biology at National Jewish Health; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Canadian Institutes of Health Research (MOP 84254; to C.A.M. and G.P.D.). This work was also supported in part by National Institutes of Health Grant HL090669 (to G.P.D.) and funds from the Harold and Mary Zirin Chair in Pulmonary Biology at National Jewish Health (to G.P.D.).; Supported by a Canada Research Chair (Tier 1). To whom correspondence should be addressed: Rm.244, Fitzgerald Bldg., University of Toronto, 150 College St., Toronto, Ontario M5S 3E2, Canada. Tel.: 416-978-1258; Fax: 416-978-5956; E-mail: christopher.mcculloch@utoronto.ca.	Abreu MTH, 2008, AM J PHYSIOL-CELL PH, V294, pC931, DOI 10.1152/ajpcell.00359.2007; Abreu MTH, 2006, J CELL PHYSIOL, V207, P132, DOI 10.1002/jcp.20544; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ARORA PD, 1995, J BIOL CHEM, V270, P6042, DOI 10.1074/jbc.270.11.6042; Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Blanchetot C, 2000, J BIOL CHEM, V275, P12446, DOI 10.1074/jbc.275.17.12446; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DIBATTISTA JA, 1995, J RHEUMATOL, V22, P123; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; HavemosePoulsen A, 1997, CRIT REV ORAL BIOL M, V8, P217, DOI 10.1177/10454411970080020801; ILLC D, 1995, NATURE, V377, P539; Jones Matthew L, 2004, Methods Mol Biol, V273, P169; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Lammers R, 2000, J BIOL CHEM, V275, P3391, DOI 10.1074/jbc.275.5.3391; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Luo L, 1997, BIOCHEM J, V324, P653, DOI 10.1042/bj3240653; MacGillivray M, 2003, J BIOL CHEM, V278, P27190, DOI 10.1074/jbc.M213083200; MAUVIEL A, 1992, J CELL BIOCHEM, V50, P53, DOI 10.1002/jcb.240500110; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Osteen KG, 1999, GYNECOL OBSTET INVES, V48, P2, DOI 10.1159/000052863; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Panetti TS, 2002, FRONT BIOSCI-LANDMRK, V7, pD143, DOI 10.2741/panetti; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; QWARNSTROM EE, 1988, J BIOL CHEM, V263, P8261; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Segal G, 2001, J CELL SCI, V114, P119; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang Q, 2005, J BIOL CHEM, V280, P8397, DOI 10.1074/jbc.M410462200; Wang Q, 2006, J BIOL CHEM, V281, P31093, DOI 10.1074/jbc.M606392200; Wang Q, 2009, J BIOL CHEM, V284, P20763, DOI 10.1074/jbc.M808828200; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	52	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22308	22317		10.1074/jbc.M110.102426	http://dx.doi.org/10.1074/jbc.M110.102426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472558	Green Published, hybrid			2022-12-25	WOS:000279702200044
J	Darwanto, A; Curtis, MP; Schrag, M; Kirsch, W; Liu, P; Xu, GL; Neidigh, JW; Zhang, KL				Darwanto, Agus; Curtis, Matthew P.; Schrag, Matthew; Kirsch, Wolff; Liu, Peng; Xu, Guoliang; Neidigh, Jonathan W.; Zhang, Kangling			A Modified "Cross-talk" between Histone H2B Lys-120 Ubiquitination and H3 Lys-79 Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; ABSOLUTE QUANTIFICATION; CHROMATIN MODIFICATIONS; GENE-EXPRESSION; ACETYLATION; FUSION; YEAST; MONOUBIQUITINATION; ELONGATION; PROTEOMICS	Western blot analysis is currently the major method utilized for quantitatively assessing histone global modifications. However, there is a growing need to develop a highly specific, accurate, and multisite quantitative method. Herein, we report a liquid chromatography-tandem mass spectrometry-multiple reaction monitoring method to simultaneously quantify multisite modifications with unmatched specificity, sensitivity, and throughput. With one set of purification of histones by high pressure liquid chromatography or SDS-PAGE, nearly 20 modification sites including acetylation, propionylation, methylation, and ubiquitination were quantified within 2 h for two samples to be compared. Using this method, the relative levels of H2B ubiquitination and H3 Lys-79 methylation were quantified in the U937 human leukemia cell line, U937 derivative cell lines overexpressing anti-secretory factor 10 (AF10) and mutant AF10 with the deletion of the hDot1 binding domain OM-LZ. We found that H2B ubiquitination is inversely correlated with H3 Lys-79 methylation. Therefore, we propose that a catalytic and inhibitory loop mechanism may better describe the crosstalk relationship between H2B ubiquitination and H3 Lys-79 methylation.	[Neidigh, Jonathan W.; Zhang, Kangling] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA 92350 USA; [Schrag, Matthew; Kirsch, Wolff] Loma Linda Univ, Neurosurg Ctr Res, Loma Linda, CA 92350 USA; [Liu, Peng; Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Loma Linda University; Loma Linda University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, KL (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA 92350 USA.	kzhang@llu.edu		Liu, Peng/0000-0002-6469-6460	Department of Basic Sciences, Biochemistry Division, Loma Linda University	Department of Basic Sciences, Biochemistry Division, Loma Linda University	This work was supported by the Department of Basic Sciences, Biochemistry Division, Loma Linda University.	Asnafi V, 2003, BLOOD, V102, P1000, DOI 10.1182/blood-2002-09-2913; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Bohlander SK, 2000, LEUKEMIA, V14, P93, DOI 10.1038/sj.leu.2401614; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Huang ZP, 2006, TETRAHEDRON LETT, V47, P5997, DOI 10.1016/j.tetlet.2006.05.190; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Kim K, 2009, EXPERT REV PROTEOMIC, V6, P225, DOI 10.1586/EPR.09.11; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lin YH, 2009, BLOOD, V114, P651, DOI 10.1182/blood-2009-03-209395; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Matysiak S, 1998, TETRAHEDRON LETT, V39, P1733, DOI 10.1016/S0040-4039(98)00055-0; Mayya V, 2006, MOL CELL PROTEOMICS, V5, P1146, DOI 10.1074/mcp.T500029-MCP200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Pan S, 2009, J PROTEOME RES, V8, P787, DOI 10.1021/pr800538n; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Yocum Anastasia K., 2009, Briefings in Functional Genomics & Proteomics, V8, P145, DOI 10.1093/bfgp/eln056; Zhang KL, 2008, INT J MASS SPECTROM, V278, P89, DOI 10.1016/j.ijms.2008.08.018; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210; Zhang KL, 2008, INT J MASS SPECTROM, V269, P101, DOI 10.1016/j.ijms.2007.09.010; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	38	51	53	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21868	21876		10.1074/jbc.M110.126813	http://dx.doi.org/10.1074/jbc.M110.126813			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442396	Green Published, hybrid			2022-12-25	WOS:000279516100071
J	Pene-Dumitrescu, T; Smithgall, TE				Pene-Dumitrescu, Teodora; Smithgall, Thomas E.			Expression of a Src Family Kinase in Chronic Myelogenous Leukemia Cells Induces Resistance to Imatinib in a Kinase-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOID-LEUKEMIA; ABL TYROSINE KINASE; REGULATES BCR-ABL; C-ABL; PROTEIN-KINASE; SIGNALING PATHWAY; BETA-CATENIN; SH2 DOMAIN; LYN KINASE; FOLLOW-UP	The Bcr-Abl kinase inhibitor imatinib is remarkably effective in chronic myelogenous leukemia (CML), although drug resistance is an emerging problem. Myeloid Src family kinases such as Hck and Lyn are often overexpressed in imatinib-resistant CML cells that lack Bcr-Abl mutations. Here we tested whether Hck overexpression is sufficient to induce imatinib resistance using both wild-type Hck and a mutant (Hck-T338A) that is uniquely sensitive to the pyrazolo-pyrimidine inhibitor, NaPP1. Expression of either kinase in K562 CML cells caused resistance to imatinib-induced apoptosis and inhibition of soft-agar colony formation. Treatment with NaPP1 restored sensitivity to imatinib in cells expressing T338A but not wild-type Hck, demonstrating that resistance requires Hck kinase activity. NaPP1 also reduced Hck-mediated phosphorylation of Bcr-Abl at sites that may affect imatinib sensitivity exclusively in cells expressing Hck-T338A. These data show that elevated Src family kinase activity is sufficient to induce imatinib resistance through a mechanism that may involve phosphorylation of Bcr-Abl.	[Pene-Dumitrescu, Teodora; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Bridgeside Point 2,Suite 523,450 Technol Dr, Pittsburgh, PA 15219 USA.	tsmithga@pitt.edu			National Institutes of Health [CA101828, GM077629]; NATIONAL CANCER INSTITUTE [R01CA101828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA101828 and GM077629 (to T. E. S.).	Alaimo PJ, 2005, BIOORGAN MED CHEM, V13, P2825, DOI 10.1016/j.bmc.2005.02.021; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Briggs SD, 1999, J BIOL CHEM, V274, P26579, DOI 10.1074/jbc.274.37.26579; Chen S, 2008, J MOL BIOL, V383, P414, DOI 10.1016/j.jmb.2008.08.040; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; Cortez D, 1996, ONCOGENE, V13, P2589; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Danial NN, 2000, ONCOGENE, V19, P2523, DOI 10.1038/sj.onc.1203484; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Donato NJ, 2004, CANCER RES, V64, P672, DOI 10.1158/0008-5472.CAN-03-1484; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hochhaus A, 2008, BLOOD, V111, P1039, DOI 10.1182/blood-2007-07-103523; Howlett CJ, 1999, BIOCHEM BIOPH RES CO, V257, P129, DOI 10.1006/bbrc.1999.0427; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Kawano T, 2007, CANCER RES, V67, P11576, DOI 10.1158/0008-5472.CAN-07-2756; Kirchner D, 2003, EXP HEMATOL, V31, P504, DOI 10.1016/S0301-472X(03)00069-9; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Lakshmikuttyamma A, 2008, ONCOGENE, V27, P3831, DOI 10.1038/onc.2008.8; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; LOZZIO BB, 1981, P SOC EXP BIOL MED, V166, P546; MACAULEY A, 1993, ONCOGENE, V8, P117; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Pene-Dumitrescu T, 2008, ONCOGENE, V27, P7055, DOI 10.1038/onc.2008.330; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; Raitano A. B., 1997, BIOCHIM BIOPHYS ACTA, V1333, P201, DOI 10.1016/S0304-419X(97)00023-1; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Sattler M, 1996, ONCOGENE, V12, P839; Sattler Martin, 1997, Cytokine and Growth Factor Reviews, V8, P63, DOI 10.1016/S1359-6101(96)00047-0; Satyamoorthy K, 2001, CANCER RES, V61, P7318; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Voss J, 2000, ONCOGENE, V19, P1684, DOI 10.1038/sj.onc.1203467; Warmuth M, 1997, J BIOL CHEM, V272, P33260, DOI 10.1074/jbc.272.52.33260; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101; Wu J, 2008, J NATL CANCER I, V100, P926, DOI 10.1093/jnci/djn188; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1	66	50	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21446	21457		10.1074/jbc.M109.090043	http://dx.doi.org/10.1074/jbc.M109.090043			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452982	Green Published, hybrid			2022-12-25	WOS:000279516100031
J	Patel, N; Kalra, VK				Patel, Nitin; Kalra, Vijay K.			Placenta Growth Factor-induced Early Growth Response 1 (Egr-1) Regulates Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE FACTOR; KAPPA-B; TRANSCELLULAR BIOSYNTHESIS; 5-LIPOXYGENASE PATHWAY; CYSTEINYL LEUKOTRIENES; INDUCED EXPRESSION; COREPRESSOR NAB2; THP-1 MONOCYTES; GENE-EXPRESSION; UP-REGULATION	Leukotrienes, the lipid inflammatory products derived from arachidonic acid, are involved in the pathogenesis of respiratory and cardiovascular diseases and reactive airway disease in sickle cell disease. Placenta growth factor (PlGF), elaborated from erythroid cells, increased the mRNA expression of 5-lipoxygenase and 5-lipoxygenase-activating protein (FLAP) in human pulmonary microvascular endothelial cells. PlGF-induced both promoter activity and mRNA expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha), which was abrogated by early growth response-1 (EGR-1) small interfering RNA. PlGF showed a temporal reciprocal relationship in the mRNA levels of EGR-1 and NAB2, the latter a repressor of Egr-1. Moreover, Nab2, but not mutant Nab2, significantly reduced promoter activity and mRNA expression of HIF-1 alpha and also reduced expression of the HIF-1 alpha target gene FLAP. Furthermore, overexpression of Egr-1 led to increased promoter activities for both HIF-1 alpha and FLAP in the absence of PlGF. Additionally, the Egr-1-mediated induction of HIF-1 alpha and FLAP promoters was reduced to basal levels by EGR-1 small interfering RNA. The binding of Egr-1 to HIF-1 alpha promoter was corroborated by electrophoretic mobility shift assay and chromatin immunoprecipitation assay, which showed increased Egr-1 binding to the HIF-1 alpha promoter in response to PlGF stimulation. These studies provide a novel mechanism for PlGF-mediated regulation of HIF-1 alpha via Egr-1, which results in increased FLAP expression. This study provides a new therapeutic target, namely Egr-1, for attenuation of elevated leukotriene levels in patients with sickle cell disease and other inflammatory diseases.	[Kalra, Vijay K.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, HMR 611, Los Angeles, CA 90033 USA	University of Southern California	Kalra, VK (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, HMR 611, Los Angeles, CA 90033 USA.	vkalra@usc.edu	Patel, Nitin/C-9625-2010		National Institutes of Health [R01-HL-079916, HL-070595]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079916, U54HL070595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL-079916 and HL-070595.	BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; FEINMARK SJ, 1986, J BIOL CHEM, V261, P6466; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Giri RK, 2004, J NEUROCHEM, V91, P1199, DOI 10.1111/j.1471-4159.2004.02800.x; Giri RK, 2003, J IMMUNOL, V170, P5281, DOI 10.4049/jimmunol.170.10.5281; Gronert K, 1999, METH MOL B, V120, P119; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Houston P, 2001, BIOCHEM BIOPH RES CO, V283, P480, DOI 10.1006/bbrc.2001.4810; Iyer NV, 1998, GENOMICS, V52, P159, DOI 10.1006/geno.1998.5416; Jennings JE, 2008, AM J HEMATOL, V83, P640, DOI 10.1002/ajh.21199; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kang J, 2009, ANAL BIOCHEM, V386, P251, DOI 10.1016/j.ab.2008.12.021; KHACHIGIAN LM, 1995, J BIOL CHEM, V270, P27679, DOI 10.1074/jbc.270.46.27679; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Lucerna M, 2003, J BIOL CHEM, V278, P11433, DOI 10.1074/jbc.M204937200; MACKMAN N, 1989, BIOCHEMISTRY-US, V28, P1755, DOI 10.1021/bi00430a050; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; MILLER DK, 1985, J BIOL CHEM, V260, P1006; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Patel N, 2008, BLOOD, V112, P856, DOI 10.1182/blood-2007-12-130567; Patel N, 2009, BLOOD, V113, P1129, DOI 10.1182/blood-2008-07-169821; Perelman N, 2003, BLOOD, V102, P1506, DOI 10.1182/blood-2002-11-3422; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; RADMARK O, 2005, AM J PHYSIOL-CELL PH, V288, pC1125; Reddy KV, 2003, J BIOL CHEM, V278, P13810, DOI 10.1074/jbc.M211102200; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rong Y, 2006, CANCER RES, V66, P7067, DOI 10.1158/0008-5472.CAN-06-0346; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Selvaraj SK, 2003, BLOOD, V102, P1515, DOI 10.1182/blood-2002-11-3423; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Silverman ES, 1998, AM J RESP CELL MOL, V19, P316, DOI 10.1165/ajrcmb.19.2.3154; Srinivasan R, 2006, J BIOL CHEM, V281, P15129, DOI 10.1074/jbc.M600775200; Stins MF, 2001, J NEUROVIROL, V7, P125; Svaren J, 1996, MOL CELL BIOL, V16, P3545; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Voelkel NF, 1996, J CLIN INVEST, V97, P2491, DOI 10.1172/JCI118696; Wright L, 1998, AM J RESP CRIT CARE, V157, P219, DOI 10.1164/ajrccm.157.1.9704003; Wu SQ, 2002, BLOOD, V100, P4454, DOI 10.1182/blood-2002-02-0415; Yan SF, 1998, P NATL ACAD SCI USA, V95, P8298, DOI 10.1073/pnas.95.14.8298; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106; Zhang YY, 2002, BIOCHEM J, V361, P267, DOI 10.1042/0264-6021:3610267; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	52	33	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20570	20579		10.1074/jbc.M110.119495	http://dx.doi.org/10.1074/jbc.M110.119495			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20448047	Green Published, hybrid			2022-12-25	WOS:000279228600020
J	Collett, GP; Linton, EA; Redman, CWG; Sargent, IL				Collett, Gavin P.; Linton, Elizabeth A.; Redman, Christopher W. G.; Sargent, Ian L.			Downregulation of Caveolin-1 Enhances Fusion of Human BeWo Choriocarcinoma Cells	PLOS ONE			English	Article							SYNCYTIAL FUSION; MYOBLAST FUSION; KINASE-ACTIVITY; HUMAN PLACENTA; CANCER CELLS; TROPHOBLAST; DIFFERENTIATION; AKT; EXPRESSION; RECEPTOR	Background: Fusion of placental villous cytotrophoblasts with the overlying syncytiotrophoblast is essential for the maintenance of successful pregnancy, and disturbances in this process have been implicated in pathological conditions such as pre-eclampsia and intra-uterine growth retardation. Caveolin-1 has been shown to be expressed in human villous cytotrophoblast and to be downregulated during fusion into syncytiotrophoblast but it is unclear whether it plays a role in this process. Methodology/Principal Findings: We used RNA interference to determine whether caveolin-1 plays a role in differentiation and fusion in the BeWo choriocarcinoma cell line, a model of villous cytotrophoblast fusion. Assessment of cell fusion by desmosomal protein immunostaining revealed that cells transfected with caveolin-1 siRNA showed significantly enhanced fusion in response to treatment with dibutyryl cyclic AMP compared with cells transfected with a non-silencing control. Furthermore, caveolin-1 knockdown alone was sufficient to promote spontaneous fusion. In addition, biochemical differentiation, assessed by expression of placental alkaline phosphatase, was upregulated in caveolin-1 siRNA-transfected cells, with or without dbcAMP treatment. Assessment of Akt phosphorylation showed that caveolin-1 knockdown resulted in a significant reduction in phosphorylation at Thr(308). Conclusions/Significance: Taken together, these results suggest that caveolin-1 regulates BeWo cell differentiation and fusion, possibly through a mechanism involving modulation of Akt activity.	[Collett, Gavin P.; Linton, Elizabeth A.; Redman, Christopher W. G.; Sargent, Ian L.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	University of Oxford	Collett, GP (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	Gavin.Collett@obs-gyn.ox.ac.uk			Wellcome Trust [GR079862MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust, grant no. GR079862MA (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benirschke K., 2000, PATHOLOGY HUMAN PLAC; Black S, 2004, CELL DEATH DIFFER, V11, P90, DOI 10.1038/sj.cdd.4401307; Bois PRJ, 2005, MOL CELL BIOL, V25, P7645, DOI 10.1128/MCB.25.17.7645-7656.2005; Byrne S, 2007, IMMUNOBIOLOGY, V212, P39, DOI 10.1016/j.imbio.2006.09.002; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Das M, 2004, PLACENTA, V25, P396, DOI 10.1016/j.placenta.2003.11.004; DOUGLAS GC, 1990, J CELL SCI, V96, P131; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Frendo JL, 2003, J CELL SCI, V116, P3413, DOI 10.1242/jcs.00648; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012; Huppertz B, 2004, J SOC GYNECOL INVEST, V11, P353, DOI 10.1016/j.jsgi.2004.06.002; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Johnstone ED, 2005, PLACENTA, V26, P548, DOI 10.1016/j.placenta.2004.08.012; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kudo Y, 2002, PLACENTA, V23, P536, DOI 10.1053/plac.2002.0839; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Leitner K, 2001, J HISTOCHEM CYTOCHEM, V49, P1155, DOI 10.1177/002215540104900909; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Li WP, 2001, J CELL SCI, V114, P1397; Lin L, 1999, PLACENTA, V20, P109, DOI 10.1053/plac.1998.0337; Linton EA, 2003, PLACENTA, V24, P745, DOI 10.1016/S0143-4004(03)00106-1; Lyden TW, 2002, PLACENTA, V23, P640, DOI 10.1053/plac.2002.0847; Mayhew TM, 2009, PLACENTA, V30, P565, DOI 10.1016/j.placenta.2009.04.013; MIDGLEY AR, 1963, SCIENCE, V141, P349, DOI 10.1126/science.141.3578.349; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; Potgens AJG, 2002, PLACENTA, V23, pS107, DOI 10.1053/plac.2002.0772; Rashid-Doubell F, 2007, PLACENTA, V28, P139, DOI 10.1016/j.placenta.2005.12.005; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Rote NS, 2004, PLACENTA, V25, P673, DOI 10.1016/j.placenta.2004.02.008; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Tannetta DS, 2008, PLACENTA, V29, P680, DOI 10.1016/j.placenta.2008.04.009; Volonte D, 2003, MOL BIOL CELL, V14, P4075, DOI 10.1091/mbc.E03-03-0161; Xu WP, 2003, CANCER RES, V63, P7777; Yun BG, 2005, CELL SIGNAL, V17, P1477, DOI 10.1016/j.cellsig.2005.03.006	43	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10529	10.1371/journal.pone.0010529	http://dx.doi.org/10.1371/journal.pone.0010529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463894	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379800016
J	Valladares, R; Sankar, D; Li, N; Williams, E; Lai, KK; Abdelgeliel, AS; Gonzalez, CF; Wasserfall, CH; Larkin, J; Schatz, D; Atkinson, MA; Triplett, EW; Neu, J; Lorca, GL				Valladares, Ricardo; Sankar, Dhyana; Li, Nan; Williams, Emily; Lai, Kin-Kwan; Abdelgeliel, Asmaa Sayed; Gonzalez, Claudio F.; Wasserfall, Clive H.; Larkin, Joseph, III; Schatz, Desmond; Atkinson, Mark A.; Triplett, Eric W.; Neu, Josef; Lorca, Graciela L.			Lactobacillus johnsonii N6.2 Mitigates the Development of Type 1 Diabetes in BB-DP Rats	PLOS ONE			English	Article							TREATMENT PARTIALLY PROTECTS; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; COMMENSAL BACTERIA; IFN-GAMMA; PRONE RAT; EXPRESSION; GUT; TRANSCRIPTION; CYCLOOXYGENASE-2	Background: The intestinal epithelium is a barrier that composes one of the most immunologically active surfaces of the body due to constant exposure to microorganisms as well as an infinite diversity of food antigens. Disruption of intestinal barrier function and aberrant mucosal immune activation have been implicated in a variety of diseases within and outside of the gastrointestinal tract. With this model in mind, recent studies have shown a link between diet, composition of intestinal microbiota, and type 1 diabetes pathogenesis. In the BioBreeding rat model of type 1 diabetes, comparison of the intestinal microbial composition of diabetes prone and diabetes resistant animals found Lactobacillus species were negatively correlated with type 1 diabetes development. Two species, Lactobacillus johnsonii and L. reuteri, were isolated from diabetes resistant rats. In this study diabetes prone rats were administered pure cultures of L. johnsonii or L. reuteri isolated from diabetes resistant rats to determine the effect on type 1 diabetes development. Methodology/Principal: Findings Results Rats administered L. johnsonii, but not L. reuteri, post-weaning developed type 1 diabetes at a protracted rate. Analysis of the intestinal ileum showed administration of L. johnsonii induced changes in the native microbiota, host mucosal proteins, and host oxidative stress response. A decreased oxidative intestinal environment was evidenced by decreased expression of several oxidative response proteins in the intestinal mucosa (Gpx1, GR, Cat). In L. johnsonii fed animals low levels of the pro-inflammatory cytokine IFN gamma were correlated with low levels of iNOS and high levels of Cox2. The administration of L. johnsonii also resulted in higher levels of the tight junction protein claudin. Conclusions: It was determined that the administration of L. johnsonii isolated from BioBreeding diabetes resistant rats delays or inhibits the onset of type 1 diabetes in BioBreeding diabetes prone rats. Taken collectively, these data suggest that the gut and the gut microbiota are potential agents of influence in type 1 diabetes development. These data also support therapeutic efforts that seek to modify gut microbiota as a means to modulate development of this disorder.	[Valladares, Ricardo; Williams, Emily; Lai, Kin-Kwan; Abdelgeliel, Asmaa Sayed; Gonzalez, Claudio F.; Larkin, Joseph, III; Triplett, Eric W.; Lorca, Graciela L.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Sankar, Dhyana; Li, Nan; Schatz, Desmond; Neu, Josef] Univ Florida, Dept Pediat, Gainesville, FL USA; [Wasserfall, Clive H.; Atkinson, Mark A.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Valladares, R (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	glorca@ufl.edu	Wasserfall, Clive/ABF-9385-2020; Neu, Josef/AAI-2799-2020; wasserfall, clive/J-9078-2012	Wasserfall, Clive/0000-0002-3522-8932; wasserfall, clive/0000-0002-3522-8932; McMackin, Emily/0000-0003-4570-1743; Larkin, Joseph/0000-0003-2066-6814	Institute of Food and Agricultural Sciences - University of Florida (IFAS-UFL)	Institute of Food and Agricultural Sciences - University of Florida (IFAS-UFL)(University of Florida)	These studies were supported, in part, by funds from The Brehm Coalition for Type 1 Diabetes Research and Research Innovation Award, Institute of Food and Agricultural Sciences - University of Florida (IFAS-UFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam TV, 2003, BRIT J PHARMACOL, V140, P71, DOI 10.1038/sj.bjp.0705402; Belley A, 1999, AM J TROP MED HYG, V60, P10, DOI 10.4269/ajtmh.1999.60.10; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Caicedo RA, 2008, PEDIATR RES, V63, P303, DOI 10.1203/PDR.0b013e31815ed662; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Charoenphandhu N, 2007, LIFE SCI, V80, P1729, DOI 10.1016/j.lfs.2007.01.063; Corbett JA, 1996, AM J PHYSIOL-CELL PH, V270, pC1581, DOI 10.1152/ajpcell.1996.270.6.C1581; Delroisse JM, 2008, MICROBIOL RES, V163, P663, DOI 10.1016/j.micres.2006.09.004; ELLIOTT RB, 1984, DIABETOLOGIA, V26, P297, DOI 10.1007/BF00283653; Gilroy DW, 2000, J MOL MED-JMM, V78, P121, DOI 10.1007/s001090000094; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Gye MC, 2003, INT J ANDROL, V26, P271, DOI 10.1046/j.1365-2605.2003.00423.x; Jiang WL, 2009, J CEREBR BLOOD F MET, V29, P944, DOI 10.1038/jcbfm.2009.18; Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; Kato Y, 2004, FREE RADICAL BIO MED, V37, P1864, DOI 10.1016/j.freeradbiomed.2004.09.007; Klampfer L, 2007, ONCOGENE, V26, P2071, DOI 10.1038/sj.onc.1210015; KLEEMANN R, 1993, FEBS LETT, V328, P9, DOI 10.1016/0014-5793(93)80954-S; Lai KK, 2009, APPL ENVIRON MICROB, V75, P5018, DOI 10.1128/AEM.02837-08; Luo C, 2002, CELL TISSUE RES, V310, P169, DOI 10.1007/s00441-002-0628-6; Luo C, 2002, ACTA PHYSIOL SCAND, V174, P265, DOI 10.1046/j.1365-201x.2002.00941.x; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Mehta JL, 2006, INT J BIOCHEM CELL B, V38, P794, DOI 10.1016/j.biocel.2005.12.008; Mendez II, 2004, J IMMUNOL, V173, P1327, DOI 10.4049/jimmunol.173.2.1327; Neu J, 2005, J PEDIATR GASTR NUTR, V40, P589, DOI 10.1097/01.MPG.0000159636.19346.C1; Neumann H, 1997, J EXP MED, V186, P2023, DOI 10.1084/jem.186.12.2023; Ohnishi M, 2004, BIOFACTORS, V21, P315, DOI 10.1002/biof.552210161; Robertson RP, 2006, FREE RADICAL BIO MED, V41, P177, DOI 10.1016/j.freeradbiomed.2005.04.030; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Schwartz RF, 2007, DIABETOLOGIA, V50, P220, DOI 10.1007/s00125-006-0526-7; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tam NNC, 2003, AM J PATHOL, V163, P2513, DOI 10.1016/S0002-9440(10)63606-1; Teng XW, 2002, AM J PHYSIOL-CELL PH, V282, pC144, DOI 10.1152/ajpcell.2002.282.1.C144; Trivedi SG, 2006, P NATL ACAD SCI USA, V103, P5179, DOI 10.1073/pnas.0507175103; Turler A, 2002, ANN SURG, V236, P56, DOI 10.1097/01.SLA.0000018561.52595.31; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Visser J, 2003, METABOLISM, V52, P333, DOI 10.1053/meta.2003.50052; Visser J, 2009, DIABETOLOGIA, V52, P1445, DOI 10.1007/s00125-009-1370-3; Yan F, 2004, CURR OPIN GASTROEN, V20, P565, DOI 10.1097/00001574-200411000-00011; Zhu FQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-78	44	178	197	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10507	10.1371/journal.pone.0010507	http://dx.doi.org/10.1371/journal.pone.0010507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463897	gold, Green Submitted, Green Published			2022-12-25	WOS:000277379800003
J	Murphy, HA; Zeyl, CW				Murphy, Helen A.; Zeyl, Clifford W.			Yeast Sex: Surprisingly High Rates of Outcrossing between Asci	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; REPRODUCTIVE ISOLATION; POPULATION-STRUCTURE; PARADOXUS; EVOLUTION; GENOMICS	Background: Saccharomyces yeasts are an important model system in many areas of biological research. Very little is known about their ecology and evolution in the wild, but interest in this natural history is growing. Extensive work with lab strains in the last century uncovered the Saccharomyces life cycle. When nutrient limited, a diploid yeast cell will form four haploid spores encased in a protective outer layer called the ascus. Confinement within the ascus is thought to enforce mating between products of the same meiotic division, minimizing outcrossing in this stage of the life cycle. Methodology/Principal Findings: Using a set of S. cerevisiae and S. paradoxus strains isolated from woodlands in North America, we set up trials in which pairs of asci were placed in contact with one another and allowed to germinate. We observed outcrossing in,40% of the trials, and multiple outcrossing events in trials with three asci in contact with each other. When entire populations of densely crowded asci germinated, similar to 10-25% of the resulting colonies were outcrossed. There were differences between the species with S. cerevisiae having an increased tendency to outcross in mass mating conditions. Conclusions/Significance: Our results highlight the potential for random mating between spores in natural strains, even in the presence of asci. If this type of mating does occur in nature and it is between close relatives, then a great deal of mating behavior may be undetectable from genome sequences.	[Murphy, Helen A.; Zeyl, Clifford W.] Wake Forest Univ, Winston Salem, NC 27109 USA	Wake Forest University	Murphy, HA (corresponding author), Wake Forest Univ, Winston Salem, NC 27109 USA.	murphyha@wfu.edu		Murphy, Helen/0000-0002-4363-4543	National Science Foundation [0820969, 0542738]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant# 0820969 awarded to CWZ and National Science Foundation Grant# 0542738 awarded to HAM and CZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; BEVAN EA, 1964, MICROBIAL GENETICS B, V21, P5; Coluccio A, 2004, MICROBIOL-SGM, V150, P3189, DOI 10.1099/mic.0.27253-0; Coluccio AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002873; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GUILLIERMOND A, 1920, YEASTS; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Johnson LJ, 2004, GENETICS, V166, P43, DOI 10.1534/genetics.166.1.43; Joseph-Strauss D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r241; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Knop M, 2006, BIOESSAYS, V28, P696, DOI 10.1002/bies.20435; Koufopanou V, 2006, PHILOS T R SOC B, V361, P1941, DOI 10.1098/rstb.2006.1922; Kuehne HA, 2007, CURR BIOL, V17, P407, DOI 10.1016/j.cub.2006.12.047; LACHANCE MA, 1995, J IND MICROBIOL, V14, P484, DOI 10.1007/BF01573963; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Maclean CJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-1; Mortimer R, 1999, RES MICROBIOL, V150, P199, DOI 10.1016/S0923-2508(99)80036-9; Murphy HA, 2006, BIOL LETT-UK, V2, P553, DOI 10.1098/rsbl.2006.0534; Naumov GI, 1998, CAN J MICROBIOL, V44, P1045, DOI 10.1139/cjm-44-11-1045; PHAFF H J, 1956, Antonie Van Leeuwenhoek, V22, P117, DOI 10.1007/BF02538319; Reuter M, 2007, CURR BIOL, V17, pR81, DOI 10.1016/j.cub.2006.11.059; Rose MD., 1990, METHODS YEAST GENETI; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Taxis C, 2005, J CELL BIOL, V171, P627, DOI 10.1083/jcb.200507168; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Zakharov I. A., 2005, Genetika, V41, P508	32	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10461	10.1371/journal.pone.0010461	http://dx.doi.org/10.1371/journal.pone.0010461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463964	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379400013
J	Sethu, S; Pushparaj, PN; Melendez, AJ				Sethu, Swaminathan; Pushparaj, Peter N.; Melendez, Alirio J.			Phospholipase D1 Mediates TNF alpha-Induced Inflammation in a Murine Model of TNF alpha-Induced Peritonitis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SERUM INTERLEUKIN-6; PHOSPHATIDIC-ACID; SIGNAL-TRANSDUCTION; HUMAN-DISEASES; KEY ROLE; ACTIVATION; RECEPTOR; GAMMA; IL-6	Background: Tumor Necrosis Factor alpha (TNF alpha) is a pleiotropic cytokine extensively studied for its role in the pathogenesis of a variety of disease conditions, including in inflammatory diseases. We have recently shown that, in vitro, that TNF alpha utilizes PLD1 to mediate the activation of NF kappa B and ERK1/2 in human monocytes. The aim of this study was to investigate the role(s) played by phospholipase D1 (PLD1) in TNF alpha-mediated inflammatory responses in vivo. Methodology/Findings: Studies were performed in vivo using a mouse model of TNF alpha-induced peritonitis. The role of PLD1 was investigated by functional genomics, utilizing a specific siRNA to silence the expression of PLD1. Administration of the siRNA against PLD1 significantly reduced PLD1 levels in vivo. TNF alpha triggers a rapid pyrogenic response, but the in vivo silencing of PLD1 protects mice from the TNFa-induced rise in temperature. Similarly TNF alpha caused an increase in the serum levels of IL-6, MIP-1 alpha and MIP-1 beta: this increase in cytokine/chemokine levels was inhibited in mice where PLD1 had been silenced. We then induced acute peritonitis with TNF alpha. Intraperitoneal injection of TNFa triggered a rapid increase in vascular permeability, and the influx of neutrophils and monocytes into the peritoneal cavity. By contrast, in mice where PLD1 had been silenced, the TNF alpha-triggered increase in vascular permeability and phagocyte influx was substantially reduced. Furthermore, we also show that the TNF alpha-mediated upregulation of the cell adhesion molecules VCAM and ICAM1, in the vascular endothelium, were dependent on PLD1. Conclusions: These novel data demonstrate a critical role for PLD1 in TNF alpha-induced inflammation in vivo and warrant further investigation. Indeed, our results suggest PLD1 as a novel target for treating inflammatory diseases, where TNF alpha play key roles: these include diseases ranging from sepsis to respiratory and autoimmune diseases; all diseases with considerable unmet medical need.	[Sethu, Swaminathan] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Pushparaj, Peter N.; Melendez, Alirio J.] Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland	National University of Singapore; University of Glasgow	Sethu, S (corresponding author), Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore.	a.melendez-romero@clinmed.gla.ac.uk	Sethu, Swaminathan/R-8577-2019; Pushparaj, Peter Natesan/H-9871-2012	Pushparaj, Peter Natesan/0000-0001-7574-1880; Sethu, Swaminathan/0000-0001-9210-2554	Medical Research Council UK [MRC G0700794]; Biomedical Research Council of Singapore [BMRC 06/1/21/19/444]; Medical Research Council [G0700794] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from: the Medical Research Council UK, grant number: MRC G0700794, MRC web site (http://www.mrc.ac.uk/index.htm); and from the Biomedical Research Council of Singapore, grant number BMRC 06/1/21/19/444 BMRC web site ( http://www.a-star.edu.sg/AboutASTAR/BiomedicalResearchCouncil/tabid/64/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Cadwallader KA, 2004, EUR J BIOCHEM, V271, P2755, DOI 10.1111/j.1432-1033.2004.04204.x; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Dana RR, 2000, J BIOL CHEM, V275, P32566, DOI 10.1074/jbc.M005406200; DeVries ME, 1999, SEMIN IMMUNOL, V11, P95, DOI 10.1006/smim.1999.0165; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; English D, 1996, CELL SIGNAL, V8, P341, DOI 10.1016/0898-6568(95)00076-3; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Gewirtz AT, 1997, J LEUKOCYTE BIOL, V61, P522, DOI 10.1002/jlb.61.4.522; Grisius MM, 1997, J RHEUMATOL, V24, P1089; Hamdi SM, 2008, BBA-MOL CELL BIOL L, V1781, P263, DOI 10.1016/j.bbalip.2008.03.005; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hehlgans T, 2002, BIOL CHEM, V383, P1581, DOI 10.1515/BC.2002.178; Heller M, 1978, Adv Lipid Res, V16, P267; Hill GR, 1999, J CLIN INVEST, V104, P459, DOI 10.1172/JCI6896; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; HOLTKAMP W, 1995, J CLIN GASTROENTEROL, V20, P123, DOI 10.1097/00004836-199503000-00010; Iyer SS, 2006, J IMMUNOL, V176, P3686, DOI 10.4049/jimmunol.176.6.3686; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kim H, 2007, CELL BIOL INT, V31, P148, DOI 10.1016/j.cellbi.2006.09.020; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kusner DJ, 1999, J IMMUNOL, V162, P2266; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Lin J, 2008, CLIN IMMUNOL, V126, P13, DOI 10.1016/j.clim.2007.08.012; Locati M, 2001, BIOCHEM J, V358, P119, DOI 10.1042/0264-6021:3580119; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; Matsumoto K, 1999, CLIN EXP IMMUNOL, V117, P361, DOI 10.1046/j.1365-2249.1999.00975.x; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Melendez AJ, 2001, BLOOD, V98, P3421, DOI 10.1182/blood.V98.12.3421; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Morgan CP, 1997, BIOCHEM J, V325, P581, DOI 10.1042/bj3250581; Murdoch C, 2000, BLOOD, V95, P3032; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pushparaj PN, 2008, INT J BIOCHEM CELL B, V40, P1817, DOI 10.1016/j.biocel.2008.01.015; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Sciorra VA, 1999, MOL BIOL CELL, V10, P3863, DOI 10.1091/mbc.10.11.3863; Sethu S, 2008, J IMMUNOL, V180, P6027, DOI 10.4049/jimmunol.180.9.6027; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; Singh N, 2006, NAT METHODS, V3, P629, DOI 10.1038/nmeth903; STUART RA, 1995, CLIN EXP RHEUMATOL, V13, P17; Sundgren-Andersson AK, 1998, AM J PHYSIOL-REG I, V275, pR2028, DOI 10.1152/ajpregu.1998.275.6.R2028; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; UR RA, 1999, CURR PHARM DESIGN, V5, P241; vanHensbroek MB, 1996, J INFECT DIS, V174, P1091, DOI 10.1093/infdis/174.5.1091; Wallis RS, 2005, CLIN INFECT DIS, V41, pS194, DOI 10.1086/429996; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Wong M, 2008, CLIN IMMUNOL, V126, P121, DOI 10.1016/j.clim.2007.08.013; YANG SF, 1967, J BIOL CHEM, V242, P477; ZANETTI G, 1992, J IMMUNOL, V148, P1890	54	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10506	10.1371/journal.pone.0010506	http://dx.doi.org/10.1371/journal.pone.0010506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463923	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000277379400037
J	Shemon, AN; Heil, GL; Granovsky, AE; Clark, MM; McElheny, D; Chimon, A; Rosner, MR; Koide, S				Shemon, Anne N.; Heil, Gary L.; Granovsky, Alexey E.; Clark, Mathew M.; McElheny, Dan; Chimon, Alexander; Rosner, Marsha R.; Koide, Shohei			Characterization of the Raf Kinase Inhibitory Protein (RKIP) Binding Pocket: NMR-Based Screening Identifies Small-Molecule Ligands	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BOVINE BRAIN; SPERMATOZOA; EXPRESSION; SUGGESTS; SEQUENCE; ROLES; CELLS; RNA	Background: Raf kinase inhibitory protein (RKIP), also known as phoshaptidylethanolamine binding protein (PEBP), has been shown to inhibit Raf and thereby negatively regulate growth factor signaling by the Raf/MAP kinase pathway. RKIP has also been shown to suppress metastasis. We have previously demonstrated that RKIP/Raf interaction is regulated by two mechanisms: phosphorylation of RKIP at Ser-153, and occupation of RKIP's conserved ligand binding domain with a phospholipid (2-dihexanoyl-sn-glycero-3-phosphoethanolamine; DHPE). In addition to phospholipids, other ligands have been reported to bind this domain; however their binding properties remain uncharacterized. Methods/Findings: In this study, we used high-resolution heteronuclear NMR spectroscopy to screen a chemical library and assay a number of potential RKIP ligands for binding to the protein. Surprisingly, many compounds previously postulated as RKIP ligands showed no detectable binding in near-physiological solution conditions even at millimolar concentrations. In contrast, we found three novel ligands for RKIP that specifically bind to the RKIP pocket. Interestingly, unlike the phospholipid, DHPE, these newly identified ligands did not affect RKIP binding to Raf-1 or RKIP phosphorylation. One out of the three ligands displayed off target biological effects, impairing EGF-induced MAPK and metabolic activity. Conclusions/Significance: This work defines the binding properties of RKIP ligands under near physiological conditions, establishing RKIP's affinity for hydrophobic ligands and the importance of bulky aliphatic chains for inhibiting its function. The common structural elements of these compounds defines a minimal requirement for RKIP binding and thus they can be used as lead compounds for future design of RKIP ligands with therapeutic potential.	[Shemon, Anne N.; Granovsky, Alexey E.; Clark, Mathew M.; Chimon, Alexander; Rosner, Marsha R.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Clark, Mathew M.; Rosner, Marsha R.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Heil, Gary L.; McElheny, Dan; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Shemon, AN (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	m-rosner@uchicago.edu	Alex, Granovsky/EUV-7323-2022	Koide, Shohei/0000-0001-5473-4358	National Institutes of Health (NIH) [GM087630, CA112310]; Medical Research Council Australia (NHMRC); NATIONAL CANCER INSTITUTE [R01CA112310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087630] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants GM087630 and CA112310 (to M. R. R.) and the Medical Research Council Australia (NHMRC) CJ Martin Fellowship (to A.N.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfield MJ, 1998, STRUCTURE, V6, P1245, DOI 10.1016/S0969-2126(98)00125-7; Banfield MJ, 2000, J MOL BIOL, V297, P1159, DOI 10.1006/jmbi.2000.3619; Baritaki S, 2009, ONCOGENE, V28, P3573, DOI 10.1038/onc.2009.214; BERNIER I, 1986, BIOCHIM BIOPHYS ACTA, V871, P19, DOI 10.1016/0167-4838(86)90128-7; BERNIER I, 1984, BIOCHIM BIOPHYS ACTA, V790, P174, DOI 10.1016/0167-4838(84)90221-8; BOLLENGIER F, 1988, J NEUROCHEM, V50, P1210, DOI 10.1111/j.1471-4159.1988.tb10594.x; Clark MC, 2006, J BIOMOL NMR, V36, P4, DOI 10.1007/s10858-005-4424-y; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; CORNWALL GA, 1990, BIOL REPROD, V43, P121, DOI 10.1095/biolreprod43.1.121; Creighton T. E., 1993, PROTEINS STRUCTURES; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Granovsky AE, 2009, MOL CELL BIOL, V29, P1306, DOI 10.1128/MCB.01271-08; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Marsh D., 1990, CRC HDB LIPID BILAYE; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; PERRY ACF, 1994, BIOCHEM J, V301, P235, DOI 10.1042/bj3010235; SCHOENTGEN F, 1995, FEBS LETT, V369, P22, DOI 10.1016/0014-5793(95)00376-K; SEDDIQI N, 1994, J MOL EVOL, V39, P655, DOI 10.1007/BF00160411; Serre L, 1998, STRUCTURE, V6, P1255, DOI 10.1016/S0969-2126(98)00126-9; Serre L, 2001, J MOL BIOL, V310, P617, DOI 10.1006/jmbi.2001.4784; Shemon AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006028; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Simister PC, 2002, ACTA CRYSTALLOGR D, V58, P1077, DOI 10.1107/S090744490200522X; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200; Vallee BS, 2001, EUR J BIOCHEM, V268, P5831, DOI 10.1046/j.0014-2956.2001.02528.x; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Zeng LC, 2008, EXPERT OPIN THER TAR, V12, P1275, DOI [10.1517/14728222.12.10.1275, 10.1517/14728222.12.10.1275 ]; Zhu ST, 2005, CHEM BIOL, V12, P981, DOI 10.1016/j.chembiol.2005.07.007	36	18	23	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10479	10.1371/journal.pone.0010479	http://dx.doi.org/10.1371/journal.pone.0010479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463977	Green Submitted, Green Published, gold			2022-12-25	WOS:000277379400015
J	Cinquin, P; Gondran, C; Giroud, F; Mazabrard, S; Pellissier, A; Boucher, F; Alcaraz, JP; Gorgy, K; Lenouvel, F; Mathe, S; Porcu, P; Cosnier, S				Cinquin, Philippe; Gondran, Chantal; Giroud, Fabien; Mazabrard, Simon; Pellissier, Aymeric; Boucher, Francois; Alcaraz, Jean-Pierre; Gorgy, Karine; Lenouvel, Francois; Mathe, Stephane; Porcu, Paolo; Cosnier, Serge			A Glucose BioFuel Cell Implanted in Rats	PLOS ONE			English	Article							OXIDASE	Powering future generations of implanted medical devices will require cumbersome transcutaneous energy transfer or harvesting energy from the human body. No functional solution that harvests power from the body is currently available, despite attempts to use the Seebeck thermoelectric effect, vibrations or body movements. Glucose fuel cells appear more promising, since they produce electrical energy from glucose and dioxygen, two substrates present in physiological fluids. The most powerful ones, Glucose BioFuel Cells (GBFCs), are based on enzymes electrically wired by redox mediators. However, GBFCs cannot be implanted in animals, mainly because the enzymes they rely on either require low pH or are inhibited by chloride or urate anions, present in the Extra Cellular Fluid (ECF). Here we present the first functional implantable GBFC, working in the retroperitoneal space of freely moving rats. The breakthrough relies on the design of a new family of GBFCs, characterized by an innovative and simple mechanical confinement of various enzymes and redox mediators: enzymes are no longer covalently bound to the surface of the electron collectors, which enables use of a wide variety of enzymes and redox mediators, augments the quantity of active enzymes, and simplifies GBFC construction. Our most efficient GBFC was based on composite graphite discs containing glucose oxidase and ubiquinone at the anode, polyphenol oxidase (PPO) and quinone at the cathode. PPO reduces dioxygen into water, at pH 7 and in the presence of chloride ions and urates at physiological concentrations. This GBFC, with electrodes of 0.133 mL, produced a peak specific power of 24.4 mu W mL(-1), which is better than pacemakers' requirements and paves the way for the development of a new generation of implantable artificial organs, covering a wide range of medical applications.	[Cinquin, Philippe; Boucher, Francois; Alcaraz, Jean-Pierre; Lenouvel, Francois; Porcu, Paolo] Univ Grenoble 1, CNRS, Lab TIMC IMAG, Grenoble, France; [Gondran, Chantal; Giroud, Fabien; Mazabrard, Simon; Pellissier, Aymeric; Gorgy, Karine; Cosnier, Serge] Univ Grenoble 1, CNRS, DCM, Grenoble, France; [Mathe, Stephane] Univ Toulouse 3, Lab Ingn Syst Biol & Procedes, CNRS, Inst Sci Appl Toulouse, F-31062 Toulouse, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier	Cinquin, P (corresponding author), Univ Grenoble 1, CNRS, Lab TIMC IMAG, Grenoble, France.	Philippe.Cinquin@imag.fr; serge.cosnier@ujf-grenoble.fr	Milton, Ross D/J-7164-2012; Boucher, François R/M-5937-2014; Ferreira, Fernanda/D-3963-2012; Cosnier, Serge/AAR-5671-2020; Cosnier, Serge/M-7712-2013; Cinquin, Philippe/M-5576-2014; ALCARAZ, jean-pierre/M-6821-2014	Cosnier, Serge/0000-0002-8290-4374; Cinquin, Philippe/0000-0002-2700-1447; ALCARAZ, jean-pierre/0000-0002-5924-9519; Gondran, Chantal/0000-0003-1021-6748	Universite Joseph Fourier (UJF); Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR); Rhone-Alpes Region EMERGENCE program	Universite Joseph Fourier (UJF); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Rhone-Alpes Region EMERGENCE program(Region Auvergne-Rhone-Alpes)	All co-workers are funded by Universite Joseph Fourier (UJF) and by Centre National de la Recherche Scientifique (CNRS). Part of this project was funded by Agence Nationale de la Recherche (ANR), by a Rhone-Alpes Region EMERGENCE program, and by UJF's subsidiary, Floralis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassov P, 2007, ELECTROCHEM SOC INTE, V16, P28; Barriere F, 2006, ELECTROCHIM ACTA, V51, P5187, DOI 10.1016/j.electacta.2006.03.050; Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k; Coman V, 2008, PHYS CHEM CHEM PHYS, V10, P6093, DOI 10.1039/b808859d; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Davenport A, 2007, LANCET, V370, P2005, DOI 10.1016/S0140-6736(07)61864-9; Deng L, 2008, BIOSENS BIOELECTRON, V24, P329, DOI 10.1016/j.bios.2008.04.006; Dowling RD, 2003, ANN THORAC SURG, V75, pS93, DOI 10.1016/S0003-4975(03)00484-3; DRAKE RF, 1970, T AM SOC ART INT ORG, V16, P199; Habrioux A, 2008, J ELECTROANAL CHEM, V622, P97, DOI 10.1016/j.jelechem.2008.05.011; Heller A, 2004, PHYS CHEM CHEM PHYS, V6, P209, DOI 10.1039/b313149a; KANG JY, 2006, ENCY MED DEVICES INS, P428; Kerzenmacher S, 2008, J POWER SOURCES, V182, P1, DOI 10.1016/j.jpowsour.2008.03.031; Kim SP, 2008, J UROLOGY, V179, P1912, DOI 10.1016/j.juro.2008.01.048; LAMRAOUI H, 2008, DESIGN IMPLEMENTATIO; Liu Y, 2007, ELECTROCHEM COMMUN, V9, P1423, DOI 10.1016/j.elecom.2007.01.055; Mano N, 2008, CHEM COMMUN, P2221, DOI 10.1039/b801786g; Minteer SD, 2007, CURR OPIN BIOTECH, V18, P228, DOI 10.1016/j.copbio.2007.03.007; Ohm OJ, 1997, PACE, V20, P2, DOI 10.1111/j.1540-8159.1997.tb04805.x; SAKAI H, 2009, ENERGY ENV IN PRESS; Shin H, 2007, ELECTROANAL, V19, P638, DOI 10.1002/elan.200603795; Soukharev V, 2004, J AM CHEM SOC, V126, P8368, DOI 10.1021/ja0475510; Togo M, 2008, J POWER SOURCES, V178, P53, DOI 10.1016/j.jpowsour.2007.12.052; Willner I, 1998, J CHEM SOC PERK T 2, P1817, DOI 10.1039/a801487f; Zayats M, 2008, ELECTROANAL, V20, P583, DOI 10.1002/elan.200704128	25	291	296	3	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10476	10.1371/journal.pone.0010476	http://dx.doi.org/10.1371/journal.pone.0010476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454563	Green Submitted, Green Published, gold			2022-12-25	WOS:000277305300011
J	Lyadova, IV; Tsiganov, EN; Kapina, MA; Shepelkova, GS; Sosunov, VV; Radaeva, TV; Majorov, KB; Shmitova, NS; van den Ham, HJ; Ganusov, VV; De Boer, RJ; Racine, R; Winslow, GM				Lyadova, Irina V.; Tsiganov, Evgeny N.; Kapina, Marina A.; Shepelkova, Galena S.; Sosunov, Vasily V.; Radaeva, Tatiana V.; Majorov, Konstantin B.; Shmitova, Natalya S.; van den Ham, Henk-Jan; Ganusov, Vitaly V.; De Boer, Rob J.; Racine, Rachael; Winslow, Gary M.			In Mice, Tuberculosis Progression Is Associated with Intensive Inflammatory Response and the Accumulation of Gr-1(dim) Cells in the Lungs	PLOS ONE			English	Article							VIRULENT MYCOBACTERIUM-TUBERCULOSIS; COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; HOST IMMUNE-RESPONSE; NITRIC-OXIDE; T-LYMPHOCYTES; SUSCEPTIBILITY; INTERLEUKIN-11; INFECTION; RECEPTOR	Background: Infection with Mycobacterium tuberculosis (Mtb) results in different clinical outcomes ranging from asymptomatic containment to rapidly progressing tuberculosis (TB). The mechanisms controlling TB progression in immunologically-competent hosts remain unclear. Methodology/Principal Findings: To address these mechanisms, we analyzed TB progression in a panel of genetically heterogeneous (A/SnxI/St) F2 mice, originating from TB-highly-susceptible I/St and more resistant A/Sn mice. In F2 mice the rates of TB progression differed. In mice that did not reach terminal stage of infection, TB progression did not correlate with lung Mtb loads. Nor was TB progression correlated with lung expression of factors involved in antibacterial immunity, such as iNOS, IFN-gamma, or IL-12p40. The major characteristics of progressing TB was high lung expression of the inflammation-related factors IL-1 beta, IL-6, IL-11 (p < 0.0003); CCL3, CCL4, CXCL2 (p, 0.002); MMP-8 (p < 0.0001). The major predictors of TB progression were high expressions of IL-1b and IL-11. TNF-alpha had both protective and harmful effects. Factors associated with TB progression were expressed mainly by macrophages (F4-80(+) cells) and granulocytes (Gr-1(hi)/Ly-6G(hi) cells). Macrophages and granulocytes from I/St and A/Sn parental strains exhibited intrinsic differences in the expression of inflammatory factors, suggesting that genetically determined peculiarities of phagocytes transcriptional response could account for the peculiarities of gene expression in the infected lungs. Another characteristic feature of progressing TB was the accumulation in the infected lungs of Gr-1(dim) cells that could contribute to TB progression. Conclusions/Significance: In a population of immunocompetent hosts, the outcome of TB depends on quantitatively-and genetically-controlled differences in the intensity of inflammatory responses, rather than being a direct consequence of mycobacterial colonization. Local accumulation of Gr-1(dim) cells is a newly identified feature of progressing TB. High expression of IL-1 beta and IL-11 are potential risk factors for TB progression and possible targets for TB immunomodulation.	[Lyadova, Irina V.; Tsiganov, Evgeny N.; Kapina, Marina A.; Shepelkova, Galena S.; Sosunov, Vasily V.; Radaeva, Tatiana V.; Majorov, Konstantin B.; Shmitova, Natalya S.] Russian Acad Med Sci, Dept Immunol, Cent TB Res Inst, Moscow, Russia; [van den Ham, Henk-Jan; Ganusov, Vitaly V.; De Boer, Rob J.] Univ Utrecht, Dept Theoret Biol & Bioinformat, Utrecht, Netherlands; [Racine, Rachael; Winslow, Gary M.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY USA; [Ganusov, Vitaly V.] Russian Acad Sci, Siberian Branch, Dept Postgrad Studies, Inst Biophys, Krasnoyarsk, Russia	Russian Academy of Medical Sciences; Utrecht University; State University of New York (SUNY) System; Wadsworth Center; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Biophysics Institute, Siberian Branch, Russian Academy of Sciences	Lyadova, IV (corresponding author), Russian Acad Med Sci, Dept Immunol, Cent TB Res Inst, Moscow, Russia.	ivlyadova@mail.ru	Shepelkova, Galina/F-3059-2017; Lyadova, Irina V/T-7806-2017; van den Ham, HJ/ABF-1071-2021; Majorov, Konstantin Borisovich/AIE-6667-2022; de Boer, Rob/B-6050-2011	Shepelkova, Galina/0000-0001-6854-7932; Lyadova, Irina V/0000-0003-3147-5386; de Boer, Rob/0000-0002-2130-691X; Ganusov, Vitaly/0000-0001-6572-1691; van den Ham, Henk-Jan/0000-0001-8582-5404	National Institutes of Health [1RO1AI078899]; United States Civilian Research and Development Foundation [RUB1-2706-MO-05]; Russian Foundation [07-04-01094]; Marie Curie Incoming International Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Civilian Research and Development Foundation; Russian Foundation(Russian Foundation for Basic Research (RFBR)); Marie Curie Incoming International Fellowship(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant # 1RO1AI078899 (to IL), www.nih.gov; United States Civilian Research and Development Foundation grant # RUB1-2706-MO-05 (to GW and IL), www.crdf.org; Russian Foundation for Basic Research grant # 07-04-01094 (to IL), www.rfbr.ru; Marie Curie Incoming International Fellowship (to VG), http://cordis.europa.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Beisiegel M, 2009, J INFECT DIS, V199, P1222, DOI 10.1086/597421; Bellamy RJ, 1998, NOVART FDN SYMP, V217, P3, DOI 10.1002/0470846526.ch2; Biermann H, 1999, J LEUKOCYTE BIOL, V65, P217, DOI 10.1002/jlb.65.2.217; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CAIRO MS, 1994, EXP HEMATOL, V22, P1118; Cardona PJ, 2003, INFECT IMMUN, V71, P5845, DOI 10.1128/IAI.71.10.5845-5854.2003; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Chen QS, 2005, J IMMUNOL, V174, P2305, DOI 10.4049/jimmunol.174.4.2305; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; Conner JR, 2008, J EXP MED, V205, P305, DOI 10.1084/jem.20071499; Curti A, 2001, BLOOD, V97, P2758, DOI 10.1182/blood.V97.9.2758; Dietrich WF, 2001, GENOME RES, V11, P325, DOI 10.1101/gr.173101; Efron B., 1994, INTRO BOOTSTRAP; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Eruslanov EB, 2004, CLIN EXP IMMUNOL, V135, P19, DOI 10.1111/j.1365-2249.2004.02328.x; Flynn JL, 2000, CURR OPIN IMMUNOL, V12, P432, DOI 10.1016/S0952-7915(00)00116-3; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Heldwein KA, 2003, J LEUKOCYTE BIOL, V74, P277, DOI 10.1189/jlb.0103026; HESTDAL K, 1991, J IMMUNOL, V147, P22; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Kapina MA, 2007, J IMMUNOL, V178, P976, DOI 10.4049/jimmunol.178.2.976; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Keller C, 2006, INFECT IMMUN, V74, P4295, DOI 10.1128/IAI.00057-06; Keller C, 2004, TUBERCULOSIS, V84, P144, DOI 10.1016/j.tube.2003.12.003; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Lavebratt C, 1999, J INFECT DIS, V180, P150, DOI 10.1086/314843; Law K, 1996, AM J RESP CRIT CARE, V153, P799, DOI 10.1164/ajrccm.153.2.8564135; Lgssiar A, 2004, EXP BIOL MED, V229, P425, DOI 10.1177/153537020422900511; Lyadova IV, 2000, J IMMUNOL, V165, P5921, DOI 10.4049/jimmunol.165.10.5921; Majorov KB, 2003, INFECT IMMUN, V71, P697, DOI 10.1128/IAI.71.2.697-707.2003; Mitsos LM, 2003, P NATL ACAD SCI USA, V100, P6610, DOI 10.1073/pnas.1031727100; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; MUSASHI M, 1991, P NATL ACAD SCI USA, V88, P765, DOI 10.1073/pnas.88.3.765; Nikonenko BV, 2000, TUBERCLE LUNG DIS, V80, P15, DOI 10.1054/tuld.1999.0225; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Orlova MO, 2006, INFECT IMMUN, V74, P3668, DOI 10.1128/IAI.00196-06; Palmqvist P, 2008, J DENT RES, V87, P558, DOI 10.1177/154405910808700614; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; Sanchez F, 2003, INFECT IMMUN, V71, P126, DOI 10.1128/IAI.71.1.126-131.2003; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; Schwertschlag US, 1999, LEUKEMIA, V13, P1307, DOI 10.1038/sj.leu.2401514; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Trepicchio WL, 1996, J IMMUNOL, V157, P3627; Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103; White CA, 2007, J REPROD IMMUNOL, V73, P28, DOI 10.1016/j.jri.2006.05.003; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; Yan BS, 2007, J IMMUNOL, V179, P6919, DOI 10.4049/jimmunol.179.10.6919	52	59	60	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10469	10.1371/journal.pone.0010469	http://dx.doi.org/10.1371/journal.pone.0010469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454613	gold, Green Submitted, Green Published			2022-12-25	WOS:000277305300009
J	Lundberg, J; Jonsson, S; Holmin, S				Lundberg, Johan; Jonsson, Stefan; Holmin, Staffan			New Endovascular Method for Transvascular Exit of Arteries and Veins: Developed in Simulator, in Rat and in Rabbit with Full Clinical Integration	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; STROMAL CELL TREATMENT; STEM-CELLS; ISLET TRANSPLANTATION; MIGRATION; STROKE	Background: Endovascular technique has benefits vis-a-vis surgical access to organs with less accessible anatomical locations. To minimize surgical risk we propose a novel endovascular technique, to create parenchymal access through endovascular methods. Methodology/Principal Findings: We have developed, manufactured and tested an endovascular catheter with a depth limiting collar and a penetrating tip that is used to perforate vessels, thereby creating a working channel to the extravascular space. Computer simulations and subsequent interventions have been performed ex vivo and in vivo in both small and large animals by testing different prototypes. All tests were designed for testing extravascular hemostasis and absence of thrombo-embolic complications when exiting the vessels from the inside to the extra vascular space. We have deposited prototypes after intervention in vascular walls over a period of 14 days in rat with no impairment on blood flow and no signs of thrombo-embolic complications upon re-exploration (n = 7). We have also incorporated the catheter system with clinically available systems both in an ex vivo simulator setting and in a full scale clinical angiographical setting in rabbit were no bleeding (0%) in any of the interventions performed (n = 40). To prevent hemorrhage during termination of the procedure, a hollow electrolysis detachment-zone leaves the distal tip in the vessel-wall after the intervention. This has also been tested with absolute hemostasis in large animals (n = 6). Conclusions/Significance: We have developed and tested a new system for transvascular tissue access in simulations, ex vivo and in vivo in small and large animals, integrating it with standard clinical catheters and angiographical environment, with absolute hemostasis and without thromboembolic complications. In a clinical setting for stem cell transplantation, local substance administration or tissue sampling, the benefit should be greatest in organs that are difficult or high-risk to access with other techniques, such as the pancreas, the central nervous system (CNS) and the heart.	[Lundberg, Johan; Holmin, Staffan] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lundberg, Johan; Holmin, Staffan] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden; [Jonsson, Stefan] Royal Inst Technol, Dept Mat Sci & Engn, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology	Lundberg, J (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	staffan.holmin@karolinska.se		Holmin, Staffan/0000-0002-1628-1615	Swedish Research Council [K2006-73X-20139-01-3]; Karolinska Institutet; Karolinska Institutet Innovations; Swedish Society of Medicine; Strokefonden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Karolinska Institutet Innovations; Swedish Society of Medicine; Strokefonden	This study was supported by grants from the Swedish Research Council (K2006-73X-20139-01-3), Karolinska Institutet funds, Karolinska Institutet Innovations, the Swedish Society of Medicine and Strokefonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale R, 2007, MINIM INVASIV THER, V16, P196, DOI 10.1080/13645700701520578; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Fay J., 1994, INTRO FLUID MECH; Guzman R, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E14; Hampton T, 2007, JAMA-J AM MED ASSOC, V298, P165, DOI 10.1001/jama.298.2.165; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; John D. B., 1996, THEORY PRACTICE HIST; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; LUNDBERG J, 2009, NEURORADIOLOGY; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Siminiak T, 2005, EUR HEART J, V26, P1188, DOI 10.1093/eurheartj/ehi159; Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8; Villiger P, 2005, AM J TRANSPLANT, V5, P2992, DOI 10.1111/j.1600-6143.2005.01108.x; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wu XH, 2007, WORLD J GASTROENTERO, V13, P3342, DOI 10.3748/wjg.v13.i24.3342	19	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10449	10.1371/journal.pone.0010449	http://dx.doi.org/10.1371/journal.pone.0010449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454668	Green Submitted, gold, Green Published			2022-12-25	WOS:000277240300022
J	Bankapur, A; Zachariah, E; Chidangil, S; Valiathan, M; Mathur, D				Bankapur, Aseefhali; Zachariah, Elsa; Chidangil, Santhosh; Valiathan, Manna; Mathur, Deepak			Raman Tweezers Spectroscopy of Live, Single Red and White Blood Cells	PLOS ONE			English	Article							UV RESONANCE RAMAN; OPTICAL TWEEZERS; LIVING CELLS; MANIPULATION	An optical trap has been combined with a Raman spectrometer to make high-resolution measurements of Raman spectra of optically-immobilized, single, live red (RBC) and white blood cells (WBC) under physiological conditions. Tightly-focused, near infrared wavelength light (1064 nm) is utilized for trapping of single cells and 785 nm light is used for Raman excitation at low levels of incident power (few mW). Raman spectra of RBC recorded using this high-sensitivity, dual-wavelength apparatus has enabled identification of several additional lines; the hitherto-unreported lines originate purely from hemoglobin molecules. Raman spectra of single granulocytes and lymphocytes are interpreted on the basis of standard protein and nucleic acid vibrational spectroscopy data. The richness of the measured spectrum illustrates that Raman studies of live cells in suspension are more informative than conventional micro-Raman studies where the cells are chemically bound to a glass cover slip.	[Bankapur, Aseefhali; Zachariah, Elsa; Chidangil, Santhosh; Mathur, Deepak] Manipal Univ, Ctr Atom & Mol Phys, Manipal, Karnataka, India; [Valiathan, Manna] Kasturba Med Coll & Hosp, Dept Pathol, Manipal, Karnataka, India; [Mathur, Deepak] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Tata Institute of Fundamental Research (TIFR)	Bankapur, A (corresponding author), Manipal Univ, Ctr Atom & Mol Phys, Manipal, Karnataka, India.	atmol1@tifr.res.in	Mathur, Deepak/K-5000-2019; Bankapur, Aseefhali/G-8637-2015; Bankapur, Aseefhali/AAN-1484-2020	Mathur, Deepak/0000-0002-2322-6331; Bankapur, Aseefhali/0000-0001-9237-8980; Bankapur, Aseefhali/0000-0001-9237-8980; CHIDANGIL, SANTHOSH/0000-0002-2973-6834	Department of Biotechnology of the Government of India [BT/PR6413/MED/14/802/2005]	Department of Biotechnology of the Government of India(Department of Biotechnology (DBT) India)	The authors acknowledge the generous support provided by the Department of Biotechnology of the Government of India for this work under grant BT/PR6413/MED/14/802/2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; BRUCE A, 2001, MOL BIOL CELL; CALMETTES PP, 1983, P NATL ACAD SCI-BIOL, V80, P7197, DOI 10.1073/pnas.80.23.7197; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; Chang WT, 2009, J RAMAN SPECTROSC, V40, P1194, DOI 10.1002/jrs.2261; Chen K, 2006, OPT LETT, V31, P2015, DOI 10.1364/OL.31.002015; Creely CM, 2005, OPT COMMUN, V245, P465, DOI 10.1016/j.optcom.2004.10.011; De Luca AC, 2008, OPT EXPRESS, V16, P7943, DOI 10.1364/OE.16.007943; DEGRUCHY C, 2001, CLIN HAEMATOLOGY MED; Deng JL, 2005, J RAMAN SPECTROSC, V36, P257, DOI 10.1002/jrs.1301; Dharmadhikari JA, 2004, CURR SCI INDIA, V86, P1432; Dharmadhikari JA, 2004, OPT EXPRESS, V12, P1179, DOI 10.1364/OPEX.12.001179; GEBNER R, 2004, CHEMPHYSCHEM, V5, P1159; Gudipati M, 2005, OPT EXPRESS, V13, P1555, DOI 10.1364/OPEX.13.001555; Harvey TJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2999609; Hawi SR, 1996, CANCER LETT, V110, P35, DOI 10.1016/S0304-3835(96)04455-2; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Jess PRT, 2007, J RAMAN SPECTROSC, V38, P1082, DOI 10.1002/jrs.1712; Lapotko DO, 2005, LASER SURG MED, V36, P22, DOI 10.1002/lsm.20119; Li P, 2005, OPT LETT, V30, P156, DOI 10.1364/OL.30.000156; Liang H, 1996, BIOPHYS J, V70, P1529, DOI 10.1016/S0006-3495(96)79716-3; MANOHARAN R, 1990, J MICROBIOL METH, V11, P1, DOI 10.1016/0167-7012(90)90042-5; Moritz TJ, 2010, J RAMAN SPECTROSC, V41, P33, DOI 10.1002/jrs.2436; NELSON WH, 1992, APPL SPECTROSC REV, V27, P67, DOI 10.1080/05704929208018270; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Ojeda JF, 2006, OPT EXPRESS, V14, P5385, DOI 10.1364/OE.14.005385; Otto C, 1998, EUR BIOPHYS J BIOPHY, V27, P582, DOI 10.1007/s002490050169; PARKER FS, 1983, APPL INFRARED RAMAN; PUPPELS GJ, 1991, BIOPHYS J, V60, P1046, DOI 10.1016/S0006-3495(91)82142-7; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Ramanandan G, 2009, OPT EXPRESS, V17, P9614, DOI 10.1364/OE.17.009614; Ramser K, 2004, J BIOMED OPT, V9, P593, DOI 10.1117/1.1689336; Rao S, 2009, BIOPHYS J, V96, P209, DOI 10.1529/biophysj.108.139097; Singh GP, 2005, ANAL CHEM, V77, P2564, DOI 10.1021/ac048359j; Snook RD, 2009, INTEGR BIOL-UK, V1, P43, DOI 10.1039/b815253e; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Tang H, 2007, OPT EXPRESS, V15, P12708, DOI 10.1364/OE.15.012708; Wood BR, 2007, ANAL BIOANAL CHEM, V387, P1691, DOI 10.1007/s00216-006-0881-8; Wood BR, 2002, J RAMAN SPECTROSC, V33, P517, DOI 10.1002/jrs.870; WOOD BR, 2001, BIOCHIM BIOPHYS ACTA, V15, P58; Xie CG, 2004, OPT EXPRESS, V12, P6208, DOI 10.1364/OPEX.12.006208; Xie CG, 2002, OPT LETT, V27, P249, DOI 10.1364/OL.27.000249	43	111	114	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10427	10.1371/journal.pone.0010427	http://dx.doi.org/10.1371/journal.pone.0010427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454686	Green Submitted, gold, Green Published			2022-12-25	WOS:000277240100029
J	Blalock, EM; Phelps, JT; Pancani, T; Searcy, JL; Anderson, KL; Gant, JC; Popovic, J; Avdiushko, MG; Cohen, DA; Chen, KC; Porter, NM; Thibault, O				Blalock, Eric M.; Phelps, Jeremiah T.; Pancani, Tristano; Searcy, James L.; Anderson, Katie L.; Gant, John C.; Popovic, Jelena; Avdiushko, Margarita G.; Cohen, Don A.; Chen, Kuey-Chu; Porter, Nada M.; Thibault, Olivier			Effects of Long-Term Pioglitazone Treatment on Peripheral and Central Markers of Aging	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; NITRIC-OXIDE SYNTHASE; MILD COGNITIVE IMPAIRMENT; TRANSIENT FOCAL ISCHEMIA; PPAR-GAMMA; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; INSULIN-RESISTANCE; SYNAPTIC PLASTICITY; CALCIUM HOMEOSTASIS	Background: Thiazolidinediones (TZDs) activate peroxisome proliferator-activated receptor gamma (PPAR gamma) and are used clinically to help restore peripheral insulin sensitivity in Type 2 diabetes (T2DM). Interestingly, long-term treatment of mouse models of Alzheimer's disease (AD) with TZDs also has been shown to reduce several well-established brain biomarkers of AD including inflammation, oxidative stress and A beta accumulation. While TZD's actions in AD models help to elucidate the mechanisms underlying their potentially beneficial effects in AD patients, little is known about the functional consequences of TZDs in animal models of normal aging. Because aging is a common risk factor for both AD and T2DM, we investigated whether the TZD, pioglitazone could alter brain aging under non-pathological conditions. Methods and Findings: We used the F344 rat model of aging, and monitored behavioral, electrophysiological, and molecular variables to assess the effects of pioglitazone (PIO-Actos (R) a TZD) on several peripheral (blood and liver) and central (hippocampal) biomarkers of aging. Starting at 3 months or 17 months of age, male rats were treated for 4-5 months with either a control or a PIO-containing diet (final dose approximately 2.3 mg/kg body weight/day). A significant reduction in the Ca2+-dependent afterhyperpolarization was seen in the aged animals, with no significant change in long-term potentiation maintenance or learning and memory performance. Blood insulin levels were unchanged with age, but significantly reduced by PIO. Finally, a combination of microarray analyses on hippocampal tissue and serum-based multiplex cytokine assays revealed that age-dependent inflammatory increases were not reversed by PIO. Conclusions: While current research efforts continue to identify the underlying processes responsible for the progressive decline in cognitive function seen during normal aging, available medical treatments are still very limited. Because TZDs have been shown to have benefits in age-related conditions such as T2DM and AD, our study was aimed at elucidating PIO's potentially beneficial actions in normal aging. Using a clinically-relevant dose and delivery method, long-term PIO treatment was able to blunt several indices of aging but apparently affected neither age-related cognitive decline nor peripheral/central age-related increases in inflammatory signaling.	[Blalock, Eric M.; Phelps, Jeremiah T.; Pancani, Tristano; Searcy, James L.; Anderson, Katie L.; Gant, John C.; Popovic, Jelena; Chen, Kuey-Chu; Porter, Nada M.; Thibault, Olivier] Univ Kentucky, Med Ctr, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Avdiushko, Margarita G.; Cohen, Don A.] Univ Kentucky, Med Ctr, Dept Microbiol & Immunol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Blalock, EM (corresponding author), Univ Kentucky, Med Ctr, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.	othibau@uky.edu	Thibault, Olivier/AAY-7614-2020	Thibault, Olivier/0000-0002-3548-3466	Neurosciences Education and Research Foundation [AG029268, AG0033649, NCRR-P20-RR15592]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033649, R21AG029268] Funding Source: NIH RePORTER	Neurosciences Education and Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this work was provided in part by a gift from the Neurosciences Education and Research Foundation (OT), and research grants AG029268 (OT), AG0033649 (OT) and NCRR-P20-RR15592 (OT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aenlle KK, 2009, NEUROBIOL AGING, V30, P932, DOI 10.1016/j.neurobiolaging.2007.09.004; Aoun P, 2003, EUR J PHARMACOL, V472, P65, DOI 10.1016/S0014-2999(03)01867-3; Arikawa M, 2004, J CARDIOVASC PHARM, V44, P109, DOI 10.1097/00005344-200407000-00015; Asano M, 1999, BRIT J PHARMACOL, V128, P673, DOI 10.1038/sj.bjp.0702818; Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875; Barnes CA, 1996, LEARN MEMORY, V3, P124, DOI 10.1101/lm.3.2-3.124; BARNES CA, 1985, BEHAV NEUROSCI, V99, P1040, DOI 10.1037/0735-7044.99.6.1040; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002; BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591; Bellelli G, 2009, J AM GERIATR SOC, V57, P178, DOI 10.1111/j.1532-5415.2009.02067.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blalock EM, 2003, J NEUROSCI, V23, P3807; BOLSTAD B, 2005, BIOINFORMATICS COMPU; BONINI JA, 1995, AM J PHYSIOL-ENDOC M, V269, pE759, DOI 10.1152/ajpendo.1995.269.4.E759; Boyle PJ, 2002, CLIN THER, V24, P378, DOI 10.1016/S0149-2918(02)85040-8; Breidert T, 2002, J NEUROCHEM, V82, P615, DOI 10.1046/j.1471-4159.2002.00990.x; Brunton L.B., 2005, GOODMAN GILMANS PHAR, V11th ed; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; Burger C, 2007, NEUROBIOL LEARN MEM, V87, P21, DOI 10.1016/j.nlm.2006.05.003; Churi SB, 2008, J PAIN, V9, P639, DOI 10.1016/j.jpain.2008.02.002; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Dasu MR, 2009, ENDOCRINOLOGY, V150, P3457, DOI 10.1210/en.2008-1757; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; Deeg MA, 2007, DIABETES CARE, V30, P2458, DOI 10.2337/dc06-1903; Dehmer T, 2004, J NEUROCHEM, V88, P494, DOI 10.1046/j.1471-4159.2003.02210.x; DETOLEDOMORRELL L, 1988, NEUROBIOL AGING, V9, P581, DOI 10.1016/S0197-4580(88)80117-9; DEUPREE DL, 1993, NEUROBIOL AGING, V14, P249, DOI 10.1016/0197-4580(93)90009-Z; Disterhoft JF, 1996, LIFE SCI, V59, P413, DOI 10.1016/0024-3205(96)00320-7; Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x; DRAZNIN B, 1989, ENDOCRINOLOGY, V125, P2341, DOI 10.1210/endo-125-5-2341; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Feinstein Douglas L, 2003, Diabetes Technol Ther, V5, P67, DOI 10.1089/152091503763816481; Fishel MA, 2005, ARCH NEUROL-CHICAGO, V62, P1539, DOI 10.1001/archneur.62.10.1539; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gant JC, 2006, J NEUROSCI, V26, P3482, DOI 10.1523/JNEUROSCI.4171-05.2006; GANT JC, 2008, NEUROBIOL AGING; Garcia-Bueno B, 2005, BIOL PSYCHIAT, V57, P885, DOI 10.1016/j.biopsych.2005.01.007; Gemma C, 2004, NEUROREPORT, V15, P2255, DOI 10.1097/00001756-200410050-00023; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gillies PS, 2000, DRUGS, V60, P333, DOI 10.2165/00003495-200060020-00009; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; GOODMAN DG, 1979, TOXICOL APPL PHARM, V48, P237, DOI 10.1016/0041-008X(79)90029-2; GRADMAN TJ, 1993, J AM GERIATR SOC, V41, P1305, DOI 10.1111/j.1532-5415.1993.tb06480.x; Gregg EW, 2000, ARCH INTERN MED, V160, P174, DOI 10.1001/archinte.160.2.174; Hauner H, 2002, DIABETES-METAB RES, V18, pS10, DOI 10.1002/dmrr.249; Heneka MT, 2000, J NEUROSCI, V20, P6862, DOI 10.1523/JNEUROSCI.20-18-06862.2000; Heneka MT, 1999, J NEUROIMMUNOL, V100, P156, DOI 10.1016/S0165-5728(99)00192-7; HENEKA MT, 2005, BRAIN; Heppner TJ, 2005, PHARMACOLOGY, V73, P15, DOI 10.1159/000081070; HOFMANN C, 1994, ENDOCRINOLOGY, V134, P264, DOI 10.1210/en.134.1.264; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang TJ, 2005, MOL CELL NEUROSCI, V28, P42, DOI 10.1016/j.mcn.2004.08.009; Huang TJ, 2002, DIABETOLOGIA, V45, P560, DOI 10.1007/s00125-002-0785-x; Hunter RL, 2008, NEUROSCI LETT, V432, P198, DOI 10.1016/j.neulet.2007.12.019; Ikeda S, 1998, EUR J PHARMACOL, V357, P243, DOI 10.1016/S0014-2999(98)00557-3; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang QG, 2008, CNS DRUGS, V22, P1, DOI 10.2165/00023210-200822010-00001; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kamal A, 2003, NEUROSCIENCE, V118, P577, DOI 10.1016/S0306-4522(02)00874-6; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; KERR DS, 1989, SCIENCE, V245, P1505, DOI 10.1126/science.2781293; Kruglikov I, 2004, PFLUG ARCH EUR J PHY, V448, P395, DOI 10.1007/s00424-004-1263-8; Lacombe P, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-11; LANDFIELD PW, 1984, SCIENCE, V226, P1089, DOI 10.1126/science.6494926; Landreth GE, 2001, NEUROBIOL AGING, V22, P937, DOI 10.1016/S0197-4580(01)00296-2; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; LEVIN BE, 1983, AM J PHYSIOL, V245, pR364, DOI 10.1152/ajpregu.1983.245.3.R364; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Messier C, 2005, NEUROBIOL AGING, V26, pS26, DOI 10.1016/j.neurobiolaging.2005.09.014; MORGENWECK J, 2009, NEUROPHARMACOLOGY; Moyer JR, 1996, J NEUROSCI, V16, P5536; MOYER JR, 1992, J NEUROPHYSIOL, V68, P2100, DOI 10.1152/jn.1992.68.6.2100; Nakajima T, 1999, CIRCULATION, V99, P2942, DOI 10.1161/01.CIR.99.22.2942; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; Pancani T, 2009, J NEUROCHEM, V109, P1800, DOI 10.1111/j.1471-4159.2009.06107.x; Parachikova A, 2007, NEUROBIOL AGING, V28, P1821, DOI 10.1016/j.neurobiolaging.2006.08.014; Pedersen WA, 2004, NEUROBIOL DIS, V17, P500, DOI 10.1016/j.nbd.2004.08.003; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Prolla TA, 2002, CHEM SENSES, V27, P299, DOI 10.1093/chemse/27.3.299; Reagan LP, 2002, INT REV NEUROBIOL, V51, P289, DOI 10.1016/S0074-7742(02)51009-6; Rex CS, 2005, J NEUROSCI, V25, P5956, DOI 10.1523/JNEUROSCI.0880-05.2005; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; Romera C, 2007, J CEREBR BLOOD F MET, V27, P1327, DOI 10.1038/sj.jcbfm.9600438; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Ryan CM, 2000, DIABETES-METAB RES, V16, P308, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR141>3.0.CO;2-X; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Shankar S, 1998, J NEUROPHYSIOL, V79, P334, DOI 10.1152/jn.1998.79.1.334; Song JB, 1997, DIABETES, V46, P659, DOI 10.2337/diabetes.46.4.659; Spanheimer R, 2009, AM J CARDIOL, V104, P234, DOI 10.1016/j.amjcard.2009.03.023; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Storozhevykh TP, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-84; STRANAHAN AM, 2008, NEUROBIOL AGING; Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021; Szapary PO, 2006, ARTERIOSCL THROM VAS, V26, P182, DOI 10.1161/01.ATV.0000195790.24531.4f; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Tombaugh GC, 2002, J NEUROSCI, V22, P9932; Tureyen K, 2007, J NEUROCHEM, V101, P41, DOI 10.1111/j.1471-4159.2006.04376.x; Uryu S, 2002, BRAIN RES, V924, P229, DOI 10.1016/S0006-8993(01)03242-5; Victor NA, 2006, EUR J NEUROSCI, V24, P1653, DOI 10.1111/j.1460-9568.2006.05037.x; Wang XK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-12; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Yan Q, 2003, J NEUROSCI, V23, P7504; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5; Zhao XR, 2006, BRAIN RES, V1073, P460, DOI 10.1016/j.brainres.2005.12.061	121	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10405	10.1371/journal.pone.0010405	http://dx.doi.org/10.1371/journal.pone.0010405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454453	Green Published, Green Submitted, gold			2022-12-25	WOS:000277240100015
J	Bithell, A; Hsu, T; Kandanearatchi, A; Landau, S; Everall, IP; Tsuang, MT; Chana, G; Williams, BP				Bithell, Angela; Hsu, Tony; Kandanearatchi, Apsara; Landau, Sabine; Everall, Ian P.; Tsuang, Ming T.; Chana, Gursharan; Williams, Brenda P.			Expression of the Rap1 Guanine Nucleotide Exchange Factor, MR-GEF, Is Altered in Individuals with Bipolar Disorder	PLOS ONE			English	Article							LOCAL CIRCUIT NEURONS; PREFRONTAL CORTEX; GENE-EXPRESSION; GABAERGIC NEURONS; MESSENGER-RNA; B-RECEPTOR; SCHIZOPHRENIA; BRAIN; INTERNEURONS; PLASTICITY	In the rodent forebrain GABAergic neurons are generated from progenitor cells that express the transcription factors Dlx1 and Dlx2. The Rap-1 guanine nucleotide exchange factor, MR-GEF, is turned on by many of these developing GABAergic neurons. Expression of both Dlx1/2 and MR-GEF is retained in both adult mouse and human forebrain where, in human, decreased Dlx1 expression has been associated with psychosis. Using in situ hybridization studies we show that MR-GEF expression is significantly down-regulated in the forebrain of Dlx1/2 double mutant mice suggesting that MR-GEF and Dlx1/2 form part of a common signalling pathway during GABAergic neuronal development. We therefore compared MR-GEF expression by in situ hybridization in individuals with major psychiatric disorders (schizophrenia, bipolar disorder, major depression) and control individuals. We observed a significant positive correlation between layers II and IV of the dorsolateral prefrontal cortex (DLPFC) in the percentage of MR-GEF expressing neurons in individuals with bipolar disorder, but not in individuals with schizophrenia, major depressive disorder or in controls. Since MR-GEF encodes a Rap1 GEF able to activate G-protein signalling, we suggest that changes in MR-GEF expression could potentially influence neurotransmission.	[Bithell, Angela] Kings Coll London, Inst Psychiat, James Black Ctr, Ctr Cellular Basis Behav,Dept Psychol Med, London WC2R 2LS, England; [Hsu, Tony; Everall, Ian P.; Tsuang, Ming T.; Chana, Gursharan] Univ Calif San Diego, Dept Psychiat, Ctr Behav Genom, San Diego, CA 92103 USA; [Landau, Sabine] Kings Coll London, Inst Psychiat, Dept Biostat & Comp, London WC2R 2LS, England	University of London; King's College London; University of California System; University of California San Diego; University of London; King's College London	Bithell, A (corresponding author), Kings Coll London, Inst Psychiat, James Black Ctr, Ctr Cellular Basis Behav,Dept Psychol Med, London WC2R 2LS, England.	brenda.p.williams@kcl.ac.uk	Landau, Sabine/B-9354-2011	Bithell, Angela/0000-0002-0294-078X; Williams, Brenda Patricia/0000-0003-4690-5932; Landau, Sabine/0000-0002-3615-8075	Stanley Foundation; Wellcome Trust; Medical Research Council	Stanley Foundation; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Stanley Foundation (http://www.stanleyfoundation.org/), the Wellcome Trust ( http://www.wellcome.ac.uk/) and the Medical Research Council (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Beasley CL, 1997, SCHIZOPHR RES, V24, P349, DOI 10.1016/S0920-9964(96)00122-3; Beasley CL, 2002, BIOL PSYCHIAT, V52, P708, DOI 10.1016/S0006-3223(02)01360-4; Benes FM, 1996, NEUROSCIENCE, V75, P1021, DOI 10.1016/0306-4522(96)00328-4; Bithell A, 2003, DEV BRAIN RES, V146, P107, DOI 10.1016/j.devbrainres.2003.09.017; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Byne W, 2002, AM J PSYCHIAT, V159, P59, DOI 10.1176/appi.ajp.159.1.59; Chana G, 2003, BIOL PSYCHIAT, V53, P1086, DOI 10.1016/S0006-3223(03)00114-8; Chance SA, 2005, BRAIN RES, V1046, P32, DOI 10.1016/j.brainres.2005.03.045; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Costa E., 2004, Critical Reviews in Neurobiology, V16, P1, DOI 10.1615/CritRevNeurobiol.v16.i12.10; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; Craddock N, 2006, SCHIZOPHRENIA BULL, V32, P9, DOI 10.1093/schbul/sbj033; Dean B, 1999, J NEUROCHEM, V72, P1593, DOI 10.1046/j.1471-4159.1999.721593.x; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Ishikawa M, 2005, NEUROSCI LETT, V383, P272, DOI 10.1016/j.neulet.2005.04.025; Kromkamp M, 2003, ARCH GEN PSYCHIAT, V60, P869, DOI 10.1001/archpsyc.60.9.869; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Letinic K, 2001, NAT NEUROSCI, V4, P931, DOI 10.1038/nn0901-931; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Lo WS, 2004, MOL PSYCHIATR, V9, P603, DOI 10.1038/sj.mp.4001461; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Mizukami K, 2002, PROG NEURO-PSYCHOPH, V26, P393, DOI 10.1016/S0278-5846(01)00247-0; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Murray RM, 2004, SCHIZOPHR RES, V71, P405, DOI 10.1016/j.schres.2004.03.002; Popken GJ, 2000, P NATL ACAD SCI USA, V97, P9276, DOI 10.1073/pnas.150243397; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Rotaru DC, 2005, J COMP NEUROL, V490, P220, DOI 10.1002/cne.20661; Saino-Saito S, 2003, J COMP NEUROL, V461, P18, DOI 10.1002/cne.10611; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Stuhmer T, 2002, CEREB CORTEX, V12, P75, DOI 10.1093/cercor/12.1.75; Talkowski ME, 2006, SCHIZOPHRENIA BULL, V32, P203, DOI 10.1093/schbul/sbj058; Volk DW, 2001, AM J PSYCHIAT, V158, P256, DOI 10.1176/appi.ajp.158.2.256; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Woo TU, 1998, P NATL ACAD SCI USA, V95, P5341, DOI 10.1073/pnas.95.9.5341	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10392	10.1371/journal.pone.0010392	http://dx.doi.org/10.1371/journal.pone.0010392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20436929	Green Published, Green Accepted, gold			2022-12-25	WOS:000277154200027
J	Pain, DJ; Cromie, RL; Newth, J; Brown, MJ; Crutcher, E; Hardman, P; Hurst, L; Mateo, R; Meharg, AA; Moran, AC; Raab, A; Taggart, MA; Green, RE				Pain, Deborah J.; Cromie, Ruth L.; Newth, Julia; Brown, Martin J.; Crutcher, Eric; Hardman, Pippa; Hurst, Louise; Mateo, Rafael; Meharg, Andrew A.; Moran, Annette C.; Raab, Andrea; Taggart, Mark A.; Green, Rhys E.			Potential Hazard to Human Health from Exposure to Fragments of Lead Bullets and Shot in the Tissues of Game Animals	PLOS ONE			English	Article							INTELLECTUAL IMPAIRMENT; CHILDREN; BIRDS; RISK	Background: Lead is highly toxic to animals. Humans eating game killed using lead ammunition generally avoid swallowing shot or bullets and dietary lead exposure from this source has been considered low. Recent evidence illustrates that lead bullets fragment on impact, leaving small lead particles widely distributed in game tissues. Our paper asks whether lead gunshot pellets also fragment upon impact, and whether lead derived from spent gunshot and bullets in the tissues of game animals could pose a threat to human health. Methodology/Principal Findings: Wild-shot gamebirds (6 species) obtained in the UK were X-rayed to determine the number of shot and shot fragments present, and cooked using typical methods. Shot were then removed to simulate realistic practice before consumption, and lead concentrations determined. Data from the Veterinary Medicines Directorate Statutory Surveillance Programme documenting lead levels in raw tissues of wild gamebirds and deer, without shot being removed, are also presented. Gamebirds containing >= 5 shot had high tissue lead concentrations, but some with fewer or no shot also had high lead concentrations, confirming X-ray results indicating that small lead fragments remain in the flesh of birds even when the shot exits the body. A high proportion of samples from both surveys had lead concentrations exceeding the European Union Maximum Level of 100 ppb w.w. (0.1 mg kg(-1) w.w.) for meat from bovine animals, sheep, pigs and poultry (no level is set for game meat), some by several orders of magnitude. High, but feasible, levels of consumption of some species could result in the current FAO/WHO Provisional Weekly Tolerable Intake of lead being exceeded. Conclusions/Significance: The potential health hazard from lead ingested in the meat of game animals may be larger than previous risk assessments indicated, especially for vulnerable groups, such as children, and those consuming large amounts of game.	[Pain, Deborah J.; Cromie, Ruth L.; Newth, Julia; Brown, Martin J.; Hardman, Pippa; Hurst, Louise] Wildfowl & Wetlands Trust, Slimbridge GL2 7BT, Glos, England; [Crutcher, Eric] Vet Med Directorate, Residues Surveillance Unit, Surrey, England; [Mateo, Rafael; Taggart, Mark A.] JCCM, UCLM, CSIC, Inst Invest Recursos Cineget,IREC, Ciudad Real, Spain; [Meharg, Andrew A.; Moran, Annette C.; Raab, Andrea] Univ Aberdeen, Inst Biol Environm Sci, Aberdeen, Scotland; [Green, Rhys E.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Green, Rhys E.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Aberdeen; Royal Society for Protection of Birds; University of Cambridge	Pain, DJ (corresponding author), Wildfowl & Wetlands Trust, Slimbridge GL2 7BT, Glos, England.	debbie.pain@wwt.org.uk	Mateo, Rafael/A-3117-2011; Mateo, Rafael/AAU-1480-2020; Meharg, Andrew Alexander/F-8182-2014	Mateo, Rafael/0000-0003-1307-9152; Mateo, Rafael/0000-0003-1307-9152; Meharg, Andrew Alexander/0000-0003-2019-0449; Raab, Andrea/0000-0003-2058-0105; Taggart, Mark/0000-0002-0649-8490	Ministerio de Ciencia e Innovacion (MICINN) [CGL2007-62797]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The analysis done at Instituto de Investigacion en Recursos Cinegeticos (IREC) for this study was funded by Ministerio de Ciencia e Innovacion (MICINN) (http://www.micinn.es/portal/site/MICINN) under CGL2007-62797. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALTROP D, 1975, POSTGRAD MED J, V51, P805; BALTROP D, 1979, ARCH ENVIRON HEALTH, V34, P280; Bjerregaard P, 2004, ENVIRON HEALTH PERSP, V112, P1496, DOI 10.1289/ehp.7083; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; CASTELLINO N, 1995, INORGANIC LEAD EXPOS; CDC, 1975, INCR LEAD ABS LEAD P; *CDC, 1985, PREV LEAD POIS YOUNG; CDC, 2005, PREV LEAD POIS YOUNG; Centers for Disease Control, 1991, PREV LEAD POIS YOUNG; Chandramouli K, 2009, ARCH DIS CHILD, V94, P844, DOI 10.1136/adc.2008.149955; CHISOLM JJ, 1956, PEDIATRICS, V18, P943; COBURN H, 2003, TOT ENV, V54, P275; Coburn HL, 2005, VET REC, V157, P321, DOI 10.1136/vr.157.11.321; Dewailly E, 2001, ARCH ENVIRON HEALTH, V56, P350, DOI 10.1080/00039890109604467; Dobrowolska A, 2008, EUR J WILDLIFE RES, V54, P231, DOI 10.1007/s10344-007-0134-y; EISLER R, 1988, US FISH WILDL SERV B, V85; FRANK A, 1986, SCI TOTAL ENVIRON, V54, P275, DOI 10.1016/0048-9697(86)90272-X; *FSA, 2007, SURV MET VAR FOODS; Haldimann M, 2002, EUR FOOD RES TECHNOL, V215, P375, DOI 10.1007/s00217-002-0581-3; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Iqbal S, 2009, ENVIRON RES, V109, P952, DOI 10.1016/j.envres.2009.08.007; Johansen P, 2004, ENVIRON POLLUT, V127, P125, DOI 10.1016/S0269-7491(03)00255-0; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; Kosnett MJ, 2009, INGESTION LEAD SPENT, P24, DOI DOI 10.4080/ILSA.2009.0103; Landrigan Philip, 2006, Med Lav, V97, P811; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Mateo R, 2007, SCI TOTAL ENVIRON, V372, P480, DOI 10.1016/j.scitotenv.2006.10.022; *MINT INT GROUP LT, 2007, GAM EX MEAT UK FEB 2; Pain Deborah J., 2009, P99, DOI 10.4080/ilsa.2009.0108; PATTEE OH, 1981, J WILDLIFE MANAGE, V45, P806, DOI 10.2307/3808728; *RHM TECHN, 2006, AN ROOT VEG NUTS DRI; Scheuhammer AM, 1998, ENVIRON POLLUT, V102, P251, DOI 10.1016/S0269-7491(98)00083-9; *SCOOP, 2004, 3211 SCOOP; Snow DW, 1998, BIRDS W PALEARCTIC, V1; Tellez-Rojo MM, 2006, PEDIATRICS, V118, pE323, DOI 10.1542/peds.2005-3123; Thomas VG, 2009, SCI TOTAL ENVIRON, V407, P3494, DOI 10.1016/j.scitotenv.2009.02.003; *VENTR TECHN LTD, 2006, SURV LEAD CADM VAR F; *WHO, 2007, 44 WHO; ZIEGLER EE, 1978, PEDIATR RES, V12, P29, DOI 10.1203/00006450-197801000-00008; 2006, OFFICIAL J EURO 1220	41	79	83	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10315	10.1371/journal.pone.0010315	http://dx.doi.org/10.1371/journal.pone.0010315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436670	gold, Green Published			2022-12-25	WOS:000277079500006
J	Chen, YC; Bathula, SR; Li, J; Huang, L				Chen, Yunching; Bathula, Surendar Reddy; Li, Jun; Huang, Leaf			Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; DOWN-REGULATION; GUANIDINO COMPOUNDS; TUMOR-CELLS; C-MYC; SIRNA; OVEREXPRESSION; EXPRESSION; LIPOSOME	Drug resistance is a major challenge to the effective treatment of cancer. We have developed two nanoparticle formulations, cationic liposome-polycation-DNA (LPD) and anionic liposome-polycation-DNA (LPD-II), for systemic co-delivery of doxorubicin (Dox) and a therapeutic small interfering RNA (siRNA) to multiple drug resistance (MDR) tumors. In this study, we have provided four strategies to overcome drug resistance. First, we formed the LPD nanoparticles with a guanidinium-containing cationic lipid, i.e. N,N-distearyl-N-methyl-N-2-(N'-arginyl) aminoethyl ammonium chloride, which can induce reactive oxygen species, down-regulate MDR transporter expression, and increase Dox uptake. Second, to block angiogenesis and increase drug penetration, we have further formulated LPD nanoparticles to co-deliver vascular endothelial growth factor siRNA and Dox. An enhanced Dox uptake and a therapeutic effect were observed when combined with vascular endothelial growth factor siRNA in the nanoparticles. Third, to avoid P-glycoprotein-mediated drug efflux, we further designed another delivery vehicle, LPD-II, which showed much higher entrapment efficiency of Dox than LPD. Finally, we delivered a therapeutic siRNA to inhibit MDR transporter. We demonstrated the first evidence of c-Myc siRNA delivered by the LPD-II nanoparticles down-regulating MDR expression and increasing Dox uptake in vivo. Three daily intravenous injections of therapeutic siRNA and Dox (1.2 mg/kg) co-formulated in either LPD or LPD-II nanoparticles showed a significant improvement in tumor growth inhibition. This study highlights a potential clinical use for the multifunctional nanoparticles with an effective delivery property and a function to overcome drug resistance in cancer. The activity and the toxicity of LPD- and LPD-II-mediated therapy are compared.	[Chen, Yunching; Bathula, Surendar Reddy; Li, Jun; Huang, Leaf] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Chen, YC (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, 1319 Kerr Hall, Chapel Hill, NC 27599 USA.	yunching@email.unc.edu		Chen, Yunching/0000-0001-6228-5169	National Institutes of Health [CA129825]; NATIONAL CANCER INSTITUTE [R01CA129825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA129825.	Almubarak M, 2008, J ONCOL, V2008, DOI 10.1155/2008/942618; BANERJEE S, 1992, CELL MOL BIOL, V38, P561; Cai Y, 2007, CANCER BIOL THER, V6, P1794, DOI 10.4161/cbt.6.11.4860; Calcabrini A, 2000, HISTOCHEM J, V32, P599, DOI 10.1023/A:1026732405381; Chen YC, 2010, MOL THER, V18, P828, DOI 10.1038/mt.2009.291; Chen YC, 2009, MOL PHARMACEUT, V6, P696, DOI 10.1021/mp800136v; Cui ZR, 2005, MOL PHARMACEUT, V2, P22, DOI 10.1021/mp049907k; Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931; GERVASONI JE, 1991, CANCER RES, V51, P4955; Goren D, 2000, CLIN CANCER RES, V6, P1949; GRANDJEANFOREST.F, 2009, ABC TRANSPORTERS MUL, P17; He Y, 2000, CHINESE MED J-PEKING, V113, P848; Hiramatsu M, 2003, MOL CELL BIOCHEM, V244, P57, DOI 10.1023/A:1022491419813; Hollo Z, 1996, FEBS LETT, V383, P99, DOI 10.1016/0014-5793(96)00237-2; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Lee RJ, 1996, J BIOL CHEM, V271, P8481, DOI 10.1074/jbc.271.14.8481; Mishima Y, 2002, J NATL CANCER I, V94, P1020; MORI A, 1987, PAVLOVIAN J BIOL SCI, V22, P85; Nakahara T, 2006, CANCER RES, V66, P1434, DOI 10.1158/0008-5472.CAN-05-0923; Nakamura Y, 2006, INT J CANCER, V118, P2448, DOI 10.1002/ijc.21691; Puhlmann U, 2005, J PHARMACOL EXP THER, V312, P346, DOI 10.1124/jpet.104.071571; Shah N, 2009, J DRUG TARGET, V17, P533, DOI 10.1080/10611860903046628; Shen Y, 2008, IDRUGS, V11, P572; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; TSURUO T, 1981, J ANTIBIOT, V34, P1206, DOI 10.7164/antibiotics.34.1206; Vlahovic G, 2007, BRIT J CANCER, V97, P735, DOI 10.1038/sj.bjc.6603941; Wartenberg M, 2001, J BIOL CHEM, V276, P17420, DOI 10.1074/jbc.M100141200; Xu DH, 2008, PHARMAZIE, V63, P646, DOI 10.1691/ph.2008.8082; Yan WL, 2007, MOL IMMUNOL, V44, P3672, DOI 10.1016/j.molimm.2007.04.009	30	195	205	4	113	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22639	22650		10.1074/jbc.M110.125906	http://dx.doi.org/10.1074/jbc.M110.125906			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460382	Green Published, hybrid			2022-12-25	WOS:000279702200074
J	Shinohara, M; Sato, N; Kurinami, H; Takeuchi, D; Takeda, S; Shimamura, M; Yamashita, T; Uchiyama, Y; Rakugi, H; Morishita, R				Shinohara, Mitsuru; Sato, Naoyuki; Kurinami, Hitomi; Takeuchi, Daisuke; Takeda, Shuko; Shimamura, Munehisa; Yamashita, Toshihide; Uchiyama, Yasuo; Rakugi, Hiromi; Morishita, Ryuichi			Reduction of Brain beta-Amyloid (A beta) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and A beta Clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-1; GAMMA-SECRETASE INHIBITOR; ALZHEIMERS-DISEASE; IN-VITRO; EFFLUX TRANSPORT; ALPHA-SECRETASE; STATIN THERAPY; PEPTIDE; ACCUMULATION; SIMVASTATIN	Epidemiological studies suggest that statins (hydroxymethylglutaryl-CoA reductase inhibitors) could reduce the risk of Alzheimer disease. Although one possible explanation is through an effect on beta-amyloid (A beta) metabolism, its effect remains to be elucidated. Here, we explored the molecular mechanisms of how statins influence A beta metabolism. Fluvastatin at clinical doses significantly reduced A beta and amyloid precursor protein C-terminal fragment (APP-CTF) levels among APP metabolites in the brain of C57BL/6 mice. Chronic intracerebroventricular infusion of lysosomal inhibitors blocked these effects, indicating that up-regulation of the lysosomal degradation of endogenous APP-CTFs is involved in reduced A beta production. Biochemical analysis suggested that this was mediated by enhanced trafficking of APP-CTFs from endosomes to lysosomes, associated with marked changes of Rab proteins, which regulate endosomal function. In primary neurons, fluvastatin enhanced the degradation of APP-CTFs through an isoprenoid-dependent mechanism. Because our previous study suggests additive effects of fluvastatin on A beta metabolism, we examined A beta clearance rates by using the brain efflux index method and found its increased rates at high A beta levels from brain. As LRP1 in brain microvessels was increased, up-regulation of LRP1-mediated A beta clearance at the blood-brain barrier might be involved. In cultured brain microvessel endothelial cells, fluvastatin increased LRP1 and the uptake of A beta, which was blocked by LRP1 antagonists, through an isoprenoid-dependent mechanism. Overall, the present study demonstrated that fluvastatin reduced A beta level by an isoprenoid-dependent mechanism. These results have important implications for the development of disease-modifying therapy for Alzheimer disease as well as understanding of A beta metabolism.	[Shinohara, Mitsuru; Sato, Naoyuki; Kurinami, Hitomi; Takeuchi, Daisuke; Takeda, Shuko; Shimamura, Munehisa; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka 5650871, Japan; [Shinohara, Mitsuru; Sato, Naoyuki; Kurinami, Hitomi; Takeuchi, Daisuke; Takeda, Shuko; Shimamura, Munehisa; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Suita, Osaka 5650871, Japan; [Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka 5650871, Japan; [Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo 1138421, Japan	Osaka University; Osaka University; Osaka University; Juntendo University	Morishita, R (corresponding author), 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	morishit@cgt.med.osaka-u.ac.jp		Rakugi, Hiromi/0000-0001-6508-4338; Yamashita, Toshihide/0000-0003-4559-7018	Japan Promotion of Science; Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Agency; Takeda Science Foundation; Novartis Pharma AG; Chiyoda; Kanae Foundation	Japan Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novartis Pharma AG; Chiyoda; Kanae Foundation	This work was supported in part by grants-in-aid from Japan Promotion of Science, the Japanese Ministry of Education, Culture, Sports, Science and Technology (to R. M. and N. S.), the Japan Science and Technology Agency (to N. S.), the Takeda Science Foundation (to R. M.), Novartis Pharma AG, Chiyoda, and the Kanae Foundation (to N. S.).	Akanuma SI, 2008, NEUROCHEM INT, V52, P956, DOI 10.1016/j.neuint.2007.12.002; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Burns A, 2009, LANCET NEUROL, V8, P4, DOI 10.1016/S1474-4422(08)70271-0; Burns MP, 2006, NEUROMOL MED, V8, P319, DOI 10.1385/NMM:8:3:319; Chauhan NB, 2004, NEUROCHEM RES, V29, P1897, DOI 10.1023/B:NERE.0000042217.90204.8d; Cole SL, 2005, J BIOL CHEM, V280, P18755, DOI 10.1074/jbc.M413895200; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Eckert GP, 2009, NEUROBIOL DIS, V35, P251, DOI 10.1016/j.nbd.2009.05.005; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Gauthier SA, 2012, METHODS MOL BIOL, V849, P261, DOI 10.1007/978-1-61779-551-0_18; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Guardia-Laguarta C, 2009, J NEUROCHEM, V110, P220, DOI 10.1111/j.1471-4159.2009.06126.x; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Hellstrom-Lindahl E, 2009, NEUROCHEM INT, V55, P243, DOI 10.1016/j.neuint.2009.03.007; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Ito S, 2006, NEUROSCI RES, V56, P246, DOI 10.1016/j.neures.2006.07.006; IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kakee A, 1996, J PHARMACOL EXP THER, V277, P1550; Kandiah N, 2009, J NEUROL SCI, V283, P230, DOI 10.1016/j.jns.2009.02.352; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kurinami H, 2008, INT J MOL MED, V21, P531; Lanz TA, 2003, J PHARMACOL EXP THER, V305, P864, DOI 10.1124/jpet.102.048280; Li G, 2004, NEUROLOGY, V63, P1624, DOI 10.1212/01.WNL.0000142963.90204.58; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Masters CL, 2006, BRAIN, V129, P2823, DOI 10.1093/brain/awl251; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003160.pub2; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Morishita R, 2002, CURR DRUG TARGETS, V3, P379, DOI 10.2174/1389450023347434; Nazer B, 2008, NEUROBIOL DIS, V30, P94, DOI 10.1016/j.nbd.2007.12.005; Nishitomi K, 2006, J NEUROCHEM, V99, P1555, DOI 10.1111/j.1471-4159.2006.04178.x; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; Park IH, 2003, NEUROBIOL AGING, V24, P637, DOI 10.1016/S0197-4580(02)00155-0; Parsons RB, 2006, BIOCHEM J, V399, P205, DOI 10.1042/BJ20060655; Parvathy S, 2004, J NEUROCHEM, V90, P1005, DOI 10.1111/j.1471-4159.2004.02521.x; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Petanceska SS, 2002, J MOL NEUROSCI, V19, P155, DOI 10.1007/s12031-002-0026-2; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Roensch J, 2007, NEUROCHEM INT, V50, P800, DOI 10.1016/j.neuint.2007.02.001; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Schmidt Stephen D., 2004, V299, P279; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Shiiki T, 2004, J NEUROSCI, V24, P9632, DOI 10.1523/JNEUROSCI.2236-04.2004; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tabaton M, 2005, INT J EXP PATHOL, V86, P139, DOI 10.1111/j.0959-9673.2005.00428.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TAKEI N, 1994, BRAIN RES, V652, P65, DOI 10.1016/0006-8993(94)90317-4; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Won JS, 2008, J NEUROCHEM, V105, P1536, DOI 10.1111/j.1471-4159.2008.05283.x; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yamada K, 2008, J BIOL CHEM, V283, P34554, DOI 10.1074/jbc.M801487200; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176; Zhou Y, 2008, FASEB J, V22, P47, DOI 10.1096/fj.07-8175com; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	62	85	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22091	22102		10.1074/jbc.M110.102277	http://dx.doi.org/10.1074/jbc.M110.102277			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472556	Green Published, hybrid			2022-12-25	WOS:000279702200022
J	Wong, VSC; Yeung, A; Schultz, W; Brubaker, PL				Wong, Victor S. C.; Yeung, Andrea; Schultz, William; Brubaker, Patricia L.			R-spondin-1 Is a Novel beta-Cell Growth Factor and Insulin Secretagogue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; PROTEIN-KINASE; BINDING-PROTEIN; WNT; EXPRESSION; GLUCOSE; CATENIN; ACTIVATION; APOPTOSIS; PROLIFERATION	R-spondin-1 (Rspo1) is an intestinal growth factor known to exert its effects through activation of the canonical Wnt (cWnt) signaling pathway and subsequent expression of cWnt target genes. We have detected Rspo1 mRNA in murine islets and the murine MIN6 and beta TC beta-cell lines, and Rspo1 protein in MIN6 beta-cells. Rspo1 activated cWnt signaling in MIN6 beta-cells by increasing nuclear beta-catenin and c-myc, a cWnt target gene. Rspo1 also induced insulin mRNA expression in MIN6 cells. Analysis of MIN6 and mouse beta-cell proliferation by [H-3]thymidine and BrdU incorporation, respectively, revealed that Rspo1 stimulated cell growth. Incubation of MIN6 and mouse beta-cells with cytokines (IL1 beta/TNF alpha/interferon-gamma) significantly increased cellular apoptosis; this increase was abolished by pretreatment with Rspo1. Rspo1 also stimulated insulin secretion in a glucose-independent fashion. We further demonstrated that the glucagon-like peptide-1 receptor agonist, exendin4 (EX4), stimulated Rspo1 mRNA transcript levels in MIN6 cells in a glucose-, time-, dose-, and PI3-kinase-dependent fashion. This effect was not limited to this beta-cell line, as similar time-dependent increases in Rspo1 were also observed in the beta TC beta-cell line and mouse islets in response to EX4 treatment. Together, these studies demonstrate that Rspo1 is a novel beta-cell growth factor and insulin secretagogue that is regulated by EX4. These findings suggest that Rspo1 and the cWnt signaling pathway may serve as a novel target to enhance beta-cell growth and function in patients with type 2 diabetes.	[Wong, Victor S. C.; Yeung, Andrea; Schultz, William; Brubaker, Patricia L.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Brubaker, Patricia L.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Brubaker, PL (corresponding author), Univ Toronto, Dept Physiol, Rm 3366 Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	p.brubaker@utoronto.ca	Wong, Victor/I-7722-2019	Wong, Victor/0000-0003-1415-2825	Canadian Diabetes Association [2374]; Banting and Best Diabetes Centre (BBDC), University of Toronto; Ontario Graduate program; Canadian Institutes of Health Research; Canada Research Chairs program; University of Toronto	Canadian Diabetes Association; Banting and Best Diabetes Centre (BBDC), University of Toronto(University of Toronto); Ontario Graduate program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); University of Toronto(University of Toronto)	This work was supported by an operating grant from the Canadian Diabetes Association (2374) and by an equipment grant from the Banting and Best Diabetes Centre (BBDC), University of Toronto.; Supported by graduate studentships from BBDC, Ontario Graduate program, Canadian Institutes of Health Research and Paul and Sally Wang (University of Toronto).; Supported by BBDC Summer Studentships, University of Toronto.; Supported by the Canada Research Chairs program. To whom correspondence should be addressed: Rm. 3366 Medical Sciences Bldg., University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. Tel./Fax: 416-978-2593; E-mail: p. brubaker@utoronto.ca.	Arnette D, 2003, J BIOL CHEM, V278, P32517, DOI 10.1074/jbc.M301174200; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen YJ, 2004, INT J DEV BIOL, V48, P867, DOI 10.1387/ijdb.041882yc; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Ding WG, 1997, DIABETES, V46, P792, DOI 10.2337/diabetes.46.5.792; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Everly DN, 2004, J VIROL, V78, P11648, DOI 10.1128/JVI.78.21.11648-11655.2004; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Heller RS, 2002, DEV DYNAM, V225, P260, DOI 10.1002/dvdy.10157; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hussain MA, 2006, MOL CELL BIOL, V26, P7747, DOI 10.1128/MCB.02353-05; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kemp DM, 2001, ENDOCRINOLOGY, V142, P1179, DOI 10.1210/en.142.3.1179; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Krutzfeldt J, 2010, DIABETOLOGIA, V53, P123, DOI 10.1007/s00125-009-1578-2; Lee SH, 2008, EXP DIABETES RES, DOI 10.1155/2008/728763; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; Liu Z, 2009, DIABETOLOGIA, V52, P1589, DOI 10.1007/s00125-009-1384-x; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Loder MK, 2008, BIOCHEM SOC T, V36, P357, DOI 10.1042/BST0360357; Lyu J, 2003, J BIOL CHEM, V278, P13487, DOI 10.1074/jbc.M300591200; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Martens GA, 2009, VITAM HORM, V80, P507, DOI 10.1016/S0083-6729(08)00617-1; Mawson A, 2005, MOL CELL ENDOCRINOL, V229, P161, DOI 10.1016/j.mce.2004.08.002; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Mohamed OA, 2004, BIOL REPROD, V71, P417, DOI 10.1095/biolreprod.103.025692; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nam JS, 2007, GENE EXPR PATTERNS, V7, P306, DOI 10.1016/j.modgep.2006.08.006; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Papadopoulou S, 2005, DIABETES, V54, P2844, DOI 10.2337/diabetes.54.10.2844; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pigeau GM, 2009, DIABETES, V58, P2084, DOI 10.2337/db08-1371; Ranheim EA, 2005, BLOOD, V105, P2487, DOI 10.1182/blood-2004-06-2334; Rhee CS, 2002, ONCOGENE, V21, P6598, DOI 10.1038/sj.onc.1205920; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Schinner S, 2008, DIABETOLOGIA, V51, P147, DOI 10.1007/s00125-007-0848-0; Strovel ET, 1999, EXP CELL RES, V253, P637, DOI 10.1006/excr.1999.4700; Stump RJW, 2003, DEV BIOL, V259, P48, DOI 10.1016/S0012-1606(03)00179-9; Torii K, 2008, CELL SIGNAL, V20, P1256, DOI 10.1016/j.cellsig.2008.02.013; Trumper J, 2005, DIABETOLOGIA, V48, P1534, DOI 10.1007/s00125-005-1820-5; Vasavada RC, 2006, INT J BIOCHEM CELL B, V38, P931, DOI 10.1016/j.biocel.2005.08.003; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wang Q, 2004, DIABETOLOGIA, V47, P478, DOI 10.1007/s00125-004-1327-5; Wang XL, 2001, ENDOCRINOLOGY, V142, P1820, DOI 10.1210/en.142.5.1820; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Yun SI, 2009, APOPTOSIS, V14, P771, DOI 10.1007/s10495-009-0348-4	66	20	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21292	21302		10.1074/jbc.M110.129874	http://dx.doi.org/10.1074/jbc.M110.129874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442404	Green Published, hybrid			2022-12-25	WOS:000279516100014
J	Zhou, M; Liu, ZX; Zhao, YH; Ding, Y; Liu, H; Xi, YG; Xiong, W; Li, GY; Lu, JR; Fodstad, O; Riker, AI; Tan, M				Zhou, Ming; Liu, Zixing; Zhao, Yuhua; Ding, Yan; Liu, Hao; Xi, Yaguang; Xiong, Wei; Li, Guiyuan; Lu, Jianrong; Fodstad, Oystein; Riker, Adam I.; Tan, Ming			MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; LACTATE-DEHYDROGENASE; TAXOL; OVARIAN; PROLIFERATION; DEREGULATION; METASTASIS; SIGNATURES; MIR-125B; MIR-222	Paclitaxel (Taxol) is an effective chemotherapeutic agent for treatment of cancer patients. Despite impressive initial clinical responses, the majority of patients eventually develop some degree of resistance to Taxol-based therapy. The mechanisms underlying cancer cells resistance to Taxol are not fully understood. MicroRNA (miRNA) has emerged to play important roles in tumorigenesis and drug resistance. However, the interaction between the development of Taxol resistance and miRNA has not been previously explored. In this study we utilized a miRNA array to compare the differentially expressed miRNAs in Taxol-resistant and their Taxol-sensitive parental cells. We verified that miR-125b, miR-221, miR-222, and miR-923 were up-regulated in Taxol-resistant cancer cells by real-time PCR. We further investigated the role and mechanisms of miR-125b in Taxol resistance. We found that miR-125b was up-regulated in Taxol-resistant cells, causing a marked inhibition of Taxol-induced cytotoxicity and apoptosis and a subsequent increase in the resistance to Taxol in cancer cells. Moreover, we demonstrated that the pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) is a direct target of miR-125b. Down-regulation of Bak1 suppressed Taxol-induced apoptosis and led to an increased resistance to Taxol. Restoring Bak1 expression by either miR-125b inhibitor or re-expression of Bak1 in miR-125b-overexpressing cells recovered Taxol sensitivity, overcoming miR-125-mediated Taxol resistance. Taken together, our data strongly support a central role for miR-125b in conferring Taxol resistance through the suppression of Bak1 expression. This finding has important implications in the development of targeted therapeutics for overcoming Taxol resistance in a number of different tumor histologies.	[Zhou, Ming; Liu, Zixing; Zhao, Yuhua; Ding, Yan; Liu, Hao; Xi, Yaguang; Fodstad, Oystein; Tan, Ming] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Tan, Ming] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36604 USA; [Zhou, Ming; Xiong, Wei; Li, Guiyuan] Cent S Univ, Canc Res Inst, Changsha 410008, Hunan, Peoples R China; [Fodstad, Oystein] Norwegian Radium Hosp, Inst Canc Res, N-0310 Oslo, Norway; [Lu, Jianrong] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Riker, Adam I.] Ochsner Hlth Syst, Ochsner Canc Inst, New Orleans, LA 70121 USA	University of South Alabama; University of South Alabama; Central South University; University of Oslo; State University System of Florida; University of Florida; Ochsner Health System	Tan, M (corresponding author), 1660 Spring Hill Ave, Mobile, AL 36604 USA.	mtan@usouthal.edu	Tan, Ming/ABD-5847-2021; Zhao, Yuhua/H-3210-2013; Xie, Huangming/B-2260-2012; Lu, Jianrong/F-5240-2013	Tan, Ming/0000-0003-2007-9898; Zhao, Yuhua/0000-0002-4060-631X; Xi, Yaguang/0000-0003-3681-9352; Lu, Jianrong/0000-0002-4969-6040	Cancer Research Foundation; Norwegian Radiumhospitalet Legater [334003]	Cancer Research Foundation; Norwegian Radiumhospitalet Legater	This work was supported by the Vincent F. Kilborn, Jr., Cancer Research Foundation (to M. T.) and The Norwegian Radiumhospitalet Legater (Project 334003, to M. T. and O.F.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; CHEN LP, 1995, GYNECOL ONCOL, V56, P231; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Henley D, 2007, CANCER CHEMOTH PHARM, V59, P235, DOI 10.1007/s00280-006-0262-1; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lu J, 2009, CLIN CANCER RES, V15, P1326, DOI 10.1158/1078-0432.CCR-08-0954; Martello LA, 2003, CANCER RES, V63, P1207; Mohri T, 2009, INT J CANCER, V125, P1328, DOI 10.1002/ijc.24459; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Ofir R, 2002, CELL DEATH DIFFER, V9, P636, DOI 10.1038/sj.cdd.4401012; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Tan M, 2002, MOL CELL, V9, P993, DOI 10.1016/S1097-2765(02)00510-5; Tan M, 2007, ADV EXP MED BIOL, V608, P119; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367; Wu WL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj015; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	56	326	343	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21496	21507		10.1074/jbc.M109.083337	http://dx.doi.org/10.1074/jbc.M109.083337			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20460378	hybrid, Green Published			2022-12-25	WOS:000279516100036
J	Kalastavadi, T; True, HL				Kalastavadi, Tejas; True, Heather L.			Analysis of the [RNQ(+)] Prion Reveals Stability of Amyloid Fibers as the Key Determinant of Yeast Prion Variant Propagation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN GENE; PSI+ PRION; TRANSLATION TERMINATION; SPECIES BARRIERS; PIN+; URE3; CONFORMATIONS; DISEASES; STRAINS	Variation in pathology of human prion disease is believed to be caused, in part, by distinct conformations of aggregated protein resulting in different prion strains. Several prions also exist in yeast and maintain different self-propagating structures, referred to as prion variants. Investigation of the yeast prion [PSI+] has been instrumental in deciphering properties of prion variants and modeling the physical basis of their formation. Here, we describe the generation of specific variants of the [RNQ(+)] prion in yeast transformed with fibers formed in vitro in different conditions. The fibers of the Rnq1p prion-forming domain (PFD) that induce different variants in vivo have distinct biochemical properties. The physical basis of propagation of prion variants has been previously correlated to rates of aggregation and disaggregation. With [RNQ(+)] prion variants, we found that the prion variant does not correlate with the rate of aggregation as anticipated but does correlate with stability. Interestingly, we found that there are differences in the ability of the [RNQ(+)] prion variants to faithfully propagate themselves and to template the aggregation of other proteins. Incorporating the mechanism of variant formation elucidated in this study with that previously proposed for [PSI+] variants has provided a framework to separate general characteristics of prion variant properties from those specific to individual prion proteins.	[Kalastavadi, Tejas; True, Heather L.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63108 USA	Washington University (WUSTL)	True, HL (corresponding author), 660 S Euclid Ave,Box 8228, St Louis, MO 63108 USA.	heather.true@wustl.edu	True, Heather/D-2979-2012		National Institutes of Health [GM072228]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM072228 (to H. L. T.) and the National Science Foundation.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bardill JP, 2009, PRION, V3, P151, DOI 10.4161/pri.3.3.9662; Bardill JP, 2009, J MOL BIOL, V388, P583, DOI 10.1016/j.jmb.2009.03.036; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Croes EA, 2004, J NEUROL NEUROSUR PS, V75, P1166, DOI 10.1136/jnnp.2003.020198; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Edskes HK, 2009, GENETICS, V181, P1159, DOI 10.1534/genetics.108.099929; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; King A, 2003, NEUROPATH APPL NEURO, V29, P98, DOI 10.1046/j.1365-2990.2003.00423.x; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nemecek J, 2009, P NATL ACAD SCI USA, V106, P1892, DOI 10.1073/pnas.0812470106; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Resende CG, 2003, MOL MICROBIOL, V49, P1005, DOI 10.1046/j.1365-2958.2003.03608.x; Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Vitrenko YA, 2007, CURR GENET, V51, P309, DOI 10.1007/s00294-007-0127-0; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	57	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20748	20755		10.1074/jbc.M110.115303	http://dx.doi.org/10.1074/jbc.M110.115303			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20442412	hybrid, Green Published			2022-12-25	WOS:000279228600039
J	Huang, PY; Huang, CT; Tsao, KC; Ye, JJ; Shie, SS; Yang, MY; Leu, HS; Chiang, PC; Weng, YC				Huang, Po-Yen; Huang, Ching-Tai; Tsao, Kuo-Chien; Ye, Jung-Jr; Shie, Shian-Sen; Yang, Ming-Yi; Leu, Hsieh-Shong; Chiang, Ping-Cherng; Weng, Yin-Che			Syndromic Recognition of Influenza A Infection in a Low Prevalence Community Setting	PLOS ONE			English	Article							CLINICAL-DIAGNOSIS; VIRUS	Background: With epidemics of influenza A virus infection, people and medical professionals are all concerned about symptoms or syndromes that may indicate the infection with influenza A virus. Methodology/Principal Findings: A prospective study was performed at a community clinic of a metropolitan area. Throat swab was sampled for 3-6 consecutive adult patients with new episode (< 3 days) of respiratory tract infection every weekday from Dec. 8, 2005 to Mar. 31, 2006. Demographic data, relevant history, symptoms and signs were recorded. Samples were processed with multiplex real time PCR for 9 common respiratory tract pathogens and by virus culture. Throat swab samples were positive for Influenza A virus with multiplex real time PCR system in 12 of 240 patients. The 12 influenza A positive cases were with more clusters and chills than the other 228. Certain symptoms and syndromes increased the likelihood of influenza A virus infection. The syndrome of high fever plus chills plus cough, better with clustering of cases in household or workplace, is with the highest likelihood (positive likelihood ratio 95; 95% CI 12-750). Absence of both cluster and chills provides moderate evidence against the infection (negative likelihood ratio 0.51; 95% CI 0.29-0.90). Conclusions/Significance: Syndromic recognition is not diagnostic but is useful for discriminating between influenza A infection and common cold. In addition to relevant travel history, confirmatory molecular test can be applied to subjects with high likelihood when the disease prevalence is low.	[Huang, Po-Yen; Huang, Ching-Tai; Ye, Jung-Jr; Shie, Shian-Sen; Yang, Ming-Yi; Leu, Hsieh-Shong; Chiang, Ping-Cherng] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med, Div Infect Dis, Tao Yuan, Taiwan; [Huang, Ching-Tai; Leu, Hsieh-Shong] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan; [Tsao, Kuo-Chien] Chang Gung Univ, Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan; [Tsao, Kuo-Chien] Chang Gung Univ, Dept Biotechnol & Lab Sci, Res Ctr Emerging Viral Infect, Tao Yuan, Taiwan; [Weng, Yin-Che] Min Shen Weng Community Clin, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Huang, PY (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Med, Div Infect Dis, Tao Yuan, Taiwan.	chingtaihuang@gmail.com	Chuang, shengHao/C-8217-2012		Chang Gung Memorial Hospital in Taiwan [CMRPG3201S, CMRPG370861, CMRP 350331]; National Science Council of Taiwan [NMRPG370061]	Chang Gung Memorial Hospital in Taiwan(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported in part by grants from the Chang Gung Memorial Hospital in Taiwan (number CMRPG3201S, CMRPG370861 and CMRP 350331) and from the National Science Council of Taiwan (number NMRPG370061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; *CDC, CDC FLU ACT SURV; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Govaert TME, 1998, FAM PRACT, V15, P16, DOI 10.1093/fampra/15.1.16; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; van Elden LJR, 2001, BRIT J GEN PRACT, V51, P630	11	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10542	10.1371/journal.pone.0010542	http://dx.doi.org/10.1371/journal.pone.0010542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479882	Green Submitted, Green Published, gold			2022-12-25	WOS:000277467800023
J	Hofmann, T; Chubanov, V; Chen, XD; Dietz, AS; Gudermann, T; Montell, C				Hofmann, Thomas; Chubanov, Vladimir; Chen, Xiaodi; Dietz, Anna S.; Gudermann, Thomas; Montell, Craig			Drosophila TRPM Channel Is Essential for the Control of Extracellular Magnesium Levels	PLOS ONE			English	Article							X-RAY-MICROANALYSIS; MG2+ HOMEOSTASIS; SECONDARY HYPOCALCEMIA; RECEPTOR-CELLS; HYPOMAGNESEMIA; IDENTIFICATION; MELANOGASTER; HEMOLYMPH; TRANSPORT; CALCIUM	The TRPM group of cation channels plays diverse roles ranging from sensory signaling to Mg(2+) homeostasis. In most metazoan organisms the TRPM subfamily is comprised of multiple members, including eight in humans. However, the Drosophila TRPM subfamily is unusual in that it consists of a single member. Currently, the functional requirements for this channel have not been reported. Here, we found that the Drosophila TRPM protein was expressed in the fly counterpart of mammalian kidneys, the Malpighian tubules, which function in the removal of electrolytes and toxic components from the hemolymph. We generated mutations in trpm and found that this resulted in shortening of the Malpighian tubules. In contrast to all other Drosophila trp mutations, loss of trpm was essential for viability, as trpm mutations resulted in pupal lethality. Supplementation of the diet with a high concentration of Mg(2+) exacerbated the phenotype, resulting in growth arrest during the larval period. Feeding high Mg(2+) also resulted in elevated Mg(2+) in the hemolymph, but had relatively little effect on cellular Mg(2+). We conclude that loss of Drosophila trpm leads to hypermagnesemia due to a defect in removal of Mg(2+) from the hemolymph. These data provide the first evidence for a role for a Drosophila TRP channel in Mg(2+) homeostasis, and underscore a broad and evolutionarily conserved role for TRPM channels in Mg(2+) homeostasis.	[Hofmann, Thomas; Chen, Xiaodi; Dietz, Anna S.] Univ Marburg, Inst Pharmakol & Toxikol, D-3550 Marburg, Germany; [Chubanov, Vladimir; Gudermann, Thomas] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-8000 Munich, Germany; [Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Philipps University Marburg; University of Munich; Johns Hopkins University; Johns Hopkins University	Hofmann, T (corresponding author), Univ Marburg, Inst Pharmakol & Toxikol, D-3550 Marburg, Germany.	cmontell@jhmi.edu	Montell, Craig/AAH-3357-2021; Chen, Xiaodi/C-9969-2013	Montell, Craig/0000-0001-5637-1482; Chen, Xiaodi/0000-0002-1860-2814	Deutsche Forschungsgemeinschaft; National Eye Institute [EY10852]; National Institute of General Medical Sciences [GM085335]; NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085335] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T. H., X. C. and A. D. were supported by a grant to T. H. from the Emmy-Noether-Programm of the Deutsche Forschungsgemeinschaft. V. C. and T. G. were supported by the Deutsche Forschungsgemeinschaft, and C. M. was supported by grants from the National Eye Institute (EY10852) and the National Institute of General Medical Sciences (GM085335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAM ME, 1978, BIOCHEM GENET, V16, P101, DOI 10.1007/BF00484387; DIRSCHERL W, 1953, MIKROCHEM MIKROCHIM, V40, P322; Dow JAT, 2003, PHYSIOL REV, V83, P687, DOI 10.1152/physrev.00035.2002; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; LEARY NO, 1992, CLIN CHEM, V38, P904; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACK SR, 1978, J PARASITOL, V64, P918, DOI 10.2307/3279531; MacPherson MR, 2005, GENETICS, V169, P1541, DOI 10.1534/genetics.104.035139; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2003, CURR BIOL, V13, pR799, DOI 10.1016/j.cub.2003.09.048; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Pollock VP, 2003, J EXP BIOL, V206, P901, DOI 10.1242/jeb.00189; Quamme GA, 2008, CURR OPIN GASTROEN, V24, P230, DOI 10.1097/MOG.0b013e3282f37b59; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; REICHHART JM, 1998, DROS INFO SERV, V81, P201; Romani A, 2007, ARCH BIOCHEM BIOPHYS, V458, P90, DOI 10.1016/j.abb.2006.07.012; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Teramoto T, 2005, CELL METAB, V1, P343, DOI 10.1016/j.cmet.2005.04.007; Teramoto T, 2010, PLOS ONE, V5, pA228, DOI 10.1371/journal.pone.0009589; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wessing A, 1999, J INSECT PHYSIOL, V45, P39, DOI 10.1016/S0022-1910(98)00097-3; WESSING A, 1988, EUR J CELL BIOL, V47, P1; Woudenberg-Vrenken TE, 2009, NAT REV NEPHROL, V5, P441, DOI 10.1038/nrneph.2009.100; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	29	36	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10519	10.1371/journal.pone.0010519	http://dx.doi.org/10.1371/journal.pone.0010519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463899	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379800013
J	Hinz, A; Hulsik, DL; Forsman, A; Koh, WWL; Belrhali, H; Gorlani, A; de Haard, H; Weiss, RA; Verrips, T; Weissenhorn, W				Hinz, Andreas; Hulsik, David Lutje; Forsman, Anna; Koh, Willie Wee-Lee; Belrhali, Hassan; Gorlani, Andrea; de Haard, Hans; Weiss, Robin A.; Verrips, Theo; Weissenhorn, Winfried			Crystal Structure of the Neutralizing Llama V-HH D7 and Its Mode of HIV-1 gp120 Interaction	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; CD4 BINDING-SITE; PROXIMAL EXTERNAL REGION; FUSION INHIBITOR T-20; ENVELOPE GLYCOPROTEIN; SACCHAROMYCES-CEREVISIAE; MEMBRANE-FUSION; HEAVY-CHAIN; GP41	HIV-1 entry into host cells is mediated by the sequential binding of the envelope glycoprotein gp120 to CD4 and a chemokine receptor. Antibodies binding to epitopes overlapping the CD4-binding site on gp120 are potent inhibitors of HIV entry, such as the llama heavy chain antibody fragment V-HH D7, which has cross-clade neutralizing properties and competes with CD4 and mAb b12 for high affinity binding to gp120. We report the crystal structure of the D7 V-HH at 1.5 angstrom resolution, which reveals the molecular details of the complementarity determining regions (CDR) and substantial flexibility of CDR3 that could facilitate an induced fit interaction with gp120. Structural comparison of CDRs from other CD4 binding site antibodies suggests diverse modes of interaction. Mutational analysis identified CDR3 as a key component of gp120 interaction as determined by surface plasmon resonance. A decrease in affinity is directly coupled to the neutralization efficiency since mutations that decrease gp120 interaction increase the IC50 required for HIV-1 IIIB neutralization. Thus the structural study identifies the long CDR3 of D7 as the key determinant of interaction and HIV-1 neutralization. Furthermore, our data confirm that the structural plasticity of gp120 can accommodate multiple modes of antibody binding within the CD4 binding site.	[Hinz, Andreas; Hulsik, David Lutje; Belrhali, Hassan; Weissenhorn, Winfried] Univ Grenoble 1, CNRS, EMBL, UVHCI,UMI 3265, Grenoble, France; [Hulsik, David Lutje; Gorlani, Andrea; de Haard, Hans; Verrips, Theo] Univ Utrecht, Dept Cellular Architecture & Dynam, Utrecht, Netherlands; [Forsman, Anna; Koh, Willie Wee-Lee; Weiss, Robin A.] UCL, Ctr Med Mol Virol, MRC, Div Infect & Immun, London, England	Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Utrecht University; University of London; University College London	Hinz, A (corresponding author), Univ Grenoble 1, CNRS, EMBL, UVHCI,UMI 3265, Grenoble, France.	weissenhorn@embl.fr	gorlani, andrea/C-5678-2014		Bill and Melinda Gates Foundation; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was conducted as part of the Collaboration for AIDS Vaccine Discovery with support from the Bill and Melinda Gates Foundation (to W. W., R. A. W. and T. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAGLEY J, 1994, MOL IMMUNOL, V31, P1149, DOI 10.1016/0161-5890(94)90029-9; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; *CCP4, 1994, ACTA CRYSTALLOGR D, V50, P157; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; Clapham PR, 2002, J GEN VIROL, V83, P1809, DOI 10.1099/0022-1317-83-8-1809; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; DSouza MP, 1997, J INFECT DIS, V175, P1056, DOI 10.1086/516443; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LESLIE AG, 1992, JNT CCP4 ESF EACMB N, V26; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Litwin V, 1996, J VIROL, V70, P6437, DOI 10.1128/JVI.70.9.6437-6441.1996; Lopes TS, 1996, YEAST, V12, P467, DOI 10.1002/(SICI)1097-0061(199604)12:5<467::AID-YEA933>3.0.CO;2-3; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOORE JP, 1994, J VIROL, V68, P8350, DOI 10.1128/JVI.68.12.8350-8364.1994; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; PANCERA M, 2009, P NATL ACAD SCI US; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POSNER MR, 1993, J ACQ IMMUN DEF SYND, V6, P7; Prabakaran P, 2006, J MOL BIOL, V357, P82, DOI 10.1016/j.jmb.2005.12.062; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sattentau Q, 2008, CURR OPIN HIV AIDS, V3, P368, DOI 10.1097/COH.0b013e3282f9ae79; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van de Laar T, 2007, BIOTECHNOL BIOENG, V96, P483, DOI 10.1002/bit.21150; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Wilkinson RA, 2005, J VIROL, V79, P13060, DOI 10.1128/JVI.79.20.13060-13069.2005; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zhang MY, 2003, J IMMUNOL METHODS, V283, P17, DOI 10.1016/j.jim.2003.07.003; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zwick MB, 2004, J VIROL, V78, P3155, DOI 10.1128/JVI.78.6.3155-3161.2004; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	58	25	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10482	10.1371/journal.pone.0010482	http://dx.doi.org/10.1371/journal.pone.0010482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463957	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379400018
J	Mailhot, G; Rabasa-Lhoret, R; Moreau, A; Berthiaume, Y; Levy, E				Mailhot, Genevieve; Rabasa-Lhoret, Remi; Moreau, Alain; Berthiaume, Yves; Levy, Emile			CFTR Depletion Results in Changes in Fatty Acid Composition and Promotes Lipogenesis in Intestinal Caco 2/15 Cells	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; INSULIN-RESISTANCE; BINDING PROTEIN; LIPID-SYNTHESIS; APOLIPOPROTEIN BIOGENESIS; CHOLESTEROL ABSORPTION; KNOCKOUT MICE; ANIMAL-MODEL	Background: Abnormal fatty acid composition (FA) in plasma and tissue lipids frequently occurs in homozygous and even in heterozygous carriers of cystic fibrosis transmembrane conductance regulator (CFTR) mutations. The mechanism(s) underlying these abnormalities remained, however, poorly understood despite the potentially CFTR contributing role. Methodology/Principal Findings: The aim of the present study was to investigate the impact of CFTR depletion on FA uptake, composition and metabolism using the intestinal Caco-2/15 cell line. shRNA-mediated cftr gene silencing induced qualitative and quantitative modifications in FA composition in differentiated enterocytes as determined by gas-liquid chromatography. With the cftr gene disruption, there was a 1,5 fold increase in the total FA amount, largely attributable to monounsaturated and saturated FA compared to controls. The activity of delta-7 desaturase, estimated by the 16: 1(n-7)/16:0, was significantly higher in knockdown cells and consistent with the striking elevation of the n-7 FA family. When incubated with [C-14]-oleic acid, CFTR-depleted cells were capable of quick incorporation and export to the medium concomitantly with the high protein expression of L-FABP known to promote intracellular FA trafficking. Accordingly, lipoprotein vehicles (CM, VLDL, LDL and HDL), isolated from CFTR knockdown cells, exhibited higher levels of radiolabeled FA. Moreover, in the presence of [C-14]-acetate, knockdown cells exhibited enhanced secretion of newly synthesized phospholipids, triglycerides, cholesteryl esters and free FA, thereby suggesting a stimulation of the lipogenic pathway. Conformably, gene expression of SREBP-1c, a key lipogenic transcription factor, was increased while protein expression of the phosphorylated and inactive form of acetylCoA carboxylase was reduced, confirming lipogenesis induction. Finally, CFTR-depleted cells exhibited lower gene expression of transcription factors (PPAR alpha, LXR alpha, LXR beta and RXR alpha). Conclusions/Significance: Collectively, our results indicate that CFTR depletion may disrupt FA homeostasis in intestinal cells through alterations in FA uptake and transport combined with stimulation of lipogenesis that occurs by an LXR/RXR-independent mechanism. These findings exclude a contributing role of CFTR in CF-associated fat malabsorption.	[Mailhot, Genevieve; Moreau, Alain; Levy, Emile] Univ Montreal, Res Ctr, CHU St Justine, Montreal, PQ, Canada; [Mailhot, Genevieve; Rabasa-Lhoret, Remi; Levy, Emile] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Moreau, Alain] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Berthiaume, Yves] CHUM Hotel Dieu, Cyst Fibrosis Clin, Montreal, PQ, Canada; [Rabasa-Lhoret, Remi] Univ Montreal, CHUM Hotel Dieu, Montreal, PQ, Canada; [Rabasa-Lhoret, Remi] Univ Montreal, Diabet & Metab Dis Res Grp, Inst Rech Clin, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Mailhot, G (corresponding author), Univ Montreal, Res Ctr, CHU St Justine, Montreal, PQ, Canada.	emile.levy@recherche-ste-Justine.qc.ca	Berthiaume, Yves/K-7588-2012; Mailhot, Genevieve/AAL-1310-2020; Mailhot, Genevieve/AAB-8928-2020	Mailhot, Genevieve/0000-0002-2673-6492; 	Canadian Institutes of Health Research [82714]; Canadian Cystic Fibrosis Foundation; JA deSeve Research Chair in nutrition	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation; JA deSeve Research Chair in nutrition	The current work was supported by research grants from the Canadian Institutes of Health Research (MOP#82714), Canadian Cystic Fibrosis Foundation and JA deSeve Research Chair in nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Turkmani MR, 2008, J LIPID RES, V49, P1946, DOI 10.1194/jlr.M800035-JLR200; Andersson C, 2008, J LIPID RES, V49, P1692, DOI 10.1194/jlr.M700388-JLR200; Bhura-Bandali FN, 2000, J NUTR, V130, P2870, DOI 10.1093/jn/130.12.2870; Bijvelds MJC, 2005, AM J PHYSIOL-GASTR L, V288, pG646, DOI 10.1152/ajpgi.00295.2004; Borowitz D, 2002, J PEDIATR GASTR NUTR, V35, P246, DOI 10.1097/00005176-200209000-00004; BRASITUS TA, 1985, BIOCHIM BIOPHYS ACTA, V812, P460, DOI 10.1016/0005-2736(85)90321-9; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Courtois F, 2000, AM J PHYSIOL-GASTR L, V279, pG12, DOI 10.1152/ajpgi.2000.279.1.G12; Russell M, 2006, CELL SIGNAL, V18, P1595, DOI 10.1016/j.cellsig.2006.01.001; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Durieu I, 2007, J CYST FIBROS, V6, P320, DOI 10.1016/j.jcf.2006.12.005; FARRELL PM, 1985, PEDIATR RES, V19, P104, DOI 10.1203/00006450-198501000-00028; Federico LM, 2006, DIABETES, V55, P1316, DOI 10.2337/db04-1084; Figueroa V, 2002, AM J CLIN NUTR, V75, P1005, DOI 10.1093/ajcn/75.6.1005; Freedman SD, 1999, P NATL ACAD SCI USA, V96, P13995, DOI 10.1073/pnas.96.24.13995; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Grenier E, 2007, AM J PHYSIOL-GASTR L, V293, pG1178, DOI 10.1152/ajpgi.00295.2007; Haidari M, 2002, J BIOL CHEM, V277, P31646, DOI 10.1074/jbc.M200544200; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; Iuliano L, 2009, AM J CLIN NUTR, V90, P477, DOI 10.3945/ajcn.2009.27757; Kalivianakis M, 1999, AM J CLIN NUTR, V69, P127; KANG JX, 1992, BIOCHEM J, V285, P725, DOI 10.1042/bj2850725; LEPAGE G, 1989, J LIPID RES, V30, P1483; LEPAGE G, 1986, J LIPID RES, V27, P114; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; LEVY E, 1992, AM J PHYSIOL, V262, pG319, DOI 10.1152/ajpgi.1992.262.2.G319; Li N, 2004, AM J PHYSIOL-GASTR L, V287, pG726, DOI 10.1152/ajpgi.00012.2004; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Luxon BA, 2000, BBA-MOL CELL BIOL L, V1487, P309, DOI 10.1016/S1388-1981(00)00104-9; Mailhot G, 2009, AM J PHYSIOL-GASTR L, V297, pG1239, DOI 10.1152/ajpgi.00206.2009; Marcil V, 2003, J NUTR, V133, P2180, DOI 10.1093/jn/133.7.2180; Marcil VR, 2002, AM J PHYSIOL-GASTR L, V283, pG340, DOI 10.1152/ajpgi.00440.2001; Mimoun M, 2009, J NUTR, V139, P2358, DOI 10.3945/jn.109.110999; Montoudis A, 2006, BIOCHEM BIOPH RES CO, V339, P248, DOI 10.1016/j.bbrc.2005.10.202; Mount PF, 2005, AM J PHYSIOL-RENAL, V289, pF1103, DOI 10.1152/ajprenal.00458.2004; Murphy EJ, 1998, AM J PHYSIOL-GASTR L, V275, pG244, DOI 10.1152/ajpgi.1998.275.2.G244; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Newberry EP, 2009, MOL CELL BIOCHEM, V326, P79, DOI 10.1007/s11010-008-0002-4; Nieto N, 2002, J NUTR, V132, P11, DOI 10.1093/jn/132.1.11; Norkina O, 2004, AM J PHYSIOL-GASTR L, V286, pG1032, DOI 10.1152/ajpgi.00473.2003; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ollero M, 2006, METABOLISM, V55, P1192, DOI 10.1016/j.metabol.2006.05.002; Pencharz PB, 2000, CLIN NUTR, V19, P387, DOI 10.1054/clnu.1999.0079; Peretti N, 2005, Nutr Metab (Lond), V2, P11, DOI 10.1186/1743-7075-2-11; Peretti N, 2006, AM J PHYSIOL-GASTR L, V290, pG609, DOI 10.1152/ajpgi.00332.2005; Raia V, 2000, PEDIATR RES, V47, P344, DOI 10.1203/00006450-200003000-00010; Ravid Z, 2008, AM J PHYSIOL-GASTR L, V295, pG873, DOI 10.1152/ajpgi.90376.2008; Roulet M, 1997, EUR J PEDIATR, V156, P952, DOI 10.1007/s004310050750; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; Smyth RL, 2000, ARCH DIS CHILD, V82, P394, DOI 10.1136/adc.82.5.394; Spahis S, 2008, PROSTAG LEUKOTR ESS, V79, P47, DOI 10.1016/j.plefa.2008.07.005; STENSON WF, 1993, AM J PHYSIOL, V265, pG955, DOI 10.1152/ajpgi.1993.265.5.G955; Strandvik B, 2001, J PEDIATR-US, V139, P650, DOI 10.1067/mpd.2001.118890; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Werner A, 2004, J LIPID RES, V45, P2277, DOI 10.1194/jlr.M400238-JLR200; Wojtaszewski JFP, 2002, BIOCHEM BIOPH RES CO, V298, P309, DOI 10.1016/S0006-291X(02)02465-8; Xu YQ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-26; ZENTLERMUNRO PL, 1985, GUT, V26, P892, DOI 10.1136/gut.26.9.892; Zoltowska M, 2003, DIABETES, V52, P2539, DOI 10.2337/diabetes.52.10.2539	59	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10446	10.1371/journal.pone.0010446	http://dx.doi.org/10.1371/journal.pone.0010446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463919	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379400009
J	Mwagomba, B; Zachariah, R; Massaquoi, M; Misindi, D; Manzi, M; Mandere, BC; Bemelmans, M; Philips, M; Kamoto, K; Schouten, EJ; Harries, AD				Mwagomba, Beatrice; Zachariah, Rony; Massaquoi, Moses; Misindi, Dalitso; Manzi, Marcel; Mandere, Bester C.; Bemelmans, Marielle; Philips, Mit; Kamoto, Kelita; Schouten, Eric J.; Harries, Anthony D.			Mortality Reduction Associated with HIV/AIDS Care and Antiretroviral Treatment in Rural Malawi: Evidence from Registers, Coffin Sales and Funerals	PLOS ONE			English	Article							HIV-1-INFECTED PATIENTS; ADULT MORTALITY; SOUTH-AFRICA; ADDIS-ABABA; HIV; THERAPY; POPULATION; AIDS; ETHIOPIA; DISTRICT	Background: To report on the trend in all-cause mortality in a rural district of Malawi that has successfully scaled-up HIV/AIDS care including antiretroviral treatment (ART) to its population, through corroborative evidence from a) registered deaths at traditional authorities (TAs), b) coffin sales and c) church funerals. Methods and Findings: Retrospective study in 5 of 12 TAs (covering approximately 50% of the population) during the period 2000-2007. A total of 210 villages, 24 coffin workshops and 23 churches were included. There were a total of 18,473 registered deaths at TAs, 15781 coffins sold, and 2762 church funerals. Between 2000 and 2007, there was a highly significant linear downward trend in death rates, sale of coffins and church funerals (X(2) for linear trend: 338.4 P < 0.0001, 989 P < 0.0001 and 197, P < 0.0001 respectively). Using data from TAs as the most reliable source of data on deaths, overall death rate reduction was 37% (95% Cl:33-40) for the period. The mean annual incremental death rate reduction was 0.52/1000/year. Death rates decreased over time as the percentage of people living with HIV/AIDS enrolled into care and ART increased. Extrapolating these data to the entire district population, an estimated 10,156 (95% Cl: 9786-10259) deaths would have been averted during the 8-year period. Conclusions: Registered deaths at traditional authorities, the sale of coffins and church funerals showed a significant downward trend over a 8-year period which we believe was associated with the scaling up HIV/AIDS care and ART.	[Mwagomba, Beatrice] Minist Hlth & Populat, Thyolo Dist Hlth Serv, Thyolo, Malawi; [Zachariah, Rony; Manzi, Marcel] Med Sans Frontieres, Med Dept Operat Res, Brussels Operat Ctr, Luxembourg, Luxembourg; [Massaquoi, Moses; Misindi, Dalitso; Bemelmans, Marielle] Med Sans Frontieres, Thyolo, Malawi; [Mandere, Bester C.] Thyolo Dist Assembly, Thyolo, Malawi; [Philips, Mit] Med Sans Frontieres, Anal & Advocacy Unit, Brussels Operat Ctr, Brussels, Belgium; [Kamoto, Kelita; Schouten, Eric J.] Minist Hlth & Populat, Lilongwe, Malawi; [Schouten, Eric J.] Management Sci Hlth, Lilongwe, Malawi; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England	Doctors Without Borders; Doctors Without Borders; University of London; London School of Hygiene & Tropical Medicine	Mwagomba, B (corresponding author), Minist Hlth & Populat, Thyolo Dist Hlth Serv, Thyolo, Malawi.	zachariah@internet.lu		zachariah, rony/0000-0002-2915-9328	Medecins Sans Frontieres; EuropeAid; Directorate General of cooperation of the Belgium Government; Children's Investment Fund Foundation; Global Fund for AIDS; Tuberculosis and Malaria; M�decins Sans Fronti�res [09_NAT_ERB_003] Funding Source: researchfish	Medecins Sans Frontieres; EuropeAid; Directorate General of cooperation of the Belgium Government; Children's Investment Fund Foundation; Global Fund for AIDS; Tuberculosis and Malaria; M�decins Sans Fronti�res	The Thyolo district HIV/AIDS program is supported by Medecins Sans Frontieres. The authors are also very grateful to EuropeAid, the Directorate General of cooperation of the Belgium Government, Children's Investment Fund Foundation, the Global Fund for AIDS, Tuberculosis and Malaria, and the World Health Organization for their continuing support for HIV/AIDS activities in Malawi. The authors thank an anonymous donor for his support for operational research activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, BBC NEWS; Antunes JLF, 2005, INT J EPIDEMIOL, V34, P586, DOI 10.1093/ije/dyi022; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Chiasson MA, 1999, J ACQ IMMUN DEF SYND, V21, P59, DOI 10.1097/00126334-199905010-00008; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; MAHERS CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; *MIN HLTH POP, 2003, GUID US ANT THER MAL; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; *MOHP, 2004, IMM COV DISTR MAL; *MOHP, 2007, HIV SYPH SER NAT HIV; Musila JW, 2002, ECON MODEL, V19, P295, DOI 10.1016/S0264-9993(01)00065-7; *NSO, 2007, POP FIG YEAR THYL DI; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; Sanders E, 2003, AIDS, V17, P1209, DOI 10.1097/00002030-200305230-00013; SMITH A, 2009, VITAL REGISTRATION S; Stover J., 2008, SEX TRANSM INFECT S1, V84, P24, DOI DOI 10.1136/STI.2008.029868; Stover J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003729; Todd J, 1997, AIDS, V11, P801, DOI 10.1097/00002030-199706000-00013; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	27	47	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10452	10.1371/journal.pone.0010452	http://dx.doi.org/10.1371/journal.pone.0010452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454611	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000277305300004
J	Cohen, AD; Schaer, DA; Liu, CL; Li, YY; Hirschhorn-Cymmerman, D; Kim, SC; Diab, A; Rizzuto, G; Duan, F; Perales, MA; Merghoub, T; Houghton, AN; Wolchok, JD				Cohen, Adam D.; Schaer, David A.; Liu, Cailian; Li, Yanyun; Hirschhorn-Cymmerman, Daniel; Kim, Soo Chong; Diab, Adi; Rizzuto, Gabrielle; Duan, Fei; Perales, Miguel A.; Merghoub, Taha; Houghton, Alan N.; Wolchok, Jedd D.			Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation	PLOS ONE			English	Article							INDUCED TNF RECEPTOR; TRANSCRIPTION FACTOR FOXP3; IN-VIVO; CUTTING EDGE; ACTIVATION; CD4(+); EXPRESSION; EFFECTOR; LIGAND; SUPPRESSION	In vivo GITR ligation has previously been shown to augment T-cell-mediated anti-tumor immunity, yet the underlying mechanisms of this activity, particularly its in vivo effects on CD4+ foxp3+ regulatory T cells (Tregs), have not been fully elucidated. In order to translate this immunotherapeutic approach to the clinic it is important gain better understanding of its mechanism(s) of action. Utilizing the agonist anti-GITR monoclonal antibody DTA-1, we found that in vivo GITR ligation modulates regulatory T cells (Tregs) directly during induction of melanoma tumor immunity. As a monotherapy, DTA-1 induced regression of small established B16 melanoma tumors. Although DTA-1 did not alter systemic Treg frequencies nor abrogate the intrinsic suppressive activity of Tregs within the tumor-draining lymph node, intra-tumor Treg accumulation was significantly impaired. This resulted in a greater Teff: Treg ratio and enhanced tumor-specific CD8+ T-cell activity. The decreased intra-tumor Treg accumulation was due both to impaired infiltration, coupled with DTA-1-induced loss of foxp3 expression in intra-tumor Tregs. Histological analysis of B16 tumors grown in Foxp3-GFP mice showed that the majority of GFP+ cells had lost Foxp3 expression. These "unstable'' Tregs were absent in IgG-treated tumors and in DTA-1 treated TDLN, demonstrating a tumor-specific effect. Impairment of Treg infiltration was lost if Tregs were GITR(-/-), and the protective effects of DTA-1 were reduced in reconstituted RAG1(-/-) mice if either the Treg or Teff subset were GITR-negative and absent if both were negative. Our results demonstrate that DTA-1 modulates both Teffs and Tregs during effective tumor treatment. The data suggest that DTA-1 prevents intra-tumor Treg accumulation by altering their stability, and as a result of the loss of foxp3 expression, may modify their intra-tumor suppressive capacity. These findings provide further support for the continued development of agonist anti-GITR mAbs as an immunotherapeutic strategy for cancer.	[Cohen, Adam D.; Perales, Miguel A.; Houghton, Alan N.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Schaer, David A.; Liu, Cailian; Li, Yanyun; Hirschhorn-Cymmerman, Daniel; Kim, Soo Chong; Diab, Adi; Rizzuto, Gabrielle; Duan, Fei; Merghoub, Taha; Houghton, Alan N.; Wolchok, Jedd D.] Sloan Kettering Inst Canc Res, Program Immunol, New York, NY USA; [Cohen, Adam D.; Rizzuto, Gabrielle; Duan, Fei; Perales, Miguel A.; Houghton, Alan N.; Wolchok, Jedd D.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Cohen, AD (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	wolchokj@mskcc.org	Cohen, Adam D/F-6729-2012; Merghoub, Taha/ABD-8362-2021; Rizzuto, Gabrielle/GWR-2224-2022	Cohen, Adam/0000-0003-0939-3843; Rizzuto, Gabrielle/0000-0003-3052-0253; Duan, Fei/0000-0002-4659-0144	ASCO Young Investigator Award; Charles A. Dana Foundation; H-C Fellowship; NIH [K08CA127143-01, K08CA10260, K12 CA120121-01]; MSKCC; NIH/NCI [T32 CA09149-30, CA56821, CA47179, CA33049, CA59350]; John D. Proctor Foundation; Damon Runyon-Lilly Clinical Investigator Award [CA56821, CA33049, CA59350]; Damon Runyon-Lilly Foundation; Swim Across America; Lita Annenberg Hazen Foundation; TJ Martell Foundation; Louis & Anne Abrons Foundation; Mr. and Mrs. Quentin J. Kennedy Fund; Mr. William H. Goodwin and Mrs. Alice Goodman Funds; MSKCC Experimental Therapeutics Center; NATIONAL CANCER INSTITUTE [K08CA127143, K12CA120121, P01CA047179, P01CA059350, P01CA033049, T32CA009149, R01CA056821] Funding Source: NIH RePORTER	ASCO Young Investigator Award; Charles A. Dana Foundation; H-C Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSKCC; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); John D. Proctor Foundation; Damon Runyon-Lilly Clinical Investigator Award; Damon Runyon-Lilly Foundation; Swim Across America; Lita Annenberg Hazen Foundation; TJ Martell Foundation; Louis & Anne Abrons Foundation; Mr. and Mrs. Quentin J. Kennedy Fund; Mr. William H. Goodwin and Mrs. Alice Goodman Funds; MSKCC Experimental Therapeutics Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: ADC (ASCO Young Investigator Award, Charles A. Dana Foundation, H-C Fellowship, and NIH K08CA127143-01). MAP (NIH K08CA10260 and MSKCC Byrne Fund). DAS (NIH Clinical Training for Scholar Grant K12 CA120121-01, NIH/NCI Immunology Training Grant T32 CA09149-30 and John D. Proctor Foundation: Margaret A. Cunningham Immune Mechanisms in Cancer Research Fellowship Award). JDW CA56821, CA33049 and CA59350 (Damon Runyon-Lilly Clinical Investigator Award). ANH (NIH/NCI (CA56821, CA47179, CA33049 and CA59350) and Damon Runyon-Lilly Foundation). Additional support provided by Swim Across America, Lita Annenberg Hazen Foundation, TJ Martell Foundation, Louis & Anne Abrons Foundation, Mr. and Mrs. Quentin J. Kennedy Fund, Mr. William H. Goodwin and Mrs. Alice Goodman Funds, and MSKCC Experimental Therapeutics Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Cohen AD, 2006, CANCER RES, V66, P4904, DOI 10.1158/0008-5472.CAN-05-2813; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Esparza EM, 2005, J IMMUNOL, V174, P7869, DOI 10.4049/jimmunol.174.12.7869; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gough MJ, 2008, CANCER RES, V68, P5206, DOI 10.1158/0008-5472.CAN-07-6484; Haas J, 2008, BLOOD, V111, P761, DOI 10.1182/blood-2007-08-104877; HARA I, 1995, J EXP MED, V182, P1609, DOI 10.1084/jem.182.5.1609; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Igarashi H, 2008, BIOCHEM BIOPH RES CO, V369, P1134, DOI 10.1016/j.bbrc.2008.03.024; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Kim CH, 2006, EXP HEMATOL, V34, P1033, DOI 10.1016/j.exphem.2006.03.014; Kim HJ, 2006, J IMMUNOL, V176, P3507, DOI 10.4049/jimmunol.176.6.3507; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Kohm AP, 2004, J IMMUNOL, V172, P4686, DOI 10.4049/jimmunol.172.8.4686; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Muriglan SJ, 2004, J EXP MED, V200, P149, DOI 10.1084/jem.20040116; Nishikawa H, 2008, CANCER RES, V68, P5948, DOI 10.1158/0008-5472.CAN-07-5839; Nocentini G, 2005, EUR J IMMUNOL, V35, P1016, DOI 10.1002/eji.200425818; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Piconese S, 2008, J EXP MED, V205, P825, DOI 10.1084/jem.20071341; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Ramirez-Montagut T, 2006, J IMMUNOL, V176, P6434, DOI 10.4049/jimmunol.176.11.6434; Ronchetti S, 2002, BLOOD, V100, P350, DOI 10.1182/blood-2001-12-0276; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Suri A, 2004, EUR J IMMUNOL, V34, P447, DOI 10.1002/eji.200324599; Suvas S, 2005, J VIROL, V79, P11935, DOI 10.1128/JVI.79.18.11935-11942.2005; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Valzasina B, 2005, BLOOD, V105, P2845, DOI 10.1182/blood-2004-07-2959; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wei S, 2006, BLOOD, V108, P426, DOI 10.1182/blood-2006-01-0177; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zhou PF, 2007, J IMMUNOL, V179, P7365, DOI 10.4049/jimmunol.179.11.7365; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007; Zhou ZC, 2008, P NATL ACAD SCI USA, V105, P5465, DOI 10.1073/pnas.0711350105	49	183	204	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10436	10.1371/journal.pone.0010436	http://dx.doi.org/10.1371/journal.pone.0010436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454651	Green Submitted, Green Published, gold			2022-12-25	WOS:000277240300012
J	Madronal, N; Gruart, A; Sacktor, TC; Delgado-Garcia, JM				Madronal, Noelia; Gruart, Agnes; Sacktor, Todd C.; Delgado-Garcia, Jose M.			PKM zeta Inhibition Reverses Learning-Induced Increases in Hippocampal Synaptic Strength and Memory during Trace Eyeblink Conditioning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; KINASE-M-ZETA; POSTSYNAPTIC AMPA RECEPTORS; CA3-CA1 SYNAPSE; BEHAVING MICE; LATE-PHASE; LTP; MAINTENANCE; CONSOLIDATION; TRANSMISSION	A leading candidate in the process of memory formation is hippocampal long-term potentiation (LTP), a persistent enhancement in synaptic strength evoked by the repetitive activation of excitatory synapses, either by experimental high-frequency stimulation (HFS) or, as recently shown, during actual learning. But are the molecular mechanisms for maintaining synaptic potentiation induced by HFS and by experience the same? Protein kinase Mzeta (PKM zeta), an autonomously active atypical protein kinase C isoform, plays a key role in the maintenance of LTP induced by tetanic stimulation and the storage of long-term memory. To test whether the persistent action of PKM zeta is necessary for the maintenance of synaptic potentiation induced after learning, the effects of ZIP (zeta inhibitory peptide), a PKM zeta inhibitor, on eyeblink-conditioned mice were studied. PKM zeta inhibition in the hippocampus disrupted both the correct retrieval of conditioned responses (CRs) and the experience-dependent persistent increase in synaptic strength observed at CA3-CA1 synapses. In addition, the effects of ZIP on the same associative test were examined when tetanic LTP was induced at the hippocampal CA3-CA1 synapse before conditioning. In this case, PKM zeta inhibition both reversed tetanic LTP and prevented the expected LTP-mediated deleterious effects on eyeblink conditioning. Thus, PKM zeta inhibition in the CA1 area is able to reverse both the expression of trace eyeblink conditioned memories and the underlying changes in CA3-CA1 synaptic strength, as well as the anterograde effects of LTP on associative learning.	[Madronal, Noelia; Gruart, Agnes; Delgado-Garcia, Jose M.] Univ Pablo Olavide, Div Neurociencias, Seville, Spain; [Sacktor, Todd C.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA	Universidad Pablo de Olavide; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Madronal, N (corresponding author), Univ Pablo Olavide, Div Neurociencias, Seville, Spain.	jmdelgar@upo.es	Delgado-Garcia, Jose M./V-1567-2019		European Community [FP7/2007-201714]; Spanish Ministry of Science and Innovation [BFU2008-00899, BFU2008-03390]; Junta de Andalucia (Spain) [BIO-122, CVI-02487]; Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain); National Institutes of Health (NIH) [MH53576, MH57068]; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH053576, R01MH057068, R01MH053576, R37MH057068] Funding Source: NIH RePORTER	European Community(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research leading to these results has received funding from the European Community Seventh Framework Program (FP7/2007-201714, DEVANX Project), the Spanish Ministry of Science and Innovation (BFU2008-00899 and BFU2008-03390), the Junta de Andalucia (Spain, BIO-122 and CVI-02487), and the Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain). Dr. Sacktor is supported by National Institutes of Health (NIH) MH53576 and MH57068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2003, PHILOS T R SOC B, V358, P735, DOI 10.1098/rstb.2002.1222; Bliss TVP, 2006, SCIENCE, V313, P1058, DOI 10.1126/science.1132538; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1993, NATURE, V31, P361, DOI DOI 10.1038/361031A0.[; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Domingo JA, 1997, J NEUROPHYSIOL, V78, P2518, DOI 10.1152/jn.1997.78.5.2518; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Eichenbaum H, 1999, NAT NEUROSCI, V2, P775, DOI 10.1038/12137; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Moyer JR, 1996, J NEUROSCI, V16, P5536; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shema R, 2009, LEARN MEMORY, V16, P122, DOI 10.1101/lm.1183309; Thompson LT, 1996, J NEUROPHYSIOL, V76, P1836, DOI 10.1152/jn.1996.76.3.1836; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008	30	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10400	10.1371/journal.pone.0010400	http://dx.doi.org/10.1371/journal.pone.0010400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454458	Green Published, Green Submitted, gold			2022-12-25	WOS:000277240100012
J	Barksdale, KA; Perez-Costas, E; Gandy, JC; Melendez-Ferro, M; Roberts, RC; Bijur, GN				Barksdale, Keri A.; Perez-Costas, Emma; Gandy, Johanna C.; Melendez-Ferro, Miguel; Roberts, Rosalinda C.; Bijur, Gautam N.			Mitochondrial viability in mouse and human postmortem brain	FASEB JOURNAL			English	Article						ATP; cortex; electron microscopy; membrane potential; rhodamine	CYTOCHROME-C RELEASE; OXIDATIVE-PHOSPHORYLATION; SYNAPTIC MITOCHONDRIA; CRYOPRESERVATION; ACCUMULATION; DISEASE; AKT	Neuronal function in the brain requires energy in the form of ATP, and mitochondria are canonically associated with ATP production in neurons. The electrochemical gradient, which underlies the mitochondrial transmembrane potential (Delta Psi(mem)), is harnessed for ATP generation. Here we show that Delta Psi(mem) and ATP-production can be engaged in mitochondria isolated from human brains up to 8.5 h postmortem. Also, a time course of postmortem intervals from 0 to 24 h using mitochondria isolated from mouse cortex reveals that Delta Psi(mem) in mitochondria can be reconstituted beyond 10 h postmortem. It was found that complex I of the mitochondrial electron transport chain was affected adversely with increasing postmortem intervals. Mitochondria isolated from postmortem mouse brains maintain the ability to produce ATP, but rates of production decreased with longer postmortem intervals. Furthermore, we show that postmortem brain mitochondria retain their Delta Psi(mem) and ATP-production capacities following cryopreservation. Our finding that Delta Psi(mem) and ATP-generating capacity can be reinitiated in brain mitochondria hours after death indicates that human postmortem brains can be an abundant source of viable mitochondria to study metabolic processes in health and disease. It is also possible to archive these mitochondria for future studies.-Barksdale, K. A., Perez-Costas, E., Gandy, J. C., Melendez-Ferro, M., Roberts, R. C., Bijur, G. N. Mitochondrial viability in mouse and human postmortem brain. FASEB J. 24, 3590-3599 (2010). www.fasebj.org	[Barksdale, Keri A.; Perez-Costas, Emma; Gandy, Johanna C.; Melendez-Ferro, Miguel; Roberts, Rosalinda C.; Bijur, Gautam N.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Roberts, RC (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Sparks Ctr 1017,1720 7th Ave S, Birmingham, AL 35294 USA.	rcusidor@uab.edu; gautam@uab.edu		PEREZ-COSTAS, EMMA/0000-0002-9050-9593	U.S. National Institutes of Health (NIH) [NS044853]; Gary Drummond, Jr. Memorial Research Award; NIH [MH60744]; Cellular and Molecular Biology Program [GM008111]; Civitan International Research Center; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044853] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gary Drummond, Jr. Memorial Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Biology Program; Civitan International Research Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Joy K. Roche for assistance in processing of electron microscopy samples. This work was supported by U.S. National Institutes of Health (NIH) grant NS044853 and the Gary Drummond, Jr. Memorial Research Award to G.N.B., and NIH grant MH60744 to R. C. R. J.C.G. is supported by the Cellular and Molecular Biology Program training grant GM008111 and the Civitan International Research Center Emerging Scholars Award.	Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Barksdale KA, 2009, J NEUROCHEM, V108, P1289, DOI 10.1111/j.1471-4159.2009.05878.x; Begley JG, 1998, BRAIN RES PROTOC, V3, P76, DOI 10.1016/S1385-299X(98)00024-5; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cellbio.4.1.155; DENNIS SC, 1977, BIOCHEM J, V164, P727, DOI 10.1042/bj1640727; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Foster KA, 2006, PROG NEUROBIOL, V79, P136, DOI 10.1016/j.pneurobio.2006.07.001; GERARDS M, 2009, J MED GENET; Gill-King H., 1997, CHEM ULTRASTRUCTURAL, P93, DOI DOI 10.1201/9781439821923.SEC2; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; GREIFF D, 1961, NATURE, V190, P1202, DOI 10.1038/1901202b0; GREIFF D, 1961, BIOCHIM BIOPHYS ACTA, V50, P233, DOI 10.1016/0006-3002(61)90321-3; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Kuznetsov AV, 2003, ANAL BIOCHEM, V319, P296, DOI 10.1016/S0003-2697(03)00326-9; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Nukala VN, 2006, J NEUROSCI METH, V152, P48, DOI 10.1016/j.jneumeth.2005.08.017; Park LCH, 2001, J NEUROSCI RES, V66, P1028, DOI 10.1002/jnr.10062; Rollins B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004913; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; SAKAMOTO J, 1984, J BIOCHEM-TOKYO, V96, P483, DOI 10.1093/oxfordjournals.jbchem.a134860; Schild L, 2001, FASEB J, V15, P565; Sheleg S, 2008, INT J CLIN EXP PATHO, V1, P440; Verkhratsky A, 2008, CELL CALCIUM, V44, P112, DOI 10.1016/j.ceca.2007.11.010; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x	29	31	31	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3590	3599		10.1096/fj.09-152108	http://dx.doi.org/10.1096/fj.09-152108			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20466876	Green Published			2022-12-25	WOS:000281446400046
J	Arent, S; Christensen, CE; Pye, VE; Norgaard, A; Henriksen, A				Arent, Susan; Christensen, Caspar E.; Pye, Valerie E.; Norgaard, Allan; Henriksen, Anette			The Multifunctional Protein in Peroxisomal beta-Oxidation STRUCTURE AND SUBSTRATE SPECIFICITY OF THE ARABIDOPSIS THALIANA PROTEIN MFP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENOYL-COA HYDRATASE; FATTY-ACID OXIDATION; ANGSTROM CRYSTAL-STRUCTURE; RAT-LIVER PEROXISOMES; ACYL-COA; COENZYME-A; DELTA(3)-DELTA(2)-ENOYL-COA ISOMERASE; L-3-HYDROXYACYL-COA DEHYDROGENASE; JASMONATE BIOSYNTHESIS; STRUCTURAL BASIS	Plant fatty acids can be completely degraded within the peroxisomes. Fatty acid degradation plays a role in several plant processes including plant hormone synthesis and seed germination. Two multifunctional peroxisomal isozymes, MFP2 and AIM1, both with 2-trans-enoyl-CoA hydratase and L-3-hydroxyacyl-CoA dehydrogenase activities, function in mouse ear cress (Arabidopsis thaliana) peroxisomal beta-oxidation, where fatty acids are degraded by the sequential removal of two carbon units. A deficiency in either of the two isozymes gives rise to a different phenotype; the biochemical and molecular background for these differences is not known. Structure determination of Arabidopsis MFP2 revealed that plant peroxisomal MFPs can be grouped into two families, as defined by a specific pattern of amino acid residues in the flexible loop of the acyl-binding pocket of the 2-trans-enoyl-CoA hydratase domain. This could explain the differences in substrate preferences and specific biological functions of the two isozymes. The in vitro substrate preference profiles illustrate that the Arabidopsis AIM1 hydratase has a preference for short chain acyl-CoAs compared with the Arabidopsis MFP2 hydratase. Remarkably, neither of the two was able to catabolize enoyl-CoA substrates longer than 14 carbon atoms efficiently, suggesting the existence of an uncharacterized long chain enoyl-CoA hydratase in Arabidopsis peroxisomes.	[Arent, Susan; Christensen, Caspar E.; Pye, Valerie E.; Norgaard, Allan; Henriksen, Anette] Carlsberg Lab, Prot Chem Grp, DK-2500 Copenhagen, Denmark		Henriksen, A (corresponding author), Carlsberg Lab, Prot Chem Grp, Gamle Carlsberg Vej 10, DK-2500 Copenhagen, Denmark.	anette@crc.dk	Christensen, Caspar Elo/K-2753-2014	Christensen, Caspar Elo/0000-0002-0214-8477; Pye, Valerie E/0000-0001-9616-2992; Henriksen, Anette/0000-0003-4051-5079	Danish Natural Science Research Council	Danish Natural Science Research Council(Danish Natural Science Research Council)	This work was supported by the Danish Natural Science Research Council, which provided a postdoctoral stipend through DANSYNC (to S. A.) and synchrotron beam time.	ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afitlhile MM, 2005, PLANT PHYSIOL BIOCH, V43, P603, DOI 10.1016/j.plaphy.2005.03.016; BAHNSON BJ, 1991, BIOCHEMISTRY-US, V30, P5894, DOI 10.1021/bi00238a013; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barycki JJ, 2000, J BIOL CHEM, V275, P27186; Barycki JJ, 1999, BIOCHEMISTRY-US, V38, P5786, DOI 10.1021/bi9829027; Barycki JJ, 2001, J BIOL CHEM, V276, P36718, DOI 10.1074/jbc.M104839200; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; Castillo MC, 2004, PLANT PHYSIOL, V135, P85, DOI 10.1104/pp.104.039925; CONSTANTINIDES PP, 1985, J BIOL CHEM, V260, P7573; COOPER TG, 1969, J BIOL CHEM, V244, P3514; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAWSON RMC, 1978, DATA BIOCH RES, P191; Delker C, 2007, PHYTOCHEMISTRY, V68, P1642, DOI 10.1016/j.phytochem.2007.04.024; Eastmond PJ, 2000, BIOCHEM SOC T, V28, P95, DOI 10.1042/bst0280095; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fath A, 2000, PLANT MOL BIOL, V44, P255, DOI 10.1023/A:1026584207243; Feng YG, 2002, BIOCHEMISTRY-US, V41, P12883, DOI 10.1021/bi020382g; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gille C, 2003, BIOINFORMATICS, V19, P2489, DOI 10.1093/bioinformatics/btg354; Goepfert S, 2006, J BIOL CHEM, V281, P35894, DOI 10.1074/jbc.M606383200; Graham IA, 2002, PROG LIPID RES, V41, P156, DOI 10.1016/S0163-7827(01)00022-4; GUHNEMANNSCHAFER K, 1995, PLANTA, V196, P642, DOI 10.1007/BF01106755; Guney E, 2008, NUCLEIC ACIDS RES, V36, pD662, DOI 10.1093/nar/gkm813; He XY, 1997, BIOCHEMISTRY-US, V36, P261, DOI 10.1021/bi961841e; Hooks MA, 1999, PLANT J, V20, P1, DOI 10.1046/j.1365-313X.1999.00559.x; HOOKS MA, 1995, PHYTOCHEMISTRY, V40, P657, DOI 10.1016/0031-9422(95)98169-H; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kiema TR, 1999, BIOCHEMISTRY-US, V38, P2991, DOI 10.1021/bi981646v; KINDL H, 1987, BIOCH PLANTS, V9, P31; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAZAROW PB, 1978, J BIOL CHEM, V253, P1522; LEMIEUX B, 1990, THEOR APPL GENET, V80, P234, DOI 10.1007/BF00224392; Leonard PM, 2004, J BIOL CHEM, V279, P31312, DOI 10.1074/jbc.M403514200; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li CY, 2005, PLANT CELL, V17, P971, DOI 10.1105/tpc.104.029108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOLLER W, 1985, FEBS LETT, V186, P1, DOI 10.1016/0014-5793(85)81326-0; MULLERNEWEN G, 1995, EUR J BIOCHEM, V228, P68, DOI 10.1111/j.1432-1033.1995.tb20230.x; Mursula AM, 2004, FEBS LETT, V557, P81, DOI 10.1016/S0014-5793(03)01450-9; NOYES B E, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1334, DOI 10.1073/pnas.71.4.1334; Ogmen U, 2005, NUCLEIC ACIDS RES, V33, pW331, DOI 10.1093/nar/gki585; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PALOSAARI PM, 1990, J BIOL CHEM, V265, P2446; Partanen ST, 2004, J MOL BIOL, V342, P1197, DOI 10.1016/j.jmb.2004.07.039; Pedersen L, 2004, ACTA CRYSTALLOGR D, V60, P1125, DOI 10.1107/S0907444904007577; Pinfield-Wells H, 2005, PLANT J, V43, P861, DOI 10.1111/j.1365-313X.2005.02498.x; PREISIGMULLER R, 1994, J BIOL CHEM, V269, P20475; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Richmond TA, 1999, PLANT CELL, V11, P1911, DOI 10.1105/tpc.11.10.1911; Rylott EL, 2006, PLANT J, V45, P930, DOI 10.1111/j.1365-313X.2005.02650.x; Sakurai T, 2005, NUCLEIC ACIDS RES, V33, pD647, DOI 10.1093/nar/gki014; Schilmiller AL, 2007, PLANT PHYSIOL, V143, P812, DOI 10.1104/pp.106.092916; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Taskinen JP, 2006, J MOL BIOL, V355, P734, DOI 10.1016/j.jmb.2005.10.085; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Titorenko VI, 2002, J CELL BIOL, V156, P481, DOI 10.1083/jcb.200111075; Tsuchiya D, 2006, STRUCTURE, V14, P237, DOI 10.1016/j.str.2005.10.011; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; WILLADSEN P, 1975, EUR J BIOCHEM, V54, P247, DOI 10.1111/j.1432-1033.1975.tb04134.x; YANG SY, 1985, J BIOL CHEM, V260, P2862; YANG SY, 1986, J BIOL CHEM, V261, P5390; Yao KW, 1996, J BIOL CHEM, V271, P17816, DOI 10.1074/jbc.271.30.17816; Ylianttila MS, 2006, J MOL BIOL, V358, P1286, DOI 10.1016/j.jmb.2006.03.001; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399	77	33	39	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24066	24077		10.1074/jbc.M110.106005	http://dx.doi.org/10.1074/jbc.M110.106005			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20463021	Green Published, hybrid			2022-12-25	WOS:000280291400057
J	Ivanov, SV; Goparaju, CMV; Lopez, P; Zavadil, J; Toren-Haritan, G; Rosenwald, S; Hoshen, M; Chajut, A; Cohen, D; Pass, HI				Ivanov, Sergey V.; Goparaju, Chandra M. V.; Lopez, Peter; Zavadil, Jiri; Toren-Haritan, Ginat; Rosenwald, Shai; Hoshen, Moshe; Chajut, Ayelet; Cohen, Dalia; Pass, Harvey I.			Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; METHYLTHIOADENOSINE PHOSPHORYLASE; TUMOR-SUPPRESSOR; HOMOZYGOUS DELETIONS; ARRAY-CGH; RT-PCR; CANCER; MICRORNAS; GENE; QUANTIFICATION	The human genome encodes several hundred microRNA (miRNA) genes that produce small (21-23n) single strand regulatory RNA molecules. Although abnormal expression of miRNAs has been linked to cancer progression, the mechanisms of this dysregulation are poorly understood. Malignant mesothelioma (MM) of pleura is an aggressive and highly lethal cancer resistant to conventional therapies. We and others previously linked loss of the 9p21.3 chromosome in MM with short time to tumor recurrence. In this study, we report that MM cell lines derived from patients with more aggressive disease fail to express miR-31, a microRNA recently linked with suppression of breast cancer metastases. We further demonstrate that this loss is due to homozygous deletion of the miR-31-encoding gene that resides in 9p21.3. Functional assessment of miR-31 activity revealed its ability to inhibit proliferation, migration, invasion, and clonogenicity of MM cells. Re-introduction of miR-31 suppressed the cell cycle and inhibited expression of multiple factors involved in cooperative maintenance of DNA replication and cell cycle progression, including pro-survival phosphatase PPP6C, which was previously associated with chemotherapy and radiation therapy resistance, and maintenance of chromosomal stability. PPP6C, whose mRNA is distinguished with three miR-31-binding sites in its 3'-untranslated region, was consistently down-regulated by miR-31 introduction and upregulated in clinical MM specimens as compared with matched normal tissues. Taken together, our data suggest that tumor-suppressive propensity of miR-31 can be used for development of new therapies against mesothelioma and other cancers that show loss of the 9p21.3 chromosome.	[Ivanov, Sergey V.] Vanderbilt Univ Sch Med, Dept Otolaryngol, Nashville, TN 37232 USA; [Goparaju, Chandra M. V.; Pass, Harvey I.] NYU, Langone Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA; [Lopez, Peter; Zavadil, Jiri] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Zavadil, Jiri; Pass, Harvey I.] NYU, Inst Canc, New York, NY 10016 USA; [Zavadil, Jiri] NYU, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Toren-Haritan, Ginat; Rosenwald, Shai; Hoshen, Moshe; Chajut, Ayelet; Cohen, Dalia] Rosetta Genom Ltd, IL-76706 Rehovot, Israel	Vanderbilt University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; New York University	Ivanov, SV (corresponding author), 654 Preston Res Bldg,2220 Pierce Ave, Nashville, TN 37232 USA.	sergey.v.ivanov@vanderbilt.edu	Lopez, Peter/AAP-7234-2020; Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562; Ivanov, Sergey/0000-0001-9770-7237; Pass, Harvey/0000-0003-3222-3471; Lopez, Peter/0000-0002-8587-7148	NCI; Mesothelioma Applied Research Foundation, Santa Barbara, CA	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mesothelioma Applied Research Foundation, Santa Barbara, CA	This work was supported, in whole or in part, by a National Institutes of Health grant from NCI, Early Detection Research Network I (to H. I. P. and Mesothelioma Biomarker Discovery Laboratory). This work was also supported by a grant from the Mesothelioma Applied Research Foundation, Santa Barbara, CA, and by donations from Belluck and Fox, LPC, and the Stephen Banner Lung Cancer Foundation.	Bastians H, 1996, J CELL SCI, V109, P2865; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chang LL, 2003, J UROLOGY, V170, P595, DOI 10.1097/01.ju.0000067626.37837.3e; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; CHENG JQ, 1994, CANCER RES, V54, P5547; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Dacic S, 2008, VIRCHOWS ARCH, V453, P627, DOI 10.1007/s00428-008-0689-3; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Garcia-Castellano JM, 2002, CLIN CANCER RES, V8, P782; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Goshima G, 2003, EMBO J, V22, P2752, DOI 10.1093/emboj/cdg266; Grafstrom E, 2005, CLIN CANCER RES, V11, P2991, DOI 10.1158/1078-0432.CCR-04-1731; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivanov SV, 2009, INT J CANCER, V124, P589, DOI 10.1002/ijc.23949; Ivanova AV, 2009, CLIN CANCER RES, V15, P2602, DOI 10.1158/1078-0432.CCR-08-2755; Ji Lin, 2005, Future Oncol, V1, P79, DOI 10.1517/14796694.1.1.79; Karikari CA, 2005, MOL CANCER THER, V4, P1860, DOI 10.1158/1535-7163.MCT-05-0103; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Lesueur F, 2008, BRIT J CANCER, V99, P364, DOI 10.1038/sj.bjc.6604470; Li WW, 2004, ONCOL RES, V14, P373, DOI 10.3727/0965040041292332; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004395; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moore E, 1999, J PATHOL, V187, P403, DOI 10.1002/(SICI)1096-9896(199903)187:4<403::AID-PATH284>3.0.CO;2-J; Murthy SS, 1999, J CELL PHYSIOL, V180, P150, DOI 10.1002/(SICI)1097-4652(199908)180:2<150::AID-JCP2>3.0.CO;2-H; NOBORI T, 1991, CANCER RES, V51, P3193; NOBORI T, 1993, CANCER RES, V53, P1098; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Pass HI, 2010, CANCER RES, V70, P1916, DOI 10.1158/0008-5472.CAN-09-3993; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Petersen I, 2000, BRAIN PATHOL, V10, P395; Racanelli AC, 2009, CANCER RES, V69, P5467, DOI 10.1158/0008-5472.CAN-08-4979; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Senff NJ, 2009, J INVEST DERMATOL, V129, P1149, DOI 10.1038/jid.2008.357; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Usvasalo A, 2008, LEUKEMIA RES, V32, P1228, DOI 10.1016/j.leukres.2008.01.014; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; ZHANG Y, 2009, MED ONCOL IN PRESS	47	101	107	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22807	22815		10.1074/jbc.M110.100354	http://dx.doi.org/10.1074/jbc.M110.100354			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20463022	hybrid, Green Published			2022-12-25	WOS:000279999900013
J	Aquilano, K; Vigilanza, P; Baldelli, S; Pagliei, B; Rotilio, G; Ciriolo, MR				Aquilano, Katia; Vigilanza, Paola; Baldelli, Sara; Pagliei, Beatrice; Rotilio, Giuseppe; Ciriolo, Maria Rosa			Peroxisome Proliferator-activated Receptor gamma Co-activator 1 alpha (PGC-1 alpha) and Sirtuin 1 (SIRT1) Reside in Mitochondria POSSIBLE DIRECT FUNCTION IN MITOCHONDRIAL BIOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-FACTOR-A; DNA; LOCALIZATION; ASSOCIATION; NUCLEOIDS; ENZYMES; MUSCLE; PGC-1; MTDNA	The transcriptional co-activator PGC-1 alpha and the NAD(+)-dependent deacetylase SIRT1 are considered important inducers of mitochondrial biogenesis because in the nucleus they regulate transcription of nucleus-encoded mitochondrial genes. We demonstrate that PGC-1 alpha and SIRT1 are also present inside mitochondria and are in close proximity to mtDNA. They interact with mitochondrial transcription factor A (TFAM) as assessed by confocal microscopy analysis and by blue native-PAGE. Nucleoid purification allowed us to identify SIRT1 and PGC-1 alpha as proteins associated with native and cross-linked nucleoids, respectively. After mtDNA immunoprecipitation analysis, carried out on mitochondrial extracts, we found that PGC-1 alpha is present on the same D-loop region recognized by TFAM. Finally, by oligonucleotide pulldown assay, we found PGC-1 alpha and SIRT1 associated with the TFAM consensus sequence (human mitochondrial transcription factor-binding site H). The results obtained suggest that in mitochondria PGC-1 alpha and SIRT1 may function as their nuclear counterparts and represent the genuine factors mediating the cross-talk between nuclear and mitochondrial genome. Finally, this work adds new knowledge on the function of SIRT1 and PGC-1 alpha and highlights the direct involvement of such proteins in regulation of mitochondrial biogenesis.	[Aquilano, Katia; Vigilanza, Paola; Baldelli, Sara; Pagliei, Beatrice; Rotilio, Giuseppe; Ciriolo, Maria Rosa] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Rotilio, Giuseppe; Ciriolo, Maria Rosa] Ist Ricovero & Cura Carattere Sci, I-00165 Rome, Italy	University of Rome Tor Vergata	Ciriolo, MR (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, I-00133 Rome, Italy.	ciriolo@bio.uniroma2.it	Ciriolo, Maria Rosa/K-6572-2016; AQUILANO, KATIA/K-8888-2016; BALDELLI, SARA/G-4318-2015	AQUILANO, KATIA/0000-0002-5905-9870; BALDELLI, SARA/0000-0001-7003-3172; Ciriolo, Maria Rosa/0000-0002-7863-9029	Ministero della Salute; MIUR; Fondazione Roma Research [2008]	Ministero della Salute(Ministry of Health, Italy); MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione Roma Research(Fondazione Roma)	This work was supported in part by grants from Ministero della Salute and MIUR and by Fondazione Roma Research Grant 2008 (to P. V.).	Aquilano K, 2006, FASEB J, V20, P1683, DOI 10.1096/fj.05-5225fje; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; BOGENHAGEN DF, 1985, J BIOL CHEM, V260, P6466; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Camacho-Carvajal MM, 2004, MOL CELL PROTEOMICS, V3, P176, DOI 10.1074/mcp.T300010-MCP200; Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chow LS, 2007, J APPL PHYSIOL, V102, P1078, DOI 10.1152/japplphysiol.00791.2006; Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5; Finkel T, 2006, NATURE, V444, P151, DOI 10.1038/444151a; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kienhofer J, 2009, FASEB J, V23, P2034, DOI 10.1096/fj.08-113571; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Pellon-Malson M, 2007, BBA-MOL CELL BIOL L, V1771, P830, DOI 10.1016/j.bbalip.2007.04.001; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	34	248	259	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21590	21599		10.1074/jbc.M109.070169	http://dx.doi.org/10.1074/jbc.M109.070169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448046	Green Published, hybrid			2022-12-25	WOS:000279516100045
J	Orr, SJ; Gaymes, T; Ladon, D; Chronis, C; Czepulkowski, B; Wang, R; Mufti, GJ; Marcotte, EM; Thomas, NSB				Orr, S. J.; Gaymes, T.; Ladon, D.; Chronis, C.; Czepulkowski, B.; Wang, R.; Mufti, G. J.; Marcotte, E. M.; Thomas, N. S. B.			Reducing MCM levels in human primary T cells during the G(0)-> G(1) transition causes genomic instability during the first cell cycle	ONCOGENE			English	Article						cell cycle; MCM; chromosomal abnormalities; DNA damage; premature chromatid separation	MINICHROMOSOME MAINTENANCE PROTEINS; SISTER-CHROMATID COHESION; MOSAIC VARIEGATED ANEUPLOIDY; DNA-REPLICATION; S-PHASE; SACCHAROMYCES-CEREVISIAE; GENETIC INSTABILITY; MAMMALIAN-CELLS; CANCER-CELLS; RECOMBINATION	DNA replication is tightly regulated, but paradoxically there is reported to be an excess of MCM DNA replication proteins over the number of replication origins. Here, we show that MCM levels in primary human T cells are induced during the G(0)-> G(1) transition and are not in excess in proliferating cells. The level of induction is critical as we show that a 50% reduction leads to increased centromere separation, premature chromatid separation (PCS) and gross chromosomal abnormalities typical of genomic instability syndromes. We investigated the mechanisms involved and show that a reduction in MCM levels causes dose-dependent DNA damage involving activation of ATR & ATM and Chk1 & Chk2. There is increased DNA mis-repair by non-homologous end joining (NHEJ) and both NHEJ and homologous recombination are necessary for Mcm7-depleted cells to progress to metaphase. Therefore, a simple reduction in MCM loading onto DNA, which occurs in cancers as a result of aberrant cell cycle control, is sufficient to cause PCS and gross genomic instability within one cell cycle. Oncogene (2010) 29, 3803-3814; doi: 10.1038/onc.2010.138; published online 3 May 2010	[Orr, S. J.; Gaymes, T.; Ladon, D.; Chronis, C.; Czepulkowski, B.; Mufti, G. J.; Thomas, N. S. B.] Kings Coll London, Dept Haematol Med, Leukaemia Sci Labs, Rayne Inst, London SE5 9NU, England; [Wang, R.; Marcotte, E. M.] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of London; King's College London; University of Texas System; University of Texas Austin	Thomas, NSB (corresponding author), Kings Coll London, Dept Haematol Med, Leukaemia Sci Labs, Rayne Inst, 123 Coldharbour Lane, London SE5 9NU, England.	nicholas.s.thomas@kcl.ac.uk		Marcotte, Edward/0000-0001-8808-180X	Leukaemia Research Fund; Department of Trade and Industry (dti); British Society for Haematology; Welch and Packard Foundations; National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067779] Funding Source: NIH RePORTER	Leukaemia Research Fund; Department of Trade and Industry (dti); British Society for Haematology; Welch and Packard Foundations; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We sincerely thank Hye Kyung Hong, Kai Stoeber and Gareth Williams, UCL for the Mcm2 plasmid and advice on expressing recombinant Mcm2. We also thank our colleagues for helpful comments. This work was supported by grants from the Leukaemia Research Fund (LRF, now Leukaemia and Lymphoma Research (LLR)), Department of Trade and Industry (dti), the British Society for Haematology, the Welch and Packard Foundations and the National Institutes of Health (NIH).	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bailis JM, 2008, MOL CELL BIOL, V28, P1724, DOI 10.1128/MCB.01717-07; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Bruemmer D, 2003, BIOCHEM BIOPH RES CO, V303, P251, DOI 10.1016/S0006-291X(03)00343-7; Budman J, 2007, J BIOL CHEM, V282, P11950, DOI 10.1074/jbc.M610058200; Chong J P, 1996, Prog Cell Cycle Res, V2, P83; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; COXON A, 1992, NUCLEIC ACIDS RES, V20, P5571, DOI 10.1093/nar/20.21.5571; Crevel G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000833; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Feng DR, 2003, CANCER RES, V63, P7356; Flores-Rozas H, 2000, TRENDS BIOCHEM SCI, V25, P196, DOI 10.1016/S0968-0004(00)01568-1; FRANCON P, 2006, ENCY LIFE SCI; Gaymes TJ, 2002, ONCOGENE, V21, P2525, DOI 10.1038/sj.onc.1205331; Gaymes TJ, 2002, CANCER RES, V62, P2791; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; HOWELL RT, 1992, HUMAN CYTOGENETICS P, P209; Hua XH, 1997, J CELL BIOL, V137, P183, DOI 10.1083/jcb.137.1.183; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Kajii T, 1998, AM J MED GENET, V78, P245, DOI 10.1002/(SICI)1096-8628(19980707)78:3<245::AID-AJMG7>3.0.CO;2-O; Kajii T, 2001, AM J MED GENET, V104, P57, DOI 10.1002/ajmg.1580; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Lea NC, 2003, MOL CELL BIOL, V23, P2351, DOI 10.1128/MCB.23.7.2351-2361.2003; Lei M, 1996, MOL CELL BIOL, V16, P5081; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Liang DT, 1999, J CELL SCI, V112, P559; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Nakanishi M, 2006, CANCER SCI, V97, P984, DOI 10.1111/j.1349-7006.2006.00289.x; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Ohtani K, 1999, ONCOGENE, V18, P2299, DOI 10.1038/sj.onc.1202544; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Shimada K, 2007, CELL, V128, P85, DOI 10.1016/j.cell.2006.11.045; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Shukla A, 2005, BIOCHEM BIOPH RES CO, V329, P1240, DOI 10.1016/j.bbrc.2005.02.106; Smith AE, 2009, GENOME RES, V19, P1325, DOI 10.1101/gr.085530.108; Stoeber K, 2001, J CELL SCI, V114, P2027; Suzuki S, 1998, GENE, V216, P85, DOI 10.1016/S0378-1119(98)00323-0; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Tanaka S, 2002, GENE DEV, V16, P2639, DOI 10.1101/gad.1011002; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Williams GH, 2007, CURR OPIN CELL BIOL, V19, P672, DOI 10.1016/j.ceb.2007.10.005	52	28	30	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 1	2010	29	26					3803	3814		10.1038/onc.2010.138	http://dx.doi.org/10.1038/onc.2010.138			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	618VW	20440261	Green Accepted			2022-12-25	WOS:000279385200008
J	Kelly, DF; Lake, RJ; Middelkoop, TC; Fan, HY; Artavanis-Tsakonas, S; Walz, T				Kelly, Deborah F.; Lake, Robert J.; Middelkoop, Teije C.; Fan, Hua-Ying; Artavanis-Tsakonas, Spyros; Walz, Thomas			Molecular Structure and Dimeric Organization of the Notch Extracellular Domain as Revealed by Electron Microscopy	PLOS ONE			English	Article							EGF REPEATS; PROTEIN; SUPPRESSOR; LOCUS; TILT	Background: The Notch receptor links cell fate decisions of one cell to that of the immediate cellular neighbor. In humans, malfunction of Notch signaling results in diseases and congenital disorders. Structural information is essential for gaining insight into the mechanism of the receptor as well as for potentially interfering with its function for therapeutic purposes. Methodology/Principal Findings: We used the Affinity Grid approach to prepare specimens of the Notch extracellular domain (NECD) of the Drosophila Notch and human Notch1 receptors suitable for analysis by electron microscopy and three-dimensional (3D) image reconstruction. The resulting 3D density maps reveal that the NECD structure is conserved across species. We show that the NECD forms a dimer and adopts different yet defined conformations, and we identify the membrane-proximal region of the receptor and its ligand-binding site. Conclusions/Significance: Our results provide direct and unambiguous evidence that the NECD forms a dimer. Our studies further show that the NECD adopts at least three distinct conformations that are likely related to different functional states of the receptor. These findings open the way to now correlate mutations in the NECD with its oligomeric state and conformation.	[Kelly, Deborah F.; Lake, Robert J.; Middelkoop, Teije C.; Artavanis-Tsakonas, Spyros; Walz, Thomas] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA; [Fan, Hua-Ying] Fox Chase Canc Ctr, Epigenet & Progenitor Cells Program, Philadelphia, PA 19111 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Fox Chase Cancer Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Kelly, DF (corresponding author), Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA.	artavanis@hms.harvard.edu; twalz@hms.harvard.edu		Walz, Thomas/0000-0003-2606-2835; Kelly, Deborah/0000-0002-7341-7435; Middelkoop, Teije/0000-0002-0346-6143	National Institutes of Health (NIH) [GM062580, NS26084, CA098402]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA098402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084983, P01GM062580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026084, R01NS026084] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants GM062580 (to Stephen C. Harrison) and NS26084 and CA098402 (to Spyros Artavanis-Tsakonas). Thomas Walz is an of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; FOSTER GG, 1975, GENETICS, V81, P99; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Hurlbut GD, 2009, P NATL ACAD SCI USA, V106, P2218, DOI 10.1073/pnas.0812024106; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kelly DF, 2008, J MOL BIOL, V382, P423, DOI 10.1016/j.jmb.2008.07.023; Kelly DF, 2008, P NATL ACAD SCI USA, V105, P4703, DOI 10.1073/pnas.0800867105; Kelly DF, 2007, P NATL ACAD SCI USA, V104, P9591, DOI 10.1073/pnas.0702887104; KIDD S, 1989, GENE DEV, V3, P1113, DOI 10.1101/gad.3.8.1113; LI Z, 2009, J ELECTRON MICROSC, V59, P53; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Sakamoto K, 2005, EXP CELL RES, V302, P281, DOI 10.1016/j.yexcr.2004.09.016; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Wall JS, 2000, METH MOL B, V148, P589; Wall JS, 1998, METHOD CELL BIOL, V53, P139; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6	26	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10532	10.1371/journal.pone.0010532	http://dx.doi.org/10.1371/journal.pone.0010532			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479883	Green Published, Green Submitted, gold			2022-12-25	WOS:000277467800014
J	Kochin, BF; Yates, AJ; de Roode, JC; Antia, R				Kochin, Beth F.; Yates, Andrew J.; de Roode, Jacobus C.; Antia, Rustom			On the Control of Acute Rodent Malaria Infections by Innate Immunity	PLOS ONE			English	Article							ENDOGENOUS GAMMA-INTERFERON; STAGE PLASMODIUM-CHABAUDI; WITHIN-HOST COMPETITION; ANTIGENIC VARIATION; DYNAMICS; RESPONSES; MODEL; PARASITEMIA; HETEROGENEITY; PHAGOCYTOSIS	Does specific immunity, innate immunity or resource (red blood cell) limitation control the first peak of the blood-stage parasite in acute rodent malaria infections? Since mice deficient in specific immunity exhibit similar initial dynamics as wildtype mice it is generally viewed that the initial control of parasite is due to either limitation of resources (RBC) or innate immune responses. There are conflicting views on the roles of these two mechanisms as there is experimental evidence supporting both these hypotheses. While mathematical models based on RBC limitation are capable of describing the dynamics of primary infections, it was not clear whether a model incorporating the key features of innate immunity would be able to do the same. We examine the conditions under which a model incorporating parasite and innate immunity can describe data from acute Plasmodium chabaudi infections in mice. We find that innate immune response must decay slowly if the parasite density is to fall rather than equilibrate. Further, we show that within this framework the differences in the dynamics of two parasite strains are best ascribed to differences in susceptibility to innate immunity, rather than differences in the strains' growth rates or their propensity to elicit innate immunity. We suggest that further work is required to determine if innate immunity or resource limitation control acute malaria infections in mice.	[Kochin, Beth F.; Yates, Andrew J.; de Roode, Jacobus C.; Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Kochin, BF (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	bkochin@emory.edu			National Institutes of Health, NIH [U01-GM070749, R01AI049334]; Fogarty Center; Fannie and John Hertz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER	National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fannie and John Hertz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Institutes of Health (NIH grants U01-GM070749 and R01AI049334), the RAPIDD Program of the Fogarty Center, and the Fannie and John Hertz Foundation provided support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTIA R, 1994, J THEOR BIOL, V168, P141, DOI 10.1006/jtbi.1994.1094; Antia R, 2008, P ROY SOC B-BIOL SCI, V275, P1449, DOI 10.1098/rspb.2008.0198; Barclay VC, 2008, P ROY SOC B-BIOL SCI, V275, P1171, DOI 10.1098/rspb.2007.1713; BORST P, 1995, CELL, V82, P1, DOI 10.1016/0092-8674(95)90044-6; BRINKMANN V, 1984, INFECT IMMUN, V44, P743, DOI 10.1128/IAI.44.3.743-746.1984; Choudhury HR, 2000, INFECT IMMUN, V68, P6127, DOI 10.1128/IAI.68.11.6127-6132.2000; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; de Roode JC, 2004, P ROY SOC B-BIOL SCI, V271, P1073, DOI 10.1098/rspb.2004.2695; DeSouza JB, 1997, INFECT IMMUN, V65, P1593, DOI 10.1128/IAI.65.5.1593-1598.1997; Dietz K, 2006, AM J TROP MED HYG, V75, P46, DOI 10.4269/ajtmh.2006.75.46; GUPTA S, 1994, P ROY SOC B-BIOL SCI, V256, P231, DOI 10.1098/rspb.1994.0075; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P289, DOI 10.1098/rspb.2002.2203; Hetzel C, 1996, PARASITOLOGY, V113, P25, DOI 10.1017/S0031182000066245; Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564; Lamb TJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-68; Li C, 2001, MED MICROBIOL IMMUN, V189, P115, DOI 10.1007/s430-001-8017-8; McQueen PG, 2004, P NATL ACAD SCI USA, V101, P9161, DOI 10.1073/pnas.0308256101; McQueen PG, 2006, AM J TROP MED HYG, V75, P112, DOI 10.4269/ajtmh.2006.75.112; McQueen PG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000149; Mideo N, 2008, AM NAT, V172, pE214, DOI 10.1086/591684; Molineaux L, 2001, PARASITOLOGY, V122, P379, DOI 10.1017/S0031182001007533; Paget-McNicol S, 2002, PARASITOLOGY, V124, P225, DOI 10.1017/S0031182001001160; PODOBA JE, 1991, INFECT IMMUN, V59, P51, DOI 10.1128/IAI.59.1.51-58.1991; Raberg L, 2006, AM NAT, V168, P41, DOI 10.1086/505160; Recker M, 2004, NATURE, V429, P555, DOI 10.1038/nature02486; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Simpson JA, 2002, PARASITOLOGY, V124, P247, DOI 10.1017/S0031182001001202; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; STEVENSON MM, 1990, INFECT IMMUN, V58, P3225, DOI 10.1128/IAI.58.10.3225-3232.1990; STEVENSON MM, 1992, INFECT IMMUN, V60, P1193, DOI 10.1128/IAI.60.3.1193-1201.1992; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; Su Z, 2002, J INFECT DIS, V186, P1321, DOI 10.1086/344576; vanderHeyde HC, 1997, EXP PARASITOL, V85, P206, DOI 10.1006/expr.1996.4132; VANDERHEYDE HC, 1994, J IMMUNOL, V152, P4557; YAP GS, 1994, INFECT IMMUN, V62, P3761, DOI 10.1128/IAI.62.9.3761-3765.1994	36	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10444	10.1371/journal.pone.0010444	http://dx.doi.org/10.1371/journal.pone.0010444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463903	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000277379800001
J	Cardarelli, F; Gratton, E				Cardarelli, Francesco; Gratton, Enrico			In Vivo Imaging of Single-Molecule Translocation Through Nuclear Pore Complexes by Pair Correlation Functions	PLOS ONE			English	Article							ARGININE-RICH MOTIF; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN IMPORT; PERMEABILITY; CELLS	Background: Nuclear pore complexes (NPCs) mediate bidirectional transport of proteins, RNAs, and ribonucleoproteins across the double-membrane nuclear envelope. Although there are many studies that look at the traffic in the nucleus and through the nuclear envelope we propose a method to detect the nucleocytoplasmic transport kinetics in an unperturbed cell, with no requirement for specific labeling of isolated molecules and, most important, in the presence of the cell milieu. Methodology: The pair correlation function method (pCF) measures the time a molecule takes to migrate from one location to another within the cell in the presence of many molecules of the same kind. The spatial and temporal correlation among two arbitrary points in the cell provides a local map of molecular transport, and also highlights the presence of barriers to diffusion with millisecond time resolution and spatial resolution limited by diffraction. We use the pair correlation method to monitor a model protein substrate undergoing transport through NPCs in living cells, a biological problem in which single particle tracking (SPT) has given results that cannot be confirmed by traditional single-point FCS measurements because of the lack of spatial resolution. Conclusions: We show that obstacles to molecular flow can be detected and that the pCF algorithm can recognize the heterogeneity of protein intra-compartment diffusion as well as the presence of barriers to transport across NE.	[Cardarelli, Francesco; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine	Cardarelli, F (corresponding author), Univ Calif Irvine, Fluorescence Dynam Lab, Dept Biomed Engn, Irvine, CA 92717 USA.	egratton22@yahoo.com			National Institutes of Health (NIH) [P41-RRO3155, P50-GM076516]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding from National Institutes of Health (NIH) P41-RRO3155, P50-GM076516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Cardarelli F, 2009, J BIOL CHEM, V284, P36638, DOI 10.1074/jbc.M109.036699; Ciciarello M, 2004, J CELL SCI, V117, P6511, DOI 10.1242/jcs.01569; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dertinger T, 2008, OPT EXPRESS, V16, P14353, DOI 10.1364/OE.16.014353; Digman MA, 2009, BIOPHYS J, V97, P665, DOI 10.1016/j.bpj.2009.04.048; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Sun C, 2008, P NATL ACAD SCI USA, V105, P8613, DOI 10.1073/pnas.0710867105; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Wei XB, 2003, BIOPHYS J, V84, P1317, DOI 10.1016/S0006-3495(03)74947-9; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	28	54	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10475	10.1371/journal.pone.0010475	http://dx.doi.org/10.1371/journal.pone.0010475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454622	gold, Green Published			2022-12-25	WOS:000277240300032
J	Wang, Q; Hall, CL; Al-Adami, MZ; He, QF				Wang, Qiang; Hall, Camille L.; Al-Adami, Mustafa Z.; He, Qingfang			IsiA Is Required for the Formation of Photosystem I Supercomplexes and for Efficient State Transition in Synechocystis PCC 6803	PLOS ONE			English	Article							CHLOROPHYLL-BINDING PROTEIN; SYNECHOCOCCUS SP PCC7942; ALGA ANACYSTIS-NIDULANS; SALT-STRESSED CELLS; IRON-DEFICIENCY; CYANOBACTERIAL PHOTOSYNTHESIS; SPECTROSCOPIC PROPERTIES; ENERGY-DISSIPATION; ELECTRON-TRANSPORT; ANTENNA RING	Iron deficiency and other stress conditions strongly impact photosynthetic apparatus in photosynthetic organisms. Two novel chlorophyll (Chl)-containing supercomplexes (F4 and F5) in addition to the photosystem (PS) I trimers (F3) were observed by sucrose gradient ultracentrifugation in Synechocystis PCC 6803 under extensive iron starvation. 77K fluorescence and Western blot analyses of these supercomplexes revealed that they all contained IsiA. The F4 was identified as an IsiA-PSI-PSII supercomplex, while the F5 was assigned as an IsiA-PSI supercomplex. Deletion of isiA resulted in diminishing the PSI trimers (including the PSI trimers in iron-replete cells) and the two novel PSI supercomplexes (F4 and F5), and a significant reduction in the saturated whole-chain electron transport rate. However, the maximum PSII activities remained at levels similar to those of the wild type under various light conditions. The isiA-mutant was defective in state transition and sensitive to high light. The sensitivity of the isiA-mutant to high light was correlated with a higher level of membrane peroxidation. These results demonstrated that IsiA is required for the formation of PSI trimers and other higher complexes, and that IsiA is critical for efficient state transition.	[Wang, Qiang; Hall, Camille L.; Al-Adami, Mustafa Z.; He, Qingfang] Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Wang, Q (corresponding author), Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA.	qfhe@ualr.edu	He, Qingfang/I-4181-2013		National Science Foundation [MCB0447788]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant MCB0447788. http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrizhiyevskaya EG, 2002, BBA-BIOENERGETICS, V1556, P265, DOI 10.1016/S0005-2728(02)00371-7; Aspinwall CL, 2004, FEBS LETT, V574, P126, DOI 10.1016/j.febslet.2004.08.016; Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Cadoret JC, 2004, BBA-BIOENERGETICS, V1659, P100, DOI 10.1016/j.bbabio.2004.08.001; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Campbell D, 1996, PLANT PHYSIOL, V111, P1293, DOI 10.1104/pp.111.4.1293; EISENBERGDOMOVICH Y, 1995, J BIOL CHEM, V270, P30181; FERREIRA F, 1994, J APPL PHYCOL, V6, P199, DOI 10.1007/BF02186073; Geiss U, 2001, APPL ENVIRON MICROB, V67, P5247; Geiss U, 2001, FEMS MICROBIOL LETT, V197, P123, DOI 10.1016/S0378-1097(01)00098-2; GUIKEMA JA, 1983, PLANT PHYSIOL, V73, P250, DOI 10.1104/pp.73.2.250; Hagemann M, 1999, PHYSIOL PLANTARUM, V105, P670, DOI 10.1034/j.1399-3054.1999.105411.x; Havaux M, 2005, FEBS LETT, V579, P2289, DOI 10.1016/j.febslet.2005.03.021; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Ihalainen JA, 2005, BIOCHEMISTRY-US, V44, P10846, DOI 10.1021/bi0510680; Ivanov AG, 2000, FEBS LETT, V485, P173, DOI 10.1016/S0014-5793(00)02211-0; Ivanov AG, 2006, PLANT PHYSIOL, V141, P1436, DOI 10.1104/pp.106.082339; Jeanjean R, 2003, FEBS LETT, V549, P52, DOI 10.1016/S0014-5793(03)00769-5; Joshua S, 2005, PLANT PHYSIOL, V138, P1577, DOI 10.1104/pp.105.061168; Karapetyan NV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1127, DOI 10.1134/S0006297907100100; Karapetyan NV, 2008, PHOTOSYNTH RES, V97, P195, DOI 10.1007/s11120-008-9336-8; Katoh H, 2000, J BACTERIOL, V182, P6523, DOI 10.1128/JB.182.22.6523-6524.2000; Kouril R, 2005, FEBS LETT, V579, P3253, DOI 10.1016/j.febslet.2005.03.051; Kunert A, 2003, FEMS MICROBIOL LETT, V227, P255, DOI 10.1016/S0378-1097(03)00689-X; LAUDENBACH DE, 1988, J BACTERIOL, V170, P5018, DOI 10.1128/jb.170.11.5018-5026.1988; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Melkozernov AN, 2003, BIOCHEMISTRY-US, V42, P3893, DOI 10.1021/bi026987u; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; OQUIST G, 1974, PHYSIOL PLANTARUM, V31, P55, DOI 10.1111/j.1399-3054.1974.tb03677.x; OQUIST G, 1974, PHYSIOL PLANTARUM, V30, P30, DOI 10.1111/j.1399-3054.1974.tb04987.x; PAKRASI HB, 1985, PLANT PHYSIOL, V79, P290, DOI 10.1104/pp.79.1.290; PAKRASI HB, 1985, P NATL ACAD SCI USA, V82, P6903, DOI 10.1073/pnas.82.20.6903; Pyndiah S, 2007, MOL CELL PROTEOMICS, V6, P193, DOI 10.1074/mcp.M600363-MCP200; Rakhimberdieva MG, 2006, BBA-BIOENERGETICS, P286; RIETHMAN HC, 1988, PLANT PHYSIOL, V88, P497, DOI 10.1104/pp.88.2.497; Sandstrom S, 2002, PHYSIOL PLANTARUM, V116, P255, DOI 10.1034/j.1399-3054.2002.1160216.x; Sandstrom S, 2001, PHOTOCHEM PHOTOBIOL, V74, P431, DOI 10.1562/0031-8655(2001)074<0431:CTIGPF>2.0.CO;2; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHUSTER G, 1988, EUR J BIOCHEM, V177, P403, DOI 10.1111/j.1432-1033.1988.tb14389.x; Singh AK, 2007, PHOTOSYNTH RES, V93, P17, DOI 10.1007/s11120-007-9151-7; VANDORSSEN RJ, 1987, BIOCHIM BIOPHYS ACTA, V890, P134, DOI 10.1016/0005-2728(87)90014-4; Vinnemeier J, 1998, FEMS MICROBIOL LETT, V169, P323, DOI 10.1111/j.1574-6968.1998.tb13336.x; Vinnemeier J, 1999, ARCH MICROBIOL, V172, P377, DOI 10.1007/s002030050774; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Yeremenko N, 2004, BIOCHEMISTRY-US, V43, P10308, DOI 10.1021/bi048772l; Yousef N, 2003, ARCH MICROBIOL, V180, P471, DOI 10.1007/s00203-003-0618-4	52	21	21	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10432	10.1371/journal.pone.0010432	http://dx.doi.org/10.1371/journal.pone.0010432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454661	Green Submitted, Green Published, gold			2022-12-25	WOS:000277240300009
J	Wu, P; Lau, EHY; Cowling, BJ; Leung, CC; Tam, CM; Leung, GM				Wu, Peng; Lau, Eric H. Y.; Cowling, Benjamin J.; Leung, Chi-Chiu; Tam, Cheuk-Ming; Leung, Gabriel M.			The Transmission Dynamics of Tuberculosis in a Recently Developed Chinese City	PLOS ONE			English	Article							EXOGENOUS REINFECTION; HONG-KONG; CHILDHOOD; EPIDEMIOLOGY; ELIMINATION; GENDER; RISKS	Background: Hong Kong is an affluent subtropical city with a well-developed healthcare infrastructure but an intermediate TB burden. Declines in notification rates through the 1960s and 1970s have slowed since the 1980s to the current level of around 82 cases per 100 000 population. We studied the transmission dynamics of TB in Hong Kong to explore the factors underlying recent trends in incidence. Methodology/Principal Findings: We fitted an age-structured compartmental model to TB notifications in Hong Kong between 1968 and 2008. We used the model to quantify the proportion of annual cases due to recent transmission versus endogenous reactivation of latent infection, and to project trends in incidence rates to 2018. The proportion of annual TB notifications attributed to endogenous reactivation increased from 46% to 70% between 1968 and 2008. Age-standardized notification rates were projected to decline to approximately 56 per 100 000 in 2018. Conclusions/Significance: Continued intermediate incidence of TB in Hong Kong is driven primarily by endogenous reactivation of latent infections. Public health interventions which focus on reducing transmission may not lead to substantial reductions in disease burden associated with endogenous reactivation of latent infections in the short- to medium-term. While reductions in transmission with socio-economic development and public health interventions will lead to declines in TB incidence in these regions, a high prevalence of latent infections may hinder substantial declines in burden in the longer term. These findings may therefore have important implications for the burden of TB in developing regions with higher levels of transmission currently.	[Wu, Peng; Lau, Eric H. Y.; Cowling, Benjamin J.; Leung, Gabriel M.] Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Wu, Peng; Lau, Eric H. Y.; Cowling, Benjamin J.; Leung, Gabriel M.] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Leung, Chi-Chiu; Tam, Cheuk-Ming] Govt Hong Kong SAR, Dept Hlth, TB & Chest Serv, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wu, P (corresponding author), Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009; Lau, Eric/AAJ-6588-2021	Cowling, Benjamin John/0000-0002-6297-7154; Lau, Eric/0000-0002-6688-9637; Wu, Peng/0000-0003-1157-9401; Leung, Gabriel/0000-0002-2503-6283	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR [09080802]; US National Institute of General Medical Sciences [1 U54 GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR; US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR (ref: 09080802) and the US National Institute of General Medical Sciences (grant no. 1 U54 GM088558, MIDAS Harvard Center for Communicable Disease Dynamics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD O, 2001, 31 GPE WHO; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Borgdorff MW, 2005, EMERG INFECT DIS, V11, P597, DOI 10.3201/eid1104.041103; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; *CENS STAT DEP, 2008, POP AG GROUP SEX; *CENS STAT DEP, 2008, HONG KONG LIF TABL 1; Chan-Yeung M, 2003, J CLIN MICROBIOL, V41, P2706, DOI 10.1128/JCM.41.6.2706-2708.2003; Chan-Yeung M, 2006, RESPIROLOGY, V11, P442, DOI 10.1111/j.1440-1843.2006.00871.x; Chee CB, 2003, B WORLD HEALTH ORGAN, V81, P217; Chiang CY, 2005, LANCET INFECT DIS, V5, P629, DOI 10.1016/S1473-3099(05)70240-1; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; *CTR HLTH PROT, 2000, TUB CONTR HONG KONG; Diwan VK, 1999, LANCET, V353, P1000, DOI 10.1016/S0140-6736(99)01318-5; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Fine PEM, 1999, NEW ENGL J MED, V341, P1226, DOI 10.1056/NEJM199910143411609; *GOV HONG KONG SAR, CENS STAT DEP POP GR; *GOV HONG KONG SAR, HONG KONG TUB CHEST; *GOV HONG KONG SAR, CENS STAT DEP STAT S; *HLTH SERV RES GRO, 2000, SERV TREATM PAT TUB; *HONG KONG TUB CHE, 2007, ANN REP DEP HTLH GOV; Hudelson P, 1996, TUBERCLE LUNG DIS, V77, P391, DOI 10.1016/S0962-8479(96)90110-0; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P278; Schooling M, 2004, INT J EPIDEMIOL, V33, P1219, DOI 10.1093/ije/dyh221; Schwander S. K., 2006, REICHMAN HERSHFIELDS, P117; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; *STOP TB PARTN WHO, 2006, WHOHTMSTB200635 STOP; *UN, 2002, A56326 UN GEN ASS; van den Dool C, 2008, PLOS MED, V5, P1453, DOI 10.1371/journal.pmed.0050200; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; World Health Organization, 2008, GLOB TUB CONTR SURV; Wu P, 2008, THORAX, V63, P312, DOI 10.1136/thx.2007.082354	40	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10468	10.1371/journal.pone.0010468	http://dx.doi.org/10.1371/journal.pone.0010468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454620	Green Published, gold, Green Submitted			2022-12-25	WOS:000277240300029
J	Hartbauer, M				Hartbauer, Manfred			Collective Defense of Aphis nerii and Uroleucon hypochoeridis (Homoptera, Aphididae) against Natural Enemies	PLOS ONE			English	Article							APHELINUS-ASYCHIS HYMENOPTERA; SCHIZAPHIS-GRAMINUM HOMOPTERA; ACYRTHOSIPHON-PISUM HARRIS; ALARM PHEROMONE; VIBRATIONAL COMMUNICATION; OVIPOSITION BEHAVIOR; PEA APHID; COLEMANI VIERECK; SOCIAL APHID; SELFISH HERD	The prevalent way aphids accomplish colony defense against natural enemies is a mutualistic relationship with ants or the occurrence of a specialised soldier caste typcial for eusocial aphids, or even both. Despite a group-living life style of those aphid species lacking these defense lines, communal defense against natural predators has not yet been observed there. Individuals of Aphis nerii (Oleander aphid) and Uroleucon hypochoeridis, an aphid species feeding on Hypochoeris radicata (hairy cat's ear), show a behavioral response to visual stimulation in the form of spinning or twitching, which is often accompanied by coordinated kicks executed with hind legs. Interestingly, this behaviour is highly synchronized among members of a colony and repetitive visual stimulation caused strong habituation. Observations of natural aphid colonies revealed that a collective twitching and kicking response (CTKR) was frequently evoked during oviposition attempts of the parasitoid wasp Aphidius colemani and during attacks of aphidophagous larvae. CTKR effectively interrupted oviposition attempts of this parasitoid wasp and even repelled this parasitoid from colonies after evoking consecutive CTKRs. In contrast, solitary feeding A. nerii individuals were not able to successfully repel this parasitoid wasp. In addition, CTKR was also evoked through gentle substrate vibrations. Laser vibrometry of the substrate revealed twitching-associated vibrations that form a train of sharp acceleration peaks in the course of a CTKR. This suggests that visual signals in combination with twitching-related substrate vibrations may play an important role in synchronising defense among members of a colony. In both aphid species collective defense in encounters with different natural enemies was executed in a stereotypical way and was similar to CTKR evoked through visual stimulation. This cooperative defense behavior provides an example of a surprising sociality that can be found in some aphid species that are not expected to be social at all.	Karl Franzens Univ Graz, Dept Zool, Behav Ecol Grp, Graz, Austria	University of Graz	Hartbauer, M (corresponding author), Karl Franzens Univ Graz, Dept Zool, Behav Ecol Grp, Graz, Austria.	manfred.hartbauer@uni-graz.at			Austrian Science Fund [P 21808-B09]; Austrian Science Fund (FWF) [P 21808] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (http://www.fwf.ac.at/, grant P 21808-B09) by contributing to equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot P, 2001, P NATL ACAD SCI USA, V98, P12068, DOI 10.1073/pnas.201212698; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; AOKI S, 1978, New Entomologist, V27, P7; Aoki Shigeyuki, 2002, Entomological Science, V5, P55; ARAKAKI N, 1989, J ETHOL, V7, P83, DOI 10.1007/BF02350028; BOYLE H, 1978, P ENTOMOL SOC WASH, V80, P441; CANGIALOSI KR, 1990, BEHAV ECOL SOCIOBIOL, V27, P49; Casas J, 1998, BIOL CONTROL, V11, P147, DOI 10.1006/bcon.1997.0593; Casas J, 2007, P ROY SOC B-BIOL SCI, V274, P1087, DOI 10.1098/rspb.2006.0306; Choe DH, 2006, SOCIOBIOLOGY, V48, P799; Choe JC, 1997, EVOLUTION SOCIAL BEH; CLARIDGE MF, 1985, ANNU REV ENTOMOL, V30, P297, DOI 10.1146/annurev.en.30.010185.001501; CLEGG JM, 1982, CAN J ZOOL, V60, P2245, DOI 10.1139/z82-289; Cocroft RB, 1996, NATURE, V382, P679, DOI 10.1038/382679a0; Cocroft RB, 2005, P ROY SOC B-BIOL SCI, V272, P1023, DOI 10.1098/rspb.2004.3041; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cocroft RB, 2001, AM ZOOL, V41, P1215, DOI 10.1668/0003-1569(2001)041[1215:VCATEO]2.0.CO;2; Cocroft RB, 2002, BEHAV ECOL, V13, P125, DOI 10.1093/beheco/13.1.125; Cokl A, 2005, J EXP BIOL, V208, P1481, DOI 10.1242/jeb.01557; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; CRESPI BJ, 1992, NATURE, V359, P724, DOI 10.1038/359724a0; De Faris AMI, 1999, ENVIRON ENTOMOL, V28, P858, DOI 10.1093/ee/28.5.858; Devetak D., 1979, Bioloski Vestnik, V26, P131; DIXON A. F. G., 1958, TRANS ROY ENTOMOL SOC LONDON, V110, P319; Eastop V., 1954, ENTOMOLOGIST, V85, P57; EL-ZIADY S., 1956, Proceedings of the Royal Entomological Society of London, V31, P61; EVANS DL, 1990, INSECT DEFENCES ADAP, pR15; FOSTER WA, 1990, BEHAV ECOL SOCIOBIOL, V27, P421, DOI 10.1007/BF00164069; Foster WA, 1998, ANIM BEHAV, V55, P761, DOI 10.1006/anbe.1997.0664; GARDNER SM, 1984, ECOL ENTOMOL, V9, P149, DOI 10.1111/j.1365-2311.1984.tb00709.x; GERLING D, 1990, J INSECT BEHAV, V3, P501, DOI 10.1007/BF01052014; Gilbert F, 2005, EUR J ENTOMOL, V102, P325, DOI 10.14411/eje.2005.050; Gilbert F.S., 1986, HOVERFLIES; GOGALA M, 1984, Bioloski Vestnik, V32, P19; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HERZIG J., 1937, Zeitschrift fur Angewandte Entomologie, V24, P367; HIGHT S C, 1972, Environmental Entomology, V1, P205; Hodek I., 1996, ECOLOGY COCCINELLIDA; HOFSVANG T, 1986, ENTOMOPHAGA, V31, P261, DOI 10.1007/BF02373335; HOGUE C, 1972, J LEPID SOC, V31, P261; KLINGAUF F, 1967, Z ANGEWANDE ENTOMOLO, V59, P266; KOUAME KL, 1991, OECOLOGIA, V88, P197, DOI 10.1007/BF00320811; KUNKEL H, 1973, Bonner Zoologische Beitraege, V24, P105; KUNKEL H, 1972, BONNER ZOOL BEITR, V2, P161; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P1432; Magal C, 2000, J ACOUST SOC AM, V108, P2412, DOI 10.1121/1.1286098; Markl H., 1983, P332; MCALLISTER MK, 1987, NATURE, V328, P797, DOI 10.1038/328797b0; MCCONNELL JA, 1990, ENVIRON ENTOMOL, V19, P1798, DOI 10.1093/ee/19.6.1798; MESSING RH, 1995, AGR ECOSYST ENVIRON, V52, P13, DOI 10.1016/0167-8809(94)09002-O; MICHELSEN A, 1982, BEHAV ECOL SOCIOBIOL, V11, P269, DOI 10.1007/BF00299304; MOORING MS, 1992, BEHAVIOUR, V123, P173, DOI 10.1163/156853992X00011; NAULT LR, 1976, SCIENCE, V192, P1349, DOI 10.1126/science.1273595; NIJVELDT W, 1988, WORLD CROP PESTS APH, P271; PAMILO P, 1984, BEHAV ECOL SOCIOBIOL, V15, P241, DOI 10.1007/BF00292985; Perdikis DC, 2004, EUR J ENTOMOL, V101, P333, DOI 10.14411/eje.2004.044; Potting RPJ, 1999, ENTOMOL EXP APPL, V91, P143, DOI 10.1023/A:1003615914287; PRINCIPI MM, 1984, BIOL CHRYSOPIDAE, P76; PROP N., 1960, ARCH NEERLAND ZOOL, V13, P380; ROITBERG BD, 1978, CAN J ZOOL, V56, P103, DOI 10.1139/z78-014; ROTHSCHILD M, 1970, J INSECT PHYSIOL, V16, P1141, DOI 10.1016/0022-1910(70)90203-9; RUTH W E, 1975, Entomophaga, V20, P65, DOI 10.1007/BF02373451; SCHUTZE M, 1991, ENTOMOL GEN, V16, P1; Shingleton AW, 2000, P ROY SOC B-BIOL SCI, V267, P1863, DOI 10.1098/rspb.2000.1222; STAMP NE, 1982, ENVIRON ENTOMOL, V11, P100, DOI 10.1093/ee/11.1.100; STARY P, 1975, ACTA ENTOMOL BOHEMOS, V72, P156; Stary P., 1970, BIOL APHID PARASITES; Stern DL, 1996, BIOL REV, V71, P27, DOI 10.1111/j.1469-185X.1996.tb00741.x; SUNDERLAND KD, 1986, J APPL ECOL, V23, P433, DOI 10.2307/2404027; Vulinec K., 1990, P251; WEISSER WW, 1995, ENTOMOL EXP APPL, V76, P133, DOI 10.1007/BF02383211; WILBERT H, 1967, BIOCONTROL, V12, P127; Williams C. B., 1922, Entomologist London, V55, P173; WINK M, 1991, ENTOMOL GEN, V15, P237	76	32	34	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10417	10.1371/journal.pone.0010417	http://dx.doi.org/10.1371/journal.pone.0010417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454683	gold, Green Published, Green Submitted			2022-12-25	WOS:000277240100023
J	Leischner, U; Schierloh, A; Zieglgansberger, W; Dodt, HU				Leischner, Ulrich; Schierloh, Anja; Zieglgaensberger, Walter; Dodt, Hans-Ulrich			Formalin-Induced Fluorescence Reveals Cell Shape and Morphology in Biological Tissue Samples	PLOS ONE			English	Article							DIMENSIONS	Ultramicroscopy is a powerful tool to reveal detailed three-dimensional structures of large microscopical objects. Using high magnification, we observed that formalin induces fluorescence more in extra-cellular space and stains cellular structures negatively, rendering cells as dark objects in front of a bright background. Here, we show this effect on a three-dimensional image stack of a hippocampus sample, focusing on the CA1 region. This method, called FIF-Ultramicroscopy, allows for the three-dimensional observation of cellular structures in various tissue types without complicated staining techniques.	[Leischner, Ulrich; Schierloh, Anja; Zieglgaensberger, Walter; Dodt, Hans-Ulrich] Max Planck Inst Psychiat, Munich, Germany	Max Planck Society	Leischner, U (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	Ulrich.leischner@lrz.tum.de		Leischner, Ulrich/0000-0001-7771-2135	Hertie foundation;  [FSB 391]	Hertie foundation; 	This work was supported by grants from the Hertie foundation and FSB 391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYAD S, 1998, EXTRACELLULAR MATRIX, P1; Buytaert JAN, 2009, APPL OPTICS, V48, P941, DOI 10.1364/AO.48.000941; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; CORRODI H, 1967, J HISTOCHEM CYTOCHEM, V15, P65, DOI 10.1177/15.2.65; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; FALCK B, 1962, J HISTOCHEM CYTOCHEM, V10, P348, DOI 10.1177/10.3.348; FRAENKELCONRAT H, 1948, J BIOL CHEM, V174, P827; GONZALEZ RC, 2009, DIGITAL IMAGE PROCES, P486; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Leischner U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005785; Reynaud EG, 2008, HFSP J, V2, P266, DOI 10.2976/1.2974980; ROST FWD, 1995, FLUORESCENCE MICROSC, V2, P54; Siedentopf H, 1902, ANN PHYS, V315, P1, DOI [10.1002/andp.19023150102, DOI 10.1002/ANDP.19023150102]; SPALTEHOLZ W, 2011, DURCHSICHTIGMACHEN M; STERNBERG SR, 1986, COMPUT VISION GRAPH, V35, P333, DOI 10.1016/0734-189X(86)90004-6; STERNBERG SR, 1983, BIOMEDICAL IMAGE PRO, P22; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Wein W, 2007, LECT NOTES COMPUT SC, V4792, P718	19	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10391	10.1371/journal.pone.0010391	http://dx.doi.org/10.1371/journal.pone.0010391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20436930	gold, Green Published, Green Submitted			2022-12-25	WOS:000277154200026
J	Marreddy, RKR; Geertsma, ER; Permentier, HP; Pinto, JPC; Kok, J; Poolman, B				Marreddy, Ravi K. R.; Geertsma, Eric R.; Permentier, Hjalmar P.; Pinto, Joao P. C.; Kok, Jan; Poolman, Bert			Amino Acid Accumulation Limits the Overexpression of Proteins in Lactococcus lactis	PLOS ONE			English	Article							CONTROLLED GENE-EXPRESSION; GREEN FLUORESCENT PROTEIN; STREPTOCOCCUS-CREMORIS; MEMBRANE-PROTEINS; SACCHAROMYCES-CEREVISIAE; TRANSPORT-SYSTEM; RECEPTOR OPPA; BINDING; IDENTIFICATION; CONSTRUCTION	Background: Understanding the biogenesis pathways for the functional expression of recombinant proteins, in particular membrane proteins and complex multidomain assemblies, is a fundamental issue in cell biology and of high importance for future progress in structural genomics. In this study, we employed a proteomic approach to understand the difference in expression levels for various multidomain membrane proteins in L. lactis cells grown in complex and synthetic media. Methodology/Principal Findings: The proteomic profiles of cells growing in media in which the proteins were expressed to high or low levels suggested a limitation in the availability of branched-chain amino acids, more specifically a too limited capacity to accumulate these nutrients. By supplying the cells with an alternative path for accumulation of Ile, Leu and/or Val, i.e., a medium supplement of the appropriate dipeptides, or by engineering the transport capacity for branched-chain amino acids, the expression levels could be increased several fold. Conclusions: We show that the availability of branched chain amino acids is a critical factor for the (over) expression of proteins in L. lactis. The forward engineering of cells for functional protein production required fine-tuning of co-expression of the branched chain amino acid transporter.	[Marreddy, Ravi K. R.; Geertsma, Eric R.; Permentier, Hjalmar P.; Poolman, Bert] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr,Zernike Inst Adv Mat, Groningen, Netherlands; [Pinto, Joao P. C.; Kok, Jan] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands	University of Groningen; University of Groningen	Marreddy, RKR (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr,Zernike Inst Adv Mat, Groningen, Netherlands.	b.poolman@rug.nl	Marreddy, RaviKanthReddy/Q-5680-2018; Kok, Jan/C-9972-2012; Permentier, Hjalmar P/H-4190-2016; Institute, Zernike/W-7033-2019; Poolman, Bert/D-1882-2012	Marreddy, RaviKanthReddy/0000-0003-0425-406X; Permentier, Hjalmar P/0000-0001-7317-8887; Geertsma, Eric R./0000-0002-2789-5444	Federation of the Societies of Biochemistry and Molecular Biology (FEBS); Human Frontier Science Program; Netherlands Proteomics Centre (NPC); European Membrane Protein Consortium EDICT (European Drug Initiative on Channels and Transporters); Netherlands Science Foundation (NWO) [700-56-302]	Federation of the Societies of Biochemistry and Molecular Biology (FEBS); Human Frontier Science Program(Human Frontier Science Program); Netherlands Proteomics Centre (NPC); European Membrane Protein Consortium EDICT (European Drug Initiative on Channels and Transporters); Netherlands Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	ERG acknowledges a long-term fellowship from Federation of the Societies of Biochemistry and Molecular Biology (FEBS) and the Human Frontier Science Program. This research work was additionally supported by the Netherlands Proteomics Centre (NPC), the European Membrane Protein Consortium EDICT (European Drug Initiative on Channels and Transporters), and the Netherlands Science Foundation (NWO; Chemical Sciences Top Subsidy to BP; grant number 700-56-302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berntsson RPA, 2009, PROTEIN SCI, V18, P1121, DOI 10.1002/pro.97; Berntsson RPA, 2009, EMBO J, V28, P1332, DOI 10.1038/emboj.2009.65; Biemans-Oldehinkel E, 2003, EMBO J, V22, P5983, DOI 10.1093/emboj/cdg581; Brooijmans RJW, 2007, J BACTERIOL, V189, P5203, DOI 10.1128/JB.00361-07; den Hengst CD, 2006, J BACTERIOL, V188, P3280, DOI 10.1128/JB.188.9.3280-3289.2006; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Detmers FJM, 2000, P NATL ACAD SCI USA, V97, P12487, DOI 10.1073/pnas.220308797; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; DRIESSEN AJM, 1987, J BACTERIOL, V169, P5193, DOI 10.1128/jb.169.11.5193-5200.1987; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Gorgens JF, 2005, APPL MICROBIOL BIOT, V67, P684, DOI 10.1007/s00253-004-1803-3; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; Hagting A, 1997, EUR J BIOCHEM, V247, P581, DOI 10.1111/j.1432-1033.1997.00581.x; JENSEN PR, 1993, APPL ENVIRON MICROB, V59, P4363, DOI 10.1128/AEM.59.12.4363-4366.1993; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; KUNJI ERS, 1995, J BIOL CHEM, V270, P1569, DOI 10.1074/jbc.270.4.1569; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; KUNJI ERS, 1993, J BACTERIOL, V175, P2052, DOI 10.1128/JB.175.7.2052-2059.1993; LINARES DM, 2010, EVOLVED LAC IN PRESS; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; Mulligan C, 2009, P NATL ACAD SCI USA, V106, P1778, DOI 10.1073/pnas.0809979106; Ngo JT, 2009, NAT CHEM BIOL, V5, P715, DOI 10.1038/nchembio.200; POOLMAN B, 1988, J BACTERIOL, V170, P700, DOI 10.1128/jb.170.2.700-707.1988; POOLMAN B, 1987, J BACTERIOL, V169, P1460, DOI 10.1128/jb.169.4.1460-1468.1987; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; Solem C, 2008, APPL ENVIRON MICROB, V74, P4772, DOI 10.1128/AEM.00134-08; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; 2008, BIOCH J, V409, P193	39	22	22	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10317	10.1371/journal.pone.0010317	http://dx.doi.org/10.1371/journal.pone.0010317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436673	Green Published, gold, Green Submitted			2022-12-25	WOS:000277079500007
J	Gibert, Y; Bernard, L; Debiais-Thibaud, M; Bourrat, F; Joly, JS; Pottin, K; Meyer, A; Retaux, S; Stock, DW; Jackman, WR; Seritrakul, P; Begemann, G; Laudet, V				Gibert, Yann; Bernard, Laure; Debiais-Thibaud, Melanie; Bourrat, Franck; Joly, Jean-Stephane; Pottin, Karen; Meyer, Axel; Retaux, Sylvie; Stock, David W.; Jackman, William R.; Seritrakul, Pawat; Begemann, Gerrit; Laudet, Vincent			Formation of oral and pharyngeal dentition in teleosts depends on differential recruitment of retinoic acid signaling	FASEB JOURNAL			English	Article						tooth; Astyanax; FGF; zebrafish	MEDAKA ORYZIAS-LATIPES; ZEBRAFISH DANIO-RERIO; PECTORAL FIN BUD; TOOTH DEVELOPMENT; FOREBRAIN DEVELOPMENT; GENE-EXPRESSION; SONIC-HEDGEHOG; IN-VIVO; FGF; RECEPTORS	One of the goals of evolutionary developmental biology is to link specific adaptations to changes in developmental pathways. The dentition of cypriniform fishes, which in contrast to many other teleost fish species possess pharyngeal teeth but lack oral teeth, provides a suitable model to study the development of feeding adaptations. Here, we have examined the involvement of retinoic acid (RA) in tooth development and show that RA is specifically required to induce the pharyngeal tooth developmental program in zebrafish. Perturbation of RA signaling at this stage abolished tooth induction without affecting the development of tooth-associated ceratobranchial bones. We show that this inductive event is dependent on RA synthesis from aldh1a2 in the ventral posterior pharynx. Fibroblast growth factor (FGF) signaling has been shown to be critical for tooth induction in zebrafish, and its loss has been associated with oral tooth loss in cypriniform fishes. Pharmacological treatments targeting the RA and FGF pathways revealed that both pathways act independently during tooth induction. In contrast, we find that in Mexican tetra and medaka, species that also possess oral teeth, both oral and pharyngeal teeth are induced independently of RA. Our analyses suggest an evolutionary scenario in which the gene network controlling tooth development obtained RA dependency in the lineage leading to the cypriniforms. The loss of pharyngeal teeth in this group was cancelled out through a shift in aldh1a2 expression, while oral teeth might have been lost ultimately due to deficient RA signaling in the oral cavity.-Gibert, Y., Bernard, L., Debiais-Thibaud, M., Bourrat, F., Joly, J.-S., Pottin, K., Meyer, A., Retaux, S., Stock, D. W., Jackman, W. R., Seritrakul, P., Begemann, G., Laudet, V. Formation of oral and pharyngeal dentition in teleosts depends on differential recruitment of retinoic acid signaling. FASEB J. 24, 3298-3309 (2010). www.fasebj.org	[Gibert, Yann; Bernard, Laure; Laudet, Vincent] Univ Lyon, CNRS, Ecole Normale Super Lyon, INRA,Mol Zool Grp,Inst Genom Fonct Lyon,UCB Lyon, F-69364 Lyon 07, France; [Debiais-Thibaud, Melanie] CNRS, UPR 9034, Equipe Genome Dev & Evolut, Gif Sur Yvette, France; [Pottin, Karen; Retaux, Sylvie] CNRS, UPR 3294, Inst Neurobiol A Fessard, Equipe DECA, Gif Sur Yvette, France; [Bourrat, Franck; Joly, Jean-Stephane] INRA, Grp U1126, Paris, France; [Meyer, Axel; Begemann, Gerrit] Univ Konstanz, Dept Biol, Constance, Germany; [Stock, David W.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Jackman, William R.; Seritrakul, Pawat] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; University of Konstanz; University of Colorado System; University of Colorado Boulder; Bowdoin College	Laudet, V (corresponding author), Univ Lyon, CNRS, Ecole Normale Super Lyon, INRA,Mol Zool Grp,Inst Genom Fonct Lyon,UCB Lyon, F-69364 Lyon 07, France.	vincent.laudet@ens-lyon.fr	Begemann, Gerrit/C-6223-2011; Meyer, Axel/C-9826-2009	Begemann, Gerrit/0000-0001-7822-7617; Meyer, Axel/0000-0002-0888-8193; Pottin, Karen/0000-0001-9491-4660; Seritrakul, Pawat/0000-0002-8320-6789; Debiais-Thibaud, Melanie/0000-0002-1377-2515	Deutsche Forschungsgemeinschaft; ENS Lyon; ANR program; French Ministry of Research; ANR-Neuro; INRA; CNRS; ANR Grant Choregnet; Marine Genomics Center of Excellence; FP6 STREP Plurigenes; NIH [5F32DE015029, P20RR016463]; NSF [IOS-0446720]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE015029] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ENS Lyon; ANR program(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); ANR-Neuro(French National Research Agency (ANR)); INRA; CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR Grant Choregnet(French National Research Agency (ANR)); Marine Genomics Center of Excellence; FP6 STREP Plurigenes; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by an ARC fellowship (to Y.G.), funding from the Deutsche Forschungsgemeinschaft (to G. B.), funding from the ENS Lyon, the ANR program and the French Ministry of Research (to V. L.), an ANR-Neuro (to S. R.), INRA, CNRS, the ANR Grant Choregnet, the Marine Genomics Center of Excellence, the FP6 STREP Plurigenes (to J.-S.J.), and NIH 5F32DE015029 and P20RR016463 (to W.R.J.), and a NSF IOS-0446720 (to D. W. S.). The authors thank Pierre Germain (Centre de Biochimie Structurale, Montpellier, France) for his kind gift of the RARa and RARg selective agonists and antagonists. Thanks to Matthieu Simion and Laurent Legendre for expert animal care in Gif.	Ahn DG, 2002, NATURE, V417, P754, DOI 10.1038/nature00814; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Begemann G, 2001, DEVELOPMENT, V128, P3081; Begemann G, 2004, DEV BIOL, V271, P119, DOI 10.1016/j.ydbio.2004.03.033; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Borday-Birraux V, 2006, EVOL DEV, V8, P130, DOI 10.1111/j.1525-142X.2006.00084.x; Canestro C, 2006, EVOL DEV, V8, P394, DOI 10.1111/j.1525-142X.2006.00113.x; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Debiais-Thibaud M, 2008, EVOL DEV, V10, P464, DOI 10.1111/j.1525-142X.2008.00257.x; Debiais-Thibaud M, 2007, J EXP ZOOL PART B, V308B, P693, DOI 10.1002/jez.b.21183; Escriva H, 2002, DEVELOPMENT, V129, P2905; Escriva H, 2006, PLOS GENET, V2, P955, DOI 10.1371/journal.pgen.0020102; Fisher S, 1999, NAT GENET, V23, P442, DOI 10.1038/70557; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Gibert Y, 2006, DEVELOPMENT, V133, P2649, DOI 10.1242/dev.02438; Grandel H, 2002, DEVELOPMENT, V129, P2851; Hale LA, 2006, GENE EXPR PATTERNS, V6, P546, DOI 10.1016/j.modgep.2005.10.007; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Hamade A, 2006, DEV BIOL, V289, P127, DOI 10.1016/j.ydbio.2005.10.019; Hernandez RE, 2004, DEVELOPMENT, V131, P4511, DOI 10.1242/dev.01297; Huysseune A, 1998, ANAT EMBRYOL, V198, P289, DOI 10.1007/s004290050185; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jackman WR, 2004, DEV BIOL, V274, P139, DOI 10.1016/j.ydbio.2004.07.003; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kopinke D, 2006, DEV DYNAM, V235, P2695, DOI 10.1002/dvdy.20905; Laurenti P, 2004, DEV DYNAM, V230, P727, DOI 10.1002/dvdy.20080; Liang D, 2008, GENE EXPR PATTERNS, V8, P248, DOI 10.1016/j.gep.2007.12.007; Linville A, 2009, DEV BIOL, V325, P60, DOI 10.1016/j.ydbio.2008.09.022; Mandler M, 2001, DEV BIOL, V240, P548, DOI 10.1006/dbio.2001.0490; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Matt N, 2003, DEVELOPMENT, V130, P2083, DOI 10.1242/dev.00428; Menuet A, 2007, DEVELOPMENT, V134, P845, DOI 10.1242/dev.02780; Miletich Isabelle, 2004, Birth Defects Res C Embryo Today, V72, P200, DOI 10.1002/bdrc.20012; Mitsiadis TA, 2006, J EXP ZOOL PART B, V306B, P177, DOI 10.1002/jez.b.21104; Morriss-Kay GM, 1999, INT REV CYTOL, V188, P73; Nelson JS, 1984, FISHES WORLD; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Peterkova R, 2006, J EXP ZOOL PART B, V306B, P234, DOI 10.1002/jez.b.21093; Pittlik S, 2008, GENE EXPR PATTERNS, V8, P141, DOI 10.1016/j.gep.2007.11.003; Ribes V, 2006, DEVELOPMENT, V133, P351, DOI 10.1242/dev.02204; Schilling TF, 1996, DEVELOPMENT, V123, P329; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Smith MM, 2009, J EXP ZOOL PART B, V312B, P260, DOI 10.1002/jez.b.21272; Stock DW, 2007, J EXP ZOOL PART B, V308B, P523, DOI 10.1002/jez.b.21187; Stock DW, 2006, DEVELOPMENT, V133, P3127, DOI 10.1242/dev.02459; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tompkins K, 2006, CONNECT TISSUE RES, V47, P111, DOI 10.1080/03008200600727756; Van der Heyden C, 2000, CELL TISSUE RES, V302, P205, DOI 10.1007/s004410000180; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304	51	23	24	3	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2010	24	9					3298	3309		10.1096/fj.09-147488	http://dx.doi.org/10.1096/fj.09-147488			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	645IK	20445074	Green Published			2022-12-25	WOS:000281446400018
J	Martin-Galiano, AJ; Buey, RM; Cabezas, M; Andreu, JM				Martin-Galiano, Antonio J.; Buey, Ruben M.; Cabezas, Marta; Andreu, Jose M.			Mapping Flexibility and the Assembly Switch of Cell Division Protein FtsZ by Computational and Mutational Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS FTSZ; ALPHA-BETA-TUBULIN; GTP HYDROLYSIS; STRUCTURAL INSIGHTS; ESSENTIAL DYNAMICS; ESCHERICHIA-COLI; BINDING-PROTEINS; POLYMERIZATION; RESIDUE; DOMAIN	The molecular switch for nucleotide-regulated assembly and disassembly of the main prokaryotic cell division protein FtsZ is unknown despite the numerous crystal structures that are available. We have characterized the functional motions in FtsZ with a computational consensus of essential dynamics, structural comparisons, sequence conservation, and networks of co-evolving residues. Employing this information, we have constructed 17 mutants, which alter the FtsZ functional cycle at different stages, to modify FtsZ flexibility. The mutant phenotypes ranged from benign to total inactivation and included increased GTPase, reduced assembly, and stabilized assembly. Six mutations clustering at the long cleft between the C-terminal beta-sheet and core helix H7 deviated FtsZ assembly into curved filaments with inhibited GTPase, which still polymerize cooperatively. These mutations may perturb the predicted closure of the C-terminal domain onto H7 required for switching between curved and straight association modes and for GTPase activation. By mapping the FtsZ assembly switch, this work also gives insight into FtsZ druggability because the curved mutations delineate the putative binding site of the promising antibacterial FtsZ inhibitor PC190723.	[Martin-Galiano, Antonio J.; Cabezas, Marta; Andreu, Jose M.] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Buey, Ruben M.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Martin-Galiano, AJ (corresponding author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, Madrid 28040, Spain.	a.martin@cib.csic.es; j.m.andreu@cib.csic.es	Martinez-Buey, Ruben/K-4296-2014	Martinez-Buey, Ruben/0000-0003-1263-0221; Martin-Galiano, Antonio Javier/0000-0002-6662-329X; Andreu, Jose M/0000-0001-8064-6933	Ministerio de Ciencia e Innovacion [BFU2008-00013]; Comunidad Autonoma de Madrid [S-BIO-0214-2006]; Juan de la Cierva; Federation of European Biochemical Societies; Comunidad de Madrid	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Juan de la Cierva(Instituto de Salud Carlos III); Federation of European Biochemical Societies; Comunidad de Madrid(Comunidad de Madrid)	This work was supported by grants from Ministerio de Ciencia e Innovacion BFU2008-00013 and Comunidad Autonoma de Madrid S-BIO-0214-2006 (to J. M. A.). This work was also supported by a Juan de la Cierva contract (to A. J. M.-G.), a Federation of European Biochemical Societies postdoctoral fellowship (to R. M. B.), and a contract from Comunidad de Madrid (to M. C.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Addinall SG, 2005, J BACTERIOL, V187, P358, DOI 10.1128/JB.187.1.358-365.2005; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Andreu JM, 2002, J BIOL CHEM, V277, P43262, DOI 10.1074/jbc.M206723200; Andreu JM, 2010, J BIOL CHEM, V285, P14239, DOI 10.1074/jbc.M109.094722; Bennett MJ, 2009, BIOCHEMISTRY-US, V48, P4858, DOI 10.1021/bi900200q; Buey RM, 2007, J MOL BIOL, V365, P411, DOI 10.1016/j.jmb.2006.09.091; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; DAI K, 1994, J BACTERIOL, V176, P130, DOI 10.1128/JB.176.1.130-136.1994; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Diaz JF, 2001, J BIOL CHEM, V276, P17307, DOI 10.1074/jbc.M010920200; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P10067, DOI 10.1021/bi00089a023; Diaz-Espinoza R, 2007, PROTEIN SCI, V16, P1543, DOI 10.1110/ps.072807607; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dorleans A, 2009, P NATL ACAD SCI USA, V106, P13775, DOI 10.1073/pnas.0904223106; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Erickson HP, 1998, TRENDS CELL BIOL, V8, P133, DOI 10.1016/S0962-8924(98)01237-9; Feucht A, 2005, MICROBIOL-SGM, V151, P2053, DOI 10.1099/mic.0.27899-0; Flores SC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-167; Gebremichael Y, 2008, BIOPHYS J, V95, P2487, DOI 10.1529/biophysj.108.129072; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Gupta P, 2008, BIOCHEM BIOPH RES CO, V368, P445, DOI 10.1016/j.bbrc.2008.01.115; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kapoor S, 2009, EXPERT OPIN THER TAR, V13, P1037, DOI 10.1517/14728220903173257; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Lan GH, 2008, BIOPHYS J, V95, P4045, DOI 10.1529/biophysj.108.132837; Lappchen T, 2008, CHEM BIOL, V15, P189, DOI 10.1016/j.chembiol.2007.12.013; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Miraldi ER, 2008, BIOPHYS J, V95, P2470, DOI 10.1529/biophysj.107.126219; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Scheffers DJ, 2001, FEBS LETT, V494, P34, DOI 10.1016/S0014-5793(01)02310-9; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANAALTEN DMF, 1995, PROTEINS, V22, P45, DOI 10.1002/prot.340220107; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; Vollmer W, 2006, APPL MICROBIOL BIOT, V73, P37, DOI 10.1007/s00253-006-0586-0; Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385	66	41	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22554	22565		10.1074/jbc.M110.117127	http://dx.doi.org/10.1074/jbc.M110.117127			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472561	Green Published, hybrid			2022-12-25	WOS:000279702200067
J	Solomon, E; Li, H; Muggy, SD; Syta, E; Zolkiewska, A				Solomon, Emilia; Li, Hui; Muggy, Sara Duhachek; Syta, Emilia; Zolkiewska, Anna			The Role of SnoN in Transforming Growth Factor beta 1 induced Expression of Metalloprotease- Disintegrin ADAM12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ANAPHASE-PROMOTING COMPLEX; TGF-BETA; KNEE OSTEOARTHRITIS; CARDIAC-HYPERTROPHY; COLORECTAL CANCERS; CELL-PROLIFERATION; TUMOR PROGRESSION; CANDIDATE GENES	Increased expression of metalloprotease-disintegrin ADAM12 is a hallmark of several pathological conditions, including cancer, cardiovascular disease, and certain inflammatory diseases of the central nervous system or the muscoskeletal system. We show that transforming growth factor beta 1 (TGF beta 1) is a potent inducer of ADAM12 mRNA and protein in mouse fibroblasts and in mouse and human mammary epithelial cells. Induction of ADAM12 is detected within 2 h of treatment with TGF beta 1, is Smad2/Smad3-dependent, and is a result of derepression of the Adam12 gene. SnoN, a negative regulator of the TGF beta signaling pathway, is a master regulator of ADAM12 expression in response to TGF beta 1 stimulation. Overexpression of SnoN in NIH3T3 cells reduces the magnitude of ADAM12 induction by TGF beta 1 treatment. Down-regulation of SnoN expression by short hairpin RNA enhances TGF beta 1-induced expression of ADAM12. In a panel of TGF beta 1-responsive cancer cell lines with high expression of SnoN, induction of ADAM12 by TGF beta 1 is significantly impaired, suggesting that the endogenous SnoN plays a role in regulating ADAM12 expression in response to TGF beta 1. Identification of SnoN as a repressor of the ADAM12 gene should contribute to advances in the studies on the role of ADAM12 in tumor progression and in the development of other pathologies.	[Solomon, Emilia; Li, Hui; Muggy, Sara Duhachek; Syta, Emilia; Zolkiewska, Anna] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Zolkiewska, A (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	zolkiea@ksu.edu	LI, HUI/G-1227-2011; Solomon, Emilia/AAH-9319-2021	LI, HUI/0000-0002-4114-8349; Solomon, Emilia/0000-0003-0265-9792	National Institutes of Health [GM065528]; Terry C. Johnson Center for Basic Cancer Research at Kansas State University; NATIONAL CANCER INSTITUTE [R15CA151065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry C. Johnson Center for Basic Cancer Research at Kansas State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065528 and Innovative Research Award from Terry C. Johnson Center for Basic Cancer Research at Kansas State University. This is Contribution 10-117-J from the Kansas Agricultural Experiment Station.	Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dyczynska E, 2008, INT J CANCER, V122, P2634, DOI 10.1002/ijc.23405; Fedak PWM, 2006, CIRCULATION, V113, P238, DOI 10.1161/CIRCULATIONAHA.105.571414; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Keating DT, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-114; Kim IY, 1996, CANCER RES, V56, P44; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Le Pabic H, 2005, J HEPATOL, V43, P1038, DOI 10.1016/j.jhep.2005.05.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Lynch MA, 2001, GENE EXPRESSION, V9, P157, DOI 10.3727/000000001783992560; Ma GF, 2005, J RHEUMATOL, V32, P1943; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mino N, 2009, J SURG ONCOL, V100, P267, DOI 10.1002/jso.21313; Mitsui Y, 2006, CANCER RES, V66, P9913, DOI 10.1158/0008-5472.CAN-06-0377; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Pot I, 2008, CURR MOL MED, V8, P319, DOI 10.2174/156652408784533797; Pouliot F, 1999, INT J CANCER, V81, P98, DOI 10.1002/(SICI)1097-0215(19990331)81:1<98::AID-IJC17>3.0.CO;2-9; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Swanborg RH, 2001, IMMUNOL REV, V184, P129, DOI 10.1034/j.1600-065x.2001.1840112.x; Tan RY, 2006, J AM SOC NEPHROL, V17, P2781, DOI 10.1681/ASN.2005101055; Toft-Hansen H, 2004, J IMMUNOL, V173, P5209, DOI 10.4049/jimmunol.173.8.5209; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Valdes AM, 2006, ARTHRITIS RHEUM-US, V54, P533, DOI 10.1002/art.21621; Valdes AM, 2004, ARTHRITIS RHEUM-US, V50, P2497, DOI 10.1002/art.20443; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wang X, 2009, HYPERTENSION, V54, P575, DOI 10.1161/HYPERTENSIONAHA.108.127670; Wang X, 2009, CIRCULATION, V119, P2480, DOI 10.1161/CIRCULATIONAHA.108.835488; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yang JW, 2003, J AM SOC NEPHROL, V14, P3167, DOI 10.1097/01.ASN.0000099373.33259.B2; Zhang F, 2002, FEBS LETT, V527, P58, DOI 10.1016/S0014-5793(02)03163-0; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	57	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21969	21977		10.1074/jbc.M110.133314	http://dx.doi.org/10.1074/jbc.M110.133314			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20457602	hybrid, Green Published			2022-12-25	WOS:000279702200009
J	Wang, Z; Wu, T; Shi, L; Zhang, L; Zheng, W; Qu, JAY; Niu, RF; Qi, RZ				Wang, Zhe; Wu, Tao; Shi, Lin; Zhang, Lin; Zheng, Wei; Qu, Jianan Y.; Niu, Ruifang; Qi, Robert Z.			Conserved Motif of CDK5RAP2 Mediates Its Localization to Centrosomes and the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE POLE BODY; GAMMA-TUBULIN COMPLEXES; MICROTUBULE NUCLEATION; CELL-CYCLE; PROTEIN; CALMODULIN; CENTRIOLES; APPARATUS; AKAP450; PERICENTRIN	As the primary microtubule-organizing centers, centrosomes require gamma-tubulin for microtubule nucleation and organization. Located in close vicinity to centrosomes, the Golgi complex is another microtubule-organizing organelle in interphase cells. CDK5RAP2 is a gamma-tubulin complex-binding protein and functions in gamma-tubulin attachment to centrosomes. In this study, we find that CDK5RAP2 localizes to the Golgi complex in an ATP- and centrosome-dependent manner and associates with Golgi membranes independently of microtubules. CDK5RAP2 contains a centrosome-targeting domain with its core region highly homologous to the Motif 2 (CM2) of centrosomin, a functionally related protein in Drosophila. This sequence, referred to as the CM2-like motif, is also conserved in related proteins in chicken and zebrafish. Therefore, CDK5RAP2 may undertake a conserved mechanism for centrosomal localization. Using a mutational approach, we demonstrate that the CM2-like motif plays a crucial role in the centrosomal and Golgi localization of CDK5RAP2. Furthermore, the CM2-like motif is essential for the association of the centrosome-targeting domain to pericentrin and AKAP450. The binding with pericentrin is required for the centrosomal and Golgi localization of CDK5RAP2, whereas the binding with AKAP450 is required for the Golgi localization. Although the CM2-like motif possesses the activity of Ca(2+)-independent calmodulin binding, binding of calmodulin to this sequence is dispensable for centrosomal and Golgi association. Altogether, CDK5RAP2 may represent a novel mechanism for centrosomal and Golgi localization.	[Wang, Zhe; Shi, Lin; Qi, Robert Z.] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Wang, Zhe; Shi, Lin; Qi, Robert Z.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wu, Tao; Zheng, Wei; Qu, Jianan Y.] Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Kowloon, Hong Kong, Peoples R China; [Zhang, Lin; Niu, Ruifang] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Tianjin Medical University	Qi, RZ (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	qirz@ust.hk	WU, Tao/C-9356-2011; Niu, Ruifang/AAJ-8017-2020; WU, Tao/B-9136-2011	Niu, Ruifang/0000-0002-1905-7408; Qi, Robert Zhong/0000-0001-5596-8172; Qu, Jianan/0000-0002-6809-0087	Research Grants Council (General Research Fund and Collaborative Research Fund); University Grants Committee (Area of Excellence and Special Equipment Grant schemes) of Hong Kong	Research Grants Council (General Research Fund and Collaborative Research Fund)(Hong Kong Research Grants Council); University Grants Committee (Area of Excellence and Special Equipment Grant schemes) of Hong Kong	This work was supported by the Research Grants Council (General Research Fund and Collaborative Research Fund) and the University Grants Committee (Area of Excellence and Special Equipment Grant schemes) of Hong Kong.	Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; del Valle M, 1999, J CELL SCI, V112, P4017; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Flory MR, 2002, CELL GROWTH DIFFER, V13, P47; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Fong KW, 2009, MOL BIOL CELL, V20, P3660, DOI 10.1091/mbc.E09-01-0009; GEISER JR, 1993, MOL CELL BIOL, V13, P7913, DOI 10.1128/MCB.13.12.7913; Gillingham AK, 2000, EMBO REP, V1, P524; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Hagiwara H, 2006, HISTOCHEM CELL BIOL, V126, P251, DOI 10.1007/s00418-006-0166-5; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; He LS, 2008, J BIOL CHEM, V283, P13252, DOI 10.1074/jbc.M706937200; Hoppeler-Lebel A, 2007, J CELL SCI, V120, P3299, DOI 10.1242/jcs.013102; Keryer G, 2003, MOL BIOL CELL, V14, P2436, DOI 10.1091/mbc.E02-09-0614; Khodjakov A, 1997, CELL MOTIL CYTOSKEL, V38, P311, DOI 10.1002/(SICI)1097-0169(1997)38:4<311::AID-CM1>3.3.CO;2-M; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kodani A, 2009, MOL BIOL CELL, V20, P1192, DOI 10.1091/mbc.E08-08-0834; Larocca MC, 2004, MOL BIOL CELL, V15, P2771, DOI 10.1091/mbc.E03-10-0757; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Marie M, 2009, MOL BIOL CELL, V20, P4458, DOI 10.1091/mbc.E08-12-1229; Matsumoto Y, 2002, SCIENCE, V295, P499, DOI 10.1126/science.1065693; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Paoletti A, 1996, J CELL SCI, V109, P3089; Rios RM, 2004, CELL, V118, P323; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Salisbury JL, 2003, CURR BIOL, V13, pR88, DOI 10.1016/S0960-9822(03)00033-2; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Schmidt PH, 1999, J BIOL CHEM, V274, P3055, DOI 10.1074/jbc.274.5.3055; Soung NK, 2006, MOL CELL BIOL, V26, P8316, DOI 10.1128/MCB.00671-06; Spang A, 1996, J CELL SCI, V109, P2229; STIRLING DA, 1994, EMBO J, V13, P4329, DOI 10.1002/j.1460-2075.1994.tb06753.x; Sundberg HA, 1996, J CELL BIOL, V133, P111, DOI 10.1083/jcb.133.1.111; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474	48	89	96	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22658	22665		10.1074/jbc.M110.105965	http://dx.doi.org/10.1074/jbc.M110.105965			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20466722	Green Published, hybrid			2022-12-25	WOS:000279702200076
J	Fishler, T; Li, YY; Wang, RH; Kim, HS; Sengupta, K; Vassilopoulos, A; Lahusen, T; Xu, X; Lee, MH; Liu, Q; Elledge, SJ; Ried, T; Deng, CX				Fishler, T.; Li, Y-Y; Wang, R-H; Kim, H-S; Sengupta, K.; Vassilopoulos, A.; Lahusen, T.; Xu, X.; Lee, M-H; Liu, Q.; Elledge, S-J; Ried, T.; Deng, C-X			Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53	ONCOGENE			English	Article						Chk1; mitotic catastrophe; genome integrity; mammary cancer; SB-218078	CELL-CYCLE CHECKPOINT; PHASE-I TRIAL; DNA-DAMAGE; SPINDLE CHECKPOINT; BRCA1; KINASE; BREAST; INHIBITOR; LACKING; ARREST	Checkpoint kinase 1 (Chk1) is a key element in the DNA-damage response pathway that is required for maintaining genomic stability. To study the potential role of Chk1 in mammary tumorigenesis, we disrupted it using a Cre/loxP system. We showed that although Chk1 heterozygosity caused abnormal development of the mammary gland, it was not sufficient to induce tumorigenesis. Simultaneous deletion of one copy of p53 failed to rescue the developmental defects; however, it synergistically induced mammary tumor formation in Chk(;)(1+/-) MMTV-Cre animals with a median time to tumor latency of about 10 months. Chk1 deficiency caused a preponderance of abnormalities, including prolongation, multipolarity, misalignment, mitotic catastrophe and loss of spindle checkpoint, that are accompanied by reduced expression of several cell cycle regulators, including Mad2. On the other hand, we also showed that Chk1 deficiency inhibited mammary tumor formation in mice carrying a homozygous deletion of p53, uncovering a complex relationship between Chk1 and p53. Furthermore, inhibition of Chk1 with a specific inhibitor, SB-218078, or acute deletion of Chk1 using small hairpin RNA killed mammary tumor cells effectively. These data show that Chk1 is critical for maintaining genome integrity and serves as a double-edged sword for cancer: although its inhibition kills cancer cells, it also triggers tumorigenesis when favorable mutations are accumulated for cell growth. Oncogene (2010) 29, 4007-4017; doi:10.1038/onc.2010.163; published online 17 May 2010	[Deng, C-X] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Sengupta, K.; Ried, T.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Liu, Q.; Elledge, S-J] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School	Deng, CX (corresponding author), NIDDKD, Genet Dev & Dis Branch, NIH, 9000 Rockville Pike,Bldg 10 Rm 9N105, Bethesda, MD 20892 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016	Lee, Mi-Hye/0000-0002-5484-3383	National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA; NATIONAL CANCER INSTITUTE [ZIABC010836, ZIABC010835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056004, ZIADK056011, ZIADK056001, ZIADK056010, ZIADK056009] Funding Source: NIH RePORTER	National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge members of Deng laboratory for a critical reading of the article. This work was supported by the Intramural Research Program of the National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA.	Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Blagden S, 2005, CURR DRUG TARGETS, V6, P325, DOI 10.2174/1389450053765824; Brodie SG, 2001, ONCOGENE, V20, P7514, DOI 10.1038/sj.onc.1204929; Brodie SG, 2001, ONCOGENE, V20, P1445, DOI 10.1038/sj.onc.1204222; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Carrassa L, 2009, J CELL MOL MED, V13, P1565, DOI [10.1111/j.1582-4934.2008.00362.x, 10.1111/j.1582-4934.2009.00362.x]; Collura A, 2005, MOL CELL BIOL, V25, P7889, DOI 10.1128/MCB.25.17.7889-7899.2005; Deng Chu-Xia, 2004, Methods Mol Biol, V280, P185; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Deng CX, 2003, HUM MOL GENET, V12, pR113, DOI 10.1093/hmg/ddg082; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Durkin SG, 2006, ONCOGENE, V25, P4381, DOI 10.1038/sj.onc.1209466; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fuse E, 1998, CANCER RES, V58, P3248; HARPER JW, 1993, CELL, V75, P805; Hotte SJ, 2006, ANN ONCOL, V17, P334, DOI 10.1093/annonc/mdj076; Jackson JR, 2000, CANCER RES, V60, P566; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kortmansky J, 2005, J CLIN ONCOL, V23, P1875, DOI 10.1200/JCO.2005.03.116; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Li W, 2007, ONCOGENE, V26, P7204, DOI 10.1038/sj.onc.1210527; Liu QH, 2000, GENE DEV, V14, P1448; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Padilla-Nash HM, 2006, NAT PROTOC, V1, P3129, DOI 10.1038/nprot.2006.358; Peddibhotla S, 2009, P NATL ACAD SCI USA, V106, P5159, DOI 10.1073/pnas.0806671106; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Puc J, 2005, CELL CYCLE, V4, P927, DOI 10.4161/cc.4.7.1795; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Takai H, 2000, GENE DEV, V14, P1439; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wang RH, 2004, P NATL ACAD SCI USA, V101, P17108, DOI 10.1073/pnas.0407585101; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yarden RI, 2001, J CELL BIOCHEM, V83, P521, DOI 10.1002/jcb.1257; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhang WH, 2008, CELL CYCLE, V7, P1668, DOI 10.4161/cc.7.11.5982; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299	48	39	41	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 15	2010	29	28					4007	4017		10.1038/onc.2010.163	http://dx.doi.org/10.1038/onc.2010.163			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	625JW	20473325	Green Accepted			2022-12-25	WOS:000279892400002
J	Hanau, S; Montin, K; Cervellati, C; Magnani, M; Dallocchio, F				Hanau, Stefania; Montin, Katy; Cervellati, Carlo; Magnani, Morena; Dallocchio, Franco			6-Phosphogluconate Dehydrogenase Mechanism EVIDENCE FOR ALLOSTERIC MODULATION BY SUBSTRATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DECARBOXYLATION; CANDIDA-UTILIS; ENZYME; BINDING; NADP; COENZYME; SUBUNITS; ANALOG; SITE	The reductive carboxylation of ribulose-5-phosphate (Ru5P) by 6-phosphogluconate dehydrogenase (6PGDH) from Candida utilis was investigated using kinetic isotope effects. The intrinsic isotope effect for proton abstraction from Ru5P was found at 4.9 from deuterium isotope effects on V and V/K and from tritium isotope effects on V/K. The presence of 6-phosphogluconate (6PG) in the assay mixture changes the magnitude of the observed isotope effects. In the absence of 6PG (D)(V/K) and (D)(V) are 1.68 and 2.46, respectively, whereas the presence of 6PG increases (D)(V/K) to 2.84 and decreases (D)(V) to 1.38. A similar increase of (T)(V/K) is observed as 6PG builds up in the reaction mixture. These data indicate that in the absence of 6PG, a slow step, which precedes the chemical process, is rate-limiting for the reaction, whereas in the presence of 6PG, the rate-limiting step follows the isotope-sensitive step. Kinetic analysis of reductive carboxylation shows that 6PG at low concentrations decreases the K-m of Ru5P, whereas at higher concentrations, the usual competitive pattern is observed. These data indicate that full activity of 6PGDH is achieved when one subunit carries out the catalysis and the other subunit carries an unreacted 6PG. Thus, 6PG is like an allosteric activator of 6PGDH.	[Hanau, Stefania; Montin, Katy; Cervellati, Carlo; Magnani, Morena; Dallocchio, Franco] Univ Ferrara, Dipartmento Biochim & Biol Mol, I-44100 Ferrara, Italy	University of Ferrara	Hanau, S (corresponding author), Univ Ferrara, Dipartmento Biochim & Biol Mol, Via Borsari 46, I-44100 Ferrara, Italy.	hns@unife.it	Cervellati, Carlo/K-6453-2015; Hanau, Stefania/AAG-7510-2021; Hanau, Stefania/AAG-7534-2021	Cervellati, Carlo/0000-0003-4777-6300; Hanau, Stefania/0000-0002-2817-9941				ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; BERDIS AJ, 1993, BIOCHEMISTRY-US, V32, P2036, DOI 10.1021/bi00059a021; Cleland W W, 1980, Methods Enzymol, V64, P104; COOK PF, 1981, BIOCHEMISTRY-US, V20, P1790, DOI 10.1021/bi00510a013; DALLOCCHIO F, 1981, J BIOL CHEM, V256, P778; DISCHE Z, 1962, METHODS CARBOHYDR CH, V1, P481; HANAU S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P273, DOI 10.1016/0167-4838(92)90404-2; HANAU S, 1992, BIOCHIM BIOPHYS ACTA, V1159, P262, DOI 10.1016/0167-4838(92)90054-H; HANAU S, 1993, BIOCHEM J, V291, P325, DOI 10.1042/bj2910325; Hwang CC, 1998, BIOCHEMISTRY-US, V37, P15698, DOI 10.1021/bi981288w; Hwang CC, 1998, BIOCHEMISTRY-US, V37, P12596, DOI 10.1021/bi980611s; Karsten WE, 1998, BIOCHEMISTRY-US, V37, P15691, DOI 10.1021/bi9812827; Lei Z, 1999, BIOCHEMISTRY-US, V38, P11231, DOI 10.1021/bi990433i; Li L, 2006, J BIOL CHEM, V281, P25568, DOI 10.1074/jbc.M601154200; LIENHARD GE, 1964, BIOCHEMISTRY-US, V3, P190, DOI 10.1021/bi00890a009; Montin K, 2007, FEBS J, V274, P6426, DOI 10.1111/j.1742-4658.2007.06160.x; NOLTMANN EA, 1972, ENZYMES, V6, P272; RENDINA AR, 1984, BIOCHEMISTRY-US, V23, P6257, DOI 10.1021/bi00320a056; RIPPA M, 1972, BIOCHEM BIOPH RES CO, V48, P764, DOI 10.1016/0006-291X(72)90672-9; RIPPA M, 1973, J BIOL CHEM, V248, P4920; Rippa M, 1975, Methods Enzymol, V41, P237; Rippa M, 1998, BBA-PROTEIN STRUCT M, V1429, P83, DOI 10.1016/S0167-4838(98)00222-2; SOMMERCORN J, 1982, J BIOL CHEM, V257, P9424	23	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21366	21371		10.1074/jbc.M110.105601	http://dx.doi.org/10.1074/jbc.M110.105601			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452987	Green Published, hybrid			2022-12-25	WOS:000279516100022
J	Neagoe, I; Stauber, T; Fidzinski, P; Bergsdorf, EY; Jentsch, TJ				Neagoe, Ioana; Stauber, Tobias; Fidzinski, Pawel; Bergsdorf, Eun-Yeong; Jentsch, Thomas J.			The Late Endosomal ClC-6 Mediates Proton/Chloride Countertransport in Heterologous Plasma Membrane Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL STORAGE DISEASE; CHLORIDE CHANNEL FAMILY; DENTS-DISEASE; CELLS; ACIDIFICATION; ANTIPORTER; TRANSPORTERS; PROTEINS; KIDNEY; DETERMINANTS	Members of the CLC protein family of Cl- channels and transporters display the remarkable ability to function as either chloride channels or Cl-/H+ antiporters. Due to the intracellular localization of ClC-6 and ClC-7, it has not yet been possible to study the biophysical properties of these members of the late endosomal/lysosomal CLC branch in heterologous expression. Whereas recent data suggest that ClC-7 functions as an antiporter, transport characteristics of ClC-6 have remained entirely unknown. Here, we report that fusing the green fluorescent protein (GFP) to the N terminus of ClC-6 increased its cell surface expression, allowing us to functionally characterize ClC-6. Compatible with ClC-6 mediating Cl-/H+ exchange, Xenopus oocytes expressing GFP-tagged ClC-6 alkalinized upon depolarization. This alkalinization was dependent on the presence of extracellular anions and could occur against an electrochemical proton gradient. As observed in other CLC exchangers, ClC-6-mediated H+ transport was abolished by mutations in either the "gating" or "proton" glutamate. Overexpression of GFP-tagged ClC-6 in CHO cells elicited small, outwardly rectifying currents with a Cl- > I- conductance sequence. Mutating the gating glutamate of ClC-6 yielded an ohmic anion conductance that was increased by additionally mutating the "anion-coordinating" tyrosine. Additionally changing the chloride-coordinating serine 157 to proline increased the NO3- conductance of this mutant. Taken together, these data demonstrate for the first time that ClC-6 is a Cl-/H+ antiporter.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Jentsch, TJ (corresponding author), Max Delbruck Ctr Mol Med, Leibniz Inst Mol Pharmakol, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Stauber, Tobias/E-4005-2010; Berindan-Neagoe, Ioana/AAH-9854-2019; Fidzinski, Pawel/AAM-8884-2020	Stauber, Tobias/0000-0003-0727-6109; Fidzinski, Pawel/0000-0001-6373-4763; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [SFB740]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (SFB740).	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Beitz E, 2006, BIOL CELL, V98, P101, DOI 10.1042/BC20050025; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; Buyse G, 1997, J BIOL CHEM, V272, P3615, DOI 10.1074/jbc.272.6.3615; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Ignoul S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000474; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; Mohammad-Panah R, 2003, J BIOL CHEM, V278, P29267, DOI 10.1074/jbc.M304357200; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; NOVARINO G, 2010, SCIENCE IN PRESS; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; WEINERT S, 2010, SCIENCE IN PRESS; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	41	62	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21689	21697		10.1074/jbc.M110.125971	http://dx.doi.org/10.1074/jbc.M110.125971			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20466723	Green Published, hybrid			2022-12-25	WOS:000279516100056
J	Rather, LJ; Knapp, B; Haehnel, W; Fuchs, G				Rather, Liv J.; Knapp, Bettina; Haehnel, Wolfgang; Fuchs, Georg			Coenzyme A-dependent Aerobic Metabolism of Benzoate via Epoxide Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURKHOLDERIA-XENOVORANS LB400; COA CATABOLIC PATHWAY; VITAMIN-K 2,3-EPOXIDE; AZOARCUS-EVANSII; CRYSTAL-STRUCTURE; MULTICOMPONENT MONOOXYGENASES; RIBONUCLEOTIDE REDUCTASE; CROTONASE-SUPERFAMILY; ANAEROBIC DEGRADATION; ALKENE MONOOXYGENASE	In the aerobic metabolism of aromatic substrates, oxygenases use molecular oxygen to hydroxylate and finally cleave the aromatic ring. In the case of the common intermediate benzoate, the ring cleavage substrates are either catechol (in bacteria) or 3,4-dihydroxybenzoate (protocatechuate, mainly in fungi). We have shown before that many bacteria, e. g. Azoarcus evansii, the organism studied here, use a completely different mechanism. This elaborate pathway requires formation of benzoyl-CoA, followed by an oxygenase reaction and a nonoxygenolytic ring cleavage. Benzoyl-CoA transformation is catalyzed by the iron-containing benzoyl-CoA oxygenase (BoxB) in conjunction with an FAD and iron-sulfur centers containing reductase (BoxA), which donates electrons from NADPH. Here we show that benzoyl-CoA oxygenase actually does not form the 2,3-dihydrodiol of benzoyl-CoA, as formerly postulated, but the 2,3-epoxide. An enoyl-CoA hydratase (BoxC) uses two molecules of water to first hydrolytically open the ring of 2,3-epoxybenzoyl-CoA, which may proceed via its tautomeric seven-membered oxepin ring form. Then ring C2 is hydrolyzed off as formic acid, yielding 3,4-dehydroadipyl-CoA semialdehyde. The semialdehyde is oxidized by a NADP(+)-dependent aldehyde dehydrogenase (BoxD) to 3,4-dehydroadipyl-CoA. Final products of the pathway are formic acid, acetyl- CoA, and succinyl-CoA. This overlooked pathway occurs in 4-5% of all bacteria whose genomes have been sequenced and represents an elegant strategy to cope with the high resonance energy of aromatic substrates by forming a nonaromatic epoxide.	[Rather, Liv J.; Fuchs, Georg] Univ Freiburg, Fak Biol, Lehrstuhl Mikrobiol, D-79104 Freiburg, Germany; [Knapp, Bettina; Haehnel, Wolfgang] Univ Freiburg, Fak Biol, Lehrstuhl Biochem, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Fuchs, G (corresponding author), Univ Freiburg, Fak Biol, Lehrstuhl Mikrobiol, Schanzlestr 1, D-79104 Freiburg, Germany.	georg.fuchs@biologie.uni-freiburg.de			Deutsche Forschungsgemeinschaft [FU 118/16-3, HA 1084/9-1]; Graduiertenkolleg Biochemie der Enzyme	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenkolleg Biochemie der Enzyme	This work was supported by Deutsche Forschungsgemeinschaft Grants FU 118/16-3 and HA 1084/9-1 and by the Graduiertenkolleg Biochemie der Enzyme.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERS HJ, 1995, INT J SYST BACTERIOL, V45, P327, DOI 10.1099/00207713-45-2-327; Bains J, 2009, J BIOL CHEM, V284, P16377, DOI 10.1074/jbc.M900226200; Bennett KL, 2002, J MASS SPECTROM, V37, P179, DOI 10.1002/jms.271; BUCH K, 1995, FEBS LETT, V376, P45, DOI 10.1016/0014-5793(95)01243-9; Choi YS, 2008, P NATL ACAD SCI USA, V105, P6858, DOI 10.1073/pnas.0712073105; COLBY J, 1977, BIOCHEM J, V165, P395, DOI 10.1042/bj1650395; COLIGAN JE, 1995, CURR PROTOC PROTEIN; CORY EJ, 1966, J AM CHEM SOC, V88, P4750; Dalluge JJ, 2002, ANAL BIOANAL CHEM, V374, P835, DOI 10.1007/s00216-002-1554-x; de Visser SF, 2008, CHEM-EUR J, V14, P4533, DOI 10.1002/chem.200701802; Denef VJ, 2006, APPL ENVIRON MICROB, V72, P585, DOI 10.1128/AEM.72.1.585-595.2006; Denef VJ, 2005, J BACTERIOL, V187, P7996, DOI 10.1128/JB.187.23.7996-8005.2005; Dupard-Jullen CL, 2007, ANAL BIOANAL CHEM, V387, P1027, DOI 10.1007/s00216-006-1003-3; Eberhard ED, 2004, J AM CHEM SOC, V126, P7188, DOI 10.1021/ja0482381; Gallagher SC, 1997, EUR J BIOCHEM, V247, P635, DOI 10.1111/j.1432-1033.1997.00635.x; Gescher J, 2006, J BACTERIOL, V188, P2919, DOI 10.1128/JB.188.8.2919-2927.2006; Gescher J, 2005, MOL MICROBIOL, V56, P1586, DOI 10.1111/j.1365-2958.2005.04637.x; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Kawaguchi K, 2006, FEMS MICROBIOL LETT, V257, P208, DOI 10.1111/j.1574-6968.2006.00165.x; LEE JJ, 1984, BIOCHEMISTRY-US, V23, P2246, DOI 10.1021/bi00305a024; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; Mohamed ME, 2001, J BACTERIOL, V183, P1899, DOI 10.1128/JB.183.6.1899-1908.2001; MUKHARJI I, 1985, P NATL ACAD SCI USA, V82, P2713, DOI 10.1073/pnas.82.9.2713; Murray LJ, 2007, ACCOUNTS CHEM RES, V40, P466, DOI 10.1021/ar600040e; Musaev DG, 2002, J AM CHEM SOC, V124, P4135, DOI 10.1021/ja0176393; Nakano C, 2007, BIOSCI BIOTECH BIOCH, V71, P2543, DOI 10.1271/bbb.70331; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; ORNSTON LN, 1966, J BIOL CHEM, V241, P3776; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Rabus R, 2005, ARCH MICROBIOL, V183, P27, DOI 10.1007/s00203-004-0742-9; RETEY J, 1966, EXPERIENTIA, V22, P72, DOI 10.1007/BF01900153; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P15392, DOI 10.1021/bi0618969; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; Schuhle K, 2003, J BACTERIOL, V185, P4920, DOI 10.1128/JB.185.16.4920-4929.2003; Small FJ, 1997, J BIOL CHEM, V272, P24913, DOI 10.1074/jbc.272.40.24913; STANIOR U, 1984, ARCH PHARM, V317, P1042, DOI 10.1002/ardp.19843171211; TSCHECH A, 1987, ARCH MICROBIOL, V148, P213, DOI 10.1007/BF00414814; VOGEL E, 1967, ANGEW CHEM INT EDIT, V6, P385, DOI 10.1002/anie.196703851; Zaar A, 2004, MOL MICROBIOL, V54, P223, DOI 10.1111/j.1365-2958.2004.04263.x; Zaar A, 2001, J BIOL CHEM, V276, P24997, DOI 10.1074/jbc.M100291200; ZEHR BD, 1989, ANAL BIOCHEM, V182, P157, DOI 10.1016/0003-2697(89)90734-3	46	39	47	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20615	20624		10.1074/jbc.M110.124156	http://dx.doi.org/10.1074/jbc.M110.124156			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20452977	hybrid, Green Published			2022-12-25	WOS:000279228600025
J	Osborne, LC; Duthie, KA; Seo, JH; Gascoyne, RD; Abraham, N				Osborne, L. C.; Duthie, K. A.; Seo, J. H.; Gascoyne, R. D.; Abraham, N.			Selective ablation of the YxxM motif of IL-7R alpha suppresses lymphomagenesis but maintains lymphocyte development	ONCOGENE			English	Article						lymphoma; haploinsufficiency; IL-7; c-myc; knock-in mouse models	ACUTE LYMPHOBLASTIC-LEUKEMIA; B-CELL RECEPTOR; C-MYC; PHOSPHATIDYLINOSITOL 3-KINASE; INTERLEUKIN (IL)-7; IL-7; ACTIVATION; BCL-2; PROLIFERATION; EXPRESSION	Tumor progression is a multiple step process in which, in addition to oncogenic mutation, other supporting factors can contribute to transformation. The role these factors have in cancer is an open question. Using the E mu-myc model of B-cell transformation, we evaluated the contribution of the cytokine interleukin-7 (IL-7) in supporting lymphomagenesis. We have previously shown that disruption of the Y449xxM motif of the IL-7 receptor alpha (IL-7R alpha) in a knock-in mouse model (IL-7R alpha(449F)) has minor effects on lymphocyte production, but interferes with the activation of survival effectors. To address the hypothesis that targeted signal ablation would selectively affect lymphocyte transformation, IL-7R alpha(449F) mice were crossed with two lymphomagenesis models, transgenic (Tg) IL-7 and E mu-myc mice. We found that the loss of IL-7R alpha Y449 signaling prevented Tg IL-7-mediated T-and B-lymphocyte transformation and decreased the development of E mu-myc-induced B-cell tumors. We showed that the IL-7R alpha(449F) mutation prevented increased survival of Tg IL-7 CD8 T cells, and decreased viability of bone marrow progenitor B cells, as well as E mu-myc-induced proliferation. This study shows that IL-7R alpha Y449 is important for lymphocyte transformation, and that unlike deficiencies in pre-B cell receptor signaling, Myc overexpression cannot compensate for the loss of IL-7R alpha signals in early B-cell development. Oncogene (2010) 29, 3854-3864; doi: 10.1038/onc.2010.133; published online 3 May 2010	[Abraham, N.] Univ British Columbia, Dept Microbiol & Immunol, Dept Zool, Inst Life Sci, Vancouver, BC V5T 2L9, Canada; [Gascoyne, R. D.] Univ British Columbia, BC Canc Agcy, Dept Pathol & Lab Med, Vancouver, BC V5T 2L9, Canada; [Abraham, N.] Univ British Columbia, Inst Life Sci, Dept Zool, Vancouver, BC V5T 2L9, Canada	University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Abraham, N (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Dept Zool, Inst Life Sci, 3552-2350 Hlth Sci Mall, Vancouver, BC V5T 2L9, Canada.	ninan@interchange.ubc.ca	Abraham, Ninan/K-5572-2012; Gascoyne, Randy D/A-6009-2013; Osborne, Lisa/K-3027-2015	Abraham, Ninan/0000-0002-2747-1246; Gascoyne, Randy D/0000-0002-2610-5690; Osborne, Lisa/0000-0002-7170-3235	Canadian Institutes for Health Research (CIHR) [MOP-67005, MOP-84532]; Michael Smith Foundation for Health Research (MSFHR); Natural Sciences and Engineering Research Council (NSERC); CIHR/MSFHR	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR/MSFHR(Michael Smith Foundation for Health ResearchCanadian Institutes of Health Research (CIHR))	We thank Dr Robert Kay, Martin Richer and Caylib Durand for critical reading of the paper; Jill Miners, Eric Ma Asavee and Rachel Kim for animal colony maintenance and genotyping; Dr Sarah Gaffen for technical assistance; Nadia Gale and staff at the Centre for Translational and Applied Genomics; Dr Christine Eischen for providing C57BL/6 E mu-myc mice; Dr Bart Vanhaesebroeck for providing C57BL/6 p110 delta<SUP>D910A</SUP> mice; Dr Philippa Marrack for providing anti-Bim-producing Ham151 cells and the Wesbrook Animal Unit staff for animal husbandry. This work is supported by the Canadian Institutes for Health Research (CIHR) (MOP-67005 and MOP-84532 to N Abraham). LCO was supported by studentships from the Michael Smith Foundation for Health Research (MSFHR), the Natural Sciences and Engineering Research Council (NSERC) and the CIHR/MSFHR Strategic Training Program in Transplantation Research. KAD was supported by an NSERC Postgraduate scholarship. NA holds CIHR New Investigator and MSFHR Career Investigator awards.	Abraham N, 2005, ONCOGENE, V24, P5252, DOI 10.1038/sj.onc.1208726; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Adams JM, 1999, ONCOGENE, V18, P5268, DOI 10.1038/sj.onc.1202997; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Cattaruzza L, 2009, INT J CANCER, V125, P1092, DOI 10.1002/ijc.24389; Duthie KA, 2007, MOL CELL PROTEOMICS, V6, P1700, DOI 10.1074/mcp.M600468-MCP200; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2001, ONCOGENE, V20, P6983, DOI 10.1038/sj.onc.1204892; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; El Kassar N, 2004, BLOOD, V104, P1419, DOI 10.1182/blood-2004-01-0201; Fleming HE, 2002, SEMIN IMMUNOL, V14, P423, DOI 10.1016/S1044532302000775; FOSS HD, 1995, AM J PATHOL, V146, P33; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Juarez J, 2007, HAEMATOLOGICA, V92, P450, DOI 10.3324/haematol.10621; Keller U, 2005, ONCOGENE, V24, P6231, DOI 10.1038/sj.onc.1208779; Kelly PN, 2007, BLOOD, V109, P4907, DOI 10.1182/blood-2006-10-051847; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Lali FV, 2004, J IMMUNOL, V172, P3527, DOI 10.4049/jimmunol.172.6.3527; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; LONG BW, 1995, P NATL ACAD SCI USA, V92, P1416, DOI 10.1073/pnas.92.5.1416; Marshall AJ, 1998, J IMMUNOL, V161, P6038; *NAT CANC I CAN CA, 2008, CAN CANC STAT; Nepal RM, 2008, ONCOGENE, V27, P4752, DOI 10.1038/onc.2008.111; Nilsson LM, 2007, ONCOGENE, V26, P2833, DOI 10.1038/sj.onc.1210104; Osborne LC, 2007, J EXP MED, V204, P619, DOI 10.1084/jem.20061871; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; RICH BE, 1993, J EXP MED, V177, P305, DOI 10.1084/jem.177.2.305; Sasson SC, 2010, CYTOKINE, V50, P58, DOI 10.1016/j.cyto.2009.12.001; Scott CL, 2004, J CELL BIOL, V164, P89, DOI 10.1083/jcb.200310041; Scupoli MT, 2007, HAEMATOLOGICA, V92, P264, DOI 10.3324/haematol.10356; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wei CJ, 2000, J IMMUNOL, V164, P1961, DOI 10.4049/jimmunol.164.4.1961; Wen RR, 2006, MOL CELL BIOL, V26, P9364, DOI 10.1128/MCB.00839-06; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Yasuda T, 2008, IMMUNITY, V28, P499, DOI 10.1016/j.immuni.2008.02.015	40	9	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2010	29	26					3854	3864		10.1038/onc.2010.133	http://dx.doi.org/10.1038/onc.2010.133			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	618VW	20440272				2022-12-25	WOS:000279385200013
J	Damiano, L; Di Stefano, P; Leal, MPC; Barba, M; Mainiero, F; Cabodi, S; Tordella, L; Sapino, A; Castellano, I; Canel, M; Frame, M; Turco, E; Defilippi, P				Damiano, L.; Di Stefano, P.; Leal, M. P. Camacho; Barba, M.; Mainiero, F.; Cabodi, S.; Tordella, L.; Sapino, A.; Castellano, I.; Canel, M.; Frame, M.; Turco, E.; Defilippi, P.			p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation	ONCOGENE			English	Article						cell motility; p140Cap; Ras; Src; tumour growth	BREAST-CANCER; EGF RECEPTOR; GROWTH; TUMORIGENESIS; PROGRESSION; ACTIVATION	The adaptor protein p140Cap/SNIP is a novel Src-binding protein that regulates Src activation through C-terminal Src kinase (Csk). Here, by gain and loss of function approaches in breast and colon cancer cells, we report that p140Cap immobilizes E-cadherin at the cell membrane and inhibits EGFR and Erk1/2 signalling, blocking scatter and proliferation of cancer cells. p140Cap-dependent regulation of E-cadherin/EGFR cross-talk and cell motility is due to the inhibition of Src kinase. However, rescue of Src activity is not sufficient to restore Erk1/2 phosphorylation and proliferation. Indeed, p140Cap also impairs Erk1/2 phosphorylation by affecting Ras activity, downstream to the EGFR. In conclusion, p140Cap stabilizes adherens junctions and inhibits EGFR and Ras signalling through the dual control of both Src and Ras activities, thus affecting crucial cancer properties such as invasion and growth. Interestingly, p140Cap expression is lost in more aggressive human breast cancers, showing an inverse correlation with EGFR expression. Therefore, p140Cap mechanistically behaves as a tumour suppressor that inhibits signalling pathways leading to aggressive phenotypes. Oncogene (2010) 29, 3677-3690; doi: 10.1038/onc.2010.128; published online 10 May 2010	[Damiano, L.; Di Stefano, P.; Leal, M. P. Camacho; Cabodi, S.; Tordella, L.; Turco, E.; Defilippi, P.] Univ Turin, Dept Genet Biol & Biochem, I-10125 Turin, TO, Italy; [Damiano, L.; Di Stefano, P.; Leal, M. P. Camacho; Cabodi, S.; Tordella, L.; Turco, E.; Defilippi, P.] Univ Turin, Ctr Mol Biotechnol, I-10125 Turin, TO, Italy; [Barba, M.; Mainiero, F.] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy; [Sapino, A.; Castellano, I.] Univ Turin, Dept Biomed Sci & Human Oncol, I-10125 Turin, TO, Italy; [Frame, M.] Western Gen Hosp, Edinburgh Canc Res Ctr, Edinburgh EH4 2XU, Midlothian, Scotland	University of Turin; University of Turin; Sapienza University Rome; University of Turin; University of Edinburgh	Defilippi, P (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Via Nizza 52, I-10125 Turin, TO, Italy.	paola.defilippi@unito.it	Sapino, Anna/J-4113-2018; Sapino, Anna/AGY-9901-2022; DEFILIPPI, Paola/L-2232-2014; Castellano, Isabella/K-1888-2018	Sapino, Anna/0000-0003-3542-9571; Sapino, Anna/0000-0003-3542-9571; Cabodi, Sara/0000-0003-1248-6549; Frame, Margaret/0000-0001-5882-1942; Tordella, Luca/0000-0002-0542-7834; Castellano, isabella/0000-0002-9072-1615; Mainiero, Fabrizio/0000-0002-7136-9839; Defilippi, Paola/0000-0001-6427-4906	AIRC; AICR; EU; MUR; Progetto Alfieri; Regione Piemonte (Oncoprot, Druidi, PiStem and BioTher); Regione Piemonte Sanita	AIRC(Fondazione AIRC per la ricerca sul cancro); AICR; EU(European Commission); MUR(Ministry of Education, Universities and Research (MIUR)); Progetto Alfieri; Regione Piemonte (Oncoprot, Druidi, PiStem and BioTher)(Regione Piemonte); Regione Piemonte Sanita	We thank PP Pandolfi (Boston, MA), A Sorkin (Denver, Co), J Stow (Brisbane, Australia), C Sasaki (Baltimore, Maryland) and K Nishida (Osaka, Japan) for reagent gifts. This work was supported by grants from the AIRC, AICR, EU FP7 Metafight program, MUR, Progetto Alfieri, Regione Piemonte (Oncoprot, Druidi, PiStem and BioTher), Regione Piemonte Sanita. MP Camacho Leal is supported by the AICR.	Alema S, 2007, BBA-MOL CELL RES, V1773, P47, DOI 10.1016/j.bbamcr.2006.06.001; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Arteaga CL, 2002, ONCOLOGIST, V7, P31; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Cavallaro U, 2004, ANN NY ACAD SCI, V1014, P58, DOI 10.1196/annals.1294.006; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Di Stefano P, 2004, MOL BIOL CELL, V15, P787, DOI 10.1091/mbc.E03-09-0689; Di Stefano P, 2007, EMBO J, V26, P2843, DOI 10.1038/sj.emboj.7601724; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Glynn RW, 2010, CANCER TREAT REV, V36, P224, DOI 10.1016/j.ctrv.2009.12.007; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Gutkind J. S., 2000, SCI STKE, pre1, DOI DOI 10.1126/STKE.2000.40.RE1; Kennedy S, 2008, BRIT J CANCER, V98, P1641, DOI 10.1038/sj.bjc.6604365; Kim H, 1999, EXP CELL RES, V253, P78, DOI 10.1006/excr.1999.4706; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Sasaki CY, 2000, CANCER RES, V60, P7057; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Takahashi K, 1996, EXP CELL RES, V226, P214, DOI 10.1006/excr.1996.0221; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; Yamasaki S, 2003, ONCOGENE, V22, P1546, DOI 10.1038/sj.onc.1206284	32	42	42	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2010	29	25					3677	3690		10.1038/onc.2010.128	http://dx.doi.org/10.1038/onc.2010.128			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	615CG	20453886				2022-12-25	WOS:000279108600008
J	Widmann, M; Trodler, P; Pleiss, J				Widmann, Michael; Trodler, Peter; Pleiss, Juergen			The Isoelectric Region of Proteins: A Systematic Analysis	PLOS ONE			English	Article							ION-EXCHANGE CHROMATOGRAPHY; ENGINEERING DATABASE; RETENTION; DESIGN; LIPASE; PURIFICATION; ADSORPTION; FAMILIES; TOOL	Background: Binding of proteins in ion exchange chromatography is dominated by electrostatic interactions and can be tuned by adjusting pH and ionic strength of the solvent. Therefore, the isoelectric region (IER), the pH region of almost zero charge near the pI, has been used to predict the binding properties of proteins. Principal findings: Usually the IER is small and binding and elution is carried out at pH values near to the pI. However, some proteins with an extended IER have been shown to bind and elute far away from its pI. To analyze factors that mediate the size of the IER and to identify proteins with an extended IER, two protein families consisting of more than 7000 proteins were systematically investigated. Most proteins were found to have a small IER and thus are expected to bind or elute near to their pI, while only a small fraction of less than 2% had a large IER. Conclusions: Only four factors, the number of histidines, the pI, the number of titratable amino acids and the ratio of acidic to basic residues, are sufficient to reliably classify proteins by their IER based on their sequence only, and thus to predict their binding and elution behaviour in ion exchange chromatography.	[Widmann, Michael; Trodler, Peter; Pleiss, Juergen] Univ Stuttgart, Inst Tech Biochem, Stuttgart, Germany	University of Stuttgart	Widmann, M (corresponding author), Univ Stuttgart, Inst Tech Biochem, Stuttgart, Germany.	Juergen.Pleiss@itb.uni-stuttgart.de			German Federal Ministry of Education and Research [PTJ 0313434D]; European Commission [BIOPRODUCTION/NMP-2-CT-2007-026515]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank the German Federal Ministry of Education and Research (PTJ 0313434D) and the European Commission (IP "Sustainable Microbial and Biocatalytic Production of Advanced Functional Materials'', BIOPRODUCTION/NMP-2-CT-2007-026515) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed T, 2006, FLUID PHASE EQUILIBR, V241, P268, DOI 10.1016/j.fluid.2005.12.011; Ahamed T, 2008, J CHROMATOGR A, V1194, P22, DOI 10.1016/j.chroma.2007.11.111; Ahamed T, 2007, J CHROMATOGR A, V1164, P181, DOI 10.1016/j.chroma.2007.07.010; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fischer M, 2003, NUCLEIC ACIDS RES, V31, P319, DOI 10.1093/nar/gkg015; Fischer M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-495; *GE HEALTHC, HEALTHC G ION EXCH C; Gotte G, 2003, J BIOL CHEM, V278, P46241, DOI 10.1074/jbc.M308470200; Grimsley GR, 2009, PROTEIN SCI, V18, P247, DOI 10.1002/pro.19; Hallgren E, 2000, J CHROMATOGR A, V877, P13, DOI 10.1016/S0021-9673(00)00190-4; Knoll M, 2008, PROTEIN SCI, V17, P1689, DOI 10.1110/ps.035428.108; Malmquist G, 2006, J CHROMATOGR A, V1115, P164, DOI 10.1016/j.chroma.2006.02.097; MELANDER WR, 1989, J CHROMATOGR, V469, P3, DOI 10.1016/S0021-9673(01)96437-4; MITRA CK, 1993, J BIOSCIENCE, V18, P213, DOI 10.1007/BF02703118; Noh H, 2008, BIOMATERIALS, V29, P2033, DOI 10.1016/j.biomaterials.2008.01.017; Palekar AA, 2000, BIOCATAL BIOTRANSFOR, V18, P177, DOI 10.3109/10242420009015244; PATRICKIOS CS, 1995, ANAL BIOCHEM, V231, P82, DOI 10.1006/abio.1995.1506; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROTH CM, 1995, LANGMUIR, V11, P3500, DOI 10.1021/la00009a036; Sheehan D, 1996, Methods Mol Biol, V59, P145; SHEEHAN D, 2001, ENCY LIFE SCI; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Trodler P, 2008, J CHROMATOGR A, V1179, P161, DOI 10.1016/j.chroma.2007.11.108	23	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10546	10.1371/journal.pone.0010546	http://dx.doi.org/10.1371/journal.pone.0010546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479870	Green Published, Green Submitted, gold			2022-12-25	WOS:000277467800025
J	Sun, JS; Hopkins, RC; Jenney, FE; McTernan, PM; Adams, MWW				Sun, Junsong; Hopkins, Robert C.; Jenney, Francis E., Jr.; McTernan, Patrick M.; Adams, Michael W. W.			Heterologous Expression and Maturation of an NADP-Dependent [NiFe]-Hydrogenase: A Key Enzyme in Biofuel Production	PLOS ONE			English	Article							ARCHAEON PYROCOCCUS-FURIOSUS; MUTATIONAL ANALYSIS; HYDROGENASE ISOENZYMES; NIFE HYDROGENASE; OPERON; GENES; GENERATION; BIOLOGY; SULFUR	Hydrogen gas is a major biofuel and is metabolized by a wide range of microorganisms. Microbial hydrogen production is catalyzed by hydrogenase, an extremely complex, air-sensitive enzyme that utilizes a binuclear nickel-iron [NiFe] catalytic site. Production and engineering of recombinant [NiFe]-hydrogenases in a genetically-tractable organism, as with metalloprotein complexes in general, has met with limited success due to the elaborate maturation process that is required, primarily in the absence of oxygen, to assemble the catalytic center and functional enzyme. We report here the successful production in Escherichia coli of the recombinant form of a cytoplasmic, NADP-dependent hydrogenase from Pyrococcus furiosus, an anaerobic hyperthermophile. This was achieved using novel expression vectors for the co-expression of thirteen P. furiosus genes (four structural genes encoding the hydrogenase and nine encoding maturation proteins). Remarkably, the native E. coli maturation machinery will also generate a functional hydrogenase when provided with only the genes encoding the hydrogenase subunits and a single protease from P. furiosus. Another novel feature is that their expression was induced by anaerobic conditions, whereby E. coli was grown aerobically and production of recombinant hydrogenase was achieved by simply changing the gas feed from air to an inert gas (N-2). The recombinant enzyme was purified and shown to be functionally similar to the native enzyme purified from P. furiosus. The methodology to generate this key hydrogen-producing enzyme has dramatic implications for the production of hydrogen and NADPH as vehicles for energy storage and transport, for engineering hydrogenase to optimize production and catalysis, as well as for the general production of complex, oxygen-sensitive metalloproteins.	[Sun, Junsong; Hopkins, Robert C.; Jenney, Francis E., Jr.; McTernan, Patrick M.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Sun, JS (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu	McTernan, Patrick/HGV-0762-2022	Jenney, Francis/0000-0002-1667-6924; Adams, Michael/0000-0002-9796-5014	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy [DE-FG02-05ER15710]	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy(United States Department of Energy (DOE))	This research was supported by a grant (DE-FG02-05ER15710) from the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; Bascones E, 2000, APPL ENVIRON MICROB, V66, P4292, DOI 10.1128/AEM.66.10.4292-4299.2000; Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; DOUGHERTY WG, 1988, EMBO J, V7, P1281, DOI 10.1002/j.1460-2075.1988.tb02942.x; Edwards PP, 2007, PHILOS T R SOC A, V365, P1043, DOI 10.1098/rsta.2006.1965; English CM, 2009, DALTON T, P9970, DOI 10.1039/b913426n; Esper B, 2006, TRENDS PLANT SCI, V11, P543, DOI 10.1016/j.tplants.2006.09.001; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; HORANYI P, 2006, Patent No. 7582475; Jenney FE, 2008, EXTREMOPHILES, V12, P39, DOI 10.1007/s00792-007-0087-9; King PW, 1999, J BACTERIOL, V181, P5250, DOI 10.1128/JB.181.17.5250-5256.1999; Kleihues L, 2000, J BACTERIOL, V182, P2716, DOI 10.1128/JB.182.10.2716-2724.2000; Lenz O, 2005, J BACTERIOL, V187, P6590, DOI 10.1128/JB.187.18.6590-6595.2005; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Ma KS, 2000, J BACTERIOL, V182, P1864, DOI 10.1128/JB.182.7.1864-1871.2000; Ma KS, 2001, METHOD ENZYMOL, V331, P208; Maeda T, 2007, APPL MICROBIOL BIOT, V76, P1035, DOI 10.1007/s00253-007-1086-6; MENON NK, 1993, FEBS LETT, V331, P91, DOI 10.1016/0014-5793(93)80303-C; MENON NK, 1991, J BACTERIOL, V173, P4851, DOI 10.1128/jb.173.15.4851-4861.1991; MENON NK, 1994, J BACTERIOL, V176, P4416, DOI 10.1128/jb.176.14.4416-4423.1994; Mertens R, 2003, J MOL CATAL B-ENZYM, V24-5, P39, DOI 10.1016/S1381-1177(03)00071-7; Miller JH, 1972, EXPT MOL GENETICS, Vxvi; Ogata H, 2009, DALTON T, P7577, DOI 10.1039/b903840j; OXER MD, 1991, NUCLEIC ACIDS RES, V19, P2889, DOI 10.1093/nar/19.11.2889; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; Porthun A, 2002, ARCH MICROBIOL, V177, P159, DOI 10.1007/s00203-001-0371-5; Posewitz MC, 2005, BIOCHEM SOC T, V33, P102, DOI 10.1042/BST0330102; Prince RC, 2005, CRIT REV MICROBIOL, V31, P19, DOI 10.1080/10408410590912961; Qazi SNA, 2001, MICROBIAL ECOL, V41, P301; ROSSMANN R, 1995, EUR J BIOCHEM, V227, P545, DOI 10.1111/j.1432-1033.1995.tb20422.x; Rousset M, 1998, J BACTERIOL, V180, P4982, DOI 10.1128/JB.180.18.4982-4986.1998; Sambrook J, 2001, MOL CLONING LAB MANU; SAWERS RG, 1985, J BACTERIOL, V164, P1324, DOI 10.1128/JB.164.3.1324-1331.1985; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; SCHNEIDER K, 1976, BIOCHIM BIOPHYS ACTA, V452, P66, DOI 10.1016/0005-2744(76)90058-9; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Shirshikova GN, 2009, DOKL BIOCHEM BIOPHYS, V425, P124, DOI 10.1134/S1607672909020185; Sigfusson TI, 2007, PHILOS T R SOC A, V365, P1025, DOI 10.1098/rsta.2006.1960; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456	44	64	72	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2010	5	5							e10526	10.1371/journal.pone.0010526	http://dx.doi.org/10.1371/journal.pone.0010526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LG	20463892	Green Submitted, Green Published, gold			2022-12-25	WOS:000277379800015
J	Matsuo, Y; Kamitani, T				Matsuo, Yasuhiro; Kamitani, Tetsu			Parkinson's Disease-Related Protein, alpha-Synuclein, in Malignant Melanoma	PLOS ONE			English	Article							MART-1; S-100; TYROSINASE; ANTIBODY; LESIONS	Background: Melanoma is the major cause of skin cancer death worldwide. Parkinson's disease is a neurodegenerative disorder that is caused by mutation of alpha-synuclein or other genes. Importantly, epidemiological studies have reported co-occurrence of melanoma and Parkinson's disease, suggesting that these two diseases could share common genetic components. Methodology/Principal Findings: Recently, we found that human melanoma cell lines highly express alpha-synuclein, whereas the protein is undetectable in the non-melanoma cancer cell lines tested. To investigate the expression of alpha-synuclein in human melanoma tissues, we immunostained sections of melanoma, nevus, non-melanocytic cutaneous carcinoma, and normal skin. alpha-Synuclein was positively detected in 86% of the primary and 85% of the metastatic melanoma sections, as well as in 89% of nevus sections. However, alpha-synuclein was undetectable in non-melanocytic cutaneous carcinoma and normal skin. Conclusions/Significance: The Parkinson's disease-related protein, alpha-synuclein, is expressed in both malignant and benign melanocytic lesions, such as melanomas and nevi. Although alpha-synuclein cannot be used to distinguish between malignant and benign melanocytic skin lesions, it might be a useful biomarker for the diagnosis of metastatic melanoma.	[Matsuo, Yasuhiro; Kamitani, Tetsu] Med Coll Georgia, Dept Med, Ctr Mol Chaperone Radiobiol & Canc Virol, Ctr Canc, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Matsuo, Y (corresponding author), Med Coll Georgia, Dept Med, Ctr Mol Chaperone Radiobiol & Canc Virol, Ctr Canc, Augusta, GA 30912 USA.	tkamitani@mcg.edu	Kamitani, Tetsu/GSI-7613-2022; Matsuo, Yasuhiro/AAT-6220-2021	Matsuo, Yasuhiro/0000-0002-2858-7179; Kamitani, Tetsu/0000-0002-3257-9630	National Institutes of Health [R01 AG024497]; Medical College of Georgia; NATIONAL INSTITUTE ON AGING [R01AG024497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical College of Georgia; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant R01 AG024497 (to T. K.) and Faculty Start-up Fund at the Medical College of Georgia (to T. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batistatou A, 2009, VIRCHOWS ARCH, V454, P505, DOI 10.1007/s00428-009-0763-5; Clarkson KS, 2001, J CLIN PATHOL, V54, P196, DOI 10.1136/jcp.54.3.196; Cormier JN, 1998, J IMMUNOTHER, V21, P27, DOI 10.1097/00002371-199801000-00003; De Maziere AM, 2002, TRAFFIC, V3, P678, DOI 10.1034/j.1600-0854.2002.30909.x; Fetsch PA, 1999, CANCER CYTOPATHOL, V87, P37, DOI 10.1002/(SICI)1097-0142(19990225)87:1<37::AID-CNCR7>3.0.CO;2-7; Gao X, 2009, NEUROLOGY, V73, P1286, DOI 10.1212/WNL.0b013e3181bd13a1; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Larson AR, 2009, NAT CLIN PRACT ONCOL, V6, P105, DOI 10.1038/ncponc1296; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Olsen JH, 2006, EPIDEMIOLOGY, V17, P582, DOI 10.1097/01.ede.0000229445.90471.5e; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Shidham VB, 2001, AM J SURG PATHOL, V25, P1039, DOI 10.1097/00000478-200108000-00008; Thompson JF, 2005, LANCET, V365, P687, DOI 10.1016/S0140-6736(05)17951-3; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Yu LL, 1999, CANCER, V86, P617, DOI 10.1002/(SICI)1097-0142(19990815)86:4<617::AID-CNCR10>3.0.CO;2-S; Zubovits J, 2004, HUM PATHOL, V35, P217, DOI 10.1016/j.humpath.2003.09.019	19	73	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10481	10.1371/journal.pone.0010481	http://dx.doi.org/10.1371/journal.pone.0010481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463956	gold, Green Published, Green Submitted			2022-12-25	WOS:000277379400017
J	Zhan, Y; Melian, NY; Pantoja, M; Haines, N; Ruohola-Baker, H; Bourque, CW; Rao, Y; Carbonetto, S				Zhan, Yougen; Melian, Nadia Y.; Pantoja, Mario; Haines, Nicola; Ruohola-Baker, Hannele; Bourque, Charles W.; Rao, Yong; Carbonetto, Salvatore			Dystroglycan and Mitochondrial Ribosomal Protein L34 Regulate Differentiation in the Drosophila Eye	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHIES; O-MANNOSYLTRANSFERASE ACTIVITY; GLYCOPROTEIN COMPLEX; NEURONAL MIGRATION; LAMININ; MUSCLE; DISORDERS; POLARITY; MUTANTS; DISEASE	Mutations that diminish the function of the extracellular matrix receptor Dystroglycan (DG) result in muscular dystrophies, with associated neuronal migration defects in the brain and mental retardation e. g. Muscle Eye Brain Disease. To gain insight into the function of DG in the nervous system we initiated a study to examine its contribution to development of the eye of Drosophila melanogaster. Immuno-histochemistry showed that DG is concentrated on the apical surface of photoreceptors (R) cells during specification of cell-fate in the third instar larva and is maintained at this location through early pupal stages. In point mutations that are null for DG we see abortive R cell elongation during differentiation that first appears in the pupa and results in stunted R cells in the adult. Overexpression of DG in R cells results in a small but significant increase in their size. R cell differentiation defects appear at the same stage in a deficiency line Df(2R)Dg(248) that affects Dg and the neighboring mitochondrial ribosomal gene, mRpL34. In the adult, these flies have severely disrupted R cells as well as defects in the lens and ommatidia. Expression of an mRpL34 transgene rescues much of this phenotype. We conclude that DG does not affect neuronal commitment but functions R cell autonomously to regulate neuronal elongation during differentiation in the pupa. We discuss these findings in view of recent work implicating DG as a regulator of cell metabolism and its genetic interaction with mRpL34, a member of a class of mitochondrial genes essential for normal metabolic function.	[Zhan, Yougen; Melian, Nadia Y.; Haines, Nicola; Bourque, Charles W.; Rao, Yong; Carbonetto, Salvatore] McGill Univ, Ctr Res Neurosci, Ctr Hlth, Montreal, PQ H3A 2T5, Canada; [Pantoja, Mario; Ruohola-Baker, Hannele] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Pantoja, Mario; Ruohola-Baker, Hannele] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	McGill University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zhan, Y (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	sal.carbonetto@mcgill.ca		Bourque, Charles/0000-0002-1594-742X	Canadian Institute for Health Research [82105]; Muscular Dystrophy Association; Amyotrophic Lateral Sclerosis (Canada); Canadian Institute for Health Research Regenerative Medicine Team [82501]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association(Muscular Dystrophy Association); Amyotrophic Lateral Sclerosis (Canada); Canadian Institute for Health Research Regenerative Medicine Team(Canadian Institutes of Health Research (CIHR))	This work was supported by grants to S. C. and Y.R. from the Canadian Institute for Health Research (82105); Muscular Dystrophy Association and Amyotrophic Lateral Sclerosis (Canada), as well as a Canadian Institute for Health Research Regenerative Medicine Team Grant (82501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Christoforou CP, 2008, DEV BIOL, V313, P519, DOI 10.1016/j.ydbio.2007.09.044; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Dekkers LC, 2004, GENE EXPR PATTERNS, V4, P153, DOI 10.1016/j.modgep.2003.09.004; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; DOUVILLE PJ, 1988, J BIOL CHEM, V263, P14964; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Gaengel Konstantin, 2008, V420, P277, DOI 10.1007/978-1-59745-583-1_17; Golden JA, 2001, NEUROPATH APPL NEURO, V27, P22, DOI 10.1046/j.0305-1846.2001.00307.x; Greener MJ, 2000, FEBS LETT, V482, P13, DOI 10.1016/S0014-5793(00)02018-4; Haenggi T, 2006, CELL MOL LIFE SCI, V63, P1614, DOI 10.1007/s00018-005-5461-0; Haines N, 2007, MOL BIOL CELL, V18, P4721, DOI 10.1091/mbc.E07-01-0047; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Hino N, 2001, BRAIN DEV-JPN, V23, P97, DOI 10.1016/S0387-7604(01)00189-9; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Liao TSV, 2006, GENETICS, V174, P525, DOI 10.1534/genetics.106.061705; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Martin PT, 2006, NAT CLIN PRACT NEURO, V2, P222, DOI 10.1038/ncpneuro0155; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Mirouse V, 2009, DEV CELL, V16, P83, DOI 10.1016/j.devcel.2008.11.006; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Muntoni F, 2004, CURR OPIN NEUROL, V17, P205, DOI 10.1097/00019052-200404000-00020; Muntoni F, 2002, NEUROMUSCULAR DISORD, V12, P438, DOI 10.1016/S0960-8966(01)00326-1; Nakamura N, 2010, GLYCOBIOLOGY, V20, P381, DOI 10.1093/glycob/cwp189; Poulton JS, 2006, P NATL ACAD SCI USA, V103, P12775, DOI 10.1073/pnas.0603817103; Qu Q, 2006, EUR J NEUROSCI, V23, P2877, DOI 10.1111/j.1460-9568.2006.04836.x; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Schneider M, 2008, FLY, V2, P29, DOI 10.4161/fly.5726; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Shcherbata HR, 2007, EMBO J, V26, P481, DOI 10.1038/sj.emboj.7601503; Sheen VL, 2006, ANN NEUROL, V60, P137, DOI 10.1002/ana.20843; SMALHEISER NR, 1987, P NATL ACAD SCI USA, V84, P6457, DOI 10.1073/pnas.84.18.6457; Stowers RS, 1999, GENETICS, V152, P1631; Takeuchi K, 2009, SCIENCE, V323, P1740, DOI 10.1126/science.1165712; Tselykh TV, 2005, EXP CELL RES, V307, P354, DOI 10.1016/j.yexcr.2005.03.037; Voit T, 2002, NEUROMUSCULAR DISORD, V12, P623, DOI 10.1016/S0960-8966(02)00018-4; Walther RF, 2006, NAT PROTOC, V1, P2635, DOI 10.1038/nprot.2006.379; Wawersik S, 2000, Results Probl Cell Differ, V31, P15; XU T, 1993, DEVELOPMENT, V117, P1223; Yatsenko AS, 2007, J BIOL CHEM, V282, P15159, DOI 10.1074/jbc.M608800200; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	50	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10488	10.1371/journal.pone.0010488	http://dx.doi.org/10.1371/journal.pone.0010488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463973	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379400024
J	Danelishvili, L; Yamazaki, Y; Selker, J; Bermudez, LE				Danelishvili, Lia; Yamazaki, Yoshitaka; Selker, Jeannie; Bermudez, Luiz E.			Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c Proteins Participate in the Suppression of Macrophage Apoptosis	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; INDUCED CELL-DEATH; PHAGOSOME MATURATION; DEFENSE-MECHANISM; INNATE IMMUNITY; NECROSIS; IDENTIFICATION; INFECTION; AUTOPHAGY; GENE	Background: Inhibition of macrophage apoptosis by Mycobacterium tuberculosis has been proposed as one of the virulence mechanisms whereby the pathogen avoids the host defense. The mechanisms by which M. tuberculosis H37Rv strain suppress apoptosis and escapes human macrophage killing was investigated. Methodology/Principal Findings: The screening of a transposon mutant bank identified several mutants, which, in contrast to the wild-type bacterium, had impaired ability to inhibit apoptosis of macrophages. Among the identified genes, Rv3659c (31G12 mutant) belongs to an operon reminiscent of type IV pili. The Rv3654c and Rv3655c putative proteins in a seven-gene operon are secreted into the macrophage cytoplasm and suppress apoptosis by blocking the extrinsic pathway. The operon is highly expressed when the bacterium is within macrophages, compared to the expression level in the extracellular environment. Rv3654c recognizes the polypyrimidine tract binding Protein-associated Splicing Factor (PSF) and cleaves it, diminishing the availability of caspase-8. While M. tuberculosis inhibits apoptosis by the extrinsic pathway, the pathogen does not appear to affect the intrinsic pathway. Inactivation of the intrinsic pathway by pharmacologic agents afftects M. tuberculosis and induces cell necrosis. Likewise, inactivation of PSF by siRNA significantly decreased the level of caspase-8 in macrophages. Conclusion: While M. tuberculosis inhibits the extrinsic pathway of apoptosis, it appears to activate the intrinsic pathway leading to macrophage necrosis as a potential exit strategy.	[Danelishvili, Lia; Bermudez, Luiz E.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Yamazaki, Yoshitaka] Shinshu Univ, Dept Infect Dis & Lab Med, Sch Med, Matsumoto, Nagano 390, Japan; [Selker, Jeannie] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Bermudez, Luiz E.] Oregon State Univ, Dept Microbiol, Coll Sci, Corvallis, OR 97331 USA	Oregon State University; Shinshu University; University of Oregon; Oregon State University	Danelishvili, L (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Luiz.Bermudez@oregonstate.edu		Danelishvili, Lia/0000-0003-1390-3121	Agricultural Experiment Station; National Institute of Allergy and Infectious Diseases [R21-AI064018]; National Institute of Environmental Health Science National Institute of Health [P30 ES00210]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	Agricultural Experiment Station; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Environmental Health Science National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by an Agricultural Experiment Station grant and by the National Institute of Allergy and Infectious Diseases grant # R21-AI064018. The mass spectrometric sequencing was supported in part by the National Institute of Environmental Health Science National Institute of Health Grant P30 ES00210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Cools J, 2002, GENE CHROMOSOME CANC, V34, P354, DOI 10.1002/gcc.10033; Danelishvili L, 2004, FEMS MICROBIOL LETT, V239, P41, DOI 10.1016/j.femsle.2004.08.014; Danelishvili L, 2003, CELL MICROBIOL, V5, P649, DOI 10.1046/j.1462-5822.2003.00312.x; Danelishvili L, 2007, P NATL ACAD SCI USA, V104, P11038, DOI 10.1073/pnas.0610746104; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Duan L, 2002, J IMMUNOL, V169, P5181, DOI 10.4049/jimmunol.169.9.5181; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Kundu M, 2009, NAT IMMUNOL, V10, P918, DOI 10.1038/ni.1754; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Ouyang T, 2003, J BIOL CHEM, V278, P30028, DOI 10.1074/jbc.M300883200; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Shav-Tal Y, 2001, MOL BIOL CELL, V12, P2328, DOI 10.1091/mbc.12.8.2328; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Tamme R, 2000, BIOTECHNIQUES, V28, P895, DOI 10.2144/00285st02; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Ting LM, 1999, J IMMUNOL, V163, P3898; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Zhang JL, 2005, MICROBIOL IMMUNOL, V49, P845, DOI 10.1111/j.1348-0421.2005.tb03673.x	33	57	64	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10474	10.1371/journal.pone.0010474	http://dx.doi.org/10.1371/journal.pone.0010474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454556	Green Published, Green Submitted, gold			2022-12-25	WOS:000277305300010
J	Salas, A; Amigo, J				Salas, Antonio; Amigo, Jorge			A Reduced Number of mtSNPs Saturates Mitochondrial DNA Haplotype Diversity of Worldwide Population Groups	PLOS ONE			English	Article							HUMAN MTDNA; REGION SEQUENCES; GENE FLOW; MUTATIONS; AMERICAN; AFRICAN; SINGLE; GENOME; POLYMORPHISMS; FRAGMENTS	Background: The high levels of variation characterising the mitochondrial DNA (mtDNA) molecule are due ultimately to its high average mutation rate; moreover, mtDNA variation is deeply structured in different populations and ethnic groups. There is growing interest in selecting a reduced number of mtDNA single nucleotide polymorphisms (mtSNPs) that account for the maximum level of discrimination power in a given population. Applications of the selected mtSNP panel range from anthropologic and medical studies to forensic genetic casework. Methodology/Principal Findings: This study proposes a new simulation-based method that explores the ability of different mtSNP panels to yield the maximum levels of discrimination power. The method explores subsets of mtSNPs of different sizes randomly chosen from a preselected panel of mtSNPs based on frequency. More than 2,000 complete genomes representing three main continental human population groups (Africa, Europe, and Asia) and two admixed populations ("African-Americans'' and "Hispanics'') were collected from GenBank and the literature, and were used as training sets. Haplotype diversity was measured for each combination of mtSNP and compared with existing mtSNP panels available in the literature. The data indicates that only a reduced number of mtSNPs ranging from six to 22 are needed to account for 95% of the maximum haplotype diversity of a given population sample. However, only a small proportion of the best mtSNPs are shared between populations, indicating that there is not a perfect set of "universal'' mtSNPs suitable for all population contexts. The discrimination power provided by these mtSNPs is much higher than the power of the mtSNP panels proposed in the literature to date. Some mtSNP combinations also yield high diversity values in admixed populations. Conclusions/Significance: The proposed computational approach for exploring combinations of mtSNPs that optimise the discrimination power of a given set of mtSNPs is more efficient than previous empirical approaches. In contrast to precedent findings, the results seem to indicate that only few mtSNPs are needed to reach high levels of discrimination power in a population, independently of its ancestral background.	[Salas, Antonio; Amigo, Jorge] Univ Santiago de Compostela, Dept Anat Patolox & Ciencias Forenses, Unidade Xenet, Galicia, Spain; [Salas, Antonio; Amigo, Jorge] Univ Santiago de Compostela, Fac Med, Inst Med Legal, Galicia, Spain; [Amigo, Jorge] Univ Santiago de Compostela, Grp Med Xenom, Galicia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Salas, A (corresponding author), Univ Santiago de Compostela, Dept Anat Patolox & Ciencias Forenses, Unidade Xenet, Galicia, Spain.	antonio.salas@usc.es	Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012; Amigo Lechuga, Jorge/A-4892-2010	Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Amigo Lechuga, Jorge/0000-0002-1362-2605	Fundacion de Investigacion Medica Mutua Madrile [2006/CL370, 2008/CL444]; Xunta de Galicia [2008/XA122]; Fondos Feder; Ministerio de Ciencia e Innovacion [SAF2008-02971]; CESGA	Fundacion de Investigacion Medica Mutua Madrile; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondos Feder(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CESGA	Two grants from Fundacion de Investigacion Medica Mutua Madrile a (2006/CL370 and 2008/CL444), a grant Grupos Emerxentes from Xunta de Galicia (2008/XA122) and "Fondos Feder'', and a grant from the Ministerio de Ciencia e Innovacion (SAF2008-02971) awarded to A. Salas supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the CESGA for their supercomputing availability and support and Yong-Gang Yao and an anonymous reviewer for critically reading and commenting on the manuscript.	Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Alvarez-Iglesias V, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-26; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2007, EUR J HUM GENET, V15, P400, DOI 10.1038/sj.ejhg.5201781; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Barros F, 1997, ELECTROPHORESIS, V18, P52, DOI 10.1002/elps.1150180110; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; Brisighelli F, 2009, EUR J HUM GENET, V17, P693, DOI 10.1038/ejhg.2008.224; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; Cerezo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007902; Cerezo M, 2009, ELECTROPHORESIS, V30, P3665, DOI 10.1002/elps.200900294; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P; Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505; Chinnery PF, 1999, J MED GENET, V36, P425; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Egeland T, 2008, TOFORENSICSJ, V1, P4; Egeland T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003988; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Just RS, 2008, FORENSIC SCI INT-GEN, V2, pE45, DOI [10.1016/j.fsigen.2007.12.001, 10.1016/j.fsigen.2007.11.004]; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003016; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mosquera-Miguel A, 2009, FORENSIC SCI INT-GEN, V3, P261, DOI 10.1016/j.fsigen.2009.04.006; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2001, FORENSIC SCI INT, V124, P97, DOI 10.1016/S0379-0738(01)00574-6; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Vega A, 2004, ONCOGENE, V23, P1314, DOI 10.1038/sj.onc.1207214; Yao YG, 2004, FORENSIC SCI INT, V141, P1, DOI 10.1016/j.forsciint.2003.12.004; YAO YG, 2009, AM J HUM GE IN PRESS	53	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10218	10.1371/journal.pone.0010218	http://dx.doi.org/10.1371/journal.pone.0010218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454657	Green Published, gold, Green Submitted			2022-12-25	WOS:000277240300001
J	Holmes, MV; Jiang, BY; McNeill, K; Wong, M; Oakley, SP; Kirkham, B; Chowienczyk, PJ				Holmes, Michael V.; Jiang, Benyu; McNeill, Karen; Wong, Melinda; Oakley, Stephen P.; Kirkham, Bruce; Chowienczyk, Phil J.			Paradoxical Association of C-Reactive Protein with Endothelial Function in Rheumatoid Arthritis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INTIMA-MEDIA THICKNESS; PULSE-WAVE VELOCITY; CARDIOVASCULAR EVENTS; NITRIC-OXIDE; CAROTID-ARTERY; OLDER-ADULTS; MYOCARDIAL-INFARCTION; VASCULAR FUNCTION; AORTIC STIFFNESS	Background: Within the general population, levels of C-reactive protein (CRP) are positively associated with atherosclerotic cardiovascular disease (CVD). Whether CRP is causally implicated in atherogenesis or is the results of atherosclerosis is disputed. A role of CRP to protect endothelium-derived nitric oxide (EDNO) has been suggested. We examined the association of CRP with EDNO-dependent vasomotor function and subclinical measures of atherosclerosis and arteriosclerosis in patients with raised CRP resulting from rheumatoid arthritis (RA). Methodology/Principal Findings: Patients with RA (n = 59) and healthy control subjects (n = 123), underwent measures of high sensitivity CRP, flow-mediated dilation (FMD, dependent on EDNO), intima-media thickness (IMT, a measure of subclinical atherosclerosis) and aortic pulse wave velocity (PWV, a measure of arteriosclerosis). IMT and PWV were elevated in patients with RA compared to controls but FMD was similar in the two groups. In patients with RA, IMT and PWV were not correlated with CRP but FMD was positively independently correlated with CRP (P<0.01). Conclusions/Significance: These findings argue against a causal role of CRP in atherogenesis and are consistent with a protective effect of CRP on EDNO bioavailability.	[Holmes, Michael V.; Jiang, Benyu; McNeill, Karen; Wong, Melinda; Chowienczyk, Phil J.] Kings Coll London, St Thomas Hosp, British Heart Fdn Ctr, Dept Clin Pharmacol, London WC2R 2LS, England; [Oakley, Stephen P.; Kirkham, Bruce] Guys & St Thomas Natl Hlth Serv Fdn Trust, Dept Rheumatol, London, England; [Kirkham, Bruce] Kings Coll London, Biomed Res Ctr, Guys & St Thomas Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Holmes, MV (corresponding author), Kings Coll London, St Thomas Hosp, British Heart Fdn Ctr, Dept Clin Pharmacol, London WC2R 2LS, England.	phil.chowienczyk@kcl.ac.uk	Holmes, Michael/AAA-2208-2021	Chowienczyk, Phil/0000-0003-4507-038X	National Institute for Health Research (NIHR); National Health Service (NHS) Foundation Trust; King's College Hospital NHS Foundation Trust; Medical Research Council [G0802432] Funding Source: researchfish; MRC [G0802432] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Health Service (NHS) Foundation Trust; King's College Hospital NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Michael V. Holmes is funded by an Academic Clinical Fellowship from the National Institute for Health Research (NIHR). The authors acknowledge financial support from the Department of Health via the NIHR comprehensive Biomedical Research Centre award to Guy's and St. Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Clapp BR, 2005, CIRCULATION, V111, P1530, DOI 10.1161/01.CIR.0000159336.31613.31; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Devaraj S, 2003, CIRCULATION, V107, P398, DOI 10.1161/01.CIR.0000052617.91920.FD; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Goodson NJ, 2005, ARTHRITIS RHEUM-US, V52, P2293, DOI 10.1002/art.21204; Graf J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006242; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Jarvisalo MJ, 2002, ARTERIOSCL THROM VAS, V22, P1323, DOI 10.1161/01.ATV.0000024222.06463.21; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Lawlor DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003011; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Matsushima Y, 2007, INT J CARDIOL, V117, P165, DOI 10.1016/j.ijcard.2006.04.063; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; MONCADA S, 1991, PHARMACOL REV, V43, P109; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pasceri V, 2000, CIRCULATION, V102, P2165; Pereira IA, 2009, ACTA REUMATOL PORT, V34, P58; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, ARTHRITIS RHEUM, V60, P1205, DOI 10.1002/art.24521; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rossi R, 2008, J AM COLL CARDIOL, V51, P997, DOI 10.1016/j.jacc.2007.11.044; Schunkert H, 2008, NEW ENGL J MED, V359, P1953, DOI 10.1056/NEJMe0807235; Shimbo D, 2007, ATHEROSCLEROSIS, V192, P197, DOI 10.1016/j.atherosclerosis.2006.05.005; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Takase B, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-61; Van Doornum S, 2003, ARTHRITIS RHEUM, V48, P72, DOI 10.1002/art.10735; Vitale Cristiana, 2003, Ital Heart J, V4, P627; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	44	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10242	10.1371/journal.pone.0010242	http://dx.doi.org/10.1371/journal.pone.0010242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436910	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079700004
J	Spiesser, TW; Diener, C; Barberis, M; Klipp, E				Spiesser, Thomas W.; Diener, Christian; Barberis, Matteo; Klipp, Edda			What Influences DNA Replication Rate in Budding Yeast?	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EPIGENETIC REGULATION; EUKARYOTIC CELLS; S-PHASE; ORIGINS; TRANSCRIPTION; COMPLEX; FORK; PROGRESSION; MODEL	Background: DNA replication begins at specific locations called replication origins, where helicase and polymerase act in concert to unwind and process the single DNA filaments. The sites of active DNA synthesis are called replication forks. The density of initiation events is low when replication forks travel fast, and is high when forks travel slowly. Despite the potential involvement of epigenetic factors, transcriptional regulation and nucleotide availability, the causes of differences in replication times during DNA synthesis have not been established satisfactorily, yet. Methodology/Principal Findings: Here, we aimed at quantifying to which extent sequence properties contribute to the DNA replication time in budding yeast. We interpreted the movement of the replication machinery along the DNA template as a directed random walk, decomposing influences on DNA replication time into sequence-specific and sequence-independent components. We found that for a large part of the genome the elongation time can be well described by a global average replication rate, thus by a single parameter. However, we also showed that there are regions within the genomic landscape of budding yeast with highly specific replication rates, which cannot be explained by global properties of the replication machinery. Conclusion/Significance: Computational models of DNA replication in budding yeast that can predict replication dynamics have rarely been developed yet. We show here that even beyond the level of initiation there are effects governing the replication time that can not be explained by the movement of the polymerase along the DNA template alone. This allows us to characterize genomic regions with significantly altered elongation characteristics, independent of initiation times or sequence composition.	[Spiesser, Thomas W.; Diener, Christian; Barberis, Matteo; Klipp, Edda] Humboldt Univ, Inst Biol, Berlin, Germany; [Barberis, Matteo] Max Planck Inst Mol Genet, Berlin, Germany	Humboldt University of Berlin; Max Planck Society	Spiesser, TW (corresponding author), Humboldt Univ, Inst Biol, Berlin, Germany.	matteo.barberis@biologie.hu-berlin.de; edda.klipp@rz.hu-berlin.de	Diener, Christian/X-9574-2019	Diener, Christian/0000-0002-7476-0868; Barberis, Matteo/0000-0001-5640-7422	European Commission [LSHG-CT-2005-518254]; German Research Foundation (DFG) [IRTG 1360]; Max Planck Society through IMPRS-CBSC (International Max Planck Research School for Computational Biology and Scientific Computing)	European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation (DFG)(German Research Foundation (DFG)); Max Planck Society through IMPRS-CBSC (International Max Planck Research School for Computational Biology and Scientific Computing)	MB was supported by the Network of Excellence of the European Commission, Project ENFIN, contract number LSHG-CT-2005-518254. TWS was supported by the German Research Foundation (DFG) through IRTG 1360 (International Research Training Group). CD was supported by the Max Planck Society through IMPRS-CBSC (International Max Planck Research School for Computational Biology and Scientific Computing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Antequera F, 2004, EMBO J, V23, P4365, DOI 10.1038/sj.emboj.7600450; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Francon P, 1999, FEBS LETT, V452, P87, DOI 10.1016/S0014-5793(99)00585-2; Hamlin JL, 2008, J CELL BIOCHEM, V105, P321, DOI 10.1002/jcb.21828; Hiraga SI, 2005, GENES CELLS, V10, P297, DOI 10.1111/j.1365-2443.2005.00843.x; HOLM S, 1979, SCAND J STAT, V6, P65; JI N, 2001, EMBO J, V20, P2857; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kohzaki H, 1999, MOL CELL BIOL, V19, P7428; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; LUCCHINI R, 1994, MOL CELL BIOL, V14, P318, DOI 10.1128/MCB.14.1.318; McCune HJ, 2008, GENETICS, V180, P1833, DOI 10.1534/genetics.108.094359; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Mechali M, 2001, NAT REV GENET, V2, P640, DOI 10.1038/35084598; Mori S, 2007, J BIOL CHEM, V282, P4447, DOI 10.1074/jbc.M609671200; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nieduszynski CA, 2005, NUCLEIC ACIDS RES, V33, P2410, DOI 10.1093/nar/gki539; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; OKAZAKI R, 1967, JPN J MED SCI BIOL, V20, P255; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; R Core Team, 2022, R LANG ENV STAT COMP; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689; Spiesser TW, 2009, MOL GENET GENOMICS, V282, P25, DOI 10.1007/s00438-009-0443-9; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Tabancay AP, 2006, CURR TOP DEV BIOL, V76, P129, DOI 10.1016/S0070-2153(06)76005-7; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Weigel C, 1997, EMBO J, V16, P6574, DOI 10.1093/emboj/16.21.6574; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Wintersberger E, 2000, CHROMOSOMA, V109, P300, DOI 10.1007/s004120000080; Zannis-Hadjopoulos M, 1998, CRIT REV EUKAR GENE, V8, P81, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.40; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhou J, 2005, CELL CYCLE, V4, P889, DOI 10.4161/cc.4.7.1823; Zhu CY, 1997, ACM T MATH SOFTWARE, V23, P550, DOI 10.1145/279232.279236; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10203	10.1371/journal.pone.0010203	http://dx.doi.org/10.1371/journal.pone.0010203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436919	gold, Green Published, Green Submitted			2022-12-25	WOS:000277079700001
J	Paris, Z; Changmai, P; Rubio, MAT; Zikova, A; Stuart, KD; Alfonzo, JD; Lukes, J				Paris, Zdenek; Changmai, Piya; Rubio, Mary Anne T.; Zikova, Alena; Stuart, Kenneth D.; Alfonzo, Juan D.; Lukes, Julius			The Fe/S Cluster Assembly Protein Isd11 Is Essential for tRNA Thiolation in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE DESULFURASE; THIO-MODIFICATION; MITOCHONDRIAL; COMPLEX; BIOGENESIS; FRATAXIN; LOCALIZATION; ACTS; 2-THIOURIDINE; BIOSYNTHESIS	Fe/S clusters are part of the active site of many enzymes and are essential for cell viability. In eukaryotes the cysteine desulfurase Nfs (IscS) donates the sulfur during Fe/S cluster assembly and was thought sufficient for this reaction. Moreover, Nfs is indispensable for tRNA thiolation, a modification generally required for tRNA function and protein synthesis. Recently, Isd11 was discovered as an integral part of the Nfs activity at an early step of Fe/S cluster assembly. Here we show, using a combination of genetic, molecular, and biochemical approaches, that Isd11, in line with its strong association with Nfs, is localized in the mitochondrion of T. brucei. In addition to its involvement in Fe/S assembly, Isd11 also partakes in both cytoplasmic and mitochondrial tRNA thiolation, whereas Mtu1, another protein proposed to collaborate with Nfs in tRNA thiolation, is required for this process solely within the mitochondrion. Taken together these data place Isd11 at the center of these sulfur transactions and raises the possibility of a connection between Fe/S metabolism and protein synthesis, helping integrate two seemingly unrelated pathways.	[Paris, Zdenek; Changmai, Piya; Zikova, Alena; Lukes, Julius] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Budweis, Czech Republic; [Paris, Zdenek; Changmai, Piya; Zikova, Alena; Lukes, Julius] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Budweis, Czech Republic; [Rubio, Mary Anne T.; Alfonzo, Juan D.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Rubio, Mary Anne T.; Alfonzo, Juan D.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Zikova, Alena; Stuart, Kenneth D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Center for Infectious Disease Research	Lukes, J (corresponding author), Branisovska 31, Ceske Budejovice 37005, Czech Republic.	jula@paru.cas.cz	Zikova, Alena/G-7855-2014; Lukes, Julius/H-6760-2012; Changmai, Piya/AAA-8208-2019; Paris, Zdenek/G-7349-2014	Zikova, Alena/0000-0002-8686-0225; Lukes, Julius/0000-0002-0578-6618; Paris, Zdenek/0000-0003-1019-7719; Changmai, Piya/0000-0003-3307-0585	National Institutes of Health [AI065935, GM084065]; National Science Foundation [MCB-0620707]; Czech Science Foundation [204/ 09/1667]; Ministry of Education of the Czech Republic [LC07032, 2B06129, 6007665801]; Praemium Academiae award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Praemium Academiae award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI065935 (to K. D. S.) and GM084065 and National Science Foundation Grant MCB-0620707 (to J. D. A.), Czech Science Foundation Grant 204/ 09/1667, Ministry of Education of the Czech Republic Grants LC07032, 2B06129, and 6007665801, and a Praemium Academiae award (to J. D. L.).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; AGRIS PF, 1973, BIOCHEMISTRY-US, V12, P4331, DOI 10.1021/bi00746a005; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; Bruske EI, 2009, J BIOL CHEM, V284, P36491, DOI 10.1074/jbc.M109.064527; Crain PF, 2002, RNA, V8, P752, DOI 10.1017/S1355838202022045; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Jensen BC, 2007, MOL BIOCHEM PARASIT, V151, P28, DOI 10.1016/j.molbiopara.2006.10.002; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Kamenski P, 2007, MOL CELL, V26, P625, DOI 10.1016/j.molcel.2007.04.019; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Long S, 2008, P NATL ACAD SCI USA, V105, P13468, DOI 10.1073/pnas.0806762105; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Mihara H, 2002, P NATL ACAD SCI USA, V99, P6679, DOI 10.1073/pnas.102176099; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Poliak P, 2010, FEBS J, V277, P383, DOI 10.1111/j.1742-4658.2009.07489.x; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Richards TA, 2006, MOL BIOL EVOL, V23, P1341, DOI 10.1093/molbev/msl001; Saas J, 2000, J BIOL CHEM, V275, P2745, DOI 10.1074/jbc.275.4.2745; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; Smid O, 2006, J BIOL CHEM, V281, P28679, DOI 10.1074/jbc.M513781200; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Wohlgamuth-Benedum JM, 2009, J BIOL CHEM, V284, P23947, DOI 10.1074/jbc.M109.029421; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zikova A, 2008, MOL CELL PROTEOMICS, V7, P1286, DOI 10.1074/mcp.M700490-MCP200; Zutz A, 2009, BBA-BIOENERGETICS, V1787, P681, DOI 10.1016/j.bbabio.2009.02.009	43	30	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22394	22402		10.1074/jbc.M109.083774	http://dx.doi.org/10.1074/jbc.M109.083774			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20442400	Green Published, hybrid			2022-12-25	WOS:000279702200052
J	Song, GA; Kim, HJ; Woo, KM; Baek, JH; Kim, GS; Choi, JY; Ryoo, HM				Song, Gin-Ah; Kim, Hyun-Jung; Woo, Kyung-Mi; Baek, Jeong-Hwa; Kim, Gwan-Shik; Choi, Jin-Young; Ryoo, Hyun-Mo			Molecular Consequences of the ACVR1(R206H) Mutation of Fibrodysplasia Ossificans Progressiva	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; OSTEOBLAST DIFFERENTIATION; I RECEPTOR; OSTEOGENIC DIFFERENTIATION; FK506-BINDING PROTEIN; FKBP12 FUNCTIONS; NATURAL-HISTORY; MICE LACKING; EXPRESSION; ALK2	Fibrodysplasia ossificans progressiva (FOP), a rare genetic and catastrophic disorder characterized by progressive heterotopic ossification, is caused by a point mutation, c.617G>A; p.R206H, in the activin A receptor type 1 (ACVR1) gene, one of the bone morphogenetic protein type I receptors (BMPR-Is). Although altered BMP signaling has been suggested to explain the pathogenesis, the molecular consequences of this mutation are still elusive. Here we studied the impact of ACVR1 R206H mutation on BMP signaling and its downstream signaling cascades in murine myogenic C2C12 cells and HEK 293 cells. We found that ACVR1 was the most abundant of the BMPR-Is expressed in mesenchymal cells but its contribution to osteogenic BMP signal transduction was minor. The R206H mutant caused weak activation of the BMP signaling pathway, unlike the Q207D mutant, a strong and constitutively active form. The R206H mutant showed a decreased binding affinity for FKBP1A/FKBP12, a known safeguard molecule against the leakage of transforming growth factor (TGF)-beta or BMP signaling. The decreased binding affinity of FKBP1A to the mutant R206H ACVR1 resulted in leaky activation of the BMP signal, and moreover, it decreased steady-state R206H ACVR1 protein levels. Interestingly, while WT ACVR1 and FKBP1A were broadly distributed in plasma membrane and cytoplasm without BMP-2 stimulation and then localized in plasma membrane on BMP-2 stimulation, R206H ACVR1 and FKBP1A were mainly distributed in plasma membrane regardless of BMP-2 stimulation. The impaired binding to FKBP1A and an altered subcellular distribution by R206H ACVR1 mutation may result in mild activation of osteogenic BMP-signaling in extraskeletal sites such as muscle, which eventually lead to delayed and progressive ectopic bone formation in FOP patients.	[Song, Gin-Ah; Woo, Kyung-Mi; Baek, Jeong-Hwa; Kim, Gwan-Shik; Choi, Jin-Young; Ryoo, Hyun-Mo] Seoul Natl Univ, Sch Dent, Program BK21, Dept Mol Genet, Seoul 110749, South Korea; [Song, Gin-Ah; Woo, Kyung-Mi; Baek, Jeong-Hwa; Kim, Gwan-Shik; Choi, Jin-Young; Ryoo, Hyun-Mo] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea; [Kim, Hyun-Jung] BioRunx Co Ltd, Bone Res Inst, Seoul 110749, South Korea; [Song, Gin-Ah; Choi, Jin-Young] Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Seoul 110749, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Ryoo, HM (corresponding author), 28 Yeongeon Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr	Baek, Jeong-Hwa/A-8628-2012; Ryoo, Hyun-Mo/D-5839-2012; Woo, Kyung Mi/A-2793-2009	Ryoo, Hyun-Mo/0000-0001-6769-8341; Woo, Kyung Mi/0000-0002-2782-1189	Korean Government [KRF-2008-313-E00562]; Ministry of Health and Welfare [A010252]	Korean Government(Korean Government); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Korea Research Foundation grant funded by the Korean Government (KRF-2008-313-E00562) and by the Korea Health 21 R&D Project, Ministry of Health and Welfare (Project A010252).	Acampora D, 1999, DEVELOPMENT, V126, P3795; Aghdasi B, 2001, P NATL ACAD SCI USA, V98, P2425, DOI 10.1073/pnas.041614198; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Billings PC, 2008, J BONE MINER RES, V23, P305, DOI 10.1359/JBMR.071030; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Chen Y, 2005, HUM MOL GENET, V14, P2559, DOI 10.1093/hmg/ddi259; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; Chen Z, 2010, FASEB J, V24, P357, DOI 10.1096/fj.09-138446; Cho YD, 2009, J BIOL CHEM, V284, P25230, DOI 10.1074/jbc.M109.008391; COHEN RB, 1993, J BONE JOINT SURG AM, V75A, P215, DOI 10.2106/00004623-199302000-00008; CONNOR JM, 1982, J BONE JOINT SURG BR, V64, P76, DOI 10.1302/0301-620X.64B1.7068725; CONNOR JM, 1993, J MED GENET, V30, P687, DOI 10.1136/jmg.30.8.687; de la Pena LS, 2005, J BONE MINER RES, V20, P1168, DOI 10.1359/JBMR.050305; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Esapa CT, 2005, HUM MOL GENET, V14, P295, DOI 10.1093/hmg/ddi026; FRUMAN DA, 1994, FASEB J, V8, P391, DOI 10.1096/fasebj.8.6.7513288; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Gregersen N, 2000, J INHERIT METAB DIS, V23, P441, DOI 10.1023/A:1005663728291; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Gu ZY, 1999, DEVELOPMENT, V126, P2551; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; HEITMAN J, 1992, NEW BIOL, V4, P448; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Howell GJ, 2006, INT REV CYTOL, V252, P1, DOI 10.1016/S0074-7696(06)52005-4; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kaartinen V, 2004, DEVELOPMENT, V131, P3481, DOI 10.1242/dev.01214; Kaplan FS, 2008, PEDIATRICS, V121, pE1295, DOI 10.1542/peds.2007-1980; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Kevenaar ME, 2009, HUM REPROD, V24, P241, DOI 10.1093/humrep/den353; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Kishigami S, 2004, DEV BIOL, V276, P185, DOI 10.1016/j.ydbio.2004.08.042; Kitterman JA, 2005, PEDIATRICS, V116, pE654, DOI 10.1542/peds.2005-0469; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; LIU F, 1995, MOL CELL BIOL, V15, P3479; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; MacMillan D, 2005, J CELL SCI, V118, P5443, DOI 10.1242/jcs.02657; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Nohe A, 2005, J CELL SCI, V118, P643, DOI 10.1242/jcs.01402; Olmsted-Davis E, 2007, AM J PATHOL, V170, P620, DOI 10.2353/ajpath.2007.060692; Renlund N, 2007, J ENDOCRINOL, V195, P95, DOI 10.1677/JOE-07-0281; Ryoo HM, 1997, MOL ENDOCRINOL, V11, P1681, DOI 10.1210/me.11.11.1681; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Schiene-Fischer C, 2001, FEBS LETT, V495, P1, DOI 10.1016/S0014-5793(01)02326-2; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shore EM, 2008, BONE, V43, P427, DOI 10.1016/j.bone.2008.05.013; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; SIEKIERKA JJ, 1989, J IMMUNOL, V143, P1580; Smith KA, 2009, CIRCULATION, V119, P3062, DOI 10.1161/CIRCULATIONAHA.108.843714; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; van Dinther M, 2010, J BONE MINER RES, V25, P1208, DOI [10.1002/jbmr.091110, 10.1359/jbmr.091110]; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Whiteman P, 2003, HUM MOL GENET, V12, P727, DOI 10.1093/hmg/ddg081; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Yamaguchi T, 2006, J MOL ENDOCRINOL, V36, P569, DOI 10.1677/jme.1.01966; Yao DY, 2000, J BIOL CHEM, V275, P13149, DOI 10.1074/jbc.275.17.13149; Yoon WJ, 2008, J BIOL CHEM, V283, P32751, DOI 10.1074/jbc.M803183200; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	67	85	88	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22542	22553		10.1074/jbc.M109.094557	http://dx.doi.org/10.1074/jbc.M109.094557			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463014	hybrid, Green Published			2022-12-25	WOS:000279702200066
J	Bock, BC; Tagscherer, KE; Fassl, A; Kramer, A; Oehme, I; Zentgraf, HW; Keith, M; Roth, W				Boeck, Barbara C.; Tagscherer, Katrin E.; Fassl, Anne; Kraemer, Anika; Oehme, Ina; Zentgraf, Hans-Walter; Keith, Martina; Roth, Wilfried			The PEA-15 Protein Regulates Autophagy via Activation of JNK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; MALIGNANT GLIOMA-CELLS; GLIOBLASTOMA CELLS; OVARIAN-CANCER; CYTOPLASMIC SEQUESTRATION; INDUCED APOPTOSIS; CHROMOSOME 17Q; RAS ACTIVATION; JUN; PHOSPHORYLATION	PEA-15/PED (phosphoprotein enriched in astrocytes 15 kDa/phosphoprotein enriched in diabetes) is a death effector domain-containing protein which is known to modulate apoptotic cell death. The mechanism by which PEA-15 inhibits caspase activation and increases ERK (extracellular-regulated kinase) activity is well characterized. Here, we demonstrate that PEA-15 is not only pivotal in the activation of the ERK pathway but also modulates JNK (c-Jun N-terminal kinase) signaling. Upon overexpression of PEA-15 in malignant glioma cells, JNK is potently activated. The PEA-15-induced JNK activation depends on the phosphorylation of PEA-15 at both phosphorylation sites (serine 104 and serine 116). The activation of JNK is substantially inhibited by siRNA-mediated down-regulation of endogenous PEA-15. Moreover, we demonstrate that glioma cells overexpressing PEA-15 show increased signs of autophagy in response to classical autophagic stimuli such as ionizing irradiation, serum deprivation, or rapamycin treatment. In contrast, the non-phosphorylatable mutants of PEA-15 are not capable of promoting autophagy. The inhibition of JNK abrogates the PEA-15-mediated increase in autophagy. In conclusion, our data show that PEA-15 promotes autophagy in glioma cells in a JNK-dependent manner. This might render glioma cells more resistant to adverse stimuli such as starvation or ionizing irradiation.	[Boeck, Barbara C.; Tagscherer, Katrin E.; Fassl, Anne; Kraemer, Anika; Keith, Martina; Roth, Wilfried] German Canc Res Ctr, Dept Mol Neurooncol, D-69120 Heidelberg, Germany; [Oehme, Ina] German Canc Res Ctr, Dept Pediat Oncol, D-69120 Heidelberg, Germany; [Zentgraf, Hans-Walter] German Canc Res Ctr, Dept Monoclonal Antibodies & Electron Microscopy, D-69120 Heidelberg, Germany; [Roth, Wilfried] Heidelberg Univ, Inst Pathol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Roth, W (corresponding author), German Canc Res Ctr, Dept Mol Neurooncol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	W.Roth@dkfz.de	Fassl, Anne/AAA-5249-2022; Oehme, Ina/AAF-3600-2021; Tagscherer, Katrin/AAS-3809-2021	Tagscherer, Katrin/0000-0002-0657-6399	Deutsche Krebshilfe	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by a grant from the Deutsche Krebshilfe (to W. R.) (German Cancer Aid, Max Eder Program).	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bartholomeusz C, 2006, ONCOGENE, V25, P79, DOI 10.1038/sj.onc.1209014; Bartholomeusz C, 2008, CANCER RES, V68, P9302, DOI 10.1158/0008-5472.CAN-08-2592; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bock BC, 2000, J BIOL CHEM, V275, P14231, DOI 10.1074/jbc.275.19.14231; Burgess GS, 1998, BLOOD, V92, P2450, DOI 10.1182/blood.V92.7.2450.2450_2450_2460; Cheng Y, 2008, BIOCHEM BIOPH RES CO, V376, P483, DOI 10.1016/j.bbrc.2008.09.018; Clark GJ, 1997, J BIOL CHEM, V272, P1677, DOI 10.1074/jbc.272.3.1677; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; Cripe LD, 2002, LEUKEMIA, V16, P799, DOI 10.1038/sj.leu.2402457; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Cui Q, 2007, J PHARMACOL SCI, V105, P317, DOI 10.1254/jphs.FP0070336; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; Dong G, 2001, CANCER RES, V61, P4797; Duerr EM, 1998, ONCOGENE, V16, P2259, DOI 10.1038/sj.onc.1201756; ECCLES DM, 1990, ONCOGENE, V5, P1599; Eckert A, 2008, ONCOGENE, V27, P1155, DOI 10.1038/sj.onc.1210732; Formisano P, 2005, ONCOGENE, V24, P7012, DOI 10.1038/sj.onc.1208871; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; FRANKLIN CC, 1992, P NATL ACAD SCI USA, V89, P7247, DOI 10.1073/pnas.89.15.7247; FUTREAL PA, 1992, CANCER RES, V52, P2624; GAO X, 1995, CANCER RES, V55, P1002; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Ito H, 2005, INT J ONCOL, V26, P1401; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kanzawa T, 2003, J NEUROSURG, V99, P1047, DOI 10.3171/jns.2003.99.6.1047; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Knobbe CB, 2002, NEURO-ONCOLOGY, V4, P196; Kubes M, 1998, J NEUROCHEM, V71, P1307; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li JY, 2008, J NEURO-ONCOL, V88, P11, DOI 10.1007/s11060-008-9529-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Peacock JW, 2009, MOL CELL BIOL, V29, P1222, DOI 10.1128/MCB.01660-08; Potapova O, 2000, J BIOL CHEM, V275, P24767, DOI 10.1074/jbc.M904591199; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ramos JW, 2000, MOL BIOL CELL, V11, P2863, DOI 10.1091/mbc.11.9.2863; Renault F, 2003, BIOCHEM PHARMACOL, V66, P1581, DOI 10.1016/S0006-2952(03)00514-8; Renault-Mihara F, 2006, MOL BIOL CELL, V17, P5141, DOI 10.1091/mbc.E05-11-1072; Renganathan H, 2005, BIOCHEM J, V390, P729, DOI 10.1042/BJ20050378; RUSSELL SEH, 1990, ONCOGENE, V5, P1581; SAITO H, 1993, CANCER RES, V53, P3382; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Sharif A, 2003, ANN NY ACAD SCI, V1010, P43, DOI 10.1196/annals.1299.006; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; Thorburn J, 2009, AUTOPHAGY, V5, P247, DOI 10.4161/auto.5.2.7552; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P684, DOI 10.1097/00005072-199807000-00005; Trencia A, 2003, MOL CELL BIOL, V23, P4511, DOI 10.1128/MCB.23.13.4511-4521.2003; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang YM, 2003, CLIN CANCER RES, V9, P391	59	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21644	21654		10.1074/jbc.M109.096628	http://dx.doi.org/10.1074/jbc.M109.096628			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452983	hybrid, Green Published			2022-12-25	WOS:000279516100051
J	Guo, X; Liu, W; Pan, Y; Ni, P; Ji, J; Guo, L; Zhang, J; Wu, J; Jiang, J; Chen, X; Cai, Q; Li, J; Zhang, J; Gu, Q; Liu, B; Zhu, Z; Yu, Y				Guo, X.; Liu, W.; Pan, Y.; Ni, P.; Ji, J.; Guo, L.; Zhang, J.; Wu, J.; Jiang, J.; Chen, X.; Cai, Q.; Li, J.; Zhang, J.; Gu, Q.; Liu, B.; Zhu, Z.; Yu, Y.			Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma	ONCOGENE			English	Article						epigenetic; gastric carcinoma; homeobox genes; IRX1; tumor suppressor	SQUAMOUS-CELL CARCINOMA; PROTEOMICS TECHNOLOGY; EPIGENETIC THERAPY; ENDOTHELIAL-CELLS; LUNG DEVELOPMENT; DNA METHYLATION; IROQUOIS GENES; BREAST-CANCER; EXPRESSION; IDENTIFICATION	The IRX1 tumor suppressor gene is located on 5p15.33, a cancer susceptibility locus. Loss of heterozygosity of 5p15.33 in gastric cancer was identified in our previous work. In this study, we analyzed the molecular features and function of IRX1. We found that IRX1 expression was lost or reduced in gastric cancer. However, no mutations were identified in IRX1-encoding regions. IRX1 transcription was suppressed by hypermethylation, and the expression of IRX1 mRNA was partially restored in gastric cancer cells after 5-Aza-dC treatment. Restoring IRX1 expression in SGC-7901 and NCI-N87 gastric cancer cells inhibited growth, invasion and tumorigenesis in vitro and in vivo. We identified a number of target genes by global microarray analysis after IRX1 transfection combined with real-time PCR and chromatin immunoprecipitation assay. BDKRB2, an angiogenesis-related gene, HIST2H2BE and FGF7, cell proliferation and invasion-related genes, were identified as direct IRX1 target genes. The hypermethylation of IRX1 was not only detected in primary gastric cancer tissues but also in the peripheral blood of gastric cancer patients, suggesting IRX1 could potentially serve as a biomarker for gastric cancer. Oncogene (2010) 29, 3908-3920; doi:10.1038/onc.2010.143; published online 3 May 2010	[Guo, X.; Liu, W.; Pan, Y.; Ji, J.; Guo, L.; Zhang, J.; Wu, J.; Jiang, J.; Chen, X.; Cai, Q.; Li, J.; Zhang, J.; Gu, Q.; Liu, B.; Zhu, Z.; Yu, Y.] Shanghai Ruijin Hosp, Dept Surg, Shanghai, Peoples R China; [Guo, X.; Liu, W.; Pan, Y.; Ji, J.; Guo, L.; Zhang, J.; Wu, J.; Jiang, J.; Chen, X.; Cai, Q.; Li, J.; Zhang, J.; Gu, Q.; Liu, B.; Zhu, Z.; Yu, Y.] Shanghai Inst Digest Surg, Shanghai, Peoples R China; [Ni, P.] Shanghai Jiao Tong Univ, Sch Med, Dept Clin Biochem, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Ruijin Er Rd 197, Shanghai 200025, Peoples R China.	surgeryzhu@yahoo.com.cn; yingyan3y@yahoo.com.cn	Liu, Bingya/GMW-5655-2022		National Natural Science Foundation of China [30572127, 30770961, 30973486]; Chinese National High Tech Program [863-2006AA02A402, 2006AA02A301]; Shanghai Pu Jiang Project [PJ200700367]; Shanghai Science and Technology Commission [09DZ1950101, 09JC1409600]; Shanghai Charity Foundation for Cancer Research	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National High Tech Program(National High Technology Research and Development Program of China); Shanghai Pu Jiang Project(Shanghai Pujiang Program); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Charity Foundation for Cancer Research	This work was supported, in part by grants from the National Natural Science Foundation of China (30572127, 30770961 and 30973486), the Chinese National High Tech Program (863-2006AA02A402, 2006AA02A301), the Shanghai Pu Jiang Project (PJ200700367), Key Research Project from Shanghai Science and Technology Commission (09DZ1950101 and 09JC1409600), and Shanghai Charity Foundation for Cancer Research.	Alarcon P, 2008, DEVELOPMENT, V135, P3197, DOI 10.1242/dev.023697; Asaka SI, 2006, SURG TODAY, V36, P793, DOI 10.1007/s00595-006-3261-2; Becker MB, 2001, MECH DEVELOP, V106, P155, DOI 10.1016/S0925-4773(01)00412-9; Bennett KL, 2008, CANCER RES, V68, P4494, DOI 10.1158/0008-5472.CAN-07-6509; Bergman Y, 1998, BIOL CHEM, V379, P401; Cairns Paul, 2009, V507, P165, DOI 10.1007/978-1-59745-522-0_13; Choi IS, 2005, CELL RES, V15, P247, DOI 10.1038/sj.cr.7290293; Do Jee C, 2009, EUR J CANCER, V45, P1282, DOI 10.1016/j.ejca.2008.12.027; Duffy MJ, 2009, EUR J CANCER, V45, P335, DOI 10.1016/j.ejca.2008.12.008; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Ferguson CA, 1998, GENE DEV, V12, P2636, DOI 10.1101/gad.12.16.2636; Garinis GA, 2002, HUM GENET, V111, P115, DOI 10.1007/s00439-002-0783-6; Hao Y, 2008, J PROTEOME RES, V7, P3668, DOI 10.1021/pr700638k; Hellebrekers DMEI, 2007, CANCER RES, V67, P4138, DOI 10.1158/0008-5472.CAN-06-3032; Huang QJ, 2008, J CANCER RES CLIN, V134, P1219, DOI 10.1007/s00432-008-0398-y; Hurtubise A, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-16; Ikeda Y, 2004, CANCER RES, V64, P5178, DOI 10.1158/0008-5472.CAN-03-3589; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Ishihara K, 2002, INT IMMUNOPHARMACOL, V2, P499, DOI 10.1016/S1567-5769(01)00193-X; Ishihara K, 2001, JPN J PHARMACOL, V87, P318, DOI 10.1254/jjp.87.318; Jin GF, 2009, CARCINOGENESIS, V30, P987, DOI 10.1093/carcin/bgp090; KAMEI M, 1992, BIOTHERAPY, V4, P17, DOI 10.1007/BF02171705; Kawakami K, 2000, J NATL CANCER I, V92, P1805, DOI 10.1093/jnci/92.22.1805; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Kuga D, 2008, NEURO-ONCOLOGY, V10, P995, DOI 10.1215/15228517-2008-064; Lai IR, 2002, HEPATO-GASTROENTEROL, V49, P1157; Lemaire M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-128; Lewis MT, 1999, CELL TISSUE RES, V296, P549, DOI 10.1007/s004410051316; Lu Y, 2005, CANCER LETT, V224, P329, DOI 10.1016/j.canlet.2004.11.057; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Perez-Diez A, 2007, ADV EXP MED BIOL, V593, P74; Plendl J, 2000, BIOL CHEM, V381, P1103, DOI 10.1515/BC.2000.135; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Ropiquet F, 1999, INT J CANCER, V82, P237, DOI 10.1002/(SICI)1097-0215(19990719)82:2<237::AID-IJC14>3.0.CO;2-Q; Schneider-Stock R, 2007, IDRUGS, V10, P557; Shaker S, 2004, ONCOL REP, V11, P1253; Shaoul R, 2006, BIOCHEM BIOPH RES CO, V350, P825, DOI 10.1016/j.bbrc.2006.08.198; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, CANCER RES, V59, P442; TELFORD JL, 1994, TRENDS BIOTECHNOL, V12, P420, DOI 10.1016/0167-7799(94)90031-0; Tocchi A, 1998, J CANCER RES CLIN, V124, P450, DOI 10.1007/s004320050198; Tommasi S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2233; Toyota M, 2005, SEMIN ONCOL, V32, P521, DOI 10.1053/j.seminoncol.2005.07.003; Tycko B, 2000, J CLIN INVEST, V105, P401, DOI 10.1172/JCI9462; Ushijima T, 2006, J GASTROENTEROL, V41, P401, DOI 10.1007/s00535-006-1846-6; van Tuyl M, 2006, AM J PHYSIOL-LUNG C, V290, pL777, DOI 10.1152/ajplung.00293.2005; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Ychou M, 2000, DIS MARKERS, V16, P105, DOI 10.1155/2000/595492; Yu Ying-yan, 2006, Zhonghua Zhongliu Zazhi, V28, P84; Zhao HJ, 2005, PROSTATE, V63, P187, DOI 10.1002/pros.20158	54	70	80	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2010	29	27					3908	3920		10.1038/onc.2010.143	http://dx.doi.org/10.1038/onc.2010.143			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	621SL	20440264				2022-12-25	WOS:000279603200004
J	El Gazzar, M; McCall, CE				El Gazzar, Mohamed; McCall, Charles E.			MicroRNAs Distinguish Translational from Transcriptional Silencing during Endotoxin Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; GENE-SPECIFIC CONTROL; ALPHA MESSENGER-RNA; AU-RICH ELEMENTS; INHIBITION; DOXYCYCLINE; EXPRESSION; PROTEINS; HISTONE; BINDING	We reported that gene-selective formation of facultative heterochromatin silences transcription of acute inflammatory genes during endotoxin (LPS) tolerance, according to function. We discovered that reversal of the epigenetically silenced transcription restored mRNA levels but not protein synthesis. Here, we find that translation repression of tumor necrosis factor-alpha (TNF alpha) occurs independent of transcription silencing during LPS tolerance. The process required to disrupt protein synthesis followed Toll-like receptor 4 (TLR4)-dependent induction of microRNA (miR)-221, miR-579, and miR-125b, which coupled with RNA-binding proteins TTP, AUF1, and TIAR at the 3'-untranslated region to arrest protein synthesis. TTP and AUF1 proteins linked to miR-221, whereas TIAR coupled with miR-579 and miR-125b. Functional inhibition of miR-221 prevented TNF alpha mRNA degradation, and blocking miR-579 and miR-125b precluded translation arrest. The functional specificity of the TNF alpha 3'-untranslated region was demonstrated using luciferase reporter with mutations in the three putative miRNA binding sites. Post-transcriptional silencing was gene-specific, because it did not affect production of the I kappa B alpha anti-inflammatory protein. These results suggest that TLR4-dependent reprogramming of inflammatory genes is regulated at two separate and distinct levels. The first level of control is mediated by epigenetic modifications at the promoters that control transcription. The second and previously unrecognized level of control is mediated by TLR4-dependent differential expression of miRNAs that exert post-transcriptional controls. The concept of distinct regulation of transcription and translation was confirmed in murine sepsis. We conclude that transcription- and translation-repressive events combine to tightly regulate pro-inflammatory genes during LPS tolerance, a common feature of severe systemic inflammation.	[El Gazzar, Mohamed; McCall, Charles E.] Wake Forest Univ, Sch Med, Sect Mol Med, Dept Internal Med, Winston Salem, NC 27157 USA; [McCall, Charles E.] Wake Forest Univ, Sch Med, Translat Sci Inst, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University	El Gazzar, M (corresponding author), Wake Forest Univ, Sch Med, Sect Mol Med, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	melgazza@wfubmc.edu	Huang, H/E-9490-2010		National Institutes of Health [R01AI065791, R01AI079144]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079144, R01AI065791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI065791 and R01AI079144.	Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Chen XP, 2009, CLIN VACCINE IMMUNOL, V16, P104, DOI 10.1128/CVI.00320-08; Chung DR, 2008, J INFECTION, V56, P44, DOI 10.1016/j.jinf.2007.09.009; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; El Gazzar M, 2010, J BIOL CHEM, V285, P1259, DOI 10.1074/jbc.M109.067330; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Han J, 1990, Eur Cytokine Netw, V1, P71; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Hoyt JC, 2006, J IMMUNOL, V176, P567, DOI 10.4049/jimmunol.176.1.567; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Ketting RF, 2007, CELL, V131, P1226, DOI 10.1016/j.cell.2007.12.004; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; LARUE KEA, 1994, J EXP MED, V180, P2269, DOI 10.1084/jem.180.6.2269; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mattes J, 2007, AM J RESP CELL MOL, V36, P8, DOI 10.1165/rcmb.2006-0227TR; McCall CE, 2007, AM J RESP CRIT CARE, V175, P763, DOI 10.1164/rccm.200610-1436CP; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Stenvang J, 2008, BIOCHEM SOC T, V36, P1197, DOI 10.1042/BST0361197; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Yoza BK, 1998, CLIN DIAGN LAB IMMUN, V5, P281, DOI 10.1128/CDLI.5.3.281-287.1998	57	113	115	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20940	20951		10.1074/jbc.M110.115063	http://dx.doi.org/10.1074/jbc.M110.115063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435889	Green Published, hybrid			2022-12-25	WOS:000279228600058
J	Hernandez, I; Moreno, JL; Zandueta, C; Montuenga, L; Lecanda, F				Hernandez, I.; Moreno, J. L.; Zandueta, C.; Montuenga, L.; Lecanda, F.			Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer	ONCOGENE			English	Article						microenvironment; tumor-stroma; splicing; osteolysis; colonization	METALLOPROTEASE-DISINTEGRIN ADAM8; OSTEOCLAST-STIMULATING FACTOR; RENAL-CELL CARCINOMA; INCREASED EXPRESSION; CATALYTIC-ACTIVITY; INTEGRIN; ADHESION; PROTEIN; FAMILY; INTERLEUKIN-8	ADAMs (a disintegrin and metalloprotease) are transmembrane proteins involved in a variety of physiological processes and tumorigenesis. Recently, ADAM8 has been associated with poor prognosis of lung cancer. However, its contribution to tumorigenesis in the context of lung cancer metastasis remains unknown. Native ADAM8 expression levels were lower in lung cancer cell lines. In contrast, we identified and characterized two novel spliced isoforms encoding truncated proteins, Delta 18a and Delta 14', which were present in several tumor cell lines and not in normal cells. Overexpression of Delta 18a protein resulted in enhanced invasive activity in vitro. ADAM8 and its Delta 14' isoform expression levels were markedly increased in lung cancer cells, in conditions mimicking tumor microenvironment. Moreover, addition of supernatants from Delta 14'-overexpressing cells resulted in a significant increase in tartrate-resistant acid phosphatase+ cells in osteoclast cultures in vitro. These findings were associated with increased pro-osteoclastogenic cytokines interleukin (IL)-8 and IL-6 protein levels. Furthermore, lung cancer cells overexpressing Delta 14' increased prometastatic activity with a high tumor burden and increased osteolysis in a murine model of bone metastasis. Thus, the expression of truncated forms of ADAM8 by the lung cancer cells may result in the specific upregulation of their invasive and osteoclastogenic activities in the bone microenvironment. These findings suggest a novel mechanism of tumor-induced osteolysis in metastatic bone colonization. Oncogene (2010) 29, 3758-3769; doi: 10.1038/onc.2010.130; published online 10 May 2010	[Hernandez, I.; Zandueta, C.; Lecanda, F.] Univ Navarra, Adhes & Metastasis Lab, Div Oncol, E-31080 Pamplona, Spain; [Moreno, J. L.] Univ Maryland, Sch Med, Dept Orthopaed, Baltimore, MD 21201 USA; [Montuenga, L.] Univ Navarra, Sch Med, Dept Histol & Pathol, E-31080 Pamplona, Spain; [Montuenga, L.] Univ Navarra, Biomarkers Lab, Ctr Appl Biomed Res CIMA, E-31080 Pamplona, Spain	University of Navarra; University System of Maryland; University of Maryland Baltimore; University of Navarra; University of Navarra	Lecanda, F (corresponding author), Univ Navarra, Adhes & Metastasis Lab, Div Oncol, Ctr Appl Biomed Res CIMA, Pio 12-55, Navarra 31080, Spain.	flecanda@unav.es	Montuenga, Luis M/AAF-7783-2020	Montuenga, Luis M/0000-0002-8739-1387; Zandueta Pascual, Carolina/0000-0002-7931-8649	'UTE project FIMA'; I3 Program; 'La Caixa Foundation'; Government of Navarra [67/2005];  [RTICCC C03/10];  [FIT-090100-2005-46];  [PI042284];  [PI070031];  [SAF-2009-11280]	'UTE project FIMA'; I3 Program; 'La Caixa Foundation'(La Caixa Foundation); Government of Navarra; ; ; ; ; 	We thank especially S Martinez and the members of the Morphology and Animal Core Facilities. C Berasain for critical reading of the article. This work was supported by 'UTE project FIMA' agreement, and RTICCC C03/10, FIT-090100-2005-46, PI042284, PI070031 and SAF-2009-11280 (to FL). FL is also supported by funds from the I3 Program, 'La Caixa Foundation', and is a recipient of the 'Ortiz de Landazuri' award (67/2005, Government of Navarra).	Amour A, 2002, FEBS LETT, V524, P154, DOI 10.1016/S0014-5793(02)03047-8; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Cao Y, 2001, BIOCHEM J, V357, P353, DOI 10.1042/0264-6021:3570353; Choi SJ, 2001, J BONE MINER RES, V16, P814, DOI 10.1359/jbmr.2001.16.5.814; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; De Larco JE, 2001, AM J PATHOL, V158, P639, DOI 10.1016/S0002-9440(10)64005-9; Foley SC, 2007, J ALLERGY CLIN IMMUN, V119, P863, DOI 10.1016/j.jaci.2006.12.665; Fourie AM, 2003, J BIOL CHEM, V278, P30469, DOI 10.1074/jbc.M213157200; Galliano MF, 2000, J BIOL CHEM, V275, P13933, DOI 10.1074/jbc.275.18.13933; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; Gee JMW, 2003, BREAST CANCER RES, V5, P223, DOI 10.1186/bcr637; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Gonzalez I, 2007, J MOL MED, V85, P1015, DOI 10.1007/s00109-007-0202-5; Haidl ID, 2002, GENE, V283, P163, DOI 10.1016/S0378-1119(01)00871-X; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Hooper NM, 2005, ADAM FAMILY PROTEASE; Ishikawa N, 2004, CLIN CANCER RES, V10, P8363, DOI 10.1158/1078-0432.CCR-04-1436; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Karadag A, 2006, BLOOD, V107, P3271, DOI 10.1182/blood-2005-09-3830; Kelly K, 2005, DEV DYNAM, V232, P221, DOI 10.1002/dvdy.20221; Kim T, 2006, BIOL REPROD, V74, P744, DOI 10.1095/biolreprod.105.048892; King NE, 2004, AM J RESP CELL MOL, V31, P257, DOI 10.1165/rcmb.2004-0026OC; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lu X., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P29; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Mandelin J, 2003, J RHEUMATOL, V30, P2033; Matsuno O, 2006, IMMUNOL LETT, V102, P67, DOI 10.1016/j.imlet.2005.07.006; Matsuno O, 2007, INT ARCH ALLERGY IMM, V142, P285, DOI 10.1159/000097359; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Naus S, 2006, BIOL CHEM, V387, P337, DOI 10.1515/BC.2006.045; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Ohtsuka T, 2006, INT J CANCER, V118, P263, DOI 10.1002/ijc.21324; Rao HW, 2006, J BONE MINER RES, V21, P1657, DOI 10.1359/JBMR.060718; Reiss K, 2006, PHARMACOL THERAPEUT, V111, P985, DOI 10.1016/j.pharmthera.2006.02.009; Roemer A, 2004, J UROLOGY, V172, P2162, DOI 10.1097/01.ju.0000144602.01322.49; Roemer A, 2004, ONCOL REP, V11, P529; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Stautz D, 2010, EXP CELL RES, V316, P55, DOI 10.1016/j.yexcr.2009.09.017; Takeda S, 2007, FEBS LETT, V581, P5859, DOI 10.1016/j.febslet.2007.11.062; Valkovskaya N, 2007, J CELL MOL MED, V11, P1162, DOI 10.1111/j.1582-4934.2007.00082.x; Verrier S, 2004, BONE, V35, P34, DOI 10.1016/j.bone.2003.12.029; Vicent S, 2008, CANCER RES, V68, P2275, DOI 10.1158/0008-5472.CAN-07-6493; Wildeboer D, 2006, J NEUROPATH EXP NEUR, V65, P516, DOI 10.1097/01.jnen.0000229240.51490.d3; YOSHIDA S, 1990, INT IMMUNOL, V2, P585, DOI 10.1093/intimm/2.6.585	50	34	37	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 1	2010	29	26					3758	3769		10.1038/onc.2010.130	http://dx.doi.org/10.1038/onc.2010.130			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	618VW	20453887				2022-12-25	WOS:000279385200004
J	Kunnev, D; Rusiniak, ME; Kudla, A; Freeland, A; Cady, GK; Pruitt, SC				Kunnev, D.; Rusiniak, M. E.; Kudla, A.; Freeland, A.; Cady, G. K.; Pruitt, S. C.			DNA damage response and tumorigenesis in Mcm2-deficient mice	ONCOGENE			English	Article						minichromosome maintenance protein; p53; licensing factor; cancer tumor spectrum; loss of heterozygosity	MCM PROTEINS; HUMAN-CELLS; REPLICATION; EXPRESSION; ORIGINS	Minichromosome maintenance proteins (Mcm's) are components of the DNA replication licensing complex. In vivo, reduced expression or activity of Mcm's has been shown to result in highly penetrant early onset cancers (Shima et al., 2007; Pruitt et al., 2007) and stem cell deficiencies ( Pruitt et al., 2007). Here we use mouse embryonic fibroblasts from an Mcm2-deficient strain of mice to show by DNA fiber analysis that origin usage is decreased in Mcm2-deficient cells under conditions of hydroxyurea (HU)-mediated replication stress. DNA damage responses (DDRs) resulting from HU and additional replication-dependent and replication-independent genotoxic agents were also examined and shown to function at wild-type (wt) levels. Further, basal levels of many components of the DDR were expressed at wt levels, showing that there is no acute replicative stress under normal growth conditions. Only very modest, 1.5- to 2-fold increases in the basal levels of gamma-H2AX, p21(cip1) and 53bp foci were found, consistent with a slight chronic elevation in DDR pathways. The one condition in which a larger difference between wt- and Mcm2-deficient cells was found occurred after ultraviolet irradiation and may reflect the role of Chk1-mediated suppression of dormant origins. In vivo, abrogating p53-mediated DDR in Mcm2-deficient mice results in increased embryonic lethality and accelerated cancer formation in surviving mice. Further, p53 mutation rescues the negative effect of Mcm2 deficiency on the survival of neural stem cells in vitro; however, the enhanced survival correlates with increased genetic damage relative to Mcm2 wt cells carrying the p53 mutation. Together these results show that even relatively minor perturbations to primary or dormant replication origin usage contribute to accelerated genetic damage in vivo. In addition, these studies show that tumor types resulting from Mcm2 deficiency are strongly affected by interaction with both genetic background and p53. Oncogene ( 2010) 29, 3630-3638; doi: 10.1038/onc.2010.125; published online 3 May 2010	[Kunnev, D.; Rusiniak, M. E.; Kudla, A.; Freeland, A.; Cady, G. K.; Pruitt, S. C.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Pruitt, SC (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Elm & Carlton St, Buffalo, NY 14263 USA.	steven.pruitt@roswellpark.org			NIH-NCI; Ellison Medical Foundation; NYSTEM; NCI-CCS; NATIONAL CANCER INSTITUTE [R01CA130995] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ellison Medical Foundation(Lawrence Ellison Foundation); NYSTEM; NCI-CCS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	BALB/c:p53<SUP>null/wt</SUP> mice were a generous gift of Dr Peter Demant.This work was supported by grants from the NIH-NCI, the Ellison Medical Foundation, and NYSTEM to SCP. Cost of animal maintenance and flow cytometry was supported in part by an NCI-CCS grant to RPCI.	Bailey KJ, 2004, AGING CELL, V3, P391, DOI 10.1111/j.1474-9728.2004.00128.x; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Lei M, 2005, CURR CANCER DRUG TAR, V5, P365, DOI 10.2174/1568009054629654; Liu PJ, 2009, CELL CYCLE, V8, P125, DOI 10.4161/cc.8.1.7528; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Martinho RG, 1998, EMBO J, V17, P7239, DOI 10.1093/emboj/17.24.7239; Maslov AY, 2007, STEM CELLS, V25, P132, DOI 10.1634/stemcells.2006-0032; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Miao H, 2003, J BIOL CHEM, V278, P4295, DOI 10.1074/jbc.M204264200; Nevis KR, 2009, CELL CYCLE, V8, P1952, DOI 10.4161/cc.8.12.8811; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649	21	68	68	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2010	29	25					3630	3638		10.1038/onc.2010.125	http://dx.doi.org/10.1038/onc.2010.125			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	615CG	20440269	Green Accepted			2022-12-25	WOS:000279108600004
J	Handley, MTW; Lian, LY; Haynes, LP; Burgoyne, RD				Handley, Mark T. W.; Lian, Lu-Yun; Haynes, Lee P.; Burgoyne, Robert D.			Structural and Functional Deficits in a Neuronal Calcium Sensor-1 Mutant Identified in a Case of Autistic Spectrum Disorder	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; PHOSPHATIDYLINOSITOL 4-OH KINASE; CA2+ SIGNAL-TRANSDUCTION; ACCESSORY PROTEIN-LIKE; TRANS-GOLGI NETWORK; BINDING-PROTEINS; NEURITE OUTGROWTH; IL1RAPL1 GENE; PC12 CELLS	Neuronal calcium sensor-1 (NCS-1) is a Ca(2+) sensor protein that has been implicated in the regulation of various aspects of neuronal development and neurotransmission. It exerts its effects through interactions with a range of target proteins one of which is interleukin receptor accessory protein like-1 (IL1RAPL1) protein. Mutations in IL1RAPL1 have recently been associated with autism spectrum disorders and a missense mutation (R102Q) on NCS-1 has been found in one individual with autism. We have examined the effect of this mutation on the structure and function of NCS-1. From use of NMR spectroscopy, it appeared that the R102Q affected the structure of the protein particularly with an increase in the extent of conformational exchange in the C-terminus of the protein. Despite this change NCS-1(R102Q) did not show changes in its affinity for Ca(2+) or binding to IL1RAPL1 and its intracellular localisation was unaffected. Assessment of NCS-1 dynamics indicated that it could rapidly cycle between cytosolic and membrane pools and that the cycling onto the plasma membrane was specifically changed in NCS-1(R102Q) with the loss of a Ca(2+)-dependent component. From these data we speculate that impairment of the normal cycling of NCS-1 by the R102Q mutation could have subtle effects on neuronal signalling and physiology in the developing and adult brain.	[Handley, Mark T. W.; Haynes, Lee P.; Burgoyne, Robert D.] Univ Liverpool, Sch Biomed Sci, Physiol Lab, Liverpool L69 3BX, Merseyside, England; [Lian, Lu-Yun] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Handley, MTW (corresponding author), Univ Liverpool, Sch Biomed Sci, Physiol Lab, Liverpool L69 3BX, Merseyside, England.	burgoyne@liv.ac.uk	Burgoyne, Robert/C-6706-2008; Burgoyne, Robert D/P-6641-2019	Burgoyne, Robert/0000-0002-9219-0387; Burgoyne, Robert D/0000-0002-9219-0387; Handley, Mark/0000-0001-7200-747X	Wellcome Trust [080796/Z/06/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (grant number 080796/Z/06/Z) to RDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind P, 2008, J MOL BIOL, V376, P1100, DOI 10.1016/j.jmb.2007.12.033; Aronica E, 2009, NEUROBIOL DIS, V36, P81, DOI 10.1016/j.nbd.2009.06.016; Bahi N, 2003, HUM MOL GENET, V12, P1415, DOI 10.1093/hmg/ddg147; Bai J, 2004, BIOL PSYCHIAT, V56, P427, DOI 10.1016/j.biopsych.2004.06.022; Bergmann M, 2002, J COMP NEUROL, V449, P231, DOI 10.1002/cne.10302; Bhat SS, 2008, CLIN GENET, V73, P94, DOI 10.1111/j.1399-0004.2007.00920.x; Blasiole B, 2005, J NEUROBIOL, V64, P285, DOI 10.1002/neu.20138; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Brackmann M, 2004, BIOCHEM BIOPH RES CO, V322, P1073, DOI 10.1016/j.bbrc.2004.08.028; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; Chen XL, 2001, J PHYSIOL-LONDON, V532, P649, DOI 10.1111/j.1469-7793.2001.0649e.x; COX JA, 1994, J BIOL CHEM, V269, P32807; Dason JS, 2009, J CELL SCI, V122, P4109, DOI 10.1242/jcs.055095; de Barry J, 2006, J BIOL CHEM, V281, P18098, DOI 10.1074/jbc.M509842200; GAMBINO F, 2009, EUR J NEUROSCI; Gambino F, 2007, P NATL ACAD SCI USA, V104, P9063, DOI 10.1073/pnas.0701133104; Gao XC, 2008, NEUROSCI LETT, V438, P163, DOI 10.1016/j.neulet.2008.03.084; Genin A, 2001, NEUROSCIENCE, V106, P571, DOI 10.1016/S0306-4522(01)00301-3; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Handley MTW, 2008, BIOCHEM BIOPH RES CO, V373, P275, DOI 10.1016/j.bbrc.2008.06.043; Handley MTW, 2007, J CELL SCI, V120, P973, DOI 10.1242/jcs.03406; Haynes LP, 2007, TRAFFIC, V8, P1080, DOI 10.1111/j.1600-0854.2007.00594.x; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; Hui H, 2006, J PHYSIOL-LONDON, V572, P165, DOI 10.1113/jphysiol.2005.102889; Hui K, 2007, DEVELOPMENT, V134, P4479, DOI 10.1242/dev.008979; Iketani M, 2009, NEUROSCIENCE, V161, P743, DOI 10.1016/j.neuroscience.2009.04.019; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; Kawasaki T, 2003, J COMP NEUROL, V460, P465, DOI 10.1002/cne.10649; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Kragelund BB, 2000, J BIOMOL NMR, V16, P85, DOI 10.1023/A:1008383002568; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; McFerran BW, 1999, J BIOL CHEM, V274, P30258, DOI 10.1074/jbc.274.42.30258; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; Mikhaylova M, 2009, P NATL ACAD SCI USA, V106, P9093, DOI 10.1073/pnas.0903001106; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Nakamura TY, 2006, J CELL BIOL, V172, P1081, DOI 10.1083/jcb.200508156; Nawara M, 2008, AM J MED GENET A, V146A, P3167, DOI 10.1002/ajmg.a.32613; O'Callaghan DW, 2003, J CELL SCI, V116, P4833, DOI 10.1242/jcs.00803; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Petko JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-27; Piton A, 2008, HUM MOL GENET, V17, P3965, DOI 10.1093/hmg/ddn300; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Rajebhosale M, 2003, J BIOL CHEM, V278, P6075, DOI 10.1074/jbc.M204702200; Romero-Pozuelo J, 2007, EUR J NEUROSCI, V26, P2428, DOI 10.1111/j.1460-9568.2007.05877.x; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Tabolacci E, 2006, AM J MED GENET A, V140A, P482, DOI 10.1002/ajmg.a.31107; Taverna E, 2002, J CELL SCI, V115, P3909, DOI 10.1242/jcs.00072; Taverna E, 2007, J NEUROCHEM, V100, P664, DOI 10.1111/j.1471-4159.2006.04225.x; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Weiss RA, 2000, EMBO REP, V1, P2, DOI 10.1093/embo-reports/kvd017; Wightman B, 2005, DEV BIOL, V287, P74, DOI 10.1016/j.ydbio.2005.08.032; Yoshida T, 2008, MOL CELL NEUROSCI, V39, P218, DOI 10.1016/j.mcn.2008.06.013; Zhang Yao-Hua, 2004, Hum Mutat, V24, P273, DOI 10.1002/humu.9269; Zhao XH, 2001, J BIOL CHEM, V276, P40183, DOI 10.1074/jbc.M104048200; Zheng Q, 2005, J NEUROCHEM, V92, P442, DOI 10.1111/j.1471-4159.2004.02897.x	66	49	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10534	10.1371/journal.pone.0010534	http://dx.doi.org/10.1371/journal.pone.0010534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479890	Green Published, Green Submitted, gold			2022-12-25	WOS:000277467800016
J	Lee, DY; Lee, KS; Lee, HJ; Kim, DH; Noh, YH; Yu, K; Jung, HY; Lee, SH; Lee, JY; Youn, YC; Jeong, Y; Kim, DK; Lee, WB; Kim, SS				Lee, Do Yeon; Lee, Kyu-Sun; Lee, Hyun Jung; Kim, Do Hee; Noh, Yoo Hun; Yu, Kweon; Jung, Hee-Yeon; Lee, Sang Hyung; Lee, Jun Young; Youn, Young Chul; Jeong, Yoonhwa; Kim, Dae Kyong; Lee, Won Bok; Kim, Sung Su			Activation of PERK Signaling Attenuates A beta-Mediated ER Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ALZHEIMERS-DISEASE; ACCUMULATION; AGGREGATION; INVOLVEMENT; PEPTIDES; CELLS; TRANSDUCERS; DEGRADATION	Alzheimer's disease (AD) is characterized by the deposition of aggregated beta-amyloid (A beta), which triggers a cellular stress response called the unfolded protein response (UPR). The UPR signaling pathway is a cellular defense system for dealing with the accumulation of misfolded proteins but switches to apoptosis when endoplasmic reticulum (ER) stress is prolonged. ER stress is involved in neurodegenerative diseases including AD, but the molecular mechanisms of ER stress-mediated A beta neurotoxicity still remain unknown. Here, we show that treatment of A beta triggers the UPR in the SK-N-SH human neuroblastoma cells. A beta mediated UPR pathway accompanies the activation of protective pathways such as Grp78/Bip and PERK-eIF2 alpha pathway, as well as the apoptotic pathways of the UPR such as CHOP and caspase-4. Knockdown of PERK enhances A beta neurotoxicity through reducing the activation of eIF2 alpha and Grp8/Bip in neurons. Salubrinal, an activator of the eIF2 alpha pathway, significantly increased the Grp78/Bip ER chaperone resulted in attenuating caspase-4 dependent apoptosis in A beta treated neurons. These results indicate that PERK-eIF2 alpha pathway is a potential target for therapeutic applications in neurodegenerative diseases including AD.	[Lee, Do Yeon; Lee, Hyun Jung; Kim, Do Hee; Noh, Yoo Hun; Lee, Won Bok; Kim, Sung Su] Chung Ang Univ, Coll Med, Dept Anat & Cell Biol, Seoul 156756, South Korea; [Lee, Do Yeon; Lee, Kyu-Sun; Yu, Kweon] KRIBB, Aging Res Ctr, Taejon, South Korea; [Jung, Hee-Yeon; Lee, Jun Young] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Lee, Sang Hyung] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Youn, Young Chul] Chung Ang Univ, Coll Med, Dept Neurol, Seoul 156756, South Korea; [Jeong, Yoonhwa] Dankook Univ, Coll Nat Sci, Dept Food Sci & Nutr, Yongin, South Korea; [Kim, Dae Kyong] Chung Ang Univ, Coll Pharm, Dept Environm & Hlth Chem, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital; Dankook University; Chung Ang University	Lee, DY (corresponding author), Chung Ang Univ, Coll Med, Dept Anat & Cell Biol, Seoul 156756, South Korea.	sungsu@cau.ac.kr	Jeon, You-Jin/AAR-5061-2020; Lee, Jun-Young/J-5604-2012; Youn, Young Chul/ABA-9938-2021; Jung, Hee Yeon/J-5659-2012; Lee, Sang Hyung/J-5581-2012; Lee, Jun-Young/N-5963-2019	Lee, Jun-Young/0000-0002-5893-3124; Lee, Jun-Young/0000-0002-5893-3124; Youn, Young Chul/0000-0002-2742-1759; Yu, Kweon/0000-0002-4942-2576	Rural Development Administration, Republic of Korea [20100301061075]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the BioGreen 21 Program (No. 20100301061075), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Gavilan MP, 2006, NEUROBIOL AGING, V27, P973, DOI 10.1016/j.neurobiolaging.2005.05.010; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hashioka S, 2005, NEUROCHEM INT, V47, P369, DOI 10.1016/j.neuint.2005.05.001; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Hussain SG, 2007, BIOCHEM BIOPH RES CO, V355, P365, DOI 10.1016/j.bbrc.2007.01.156; Katayama T, 2001, J BIOL CHEM, V276, P43446, DOI 10.1074/jbc.M104096200; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kim AJ, 2005, J CELL SCI, V118, P89, DOI 10.1242/jcs.01562; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee DY, 2008, EUR J CELL BIOL, V87, P389, DOI 10.1016/j.ejcb.2008.03.003; Lee DY, 2008, FEBS LETT, V582, P4185, DOI 10.1016/j.febslet.2008.11.007; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Naidoo N, 2008, J NEUROSCI, V28, P6539, DOI 10.1523/JNEUROSCI.5685-07.2008; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oh S, 2005, MECH AGEING DEV, V126, P1292, DOI 10.1016/j.mad.2005.07.006; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pereira C, 1999, NEUROBIOL DIS, V6, P209, DOI 10.1006/nbdi.1999.0241; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; Resende R, 2008, NEUROSCIENCE, V155, P725, DOI 10.1016/j.neuroscience.2008.06.036; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sisodia SS, 2001, TRENDS NEUROSCI, V24, pS2, DOI 10.1016/S0166-2236(00)01987-1; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sun XD, 2003, NEUROBIOL DIS, V14, P567, DOI 10.1016/j.nbd.2003.08.007; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Walter J, 1996, MOL MED, V2, P673, DOI 10.1007/BF03401652; Yazawa H, 2001, FASEB J, V15, P2454, DOI 10.1096/fj.01-0251com; Yoneda T, 2002, GENE DEV, V16, P1307, DOI 10.1101/gad.1000902; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	49	88	93	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10489	10.1371/journal.pone.0010489	http://dx.doi.org/10.1371/journal.pone.0010489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463975	gold, Green Submitted, Green Published			2022-12-25	WOS:000277379400025
J	Liu, CF; Parker, K; Yao, HHC				Liu, Chia-Feng; Parker, Keith; Yao, Humphrey H. -C.			WNT4/beta-Catenin Pathway Maintains Female Germ Cell Survival by Inhibiting Activin beta B in the Mouse Fetal Ovary	PLOS ONE			English	Article							SEX-REVERSAL; MAMMALIAN OVARY; GENE-EXPRESSION; CATENIN; MICE; WNT-4; DIFFERENTIATION; FOLLISTATIN; DEATH; STABILIZATION	Female germ cells are essential for organogenesis of the ovary; without them, ovarian follicles do not form and functional and structural characteristics of the ovary are lost. We and others showed previously that when either Wnt4 or beta-catenin was inactivated in the fetal ovary, female germ cells underwent degeneration. In this study, we set out to understand whether these two factors belong to the same pathway and how they maintain female germ cell survival. We found that activation of beta-catenin in somatic cells in the Wnt4 knockout ovary restored germ cell numbers, placing beta-catenin downstream of WNT4. In the absence of Wnt4 or beta-catenin, female germ cells entered meiosis properly; however, they underwent apoptosis afterwards. Activin beta B (Inhbb), a subunit of activins, was upregulated in the Wnt4 and beta-catenin knockout ovaries, suggesting that Inhbb could be the cause for the loss of female germ cells, which are positive for activin receptors. Indeed, removal of Inhbb in the Wnt4 knockout ovaries prevented female germ cells from undergoing degeneration. We conclude that WNT4 maintains female germ cell survival by inhibiting Inhbb expression via beta-catenin in the somatic cells. Maintenance of female germ cells hinge upon a delicate balance between positive (WNT4 and beta-catenin) and negative (activin beta B) regulators derived from the somatic cells in the fetal ovary.	[Liu, Chia-Feng; Yao, Humphrey H. -C.] Univ Illinois, Dept Vet Biosci, Urbana, IL 61801 USA; [Parker, Keith] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, CF (corresponding author), Univ Illinois, Dept Vet Biosci, 2001 S Lincoln Ave, Urbana, IL 61801 USA.	hhyao@illinois.edu	Yao, Hung-Chang Humphrey/B-4795-2010	Yao, Hung-Chang Humphrey/0000-0003-2944-8469	NIH [HD046861]; Basal O'Connor Starter Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basal O'Connor Starter Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research is supported by NIH HD046861 and Basal O'Connor Starter Award to H. H. Yao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JS, 2005, SEMIN CELL DEV BIOL, V16, P245, DOI 10.1016/j.semcdb.2004.12.008; BEHRINGER RR, 1990, NATURE, V345, P167, DOI 10.1038/345167a0; Bingham NC, 2006, GENESIS, V44, P419, DOI 10.1002/dvg.20231; Boerboom D, 2006, CANCER RES, V66, P1964, DOI 10.1158/0008-5472.CAN-05-3493; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cederroth CR, 2007, MOL CELL ENDOCRINOL, V265, P3, DOI 10.1016/j.mce.2006.12.029; Chang H, 2009, BIOL REPROD, V81, P842, DOI 10.1095/biolreprod.109.077446; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Cohen PE, 2006, ENDOCR REV, V27, P398, DOI 10.1210/er.2005-0017; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; de Groot E, 2000, MOL BIOL REP, V27, P129, DOI 10.1023/A:1007159031000; Drews U, 2001, HISTOCHEM CELL BIOL, V116, P427, DOI 10.1007/s00418-001-0335-5; Farini D, 2005, DEV BIOL, V285, P49, DOI 10.1016/j.ydbio.2005.06.036; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HASHIMOTO N, 1990, J EXP ZOOL, V253, P61, DOI 10.1002/jez.1402530109; Heikkila M, 2005, ENDOCRINOLOGY, V146, P4016, DOI 10.1210/en.2005-0463; Heikkila M, 2002, ENDOCRINOLOGY, V143, P4358, DOI 10.1210/en.2002-220275; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Kimura T, 2006, DEV BIOL, V300, P545, DOI 10.1016/j.ydbio.2006.06.038; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Manuylov NL, 2008, DEVELOPMENT, V135, P3731, DOI 10.1242/dev.024653; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; McNeilly JR, 2000, ENDOCRINOLOGY, V141, P4284, DOI 10.1210/en.141.11.4284; Miyoshi K, 2003, BREAST CANCER RES, V5, P63, DOI 10.1186/bcr566; Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Olaso R, 1998, ENDOCRINOLOGY, V139, P733, DOI 10.1210/en.139.2.733; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Paul S, 2008, NEOPLASMA, V55, P165; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Reinholdt Laura, 2004, Methods Mol Biol, V262, P87; Richards AJ, 1999, DEV BIOL, V207, P470, DOI 10.1006/dbio.1998.9174; Ross AJ, 2003, MOL CELL ENDOCRINOL, V211, P1, DOI 10.1016/j.mce.2003.09.021; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sato T, 2008, MECH DEVELOP, V125, P498, DOI 10.1016/j.mod.2008.01.004; Schulz R, 2008, CELL TISSUE RES, V334, P327, DOI 10.1007/s00441-008-0714-5; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Surendran K, 2003, AM J PHYSIOL-RENAL, V284, pF653, DOI 10.1152/ajprenal.00343.2002; Surendran K, 2002, AM J PHYSIOL-RENAL, V282, pF431, DOI 10.1152/ajprenal.0009.2001; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; UPADHYAY S, 1982, P NATL ACAD SCI-BIOL, V79, P6584, DOI 10.1073/pnas.79.21.6584; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; VASSALLI A, 1994, GENE DEV, V8, P414, DOI 10.1101/gad.8.4.414; VIGIER B, 1988, REPROD NUTR DEV, V28, P1113, DOI 10.1051/rnd:19880709; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Yao HHC, 2006, BIOL REPROD, V74, P978, DOI 10.1095/biolreprod.105.050286	55	57	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10382	10.1371/journal.pone.0010382	http://dx.doi.org/10.1371/journal.pone.0010382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454446	Green Submitted, Green Published, gold			2022-12-25	WOS:000277240100009
J	Masson, CJ; Plat, J; Mensink, RP; Namiot, A; Kisielewski, W; Namiot, Z; Fullekrug, J; Ehehalt, R; Glatz, JFC; Pelsers, MMAL				Masson, Christiaan J.; Plat, Jogchum; Mensink, Ronald P.; Namiot, Andrzej; Kisielewski, Wojciech; Namiot, Zbigniew; Fuellekrug, Joachim; Ehehalt, Robert; Glatz, Jan F. C.; Pelsers, Maurice M. A. L.			Fatty Acid- and Cholesterol Transporter Protein Expression along the Human Intestinal Tract	PLOS ONE			English	Article							ATP-BINDING CASSETTE; NIEMANN-PICK C1-LIKE-1; ILEAL AUTOTRANSPLANTATION; STEROL TRANSPORTERS; SKELETAL-MUSCLE; PLANT STEROLS; ABSORPTION; METABOLISM; ABCG5; CD36	Protein distribution profiles along the human intestinal tract of transporters involved in the absorption of cholesterol and long-chain fatty acids (LCFA) have been scarcely evaluated. Methodology/Principal Findings: In post-mortem samples from 11 subjects, intestinal transporter distribution profiles were determined via Western Blot. Differences in transporter protein levels were statistically tested using ANOVA and Tukey's Post Hoc comparisons. Levels in all segments were expressed relative to those in duodenum. Except for ABCG5 and FATP4, levels (mean +/- SEM) were the highest in the ileum. For ABCA1, ileal levels (1.80 +/- 0.26) differed significantly from those in duodenum (P = 0.049) and proximal colon (0.92 +/- 0.14; P = 0.029). ABCG8 levels in ileum (1.91 +/- 0.30) differed from those in duodenum (P = 0.041) and distal colon (0.84 +/- 0.22; P = 0.010) and jejunum (1.64 +/- 0.26) tended to be higher than distal colon (0.84 +/- 0.22; P = 0.087). Ileal NPC1L1 levels (2.56 +/- 0.51) differed from duodenum levels (P = 0.019) and from distal colon (1.09 +/- 0.22; P = 0.030). There was also a trend (P = 0.098) for higher jejunal (2.23 +/- 0.37) than duodenal NPC1L1 levels. The levels of ABCG5 did not correlate with those of ABCG8. FAT/CD36 levels in ileum (2.03 +/- 0.42) differed from those in duodenum (P = 0.017), and proximal and distal colon (0.89 +/- 0.13 and 0.97 +/- 0.15 respectively; P = 0.011 and P = 0.014). FABPpm levels in ileum (1.04 +/- 0.13) differed from proximal (0.64 +/- 0.07; P = 0.026) and distal colon (0.66 +/- 0.09; P = 0.037). Conclusions/Significance: The distribution profiles showed a bell-shape pattern along the GI-tract with the highest levels in ileum for ABCA1, ABCG8, NPC1L1, FATCD36 and FABPm, suggesting a prominent role for ileum in transporter-mediated uptake of cholesterol and LCFAs.	[Masson, Christiaan J.; Plat, Jogchum; Mensink, Ronald P.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands; [Namiot, Andrzej] Med Univ Bialystok, Dept Human Anat, Bialystok, Poland; [Kisielewski, Wojciech] Med Univ Bialystok, Dept Clin Pathomorphol, Bialystok, Poland; [Namiot, Zbigniew] Med Univ Bialystok, Dept Physiol, Bialystok, Poland; [Fuellekrug, Joachim; Ehehalt, Robert] Univ Heidelberg Hosp, Dept Gastroenterol, Heidelberg, Germany; [Glatz, Jan F. C.] Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Dept Mol Genet, Maastricht, Netherlands; [Pelsers, Maurice M. A. L.] Maastricht Univ, Med Ctr, Dept Clin Chem, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok; Ruprecht Karls University Heidelberg; Maastricht University; Maastricht University	Masson, CJ (corresponding author), Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands.	maurice.pelsers@gmail.com	Namiot, Andrzej/T-8442-2018; Füllekrug, Joachim/A-6581-2008; Kisielewski, Wojciech/U-2355-2018	Namiot, Andrzej/0000-0002-0678-9458; Kisielewski, Wojciech/0000-0003-1357-2000; Ehehalt, Robert/0000-0003-4252-5801	Medical University of Bialystok [3-13556 L]; Dutch Dairy Association (NZO)	Medical University of Bialystok; Dutch Dairy Association (NZO)	The study was partially funded by grant 3-13556 L by the Medical University of Bialystok and partially by the Dutch Dairy Association (NZO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Agerholm-Larsen B, 2000, CIRCULATION, V102, P2197; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; BECKER GH, 1950, GASTROENTEROLOGY, V14, P80, DOI 10.1016/S0016-5085(50)80113-0; Besnard P, 1996, P NUTR SOC, V55, P19, DOI 10.1079/PNS19960009; Boden G, 1999, P ASSOC AM PHYSICIAN, V111, P241, DOI 10.1046/j.1525-1381.1999.99220.x; BOOTH CC, 1961, GUT, V2, P23, DOI 10.1136/gut.2.1.23; BRAND SJ, 1974, BIOCHIM BIOPHYS ACTA, V369, P1, DOI 10.1016/0005-2760(74)90185-4; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Chen M, 2001, AM J PHYSIOL-ENDOC M, V281, pE916, DOI 10.1152/ajpendo.2001.281.5.E916; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; den Bosch HMD, 2008, AM J PHYSIOL-GASTR L, V294, pG1171, DOI 10.1152/ajpgi.00360.2007; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; Duan LP, 2006, AM J PHYSIOL-GASTR L, V290, pG269, DOI 10.1152/ajpgi.00172.2005; EDMONDS CJ, 1971, GUT, V12, P356, DOI 10.1136/gut.12.5.356; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Field FJ, 2004, J LIPID RES, V45, P2252, DOI 10.1194/jlr.M400208-JLR200; FLORES CA, 1989, AM J PHYSIOL, V257, pG823, DOI 10.1152/ajpgi.1989.257.5.G823; Gimeno RE, 2003, J BIOL CHEM, V278, P49512, DOI 10.1074/jbc.M309759200; GLATZ JF, PHYSL REV, V90, P367; Glatz JFC, 1997, PROSTAG LEUKOTR ESS, V57, P373, DOI 10.1016/S0952-3278(97)90413-0; Glatz JFC, 1996, PROG LIPID RES, V35, P243, DOI 10.1016/S0163-7827(96)00006-9; Glatz JFC, 2001, CURR OPIN LIPIDOL, V12, P267, DOI 10.1097/00041433-200106000-00005; Glatz JFC, 1998, ADV EXP MED BIOL, V441, P207; Gogia Atul, 2006, Indian J Med Sci, V60, P72; Graf GA, 2004, J BIOL CHEM, V279, P24881, DOI 10.1074/jbc.M402634200; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Grundy Scott M, 2007, Am J Med, V120, pS3, DOI 10.1016/j.amjmed.2007.06.005; GRUNDY SM, 2007, AM J MED, V120, pS9; Gylling H, 2007, TRANSL RES, V149, P310, DOI 10.1016/j.trsl.2006.11.012; Hakala K, 1996, DIGESTION, V57, P83, DOI 10.1159/000201318; HOLLANDER D, 1983, EXP GERONTOL, V18, P287, DOI 10.1016/0531-5565(83)90039-6; Holt PR, 2001, GASTROENTEROL CLIN N, V30, P427, DOI 10.1016/S0889-8553(05)70189-8; Hrabovsky V, 2009, WIEN KLIN WOCHENSCHR, V121, P270, DOI 10.1007/s00508-009-1150-6; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Klett EL, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-21; Kruit JK, 2006, WORLD J GASTROENTERO, V12, P6429, DOI 10.3748/wjg.v12.i40.6429; Lally S, 2006, DIABETOLOGIA, V49, P1008, DOI 10.1007/s00125-006-0177-8; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Lorenzo C, 2006, DIABETES CARE, V29, P625, DOI 10.2337/diacare.29.03.06.dc05-1755; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Miettinen TA, 2000, ATHEROSCLEROSIS, V153, P241, DOI 10.1016/S0021-9150(00)00404-4; Miettinen TA, 2000, ARTERIOSCL THROM VAS, V20, P1340, DOI 10.1161/01.ATV.20.5.1340; Montoudis A, 2008, J LIPID RES, V49, P961, DOI 10.1194/jlr.M700363-JLR200; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nordestgaard BG, 1997, CIRCULATION, V96, P1737, DOI 10.1161/01.CIR.96.6.1737; OCKNER RK, 1974, J CLIN INVEST, V54, P326, DOI 10.1172/JCI107768; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Pakarinen M, 1997, HEPATOLOGY, V25, P1315, DOI 10.1002/hep.510250602; Pakarinen MP, 1998, LIPIDS, V33, P267, DOI 10.1007/s11745-998-0205-y; Pakarinen MP, 1997, SURGERY, V122, P950, DOI 10.1016/S0039-6060(97)90337-8; Pei ZT, 2004, J BIOL CHEM, V279, P54454, DOI 10.1074/jbc.M410091200; Pelsers MMAL, 2008, SPORTS MED, V38, P387, DOI 10.2165/00007256-200838050-00003; Pelsers MMAL, 1999, BIOCHEM J, V337, P407, DOI 10.1042/0264-6021:3370407; PIHLAJAMAKI J, 2009, METABOLISM; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Pollex RL, 2006, NAT CLIN PRACT CARD, V3, P482, DOI 10.1038/ncpcardio0638; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; Sehayek E, 2008, ARTERIOSCL THROM VAS, V28, P1296, DOI 10.1161/ATVBAHA.108.165803; SINGLETON AO, 1964, ANN SURG, V159, P690, DOI 10.1097/00000658-196405000-00006; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; STUMP DD, 1993, AM J PHYSIOL, V265, pG894, DOI 10.1152/ajpgi.1993.265.5.G894; SYLVEN C, 1970, SCAND J GASTROENTERO, V5, P57; THOMSON ABR, 1980, AM J PHYSIOL, V239, pG363, DOI 10.1152/ajpgi.1980.239.5.G363; Tomkin GH, 2008, DIABETES CARE, V31, pS241, DOI 10.2337/dc08-s260; TURNER DA, 1958, AM J DIG DIS, V3, P682, DOI 10.1007/BF02231240; Wang Q, 2005, J PHARM SCI-US, V94, P363, DOI 10.1002/jps.20264; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; WEBSTER S G P, 1975, Age and Ageing, V4, P168, DOI 10.1093/ageing/4.3.168; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wodzig KWH, 1997, ANN CLIN BIOCHEM, V34, P263, DOI 10.1177/000456329703400307; Woudstra TD, 2004, LIPIDS, V39, P343, DOI 10.1007/s11745-004-1238-y; Yokoyama S, 2006, J ATHEROSCLER THROMB, V13, P1, DOI 10.5551/jat.13.1	77	35	36	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10380	10.1371/journal.pone.0010380	http://dx.doi.org/10.1371/journal.pone.0010380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454462	Green Published, gold, Green Submitted			2022-12-25	WOS:000277240100007
J	Forst, B; Hansen, MT; Klingelhofer, J; Moller, HD; Nielsen, GH; Grum-Schwensen, B; Ambartsumian, N; Lukanidin, E; Grigorian, M				Forst, Birgitte; Hansen, Matilde Thye; Klingelhofer, Jorg; Moller, Henrik Devitt; Nielsen, Gitte Helle; Grum-Schwensen, Birgitte; Ambartsumian, Noona; Lukanidin, Eugene; Grigorian, Mariam			Metastasis-Inducing S100A4 and RANTES Cooperate in Promoting Tumor Progression in Mice	PLOS ONE			English	Article							BREAST-CANCER; PROTEIN S100A4; RHEUMATOID-ARTHRITIS; MTS1/S100A4 PROTEIN; UP-REGULATION; CELLS; EXPRESSION; GROWTH; INVOLVEMENT; TARGET	Background: The tumor microenvironment has been described as a critical milieu determining tumor growth and metastases. A pivotal role of metastasis-inducing S100A4 in the development of tumor stroma has been proven in animal models and verified in human breast cancer biopsies. Expression and release of S100A4 has been shown in various types of stroma composing cells, including fibroblasts and immune cells. However, the events implicated in upstream and downstream pathways regulating the activity of the extracellular S100A4 protein in the tumor milieu remain unsolved. Methodology/Principal Findings: We studied the interplay between the tumor cell-derived cytokine regulated-upon-activation, normal T-cell expressed and secreted (RANTES; CCL5) and S100A4 which were shown to be critical factors in tumor progression. We found that RANTES stimulates the externalization of S100A4 via microparticle shedding from the plasma membrane of tumor and stroma cells. Conversely, the released S100A4 protein induces the upregulation of fibronectin (FN) in fibroblasts and a number of cytokines, including RANTES in tumor cells as well as stimulates cell motility in a wound healing assay. Importantly, using wild type and S100A4-deficient mouse models, we demonstrated a substantial influence of tumor cell-derived RANTES on S100A4 release into blood circulation which ultimately increases the metastatic burden in mice. Conclusions/Significance: Altogether, the data presented strongly validate the pro-metastatic function of S100A4 in the tumor microenvironment and define how the tumor cell-derived cytokine RANTES acts as a critical regulator of S100A4-dependent tumor cell dissemination. Additionally, for the first time we demonstrated the mechanism of S100A4 release associated with plasma membrane microparticle shedding from various cells types.	[Forst, Birgitte; Hansen, Matilde Thye; Klingelhofer, Jorg; Moller, Henrik Devitt; Nielsen, Gitte Helle; Grum-Schwensen, Birgitte; Ambartsumian, Noona; Lukanidin, Eugene; Grigorian, Mariam] Danish Canc Soc, Dept Mol Canc Biol, Copenhagen, Denmark	Danish Cancer Society	Forst, B (corresponding author), Danish Canc Soc, Dept Mol Canc Biol, Copenhagen, Denmark.	mg@cancer.dk	Klingelhöfer, Jörg/C-1676-2013; Møller, Henrik/K-5415-2014	Møller, Henrik/0000-0002-1886-3053; Grum-Schwensen, Birgitte/0000-0001-6677-1869	European Union [EU7 Tumic-Health-F2-2008-201662]; Danish Cancer Society; Cancer Research Foundation; Novo Nordisk Foundation; Familien Spogaards Fond	European Union(European Commission); Danish Cancer Society(Danish Cancer Society); Cancer Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Familien Spogaards Fond	Research was supported by European Union grant EU7 Tumic-Health-F2-2008-201662 (EL), the Danish Cancer Society (EL, MG, NA), Danish Cancer Research Foundation (BF, BGS), Novo Nordisk Foundation (MG, BF, MTH) and Familien Spogaards Fond (BGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; Bachmeier BE, 2008, CARCINOGENESIS, V29, P779, DOI 10.1093/carcin/bgm248; BEAUDOIN AR, 1991, BIOCHIM BIOPHYS ACTA, V1071, P203, DOI 10.1016/0304-4157(91)90014-N; Belot N, 2002, BBA-PROTEINS PROTEOM, V1600, P74, DOI 10.1016/S1570-9639(02)00447-8; Bjornland K, 1999, CANCER RES, V59, P4702; Cabezon T, 2007, INT J CANCER, V121, P1433, DOI 10.1002/ijc.22850; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5; Duarte WR, 1999, BIOCHEM BIOPH RES CO, V255, P416, DOI 10.1006/bbrc.1999.0214; EBRALIDZE A, 1989, GENE DEV, V3, P1086, DOI 10.1101/gad.3.7.1086; Geng JG, 2004, CURR MED CHEM, V11, P2153, DOI 10.2174/0929867043364720; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Grum-Schwensen B, 2005, CANCER RES, V65, P3772, DOI 10.1158/0008-5472.CAN-04-4510; Grum-Schwensen B, 2010, CANCER RES, V70, P936, DOI 10.1158/0008-5472.CAN-09-3220; Gutschalk CM, 2006, CANCER RES, V66, P8026, DOI 10.1158/0008-5472.CAN-06-0158; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kikuchi N, 2006, CANCER SCI, V97, P1061, DOI 10.1111/j.1349-7006.2006.00295.x; Klingelhofer J, 2007, ARTHRITIS RHEUM-US, V56, P779, DOI 10.1002/art.22398; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679; Leeb SN, 2004, AM J GASTROENTEROL, V99, P335, DOI 10.1111/j.1572-0241.2004.04044.x; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Lunt SJ, 2009, CLIN EXP METASTAS, V26, P19, DOI 10.1007/s10585-008-9182-2; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MACK RN, 2000, ISSUES ECOL, V5, P1; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pedersen MV, 2004, J NEUROSCI RES, V77, P777, DOI 10.1002/jnr.20221; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; Schmidt-Hansen B, 2004, ONCOGENE, V23, P5487, DOI 10.1038/sj.onc.1207720; Schmidt-Hansen B, 2004, J BIOL CHEM, V279, P24498, DOI 10.1074/jbc.M400441200; Schneider M, 2008, J MOL MED, V86, P507, DOI 10.1007/s00109-007-0301-3; Schneider M, 2007, CARDIOVASC RES, V75, P40, DOI 10.1016/j.cardiores.2007.03.027; Senolt L, 2006, ANN RHEUM DIS, V65, P1645, DOI 10.1136/ard.2005.047704; Soria G, 2008, CYTOKINE, V44, P191, DOI 10.1016/j.cyto.2008.08.002; Stormes KA, 2005, BREAST CANCER RES TR, V89, P209, DOI 10.1007/s10549-004-5328-3; Tang CH, 2010, BIOCHEM PHARMACOL, V79, P209, DOI 10.1016/j.bcp.2009.08.006; Tarabykina S, 2007, CURR CANCER DRUG TAR, V7, P217, DOI 10.2174/156800907780618329; Wente MN, 2008, INT J ONCOL, V33, P297, DOI 10.3892/ijo_00000009; Yaal-Hahoshen N, 2006, CLIN CANCER RES, V12, P4474, DOI 10.1158/1078-0432.CCR-06-0074; Yammani RR, 2006, ARTHRITIS RHEUM-US, V54, P2901, DOI 10.1002/art.22042; Yammani RR, 2009, ARTHRITIS RHEUM, V60, P792, DOI 10.1002/art.24295; Zibert JR, 2010, J INVEST DERMATOL, V130, P150, DOI 10.1038/jid.2009.206	53	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10374	10.1371/journal.pone.0010374	http://dx.doi.org/10.1371/journal.pone.0010374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442771	Green Published, Green Submitted, gold			2022-12-25	WOS:000277154200014
J	Shinoda, Y; Tanaka, T; Tominaga-Yoshino, K; Ogura, A				Shinoda, Yo; Tanaka, Tsunehiro; Tominaga-Yoshino, Keiko; Ogura, Akihiko			Persistent Synapse Loss Induced by Repetitive LTD in Developing Rat Hippocampal Neurons	PLOS ONE			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE RECEPTORS; POSTSYNAPTIC DENSITY PROTEINS; REPEATED PKA ACTIVATION; DENDRITIC SPINES; MONOCULAR DEPRIVATION; POSTNATAL-DEVELOPMENT; PREFRONTAL CORTEX; PYRAMIDAL NEURONS; VISUAL-CORTEX	Synaptic pruning is a physiological event that eliminates excessive or inappropriate synapses to form proper synaptic connections during development of neurons. Appropriate synaptic pruning is required for normal neural development. However, the mechanism of synaptic pruning is not fully understood. Strength of synaptic activity under competitive circumstances is thought to act as a selective force for synaptic pruning. Long-term depression (LTD) is a synaptic plasticity showing persistent decreased synaptic efficacy, which is accompanied by morphological changes of dendritic spines including transient retraction. Repetitive induction of LTD has been shown to cause persistent loss of synapses in mature neurons. Here, we show that multiple, but not single, induction of LTD caused a persistent reduction in the number of dendritic synapses in cultured rat developing hippocampal neurons. When LTD was induced in 14 days in vitro cultures by application of (RS)-3,5-dihydroxyphenylglycine (DHPG), a group I metabotropic glutamate receptor (mGluR) agonist, and repeated three times with a one day interval, there was a significant decrease in the number of dendritic synapses. This effect continued up to at least two weeks after the triple LTD induction. The persistent reduction in synapse number occurred in the proximal dendrites, but not the distal dendrites, and was prevented by simultaneous application of the group I/II mGluR antagonist (S)-a-methyl-4-carboxyphenylglycine (MCPG). In conclusion, we found that repetitive LTD induction in developing neurons elicits synaptic pruning and contributes to activity-dependent regulation of synapse number in rat hippocampal neurons.	[Shinoda, Yo] RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama, Japan; [Shinoda, Yo; Tanaka, Tsunehiro; Tominaga-Yoshino, Keiko; Ogura, Akihiko] Osaka Univ, Dept Neurosci, Grad Sch Frontier Biosci, Osaka, Japan; [Shinoda, Yo] JST CREST, Kawaguchi, Saitama, Japan	RIKEN; Osaka University; Japan Science & Technology Agency (JST)	Shinoda, Y (corresponding author), RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama, Japan.	yshinoda-ns@umin.ac.jp	Shinoda, Yo/H-3091-2019	Shinoda, Yo/0000-0003-3253-2194	Japanese Ministry of Education, Culture, Sports, Science, and Technology [21790219]; CREST	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST(Core Research for Evolutional Science and Technology (CREST))	This study was supported by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#21790219, http://www.mext.go.jp/english/) and CREST (http://www.jst.go.jp/kisoken/crest/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; ANDERSON SA, 1995, NEUROSCIENCE, V67, P7, DOI 10.1016/0306-4522(95)00051-J; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bastrikova N, 2008, P NATL ACAD SCI USA, V105, P3123, DOI 10.1073/pnas.0800027105; Becker N, 2008, NEURON, V60, P590, DOI 10.1016/j.neuron.2008.09.018; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; BROSE N, 1993, J BIOL CHEM, V268, P22663; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Cesa R, 2007, J NEUROSCI, V27, P4603, DOI 10.1523/JNEUROSCI.5617-06.2007; Defagot MC, 2002, DEV NEUROSCI-BASEL, V24, P272, DOI 10.1159/000066741; Ehlers MD, 1999, CURR BIOL, V9, pR848, DOI 10.1016/S0960-9822(00)80043-3; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Gonzalez-Burgos G, 2008, CEREB CORTEX, V18, P626, DOI 10.1093/cercor/bhm095; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Hensch TK, 2005, CURR TOP DEV BIOL, V69, P215, DOI 10.1016/S0070-2153(05)69008-4; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Johnston MV, 2003, J CHILD NEUROL, V18, P688, DOI 10.1177/08830738030180100501; Kamikubo Y, 2006, EUR J NEUROSCI, V24, P1606, DOI 10.1111/j.1460-9568.2006.05032.x; KESHAVAN MS, 1994, J PSYCHIATR RES, V28, P239, DOI 10.1016/0022-3956(94)90009-4; Knafo S, 2005, EUR J NEUROSCI, V21, P927, DOI 10.1111/j.1460-9568.2005.03936.x; KNOBLAUCH A, 2010, NEURAL COMPUT, V289, P341; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Moody WJ, 1998, J NEUROBIOL, V37, P97, DOI 10.1002/(SICI)1097-4695(199810)37:1<97::AID-NEU8>3.0.CO;2-3; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; RAUSCHECKER JP, 1987, WHAT SIGNALS ARE RES, P193; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Segal M, 2001, PROG NEUROBIOL, V63, P61, DOI 10.1016/S0301-0082(00)00021-6; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shinoda Y, 2005, BRAIN RES, V1042, P99, DOI 10.1016/j.brainres.2005.02.028; Shinoda Y, 2003, NEUROSCI RES, V47, P191, DOI 10.1016/S0168-0102(03)00199-8; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Taniguchi N, 2006, NEUROSCI LETT, V406, P38, DOI 10.1016/j.neulet.2006.06.071; Tessier CR, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.008.2009; Tominaga-Yoshino K, 2002, NEUROSCI RES, V44, P357, DOI 10.1016/S0168-0102(02)00155-4; Tominaga-Yoshino K, 2008, HIPPOCAMPUS, V18, P281, DOI 10.1002/hipo.20391; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Urakubo T, 2006, NEUROSCI LETT, V407, P1, DOI 10.1016/j.neulet.2006.07.057; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Woo TUW, 2005, SCHIZOPHR RES, V73, P193, DOI 10.1016/j.schres.2004.07.022; Yamamoto M, 2005, BRAIN RES, V1042, P6, DOI 10.1016/j.brainres.2005.01.102; Young A, 2007, CHEM SENSES, V32, P783, DOI 10.1093/chemse/bjm046; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	54	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10390	10.1371/journal.pone.0010390	http://dx.doi.org/10.1371/journal.pone.0010390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20436928	Green Published, Green Submitted, gold			2022-12-25	WOS:000277154200025
J	Schulze, J; Seitz, S; Saito, H; Schneebauer, M; Marshall, RP; Baranowsky, A; Busse, B; Schilling, AF; Friedrich, FW; Albers, J; Spiro, AS; Zustin, J; Streichert, T; Ellwanger, K; Niehrs, C; Amling, M; Baron, R; Schinke, T				Schulze, Jochen; Seitz, Sebastian; Saito, Hiroaki; Schneebauer, Michael; Marshall, Robert P.; Baranowsky, Anke; Busse, Bjoern; Schilling, Arndt F.; Friedrich, Felix W.; Albers, Joachim; Spiro, Alexander S.; Zustin, Jozef; Streichert, Thomas; Ellwanger, Kristina; Niehrs, Christof; Amling, Michael; Baron, Roland; Schinke, Thorsten			Negative Regulation of Bone Formation by the Transmembrane Wnt Antagonist Kremen-2	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; SOST GENE; LRP5; MICE; SCLEROSTIN; EXPRESSION; DELETION; MUTATION; DKK1; MASS	Wnt signalling is a key pathway controlling bone formation in mice and humans. One of the regulators of this pathway is Dkk1, which antagonizes Wnt signalling through the formation of a ternary complex with the transmembrane receptors Krm1/2 and Lrp5/6, thereby blocking the induction of Wnt signalling by the latter ones. Here we show that Kremen-2 (Krm2) is predominantly expressed in bone, and that its osteoblast-specific over-expression in transgenic mice (Col1a1-Krm2) results in severe osteoporosis. Histomorphometric analysis revealed that osteoblast maturation and bone formation are disturbed in Col1a1-Krm2 mice, whereas bone resorption is increased. In line with these findings, primary osteoblasts derived from Col1a1-Krm2 mice display a cell-autonomous differentiation defect, impaired canonical Wnt signalling and decreased production of the osteoclast inhibitory factor Opg. To determine whether the observed effects of Krm2 on bone remodeling are physiologically relevant, we analyzed the skeletal phenotype of 24 weeks old Krm2-deficient mice and observed high bone mass caused by a more than three-fold increase in bone formation. Taken together, these data identify Krm2 as a regulator of bone remodeling and raise the possibility that antagonizing KRM2 might prove beneficial in patients with bone loss disorders.	[Schulze, Jochen; Seitz, Sebastian; Schneebauer, Michael; Marshall, Robert P.; Baranowsky, Anke; Busse, Bjoern; Schilling, Arndt F.; Friedrich, Felix W.; Albers, Joachim; Spiro, Alexander S.; Amling, Michael; Schinke, Thorsten] Univ Med Ctr Hamburg Eppendorf, Inst Osteol & Biomech, Hamburg, Germany; [Saito, Hiroaki; Baron, Roland] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Saito, Hiroaki; Baron, Roland] Harvard Univ, Sch Med, Boston, MA USA; [Zustin, Jozef] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany; [Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany; [Ellwanger, Kristina; Niehrs, Christof] Univ Heidelberg DKFZ ZMBH Alliance, German Canc Res Ctr, Res Program Cell & Tumor Biol, Div Mol Embryol, Heidelberg, Germany; [Ellwanger, Kristina; Niehrs, Christof] Univ Heidelberg DKFZ ZMBH Alliance, German Canc Res Ctr, Ctr Mol Biol, Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Schulze, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Osteol & Biomech, Hamburg, Germany.	schinke@uke.uni-hamburg.de	Friedrich, Felix W./C-7366-2009; Busse, Björn/O-8462-2016; Busse, Björn/AAC-4033-2020; Marshall, Robert Percy/AAD-5269-2022	Busse, Björn/0000-0002-3099-8073; Busse, Björn/0000-0002-3099-8073; Marshall, Robert Percy/0000-0003-4247-1006; Friedrich, Felix/0000-0002-8400-9445; Albers, Joachim/0000-0003-0582-1863	Deutsche Forschungsgemeinschaft [SCHI 504/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to T. Schinke (SCHI 504/5-1) within the transregional research group 793. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Forlino A, 2000, MOL GENET METAB, V71, P225, DOI 10.1006/mgme.2000.3039; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Goldberg M, 2008, J DENT RES, V87, P9, DOI 10.1177/154405910808700103; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grundberg E, 2008, OSTEOPOROSIS INT, V19, P829, DOI 10.1007/s00198-007-0512-z; GUENET JL, 1981, J HERED, V72, P440, DOI 10.1093/oxfordjournals.jhered.a109554; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hassler C, 2007, DEVELOPMENT, V134, P4255, DOI 10.1242/dev.005942; Heinzel K, 2007, EUR J IMMUNOL, V37, P2562, DOI 10.1002/eji.200637474; Huebner AK, 2006, J BONE MINER RES, V21, P1924, DOI 10.1359/JBMR.060820; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Laroche M, 2008, AM J MED, V121, P744, DOI 10.1016/j.amjmed.2008.03.048; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schinke T, 1999, J BIOL CHEM, V274, P30182, DOI 10.1074/jbc.274.42.30182; Schinke T, 2009, NAT MED, V15, P674, DOI 10.1038/nm.1963; Schmidt K, 2005, J CELL BIOL, V168, P899, DOI 10.1083/jcb.200408013; Seitz S, 2009, J BONE MINER RES, V24, P62, DOI 10.1359/JBMR.080907; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Wang CJ, 2008, J BONE MINER RES, V23, P837, DOI 10.1359/JBMR.080214; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	63	43	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2010	5	4							e10309	10.1371/journal.pone.0010309	http://dx.doi.org/10.1371/journal.pone.0010309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NX	20436912	Green Submitted, gold, Green Published			2022-12-25	WOS:000277079700005
J	Baron, T; Bencsik, A; Morignat, E				Baron, Thierry; Bencsik, Anna; Morignat, Eric			Prions of Ruminants Show Distinct Splenotropisms in an Ovine Transgenic Mouse Model	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; TRANSMISSIBLE MINK ENCEPHALOPATHY; MOLECULAR ANALYSIS; SCRAPIE; PROTEIN; SHEEP; INFECTION; ISOLATE; SIMILARITIES; DISEASE	Background: Transmissible agents involved in prion diseases differ in their capacities to target different regions of the central nervous system and lymphoid tissues, which are also host-dependent. Methodology/Principal Findings: Protease-resistant prion protein (PrPres) was analysed by Western blot in the spleen of transgenic mice (TgOvPrP4) that express the ovine prion protein under the control of the neuron-specific enolase promoter, after infection by intra-cerebral route with a variety of transmissible spongiform encephalopathies (TSEs) from cattle and small ruminants. Splenic PrPres was consistently detected in classical BSE and in most natural scrapie sources, the electrophoretic pattern showing similar features to that of cerebral PrPres. However splenic PrPres was not detected in L-type BSE and TME-in-cattle, or in the CH1641 experimental scrapie isolate, indicating that some TSE strains showed reduced splenotropism in the ovine transgenic mice. In contrast with CH1641, PrPres was also consistently detected in the spleen of mice infected with six natural "CH1641-like" scrapie isolates, but then showed clearly different molecular features from those identified in the brains (unglycosylated PrPres at similar to 18 kDa with removal of the 12B2 epitope) of ovine transgenic mice or of sheep. These features included different cleavage of the main PrPres cleavage product (unglycosylated PrPres at similar to 19 kDa with preservation of the 12B2 epitope) and absence of the additional C-terminally cleaved PrPres product (unglycosylated form at similar to 14 kDa) that was detected in the brain. Conclusion/Significance: Studies in a transgenic mouse model expressing the sheep prion protein revealed different capacities of ruminant prions to propagate in the spleen. They showed unexpected features in "CH1641-like" ovine scrapie suggesting that such isolates contain mixed conformers with distinct capacities to propagate in the brain or lymphoid tissues of these mice.	[Baron, Thierry; Bencsik, Anna; Morignat, Eric] Agence Francaise Secur Sanit Aliments Lyon, Unite ATNC, Lyon, France		Baron, T (corresponding author), Agence Francaise Secur Sanit Aliments Lyon, Unite ATNC, Lyon, France.	t.baron@afssa.fr	BENCSIK, Anna A/HGC-4260-2022	BENCSIK, Anna A/0000-0002-8671-6290	Neuroprion network of excellence [FOOD-CT-2004-506579]	Neuroprion network of excellence(European Commission)	This work was supported by grants from the Neuroprion network of excellence (FOOD-CT-2004-506579, EUROSTRAINS project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Baron T, 2004, J VIROL, V78, P6243, DOI 10.1128/JVI.78.12.6243-6251.2004; Baron T, 2007, EMERG INFECT DIS, V13, P1887, DOI 10.3201/eid1312.070635; Baron T, 2007, J VIROL, V81, P7230, DOI 10.1128/JVI.02475-06; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; Baron TGM, 2006, EMERG INFECT DIS, V12, P1125; Bartz JC, 2004, J GEN VIROL, V85, P265, DOI 10.1099/vir.0.19394-0; Bencsik AA, 2006, J HISTOCHEM CYTOCHEM, V54, P849, DOI 10.1369/jhc.5C6895.2006; Beringue V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001419; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Biacabe AG, 2008, EMERG INFECT DIS, V14, P298, DOI 10.3201/eid1402.071141; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; COLLIS SC, 1985, FEMS MICROBIOL LETT, V29, P111; Cordier C, 2006, J GEN VIROL, V87, P3763, DOI 10.1099/vir.0.82062-0; Crozet C, 2001, EMBO REP, V2, P952, DOI 10.1093/embo-reports/kve204; Crozet C, 2001, J VIROL, V75, P5328, DOI 10.1128/JVI.75.11.5328-5334.2001; Crozet C, 2007, J INFECT DIS, V195, P997, DOI 10.1086/512085; FARQUHAR CF, 1994, J GEN VIROL, V75, P495, DOI 10.1099/0022-1317-75-3-495; FOSTER JD, 1988, VET REC, V123, P5, DOI 10.1136/vr.123.1.5; HADLOW WJ, 1987, CAN J VET RES, V51, P135; HADLOW WJ, 1987, J VIROL, V61, P3235, DOI 10.1128/JVI.61.10.3235-3240.1987; Hill AF, 1998, NEUROSCI LETT, V255, P159, DOI 10.1016/S0304-3940(98)00736-8; Hope J, 1999, J GEN VIROL, V80, P1, DOI 10.1099/0022-1317-80-1-1; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; Konold Timm, 2006, BMC Vet Res, V2, P31, DOI 10.1186/1746-6148-2-31; Lezmi S, 2004, J VIROL, V78, P3654, DOI 10.1128/JVI.78.7.3654-3662.2004; Madec JY, 2000, MICROB PATHOGENESIS, V28, P353, DOI 10.1006/mpat.2000.0357; Nicot S, 2010, J GEN VIROL, V91, P570, DOI 10.1099/vir.0.014464-0; NONNO R, 2008, PRION 2008 C MADR SP; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Parchi P, 2009, ACTA NEUROPATHOL, V118, P659, DOI 10.1007/s00401-009-0585-1; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; Somerville RA, 1997, J GEN VIROL, V78, P2389, DOI 10.1099/0022-1317-78-9-2389; Sorby R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006885; Stack M, 2006, J GEN VIROL, V87, P2099, DOI 10.1099/vir.0.81254-0; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4	42	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10310	10.1371/journal.pone.0010310	http://dx.doi.org/10.1371/journal.pone.0010310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436680	gold, Green Published, Green Submitted			2022-12-25	WOS:000277079500004
J	Brown, RH; Kaczka, DW; Mitzner, W				Brown, Robert H.; Kaczka, David W.; Mitzner, Wayne			Effect of Parenchymal Stiffness on Canine Airway Size with Lung Inflation	PLOS ONE			English	Article							DEEP INSPIRATION; SMOOTH-MUSCLE; COMPUTED-TOMOGRAPHY; IN-VIVO; MECHANICAL RESPONSE; LENGTH OSCILLATION; TISSUE MECHANICS; TREE-STRUCTURES; SHEAR MODULUS; BRONCHOCONSTRICTION	Although airway patency is partially maintained by parenchymal tethering, this structural support is often ignored in many discussions of asthma. However, agonists that induce smooth muscle contraction also stiffen the parenchyma, so such parenchymal stiffening may serve as a defense mechanism to prevent airway narrowing or closure. To quantify this effect, specifically how changes in parenchymal stiffness alter airway size at different levels of lung inflation, in the present study, we devised a method to separate the effect of parenchymal stiffening from that of direct airway narrowing. Six anesthetized dogs were studied under four conditions: baseline, after whole lung aerosol histamine challenge, after local airway histamine challenge, and after complete relaxation of the airways. In each of these conditions, we used High resolution Computed Tomography to measure airway size and lung volume at five different airway pressures ( 0, 12, 25, 32, and 45 cm H(2)O). Parenchymal stiffening had a protective effect on airway narrowing, a fact that may be important in the airway response to deep inspiration in asthma. When the parenchyma was stiffened by whole lung aerosol histamine challenge, at every lung volume above FRC, the airways were larger than when they were directly challenged with histamine to the same initial constriction. These results show for the first time that a stiff parenchyma per se minimizes the airway narrowing that occurs with histamine challenge at any lung volume. Thus in clinical asthma, it is not simply increased airway smooth muscle contraction, but perhaps a lack of homogeneous parenchymal stiffening that contributes to the symptomatic airway hyperresponsiveness.	[Brown, Robert H.; Mitzner, Wayne] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21218 USA; [Brown, Robert H.; Mitzner, Wayne] Johns Hopkins Univ, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Brown, Robert H.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD 21205 USA; [Kaczka, David W.; Mitzner, Wayne] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Brown, RH (corresponding author), Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21218 USA.	wmitzner@jhsph.edu	Kaczka, David Walter/A-2984-2008; Kaczka, David W./U-2580-2018	Kaczka, David Walter/0000-0003-4378-5242; Kaczka, David W./0000-0003-4378-5242	National Institutes of Health (NIH) [HL-10342]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL010342] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) research grant HL-10342. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIRAV I, 1993, J APPL PHYSIOL, V75, P2239, DOI 10.1152/jappl.1993.75.5.2239; [Anonymous], 1977, HDB PHYSL SECTION RE; Bates JHT, 2005, RESP PHYSIOL NEUROBI, V148, P153, DOI 10.1016/j.resp.2005.04.021; BEAUPRE A, 1983, EUR J RESPIR DIS, V64, P108; BEAUPRE A, 1982, THORAX, V37, P124, DOI 10.1136/thx.37.2.124; Brown RH, 2000, J APPL PHYSIOL, V89, P956, DOI 10.1152/jappl.2000.89.3.956; Brown RH, 1998, J APPL PHYSIOL, V85, P2012, DOI 10.1152/jappl.1998.85.6.2012; Brown RH, 1996, J APPL PHYSIOL, V80, P1581, DOI 10.1152/jappl.1996.80.5.1581; Brusasco V, 1999, J APPL PHYSIOL, V87, P567, DOI 10.1152/jappl.1999.87.2.567; FISH JE, 1977, J ALLERGY CLIN IMMUN, V60, P41, DOI 10.1016/0091-6749(77)90081-1; Gunst SJ, 2001, J APPL PHYSIOL, V91, P2511, DOI 10.1152/jappl.2001.91.6.2511; HEROLD CJ, 1991, RADIOLOGY, V181, P369, DOI 10.1148/radiology.181.2.1924774; Kaczka DW, 2009, J APPL PHYSIOL, V106, P520, DOI 10.1152/japplphysiol.90576.2008; Kaczka DW, 1997, J APPL PHYSIOL, V82, P1531, DOI 10.1152/jappl.1997.82.5.1531; Kaczka DW, 1999, AM J RESP CRIT CARE, V159, P169, DOI 10.1164/ajrccm.159.1.9709109; KAPANCI Y, 1974, J CELL BIOL, V60, P375, DOI 10.1083/jcb.60.2.375; LAIFOOK SJ, 1978, J APPL PHYSIOL, V44, P859, DOI 10.1152/jappl.1978.44.6.859; Lambert RK, 1997, J APPL PHYSIOL, V83, P140, DOI 10.1152/jappl.1997.83.1.140; Lutchen KR, 1996, J APPL PHYSIOL, V80, P1696, DOI 10.1152/jappl.1996.80.5.1696; LUTCHEN KR, 1994, J APPL PHYSIOL, V77, P373, DOI 10.1152/jappl.1994.77.1.373; Macklin CC, 1929, PHYSIOL REV, V9, P1, DOI 10.1152/physrev.1929.9.1.1; MALMBERG P, 1993, EUR RESPIR J, V6, P680; MILICEMILI J, 1964, J APPL PHYSIOL, V19, P207, DOI 10.1152/jappl.1964.19.2.207; MITZNER W, 1992, J APPL PHYSIOL, V72, P158, DOI 10.1152/jappl.1992.72.1.158; NADEL JA, 1964, J APPL PHYSIOL, V19, P387, DOI 10.1152/jappl.1964.19.3.387; Noble PB, 2005, EUR RESPIR J, V26, P804, DOI 10.1183/09031936.05.00065405; Noble PB, 2002, J APPL PHYSIOL, V92, P1119, DOI 10.1152/japplphysiol.00662.2001; Okazawa M, 1999, J APPL PHYSIOL, V86, P496, DOI 10.1152/jappl.1999.86.2.496; OREHEK J, 1980, AM REV RESPIR DIS, V121, P297; Pyrgos G, 2003, AM J RESP CRIT CARE, V167, P1660, DOI 10.1164/rccm.2201048; Scichilone N, 2004, CURR ALLERGY ASTHM R, V4, P166, DOI 10.1007/s11882-004-0063-8; Scichilone N, 2001, INT ARCH ALLERGY IMM, V124, P262, DOI 10.1159/000053728; Scichilone N, 2008, J APPL PHYSIOL, V105, P832, DOI 10.1152/japplphysiol.01307.2007; Scichilone N, 2007, RESP MED, V101, P951, DOI 10.1016/j.rmed.2006.09.009; Shen X, 1997, J APPL PHYSIOL, V83, P739, DOI 10.1152/jappl.1997.83.3.739; Shen X, 1997, J APPL PHYSIOL, V83, P731, DOI 10.1152/jappl.1997.83.3.731; Silva PL, 2008, RESP PHYSIOL NEUROBI, V160, P239, DOI 10.1016/j.resp.2007.10.009; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; SMITH JC, 1980, J APPL PHYSIOL, V48, P450, DOI 10.1152/jappl.1980.48.3.450; SMITH JC, 1984, J APPL PHYSIOL, V57, P1422, DOI 10.1152/jappl.1984.57.5.1422; TEPPER RS, 1995, J APPL PHYSIOL, V79, P1190, DOI 10.1152/jappl.1995.79.4.1190; WOOD SA, 1995, J APPL PHYSIOL, V79, P1687, DOI 10.1152/jappl.1995.79.5.1687	42	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2010	5	4							e10332	10.1371/journal.pone.0010332	http://dx.doi.org/10.1371/journal.pone.0010332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NW	20436667	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079500012
J	Pye, VE; Christensen, CE; Dyer, JH; Arent, S; Henriksen, A				Pye, Valerie E.; Christensen, Caspar E.; Dyer, James H.; Arent, Susan; Henriksen, Anette			Peroxisomal Plant 3-Ketoacyl-CoA Thiolase Structure and Activity Are Regulated by a Sensitive Redox Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID BETA-OXIDATION; ACYL-COA OXIDASES; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; MULTIFUNCTIONAL PROTEIN; BRASSICA-NAPUS; CATALASE; H2O2; TRIACYLGLYCEROL	The breakdown of fatty acids, performed by the beta-oxidation cycle, is crucial for plant germination and sustainability. beta-Oxidation involves four enzymatic reactions. The final step, in which a two-carbon unit is cleaved from the fatty acid, is performed by a 3-ketoacyl-CoA thiolase (KAT). The shortened fatty acid may then pass through the cycle again (until reaching acetoacetyl-CoA) or be directed to a different cellular function. Crystal structures of KAT from Arabidopsis thaliana and Helianthus annuus have been solved to 1.5 and 1.8 angstrom resolution, respectively. Their dimeric structures are very similar and exhibit a typical thiolase-like fold; dimer formation and active site conformation appear in an open, active, reduced state. Using an interdisciplinary approach, we confirmed the potential of plant KATs to be regulated by the redox environment in the peroxisome within a physiological range. In addition, co-immunoprecipitation studies suggest an interaction between KAT and the multifunctional protein that is responsible for the preceding two steps in beta-oxidation, which would allow a route for substrate channeling. We suggest a model for this complex based on the bacterial system.	Carlsberg Lab, Prot Chem Grp, DK-2500 Copenhagen, Denmark; [Dyer, James H.] Montclair State Univ, Dept Chem & Biochem, Montclair, NJ 07043 USA	Montclair State University	Pye, VE (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	vpye@tcd.ie; anette@crc.dk	Christensen, Caspar Elo/K-2753-2014	Christensen, Caspar Elo/0000-0002-0214-8477; Pye, Valerie E/0000-0001-9616-2992; Henriksen, Anette/0000-0003-4051-5079	Danish Natural Science Research Council	Danish Natural Science Research Council(Danish Natural Science Research Council)	This work was supported by the Danish Natural Science Research Council, which provided a postdoctoral stipend through DANSYNC (to S. A.) and synchrotron beam time.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTOMARE RE, 1974, BIOTECHNOL BIOENG, V16, P1675, DOI 10.1002/bit.260161209; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arent S, 2010, J BIOL CHEM, V285, P24066, DOI 10.1074/jbc.M110.106005; Brehelin C, 2004, PHOTOSYNTH RES, V79, P295, DOI 10.1023/B:PRES.0000017165.55488.ca; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrie C, 2007, PLANT MOL BIOL, V63, P97, DOI 10.1007/s11103-006-9075-1; CHANCE B, 1952, ARCH BIOCHEM BIOPHYS, V41, P404, DOI 10.1016/0003-9861(52)90469-4; Cheeseman JM, 2006, J EXP BOT, V57, P2435, DOI 10.1093/jxb/erl004; Dansen TB, 2001, IUBMB LIFE, V51, P223; DAWSON RM, 1974, DATA BIOCH RES, P191; Delker C, 2007, PHYTOCHEMISTRY, V68, P1642, DOI 10.1016/j.phytochem.2007.04.024; Dutton P L, 1978, Methods Enzymol, V54, P411; Eastmond PJ, 2000, BIOCHEM SOC T, V28, P95, DOI 10.1042/bst0280095; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; Eccleston VS, 1998, PLANT CELL, V10, P613, DOI 10.1105/tpc.10.4.613; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Fritz R, 2007, FREE RADICAL BIO MED, V42, P1119, DOI 10.1016/j.freeradbiomed.2007.01.014; Germain V, 2001, PLANT J, V28, P1, DOI 10.1046/j.1365-313X.2001.01095.x; HASHIMOTO F, 1987, BIOCHIM BIOPHYS ACTA, V921, P142; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Hooks MA, 1996, BIOCHEM J, V320, P607, DOI 10.1042/bj3200607; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Ishikawa M, 1997, BIOCHEM J, V328, P815, DOI 10.1042/bj3280815; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; KINDL H, 1987, BIOCH PLANTS, V9, P31; KIRKMAN HN, 1987, J BIOL CHEM, V262, P660; KNOOP F, 1905, CHEM PHYSL PATHOL S, V6, P150; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lardinois OM, 1996, BBA-PROTEIN STRUCT M, V1298, P180, DOI 10.1016/S0167-4838(96)00130-6; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; LAZAROW PB, 1978, J BIOL CHEM, V253, P1522; Mason JT, 2006, BIOCHEMISTRY-US, V45, P13409, DOI 10.1021/bi061136y; Mathieu M, 1997, J MOL BIOL, V273, P714, DOI 10.1006/jmbi.1997.1331; MATHIEU M, 1994, STRUCTURE, V2, P797, DOI 10.1016/S0969-2126(94)00081-6; MILLIS KK, 1993, J ORG CHEM, V58, P4144, DOI 10.1021/jo00067a060; Mueller S, 2002, BIOCHEM J, V363, P483, DOI 10.1042/0264-6021:3630483; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Nicholls P., 1963, ENZYMES, V8, P147; Nyathi Y, 2006, BBA-MOL CELL RES, V1763, P1478, DOI 10.1016/j.bbamcr.2006.08.031; Olesen C, 1997, FEBS LETT, V412, P138, DOI 10.1016/S0014-5793(97)00766-7; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reumann S, 2009, PLANT PHYSIOL, V150, P125, DOI 10.1104/pp.109.137703; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Richmond TA, 1999, PLANT CELL, V11, P1911, DOI 10.1105/tpc.11.10.1911; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schiedl AC, 2004, PROTEIN EXPRES PURIF, V33, P25, DOI 10.1016/j.pep.2003.08.022; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Setterdahl AT, 2003, BIOCHEMISTRY-US, V42, P14877, DOI 10.1021/bi0302088; Simova-Stoilova L, 2009, PLANT GROWTH REGUL, V58, P107, DOI 10.1007/s10725-008-9356-6; Sinclair AM, 2009, PLANT J, V59, P231, DOI 10.1111/j.1365-313X.2009.03863.x; Sundaramoorthy R, 2006, J MOL BIOL, V359, P347, DOI 10.1016/j.jmb.2006.03.032; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuchiya D, 2006, STRUCTURE, V14, P237, DOI 10.1016/j.str.2005.10.011; van Roermund CWT, 2003, CELL MOL LIFE SCI, V60, P1838, DOI 10.1007/s00018-003-3076-x; VANVELDHOVEN PP, 1992, J BIOL CHEM, V267, P20065; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yao KW, 1996, J BIOL CHEM, V271, P17816, DOI 10.1074/jbc.271.30.17816; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399	68	27	27	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24078	24088		10.1074/jbc.M110.106013	http://dx.doi.org/10.1074/jbc.M110.106013			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20463027	Green Published, hybrid			2022-12-25	WOS:000280291400058
J	Zhou, Y; Hagood, JS; Lu, BG; Merryman, WD; Murphy-Ullrich, JE				Zhou, Yong; Hagood, James S.; Lu, Baogen; Merryman, W. David; Murphy-Ullrich, Joanne E.			Thy-1-Integrin alpha(v)beta(5) Interactions Inhibit Lung Fibroblast Contraction-induced Latent Transforming Growth Factor-beta 1 Activation and Myofibroblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SMOOTH MUSCLE ACTIN; IDIOPATHIC PULMONARY-FIBROSIS; LIGHT-CHAIN PHOSPHATASE; INTEGRIN-LINKED KINASE; TGF-BETA; IN-VIVO; EXTRACELLULAR-MATRIX; BINDING-PROTEIN; GRANULATION-TISSUE	Myofibroblasts, key effector cells in tissue fibrosis, are specialized contractile cells. Lung myofibroblast contraction induces integrin alpha(v)beta(5)-dependent latent transforming growth factor (TGF)-beta 1 activation suggests that myofibroblast contractility may be a driving force for the persistent myofibroblast differentiation observed in fibrotic lungs. Understanding the mechanisms that regulate fibroblast contraction and mechanotransduction will add new insights into the pathogenesis of lung fibrosis and may lead to new therapeutic approaches for treating fibrotic lung diseases. We and others previously demonstrated that lung fibroblast expression of Thy-1 prevents lung fibrosis. The mechanisms underlying the anti-fibrotic effect of Thy-1 are not well understood. In this study, we showed that Thy-1 interacts with integrin alpha(v)beta(5), both in a cell-free system and on the cell surface of rat lung fibroblasts. Thy-1-integrin alpha(v)beta(5) interactions are RLD-dependent because mutated Thy-1, in which RLD is replaced by RLE, loses the ability to bind the integrin. Furthermore, Thy-1 expression prevents fibroblast contraction-induced, integrin alpha(v)beta(5)-dependent latent TGF-beta 1 activation and TGF-beta 1-dependent lung myofibroblast differentiation. In contrast, lack of Thy-1 expression or disruption of Thy-1-alpha(v)beta(5) interactions renders lung fibroblasts susceptible to contraction-induced latent TGF-beta 1 activation and myofibroblast differentiation. These data suggest that Thy-1-integrin alpha(v)beta(5) interactions inhibit contraction-induced latent TGF-beta 1 activation, presumably by blocking the binding of extracellular matrix-bound latent TGF-beta 1 with integrin alpha(v)beta(5). Our studies suggest that targeting key mechanotransducers to inhibit mechanotransduction might be an effective approach to inhibit the deleterious effects of myofibroblast contraction on lung fibrogenesis.	[Zhou, Yong; Lu, Baogen] Univ Alabama, Div Pulm Allergy & Crit Care Med, Dept Med, Birmingham, AL 35294 USA; [Murphy-Ullrich, Joanne E.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Hagood, James S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Merryman, W. David] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37240 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego; Vanderbilt University	Zhou, Y (corresponding author), Univ Alabama, Div Pulm Allergy & Crit Care Med, Dept Med, Tinsley Harrison Tower 437B,1900 Univ Blvd, Birmingham, AL 35294 USA.	yzhou@uab.edu	Merryman, W. David/AAY-4781-2021		National Institutes of Health [HL097215, HL094707, HL082818, HL86706]; American Heart Association [0835432N, 0835496N]; Department of Medicine, University of Alabama at Birmingham; National Center for Research Resources, National Institutes of Health [C06 RR 15490]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015490] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097215, R01HL082818, K25HL094707, R21HL086706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Medicine, University of Alabama at Birmingham; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL097215 (to Y.Z.), HL094707 (to W. D. M.), HL082818 (to J. S. H.), and HL86706 (to J. E. M.-U.). This work was also supported by American Heart Association Scientist Development Grant 0835432N, start-up funding from the Department of Medicine, University of Alabama at Birmingham (to Y. Z.), and American Heart Association Scientist Development Grant 0835496N (to W. D. M.). A part of the present study was conducted in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR 15490 from the National Center for Research Resources, National Institutes of Health.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Ahamed J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006608; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Asano Y, 2006, J INVEST DERMATOL, V126, P1761, DOI 10.1038/sj.jid.5700331; Avalos AM, 2002, BIOL RES, V35, P231, DOI 10.4067/S0716-97602002000200015; Barker TH, 2004, J BIOL CHEM, V279, P23510, DOI 10.1074/jbc.M402169200; Barker TH, 2004, EXP CELL RES, V295, P488, DOI 10.1016/j.yexcr.2004.01.026; Bogatcheva NV, 2003, AM J PHYSIOL-LUNG C, V285, pL415, DOI 10.1152/ajplung.00364.2001; Carlson MA, 2002, SURGERY, V131, P332, DOI 10.1067/msy.2002.120673; CHAPONNIER C, 1995, J CELL BIOL, V130, P887, DOI 10.1083/jcb.130.4.887; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Deng JT, 2002, BIOCHEM J, V367, P517, DOI 10.1042/BJ20020522; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Goodwin A, 2009, BIOCHEM SOC T, V37, P849, DOI 10.1042/BST0370849; Grinnell F, 1999, EXP CELL RES, V248, P608, DOI 10.1006/excr.1999.4440; Grinnell F, 1998, J INVEST DERMATOL, V110, P771, DOI 10.1046/j.1523-1747.1998.00192.x; Hagood JS, 2005, AM J PATHOL, V167, P365, DOI 10.1016/S0002-9440(10)62982-3; Hagood JS, 2001, CHEST, V120, p64S, DOI 10.1378/chest.120.1_suppl.S64; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; HEDMAN K, 1979, J CELL BIOL, V81, P83, DOI 10.1083/jcb.81.1.83; Hermosilla T, 2008, BBA-MOL CELL RES, V1783, P1111, DOI 10.1016/j.bbamcr.2008.01.034; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; KARLSSON JO, 1994, ANAL BIOCHEM, V219, P144, DOI 10.1006/abio.1994.1243; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Keski-Oja J, 2004, TRENDS CELL BIOL, V14, P657, DOI 10.1016/j.tcb.2004.10.003; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Koli K, 2004, J CELL BIOL, V167, P123, DOI 10.1083/jcb.200403067; LAWRENCE DA, 1984, J CELL PHYSIOL, V121, P184, DOI 10.1002/jcp.1041210123; Leyton L, 2001, CURR BIOL, V11, P1028, DOI 10.1016/S0960-9822(01)00262-7; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; MCINTOSH JC, 1994, EUR RESPIR J, V7, P2131, DOI 10.1183/09031936.94.07122131; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nozaki Y, 2000, AM J RESP CELL MOL, V23, P460, DOI 10.1165/ajrcmb.23.4.3958; Parizi M, 2000, EXP CELL RES, V254, P210, DOI 10.1006/excr.1999.4754; Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc.E03-09-0696; Rege TA, 2006, EXP CELL RES, V312, P3752, DOI 10.1016/j.yexcr.2006.07.029; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Saalbach A, 2005, ONCOGENE, V24, P4710, DOI 10.1038/sj.onc.1208559; Saharinen J, 1996, EMBO J, V15, P245, DOI 10.1002/j.1460-2075.1996.tb00355.x; Sanders YY, 2007, AM J RESP CELL MOL, V36, P226, DOI 10.1165/rcmb.2006-0178OC; Sheppard D, 2005, CANCER METAST REV, V24, P395, DOI 10.1007/s10555-005-5131-6; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; TAIPALE J, 1992, J BIOL CHEM, V267, P25378; Tomasek JJ, 2006, WOUND REPAIR REGEN, V14, P313, DOI 10.1111/j.1743-6109.2006.00126.x; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wetzel A, 2004, J IMMUNOL, V172, P3850, DOI 10.4049/jimmunol.172.6.3850; Wetzel A, 2006, J INVEST DERMATOL, V126, P441, DOI 10.1038/sj.jid.5700072; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Zhou Y, 2004, AM J PATHOL, V165, P659, DOI 10.1016/S0002-9440(10)63330-5; Zhou Y, 2009, AM J PATHOL, V174, P21, DOI 10.2353/ajpath.2009.080620	70	94	95	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22382	22393		10.1074/jbc.M110.126227	http://dx.doi.org/10.1074/jbc.M110.126227			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463011	hybrid, Green Published			2022-12-25	WOS:000279702200051
J	D'Angelo, ME; Bird, PI; Peters, C; Reinheckel, T; Trapani, JA; Sutton, VR				D'Angelo, Michael E.; Bird, Phillip I.; Peters, Christoph; Reinheckel, Thomas; Trapani, Joseph A.; Sutton, Vivien R.			Cathepsin H Is an Additional Convertase of Pro-granzyme B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL-PEPTIDASE-II; TARGET-CELL APOPTOSIS; CYTOTOXIC LYMPHOCYTES; DNA FRAGMENTATION; SERINE PROTEASES; LYTIC GRANULES; ACTIVATION; INHIBITION; PURIFICATION; EXPRESSION	The serine protease granzyme B (GrB) is the most potent proapoptotic cytotoxin of the granule exocytosis pathway of cytotoxic lymphocytes. GrB is synthesized as a zymogen (proGrB) and activated in cytotoxic granules by the lysosomal cysteine protease cathepsin C (CatC) which removes the N-terminal dipeptide Gly-Glu. It has been shown recently that mice lacking CatC nonetheless express significant residual GrB activity, indicating the presence of additional proGrB convertases. Here, we describe an assay to assess activation of proGrB and show that the amino-peptidase cathepsin H (CatH) has proGrB convertase activity in vitro, whereas dipeptidylpeptidase II does not. We generated mice lacking both CatC and CatH expression (CatCH(-/-)) and found that their lymphocytes have reduced convertase activity compared with those from CatC-deficient mice. Despite this, cytotoxic lymphocytes from CatCH(-/-) mice retain cytotoxic activity and some residual GrB activity. We conclude that CatH can act as an additional proGrB convertase and that other protease/s (apart from dipeptidylpeptidase II) must also possess convertase activity. This indicates a great deal of functional redundancy in GrB maturation, which would prevent pathogen-mediated immune suppression by via convertase inhibition.	[D'Angelo, Michael E.; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Peters, Christoph; Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Trapani, Joseph A.; Sutton, Vivien R.] Peter MacCallum Canc Ctr, Canc Cell Death Lab, Melbourne, Vic 8006, Australia	Monash University; University of Freiburg; Peter Maccallum Cancer Center	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	phillip.bird@med.monash.edu.au; viv.sutton@petermac.org	Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Bird, Phillip/0000-0002-6695-606X; Trapani, Joseph/0000-0003-0983-1532; D'Angelo, Michael/0000-0001-9342-0132	Australian postgraduate award; National Health and Medical Research Council of Australia (NHMRC) [490900, 288999, 454569]	Australian postgraduate award(Australian Government); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Supported by an Australian postgraduate award.; Supported by Program Grant 490900 from the National Health and Medical Research Council of Australia (NHMRC). To whom correspondence may be addressed: Dept. of Biochemistry and Molecular Biology, Monash University, Clayton, 3800 Victoria, Australia. Tel.: 61-3-9902-9365; Fax: 61-3-99029500; E-mail: phillip.bird@med.monash.edu.au.; Recipient of a senior fellowship from the NHMRC (288999).; Supported by Program Grant 454569 from the NHMRC.	Andrade F, 2007, EMBO J, V26, P2148, DOI 10.1038/sj.emboj.7601650; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; Buzza MS, 2008, J BIOL CHEM, V283, P22498, DOI 10.1074/jbc.M709080200; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; CAPUTO A, 1993, J BIOL CHEM, V268, P17672; Davis JE, 2003, J IMMUNOL METHODS, V276, P59, DOI 10.1016/S0022-1759(03)00077-2; de Haar Susanne F, 2004, Hum Mutat, V23, P524, DOI 10.1002/humu.9243; GRIFFITHS GM, 1993, J CELL BIOL, V120, P885, DOI 10.1083/jcb.120.4.885; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Leiting B, 2003, BIOCHEM J, V371, P525, DOI 10.1042/BJ20021643; LOBE CG, 1986, SCIENCE, V232, P858, DOI 10.1126/science.3518058; Maes MB, 2005, BIOCHEM J, V386, P315, DOI 10.1042/BJ20041156; Methot N, 2007, J BIOL CHEM, V282, P20836, DOI 10.1074/jbc.M702615200; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Prakash MD, 2009, IMMUNOL CELL BIOL, V87, P249, DOI 10.1038/icb.2008.98; SALVESEN G, 1990, BIOCHEMISTRY-US, V29, P5304, DOI 10.1021/bi00474a013; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Simon MM, 1997, J EXP MED, V186, P1781, DOI 10.1084/jem.186.10.1781; SMYTH MJ, 1995, J IMMUNOL, V154, P6299; Sun J, 2001, J BIOL CHEM, V276, P15177, DOI 10.1074/jbc.M006645200; Sun JR, 1999, BIOCHEM BIOPH RES CO, V261, P251, DOI 10.1006/bbrc.1999.0989; Sutton VR, 2007, J CELL BIOL, V176, P425, DOI 10.1083/jcb.200609077; Sutton VR, 1997, J IMMUNOL, V158, P5783; YANNELLI JR, 1986, J IMMUNOL, V136, P377	26	53	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20514	20519		10.1074/jbc.M109.094573	http://dx.doi.org/10.1074/jbc.M109.094573			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435891	Green Published, hybrid			2022-12-25	WOS:000279228600012
J	Raska, M; Takahashi, K; Czernekova, L; Zachova, K; Hall, S; Moldoveanu, Z; Elliott, MC; Wilson, L; Brown, R; Jancova, D; Barnes, S; Vrbkova, J; Tomana, M; Smith, PD; Mestecky, J; Renfrow, MB; Novak, J				Raska, Milan; Takahashi, Kazuo; Czernekova, Lydie; Zachova, Katerina; Hall, Stacy; Moldoveanu, Zina; Elliott, Matt C.; Wilson, Landon; Brown, Rhubell; Jancova, Dagmar; Barnes, Stephen; Vrbkova, Jana; Tomana, Milan; Smith, Phillip D.; Mestecky, Jiri; Renfrow, Matthew B.; Novak, Jan			Glycosylation Patterns of HIV-1 gp120 Depend on the Type of Expressing Cells and Affect Antibody Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; N-LINKED GLYCOSYLATION; BROADLY NEUTRALIZING ANTIBODIES; RESONANCE MASS-SPECTROMETRY; ENVELOPE GLYCOPROTEIN; V3 LOOP; IMMUNE-RESPONSES; O-GLYCOSYLATION; CARBOHYDRATE EPITOPES; IGA NEPHROPATHY	Human immunodeficiency virus type 1 (HIV-1) entry is mediated by the interaction between a variably glycosylated envelope glycoprotein (gp120) and host-cell receptors. Approximately half of the molecular mass of gp120 is contributed by N-glycans, which serve as potential epitopes and may shield gp120 from immunerecognition. The role of gp120 glycans in the host immune response to HIV-1 has not been comprehensively studied at the molecular level. We developed a new approach to characterize cell-specific gp120 glycosylation, the regulation of glycosylation, and the effect of variable glycosylation on antibody reactivity. A model oligomeric gp120 was expressed in different cell types, including cell lines that represent host-infected cells or cells used to produce gp120 for vaccination purposes. N-Glycosylation of gp120 varied, depending on the cell type used for its expression and the metabolic manipulation during expression. The resultant glycosylation included changes in the ratio of high-mannose to complex N-glycans, terminal decoration, and branching. Differential glycosylation of gp120 affected envelope recognition by polyclonal antibodies from the sera of HIV-1-infected subjects. These results indicate that gp120 glycans contribute to antibody reactivity and should be considered in HIV-1 vaccine design.	[Jancova, Dagmar] Palacky Univ, Dept Immunol, Olomouc 77100, Czech Republic; [Vrbkova, Jana] Palacky Univ, Dept Math Anal & Applicat Math, Olomouc 77100, Czech Republic; [Raska, Milan; Takahashi, Kazuo; Hall, Stacy; Moldoveanu, Zina; Elliott, Matt C.; Brown, Rhubell; Tomana, Milan; Mestecky, Jiri; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Wilson, Landon; Barnes, Stephen] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Smith, Phillip D.; Mestecky, Jiri] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Renfrow, Matthew B.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Vet Affairs Med Ctr, Birmingham, AL 35205 USA; [Mestecky, Jiri] Charles Univ Prague, Fac Med 1, Inst Microbiol & Immunol, Prague 12108, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Charles University Prague	Raska, M (corresponding author), Hnevotinska 3, Olomouc 77200, Czech Republic.	raskamil@uab.edu; renfrow@uab.edu; jannovak@uab.edu	ZACHOVÁ, Kateřina/AAG-5599-2019; Raska, Milan/E-9813-2013	Raska, Milan/0000-0002-8572-7246; Renfrow, Matthew B./0000-0002-4193-7305	National Institutes of Health [DK047322, AI028147, AI083027, RR-20136, T35 HL007473, AI078477, DK054495, AI067854, AI071739]; Research Services of the Veterans Administration; Ministry of Education, Youth and Sport, Czech Republic [KONTAKT ME875, MSM 6198959223, MSM 0021620812]; University of Alabama Mucosal HIV and Immunobiology Center [DK064400]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020136] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI028147, U19AI028147, U19AI067854, P01AI083027, U01AI028147, U01AI067854, R21AI078477, P01AI071739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047322, R24DK064400, R01DK054495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Services of the Veterans Administration; Ministry of Education, Youth and Sport, Czech Republic(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government); University of Alabama Mucosal HIV and Immunobiology Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK047322, AI028147, AI083027, RR-20136, T35 HL007473, AI078477, DK054495, AI067854, and AI071739, the Research Services of the Veterans Administration, Grants KONTAKT ME875, MSM 6198959223, and MSM 0021620812 from the Ministry of Education, Youth and Sport, Czech Republic, and a Pilot Project University of Alabama Mucosal HIV and Immunobiology Center Grant DK064400.	Astronomo RD, 2008, J VIROL, V82, P6359, DOI 10.1128/JVI.00293-08; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini O, 2005, LANCET INFECT DIS, V5, P726, DOI 10.1016/S1473-3099(05)70271-1; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Clevestig P, 2006, J GEN VIROL, V87, P607, DOI 10.1099/vir.0.81510-0; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Go EP, 2008, J PROTEOME RES, V7, P1660, DOI 10.1021/pr7006957; Gomes MM, 2008, BIOCHEMISTRY-US, V47, P11285, DOI 10.1021/bi801185b; Gray ES, 2007, J VIROL, V81, P10769, DOI 10.1128/JVI.01106-07; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grundner C, 2002, J VIROL, V76, P3511, DOI 10.1128/JVI.76.7.3511-3521.2002; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; HANSEN JES, 1991, J VIROL, V65, P6461, DOI 10.1128/JVI.65.12.6461-6467.1991; Hansen JES, 1996, ARCH VIROL, V141, P291, DOI 10.1007/BF01718400; HANSEN JES, 1990, J VIROL, V64, P2833, DOI 10.1128/JVI.64.6.2833-2840.1990; HANSEN JES, 1992, APMIS, V100, P96; Hinkula J, 2007, EXPERT REV VACCINES, V6, P203, DOI 10.1586/14760584.6.2.203; Ho YS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-14; Huang XL, 1997, BIOCHEMISTRY-US, V36, P10846, DOI 10.1021/bi9703655; Irungu J, 2008, J AM SOC MASS SPECTR, V19, P1209, DOI 10.1016/j.jasms.2008.05.010; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Klein A, 2008, ADV CLIN CHEM, V46, P51, DOI 10.1016/S0065-2423(08)00402-2; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Letvin NL, 2007, J VIROL, V81, P12368, DOI 10.1128/JVI.00822-07; Li HL, 2008, J IMMUNOL, V180, P4011, DOI 10.4049/jimmunol.180.6.4011; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; Lin G, 2007, CURR HIV RES, V5, P514, DOI 10.2174/157016207782418489; Liu JY, 2007, VACCINE, V25, P2951, DOI 10.1016/j.vaccine.2006.05.081; Lu S, 2008, HUM VACCINES, V4, P449, DOI 10.4161/hv.4.6.6179; Lu S, 2006, SPRINGER SEMIN IMMUN, V28, P255, DOI 10.1007/s00281-006-0028-1; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; MIZUOCHI T, 1988, BIOCHEM J, V254, P599, DOI 10.1042/bj2540599; Mizuochi T, 1988, Biomed Chromatogr, V2, P260; MONTEFIORI DC, 1988, P NATL ACAD SCI USA, V85, P9248, DOI 10.1073/pnas.85.23.9248; Moore JS, 2005, AIDS, V19, P381, DOI 10.1097/01.aids.0000161767.21405.68; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pantophlet R, 2009, J VIROL, V83, P1649, DOI 10.1128/JVI.02046-08; Pinter A, 2005, J VIROL, V79, P6909, DOI 10.1128/JVI.79.11.6909-6917.2005; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Polzer S, 2002, VIROLOGY, V304, P70, DOI 10.1006/viro.2002.1760; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P110, DOI 10.1371/journal.pcbi.0030011; Raska M, 2008, VACCINE, V26, P1541, DOI 10.1016/j.vaccine.2008.01.035; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Reitter JN, 1998, J VIROL, V72, P5399, DOI 10.1128/JVI.72.7.5399-5407.1998; REITZ MS, 1994, AIDS RES HUM RETROV, V10, P1143, DOI 10.1089/aid.1994.10.1143; Renfrow MB, 2007, ANAL BIOANAL CHEM, V389, P1397, DOI 10.1007/s00216-007-1500-z; Renfrow MB, 2005, J BIOL CHEM, V280, P19136, DOI 10.1074/jbc.M411368200; Robinson HL, 2007, CLIN PHARMACOL THER, V82, P686, DOI 10.1038/sj.clpt.6100408; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Sailaja G, 2007, VIROLOGY, V362, P331, DOI 10.1016/j.virol.2006.12.014; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2003, ADV EXP MED BIOL, V535, P205; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Smith O, 1997, NAT MED, V3, P372, DOI 10.1038/nm0497-372b; Smith PD, 2003, J LEUKOCYTE BIOL, V74, P642, DOI 10.1189/jlb.0503219; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wain LV, 2007, MOL BIOL EVOL, V24, P1853, DOI 10.1093/molbev/msm110; WAINBERG MA, 1988, CAN MED ASSOC J, V138, P797; Wang S, 2008, VACCINE, V26, P1098, DOI 10.1016/j.vaccine.2007.12.024; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wolk T, 2006, MED MICROBIOL IMMUN, V195, P165, DOI 10.1007/s00430-006-0016-z; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	77	117	143	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20860	20869		10.1074/jbc.M109.085472	http://dx.doi.org/10.1074/jbc.M109.085472			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439465	Green Published, hybrid			2022-12-25	WOS:000279228600050
J	Ogba, N; Doughman, YQ; Chaplin, LJ; Hu, Y; Gargesha, M; Watanabe, M; Montano, MM				Ogba, N.; Doughman, Y. Q.; Chaplin, L. J.; Hu, Y.; Gargesha, M.; Watanabe, M.; Montano, M. M.			HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland	ONCOGENE			English	Article						HEXIM1; VEGF; HIF-1 alpha; P-TEFb; angiogenesis; mammary tumors	ESTROGEN-RECEPTOR-ALPHA; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CANCER CELLS; GENE-EXPRESSION; DOWN-REGULATION; RAT UTERUS; IN-VIVO; VEGF; ESTRADIOL; TRANSCRIPTION	Recently, we found that mutation of the C-terminus of transcription factor hexamethylene bisacetamide-inducible protein 1 (HEXIM1) in mice leads to abnormalities in cardiovascular development because of aberrant vascular endothelial growth factor ( VEGF) expression. HEXIM1 regulation of some genes has also been shown to be positive transcription elongation factor b ( P-TEFb) dependent. However, it is not known whether HEXIM1 regulates VEGF in the mammary gland. We demonstrate that HEXIM1 regulates estrogen-induced VEGF transcription through inhibition of estrogen receptor-alpha recruitment to the VEGF promoter in a P-TEFb-independent manner in MCF-7 cells. Under hypoxic conditions, HEXIM1 inhibits estrogen-induced hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein expression and recruitment of HIF-1 alpha to the hypoxia-response element in the VEGF promoter. In the mouse mammary gland, increased HEXIM1 expression decreased estrogen-driven VEGF and HIF-1 alpha expression. Conversely, a mutation in the C-terminus of HEXIM1 ( HEXIM1(1- 312)) led to increased VEGF and HIF-1 alpha expression and vascularization in mammary glands of heterozygous HEXIM1(1-312) mice when compared with their wild-type littermates. In addition, HEXIM1(1-312) mice have a higher incidence of carcinogen-induced mammary tumors with increased vascularization, suggesting an inhibitory role for HEXIM1 during angiogenesis. Taken together, our data provide evidence to suggest a novel role for HEXIM1 in cancer progression. Oncogene ( 2010) 29, 3639-3649; doi: 10.1038/onc.2010.110; published online 10 May 2010	[Ogba, N.; Chaplin, L. J.; Hu, Y.; Montano, M. M.] Rainbow Babies & Childrens Hosp, Dept Pharmacol, Cleveland, OH 44106 USA; [Doughman, Y. Q.; Watanabe, M.] Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Gargesha, M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University	Montano, MM (corresponding author), Case Western Reserve Univ, Dept Pharmacol, HG Wood Bldg W305,2109 Adelbert Rd, Cleveland, OH 44106 USA.	mxm126@case.edu	Ogba, Ndiya/K-8429-2014	Ogba, Ndiya/0000-0003-0453-3763	National Institute of Health [CA92440]; American Heart Association; Department of Defense [W81XWH-06-1-0426]; NATIONAL CANCER INSTITUTE [R01CA092440] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Anthony J Berdis and Jay Prendergast for reagents and their help with kinase and ELISA assays. This work was supported by the National Institute of Health Grant CA92440 and the American Heart Association Grant to MMM and a Department of Defense predoctoral Fellowship W81XWH-06-1-0426 to NO.	Bogin L, 2002, CANCER RES, V62, P1948; Bos R, 2004, BREAST CANCER RES, V6, pR450, DOI 10.1186/bcr813; Buteau-Lozano H, 2002, CANCER RES, V62, P4977; Cho JY, 2005, MOL ENDOCRINOL, V19, P1191, DOI 10.1210/me.2004-0162; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Garvin S, 2005, BRIT J CANCER, V93, P1005, DOI 10.1038/sj.bjc.6602824; Higgins KJ, 2006, ENDOCRINOLOGY, V147, P3285, DOI 10.1210/EN.2006-0081; Hyder SM, 2006, ENDOCR-RELAT CANCER, V13, P667, DOI 10.1677/erc.1.00931; Kawai H, 2002, ONCOGENE, V21, P7730, DOI 10.1038/sj.onc.1205971; Kazi AA, 2005, MOL ENDOCRINOL, V19, P2006, DOI 10.1210/me.2004-0388; Kazi AA, 2007, ENDOCRINOLOGY, V148, P2363, DOI 10.1210/en.2006-1394; Kazi AA, 2009, BIOL REPROD, V81, P378, DOI 10.1095/biolreprod.109.076117; Kimbro KS, 2006, ENDOCR-RELAT CANCER, V13, P739, DOI 10.1677/erc.1.00728; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; LI BL, 1995, MOL CARCINOGEN, V14, P75, DOI 10.1002/mc.2940140203; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Lydon JP, 1999, CANCER RES, V59, P4276; Maity A, 2001, BREAST CANCER RES TR, V67, P51, DOI 10.1023/A:1010662905549; Molitoris KH, 2009, ENDOCRINOLOGY, V150, P5405, DOI 10.1210/en.2009-0884; Montano MM, 2008, CIRC RES, V102, P415, DOI 10.1161/CIRCRESAHA.107.157859; Ogba N, 2008, CANCER RES, V68, P7015, DOI 10.1158/0008-5472.CAN-08-0814; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Rossiter H, 2007, FASEB J, V21, P3994, DOI 10.1096/fj.07-8720com; Rugo HS, 2004, ONCOLOGIST, V9, P43, DOI 10.1634/theoncologist.9-suppl_1-43; Seifeddine R, 2007, J STEROID BIOCHEM, V104, P169, DOI 10.1016/j.jsbmb.2007.03.025; Shimizu N, 2005, P NATL ACAD SCI USA, V102, P8555, DOI 10.1073/pnas.0409863102; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Stoner M, 2004, ONCOGENE, V23, P1052, DOI 10.1038/sj.onc.1207201; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Wittmann BM, 2003, CANCER RES, V63, P5151; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456	33	22	22	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2010	29	25					3639	3649		10.1038/onc.2010.110	http://dx.doi.org/10.1038/onc.2010.110			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	615CG	20453883	Green Accepted			2022-12-25	WOS:000279108600005
J	Greene, DM; Hsu, DW; Pears, CJ				Greene, David M.; Hsu, Duen-Wei; Pears, Catherine J.			Control of Cyclin C Levels during Development of Dictyostelium	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; RNA-POLYMERASE-II; HUMAN CDK8 SUBCOMPLEX; MEDIATOR COMPLEX; OXIDATIVE STRESS; EXPRESSION; DISCOIDEUM; SUBUNITS; PATHWAY; DIFFERENTIATION	Background: Cdk8 and its partner cyclin C form part of the mediator complex which links the basal transcription machinery to regulatory proteins. The pair are required for correct regulation of a subset of genes and have been implicated in control of development in a number of organisms including the social amoeba Dictyostelium discoideum. When feeding, Dictyostelium amoebae are unicellular but upon starvation they aggregate to form a multicellular structure which develops into a fruiting body containing spores. Cells in which the gene encoding Cdk8 has been deleted fail to enter aggregates due to a failure of early gene expression. Principal Findings: We have monitored the expression levels of cyclin C protein during development and find levels decrease after the multicellular mound is formed. This decrease is triggered by extracellular cAMP that, in turn, is working in part through an increase in intracellular cAMP. The loss of cyclin C is coincident with a reduction in the association of Cdk8 with a high molecular weight complex in the nucleus. Overexpression of cyclin C and Cdk8 lead to an increased rate of early development, consistent with the levels being rate limiting. Conclusions: Overall these results show that both cyclin C and Cdk8 are regulated during development in response to extracellular signals and the levels of these proteins are important in controlling the timing of developmental processes. These findings have important implications for the role of these proteins in controlling development, suggesting that they are targets for developmental signals to regulate gene expression.	[Greene, David M.; Hsu, Duen-Wei; Pears, Catherine J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Greene, DM (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	catherine.pears@bioch.ox.ac.uk		Pears, Catherine/0000-0003-1290-8326	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust [081548/Z/06/Z]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	D.G. was the recipient of a Biotechnology and Biological Sciences Research Council (BBSRC) studentship and the work was supported by The Wellcome Trust (Grant ref 081548/Z/06/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barette C, 2001, ONCOGENE, V20, P551, DOI 10.1038/sj.onc.1204129; Brabazon ED, 2002, BBA-GENE STRUCT EXPR, V1576, P203, DOI 10.1016/S0167-4781(02)00302-0; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Cooper KF, 1999, MOL CELL BIOL, V19, P3338; Cooper KF, 2002, EUKARYOT CELL, V1, P66, DOI 10.1128/EC.01.1.66-74.2002; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Hirst M, 1999, MOL CELL, V3, P673, DOI 10.1016/S1097-2765(00)80360-3; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HOPPER NA, 1993, EMBO J, V12, P2459, DOI 10.1002/j.1460-2075.1993.tb05900.x; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Katoch B, 2003, J BIOSCIENCES, V28, P581, DOI 10.1007/BF02703333; Katona RL, 2007, ACTA BIOL HUNG, V58, P133, DOI 10.1556/ABiol.58.2007.1.12; KAY RR, 1989, DEVELOPMENT, V105, P753; Knetsch MLW, 2002, J MUSCLE RES CELL M, V23, P605, DOI 10.1023/A:1024498805771; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Lin HHS, 2004, DEV BIOL, V271, P49, DOI 10.1016/j.ydbio.2004.03.020; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Meima ME, 2007, PROTEIN EXPRES PURIF, V53, P283, DOI 10.1016/j.pep.2007.01.001; Nelson C, 2003, NATURE, V421, P187, DOI 10.1038/nature01243; Oh C, 2006, ADV EXP MED BIOL, V583, P49; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Plyte SE, 1999, DEVELOPMENT, V126, P325; Strmecki L, 2005, DEV BIOL, V284, P25, DOI 10.1016/j.ydbio.2005.05.011; Strmecki L, 2007, EUKARYOT CELL, V6, P245, DOI 10.1128/EC.00204-06; Takeda K, 2002, DEV GROWTH DIFFER, V44, P213; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Treisman JE, 2001, DEVELOPMENT, V128, P603; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang WM, 2004, DEVELOPMENT, V131, P3147, DOI 10.1242/dev.01187; Yoda A, 2005, DEVELOPMENT, V132, P1885, DOI 10.1242/dev.01776	36	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10543	10.1371/journal.pone.0010543	http://dx.doi.org/10.1371/journal.pone.0010543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479885	gold, Green Submitted, Green Published			2022-12-25	WOS:000277467800024
J	Kuroshu, RM; Watanabe, J; Sugano, S; Morishita, S; Suzuki, Y; Kasahara, M				Kuroshu, Reginaldo M.; Watanabe, Junichi; Sugano, Sumio; Morishita, Shinichi; Suzuki, Yutaka; Kasahara, Masahiro			Cost-Effective Sequencing of Full-Length cDNA Clones Powered by a De Novo-Reference Hybrid Assembly	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; RNA-SEQ; TRANSCRIPTOME ANALYSIS; GENOME SEQUENCE; EVOLUTION; INSIGHTS; REVEALS; IDENTIFICATION; TECHNOLOGIES; REPERTOIRE	Background: Sequencing full-length cDNA clones is important to determine gene structures including alternative splice forms, and provides valuable resources for experimental analyses to reveal the biological functions of coded proteins. However, previous approaches for sequencing cDNA clones were expensive or time-consuming, and therefore, a fast and efficient sequencing approach was demanded. Methodology: We developed a program, MuSICA 2, that assembles millions of short (36-nucleotide) reads collected from a single flow cell lane of Illumina Genome Analyzer to shotgun-sequence,800 human full-length cDNA clones. MuSICA 2 performs a hybrid assembly in which an external de novo assembler is run first and the result is then improved by reference alignment of shotgun reads. We compared the MuSICA 2 assembly with 200 pooled full-length cDNA clones finished independently by the conventional primer-walking using Sanger sequencers. The exon-intron structure of the coding sequence was correct for more than 95% of the clones with coding sequence annotation when we excluded cDNA clones insufficiently represented in the shotgun library due to PCR failure (42 out of 200 clones excluded), and the nucleotide-level accuracy of coding sequences of those correct clones was over 99.99%. We also applied MuSICA 2 to full-length cDNA clones from Toxoplasma gondii, to confirm that its ability was competent even for non-human species. Conclusions: The entire sequencing and shotgun assembly takes less than 1 week and the consumables cost only, similar to US$3 per clone, demonstrating a significant advantage over previous approaches.	[Kuroshu, Reginaldo M.; Morishita, Shinichi; Kasahara, Masahiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba, Japan; [Watanabe, Junichi; Sugano, Sumio; Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Morishita, Shinichi] Japan Sci & Technol Agcy, Bioinformat Res & Dev BIRD, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Kuroshu, RM (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba, Japan.	ysuzuki@k.u-tokyo.ac.jp; mkasa@cb.k.u-tokyo.ac.jp		Kasahara, Masahiro/0000-0001-8430-1414; Morishita, Shinichi/0000-0002-6201-8885	Ministry of Education, Culture, Sports, Science and Technology of Japan; Bioinformatics Research and Development (BIRD); Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bioinformatics Research and Development (BIRD); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas "Systems Genomics'' and "Comparative Genomics'' from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Bioinformatics Research and Development (BIRD), Japan Science and Technology Agency (JST). Computation time was provided in part by T2K Open Supercomputer (Todai Combined Cluster), Information Technology Center, The University of Tokyo and by the Super Computer System, Human Genome Center, Institute of Medical	Andersson B, 1997, DNA SEQUENCE, V7, P63, DOI 10.3109/10425179709020153; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Carninci P, 2009, NAT METHODS, V6, P711, DOI 10.1038/nmeth1009-711; CLOONAN N, 2008, NAT METHODS; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; DJEBALI S, 2008, NAT METHODS; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Forrest ARR, 2009, RNA BIOL, V6, P107, DOI 10.4161/rna.6.2.7931; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Salehi-Ashtiani K, 2008, NAT METHODS, V5, P597, DOI 10.1038/nmeth.1224; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yu W, 1997, GENOME RES, V7, P353, DOI 10.1101/gr.7.4.353; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	51	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2010	5	5							e10517	10.1371/journal.pone.0010517	http://dx.doi.org/10.1371/journal.pone.0010517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	593OI	20479877	Green Published, gold, Green Submitted			2022-12-25	WOS:000277467800006
J	Letzen, BS; Liu, C; Thakor, NV; Gearhart, JD; All, AH; Kerr, CL				Letzen, Brian S.; Liu, Cyndi; Thakor, Nitish V.; Gearhart, John D.; All, Angelo H.; Kerr, Candace L.			MicroRNA Expression Profiling of Oligodendrocyte Differentiation from Human Embryonic Stem Cells	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; CNS; NEUROBLASTOMA; PRECURSORS; MYELINATE; NETWORKS; PATTERNS; RECOVERY; BIOLOGY	Background: Cells of the oligodendrocyte (OL) lineage play a vital role in the production and maintenance of myelin, a multilamellar membrane which allows for saltatory conduction along axons. These cells may provide immense therapeutic potential for lost sensory and motor function in demyelinating conditions, such as spinal cord injury, multiple sclerosis, and transverse myelitis. However, the molecular mechanisms controlling OL differentiation are largely unknown. MicroRNAs (miRNAs) are considered the "micromanagers'' of gene expression with suggestive roles in cellular differentiation and maintenance. Although unique patterns of miRNA expression in various cell lineages have been characterized, this is the first report documenting their expression during oligodendrocyte maturation from human embryonic stem (hES) cells. Here, we performed a global miRNA analysis to reveal and identify characteristic patterns in the multiple stages leading to OL maturation from hES cells including those targeting factors involved in myelin production. Methodology/Principal Findings: We isolated cells from 8 stages of OL differentiation. Total RNA was subjected to miRNA profiling and validations preformed using real-time qRT-PCR. A comparison of miRNAs from our cultured OLs and OL progenitors showed significant similarities with published results from equivalent cells found in the rat and mouse central nervous system. Principal component analysis revealed four main clusters of miRNA expression corresponding to early, mid, and late progenitors, and mature OLs. These results were supported by correlation analyses between adjacent stages. Interestingly, the highest differentially-expressed miRNAs demonstrated a similar pattern of expression throughout all stages of differentiation, suggesting that they potentially regulate a common target or set of targets in this process. The predicted targets of these miRNAs include those with known or suspected roles in oligodendrocyte development and myelination including C11Orf9, CLDN11, MYTL1, MBOP, MPZL2, and DDR1. Conclusions/Significance: We demonstrate miRNA profiles during distinct stages in oligodendroglial differentiation that may provide key markers of OL maturation. Our results reveal pronounced trends in miRNA expression and their potential mRNA target interactions that could provide valuable insight into the molecular mechanisms of differentiation.	[Letzen, Brian S.; Thakor, Nitish V.; All, Angelo H.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Gearhart, John D.] Univ Penn, Dept Cell & Dev Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Gearhart, John D.] Univ Penn, Dept Anim Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA; [All, Angelo H.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; [Kerr, Candace L.] Johns Hopkins Univ, Dept Gynecol & Obstet, Inst Cell Engn, Baltimore, MD 21205 USA; [Liu, Cyndi; Kerr, Candace L.] Johns Hopkins Univ, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21205 USA	Johns Hopkins University; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Letzen, BS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	ckerr@jhmi.edu	Thakor, Nitish V/A-5878-2008; Thakor, Nitish/G-9110-2015	Thakor, Nitish/0000-0002-9981-9395	Maryland Stem Cell Research Fund [2008-MSCRFE-0129-00, 2009-MSCRFII-0091-00]	Maryland Stem Cell Research Fund	This work was funded by the Maryland Stem Cell Research Fund (http://www.mscrf.org) Tedco #2008-MSCRFE-0129-00 (Kerr) and 2009-MSCRFII-0091-00 (All). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsky K, 2003, J CELL SCI, V116, P1279, DOI 10.1242/jcs.00302; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Franco-Pons N, 2009, J MOL NEUROSCI, V38, P2, DOI 10.1007/s12031-008-9151-x; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Jakovcevski I, 2005, J NEUROSCI, V25, P10064, DOI 10.1523/JNEUROSCI.2324-05.2005; Jakovcevski I, 2005, GLIA, V49, P480, DOI 10.1002/glia.20134; KAWASEKOGA Y, 2009, DIFFERENT TIMINGS DI; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; KERR C, 2010, INT J NEUROSCIENCE; Kerr DA, 2003, J NEUROSCI, V23, P5131; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; LEHOTZKY A, 2009, GLIA; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; LOAYZAPUCH F, ONCOGENE; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Magnus T, 2005, J CELL MOL MED, V9, P303, DOI 10.1111/j.1582-4934.2005.tb00357.x; MALZKORN B, 2009, BRAIN PATHOLOGY, V9999; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Miller RH, 1996, TRENDS NEUROSCI, V19, P92, DOI 10.1016/S0166-2236(96)80036-1; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; SHI L, 2009, BRAIN RES; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; SHIN D, 2009, ANN NEUROLOGY, V9999; SKALSKY R, BMC GENOMICS, V11, P119; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Tan KB, 2006, J NEURO-ONCOL, V80, P235, DOI 10.1007/s11060-006-9184-3; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Tsai ZY, 2010, J CELL BIOCHEM, V109, P93, DOI 10.1002/jcb.22385; Van Landeghem FKH, 2002, PEDIATR RES, V51, P129, DOI 10.1203/00006450-200202000-00003; VOORHOEVE P, ADV MOL ONCOLOGY, P17; Wingerchuk DM, 2001, LAB INVEST, V81, P263, DOI 10.1038/labinvest.3780235; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yoshikawa Hiroo, 2001, Medical Electron Microscopy, V34, P160, DOI 10.1007/s007950100009; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2000, J NEUROSCI RES, V59, P421, DOI 10.1002/(SICI)1097-4547(20000201)59:3<421::AID-JNR17>3.3.CO;2-3; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; ZHI F, EUROPEAN J CANC	60	79	92	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10480	10.1371/journal.pone.0010480	http://dx.doi.org/10.1371/journal.pone.0010480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463920	Green Published, Green Submitted, gold			2022-12-25	WOS:000277379400016
J	Steitz, J; Barlow, PG; Hossain, J; Kim, E; Okada, K; Kenniston, T; Rea, S; Donis, RO; Gambotto, A				Steitz, Julia; Barlow, Peter G.; Hossain, Jaber; Kim, Eun; Okada, Kaori; Kenniston, Tom; Rea, Sheri; Donis, Ruben O.; Gambotto, Andrea			A Candidate H1N1 Pandemic Influenza Vaccine Elicits Protective Immunity in Mice	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES; CODON OPTIMIZATION; REVERSE GENETICS; HUMAN ADENOVIRUS; DNA VACCINATION; RHESUS-MONKEYS; VIRUS; VECTORS; HUMANS; IMMUNIZATION	Background: In 2009 a new pandemic disease appeared and spread globally. The recent emergence of the pandemic influenza virus H1N1 first isolated in Mexico and USA raised concerns about vaccine availability. We here report our development of an adenovirus-based influenza H1N1 vaccine tested for immunogenicity and efficacy to confer protection in animal model. Methods: We generated two adenovirus(Ad5)-based influenza vaccine candidates encoding the wildtype or a codon-optimized hemagglutinin antigen (HA) from the recently emerged swine influenza isolate A/California/04/2009 (H1N1)pdm. After verification of antigen expression, immunogenicity of the vaccine candidates were tested in a mouse model using dose escalations for subcutaneous immunization. Sera of immunized animals were tested in microneutalization and hemagglutination inhibition assays for the presence of HA-specific antibodies. HA-specific T-cells were measured in IFN gamma Elispot assays. The efficiency of the influenza vaccine candidates were evaluated in a challenge model by measuring viral titer in lung and nasal turbinate 3 days after inoculation of a homologous H1N1 virus. Conclusions/Significance: A single immunization resulted in robust cellular and humoral immune response. Remarkably, the intensity of the immune response was substantially enhanced with codon-optimized antigen, indicating the benefit of manipulating the genetic code of HA antigens in the context of recombinant influenza vaccine design. These results highlight the value of advanced technologies in vaccine development and deployment in response to infections with pandemic potential. Our study emphasizes the potential of an adenoviral-based influenza vaccine platform with the benefits of speed of manufacture and efficacy of a single dose immunization.	[Steitz, Julia; Kim, Eun; Okada, Kaori; Kenniston, Tom; Rea, Sheri; Gambotto, Andrea] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Gambotto, Andrea] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA USA; [Barlow, Peter G.; Hossain, Jaber; Donis, Ruben O.] Ctr Dis Control & Prevent, Mol Virol & Vaccines Branch, Influenza Div, Natl Ctr Infect Dis, Atlanta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA	Steitz, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA.	gambottoa@upmc.edu	Barlow, Peter/O-4078-2019	Barlow, Peter/0000-0002-6516-9312; Molodiuc, Veaceslav/0000-0002-3014-4203	National Institutes of Health (NIH) [5R01AI069282-02]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069282] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant 5R01AI069282-02 (A. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Barouch DH, 2001, J VIROL, V75, P2462, DOI 10.1128/JVI.75.5.2462-2467.2001; Butler D, 2009, NATURE, V458, P1082, DOI 10.1038/4581082a; Chen JD, 1996, HUM GENE THER, V7, P1515, DOI 10.1089/hum.1996.7.13-1515; Cohen J, 2009, SCIENCE, V324, P572, DOI 10.1126/science.324_572; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DiNapoli JM, 2007, J VIROL, V81, P11560, DOI 10.1128/JVI.00713-07; Farina SF, 2001, J VIROL, V75, P11603, DOI 10.1128/JVI.75.23.11603-11613.2001; Gao W, 2003, GENE THER, V10, P1941, DOI 10.1038/sj.gt.3302097; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Gao WT, 2004, BIOTECHNOL PROGR, V20, P443, DOI 10.1021/bp0300467; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GREENBERG ME, 2009, N ENGL J MED; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Lipatov AS, 2005, J INFECT DIS, V191, P1216, DOI 10.1086/428951; Mayrhofer J, 2009, J VIROL, V83, P5192, DOI 10.1128/JVI.02081-08; Mossadegh N, 2004, VIROLOGY, V326, P57, DOI 10.1016/j.virol.2004.04.050; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Ozawa M, 2007, J VIROL, V81, P9556, DOI 10.1128/JVI.01042-07; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Ramakrishna L, 2004, VACCINE, V22, P2586, DOI 10.1016/j.vaccine.2003.12.007; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Schwartz JA, 2007, VIROLOGY, V366, P166, DOI 10.1016/j.virol.2007.04.021; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Singh N, 2008, MOL THER, V16, P965, DOI 10.1038/mt.2008.12; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Ternette N, 2007, VACCINE, V25, P7271, DOI 10.1016/j.vaccine.2007.07.025; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043	34	28	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10492	10.1371/journal.pone.0010492	http://dx.doi.org/10.1371/journal.pone.0010492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463955	Green Published, gold, Green Accepted			2022-12-25	WOS:000277379400026
J	Vila, B; Jackson, FD; Fortuny, J; Selles, AG; Galobart, A				Vila, Bernat; Jackson, Frankie D.; Fortuny, Josep; Selles, Albert G.; Galobart, Angel			3-D Modelling of Megaloolithid Clutches: Insights about Nest Construction and Dinosaur Behaviour	PLOS ONE			English	Article							SOUTHERN PYRENEES; EGGS; EGGSHELLS; CONDUCTANCE; ARGENTINA; BASIN	Background: Megaloolithid eggs have long been associated with sauropod dinosaurs. Despite their extensive and worldwide fossil record, interpretations of egg size and shape, clutch morphology, and incubation strategy vary. The Pinyes locality in the Upper Cretaceous Tremp Formation in the southern Pyrenees, Catalonia provides new information for addressing these issues. Nine horizons containing Megaloolithus siruguei clutches are exposed near the village of Coll de Nargo. Tectonic deformation in the study area strongly influenced egg size and shape, which could potentially lead to misinterpretation of reproductive biology if 2D and 3D maps are not corrected for bed dip that results from tectonism. Methodology/Findings: Detailed taphonomic study and three-dimensional modelling of fossil eggs show that intact M. siruguei clutches contained 20-28 eggs, which is substantially larger than commonly reported from Europe and India. Linear and grouped eggs occur in three superimposed levels and form an asymmetric, elongate, bowl-shaped profile in lateral view. Computed tomography data support previous interpretations that the eggs hatched within the substrate. Megaloolithid clutch sizes reported from other European and Indian localities are typically less than 15 eggs; however, these clutches often include linear or grouped eggs that resemble those of the larger Pinyes clutches and may reflect preservation of incomplete clutches. Conclusions/Significance: We propose that 25 eggs represent a typical megaloolithid clutch size and smaller egg clusters that display linear or grouped egg arrangements reported at Pinyes and other localities may represent eroded remnants of larger clutches. The similarity of megaloolithid clutch morphology from localities worldwide strongly suggests common reproductive behaviour. The distinct clutch geometry at Pinyes and other localities likely resulted from the asymmetrical, inclined, and laterally compressed titanosaur pes unguals of the female, using the hind foot for scratch-digging during nest excavation.	[Vila, Bernat; Fortuny, Josep; Selles, Albert G.; Galobart, Angel] Campus Univ Autonoma Barcelona, Inst Catala Paleontol, Barcelona, Spain; [Jackson, Frankie D.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Montana State University System; Montana State University Bozeman	Vila, B (corresponding author), Campus Univ Autonoma Barcelona, Inst Catala Paleontol, Barcelona, Spain.	bernat.vila@icp.cat	Selles, Albert G./ACZ-6076-2022; Galobart, Àngel À/H-5024-2011; Fortuny, Josep/L-2523-2014; VILA, BERNAT/AAA-7367-2021	Selles, Albert G./0000-0002-4637-6084; Galobart, Àngel À/0000-0003-1508-4561; Fortuny, Josep/0000-0003-4282-1619; VILA, BERNAT/0000-0002-5935-1732	Ministerio de Ciencia e Innovacion [CGL2008-06533-C03-01]; Departament de Cultura de la Generalitat de Catalunya; Jurassic Foundation; College of Letters and Sciences, Montana State University-Bozeman	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Departament de Cultura de la Generalitat de Catalunya; Jurassic Foundation; College of Letters and Sciences, Montana State University-Bozeman	This research was financially supported by the following organizations: Ministerio de Ciencia e Innovacion (CGL2008-06533-C03-01), Departament de Cultura de la Generalitat de Catalunya, Jurassic Foundation and the College of Letters and Sciences, Montana State University-Bozeman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardevol L, 2000, AAPG BULL, V84, P566; BEETSCHEN JC, 1985, ACT C DIN CHIN FRANC, P113; Bonnan MF, 2005, LIFE O PAST, P346; BORSUKBIALYNICK.M, 1977, PALAEONTOLOGICA POLO, V37, P45; Bravo A.M., 2005, REV ESPANOLA PALEONT, V10, P49; Bravo AM, 2000, 1 INT S DIN EGGS BAB, P15; Bravo Ana Maria, 2003, Palaeovertebrata (Montpellier), V32, P77; BRETON G, 1986, ANN MUS HAVRE, V32, P1; CAMARA P., 1985, ESTUDIOS GEOLGICOS, V41, P391, DOI DOI 10.3989/EGEOL.85415-6720; Carpenter K., 1999, EGGS NESTS BABY DINO; Chiappe L.M., 2000, 1 INT S DIN EGGS BAB, P23; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Chiappe LM, 2004, PALAIOS, V19, P89, DOI 10.1669/0883-1351(2004)019<0089:NSFSSC>2.0.CO;2; Chiappe LM, 2001, SCIENCE, V293, P2444, DOI 10.1126/science.1063723; Chiappe LM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P285; Codrea V, 2002, CR PALEVOL, V1, P173, DOI 10.1016/S1631-0683(02)00021-0; Cousin R., 1989, Historical Biology, V2, P157; Cousin R, 2000, 1 INT S DIN EGGS BAB, P31; Cousin Remi, 1994, P56; Cousin Remi, 2004, Bulletin Trimestriel de la Societe Geologique de Normandie et des Amis du Museum du Havre, V89, P1; Deeming DC, 2006, PALAEONTOLOGY, V49, P171, DOI 10.1111/j.1475-4983.2005.00536.x; DUGHI R, 1966, CR ACAD SCI D NAT, V262, P2330; DUGHI R, 1958, CR HEBD ACAD SCI, V246, P2271; Elez J., 2000, 1 INT S DIN EGGS BAB, P43; ERBEN HK, 1979, PALEOBIOLOGY, V5, P380, DOI 10.1017/S0094837300016900; Faccio Guillermo, 1994, P47; Feist M., 1983, GEOLOGIE MEDITERRANE, V10, P303, DOI 10.3406/geolm.1983.1273; Fortuny J., 2007, CANTERA PALEONTOLOGI, P181; FOWLER D, MUSEUM ROCKIES OCCAS, V4, P18; FREYTET P, 1965, B SOC ETUDES SCI AUD, V65, P121; GALLUP MR, 1989, GEOL S AM S, V238, P71; Garcia G, 2001, CR ACAD SCI II A, V332, P185, DOI 10.1016/S1251-8050(00)91401-0; Garcia G, 1998, THESIS U MONTPELLIER; Garcia Geraldine, 2003, Palaeovertebrata (Montpellier), V32, P109; Gonzalez-Manteiga W, 2008, TEST-SPAIN, V17, P40, DOI 10.1007/s11749-008-0105-y; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; GRIGORESCU D, 2006, AMEGHINIANA, V43, pR18; Grigorescu Dan, 1994, P75; Hayward J.L., 1989, Journal of Vertebrate Paleontology, V9, P196; HAYWARD JL, HIST BIOL IN PRESS; Horner JR, 2000, ANNU REV EARTH PL SC, V28, P19, DOI 10.1146/annurev.earth.28.1.19; Jackson F.D., 2007, THESIS MONTANA STATE; Jackson FD, 2008, PALEOBIOLOGY, V34, P229, DOI 10.1666/0094-8373(2008)034[0229:COWVCI]2.0.CO;2; KEROURIO P, 1981, COMPTE RENDU SOMMAIR, V1, P25; Lopez-Martinez N, 2000, PALAEOGEOGR PALAEOCL, V160, P153, DOI 10.1016/S0031-0182(00)00063-8; LOPEZMARTINEZ N, 1999, 1 INT S DIN EGGS BAB, P12; Manera de Bianco T, 1996, ASOCIACION PALEONTOL, V4, P59; Martinez RD, 2004, J VERTEBR PALEONTOL, V24, P107, DOI 10.1671/9.1; Mey P.H.W., 1968, LEIDSE GEOL MEDED, V41, P221; Mikhailov K.E., 1997, SPEC PAP PALAEONTOL, V56, P1; Mohabey DM, 2005, LIFE O PAST, P466; Mohabey DM, 1996, CRETACEOUS RES, V17, P183, DOI 10.1006/cres.1996.0014; MOHABEY DM, 1984, J GEOL SOC INDIA, V25, P329; MOHABEY DM, 2000, 1 INT S DIN EGGS BAB, P139; Mohabey DM, 1990, CRETACEOUS EVENT STR; MOLINA MD, 1987, SEDIMENTACION SINTEC, P69; Moratalla J.J., 1994, P37; Mueller-Towe IJ, 2002, PALAEONTOGR ABT A, V267, P119; MUNOZ JA, 1992, THRUST TECTONICS, P235; PEITZ C, 2000, THESIS RF WILHELMS U; Powell Jaime Eduardo, 1992, Acta Zoologica Lilloana, V41, P381; POWELL JE, 1996, AMEHINIANA, V33, P470; PUIGDEFABREGAS C, 1986, TECTONOPHYSICS, V129, P173, DOI 10.1016/0040-1951(86)90251-9; Riera V, 2009, PALAEOGEOGR PALAEOCL, V283, P160, DOI 10.1016/j.palaeo.2009.09.018; Rosell J., 2001, REV SOC GEOLOGICA ES, V14, P47; Sahni A, 2003, CURR SCI INDIA, V85, P904; Sahni Ashok, 1994, P204; Salgado L, 2009, AMEGHINIANA, V46, P605; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander PM, 1998, CR ACAD SCI II A, V327, P67, DOI 10.1016/S1251-8050(98)80020-7; SANZ JL, 1995, NATURE, V376, P731, DOI 10.1038/376731a0; SEYMOUR RS, 1980, AM ZOOL, V20, P437; SEYMOUR RS, 1979, PALEOBIOLOGY, V5, P1; Soja Constance M., 2008, American Paleontologist, V16, P21; SRIVASTAVA S, 1986, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V193, P219; Varricchio DJ, 1999, J VERTEBR PALEONTOL, V19, P91, DOI 10.1080/02724634.1999.10011125; Vianey-Liaud M., 2000, 1 INT S DIN EGGS BAB, P165; Vianey-Liaud Monique, 1994, P151; VianeyLiaud M, 1997, J PALEONTOL, V71, P1157, DOI 10.1017/S002233600003609X; Vila B, 2006, ACT 3 JORN INT PAL D, P365; Vila B, 2010, AMEGHINIANA, V47, P79, DOI 10.5710/AMGH.v47i1.3; Vila B, 2010, LETHAIA, V43, P197, DOI 10.1111/j.1502-3931.2009.00183.x; WILLIAMS DLG, 1984, PALAEOGEOGR PALAEOCL, V45, P23, DOI 10.1016/0031-0182(84)90107-X	83	32	33	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10362	10.1371/journal.pone.0010362	http://dx.doi.org/10.1371/journal.pone.0010362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463953	Green Published, gold, Green Submitted			2022-12-25	WOS:000277379400002
J	Aspord, C; Charles, J; Leccia, MT; Laurin, D; Richard, MJ; Chaperot, L; Plumas, J				Aspord, Caroline; Charles, Julie; Leccia, Marie-Therese; Laurin, David; Richard, Marie-Jeanne; Chaperot, Laurence; Plumas, Joel			A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							CD8(+) T-CELLS; INTERFERON-PRODUCING CELLS; INFLUENZA-VIRUS; IN-VITRO; THERAPEUTIC VACCINES; METASTATIC MELANOMA; ANTITUMOR IMMUNITY; TUMOR; ANTIGEN; RESPONSES	Background: The development of effective cancer vaccines still remains a challenge. Despite the crucial role of plasmacytoid dendritic cells (pDCs) in anti-tumor responses, their therapeutic potential has not yet been worked out. We explored the relevance of HLA-A*0201 matched allogeneic pDCs as vectors for immunotherapy. Methods and Findings: Stimulation of PBMC from HLA-A*0201(+) donors by HLA-A*0201 matched allogeneic pDCs pulsed with tumor-derived peptides triggered high levels of antigen-specific and functional cytotoxic T cell responses (up to 98% tetramer(+) CD8 T cells). The pDC vaccine demonstrated strong anti-tumor therapeutic in vivo efficacy as shown by the inhibition of tumor growth in a humanized mouse model. It also elicited highly functional tumor-specific T cells ex-vivo from PBMC and TIL of stage I-IV melanoma patients. Responses against MelA, GP100, tyrosinase and MAGE-3 antigens reached tetramer levels up to 62%, 24%, 85% and 4.3% respectively. pDC vaccine-primed T cells specifically killed patients' own autologous melanoma tumor cells. This semi-allogeneic pDC vaccine was more effective than conventional myeloid DC-based vaccines. Furthermore, the pDC vaccine design endows it with a strong potential for clinical application in cancer treatment. Conclusions: These findings highlight HLA-A*0201 matched allogeneic pDCs as potent inducers of tumor immunity and provide a promising immunotherapeutic strategy to fight cancer.	[Aspord, Caroline; Charles, Julie; Laurin, David; Chaperot, Laurence; Plumas, Joel] Etab Francais Sang Rhone Alpes, R&D Lab, La Tronche, France; [Aspord, Caroline; Charles, Julie; Leccia, Marie-Therese; Laurin, David; Richard, Marie-Jeanne; Chaperot, Laurence; Plumas, Joel] Univ Grenoble 1, Grenoble, France; [Aspord, Caroline; Charles, Julie; Leccia, Marie-Therese; Laurin, David; Richard, Marie-Jeanne; Chaperot, Laurence; Plumas, Joel] INSERM, U823, La Tronche, France; [Charles, Julie; Leccia, Marie-Therese; Richard, Marie-Jeanne] CHU Grenoble, Michallon Hosp, F-38043 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Aspord, C (corresponding author), Etab Francais Sang Rhone Alpes, R&D Lab, La Tronche, France.	carolineaspord@yahoo.com; joel.plumas@wanadoo.fr	Laurin, David/M-7895-2014; Aspord, Caroline/N-3179-2013; chaperot, laurence/N-2927-2013; ASPORD, Caroline/AAU-1805-2020; charles, julie/E-8929-2013; Plumas, Joel/N-2516-2013	Laurin, David/0000-0001-9339-8369; Aspord, Caroline/0000-0002-4979-7044; chaperot, laurence/0000-0002-1479-9410; charles, julie/0000-0003-4667-6009; Leccia, M.Therese/0000-0003-1222-0396	Institut National du Cancer [ACI-63-04, 2004-05]; Etablissement Francais du Sang; National Academy of Medicine [2004-05]	Institut National du Cancer(Institut National du Cancer (INCA) France); Etablissement Francais du Sang; National Academy of Medicine	This work was supported by grants from the Institut National du Cancer (ACI-63-04 and canceropole 2004-05) and Etablissement Francais du Sang. J. Charles was a recipient of grants from the National Academy of Medicine and canceropole 2004-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, AM J TRANSPLANT, V5, P1808, DOI 10.1111/j.1600-6143.2005.00954.x; Aspord C, 2007, EXPERT OPIN DRUG DIS, V2, P949, DOI 10.1517/17460441.2.7.949; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Blom B, 2000, J EXP MED, V192, P1785, DOI 10.1084/jem.192.12.1785; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Di Domizio J, 2009, BLOOD, V114, P1794, DOI 10.1182/blood-2009-04-216770; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Fabre JW, 2001, NAT MED, V7, P649, DOI 10.1038/89008; Fajardo-Moser M, 2008, INT J MED MICROBIOL, V298, P11, DOI 10.1016/j.ijmm.2007.07.003; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Furumoto K, 2004, J CLIN INVEST, V113, P774, DOI 10.1172/JCI200419762; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gjertsen H A, 1993, Transpl Immunol, V1, P126, DOI 10.1016/0966-3274(93)90005-S; Hartmann E, 2003, CANCER RES, V63, P6478; Holtl L, 2005, CANCER IMMUNOL IMMUN, V54, P663, DOI 10.1007/s00262-004-0629-2; Hus I, 2005, LEUKEMIA, V19, P1621, DOI 10.1038/sj.leu.2403860; Kim R, 2007, IMMUNOLOGY, V121, P149, DOI 10.1111/j.1365-2567.2007.02579.x; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Liu CW, 2008, J CLIN INVEST, V118, P1165, DOI 10.1172/JCI33583; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; LUI G, 2009, PLOS ONE IN PRESS; Lui G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007111; Maranon C, 2004, P NATL ACAD SCI USA, V101, P6092, DOI 10.1073/pnas.0304860101; Masterson AJ, 2002, BLOOD, V100, P701, DOI 10.1182/blood.V100.2.701; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; MITCHISON NA, 1987, EUR J IMMUNOL, V17, P1579, DOI 10.1002/eji.1830171109; Molenkamp BG, 2008, CLIN CANCER RES, V14, P4532, DOI 10.1158/1078-0432.CCR-07-4711; Molenkamp BG, 2007, CLIN CANCER RES, V13, P2961, DOI 10.1158/1078-0432.CCR-07-0050; Muir G, 2006, BJU INT, V98, P989, DOI 10.1111/j.1464-410X.2006.06421.x; Newton DA, 2000, J IMMUNOTHER, V23, P246, DOI 10.1097/00002371-200003000-00009; Palamara F, 2004, J IMMUNOL, V173, P3051, DOI 10.4049/jimmunol.173.5.3051; Palucka AK, 2005, J IMMUNOTHER, V28, P158, DOI 10.1097/01.cji.0000154249.74383.17; Perrot I, 2007, J IMMUNOL, V178, P2763, DOI 10.4049/jimmunol.178.5.2763; Rothenfusser S, 2004, BLOOD, V103, P2162, DOI 10.1182/blood-2003-04-1091; Salio M, 2003, EUR J IMMUNOL, V33, P1052, DOI 10.1002/eji.200323676; Santegoets SJAM, 2006, CANCER IMMUNOL IMMUN, V55, P1480, DOI 10.1007/s00262-006-0142-x; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Schettini J, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/106321; Schlecht G, 2004, BLOOD, V104, P1808, DOI 10.1182/blood-2004-02-0426; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Tamir A, 2007, CANCER IMMUNOL IMMUN, V56, P2003, DOI 10.1007/s00262-007-0299-y; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669; Trefzer U, 2004, INT J CANCER, V110, P730, DOI 10.1002/ijc.20191; Treilleux I, 2004, CLIN CANCER RES, V10, P7466, DOI 10.1158/1078-0432.CCR-04-0684; van den Hoorn T, 2008, NAT IMMUNOL, V9, P1208, DOI 10.1038/ni1108-1208; Vermi W, 2003, J PATHOL, V200, P255, DOI 10.1002/path.1344; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	55	37	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2010	5	5							e10458	10.1371/journal.pone.0010458	http://dx.doi.org/10.1371/journal.pone.0010458			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591MQ	20454561	Green Submitted, Green Published, gold			2022-12-25	WOS:000277305300007
J	Massignani, M; Canton, I; Sun, T; Hearnden, V; MacNeil, S; Blanazs, A; Armes, SP; Lewis, A; Battaglia, G				Massignani, Marzia; Canton, Irene; Sun, Tao; Hearnden, Vanessa; MacNeil, Sheila; Blanazs, Adam; Armes, Steven P.; Lewis, Andrew; Battaglia, Giuseppe			Enhanced Fluorescence Imaging of Live Cells by Effective Cytosolic Delivery of Probes	PLOS ONE			English	Article							POLYMER VESICLES; GENE-EXPRESSION; LIVING CELLS; MICROSCOPY; SKIN; COPOLYMERS; NANOSCOPY; PROGRESS	Background: Microscopic techniques enable real-space imaging of complex biological events and processes. They have become an essential tool to confirm and complement hypotheses made by biomedical scientists and also allow the re-examination of existing models, hence influencing future investigations. Particularly imaging live cells is crucial for an improved understanding of dynamic biological processes, however hitherto live cell imaging has been limited by the necessity to introduce probes within a cell without altering its physiological and structural integrity. We demonstrate herein that this hurdle can be overcome by effective cytosolic delivery. Principal Findings: We show the delivery within several types of mammalian cells using nanometre-sized biomimetic polymer vesicles (a.k.a. polymersomes) that offer both highly efficient cellular uptake and endolysomal escape capability without any effect on the cellular metabolic activity. Such biocompatible polymersomes can encapsulate various types of probes including cell membrane probes and nucleic acid probes as well as labelled nucleic acids, antibodies and quantum dots. Significance: We show the delivery of sufficient quantities of probes to the cytosol, allowing sustained functional imaging of live cells over time periods of days to weeks. Finally the combination of such effective staining with three-dimensional imaging by confocal laser scanning microscopy allows cell imaging in complex three-dimensional environments under both mono-culture and co-culture conditions. Thus cell migration and proliferation can be studied in models that are much closer to the in vivo situation.	[Massignani, Marzia; Canton, Irene; Hearnden, Vanessa; Battaglia, Giuseppe] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Massignani, Marzia; Sun, Tao; Hearnden, Vanessa; MacNeil, Sheila] Univ Sheffield, Dept Mat Engn, Sheffield S10 2TN, S Yorkshire, England; [Blanazs, Adam; Armes, Steven P.] Univ Sheffield, Dept Chem, Sheffield S10 2TN, S Yorkshire, England; [Hearnden, Vanessa] Univ Sheffield, Sch Clin Dent, Dept Oral & Maxillofacial Med & Surg, Sheffield S10 2TN, S Yorkshire, England; [Lewis, Andrew] Biocompatibles UK Ltd, Farnham, Surrey, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Biocompatibles International PLC	Massignani, M (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	g.battaglia@sheffield.ac.uk	Battaglia, Giuseppe/A-2253-2012; Battaglia, Giuseppe/I-2142-2013	Battaglia, Giuseppe/0000-0003-3349-6770; Hearnden, Vanessa/0000-0003-0838-7783; Blanazs, Adam/0000-0001-5956-0860; Canton, Irene/0000-0003-2768-4425; Armes, Steven/0000-0002-8289-6351	Biocompatibles ltd.	Biocompatibles ltd.	The present work was sponsored by Biocompatibles ltd. The funders, Biocompatibles, had no role in study design. However, Prof Lewis (co-author of the paper) from Biocompatibles has been involved in preparation of the manuscript. Some of the data were also reproduced within Biocompatibles laboratories. Prof Andrew Lewis is an employee of the commercial funder. This won't alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AMBROSE E. J., 1961, EXPTL CELL RES SUPPL, V8, P54, DOI 10.1016/0014-4827(61)90340-8; BATTAGLIA G, 2008, RAPID NONTOXIC INTRA; BATTAGLIA G, 2008, POLYMERSOMES NUCL AC; Bhargava S, 2004, BJU INT, V93, P807, DOI 10.1111/j.1464-410X.2003.04723.x; BRAKENHOFF GJ, 1979, J MICROSC-OXFORD, V117, P219, DOI 10.1111/j.1365-2818.1979.tb01178.x; Chakrabarty KH, 1999, BRIT J DERMATOL, V141, P811, DOI 10.1046/j.1365-2133.1999.03153.x; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; COLING D, 2001, CURR PROTOC MOL BIOL; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Du JZ, 2005, J AM CHEM SOC, V127, P12800, DOI 10.1021/ja054755n; Eves P, 2000, BRIT J DERMATOL, V142, P210, DOI 10.1046/j.1365-2133.2000.03287.x; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; GADELLA TWJ, 1993, BIOPHYS CHEM, V48, P221, DOI 10.1016/0301-4622(93)85012-7; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; HAUGLAND RP, 1999, Patent No. 19920919254; HAUGLAND RP, 1993, Patent No. 5362628; HEARNDEN V, 2008, EUR CELLS MATER, V16, P58; Hearnden V, 2009, PHARM RES-DORDR, V26, P1718, DOI 10.1007/s11095-009-9882-6; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Johnson I, 1998, HISTOCHEM J, V30, P123, DOI 10.1023/A:1003287101868; LANSINGTAYLOR D, 1980, NATURE, V284, P405; Lewis A, 2003, NAT BIOTECHNOL, V21, P1377, DOI 10.1038/nbt898; Lomas H, 2008, FARADAY DISCUSS, V139, P143, DOI 10.1039/b717431d; Lomas H, 2007, ADV MATER, V19, P4238, DOI 10.1002/adma.200700941; LoPresti C, 2009, J MATER CHEM, V19, P3576, DOI 10.1039/b818869f; MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664; MASSIGNANI M, 2009, IMMUNOPOLYM IN PRESS; Massignani M, 2009, SMALL, V5, P2424, DOI 10.1002/smll.200900578; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Robinson KL, 2002, J MATER CHEM, V12, P890, DOI 10.1039/b200348c; Schmidt T, 1996, P NATL ACAD SCI USA, V93, P2926, DOI 10.1073/pnas.93.7.2926; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2005.12.021; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Thompson R.B., 2006, FLUORESCENCE SENSORS; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	41	64	71	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10459	10.1371/journal.pone.0010459	http://dx.doi.org/10.1371/journal.pone.0010459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454666	Green Published, gold, Green Accepted			2022-12-25	WOS:000277240300025
J	Sehlmeyer, S; Wang, LZ; Langel, D; Heckel, DG; Mohagheghi, H; Petschenka, G; Ober, D				Sehlmeyer, Sven; Wang, Linzhu; Langel, Dorothee; Heckel, David G.; Mohagheghi, Hoda; Petschenka, Georg; Ober, Dietrich			Flavin-Dependent Monooxygenases as a Detoxification Mechanism in Insects: New Insights from the Arctiids (Lepidoptera)	PLOS ONE			English	Article							MOTH UTETHEISA-ORNATRIX; PYRROLIZIDINE ALKALOID BIOSYNTHESIS; AMINO-ACID-SEQUENCE; CYTOCHROME-P450 MONOOXYGENASES; HOMOSPERMIDINE SYNTHASE; DEOXYHYPUSINE SYNTHASE; DEFENSE-MECHANISMS; DROSOPHILA-MELANOGASTER; PHALAENOPSIS ORCHIDS; CATALYTIC-PROPERTIES	Insects experience a wide array of chemical pressures from plant allelochemicals and pesticides and have developed several effective counterstrategies to cope with such toxins. Among these, cytochrome P450 monooxygenases are crucial in plant-insect interactions. Flavin-dependent monooxygenases (FMOs) seem not to play a central role in xenobiotic detoxification in insects, in contrast to mammals. However, the previously identified senecionine N-oxygenase of the arctiid moth Tyria jacobaeae (Lepidoptera) indicates that FMOs have been recruited during the adaptation of this insect to plants that accumulate toxic pyrrolizidine alkaloids. Identification of related FMO-like sequences of various arctiids and other Lepidoptera and their combination with expressed sequence tag (EST) data and sequences emerging from the Bombyx mori genome project show that FMOs in Lepidoptera form a gene family with three members (FMO1 to FMO3). Phylogenetic analyses suggest that FMO3 is only distantly related to lepidopteran FMO1 and FMO2 that originated from a more recent gene duplication event. Within the FMO1 gene cluster, an additional gene duplication early in the arctiid lineage provided the basis for the evolution of the highly specific biochemical, physiological, and behavioral adaptations of these butterflies to pyrrolizidine-alkaloid-producing plants. The genes encoding pyrrolizidine-alkaloid-N-oxygenizing enzymes (PNOs) are transcribed in the fat body and the head of the larvae. An N-terminal signal peptide mediates the transport of the soluble proteins into the hemolymph where PNOs efficiently convert pro-toxic pyrrolizidine alkaloids into their non-toxic N-oxide derivatives. Heterologous expression of a PNO of the generalist arctiid Grammia geneura produced an N-oxygenizing enzyme that shows noticeably expanded substrate specificity compared with the related enzyme of the specialist Tyria jacobaeae. The data about the evolution of FMOs within lepidopteran insects and the functional characterization of a further member of this enzyme family shed light on this almost uncharacterized detoxification system in insects.	[Sehlmeyer, Sven; Mohagheghi, Hoda] TU Braunschweig, Inst Pharmaceut Biol, Braunschweig, Germany; [Wang, Linzhu; Langel, Dorothee; Ober, Dietrich] Univ Kiel, Inst Bot, D-2300 Kiel, Germany; [Wang, Linzhu; Langel, Dorothee; Ober, Dietrich] Univ Kiel, Bot Garden, D-2300 Kiel, Germany; [Heckel, David G.] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany; [Petschenka, Georg] Univ Hamburg, Inst Zool, D-2000 Hamburg, Germany	Braunschweig University of Technology; University of Kiel; University of Kiel; Max Planck Society; University of Hamburg	Sehlmeyer, S (corresponding author), TU Braunschweig, Inst Pharmaceut Biol, Braunschweig, Germany.	dober@bot.uni-kiel.de	Heckel, David G/K-2138-2013	Heckel, David G/0000-0001-8991-2150	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSIN M, 1987, DRUG METAB DISPOS, V15, P200; Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; Anke S, 2008, PLANT PHYSIOL, V148, P751, DOI 10.1104/pp.108.124859; [Anonymous], PHYLIP PHYLOGENY INF; Becker DP, 2006, J MED CHEM, V49, P1125, DOI 10.1021/jm0509501; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berenbaum MR, 1996, AM NAT, V148, pS139, DOI 10.1086/285907; BERGOMAZ R, 1986, Journal of the Lepidopterists' Society, V40, P131; Bezzerides A, 2004, P NATL ACAD SCI USA, V101, P9029, DOI 10.1073/pnas.0402480101; BLACKWELL JR, 1991, FEBS LETT, V295, P10, DOI 10.1016/0014-5793(91)81372-F; Cashman JR, 2005, BIOCHEM BIOPH RES CO, V338, P599, DOI 10.1016/j.bbrc.2005.08.009; CASHMAN JR, 1995, CHEM RES TOXICOL, V8, P165, DOI 10.1021/tx00044a001; CASHMAN JR, 2002, ENZYME SYSTEMS METAB, P67; CASPERS P, 1994, CELL MOL BIOL, V40, P635; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; CONNER WE, 1981, BEHAV ECOL SOCIOBIOL, V9, P227, DOI 10.1007/BF00302942; Conner WE, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P248, DOI 10.1017/CBO9780511542664.008; CONNER WE, 1990, J CHEM ECOL, V16, P543, DOI 10.1007/BF01021785; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; DUSSOURD DE, 1988, P NATL ACAD SCI USA, V85, P5992, DOI 10.1073/pnas.85.16.5992; EISNER T, 1995, P NATL ACAD SCI USA, V92, P50, DOI 10.1073/pnas.92.1.50; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Feyereisen R., 2005, P1; Frolich C, 2006, PHYTOCHEMISTRY, V67, P1493, DOI 10.1016/j.phytochem.2006.05.031; Fu PP, 2004, DRUG METAB REV, V36, P1, DOI 10.1081/DMR-120028426; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; GRUBOR VD, 2003, THESIS U MELBOURNE M; Guengerich F, 2002, ENZYME SYSTEMS METAB, P33; Hao D, 2009, GENETICA, V137, P173, DOI 10.1007/s10709-009-9382-y; HARE JF, 1993, OECOLOGIA, V96, P9, DOI 10.1007/BF00318024; Harrison TL, 2001, ARCH INSECT BIOCHEM, V48, P179, DOI 10.1002/arch.1070; Hartmann T, 2000, TOP CURR CHEM, V209, P207; Hartmann T, 2005, INSECT BIOCHEM MOLEC, V35, P1083, DOI 10.1016/j.ibmb.2005.05.011; Hartmann Thomas, 2008, P213, DOI 10.1007/978-1-4020-8182-8_10; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Hung CF, 1997, INSECT BIOCHEM MOLEC, V27, P377, DOI 10.1016/S0965-1748(97)00009-X; JEAN D, 1989, DEV GENET, V10, P220; KRASNOFF SB, 1989, J CHEM ECOL, V15, P1077, DOI 10.1007/BF01015201; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAWTON MP, 1994, ARCH BIOCHEM BIOPHYS, V308, P254, DOI 10.1006/abbi.1994.1035; Li WM, 2003, P NATL ACAD SCI USA, V100, P14593, DOI 10.1073/pnas.1934643100; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Lindigkeit R, 1997, EUR J BIOCHEM, V245, P626, DOI 10.1111/j.1432-1033.1997.00626.x; Mattocks A.R., 1986, CHEM TOXICOLOGY PYRR; Michalski C, 2008, J BIOL CHEM, V283, P19219, DOI 10.1074/jbc.M802236200; Narberhaus I, 2005, CHEMOECOLOGY, V15, P121, DOI 10.1007/s00049-005-0302-z; Naumann C, 2002, P NATL ACAD SCI USA, V99, P6085, DOI 10.1073/pnas.082674499; Nurhayati N, 2009, PHYTOCHEMISTRY, V70, P508, DOI 10.1016/j.phytochem.2009.01.019; Ober D, 1999, J BIOL CHEM, V274, P32040, DOI 10.1074/jbc.274.45.32040; Ober D, 1999, P NATL ACAD SCI USA, V96, P14777, DOI 10.1073/pnas.96.26.14777; OVERBY LH, 1995, ARCH BIOCHEM BIOPHYS, V317, P275, DOI 10.1006/abbi.1995.1163; Petersen RA, 2001, INSECT BIOCHEM MOLEC, V31, P679, DOI 10.1016/S0965-1748(00)00174-0; Reina M, 1997, PHYTOCHEMISTRY, V46, P845, DOI 10.1016/S0031-9422(97)00354-3; Rhoades DF, 1979, HERBIVORES THEIR INT, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scharf ME, 2004, ARCH INSECT BIOCHEM, V57, P28, DOI 10.1002/arch.20012; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Schulz Stefan, 2009, P145; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Singer MS, 2002, ANIM BEHAV, V64, P629, DOI 10.1006/anbe.2002.3082; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suh JK, 2000, ARCH BIOCHEM BIOPHYS, V381, P317, DOI 10.1006/abbi.2000.1965; Suh JK, 2000, P NATL ACAD SCI USA, V97, P121, DOI 10.1073/pnas.97.1.121; Suh JK, 1999, P NATL ACAD SCI USA, V96, P2687, DOI 10.1073/pnas.96.6.2687; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Weller SJ, 1999, BIOL J LINN SOC, V68, P557, DOI 10.1111/j.1095-8312.1999.tb01188.x; Zhang M, 2002, ARCH BIOCHEM BIOPHYS, V403, P277, DOI 10.1016/S0003-9861(02)00237-0; ZIEGLER DM, 1977, TRENDS BIOCHEM SCI, V2, P79, DOI 10.1016/0968-0004(77)90042-1; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650; ZIEGLER DM, 1993, ANNU REV PHARMACOL, V33, P179, DOI 10.1146/annurev.pharmtox.33.1.179	72	43	45	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10435	10.1371/journal.pone.0010435	http://dx.doi.org/10.1371/journal.pone.0010435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	20454663	Green Submitted, gold, Green Published			2022-12-25	WOS:000277240300011
J	Wong, MS; Sun, DS; Chang, HH				Wong, Ming-Show; Sun, Der-Shan; Chang, Hsin-Hou			Bactericidal Performance of Visible-Light Responsive Titania Photocatalyst with Silver Nanostructures	PLOS ONE			English	Article							FERRITE COMPOSITE NANOPARTICLES; ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; MAGNETIC CORE; INACTIVATION; SHELL; DISINFECTION; ANTIBIOTICS; RESISTANCE	Background: Titania dioxide (TiO2) photocatalyst is primarily induced by ultraviolet light irradiation. Visible-light responsive anion-doped TiO2 photocatalysts contain higher quantum efficiency under sunlight and can be used safely in indoor settings without exposing to biohazardous ultraviolet light. The antibacterial efficiency, however, remains to be further improved. Methodology/Principal Findings: Using thermal reduction method, here we synthesized silver-nanostructures coated TiO2 thin films that contain a high visible-light responsive antibacterial property. Among our tested titania substrates including TiO2, carbon-doped TiO2 [TiO2 (C)] and nitrogen-doped TiO2 [TiO2 (N)], TiO2 (N) showed the best performance after silver coating. The synergistic antibacterial effect results approximately 5 log reductions of surviving bacteria of Escherichia coli, Streptococcus pyogenes, Staphylococcus aureus and Acinetobacter baumannii. Scanning electron microscope analysis indicated that crystalline silver formed unique wire-like nanostructures on TiO2 (N) substrates, while formed relatively straight and thicker rod-shaped precipitates on the other two titania materials. Conclusion/Significance: Our results suggested that proper forms of silver on various titania materials could further influence the bactericidal property.	[Wong, Ming-Show] Natl Dong Hwa Univ, Dept Mat Sci & Engn, Hualien, Taiwan; [Wong, Ming-Show; Chang, Hsin-Hou] Natl Dong Hwa Univ, Nanotechnol Res Ctr, Hualien, Taiwan; [Sun, Der-Shan; Chang, Hsin-Hou] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chang, Hsin-Hou] Tzu Chi Univ, Ctr Vasc Med, Hualien, Taiwan	National Dong Hwa University; National Dong Hwa University; Tzu Chi University; Tzu Chi University	Wong, MS (corresponding author), Natl Dong Hwa Univ, Dept Mat Sci & Engn, Hualien, Taiwan.	hhchang@mail.tcu.edu.tw	Chang, Hsin-Hou/B-6225-2012	Chang, Hsin-Hou/0000-0002-8731-3485	National Science Council of Taiwan ROC [95-2314-B-320-009-MY3, 95-2120-M-259-003, 96-2221-E-259-010-MY3]; Ministry of Economic Affairs of Taiwan ROC [98-EC-17-A-19-S2-0111]	National Science Council of Taiwan ROC(Ministry of Science and Technology, Taiwan); Ministry of Economic Affairs of Taiwan ROC(Ministry of Economic Affairs, Taiwan)	This work was supported by National Science Council of Taiwan ROC under grant no. 95-2314-B-320-009-MY3, 95-2120-M-259-003 and 96-2221-E-259-010-MY3, and Ministry of Economic Affairs of Taiwan ROC under grant no. 98-EC-17-A-19-S2-0111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAHI R, 2001, SCIENCE, V269, P293; BERNARD BK, 1990, J TOXICOL ENV HEALTH, V29, P417, DOI 10.1080/15287399009531402; Butkus MA, 2004, APPL ENVIRON MICROB, V70, P2848, DOI 10.1128/AEM.70.5.2848-2853.2004; Chang CW, 2007, J BIOMED SCI, V14, P419, DOI 10.1007/s11373-007-9154-6; Chang JC, 2005, J BIOMED SCI, V12, P881, DOI 10.1007/s11373-005-9021-2; Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7; Choi JY, 2007, J BIOMED MATER RES B, V80B, P353, DOI 10.1002/jbm.b.30604; Dunn K, 2004, BURNS, V30, pS1, DOI 10.1016/S0305-4179(04)90000-9; Elechiguerra J.L., 2005, J NANOBIOTECHNOLOGY, V3, P6, DOI [10.1186/1477-3155-3-6, DOI 10.1186/1477-3155-3-6]; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400; Hu C, 2007, LANGMUIR, V23, P4982, DOI 10.1021/la063626x; Iroha IR, 2007, SCI RES ESSAYS, V2, P338; Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167; Kisch H, 2002, CHEMPHYSCHEM, V3, P399, DOI 10.1002/1439-7641(20020517)3:5<399::AID-CPHC399>3.0.CO;2-H; Li P, 2005, NANOTECHNOLOGY, V16, P1912, DOI 10.1088/0957-4484/16/9/082; Li Q, 2007, ENVIRON SCI TECHNOL, V41, P5050, DOI 10.1021/es062753c; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Matsui Y, 2004, MICROBIOL IMMUNOL, V48, P489, DOI 10.1111/j.1348-0421.2004.tb03541.x; Mitoraj D, 2007, PHOTOCH PHOTOBIO SCI, V6, P642, DOI 10.1039/b617043a; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Panyala NR, 2008, J APPL BIOMED, V6, P117, DOI 10.32725/jab.2008.015; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005; Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007; Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043; Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488; Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021; Rengifo-Herrera JA, 2008, APPL CATAL B-ENVIRON, V84, P448, DOI 10.1016/j.apcatb.2008.04.030; Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001; Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103; Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0; Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sun DS, 2005, J BIOMED SCI, V12, P321, DOI 10.1007/s11373-005-0979-6; Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002; Warheit DB, 2007, TOXICOLOGY, V230, P90, DOI 10.1016/j.tox.2006.11.002; Wong MS, 2008, J MOL CATAL A-CHEM, V279, P20, DOI 10.1016/j.molcata.2007.09.024; Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05; Yang GX, 2004, PLANT PHYSIOL BIOCH, V42, P1, DOI 10.1016/j.plaphy.2003.10.001; Yang TS, 2004, SURF SCI, V548, P75, DOI 10.1016/j.susc.2003.10.044; Yao Y, 2008, J BIOMED MATER RES B, V85B, P453, DOI 10.1002/jbm.b.30965	45	48	48	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2010	5	4							e10394	10.1371/journal.pone.0010394	http://dx.doi.org/10.1371/journal.pone.0010394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PU	20454454	gold, Green Submitted, Green Published			2022-12-25	WOS:000277240100010
J	Jarlestedt, K; Rousset, CI; Faiz, M; Wilhelmsson, U; Stahlberg, A; Sourkova, H; Pekna, M; Mallard, C; Hagberg, H; Pekny, M				Jarlestedt, Katarina; Rousset, Catherine I.; Faiz, Maryam; Wilhelmsson, Ulrika; Stahlberg, Anders; Sourkova, Hana; Pekna, Marcela; Mallard, Carina; Hagberg, Henrik; Pekny, Milos			Attenuation of Reactive Gliosis Does Not Affect Infarct Volume in Neonatal Hypoxic-Ischemic Brain Injury in Mice	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE-FILAMENTS; HYPOTONIC STRESS; ASTROCYTES; VIMENTIN; GFAP; REGENERATION; DEFICIENT; PCR; NEUROGENESIS	Background: Astroglial cells are activated following injury and up-regulate the expression of the intermediate filament proteins glial fibrillary acidic protein (GFAP) and vimentin. Adult mice lacking the intermediate filament proteins GFAP and vimentin (GFAP(-/-) Vim(-/-)) show attenuated reactive gliosis, reduced glial scar formation and improved regeneration of neuronal synapses after neurotrauma. GFAP(-/-) Vim(-/-) mice exhibit larger brain infarcts after middle cerebral artery occlusion suggesting protective role of reactive gliosis after adult focal brain ischemia. However, the role of astrocyte activation and reactive gliosis in the injured developing brain is unknown. Methodology/Principal Findings: We subjected GFAP(-/-) Vim(-/-) and wild-type mice to unilateral hypoxia-ischemia (HI) at postnatal day 9 (P9). Bromodeoxyuridine (BrdU; 25 mg/kg) was injected intraperitoneally twice daily from P9 to P12. On P12 and P31, the animals were perfused intracardially. Immunohistochemistry with MAP-2, BrdU, NeuN, and S100 antibodies was performed on coronal sections. We found no difference in the hemisphere or infarct volume between GFAP(-/-) Vim(-/-) and wild-type mice at P12 and P31, i.e. 3 and 22 days after HI. At P31, the number of NeuN(+) neurons in the ischemic and contralateral hemisphere was comparable between GFAP(-/-) Vim(-/-) and wild-type mice. In wild-type mice, the number of S100(+) astrocytes was lower in the ipsilateral compared to contralateral hemisphere (65.0 +/- 50.1 vs. 85.6 +/- 34.0, p<0.05). In the GFAP(-/-) Vim(-/-) mice, the number of S100(+) astrocytes did not differ between the ischemic and contralateral hemisphere at P31. At P31, GFAP(-/-) Vim(-/-) mice showed an increase in NeuN(+)BrdU(+) (surviving newly born) neurons in the ischemic cortex compared to wild-type mice (6.7 +/- 7.7; n = 29 versus 2.9 +/- 3.6; n = 28, respectively, p<0.05), but a comparable number of S100(+)BrdU(+) (surviving newly born) astrocytes. Conclusions/Significance: Our results suggest that attenuation of reactive gliosis in the developing brain does not affect the hemisphere or infarct volume after HI, but increases the number of surviving newborn neurons.	[Jarlestedt, Katarina; Mallard, Carina; Hagberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Perinatal Ctr, Gothenburg, Sweden; [Rousset, Catherine I.; Hagberg, Henrik] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Hagberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Obstet & Gynecol, Gothenburg, Sweden; [Pekna, Marcela] Univ Gothenburg, Sahlgrenska Acad, Dept Med Chem & Cell Biol, Inst Biomed, Gothenburg, Sweden; [Faiz, Maryam; Wilhelmsson, Ulrika; Stahlberg, Anders; Sourkova, Hana; Pekny, Milos] Univ Gothenburg, Ctr Brain Repair & Rehabil, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; Imperial College London; University of Gothenburg; University of Gothenburg; University of Gothenburg	Jarlestedt, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Perinatal Ctr, Gothenburg, Sweden.	Milos.Pekny@neuro.gu.se	Pekna, Marcela/AAM-3261-2021; Pekna, Marcela/AAM-3249-2021	Pekna, Marcela/0000-0003-2734-8237; Pekna, Marcela/0000-0003-2734-8237; Mallard, Carina/0000-0001-8953-919X; Wilhelmsson, Ulrika/0000-0003-3227-2687; Stahlberg, Anders/0000-0003-4243-0191; Faiz, Maryam/0000-0003-0671-3557; Hagberg, Henrik/0000-0003-3962-1448	Swedish Research Council [11548, 20116, 09455, 14185]; Medical Research Council (United Kingdom) [P19381]; LUA/ALF Gothenburg; Region of Vastra Gotaland; Ragnar and Torsten Soderberg's Foundations; Hjarnfonden; Edith Jacobsson's Foundation; John and Brit Wennerstrom's Foundation; W. and M. Lundgren's Foundation; A. and U. Amlov's Foundation; Free Mason Foundation; Swedish Stroke Foundation;  [ALFGBG7592];  [ALFGBG11267];  [ALFGBG2863]; MRC [G0802853] Funding Source: UKRI; Medical Research Council [G0802853] Funding Source: researchfish; Action Medical Research [1764] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); LUA/ALF Gothenburg; Region of Vastra Gotaland; Ragnar and Torsten Soderberg's Foundations; Hjarnfonden; Edith Jacobsson's Foundation; John and Brit Wennerstrom's Foundation; W. and M. Lundgren's Foundation; A. and U. Amlov's Foundation; Free Mason Foundation; Swedish Stroke Foundation; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research	This study was supported by the Swedish Research Council, 11548 ( M. P.), 20116 ( M. P.), 09455 ( H. H.), 14185 ( C. M.), Medical Research Council (United Kingdom) contract: P19381 ( H. H.), LUA/ALF Gothenburg, ALFGBG7592 ( M. P.), ALFGBG11267 ( M. P.), ALFGBG2863 ( H. H.), The Region of Vastra Gotaland ( RUN), Ragnar and Torsten Soderberg's Foundations, Hjarnfonden, Edith Jacobsson's Foundation, John and Brit Wennerstrom's Foundation for Neurological Research, W. and M. Lundgren's Foundation, A. and U. Amlov's Foundation, The Free Mason Foundation and the Swedish Stroke Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderova M, 2001, GLIA, V35, P189, DOI 10.1002/glia.1084; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Ding M, 1998, MOL BRAIN RES, V62, P77, DOI 10.1016/S0169-328X(98)00240-X; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Hagberg H, 2004, J BIOENERG BIOMEMBR, V36, P369, DOI 10.1023/B:JOBB.0000041770.00567.4f; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Hudome S, 1997, PEDIATR RES, V41, P607, DOI 10.1203/00006450-199705000-00002; Iwata-Ichikawa E, 1999, J NEUROCHEM, V72, P2334, DOI 10.1046/j.1471-4159.1999.0722334.x; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Johnston MV, 2005, BRAIN PATHOL, V15, P234; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; MCRAE A, 1995, DEV BRAIN RES, V84, P245, DOI 10.1016/0165-3806(94)00177-2; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2001, Prog Brain Res, V132, P23; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Sent E, 2006, MENT RETARD DEV D R, V12, P97, DOI 10.1002/mrdd.20106; Sheldon RA, 1998, BRAIN RES, V810, P114, DOI 10.1016/S0006-8993(98)00892-0; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Stahlberg A, 2005, EXPERT REV MOL DIAGN, V5, P221, DOI 10.1586/14737159.5.2.221; Sullivan SM, 2010, GLIA, V58, P181, DOI 10.1002/glia.20911; Vexler ZS, 2009, DEV NEUROSCI-BASEL, V31, P378, DOI 10.1159/000232556; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	32	47	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10397	10.1371/journal.pone.0010397	http://dx.doi.org/10.1371/journal.pone.0010397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442854	gold, Green Published, Green Submitted			2022-12-25	WOS:000277154200029
J	Masuda, H; Matsuzaki, Y; Hiratsu, E; Ono, M; Nagashima, T; Kajitani, T; Arase, T; Oda, H; Uchida, H; Asada, H; Ito, M; Yoshimura, Y; Maruyama, T; Okano, H				Masuda, Hirotaka; Matsuzaki, Yumi; Hiratsu, Emi; Ono, Masanori; Nagashima, Takashi; Kajitani, Takashi; Arase, Toru; Oda, Hideyuki; Uchida, Hiroshi; Asada, Hironori; Ito, Mamoru; Yoshimura, Yasunori; Maruyama, Tetsuo; Okano, Hideyuki			Stem Cell-Like Properties of the Endometrial Side Population: Implication in Endometrial Regeneration	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; BCRP1/ABCG2; CONTRIBUTE; MODEL	Background: The human endometrium undergoes cyclical regeneration throughout a woman's reproductive life. Ectopic implantation of endometrial cells through retrograde menstruation gives rise to endometriotic lesions which affect approximately 10% of reproductive-aged women. The high regenerative capacity of the human endometrium at eutopic and ectopic sites suggests the existence of stem/progenitor cells and a unique angiogenic system. The objective of this study was to isolate and characterize putative endometrial stem/progenitor cells and to address how they might be involved in the physiology of endometrium. Methodology/Principal Findings: We found that approximately 2% of the total cells obtained from human endometrium displayed a side population (SP) phenotype, as determined by flow cytometric analysis of Hoechst-stained cells. The endometrial SP (ESP) cells exhibited preferential expression of several endothelial cell markers compared to endometrial main population (EMP) cells. A medium specific for endothelial cell culture enabled ESP cells to proliferate and differentiate into various types of endometrial cells, including glandular epithelial, stromal and endothelial cells in vitro, whereas in the same medium, EMP cells differentiated only into stromal cells. Furthermore, ESP cells, but not EMP cells, reconstituted organized endometrial tissue with well-delineated glandular structures when transplanted under the kidney capsule of severely immunodeficient mice. Notably, ESP cells generated endothelial cells that migrated into the mouse kidney parenchyma and formed mature blood vessels. This potential for in vivo angiogenesis and endometrial cell regeneration was more prominent in the ESP fraction than in the EMP fraction, as the latter mainly gave rise to stromal cells in vivo. Conclusions/Significance: These results indicate that putative endometrial stem cells are highly enriched in the ESP cells. These unique characteristics suggest that ESP cells might drive physiological endometrial regeneration and be involved in the pathogenesis of endometriosis.	[Masuda, Hirotaka; Matsuzaki, Yumi; Hiratsu, Emi; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Masuda, Hirotaka; Ono, Masanori; Nagashima, Takashi; Kajitani, Takashi; Arase, Toru; Oda, Hideyuki; Uchida, Hiroshi; Asada, Hironori; Yoshimura, Yasunori; Maruyama, Tetsuo] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Ito, Mamoru] Cent Inst Expt Anim, Kanagawa, Japan	Keio University; Keio University	Masuda, H (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan.	penguin@sc.itc.keio.ac.jp; tetsuo@sc.itc.keio.ac.jp	UCHIDA, HIROSHI/AAB-2296-2019; Ono, Masanori/F-7443-2019	UCHIDA, HIROSHI/0000-0001-6148-7658; Ono, Masanori/0000-0001-9249-6813; Matsuzaki, Yumi/0000-0002-3729-2997	Ministry of Education, Science, and Culture of Japan; High-Tech Research Center in a Private University; Ministry of Education, Science, and Culture of Japan to Keio University	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High-Tech Research Center in a Private University; Ministry of Education, Science, and Culture of Japan to Keio University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported, in part, by the Ministry of Education, Science, and Culture of Japan (to T. M., Y.Y., and H. M.), by a National Grant-in-Aid for the Establishment of a High-Tech Research Center in a Private University (to T. M.) and by a grant-in-aid from the Global Centers of Excellence program of the Ministry of Education, Science, and Culture of Japan to Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bratincsak A, 2007, STEM CELLS, V25, P2820, DOI 10.1634/stemcells.2007-0301; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Critchley HOD, 2001, J CLIN ENDOCR METAB, V86, P1370, DOI 10.1210/jc.86.3.1370; Dabrosin C, 2002, AM J PATHOL, V161, P909, DOI 10.1016/S0002-9440(10)64251-4; Dimitrov R, 2008, REPRODUCTION, V135, P551, DOI 10.1530/REP-07-0428; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; FERENCZY A, 1976, AM J OBSTET GYNECOL, V124, P582, DOI 10.1016/0002-9378(76)90059-4; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Garry R, 2009, HUM REPROD, V24, P1393, DOI 10.1093/humrep/dep036; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hishikawa K, 2005, J CELL BIOL, V169, P921, DOI 10.1083/jcb.200412167; Hull ML, 2003, J CLIN ENDOCR METAB, V88, P2889, DOI 10.1210/jc.2002-021912; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Kato K, 2007, HUM REPROD, V22, P1214, DOI 10.1093/humrep/del514; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Mints M, 2008, HUM REPROD, V23, P139, DOI 10.1093/humrep/dem342; Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406; Okulicz W.C, 2002, ENDOMETRIUM, P110; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; PADYKULA HA, 1989, BIOL REPROD, V40, P681, DOI 10.1095/biolreprod40.3.681; Padykula HA, 1991, ANN N Y ACAD SCI, V622, P47, DOI 10.1111/j.1749-6632.1991.tb37849.x; PRIANISHNIKOV VA, 1978, CONTRACEPTION, V18, P213, DOI 10.1016/S0010-7824(78)80015-8; Salamonsen LA, 2003, REPRODUCTION, V125, P301, DOI 10.1530/rep.0.1250301; Sasson IE, 2008, ANN NY ACAD SCI, V1127, P106, DOI 10.1196/annals.1434.014; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; TIMMERMANS F, 2008, J CELL MOL MED; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Tsuji S, 2008, FERTIL STERIL, V90, P1528, DOI 10.1016/j.fertnstert.2007.08.005; Umemoto T, 2006, STEM CELLS, V24, P86, DOI 10.1634/stemcells.2005-0064; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Zhou S, 2003, BIOTECHNIQUES, V35, P1248, DOI 10.2144/03356ss04; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	38	198	215	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10387	10.1371/journal.pone.0010387	http://dx.doi.org/10.1371/journal.pone.0010387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442847	Green Published, Green Submitted, gold			2022-12-25	WOS:000277154200023
J	Witten, IB; Knudsen, PF; Knudsen, EI				Witten, Ilana B.; Knudsen, Phyllis F.; Knudsen, Eric I.			A Dominance Hierarchy of Auditory Spatial Cues in Barn Owls	PLOS ONE			English	Article							FREQUENCY-SPECIFIC ADJUSTMENTS; OPTIC TECTUM; BINAURAL INTERFERENCE; INFERIOR COLLICULUS; SPACE MAP; TYTO-ALBA; LOCALIZATION; MIDBRAIN; REPRESENTATION; RESPONSES	Background: Barn owls integrate spatial information across frequency channels to localize sounds in space. Methodology/Principal Findings: We presented barn owls with synchronous sounds that contained different bands of frequencies (3-5 kHz and 7-9 kHz) from different locations in space. When the owls were confronted with the conflicting localization cues from two synchronous sounds of equal level, their orienting responses were dominated by one of the sounds: they oriented toward the location of the low frequency sound when the sources were separated in azimuth; in contrast, they oriented toward the location of the high frequency sound when the sources were separated in elevation. We identified neural correlates of this behavioral effect in the optic tectum (OT, superior colliculus in mammals), which contains a map of auditory space and is involved in generating orienting movements to sounds. We found that low frequency cues dominate the representation of sound azimuth in the OT space map, whereas high frequency cues dominate the representation of sound elevation. Conclusions/Significance: We argue that the dominance hierarchy of localization cues reflects several factors: 1) the relative amplitude of the sound providing the cue, 2) the resolution with which the auditory system measures the value of a cue, and 3) the spatial ambiguity in interpreting the cue. These same factors may contribute to the relative weighting of sound localization cues in other species, including humans.	[Witten, Ilana B.; Knudsen, Phyllis F.; Knudsen, Eric I.] Stanford Univ, Med Ctr, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Witten, IB (corresponding author), Stanford Univ, Med Ctr, Dept Neurobiol, Stanford, CA 94305 USA.	eknudsen@stanford.edu			National Institutes of Health (NIH); National Science Foundation (NSF); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000155] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (NIH) and National Science Foundation (NSF) graduate research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best V, 2007, J ACOUST SOC AM, V121, P1070, DOI 10.1121/1.2407738; Blauert J., 1997, SPATIAL HEARING PSYC; Bregman AS, 1990, AUDITORY SCENE ANAL, pxiii; BUELL TN, 1991, J ACOUST SOC AM, V90, P1894, DOI 10.1121/1.401668; DeBello WM, 2004, J NEUROSCI, V24, P6853, DOI 10.1523/JNEUROSCI.0480-04.2004; Fischer BJ, 2007, J NEUROPHYSIOL, V98, P1181, DOI 10.1152/jn.00370.2007; Gold JI, 1999, J NEUROPHYSIOL, V82, P2197, DOI 10.1152/jn.1999.82.5.2197; Gold JI, 2000, J NEUROSCI, V20, P862, DOI 10.1523/JNEUROSCI.20-02-00862.2000; HELLER LM, 1995, J ACOUST SOC AM, V97, P1808, DOI 10.1121/1.413096; Heller LM, 1996, J ACOUST SOC AM, V99, P3632, DOI 10.1121/1.414961; Keller CH, 2005, J NEUROSCI, V25, P10446, DOI 10.1523/JNEUROSCI.2093-05.2005; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KNUDSEN EI, 1978, J NEUROPHYSIOL, V41, P870, DOI 10.1152/jn.1978.41.4.870; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; Koppl C, 1997, J NEUROSCI, V17, P3312; LICKLIDER JCR, 1950, J ACOUST SOC AM, V22; Litovsky RY, 1998, J NEUROPHYSIOL, V80, P1285, DOI 10.1152/jn.1998.80.3.1285; MANLEY GA, 1988, J NEUROSCI, V8, P2665; MCFADDEN D, 1976, J ACOUST SOC AM, V59, P634, DOI 10.1121/1.380913; MIDDLEBROOKS JC, 1989, J ACOUST SOC AM, V86, P89, DOI 10.1121/1.398224; PAYNE RS, 1971, J EXP BIOL, V54, P535; Pena JL, 2001, J NEUROSCI, V21, P9455, DOI 10.1523/JNEUROSCI.21-23-09455.2001; Proakis J. G., 2007, DIGITAL SIGNAL PROCE; Spitzer MW, 2006, J NEUROPHYSIOL, V95, P3571, DOI 10.1152/jn.00982.2005; Spitzer MW, 2004, J NEUROPHYSIOL, V92, P2051, DOI 10.1152/jn.01235.2003; TAKAHASHI TT, 1994, J NEUROSCI, V14, P4780; WAGNER H, 1987, J NEUROSCI, V7, P3105; WALLACH H, 1949, AM J PSYCHOL, V62, P315, DOI 10.2307/1418275; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P860, DOI 10.1121/1.1908495	29	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2010	5	4							e10396	10.1371/journal.pone.0010396	http://dx.doi.org/10.1371/journal.pone.0010396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589MV	20442852	Green Submitted, gold, Green Published			2022-12-25	WOS:000277154200028
J	Zhang, Y; Zhu, SL; Yan, DM; Liu, GY; Bai, RY; Wang, DY; Chen, L; Zhu, H; An, HQ; Kew, O; Xu, WB				Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Kew, Olen; Xu, Wenbo			Natural Type 3/Type 2 Intertypic Vaccine-Related Poliovirus Recombinants with the First Crossover Sites within the VP1 Capsid Coding Region	PLOS ONE			English	Article							POLIOMYELITIS; GENOMES; VIRUS; CHILD; CIRCULATION; SEROTYPE-2; SEQUENCES; OUTBREAK; MUTATION; STRAINS	Background: Ten uncommon natural type 3/type 2 intertypic poliovirus recombinants were isolated from stool specimens from nine acute flaccid paralysis case patients and one healthy vaccinee in China from 2001 to 2008. Principal Findings: Complete genomic sequences revealed their vaccine-related genomic features and showed that their first crossover sites were randomly distributed in the 39 end of the VP1 coding region. The length of donor Sabin 2 sequences ranged from 55 to 136 nucleotides, which is the longest donor sequence reported in the literature for this type of poliovirus recombination. The recombination resulted in the introduction of Sabin 2 neutralizing antigenic site 3a (NAg3a) into a Sabin 3 genomic background in the VP1 coding region, which may have been altered by some of the type 3-specific antigenic properties, but had not acquired any type 2-specific characterizations. NAg3a of the Sabin 3 strain seems atypical; other wild-type poliovirus isolates that have circulated in recent years have sequences of NAg3a more like the Sabin 2 strain. Conclusions: 10 natural type 3/type 2 intertypic VP1 capsid-recombinant polioviruses, in which the first crossover sites were found to be in the VP1 coding region, were isolated and characterized. In spite of the complete replacement of NAg3a by type 2-specific amino acids, the serotypes of the recombinants were not altered, and they were totally neutralized by polyclonal type 3 antisera but not at all by type 2 antisera. It is possible that recent type 3 wild poliovirus isolates may be a recombinant having NAg3a sequences derived from another strain during between 1967 and 1980, and the type 3/type 2 recombination events in the 39 end of the VP1 coding region may result in a higher fitness.	[Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Bai, Ruyin] Taishan Med Univ, Taishan City, Peoples R China; [Kew, Olen] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong First Medical University & Shandong Academy of Medical Sciences; Centers for Disease Control & Prevention - USA	Zhang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	National Key Technology R&D Program of China [2008BAI56B00]; National Key Science and Technology Projects of China [2008ZX10004-008]; World Health Organization [I8/181/978]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	National Key Technology R&D Program of China(National Key Technology R&D Program); National Key Science and Technology Projects of China; World Health Organization(World Health Organization); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Key Technology R&D Program of China (Project No. 2008BAI56B00), National Key Science and Technology Projects of China (Project No. 2008ZX10004-008), and a grant I8/181/978 from the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; BALANANT J, 1991, VIROLOGY, V184, P645, DOI 10.1016/0042-6822(91)90434-D; Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; Dedepsidis E, 2008, FEMS IMMUNOL MED MIC, V52, P343, DOI 10.1111/j.1574-695X.2008.00381.x; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-28; Friedrich F, 1996, ACTA VIROL, V40, P27; FURIONE M, 1993, VIROLOGY, V196, P199; HIRST GK, 1962, COLD SPRING HARB SYM, V27, P303, DOI 10.1101/SQB.1962.027.001.028; JARVIS TC, 1992, EMBO J, V11, P3135, DOI 10.1002/j.1460-2075.1992.tb05386.x; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Karakasiliotis L, 2004, MOL CELL PROBE, V18, P103, DOI 10.1016/j.mcp.2003.09.009; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KOHARA M, 1988, J VIROL, V62, P2828, DOI 10.1128/JVI.62.8.2828-2835.1988; KOHARA M, 1985, J VIROL, V53, P786, DOI 10.1128/JVI.53.3.786-792.1985; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; LIPSKAYA GY, 1991, J MED VIROL, V35, P290, DOI 10.1002/jmv.1890350415; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin J, 2002, J VIROL, V76, P10921, DOI 10.1128/JVI.76.21.10921-10928.2002; Martinez CV, 2004, J INFECT DIS, V190, P409, DOI 10.1086/421703; MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283; MINOR PD, 1989, J GEN VIROL, V70, P1117, DOI 10.1099/0022-1317-70-5-1117; MINOR PD, 1992, J GEN VIROL, V73, P3065, DOI 10.1099/0022-1317-73-12-3065; MINOR PD, 1993, DEV BIOL STAND, V78, P17; Minor P, 2009, VACCINE, V27, P2649, DOI 10.1016/j.vaccine.2009.02.071; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Shahmahmoodi S, 2008, VIRUS RES, V137, P168, DOI 10.1016/j.virusres.2008.07.006; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao ZX, 2010, VIRUS RES, V150, P56, DOI 10.1016/j.virusres.2010.02.014; TOYODA H, 1984, J MOL BIOL, V174, P561, DOI 10.1016/0022-2836(84)90084-6; VANDERAVOORT HGAM, 1995, J CLIN MICROBIOL, V33, P2562, DOI 10.1128/JCM.33.10.2562-2566.1995; WHO, 2004, POL LAB MAN; YANG CF, 1992, VIRUS RES, V24, P277, DOI 10.1016/0168-1702(92)90124-R; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zhang Y, 2010, J GEN VIROL, V91, P421, DOI 10.1099/vir.0.014258-0; Zhang Y, 2010, ARCH VIROL, V155, P197, DOI 10.1007/s00705-009-0564-9	43	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15300	10.1371/journal.pone.0015300	http://dx.doi.org/10.1371/journal.pone.0015300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	20463924	Green Published, gold, Green Submitted			2022-12-25	WOS:000285576900026
J	Zhang, Y; Schulte, W; Pink, D; Phipps, K; Zijlstra, A; Lewis, JD; Waisman, DM				Zhang, Yi; Schulte, Wendy; Pink, Desmond; Phipps, Kyle; Zijlstra, Andries; Lewis, John D.; Waisman, David Morton			Sensitivity of Cancer Cells to Truncated Diphtheria Toxin	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; FACTOR FUSION PROTEIN; GROWTH-FACTOR; DENILEUKIN DIFTITOX; CYNOMOLGUS MONKEYS; MOUSE MODEL; IN-VIVO; EXPRESSION; CYTOTOXICITY	Background: Diphtheria toxin (DT) has been utilized as a prospective anti-cancer agent for the targeted delivery of cytotoxic therapy to otherwise untreatable neoplasia. DT is an extremely potent toxin for which the entry of a single molecule into a cell can be lethal. DT has been targeted to cancer cells by deleting the cell receptor-binding domain and combining the remaining catalytic portion with targeting proteins that selectively bind to the surface of cancer cells. It has been assumed that "receptorless'' DT cannot bind to and kill cells. In the present study, we report that "receptorless'' recombinant DT385 is in fact cytotoxic to a variety of cancer cell lines. Methods: In vitro cytotoxicity of DT385 was measured by cell proliferation, cell staining and apoptosis assays. For in vivo studies, the chick chorioallantoic membrane (CAM) system was used to evaluate the effect of DT385 on angiogenesis. The CAM and mouse model system was used to evaluate the effect of DT385 on HEp3 and Lewis lung carcinoma (LLC) tumor growth, respectively. Results: Of 18 human cancer cell lines tested, 15 were affected by DT385 with IC(50) ranging from 0.12-2.8 mu M. Furthermore, high concentrations of DT385 failed to affect growth arrested cells. The cellular toxicity of DT385 was due to the inhibition of protein synthesis and induction of apoptosis. In vivo, DT385 diminished angiogenesis and decreased tumor growth in the CAM system, and inhibited the subcutaneous growth of LLC tumors in mice. Conclusion: DT385 possesses anti-angiogenic and anti-tumor activity and may have potential as a therapeutic agent.	[Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Schulte, Wendy; Pink, Desmond; Zijlstra, Andries; Lewis, John D.] Innovascreen Inc, Halifax, NS, Canada; [Zijlstra, Andries] Vanderbilt Univ, Dept Pathol, Nashville, TN USA; [Lewis, John D.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Dalhousie University; Dalhousie University; Vanderbilt University; Western University (University of Western Ontario)	Zhang, Y (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	david.waisman@dal.ca	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation [018176]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Nova Scotia Health Research Foundation (NSHRF). YZ is supported by a studentship from the Cancer Research Training Program, Dalhousie University. JDL is supported by grant #018176 from the NCIC/Terry Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley RG, 2003, CANCER RES, V63, P5866; BENITEZKING G, 1989, J CELL SCI, V93, P53; Black JH, 2003, LEUKEMIA, V17, P155, DOI 10.1038/sj.leu.2402744; CHADWICK DE, 1993, LEUKEMIA LYMPHOMA, V11, P249, DOI 10.3109/10428199309087002; Chan CH, 1996, BLOOD, V88, P1445, DOI 10.1182/blood.V88.4.1445.bloodjournal8841445; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Cohen KA, 2004, LEUKEMIA LYMPHOMA, V45, P1647, DOI 10.1080/10428190410001663572; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; Duvic M, 2008, FUTURE ONCOL, V4, P457, DOI 10.2217/14796694.4.4.457; Falnes PO, 1998, EMBO J, V17, P615, DOI 10.1093/emboj/17.2.615; Feuring-Buske M, 2000, EXP HEMATOL, V28, P1390, DOI 10.1016/S0301-472X(00)00542-7; FITZGERALD D, 1989, J NATL CANCER I, V81, P1455, DOI 10.1093/jnci/81.19.1455; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GILL DM, 1973, J BIOL CHEM, V248, P654; Gonzalez-Moreno O, 2005, INT J CANCER, V114, P870, DOI 10.1002/ijc.20789; Hall PD, 1999, LEUKEMIA, V13, P629, DOI 10.1038/sj.leu.2401357; Hogge DE, 2006, CLIN CANCER RES, V12, P1284, DOI 10.1158/1078-0432.CCR-05-2070; HONJO T, 1971, J BIOL CHEM, V246, P4251; Hotchkiss CE, 1999, TOXICOL APPL PHARM, V158, P152, DOI 10.1006/taap.1999.8691; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; KIND C, 1975, ANAT EMBRYOL, V147, P127, DOI 10.1007/BF00306727; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kwon M, 2001, BIOCHEMISTRY-US, V40, P13246, DOI 10.1021/bi0113420; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; MADSHUS IH, 1992, CURR TOP MICROBIOL, V175, P1; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; MOYNIHAN MR, 1981, INFECT IMMUN, V32, P575, DOI 10.1128/IAI.32.2.575-582.1981; MURPHY JR, 1986, P NATL ACAD SCI USA, V83, P8258, DOI 10.1073/pnas.83.21.8258; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; PAPPENHEIMER AM, 1993, PROTEIN SCI, V2, P292; Ramage JG, 2003, LEUKEMIA RES, V27, P79, DOI 10.1016/S0145-2126(02)00077-2; Ramakrishnan S, 1996, CANCER RES, V56, P1324; Turturro F, 2007, EXPERT REV ANTICANC, V7, P11, DOI 10.1586/14737140.7.1.11; Urieto JO, 2004, PROTEIN EXPRES PURIF, V33, P123, DOI 10.1016/j.pep.2003.09.003; Wild R, 2004, BREAST CANCER RES TR, V85, P161, DOI 10.1023/B:BREA.0000025407.02896.ec; WILLIAMS DP, 1990, J BIOL CHEM, V265, P20673; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	40	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10498	10.1371/journal.pone.0010498	http://dx.doi.org/10.1371/journal.pone.0010498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463924	Green Submitted, Green Published, gold			2022-12-25	WOS:000277379400031
